<SEC-DOCUMENT>0001193125-25-220421.txt : 20250926
<SEC-HEADER>0001193125-25-220421.hdr.sgml : 20250926
<ACCEPTANCE-DATETIME>20250926160057
ACCESSION NUMBER:		0001193125-25-220421
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		100
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250926
DATE AS OF CHANGE:		20250926

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lite Strategy, Inc.
		CENTRAL INDEX KEY:			0001262104
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				510407811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41827
		FILM NUMBER:		251350352

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-369-7100

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEI Pharma, Inc.
		DATE OF NAME CHANGE:	20120629

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARSHALL EDWARDS INC
		DATE OF NAME CHANGE:	20030902
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>lits-20250630.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-09-26T15:24:38.1978+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:lits="http://litestrategy.com/20250630" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_8b0c33e1-cfa0-4fed-8816-08de9d856383" name="dei:DocumentFiscalPeriodFocus" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07">FY</ix:nonNumeric><ix:nonNumeric id="F_f56f3522-384a-4bd7-ad81-4686c43c3bd4" name="dei:EntityCentralIndexKey" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07">0001262104</ix:nonNumeric><ix:nonNumeric id="F_49c0e231-c7b9-4db0-9427-d64700ca3649" name="dei:AmendmentFlag" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07">false</ix:nonNumeric><ix:nonFraction id="F_4abf2385-31d7-4f40-98f7-48e586e0041c" name="us-gaap:CommitmentsAndContingencies" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_9575a425-5462-4e8e-92d8-a90e668798ea" name="us-gaap:CommitmentsAndContingencies" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_75abda38-a80b-45e0-b57c-64913feff94d" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_8bbbca48-d932-4c1f-9137-b00bdcc4ecdb">P3Y</ix:nonNumeric><ix:nonNumeric id="F_10d9387d-fef2-414e-8898-e24c8f8f9759" name="us-gaap:LeaseExpirationDate1" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07">2028-03-31</ix:nonNumeric><ix:nonNumeric id="F_bee66b44-7fcb-482f-938b-2dcb4681b6b7" name="us-gaap:LeaseExpirationDate1" contextRef="C_36dd6fec-f2fe-427e-a87d-51412c3f9ec9">2028-03-31</ix:nonNumeric><ix:nonNumeric id="F_2254fbc2-926d-4ef0-b4be-2c017a79ef44" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember http://fasb.org/srt/2025#ChiefFinancialOfficerMember</ix:nonNumeric><ix:nonFraction id="F_b5129ee1-cc18-4e29-a225-35da57c0a01a" name="us-gaap:NumberOfOperatingSegments" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">One</ix:nonFraction><ix:nonNumeric id="F_471041f0-6337-4d57-89cb-a763e2396550" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" contextRef="C_417b9e3c-996d-4ced-8745-037e7a936560" format="ixt:date-month-day-year">07-22-2030</ix:nonNumeric><ix:nonNumeric id="F_da2a1c44-7a41-4557-8068-3921e2100485" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" contextRef="C_db8a5320-d917-40b0-808a-594d2f634033" format="ixt:date-month-day-year">07-22-2030</ix:nonNumeric><ix:nonNumeric id="F_e6417c3a-45fe-44f8-aa59-aea60d182067" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" contextRef="C_3bdebc26-b1ff-4f0d-9742-becf52c22f69" format="ixt:date-month-day-year">07-22-2030</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="lits-20250630.xsd"/></ix:references><ix:resources><xbrli:context id="C_801bb470-1666-486b-9626-f457beb6c0e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8324ec45-0eb9-4638-b615-b1ee584086e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:StrategicAdvisorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_84359d17-853f-46e4-b937-cd4a49546ae7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_85f05b2c-f599-4c78-bc7d-791065172d82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_87078fb9-2267-4137-924d-3f4e8270a7ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_870e143e-2c95-4ffb-9924-d47b9fd9da81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-17</xbrli:startDate><xbrli:endDate>2025-07-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_890346b8-8f3f-4053-845e-8155a5f5e602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_89a3be5d-5e0b-4c67-94dd-9a9af04f8589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-02</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8bbbca48-d932-4c1f-9137-b00bdcc4ecdb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e54884a-d867-4942-80ac-35ef13f92073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:METhreeFourFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f477f08-619a-4dd4-bf96-14b4f5bbc093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">lits:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8fb49a6d-13d9-4bc0-8564-85ae7e671e0d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:METhreeFourFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_901ccdf2-1321-455f-9644-864349d54328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_90b552c8-e654-4d0a-8162-fa00aec0af5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_93b9e9e8-1270-4323-afb0-75af92765160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94b1e5ac-8b72-4ae2-99a3-f4cb17a258fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_96669720-7ee3-4ea8-afce-e422997f939e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_967fee19-8d30-4bd1-968e-c52107261bbc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_983ed5f1-6f8b-49fe-952b-3b1ada647fbb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_98cbe3d9-5dfd-438f-a31c-71c63b05ef14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">lits:RevenueFromCollaborationAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d600850-46b8-413c-9e85-0dc26debca2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9de02997-3191-4520-97dc-7a314cccb702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-14</xbrli:startDate><xbrli:endDate>2023-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e2c011a-0538-44df-bed0-dea64b704da8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f90a9a5-a66d-4313-8307-9321f5ab31b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9fad389a-e538-433a-b7d3-4a232940c916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a06c0f95-2711-45fa-8758-3af29c6ca47e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-17</xbrli:startDate><xbrli:endDate>2025-07-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a389e895-814a-41cb-8aac-4d799cc61fe6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-02</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5fffeed-2536-49c6-8e93-f0cbbb5cdefa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-08</xbrli:startDate><xbrli:endDate>2025-08-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6339fc6-e7e2-479d-814d-64200ed7d803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aa5f4327-ba0e-4b78-9b28-61fb4396f64d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa875931-fb24-4796-91f3-c3924bcf1ebb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2d601f8-e5d6-44a2-a04a-f2df09be09f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7080d02-4c79-40ef-9fa1-ea37d0856660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b8e64ad8-9663-44a6-afdd-eb5bc7829282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b9008131-b16c-4d88-88b8-b98335565844"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bbdcc299-39eb-4e27-b604-ab146bacfa01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:TwoThousandAndEightOmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf2d5251-793c-4326-8260-9fc5c59df6da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c80491ff-d878-4596-938d-77d3e4dc6ba0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb253871-f434-42be-badc-455136d75117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf8f1efe-c282-41f0-90aa-477e9df58d2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-20</xbrli:startDate><xbrli:endDate>2024-02-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cfc6a080-d7ad-48cf-9593-13de2e93cbdd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d153b937-6a62-4ec2-97ea-eb68558e59ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-18</xbrli:startDate><xbrli:endDate>2025-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d190719d-ba9d-4549-9346-f6c2c6a02045"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-23</xbrli:startDate><xbrli:endDate>2025-09-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2e5d3c1-839a-4550-89aa-0ed3da951bff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d31b2e6f-0ff1-46fd-864d-d501e482dc79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d3e5d951-4348-4f5f-b2be-82d3b6a4f3ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lits:SanDiegoCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d5b61db4-8dab-4058-ac3f-a2da29438702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db6f4ce3-b159-4f84-a6ec-7529098c2c22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db8a5320-d917-40b0-808a-594d2f634033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AssetManagementAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dcba7e4a-11d0-4a3e-b398-fd6721e793ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dd4f6857-b631-463e-8ad2-bfe9435bf776"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:JustinJFileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dfabb534-74be-4288-92af-5556895040ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e1e0a909-dd46-42bb-8478-62d44158460b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e3b3e1bb-0d52-409c-8d44-386e016474a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7db8cf6-cb55-4ae2-94f9-5eb5ba8827f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:BeigeneLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e8ae3059-8bf8-46fc-9780-e37bde448693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e968e6a1-e1dc-4b6b-b7eb-2349e035aa81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-22</xbrli:startDate><xbrli:endDate>2024-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e9c5cddf-20f7-4aeb-a9be-fe852d96546b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb4c8b50-1cde-40b3-95ce-38094a76fdac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eb55a398-d9e2-4bc4-b646-4c8ff5f95e44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eb963958-2863-459f-bc33-6b787def5d3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ebb8eacd-9a9f-4b19-8cc4-c8435984244b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">lits:PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ec033cf6-6de4-4e18-90c4-48d44d401981"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eebe7de3-feed-4cd9-8e5d-19e4577417b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:StrategicAdvisorAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_efee07f7-2a59-42fe-b86a-e2563b5f1277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">lits:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0b7c1b2-6b39-4391-a802-da6e61227686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-31</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f12fbef6-72e6-4260-86e6-fc02f15df7a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">lits:O2024Q2DividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3472b73-4e34-47a0-be62-77eed918f8bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-18</xbrli:startDate><xbrli:endDate>2024-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f738a573-a0f1-4605-bcb6-b67c8411a1fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-02</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fa1c20a4-edb7-43ee-b979-1cf83c11f686"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbc3fa56-1138-411a-86db-d0f5176a096d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-01</xbrli:startDate><xbrli:endDate>2017-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fcab84f5-286d-44a9-a098-875d5677014f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_03a52d86-9327-469f-9cca-e384b91706f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_046dad52-7060-4b22-a684-7b4095cf956f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">lits:IncrementalPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07682bb1-2b3e-4319-8e57-ef12c2e28266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-15</xbrli:startDate><xbrli:endDate>2025-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_07f286c0-e5a6-4c38-9799-941180c82a4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08b96565-9169-4635-945d-9321b9c399be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08fe00f6-b289-43d7-b3de-b6f4be2b0660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09f1e527-d411-49b0-8987-c4eeed8a7d14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a639547-5eb3-4035-a49b-df9413032521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b16e06a-f891-41fa-a61d-1dcab0a16b52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b90534f-7f35-47c8-a101-7fbee1ae76c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0c124857-32c7-4d51-83ca-319184ab60ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-17</xbrli:startDate><xbrli:endDate>2025-07-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0eba68b0-9adf-4ac8-8967-f51e2cef9d7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0f41c2fa-b332-4ddf-b708-46d3bd043fa7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_17b85b55-1836-4eb6-8ee3-7afafbc45023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:StrategicAdvisorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1d242087-6da3-4ba4-9ecd-f789815f32a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d85b2ba-2068-4a8d-b780-07d1f807c029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_21e223f0-5d79-475c-a98b-446086b5ce4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23b7781d-5a70-4950-ab3d-ed36fea479a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2537ecc2-706a-441e-abb0-6c81823b2c71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2847194b-f51e-4d7d-8f4b-3169aeb8ad38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_28d2a101-457d-43c9-9dbe-68711aac1f9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c0b1dcd-adce-47b9-ae07-a9ae57be522c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AssetManagementAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2d40854b-8b85-47ad-ae8c-ed3f241c7c66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f5d0c47-45b0-40b0-8304-92a36ee32203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_303a0d36-3cb7-4d85-bdff-8bcece057b3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31fc6baf-8276-4e06-a067-f35d671133c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32364034-e8a2-411c-b37e-a487f90ff512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32d99983-1b3d-4c08-8e53-fb1cf89c3852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-06</xbrli:startDate><xbrli:endDate>2023-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32df5392-7969-40b6-9827-2e4cab47aa33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_365bd362-44cf-4f5e-882d-def50fff7f57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36dd6fec-f2fe-427e-a87d-51412c3f9ec9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37467610-00f1-43d7-b2ec-970dbeaab385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:JustinJFileMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_39b6c9ec-a171-463c-827e-3d4ee41454a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ad957d5-2461-4ae3-9be5-d6b77b9afb1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-09-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3b1ff24a-8449-4e09-abf5-5f426b41e513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:DevelopmentServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:KkcAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3b4342ff-1351-43aa-bf51-fe4957ccc32c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3bdebc26-b1ff-4f0d-9742-becf52c22f69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AdvisoryAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d482d2c-7007-47bd-bd9f-a3222d384265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e7dfd70-bc4a-4b0f-89af-eaa0c4be659f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3e8cceec-9f3f-4c61-8560-6f8645289b52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:TwoThousandAndEightOmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f481bc3-5122-47d6-b340-52e2c78f1b31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3fc533f8-752c-4ec5-904f-8e635dc124f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4022bccc-441f-4478-9790-7dc6fba82efc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4038fe7e-0797-4545-9817-044b66f01547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_417b9e3c-996d-4ced-8745-037e7a936560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_42469529-12e3-4edc-a0e6-3a47d45ab69f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:TheSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-20</xbrli:startDate><xbrli:endDate>2024-02-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4477116c-5b49-4100-b4a7-28181e73d4e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lits:TorreyaPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44c9191d-9975-403e-a883-48ca3b8d97f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4599d307-ed5c-4842-ac28-146c1c1c5cbd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">lits:AssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-22</xbrli:startDate><xbrli:endDate>2024-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_45f6bbd9-6d25-4221-88e3-beeb4bcc1f68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-02</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_47d0895f-dcab-4868-bb7e-4888006739cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_496692d5-8b11-4647-b7db-ff47b1d1be07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_498df639-b914-4e6f-a5bd-5f79abcd206f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a72990a-99c7-448b-bc43-8b9348a0a984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4aadd502-4418-4743-994c-0a56dc532d10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4dfa8660-229c-4efc-b1ce-209781894ed6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:UsLicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:KkcAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f503b69-15af-4b8f-a96a-caa0ddcce497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_55a276dd-3278-431b-bb6a-72afcf0a97f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57a12f24-8485-49fc-8a47-a37e1dd17d35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_588ef89b-8dde-48fe-9eb4-42e303780ef8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5c746096-0191-4a12-b56d-6cedc776485d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5da12cd1-97de-4b4d-b577-ec7e3184e27c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-02</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5de81fb4-2434-47f3-8fae-5c41690c6230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:VoruciclibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5eb52ed6-f76b-48ea-a2e5-62167666a0fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5fb23a8d-14cb-4175-877b-89e01b2aff80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60c2b2ea-9737-4be7-9d43-b2cdb939b23d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_65ce1f21-fab6-461d-b692-0bcf9b01d489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_68bebf1e-062c-4c48-8787-5346a1c6828d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6b9d4b1e-ad8f-4235-877b-c5777163e5ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d37e90f-283f-41b0-b124-b327504c907e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:TheSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-22</xbrli:startDate><xbrli:endDate>2025-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e8266ff-577a-497b-a576-2b0ca18d975a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">lits:RevenueFromCollaborationAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6f868094-4e34-494e-b2e9-24e875f17c58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6fd2496a-603e-4079-bd68-56583b109120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_71ae9d25-7183-44c7-86d1-e4821a8dc42d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_782d4804-c6b3-4521-80f5-fc558e241284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78b08baa-a398-4c87-8856-dccadb025d83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7bc39535-b788-4030-8e06-f7b6e0eac901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c38ad79-231e-469a-9a63-b80988a7ff5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c7a543b-cf8d-4e11-8cd1-eb898eaf4c1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:LegalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7d0e8349-e426-46da-ab51-1707c24a1af7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:JustinJFileMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d14d4db-d882-45a5-8109-0ae6bd9376fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:VoruciclibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d1dd293-c91b-41db-ae9c-cff76e94081f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">lits:AssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e65b259-8510-471f-b0d9-635c29c62a42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7ee6ad01-be31-465e-9644-4d6400b09ee1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">lits:PassThroughServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7fd455f4-c990-45c2-b727-b3da37aaffb0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7fda2453-8aa5-405b-b3ee-795a3fca2cda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>lits:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_c0357743-16b9-4466-828d-a177877f67f6" fromRefs="F_f4e683b4-eea6-4c3b-91ee-2e4e849aa6a2"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_4cf4506a-9cb5-4411-a0e1-ff4c3f4d43e7" fromRefs="F_ff070178-64d3-451b-afc0-28aaa364dc42"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_457d9bd2-0d55-4b6e-a5ce-4e011cdc6cae" fromRefs="F_92c3a739-20a7-4fb8-b471-9586192be188 F_7a425758-0352-4dbc-bf50-c6ed7dd8ba32"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_8630c987-7a19-4c14-a093-626d0f0d4875" fromRefs="F_6672378b-77c3-44f1-871c-5952bed8854f F_d33196ca-3de0-4094-82d0-c8df56d8e926"/></ix:resources></ix:header></div>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="margin-left:41.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;margin-right:41.417%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1936cd8c-aabf-4ce4-a7e2-9ff740c0b05e" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p><p style="margin-left:41.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;margin-right:41.417%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;box-sizing:content-box;"/>
     <td style="width:95.84%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="font-size:11pt;"><ix:nonNumeric id="F_053e6e05-7746-413e-8ab0-8667de659cc7" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f454bd0c-f0cf-4a79-a753-8acfeb501d12" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_72397549-909b-4c70-b91f-852333ab4191" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2490b6b1-712e-4686-bb1a-eabfb1834acf" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025</span></ix:nonNumeric></span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;box-sizing:content-box;"/>
     <td style="width:95.84%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="font-size:11pt;"><ix:nonNumeric id="F_d7b5e082-df92-4049-ad32-621aa3f8b0d2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the transition period from </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                    </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                    </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number: </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_071511cf-7d0e-4a60-8dfb-d3f028b8c6ca" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">000-50484</span></ix:nonNumeric></span></p><p style="margin-left:41.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;margin-right:41.417%;text-align:center;" id="fis_unidentified_table"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ebad043-ab0e-46bd-be03-36c551385f48" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p><p style="margin-left:41.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;margin-right:41.417%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50.44%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:48.4%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_a89ab4b9-d655-4573-add5-61de488234f8" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_f277a69b-5bde-4d7e-af9d-e1102f2debad" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">51-0407811</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aece8f20-10c4-418c-a5ea-e041ec6b832e" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9920 Pacific Heights Blvd</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d22c4eb3-c075-4ccf-95ac-f8ad0f047e6f" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Suite 150</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_39bf79fb-a086-466f-94d1-49fec7b958a2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41585427-3077-4eb3-8611-c8d3a2711140" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ac2e2445-2a30-4c7a-88f5-d0fdc388b0a5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92121</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices) (Zip Code)</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6330ed5f-e60c-422d-95d1-8a7c58a863c5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">858</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5111de49-a856-4bb8-a3d2-33016086052b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">369-7100</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code)</span></p><p style="margin-left:41.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;margin-right:41.417%;text-align:center;" id="fis_unidentified_table_2"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.873%;box-sizing:content-box;"/>
     <td style="width:1.18%;box-sizing:content-box;"/>
     <td style="width:31.894%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:31.894%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Symbol</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">on which registered</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span><ix:nonNumeric id="F_7cd43ff9-a177-4b9a-9726-0d34a4c13143" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock, $</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">0.00000002</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> par value</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_a51c57a8-743f-46a2-bb23-d58ae041404b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LITS</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:9pt;"><ix:nonNumeric id="F_53fed102-8085-47b7-8bb7-cf2f5ad1e42a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;Stock Market LLC</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act:</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Title of Class)</span></p><p style="margin-left:41.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;margin-right:41.417%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by a check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  &#9744;    </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_00fb045b-91c9-4845-b349-5cd05f2a2d2a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  &#9746;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="eolpage2"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by a check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  &#9744;    </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77d1be78-4b0b-4f06-844e-a103b4e48081" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  &#9746;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2bc7c17a-6cb2-4dae-9372-08cf2d377d68" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  &#9746;    No  &#9744;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f3800a66-f73a-4045-aad8-0f44591984b5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  &#9746;    No  &#9744;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_unidentified_table_3"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:23%;box-sizing:content-box;"/>
     <td style="width:2.2%;box-sizing:content-box;"/>
     <td style="width:17.16%;box-sizing:content-box;"/>
     <td style="width:3%;box-sizing:content-box;"/>
     <td style="width:28%;box-sizing:content-box;"/>
     <td style="width:24.56%;box-sizing:content-box;"/>
     <td style="width:2.08%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_34b92d3e-071a-4bec-baca-244076b974e3" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_f6d125e7-533b-4953-ac49-7a45b01a067f" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_e591a1f4-3a0c-4972-9d2a-30c7de52c2cc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e99911b-1c57-4fea-b594-6f0e27df38f7" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_999367fd-6b44-4ebd-a305-8f857725a7da" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to </span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#167;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">240.10D-1(b).  &#9744;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  &#9744;    No  </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a94c5ee5-f320-4e48-82fa-0e6fb6ec5fba" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates, based on the closing price per share of Registrant's Common Stock on the Nasdaq Capital Market was approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_159b5798-1aad-47e3-9b48-3e3cf97fceed" contextRef="C_0b90534f-7f35-47c8-a101-7fbee1ae76c8" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of September 23, 2025, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf27d54c-16a4-4d72-af28-5ef38684b2bf" contextRef="C_08fe00f6-b289-43d7-b3de-b6f4be2b0660" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">35,655,155</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the registrant&#8217;s common stock, par value $0.00000002 per share, outstanding.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="toc_page"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> CONTENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:9.038%;box-sizing:content-box;"/>
     <td style="width:1.14%;box-sizing:content-box;"/>
     <td style="width:82.723%;box-sizing:content-box;"/>
     <td style="width:1.26%;box-sizing:content-box;"/>
     <td style="width:1.4%;box-sizing:content-box;"/>
     <td style="width:3.439%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.333%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.875pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_1"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART I</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_2"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_3"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_4"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_5"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_6"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_7"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_8"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART II</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_9"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_10"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved]</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_11"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7a:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_12"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures about Market Risk</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_13"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_14"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_15"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_16"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#item_9c"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_17"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART III</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_18"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_19"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_20"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_21"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions and Director Independence</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_22"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_23"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART IV</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_24"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;text-indent:9pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="text-indent:-1.697%;padding-left:1.667%;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_toc58841_25"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K (Annual Report) includes forward-looking statements, which involve a number of risks and uncertainties. These forward-looking statements can generally be identified as such because the context of the statement will include words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; or &#8220;opportunity,&#8221; the negative of these words or other similar words. Similarly, statements that describe our future plans, strategies, intentions, expectations, objectives, goals or prospects and other statements that are not historical facts are also forward-looking statements. Discussions containing these forward-looking statements may be found, among other places, in &#8220;Business&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in this Annual Report. For such statements, we claim the protection of the Private Securities Litigation Reform Act of 1995. Readers of this Annual Report are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the time this Annual Report was filed with the Securities and Exchange Commission, or SEC. These forward-looking statements are based largely on our expectations and projections about future events and future trends affecting our business and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. These risks and uncertainties include, without limitation, those discussed in &#8220;Risk Factors&#8221; and in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of this Annual Report. Other sections of this report and our other filings with the SEC may include additional factors which could adversely impact our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. There is substantial uncertainty regarding the impact of activist investors, current or expected inflation rates and fluctuating interest rates as a result and other responses from the Federal Reserve thereto, a potential economic downturn, industry, global economic conditions, government policy including the evolving regulatory environment and the implementation of our business model and strategic plans for our business, including our ability to manage the risks inherent in operating our cryptocurrency business and in safekeeping cryptocurrency assets. New risk factors emerge from time to time and it is not possible for us to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. In addition, past financial or operating performance is not necessarily a reliable indicator of future performance and you should not use our historical performance to anticipate results or future period trends. We can give no assurances that any of the events anticipated by the forward-looking statements will occur or, if any of them do, what impact they will have on our results of operations and financial condition. Except as required by law, we undertake no obligation to update publicly or revise our forward-looking statements to reflect events or circumstances that arise after the filing of this Annual Report or documents incorporated by reference herein that include forward-looking statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless the context requires otherwise, references in this Annual Report to &#8220;Lite Strategy,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Lite Strategy, Inc.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_part_i"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc. and our corporate logo are registered service marks of Lite Strategy. Any other brand names or trademarks appearing in this Annual Report are the property of their respective holders.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_toc58841_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I</span><span id="fis_business"></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. Business</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pharmaceutical company that has been developing novel and differentiated cancer therapies. We </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships and out-licensing or commercialization, as appropriate. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit. Our drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an oral, once-daily, selective PI3K&#948; inhibitor, which is a pre-clinical candidate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In August 2025, as described below, we implemented a Litecoin Treasury Strategy with the net proceeds from the PIPE (as defined below).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2024, we announced that our Board of Directors (Board) had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force beginning August 1, 2024, that continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets continued to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing opportunities for or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities. Consistent with our intention to preserve cash, David M. Urso, our President and Chief Executive Officer and Richard Ghalie, M.D., our Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our current Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as Chairperson of the Board. The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy (as discussed below) and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Investment in Private Equity (PIPE) and Related Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in July 2025, we closed on a $100.0 million PIPE and issued an aggregate of (i) 23,216,898 shares (the Shares) of our common stock, at an offering price of $3.42 per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the common stock, the Securities)), to purchase up to an aggregate of 6,022,869 shares of our common stock (the Pre-Funded Warrant Shares) at an offering price of $3.4199 per Pre-Funded Warrant (collectively, the Offering or the PIPE). On July 24, 2025, Pre-Funded Warrants for the purchase of 2,084,509 shares of common stock were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued 2,807,967 shares of common stock upon cashless exercises of 2,808,070 Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, in July 2025 and as more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Treasury Strategy (discussed below), including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the- market sales agreement. As partial consideration for services provided associated with the PIPE, we issued warrants for the purchase of up to 3,070,177 shares of our common stock with a weighted-average exercise price of approximately $4.10 per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement (as defined below), we issued to GSR Strategies LLC (GSR), 546,348 Pre-Funded Warrants with an exercise price of $0.0001 per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litecoin Treasury Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $1.75 per share of common stock, that was declared on November 6, 2023, to stockholders of record at the close of business on November 17, 2023 (Capital Return). The total dividend of $11.7 million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective July 22, 2025, in conjunction with the closing of the Offering, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Merger Termination</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At a special meeting of our stockholders held on July 23, 2023, stockholders voted on the agreement and plan of merger (Merger Agreement) entered into in February 2023, by us, Infinity Pharmaceuticals, Inc. (Infinity) and Meadow Merger Sub, Inc., our wholly owned subsidiary (Merger Sub). At such special meeting, the Merger Agreement did not obtain the necessary approval from our stockholders and, accordingly, on July 23, 2023, we sent Infinity a notice terminating the Merger Agreement.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug Candidate Development Programs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our drug candidate pipeline includes voruciclib, an oral CDK9 inhibitor, and zandelisib, </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an oral, once-daily, selective PI3K&#948; inhibitor</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voruciclib: Potent Orally Administered CDK9 Inhibitor in Phase 1 Studies</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Voruciclib, a selective orally administered CDK9 inhibitor completed a Phase 1 trial in September 2024 evaluating dose and schedule in patients with acute myeloid leukemia (AML) in combination with the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax (marketed as Venclexta&#174;). Previously, voruciclib was also being evaluated in pre-clinical studies to explore potential activity in various solid tumor cancers including in combination with therapies that target the RAS signaling pathway, such as KRAS inhibitors. All clinical trial efforts for voruciclib were ceased as of July 22, 2024, and we are currently assessing the pre-clinical development program in potentially non-oncology disease indications.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voruciclib Scientific Overview: Cell Cycle Signaling</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CDK9 has important functions in cell cycle regulation, including the modulation of two therapeutic targets in cancer:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CDK9 is a transcriptional regulator of the myeloid leukemia cell differentiation protein (Mcl-1), a member of the family of anti-apoptotic proteins which, when elevated, may prevent the cell from undergoing cell death and result in poor prognosis in cancer. Inhibition of CDK9 blocks the production of Mcl-1, which is also an established resistance mechanism to the BCL-2 inhibitor venetoclax.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CDK9 is a transcriptional regulator of the MYC proto-oncogene protein (MYC) which regulates cell proliferation and growth. Upregulation of MYC is implicated in many human cancers and is frequently associated with poor prognosis and unfavorable patient survival. CDK9, in addition to being a transcription factor for MYC, also decreases phosphorylation of MYC protein that is implicated in stabilizing MYC in KRAS mutant cancers.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Directly inhibiting MCL1 and MYC has historically been difficult, but CDK9 is a promising approach to indirectly target these oncogenes.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voruciclib: Inhibition of MCL1</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CDK9 is a known transcriptional regulator of MCL1. Over expression of MCL1 is frequently observed in many tumor types and is closely associated with tumorigenesis, poor prognosis and drug resistance. In AML, MCL1 is upregulated in about half of patients with</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">relapsed and refractory (R/R) disease</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and is associated with poor prognosis in these patients. Also important, high levels of MCL1 expression are associated with resistance to venetoclax.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In pre-clinical studies, voruciclib shows dose-dependent suppression of MCL1; in December 2017, a study of voruciclib published in the journal Nature Scientific Reports reported that the combination of voruciclib plus the BCL-2 inhibitor venetoclax was capable of inhibiting two master regulators of cell survival, MCL-1 and BCL-2 and achieved synergistic antitumor effect in an aggressive subset of DLBCL cells.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In a peer reviewed manuscript published in 2020, it was reported that the inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the BCL-2 inhibitor venetoclax in preclinical models of AML. The data demonstrated that voruciclib synergizes with venetoclax to induce programmed cell death, or apoptosis, in both AML cell lines and primary patient samples. It was also demonstrated that voruciclib downregulates MCL1, which is relevant for the synergy between voruciclib and venetoclax and further that voruciclib downregulates MYC, which also contributes to the synergies with venetoclax.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequently and consistent with the reported pre-clinical studies, data from a prior Phase 1 study evaluating voruciclib as a single agent and in combination with venetoclax in patients with relapsed or refractory (R/R) AML have also demonstrated the anticipated decreases in Mcl-1 protein.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The research suggests that voruciclib is potentially an attractive therapeutic agent for treating cancers in combination with venetoclax or other BCL-2 inhibitors, to address potential resistance associated with MCL1 and is supportive of our clinical evaluation of voruciclib in AML.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voruciclib: Inhibition of MYC</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many cancers are associated with over expression of MYC, a transcription factor regulating cell proliferation and growth. CDK9 is a known regulator of MYC transcription and a modulator of MYC protein phosphorylation. Data reported at the American Association for Cancer Research (AACR) Annual Meeting 2021 in preclinical models demonstrated that voruciclib:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results in a rapid decrease in the phosphorylation of proteins that promote MYC transcription;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rapidly decreases phosphorylation of MYC protein on Ser62, a site implicated in stabilizing MYC in KRAS mutant cancers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Possesses single agent activity against multiple KRAS mutant cancer cell lines both in vitro and in vivo; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Synergistically inhibits KRAS G12C mutant cancer cell lines in combination with KRAS G12C inhibitors, both in vitro and in vivo.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The research presented suggests that voruciclib could be an attractive therapeutic agent for both hematological cancers, as well as solid tumors, dependent on the activity of MYC.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Terminated Clinical Programs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In a Phase 1 clinical trial, we evaluated the dose and schedule of voruciclib in combination with venetoclax, a BCL-2 inhibitor, in patients with R/R AML. The trial started with the evaluation of dose and schedule of voruciclib as a monotherapy in patients with relapsed and refractory B-cell malignancies and AML after failure of prior standard therapies to determine the safety, preliminary efficacy and maximum tolerated dose. The primary objectives of the study were to determine the safety and biologic effective dose of voruciclib monotherapy or voruciclib in combination with venetoclax. Secondary objectives of the study included assessing the preliminary efficacy, pharmacokinetics, pharmacodynamics and biomarkers of voruciclib monotherapy or voruciclib in combination with venetoclax.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we reported in a poster presented at the American Society of Hematology (ASH) Annual Meeting in December 2023, the voruciclib monotherapy dose escalation/expansion stage of the study enrolled a total of 40 patients and is complete. The majority of patients (n=21) had AML and the remaining patients (n=19) had B-cell malignancies. Of the 40 patients enrolled, the first 16 were dosed daily continuously at 50 and 100 mg and the following 24 patients were dosed on an intermittent schedule (14 consecutive days on therapy in a 28-day cycle) at 100, 150 and 200 mg. All patients were heavily pre-treated with a median of three prior therapies (range 1-9) and five patients had prior hematopoietic stem cell transplant. Voruciclib at doses up to 200 mg administered on 14 consecutive days in a 28-day cycle (Cohort 2) was well tolerated with no dose limiting toxicities (DLT) reported. The most common adverse events (&#8805;20% of patients) were diarrhea, nausea, anemia and fatigue. The large majority of adverse events were Grade 1-2; of note, the only Grade 3-4 adverse events in Cohort 2 were diarrhea (n=1) and anemia (n=5). Pharmacokinetics were dose proportional and a mean half-life of approximately 24 hours supports once daily dosing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the intermittent dosing schedule selected for further development, no DLTs were observed, there were no Grade 3 or higher drug related toxicities and dose escalation was stopped at 200 mg before reaching the maximum tolerated dose because plasma concentrations reached levels considered sufficient for target inhibition. In the 21 patients enrolled with AML, one patient at 100 mg achieved a morphologic leukemia-free state and nine patients had disease stabilization, which lasted at least three months in two patients. In the 19 patients enrolled with B-cell malignancies, four patients had stable disease with a decrease in tumor size. Initial results from correlative studies assessing myeloid leukemia cell differentiation protein (Mcl-1) and RNA Pol II phosphorylation on</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ser2 (RNA Pol II p-S2) demonstrated reduction in expression consistent with the anticipated on-target pharmacodynamic effect of voruciclib on Mcl-1 and RNA Pol II p-S2.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The next stage of the study evaluated seven voruciclib dose levels from 50 mg every other day to 300 mg daily for 14 consecutive days in a 28-day cycle in combination with standard dose venetoclax in patients with R/R AML. A total of 41 patients with R/R AML, median age 67 years (range 34-89), enrolled in this dose escalation stage of the study evaluating voruciclib in combination with venetoclax. These patients were generally heavily pretreated; the median number of prior therapies was 2 (range 1-7) and 18 (44%) patients had &#8805;3 prior lines. Almost all patients (39/41) were treated with venetoclax in an earlier line of therapy. Additionally, 30 (73%) patients were noted as being in an adverse 2017 ELN Risk Category due to adverse cytogenetics and molecular mutations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Of the 32 patients administered voruciclib at doses &#8805; 100 mg in combination with venetoclax 10 (31%) achieved disease control. Three patients achieved a response, including two patients that achieved a complete response with incomplete hematologic recovery (CRi) and one patient that achieved a morphologic leukemia-free state (MLFS), in each case having received venetoclax in an earlier line of treatment. Responses lasted 6 months in one patient, 9 months and ongoing in the second patient and the third patient was referred to stem cell transplant. Further, an additional 7 patients had stable disease which lasted more than 90 days and 13 had stable disease &lt; 3 months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In the 28 patients administered voruciclib in combination with venetoclax and with blood samples available for analysis, initial results from correlative biomarker assay studies demonstrated anticipated decreases of Mcl-1, including a greater decrease in Mcl-1 in responding patients. This supports our hypothesis that voruciclib, as an inhibitor or CDK9, regulates Mcl-1 and therefore may address the upregulation of MCL1 associated with venetoclax. Additional evidence of anti-leukemic activity was also demonstrated including decreases in bone marrow blast counts post voruciclib/venetoclax administration versus pre drug administration in ~50% (11/21) of evaluable patients.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Voruciclib at doses up to 300 mg administered on 14 consecutive days in a 28-day cycle in combination with standard dose venetoclax was well tolerated with no dose limiting toxicities observed. The maximum tolerated dose of voruciclib administered on this schedule with venetoclax has not been established. There were no discontinuations due to drug-related adverse events and no evidence of overlapping toxicity has been observed to date. The most common (&#8805;5% of patients) grade 3 adverse events were myelosuppression associated with AML. Only 1 patient was observed as having a non-hematologic grade 3 drug-related adverse event (di</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arrhea).</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Before ending the study, three patients were administered 150 mg voruciclib over 21</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consecutive days in a 28-day cycle</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in combination with venetoclax to increase dose intensity and potentially optimize patient response based upon the rebound of peripheral blast counts in 44% (8/18) of the patients between Day 14 and Day 28 when voruciclib was stopped while continuing venetoclax.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Voruciclib was also previously evaluated in more than 70 patients with solid tumors in multiple Phase 1 studies. The totality of the clinical data, along with data from pre-clinical studies, suggests voruciclib&#8217;s ability to inhibit its molecular target at a projected dose as low as 150 mg daily. In one clinical study, voruciclib was evaluated in combination with vemurafenib (marketed as Zelboraf&#174;) in nine patients with BRAF mutated advanced/ inoperable malignant melanoma. All three BRAF/MEK naive patients achieved a response: two partial responses and one complete response. In this study voruciclib was dosed at 150 mg daily plus vemurafenib 720 mg or 960 mg twice daily in 28-day cycles. The most common adverse events were fatigue, constipation, diarrhea, arthralgia and headache. One instance of grade 3 fatigue was dose limiting and no serious adverse events related to voruciclib were reported. Other clinical studies evaluated voruciclib at doses up to 850 mg in patients with solid tumors, demonstrating additional evidence of potential biologic activity and an adverse event profile generally consistent with other drugs in its class.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zandelisib: PI3K&#948; Inhibitor Overview</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Zandelisib is an oral, once-daily, selective PI3K&#948; inhibitor that we were jointly developing with Kyowa Kirin Co., Ltd (KKC) under a global license, development and commercialization agreement entered into in April 2020 that was later terminated in 2023 (as further discussed below). Currently, there are no clinical trial efforts for zandelisib and we are assessing the pre-clinical development program.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March 2022, we and KKC reported the outcome of an end of Phase 2 meeting with the FDA wherein the agency discouraged a filing based on data from a single-arm Phase 2 TIDAL trial. At this meeting, the FDA stated that data generated from single arm studies such as the Phase 2 TIDAL trial are insufficient to adequately assess the risk/benefit of PI3K&#948; inhibitors evaluating indolent non-Hodgkin lymphoma. Additionally, the FDA emphasized that we continue efforts with the randomized Phase 3 COASTAL trial evaluating patients with relapsed or refractory follicular or marginal zone lymphomas. Subsequently, at an April 2022 meeting of the FDA Oncology Drugs Advisory Committee, the committee voted that future approvals of PI3K&#948; inhibitors for hematologic malignancies should be supported by randomized data.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2022, we and KKC met with the FDA in a follow-up meeting to the March 2022 end of Phase 2 meeting. At this meeting, the FDA provided further guidance regarding the design and statistical analysis for the Phase 3 COASTAL trial. Following the November meeting, the companies jointly concluded that a clinical trial consistent with the recent FDA guidance, including</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">modification of the COASTAL trial, would likely not be feasible to complete within a time period that would support further investment or with sufficient certainty of the regulatory requirements for approval to justify continued global development efforts. As a result, we and KKC jointly decided to discontinue global development of zandelisib for indolent forms of non-Hodgkin lymphoma outside of Japan. The discontinuation of zandelisib development outside of Japan was a business decision based on the most recent regulatory guidance from the FDA and is not related to the zandelisib clinical data generated to date. After making the joint decision to terminate development outside of Japan, we and KKC began closing all zandelisib clinical studies outside of Japan, including the Phase 3 COASTAL trial, the Phase 2 TIDAL trial and the Phase 2 CORAL trial. Subsequently, in May 2023, KKC decided to discontinue development of zandelisib in Japan. The discontinuation of zandelisib in Japan was a business decision by KKC based on the most recent regulatory guidance from the Pharmaceuticals and Medical Devices Agency in Japan and was not related to the zandelisib clinical data that had been generated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 14, 2023, we entered into a Termination Agreement (the Termination Agreement) with KKC to terminate all agreements between the parties and cease further zandelisib clinical development globally. Activities associated with the compassionate use supply and wind down of the KKC Commercialization Agreement were completed in fiscal year 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">KKC License, Development and Commercialization Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2020, we entered into the KKC Commercialization Agreement under which we granted to KKC a co-exclusive, sublicensable, payment-bearing license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in the U.S. (the U.S. License) and an exclusive (subject to certain retained rights to perform obligations under the KKC Commercialization Agreement), sublicensable, payment- bearing, license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in countries outside of the U.S. (the Ex-U.S. and the Ex-U.S. License). Also under the KKC Commercialization Agreement, we were granted a co-exclusive, sublicensable, license under certain patents and know-how controlled by KKC to develop and commercialize zandelisib for all human indications in the U.S. and a co-exclusive, sublicensable, royalty-free, fully paid license under certain patents and know-how controlled by KKC to perform our obligations in the Ex-U.S. and were paid an initial non-refundable payment of $100.0 million. Additionally, in Japan, the KKC Commercialization Agreement included potential regulatory and commercialization milestone payments plus royalties on net sales of zandelisib in Japan, which are tiered beginning in the teens. Prior to the execution of the Termination Agreement on July 14, 2023, KKC was responsible for the development and commercialization of zandelisib in the Ex-U.S. and, subject to certain exceptions, solely responsible for all costs related thereto. We also provided to KKC certain drug supplies necessary for the development and commercialization of zandelisib in the Ex-U.S., with the understanding that KKC would have assumed responsibility for manufacturing for the Ex-U.S. as soon as practicable.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As noted above, on July 14, 2023, we entered into a Termination Agreement with KKC to mutually terminate the KKC Commercialization Agreement and all other related agreements between the parties. Pursuant to the Termi</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nation Agreement:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we regained full, global rights to develop, manufacture and commercialize zandelisib, subject to KKC's limited rights to use zandelisib for compassionate use (as more specifically defined in the Termination Agreement) in certain expanded access programs for the existing patients who have been enrolled in Japanese clinical trial sponsored by KKC until November 30, 2027, and for which KKC is fully liable; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">each party released the other party from any and all claims, demands, etc. arising from the </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KKC Commercialization Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, excluding certain surviving claims; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we are obligated to deliver a discrete quantity of materials to facilitate KKC's compassionate use activities.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2023, we had $64.9 million of aggregate deferred revenue associated with the KKC Commercialization Agreement, of which $64.5 million was allocated to the U.S. License and $0.3 million was allocated to the Development Services performance obligations which were recognized based on the proportional performance of these development activities through wind-down of the associated trials. As further discussed in </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. License Agreements</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in connection with the execution of the Termination Agreement during the three months ended September 30, 2023, we recognized the $64.5 million of noncash long-term deferred revenue associated with the U.S. License as well as the remaining $0.3 million noncash deferred revenue associated with the completion of the underlying proportional performance activities. As of September 30, 2023, all deferred revenue associated with the KKC Commercialization Agreement had been recognized.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The marketplace for our drug candidates is highly competitive. A number of other companies have products or drug candidates in various stages of pre-clinical or clinical development that are intended for the same therapeutic indications for which our drug candidates are being developed. Some of these potential competing drug candidates are further advanced in development than our drug candidates and may be commercialized sooner. Even if we are successful in developing products that receive regulatory</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval, such products may not compete successfully with products produced by our competitors or with products that may subsequently receive regulatory approval.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our competitors include pharmaceutical companies and biotechnology companies, as well as universities and public and private research institutions. In addition, companies active in different but related fields represent substantial competition for us. Many of our competitors developing oncology drugs have significantly greater capital resources, larger research and development staffs and facilities and greater experience in drug development, regulation, manufacturing, marketing and commercialization than we do. They compete with us in recruiting sites and eligible patients to participate in clinical studies and in attracting development and/or commercialization partners. They also license technologies that are competitive with our technologies. As a result, our competitors may be able to more easily develop technologies and products that would render our technologies or our drug candidates obsolete or non-competitive.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We own, by assignment or exclusive license, worldwide rights to each of our current drug candidates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have acquired exclusive worldwide rights to develop, manufacture and commercialize voruciclib from Presage Biosciences, Inc. (Presage). The U.S. Patent and Trademark Office (USPTO) has allowed or issued 21 U.S. patents covering the composition of matter, pharmaceutical compositions and methods of use to treat cancer which are projected to expire between 2026 and 2039, not including any patent term extension. There are approximately 90 allowed or issued foreign patents, 8 pending U.S. provisional patent applications and approximately 50 pending foreign patent applications for voruciclib, related compounds and related methods of use.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have acquired, by assignment, worldwide rights to zandelisib and other related compounds from Pathway Therapeutics, Inc. The USPTO has issued nine patents covering zandelisib as composition of matter, pharmaceutical compositions, methods of use to treat cancer and combinations with additional therapies. The issued U.S. patents with composition of matter claims covering zandelisib are projected to expire between 2030 and 2032, not including any patent term adjustment and patent term extension. There are approximately 48 foreign patents granted. There is 1 pending U.S. patent application and are approximately 13 pending foreign patent applications directed to zandelisib and related compounds or methods of use thereof.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends in large part on our ability to protect our proprietary technologies, compounds and information and to operate without infringing the proprietary rights of third parties. We rely on a combination of patent, trade secret, copyright and trademark laws, as well as confidentiality, licensing and other agreements, to establish and protect our proprietary rights. We seek patent protection for our key inventions, including drug candidates we identify, routes for chemical synthesis and pharmaceutical formulations. There is no assurance that any of our pending patent applications will issue, or that any of our patents will be enforceable or will cover a drug or other commercially significant product or method. In addition, we regularly review our patent portfolio to identify patents and patent applications that we deem to have relatively low value to our ongoing business operations for potential abandonment. There is also no assurance that we will correctly identify which of our patents and patent applications should be maintained and which should be abandoned. The term of most of our other current patents commenced and most of our future patents, if any, will commence, on the date of issuance and terminate 20 years from the earliest effective filing date of the non-provisional patent application. Because any marketing and regulatory approval for a drug often occurs several years after the related patent application is filed, the resulting market exclusivity afforded by any patent on our drug candidates and technologies will likely be substantially less than 20 years.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As most patent applications in the U.S. are maintained as confidential until published by the USPTO at 18 months from filing for all cases filed after November 29, 2000, or at issue, for cases filed prior to November 29, 2000, we cannot be certain that we or Presage were the first to make the inventions covered by the patents and applications referred to above. Additionally, publication of discoveries in the scientific or patent literature often lags behind the actual discoveries. Moreover, pursuant to the terms of the Uruguay Round Agreements Act, patents filed on or after June 8, 1995 have a term of twenty years from the date of such filing except for provisional applications, irrespective of the period of time it may take for such patent to ultimately issue. This may shorten the period of patent protection afforded to therapeutic uses of zandelisib or voruciclib as patent applications in the biopharmaceutical sector often take considerable time to issue. However, in some countries the patent term may be extended.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to protect the confidentiality of our technology, including trade secrets and know-how and other proprietary technical and business information, we require all of our consultants, advisors and collaborators to enter into agreements that prohibit the use or disclosure of information that is deemed confidential. These agreements also oblige our consultants, advisors and collaborators to assign to us, or negotiate a license to developments, discoveries and inventions made by such persons in connection with their work relating to our products. We cannot be sure that confidentiality will be maintained by those from whom we have acquired technology or disclosure prevented by these agreements. We also cannot be sure that our proprietary information or intellectual property will be</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">protected by these agreements or that others will not independently develop substantially equivalent proprietary information or intellectual property.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The pharmaceutical industry is highly competitive and patents may have been applied for by and issued to, other parties relating to products competitive with voruciclib or zandelisib. Use of these compounds and any other drug candidates may give rise to claims that they infringe the patents or proprietary rights of other parties, existing now and in the future. An adverse claim could subject us to significant liabilities to such other parties and/or require disputed rights to be licensed from such other parties. We cannot be sure that any license required under any such patents or proprietary rights would be made available on terms acceptable to us, if at all. If we do not obtain such licenses, we may encounter delays in product market introductions, or may find that the development, manufacture or sale of products requiring such licenses may be precluded.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and Development</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The objective of our research and development (R&amp;D) program is the generation of data sufficient to meet medical needs and develop a clinical and commercial profile with attractive attributes and/or to allow us to enter into a development and/or commercial relationship with another party. The data are generated by our pre-clinical studies and clinical trial programs.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The key aspects of our R&amp;D program have been to provide more complete characterization of the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the relevant molecular targets of action of our drug candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the relative therapeutic benefits and indications for use of our drug candidates as a monotherapy or as part of combinational therapy with other agents; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the most appropriate therapeutic indications and dosage forms for voruciclib or zandelisib, based upon pre-clinical findings.</span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Regulatory Requirements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Food and Drug Administration (FDA) and comparable regulatory agencies in other countries, regulate and impose substantial requirements upon the research, development, nonclinical and clinical testing, labeling, manufacture, quality control, storage, approval, advertising, promotion, marketing, distribution, import and export of pharmaceutical products, as well as significant reporting and record-keeping obligations. State governments may also impose obligations in these and other areas. These requirements are extensive and are frequently changing.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., pharmaceutical products are regulated by the FDA under the Federal Food, Drug and Cosmetic Act (FDCA) and other laws. The process required by the FDA before drugs may be marketed in the U.S. generally involves the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nonclinical laboratory evaluations, including formulation and stability testing and animal tests performed under the FDA&#8217;s Good Laboratory Practices (GLP) regulations to assess pharmacological activity and toxicity potential. This last year, the FDA announced a plan to phase out animal testing for certain kinds of drugs, potentially replacing animal testing with new approach methodologies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission and approval of an investigational new drug (IND) application, including results of nonclinical tests, manufacturing information and protocols for clinical tests, which must become effective before clinical trials may begin in the U.S.;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining approval of institutional review boards (IRBs) to administer the products to human subjects in clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adequate and well-controlled human clinical trials to establish the safety and efficacy of the product for the product&#8217;s intended use;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">development of manufacturing processes which conform to the FDA&#8217;s current Good Manufacturing Practices (cGMP), as confirmed by FDA inspection or remote regulatory assessments;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission of results for nonclinical, toxicology and clinical studies and chemistry, manufacture and control information on the product to the FDA in a non-disclosure agreement (NDA); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of an NDA, prior to any commercial sale or shipment of a product.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The testing and approval process requires substantial time, effort and financial resources and we cannot be certain that we will be able to ultimately submit marketing applications for any of our product candidates, that our development efforts will prove to be successful, that our studies will have positive outcomes, or that any approval will be granted on a timely basis, if at all.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of the nonclinical studies, together with initial specified manufacturing information, the proposed clinical trial protocol and information about the participating investigators are submitted to the FDA as part of an investigational new drug (IND) application, which must become effective before we may begin human clinical trials in the U.S. Clinical trials must be conducted in accordance with federal regulations and Good Clinical Practice (GCP) requirements and with investigational products that follow cGMP. GCPs include, among other requirements, the requirements related to monitoring, drug accountability, data integrity and that all research subjects provide their informed consent in writing for their participation in any clinical trial. FDA has issued a number of guidances regarding the conduct of clinical studies including with respect to good clinical practices and the conduct of different clinical studies.Following issuance of a final guidance, the FDA will further be requiring diversity action plans for certain clinical studies.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, an independent IRB must review and approve each study protocol and oversee conduct of the trial. An IND becomes effective 30-days after receipt by the FDA, unless the FDA, within the 30-day period, raises concerns or questions about the conduct of the trials as outlined in the IND and imposes a clinical hold. If the FDA imposes a clinical hold at any time before or during clinical trials, the IND sponsor must resolve the FDA&#8217;s concerns before clinical trials can begin or continue. Nonclinical tests and studies can take several years to complete and there is no guarantee that an IND that is submitted based on such tests and studies will become effective within any specific time period, if at all.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sponsors must make certain reports and submissions to the FDA and global health authorities, as appropriate and to clinical investigators who, in turn, make certain reports and submissions to the IRB or ethics committee, including annual reports and reports of investigator financial interests, serious adverse events and other significant safety information, study amendments and new study protocols. Information about certain clinical trials, including a description of the study and study results, must also be submitted within specific time frames to the National Institutes of Health (the NIH), for public dissemination on the clinicaltrials.gov website. Sponsors of investigational products for serious diseases must also have a publicly available policy on requests for expanded access.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investigational drugs and active ingredients imported into the U.S. are also subject to regulation by the FDA. Further, the export of investigational products outside of the U.S. is subject to regulatory requirements of the receiving country as well as U.S. export requirements under the FDCA.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human clinical trials are typically conducted in three sequential phases that may overlap.</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 1</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The drug is initially introduced into healthy human subjects or patients and tested for safety and dosage tolerance. Absorption, metabolism, distribution and excretion testing is generally performed at this stage.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 2</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The drug is studied in controlled, exploratory therapeutic trials in a limited number of subjects with the disease or medical condition for which the new drug is intended to be used in order to identify possible adverse effects and safety risks, to determine the preliminary or potential efficacy of the product for specific targeted diseases or medical conditions and to determine dosage tolerance and the optimal effective dose.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 3</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: When Phase 2 studies demonstrate that a specific dosage range of the drug may be efficacious and the drug has an acceptable safety profile for further investigation, controlled, large-scale therapeutic Phase 3 trials are undertaken at multiple study sites to demonstrate clinical efficacy and to further test for safety in an expanded patient population. Typically, two Phase 3 trials are required by the FDA for product approval. Under some limited circumstances, however, the FDA may approve an NDA based upon a single Phase 3 clinical study plus confirmatory evidence or a single large multi-center trial without confirmatory evidence.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concurrent with clinical trials, companies usually complete additional nonclinical and toxicology studies and must also develop additional information about the chemistry, manufacturing and controls (CMC) of the product candidate.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data monitoring committee. This group reviews data and advises the study sponsor regarding the continuing safety of the trial. This group may also review interim data to assess the continuing validity and scientific merit of the clinical trial. The data monitoring committee may advise the sponsor to halt the clinical trial, modify the clinical trial, or continue the clinical trial depending on safety results and the trial&#8217;s likelihood of success.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be certain that we will successfully complete clinical testing of our products within any specific time period, if at all. Furthermore, the FDA, the IRB or we may suspend or terminate clinical trials at any time on various grounds, including a finding that the subjects or patients are being exposed to an unacceptable safety risk or noncompliance with applicable regulatory requirements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of nonclinical and toxicology studies and clinical trials, as well as detailed information about the manufacturing process, quality control methods and product composition, among other things, are submitted to the FDA as part of an NDA seeking approval to market and commercially distribute the product on the basis of a determination that the product is safe and effective for its intended use. Once the FDA receives an application, it has 60 days to review the NDA to determine if it is substantially complete to permit a substantive review, before it accepts the application for filing. The FDA may request additional information rather than accept an application for filing. In this event, the application must be resubmitted with the additional information. Once the submission is accepted for filing, the FDA begins an in-depth substantive review. Under the goals agreed to by the FDA under the Prescription Drug User Fee Act (PDUFA), the agency currently aims to review 90% of all applications for new molecular entities within ten months of the 60-day filing date for a standard review. The PDUFA date is only a goal, thus, the FDA does not always meet its PDUFA dates. The PDUFA date may also be extended if the FDA requests or the sponsor provides substantial additional information regarding the submission.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may refer certain applications to an advisory committee, which is a panel of experts that make a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving an NDA, the FDA will inspect the facilities at which the product is manufactured and may inspect the sponsor, clinical study vendors and clinical sites at which the product candidate was studied and will not approve the product unless cGMP and GCP compliance are satisfactory. Inspections may be in-person or conducted remotely. If applicable regulatory criteria are not satisfied, the FDA may issue a complete response letter (CRL) to the sponsor requiring additional nonclinical or clinical studies or data or additional CMC information. If a CRL is issued, the applicant may either: resubmit the marketing application, addressing all of the deficiencies identified in the letter; withdraw the application; or request an opportunity for a hearing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once the FDA determines that the approval requirements are met, it will issue an approval letter that authorizes commercial marketing of the product with specific prescribing information for specific indications. As a condition of approval, the FDA also may require post-marketing commitments and requirements, including studies and/or surveillance to monitor the product&#8217;s safety or efficacy. The FDA also may require a Medication Guide and also a risk evaluation and mitigation strategy (REMS), or other conditions for a product&#8217;s approval or following approval to ensure that the benefits of the product candidate outweigh the risks. Moreover, even if the FDA approves a product, it may limit the approved indications or populations for use of the product, require that contraindications, warnings, or precautions be included in the product labeling, including a black box warning, impose other conditions, such as post-approval studies, or may not approve label statements that are necessary for successful commercialization and marketing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even after an NDA is approved, the FDA may impose additional obligations or restrictions (such as labeling changes, or clinical post-marketing requirements), or even suspend or withdraw a product approval or require additional testing or label revisions on the basis of data that arise after the product reaches the market, or if compliance with regulatory standards is not maintained. We cannot be certain that any NDA we submit will be approved by the FDA for full or accelerated approval on a timely basis, if at all. Also, any such approval may limit the indicated uses for which the product may be marketed. Any refusal to approve, delay in approval, suspension or withdrawal of approval, or restrictions on indicated uses could have a material adverse impact on our business prospects.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each NDA must be accompanied by a substantial user fee pursuant to the requirements of the PDUFA and its amendments. Fee waivers or reductions are available in certain circumstances. Following product approval, drug products are also subject to annual program fees. The FDA adjusts the PDUFA user fees on an annual basis. Subject to meeting certain requirements, a written request can be submitted for a waiver for the application fee for the first human drug application that is filed by a small business, but there are no small business waivers for program fees. Product candidates that are designated as orphan products are not subject to application user fees unless the application includes an indication other than the orphan indication and may be exempt from program fees if certain criteria are met. We are not at the stage of development with our products where we are subject to these fees, but they are significant expenditures that may be incurred in the future and must be paid at the time of application submissions to the FDA.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Satisfaction of FDA requirements typically takes many years. The actual time required varies substantially, based upon the type, complexity and novelty of the pharmaceutical product, among other things. Government regulation imposes costly and time-consuming requirements and restrictions throughout the product life cycle and may delay product marketing for a considerable period of time, limit product marketing, or prevent marketing altogether. Success in nonclinical or early-stage clinical trials does not ensure success in later stage clinical trials. Data obtained from nonclinical and clinical activities are not always conclusive and may be</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">susceptible to varying interpretations that could delay, limit, or prevent marketing approval. Even if a product receives marketing approval, the approval is limited to specific clinical indications. Further, even after marketing approval is obtained, the discovery of previously unknown problems with a product may result in restrictions on the product or even complete withdrawal of the product from the market.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After product approval, there are continuing significant regulatory requirements imposed by the FDA, including record-keeping requirements, obligations to report adverse side effects in patients using the products and restrictions on advertising and promotional activities. Quality control and manufacturing procedures must continue to conform to cGMPs and the FDA periodically inspects facilities, via in person inspections and remote regulatory assessments, to assess cGMP compliance. Additionally, post-approval changes in ingredient composition, manufacturing processes or facilities, product labeling, or other areas may require submission of an NDA Supplement to the FDA for review and approval. New indications will require additional clinical studies and submission of an NDA Supplement. Commercially distributed products are also subject to a variety of additional requirements, including requirements regarding tacking, tracing and supply chain integrity; and requirements related to drug shortages and drug shortage prevention.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to comply with the FDA&#8217;s regulatory requirements may result in an enforcement action by the FDA, including clinical holds, refusal to approve marketing applications or supplements, Warning Letters, product recalls, suspension or revocation of product approval, seizure of product to prevent distribution, impositions of injunctions prohibiting product manufacture or distribution and civil and criminal penalties, among other actions. Maintaining compliance is costly and time-consuming. We cannot be certain that we, or our present or future suppliers or third-party manufacturers, will be able to comply with all FDA regulatory requirements and potential consequences of noncompliance could have a material adverse impact on our business prospects.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA&#8217;s policies may change and additional governmental regulations may be enacted that could delay, limit, or prevent regulatory approval of our products, that require that we implement additional compliance steps, or affect our ability to manufacture, market, or distribute our products after approval.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our activities also may be subject to state laws and regulations that affect our ability to develop and sell our products. We are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, clinical, laboratory and manufacturing practices, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous substances. We may incur significant costs to comply with such laws and regulations now or in the future and the failure to comply may have a material adverse impact on our business prospects.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDCA includes provisions designed to facilitate the development and expedite the review of drugs intended for treatment of serious or life-threatening conditions that demonstrate the potential to address unmet medical needs for such conditions or present a significant improvement over existing therapy. These provisions set forth a procedure for designation of a drug as a fast track product. The fast track designation applies to the combination of the product and specific indication for which it is being studied. A product designated as fast track is ordinarily eligible for additional programs for expediting development and review, such as increased FDA interactions and rolling submission of the application.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Products that are intended to treat serious or life-threatening conditions and that provide a meaningful therapeutic benefit over existing treatments may also be eligible for accelerated approval. Drug approval under the accelerated approval regulations may be based on evidence of clinical effect on a surrogate endpoint that is reasonably likely to predict clinical benefit. A post-marketing clinical study will be required to be completed to verify clinical benefit and other restrictions to assure safe use may be imposed. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By the date of approval of an accelerated approval product, the FDA must specify the conditions for the required post approval studies, including enrollment targets, the study protocol, milestones and target completion dates. The FDA may also require that the confirmatory Phase 4 studies be commenced prior to the FDA granting a product accelerated approval. Reports on the progress of the required Phase 4 confirmatory studies must be submitted to the FDA every 180 days after approval. </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to conduct required post-approval studies, or confirm a clinical benefit, will allow the FDA to withdraw the drug or biologic from the market on a statutorily defined expedited basis. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to conduct the required Phase 4 confirmatory studies or to conduct such studies with due diligence, as well as failure to submit the required update reports can subject a sponsor to penalties. I</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n recent years, the accelerated approval pathway has come under significant FDA and public scrutiny. Accordingly, the FDA may be more conservative in granting accelerated approval or, if granted, may be more apt to withdrawal approval if clinical benefit is not confirmed or the risk benefit assessment changes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A third potential designation that may be available is breakthrough therapy designation. A breakthrough therapy is a product that is intended, alone or in combination with one or more other products, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. Products designated as breakthrough therapies are eligible for intensive FDA guidance, a commitment from the FDA to involve senior managers and experienced review staff in a proactive collaborative and cross-disciplinary review, rolling submission of the application and the facilitation of cross-disciplinary review.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, if a product is intended to treat a serious condition and, if approved, would provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of the condition, the product may be eligible for priority review meaning that the FDA&#8217;s goal for the review of an NDA is shortened to six months (after a two month period during which the FDA decides whether the application is ready for filing) rather than the standard review of ten months from application acceptance. If we should seek additional designations for any of our programs, we cannot be assured that it will be granted by the FDA. There is also no guarantee that we will be able to maintain any designation that we have received or may receive.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the FDA&#8217;s approval of an NDA, sponsors are required to list with the FDA each patent with claims that cover the applicant&#8217;s drug or a method of using the drug. These patents are published in the FDA&#8217;s list of Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Drugs listed in the Orange Book can be cited by potential competitors as a reference listed drug in support of a 505(b)(2) NDA or an Abbreviated New Drug Application, (ANDA). In an effort to clarify which patents must be listed in the Orange Book, in January 2021, Congress passed the Orange Book Transparency Act of 2020, which largely codified the FDA&#8217;s existing practices into the FDCA. Listing patents in the Orange Book that do not qualify for listing can be considered to be anticompetitive conduct and, the Federal Trade Commission has sent letters to a number of companies with respect to certain patents that the agency asserted were improperly listed or inaccurate. Listings have also been the subject of court cases.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A 505(b)(2) NDA is an application that contains full reports of investigations of safety and efficacy but where at least some of the information required for approval comes from investigations that were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted. This regulatory pathway enables the applicant to rely, in part, on the FDA&#8217;s prior findings of safety and efficacy for an existing product, or published literature. An ANDA provides for marketing of a generic drug product that has the same active ingredients, dosage form, strength, route of administration, labeling, performance characteristics and intended use as a previously approved product. ANDA applicants generally must only scientifically demonstrate that their product is bioequivalent to, or performs in the same manner as, the innovator drug and can often be substituted by pharmacists under prescriptions written for the reference listed drug.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, the FDA may not approve an abbreviated new drug application (ANDA) or 505(b)(2) NDA unless the reference listed drug&#8217;s Orange Book listed patents have expired and/or if the applicant certifies that it is not seeking approval for a patented method of use. The FDA may approve these applications, however, if the 505(b)(2) NDA or ANDA sponsor certifies that the Orange Book listed patents for the reference listed drug are invalid or will not be infringed upon by the manufacture, use or sale of the drug product for which the application is submitted. This later certification is called a paragraph IV certification. If the ANDA or 505(b)(2) NDA applicant has made a paragraph IV certification, following notice to the NDA and patent holders, the NDA and patent holders may then initiate a patent infringement lawsuit. If a lawsuit is brought, the FDA may not make an approval effective until the earlier of 30 months from the patent or application owner&#8217;s receipt of the notice of the paragraph IV certification, the expiration of the patent, when the infringement case concerning each such patent is favorably decided in the applicant&#8217;s favor or settled, or such shorter or longer period as may be ordered by a court.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Congress and U.S. federal administrative agencies have taken certain measures to increase drug competition and thus decrease drug prices, including by facilitating 505(b)(2) NDAs and ANDAs and by introducing additional products into the U.S. market. For example, the FDA finalized a rule and a guidance to facilitate drug importation. Congress also passed a bill requiring sponsors of NDA products to provide sufficient quantities of drug product on commercially reasonable market-based terms to entities developing generic and 505(b)(2) products. This bill also included provisions on shared and individual REMS for generic drug products.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Drug Price Competition and Patent Term Restoration Act of 1984, a sponsor may obtain marketing exclusivity for a specified period of time following FDA approval of certain drug applications. For example, new drugs containing new chemical entities that have not been previously approved by the FDA may obtain five years of exclusivity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the therapeutic activity of the drug substance. During the exclusivity period, the FDA may not accept for review an ANDA or a 505(b)(2) NDA submitted by another company that contains the previously approved active moiety. However, an ANDA or 505(b)(2) NDA may be submitted after four years if it contains a paragraph IV certification. This exclusivity is not absolute. For instance, it will not delay the submission or approval of a full NDA; though, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the pre-clinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and efficacy.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following NDA approval, a patent owner may obtain an extension of a single unexpired patent that has not previously been extended for a period equal to one-half the period of time elapsed between the filing of an IND and the filing of the corresponding NDA plus the period of time between the filing of the NDA and FDA approval, with a five year maximum patent extension. The total patent life of the product with the extension cannot exceed fourteen years from the product&#8217;s approval date. The period of patent extension may also be reduced for any time that the applicant did not act with due diligence. We cannot be certain that we will be able</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to take advantage of either the patent term extension or marketing exclusivity provisions of these laws or that, if received, they will adequately protect any approved products from competition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Best Pharmaceuticals for Children Act (BPCA) adds an additional six months of marketing exclusivity and patent protection to unexpired exclusivities and unexpired patents listed with the FDA for NDA applicants that conduct acceptable pediatric studies of new and currently marketed drug products for which pediatric information would be beneficial, as identified by the FDA in a Pediatric Written Request. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly address the agreement between the sponsor and the FDA in the Pediatric Written Request, the additional protection is granted.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pediatric Research Equity Act (PREA) also requires that most applications for drugs include a pediatric assessment (unless waived or deferred) to ensure the drugs&#8217; safety and effectiveness in children. Such pediatric assessment must contain data, gathered using appropriate formulations for each age group for which the assessment is required, that are adequate to assess the safety and effectiveness of the drug product for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the drug product is safe and effective. The pediatric assessments can only be deferred provided there is a timeline for the completion of such studies. The FDA may waive (partially or fully) the pediatric assessment requirement for several reasons, including if the applicant can demonstrate that reasonable attempts to produce a pediatric formulation necessary for that age group have failed. Orphan products are also exempt from the PREA requirements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, sponsors submitting original applications on or after August 18, 2020, for product candidates intended for the treatment of adult cancer which are directed at molecular targets that the FDA determines to be substantially relevant to the growth or progression of pediatric cancer must submit, prior to marketing application submission, an initial Pediatric Study Plan for FDA agreement and with the application, reports from molecularly targeted pediatric cancer clinical investigations designed to yield clinically meaningful pediatric study data, using appropriate pediatric formulations, to inform potential pediatric labeling. While orphan products are not exempt from this requirement, the FDA may grant full or partial waivers, or deferrals, for submission of data.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Orphan Drug Act, the FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition, which generally is a disease or condition that affects fewer than 200,000 individuals in the U.S. Additionally, sponsors must present a plausible hypothesis for clinical superiority to obtain orphan drug designation if there is a product already approved by the FDA that is considered by the FDA to be the same as the already approved product and is intended for the same indication. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. If a product which has an orphan drug designation subsequently receives the first FDA approval for the indication for which it has such designation, the product is entitled to orphan exclusivity, i.e., the FDA may not approve any other applications to market the same drug for the same indication for a period of seven years, except in limited circumstances. By example, if there is already a product approved by the FDA that is the same product for the same indication, the orphan designated product will only receive orphan drug exclusivity if the prior hypothesis of clinical superiority is demonstrated. Competitors may also be able to receive approval for different drugs for the indication for which the orphan product has exclusivity or the same drug for a different indication.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notably, the exact scope of any period of orphan drug exclusivity may change. Specifically, 2021 judicial decision, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Catalyst Pharms., Inc. v. Becerra</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, challenged and reversed an FDA decision on the scope of orphan product exclusivity for the drug, Firdapse. Under this decision, orphan drug exclusivity for Firdapse blocked approval of another company&#8217;s application for the same drug for the entire disease or condition for which orphan drug designation was granted, not just the disease or condition for which approval was received. In a January 2023 Federal Register notice, however, the FDA stated that it intends to continue to apply its regulations tying the scope of orphan-drug exclusivity to the uses or indications for which a drug is approved. The exact scope of orphan drug exclusivity will likely be an evolving area.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pharmaceutical Coverage, Pricing and Reimbursement &amp; Healthcare Reform</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, future sales of our products, if approved for marketing, will depend, in part, on the availability and extent of coverage and reimbursement by third-party payors, such as government healthcare programs, including Medicare and Medicaid, commercial insurance and managed healthcare organizations. These third-party payors are increasingly challenging the price and limiting the coverage and reimbursement amounts for medical products and services. There may be significant delays in obtaining coverage and reimbursement for approved products and coverage may be more limited than the purposes for which the product is approved by the FDA or regulatory authority in other countries. It is time-consuming and expensive to seek reimbursement from third- party payors. Moreover, eligibility for reimbursement does not imply that any product will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution. In the United States, third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies, but they also have their own methods and approval process apart from Medicare coverage and reimbursement determinations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the containment of healthcare costs has become a priority for federal and state governments and the prices of drugs have been a focus in this effort. The U.S. government, state legislatures and foreign governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our net revenue and results. Decreases in third-party reimbursement for our product candidates or a decision by a third-party payor to not cover our product candidates could reduce physician usage of the product candidate and have a material adverse effect on our sales, results of operations and financial condition. Moreover, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform government healthcare program reimbursement methodologies for drug products. Individual states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and drug price transparency measures and, in some cases, designed to encourage importation from other countries and bulk purchasing. On August 16, 2022, President Biden signed into the law the Inflation Reduction Act of 2022, or the IRA. Among other things, the IRA has multiple provisions that may impact the prices of drug products, such as negotiated ceiling prices and penalties for price increases that exceed the rate of inflation, that are both sold into the Medicare program and throughout the United States.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory Changes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Over the last year, there have been a number of changes in the regulation of pharmaceutical products and legal standards, including the reduced level of judicial deference due to administrative agencies following a 2024 Supreme Court decision. This may introduce uncertainties with respect to how we or any product candidates may be regulated and our future likelihood of success. It is possible that new federal or state laws or regulations may be passed, or laws and regulations may be enforced differently than they were before, which may expose us to additional legal and regulatory risk or uncertainty and require the expenditure of additional resources to ensure that we are able to comply. Such actions could also adversely restrict our business and operations. There could also be changes in FDA&#8217;s approval standards that could impact our ability to obtain product approvals in the future and to competitively market any product candidates,including change in product reimbursement to the extent applicable. Such changes may necessitate the conduct of additional development work, including preclinical and clinical trials and manufacturing development or may limit our ability to successfully market any product. Moreover, changes in the federal workforce and agency policies may result in regulatory delays or changes in administrative agencies&#8217; regulatory approach. At the same time, FDA has created new programs intended to facilitate drug development, which, if we qualify for them, may provide new opportunities. Any of the foregoing may impact our business and results of operation.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Regulatory Requirements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outside the U.S., our ability to market our products will also be contingent upon receiving marketing authorizations from the appropriate regulatory authorities and compliance with applicable post-approval regulatory requirements. Although the specific requirements and restrictions vary from country to country, as a general matter, foreign regulatory systems include risks similar to those associated with the FDA&#8217;s regulations, described above.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under European Union (European Union) regulatory systems, marketing authorizations may be submitted either under a centralized or a decentralized procedure (DCP). Under the centralized procedure, a single application to the European Medicines Agency (EMA) leads to an approval granted by the European Commission which permits the marketing of the product throughout the EU. The centralized procedure is mandatory for certain classes of medicinal products such as new substances for the treatment of oncology. In addition, all medicinal products developed by certain biotechnological means and those developed for cancer and other specified diseases and disorders, must be authorized via the centralized procedure. The centralized procedure will apply to any of our products that are developed by means of a biotechnology process or are intended for treatment of cancer. The DCP is used for products that are not eligible or not required to be authorized by the centralized procedure. The centralized procedure is optional for certain other products. Since the exit of the UK from the European Union, the UK has been excluded from the centralized procedure. It will be necessary for applicants to make a separate application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for a UK marketing authorization. There is currently no procedure for mutual EU/UK recognition of new medicinal products although there is an expedited review procedure (the EC Decision Reliance Procedure) for approval in the UK of EU approved products which is currently to run to December 31, 2023. Thereafter a new international recognition framework will be in place, which will have regard to decisions already made by the EMA. This means applications with a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) received after December 31, 2023 will be eligible.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As with FDA approval, we may not be able to secure regulatory approvals in the EU in a timely manner, if at all. Additionally, as in the U.S., post-approval regulatory requirements, such as those regarding product manufacture, marketing, or distribution, would</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">apply to any product that is approved in the EU and failure to comply with such obligations could have a material adverse effect on our ability to successfully commercialize any product.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The conduct of clinical trials in the EU is governed by the European Clinical Trials Regulation (CTR), which was implemented in June 2022. This CTR governs how regulatory bodies in member states control clinical trials. No clinical trial may be started without a clinical trial authorization granted by the national competent authority and favorable ethics approval. Under the CTER, clinical trial sponsors were able to use the Clinical Trials Information System (CTIS) since January 31, 2022, but were not obliged to use it immediately, in line with a three-year transition period, which expired January 31, 2025. National regulators in the EU Member States and European Economic Area (EEA) countries have been able to use the CTIS since January 31, 2022. With the exit of the UK from the EU in January 2021, the UK did not implement the CTR and the UK provisions implementing the previous law as set out in the previous Clinical Trial Directive (which fundamentally covered the same area as the CTR but was far less detailed and predated the CTIS) will continue to apply until amended by the UK. However, the UK has recently enacted the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 which is intended in part to align the US with the US/EEA as well as seeking to streamline approval procedures (including a combined MHRA and ethics committee approval process) acknowledging the effect of the non-inclusion of UK trials in the CRIS. This UK legislation comes into effect on April 28, 2026.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, there is a marked degree of change and uncertainty both in the regulation of clinical trials and in respect of marketing authorizations which we face for our products in the EU.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have the facilities or capabilities to commercially manufacture any of our drug candidates. We are and expect to continue to be dependent on contract manufacturers for supplying our existing and future candidates for clinical trials and commercial scale manufacturing of our candidates in accordance with regulatory requirements, including cGMP. Contract manufacturers may utilize their own technology, technology developed by us, or technology acquired or licensed from third parties. FDA approval of the manufacturing procedures and the site will be required prior to commercial distribution.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human Capital Management</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025, we had four employees whom all reside in the United States and were engaged in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">business development, finance, information systems or administrative support. </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other personnel resources are used from time to time as consultants or third-party service organizations on an as-needed basis for scientific and human resources activities. Our Acting Chief Executive Officer and Chief Financial Officer has prior experience with pharmaceutical, biotechnology and medical product companies. We believe that we have been successful in attracting skilled and experienced personnel, but there can be no assurance that we will be able to attract and retain the individuals needed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We strive to create a workplace of choice to attract, retain and develop top talent to achieve our strategic goals. We strive to maximize the potential of our human capital resources by creating a respectful, rewarding and inclusive work environment that enables our employees to further our mission. We adhere to a philosophy that includes, among other things, commitments to create ongoing job opportunities, pay fair wages and protect worker health and safety.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We invest in our workforce by offering competitive salaries and benefits. We endeavor to foster a strong sense of ownership by offering stock options under our equity incentive plan. We also offer locally relevant benefits for all eligible employees.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None of our employees are represented by a labor union or covered by collective bargaining agreements. We have never experienced a work stoppage and believe our relationship with our employees is good. Management considers our relations with employees to generally be positive.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Available Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed with or furnished to the SEC pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are available free of charge through our website at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">https://litestrategy.com</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Further, the SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC and can be found on our EDGAR page at http://www.sec.gov.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_3">&#160;</p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Risk Factors</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investment in our securities involves a high degree of risk. You should consider carefully the risks described below, together with other information in this Annual Report and other public filings, before making investment decisions regarding our securities. If any of the following events actually occur, our business, operating results, prospects or financial condition could be materially and adversely affected. This could cause the trading price of our common stock to decline and you may lose all or part of your investment. Moreover, the risks described below are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business, operating results, prospects or financial condition.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Investing in Litecoin</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The price of Litecoin has been and will likely continue to be, highly volatile.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Litecoin is a highly volatile asset that has traded between $50.43 and $146.61 per Litecoin on Coinbase in the 12 months ended July 3, 2025. More recently, during the second calendar quarter of 2025, Litecoin has traded between $63.75 and $106.15 per Litecoin through June 30, 2025. In addition, Litecoin does not pay interest. The ability to generate a return on investment from the purchase of Litecoin will depend on whether there is appreciation in the value of Litecoin following our purchases. Future fluctuations in Litecoin&#8217;s trading prices may result in our converting Litecoin into cash with a value substantially below the cost of such purchases. Our Litecoin holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historically, the crypto markets have been characterized by significant volatility in price, limited liquidity and trading volumes compared to sovereign currencies markets, relative anonymity, a developing regulatory landscape, potential susceptibility to market abuse and manipulation, compliance and internal control failures at exchanges and various other risks inherent in its entirely electronic, virtual form and decentralized network. During times of market instability, we may not be able to sell our Litecoin at favorable prices or at all. Further, any Litecoin we hold with our custodians and transact with our trade execution partners does not enjoy the same protections as are available to cash or securities deposited with or transacted by institutions subject to regulation by the Federal Deposit Insurance Corporation or the Securities Investor Protection Corporation. Additionally, we may be unable to enter into term loans or other capital raising transactions collateralized by our unencumbered Litecoin or otherwise generate funds using our Litecoin holdings, including in particular during times of market instability or when the price of Litecoin has declined significantly. If we are unable to sell our Litecoin, enter into additional capital raising transactions using Litecoin as collateral, or otherwise generate funds using our Litecoin holdings, or if we are forced to sell our Litecoin at a significant loss, in order to meet our working capital requirements, our business and financial condition could be negatively impacted.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The launch of central bank digital currencies (CBDCs) may adversely impact our business.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The introduction of a government-issued digital currency could eliminate or reduce the need or demand for private-sector issued crypto currencies, or significantly limit their utility. National governments around the world could introduce CBDCs, which could in turn limit the size of the market opportunity for cryptocurrencies, including Litecoin.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As Litecoin and other digital assets are relatively novel and the application of state and federal securities laws and other laws and regulations to digital assets is unclear in certain respects, it is possible that regulators in the United States or foreign countries may interpret or apply existing laws and regulations in a manner that adversely affects the price of Litecoin. The U.S. federal government, states, regulatory agencies and foreign countries may also enact new laws and regulations, or pursue regulatory, legislative, enforcement or judicial actions, that could materially impact the price of Litecoin or the ability of individuals or institutions such as us to own or transfer Litecoin.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Litecoin is determined to constitute a security for purposes of the federal securities laws, the additional regulatory restrictions imposed by such a determination could adversely affect the market price of Litecoin and in turn adversely affect the market price of our common stock. Moreover, the risks of us engaging in a Litecoin treasury strategy could create complications due to the lack of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">experience that third parties have with companies engaging in such a strategy, such as increased costs of director and officer liability insurance or the potential inability to obtain such coverage on acceptable terms in the future.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory change reclassifying Litecoin as a security could lead to our falling within the definition of &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended, or the 1940 Act and could adversely affect the market price of Litecoin and the market price of our common stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under Sections 3(a)(1)(A) and (C) of the 1940 Act, a company generally will be deemed to be an &#8220;investment company&#8221; for purposes of the 1940 Act if (1) it is, or holds itself out as being, engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting or trading in securities or (2) it is engaged, or proposes to engage, in the business of investing, reinvesting, owning, holding or trading in securities and it owns or proposes to acquire investment securities having a value exceeding 40% of the value of its total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While the SEC has not stated a view as to whether Litecoin is or is not a &#8220;security&#8221; for purposes of the federal securities laws, a determination by the SEC or a court of competent jurisdiction that Litecoin is a security could lead to our meeting the definition of &#8220;investment company&#8221; under the 1940 Act, if the portion of our assets that consists of investments in Litecoin exceeds the 40% limit prescribed in the 1940 Act, which would subject us to significant additional regulatory requirements that could have a material adverse effect on our business and operations and may also require us to change the manner in which we conduct our business.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We intend to monitor our assets and income in order to conduct our business activities in a manner such that we do not fall within the definition of &#8220;investment company&#8221; under the 1940 Act or would qualify under one of the exemptions or exclusions provided by the 1940 Act and corresponding SEC rules. If Litecoin is determined to be a security for purposes of the federal securities laws, we would take steps to reduce our holdings of Litecoin as a percentage of our total assets. These steps may include, among others, selling Litecoin that we might otherwise hold for the long term and deploying our cash in assets that are not considered to be investment securities under the 1940 Act, in which case we may be forced to sell our Litecoin at unattractive prices. We may also seek to acquire additional assets that are not considered to be investment securities under the 1940 Act and we may need to incur debt, issue additional equity or enter into other financing arrangements that are not otherwise attractive to our business. Any of these actions could have a material adverse effect on our results of operations and financial condition. Moreover, we can make no assurance that we would successfully be able to take the necessary steps to avoid meeting the definition of &#8220;investment company&#8221; under the 1940 Act and becoming subject to its requirements. If Litecoin is determined to constitute a security for purposes of the federal securities laws and if we are not able to come within an available exemption or exclusion under the 1940 Act, then we would have to register as an investment company and require us to change the manner in which we conduct our business. In addition, such a determination could adversely affect the market price of Litecoin and in turn adversely affect the market price of our common stock.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisers.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mutual funds, exchange-traded funds and their directors and management are subject to extensive regulation as &#8220;investment companies&#8221; and &#8220;investment advisers&#8221; under U.S. federal and state law; this regulation is intended for the benefit and protection of investors. We do not currently comply with and do not intend to voluntarily comply with these laws and regulations. This means, among other things, that the execution of or changes to our Litecoin strategy, our use of leverage, the manner in which our Litecoin is custodied, our ability to engage in transactions with affiliated parties and our operating and investment activities generally are not subject to the extensive legal and regulatory requirements and prohibitions that apply to investment companies and investment advisers. Consequently, our Board has broad discretion over the investment, leverage and cash management policies it authorizes, whether in respect of our Litecoin holdings or other activities we may pursue and has the power to change our current policies, including our strategy of acquiring and holding Litecoin.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we or our third-party service providers experience a security breach or cyberattack and unauthorized parties obtain access to our Litecoin, or if our private keys are lost or destroyed, or other similar circumstances or events occur, we may lose some or all of our Litecoin and our financial condition and results of operations could be materially adversely affected.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that substantially all of the Litecoin we acquire will be held in custody accounts at U.S.-based institutional-grade digital asset custodians. Security breaches and cyberattacks are of particular concern with respect to digital assets, including Litecoin. Litecoin and other blockchain-based cryptocurrencies and the entities that provide services to participants in the Litecoin ecosystem have been and may in the future be, subject to security breaches, cyberattacks, or other malicious activities. For example, in October 2021 it was reported that hackers exploited a flaw in the account recovery process and stole from the accounts of at least 6,000 customers of the Coinbase exchange, although the flaw was subsequently fixed and Coinbase reimbursed affected customers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Similarly, in November 2022, hackers exploited weaknesses in the security architecture of the FTX Trading digital asset exchange and reportedly stole over $400 million in digital assets from customers. A successful security breach or cyberattack could result in:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a partial or total loss of our Litecoin in a manner that may not be covered by insurance or the liability provisions of the custody agreements with the custodians who hold our Litecoin;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">harm to our reputation and brand;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">improper disclosure of data and violations of applicable data privacy and other laws; or </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant regulatory scrutiny, investigations, fines, penalties and other legal, regulatory, contractual and financial exposure. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, any actual or perceived data security breach or cybersecurity attack directed at other companies with digital assets or companies that operate digital asset networks, regardless of whether we are directly impacted, could lead to a general loss of confidence in the broader Litecoin ecosystem or in the use of the Litecoin network to conduct financial transactions, which could negatively impact us.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attacks upon systems across a variety of industries, including industries related to Litecoin, are increasing in frequency, persistence and sophistication and, in many cases, are being conducted by sophisticated, well-funded and organized groups and individuals, including state actors. The techniques used to obtain unauthorized, improper or illegal access to systems and information (including personal data and digital assets), disable or degrade services, or sabotage systems are constantly evolving, may be difficult to detect quickly and often are not recognized or detected until after they have been launched against a target. These attacks may occur on our systems or those of our third-party service providers or partners. We may experience breaches of our security measures due to human error, malfeasance, insider threats, system errors or vulnerabilities or other irregularities. In particular, we expect that unauthorized parties will attempt to gain access to our systems and facilities, as well as those of our partners and third-party service providers, through various means, such as hacking, social engineering, phishing and fraud. Threats can come from a variety of sources, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage and insiders. In addition, certain types of attacks could harm us even if our systems are left undisturbed. For example, certain threats are designed to remain dormant or undetectable, sometimes for extended periods of time, or until launched against a target and we may not be able to implement adequate preventative measures. Further, there has been an increase in such activities due to the increase in work-from-home arrangements. The risk of cyberattacks could also be increased by cyberwarfare in connection with the ongoing Russia-Ukraine and Israel-Hamas conflicts, or other future conflicts, including potential proliferation of malware into systems unrelated to such conflicts. Any future breach of our operations or those of others in the Litecoin industry, including third-party services on which we rely, could materially and adversely affect our financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Financial Condition and Capital Requirements</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred significant losses from our inception and we anticipate that we may incur losses in the foreseeable future.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage pharmaceutical company. Until recently, we had focused our efforts primarily on developing voruciclib, a selective orally administered CDK9 inhibitor and ME-344 (prior to its sale in October 2024), an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway, with the goal of achieving regulatory approval. In connection with our decision to undertake a comprehensive exploration of strategic alternatives, we have discontinued our clinical programs involving voruciclib and we are currently assessing the recommencement of pre-clinical development of both voruciclib and zandelisib.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since inception, we have incurred significant operating losses. During the fiscal year ended June 30, 2025, we incurred a net loss of $15.9 million, while during the fiscal year ended June 30, 2024, we had net income of $17.8 million. As of June 30, 2025, we have an accumulated deficit of $404.2 million. In connection with the termination of all clinical programs noted above, our R&amp;D expenses have decreased.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Should we resume development activities in the future, we expect that R&amp;D costs would increase and we would continue to incur expenses and operating and net losses, as we develop and seek development and/or commercial relationships with other partners for such drug candidates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our financial results may fluctuate significantly from year to year, depending on the timing of whether we resume development of our drug candidates or any future drug candidates, the timing of any clinical trials, the receipt of payments under any future agreements we may enter into and our expenditures on other R&amp;D activities as well as any payments owed under the License Agreement with Presage and any future similar agreements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Should we resume R&amp;D activities in the future, we expect we would to continue to incur losses for the foreseeable future as we:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue the development of any drug candidate;</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, expand and protect our global intellectual property portfolio;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hire additional clinical, quality control and scientific personnel or utilize consultants or third-party organizations; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support our drug development efforts.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the numerous risks and uncertainties associated with pharmaceutical drug development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve profitability. If we are required by the FDA or foreign regulatory authorities, to perform studies in addition to those currently expected, or if there are any delays in completing our clinical trials or the development of our drug candidate, our expenses could increase.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Whenever we decide to resume development of our drug candidate or any future drug candidate, we may need additional funding and may be unable to raise capital when needed, which would force us to delay, reduce or eliminate our drug development programs.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whenever we resume development of our drug candidates or any future drug candidate, we may need to raise additional capital to continue such development.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our current unrestricted cash and cash equivalents will be sufficient to fund our currently anticipated operating plan for at least the next 12 months. In connection with the termination of all clinical programs, our R&amp;D expenses have decreased, but will resume should we re-commence pre-clinical development of either or both voruciclib and zandelisib. Whenever we resume development activities in the future, we expect that R&amp;D costs would increase. It is possible that the assumptions upon which we have based this estimate may prove to be wrong and we could use our capital resources sooner than we presently expect.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future funding requirements will depend on many factors, including, but not limited to:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the implementation and execution of our Litecoin Treasury Strategy;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whenever we resume development activities in the future, the rate of progress and costs related to development of any drug candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whenever we resume development activities in the future, the rate of progress and costs for any drug candidates that we may in-license or acquire in the future;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights associated with any drug candidate, including any such costs we may be required to expend if our licensors are unwilling or unable to do so;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effect of competing technological and market developments; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms and timing of any collaborative, licensing, co-promotion or other arrangements that we may establish.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future capital requirements will also depend on the extent to which we acquire or invest in additional complementary businesses, products and technologies. Until we can generate a sufficient amount of product revenue, if ever, we may seek to finance future cash needs through public or private equity offerings, debt financings, milestone and royalty payments from corporate collaboration and licensing arrangements, as well as through interest income earned on cash and investment balances. We cannot be certain that additional funding will be available on acceptable terms, or at all and our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions, including high rates of inflation and interest rates, the continuing disruptions to and volatility in the credit and financial markets in the United States and worldwide, including resulting from the ongoing conflicts between Russia and the Ukraine, conflicts in the Middle East and increasing tensions between China and Taiwan.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Any Future Development and Commercialization of Our Drug and Potential Drug Candidates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Should we resume development of our drug candidate or future drug candidates, if we are unable to successfully complete clinical development, obtain regulatory approvals and commercialize our drug candidate or future drug candidates, or experience significant delays in doing so, our business will be materially harmed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2024, we discontinued the clinical programs in our pipeline in connection with our undertaking a comprehensive exploration of strategic alternatives. Should we resume development activities in the future, we cannot be certain that any such drug candidates will be successful in clinical trials or receive regulatory approval. Regulatory authorities may interpret our data differently than we do. We are not permitted to market or promote any of our drug candidates before we receive regulatory approval from the FDA or comparable foreign regulatory authorities; should we resume development activities in the future we may never receive such regulatory approval for voruciclib or any future drug candidates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Should we resume development of our drug candidate or any future drug candidates, the success of such drug candidates will depend on many factors, including but not limited to:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	successful enrollment in and completion of, clinical trials, as well as completion of pre-clinical studies&#894;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	favorable efficacy and acceptable safety data from our clinical trials and other studies&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	receipt of additional regulatory approvals&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	managing our reliance on sole-source third parties such as our third-party vendors, suppliers and manufacturers&#894;</span></p><p style="margin-left:4.533%;text-indent:-2.579%;padding-left:2.4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	the performance by CROs or other third parties and consultants we may retain of their duties to us in a manner that complies with our protocols and applicable laws and that protects the integrity of the resulting data&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	obtaining and maintaining patent, trade secret and other intellectual property protection and regulatory exclusivity&#894;</span></p><p style="margin-left:4.533%;text-indent:-2.579%;padding-left:2.4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	ensuring we do not infringe, misappropriate or otherwise violate the valid patent, trade secret or other intellectual property rights of third parties&#894;</span></p><p style="margin-left:4.533%;text-indent:-2.579%;padding-left:2.4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	successfully launching, either alone or with a commercial partner, any drug candidate for which regulatory approval is received&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	obtaining and maintaining favorable reimbursement from third-party payers and governments for drugs and drug candidates&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	competition with other drugs&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	post-marketing commitments, if any, to regulatory agencies following regulatory approval of any drug candidate&#894;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	continued acceptable safety profile following regulatory approval&#894; and</span></p><p style="margin-left:4.533%;text-indent:-2.579%;padding-left:2.4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9679;	manufacturing or obtaining sufficient supplies of our drugs and any drug candidate that may be necessary for use in clinical trials for evaluation of any drug candidate and commercialization of any approved drug.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we do not achieve and maintain one or more of these factors in a timely manner or at all, we could experience significant delays in our ability to, or be unable to obtain regulatory approvals for and/or to successfully commercialize any drugs or drug candidates, which would materially harm our business and we may not be able to generate sufficient revenues and cash flows to continue our operations.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The value of our intellectual property is dependent, in part, on obtaining and maintaining patent protection and preserving trade secrets, which cannot be guaranteed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patent protection and trade secret protection are important to our business and our future will depend, in part on our ability to maintain trade secret protection, obtain patents and operate without infringing the proprietary rights of others both in the U.S. and abroad. Litigation or other legal proceedings may be necessary to defend against claims of infringement, to enforce our patents or to protect our trade secrets. Such litigation could result in substantial costs and diversion of our management&#8217;s attention.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent positions of pharmaceutical and biotechnology companies can be highly uncertain and involve complex legal and factual questions. We acquired patents and patent applications related to voruciclib from Presage in 2017 and in September 2013, we acquired patents and patent applications related to zandelisib from Pathway Therapeutics, Inc.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent applications may not proceed to grant or may be amended to reduce the scope of protection of any patent granted. The applications and patents may also be opposed or challenged by third parties. Should we resume development of our drug candidate or any future drug candidates, our commercial success will depend, in part, on our ability to obtain and maintain effective patent protection for our compounds and their use in treating, preventing, or curing cancer and to successfully defend patent rights in those technologies against third-party challenges. As patent applications in the U.S. are maintained in secrecy until published or issued and as publication of discoveries in the scientific or patent literature often lag behind the actual discoveries, we cannot be certain that we or Presage were the first to make the inventions covered by the pending patent applications or issued patents referred to above or that we or they were the first to file patent applications for such inventions. Additionally, the breadth of claims allowed in biotechnology and pharmaceutical patents or their enforceability cannot be predicted. We cannot be sure that, should any patents issue, we will be provided with adequate protection against potentially competitive products. Furthermore, we cannot be sure that should patents issue, they will be of commercial value to us, or that private parties, including competitors, will not successfully challenge our patents or circumvent our patent position in the U.S. or abroad.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Business Risks</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our employees, independent contractors, consultants or commercial partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees, independent contractors, consultants or commercial partners could include intentional, reckless, negligent, or unintentional failures to comply with FDA regulations, comply with applicable fraud and abuse laws, provide accurate information to the FDA, properly calculate pricing information required by federal programs, comply with federal procurement rules or contract terms, report financial information or data accurately or disclose unauthorized activities to us. It is not always possible to identify and deter this type of misconduct and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Moreover, it is possible for a whistleblower to pursue a False Claims Act (FCA), case against us even if the government considers the claim unmeritorious and declines to intervene, which could require us to incur costs defending against such a claim. Further, due to the risk that a judgment in an FCA case could result in exclusion from federal health programs or debarment from government contracts, whistleblower cases often result in large settlements. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, financial condition and results of operations, including the imposition of significant fines or other sanctions.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business and operations would suffer in the event of system failures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our internal computer systems and those of other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our drug candidate development and, if such drug candidates are approved commercialization programs. For example, the loss of clinical trial data from completed clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of or damage to our data or applications, or inappropriate disclosure of personal, confidential or proprietary information, we could incur liability and regulatory enforcement actions and the further development of any of our drug candidates could be delayed.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our efforts will be seriously jeopardized if we are unable to retain and attract key employees.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends on the continued contributions of our principal management, development and availability of consultants or third-party scientific personnel. We face competition for such personnel and we believe that risks and uncertainties related to our business, including the timing and risk associated with R&amp;D, our available and anticipated cash resources and the volatility of our stock price, may impact our ability to hire and retain key and other personnel. The loss of services of our Acting Chief Executive Officer and Chief Financial Officer or other key employees could adversely impact our operations and ability to generate or raise additional capital.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Negative U.S. and global economic conditions may pose challenges to our business strategy, which relies on funding from the financial markets or collaborators.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Negative conditions in the U.S. or global economy, including financial markets, may adversely affect our business and the business of current and prospective vendors, licensees and collaborators and others with whom we do or may conduct business. The duration and severity of these conditions is uncertain. If negative economic conditions occur, we may be unable to secure funding on terms satisfactory to us to sustain our operations or to find suitable collaborators to advance our internal programs, even if we achieve positive results from our drug development programs.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Laws, rules and regulations relating to public companies may be costly and impact our ability to attract and retain directors and executive officers.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws and regulations affecting public companies, including rules adopted by the SEC and by Nasdaq, may result in increased costs to us. These laws, rules and regulations could make it more difficult or costly for us to obtain certain types of insurance, including director and officer liability insurance and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified persons to serve on our Board, on our board committees or as executive officers. We cannot estimate accurately the amount or timing of additional costs we may incur to respond to these laws, rules and regulations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security breaches and privacy issues could compromise our information and expose us to liability, which would cause our business and reputation to suffer.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of our business, we collect and store sensitive data, including intellectual property, our proprietary business information and that of our suppliers, as well as personally identifiable information of clinical trial participants and employees. Similarly, our third-party providers possess certain of our sensitive protected health data. The secure maintenance of this information is critical to our operations and business strategy. Despite our reasonable security measures, our information technology and infrastructure may be vulnerable to cyber-attacks or breached due to employee error, malfeasance or other disruptions. Cyber-attacks and other security incidents are increasing in their frequency, levels of persistence, sophistication and intensity and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise. Although we develop and maintain systems and controls designed to prevent these events from occurring and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become more sophisticated and such systems, controls and processes may not be successful in preventing a breach or other incident. Any such security incident could compromise our networks and the information stored there could be accessed, publicly disclosed, encrypted, lost or stolen. We could be required to expend significant amounts of money and other resources to repair or replace information systems or networks. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyber-attacks and other related security incidents.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The legislative and regulatory landscape for privacy and data protection continues to evolve and there has been an increasing amount of focus on privacy and data protection issues with the potential to affect our business, including compliance with the Health Insurance Portability and Accountability Act of 1996 and state laws requiring security breach notification. The collection and use of personal health data of individuals in the European Union is also governed by strict data protection laws. In addition to existing laws, since May 25, 2018, the General Data Protection Regulation (GDPR) has imposed obligations with respect to European Union data and substantial fines for breaches of the data protection rules. The GDPR increased our responsibility and potential liability in relation to personal data that we process and we were required to implement additional mechanisms to comply with the GDPR and related European Union data protection rules. Enforcement uncertainty and the costs associated with ensuring GDPR compliance may be onerous and adversely affect our business, operating results, prospects and financial condition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to evaluate the legal issues that arise concerning transfer of personal data of residents of the European Economic Area (EEA) member states or the U.K. to the U.S. or other jurisdictions that are not deemed adequate by the European Commission. Among other steps, we are implementing the new standard contractual clauses issued on June 4, 2021 by the European Commission. It remains uncertain how these standard contractual clauses will be implemented by the data exporters and data importers and whether they will ultimately be deemed sufficient by European courts. Lite Strategy observes the developments and will agree to the appropriate data transfer mechanism. In addition to standard contractual clauses, we may rely on individual contents of the patients where appropriate and necessary to safeguard the data flow from the EU to the U.S. Present solutions to legitimize transfers of personal data from the EEA may be challenged or deemed insufficient. We may, in addition to other impacts, experience additional costs associated with increased compliance burdens and we and our customers face the potential for regulators in the EEA or U.K. to apply different standards to the transfer of personal data from the EEA/U.K. to the U.S. and to block, or require ad hoc verification of measures taken with respect to, certain data flows from the EEA or U.K. to the U.S. We also may be required to engage in new contract negotiations with third parties that aid in processing data on our behalf. We may experience reluctance or refusal by current or prospective European clinical trial sites and CROs to use our products and we may find it necessary or desirable to make further changes to our processing of personal data of EEA or U.K. data subjects.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, California has the California Consumer Privacy Act (CCPA), which creates individual privacy rights for consumers (as that word is broadly defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA may significantly impact our business activities and require substantial compliance costs that adversely affect business, operating results, prospects and financial condition. Amendments to the CCPA mandated by the California Privacy Rights Act (CPRA) will impose additional privacy requirements, effective on January 1, 2023. Similarly comprehensive state consumer privacy laws in other states, such as Virginia, Utah, Connecticut and Colorado will also become effective in 2023. These new state privacy measures may reflect the start of a movement in other state legislatures to enact more comprehensive privacy laws, which would create a more complex privacy regulatory landscape for our business in the U.S. In addition, there is privacy legislation and rule making efforts at the federal level which may increase our privacy obligations in the U.S.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Thus, any access, disclosure or other loss of information, including our data being breached at our partners or third-party providers, along with violations of privacy laws that exist and are increasing around the world, could result in legal claims or proceedings and liability under laws that protect the privacy of personal information, disrupt our operations and damage our reputation, which could adversely affect our business.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable materials, including chemicals and biological materials and may also produce hazardous waste. Even if we contract with third parties for the disposal of these materials and waste, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any resulting damages and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, but this insurance may not provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We or the third parties upon whom we depend may be adversely affected by natural disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Events outside of our control, including natural disasters and public health emergencies, could severely disrupt our operations and have a material adverse effect on our business, operating results, prospects or financial condition. If a natural disaster, or public health emergency, power outage or other event occurred that prevented us from conducting our clinical trials, including by damaging our critical infrastructure, such as third-party facilities, or that otherwise disrupted operations and travel, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. The disaster recovery and business continuity plans we have in place may prove inadequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which could have a material adverse effect on our business, operating results, prospects or financial condition.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Limitations on the deductibility of net operating losses could adversely affect our business and financial condition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a history of net operating losses. In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the Tax Act). The Tax Act limits the deduction of net operating losses to 80% of current year taxable income. The limitations on the net operating loss deduction, as well other changes in tax policy, may subject us to additional taxation, adversely affecting our results of operations and financial condition.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Securities Markets and Investment in our Stock</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are currently operating in a period of capital markets disruption and economic uncertainty.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. capital markets </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are currently experiencing extreme volatility and disruption following the global outbreak of COVID-19, high inflation and the government response thereto, potential economic downturn, publicized failures in the regional banking sector, the war in Ukraine, the upcoming U.S. presidential election and other global events. Disruptions in the capital markets in the past have resulted in illiquidity in parts of the capital markets. Future market disruptions and/or illiquidity would be expected to have an adverse effect on our business, financial condition, results of operations and cash flows. Unfavorable economic conditions also would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us should that become required for us to fund ongoing operations. These events have limited and could continue to limit our capital investment considerations, limit our abilit</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">y to fund further clinical development, limit our ability to implement our Litecoin Treasury Strategy and have a material negative impact on our operating results.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with the continued listing standards of the Nasdaq Capital Market, we may be delisted and the price of our common stock, our ability to access the capital markets and our financial condition could be negatively impacted.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is currently listed on Nasdaq under the symbol LITS. To maintain the listing of our common stock on the Nasdaq Capital Market, we are required to meet certain listing requirements, including, among others, maintaining a minimum closing bid price of $1.00 per share. If we fail to comply with the continued listing standards and the Nasdaq Capital Market delists our securities from trading on its exchange, we and our stockholders could face significant negative consequences including: reducing the liquidity and market price of our common stock; reducing the number of investors willing to hold or acquire our common stock, which could negatively impact our ability to raise equity financing; decreasing the amount of news and analyst coverage of us; and limiting</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to issue additional securities or obtain additional financing in the future. In addition, delisting from Nasdaq may negatively impact our reputation and, consequently, our business.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The trading price of the shares of our common stock has been and may continue to be highly volatile and could decline in value and we may incur significant costs from class action litigation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading price of our common stock could be highly volatile in response to various factors, many of which are beyond our control, including, but not limited to, the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to successfully develop our drug candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the trading price of, and other developments or events relating to the value of Litecoin; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">design, results and timing of pre-clinical studies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements of technological innovations by us or our competitors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">new products introduced or announced by us or our competitors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in financial estimates by securities analysts;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actual or anticipated variations in operating results;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expiration or termination of licenses, research contracts or other collaboration agreements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conditions or trends in the regulatory climate and the biotechnology, pharmaceutical and genomics industries;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">instability in the stock market as a result of current or future domestic and global events;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the market valuations of similar companies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the liquidity of any market for our securities; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">threatened or actual delisting of our common stock from a national stock exchange.</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity markets in general and the market for biotechnology and life sciences companies in particular, have experienced substantial price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of companies traded in those markets. In addition, changes in economic conditions in the U.S., the Europe or globally, particularly in the context of current global events, could impact upon our ability to grow profitably. Adverse economic changes are outside our control and may result in material adverse impacts on our business or our results of operations. These broad market and industry factors may materially affect the market price of shares of our common stock, regardless of our development and operating performance. In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class-action litigation has often been instituted against that company. Such litigation, if instituted against us, could cause us to incur substantial costs and divert management&#8217;s attention and resources.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future sales of our common stock, including common stock issued upon exercise of outstanding warrants or options, may depress the market price of our common stock and cause stockholders to experience dilution.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price of our common stock could decline as a result of sales of substantial amounts of our common stock in the public market, including upon exercise of outstanding warrants or stock options and any subsequent sales of such shares. As of June 30, 2025, we had outstanding warrants exercisable to purchase 102,513 shares of common stock at an exercise price of $6.80 per share, which expire in </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 2027. Subsequent to June 30, 2025, we issued warrants exercisable to purchase up to 3,070,177 shares of common stock with a weighted-average exercise price of $4.10 as </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more fully described in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also have outstanding options to purchase 869,148 shares of common stock. We may seek additional capital through one or more additional equity transactions in the future, such as the one completed subsequent to June 30, 2025 and more fully described in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; however, such transactions will be subject to market conditions and there can be no assurance any such transactions will be completed. If we sell shares in the future, the prices at which we sell these future shares will vary and these variations may be significant. Stockholders will experience significant dilution if we sell these future shares at prices significantly below the price at which such previous stockholders invested.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other than as described below or in connection with a strategic transaction we do not intend to pay and we have not paid, any cash dividends on our shares of common stock. Our stockholders will not be able to receive a return on their shares unless the value of our common stock appreciates and they sell their shares.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#1d2228;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than the Capital Return, w</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e have never paid or declared any cash dividends on our common stock and we intend to retain any future earnings to finance the development and expansion of our business. We do not anticipate paying any cash dividends on our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">common stock in the foreseeable future. Therefore, our stockholders will not be able to receive a return on their investment unless the value of our common stock appreciates and they sell their shares.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will have broad discretion over the use of the net proceeds from any exercise of outstanding warrants and options.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will have broad discretion to use the net proceeds to us upon any exercise of outstanding warrants and options and investors in our stock will be relying on the judgment of our Board and management regarding the application of these proceeds. Although we expect to use a substantial portion of the net proceeds from any exercise of the warrants and options for general corporate purposes and progression of our clinical trial programs, we have not allocated these net proceeds for specific purposes.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are authorized to issue blank check preferred stock, which could adversely affect the holders of our common stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation allows us to issue blank check preferred stock with rights potentially senior to those of our common stock without any further vote or action by the holders of our common stock. The issuance of a class of preferred stock could decrease the amount of earnings and assets available for distribution to the holders of our common stock or could adversely affect the rights and powers, including voting rights, of such holders. In certain circumstances, such issuance could have the effect of decreasing the market price of our shares or making a change in control of the company more difficult.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-takeover provisions contained in our amended and restated certificate of incorporation and sixth amended and restated bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation and sixth amended and restated bylaws contain provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together, these provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities. These provisions include:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a staggered board providing for three classes of directors, which limits the ability of a stockholder or group to gain control of our board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the right of our board to elect a director to fill a vacancy created by the expansion of our board or the resignation, death or removal of a director in certain circumstances, which prevents stockholders from being able to fill vacancies on our board; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advance notice procedures that stockholders must comply with in order to nominate candidates to our board or to propose matters to be acted upon at a meeting of stockholders, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of us. </span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our sixth amended and restated bylaws require, to the fullest extent permitted by law, that derivative actions brought in our name, actions against our directors, officers, other employees or stockholders for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder&#8217;s counsel, which may have the effect of discouraging lawsuits against our directors, officers, other employees or stockholders.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our sixth amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will, to the fullest extent permitted by law, be the sole and exclusive forum for any stockholder to bring (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of ours to us or our stockholders, (iii) any action asserting a claim pursuant to any provision of the Delaware General Corporation Law, or (iv) any action asserting a claim governed by the internal affairs doctrine and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder&#8217;s counsel, provided, however, that, in each case, if the Court of Chancery does not have jurisdiction, the forum for such action shall be another state court located within the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware, in all cases subject to the court having personal jurisdiction over the indispensable parties named as defendants therein.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any person or entity purchasing or otherwise acquiring or holding any interest in our shares of capital stock shall be deemed to have notice of and consented to such provisions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, the forum selection provision of our sixth amended and restated bylaws will not apply to suits brought to enforce any liability or duty created by the federal securities laws or any other claim for which the federal district courts of the U.S. of America shall be the sole and exclusive forum.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provision contained in our sixth amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our executive officer and directors may sell shares of their stock and these sales could adversely affect our stock price.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of our stock by our executive officer and directors, or the perception that such sales may occur, could cause the market price of our common stock to decline or could make it more difficult for us to raise funds through the sale of equity in the future, either as part, or outside, of trading plans under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the Exchange Act).</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_4"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolved Staff Comments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_properties"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><div><ix:nonNumeric id="F_851bdded-de42-4a3e-ae5e-445113cf5da2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_851bdded-de42-4a3e-ae5e-445113cf5da2_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the importance cybersecurity has to the success of our business, as well as recognize the need to continually assess cybersecurity risks and evolve our responses in the face of a rapidly and ever-changing environment. Accordingly, we aim to protect our business operations, records and information against known and evolving cybersecurity threats.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Risk Management and Strategy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_e89b2f3e-b3a3-4349-9eac-0c4f9b0a154a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established policies and processes for assessing, identifying and managing material risk from cybersecurity threats and have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_91d48d31-a236-4a58-a031-c44f3ca6632b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing within these systems.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks and the sufficiency of existing policies, procedures, systems and safeguards in place to manage such risks.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Following these risk assessments, we re-design, implement and maintain reasonable safeguards to minimize identified risks, reasonably address any identified gaps in existing safeguards and regularly monitor the effectiveness of our safeguards. Primary responsibility for assessing, monitoring and managing our cybersecurity risks rests with the Senior Director, Information Security and Infrastructure who reports to our Acting Chief Executive Officer and Chief Financial Officer to manage the risk assessment and mitigation process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with our Information Technology department. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings and internal communications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If required, we </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8058ccb8-6686-4a39-8f9e-c69ea6ded67b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">engage</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consultants, or other third parties in connection with our risk assessment processes. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0939c083-93a6-406a-aa19-66c6c8acf782" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These service providers, where appropriate, assist us in the assessment, testing or other aspects of our security controls to help identify material cybersecurity risks to our critical systems, information, products, services and our broader enterprise IT environment, as well as assist us in designing and implementing our cybersecurity policies and procedures. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_941b5fce-7f0d-4ddb-837b-b01becff5879" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing. For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#8220;Risk Factors,&#8221; in this annual report on Form 10-K.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_2d3a1bbb-5d39-44b5-8aa9-8df0c593dfa4" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true" continuedAt="F_2d3a1bbb-5d39-44b5-8aa9-8df0c593dfa4_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Governance </span></ix:nonNumeric></span><span style=""></span></p><div><ix:continuation id="F_2d3a1bbb-5d39-44b5-8aa9-8df0c593dfa4_1" continuedAt="F_2d3a1bbb-5d39-44b5-8aa9-8df0c593dfa4_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board considers cybersecurity risk as part of its risk oversight function and has delegated oversight of cybersecurity and other information technology risks to the Audit Committee. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ab63ce1e-c060-41e0-b36f-b1cc94c0a840" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af7bdff5-7fbe-424f-bd15-a1bbb215a882" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee oversees management&#8217;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.</span></ix:nonNumeric></span></p></ix:continuation></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_851bdded-de42-4a3e-ae5e-445113cf5da2_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2d3a1bbb-5d39-44b5-8aa9-8df0c593dfa4_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fae7a987-c780-431c-b8c1-1c65a2f65482" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee receives annual reports from management on our cybersecurity risks. In addition, management updates the Audit Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential.</span></ix:nonNumeric></span></p><div><ix:nonNumeric id="F_eed4e0a5-efbd-4dae-b89f-c999b792fab2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5b50b3fc-36c5-4848-9563-6498b19e8aeb" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_429eaafb-c5f7-4341-8fca-87ba3876e8b2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67b1ef74-92fc-4704-a867-4325737df9fd" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p></ix:continuation></div></ix:continuation></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_5"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Properties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_6"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Legal Proceedings</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are not currently party to a material legal proceeding that we believe will have a material adverse effect on our business or financial conditions.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_7"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine Safety Disclosures</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_toc58841_8"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II</span><span id="fis_market"></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_9"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is listed on the Nasdaq Capital Market under the symbol LITS.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of September 23, 2025, there were 35,655,155 shares of our common stock outstanding and 315 holders of record of our common stock. This number was derived from our stockholder records and does not include beneficial owners of our common stock whose shares are held in the name of various dealers, clearing agencies, banks, brokers and other fiduciaries.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a discussion of outstanding warrants and other securities exercisable for or convertible into shares of our common stock, see </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 10 - Stockholders' Equity</span><span style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><a href="#fn11_sbc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 11 - Share-based Compensation</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> under </span><a href="#d58841d10k_htm_toc58841_13"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Item 8 Consolidated Financial Statements and Supplementary Data</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in this Annual Report.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 6, 2023, pursuant to the Cooperation Agreement, the Board declared a special cash dividend of $1.75 per share of common stock to stockholders of record at the close of business on November 17, 2023. The total dividend of $11.7 million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. We do not anticipate paying additional cash dividends in the foreseeable future and currently intend to retain all available funds and future earnings, if any, to support operations. Any future determination related to our dividend policy will be made at the discretion of our board of directors.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities authorized for issuance under equity compensation plans</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below shows, as of June 30, 2025, information for equity compensation plans previously approved by stockholders and for compensation plans not previously approved by stockholders.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.309%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:14.783%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.26%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.442%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:19.204%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Plan Category</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities<br/>to be issued upon<br/>exercise of<br/>outstanding options,<br/>warrants and rights<br/>(a)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-average<br/>exercise price of<br/>outstanding options,<br/>warrants and rights<br/>(b)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities<br/>remaining available for future<br/>issuance under equity<br/>compensation plans<br/>(excluding securities<br/>reflected in column (a))<br/>(c)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation plans approved by security<br/>&#160;&#160;&#160;&#160;holders (1)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">815,846</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.66</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">920,737</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation plans not approved by security<br/>&#160;&#160;&#160;&#160;holders (2)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,302</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.01</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163,698</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869,148</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.90</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,084,435</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 815,846 shares of common stock issuable upon exercise of options granted under the MEI Pharma, Inc. Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Omnibus Plan), under which 1,850,739 shares of common stock are authorized for issuance. The Omnibus Plan provides for the grant of options and/or other stock-based or stock-denominated awards to our non-employee directors, officers, employees and advisors. The weighted-average exercise price presented is the weighted-average exercise price of vested and unvested options. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 53,302 shares of common stock issuable upon exercise of options granted under the MEI Pharma, Inc. 2021 Inducement Plan (Inducement Plan), under which 217,000 shares of common stock are authorized for issuance. The Inducement Plan provides for the grant of options and/or other stock-based or stock-denominated awards to attract and retain selected individuals to serve as employees. The weighted-average exercise price presented is the weighted-average exercise price of vested and unvested options. </span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_10"><span id="fis_financial_data"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6. [Reserved]</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_11"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following discussion and analysis should be read in conjunction with </span><a href="#d58841d10k_htm_toc58841_13"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Item 8. Consolidated Financial Statements and Supplementary Data</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> included below in this Annual Report. Operating results are not necessarily indicative of results that may occur in future periods.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This discussion and analysis contains forward-looking statements that involve a number of risks, uncertainties and assumptions. Actual results may differ materially from those anticipated in the forward-looking statements as a result of many factors including, but not limited to, those set forth under Cautionary Statement About Forward-Looking Statements and Risk Factors in </span><a href="#d58841d10k_htm_toc58841_3"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Item 1A. Risk Factors</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> included above in this Annual Report. All forward-looking statements included in this Annual Report are based on the information available to us as of the time we file this Annual Report and except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pharmaceutical company that has been developing novel and differentiated cancer therapies. We </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships and out-licensing or commercialization, as appropriate. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development Programs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PI3K&#948;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> inhibitor.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a more complete discussion of our business, see the section of this Annual Report </span><a href="#d58841d10k_htm_toc58841_2"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Item 1. Business</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> above.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="mda_recentdevel"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Developments</span></p><p style="margin-left:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Notification of Strategic Alternatives Evaluation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On July 22, 2024, we announced that our Board had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force beginning August 1, 2024, which continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets will continue to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing opportunities for or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consistent with our intention to preserve cash, David M. Urso, our President and Chief Executive Officer and Richard Ghalie, MD, our Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our current Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as Chairperson of the Board.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Investment in Private Equity (PIPE) and Related Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in July 2025, we closed on a $100.0 million PIPE and issued an aggregate of (i) 23,216,898 shares (the Shares) of our common stock, at an offering price of $3.42 per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the common stock, the Securities)), to purchase up to an aggregate of 6,022,869 shares of our common stock (the Pre-Funded Warrant Shares) at an offering price of $3.4199 per Pre-Funded Warrant (collectively, the Offering). On July 24, 2025, Pre-Funded Warrants for the purchase of 2,084,509 shares of common stock were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued 2,807,967 shares of common stock upon cashless exercises of 2,808,070 Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, in July 2025 and as more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Investment Strategy, including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the-market sales agreement. In connection with these various agreements associated with the PIPE, we issued warrants for the purchase of up to 3,070,177 shares of our common stock with a weighted-average exercise price of approximately $4.10 per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, 546,348 Pre-Funded Warrants with an exercise price of $0.0001 per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litecoin Treasury Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.</span></p><p style="margin-left:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $1.75 per share of common stock that was declared on November 6, 2023 to stockholders of record at the close of business on November 17, 2023 (Cooperation Agreement). The total dividend of $11.7 million was paid on</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 6, 2023 and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Merger Termination</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At a special meeting of our stockholders held on July 23, 2023, stockholders voted on the agreement and plan of merger (Merger Agreement) entered into in February 2023, by us, Infinity Pharmaceuticals, Inc. (Infinity) and Meadow Merger Sub, Inc., our wholly owned subsidiary (Merger Sub). At such special meeting, the Merger Agreement did not obtain the necessary approval from our stockholders and, accordingly, on July 23, 2023, we sent Infinity a notice terminating the Merger Agreement.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical accounting policies are those most important to the portrayal of our financial condition and results of operations and require management&#8217;s difficult, subjective, or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Certain accounting estimates are particularly sensitive because of their significance to financial statements and because of the possibility future events affecting the estimate may differ significantly from management&#8217;s current judgments. We believe the following critical accounting policies involve the most significant estimates and judgments used in the preparation of our consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as provided below, there have been no material changes from the critical accounting estimates identified below nor our significant accounting policies set forth in </span><a href="#fn2_sumsigpolicies"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets (Property and Equipment and Intangible Assets)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the authoritative guidance for impairment or disposal of long-lived assets Accounting Standards Codification (ASC) Topic 360, Property, Plant and Equipment (ASC 360), we assess potential impairments to our long-lived assets, including property, equipment and right-of-use assets, when there is evidence that events or changes in circumstances indicate that the carrying value may not be recoverable. We recognize an impairment loss when the undiscounted cash flows expected to be generated by an asset (or group of assets) are less than the asset&#8217;s carrying value. Any required impairment loss would be measured as the amount by which the asset&#8217;s carrying value exceeds its fair value and would be recorded as a reduction in the carrying value of the related asset and charged to results of operations. Assumptions and estimates used in evaluating our long-lived assets future values and remaining useful lives are complex and often subjective. They can be affected by a variety of factors, including external factors such as industry and economic trends and internal factors such as changes in our business strategy, internal forecasts and clinical trial results. For example, if we experience a sustained decline in our market capitalization determined to be indicative of a reduction in fair value of our enterprise, we may be required to record future impairment charges for our acquired technology intangible assets with finite lives.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impairment charges could materially decrease our future net income and result in lower asset values on our balance sheet. Key assumptions include, but are not limited to, future cash flows, operating margins, capital expenditures, terminal growth rates and discount rates. We also consider our market capitalization as a part of our analysis. During the fiscal year ended June 30, 2024, we recorded long-lived asset impairment charges of $10.9 million. During the fiscal year ended June 30, 2025, we had no similar charge. For additional details regarding our intangible assets and related impairments see </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3&#8212;Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9&#8212;Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to our consolidated financial statements and related notes included elsewhere in this Annual Report.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We apply the five-step revenue recognition model within the scope of ASC Topic 606, Revenue from Contracts with Customers (ASC 606). Under this model, we: (i) identify the contract, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract and (v) recognize revenue when, or as, a company satisfies a performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service and is the unit of accounting in ASC 606. A contract&#8217;s transaction price is allocated among each distinct performance obligation based on relative standalone selling price and recognized as revenue when, or as, the applicable performance obligation is satisfied.&#8204;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The terms of our arrangements include upfront and license fees, R&amp;D services, milestone and other contingent payments for the achievement of defined objectives and certain pre-clinical, clinical, regulatory and sales-based events, as well as royalties on sales of commercialized products. Agreements with certain upfront payments may require deferral of revenue recognition to a future period until we perform the obligations under these agreements. We use the most likely amount method to estimate variable consideration for event-based milestones and other contingent payments. Given the high degree of uncertainty around the occurrence of such events, the event-based milestones and other contingent payments have been fully constrained until any uncertainty associated with these payments is resolved. Revenue from sales-based milestones and royalty payments is recognized at the later of when or as the sales occur or when the related performance obligation has been satisfied or partially satisfied. We continue to re-evaluate the transaction price in each reporting period as contingencies are resolved and other changes in circumstances occur.&#8204;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue recognition is subject to uncertainty due to the variable consideration estimates required to be made. These estimates include the level of effort required to satisfy our obligations under our R&amp;D services arrangements. These amounts are estimated at the inception of the services arrangement and are re-evaluated at each reporting period. To accomplish this, we rely on management&#8217;s experience, relevant internal data reports and regulatory approvals. The recorded variable consideration is directly sensitive to the estimated inputs made by management used in the calculation. Changes in estimates are accounted for prospectively.&#8204;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In response to the discontinuance of zandelisib development with KKC during the fiscal year ended June 30, 2023, we updated our estimated costs to complete each of the performance obligations, which resulted in a higher progress towards completion based on the ratio of costs incurred to date to the total estimated costs and a corresponding decrease in our deferred revenue. Additionally, we recognized revenue related to non-refundable payments for performance obligations that have not commenced and will no longer be initiated. During fiscal year 2024, in regard to the KKC Commercialization Agreement, </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all deferred revenue had been recognized </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and all wind-down activities were completed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred and include costs paid to third-party contractors to perform research, conduct clinical trials and develop and manufacture drug materials. Clinical trial costs, including costs associated with third-party contractors, are a significant component of R&amp;D expenses and we expense R&amp;D costs based on work performed. Costs incurred related to the purchase or licensing of in-process R&amp;D for early-stage products or products that are not commercially viable and ready for use, or have no alternative future use, are charged to expense in the period incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the process of preparing the consolidated financial statements, we are required to estimate expenses resulting from obligations under contracts with vendors, clinical research organizations (CROs), consultants and under clinical site agreements relating to conducting clinical trials. The financial terms of these contracts vary and may result in payment flows that do not match the periods over which materials or services are provided under such contracts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our objective is to reflect the appropriate clinical trial expenses in our consolidated financial statements by recording those expenses in the period in which services are performed and efforts are expended. We account for these expenses according to the progress of the clinical trial as measured by patient progression and the timing of various aspects of the trial. Management determines accrual estimates through financial models and discussions with applicable personnel and outside service providers as to the progress of clinical trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During a clinical trial, we adjust the clinical expense recognition if actual results differ from our estimates. We make estimates of accrued expenses as of each balance sheet date based on the facts and circumstances known at that time. Our clinical trial accruals are partially dependent upon accurate reporting by CROs and other third-party vendors. Our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in changes in our estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025, we had no active clinical trial programs.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comparison of Fiscal Years Ended June 30, 2025 and 2024</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes certain components of our results of operations (in thousands):</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:91.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:43.189%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.022%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.342%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.602%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.842%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Change</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenues</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,297</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(65,297</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100.0</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,923</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,561</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(12,638</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(76.3</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,532</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,295</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(9,763</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(41.9</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,899</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(10,899</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100.0</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,510</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,236</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,726</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(53.3</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
   </table><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> During the fiscal year ended June 30, 2025, we recognized no revenue due to all deferred revenue associated with the KKC Commercialization Agreement having been recognized in fiscal year 2024, upon entry into the Termination Agreement. During the fiscal year ended June 30, 2024, we recognized revenue of $65.3 million from </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the KKC Commercialization Agreement.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The following table illustrates the components of our research and development expenses for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_unidentified_table_9"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:63.78%;box-sizing:content-box;"/>
     <td style="width:1.3%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.72%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.3%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:13.9%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zandelisib</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">435</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">voruciclib</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">801</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,413</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ME-344</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">253</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,724</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,887</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,923</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,561</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs decreased by $12.6 million to $3.9 million for the fiscal year ended June 30, 2025, compared to $16.6 million for the fiscal year ended June 30, 2024. This decrease was as a result of our announcement in July 2024 to explore strategic alternatives, at which time all clinical studies were ceased and we initiated reductions in our workforce, along with the ME-344 Sale (as defined in </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disposition of a Non-Financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> General and administrative expenses decreased $9.8 million to $13.5 million for the fiscal year ended June 30, 2025, compared to $23.3 million for the fiscal year ended June 30, 2024. This decrease was primarily a result of reduced legal and professional fees of $3.7 million due to various stockholder related items from the prior fiscal year with no current period recurrence. Additionally, corporate overhead, employee related expense and noncash share-based compensation decreased by $3.4 million, $4.4 million and $1.9 million, respectively, primarily due to the termination of our lease and our announcement in July 2024 to explore strategic alternatives, at which time all administrative support activities related to clinical studies were ceased. These decreases were partially offset by increases in termination benefits of $3.6 million.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, we recognized impairment losses of $10.4 million and $0.5 million, on our long-lived assets related to our right-of-use (ROU) asset (which is more fully described in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and our furniture and fixtures we agreed to sell to our landlord (which is more fully described in </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3 - Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, recorded in accordance with Accounting Standards Codification 360 - </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property, Plant and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), respectively. During the fiscal year ended June 30, 2025, there were no similar transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Other income, net, decreased by $1.7 million to $1.5 million for the fiscal year ended June 30, 2025, as compared to $3.2 million for the fiscal year ended June 30, 2024. The decrease in other income, net, was due to lower average investment balances partially offset by a gain recognized on the sale of our ME-344 asset.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See </span><a href="#fn1_title"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the Consolidated Financial Statements included in </span><a href="#d58841d10k_htm_toc58841_13"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Item 8. Consolidated Financial Statements and Supplementary Data</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of this Annual Report.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have accumulated losses of $404.2 million since inception and expect to incur operating losses and generate negative cash flows from operations for the foreseeable future. As of June 30, 2025, we had $18.0 million in cash and cash equivalents. On July 22, 2024, we announced that our Board had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. In connection with the exploration of strategic alternatives, we commenced a reduction-in-force on August 1, 2024 and discontinued the clinical development of voruciclib. As a result of this announcement, our R&amp;D expenses decreased significantly as we discontinued our clinical R&amp;D activities. We are currently assessing the recommencement of pre-clinical development of our two drug candidates. We believe our current cash balance is sufficient to fund operations for at least the next 12 months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2025, we entered into securities purchase agreements pursuant to which we sold common stock and Pre-Funded Warrants in a PIPE for aggregate net proceeds of $92.1 million, as more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In August 2025, we initiated a primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the deployment of the net proceeds of the PIPE.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> between the SPA Closing Date (as defined in  </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and September 19, 2025, we issued and sold 882,924 shares of our common stock for aggregate proceeds, net of the underwriter's commission of $4.6 million, through our ATM Program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements and to resume the development of our drug candidates we would require one or more capital transactions, whether through the sale of equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">securities, debt financing, license agreements or entry into strategic partnerships at some point in the future. There can be no assurance that we will be able to continue to raise additional capital in the future.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources and Uses of Our Cash</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in operating activities for the fiscal year ended June 30, 2025, of $20.8 million consisted of our net loss of $15.9 million and $4.9 million associated with changes in our operating assets and liabilities used in our operations. Net cash used in operating activities during the fiscal year ended June 30, 2024, of $50.5 million consisted of our net income of $17.8 million and $84.3 million associated with changes in our assets and liabilities used in our operations partially offset by $16.0 million of noncash items.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by investing activities for the fiscal year ended June 30, 2025, was $35.2 million compared to $49.1 million for the fiscal year ended June 30, 2024. The decrease in net cash provided by investing activities was due to a greater investment balance and maturities in fiscal year ended June 30, 2024 as compared to June 30, 2025 with the matured investments utilized to fund ongoing operations during each of the fiscal years.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year ended June 30, 2025, we had no financing activities. During the fiscal year ended June 30, 2024, cash used in financing activities totaled $11.9 million. The decrease from prior year was primarily due to the payment of $11.7 million in dividends agreed to under the Cooperation Agreement and the payment of approximately $0.2 million for issuance costs of our ATM Program during fiscal 2024, with no financing activities occurring during fiscal year 2025.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Capital Resource Requirements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 18, 2024, we entered into a lease termination agreement (Agreement) with our landlord, for our offices at 11455 El Camino Real, Suite 200 and Suite 250, San Diego, California. Under the Agreement, the lease terminated as of September 30, 2024, rather than its scheduled expiration date of November 30, 2029 and we paid the landlord a termination fee totaling approximately $11.1 million in addition to prepaying the remaining rent under the Agreement in the amount of approximately $0.2 million (collectively, the Termination Amounts). Prior to June 30, 2025, the Termination Amounts had been paid and we had no further financial obligations under the Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025, we have the following potential purchase obligations for which the timing and/or likelihood of occurrence is unknown; however, if such claims arise in the future, they could have a material effect on our financial position, results of operations and cash flows.</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under our remaining license agreements, we have payment obligations, which are contingent upon future events such as our achievement of specified development, regulatory and commercial milestones and are required to make royalty payments in connection with the sales of products developed under those agreements. For additional details regarding these agreements, see the section titled </span><a href="#fn8_othlicagree"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8&#8212;Other License Agreements</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><a href="#fn6_commitcon"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 6&#8212;Commitments and Contingencies</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to our consolidated financial statements and related notes included elsewhere in this Annual Report;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obligations under contracts which are cancelable without significant penalty;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchase orders issued in the ordinary course of business as they represent authorizations to purchase the items rather than binding agreements; and</span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future capital requirements will depend on many factors, including:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope and nature of our Litecoin Treasury Strategy;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, progress, results and costs of drug discovery, pre-clinical development, laboratory testing and clinical trials for our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing and outcome of regulatory review of our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of establishing or contracting for sales, marketing and distribution capabilities if we obtain regulatory approvals to market our product candidates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of securing and producing drug substance and drug product material for use in pre-clinical studies, clinical trials and for use as commercial supply;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of securing manufacturing arrangements for development activities and commercial production;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, prioritization and number of our research and development programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we are obligated to reimburse, or entitled to reimbursement of, clinical trial costs under future collaboration agreements, if any; and</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims.</span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_12"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7a. Quantitative and Qualitative Disclosures about Market Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#1d2228;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a smaller reporting company, we are not required to provide the information otherwise required by this Item.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_13"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. Consolidated Financial Statements and Supplementary Data</span><span id="fis_unidentified_table_10"></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_index"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Index to Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:92.8%;box-sizing:content-box;"/>
     <td style="width:1.42%;box-sizing:content-box;"/>
     <td style="width:1.26%;box-sizing:content-box;"/>
     <td style="width:3.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#audit_opinion"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (</span><span style="font-size:9pt;"><ix:nonNumeric id="F_f6905033-b1a3-4b50-b5f1-14d662f77a00" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:AuditorName"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Deloitte and Touche LLP</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-kerning:none;min-width:fit-content;">; </span><span style="font-size:9pt;"><ix:nonNumeric id="F_53b4b5b5-1395-4c24-8cf2-f1feb8a85abb" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:AuditorLocation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">San Diego, California</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-kerning:none;min-width:fit-content;">; PCAOB ID# </span><span style="font-size:9pt;"><ix:nonNumeric id="F_7ce17d27-2106-46dd-b00e-49c7c6e24e88" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:AuditorFirmId"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">34</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_tx58841_102"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_tx58841_103"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_tx58841_104"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_tx58841_105"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="#d58841d10k_htm_tx58841_106"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;" id="audit_opinion"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the shareholders and the Board of Directors of Lite Strategy, Inc.</span></p><div style="font-size:11pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b03a700-6f52-4744-9230-bbde9225dfff" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="dei:AuditorOpinionTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Lite Strategy, Inc. and subsidiary (the "Company") as of June 30, 2025 and 2024, the related consolidated statements of operations, stockholders' equity, and cash flows, for each of the two years in the period ended June 30, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2025, in conformity with accounting principles generally accepted in the United States of America.</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matter</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/>Critical audit matters are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deloitte &amp; Touche LLP</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, CA</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company's auditor since 2024.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_tx58841_102"><span id="fis_balance_sheet"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED BALANCE SHEETS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except par value amounts)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:68.04%;box-sizing:content-box;"/>
     <td style="width:1.28%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.64%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.28%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.76%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ASSETS</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fac06d6e-340b-4163-a306-3cabf757985c" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,011</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_698bb029-76e5-4060-a3e1-026f3ac3e3b7" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,705</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ed7e186-7e81-41be-8337-b7a916ea3afe" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_086d0008-7300-450c-a30f-59dedd709fd5" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,640</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5945d1a1-d17b-44f3-9ec5-7bc1c10aa123" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77bdd6c9-1b35-4e5d-853a-0d0645b94a81" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,424</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42b1bc86-9557-487d-a091-b1cc2436b646" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,285</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0912ad40-098b-463b-af66-29373e101151" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,769</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51725ae3-1188-4e7f-835c-f4c09abd8bb4" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_904318c4-734c-44a2-a82e-e2ccc5632b9c" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_786e8873-6c37-4009-afa4-4fda5afbef72" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dc0bccb-ec80-4427-a97f-1393638c20f7" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">392</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ecf9c97-f720-4762-a703-03fd76ecb675" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,285</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26a966a6-5b30-4f4d-823f-56aec429cf6d" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,375</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af06ac71-f3a8-48e5-aa8b-8ba351b85f2b" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f48c87b3-a3a0-478a-b1ab-b19ad6cfe445" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,168</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_716136b5-7631-4669-8431-e25910e870f6" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,178</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2aefd396-dc3c-49be-9aa0-5c110ec3b9c4" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,187</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa2d36a0-3149-4b62-8a7a-b7786e0cd7e2" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,354</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f61696e1-0414-4c2a-892e-709c8b8e0e34" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,355</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dcf18ebf-8b92-4d2e-a5ff-286b0c29d7b8" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,354</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37cd8c58-60e3-4f80-8d60-18e18e388ae0" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,355</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_4abf2385-31d7-4f40-98f7-48e586e0041c;"><span style="-sec-ix-hidden:F_9575a425-5462-4e8e-92d8-a90e668798ea;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 6)</span></span></span></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dff7e3ad-4234-45f4-aff7-2df46c8ccce5" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_55080544-54b9-4099-8853-a628cadb1ce5" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7368760d-1789-4d60-891a-786baf189ea3" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_abf78a20-26df-4cc8-954c-9604a83705eb" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_337458a6-b0e4-4e27-8b3e-b43f2fdcad36" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_71902b3d-0ec9-48d3-a960-a904c92aa480" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen">none</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;outstanding</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1962113-24ff-4631-9f39-85532461689a" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99e7219b-e72d-4f5b-9002-548ce2aa375a" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_865c7ff9-15e9-41ff-ae07-ada8821dbf0b" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="8" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e63d41f1-1c71-4bab-a591-45c9cc385afa" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="8" format="ixt:num-dot-decimal">0.00000002</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb0cc765-826e-46e9-b701-30596e416f75" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_30fc679d-b032-4419-affc-a9e403710367" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">226,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8beda4ec-5c20-4fa6-9c26-88963f559977" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1b391154-1871-4d5d-88d2-6168b13c0c3c" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ae1c7aa9-35eb-4110-acec-72db64005c45" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_916dccf4-f540-4676-b813-1fb6e57a33ff" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,663</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>&#160;&#160;&#160;&#160;shares issued and outstanding at June 30, 2025 and June 30, 2024.</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0cfb2e1-3b91-435c-9210-5a156dae9e22" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe8bfc48-13b1-4946-843d-92c38c837822" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5731e8ca-f0d0-4400-a2c8-b65f3399cf76" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">421,095</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dff8c40-75d6-4883-82f7-f8e655940e2e" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">421,239</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02527798-6426-4502-96f3-f7cffb794399" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">404,164</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d68aa9e8-bd6a-48a1-b4d0-2f381922923c" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">388,219</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8b876ba-5312-434f-9a57-6482cbc02bbb" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,931</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdb03ff1-d03b-4652-83a8-97212ae7c379" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,020</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders&#8217; equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4fd20c0-992d-4d3c-8dbc-c55a0fd0cb1e" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,285</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55295ea3-eced-496a-a91a-5f97768d56a9" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,375</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_tx58841_103"><span id="fis_income_statement"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF OPERATIONS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except per share amounts)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:65.413%;box-sizing:content-box;"/>
     <td style="width:1.3%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:13.923%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.3%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:14.063%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenues:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue from customers</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a9fd86c-a201-4923-8104-3142709a61cf" contextRef="C_983ed5f1-6f8b-49fe-952b-3b1ada647fbb" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae5b5025-3c02-459b-adf7-b367cb7cdb17" contextRef="C_2537ecc2-706a-441e-abb0-6c81823b2c71" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue from collaboration agreements</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a01330e-66c5-4478-9126-357e88367ccd" contextRef="C_6e8266ff-577a-497b-a576-2b0ca18d975a" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d56ec97-0983-48c9-9bdb-8fd69be1fe5d" contextRef="C_98cbe3d9-5dfd-438f-a31c-71c63b05ef14" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,545</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_227ccb91-668d-4438-acdc-b8922b9940f4" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f761b8d-44ed-4024-9a30-cf0dfd433cc8" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,297</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d69a785-0c60-4896-ae3b-07c9d991a6f9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,923</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd9fb1dc-3dc0-4cf1-a6c8-88dee0b17feb" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,561</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8cf6031e-b3be-4f1d-b236-437ad46c4dd9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,532</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_116e1cd4-dc6d-458f-abf5-b108932c48f4" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,295</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_039a1027-d466-4284-aa60-6550f538f7ca" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fea677ee-66f3-4b69-a01e-2f3ed7b3877e" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,899</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_606b1949-fc79-4fc4-b5e3-4fdfc0d37fa1" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,455</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01391c63-cd31-4e06-b48b-511bfe369e9e" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,755</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from operations</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fd71cb6-c06c-4002-9d2d-68236b323a67" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">17,455</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9eea937-2486-496b-a5cb-c1690cbad622" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense):</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_363b8e2c-31bb-4478-a7d3-fa7a521e8573" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:InvestmentIncomeInterestAndDividend" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4730c153-5b2e-458d-8600-ed15a6739e3c" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:InvestmentIncomeInterestAndDividend" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,277</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on disposition of a non-financial asset</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3101869a-b006-4b1b-8e9b-19bcc305c126" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9299a358-d1dc-4530-999d-467dfc8644ff" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expense, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dc67b45-23de-4031-b5c7-ab120e186e39" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2328f151-9492-43c7-896f-d7bea5dd0f93" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">41</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc64b91b-357f-4a4c-ac4a-ad8a5e6f5f80" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,510</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70f9e5b8-b22e-406a-811c-8fa65c854afe" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,236</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f6666f6-a60d-486f-ba31-943313d3fe22" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eaf7490b-b615-44cf-81da-47b175cc499c" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income per share - basic and diluted</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_735a4b0e-a5a1-4dca-ab16-efa7cef8a27a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_37bdb40f-cbc6-4d61-a261-27861f53aabb" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">2.39</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41fbf39c-f462-47af-8c76-94d2372295eb" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9a941219-2545-473e-9c68-b984c76cff1e" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.67</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares used in computing net (loss) income<br/>&#160;&#160;&#160;&#160;per share - basic and diluted</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1521c4ba-c181-4920-8fa7-08188a0822b1" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_bda9ec18-2fad-4fa7-86fc-0f8b3bf78a5f" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,663</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71fe6eee-e956-4a4a-bf0d-275fb100eb4a" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a1f29c91-37cb-4364-b6d6-917f77177d9c" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,663</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="fis_stockholders_equity"><span id="d58841d10k_htm_tx58841_104"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.851%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.778%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.14%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.318%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.14%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.318%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.14%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.318%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common<br/>Shares</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional<br/>Paid-In<br/>Capital</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Deficit</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Stockholders&#8217;<br/>Equity</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2023</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7badc35-b039-42b9-9a5d-66154c519e85" contextRef="C_68bebf1e-062c-4c48-8787-5346a1c6828d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,663</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30a5c8f9-5b32-4be6-ba86-8acc4864facb" contextRef="C_6fd2496a-603e-4079-bd68-56583b109120" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">430,621</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb68594a-592e-4dbd-b36c-2cc236b0d5e2" contextRef="C_bf2d5251-793c-4326-8260-9fc5c59df6da" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">405,997</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6caec5f2-ba1b-41d0-badd-0a1359fb913e" contextRef="C_57a12f24-8485-49fc-8a47-a37e1dd17d35" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,624</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d36b87c1-76e4-45ea-bea0-b6fae085f49c" contextRef="C_a6339fc6-e7e2-479d-814d-64200ed7d803" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b2007eb-787a-4391-a8c8-fc9c875b7d17" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">Cash dividends declared ($</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98625982-bb86-4864-b357-8c4026a31aee" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:CommonStockDividendsPerShareDeclared" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;per share)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd9c6fb0-3e5d-450e-afc1-a270ed53c3de" contextRef="C_d5b61db4-8dab-4058-ac3f-a2da29438702" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,660</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0d42c1a-635d-4c6e-927f-dcd3bf96e92b" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,660</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c198e6a8-0848-47fd-ad4a-def9f29a7f45" contextRef="C_d5b61db4-8dab-4058-ac3f-a2da29438702" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,278</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c9f4874-c088-494c-8b64-d8c145a422fd" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,278</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2024</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be31c8ff-5f0b-4fc9-aeb1-235ec334bb23" contextRef="C_84359d17-853f-46e4-b937-cd4a49546ae7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,663</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ce4fcf8-b120-493e-8b73-a83ae0aa6649" contextRef="C_b7080d02-4c79-40ef-9fa1-ea37d0856660" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">421,239</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a8e8bcb-36f3-4cc6-bebb-15cfe7ad1376" contextRef="C_44c9191d-9975-403e-a883-48ca3b8d97f4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">388,219</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27534d2b-cfde-4812-9835-427247a0cde5" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,020</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41628754-6862-4729-9fa3-9be9ea0bab15" contextRef="C_1d85b2ba-2068-4a8d-b780-07d1f807c029" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab15aaca-c297-4a72-b2d3-eb3520462c62" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b342206-2c4d-4afb-a45c-c7a372e4745a" contextRef="C_0f41c2fa-b332-4ddf-b708-46d3bd043fa7" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">144</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71ee96e2-451c-406d-8dd2-2c8afffce2c5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">144</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c266c816-25ec-4a8e-95ec-e3a6fea849e9" contextRef="C_c80491ff-d878-4596-938d-77d3e4dc6ba0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,663</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab3d1f21-3381-403b-b1e8-be84013e834e" contextRef="C_b2d601f8-e5d6-44a2-a04a-f2df09be09f8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">421,095</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08aff056-a299-4781-bdbe-d17b8f91d686" contextRef="C_31fc6baf-8276-4e06-a067-f35d671133c1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">404,164</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ea92a46-d56d-4b1b-bb6f-141955208291" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,931</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_tx58841_105"><span id="fis_cash_flow"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:63.753%;box-sizing:content-box;"/>
     <td style="width:1.34%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:14.983%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.34%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:14.583%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04d4ce33-4017-4696-a24f-dc65596e0875" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85c66db6-47a5-4b00-af81-7e5ea266e5a8" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net (loss) income to net cash used in operating activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebe12d41-bf58-408f-9558-24b5994836ca" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">144</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4f7bb11-d0fc-411f-b220-f4c57850865a" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,278</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a9c9ce4-f3f4-4f54-86e4-0b91f337ae71" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_498d5d8f-e870-4d36-846b-392bea4a2570" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,899</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncash lease expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_401a1082-5e1b-4537-a1f1-3d8058605093" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:NonCashLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33f445ed-2bd4-4f8a-8797-7b6613f9d038" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:NonCashLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,433</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd557f82-c7e4-47b1-9068-470d4db78d22" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">368</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44cf1278-e3d3-457f-be55-274326507631" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">383</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on disposal of property and equipment</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ffb7db6-dd13-4414-a5f1-ed06447852bd" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36cf641f-ae00-44be-a23a-7b09aeee2a5d" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on disposition of a non-financial asset</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3db07e74-b57e-4df0-b328-5b53713605fc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_494898b8-58c1-4ae2-b019-05cbbf072435" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unbilled receivables</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_191daafd-4946-4ae8-83a9-d333e2ddee29" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:IncreaseDecreaseInUnbilledReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d2d6371-b23b-45e7-82b9-ff5f28b1858d" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:IncreaseDecreaseInUnbilledReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">85</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8ee87c8-7df8-477d-a341-2608d89ef3ab" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,150</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d22cef4c-5159-453b-8019-782a69d2347d" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,534</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de1a551e-a5c4-4430-906e-2f368af2d576" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,992</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14e32910-5393-4651-af71-2f6378e58258" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,147</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52048378-cab4-44f1-915d-fece5b6c3a3c" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,009</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_927c8e6f-eedc-442e-b45f-c5821d36616f" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,274</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc5b203e-7ad3-466e-82c5-3bf675b18b30" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_668c229b-fe9a-4846-9c2a-730150167f74" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64,862</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2033087-9e0a-4295-a1f8-d61793884a22" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eadeb9d2-d1c2-4060-bfc3-8a560fffa0d8" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,612</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d32af503-73c8-4df3-b2f9-222e49fc201e" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">20,844</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_977e4d1c-5132-4318-830a-0e2462fd288f" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">50,473</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of short-term investments</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3db5f6b-80fa-4f4c-adb4-b05bfa3475c9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec828633-9e49-42ce-91fa-d96d094018fb" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,232</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from maturity of short-term investments</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a456a9d8-9ebc-4782-a2c4-e903e6165212" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,640</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4381b002-96a1-4683-9be0-cc2e663d36c1" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,379</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from sale of property and equipment</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa81bb8d-69af-424d-9b58-a49113f57ea4" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae67cf3b-777b-43c7-b3d9-1da8ac05f9db" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from the disposition of a non-financial asset</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7da8de1-c666-4826-bbee-8292efc72ad5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7976c063-5e57-436a-8048-fdec29976030" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fc4150d-57db-49c7-9de7-83cbfa2724f7" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22e139e7-e98b-40fc-a35f-648f09095f3d" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by investing activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8d6748b-16f5-4052-a57d-c07a50e5110b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,150</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e167d15e-73ba-4c5a-94bf-c9b83ce0e370" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,140</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of cash dividend</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c262af4-04af-476b-bcb5-68e489761132" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:PaymentsOfDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ded16b0-53e5-45fd-a273-ce85d5bc21f7" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:PaymentsOfDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,660</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of financing costs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d337e0b-0ed0-4b6a-830c-1ebafe4f8a4a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_243ca418-6afa-4dc4-b92f-1679e9093775" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in financing activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cdbc6a7-ffc2-4af4-b64e-459f88d8b620" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b000f44f-1769-4145-8744-e9ad8e7422f9" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">11,868</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash and cash equivalents</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0c304cc-07c6-4c00-beb9-a84a70cdc0ca" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,306</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21e61e3f-4526-4f40-8e6f-9dd48f2a4bc8" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,201</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at beginning of the year</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6eb23285-3760-492b-b8ec-3ca7a8f57194" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,705</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd6aef9f-eea4-4da5-8f16-ba97d96da642" contextRef="C_57a12f24-8485-49fc-8a47-a37e1dd17d35" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,906</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at end of the year</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_511a451f-faa0-4ae9-9b4c-32054f8fed77" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,011</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23d5031c-dfac-4886-b5d2-562670ed48b7" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,705</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental cash flow information:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Re-measurement of right-of-use asset and related lease liability upon lease<br/>&#160;&#160;&#160;&#160;modification</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_585d8e40-d3d3-45f0-8d6f-8d5996348948" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d71c8de-5856-4fac-8887-36dd0a3aa18d" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Re-measurement of right-of-use asset for direct costs associated with lease<br/>&#160;&#160;&#160;&#160;modification</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_539bac13-e1e9-4ac9-a32c-02f65062faa2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4cc32a4-13e7-4e06-80fa-84ddc3b31cdc" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">181</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="fis_notes_to_financial_statement"><span id="d58841d10k_htm_tx58841_106"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p><div><ix:nonNumeric id="F_24c95209-e342-4fc3-8eba-4532437cd1b0" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_24c95209-e342-4fc3-8eba-4532437cd1b0_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn1_title"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. Description of Business and</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Basis of Presentation</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c437a560-b26b-48b2-aba6-7681a3d15518" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Business</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pharmaceutical company that has been developing novel and differentiated cancer therapies. In August 2025, we implemented a Litecoin Treasury Strategy (as described below) with the net proceeds from the PIPE (as defined below). We built our pipeline by acquiring promising cancer agents and creating value in programs through development, strategic partnerships and out-licensing or commercialization, as appropriate. Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit. Our pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, zandelisib, </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an oral, once-daily, selective PI3K&#948; inhibitor </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and prior to its sale, ME-344 as more fully discussed in </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd01128f-0ddd-4d39-bcdf-604a2c4f81cc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) related to annual reports on Form 10&#8209;K. The accompanying consolidated financial statements include the accounts of Lite Strategy, Inc. and our wholly owned subsidiary, Meadow Merger Sub, Inc. We have eliminated all intercompany accounts and transactions in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated subsequent events through the date the consolidated financial statements were issued.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_13b31399-25c1-41f1-9b6f-c042e21f8ae6" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:CurrentEventsAndReductionInForcePolicyTextBlock" escape="true" continuedAt="F_13b31399-25c1-41f1-9b6f-c042e21f8ae6_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Events</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn1_stratalt"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2024, we announced that our Board of Directors (Board) had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force (the Strategic Alternatives RIF) beginning August 1, 2024, which continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets will continue to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consistent with our intention to preserve cash, David M. Urso, our former President and Chief Executive Officer and Richard Ghalie, M.D., our former Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the former Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as our Chairperson of the Board.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy (as described below) and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Investment in Private Equity (PIPE) and Related Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in July 2025, we closed on a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad2e0020-1242-4b61-b990-66f016f01dd5" contextRef="C_5eb52ed6-f76b-48ea-a2e5-62167666a0fd" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million PIPE and issued an aggregate of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dfb2c7a-3c10-4301-977c-7f9f5d94b3da" contextRef="C_870e143e-2c95-4ffb-9924-d47b9fd9da81" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">23,216,898</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the Shares) of our Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a27031ff-1478-4e9d-9248-2ecf14e828f6" contextRef="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the Common Stock, the Securities)), to purchase up to an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_8817aca8-e1af-4377-935b-b38d414a922c" contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,022,869</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the Pre-Funded Warrant Shares) at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_713d62f0-3c54-4c29-9ce7-2cc90d059129" contextRef="C_4aadd502-4418-4743-994c-0a56dc532d10" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">3.4199</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant. On July 24, 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e3a8eb5-4936-4e05-bd8d-50475988c17d" contextRef="C_07f286c0-e5a6-4c38-9799-941180c82a4c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,084,509</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_c4f064f2-a8ba-41e4-ae3a-b9ed9b5bbd94" contextRef="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,807,967</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock upon </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30beb6cb-315a-4c0b-ae66-81ded3b26626" contextRef="C_d190719d-ba9d-4549-9346-f6c2c6a02045" name="lits:SurrenderedWarrantsToAcheiveCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,808,070</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_24c95209-e342-4fc3-8eba-4532437cd1b0_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_13b31399-25c1-41f1-9b6f-c042e21f8ae6_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, in July 2025 and as more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Treasury Strategy (as described below), including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the-market sales agreement. As partial consideration for services provided associated with the PIPE, we issued warrants for the purchase of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aeaf7b07-4a0a-4aee-9085-3be15b3e06af" contextRef="C_9e2c011a-0538-44df-bed0-dea64b704da8" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,070,177</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock with a weighted-average exercise price of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2c9ee75-47dd-4e72-b86a-b77c9c7fdc06" contextRef="C_b9008131-b16c-4d88-88b8-b98335565844" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c738df08-1264-4d42-be1f-926c42841a20" contextRef="C_08b96565-9169-4635-945d-9321b9c399be" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">546,348</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c847937-4ded-49ef-9d8e-f3efe5f49a91" contextRef="C_08b96565-9169-4635-945d-9321b9c399be" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litecoin Treasury Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), a related party, which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b525380-138b-47ca-9f77-5d76ac0c0088" contextRef="C_f12fbef6-72e6-4260-86e6-fc02f15df7a4" name="us-gaap:CommonStockDividendsPerShareDeclared" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Common Stock that was declared on November 6, 2023 to stockholders of record at the close of business on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a4f2d7db-388f-487f-8560-65bb822d49ee" contextRef="C_f0b7c1b2-6b39-4391-a802-da6e61227686" name="lits:ClosingAgreement" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 17, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Cooperation Agreement). The total dividend of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dff9fa4-d0d4-41e0-92d4-86770a1d633e" contextRef="C_32d99983-1b3d-4c08-8e53-fb1cf89c3852" name="us-gaap:PaymentsOfDividends" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4543b1ac-ac12-4501-89d2-546339066878" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:LiquidityPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements. We have accumulated losses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24683460-5aa7-4a57-8f18-18eb6f2d3a62" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">404.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million since inception and expect to incur operating losses and generate negative cash flows from operations for the foreseeable future. As of June 30, 2025, we had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d04b2466-9c02-48c2-b80a-b848aa6795f0" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">18.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash and cash equivalents. In connection with our July 2024 announcement regarding the evaluation of our strategic alternatives, we discontinued the clinical development of voruciclib, while certain nonclinical research and development (R&amp;D) activities continue. As a result, we will continue to incur R&amp;D expenses in connection with our nonclinical projects. We believe that our cash balance will be sufficient to meet our obligations and fund operations for at least the next 12 months from the issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements and to continue the development of our drug candidates, we would require one or more capital transactions, whether through the sale of equity securities, debt financing, license agreements or entry into strategic partnerships at some point in the future. There can be no assurance that we will be able to continue to raise additional capital in the future.</span></p></ix:nonNumeric></div></ix:continuation></div><div><ix:nonNumeric id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn2_sumsigpolicies"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_405f6580-86a2-4bf1-b8a0-8f7c09fcf836" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosures made in the accompanying notes to the consolidated financial statements. We use estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_1" continuedAt="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ddcf8c93-0ac8-4c96-a8fc-8d801bf149aa" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents consist of cash and highly liquid investments with original maturities of three months or less when purchased. Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We attempt to minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. Our investment portfolio is maintained in accordance with our investment policy, which is designed to preserve capital, safeguard funds and limit exposure to risk. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_99e56a92-345c-416b-b35c-7581ee58acec" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:InvestmentPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short-term investments are marketable securities with maturities greater than three months but less than one year from date of purchase. As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_244eedd9-5ee0-45ba-9c97-2d23f376843e" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t hold any short-term investments. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024, we held short-term investments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_952e7843-b720-4b21-85d6-e37848f57b22" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">34.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in United States government securities. Our short-term investments were considered to be held to maturity and were carried at amortized cost. For the fiscal year ended June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d96f87ad-8113-4605-a63d-eecdf99206dc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gross unrealized gains and losses. For the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the gross unrealized gains and losses were immaterial.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e4604121-27f5-408c-9a85-647c5699ffda" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value is as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1 &#8212; Observable inputs such as quoted prices in active markets for identical assets or liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2 &#8212; Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div></div></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d6bb6a9b-9550-48b3-be1f-da5c7e2f7c88" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34e3844b-58a0-4bc6-8d71-ca014dfe8a51" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> property and equipment. Property and equipment were previously stated at cost and depreciated over the estimated useful lives of the assets (generally </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_75abda38-a80b-45e0-b57c-64913feff94d;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_178f31f1-8b9b-4137-a0e5-51e5aa004f7a" contextRef="C_3e7dfd70-bc4a-4b0f-89af-eaa0c4be659f" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) using the straight-line method and leasehold improvements were stated at cost and were amortized over the shorter of the estimated useful lives of the assets or the lease term.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_688d7246-8365-4592-b624-ce53d0c940c9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true" continuedAt="F_688d7246-8365-4592-b624-ce53d0c940c9_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for our leases under ASC Topic 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Topic 842). Leases which are identified within the scope of Topic 842 and which have a term greater than one year are recognized on our consolidated balance sheets as right-of-use (ROU) assets and lease liabilities. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected remaining lease term. The lease term includes any renewal options and termination options that we are reasonably certain to exercise. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, we use our incremental borrowing rate. The incremental borrowing rate is determined based on the rate of interest that we would pay to borrow on a collateralized basis an amount equal to the lease payments for a similar term and in a similar economic environment. The interest rate implicit in lease contracts to calculate the present value is typically not readily determinable. As such, significant management judgment is required to estimate the incremental borrowing rate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease expense for operating leases is recognized on a straight-line basis over the lease term based on the total lease payments. We have elected the practical expedient to not separate lease and non-lease components for our real estate leases. Our non-lease components are primarily related to property maintenance, which varies based on future outcomes and thus is recognized in operating lease expense when incurred.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_2" continuedAt="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_688d7246-8365-4592-b624-ce53d0c940c9_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 18, 2024, we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of September 30, 2024, the lease for our existing office space. See </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the impact of the Agreement on our consolidated financial statements.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_9482d861-b342-4fa1-902d-7e0b38deb47b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true" continuedAt="F_9482d861-b342-4fa1-902d-7e0b38deb47b_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Customers</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606), we recognized revenue when control of the promised goods or services was transferred to our customers, in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. For enforceable contracts with our customers, we first identified the distinct performance obligations &#8211; or accounting units &#8211; within the contract. Performance obligations are commitments in a contract to transfer a distinct good or service to the customer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments received under commercial arrangements, such as licensing technology rights, may include non-refundable fees at the inception of the arrangements, milestone payments for specific achievements designated in the agreements and royalties on the sale of products. At the inception of arrangements that include milestone payments, we used judgment to evaluate whether the milestones were probable of being achieved and we estimated the amount, if any, to include in the transaction price using the most likely method. If it were probable that a significant revenue reversal would not occur, the estimated amount was included in the transaction price. Milestone payments that were not within our or the licensee&#8217;s control, such as regulatory approvals, were not included in the transaction price until those approvals were received. At the end of each reporting period, we re-evaluated the probability of achievement of development milestones and any related constraint and, as necessary, we adjusted our estimate of the overall transaction price.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent a contract included multiple promised deliverables, we applied judgment to determine whether promised deliverables were capable of being distinct and were distinct within the context of the contract. If these criteria were not met, the promised deliverables were accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, we allocated variable consideration related to our 50-50 cost share for development services directly to the associated performance obligation and then allocated the remaining consideration among the performance obligations based on their relative stand-alone selling price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When not directly observable, we typically estimated the stand-alone selling price for each distinct performance obligation. Variable consideration that related specifically to our efforts to satisfy specific performance obligations was allocated entirely to those performance obligations. Other components of the transaction price were allocated based on the relative stand-alone selling price, over which management has applied significant judgment. We developed assumptions that required judgment to determine the stand-alone selling price for license-related performance obligations, which may have included forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical, regulatory and commercial success. We estimated stand-alone selling price for R&amp;D performance obligations by forecasting the expected costs of satisfying a performance obligation plus an appropriate margin.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the case of a license that is a distinct performance obligation, we recognized revenue allocated to the license from non-refundable, up-front fees at the point in time when the license was transferred to the licensee and the licensee can use and benefit from the license. For licenses that are bundled with other distinct or combined obligations, we used judgment to assess the nature of the performance obligation to determine whether the performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. If the performance obligation is satisfied over time, we evaluated the measure of progress in each reporting period and, if necessary, adjusted the measure of performance and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. Revenue is recorded proportionally as costs are incurred. We generally used the cost-to-cost measure of progress because it best depicted the transfer of control to the customer which occurred as we incurred costs. Under the cost-to-cost measure of progress, the extent of progress towards completion was measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation (an input method under Topic 606). We used judgment to estimate the total cost expected to complete the R&amp;D performance obligations, which included subcontractors&#8217; costs, labor, materials, other direct costs and an allocation of indirect costs. We evaluated these cost estimates and the progress during each reporting period and, as necessary, we adjusted the measure of progress and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In connection with our now terminated April 2020 License, Development and Commercialization Agreement with Kyowa Kirin Co., Ltd. (KKC) (the KKC Commercialization Agreement) described in Note 7. License Agreements, we performed development services related to our 50-50 cost sharing arrangement for which revenue was recognized over time. Additionally, we performed services for KKC at their request, the costs of which were fully reimbursed to us. We recorded the reimbursement for such pass through services as revenue at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35325e0b-f996-4ee9-b8c3-0dfa504c1ebe" contextRef="C_7ee6ad01-be31-465e-9644-4d6400b09ee1" name="lits:PercentageOfReimbursementOfPassThroughCostsAsRevenue" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of reimbursed costs, as control of the additional services for KKC was transferred at the time we</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_3" continuedAt="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_4"><div><ix:continuation id="F_9482d861-b342-4fa1-902d-7e0b38deb47b_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incurred </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such costs. The costs of these services were recognized in the consolidated statements of operations as research and development expense. The costs of these services were recognized in the consolidated statements of operations as research and development expense.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended June 30, 2025, we did not recognize any revenue associated with the KKC Commercialization Agreement. During the year ended June 30, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b3c86ec-38d6-4ec4-83c4-aa8b11ea3bf0" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:DisaggregationOfRevenueTableTextBlock" escape="true" continuedAt="F_4b3c86ec-38d6-4ec4-83c4-aa8b11ea3bf0_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4b3c86ec-38d6-4ec4-83c4-aa8b11ea3bf0_1">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:77.16%;box-sizing:content-box;"/>
           <td style="width:1.56%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:19.279999999999998%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Timing of Revenue Recognition:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Services performed over time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e463592-b60e-4b95-a4cc-01ec1c0334d2" contextRef="C_71ae9d25-7183-44c7-86d1-e4821a8dc42d" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">743</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pass through services at a point in time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91c39a0a-15ce-47fc-a9e7-970afdcfdd25" contextRef="C_2847194b-f51e-4d7d-8f4b-3169aeb8ad38" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51c6f038-d759-4a67-9759-9b7f14256530" contextRef="C_2537ecc2-706a-441e-abb0-6c81823b2c71" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:continuation></div><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contract Balances</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contract liabilities were included in deferred revenue and deferred revenue, long-term in our consolidated balance sheets. Our contract liabilities accounted for under Topic 606 related to the amount of initial upfront consideration allocated to the development services performance obligations.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_afe2ccca-be14-4f08-9f81-5dde435054e2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c64a70a-c2b3-4502-94d2-1de6fa7c130e" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_312f9a01-4e60-4048-85e2-6a746a0b3177" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:75.52%;box-sizing:content-box;"/>
           <td style="width:1.86%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:20.619999999999997%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beginning balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b4c0d4d-a95b-482e-bcfc-4f387cb70588" contextRef="C_57a12f24-8485-49fc-8a47-a37e1dd17d35" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">317</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Recognized as revenue:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized upon satisfaction of performance obligations</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30a86dcb-f5dc-464c-a6c3-a8bfe0d35eb7" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">317</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized from change in estimate for performance<br/>&#160;&#160;&#160;&#160;obligations that are being closed</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8dfcde7-d2c2-4447-a35d-fd36a4384888" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized for performance obligations that will no longer <br/>&#160;&#160;&#160;&#160;commence</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1295be2-1594-4b0c-992b-6359d1bbfa65" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ending balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81592088-8d38-43fb-b695-97fe7197e30d" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The timing of revenue recognition, invoicing and cash collections results in billed accounts receivable and unbilled receivables (contract assets) and deferred revenue (contract liabilities). We invoiced our customers in accordance with agreed-upon contractual terms, typically at periodic intervals or upon achievement of contractual milestones. Invoicing may have occurred subsequent to revenue recognition, resulting in unbilled receivables. Advanced payments from our customers before revenue was recognized resulted in contract liabilities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Collaborators</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At contract inception, we assessed whether the collaboration arrangements were within the scope of ASC Topic 808 Collaborative Agreements (Topic 808), to determine whether such arrangements involved joint operating activities performed by parties that were both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment was performed based on the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of Topic 808 that contain multiple units of account, we first determined which units of account within the arrangement were within the scope of Topic 808 and which elements were within the scope of Topic 606. For units of account within collaboration arrangements that were accounted for pursuant to Topic 808, an appropriate recognition method was determined and applied consistently, by analogy to authoritative accounting literature. For elements of collaboration arrangements that were accounted for pursuant to Topic 606, we recognized revenue as discussed above. Consideration received that did not meet the requirements to satisfy Topic 606 revenue recognition criteria was recorded as deferred revenue and classified as either current or long-term deferred revenue based on our best estimate of when such amounts would be recognized.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_c42d5d09-252a-45fe-a915-f169db9a72d5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true" continuedAt="F_c42d5d09-252a-45fe-a915-f169db9a72d5_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and development costs are expensed as incurred and include costs paid to third-party contractors to perform research, conduct clinical trials and develop and manufacture drug materials, as well as personnel, related benefits (including share-based compensation) and other expenses attributable to our R&amp;D activities. Clinical trial costs, including costs associated with third-party contractors, are a significant component of R&amp;D expenses. We expense R&amp;D costs based on work performed. In determining the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_4" continuedAt="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c42d5d09-252a-45fe-a915-f169db9a72d5_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to expense, management relies on estimates of total costs based on contract components completed, the enrollment of subjects, the completion of trials and other events. Costs incurred related to the purchase or licensing of in-process R&amp;D for early-stage products or products that are not commercially viable and ready for use, or have no alternative future use, are charged to expense in the period incurred.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f3929912-e8ed-4890-b6a9-ece2c7afca27" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Share-based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Share-based compensation expense for stock options and restricted stock units (RSUs) granted to employees and directors is recognized in the consolidated statements of operations based on estimated amounts. The cost of stock options is measured at the grant date, based on the estimated fair value of the stock option using the Black-Scholes valuation model, which incorporates various assumptions including expected volatility, risk-free interest rate, the expected term of the award and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our stock over the expected option life and other appropriate factors. We use the simplified method to calculate the expected term of share options and similar instruments as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as we do not intend to do so in the foreseeable future. For RSUs, we estimate the grant date fair value using our closing stock price on the date of grant. The estimated fair value of stock options and RSUs is amortized over the requisite service period, adjusted for actual forfeitures at the time they occur. The requisite service period is generally the time over which our share-based awards vest.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b43288e1-5530-458b-805f-782d712769fc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:InterestIncomePolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest and Dividend Income</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest on cash and investment balances is recognized when earned. Dividend income is recognized when the right to receive the payment is established.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_feea44a1-4948-401a-934e-eb2597d70aad" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our income tax expense consists of current and deferred income tax expense or benefit. Current income tax expense or benefit is the amount of income taxes expected to be payable or refundable for the current year. A deferred income tax asset or liability is recognized for the future tax consequences attributable to tax credits and loss carryforwards and to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2025 and 2024, we have established a valuation allowance to fully reserve our net deferred tax assets. Tax rate changes are reflected in income during the period such changes are enacted. Changes in our ownership may limit the amount of net operating loss carryforwards that can be utilized in the future to offset taxable income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Financial Accounting Standards Board (FASB) Topic ASC 740 - </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prescribes a recogn</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ition threshold and measurement attribute criteria for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_19f2cb3a-d84c-4aac-ac7d-b438632f0feb" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfa8c2fa-5b8d-420d-9c97-d8fa22c469bb" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_00d570e0-e53c-4283-a0a2-b83ee70e6d57" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unrecognized tax benefits as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b6d3a4a0-87d4-4eaa-9027-4cd5e4f1c5ac" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:DispositionOfNon-FinancialAssetsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disposition of Non-Financial Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for infrequent dispositions of assets in its product pipeline in accordance with ASC 610-20, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets, which requires dispositions of long-lived assets that are not a discontinued operation be accounted for on a net basis and included in income from continuing operations before income taxes in accordance with ASC 350, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets - Goodwill and Other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Proceeds from sales designated as dispositions of non-financial assets are classified as cash flows from investing activities in the consolidated statements of cash flows.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_89c00c7c-959b-46b2-9098-7ef26e62890c" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_89c00c7c-959b-46b2-9098-7ef26e62890c_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Income Per Share</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net (loss) income per share is computed using the weighted-average number of shares of Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) outstanding during the period, less any shares subject to repurchase or forfeiture. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33a3cc1a-c0e6-4493-8cd9-00f84a0eb458" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_c2520cf0-d9d1-4bb5-a10f-e019ae41393c" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) subject to repurchase or forfeiture for the fiscal years ended June 30, 2025 and 2024. Diluted net (loss) income per share is computed based on the sum of the weighted-average number of common shares (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) and potentially dilutive common shares outstanding during the period determined using the treasury-stock and if-converted methods.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_89c00c7c-959b-46b2-9098-7ef26e62890c_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the diluted net loss per share calculation for the fiscal year ended June 30, 2025, potentially dilutive securities are excluded from the calculation of diluted net loss per share because their effect was anti-dilutive due to our net loss. For purposes of the diluted net income per share calculation for the fiscal year ended June 30, 2024, potentially dilutive securities are excluded from the calculation of diluted net income per share because their weighted-average exercise prices were above our weighted-average share price. Therefore, basic and diluted net (loss) income per share were the same for the fiscal years ended June 30, 2025 and 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2f3f49a3-14d6-4962-9725-4094130dc813" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:65.5%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:13.8%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:14.7%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95a54a85-06dd-42c4-a8d6-01ab8eb793b8" contextRef="C_ec033cf6-6de4-4e18-90c4-48d44d401981" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">869</ix:nonFraction></span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28315101-673e-486f-87dc-898dc7990932" contextRef="C_3b4342ff-1351-43aa-bf51-fe4957ccc32c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,357</ix:nonFraction></span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27a8aa30-860d-4481-b2fc-25479c95d3a4" contextRef="C_0eba68b0-9adf-4ac8-8967-f51e2cef9d7f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf1bd0d2-d573-4363-a657-dbdfc6eec80a" contextRef="C_94b1e5ac-8b72-4ae2-99a3-f4cb17a258fa" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total anti-dilutive shares</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca684fad-f00f-41a3-9141-356bb0a031b9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">972</ix:nonFraction></span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69087556-db20-4b2d-9dc0-be4c45428957" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,460</ix:nonFraction></span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:nonNumeric></div></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c5420ec3-321c-42fa-bb56-34491b983df7" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncement</span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures, which modifies the disclosure and presentation requirements of reportable segments (ASU 2023-07). The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (the CODM) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Lastly, the amendment requires that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The adoption of ASU 2023-07 resulted in enhanced disclosures as included in </span><a href="#fn_segments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 12 Segment Information</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, but did not impact to our results of operations, cash flows and financial condition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that are adopted as of the specified effective date. We believe the impact of recently issued standards, other than those noted below and any issued but not yet effective standards will not have a material impact on our consolidated financial statements upon adoption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (PBE) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local,and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all periods presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows and financial condition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2025, the FASB issued ASU No. 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment in this update clarifies the effective date of ASU 2024-03, which is that public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026 and in interim periods within annual reporting periods beginning after December 15, 2027. The impact of adoption of this ASU on our disclosures is currently being evaluated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act of 2017, including 100% bonus depreciation, domestic research cost expensing and the business interest expense limitation, among other tax changes. Many of the tax provisions of the OBBBA are designed to accelerate tax deductions, which could lead to lower cash tax payments. The new legislation has multiple effective dates, with certain provisions effective in 2025 and others in the future. While we continue to assess the impact of the tax provisions of the OBBBA on our consolidated financial statements, we currently believe that the tax provisions of the legislation are not expected to have a material impact on our statement of operations.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_e2839339-0eba-491b-8d23-3d09a9fb0a52" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn3_bs_details"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prepaid and Other Current Assets</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e0c83877-9985-4f48-8180-1a10a2e7ecf8" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid and other current assets consisted of the following in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.863000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.083%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insurance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c1c5ce7-5f95-48c0-8fcf-3388122ca13f" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c4fc11e-9998-47b6-9bae-64086097a56d" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">460</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software license</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_368f3a5d-b6c9-4235-a9f3-aaf7bdb76149" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:SoftwareLicenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_424f6e03-b542-4cc8-9281-da230bbda618" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:SoftwareLicenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">442</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Security deposit</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dd06d80-b56a-465f-b3b9-7fd2e43b27f4" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:SecurityDeposit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5ebf50a-d8bb-4ddd-85bf-b079a581c7bd" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:SecurityDeposit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">263</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical costs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72286f9c-4d43-4d9c-98d6-5af0c0b6299f" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:PrepaidClinicalCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_572c77df-7438-405a-aaa7-9efb362919e8" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:PrepaidClinicalCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,050</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_acbde673-1092-4a99-89ab-17ec075a5ec8" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73a05daa-1e62-4d1d-b2fb-b7a84b778813" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid and other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1015f61-89f1-4335-97d5-24e743ac8dd4" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f10a8d6a-975c-4117-9e91-df9b8bfc9650" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,424</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn3_prop_equip"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30. 2025, we had no property and equipment, net. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ca4e87a-99f7-4769-b611-d758bbd1a7c0" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true" continuedAt="F_4ca4e87a-99f7-4769-b611-d758bbd1a7c0_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consisted of the following as of June 30, 2024, in thousands:</span></ix:nonNumeric></span></p><div style="font-size:11pt;font-family:Times New Roman;"><ix:continuation id="F_4ca4e87a-99f7-4769-b611-d758bbd1a7c0_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.68%;box-sizing:content-box;"/>
         <td style="width:1.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.68%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="border-top:0.5pt solid #ffffff;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f303eaf-aca8-4b56-8dcb-b310dd192842" contextRef="C_dcba7e4a-11d0-4a3e-b398-fd6721e793ed" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equipment</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e930d41-2e04-43b9-9a13-b006397f273a" contextRef="C_cb253871-f434-42be-badc-455136d75117" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e756e1cb-cd53-46df-b7dd-0e7d0c829c03" contextRef="C_47d0895f-dcab-4868-bb7e-4888006739cb" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">969</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8905090e-119b-4df2-a073-5b9c5be34a14" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,156</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4e683b4-eea6-4c3b-91ee-2e4e849aa6a2" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff070178-64d3-451b-afc0-28aaa364dc42" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">392</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">_____</span></p><p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><ix:footnote id="FNT_c0357743-16b9-4466-828d-a177877f67f6" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes impairment charge of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f7dbc00-ff0c-494f-b25e-f4f56c828018" contextRef="C_498df639-b914-4e6f-a5bd-5f79abcd206f" name="us-gaap:AssetImpairmentCharges" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></ix:footnote></p><p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) </span><ix:footnote id="FNT_4cf4506a-9cb5-4411-a0e1-ff4c3f4d43e7" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</span></ix:footnote></p></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation expense of property and equipment for the fiscal years ended June 30, 2025 and 2024 are presented in the consolidated statements of cash flows.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impact of the Agreement (as discussed in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As noted in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we agreed to sell our furniture and fixtures to the landlord for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5e7191e-0415-4f6e-bb58-09f8a7f0605e" contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a" name="us-gaap:ProceedsFromSaleOfFurnitureAndFixtures" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on our lease termination date of September 30, 2024. We completed an evaluation of the impact of the Agreement, as defined in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, on the carrying value of our property and equipment (Other Long-Lived Assets). This process included evaluating the remaining estimated useful lives, significant changes in the use and potential impairment charges related to the Other Long-Lived Assets. Based upon our evaluation, we recorded an impairment charge of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a99d74df-aea7-4614-b50f-d752aeab7fac" contextRef="C_498df639-b914-4e6f-a5bd-5f79abcd206f" name="us-gaap:AssetImpairmentCharges" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the furniture and fixtures to be sold to the landlord, which is included in the impairment of long-lived assets in the consolidated statements of operations. We also changed our estimate of the remaining useful lives of our leasehold improvements resulting in an acceleration of depreciation of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f05bb2c0-0ecc-4727-b7b9-022ddc081d5f" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during our fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6a436f7-ab85-4512-92e3-b95df01144d2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued liabilities consisted of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.863000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.083%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued pre-clinical and clinical trial expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_781afde8-544b-47d2-9efb-9be03043f39f" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:AccruedPreclinicalAndClinicalCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">134</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01ab3448-7e8e-4d7c-a655-fb0be82676cf" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:AccruedPreclinicalAndClinicalCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,407</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and benefits</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a425758-0352-4dbc-bf50-c6ed7dd8ba32" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">873</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92c3a739-20a7-4fb8-b471-9586192be188" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,821</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued legal and professional services</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe610b15-8c91-4a03-a4c4-578e6b90c40b" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">144</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d0f35c3-738b-43bd-a8fe-644433f13656" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued reimbursement to KKC</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2a188fe-a4ef-4f26-b1f1-be100ffed2ab" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:AccruedReimbursementToRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a766fd55-ec97-4958-8971-cfa95b9cfeef" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:AccruedReimbursementToRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">892</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2bfaa0f-4044-47fc-956f-266b09a2c5da" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_032dd384-7db1-4d20-a081-2cfd3d173489" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bead8922-8db6-4b8a-8f22-0964f3af6a69" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,178</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fb4f286-a6a5-4aab-8788-63635ac3ec05" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,187</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><ix:footnote id="FNT_457d9bd2-0d55-4b6e-a5ce-4e011cdc6cae" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Includes one-time employee benefits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c31c4a78-4b89-433d-a963-3ef9fdebae77" contextRef="C_7c38ad79-231e-469a-9a63-b80988a7ff5e" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_58ca6b4f-6338-4cd6-837b-e712c38e41e6" contextRef="C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">21,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></ix:footnote></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c5cfe1b9-f14f-49a9-b317-a1b91e3d292a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn4_fvm"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts of financial instruments such as cash equivalents, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. We invest our excess cash in financial instruments which are readily convertible into cash, such as money market funds and U.S. government securities. Cash equivalents are classified as Level 1 as defined by the fair value hierarchy. As of June 30, 2025 and June 30, 2024, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da0b91bf-c1ba-4c5e-b658-59f4d61e1db3" contextRef="C_aa875931-fb24-4796-91f3-c3924bcf1ebb" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_657b5465-d948-476b-a862-486555b8d5ae" contextRef="C_901ccdf2-1321-455f-9644-864349d54328" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_09d93d5f-9041-446f-b70c-20d2ca9eeed2" contextRef="C_901ccdf2-1321-455f-9644-864349d54328" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_3f76173b-b212-4c4b-be17-890adb40b14b" contextRef="C_aa875931-fb24-4796-91f3-c3924bcf1ebb" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> assets or liabilities measured on a recurring or non-recurring basis.</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;">&#160;</p><div><ix:nonNumeric id="F_f6202e86-9002-4a63-bfb9-faa5697a84da" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn5_onetimetermbene"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. One-time Employee Termination Benefits</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with our joint decision to discontinue development of zandelisib outside of Japan, in December 2022, we announced a realignment of our clinical development efforts that streamlined our organization towards the continued clinical development of our two earlier clinical-stage assets, voruciclib and ME-344 (prior to its sale in October 2024).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, we commenced the </span><a href="#fn1_stratalt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> RIF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as discussed in our strategic alternatives announcement described in </span><a href="#fn1_title"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 1. Description of Business and Basis of Presentation</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Including contractual pro-rata bonuses, we expect to incur charges not to exceed a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80fdac50-2af0-407c-86de-6d5b1c2ab8ec" contextRef="C_eb55a398-d9e2-4bc4-b646-4c8ff5f95e44" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in retentions, severance and COBRA costs related to the termination of our employees due to our related wind down activities. The charges that we expect to incur in connection with the </span><a href="#fn1_stratalt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> RIF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are subject to a number of assumptions and actual results may differ materially. We may also incur additional costs not currently contemplated due to events that may occur as a result of, or that are associated with, the </span><a href="#fn1_stratalt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> RIF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For each of the periods presented, one-time termination benefits primarily represent severance related costs and payments. During the fiscal years ended June 30, 2025 and 2024, we recorded employee termination benefits of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_313e69e5-76d7-480b-b01c-076aa04869d7" contextRef="C_65ce1f21-fab6-461d-b692-0bcf9b01d489" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c3296e1-fc23-4a07-afc3-1eac9afa78a8" contextRef="C_0b16e06a-f891-41fa-a61d-1dcab0a16b52" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within research and development expense, respectively. During the fiscal years ended June 30, 2025 and 2024, we recorded employee termination benefits of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f6f6f58-5490-4e71-b40d-73f70e606141" contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_266d0de4-be74-4647-bbf9-27380f1292dc" contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within general and administrative expense, respectively.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2ebaeb00-7255-4fd6-b426-25da7139a9af" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" escape="true" continuedAt="F_2ebaeb00-7255-4fd6-b426-25da7139a9af_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our activity related to one-time employee termination benefits, included in accrued liabilities, in thousands:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:69.96%;box-sizing:content-box;"/>
         <td style="width:2.06%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:25.98%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">One-time Employee Termination Benefits</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98e48a1d-a01c-4009-bcdf-88ae30b49d6a" contextRef="C_aa5f4327-ba0e-4b78-9b28-61fb4396f64d" name="us-gaap:RestructuringReserve" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">993</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in accrued restructuring</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0262c272-6915-41ec-8510-10b26059ad55" contextRef="C_f738a573-a0f1-4605-bcb6-b67c8411a1fb" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">556</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a933f41-6f04-4e68-b499-f21fd59e00f4" contextRef="C_f738a573-a0f1-4605-bcb6-b67c8411a1fb" name="us-gaap:PaymentsForRestructuring" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,528</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78674ba8-490b-4a38-ae5b-76ae17c4dc2b" contextRef="C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0" name="us-gaap:RestructuringReserve" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in accrued restructuring</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8642635f-80aa-4169-88b2-13d126648719" contextRef="C_2d40854b-8b85-47ad-ae8c-ed3f241c7c66" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,734</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80966d92-dacb-434a-a738-b9fb77cbb51d" contextRef="C_2d40854b-8b85-47ad-ae8c-ed3f241c7c66" name="us-gaap:PaymentsForRestructuring" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,027</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_baaff4ab-be9d-4006-929c-3b2dabdf0a20" contextRef="C_7c38ad79-231e-469a-9a63-b80988a7ff5e" name="us-gaap:RestructuringReserve" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">728</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div><div><ix:continuation id="F_2ebaeb00-7255-4fd6-b426-25da7139a9af_1"></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_fd5e3390-6270-49ef-aff6-0831eef1d497" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_fd5e3390-6270-49ef-aff6-0831eef1d497_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn6_commitcon"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have contracted with various consultants and third parties to assist us in pre-clinical R&amp;D and clinical trials work for our leading drug compounds and general and administrative activities. The contracts are terminable at any time but obligate us to reimburse the providers for any time or costs incurred through the date of termination. See the discussion of the sale of ME-344 within </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for additional information regarding contracts associated with ME-344 assumed by the Purchaser (as defined in </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ). We also have an employment agreement with our Acting Chief Executive Officer and Chief Financial Officer that provides for severance payments and accelerated vesting for share-based awards if their employment is terminated under specified circumstances.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litigation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may be involved in various lawsuits, legal proceedings, or claims that arise in the ordinary course of business. Management believes there are no claims or actions pending against us as of June 30, 2025, which will have, individually or in the aggregate, a material adverse effect on its business, liquidity, financial position, or results of operations. Litigation, however, is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with our amended and restated certificate of incorporation and sixth amended and restated bylaws, we have indemnification obligations to our officers and directors for certain events or occurrences, subject to certain limits, while they are</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_fd5e3390-6270-49ef-aff6-0831eef1d497_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">serving in such capacity. There have been no claims to date and we have a directors and officers liability insurance policy that may enable it to recover a portion of any amounts paid for future claims.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Presage License Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in</span><a href="#fn8_othlicagree"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Other License Agreements</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we are party to a license agreement with Presage under which we may be required to make future payments upon the achievement of certain development, regulatory and commercial milestones, as well as potential future royalties based upon net sales. As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f68bdd31-d1b6-48b8-83ab-39c668877749" contextRef="C_5c746096-0191-4a12-b56d-6cedc776485d" name="lits:AccruedMilestonePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accruals for potential future payments as achievement of the milestones had not been met.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc0938df-f9bd-4478-9104-a9e848610bb8" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:RevenueFromContractWithCustomerTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn7_licagree"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">KKC License, Development and Commercialization Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2020, we entered into the KKC Commercialization Agreement under which we granted to KKC a co-exclusive, sublicensable, payment-bearing license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in the U.S. (the U.S. License) and an exclusive (subject to certain retained rights to perform obligations under the KKC Commercialization Agreement), sublicensable, payment-bearing, license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in countries outside of the U.S. KKC granted to us a co-exclusive, sublicensable, license under certain patents and know-how controlled by KKC to develop and commercialize zandelisib for all human indications in the U.S. and a co-exclusive, sublicensable, royalty-free, fully paid license under certain patents and know-how controlled by KKC to perform our obligations in the Ex-U.S. under the KKC Commercialization Agreement. KKC paid us an initial nonrefundable payment </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0238754-45f4-400c-998f-38a21aa45be2" contextRef="C_4038fe7e-0797-4545-9817-044b66f01547" name="lits:TotalUpfrontPaymentReceivableForGrantOfRights" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2023, we entered into a termination agreement with KKC to mutually terminate the KKC Commercialization Agreement and all other related agreements between the parties (Termination Agreement) and jointly decided to discontinue zandelisib development in the U.S. Prior to the execution of the Termination Agreement, KKC was responsible for the development and commercialization of zandelisib in Ex-U.S. and, subject to certain exceptions, was solely responsible for all costs related thereto. We also provided to KKC certain drug supplies necessary for the development and commercialization of zandelisib in the Ex-U.S., with the understanding that KKC would have assumed responsibility for manufacturing for the Ex-U.S. as soon as practicable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2023, we updated our assessment of the total transaction price from the KKC Commercialization Agreement to reflect the upfront payment, milestone payments, estimated development cost-sharing and deferred revenue. After announcing our plan to discontinue the global development of zandelisib outside of Japan, in December 2022, we decreased our estimate for variable consideration related to development cost sharing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With the execution of the Termination Agreement, we regained full, global rights (subject to KKC's limited rights for compassionate use) and KKC has no further rights to develop, use or commercialize zandelisib in the U.S., nor do we have any remaining performance obligations with all consideration received from KKC being nonrefundable. Therefore, the remaining long-term deferred revenue as of June 30, 2023, of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_618012cb-b18d-4cda-9a44-1c00dcb6a4c6" contextRef="C_4dfa8660-229c-4efc-b1ce-209781894ed6" name="us-gaap:DeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">64.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that was allocated to the U.S. License obligation accounted for under Topic 808 at inception of the KKC Commercialization Agreement was recognized as revenue from collaboration agreements in the three months ended September 30, 2023, utilizing contract termination analogous to guidance provided in Topic 606.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc2064cc-bd48-40ff-ae52-b0cfe6d0de8f" contextRef="C_4dfa8660-229c-4efc-b1ce-209781894ed6" name="us-gaap:DeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">64.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million transaction price allocated to the U.S. License obligation accounted for under Topic 808 was included as noncurrent deferred revenue as of June 30, 2023. As of June 30, 2023, we also had deferred revenue of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31819369-ab4e-4a6b-b53e-19736630b877" contextRef="C_3b1ff24a-8449-4e09-abf5-5f426b41e513" name="lits:LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the transaction price allocated to the Development Services performance obligations and recognized the remaining revenue based on the proportional performance of these development activities. The KKC Agreement was terminated on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a9d2540-b721-4e10-82fb-9b5fe92406d9" contextRef="C_9de02997-3191-4520-97dc-7a314cccb702" name="lits:TerminationAgreement" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 14, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and all remaining amounts of deferred revenue were recognized during the fiscal year ended June 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_4f1c1e4f-1ed6-4be6-a046-6f8450240e68" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:OtherLicensingArrangementsTextBlock" escape="true" continuedAt="F_4f1c1e4f-1ed6-4be6-a046-6f8450240e68_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn8_othlicagree"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. Other License Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Presage License Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2017, we, as licensee, entered into a license agreement with Presage Biosciences, Inc. (Presage). Under the terms of the license agreement, Presage granted to us exclusive worldwide rights to develop, manufacture and commercialize voruciclib, a clinical-stage, oral and selective CDK inhibitor and related compounds. In exchange, we paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fe3616a-0ee1-4068-9984-4027ecbf76d9" contextRef="C_fbc3fa56-1138-411a-86db-d0f5176a096d" name="lits:PaymentForLicenseAgreement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to Presage. With respect to the first indication, an incremental $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7b05da7-ad94-4efd-bb05-a865c5d41748" contextRef="C_046dad52-7060-4b22-a684-7b4095cf956f" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million payment, due upon dosing of the first subject in the first registration trial, will be owed to Presage, for total payments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49eb166c-d2ea-4113-8aac-280f5463fc73" contextRef="C_03a52d86-9327-469f-9cca-e384b91706f2" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million prior to receipt of marketing approval of the first indication in the U.S., EU or Japan. Additional potential payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bce2ec28-ca02-4460-8d7d-c0e44645a559" contextRef="C_ebb8eacd-9a9f-4b19-8cc4-c8435984244b" name="lits:PotentialMilestonePaymentsReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">179.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will be due upon the achievement of certain development, regulatory and commercial milestones. We will also pay mid-single digit tiered royalties on the net sales of any product successfully developed. As an alternative to milestone and royalty payments related to countries in which we sublicense product rights, we will pay to Presage a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4f1c1e4f-1ed6-4be6-a046-6f8450240e68_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tiered </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">percentage (which decreases as product development progresses) of amounts received from such sublicensees. During the fiscal years ended June 30, 2025 and 2024, we made no payments under the Presage license agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BeiGene Collaboration</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2018, we entered into a clinical collaboration with BeiGene, Ltd. (BeiGene) to evaluate the safety and efficacy of zandelisib in combination with BeiGene&#8217;s zanubrutinib (marketed as Brukinsa&#174;), an inhibitor of Bruton&#8217;s tyrosine kinase, for the treatment of patients with B-cell malignancies. Under the terms of the clinical collaboration agreement, we amended our Phase 1b trial to include evaluation of zandelisib in combination with zanubrutinib in patients with B-cell malignancies. Study costs are being shared equally by the parties and we agreed to supply zandelisib and BeiGene agreed to supply zanubrutinib. We record the costs reimbursed by BeiGene as a reduction of our research and development expenses. We retained full commercial rights for zandelisib and BeiGene retained full commercial rights for zanubrutinib. With the discontinuation of the zandelisib program outside of Japan, this clinical collaboration was terminated on September 28, 2023. During the fiscal year ended June 30, 2025, we did not recognize cost reimbursements as a reduction of research and development expenses. Cost reimbursements recorded as a reduction of research and development expenses, in the consolidated statements of operations, during the fiscal year ended June 30, 2024, was approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97b154ce-6aba-4e28-b430-3486955374eb" contextRef="C_e7db8cf6-cb55-4ae2-94f9-5eb5ba8827f8" name="us-gaap:RecoveryOfDirectCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_0751a7bd-12c1-4a5a-accc-c38232af236b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true" continuedAt="F_0751a7bd-12c1-4a5a-accc-c38232af236b_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn9_leases"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2020, we entered into a lease agreement for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3ab1414-b053-488d-b98b-65bc07889ad4" contextRef="C_1d242087-6da3-4ba4-9ecd-f789815f32a7" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">32,800</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in San Diego, California. The lease agreement contained rent escalations over the lease term and was originally scheduled to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_10d9387d-fef2-414e-8898-e24c8f8f9759;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2028</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We accounted for the lease agreement as an operating lease. The lease agreement contained an option to renew and extend the lease term, which was not included in the determination of the ROU asset and operating lease liability, as it was not reasonably certain to be exercised. In July 2022, we amended the lease to extend the lease termination date from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bee66b44-7fcb-482f-938b-2dcb4681b6b7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2028</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1cdf4b67-f67d-424f-8fb3-537963ec519e" contextRef="C_36dd6fec-f2fe-427e-a87d-51412c3f9ec9" name="lits:LeaseTerminationDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 30, 2029</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and to add an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e2843de-56ff-4508-9b24-78fd464f7422" contextRef="C_5fb23a8d-14cb-4175-877b-89e01b2aff80" name="us-gaap:AreaOfLand" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">12,300</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space adjacent to our current office in San Diego (the Amended Lease). Upon commencement of the Amended Lease, we recognized an additional ROU asset and a corresponding operating lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ad67a0c-8e3f-4d22-98e1-03617356b294" contextRef="C_d3e5d951-4348-4f5f-b2be-82d3b6a4f3ea" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Amended Lease includes variable non-lease components (e.g., common area maintenance, maintenance, etc.) that are not included in the ROU asset and operating lease liability and are reflected as an expense in the period incurred as a component of the lease cost.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lease Termination</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 18, 2024 (the Agreement Date), we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_156ed20d-4c27-455a-83b0-f6c0826deb1c" contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a" name="lits:LeaseExpirationAmendedDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 30, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the lease for our existing office space. The original (as amended) scheduled expiration date was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98c5b395-f9c0-4c08-9807-23d1fbdd53ae" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:LeaseTerminationDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 30, 2029</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As consideration for the Agreement, we agreed to pay the landlord a termination fee of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_499f4515-3481-4fda-8c37-1280346ff68c" contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57" name="lits:LeaseTerminationFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the Termination Fee) and to prepay the remaining rent due under the Agreement in the amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04dc5e3e-8ddf-4521-a7da-3998aede96b4" contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57" name="lits:PrepaymentOfRemainingRent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the Remaining Rent) and sell all the furniture and fixtures to the landlord for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_606de046-ed67-4075-8a12-c65513b128f0" contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a" name="us-gaap:ProceedsFromSaleOfFurnitureAndFixtures" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (see </span><a href="#fn3_prop_equip"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">within </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for further discussion on the impact of the Agreement on our property and equipment). During fiscal year 2025, we received our security deposit from the landlord, which was previously classified as a component of prepaid and other current assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreement was accounted for as a lease modification of the original contract. As a result of the Agreement, we reduced both the remaining ROU asset and lease liability by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5efcf5d-107d-440e-9675-aee8371e33f3" contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a" name="lits:AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">22,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, resulting in no impact to our consolidated statements of operations. We reassessed the lease classification, as of the Agreement Date, noting the current classification as an operating lease remained appropriate. Both the Termination Fee and the Remaining Rent were paid prior to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subsequent to the payment of both the Termination Fee and the Remaining Rent, our lease liability was relieved and the balance was reduced to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76e31c3e-722f-4481-8095-563aace9f36c" contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We incurred direct costs of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bab2af89-3446-4e31-8883-d904f8c10a70" contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57" name="lits:DirectCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in connection with the Agreement which accordingly was recorded to the ROU assets as a direct cost of modifying the Agreement. As of the Agreement Date, we determined a triggering event, in accordance with ASC 360, had occurred and therefore completed an impairment analysis on its ROU asset resulting in an impairment charge of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3604da4-421e-4c8c-9925-b4004e9c1590" contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million being recorded in our consolidated statements of operations for the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2392920-e68d-4b7d-99fd-b3484f8753fc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease costs for the Amended Lease were as follows for the periods presented, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.643%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.303%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_609cf61b-6e74-4380-8f17-1e5ea1ccdc51" contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8c828ad-cca0-4542-9d52-c1597432bf7c" contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,434</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0284e5ac-15f0-4cc2-b5c8-c61b87a04642" contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f63d1ee6-6ee7-4336-ba80-01984748e0b2" contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs included in operating expenses</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89ad9260-bee5-40ee-9237-8a74b14bcd43" contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a3bc181-b318-4bd0-ad18-045d64ae86e2" contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,557</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_0751a7bd-12c1-4a5a-accc-c38232af236b_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended June 30, 2025, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81623d9d-1b58-4917-83a8-8d0869c1123a" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> supplemental cash flow activity. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_636fbb51-aec7-489d-8ce4-6cd347e9d5fb" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" escape="true" continuedAt="F_636fbb51-aec7-489d-8ce4-6cd347e9d5fb_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplemental cash flow information related to our operating leases for the year ended June 30, 2024 was as follows, in thousands:</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_636fbb51-aec7-489d-8ce4-6cd347e9d5fb_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:76.155%;box-sizing:content-box;"/>
         <td style="width:1.98%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.863999999999997%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amount included in the measurement <br/>&#160;&#160;&#160;&#160;of lease liabilities:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_373dadec-fcd3-4fe8-8f21-85c4aff8e52b" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,612</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b130a85b-6c6b-4e11-983e-fd45040d3e55" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> remaining future minimum rental payments for our operating leases and the remaining ROU asset balance was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f735c248-43e8-41d8-b6d8-e61899d3b8cd" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. During fiscal year 2024, the ROU asset balance was increased by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4144542-2060-4d09-8dfa-072a437cfffb" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:DirectCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to direct costs associated with the Agreement. Additionally, the ROU asset balance was decreased by: (1) approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bbc3cd0-70e7-4b7b-b91a-ee098af72db1" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">22,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> associated with our reassessment of the lease liability as of the Agreement date and (2) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd4ca17b-cf59-4e00-8cf1-28345946b1d9" contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million associated with the impairment of the ROU asset, as discussed above. As of September 30, 2024, we had vacated the facility and the leased property reverted to the landlord. In addition, the ROU asset has been fully amortized.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_08f658da-4bf4-4a25-ad74-7ec0c6e64162" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="F_08f658da-4bf4-4a25-ad74-7ec0c6e64162_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn10_stockequity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. Stockholders&#8217; Equity</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Shelf Registration Statement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a shelf registration statement (February 2024 Shelf Registration Statement) that permits us to sell, from time to time, up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59e6718f-61f6-4e1f-92d4-a129618af70d" contextRef="C_cfc6a080-d7ad-48cf-9593-13de2e93cbdd" name="lits:SaleOfSharesAndWarrantsUnderAgreement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of common stock, preferred stock, warrants rights and units. The February 2024 Shelf Registration Statement was filed February 20, 2024 and declared effective February 28, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">At-The-Market Equity Offering</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 20, 2024, we entered into a capital on demand sales agreement (the On Demand Sales Agreement) with JonesTrading Institution Services LLC, pursuant to which we can offer and sell shares having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a541589c-d9de-455d-8cd9-d22135cb4b51" contextRef="C_cf8f1efe-c282-41f0-90aa-477e9df58d2c" name="lits:MaximumAmountOfCommonStockOfferingPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the ATM Program). </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_99873aca-4df4-42f5-a899-d6c9ea1dcbc4" contextRef="C_7fda2453-8aa5-405b-b3ee-795a3fca2cda" name="lits:AtTheMarketOfferingAgreementDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of January 2, 2024, the date used under applicable rules of the SEC to determine our public float at the commencement of the offering, one-third of our public float was equal to approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb4d46a4-ce6a-4003-ac6e-46480b626aae" contextRef="C_78b08baa-a398-4c87-8856-dccadb025d83" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> did not offer or sell any shares of our Common Stock (as defined below) under the On Demand Sales Agreement. Effective July 21, 2025, we terminated the On Demand Sales Agreement. On July 22, 2025, we entered a new Sales Agreement (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), see </span><a href="#fn_new_sales_agree"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Entry into a New Sales Agreement</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> discussion within </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for details related to the Sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> between the SPA Closing date (as defined in  </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) and September 19, 2025, we issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b38838c-f79c-4360-9028-62d39802d078" contextRef="C_93b9e9e8-1270-4323-afb0-75af92765160" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">882,924</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock (as defined below) for aggregate proceeds, net of the underwriter's commission of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_c8fb003e-702b-4086-8164-58f62bef2b96" contextRef="C_93b9e9e8-1270-4323-afb0-75af92765160" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, through our ATM Program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cooperation Agreement, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e98d41df-98e3-45ba-b3a8-6757954bfd50" contextRef="C_f12fbef6-72e6-4260-86e6-fc02f15df7a4" name="us-gaap:CommonStockDividendsPerShareDeclared" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Common Stock (as defined below) that was declared on November 6, 2023 to stockholders of record at the close of business on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_63288475-3749-4138-abfe-19935b97c7d5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:ClosingAgreement" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 17, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The total dividend of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b509ce35-2d84-43b9-ad2c-f60cb82a2fb8" contextRef="C_32d99983-1b3d-4c08-8e53-fb1cf89c3852" name="us-gaap:PaymentsOfDividends" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid on December 6, 2023 and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rights Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b30b9d0a-e8b9-4adc-a995-9573aa4b33ce" contextRef="C_23b7781d-5a70-4950-ab3d-ed36fea479a3" name="lits:AdoptedAgreement" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 1, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, our Board approved and adopted a rights agreement (Rights Agreement) by and between us and Computershare, Inc., as Rights Agent (as defined in the Rights Agreement). Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a Right) for each outstanding share of our Common Stock (as defined below), par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2057ccfc-87fb-4191-a76f-d6178cf2fd98" contextRef="C_90b552c8-e654-4d0a-8162-fa00aec0af5a" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="8" format="ixt:num-dot-decimal">0.00000002</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (each a Common Share and collectively, the Common Shares). The Rights were distributable to stockholders of record as of the close of business on October 12, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ecb68564-98f4-43da-976e-2782541caedb" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:RightsAndTheRightsAgreementExpirationDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Rights and the Rights Agreement expired at the close of business on September 30, 2024. No rights were redeemed or exchanged under the Rights Agreement.</span></ix:nonNumeric></span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_08f658da-4bf4-4a25-ad74-7ec0c6e64162_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrants</span></p><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we have outstanding warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0863fe08-c065-480e-b834-3e0376a14476" contextRef="C_4477116c-5b49-4100-b4a7-28181e73d4e7" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">102,513</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock (as defined below) issued to Torreya Partners LLC. The warrants are fully vested, exercisable at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de263f14-9a31-4a6d-a50d-d0357f21327b" contextRef="C_4477116c-5b49-4100-b4a7-28181e73d4e7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expire in October 2027. During the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f201b87f-bdaf-44a3-b766-d2f3f35b23c1" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:NumberOfWarrantsExercised" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6e926b47-340a-4812-b2af-84aa6b7dfbf3" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:NumberOfWarrantsExercised" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants were exercised.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b684b22f-bbf3-4544-acdd-9925304f02ee" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), we issued the following warrants:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.025%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.484%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.502%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.103%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:23.885%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Warrants Outstanding</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial Exercise Date</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Asset Manager Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 1</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af7f0cfb-be98-4c63-bcf9-7815929bc4f3" contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">584,795</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_190c356a-43b7-4f56-9ec1-eae4d690bbd1" contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.42</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_b927ed91-52d8-4f7a-bad7-dfd41645166a" contextRef="C_39b6c9ec-a171-463c-827e-3d4ee41454a2" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_dedd9dd5-78d1-4d0d-b5ce-abc27a237288" contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 2</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17249155-4278-4a5f-83e8-289f64e95d52" contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">292,398</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb2a0032-aefb-4bfe-8a21-f3dbc16d2a8b" contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.93</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_1ffe16fa-d940-4f90-a667-634c93751e44" contextRef="C_96669720-7ee3-4ea8-afce-e422997f939e" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_5448a6e3-9fdd-4c6a-bf55-4c2624f64fca" contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 3</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c632242b-c704-4e13-94fe-6afbc333c441" contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">292,398</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95bc4a61-1a24-464c-8b7c-7c5fd9b13a2a" contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.62</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_7e0b4874-b47e-4a7e-aca1-ab82e0cfb6b3" contextRef="C_890346b8-8f3f-4053-845e-8155a5f5e602" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ea57b926-bd13-470f-a409-b389212a550e" contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 4</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18a6df1f-94b9-4ee8-9d76-91669058b80c" contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">292,398</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e54a7d3f-ed92-4a60-b139-6ef67e396ecc" contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.13</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_4d5eb19a-59d7-40e2-ada6-b6ee2875f91c" contextRef="C_e3b3e1bb-0d52-409c-8d44-386e016474a0" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a4111205-16c6-438c-99e3-1a9c819f2647" contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Strategic Advisor Warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e59c8e57-8b39-48b3-83d1-e9a7adbe38a8" contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">438,597</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28835757-d844-4130-9540-a3bf11acd7c7" contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.10</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_d9fe3d73-ed51-4216-9925-2ddc335465c0" contextRef="C_17b85b55-1836-4eb6-8ee3-7afafbc45023" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_e64d9926-a670-4a43-a1be-21d68e519580" contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Placement Agent Warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69a262e8-29e2-43d9-abfd-5bd91e9038fd" contextRef="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,169,591</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_035867d9-587d-4a06-b3e3-4660c4168881" contextRef="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.10</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_aa0e5770-b21d-4551-bc80-2b76aec67b8d" contextRef="C_eb4c8b50-1cde-40b3-95ce-38094a76fdac" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_98eeb208-82fd-40ee-9cf8-a49d9d46a4ca" contextRef="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></ix:nonNumeric></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52878f1e-2727-46be-915b-b86b9e8d7f71" contextRef="C_fa1c20a4-edb7-43ee-b979-1cf83c11f686" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,070,177</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bb1804b-05bb-4de9-a7ce-33c8b8a6a36b" contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,022,869</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to an investor that participated in the Offering. The Pre-Funded Warrants are immediately exercisable and have an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_780666a3-abc5-4576-9032-7041da44e8bf" contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In July 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_207b9938-39ce-43b9-84e6-cc96a025596e" contextRef="C_07f286c0-e5a6-4c38-9799-941180c82a4c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,084,509</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined below) were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ff5c976-42a1-4948-b391-139b620e08a6" contextRef="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,807,967</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined below) upon cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03899286-2512-446d-a7c6-9c2e1e7bfe2e" contextRef="C_d190719d-ba9d-4549-9346-f6c2c6a02045" name="lits:SurrenderedWarrantsToAcheiveCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,808,070</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94da3d06-50b8-4ee3-9848-d4251d19b1f8" contextRef="C_08b96565-9169-4635-945d-9321b9c399be" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">546,348</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eec800d7-c1c3-4659-992f-7c2d48d588df" contextRef="C_08b96565-9169-4635-945d-9321b9c399be" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Description of Capital Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our total authorized share capital is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e9fe592-ed80-4fad-98db-a8e402c6cc04" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CapitalUnitsAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">226,100,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares consisting of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0693a282-2899-4f66-ace3-e1025fec600b" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">226,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c1b7804-b616-4615-994b-27866ddd069d" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.00000002</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share (Common Stock) and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b928825b-60ab-46cb-a8b4-ec281d9e41d8" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">100,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18ebcbd5-0e3b-460c-ba69-05a22b7ace1e" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.01</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The holders of Common Stock are entitled to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_552bbee9-f3ca-4e3e-9aa4-c84632608c65" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:CommonStockVotingRights"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one vote per share</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In the event of a liquidation, dissolution or winding up of our affairs, holders of the Common Stock will be entitled to share ratably in all our assets that are remaining after payment of our liabilities and the liquidation preference of any outstanding shares of preferred stock. All outstanding shares of Common Stock are fully paid and non-assessable. The rights, preferences and privileges of holders of Common Stock are subject to any series of preferred stock that we have issued or that we may issue in the future. The holders of Common Stock have no preemptive rights and are not subject to future calls or assessments by us.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), we issued </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_95f9498f-8276-4108-93f7-cffc95fa99ec" contextRef="C_870e143e-2c95-4ffb-9924-d47b9fd9da81" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">23,216,898</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_784b860f-e35f-4c04-a62b-28e639747215" contextRef="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, for net cash proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb977883-2a69-4814-9763-c60dd1fddb42" contextRef="C_a06c0f95-2711-45fa-8758-3af29c6ca47e" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">92.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board has the authority to issue up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d995dc68-9c91-40b3-9755-2a800d6f6104" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">100,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock with a par value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf238d7a-9a4f-4ceb-b8d3-76fe921fb5ce" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share in one or more series and to fix the rights, preferences, privileges and restrictions in respect of that preferred stock, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption (including sinking fund provisions), redemption prices and liquidation preferences and the number of shares constituting such series and the designation of any such series, without future vote or action by the stockholders. Therefore, the Board, without the approval of the stockholders, could authorize the issue of preferred stock with voting, conversion and other rights that could affect the voting power, dividend and other rights of the holders of shares or that could have the effect of delaying, deferring or preventing a change of control. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed905e36-6ca7-4ed2-bc15-a96b3138f737" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_469ac399-e625-45e0-b89f-229e61a65daf" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock outstanding as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_4e909bb2-60fa-4a8c-8ea4-2358aae161c8" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn11_sbc"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. Share-based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use equity-based compensation programs to provide long-term performance incentives for our employees. These incentives consist primarily of stock options and RSUs. In December 2008, we adopted the MEI Pharma, Inc. 2008 Stock Omnibus Equity Compensation Plan (the Omnibus Plan), as amended and restated from time to time, under which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7db99271-f378-405e-96b6-2e5d85b94fef" contextRef="C_bbdcc299-39eb-4e27-b604-ab146bacfa01" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,850,739</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock are authorized for issuance. The Omnibus Plan provides for the grant of options and/or other stock-based or stock-denominated awards to our non-employee directors, officers, employees and advisors. As of June 30, 2025, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a9cc37d-01ce-4b9b-9930-ee61100e331b" contextRef="C_bbdcc299-39eb-4e27-b604-ab146bacfa01" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">920,737</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares available for future grant under the Omnibus Plan.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, we adopted the 2021 Inducement Plan (Inducement Plan, together with the Omnibus Plan, the Equity Plans), under which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03f90676-c065-4df0-8e34-7b786ab58ca0" contextRef="C_4022bccc-441f-4478-9790-7dc6fba82efc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">125,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were authorized for issuance. On June 9, 2023 our Board approved an amendment and restatement of the Inducement Plan to increase the aggregate number of shares of Common Stock authorized for issuance by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73d2d0cb-8137-4efe-b7cb-0d8b2e314b1d" contextRef="C_0a639547-5eb3-4035-a49b-df9413032521" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">92,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares. The Inducement Plan is intended to assist us in attracting and retaining selected individuals to serve as employees who are expected to contribute to our success, by providing an inducement for such individuals to enter into employment with us and to achieve long-term objectives that will benefit our stockholders. As of June 30, 2025, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_278f595f-6ae2-43b2-88bd-076df48d348a" contextRef="C_801bb470-1666-486b-9626-f457beb6c0e0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">163,698</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares available for future grant under the Inducement Plan.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d88534ab-3cd5-458f-b3ab-a7d29270fbc9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total share-based compensation expense for all stock awards consists of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.86%;box-sizing:content-box;"/>
         <td style="width:1.3%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.940000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.700000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_122305e1-b12a-4855-a4d5-f211110725e9" contextRef="C_65ce1f21-fab6-461d-b692-0bcf9b01d489" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">128</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1595c22c-4c46-4343-a3e0-b21c1f0c6ce8" contextRef="C_0b16e06a-f891-41fa-a61d-1dcab0a16b52" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">349</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f27e1f69-fb1c-42bd-9fb9-b677d717854c" contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19acdb29-905d-4b2d-b058-fcb621119caa" contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,929</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total share-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11ff3fe6-3673-4319-9284-a7c1e46f8f44" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">144</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_893671fc-6764-47e8-bf23-2fae0fab14d0" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,278</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock options granted to employees vest </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5e4d31c-2585-4a0a-b4ed-d26d393685b8" contextRef="C_8f477f08-619a-4dd4-bf96-14b4f5bbc093" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% one year from the date of grant and ratably each month thereafter for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c0106206-aad7-43f1-b79d-a5a660edf5d6" contextRef="C_8f477f08-619a-4dd4-bf96-14b4f5bbc093" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months and expire ten years from the date of grant. Stock options granted to directors vest ratably each month for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_58426dec-0d8f-4c18-b421-99513f925d94" contextRef="C_4f503b69-15af-4b8f-a96a-caa0ddcce497" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months from the date of grant and expire </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_56c2981a-0ffe-44cc-b52f-72fe564a2291" contextRef="C_4f503b69-15af-4b8f-a96a-caa0ddcce497" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of grant. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025, there were a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9531ba9e-ba97-431e-b09c-7814e2405464" contextRef="C_09f1e527-d411-49b0-8987-c4eeed8a7d14" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">869,148</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options outstanding of which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cdecf96-7bcc-44d0-bee2-7c1fc298813a" contextRef="C_3e8cceec-9f3f-4c61-8560-6f8645289b52" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">815,846</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> were granted under the Omnibus Plan and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f11f5b59-3df2-45bf-ab28-5110077f1797" contextRef="C_32df5392-7969-40b6-9827-2e4cab47aa33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">53,302</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> were granted under the Inducement Plan.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e7fe1e55-fa7d-41da-87f7-c0630f24af82" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> A summary of our stock option activity and related data follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.689%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.902%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:11.202%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.523%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:6.2010000000000005%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Options</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Remaining Contractual<br/>Term (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b85b9995-c1c4-45ce-949d-5370e308b7ed" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,357,213</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31f6b80a-06ee-4dc0-a858-c91b69f353e4" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">31.60</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4983d688-9a91-4c1b-bf6f-230c07c4ba45" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">488,065</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb3031eb-0055-4fee-98dc-0cb54a22b434" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">25.64</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8506d544-ed81-492e-8603-5caa2622fc9a" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">869,148</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a6c4762-b2a9-4bad-accf-0fd62a294946" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">32.90</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;"><ix:nonNumeric id="F_bdb841e4-2b0a-485f-b6cd-05c463159218" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e767c862-5e6e-4b59-b554-8082f34cda07" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5182fe6-568a-4b48-b0da-2edc330404e1" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">869,148</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;"><ix:nonNumeric id="F_d3e1fbbd-3e1b-43a3-9063-400fdd3797d3" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77440a3d-b1e0-4c54-b309-5fc84ff725aa" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025, the aggregate intrinsic value of outstanding options is calculated as the difference between the exercise price of the underlying options and the closing price of our Common Stock of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_66c800d0-084a-47be-bc99-6d1016de683e" contextRef="C_09f1e527-d411-49b0-8987-c4eeed8a7d14" name="lits:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.47</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on that date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unrecognized compensation expense related to non-vested stock options totaled </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_60499f59-0e81-4fd6-8a3d-40cc97b810a8" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025. Such compensation expense is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b61a9fd-54e3-4a2a-8eb1-e24d16daf8c7" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.17</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025, we expect all outstanding options to vest.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use a Black-Scholes valuation model to estimate the grant date fair value of stock options. During the year ended June 30, 2025, we did not grant any stock options. During the fiscal year ended June 30, 2024,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_218e1b8d-4fcf-425e-8642-332e17cf5def" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_218e1b8d-4fcf-425e-8642-332e17cf5def_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">following weighted-average assumptions were used to calculate these fair values:</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_218e1b8d-4fcf-425e-8642-332e17cf5def_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:79.52%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.86%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1946f39f-118f-4c9b-b8ad-68769ed12dc3" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life (years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_d6a9cab3-c3a7-450b-8c33-fb51fde21840" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.7</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ca6f0c8-96ed-4b80-9363-8b89a21eba95" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">89.8</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend yield</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_573877c6-f307-47a2-95d2-3321b697b161" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average grant date fair value</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_328db247-e9c8-4cfb-b786-7886b1285ec1" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.20</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d25a2024-7e9c-4cc0-aaf6-d4d188626320" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn_segments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 12. Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the CODM, which is our Acting </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2254fbc2-926d-4ef0-b4be-2c017a79ef44;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Chief Financial Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in deciding how to allocate resources and assess performance. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_90745f29-5abc-43e5-b0d5-52837f1944e6" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our CODM evaluates our financial information including year over year profit and loss comparisons and cash projections on an aggregate basis when assessing performance for allocating financial and personnel resources.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are not organized by market and are managed and operated as one business.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We identify our operating segments based on our business activities. We operate within a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b5129ee1-cc18-4e29-a225-35da57c0a01a;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment, the development of pharmaceutical products. During fiscal 2025, we did not generate any revenue. During fiscal 2024, all revenues were generated in the United States. Our administrative functions including finance, business development and information systems, support the development of pharmaceutical products segment. We operate in one geographic area, the United States. The CODM allocates resources (inclusive of both capital and personnel) based upon our net loss, which is utilized to monitor year over year variances on a quarterly basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the development of pharmaceutical products segment are the same as those described in </span><a href="#fn2_sumsigpolicies"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Significant Accounting Policies</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All our assets are in the United States. The measure of segment assets is reported on the balance sheets as total assets. We do not have intra-entity sales or transfers.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended, June 30, 2025 and 2024, we had no transactions denominated in foreign currencies nor any intangible property for which we recognized amortization expense. During the years ended June 30, 2025 and 2024, we did recognize depreciation expense which we have included in "other expenses" within the table below. Depreciation expense is reported in our statements of cash flows and is expected to be zero during fiscal 2026. Non-cash expenses such as depreciating assets and share-based compensation are not part of the CODM's evaluation or decision-making process.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_86acc6d8-b55f-4522-a52c-e9cfce1b0ca5" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our financial data for the development of pharmaceutical products segment:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenues</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e385c18a-4334-4ca4-a720-f9b4de0dfc56" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72bfb449-79dd-4d23-b484-d4271c87fcba" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,297</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating and other (income) expense</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employee expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15f877ef-8b55-42ee-9852-7c64581f51dc" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:LaborAndRelatedExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,293</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b97ff31f-94b1-41a3-b090-506b5e33d3ad" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:LaborAndRelatedExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,207</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment expenses</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6672378b-77c3-44f1-871c-5952bed8854f" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:OtherExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,647</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d33196ca-3de0-4094-82d0-c8df56d8e926" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:OtherExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,946</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09ef7c23-e10e-44f9-a1e5-6eef18705ef6" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,754</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b438aea6-7d20-4213-bdae-03069884de77" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,092</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal fees</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b8828b6-8d0a-4e03-bc21-4d7804cb30c2" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:LegalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,723</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c3448ed-6227-4b40-bd6a-a27edd602528" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:LegalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,397</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dffbd0d0-5695-4a72-8b9e-1c8a931080b1" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29ae7fac-fb10-42f4-a587-e9d0934bd714" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,899</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fees paid on behalf of a related party</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb0c9cb1-3d8d-4963-af57-4c93161677a7" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="lits:FeesPaidOnBehalfOfRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e54b0873-64ec-4dcc-bfc5-0442427e6b68" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="lits:FeesPaidOnBehalfOfRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,118</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">voruciclib</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc4edfc9-43f2-44b7-aec3-290d1e42de06" contextRef="C_7d14d4db-d882-45a5-8109-0ae6bd9376fc" name="us-gaap:OtherExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">801</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47b11a89-62c8-48ec-a3c1-a19cdd866493" contextRef="C_5de81fb4-2434-47f3-8fae-5c41690c6230" name="us-gaap:OtherExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,413</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ME-344</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d489e53-c0bd-4c39-b4e3-f3f542afaae9" contextRef="C_8fb49a6d-13d9-4bc0-8564-85ae7e671e0d" name="us-gaap:OtherExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71a137c3-8fc6-49d8-9cd4-03942dc78560" contextRef="C_8e54884a-d867-4942-80ac-35ef13f92073" name="us-gaap:OtherExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,724</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on disposition of a non-financial asset</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd0fa07d-961d-4cd0-aa59-55e4fc1ad253" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d7f4fe6-1767-4cbd-a6f0-3a285589835f" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5abb520-49d5-489e-80d8-2645b1b23986" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b33b70e2-64cc-466e-b0c0-0ed351e7eb1b" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:InterestAndDividendIncomeOperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,277</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating and other (income) expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_632e5b54-f4b4-46bd-a4e9-47fc0be6bc82" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bed2cd1-a0f6-4b3c-a390-193c56f06be1" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,519</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total segment costs (loss) income and net (loss) income</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b3607a6-15bc-4334-b19a-60cbcae63482" contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43b7cef3-edf2-4205-a080-ed142f77d159" contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________</span></p><ix:footnote id="FNT_8630c987-7a19-4c14-a093-626d0f0d4875" xml:lang="en-US"><p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.</span></p></ix:footnote></ix:nonNumeric></div></ix:nonNumeric></div><div><ix:nonNumeric id="F_10b8b78b-6887-489d-b11b-8367e197cd79" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" escape="true" continuedAt="F_10b8b78b-6887-489d-b11b-8367e197cd79_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn_dis_nonfin_asset"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_843f9b21-45b1-4419-a088-65ce9489ba0e" contextRef="C_e968e6a1-e1dc-4b6b-b7eb-2349e035aa81" name="lits:AdoptedAgreement" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 22, 2024 </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Closing Date), we and Aardvark Therapeutics, Inc. (the Purchaser), entered into an Asset Purchase Agreement (the Asset Purchase Agreement), whereby we sold to the Purchaser our rights, title and interest in and to certain assets related to ME-344, including relevant intellectual property rights, technology and contracts (the ME-344 Sale). Pursuant to the Asset</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_10b8b78b-6887-489d-b11b-8367e197cd79_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchase </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreement, the Purchaser paid us an initial payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9241d46-a8fb-462a-bdf6-be8c3e3e7e63" contextRef="C_4599d307-ed5c-4842-ac28-146c1c1c5cbd" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash plus a reimbursement amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66d2117e-e0aa-4ca2-a200-bace655a4949" contextRef="C_7d1dd293-c91b-41db-ae9c-cff76e94081f" name="lits:ReimbursementAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">55,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> at the closing of the transaction. The Purchaser may also make future milestone payments up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05c00e1a-144b-4e68-8ca4-65d9ebf3cba5" contextRef="C_efee07f7-2a59-42fe-b86a-e2563b5f1277" name="lits:MilestonePayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">62.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after the Closing Date, payable upon the achievement of certain regulatory and revenue milestones. The Purchaser also assumed certain of our liabilities after the Closing Date, including liabilities arising under the contracts transferred under the Asset Purchase Agreement. During the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025, no milestone were met.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ME-344 Sale did not trigger a discontinued operation as the intellectual property sold did not represent a component of our business. Additionally, we concluded the ME-344 Sale met all the criteria to be derecognized on the Closing Date. Variable consideration, such as future potential regulatory and revenue milestones have been fully constrained. As such, as of the Closing Date and December 31, 2024, we determined the transaction price to be the initial payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7321abb6-bb95-41fe-8ef7-fdb73f05ac95" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Accordingly, we recognized a gain, upon satisfaction of our obligations under the Asset Purchase Agreement, of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a4aa4c0-672c-443f-bf9d-e300b9e485e3" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a separate component of other income (expense), net in the consolidated statements of operations. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5fbd8ce-bf44-4a0f-9c27-27f3becdb688" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:ReimbursementAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">55,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reimbursement by the Purchaser represented work performed at the Purchaser's request prior to the Closing Date, which they agreed to reimburse. The reimbursement did not represent a liability assumed or relieved by the Purchaser and was, therefore, not included in the calculation of the gain on the disposition of the ME-344 asset. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48e9bd41-fb30-45ef-8dbe-36fbe41d813f" contextRef="C_e9c5cddf-20f7-4aeb-a9be-fe852d96546b" name="lits:ReimbursementAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">55,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reimbursement was recognized as contra research and development expense in accordance with our reimbursement policy for pass through services.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_fe5edc01-2e08-459f-a6e7-dc578dc5e1ac" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_fe5edc01-2e08-459f-a6e7-dc578dc5e1ac_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 14. Income Taxes</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b5a5e7b9-ed2e-4ff8-88b8-5d92d0b9d93f" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-tax loss consists of the following jurisdictions, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:67.313%;box-sizing:content-box;"/>
         <td style="width:1.5%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.843%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.5%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.843%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Domestic</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fdd132b-a39c-4284-8e32-b1a71979e79c" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1095fce9-5cb3-4a14-8754-1bbfa43b1206" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed2a0c8c-2f90-464b-ab68-316e78c83b3b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dc9745f-8062-47e1-b3ed-b4001927f74e" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-tax (loss) income</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc422db1-b77f-4602-9ab9-a07b551f1b89" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,945</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_972ebdc0-e565-4651-aef6-826ec9dacbdd" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a420fa1-1581-4acc-b422-7554c17144d2" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The reconciliation of income tax computed at the U.S. federal statutory tax rates to income tax expense is as follows, in thousands:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:39.1%;box-sizing:content-box;"/>
         <td style="width:1.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.84%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.98%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax (benefit) expense at U.S. statutory rates</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_628c3006-2c04-4f87-a71b-0650d3ebcf2d" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,349</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b4c0b05-8b25-4205-8fe1-e0dcd7d11ff9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab7b4a38-24aa-43ba-b74d-443ff4161005" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,733</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51ceac99-3ffe-45a0-a36a-0eefd5950526" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax (benefit) expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b3ab206-b173-4be1-8d57-7f30b5f56bfe" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,733</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_facb08e8-92ca-4f62-a002-0e577b368c29" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">17</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_035b2003-1961-4795-8f38-e066e8a0662f" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">796</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f0ef29c-7c21-478d-bb09-814a4ae450a7" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88c62756-5c53-4ad2-821b-302a6b8d10a7" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,671</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38e9c23f-1ede-431e-8197-47e2fd76c0c1" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="2" sign="-" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4f5ad32-3081-4f67-9595-4b27f0bced7e" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">901</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa908e19-5b24-4308-83fd-b864222e1174" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79e28d15-f5bf-4268-a8f2-906bfbf8db6d" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,782</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_634ae3a9-ad47-4b7a-b20a-81265ca7d062" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="2" sign="-" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_605338da-bc36-4ae1-9a82-d413a822c3d0" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,281</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d21b805-7202-48b7-a768-fbdc5fb77056" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="2" sign="-" format="ixt:num-dot-decimal">35</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 162(m) limitation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2a7a05b-6003-4a59-90ec-082afd5e2c7c" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">507</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98795853-5c55-4294-b81c-dd5d2f5dc0fc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" unitRef="U_pure" scale="-2" decimals="2" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b50e1f78-55a5-4ea5-904f-e8e0474513ba" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">483</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c85c355-4803-406f-9170-f0d94928a05b" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="lits:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f4ca980-fed5-49c2-9c43-867f804730fd" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">122</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fc4b6ee-5362-49f7-9db0-d8cd59338fa3" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" unitRef="U_pure" scale="-2" decimals="2" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78559cce-d459-441c-85a1-d06ebfe395b7" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">368</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b7cf371-ae7c-41bc-a67c-f02379c3c456" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b250988d-458e-49fc-9bdc-d50955ceb006" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6588a34-7b14-4ad0-9093-f046cf498211" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f74ce751-1273-42fa-948f-3396bc4000ca" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b65a3551-7b56-4f65-8b45-2a0f775e9fe7" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3ff97ca0-73b8-4685-8bd7-b027834bf454" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax liabilities and assets are comprised of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:67.606%;box-sizing:content-box;"/>
         <td style="width:1.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.817%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.38%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.817%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets (liabilities):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax losses carried forward</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_291eed64-26e7-4e2a-b132-3fceaae95d66" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,346</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b03b020b-065f-4672-a7c9-9d3319379ee9" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,721</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalization of R&amp;D costs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f0b9f6c-955e-4732-925a-dd4d0fcb11d7" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,398</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3592660c-5e21-46c5-9e4d-0dde8f40ce56" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,456</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed and intangible assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da670191-0e9d-4c00-b3e6-fa8d57be5de9" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,881</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7625e53d-1f57-4216-8e57-e3e976dac037" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,058</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4b615f4-1658-4f76-94cf-dfc8581d2889" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,375</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c32a3772-3774-40c4-b160-1f006cff734d" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,081</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29a7c65e-6c93-4d69-95f2-c49d5646a1b8" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="lits:DeferredTaxAssetsRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b08241-bfdf-4ee1-9ce5-2cac310c4adf" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="lits:DeferredTaxAssetsRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93ffb517-1ab4-4e92-abf2-37ae6af566c9" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">700</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_697e894c-70e9-4901-8bf9-db4e025e0a2d" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8a79d37-d41a-4c4a-8ca3-66cdcda96b80" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,700</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a29eede2-685e-4ea5-b728-10aee770bf73" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,918</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance for deferred tax assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e16e180-65a7-43d2-a31c-1ba73ab4c04a" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,700</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fa18258-1af6-41dd-ae81-48ec2bb8adb6" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,918</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets and liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3ff5daa-26a4-4940-8113-26693a5270fd" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10c728a0-5236-4f4d-a9e1-fee230607a55" contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We evaluate the recoverability of the deferred tax assets and the amount of the required valuation allowance. Due to the uncertainty surrounding the realization of the tax deductions in future tax returns, we have recorded a valuation allowance against our net deferred tax assets as of June 30, 2025 and 2024. At such time as it is determined that it is more likely than not that the deferred tax assets will be realized, the valuation allowance would be reduced.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_fe5edc01-2e08-459f-a6e7-dc578dc5e1ac_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We had federal and state net operating loss carryforwards of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c82571c-4607-49fd-8f7a-2acc76ac377f" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">246.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57a1749b-92e8-4e00-a973-52dc7595ac69" contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">23.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The federal net operating loss will carry forward indefinitely subject to an </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55ba3ae1-e925-42e5-8fd4-3884dbec59d0" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="lits:TaxableIncomePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% taxable income limitation. The state net operating loss carryforwards will begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3b168a8d-253d-4a6a-a154-0106f8c69a56" contextRef="C_87078fb9-2267-4137-924d-3f4e8270a7ef" name="lits:DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2031</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unless previously utilized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards may be substantially limited due to ownership changes that have occurred or that could occur in the future under Section 382 of the Internal Revenue Code (Section 382) and similar state laws. A Section 382 study was completed through December 31, 2021, to analyze whether one or more ownership changes had occurred and determined that two such ownership changes did occur. We have not completed a Section 382 study through June 30, 2025. If an ownership change occurred our ability to utilize our net operating loss carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None of our prior income tax returns have been selected for examination by a major taxing jurisdiction; however, the statutes of limitations for various filings remain open. The oldest filings subject to potential examination for federal and state purposes are 2021 and 2020, respectively. If we utilize a net operating loss related to a closed tax year, the tax year in which the loss was incurred is subject to adjustment up to the amount of the net operating loss.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not reduced any tax benefit on our consolidated financial statements due to uncertain tax positions as of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and we are not aware of any circumstance that would significantly change this result through the end of fiscal year 2026. To the extent we incur income-tax related penalties or interest, we will recognize them as additional income tax expense.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_c6598c48-41e0-4082-be09-30da8df10ae9" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:SubsequentEventsTextBlock" escape="true" continuedAt="F_c6598c48-41e0-4082-be09-30da8df10ae9_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn_subevent"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. Subsequent Events</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Securities Purchase Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 17, 2025, we entered into securities purchase agreements (the Securities Purchase Agreements) with certain investors (the Purchasers) pursuant to which we agreed to sell and issue to the Purchasers in a private placement offering (the Offering or the PIPE) an aggregate of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63836c53-6a9e-4c8a-b330-a2c6800616d4" contextRef="C_870e143e-2c95-4ffb-9924-d47b9fd9da81" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">23,216,898</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock, at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40260e3e-986f-4c20-a6b5-0f145f65fdae" contextRef="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and (ii) Pre-Funded Warrants, to purchase up to an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_cc65713e-c597-47fc-b8ed-0404cde2aeb8" contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,022,869</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_820ff5c7-68d0-430a-8468-f3043b82a2da" contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">3.4199</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant in exchange for net proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4997fbc5-b52f-470d-bb45-c599f06960e4" contextRef="C_a06c0f95-2711-45fa-8758-3af29c6ca47e" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">92.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at the exercise price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47c15284-5eef-407e-929e-72325c11fbc1" contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant Share and may be exercised at any time until all the Pre-Funded Warrants issued in the Offering are exercised in full. Each Purchaser&#8217;s ability to exercise its Pre-Funded Warrants in exchange for shares of Common Stock is subject to certain beneficial ownership limitations set forth therein. The Offering closed on July 22, 2025 (the SPA Closing Date). On July 24, 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e84da28a-0de2-42a8-afba-0b0ee0421d59" contextRef="C_07f286c0-e5a6-4c38-9799-941180c82a4c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,084,509</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were exercised, respectively, for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9858f9de-a20f-472d-854e-02272c4cc9f8" contextRef="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,807,967</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock upon</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_370cf18e-4626-4f60-94c6-ac14762aa8f3" contextRef="C_d190719d-ba9d-4549-9346-f6c2c6a02045" name="lits:SurrenderedWarrantsToAcheiveCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,808,070</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Placement Agency Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 17, 2025, we also entered into a Placement Agency Agreement (the Placement Agency Agreement) with Titan Partners Group LLC, a division of American Capital Partners, LLC (Titan), pursuant to which Titan agreed to serve as the exclusive placement agent for us in connection with the Offering. We agreed to pay Titan a cash fee equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32bebab9-7e92-46d2-b77f-e969431de049" contextRef="C_0c124857-32c7-4d51-83ca-319184ab60ce" name="lits:PercentageOfDeferredOfferingCosts" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate gross cash proceeds received in the Offering (or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61791c93-a6d5-466b-872b-535d1c2ce3b8" contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million). We also agreed to issue Titan warrants (the Placement Agent Warrants) to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a1f3e6c-709f-4c71-9af8-5f56276ade4f" contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,169,591</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6193d006-de85-427f-afca-78e411f8ed8d" contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8" name="lits:PercentageOfSecuritiesSoldAtOffering" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Securities sold in the Offering) (the Placement Agent Warrant Shares), at an exercise price per share equal to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30377f66-9f9e-46a6-a59c-96a2cf7b4ea2" contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, exercisable, in whole or in part, at any time and from time to time, for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_471041f0-6337-4d57-89cb-a763e2396550;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance. In addition, we agreed to reimburse Titan for reasonable accountable expenses in an amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0087a535-2d45-40f4-919a-1642ab0ccc95" contextRef="C_7c7a543b-cf8d-4e11-8cd1-eb898eaf4c1a" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">150,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including legal fees in connection with the Offering.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Asset Management Agreement (the Asset Management Agreement)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, we and GSR Strategies LLC (GSR or the Asset Manager) entered into the Asset Management Agreement. The Asset Manager shall provide discretionary investment management services with respect to, among other assets, our proceeds from the Offering (the Account Assets) in accordance with the terms of the Asset Management Agreement. The Asset Manager will pursue a long-only investment strategy investing primarily in LTC. The custodians under the Asset Management Agreement will consist of Coinbase and other cryptocurrency wallet providers agreed to by us and the Asset Manager.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We shall pay the Asset Manager an asset-based fee (the Asset-based Fee) equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29c14fbf-3ffe-4d89-9295-5e3e69c82249" contextRef="C_db8a5320-d917-40b0-808a-594d2f634033" name="us-gaap:ManagementAndServiceFeesRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum of the Account Assets under management. The Asset-based Fee shall be paid in shares of Common Stock until the Asset Manager owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58ac882c-39b3-4552-ae79-0c40182d2bfc" contextRef="C_db8a5320-d917-40b0-808a-594d2f634033" name="lits:AssetManagerOwnershipThresholdRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our issued</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_c6598c48-41e0-4082-be09-30da8df10ae9_1" continuedAt="F_c6598c48-41e0-4082-be09-30da8df10ae9_2"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">outstanding Common Stock and thereafter, the Asset-based Fee shall be paid in Pre-Funded Warrants (the GSR Pre-Funded Warrants) to purchase shares of Common Stock (the GSR Pre-Funded Warrant Shares). The number of shares of Common Stock or GSR Pre-Funded Warrants will be issued to be equal to the dollar amount of the Asset-based Fee being paid, divided by the average volume-weighted average price (VWAP) of the Common Stock for the 30 trading days ending with the trading day prior to the date that is the applicable 12-month anniversary of the SPA Closing Date (the Fee Reference Date).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As compensation for services rendered by the Asset Manager under the Asset Management Agreement, we issued warrants (the GSR Warrants) to the Asset Manager on the SPA Closing Date to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d2b1798-84e9-4382-8656-c937600097f1" contextRef="C_2c0b1dcd-adce-47b9-ae07-a9ae57be522c" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,461,989</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the GSR Warrant Shares) at various exercise prices per share of Common Stock as follows: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b16c50e6-1eb4-42a4-b845-29afc2ce641f" contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">584,795</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c261be23-554f-4512-b404-816b2c687514" contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f83712a-247f-4a9d-9e52-a5796e9fd35c" contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">292,398</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f216bb2-3339-4875-8dbb-1741693eb950" contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.93</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; (iii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bb58ffe-fe23-4daa-bbe7-3cb77334308e" contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">292,398</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ab42383-6edb-493a-aeb2-563ece250a8e" contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.62</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; and (iv) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77bc0665-9a38-4082-9022-351f3bb81592" contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">292,398</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8823fc2a-c50d-446d-b512-341211c38e3d" contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.13</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The GSR Warrants are exercisable, in whole or in part, at any time for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_da2a1c44-7a41-4557-8068-3921e2100485;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Asset Management Agreement will, unless terminated earlier in accordance with its terms, remain in effect until the tenth anniversary of the date of the Asset Management Agreement. Beginning on the first anniversary of the AMA Effective Date (as defined below), the Asset Management Agreement may be terminated upon at least 90 days prior written notice to the other party (i) by us upon a determination of the Board to end the Lite Treasury Strategy, or (ii) by the Asset Manager for any reason. Additionally, the Asset Management Agreement may be terminated for cause (i) by us upon at least 30 days prior written notice to the Asset Manager or (ii) by the Asset Manager upon at least 60 days prior written notice to us.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed2546a4-f9f5-449c-a3c2-d40225e4f24f" contextRef="C_08b96565-9169-4635-945d-9321b9c399be" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">546,348</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fdb3e1f-4672-4f07-b831-6b2217e119cc" contextRef="C_08b96565-9169-4635-945d-9321b9c399be" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advisory Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025 (the AMA Effective Date), we also entered into an Advisory Agreement (the Advisory Agreement) with Green Dragon Investments LLC (Green Dragon). Pursuant to the Advisory Agreement, Green Dragon will provide us with asset management services with respect to the Account Assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We shall pay Green Dragon an asset-based fee (the Annual Advisory Fee) in warrants (the Advisory Warrants) to purchase a number of shares of the Common Stock (Advisory Warrant Shares) equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d0ba9c6-582d-4f86-8f6e-d65893176b13" contextRef="C_3bdebc26-b1ff-4f0d-9742-becf52c22f69" name="lits:AdvisoryFeeRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum of the Account Assets for such year, as calculated in accordance with the Asset Management Agreement. The number of Advisory Warrants to be issued for any given year shall be equal to the dollar amount of the Annual Advisory Fee for such year, divided by the average VWAP of the Common Stock for the 30 trading days ending with the trading day prior to the associated Fee Reference Date. The exercise price per share of the Advisory Warrants shall be set at a price equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_346e663a-f624-4b9a-89c2-6610c8172409" contextRef="C_303a0d36-3cb7-4d85-bdff-8bcece057b3b" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Advisory Warrants shall be exercisable, in whole or in part, at any time for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e6417c3a-45fe-44f8-aa59-aea60d182067;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance. The Advisory Warrants issued each year shall vest in four equal installments on the Fee Reference Date on which they are issued and then the succeeding three month anniversaries thereof.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Advisory Agreement will, unless terminated earlier in accordance with its terms, remain in effect until the tenth anniversary of the Advisory Agreement. Either party may terminate the Advisory Agreement, with or without reason, by written notice to the other.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Advisor Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, we also entered into a Strategic Advisor Agreement (the Strategic Advisor Agreement) with Green Grass Ventures (GGV). Pursuant to the Strategic Advisor Agreement, GGV provides us with strategic advice and guidance relating to the private placement of equity and equity-linked securities in connection with a proposed cryptocurrency asset management strategy, as well as with the Offering. As compensation for services rendered by GGV under the Strategic Advisor Agreement, upon the closing of the Offering, we issued warrants (the Strategic Advisor Warrants) to GGV to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c156edf-a0e3-471c-ae15-ffc5a87b2b37" contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">438,597</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the Strategic Advisor Warrant Shares). The exercise price per share of the Strategic Advisor Warrants is equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9625b7a-7b11-4dff-88a6-c12482836e78" contextRef="C_eebe7de3-feed-4cd9-8e5d-19e4577417b5" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Warrants shall be exercisable, in whole or in part, at any time for a period of five years from the date of issuance. The Strategic Advisor Agreement terminated in accordance with its terms on the SPA Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Termination of the Cooperation Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective July 22, 2025, upon closing of the Offering, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_c6598c48-41e0-4082-be09-30da8df10ae9_2" continuedAt="F_c6598c48-41e0-4082-be09-30da8df10ae9_3"><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Board of Directors Composition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, in accordance with the certain Cooperation Agreement, Taheer Datoo and James Flynn tendered their resignations from the Board upon the Investors (as defined in the Cooperation Agreement) ceasing to own the Minimum Ownership Amount (as defined in the Cooperation Agreement). The Board accepted the resignation of Taheer Datoo and rejected the resignation of James Flynn. Upon closing of the Offering, the Board elected Charlie Lee to the Board. Mr. Lee is the creator of LTC and Director of the Litecoin Foundation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, Steven D. Wood informed the Board of his decision to resign from the Board, effective immediately. On August 5, 2025, the Board elected Joshua Riezman to the Board. Mr. Riezman is Managing Director and Head of U.S. Legal and Compliance for GSR.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fn_new_sales_agree"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Entry into a New Sales Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We entered into a Sales Agreement (the Sales Agreement) with Titan (in such capacity, the Agent), pursuant to which we may sell, from time to time, at its option, up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdd49ed7-547f-494d-81c4-6272b417f333" contextRef="C_e1e0a909-dd46-42bb-8478-62d44158460b" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="U_USD" scale="6" decimals="INF" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in aggregate principal amount of an indeterminate amount of shares (the ATM Shares) of Common Stock, through the Agent, as our sales agent. We will pay the Agent a commission of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b664ec9-c0ee-4ffb-9af0-ed24724ce86f" contextRef="C_6d37e90f-283f-41b0-b124-b327504c907e" name="lits:AgentCommissionRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the gross sales price of the ATM Shares sold pursuant to the Sales Agreement, if any.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any ATM Shares to be offered and sold under the Sales Agreement will be issued and sold (i) by methods deemed to be an at-the-market offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or in negotiated transactions, if authorized by us and (ii) pursuant to the Registration Statement on Form S-3 filed by us with the SEC on February 20, 2024 for an offering of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44159f57-3cdc-4e6a-91ba-e09692ea468b" contextRef="C_42469529-12e3-4edc-a0e6-3a47d45ab69f" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">100,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of various securities, including shares of our Common Stock, preferred stock, warrants, rights and/or units for sale to the public in one or more public offerings, which became effective on February 28, 2024 (the Registration Statement).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The offering of the ATM Shares will terminate upon the earliest of (a) the issuance and sale of all of the ATM Shares by the Agent on the terms and subject to the conditions set forth in the Sales Agreement and (b) the termination of the Sales Agreement by either of the parties thereto.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Option Grants</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 15, 2025, our Board approved option grants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85b2201f-726c-4d32-b745-9f36890d7f79" contextRef="C_07682bb1-2b3e-4319-8e57-ef12c2e28266" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">124,250</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options to members of our Board and employees, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2394aeca-a3e2-4153-8c5b-cfcacac107b1" contextRef="C_07682bb1-2b3e-4319-8e57-ef12c2e28266" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.07</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On August 8, 2025, commensurate with Mr. Riezman's appointment to our Board, our Board approved an initial option grant for Mr. Riezman for the purchase of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fc9ca41-4768-4ce0-800c-1a74b2f24b47" contextRef="C_a5fffeed-2536-49c6-8e93-f0cbbb5cdefa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31578b86-ae49-46e3-8ea6-6b67e94eb21c" contextRef="C_a5fffeed-2536-49c6-8e93-f0cbbb5cdefa" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.19</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sales under our ATM Program</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Between the SPA Closing Date and September 23, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_368bd469-e276-4b53-a788-0bb01640f243" contextRef="C_3ad957d5-2461-4ae3-9be5-d6b77b9afb1e" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">882,924</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock at an average selling price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36b4c992-e081-4b2a-a52b-4d3146e15392" contextRef="C_b8e64ad8-9663-44a6-afdd-eb5bc7829282" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">5.4484</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for gross proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d01c275a-a7e1-4619-adde-0cf64813e92f" contextRef="C_3ad957d5-2461-4ae3-9be5-d6b77b9afb1e" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, less underwriter's commission and expenses of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57ee70f2-96a3-4b9c-8fe3-9f917f02dda3" contextRef="C_d153b937-6a62-4ec2-97ea-eb68558e59ce" name="us-gaap:PaymentsForCommissions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, for net proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d06c017-8245-4f0f-aaeb-33f6e1510b42" contextRef="C_d153b937-6a62-4ec2-97ea-eb68558e59ce" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, through our ATM Program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Master Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 3, 2025, we entered into a master loan agreement (the Loan Agreement) with BitGo Prime, LLC (Lender). The Loan Agreement creates a framework under which we may borrow any digital assets or cash from Lender from time to time. Each loan is documented in a separate loan request agreed to by the parties setting for the specific terms, including principal amount, fees, collateral requirements and the date on which the loan is to commence and mature.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The loan fee, effectively the interest rate on the borrowed amounts, is to be determined for each loan and is calculated on a daily basis at the annualized rate specified in each confirmation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each loan may have a fixed term, or may include a call option or prepayment option, as specified in each loan request. In general, either party can terminate a loan by providing notice within the time frame set forth in the Loan Agreement. Upon termination, the borrowed digital assets or cash must be returned and the related collateral released.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Borrowings under the Loan Agreement are secured by collateral in favor of the Lender. Collateral may include cash or other forms agreed upon by the Parties. The collateral&#8217;s required value is typically higher than the borrowed amount, subject to margin calls as set forth in the Loan Agreement. If the value of posted collateral falls below the margin call threshold, the Company must promptly</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c6598c48-41e0-4082-be09-30da8df10ae9_3"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">post additional collateral. Failure to maintain sufficient collateral can result in an event of default and remedies available to the Lender, including the right to liquidate pledged collateral.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Loan Agreement contains representations and warranties and affirmative and negative covenants customary for financings of this type, as well as customary events of default.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_14"><span id="fis_accounting_changes"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_15"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosure controls and procedures are controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period covered by this Annual Report, or June 30, 2025, our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of June 30, 2025. Based on such evaluation, our principal executive officer and principal financial officer have concluded that, as of such date, our disclosure controls and procedures were effective.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control&#8212;Integrated Framework (2013). Based on this assessment, our management concluded that, as of June 30, 2025, our internal control over financial reporting was effective based on those criteria.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management&#8217;s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management&#8217;s report in this annual report.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended June 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inherent Limitations of Internal Controls</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our management, including our Acting Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_other_information"><span id="d58841d10k_htm_toc58841_16"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. Other Information</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, our officers (as defined in Rule 16a-1(f) of the Exchange Act) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months ended June 30, 2025 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">none of our officers or directors </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_92f1aa60-9e86-4861-a976-19557f6a5652" contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_b51f4229-660b-4ea5-8c55-1546f90df429" contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_20ab998e-b82b-4e28-b565-e04f0bda8e09" contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916" name="lits:Rule10B51ArrModifiedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_cff8ec69-8e3d-4397-b65a-1773d89c65e7" contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916" name="lits:NonRule10B51ArrModifiedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">modified</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e6044d7e-9dc7-4294-be5d-ea9a5679d8c4" contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_e780411a-67ad-49ff-8a16-b054c27ca363" contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terminated</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> any </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contract, instruction or written plan for the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">purchase </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Di</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_toc58841_17"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III</span><span id="fis_directors_and_officers"></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_18"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Directors, Executive Officers and Corporate Governance</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Set forth below are the names, ages and certain biographical information as of the date of filing of this Annual Report on Form 10-K (Annual Report) regarding our directors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:26.475%;box-sizing:content-box;"/>
     <td style="width:1.6%;box-sizing:content-box;"/>
     <td style="width:10.518%;box-sizing:content-box;"/>
     <td style="width:1.6%;box-sizing:content-box;"/>
     <td style="width:20.896%;box-sizing:content-box;"/>
     <td style="width:1.6%;box-sizing:content-box;"/>
     <td style="width:37.313%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Age</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Positions Held</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration of Term</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas C. Reynolds, M.D., Ph.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiscal 2026 Annual Meeting of Stockholders</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joshua Riezman</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiscal 2026 Annual Meeting of Stockholders</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">James Flynn</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiscal 2027 Annual Meeting of Stockholders</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Charles B. Lee</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiscal 2027 Annual Meeting of Stockholders</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nicholas R. Glover, Ph.D.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiscal 2028 Annual Meeting of Stockholders</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frederick W. Driscoll</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiscal 2028 Annual Meeting of Stockholders</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Thomas C. Reynolds, M.D., Ph.D., age 66, Director</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Reynolds has been a director of Lite Strategy since February 2013. He is President of Two Paddles Consulting LLC since December 2013, providing consulting services to biotechnology and pharmaceutical companies. Dr. Reynolds served as an independent director of Trillium Therapeutics Inc. (NASDAQ: TRIL; TSX: TR), an immuno-oncology company, from March 2014 to April 2021. Previously, he served as Chief Medical Officer of Seattle Genetics, a biotechnology company, from March 2007 until his retirement in February 2013. While at Seattle Genetics, he was responsible for building and leading an integrated clinical development, regulatory and medical affairs organization, highlighted by the development and approval of ADCETRIS&#174;. From 2002 to 2007, Dr. Reynolds served at ZymoGenetics (acquired by BMS in 2010), most recently as Vice President, Medical Affairs, where he oversaw the clinical development and regulatory filing of RECOTHROM&#174;. Previously, he was Vice President, Clinical Affairs at Targeted Genetics and before that was at Somatix Therapy (acquired by Cell Genesys in 1997). Dr. Reynolds received his M.D. and Ph.D. in Biophysics from Stanford University and a B.A. in Chemistry from Dartmouth College.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Joshua Riezman, age 42, Director</span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Joshua Riezman was appointed as a director of Lite Strategy on August 5, 2025 pursuant to a Side Letter with GSR Strategies LLC entered into in connection with the PIPE on July 22, 2025. Mr. Riezman currently serves as Chief Strategy Officer &#8211; US and Global Deputy General Counsel at GSR Services US LLC, a global digital asset trading and investment firm. He leads U.S. business strategy and regulatory initiatives, while also overseeing the firm&#8217;s US legal and compliance functions. Prior to GSR Services USA LLC, Mr. Riezman was Assistant General Counsel &#8211; Head of Product and Regulatory Legal at Circle, a global digital currency fintech firm, where he led the product and regulatory legal function and advised on complex global financial regulatory matters. Before Circle, he served as Director and Counsel &#8211; Head of Prime Services and Clearing Legal (Americas) at Soci&#233;t&#233; G&#233;n&#233;rale and previously held legal roles at Deutsche Bank and Teigland-Hunt LLP, with expertise in U.S. and international derivatives, clearing and financial regulation. Mr. Riezman received his J.D. from Fordham University School of Law, where he served as Senior Articles Editor for the Environmental Law Review and earned his B.A. in International Affairs from The George Washington University.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">James Flynn, age 45, Director</span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Flynn has been a director of Lite Strategy since October 2023. Mr. Flynn is currently a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. Mr. Flynn also currently serves on the board of directors of Synlogic, Inc. (NASDAQ: SYBX), a biopharmaceutical company with a focus on rare metabolic disorders and RiceBran Technologies, an innovative specialty ingredients company, both since 2024. Previously, Mr. Flynn served on the board of directors of ARCA Biopharma and Axiom Health, Inc. Prior to that, Mr. Flynn worked in various investment management roles at Aptigon Capital (a division of Citadel LLC), Amici Capital, LLC and Putnam Investments LLC. Mr. Flynn earned a S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology. Mr. Flynn is a Chartered Financial Analyst (CFA) charterholder.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Charles B. Lee, age 48, Director</span></p><p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charles B. Lee was appointed as a director of Lite Strategy on July 22, 2025. Mr. Lee also currently serves on the board of BTCS, Inc (NASDAQ: BTCS), a digital asset and blockchain technology focused company since 2021. Mr. Lee is the creator of Litecoin and Director of the Litecoin Foundation. Mr. Lee attended MIT where he graduated in 2000 with a bachelor&#8217;s and master&#8217;s degree in electrical engineering and computer science. Prior to creating Litecoin, Mr. Lee was a Software Engineer at Google. In 2011, Mr. Lee created Litecoin in an effort to improve upon Bitcoin&#8217;s high fees, slower transaction times and scalability issues. Mr. Lee went on to work for Coinbase where he became Director of Engineering before leaving the company in 2017 to focus on supporting the development of Litecoin full time.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nicholas R. Glover, Ph.D., age 56, Director</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Glover has been a director of Lite Strategy since June 2013. He is currently Chief Executive Officer of MycRx Holdings Inc., a privately held drug discovery company and serves as a consultant to the biotech industry. Previously, he served as President and Chief Executive Officer of Sierra Oncology (NASDAQ: SRRA), a drug development company focused on advancing targeted therapeutics for the treatment of patients with cancer, from July 2014 through May 2020. Prior to joining Sierra, he served as President and Chief Executive Officer of YM Biosciences, an oncology drug development company, from November 2010 until its acquisition by Gilead Sciences in February 2013. Previously, Dr. Glover was President and Chief Executive Officer of Viventia Biotech, a biopharmaceutical company involved in the discovery and development of monoclonal antibody-based technologies for the treatment of cancer, which he joined after serving as an investment manager for MDS Capital, a life sciences venture capital firm. Dr. Glover holds a B.Sc. (Hons) in Chemistry from the University of East Anglia, U.K., a M.Sc. in Chemistry from the University of British Columbia, Canada and a Ph.D. in Chemistry from Simon Fraser University, Canada.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Frederick W. Driscoll, age 74, Chair</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Driscoll has been a director of Lite Strategy since February 2018 and was appointed as chairperson of the board of directors on July 22, 2024. He currently serves on the board of directors of Cellectar Biosciences, Inc., a clinical-stage biopharmaceutical company and Adipo Therapeutics, a private preclinical stage biopharmaceutical company. He served as interim Chief Financial Officer at Invivyd, Inc. from September 2022 to May 2023. He served as Chief Financial Officer of Renovacor, Inc., a leading late-stage biotechnology company, from March to June 2022. He served as the Chief Financial Officer of Flexion Therapeutics, Inc., a commercial-stage biopharmaceutical company, from 2013 to 2017 and rejoined in June 2021 as Chief Financial Officer until it was sold to Pacira BioScience. Prior to joining Flexion, he was the Chief Financial Officer at Novavax, Inc. from 2009 to 2013. From 2008 to 2009, Mr. Driscoll served as the Chief Executive Officer at Genelabs Technologies, Inc. and from 2007 to 2008 he served as its Chief Financial Officer. He was also the Chief Executive Officer of OXiGENE, Inc. from 2000 to 2006. Mr. Driscoll also served as the chairman of the board and audit committee chair at OXiGENE and as a member of the audit committee for Cynapsus Therapeutics, Inc. Mr. Driscoll earned a bachelor&#8217;s degree in Accounting and Finance from Bentley University.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about the Board of Directors and its Committees</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board has responsibility for the overall corporate governance of Lite Strategy. During the fiscal year ended June 30, 2025, a majority of the members of the Board were and as of the date of this Annual Report are, independent within the meaning of the Nasdaq Stock Market (Nasdaq) rules.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board has established an Audit Committee to oversee Lite Strategy&#8217;s financial matters, a Compensation Committee to oversee our compensation policies, plans and programs and a Nominating and Governance Committee to assist the Board in nominating board members to be elected by the stockholders at the Annual Meeting, to fill vacancies and newly created directorships and to evaluate and monitor all matters with respect to governance of Lite Strategy and oversee compliance by Lite Strategy with its legal and regulatory obligations. As of the date of this Annual Report, our schedule of committee members is as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Board Member</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Audit Committee</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Committee</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nominating &amp; Governance Committee</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frederick W. Driscoll</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_0.jpg" alt="img155424085_0.jpg" style="width:13px;height:16px;"/><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><img src="img155424085_1.jpg" alt="img155424085_1.jpg" style="width:18px;height:16px;"/></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_2.jpg" alt="img155424085_2.jpg" style="width:12px;height:16px;"/></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">James Flynn</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_3.jpg" alt="img155424085_3.jpg" style="width:12px;height:16px;"/></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_2.jpg" alt="img155424085_2.jpg" style="width:12px;height:16px;"/></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_2.jpg" alt="img155424085_2.jpg" style="width:12px;height:16px;"/></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nick Glover, PhD.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_4.jpg" alt="img155424085_4.jpg" style="width:12px;height:16px;"/></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_5.jpg" alt="img155424085_5.jpg" style="width:13px;height:16px;"/></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas C. Reynolds, MD, PhD.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_6.jpg" alt="img155424085_6.jpg" style="width:12px;height:16px;"/></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_7.jpg" alt="img155424085_7.jpg" style="width:13px;height:16px;"/></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Charles B. Lee*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joshua Riezman*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* - Is not an independent member of the Board</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img155424085_8.jpg" alt="img155424085_8.jpg" style="width:12px;height:16px;"/><span style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> = Committee Member</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img155424085_9.jpg" alt="img155424085_9.jpg" style="width:13px;height:16px;"/><span style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> = Committee Chair</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img155424085_10.jpg" alt="img155424085_10.jpg" style="width:18px;height:16px;"/><span style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">= Financial Expert</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board has been established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the Exchange Act). The Audit Committee&#8217;s responsibilities include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">overseeing financial and accounting activities; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">selecting and recommending the annual appointment of independent auditors; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reviewing and approving the scope of audit and non-audit assignments and related fees; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assessing annually Lite Strategy&#8217;s major financial risks and exposures; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evaluating the independence and performance of the independent auditors: </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reviewing the accounting principles used in financial reporting; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reviewing and assessing our financial reporting activities and disclosures included in our periodic reports and the accounting standards and principles followed;</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reviewing the adequacy and effectiveness of our internal control over financial reporting; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reviewing and approving related party transactions. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Driscoll has served as Chairman of the Audit Committee since August 29, 2019. The other members of the Audit Committee are Dr. Glover and Mr. Flynn. Mr. Driscoll has been determined by the Board to be an audit committee financial expert as defined by the SEC.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board of Directors has determined that each of the Audit Committee members is independent, as defined in accordance with Nasdaq and SEC rules. We have adopted an Audit Committee Charter, which is posted on its website at https://litestrategy.com.</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee met four times during the fiscal year ended June 30, 2025.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Committee</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee acts on behalf of the Board to fulfill the Board&#8217;s responsibilities to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">oversee, review, modify and approve our compensation strategy and policies; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assess the independence of compensation consultants and legal advisors prior to engagement;</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exercise sole power to retain compensation consultants and advisors and to determine the scope of the associated engagements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">review and approve annual corporate performance goals; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evaluate the Chief Executive Officer&#8217;s and executive officers&#8217; performance; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">review and determine the compensation to be paid to our executive officers, including the allocation of equity related grants; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recommend the compensation and terms of appointment of non-executive directors to the Board for review and approval; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ensure Lite Strategy meets the reporting requirements promulgated by the SEC regarding compensation and disclosure of compensation and compensation related practices;</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assess potential compensation related risks; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evaluate and ensure compliance with Say-on-Pay requirements. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee also consults with and considers the recommendations of the Acting Chief Executive Officer and Chief Financial Officer with respect to the appropriate level and mix of the various compensation components, focused primarily on the particular goals of applicable executives and employees in a particular year. The Board has adopted a written charter for the Compensation Committee, which is available on our website at https://litestrategy.com. Dr. Glover has served as the Chairman of the Compensation Committee since December 16, 2021. The other members of the Compensation Committee during the fiscal year ended June 30, 2025, were  Dr. Reynolds and Mr. Wood. On August 5, 2025, Mr. Wood resigned his position on the Board and his position on the Compensation Committee and the position was subsequently filled by Mr. Flynn upon approval of the Board on August 8, 2025. The Board has determined that each member of the Compensation Committee is independent in accordance with the applicable Nasdaq and SEC rules. The Compensation Committee met one time during the fiscal year ended June 30, 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nominating and Governance Committee</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Nominating and Governance Committee is responsible for assisting the Board in:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identifying qualified individuals who possess the desired experience and skills to serve on the Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">proposing chairpersons and members on committees to the Board; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">considering all qualified director candidates identified by the Nominating and Governance Committee, or by stockholders, in the event any member of the Board does not wish to continue in service or if the Board decides not to re-nominate a member for re-election;</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">overseeing the Board evaluation process and evaluating the size and composition of the Board; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evaluating any stockholder proposal and whether to recommend to the Board and whether Lite Strategy shall support or oppose the proposal. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Reynolds has served as Chairman of the Nominating and Governance Committee since January 2023. The other members of the Nominating and Governance Committee for the fiscal year ended June 30, 2025 were Mr. Flynn and Mr. Datoo. On July 22, 2025, Mr. Datoo resigned his position on the Board and his position on the Nominating and Governance Committee and the position was subsequently filled by Mr. Driscoll upon approval of the Board on August 5, 2025. Lite Strategy&#8217;s Nominating and Governance Committee Charter is posted on its website at https://litestrategy.com.</span><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board has determined that Dr. Reynolds, Mr. Flynn and Mr. Driscoll are independent members of the Nominating and Governance Committee in accordance with applicable Nasdaq and SEC rules and Mr. Datoo was not considered independent in accordance with the applicable Nasdaq and SEC rules. The Nominating and Governance Committee met one time during the fiscal year ended June 30, 2025.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stockholders who would like to propose an independent director candidate for consideration for nomination by the Board at next year&#8217;s annual meeting of stockholders may do so by submitting the candidate&#8217;s name, resume and biographical information to the attention of Justin J. File, Secretary, Lite Strategy, Inc., 9920 Pacific Heights Blvd, Suite 150, San Diego, California 92121. All stockholder nominations received by the Secretary, which comply with the advance notice provisions of MEI Pharma's Amended and Restated Bylaws, will be presented to the Nominating and Governance Committee for the same consideration as individuals identified by the Nominating and Governance Committee through other means.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we have no minimum qualifications for director nominees, the Nominating and Governance Committee reviews the prospective candidate&#8217;s biographical information and assesses each candidate&#8217;s independence, diversity, skills and expertise based on a variety of factors, including the following criteria:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the candidate has exhibited behavior that indicates he or she is committed to the highest ethical standards; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the candidate has had broad business, governmental, non-profit or professional experience that indicates that the candidate will be able to make a significant and immediate contribution to the Board's discussion and decision-making; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the candidate will be able to devote sufficient time and energy to the performance of his or her duties as a director. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Application of these factors requires the exercise of judgment by members of the Nominating and Governance Committee when the Committee makes recommendations to the Board and cannot be measured in a quantitative way. The Nominating and Governance Committee and the Board generally value the broad business experience and independent business judgment in the health care, life sciences and other fields of each member. Specifically, Mr. Driscoll is qualified for the Board based on his business experience in the pharmaceutical industry, the area of finance and his status as an audit committee financial expert. Dr. Glover is qualified for the Board based on his business experience and his drug development experience in the oncology field. Dr. Reynolds is qualified for the Board based on his medical experience and experience in clinical development and regulatory and medical affairs. Mr. Flynn is qualified for the Board based on his business experience in the pharmaceutical industry and his business development experience. Mr. Lee is qualified for the Board based on his knowledge of Litecoin and his experience in the cryptocurrency industry. Mr. Riezman is qualified for the Board based on his experience in the cryptocurrency industry. Mr. Datoo was qualified for the Board based on his business development experience. Mr. Wood was qualified for the Board based on his business development experience.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Nominating and Governance Committee oversees compliance by Lite Strategy with its legal and regulatory obligations and periodically reviews our:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Code of Business Conduct and Ethics; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Disclosure Policy; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amended and restated certificate of incorporation; </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amended and restated bylaws; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.86108878960282%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the independent status of our directors. </span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Director Independence</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board has determined the independence of each director in accordance with the elements of independence set forth in the Nasdaq listing standards. Based upon information solicited from each director, the Board has determined that each of Mr. Driscoll, Dr. Glover, Dr. Reynolds, Mr. Flynn, Mr. Wood during his service on the Board, had no material relationship with Lite Strategy and is independent within the meaning of Nasdaq&#8217;s director independence standards as currently in effect. Mr. Datoo was not considered independent within the meaning of Nasdaq&#8217;s director independence standards as currently in effect and Messrs. Lee and Riezman are not considered independent within the meaning of Nasdaq's director independence standards currently in effect. In making the foregoing determinations, the Board has considered both the objective tests set forth in the Nasdaq independence standards and subjective measures with respect to each director necessary to determine that no relationships exist that would interfere with the exercise of independent judgment by each such director in carrying out responsibilities of a director.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board Leadership Structure</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Driscoll has served as the Chair of our Board since July 2024. The Board does not have a policy addressing whether the same person should serve as both the Chief Executive Officer and Chair of the Board or if the roles should be separate. Our Board believes that it should have the flexibility to make its determination based upon what it considers to be the appropriate leadership structure for Lite Strategy at the time. The Board believes that its current leadership structure is appropriate for Lite Strategy at this time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board Role in Risk Oversight</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk is an integral part of the Board and Committee deliberations throughout the year. While the Board has the ultimate oversight responsibility for the risk management process, various committees of the Board also have responsibility for risk management. In particular, the Audit Committee focuses on financial risk, including internal controls and receives financial risk assessment reports from management. Risks related to the compensation programs are reviewed by the Compensation Committee. The Nominating and Governance Committee exercises oversight of governance risks, including succession planning and legal compliance. The Board is advised by these committees of significant risks and management&#8217;s response through periodic updates.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Anti-Hedging and Pledging Policies</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8968c567-f37b-48cc-b001-63ec1eaee33f" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under our Insider Trading Policy, all directors, officers, employees and consultants of Lite Strategy are subject to restrictions on hedging of securities of Lite Strategy.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> These restrictions apply to securities of Lite Strategy owned by such persons, regardless of whether such securities were granted by us to such persons as compensatory awards. Our Insider Trading Policy prohibits such persons from engaging in short sales of securities of Lite Strategy or in transactions in publicly traded options with respect to our securities. In addition, our Insider Trading Policy permits, but discourages, such persons from holding our securities in a margin account or pledging securities of Lite Strategy as collateral for a loan and from entering standing orders with respect to our securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stockholder Communications with the Board of Directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stockholders may communicate with the Board, including non-executive directors or officers, by sending written communications addressed to such person or persons in care of Lite Strategy, Inc., Attention: Secretary, 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121. All communications will be compiled by the Secretary and submitted to the addressee. If the Board modifies this process, the revised process will be posted on our website.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appointment of Directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation and amended and restated by-laws provide that the number of directors will be set by resolution of the board, but shall be between two and nine. We currently have six directors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under our amended and restated certificate of incorporation and amended and restated by-laws, directors are to be elected at each annual meeting of stockholders for a term of three years unless the director is removed, retires or the office is vacated earlier. The board is divided into three classes with respect to the term of office, with the terms of office of one class expiring each successive year. This classified board provision could discourage a third-party from making a tender offer for Lite Strategy's shares or attempting to obtain control of Lite Strategy. It could also delay stockholders who do not agree with the policies of the Board from removing a majority of the Board for two years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A director may resign at any time. The resignation is effective upon receipt of notice. Any or all directors may be removed with cause by a resolution of stockholders entitled to vote to elect directors. Vacancies from resignation or removal or expansion of the size of the board may be filled by resolution of a majority of directors then in office or by a sole remaining director and any director so appointed shall serve for the remainder of the full term of the class of directors in which the vacancy occurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attendance of Directors at Board Meetings and Stockholder Meetings</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the fiscal year ended June 30, 2025, the Board held a total of 46 meetings and each director attended at least 75% of the total number of meetings of the Board and of the meetings of each committee of the Board on which such director served.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All directors are expected to attend our annual meetings of stockholders. Four of six of our directors then in the office attended the annual meeting of stockholders held in January 2025.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Code of Ethics</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a Code of Business and Ethics policy that applies to our directors and employees (including our principal executive officer and our principal financial officer) and have posted the text of our policy on our website (https://litestrategy.com), under Investors &#8211; Governance Documents. In addition, we intend to promptly disclose (i) the nature of any amendment to the policy that applies to our principal executive officer and principal financial officer and (ii) the nature of any waiver, including an implicit waiver, from a provision of the policy that is granted to one of these specified individuals, the name of such person who is granted the waiver and the date of the waiver on our website in the future. Except as expressly stated herein, information contained on our website is not incorporated by reference herein and shall not be deemed a part of this Annual Report on Form 10-K.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Officers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive officers are appointed by and serve at the discretion of the Board. Set forth below is the name and certain biographical information regarding Lite Strategy&#8217;s executive officer as of the date of filing of this Annual Report.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Justin J. File, age 55, Acting Chief Executive Officer, Chief Financial Officer and Secretary</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. File has been our Acting Chief Executive Officer since August 1, 2024 and our Chief Financial Officer since August 1, 2023. Mr. File has over 30 years of experience in accounting and finance, working in both public and private companies. He has a diverse range of experience, having worked in various industries, including the life sciences industry for the past 17 years. From 2015 to 2023, Mr. File was the Chief Financial Officer and Corporate Secretary of Evofem Biosciences, Inc., a women's health company that developed and commercialized Phexxi&#174;, a nonhormonal contraceptive for women. While at Evofem he helped bring the company public through a reverse merger and was responsible for overseeing corporate finance and accounting, information technology and investor relations. Previously, Mr. File provided executive financial and accounting oversight consulting services to biotechnology companies and before that led accounting operations and reporting at Sequenom, Inc., a molecular diagnostic company. He additionally served as Treasurer of Sequenom&#8217;s diagnostic subsidiary. Before joining industry, Mr. File worked for approximately ten years in public accounting, primarily with Arthur Andersen LLP. Mr. File graduated from Central Washington University with a Bachelor of Science in Accounting and Business Administration. He is a Certified Public Accountant (inactive).</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to Item 408(b)of Regulation S-K, we have an insider trading policy governing the purchase, sale and other dispositions of our securities that applies to us and our personnel, including officers, directors, employees and agents, and other covered persons (the Insider Trading Policy). The Company believes that the Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, and listing standards applicable to us. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to this Annual Report on Form 10-K.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_19"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11. Executive Compensation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPENSATION DISCUSSION AND ANALYSIS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Compensation Discussion and Analysis describes the compensation strategy, policies, programs and practices for the named executive officers identified in the Summary Compensation Table. For fiscal year 2025, the named executive officers consist of Justin J. File, Acting Chief Executive Officer, Chief Financial Officer and Secretary, David M. Urso, Chief Executive Officer and General Counsel and Richard G. Ghalie, M.D., Chief Medical Officer, to whom we collectively refer in this Compensation Discussion and Analysis as our named executive officers. Mr. Urso and Dr. Ghalie resigned their respective positions as of August 1, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Philosophy and Objectives</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We believe that the performance of our executive officers significantly impacts our ability to achieve our corporate goals. We, therefore, place considerable importance on the design and administration of our executive officer compensation program. This program is intended to enhance stockholder value by attracting, motivating and retaining qualified individuals to perform at the highest levels and to contribute to our growth and success. Our executive officer compensation program is designed to provide compensation opportunities that are tied to individual and corporate performance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our overall compensation philosophy has been to pay our executive officers an annual base salary and to provide opportunities, through cash and equity incentives, to deliver higher compensation if certain key performance goals are satisfied or exceeded. However, for fiscal year 2025, we realigned our compensation philosophy in connection with the July 22, 2024, announcement that the Board was beginning an evaluation of our strategic alternatives, including potential transactions or an orderly wind-down of operations, if necessary with a goal of  maximizing the value of our assets for our shareholders. The new fiscal year 2025 compensation approach focused on the retention of key employees and our remaining executive officer in order to effectively conduct daily operating activities while pursuing strategic alternatives.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee&#8217;s Process</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee acts on behalf of the Board with respect to fulfilling the Board&#8217;s responsibilities to oversee our compensation policies, plans and programs and reviewing and determining, as appropriate, the compensation to be paid to executive officers and directors. To achieve this task, the Compensation Committee (i) reviews and approves corporate performance goals and objectives that support and reinforce our long-term strategic goals and compensation plans; (ii) reviews the individual performance of the executive officers; (iii) establishes policies with respect to equity compensation arrangements, timing and pricing of equity awards for newly hired employees, promotions and annual grants for executive and non-executive employees and directors; (iv) reviews regional and industry-wide compensation practices and trends to assess the propriety, adequacy and competitiveness of our executive compensation programs among comparable companies in our industry; (v) reviews and approves the terms of any employment agreements, severance agreements, change-of-control protections and any other compensation arrangements of the executive officers; (vi) performs and considers a compensation risk assessment; and (vii) considers stockholder feedback and Say-on-Pay voting results. The Compensation Committee also makes recommendations to the Board with respect to this Compensation Discussion and Analysis section and recommends that such section be included in any of our annual reports on Form 10-K, registration statements, Proxy statements or information statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee meets at least once a year or more frequently as its members deem necessary or appropriate. Under its charter, the Compensation Committee has the authority, in its sole discretion, to retain or obtain the advice of a compensation consultant, legal counsel or other advisors as the Compensation Committee may determine to assist in the performance of the Compensation Committee&#8217;s duties and responsibilities, only after taking into consideration the factors prescribed by the SEC and Nasdaq that bear upon the adviser&#8217;s independence.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Setting Executive Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee considers peer group analysis as a component of its overall executive compensation decision process, but it does not attempt to set executive compensation to a specific benchmark level or percentile as compared to executive compensation levels at other companies and determines the mix of compensation based on its review of such competitive data. We believe our approach to compensation does not encourage excessive risk-taking by our executives as it is not a market outlier, is based on a typical mix of short- and long-term compensation tied to both internal objectives and to stockholder value and reflects the importance of the retention of our remaining executive employee throughout our strategic alternative phase of operations during fiscal year 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our peer group of companies used for context when setting fiscal year 2025 officer compensation consisted of the same 20 publicly traded drug development companies that were approved by the Compensation Committee with input from management and F. W. Cook, our compensation consultant, for fiscal year 2024 decisions. The peer group is composed of drug development companies with a broadly similar market cap at the time, (median peer market cap at the time the peer data were reviewed by the Committee in</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> June 2023 was $111 million), generally without material revenue from commercial products and with emphasis on oncology drug development companies and was used as context for setting fiscal year 2025 executive officer compensation in light of our strategic alternative operations. This peer group was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:53.8%;box-sizing:content-box;"/>
     <td style="width:46.2%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Aeglea BioTherapeutics</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Kronos Bio</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">BioAtla</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leap Therapeutics</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cardiff Oncology</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Molecular Templates</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CEL-SCI Corporation</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Oncternal Therapeutics</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CytomX Therapeutics</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pieris Pharmaceuticals</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ESSA Pharma</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rigel Pharmaceuticals</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fusion Pharma</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Surface Oncology</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">G1 Therapeutics</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Syros Pharmaceuticals</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Glycomimetics</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">UroGen Pharma Ltd.</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Karyopharm Therapeutics</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Verastem</span></p></td>
    </tr>
   </table><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Role of Stockholder Say-on-Pay Votes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At our annual meeting of stockholders held in January 2025, approximately 66% of the shares voted at the meeting approved, on an advisory basis, the compensation of our named executive officers. The Compensation Committee considers input from stockholders, its compensation consultant and proxy advisors, when assessing its compensation philosophy and the components of its compensation program, giving further consideration to the level of attainment of corporate goals and to the compensation data of our peer group so that compensation decisions are broadly consistent with market practice. The Compensation Committee  did not change the compensation program for fiscal 2025 as a result of the Say on Pay vote in January 2025 because principal executive officer had changed in the meantime, and CEO compensation during fiscal year 2025 had a relatively low value in recognition of the strategic alternatives review</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elements of Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Acting Chief Executive Officer and Chief Financial Officer&#8217;s compensation has three key elements: (i) base salary, (ii) performance-based cash incentives and (iii) equity-based compensation. These elements of executive compensation are intended to align the interests of our executive officers with those of our stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Base Salary</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Base salaries serve to provide a fixed amount of compensation to our executive officers for successfully fulfilling their responsibilities. We establish base salaries for our executive officers when they join us or upon promotion. Base salaries for executive officers are reviewed and determined by the Compensation Committee annually during the first fiscal quarter, or upon promotion, following consultation with our compensation consultant. In connection with the Board's appointment of Justin J. File, our then current Chief Financial Officer, to serve in the additional capacity of Acting Chief Executive Officer, the Compensation Committee increased Mr. File's salary from $450,000 to $550,000, effective August 1, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Urso&#8217;s and Mr. Ghalie&#8217;s employment terminated after approximately one month of service during fiscal year 2025. They were not provided a salary increase during that time and most of their compensation reported in the Summary Compensation Table reflects severance provided upon their termination.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Performance-based Cash Incentives</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee believes that allocating a meaningful amount of our executive officers&#8217; total cash compensation to the achievement of corporate goals and objectives aligns their interests with those of our stockholders. The Compensation Committee establishes annual corporate incentive bonus targets for each of our executive officers, expressed as a percent of base salary. Fiscal year 2025 bonus targets as a percent of base salary were set at the start of the fiscal year at 50% for Mr. Urso and 40% for Dr. Ghalie and Mr. File. In connection with the Board's appointment of Justin J. File, our then current Chief Financial Officer, to serve in the additional capacity of Acting Chief Executive Officer, the Compensation Committee increased Mr. File's annual corporate incentive bonus target from 40% to 50%. The corporate goals and objectives are generally critical activities or strategic initiatives designed to move forward the clinical and operating activities and enhance stockholder return. However, in light of the strategic alternatives announcement and potential cessation of operations during the year Mr. File&#8217;s, the Acting Chief Executive Officer, performance-based cash incentive for fiscal year 2025 was based on his 50% target bonuses as Acting Chief Executive Officer, and he was also provided a </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$96,000 Success Fee related to retention of cash in excess of the forecast during the nine months ending March 31, 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Committee viewed preserving the Company&#8217;s cash as the most important metric for measuring Mr. File&#8217;s success as it directly benefited shareholders in the event that the strategic review had resulted in liquidation of the Company.  Mr. Urso and Mr, Ghalie terminated employment after approximately one month of fiscal 2025 service and did not participate in the cash bonus plan for fiscal 2025.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity-based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee believes that long-term value creation is achieved through an ownership culture that encourages performance by our executive officers through stock and stock-based awards. This potential reward for stockholder value creation is also key to our retention strategy. Under our Amended and Restated MEI Pharma, Inc. 2008 Omnibus Equity Compensation Plan (the 2008 Equity Plan), we may award incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and performance shares and units. Stock options expire after 10 years, have an exercise price equal to the fair market value at grant, typically vest 25% after one year and in equal monthly installments thereafter over the next 36 months and have a three-month post-termination exercise period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to our strategic alternatives announcement during the first quarter of fiscal year 2025, we did not conduct our regular annual equity grant cycle and no equity compensation grants were awarded to our executive officers or employees during our fiscal year ended June 30, 2025. All options granted before and during fiscal year 2024 are currently underwater as of the date of the filing of this Annual Report and do not provide any value at our current share price.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Benefits and Perquisites</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We offer benefit programs to our employees, including named executive officers, which include paid time off, health insurance and a company sponsored 401(k) plan. Our executive officers generally do not receive any supplemental retirement benefits or perquisites and participate in the above listed benefit programs on the same basis as other full-time employees.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severance and Change in Control Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of Messrs File, Urso and Dr. Ghalie&#8217;s employment agreements provide or provided for certain severance payments upon the applicable employee&#8217;s termination by us, other than for cause or by the applicable employee for good reason, as such terms are defined in the respective employment agreement. Upon such a termination of employment, the employment agreements require us to: (i) make a payment to the applicable employee in lieu of notice in an amount equal to twelve months of such employee&#8217;s base salary (as in effect at the time of such employee&#8217;s termination from employment) and (ii) accelerate the vesting of the applicable employee&#8217;s options so that such employee will be vested in the same number of shares of common stock subject to the options as if such employee had continued to be employed by us for an additional twelve months. Such payment and additional option vesting are conditional upon the execution of a customary release of claims in favor of us and our affiliates, in a form prescribed by us. The payment in lieu of notice will be paid to the applicable employee in a single lump sum payment as soon as administratively practicable after the maximum review and revocation period for the release agreement as may be required under applicable law, if any, or such earlier date as determined in our sole discretion, but in no event more than 60 days after the applicable employee&#8217;s termination of employment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Urso's and Dr. Ghalie's last day as CEO and CMO was on August 1, 2024. Mr. Urso and Dr. Ghalie&#8217;s severance was paid pursuant to their employment agreements dated June 2, 2023 and January 16, 2024, respectively, (and as further documented in their respective separation and release agreements dated August 4, 2024 and August 3, 2024, respectively) with 12 months base salary and accelerated vesting of the portion of their stock options that would have vested over the next 12 months, plus their pro-rata fiscal year 2025 bonus as calculated from their last day of employment. Further, a total of 61,646 options accelerated for Mr. Urso and 18,861 for Dr. Ghalie, reflecting the number of shares which would have vested during the next 12 months, respectively. Mr. Urso&#8217;s and Dr. Ghalie&#8217;s vested options may be exercised after separation of service for one year until August 1, 2025, not to exceed their original term, if applicable. If their respective consulting agreements remain in place after August 1, 2025, their vested option grants will continue to be exercisable until 90 days post termination of their respective consulting agreements, as provided for in our equity compensation plan. As of the fiscal year ended June 30, 2025, only Dr. Ghalie&#8217;s consulting agreement continues to be active and his vested options exercisable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Mr. File&#8217;s employment would have been terminated as of June 30, 2025, he would have been entitled to receive payments in accordance with this Amended and Restated Employment Agreement dated March 30, 2025. Additionally, he would have been entitled to 12 months of options vesting that aggregated 13,326 as of June 30, 2025. There was no intrinsic value of the option vesting acceleration as of June 30, 2025, because all options were underwater.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of a change in control, as defined in the 2008 Equity Plan, unless the Compensation Committee of the Board determines otherwise, all options granted to Mr. File will accelerate and become fully exercisable effective upon the date of the change in control. There was no intrinsic value of unvested stock options as of June 30, 2025, upon a change in control, because all options were underwater.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Retention Bonus</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As provided for in Mr. File&#8217;s Amended and Restated Employment Agreement, he is entitled to receive a retention bonus equal to $412,500 that will be payable as a lump sum payment within 30 days of the Retention Date (defined below), provided that through the Retention Date, Mr. File (i) remains actively employed by the Company in good standing and has not provided notice of his resignation from the Company, (ii) continues to perform his regular job duties and other duties specifically assigned to him by the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board, and (iii) continues to comply with the Company&#8217;s policies and agreements (as defined in the Amended and Restated Employment Agreement). The &#8220;Retention Date&#8221; means the first to occur of (i) the closing date of a change in control, (ii) the date of Mr. File&#8217;s termination of employment by the Company without cause, termination for good reason, or termination due to death or disability, (iii) the date that is 30 days after the date on which the Board of the Company approves the dissolution, wind down, liquidation or other winding-up of the Company, or (iv) September 30, 2025.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tax and Accounting Considerations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The tax and accounting consequences to us of certain compensation elements are important considerations for the Compensation Committee when evaluating and recommending compensation packages for our executive officers. Generally, the Compensation Committee seeks to balance its objective to create an effective compensation program that attracts, retains and rewards executives in order to maximize the return to stockholders with the need for appropriate tax and accounting consequences of such compensation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to considering the tax consequences, the Compensation Committee considers the accounting consequences of its decisions, including the impact of expenses being recognized in connection with equity-based awards, in determining the size and form of different equity-based awards.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CEO Pay Ratio</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC rules require us to disclose the total annual compensation of our principal executive officer for fiscal year 2025, who was Justin J. File, our Acting Chief Executive Officer and Chief Financial Officer, the median of the total annual compensation of all employees other than our principal executive officer, as well as their ratio to each other (the CEO Pay Ratio). Total annual compensation for our principal executive officer and for the median of the total annual compensation of all employees is calculated in accordance with SEC rules applicable to the Summary Compensation Table. For fiscal year 2025, these amounts were as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our principal executive officer&#8217;s total annual compensation: $912,667 </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our median employee&#8217;s total annual compensation: $350,117</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CEO Pay Ratio: 2.61 to 1 </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the median compensated employee, we chose June 30, 2025, as the determination date. As of this date, we had three employees, excluding our principal executive officer. In determining our median compensated employee and calculating the CEO Pay Ratio, we did not use any of the exemptions permitted under SEC rules, nor did we rely upon any material assumptions, adjustments or estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that the CEO Pay Ratio set forth above is a reasonable estimate for fiscal year 2025, determined in a manner consistent with SEC rules. The SEC rules for identifying the median compensated employee and calculating the CEO Pay Ratio based on that employee&#8217;s total annual compensation permit companies to adopt a variety of methodologies, to apply certain exemptions and to make certain assumptions, adjustments or estimates that reflect their compensation policies. Accordingly, the CEO Pay Ratio may not be comparable to the pay ratios reported by other companies, which may have used different methodologies, assumptions, adjustments or estimates in calculating their pay ratios.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPENSATION COMMITTEE REPORT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K and contained within this Proxy Statement with management. Based on such review and discussions, our Compensation Committee recommended to our Board that the Compensation Discussion and Analysis be included as of the date of filing for this Annual Report, by the members of the Compensation Committee of the Board:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Nicholas R. Glover</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Thomas C. Reynolds</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. James Flynn</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">This Section is not soliciting material, is not deemed filed with the SEC and is not to be incorporated by reference in any filing of our under the Exchange Act or the Securities Act, other than in our Annual Report on Form 10-K where it shall be deemed to be furnished, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE COMPENSATION</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Executive Officers</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our named executive officers for the fiscal year ended June 30, 2025, were:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Justin J. File, Acting Chief Financial Officer, Chief Financial Officer</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">David M. Urso, former President and Chief Executive Officer</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Richard G. Ghalie, former Chief Medical Officer</span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary Compensation Table</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below sets forth for the fiscal years ended June 30, 2025 and 2024, the compensation of our named executive officers.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:23.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.76%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.5%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.5%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.06%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:5.14%;box-sizing:content-box;"/>
     <td style="width:1.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.46%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name and Principal Position</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Salary ($)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stock Awards ($) (1)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option Awards ($) (2)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-Equity Incentive Plan Compensation ($)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All Other Compensation ($)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total ($) (3)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File (4)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">541,667</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">371,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(5)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">912,667</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Acting Chief Executive Officer, Chief Financial Officer</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">450,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">164,700</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(6)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">614,700</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso (7)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,528</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">812,730</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(9)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866,258</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Former President and Chief Executive Officer</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">614,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">280,905</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(8)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,905</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie (10)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,866</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">633,796</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(12)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">677,662</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Former Chief Medical Officer</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">503,165</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">159,800</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">184,158</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(11)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">847,123</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Represents the aggregate grant date fair value of restricted stock unit awards (RSUs) granted in accordance with Financial Accounting Standards Board, Accounting Standards Codification, Topic 718, Stock Compensation (ASC Topic 718), calculated based on the closing market price of our common stock on the date of grant.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Represents the aggregate grant date fair value of options granted in accordance with ASC Topic 718. There we no equity awards granted to our named executive officers during fiscal year 2025.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the SEC rules, the compensation described in this table does not include various health and welfare or other benefits received by our named executive officers that were generally available to all our regular, full-time employees, as well as certain perquisites and other benefits received by our name executive officers that, in the aggregated, were less than $10,000 for any officer.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective August 1, 2024, Mr. File became our Acting Chief Executive Officer, in addition to his Chief Financial Officer role that was effective August 1, 2023.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the terms of his Amended and Restated Employment Agreement dated March 30, 2025, during fiscal year 2025 Mr. File was paid a $275,000 annual incentive bonus, which represented 50% of his base salary and a $96,000 Success Fee related to the net absolute cash retention from operations as compared to forecasted cash usage through the nine months ending March 31, 2025.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, Mr. File received a bonus of 37% of his base salary for fiscal year 2024 upon the Compensation Committee's determination to award bonuses at 91.5% of target levels.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(7)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Urso resigned as our President and chief Executive Officer on August 1, 2024.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(8)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, Mr. Urso received a bonus of 46% of his base salary for the fiscal year 2024 upon the Compensation Committee's determination to award bonuses at 91.5% of target levels.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(9)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the terms of Mr. Urso's Separation and Release Agreement, dated August 4, 2024 (Mr. Urso's Separation and Release Agreement), during fiscal year 2025, he received a bonus of $25,583, which represented 48% of his base salary and reflected his pro-rata bonus through the date of resignation. Additionally, per the terms of Mr. Urso's Separation and Release Agreement, he received $614,000 in severance, $95,639 for his paid time off benefits accumulated as of his resignation date and $77,358 for COBRA.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(10)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr Ghalie resigned as our Chief Medical Officer on August 1, 2024.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(11)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, Dr. Ghalie received a bonus of 37% of his base salary for fiscal year 2024 upon the Compensation Committee's determination to award bonuses at 91.5% of target levels.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(12)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the terms of Dr. Ghalie's Separation and Release Agreement, dated August 3, 2024 (Dr. Ghalie's Separation and Release Agreement), during fiscal year, he received a bonus of $16,772, which represented 38% of his base salary and reflected his pro-rata bonus </span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">through the date of his resignation. Additionally, per the terms of Dr. Ghalie's Separation and Release Agreement, he received $503,165 in severance, $78,375 for his paid time off benefits accumulated as of his resignation date and $35,334 for COBRA.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employment Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into written employment agreements with each of the named executive officers, which set forth the terms of their respective employments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employment Agreement between Justin J. File and Lite Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with Mr. File&#8217;s appointment as Chief Financial Officer, Mr. File and Lite Strategy entered into an employment agreement (the CFO Employment Agreement), effective as of June 12, 2023. The CFO Employment Agreement provides for an annual base salary of $450,000, with a target annual bonus opportunity of 40% of base salary. Mr. File is also eligible to participate in Lite Strategy&#8217;s health, retirement, expense reimbursement and other benefit plans.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CFO Employment Agreement provides for a grant as of June 12, 2023 of an option to purchase a number of shares of Lite Strategy&#8217;s common stock, under Lite Strategy&#8217;s equity compensation plan, equal to 0.8% of Lite Strategy&#8217;s outstanding shares as of the date of grant, with vesting over a 4-year period, full vesting on a change in control and other terms and conditions consistent with the CFO Employment Agreement and grants made to other senior executives. The exercise price of the CFO Initial Grant was equal to the Nasdaq closing price per share of Lite Strategy&#8217;s stock on the date of grant. For 2024 and subsequent years, Mr. File will be eligible to receive equity awards on similar terms as other senior executives of Lite Strategy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the CFO Employment Agreement, if Mr. File&#8217;s employment is terminated by Lite Strategy without cause or Mr. File resigns for good reason, Mr. File will be eligible to receive the following severance benefits if he signs an effective release of claims: (i) lump sum payment equal to 12 months of his base salary, (ii) if he elects COBRA health care continuation coverage, Lite Strategy will pay the monthly COBRA premium for 12 months, (iii) payment of a pro-rata annual bonus, if any, for the year of termination and (iv) accelerated vesting of a portion of Mr. File&#8217;s outstanding stock options equal to the number of options that would have vested if he had continued to be employed by Lite Strategy for 12 months following termination. The CFO Employment Agreement also provides that if, within three months before a change in control, Lite Strategy terminates Mr. File&#8217;s employment without cause at the request of the other party to the change in control transaction, or if, upon or within two years following a change in control, Mr. File&#8217;s employment is terminated by Lite Strategy without cause or Mr. File resigns for good reason, Mr. File&#8217;s outstanding stock options will fully vest and become exercisable as of his termination date, provided that he signs an effective release.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that Mr. File&#8217;s employment is terminated due to his death or disability, vesting of a portion of Mr. File&#8217;s outstanding stock options will accelerate equal to the number of options that would have vested if he had continued to be employed by Lite Strategy for 12 months following termination, subject to his execution of an effective release in the event of disability.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with our announcement on July 22, 2024 to pursue strategic alternatives, Mr. File and Lite Strategy entered into an addendum to his employment agreement effective August 1, 2024. Under the addendum, Mr. File was appointed by the Board to serve in the additional capacity of Acting Chief Executive Officer and provided an increase in his annual base salary to $550,000 and an increase in his target annual bonus opportunity to 50% of base salary. In addition, Mr. File was eligible to receive a success fee if the closing cash balance exceeds a specified amount determined by the Board as of the first to occur of (i) December 31, 2024 or (ii) the closing date of a change in control (the Measurement Date). The success fee will equal 10% of the closing cash balance in excess of the specified amount as of the Measurement Date and will be paid in a lump sum cash payment on the first to occur of (i) June 30, 2025, or (ii) Mr. File&#8217;s termination of employment by us without cause, subject to Mr. File remaining employed by us through the payment date of the success fee.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequently, on March 3, 2025, Mr. File and Lite Strategy entered into an amendment and restatement of the addendum (the Amended and Restated File Employment Agreement), whereby he would receive:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a retention bonus equal to $412,500 if certain conditions were met within 30 days of the Retention Date (as defined therein); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the success fee was redefined to be 10% of our net absolute cash retention as compared to our forecasted cash usage, measured as of March 31, 2025.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Mr. File&#8217;s employment is terminated by us other than for cause or Mr. File resigns for &#8220;good reason&#8221; (as defined), Mr. File would be eligible to receive the following severance benefits:</span></p><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a lump sum payment equal to 12 months of his base salary;</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a lump sum payment equal to $70,669;</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if the termination date is prior to June 30, 2025, a lump sum payment of a pro-rata target annual bonus for the year of termination;</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">accelerated vesting of a portion of his outstanding stock options equal to the number of options that would have vested if he had continued to be employed by us for 12 months following termination;</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the retention bonus; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the success fee.</span></div></div><p style="text-indent:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Mr. File was employed by us through our fiscal year end of June 30, 2025, he would be eligible to receive his full year&#8217;s annual bonus opportunity of 50% of his base salary.  The term of the Amended and Restated File Employment Agreement is from the date of the agreement through September 30, 2025, unless terminated earlier by us or Mr. File.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employment Agreements between David M. Urso and Richard Ghalie and Lite Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective August 1, 2024, both our former Chief Executive Officer, David Urso and our former Chief Medical Officer, Richard G. Ghalie, resigned. In accordance with the terms of Mr. Urso and Dr. Ghalie&#8217;s separation agreements, each was eligible to receive the following benefits under their respective employment agreements commensurate with a termination without cause (as defined):</span></p><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">severance pay equal to 12 months of base salary;</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a pro-rated annual bonus for the fiscal year ending June 30, 2025;</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12 months of monthly COBRA premiums; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:7.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6173607267280956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">accelerated vesting of the stock options that would have vested during the 12 months following their separation date.</span></div></div><p style="text-indent:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, the Board determined that Mr. Urso and Dr. Ghalie could exercise their vested options through the first anniversary of their separation date (until August 1, 2025), not to exceed their original term, as applicable.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Grants of Plan Based Awards for Fiscal Year Ended June 30, 2025</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:16.6%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.96%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:10.8%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="5" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Possible Payouts Under Non-Equity Incentive Plan Awards (1)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All Other Stock Awards Number of Shares of Stocks of Units</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All Other Option Awards Number of Securities Underlying Options</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise or Base Price of Option Awards</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Grant Date Fair Value of Stock and Option Awards</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Grant Date</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Target</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Maximum</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">275,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,583</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie, M.D.</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,772</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:1.333%;text-indent:-4.816%;padding-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (1)     As disclosed in the Summary Compensation table, single bonus targets were time based pro-rata calculations as determined from Mr. File's Amended and Restated Employment Agreement, as well as Mr. Urso's and Dr. Ghalie's respective separation and release agreements.</span></p><div><ix:nonNumeric id="F_1b470f53-5e95-46a8-9dc8-ab73866e2b9d" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:AwardTmgMnpiDiscTextBlock" escape="true" continuedAt="F_1b470f53-5e95-46a8-9dc8-ab73866e2b9d_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Award Grant Practices</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ecfa733c-b325-4e69-a959-8e271e460ef6" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:AwardTmgMnpiCnsdrdFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have had no program, plan or practice pertaining to the timing of stock option grants to named executive officers coinciding with the release of material non-public information, or MNPI.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_771e4d9a-e7be-4111-b867-737706ba9806" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee has historically approved grants of options </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_726818f1-f474-46f3-afcf-1e77fd17b87c" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:AwardTmgPredtrmndFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">annually each year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as part of our annual compensation cycle. The timing of any equity grants to newly-hired employees, or in connection with promotions or other non-routine grants, is generally tied to the event giving rise to the award (such as an executive officer&#8217;s commencement of employment or promotion effective date). Any grants to executive officers are approved at meetings of the Compensation Committee or our board of directors. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all stock option awards, the exercise price is no less than the closing price of our common stock on the date of the grant. The following table sets forth information for certain stock options granted to our named executive officers through fiscal year 2025, which there were no grants made to our named executive officers or any employees during the fiscal year ended June 30, 2025. In the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_1b470f53-5e95-46a8-9dc8-ab73866e2b9d_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">event </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an issuer grants stock options or option-like instruments within the period commencing four business days prior to and ending one business day following the filing by the Company of a Form 10-K, Form 10-Q or Form 8-K containing material non-public information as required under Item 402(x) of Regulation S-K, Item 402(x) of Regulation S-K requires tabular disclosure of certain information related to such awards.</span></p></ix:continuation></div><p style="margin-left:1.333%;text-indent:-4.816%;padding-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding Equity Awards at June 30, 2025</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information on all stock options and RSUs held by our named executive officers on June 30, 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:13.937%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.198%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.218%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.2%;box-sizing:content-box;"/>
     <td style="width:7.099%;box-sizing:content-box;"/>
     <td style="width:1.06%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.618%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.2%;box-sizing:content-box;"/>
     <td style="width:11.318%;box-sizing:content-box;"/>
     <td style="width:1.2%;box-sizing:content-box;"/>
     <td style="width:11.438%;box-sizing:content-box;"/>
     <td style="width:1.06%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.458%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="15" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option Awards</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stock Awards</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Securities Underlying Unexercised Options (Exercisable)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Securities Underlying Unexercised Options (Unexercisable)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Options Exercise Price</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option Expiration</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares or Units of Stock That Have Not Vested</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Market Value of Shares or Units of Stock That Have Not Vested</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(#)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(#)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Footnote</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">($/Share)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(#)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">($)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,651</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,651</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.01</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/12/2033</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90,226</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.16</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,472</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.46</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57.66</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,250</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.46</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49.06</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84.26</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85.26</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.26</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.86</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,375</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.06</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8/1/2025</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,625</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.67</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9/23/2033</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,587</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.46</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/5/2032</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57.66</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/1/2031</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,750</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.66</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/3/2031</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.46</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/2/2030</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49.06</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/1/2029</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84.26</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/12/2028</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,250</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56.26</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/7/2027</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,250</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26.26</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/13/2026</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,500</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.86</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3/6/2026</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Twenty-five percent of the options vested on June 12, 2024; the remaining 75% of the options were expected to vest in equal monthly installments over the following 36 months.</span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with Mr. Urso's Separation and Release Agreement, all outstanding options vested and became exercisable on an accelerated basis as of the transition date (August 1, 2024) for the same number of shares which would have vested had he continued to be employed by Lite Strategy through the first anniversary of the transition date (August 1, 2025). Additionally, the vested options could be exercised through August 1, 2025, not to exceed their original term, if applicable, or would be extended to 90 days post termination of his consulting agreement should it occur beyond August 1, 2025, as provided for in our equity compensation plans. Mr. Urso's consulting agreement terminated on February 14, 2025 and his vested options expired on August 1, 2025. </span></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.598295276029473%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with Dr. Ghalie's Separation and Release Agreement, all outstanding options vested and became exercisable on an accelerated basis as of the transition date (August 1, 2024) for the same number of shares which would have vested had he continued to be employed by Lite Strategy through the first anniversary of the transition date (August 1, 2025). Additionally, the vested options could be exercised through August 1, 2025, not to exceed their original term, if applicable, or would be extended to 90 days post termination of his consulting agreement should it occur beyond August 1, 2025, as provided for in our equity compensation plans. As of fiscal year end June 30, 2025, Dr. Ghalie's consulting agreement remains active and his vested options continue to be exercisable.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Option Exercises and Stock Vested</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Messrs. File and Urso and Dr. Ghalie did not exercise any stock options during the fiscal year ended June 30, 2025.</span></p><div><ix:nonNumeric id="F_06ec4875-7ba3-46cd-931c-8bb5ea46be56" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:PvpTableTextBlock" escape="true" continuedAt="F_06ec4875-7ba3-46cd-931c-8bb5ea46be56_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pay Versus Performance</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provided below is our pay versus performance disclosure as required pursuant to Item 402(v) of Regulation S-K promulgated under the Exchange Act. As required by Item 402(v), we have included:</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_06ec4875-7ba3-46cd-931c-8bb5ea46be56_1" continuedAt="F_06ec4875-7ba3-46cd-931c-8bb5ea46be56_2"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of our most important measures that our Compensation Committee used in fiscal year 2025 to link a measure of pay calculated in accordance with Item 402(v) (referred to as compensation actually paid, or CAP) to our performance; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A table that compares the total compensation of our named executive officers&#8217; (also known as NEOs) as presented in the Summary Compensation Table (SCT) to CAP and that compares CAP to specified performance measures; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Graphs that describe:</span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the relationships between CAP and our cumulative total shareholder return (TSR), GAAP Net Income and our selected measure, Total Cash (defined as all cash and cash equivalents); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the relationship between our TSR and the TSR of the Nasdaq Biotechnology Index (Peer Group TSR).</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note: pursuant to Item 402(v)(8), Lite Strategy, as a smaller reporting company (SRC), has provided the information required by 402(v) for three years, instead of five years and is not required to provide the disclosure required by 402(v)(2)(iv) or 402(v)(5) with respect to the total shareholder return of any peer group, or our-Selected Measure disclosure required by 402 (v)(2)(vi), or the Tabular List provided pursuant to 402(v)(6).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given our current pay program, the only difference between the SCT and CAP amounts for our NEOs is the value of equity awards, which for purposes of the SCT is based on the grant date fair value of equity awards granted during the year and for purposes of CAP is based on the year over year change in the fair value of equity awards that are unvested as of the end of the year, or that vested, or were forfeited during the year.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Most Important Metrics Used for Linking Pay and Performance. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required by Item 402(v), below are the most important metrics linking CAP to performance for fiscal year 2025. Besides stock price, the only financial performance measure the Committee used to link executive compensation to performance in 2025 was Total Cash which is defined as total cash and cash equivalents on the consolidated balance sheets as of June 30, 2025.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation decisions are made each year taking into account a number of other factors. Target pay levels are primarily set based on clinical milestones, individual performance, scope of responsibility, and an annual assessment of pay competitiveness within the market, but aside from Total Cash and stock price, no additional financial performance measures were used by the Company to link compensation actually paid to our NEOs in fiscal year 2025 to our performance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pay Versus Performance Table</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In accordance with Item 402(v) and under rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the tabular disclosure for our Chief Executive Officer (our Principal Executive Officer or PEO) and the average of our NEOs other than the PEO for fiscal years 2023, 2024 and 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
     <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:96.0%;border-collapse:separate;margin-right:auto;">
      <tr style="visibility:collapse;">
       <td style="width:2.28%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.26%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.18%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.18%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:4.44%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.18%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.18%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.26%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.18%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.92%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:4.68%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:4.58%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
       <td style="width:5.68%;box-sizing:content-box;"/>
       <td style="width:1%;box-sizing:content-box;"/>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="5" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Value of Initial Fixed $100 Investment Based on Total Shareholder Return</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table for Total Current PEO<br/>(File)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Actually Paid to Current PEO<br/>(File)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table for Total Former PEO<br/>(Urso)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Actually Paid to Former PEO<br/>(Urso)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table for Total Former PEO<br/>(Gold)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Actually Paid to Former PEO<br/>(Gold)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Summary Compensation Table Total for Non-PEO<br/>NEOs</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Compensation Actually Paid to Non-PEO<br/>NEOs</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lite Strategy Total Shareholder Return</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Peer Total Shareholder<br/>Return</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(4)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lite Strategy Net (Loss) Income<br/>($ Millions)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Company Selected Measure: Total Cash ($Millions)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(5)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(d)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(e)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(f)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(h)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(i)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;">
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fbb24c6-102d-4a9e-b528-566b203be8d8" contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">912,667</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_efa2de60-439b-4500-a3f7-b43426cf6b06" contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">893,199</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13764353-6616-4e20-b300-13d349f6394e" contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">866,258</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2551e09c-7e1b-4d3c-b352-093299b9ca30" contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">615,372</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ecb21e4-6ac2-422a-9a55-4cdcf4e57e4e" contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">677,662</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52f2ec8a-9fad-4692-a9bc-4d639581d3af" contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">614,958</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78fa81dd-4c5c-4620-a95f-2a2249b74fac" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:TotalShareholderRtnAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_845ee64f-5f2b-4fdd-8eee-b63b8bb10f1e" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:PeerGroupTotalShareholderRtnAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">113</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87658232-02b8-41ea-bc96-13b2cc0a5e6b" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-6" sign="-" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36aae0d1-929b-4224-b556-ad9dc7c9ed93" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:CoSelectedMeasureAmt" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#cff0fc;word-break:break-word;">
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdef6975-eda0-46c8-8505-ee0af5821369" contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">894,905</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_658de52b-01c9-4880-ae8c-b6678ce9c2a8" contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">220,789</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_309d4f0d-44ca-4aa7-b532-c4aa2672483b" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">730,912</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84ee108f-76cd-4fec-8939-c6b61796dc08" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">558,052</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_813cdbb3-d3bc-4105-b0b3-3e000d154f8d" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:TotalShareholderRtnAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">31</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf93602e-6eb7-4984-b605-282f2990c967" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:PeerGroupTotalShareholderRtnAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">121</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ccbcc27e-659a-45fe-84d4-738c8cd1a3f9" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed3c60cd-7fc1-4241-ac2b-e8a0fa844627" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:CoSelectedMeasureAmt" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">38</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;">
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23906535-b6e6-4e01-8a84-c8fbea7cca6e" contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">2,101,058</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72bf4207-c5bf-4e8f-a567-ed15bc3bb318" contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,721,979</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_798af036-556d-4df9-8a5f-111bb4eb220e" contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">2,446,640</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_504a088d-23a3-4cfa-a92d-fdff6b1ae5da" contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,857,113</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_454c4a97-f809-4376-a469-cfd41d4ce89b" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">772,486</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9dd03e5-b42f-4127-8150-5e3939c659c0" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">642,744</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_271234ef-aff4-4503-8b84-e964f5a12c0a" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:TotalShareholderRtnAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">54</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9a675ff-242e-495c-8bb3-6b18e097da38" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:PeerGroupTotalShareholderRtnAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">109</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3f9f477-9299-440e-b338-84956a009d81" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-6" sign="-" format="ixt:num-dot-decimal">32</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_293cf8f5-cb83-4e4b-955d-36c55f90de4f" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:CoSelectedMeasureAmt" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">101</ix:nonFraction></span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
     </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PVP table reflects required disclosures for fiscal years 2023, 2024 and 2025. The following table reflects our Principal Executive Officer (PEO) and non-PEO NEOs in each of the fiscal years presented:.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5140fab0-2013-4a96-9e5f-8f0b200a5969" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:NamedExecutiveOfficersFnTextBlock" escape="true">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:12.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:26.6%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:59.18%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PEO</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-PEO NEOs</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_446d7c70-4927-49c7-b355-5f93940b21aa" contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776" name="ecd:PeoName"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current) <br/></span><span style="font-size:8pt;"><ix:nonNumeric id="F_ba6bbcda-d133-4cca-b11d-4bbfb4068ed6" contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58" name="ecd:PeoName"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Former)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_0717132c-b610-4b62-9746-dcfbb73dadd2" contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0" name="ecd:PeoName"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File and Richard G. Ghalie</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_aaad0df8-3246-488e-9ef7-7c5074f98794" contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913" name="ecd:PeoName"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current)<br/></span><span style="font-size:8pt;"><ix:nonNumeric id="F_3e6f54dc-0754-40d0-8e80-f39d6be7ec73" contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b" name="ecd:PeoName"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Daniel P. Gold</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Former)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Brian G. Drazba and Richard G. Ghalie</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div><ix:nonNumeric id="F_883e1701-9b90-4962-894a-41c759b15c53" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:Additional402vDisclosureTextBlock" escape="true"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.</span></div></div></ix:nonNumeric></div><div><ix:nonNumeric id="F_e2216ef8-b3b9-4f11-b501-6db5fa7e0853" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:AdjToPeoCompFnTextBlock" escape="true" continuedAt="F_e2216ef8-b3b9-4f11-b501-6db5fa7e0853_1"><ix:nonNumeric id="F_5a3bff3d-41b8-4b5f-8804-0ee20a406652" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:AdjToNonPeoNeoCompFnTextBlock" escape="true" continuedAt="F_5a3bff3d-41b8-4b5f-8804-0ee20a406652_1"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div></ix:nonNumeric></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:9pt;font-family:Times New Roman;"><ix:continuation id="F_06ec4875-7ba3-46cd-931c-8bb5ea46be56_2"><div style="font-size:9pt;font-family:Times New Roman;"><ix:continuation id="F_e2216ef8-b3b9-4f11-b501-6db5fa7e0853_1"><ix:continuation id="F_5a3bff3d-41b8-4b5f-8804-0ee20a406652_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.306%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:7.479%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:7.479%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:7.738%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current PEO (File)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b9180a8-cf71-43f2-a125-eeaf5d08701d" contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">912,667</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bf054b1-fb72-4007-a8c4-62a2f1ca8109" contextRef="C_7d0e8349-e426-46da-ab51-1707c24a1af7" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">15,787</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb311044-83e8-443c-8015-a7ff3e0d08b5" contextRef="C_37467610-00f1-43d7-b2ec-970dbeaab385" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">3,681</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57487e2e-e479-46dc-83b1-fe9556d6fc93" contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">893,199</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Urso)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3156ec40-2203-4741-8e45-847123b66064" contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">2,101,058</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a6bc536-70bc-4b66-b2fe-956ee7ddfb80" contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">894,905</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b748c40-503f-4058-b6ac-1db4f247e011" contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">866,258</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76668768-4062-4574-b306-6a86d1d723b0" contextRef="C_45f6bbd9-6d25-4221-88e3-beeb4bcc1f68" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">1,352,600</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c4d0691-69cb-41d5-97d4-af88226d19a0" contextRef="C_5da12cd1-97de-4b4d-b577-ec7e3184e27c" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,097,045</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba805486-0f52-4834-a8fa-2fc36c809c88" contextRef="C_89a3be5d-5e0b-4c67-94dd-9a9af04f8589" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">70,864</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b523756-5aae-4a38-81e2-712d019406d9" contextRef="C_32364034-e8a2-411c-b37e-a487f90ff512" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">511,128</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4982a5e8-1ba7-4bec-9208-c9f37f0f7c2f" contextRef="C_a389e895-814a-41cb-8aac-4d799cc61fe6" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">52,660</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c98318c2-8297-4a15-9fc8-cb615bf6b450" contextRef="C_3f481bc3-5122-47d6-b340-52e2c78f1b31" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">162,988</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92ad1c51-034b-46ef-b406-5fb462e7b228" contextRef="C_28d2a101-457d-43c9-9dbe-68711aac1f9d" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,757</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae18fdf3-ca4c-426c-ae30-e08972ef42a7" contextRef="C_f3472b73-4e34-47a0-be62-77eed918f8bc" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">252,643</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44081d8f-4de1-42e4-8bc0-892f8f2c4d44" contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,721,979</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3388f73d-978d-4eed-95ff-4bb2d83c602d" contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">220,789</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c39ad00-7876-4cb5-a9c1-ede58eb390b7" contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">615,372</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d9b111a-46bc-4722-a27c-bf5a6f4cbacc" contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b" name="ecd:PeoTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">2,446,640</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18d97c99-07e7-42ce-bc1d-971b69576101" contextRef="C_dfabb534-74be-4288-92af-5556895040ee" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">584,700</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2889bd38-612a-4ca0-b3a3-0a550ac1acb2" contextRef="C_d2e5d3c1-839a-4550-89aa-0ed3da951bff" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">193,830</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdf481db-4538-4b3f-b12d-9d99b9bce529" contextRef="C_3d482d2c-7007-47bd-bd9f-a3222d384265" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">130,139</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21ec85eb-9743-4ac1-af5e-c47bcd250a98" contextRef="C_60c2b2ea-9737-4be7-9d43-b2cdb939b23d" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">68,518</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78130aaf-a6e5-4fdb-ab16-9ba15994e4ed" contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b" name="ecd:PeoActuallyPaidCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,857,113</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Non-PEO(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0c6b484-bc76-4af9-81d4-03cd63b6eb28" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">772,486</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fde3da9-1602-488d-8ada-700c84fd7404" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">730,912</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32f42cec-688e-4aa0-85f3-4bc23c6395bb" contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">677,662</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e3d1c52-9159-49ef-906a-75c8e82fece7" contextRef="C_85f05b2c-f599-4c78-bc7d-791065172d82" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">177,850</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3481d4b-0300-44d1-88b0-954aaecdc5ef" contextRef="C_eb963958-2863-459f-bc33-6b787def5d3b" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">79,900</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ceaf5d28-eca9-4a98-b17e-0ab72e69c54c" contextRef="C_9d600850-46b8-413c-9e85-0dc26debca2e" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">104,625</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49cdaca8-a33e-4861-bddf-a5cd8b87c6e4" contextRef="C_9f90a9a5-a66d-4313-8307-9321f5ab31b2" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">28,797</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08cbcd76-540e-40d6-8896-bfc8954ac03f" contextRef="C_7bc39535-b788-4030-8e06-f7b6e0eac901" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">32,041</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1376c0e4-1afc-4d89-a882-767fc6a92064" contextRef="C_d31b2e6f-0ff1-46fd-864d-d501e482dc79" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">93,289</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37708eb0-00a1-467d-afaa-7c0787ac293e" contextRef="C_6b9d4b1e-ad8f-4235-877b-c5777163e5ac" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">24,476</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9e4525e-32bd-4204-8907-30138429f6ca" contextRef="C_7fd455f4-c990-45c2-b727-b3da37aaffb0" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">28,468</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e5cf73-5c7b-4b46-a0f0-8802236ef6f0" contextRef="C_fcab84f5-286d-44a9-a098-875d5677014f" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">154</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a31ed3c4-e0f5-4e6d-a870-521b6ef16ca6" contextRef="C_967fee19-8d30-4bd1-968e-c52107261bbc" name="ecd:AdjToCompAmt" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">62,858</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad6a9e25-d13b-453e-b960-8f9463adb0af" contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">642,744</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58c262fb-56e8-43d3-8ef9-b2d2b560b918" contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">558,052</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0dfeb70-463e-467f-823b-59e6a8dc2d03" contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">614,958</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></ix:continuation></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_282910e8-7e11-4bfa-b030-76a1a0538953" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:PeerGroupIssuersFnTextBlock" escape="true"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilized in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the fiscal year ended June 30, 2019. As a SRC, we do not have to provide and have not provided, this stock performance graph in subsequent annual reports. The comparison assumes $100 was invested for the period starting June 30, 2022, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. </span></div></div></ix:nonNumeric></div><div style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7f7847e7-2102-473e-a93d-544de41b7de0" contextRef="C_db6f4ce3-b159-4f84-a6ec-7529098c2c22" name="ecd:NonGaapMeasureDescriptionTextBlock" escape="true"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We determined </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5afde0a5-9e4d-48a3-af28-4bc45e35a1fc" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:CoSelectedMeasureName"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total Cash</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Total Cash is defined as total cash and cash equivalents. </span></div></div></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_15250011-9efa-46ae-8547-058ca986e146" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" escape="true"><ix:nonNumeric id="F_c1db31c4-165e-4229-b891-7c13fbd6b924" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and TSR</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><img src="img155424085_11.jpg" alt="img155424085_11.jpg" style="width:609px;height:286px;"/></p></ix:nonNumeric></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_10001570-7ac4-40dc-b137-a15d426417da" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and GAAP Net Income (Loss)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP and our GAAP Net Income (Loss).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_12.jpg" alt="img155424085_12.jpg" style="width:531px;height:286px;"/></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_26b24806-ad4f-4e7c-91a1-07f9e9e7c075" contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and Total Cash (our Selected Measure).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The chart below reflects the relationship between the PEO CAP and average non-PEO NEO CAP and our Total Cash.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img155424085_13.jpg" alt="img155424085_13.jpg" style="width:525px;height:287px;"/></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation of Directors</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides details of the fees paid to our non-executive directors who served on the Board for the fiscal year ended June 30, 2025.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.42%;box-sizing:content-box;"/>
     <td style="width:1.46%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.48%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.46%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:13.24%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.46%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.48%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fees Earned or Paid in Cash ($) (1)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">OptionAwards($)(2)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total($)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Charles V. Baltic III  (3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,654</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,654</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frederick W. Driscoll (4)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98,530</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98,530</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nicholas R. Glover, Ph.D. (5)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,600</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,600</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas C. Reynolds, M.D., Ph.D. (6)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Taheer Datoo (7)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,915</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,915</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">James Flynn (8)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,304</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,304</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Steven Wood (9)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)       For the fiscal year ended June 30, 2025, each of our non-executive directors received an annual cash retainer of $45,600. In addition to the annual cash retainer, the chair received additional annual compensation of $35,000 and each Board Committee chair received additional compensation as follows: Audit Committee: $20,000; Compensation Committee: $15,000; and Nominating and Governance Committee: $10,000. Committee members not receiving compensation as a committee chairperson received additional compensation as follows: Audit Committee: $10,000; Compensation Committee: $7,500 and Nominating and Governance Committee: $5,000. Such amounts are pro-rated for periods of service less than the full fiscal year.</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Represents the aggregate grant date fair value of options granted in accordance with FASB ASC Topic 718. No stock options were granted to non-employee directors during fiscal year 2025. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Baltic resigned as chair of our Board effective July 22, 2024 and received pro-rated cash compensation of $5,654 in connection with his service as chair of the Board.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Driscoll became the chair of our Board as of July 22, 2024. He received cash compensation of $78,530 in connection with his service as chair of our Board and $20,000 in connection with his service as the chair of the Audit Committee.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Glover received cash compensation of $45,600 in connection with his service on the Board, $15,000 in connection with his service as chair of the Compensation Committee and $10,000 in connection with his service on the Audit Committee.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Reynolds received cash compensation of $45,600 in connection with his service on the Board, $7,500 in connection with his service on the Compensation Committee and $10,000 in connection with his service as chair of the Nominating and Governance Committee.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(7)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Datoo received cash compensation of $45,600 in connection with his service on our Board and $5,000 in connection with his service on the Nominating and Governance committee. Mr. Datoo also received $19,315 as the cash equivalent of the vested grant date fair value of options granted in accordance with FASB ASC Topic 718.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(8)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Flynn received cash compensation of $45,600 in connection with his service on our Board, $10,000 in connection with his service on the Audit Committee and $4,704 in connection with his service on the Nominating and Governance Committee.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(9)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Wood received waived all compensation associated with his service on our Board for fiscal year 2025.</span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indemnification Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into an indemnification agreement with each of our directors and executive officers. Subject to certain exceptions, the indemnification agreements provide that an indemnitee will be indemnified for all expenses incurred or paid by the indemnitee in connection with a proceeding to which the indemnitee was or is a party, or is threatened to be made a party, by reason of the indemnitee&#8217;s status with or service to us or to another entity at our request. In connection with proceedings other than those by or in the right of our company and to which the indemnitee was or is a party, or is threatened to be made a party, by reason of the indemnitee&#8217;s status with or service to us or to another entity at our request, the indemnification agreements provide that an indemnitee will also be indemnified for all liabilities incurred or paid by the indemnitee. The indemnification agreements also provide for advancement of expenses incurred by an indemnitee in connection with an indemnifiable claim, subject to reimbursement in certain circumstances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rights of each indemnitee are in addition to any other rights provided for under our amended and restated certificate of incorporation and our amended and restated by-laws, as may be amended from time to time, and under Delaware law.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_20"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth information with respect to the beneficial ownership of shares of our common stock as of September 23, 2025 (except as otherwise indicated below) by (i) each person known to beneficially own more than 5% of our common stock, (ii) each of our named executive officers and directors and (iii) our officers and directors as a group. Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to options, warrants or restricted stock units, exercisable or convertible on or within sixty (60) days of September 23, 2025, are deemed outstanding. Such shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. The percentage of beneficial ownership described below is based on 35,655,155 shares of common stock outstanding, plus adjustments to the number of shares of common stock outstanding as described above, as of September 23, 2025.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.56%;box-sizing:content-box;"/>
     <td style="width:1.18%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:21.16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.18%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:18.72%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:4.2%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name and Address of Beneficial Owner</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount &amp; Nature of Beneficial Ownership</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Percentage of Shares Beneficially Owned</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Alexander Schornstein (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,365,472</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.24</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Citadel CEMF Investments Ltd (2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,561,950</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GSR Growth Investments LP</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,779,192</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Directors and Named Executive Officers</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File (3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,203</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frederick W. Driscoll (4)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,916</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nicholas R. Glover, Ph.D. (5)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,375</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas C. Reynolds, M.D., Ph.D. (6)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,875</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">James Flynn (7)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,989</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Charles B. Lee (8)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,397</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joshua Riezman (9)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">833</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie (10)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90,908</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All Current Directors and Executive Officers as <br/>&#160;&#160;&#160;&#160;a Group (9 People)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">619,496</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.74</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
   </table><p style="margin-left:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Less than 1%</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based upon information contained in Amendment No. 1 to Schedule G filed by Alexander Schornstein on September 10 2025. Mr. Schornstein has sole voting and dispositive power as to the shares. The principal address is Kaiser-Friedrich-Allee 2, 52074 Aachen, Germany 004915142314669.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based upon information contained in Schedule G filed by Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Securities GP LLC and Kenneth Griffin on July 29, 2025, shares beneficially owned consists of (i) 3,167,695 shares of common stock held directly, with respect to which each Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC have shared voting and dispositive power, (ii) 78,193 shares of common stock held directly, with respect to which each Citadel Securities LLC, Citadel Securities Group LP and Citadel Securities GP LLC have shared voting and dispositive power. Mr. Griffin has shared voting and dispositive power for the total 3,245,888 shares of common stock. This number also includes 242,039 shares underlying Pre-Funded Warrants that are immediately exercisable based on our records after giving effect to a beneficial ownership blocker in such warrants which prohibits the holder from beneficially owning more than 9.99% of the outstanding shares of our common stock, with respect to which each Citadel Securities LLC, Citadel Securities Group LP and Citadel Securities GP LLC have shared voting and dispositive power. The shares are held of record by Citadel CEMF Investments Ltd. and Citadel Securities. The principal address is 830 Brickell Plaza, Miami, Florida 33131.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 52,203 shares issuable to Mr. File upon the exercise of vested stock options that are exercisable within 60 days of September 23, 2025. Mr. File exercises sole voting and investment control with respect to the shares. Mr. File's business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 45,041 shares issuable to Mr. Driscoll upon the exercise of stock options that are exercisable within 60 days of September 23, 2025, and 1,875 shares of common stock. Mr. Driscoll exercises sole voting and investment control with respect to the shares. Mr. Driscoll&#8217;s business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 47,375 shares issuable to Dr. Glover upon the exercise of stock options that are exercisable within 60 days of September 23, 2025. Dr. Glover&#8217;s business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 47,735 shares issuable to Dr. Reynolds upon the exercise of stock options that are exercisable within 60 days of September 23, 2025, and 500 shares of common stock. Dr. Reynolds exercises sole voting and investment control with respect to the shares. Dr. Reynolds&#8217; business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(7)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 33,089 shares issuable to Mr. Flynn upon the exercise of stock options that are exercisable within 60 days of September 23, 2025, and 7,900 shares of common stock. Mr. Flynn exercises sole voting and investment control with respect to the shares. Mr. Flynn&#8217;s business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(8)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 292,397 shares of common stock. Mr. Lee exercises sole voting and investment control with respect to the shares. Mr. Lee's business address is c/o Lite Strategy, Inc. 9920 Pacific Heights Blvd. Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(9)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 833 shares issuable to Mr. Riezman upon the exercise of stock options that are exercisable within 60 days of September 23, 2025. Mr. Riezman exercises sold voting and investment control with respect to the shares. Mr. Riezman's business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(10)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 89,462 shares issuable to Dr. Ghalie upon the exercise of stock options that are exercisable within 60 days of September 23, 2025, and 1,446 shares of common stock. Dr. Ghalie exercises sole voting and investment control with respect to the shares. Dr. Ghalie&#8217;s business address is c/o Lite Strategy, Inc., 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delinquent Section 16(a) Reports</span></p><p style="text-indent:5.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_21"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. Certain Relationships and Related Transactions and Director Independence</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were no related party transactions required to be disclosed pursuant to Item 404 of the Regulation S-K during the two years ended June 30, 2025.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As previously disclosed in the Company&#8217;s Current Report on Form 8-K dated August 6, 2025, the Board approved the appointment of Joshua Riezman to the Board on August 5, 2025 pursuant to a Side Letter (the &#8220;Side Letter&#8221;) with GSR Strategies LLC (&#8220;GSR&#8221;) entered into in connection with the PIPE on July 22, 2025. Pursuant to the Side Letter, GSR, a Purchaser in the PIPE, had the right to nominate one person to serve on the Board. In accordance with the Side Letter, Mr. Riezman was appointed to the class of directors who will be up for reelection at the Company&#8217;s annual meeting of stockholders for fiscal 2026.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In connection with the PIPE, the Company entered into an Advisory Agreement (the &#8220;Advisory Agreement&#8221;) with Green Dragon Investments LLC (&#8220;Green Dragon&#8221;). Charlie Lee, who was appointed as a member of the Board and serves in the class of directors who will be up for reelection at the Company&#8217;s annual meeting of stockholders for fiscal 2027, is a beneficiary of Green Dragon. Pursuant to the Advisory Agreement, Green Dragon provides the Company with asset management services and the Company pays Green Dragon a fee in warrants to purchase a number of shares of the common stock calculated based on the amount of assets under management.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_22"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principal Accountant Fees and Services.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee has selected Deloitte &amp; Touche LLP (Deloitte) as independent registered public accounting firm to audit the financial statements of Lite Strategy for the fiscal year ending June 30, 2025. The Board is submitting the appointment of Deloitte to the stockholders for ratification as a matter of good corporate practice.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Representatives of Deloitte are expected to attend the Annual Meeting. The Deloitte representatives will have an opportunity to make a statement at the meeting and are expected to be available to respond to appropriate questions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fees Paid to Independent Registered Public Accounting Firm</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our independent registered public accounting firm is Deloitte &amp; Touche LLP (Deloitte) Auditor Firm ID: 34.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table represents the aggregate fees from our principal accounting firm, Deloitte for the fiscal years ended June 30, 2025 and 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:67.634%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.963%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.963%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit Fees (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">579,711</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">528,525</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit-Related Fees</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax Fees (2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">All Other Fees</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Fees</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">579,711</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">528,525</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Fees relate to professional services rendered in connection with the audit of our annual consolidated financial statements, quarterly review of consolidated financial statements included in our Quarterly Reports on Form 10-Q and audit services provided in connection with other statutory and regulatory filings, including providing consents for inclusion of their opinion in registration statements filed with the Securities and Exchange Commission and comfort letters in connection with sales of securities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tax Fees consist of fees for professional services related to tax compliance and advice.</span></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Approval Policies and Procedures</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee has adopted a policy and procedure for pre-approving all audit and non-audit services to be performed by our independent auditors. The policy requires pre-approval of all services rendered by our independent auditors either as part of the Audit Committee&#8217;s approval of the scope of the engagement of the independent auditors or on a case-by-case basis.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="d58841d10k_htm_toc58841_23"><span id="fis_part_iv"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV</span><span id="fis_exhibits"></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_24"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits, Financial Statement Schedules</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Consolidated Financial Statements</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reference is made to the Consolidated Financial Statements under </span><a href="#d58841d10k_htm_toc58841_13"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Item 8. Consolidated Financial Statements and Supplementary Data</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in Part II hereof.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Financial Statement Schedules</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Financial Statement Schedules have been omitted either because they are not required or because the information has been included in the consolidated financial statements or the notes thereto included in this Annual Report on Form 10-K.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_exhibit_index"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Exhibits</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit Index</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:38.808%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:11.222%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:12.242%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:10.202%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:13.263%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td colspan="7" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference Herein</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Schedule/</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="lits-ex3_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation of Lite Strategy, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017023072612/meip-ex3_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Sixth Amended and Restated Bylaws of MEI Pharma, Inc. adopted as of December 18, 2023</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 22, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095012303012005/y90124a1exv4w1.txt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen Stock Certificate</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-109129</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 31, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312518165462/d586784dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 16, 2018</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312520242169/d58841dex43.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of Capital Stock of MEI Pharma, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 9, 2020</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017023049927/meip-ex4_4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of MEI Common Stock</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex4-1.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex4-2.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Placement Agent Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex4-3.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of GSR Pre-Funded Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex4-4.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of GSR Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex4-5.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Advisory Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex4-6.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Strategic Advisor Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.11</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017023049927/meip-ex10_22.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Warrant</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 23, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1&#134;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017024056834/meip-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (December 2023)</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2024</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:38.808%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:11.222%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:12.242%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:10.202%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:13.263%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2&#134;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312511235271/dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 29, 2011</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3**</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312517336509/d445348dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">License Agreement, dated as of September 5, 2017, by and between MEI Pharma, Inc. and Presage Biosciences, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 8, 2017</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4**</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312519030835/d656704dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">License, Development and Commercialization Agreement, dated as of October 31, 2018, by and between the Company and Kyowa Hakko Kirin Co., Ltd., now known as Kyowa Kirin Company</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 7, 2019</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5+</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312520242169/d58841dex1018.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">License, Development and Commercialization Agreement, dated as of April 13, 2020, by and between the Company and Kyowa Kirin Co., Ltd. (formerly known as Kyowa Hakko Kirin Co., Ltd.)</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2, 2021</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6&#134;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312523166013/d516259dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employee Proprietary Information and Inventions Agreement between MEI Pharma, Inc. and Justin J. File, dated June 9, 2023</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">June 13, 2023</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:38.808%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:11.222%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:12.242%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:10.202%;box-sizing:content-box;"/>
     <td style="width:1.02%;box-sizing:content-box;"/>
     <td style="width:13.263%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7&#134;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017025035544/meip-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Employment Agreement between MEI Pharma, Inc. and Justin J. File, dated March 3, 2025</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 7, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8&#134;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312523166013/d516259dex103.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated MEI Pharma, Inc. 2021 Inducement Grant Equity Compensation Plan</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">June 13, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000119312523189610/d529233dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Termination Agreement, by and between MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. (formerly known as Kyowa Hakko Kirin Co., Ltd.) dated as of July 14, 2023</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">000-50484</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 19, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017024125328/meip-ex10_4.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consulting Services Agreement, dated as of August 2, 2024, by and between MEI Pharma, Inc. and Richard G. Ghalie</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 12, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-1.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Securities Purchase Agreement, dated as of July 17, 2025, by and between MEI Pharma, Inc. and each Purchaser (as defined therein)</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-2.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Placement Agency Agreement, dated July 17, 2025, by and between MEI Pharma, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-3.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Registration Rights Agreement, dated July 17, 2025, by and between MEI Pharma, Inc. and each Purchaser (as defined therein)</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-4.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Asset Management Agreement, dated July 22, 2025, by and between MEI Pharma, Inc. and GSR Strategies LLC</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-5.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Side Letter Agreement, dated July 22, 2025, by and between MEI Pharma, Inc. and GSR Strategies LLC</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-6.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Advisory Agreement, dated July 22, 2025, by and between MEI Pharma, Inc. and Green Dragon Investments LLC</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000114036125026773/ef20052363_ex10-7.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Strategic Advisor Agreement, dated July 22, 2025, by and between Green Grass Ventures</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22,2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000092963825003398/exhibit10-1.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Master Loan Agreement, dated September 3, 2025, between BitGo Prime and MEI Pharma, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-418247</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 4, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="lits-ex19_insider.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="lits-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Deloitte &amp; Touche LLP Independent Registered Public Accounting Firm</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="lits-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive and Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1*</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="lits-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C 1350).</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1262104/000095017024108185/meip-ex97.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">MEI Pharma, Inc. Clawback Policy</span></a></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-41827</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 19, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101INS</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File &#8211; the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the XBRL document.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:91%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Filed herewith</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">**</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Portions of this exhibit have been redacted pursuant to a confidential treatment request filed with the Securities and Exchange Commission.</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">+</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Portions of this exhibit have been omitted in accordance with Item 601(a)(6) and Item 601(b)(10) of Regulation S-K because such information (i) is not material and (ii) is the type that the registrant treats as private or confidential.</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Each marked exhibit is a management contract or a compensatory plan, contract or arrangement in which a director or executive officer of the registrant participates or has participated.</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="d58841d10k_htm_toc58841_25"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16. Form 10-K Summary</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.25in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused report to be signed on its behalf by the undersigned, thereunto duly authorized, on September 26, 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:43.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:7.319%;box-sizing:content-box;"/>
     <td style="width:2.719%;box-sizing:content-box;"/>
     <td style="width:89.962%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="3" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.519%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lite Strategy, Inc.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Justin J. File</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acting Chief Executive Officer,<br/>Chief Financial Officer and Secretary<br/>September 26, 2025</span></p></td>
    </tr>
   </table><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:42.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:16.8%;box-sizing:content-box;"/>
     <td style="width:2.38%;box-sizing:content-box;"/>
     <td style="width:78.14%;box-sizing:content-box;"/>
     <td style="width:2.68%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Signatures</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Justin J. File</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acting Chief Executive Officer, Chief Financial Officer and Secretary (Principal Executive Officer, Principal Financial and Accounting Officer)</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Thomas C. Reynolds</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas C. Reynolds</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Nicholas R. Glover</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nicholas R. Glover</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ James Flynn</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">James Flynn</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Frederick W. Driscoll</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frederick W. Driscoll</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Charles B. Lee</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Charles B. Lee</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.625pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Joshua Riezman</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joshua Riezman</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_exhibit_4"><span id="d58841dex43_htm"></span><span id="eolpage75"></span>&#160;</p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.25in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>lits-ex3_1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-09-26T15:24:36.0414+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-3.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 3.1</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:46pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATE OF AMENDMENT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MEI PHARMA, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	MEI Pharma, Inc., a corporation organized and existing under the laws of the State of Delaware (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), hereby certifies as follows:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The name of the Corporation is MEI Pharma, Inc. and the corporation was originally incorporated under the name, Marshall Edwards, Inc.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Article I</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Certificate of Incorporation of the Corporation is hereby amended and restated in its entirety to read as follows:</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;I.  The name of the corporation (hereinafter referred to as the &#x201c;Corporation&#x201d;) is Lite Strategy, Inc.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The future effective time of the foregoing amendment is 12:01 a.m. on September 10, 2025.</font></div></div><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">That the foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">[Signature page follows]</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Corporation has caused this certificate to be signed by an officer of the Corporation this 2nd day of September, 2025.</font></p><p style="text-indent:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MEI PHARMA, INC.</font></p><p style="text-indent:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Justin J. File			</font></p><p style="text-indent:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	Name: Justin J. File</font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title: Acting Chief Executive Officer, Chief Financial Officer and Secretary</font></p><p style="text-indent:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.107%;padding-left:0.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MEI PHARMA, INC.</font></p><p style="font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.347%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MEI PHARMA, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware, which was originally incorporated under the name, Marshall Edwards, Inc. (the &#x201c;Corporation&#x201d;), does hereby certify as follows:</font></p><p style="margin-left:4.347%;font-size:10pt;margin-top:4.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIRST</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Upon the filing and effectiveness (the &#x201c;Effective Time&#x201d;) of this Certificate of Amendment pursuant to the Section 242 of the General Corporation Law of the State of Delaware, each twenty (20) shares of the Common Stock, issued and outstanding (or held in treasury) immediately prior to the Effective Time (the &#x201c;Old Common Stock&#x201d;) shall automatically without further action on the part of the Corporation or any holder of Old Common Stock, be reclassified, combined, converted and changed into one (1) fully paid and nonassessable share of common stock, par value of $0.00000002 per share (the &#x201c;New Common Stock&#x201d;), subject to the treatment of fractional share interests as described below (the &#x201c;Reverse Stock Split&#x201d;). The conversion of the Old Common Stock into New Common Stock will be deemed to occur at the Effective Time. No fractional shares will be issued, and, stockholders otherwise entitled to receive fractional shares shall have no further interest as a stockholder with respect to such fractional shares. Stockholders of record who otherwise would be entitled to receive fractional shares in connection with such combination will instead be entitled to receive, in lieu of such fractional shares, an amount in cash equal to the fraction to which the stockholder would otherwise be entitled multiplied by the closing price of our Common Stock on the Nasdaq Capital Market on the date on which the Effective Time occurs. Each stock certificate or book-entry position that, immediately prior to the Effective Time, representing shares of Old Common Stock shall, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of shares of New Common Stock after the Effective Time into which the shares of Old Common Stock have been reclassified pursuant to this paragraph, until the same shall be surrendered to the Corporation. The Reverse Stock Split shall also apply to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Old Common Stock of the Corporation and all references to the Old Common Stock in agreements, arrangements, documents and plans relating thereto or any option or right to purchase or acquire shares of Old Common Stock shall be deemed to be references to the New Common Stock or options or rights to purchase or acquire shares of New Common Stock, as the case may be.&#x201d;</font></p><p style="margin-left:4.347%;font-size:10pt;margin-top:4.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECOND</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The stockholders of the Corporation have duly approved the foregoing amendment in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</font></p><p style="margin-left:4.347%;font-size:10pt;margin-top:4.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly adopted and executed in its corporate name and on its behalf by its duly authorized officer as of April 14, 2023.</font></p><p style="font-size:10pt;margin-top:7.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MEI PHARMA, INC.</font></p><p style="margin-left:60%;font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:60%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By: /s/ Daniel P. Gold</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:60%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name: Daniel P. Gold</font></p><p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title: Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:0.053%;text-indent:-0.08%;padding-left:0.08%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">State of Delaware Secretary of State</font></p><p style="margin-left:0.053%;text-indent:-0.08%;padding-left:0.08%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Division of Corporations</font></p><p style="margin-left:0.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivered 04:15 PM 11/29/2018 FILED 04:15</font></p><p style="margin-left:0.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PM 11/29/2018</font></p><p style="margin-left:0.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SR 20187877521 - File Number 3323531</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:2.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MEI PHARMA, INC.</font></p><p style="font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I.	 The name of the corporation (hereinafter referred to as the &#x201c;Corporation&#x201d;) is MEI Pharma, Inc. The date of filing of the Corporation&#x2019;s original certificate of incorporation with the Secretary of State of the State of Delaware was December 1, 2000. The Corporation&#x2019;s original name, which was included in the original certificate of incorporation, was Marshall Edwards, Inc. The Corporation&#x2019;s name was changed to MEI Pharma, Inc., pursuant to the Certificate of Ownership and Merger filed with the Secretary of State of the State of Delaware on June 28, 2012 and effective on July 2, 2012.</font></p><p style="font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.36%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II.	  Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware (the &#x201c;DGCL&#x201d;), this Amended and Restated Certificate of Incorporation restates and integrates and further amends the Certificate of Incorporation of the Corporation, as heretofore amended or supplemented.</font></p><p style="font-size:10pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.373%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">III.	  This Amended and Restated Certificate of Incorporation was duly adopted in accordance with the provisions of Section 245 of the DGCL, the Board of Directors of the Corporation having duly adopted resolutions setting forth and declaring advisable the Amended and Restated Certificate of Incorporation, including said amendments, and thereafter, pursuant to resolution of the Board of Directors, a special meeting of the stockholders of the Corporation was duly called and held upon notice in accordance with Section 222 of the DGCL at which the number of shares as required by Section 242 of the DGCL approved such amendments.</font></p><p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.373%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IV.	  The Amended and Restated Certificate of Incorporation of the Corporation shall read as follows:</font></p><p style="font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.347%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIRST: The name of the Corporation is MEI Pharma, Inc.</font></p><p style="font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.347%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECOND: The address of the Corporation&#x2019;s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle. The name of its registered agent at such address is The Corporation Trust Company.</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.36%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THIRD: The total number of shares of all classes of stock which the Corporation shall have authority to issue is 226,100,000, consisting of (1) 100,000 shares of preferred stock, par value US$.01 per share (the &#x201c;Preferred Stock&#x201d;) and (2) 226,000,000 shares of common stock, par value US$.00000002 per share (the &#x201c;Common Stock&#x201d;).</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.373%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board of Directors of the Corporation is expressly authorized, by resolution or resolutions, to provide, out of the unissued shares of the Preferred Stock, for series of the Preferred Stock. Before any shares of any such series are issued, the Board of Directors shall fix, and is expressly empowered to fix, by resolution or resolutions, the following provisions of the shares thereof:</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) the designation of such series, the number of shares to constitute such series and the stated value thereof, if different from the par value</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">thereof&#x37e;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) whether the shares of such series shall have voting rights, in addition to any voting rights provided by law, and, if so, the terms of such voting rights (which may be special voting rights) and the preference or relation which such voting rights shall bear to the voting rights of any other class or any other series of this class&#x37e;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) the annual dividend rate (or method of determining such rate), if any, payable on such series, the conditions and dates upon which such dividends shall be payable, the preference or relation which such dividends shall bear to the dividends payable on any other class or any other series of this class&#x37e;</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) whether dividends on the shares of such series shall be cumulative, and, in the case of shares of a series having cumulative dividend rights, the date or dates (or method of determining the date or dates) from which dividends on the shares of such series shall be cumulative&#x37e;</font></p><p style="font-size:10pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) whether the shares of such series shall be subject to redemption by the Corporation and, if so, the times, prices and other conditions of such redemption&#x37e;</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) the amount or amounts payable upon shares of such series upon, and the rights of the holders of such series in, the voluntary or involuntary liquidation, dissolution or winding up of the Corporation&#x37e;</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) whether the shares of such series shall be subject to the operation of a retirement or sinking fund and, if so, the extent to and manner in which any such retirement or sinking fund shall be applied to the purchase or redemption of the shares of such series for retirement or other corporate purposes and the terms and provisions relative to the operation thereof&#x37e;</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) whether the shares of such series shall be convertible into, or exchangeable for, at the option of the holder or the Corporation or upon the happening of a specified event, shares of stock of any other class or of any other series of this class and, if so, the price or prices or the rate or rates of conversion or exchange and the method, if any, of adjusting the same&#x37e;</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) the limitations and restrictions, if any, to be effective while any shares of such series are outstanding upon the payment of dividends or the making of other distributions on, and upon the purchase, redemption or other acquisition by the Corporation of, the Common Stock, any other series of the Preferred Stock or any other class of capital stock&#x37e;</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(j) the conditions or restrictions, if any, upon the creation of indebtedness of the Corporation or upon the issue of any additional stock, including additional shares of such series or of any other series of the Preferred Stock or of any other class of capital stock&#x37e; and</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(k) any other powers, preferences or rights, or any qualifications, limitations or restrictions thereof.</font></p><p style="font-size:10pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:4.36%;font-size:10pt;margin-top:4.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise provided by such resolution or resolutions, all shares of the Preferred Stock shall be of equal rank. All shares of any one series of the Preferred Stock shall be identical in all respects with all other shares of such series, except that shares of any one series issued at different times may differ as to the dates from which dividends thereon shall be cumulative.</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.36%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOURTH: The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the DGCL.</font></p><p style="font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.36%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIFTH: The Board of Directors is expressly authorized to adopt, amend or repeal the By-Laws of the Corporation, subject to the reserved power of the stockholders to amend and repeal any By-Laws of the Corporation adopted by the Board of Directors.</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.347%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIXTH: Each person who at any time is or was an officer or director of the Corporation, and is or was threatened to be made a party to any threatened, pending or complete action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was an officer or director of the Corporation, or is or was serving at the request of the Corporation as an officer or director of another corporation, partnership, joint venture, trust or other enterprise, shall be indemnified against expenses (including attorneys&#x2019; fees) judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with any such action, suit or proceeding to the full extent permitted by Section 145 of the DGCL. The foregoing right of indemnification shall in no way be deemed exclusive of any other rights of indemnification to which such officer or director may be entitled under any statute, this Certificate of Incorporation, the By-Laws of the Corporation or any agreement, vote of stockholders or disinterested directors or otherwise.</font></p><p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEVENTH: No person who is or was a director of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director unless, and only to the extent that such director is liable (i) for any breach of the director&#x2019;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL or any amendment thereto or successor provision thereto, or (iv) for any transaction from which the director derived an improper personal benefit. This article shall not eliminate or limit the liability or a director for any act or omission occurring prior to the date when this article becomes effective. No amendment to, repeal or adoption of any provision of this Certificate of Incorporation inconsistent with this article shall apply to or have any effect on the liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment, repeal, or adoption of an inconsistent provision.</font></p><p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.413%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EIGHTH: Any and all right, title, interest and claim in or to any dividends declared by the Corporation, whether in cash, stock or otherwise, which are unclaimed by the stockholder entitled thereto for a period of six (6) years after the close of business on the payment date, shall be and be deemed to be extinguished and abandoned, and such unclaimed dividends in the possession of the Corporation, its transfer agents or other agents or depositaries, shall at such time become the absolute property of the Corporation, free and clear of any and all claims of any persons whatsoever.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.413%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.413%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NINTH: Whenever a compromise or arrangement is proposed between the Corporation and its creditors or any class of them and/or between the Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on application in a summary way of the Corporation or of any creditor or stockholder thereof, or on the application of any receiver or receivers appointed for the Corporation under Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver or receivers appointed for the Corporation under Section 279 of Title 8 of the Delaware Code, order a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the case may be, to be summoned in such manner as the said court directs. If a majority in number representing three- fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of the Corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">court to which the said application has been made, be binding on all the creditors or class of creditors, and/or on all the stockholders or class of stockholders, of the Corporation, as the case may be, and also on the Corporation.</font></p><p style="font-size:10pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENTH: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:8.547%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Number of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The total number of directors which shall constitute the whole Board of Directors shall be determined in accordance with the By-laws of the Corporation, but shall not be less than two (2) nor more than nine (9).</font></p><p style="font-size:10pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:8.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Classification of Board</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. (i) Subject to the rights of any holders of any series of Preferred Stock that may be issued by the Corporation pursuant to a resolution or resolutions of the Board of Directors providing for such issuance, the directors of the Corporation shall be divided into three classes with respect to the term of office, each class to contain, as near as may be possible, one-third of the whole number of the Board, with the terms of office of one class expiring each successive year. At each annual meeting of stockholders, the successors to the class of directors whose term expires at that time shall be elected by the stockholders to serve until the annual meeting of stockholders held three years next following and until their successors shall be elected and qualified.</font></p><p style="font-size:10pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:14.013%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) In the event of any intervening changes in the authorized number of directors, the Board of Directors shall designate the class or classes to which the increases or decreases in directorships shall be apportioned and may designate one or more directorships as directorships of another class in order more nearly to achieve equality of number of directors among the classes&#x37e; provided, however, that no such apportionment or redesignation shall shorten the term of any incumbent director.</font></p><p style="font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:8.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Vacancies</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to the limitations prescribed by law and this Restated Certificate of Incorporation, all vacancies in the office of director, including vacancies created by newly created directorships resulting from an increase in the authorized number of directors, may be filled only by a vote of a majority of the directors then holding office, although less than a quorum, or by a sole remaining director&#x37e; and any director so elected shall serve for the remainder of the full term of the class of directors in which the new directorship was created or the vacancy occurred and until such director&#x2019;s successor is duly elected and shall qualify or until such director&#x2019;s earlier resignation or removal.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:8.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment to this Paragraph</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In addition to any requirements of law or of any other provisions of this Restated Certificate of Incorporation, the affirmative vote of the holders of not less than eighty percent (80%) of the total number of votes eligible to be cast by the holders of all outstanding shares of capital stock entitled to vote thereon shall be required to amend, alter, rescind or repeal any provision of this Article TENTH.</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:8.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written Ballo</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t. Unless and to the extent that the By-Laws so provide, elections of directors need not be by written ballot.</font></p><p style="font-size:10pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[SIGNATURE PAGE FOLLOWS.]</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:4.347%;font-size:10pt;margin-top:4.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, MEI Pharma, Inc. has caused this Amended and Restated Certificate of Incorporation to be signed by its President this 29th day of November, 2018.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:52.63%;border-spacing:0;table-layout:auto;width:39.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:2.44%;box-sizing:content-box;"></td>
     <td style="width:97.56%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.139%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MEI Pharma, Inc.</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:10.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Daniel P. Gold</font></p></td>
    </tr>
    <tr style="height:10.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Daniel P. Gold</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and CEO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.INSIDER
<SEQUENCE>3
<FILENAME>lits-ex19_insider.htm
<DESCRIPTION>EX-19.INSIDER
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-09-26T15:24:36.0865+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-19.Insider</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 19</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><img src="img160360374_0.jpg" alt="img160360374_0.jpg" style="width:87px;height:87px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">BACKGROUND</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The board of directors of MEI Pharma, Inc. (the &#x201c;Company&#x201d; or &#x201c;MEI Pharma&#x201d;) has adopted this Insider Trading Policy (the &#x201c;Policy&#x201d;) for our directors, officers, employees and consultants (collectively, &#x201c;Insiders&#x201d;) with respect to the trading of the Company&#x2019;s securities, as well as the securities of publicly traded companies with whom we have a relationship.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Federal and state securities laws prohibit the purchase or sale of a company&#x2019;s securities by persons who are aware of material information about the company that is not generally known or available to the public. These laws also prohibit persons who are aware of such material nonpublic information from disclosing this information, directly or indirectly, to others who may trade. Companies and their controlling persons are also subject to liability if they fail to take reasonable steps to prevent insider trading by company personnel.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">It is important that you understand the breadth of activities that constitute illegal insider trading and the consequences, which can be severe. Both the U.S. Securities and Exchange Commission and the Nasdaq Stock Market, investigate and are very effective at detecting insider trading.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The SEC, together with the U.S. Attorneys, pursue insider trading vigorously. Cases have been successfully prosecuted against trading by employees at all levels through foreign accounts, trading by family members and friends and trading involving only a small number of shares.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This Policy is designed to prevent insider trading or allegations of insider trading, and to protect</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">MEI Pharma&#x2019;s reputation for integrity and ethical conduct. It is your obligation to understand and comply with this Policy. Should you have any questions regarding this Policy, please contact the Company&#x2019;s Chief Financial Officer, at 858-369-7111 or the Company&#x2019;s Compliance Officer by e-mail at </font><font style="color:#365f91;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Compliance@MEIPharma.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PENALTIES FOR NONCOMPLIANCE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Civil and Criminal Penalties. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Potential penalties for insider trading violations include (1)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Imprisonment, (2) criminal fines and (3) civil fines of up to 3 times the profit gained, or loss avoided.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Controlling Person Liability. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If MEI Pharma fails to take appropriate steps to prevent illegal insider trading, the Company may have &#x201c;controlling person&#x201d; liability for a trading violation, with civil penalties of up to the greater of a significant fixed monetary penalty amount or 3 times the profit gained or loss avoided, as well as a significant criminal penalty fine. The civil penalties can extend personal liability to MEI Pharma&#x2019;s directors, officers and other supervisory personnel, if they fail to take appropriate steps to prevent insider trading.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  March 18, 2022</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Company Sanctions. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Failure to comply with this Policy may also subject you to MEI Pharma imposed sanctions, including dismissal for cause, whether or not your failure to comply with this Policy results in violations of law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">SCOPE OF POLICY</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Persons Covered. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">As a director, officer, employee or consultant of MEI Pharma or its subsidiary, this Policy applies to you. The same restrictions that apply to you apply to your family members who reside with you, anyone else who lives in your household and any family members who do not live in your household but whose transactions in MEI Pharma securities are directed by you or are subject to your influence or control (such as parents or children who consult with you before they trade in MEI Pharma securities). You are responsible for making sure that the purchase or sale of any security covered by this Policy by any such person complies with this Policy.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Companies Covered. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The prohibition on insider trading in this Policy is not limited to trading in</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">MEI Pharma&#x2019;s securities. It includes trading in the securities of other firms, such as customers or suppliers of MEI Pharma and those with which MEI Pharma may be negotiating major transactions, such as a corporate collaboration, license, acquisition, investment or sale. Information that is not material to the Company may nevertheless be material to one of those other firms. The prohibition on insider trading in this Policy also applies to trading in the securities of all other companies from which you have obtained material nonpublic information in the scope of your employment.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Transactions Covered. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Trading includes purchases and sales of stock, derivative securities in hedging transactions such as put and call options and short and long sales, convertible debentures or preferred stock, and debt securities (debentures, bonds and notes).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">STATEMENT OF POLICY</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">No Trading on Inside Information. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">You may not trade in the securities of MEI Pharma, directly or through family members or other persons or entities, if you are aware of material nonpublic information relating to the Company. Similarly, you may not trade in the securities of any other company if you are aware of material nonpublic information about that company which you obtained in the course of your employment with MEI Pharma.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">No Tipping. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">You may not pass material nonpublic information directly or indirectly on to others or recommend to anyone the purchase or sale of any securities when you are aware of such information. This practice, known as &#x201c;tipping,&#x201d; also violates the securities laws and can result in the same civil and criminal penalties that apply to insider trading, even though you did not trade and did not gain any benefit from another&#x2019;s trading.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">No Recommendations</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. You may not make recommendations or express opinions to any person about trading in securities of MEI Pharma on the basis of material nonpublic information, even if the specific material nonpublic information is not shared with the other party. You may not also answer questions or provide information, including material nonpublic information, about MEI Pharma and its business affairs to outsiders unless specifically authorized to do so, or as required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">No Exception for Hardship. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The existence of a personal financial emergency does not excuse you from compliance with this Policy.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Pre-Clearance Procedures. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">To help prevent inadvertent violations of the federal securities laws and to avoid even the appearance of trading on the basis of inside information, MEI Pharma&#x2019;s board of directors has adopted certain Pre-Clearance Procedures. All Insiders of MEI Pharma may not engage in any transaction involving MEI Pharma&#x2019;s securities (including an option exercise, or a gift, loan, pledge or hedge, contribution to a trust or any other transfer) without first obtaining pre-clearance of the transaction from the Company&#x2019;s Chief Financial Officer or if the Company&#x2019;s Chief Financial Officer is unavailable, by the Chief Executive Officer. A request for pre-clearance should be submitted to the Chief Financial Officer at least two business days in advance of the proposed transaction whenever possible. The Chief Executive Officer himself may not trade in MEI Pharma securities unless the Company&#x2019;s Chief Financial Officer or, if the Company&#x2019;s Chief Financial Officer is unavailable, the Company&#x2019;s Chief Operating Officer, has approved the trade(s) in accordance with the procedures set forth in this Policy. The Chief Financial Officer himself may not trade in MEI Pharma securities unless the Company&#x2019;s Chief Executive Officer or, if the Company&#x2019;s Chief Executive Officer is unavailable, the Company&#x2019;s Chief Operating Officer, has approved the trade(s) in accordance with the procedures set forth in this Policy. However, none of the Company&#x2019;s Chief Executive Officer, Chief Financial Officer or Chief Operating Officer (each, the &#x201c;Applicable Compliance Officer&#x201d;) is under any obligation to approve a trade submitted for pre-clearance, and such Applicable Compliance Officer may determine not to permit the trade.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Trading Periods (&#x201c;Windows&#x201d;) and Related Procedures. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">All Insiders of the Company are subject to certain Windows-Related Procedures. In general, Insiders of MEI Pharma may freely buy or sell the Company&#x2019;s stock when the trading Window is open as long as they are not in possession of material nonpublic information and they first obtain pre-clearance for a proposed transaction from the Applicable Compliance Officer, as explained in this Policy. However, Insiders may not buy or sell the Company&#x2019;s stock when the Window is closed. Officers of the Company will notify Insiders, by e-mail or otherwise, that trading of MEI Pharma securities or any other company is prohibited (i.e. that the Window is closed). Windows will generally be closed during the following time periods:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:-1.818%;padding-left:1.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Quarterly Closed Window Periods. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company&#x2019;s announcement of its quarterly financial results almost always has the potential to have a material effect on the market for the Company&#x2019;s securities. Therefore, to avoid even the appearance of trading on the basis of material nonpublic information, you may not trade in the Company&#x2019;s securities during the period beginning after the last trading day of each quarter end  and ending after the second full business day following the release of the Company&#x2019;s earnings for that quarter.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:-1.818%;padding-left:1.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Closed Window Periods for Interim Earnings Releases and Event-Specific Releases. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company may on occasion issue interim earnings guidance or other potentially material information such as execution of an important contract or product development milestone, by means of a press release, SEC filing on Form 8-K, other SEC filing or other means designed to achieve widespread dissemination of the information. You should anticipate that the window will also be closed while the Company is in the process of assembling the information to be released until the second full business day following the release of that information.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Windows may also be closed during times that the Company&#x2019;s General Counsel in consultation with the Company&#x2019;s appropriate executive officers deems appropriate.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Exceptions for Approved 10b5-1 Plans. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In certain circumstances, the Company may adopt a 10b5-1 selling program under Rule 10b-5 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;) after prior review and consent of the Company&#x2019;s Chief Executive Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">and Chief Financial Officer. 10b5-1 selling programs generally may not be adopted when the Window is closed and may only be adopted while the person adopting the program is not aware of any material nonpublic information. Trades by individuals in the Company&#x2019;s securities that are executed pursuant to such an approved 10b5-1 plan are not subject to the prohibition on trading on the basis of material nonpublic information contained in this Policy or to the restrictions set forth above relating to pre-clearance procedures and Windows. Rule 10b5-1 provides an affirmative defense from insider trading liability under the federal securities laws for trading programs that meet certain requirements. Once the program is adopted, you must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded or the date of the trade. The program must either specify (including by formula) the amount, pricing and timing of transactions in advance or delegate discretion on those matters to any independent third party. Additionally, the 10b5-1 plan must include a representation certifying that (i) at the time the 10b5-1 plan was adopted or modified the Insider was not aware of material nonpublic information and (ii) the Insider adopted or modified the 10b5-1 plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5 of the Exchange Act.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Any individual who wishes to enter into a 10b5-1 plan must submit the 10b5-1 plan to the Company for prior written approval.  Subsequent modifications, amendments, replacements, or early terminations of any 10b5-1 plan must also be pre-approved by the Company.  Whether or not pre-approval will be granted will depend on all the facts and circumstances at the time.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">10b5-1 plans for directors and Section 16 officers are prohibited from trading in MEI Pharma securities pursuant to a 10b5-1 plan until the later of (i) 90 days following the 10b5-1 plan&#x2019;s adoption or modification or (ii) two business days following MEI Pharma&#x2019;s disclosure of its financial results for the fiscal quarter in which the 10b5-1 plan was adopted or modified in an Annual Report on Form 10-K or a Quarterly Report on Form 10-Q (the &#x201c;Covered Insider Cooling-Off Period&#x201d;); provided, however, the Covered Insider Cooling-Off Period shall not exceed 120 days following the adoption or modification of the 10b5-1 plan. An individual who is not an Insider must comply with all applicable requirements of Rule 10b5-1, including, without limitation, any required cooling-off periods.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In connection with an Insider&#x2019;s entry into any 10b5-1 plan, the Insider agrees to promptly provide to MEI Pharma upon request any information relating to the 10b5-1 plan that would assist MEI Pharma in timely satisfying its disclosure obligations in connection with required Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, proxy statements, filings on Forms 3, 4, and 5, and other SEC filings.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">DEFINITION OF MATERIAL NONPUBLIC INFORMATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Note that inside information has two important elements - (1) materiality and (2) public availability.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Materiality. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Information is material if there is a substantial likelihood that a reasonable investor would consider it important in deciding whether to buy, hold or sell a security. Any information that could reasonably be expected to affect the price of the security is material. It is not possible to define all categories of material information, as the ultimate determination of materiality by enforcement authorities will be based on an assessment of all the facts and circumstances, however, common examples of material information are:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Projections of future earnings or losses or other earnings guidance.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Earnings which are inconsistent with the consensus expectations of the investment</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">community.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:-1.818%;padding-left:1.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; A pending or proposed merger, acquisition, tender offer, joint venture or an acquisition or disposition of significant assets that has a reasonable expectation of being consummated.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; A change in management.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Results of clinical trials, whether such results are overly positive, negative or as</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">expected.</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Major events regarding MEI Pharma, generally, including the commencement or</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">termination of corporate collaborations, receipt of governmental grants, the</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">execution of licenses, financial developments, or patent or product developments,</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">both positive and negative.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Severe financial liquidity problems.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Actual or threatened major litigation or the resolution of such litigation.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; New major contracts, orders, suppliers, customers or finance sources, or the loss</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">thereof.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:-1.818%;padding-left:1.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; Major events regarding MEI Pharma&#x2019;s securities, including the declaration of stock split or the offering of additional securities.</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149; E-mails or other notices prohibiting the trading of MEI Pharma securities (i.e.</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">opening or closing the Window) or any other company.</font></p><p style="margin-left:6.667%;text-indent:1.786%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:1.602%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:1.718810351487061%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Knowledge of a significant data security, privacy or cybersecurity incident.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Both positive and negative information can be material. Because trading that receives scrutiny</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">will be evaluated after the fact with the benefit of hindsight, questions concerning the materiality</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">of particular information should be resolved in favor of materiality, and trading should be avoided.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Public Availability. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Nonpublic information is information that is not generally known or available to the public. One common misconception is that material information loses its &#x201c;nonpublic&#x201d; status as soon as a press release is issued disclosing the information. In fact, information is considered to be available to the public only when it has been released broadly to the marketplace (such as by a press release or an SEC filing) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">and </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">the investing public has had time to absorb the information fully. As a general rule and pursuant to this Policy, information is considered nonpublic until after the second full trading day after the information is released. For example, if the Company announces financial earnings after trading begins or ends on a Monday or before trading begins on a Tuesday, the first time you can buy or sell the Company&#x2019;s securities is the opening of the market on Thursday </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(assuming you are not aware of other material nonpublic information at that time and you have received pre-clearance on the transaction from the Applicable Compliance Officer)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. However, if the Company announces earnings after trading begins or ends on that Tuesday, the first time you can buy or sell the Company&#x2019;s securities is the opening of the market on Friday.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">DEFINITION OF &#x201c;TIPPING&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In addition to being forbidden from using material non-public information to trade in securities for your own advantage, you are also prohibited from tipping material non-public information &#x2013; even if you do not share the specifics of the Inside Information &#x2013; to any other Insider, or to any other person (including, but not limited to, friends, business associates, spouses, or other family members), who then trades on, or passes along, that information.  Under the securities laws, both the discloser (&#x201c;tipper&#x201d;) and recipient (&#x201c;tippee&#x201d;) of material non-public information are liable for violations and you will be held accountable for trading by your family members and related entities.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Material non-public information must be protected.  Common sense applies.  Avoid inadvertent communication.  For example:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Do not discuss new developments in public places such as elevators, hallways, restaurants, airplanes, taxicabs, or any place where you can be overheard.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Do not gossip.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Do not read documents with material non-public information in public places or discard them where others can retrieve them.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Do not carry documents with material non-public information in public places in an exposed manner.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Cover documents with material non-public information on your desk before you leave your office or room and do not leave them where visitors can read them.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Do not copy documents with material non-public information for personal use, without express consent of a supervisor.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Do not disclose material non-public information to other MEI Pharma personnel unless they have a legitimate business need to be made aware of such information.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ADDITIONAL GUIDANCE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">MEI Pharma considers it improper and inappropriate for those employed by or associated with the Company to engage in short-term, speculative transactions, including derivatives or hedges, in or related to the Company&#x2019;s securities or in other transactions in the Company&#x2019;s securities that may lead to inadvertent violations of the insider trading laws. Accordingly, your trading in the Company&#x2019;s securities is subject to the following additional guidance.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Short Sales. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">You may not engage in short sales of the Company&#x2019;s securities, defined as sales of securities that are not then owned, including a &#x201c;sale against the box,&#x201d; defined as a sale with</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">delayed delivery.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Publicly Traded Options. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">You may not engage in transactions in publicly traded options with respect to the Company&#x2019;s securities, such as</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">puts, calls and other derivative securities, on an exchange or in any other organized market.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Exercising Stock Options. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">You may exercise your vested options to purchase shares of common stock of the Company. However, any sale of those shares is subject to the prohibition</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">on trading in the securities under this policy. This prohibition applies to cashless exercises and sales made to cover any tax liability arising from the exercise of the options. Thus, if you choose to exercise stock options when the window is closed or you are in possession of material non-public information, then you must hold all of the shares of stock purchased upon such exercise until the window is open or the inside information is no longer material or is publicly available.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Standing Orders. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Standing orders should be used only for a very brief period of time. A standing order placed with a broker to sell or purchase stock at a specified price leaves you with no control over the timing of the transaction. A standing order transaction executed by the broker when you are aware of material nonpublic information may result in unlawful insider trading. However, as previously explained in this Policy, trades by individuals in the Company&#x2019;s securities that are executed pursuant to a pre-approved 10b5-1 plan are not subject to the</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">prohibition on trading on the basis of material nonpublic information contained in this Policy or to the restrictions set forth above relating to pre-clearance procedures and Windows.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Margin Accounts and Pledges. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">When securities are held in a margin account or pledged as collateral for a loan, such securities may be sold without your consent by the broker if you fail to</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">meet a margin call or by the lender in foreclosure if you default on the loan. A margin or foreclosure sale that occurs when you are aware of material nonpublic information may, under</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">some circumstances result in unlawful insider trading. Because of this danger, you should exercise caution in holding the Company&#x2019;s securities in a margin account or pledging the Company&#x2019;s securities as collateral for a loan.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">POST-TERMINATION TRANSACTIONS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This Policy continues to apply to your transactions in MEI Pharma securities even after you have terminated your employment or other services to MEI Pharma as follows: if you are aware of material nonpublic information when your employment or service relationship terminates, you may not trade in MEI Pharma securities until that information has become public or is no longer material. In all other respects, the procedures set forth in this Policy will cease to apply to your transactions in MEI Pharma securities upon the expiration of any closed Window period that is applicable to your transactions at the time of your termination of employment or services.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">UNAUTHORIZED DISCLOSURE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Maintaining the confidentiality of MEI Pharma&#x2019;s information is essential for competitive, security and other business reasons, as well as to comply with securities laws and the confidentiality obligations you have promised to the Company upon commencing your employment or other affiliation with the Company. You should treat all information you learn about MEI Pharma or its business plans in connection with your employment as confidential and proprietary to the Company. Inadvertent disclosure of confidential or inside information may expose MEI Pharma and you to significant risk of investigation and litigation.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The timing and nature of MEI Pharma&#x2019;s disclosure of material information to outsiders is subject to legal rules, the breach of which could result in substantial liability to you, the Company and its management. Accordingly, it is important that responses to inquiries about MEI Pharma by the press, investment analysts or others in the financial community be made on MEI Pharma&#x2019;s behalf only through authorized individuals. Please consult MEI Pharma&#x2019;s Non-Disclosure policy in the Company&#x2019;s Employee Handbook for more details regarding its policy.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PERSONAL RESPONSIBILITY</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">You should remember that the ultimate responsibility for adhering to this Policy and avoiding improper trading rests with you. If you violate this Policy, MEI Pharma may take disciplinary action, including dismissal for cause.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">COMPANY ASSISTANCE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Your compliance with this Policy is of the utmost importance both for you and for the Company.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If you have any questions about this Policy or its application to any proposed transaction, you may obtain additional guidance from the Company&#x2019;s Chief Financial Officer at 3611 Valley Centre Drive, San Diego, CA 92130 or 858-369-7111. Do not try to resolve uncertainties on your own, as the rules relating to insider trading are often complex, not always intuitive and carry severe consequences.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CERTIFICATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">All employees must certify their understanding of, and intent to comply with, this Policy. A copy of the certification that employees must sign is enclosed with this Policy. This Policy is dated March 18 2020 and supersedes any previous policy of MEI Pharma, Inc. concerning insider trading.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.56in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">MEI PHARMA, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">INSIDER TRADING POLICY CERTIFICATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">To MEI Pharma, Inc.:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I, _____________________________ (name), have received and read a copy of the MEI Pharma, Inc. Insider Trading Policy dated [&#149;], 2023 (the &#x201c;Policy&#x201d;). I hereby agree to comply with the specific requirements of the Policy in all respects during my employment or other service relationship with MEI Pharma, Inc. I understand that my failure to comply in all respects with the Policy is a basis for termination for cause of my employment or other service relationship with MEI Pharma, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Signature)		(Date)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reviewed &amp; Approved:  [&#149;], 2023</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>lits-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-09-26T15:24:36.0020+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>Exhibit 23.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in Registration Statement Nos. 333-277201, 333-186070, 333-184011, 333-174789, 333-146453, and 333-136440 on Form S-3 and Registration Statement Nos. 333-272627, 333-269666, 333-255830, 333-251976, 333-229554, 333-216103, 333-213278, 333-201703, 333-179591, 333-174790, 333-169719, and 333-156985 on Form S-8 of our report dated September 26, 2025 relating to the financial statements of Lite Strategy, Inc. appearing in this Annual Report on Form 10-K for the year ended June 30, 2025.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, California</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 26, 2025</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>lits-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-09-26T15:24:36.2481+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Justin J. File, certify that:</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K for the year ended June 30, 2025, of MEI Pharma, Inc.;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting.</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.92%;box-sizing:content-box;"></td>
     <td style="width:1.16%;box-sizing:content-box;"></td>
     <td style="width:48.92%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: September 26, 2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Justin J. File</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acting Chief Executive Officer and</font></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Secretary</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer and Principal Financial Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>lits-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-09-26T15:24:36.0043+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned hereby certifies, for the purposes of Section 1350 of Chapter 63 of Title 18 of the U.S. Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as Acting Chief Executive Officer and Chief Financial Officer of MEI Pharma, Inc. (&#x201c;MEI Pharma&#x201d;) that, to his knowledge, this Annual Report on Form 10-K of MEI Pharma, for the year ended June 30, 2025, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of MEI Pharma.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: September 26, 2025</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:48.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:2.4%;box-sizing:content-box;"></td>
     <td style="width:97.6%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Justin J. File</font></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</font></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acting Chief Executive Officer and Chief Financial Officer</font></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer and Principal Financial Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These certifications accompanying the report to which they relate, are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of MEI Pharma under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent MEI Pharma specifically incorporates it by reference.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A signed original of this written statement required by Section 906 has been provided to MEI Pharma and will be retained by MEI Pharma and furnished to the Securities and Exchange Commission or its staff upon request.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img155424085_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  T# 2(  A$! Q$!_\0
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M8>*_A/XP^(7A75)SXPTF_P##]QI7C_\ L^]:UL-+;2;R;2;+3[&;4OZLO^"
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+6-0B@;6;-[@ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img155424085_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0 !(# 2(  A$! Q$!_\0
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EN-+U?P18:KIL\EK/$\MAJ=C9ZA9R,UO>VEO<QRPH5[%10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img155424085_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  P# 2(  A$! Q$!_\0
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-E<,KI#<2/#*J '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img155424085_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_3.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  P# 2(  A$! Q$!_\0
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-E<,KI#<2/#*J '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img155424085_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_4.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  P# 2(  A$! Q$!_\0
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-E<,KI#<2/#*J '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img155424085_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_5.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#RK_@[G^'/
M[2OQ>_;"^$Z_#S]I3X3>*?@]X9^&6A:1#^SDO[4'PA^'OC'X2_$U-8UK4=;\
M8>*_A/XP^(7A75)SXPTF_P##]QI7C_\ L^]:UL-+;2;R;2;+3[&;4OZLO^"
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+6-0B@;6;-[@ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img155424085_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  P# 2(  A$! Q$!_\0
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-E<,KI#<2/#*J '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img155424085_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_7.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  T# 2(  A$! Q$!_\0
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M8>*_A/XP^(7A75)SXPTF_P##]QI7C_\ L^]:UL-+;2;R;2;+3[&;4OZLO^"
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+6-0B@;6;-[@ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img155424085_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_8.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]A?\ @L)X
M9^*?B_\ :.\,S^&OBEX+U/PMI7AW1;72/!9^+_@CPSJOP]\30RS2:A=:SX8U
M[Q/HUSIESJ[RV^I0>)WM_+EL_)L[J\MX]-M4;][/V3F\0_\ #./P>@\7>/-#
M^)GBFR\%:39>(/&GAWQ%9^+M+U;4[6,Q2I'XFL;BZMM=N-.C$6F7NK+<3-J-
MY9SWDDLCSL[?Q7?'CX9_'32OBKXWN_B7\./B#X?\3>(?%NO:O=1>(-!U>.>]
MNM5U2YO99[6\E@:#589Y9V>._L;B[M;K/FP7$R,'/Z2?L8^'OV[_ (??"&YT
M[X>?!?XLMX9U?Q=JFOVTTD4WAN*YEN=)T&P>XM+/6[[2;BYM)(]-B$5_;V\E
-E<,KI#<2/#*J '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img155424085_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_9.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0  T# 2(  A$! Q$!_\0
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M8>*_A/XP^(7A75)SXPTF_P##]QI7C_\ L^]:UL-+;2;R;2;+3[&;4OZLO^"
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+6-0B@;6;-[@ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img155424085_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_10.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0 !(# 2(  A$! Q$!_\0
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EN-+U?P18:KIL\EK/$\MAJ=C9ZA9R,UO>VEO<QRPH5[%10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img155424085_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_11.jpg
M_]C_X  02D9)1@ ! @$!2@%*  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /8""T# 2(  A$! Q$!_\0
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\*
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUS$65E$D,KH2I .0: -"BBB@ HHHH **** "BBB@ HHHH **0D $D@  DDG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7PO\ &7_DHWB'_N$_^F+2Z^Z*^%_C+_R4;Q#_ -PG_P!,
M6ET >[? #_D3=3_[&:\_]-6C5[E7AOP _P"1-U/_ +&:\_\ 35HU>Y4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'X8?\%A?^"GVJ_LB:+IWP*^!U[9+\?O'>B-J^K>))8(K^/X
M5^#+XW5E9:K;6LP>RF\::]<V]RV@6]]'=6^D6%G-K.H6$OVW0_M/\S?[/W[%
M7[:?_!1'Q+XI\?>$-*UWQSOU+_BK_C+\5?%%W:Z+=ZW,8S)9S>+->>^U/Q+K
M-O#)'/>V&B0:S>:79O:O?0V<5U8"XX;_ (*!_$_4_C'^VQ^TUXXU"XN+L7'Q
M@\8^'-&-P[R2Q>&/!.JS>"O"EL%8GRA#X=T#3(_L\>4B<,B%L;V_T ?V</@Q
MX>_9Y^!'PH^"WABQM;'3?AYX(T+P_-]DBBB74=;@LHY?$FO7/DJL<NH^(O$,
MVIZ[J=R%'VG4-0N9\#S,  _AM_:C_P""2W[9?[(W@RX^)WC?PSX9\7> =',4
MFO\ C'X6^(KCQ':>%!)<QP6MWKVGZCI7A[Q)8V,D\D8_MB'1KC2;)VB34+^S
MEFMTE_2O_@B__P %1?B.OQ-\+_LB_M!^+-7\<^%?',IT7X0>-?$M_)J?B+PA
MXI2&XN=/\&:IK5Z\FI:SX:\2",Z5X>%]<7M[H&M'2M'L2N@WHBT?^K[7-$TG
MQ+HNL>'-?T^UU;0O$&EZAHFM:5>QB:RU/2=5M)K#4M/NX6^66UO;.>:VN(SQ
M)%(ZG@U^7WP/_P"",G[!_P "_$&A>,-*\ ^+/&_C+POK&G^(/#?BCX@>/=?O
MK[1=9TF]@U'2]1L],\,2^%/#37>GWMM;W-I/=:%<2P30I)&ZN"Q /U5HKQ/]
MHOX^_#_]F'X,^.OC?\3+]K/PKX'TA[Z2V@,9U+7=5N)$L]#\,Z+#(R)<:SXA
MU:>TTK3TD:.WBFN?M5]-;6%O=74/\8OQC_X*J?\ !0W]M'XGKX-^".O_ !!^
M'=AX@U.>+P+\(?V>3JMMXN%O''Y@6]\8^&;.T\>>([^.SMVN]6NQ?:=H<.R[
MO+;1=(LS)&@!_=-17\#?B/XM?\%<?V(K_0_%_P 0O'/[5?PXL=4U,_V9/\3M
M<\3>,_ &LZN$2[FLKFP\8W7B?P1?ZI/;V_F3V=U;MJ4UI#*2AABD*?TQ?\$K
MO^"H>F_MT>']8^'WQ%TW2/"7[0W@328M6UC3M':6'0/'_A=)K>QG\8^&K*YE
MGN-,N=/O[JSL_$V@/<W<5E-J&G:CIMU)9:A+8:* ?L%17\\/_!??]H?XZ? '
M2/V6YO@G\6?'GPME\4ZE\8HO$<G@?Q'J/A]];CT>V^&;:4FI'3YH3=KI[:GJ
M#6@EW" WMR4QYKY_,3X*_P#!1+_@IC^T/\)/"O[*O[,G_"Q?'OQ:M6\4^(_B
M5\8Y+^#Q!\0KK1]1\0,=$TZV\7>)YXM$^'WAG1[&6SL)=?U*^MM4O=2NH;#2
MM0TB*WV:N ?VLT5_G]^,/VB/^"H'[#GQGBTKXH_&/]H/P7\2+:.Q\27'AOXC
M_$?5_B-X:\4Z9-=W$-OJ-U8:QK_BSP7XPTF[N+"_T\:G;2:@J20W]M;7T%S'
M-L_0[QG_ ,%/?^"A_P#P45'AGX+_ +$OPX\2_#_6K#P5I-Y\7=8^&^I6.FZY
M?>)9@EKJM]9_$37K[3;+X6^!I-1VKX?1O$&G>)+B031WGB2[A5[- #^O:BO\
M_P NOVL?^"F7["WQJE\.?$'XN_''P[X\\.W5EK&M?#WXM>-M;^(OA#7[/4Q!
M>?:+O2=<USQ!X:US3=<MXC:R>(O#UX+X!;F+3M=LM1M&DMO[</V0/VB-+_:O
M_9L^$WQ^TO3ET;_A8/AQ[G5]%2;SXM%\4:+J=_X:\6Z3;3EFDGL;'Q-H^JP:
M;<7 BN;K34M+JX@@EF>% #Z3HK^!_0_^"FG[6OPS_:?M/$7C']H'XW^,_AOX
M$^-DFJ>(/ATWQ!U<Z=XF\)^'?&<EQ>^$&M[RZ>Q6QU73+1M)>.XBEMX[>8AX
M944Q-[?X]^)O_!:']N32=4^._@_2/VAM+^$-X;R\\-^'?@I>Z[\._!1T6VN=
MR0>&="TC6-*\3?$Q+.YMF2/69QXQU*2^AN(;>]0P_9+< _MQHK^(G]AC_@LI
M^TE^SS\3M)\)_M*>./&?QD^#.H:S'HWC6#X@W>H>(_B/X#\RY%G>>(]#\1ZN
M;CQ1?W.AR S:GX4UR\O[:_MK:YLM/32-4F2_3^TK6_'7A#P[X&U;XEZQK^G6
MG@/0_"E]XXU/Q3YWGZ3;>$M-TB77KS7A<6XE\[3XM'ADU 2P++YMNH:(/N4$
M ZRBOXEOVI_^"N?[9/[87Q@'PS_90U3XA?#'P+JVO-H'PX\&?"87UE\6_'#>
M8R6>K:[XET 'Q/;ZG?Q1RWIT'PSJ&FZ-HUC(;?4'UB;3Y-;F\X\9Z]_P64_8
M(M_#_P 3_B/XS_:-\$>&M2U2)+6]\7_$>'XN^ )]5N569+#Q+HEUXE\>^%=.
MU+4H;=HXK;Q%8V&IWD<$\=KN>VD\H _NPHK\M/\ @EK_ ,%%[+]O7X7:['XK
MTO2O"WQP^&,FF6?Q!T'1WG31M<TW5HIAHWCCPW;7DDUS::;J=S9:A8:EH[WF
MHRZ'J=HOFW9L]6TDR?G+_P %[?VF?V@_@)\1?V=].^"WQE^(GPNL/$7@KQS>
MZ[:>"/%&I^'[?5KNQUW1(+.YOXK">%;F:VAGFBA>0,T:2NJD!C0!_3+17\87
MPJ_X*"_\%+_VIO@E\-OV6?V4K+XF>+OBAX4T;Q3J'QO^. U&SOO'FNR^(OB!
MXNU+PO:?\+"\37UMHWP_\/:7X4OM$T2VU?4=4TWQ'J>IZ7+9:/?:?INDE=4^
M+/'/QY_X*?\ [%'Q;BTWXH?&/]I'X>?$8Q6OB(Z3X^^(VN^.-"\3V'VR\M[?
M59K'7=;\5>"/&^E/>VVHV@O"NL6?VB.^MUE643K0!_H(45\'_P#!-_\ ; ;]
MMK]EKPI\7]6L]-TSQWINJZMX#^)VE:.LZ:59^-_#B65S/<:='<-)+!9Z]H&K
M>'_$T-F9K@::-;;2_M5V;%KB3^>']NW_ (*P_M8_'7]I36OV;?V-]?\ $7@C
MPCIWQ 'PR\)'X>PPVWQ)^*7B_3]6.A3:D/$Z-+J&D:)J.O1SIH-AHEWH\4VA
MK;W_ (DGE:XFM=/ /[#J*_B@\>?LL?\ !<[X/>%-=^,.O?$']I5[30M-CUSQ
M5+X<_:IU+QCXFM=*TNU^UW%QJ>AZ'\2=4U'7K/2+>U"WUK90:S'';Q,WD3:?
M%-*GW7_P1]_X*S_%_P",GQ5T_P#9>_::UG_A.]2\4:=?2_#+XH2Z?8Z?KUOJ
MFB6$E[-X3\8MI-A9V&JVVJZ?:SMHOB2\C@U@:W#'I6IW6MSZ]8RZ: ?TZ45\
M2?\ !0/]LC1/V'OV<?$?QAN]-M?$/BR\OK3P?\-?"UY=?9K;7O'&M07DU@-0
M:.2.[;1=%L;'4/$&MQV3)=W.GZ9+86UQ:7-[!=0_R0>#?C1_P5\_X**^+O$]
MQ\)/B)\=_%@TF.-=?TSX9^/(?@K\,] MM0:22PTJ^:Q\0^ _! N9H[63[!;Z
MS?7NO7L-M/<-+=LMS.0#^[JBOX'/$W[2O_!5K]@?XC:/H'Q1^+'Q]\&^(386
M6K:9X4^*_C*[^*7@O7-!@NY8B-+M?$>K>,/"-[ILDT4]A?S^'+J*\MGS";NT
MNHX'C_J2\&?M2?$C]L?_ ();>-/CM\(M+UK0?CSKWPA^(NBV6@_#F34I-=TK
MXO\ A>/4]#9?!GDM+JD4FJ:A:6NO^&K5+F\U"RL-7T^RGO;N]MYIY #\D/\
M@KW_ ,%6?VE/ 7QS^*'[(_P7OK;X1^&O!*>'=-\0_$'P[<S3?$?Q8WB7P;X?
M\631Z;K<D4(\"Z?;)X@33U/AZ,^(I9+%KQ/$UM;7LFE0_P!&_P"R!=W5_P#L
MF?LO7U]<W%[>WO[.WP3N[R\NYI+FZN[JY^&OAF:XN;FXF9YI[B>9WEFFE=Y)
M9'9W9F8D_P"=S\?O^%X?\+=\8_\ #2/_  G7_"Z_/TG_ (3C_A9?]H?\)O\
M:/[ TK^Q?[=_M7_B8>9_PC?]C?8OM'/]F?8O+_=>77]%W_!&_P#X>*_\+Y^&
M7_"Z?^&D/^&7/^%,ZC_PAW_";?\ "4_\*K_LG_A&=*_X5U_8WV__ (D_V/\
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M)H7NY-1\/Z19ZW#>2>'[BU>2:.31=*;1[FT=VA\RW9L@'][E%?Q]_P#!/?\
MX+C?%SP7XZ\/?"W]L?Q$/B#\+]>U"VT2/XJZI:6EGXW^&]Q=3>3;ZGXBO-/M
M;:/Q;X5AN)!_;DFJ6\GB;3+1I-3MM6U"'3UT*[_K+^(FIS6GPU\=:QI%ZT-Q
M;>!O$^IZ9J-C. \4T.@7UU97MI<Q,0&1UBGMYXV(R$D1NAH [FBOX%OV:?\
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MOAUX*6]N--L;RTT+4([JQO?$?B74K+4(=,?6+2ZTS3M/TG4+B;3[VXO;"2T
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MMSH.KZQ=^([O4XM"T364'D>(-.\.HT\PU?39+G1I[S7+R+3KRZ\FXDK]HO\
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M:QK?Q7U'2=8U/P3K]_H%[J6F1^$-4O([&\GL)89)[5+J*.X6%R4$J*X&X T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^%_C+_R4;Q#_P!PG_TQ:77W17PO\9?^2C>(?^X3_P"F+2Z /=O@!_R)NI_]
MC->?^FK1J]RKPWX ?\B;J?\ V,UY_P"FK1J]RH **** "BBB@ HHHH ****
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M6GPJ\*_&S]FGXW_#/QG8VM]HGB7X;>*T#7915TS5]/TFYU3P_KUO-(&2VO=
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M%=W98O$_Q9CB5F+"-#\3/$TI2,$D(AEDDD*K@&21WQN9B?QS_P"#CW_DX?\
M9]_[(QJG_J<:O7[$_P#!#3_E''\)/^QJ^+'_ *LCQ'0!_&/%X7L/''[54?@K
M59%BTOQ?^T$GA?4I7E>W2*P\0?$8:3>2-/&RR0JEO=R,TJ,KQ@%U8,H(_P!)
MS1M'TKP[H^E>']"T^UTG1-"TVQT?1]*L84M['3-*TRUBLM/T^SMXP(X+6SM(
M(;:WA0!(H8T10%4"O\S'X@:MJ&@_&CQMKFE7!M-4T;XH>)-6TVZ5(Y&MM0T[
MQ7>WEG<*DJO$YAN(8Y DB/&Q7#JRD@_VC? ;_@N'^Q-X[^#VD>+?B[\16^$G
MQ+TW1K8>.?A_J/A/QGJ\_P#;L,4<%Y<>#[OP[H.MV.OZ-JMZLL^D117HUBRL
MW0:]8:;L,S@'\\?_  7&^'6@?#__ (*#?$&Z\/6EK80_$3PCX'^(NJ6EIM6)
M=?U?39M'UN[>)>(;K5[_ ,/RZU>Y^:XO=1N+ULM=$U^MGQF^+/BL_P#!O+X'
MUI;JZ75->^&OPN^%EU?-'.9T\-:5\4-.\%21.Y=]L-_X7\.)H[SS$QSVU\P1
M4DGA"?@!^W#^T1JG[>G[8WBSXD^!O"FM>1XYUGPQX!^%/@Y;1;CQ/?:3IT-E
MX9\*V5Q8V,]\DGB/Q)?,VH7&G65S>16VHZNVFVES=16\4\O]>_Q9_8>UO5?^
M"3=U^QAHIM[GQWX<^!'A"WLA:KYT&L_%'P#>:'\1;JRL'\PF&#Q5XXT.[TJW
MN!(XM[76-SB:)7CD /Y!?^"?7[8FB?L-?':[^.6J?!VV^,VH1^!=?\)>'-(N
M/&$/@E_#.J^(+[16NO%5CK$G@WQK(;U=!L=9\.&W@L+*26P\1Z@'OQ#YEK<_
MJ#^TS_P7FT3]I?X!?%CX$:_^QQ;Z78_$WP9JOARWUNY^.T>OIX;UN6,77AOQ
M2FC2_!335U.X\+^(;;2]?M;-=3TV2XN-.BCBU&PE9+N'X&_X):_M5> OV./V
MJAXG^->AR7'PT\6^%-<^&?CM[G07UN]\'M=ZKH^L:=XF'A]X)+RYGT76_#MM
MI^JVUM!+J<&BZGK3V5E>W\4%A<?TA_M@_P#!63]BCX,_!>^\1_L_:W\%_CA\
M8M9_LZ+P+X,T_P .2:MH< EU&%=5U;QU/IUOH\V@Z?IVEQWKPZ9/J=CK^H:E
M+ID-M8&PDOK^R /PU_X()>-[_P +_M_Z%X<MKATLOB1\+_B/X5U&W\_RXITT
MK3+?QY:NT!.VXF@N/!Z^5A3+%'+<.I6,S!OK3_@Y(_Y*E^R[_P!B!\0__4B\
M/U^CW_!*_P#X*&>-?VZ/%OC;3]5_99\ ?#K2?AMX;M-0UKXL^#]9FCT\>)-:
MN_L6D>$[#PY>^%I;Q;O6M.CUS4I)U\8N-.L-'EBN8+IM3M"/SA_X.2/^2I?L
MN_\ 8@?$/_U(O#] 'Z'?\&_7@K1/#_[#6H>*[*RCCUOQ]\8O&NH:YJ+0J+JZ
MAT"TT/PYI-E]HQYDEA816%U/:P%O*@O-2U22-5DNIV?Y6_X.3=$LI?!O[*'B
M0PQ#4;+Q-\6-$6X"8G>RU/2O ]^\+2 C=%'/I$;HCAO+>21HBGF3>9]S_P#!
M"3_E'=X!_P"Q_P#BG_ZEMW7QC_P<D?\ )+?V7?\ L?\ XA_^H[X?H [[_@W(
M9C^RW\<4+$JOQ]F8+D[0S?#OP2&8#H"P1 Q R0J@YVC'X/\ [=O[%G[1?["W
M[1?B;QQINC>,[+P!!\0KKQW\'_CEX5AU,:7913Z_)K?A@77B?30R^%_'/A^X
M,%K<V&H7%A?OJ-@=3TE;O2[BRO9OW/\ ^#=U]3C_ &2?VA)-%@L[K68_C9J+
MZ3:ZA<2VMA<ZFGPS\'M807UU!#<36UG-="*.YN(;>>6&%GDCAE=0C?-W_$0#
M\;=(^.VF^ /C;^SY\.? 'PPT?QQ=^$/C3X?2T\6>*/B-HNCP7T^B^((+">\U
M_2-!N-0T1Q/->6-UX8NHM:BM9;&W%F;E)U /CGX0_P#!>K]N?X>06FF>.KKX
M;_''1X8TM;@^/O"$>D^(9;%%V"*+7/ =WX5MY+HQA8WO];T?79KA=\EX+FYD
M:>OW-_X)Q?\ !6#]EW]I#7=+^!VG?"C2_P!F/XI:M;-_8'@W2H-!/@#QE/IE
MI+/)I_A;7M$TCP[Y>LQ6<-Y>6^@ZWH&G$VJM:Z3J>LW8DBKB/C=-_P $$/C/
MX1U3QKXRU[]FW3I;[2FUA]7^&-U?^ /B49+B-'CNO^$2\!6^C^*-3\0*S(TF
ME:[X7U*\\T,FIZ8Z).@_F!_8H\%:WXZ_;E_9U\/?":+6[N2#]H3P%KNA7[V7
MG:KI/A7PIXWT_P 1WGBC5[:R9XH1X?\ #.E7.N:R8Y/L\*65P%EV!20#^_']
MI/XB? #X3_";Q%\0/VE;CP=;_"_0HT&I?\)GH=IXEM+Z[NV\NSTC2_#UQ8ZG
M<:YK.I2KY5EI6G6%W>7)1Y!%Y$$TL7\\FL?\%XOV8?@;;>(/"G[&O[&4&EZ+
MK.OW&LW4\Z^$/@MX<U37Y[.QTR?Q*_@OP%H?B5]2N;^UTNPM]UU>Z%J5U;PV
M\]Z8+E'M&Z3_ (.39?&2^#/V48+2:\7X>R>)_BM+K]O"T@T^7QE#I7@E/"$V
MH)CRFO(-$G\;IH[ B18+G7 05<$>6_\ !"SXV_L'?"GX:_$1OC-XD^$OPY_:
M(MO'=WJ]KXW^+%QH&AW=U\/!X?T9=$T[P-XN\2F"RL6LM9M/$<NJZ#I%[;ZU
M?WEU87-Q'J,)TF+3P#\M/^"A_P"U]^U#^V)J7PJ\<?M!?"*U^%/A?2+/QC9_
M"5--\#>,/#.EZ]9W\WAJ;Q3-;>(?%UW>R>+Y["2V\/B[FTR:&QTPWL(%C:OJ
M&9OZ7?\ @@,[M^P';!F9A'\9?B0B!F)"(8O#KE4!.%4N[N5&!O=FQEB3^'O_
M  6\_;9^#G[6WQ=^%7AKX'ZU_P )AX1^"V@^+[._\=V]M>6>D>(/$OC/4="?
M4[+0$OX+:YO](T6T\*Z:D>N"&.TU2\OKW^S?M.G6MKJ-_P#MM_P;^WMM=?L$
MSP02K)+IWQQ^(ME>HO6"Y?2_!^H)$_\ M&SO[2<?[$RT ?SA_P#!9'_E)/\
MM-_]A7X<?^J;^'=?VT?L;?\ )H/[*G_9MWP-_P#58>%Z_BQ_X+5Z3/I?_!2K
M]HB22VEM[;5HOA-JU@\@<+=P3?!;X>6MS<P,_P!^+^U;34;?*$HDMO+$,&,J
MO].O_!.K_@H9^RI\6OAA^RY^S;X,^(-W??'#3O@1X.\/:UX%F\)>+K)M'U3X
M9?#W3['Q3'<>(K[1+;PM=Q))H=]<:<VFZS>SWUEY%S]GA5W6( _GL_X+]_\
M)_<__9&/AQ_Z4>):_HI_8V\8:K\//^"07P^\?Z$)#K?@;]E'QQXPT<11+-*=
M5\,Z!XMUK3Q'"ZLDLAN[*'9$ZLLC81E()%?SK?\ !?O_ )/[G_[(Q\./_2CQ
M+7],?_!.7PSIGC7_ ()G?L\^#=;25]&\6_ N[\,ZND+B.9],UXZ[I5^D4C*Z
MI*UI=RB-RCA7(8JP&" ?QG?\$XOAEX?^.W[=W[.G@3Q]"FN:!K_Q$EU_Q'9Z
MK,TT6OQ^$]%UKQW/IVJ/,S/>0ZW<>'ULK^*1R]]%=S0,Q:<FO]$I555554*J
M@*JJ %50,!5 P     !@#@5_G+SV'Q=_X)R?MH63:MI @^(G[//Q-M=4M;74
MH7ATOQ?H=G<^;97L$@WNWAWQ[X3NA+:WENWVB+3=8#H8+Z%DB_KF\/?\%SO^
M">^J_#>W\;ZS\1_$_AGQ-_9L4]_\*[OX>>-=1\9VVKO;2S-HEI?Z7HESX*U!
MFD@EA@U<>*;?106MCJ-[IDMU'  #^;W_ (+:_"KPK\*_V_OB(/"%C:Z78?$/
MPWX2^)VI:;9%%MK;Q)XEM;JT\1W"P(!]FEUK5]'NO$-W$Q)>\U>XN$V0SQ1)
M_4Q^P[XWUGXA_P#!++X2>)?$$\MUJ@_9P\1>')KJ<LT]S;^"-.\2>"=/N)Y&
M9WFGGT[P]:2SW$C&2XE=YY#OD:OXW_VF/C#\2?\ @H]^V;K?B[P;X,U*[\3?
M%?Q+H_@[X7?#^Q6"YU*Q\/:;!%H_A?2[RYAV6INX]/MVUCQ+JDTRZ;97,^K7
MTES;Z3;!X?[F?AU\&+7]G;]BC1?@A:W4-^WPS_9_OO"^HZE;(\=OJVNV?@Z]
M?Q'K%O%(!)#!J^ORZEJ<4,F7ACNEC<LRDD _A2_X)V>"M$^(7[<O[+?A3Q'9
M1ZEHEY\8O">H:AIT\*W%KJ$/AZ[/B-;*]MW!CN+"[ETF."_@E5HIK.2>.56C
M9E/^B[+%%<12P3Q1S031O%-#*BR12Q2*4DBEC<,DD<B,4='!5E)5@02*_P ^
M#_@E!_RD1_98_P"Q_O?_ %$O$=?Z$= '^;M\"]+A\/?MM_!W1;+]W;Z'^U/\
M/=+M/++KY<.F?%O2+2WV%F:0;4@3:6=G& 2Q;FO](FO\XKX5?\GZ?#?_ +.[
M\'_^KETZO]'6@ K@/BO\2?#?P=^&7C_XK^,+C[+X7^'/@_Q#XSUR0,HE;3O#
MNEW.J3V]L&_UM[>+;?9+&W4-)<WD\%O$CRRHC=_7\_?_  <&?M*?\*[_ &;O
M!W[/&A7_ )/B/X]>)!J/B2*&3]]#\-_A]=6&K7<,XCQ);?VYXQG\+Q6LC.D=
M]8Z/X@LMD\?V@1 '\FOBKXEQ_&3X\ZS\6/C3=:W/9?$;XHS^,_B7-X9AMK[7
M8=&\0^)?[3\36WA6SU34-,L9;RPTFXNK/PUI][J>FZ>AM["RDO+&T0RP_P!4
M?B+_ (+R?\$]/%'PUUOX1:I\%?VG3\/]?\$:C\.[_P /P>!_A'%:#PAJ>A3>
M&[C2+=6^-LBQ0IH\S6D'ROY2!" =M?E7_P $E/\ @E]X#_;QT?XO>.?C+X@^
M)/A7P!X&U+P_X3\*WGPYU+PUI-]KOC"]M;C6/$5M=W?B?PCXOM&M?#^BR^'Y
M9;:WLK6XDF\1V<OVKRX7BD_8W_B'3_8F_P"BH_M3?^%M\)?_ )R% '\C?PF^
M*FK_  (^-7@;XO\ PYO+Q]1^&GCS2_%GAF;488M/NM2M-%U5+F*RUFTM+K4+
M>WCUS3$?3M;L(+V^MC;7UY9K<W4+>9)_H=^._C;IWB#]CGQU^T1\,M0>XT_4
M?V</%WQ=\#W\*B2Y4'X;:EXLT-GABDRM_:RK;QW-IO6:"]AEM9-DL;!?Y ?^
M"M7_  3-\&_L%7?PB\2_"'7?B%XJ^&7Q#MM>T/5[_P"(6H>'=7U?1/'>ARQ7
M\-F+[PUX6\(6$>FZ]X?O1-I5I)IEQ=K=>'M?FFOFADM;>#]<O^"%WQMTO]H7
M]COXM?L?^.;YKB]^&L&OZ!9P/*/M5W\(?B_::RIBMO-)DN7T+Q'/XKM+B1&:
M+3[#5?#=F5A1H!( ?SS?\$R/!FA?$;]OO]F#PWXLM;35-(N/B9!KUY9ZH&FM
M+^Z\*:3JWB_3X;N-B5NEN-5T2T5K:<26]XS"WNXY;>66-O\ 0]DC25'BE1)(
MI$:.2.10Z2(X*NCHP*LC*2K*P(8$@@@U_G%:!/\ $S_@GY^V9HMYXFT*2+Q]
M^SC\7+&ZU71;N*6SMO$FG:)J2-<K9374!D_L/QSX7F>;1M8BB;SM'UNSU:Q<
M[X)*_KOO_P#@NC_P3_@^%,_Q L/'_B:_\7C1?MEM\''\!^,;/QO)X@:T\^/P
MS<ZJ^AS>!;9TF(@NM?A\57GAZ)5D:VU"]N5CLY0#Z:^%G_!,G]A+X->(]-\8
M> _V</!5KXKT?6;3Q%I'B#7[CQ%XSU#2->L+Y-2L-7T8^,=:UVWT6]L+^.*[
MT]](M[%-/FAA-BEN(8E3\Y_^#C+_ )-!^#W_ &<CH7_JL/BE7YI_L#?\%"?^
M"D_[27[7_@3X6>'OC/J^J>$/&_CR7Q/X]T75?!?@WQ5I/@[X9VFJMK7BV2TU
M74_#<VM:%I^FZ-))H6@,FM6%L^JWNA:9N>YN;.(_J-_P<2Z3/>_L4?#G4;>V
MEG_L7]I7P;/>31AV2ST^]^&_Q9L&FGVY5(Y-1GTNV61\ 33Q1JP:7# 'S3_P
M;5_\@/\ ;#_["OP*_P#23XMU]R?\%Z_^4?/B+_LJ?PR_].=[7XQ_\$0_VY/V
M;?V/[;]I?3_VAO'-SX#3QU'\+]6\)7L?A;Q9XH@U>3PF/'MKK.EK%X2T37+N
MTU!?^$ETF:S^V6\-G<PM>LUU ;,B7]K?^"R%K'\9_P#@F%XR\>>!UGUC1%_X
M5#\6]-DCADCN+CPE?Z_H4G]I-;-B1$M=$\1C5;Q'&;:TM[F60 0,0 ?EM_P;
M;_\ )4OVHO\ L0/AY_ZD7B"OVR_X*^21Q?\ !.']J!I75%/ACPC&&8@ R3?$
MWP3#$@)_BDED2-!U9V51R17\PO\ P1:_;-^$?[(7[0/CD_&_5YO"O@/XJ^!H
M/#9\9K9:IJEAX<\1:)J\6K:,VM:?H]G?ZC_96J0R:EIK:E;65S_9E_-82WB6
M^DRZEJ%C^E__  6$_P""H?[-_P 4OV:-?_9J_9[\;0?%CQ+\4+_PU/XMU[PW
M9:HOAOPEX3\)^(M+\:2!]8O[*SBU+6=6U'P_I]H+#25O8;+21K%QK%UI\JV-
MM?@'QC_P;I_\GL_%'_LUGQM_ZMKX(5_13^W[^TG^PK^SGX:TJ[_:X\(>!_B1
MJ_B.WO'\*?#>_P#AOX5^)GC+Q):V2B.YN+31_$ML=-TW28Y-MH=6\0:EH^D2
M7.;."[FND>!?YUO^#=/_ )/9^*/_ &:SXV_]6U\$*\ _X+CR^,I/^"C/Q:3Q
M3->2Z5!X8^%L7P_2X:1K2V\&GX?:#/+#I0D V6;>-)O&-Q=*A,9UJ?5G0X;
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MD_\ \&WG_);?VDO^R6>$_P#U+9:_6#_@NW_RCN\??]C_ /"S_P!2VTK\G_\
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M;_[&KX3_ /JR/#E?Q_?LT?"GQ[^V?^U_X*\(V%@]_KOQ0^*1\6^.K[3K"?\
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M_P!RO_!.G]L[0_VW?V;?#/Q+#V5G\1=!\KPA\7O#EL4C_LCQSIMK"USJ-I:
M[X=!\5VKP^(M"(\V*W@O+C1C<W%]HU^4 /O"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX7^,O_
M "4;Q#_W"?\ TQ:77W17PO\ &7_DHWB'_N$_^F+2Z /=O@!_R)NI_P#8S7G_
M *:M&KW*O#?@!_R)NI_]C->?^FK1J]RH **** "BBB@ HHHH **** "BBB@
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M7K$G@4Z5J&I>%-:L];L[+4A9>$K6\-C<W%E'%<BUN;>?R7?RIHWVL/W0HHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
M+_&7_DHWB'_N$_\ IBTNONBOA?XR_P#)1O$/_<)_],6ET >[? #_ )$W4_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *^%_C+_R4;Q#_ -PG_P!,6EU]T5\+_&7_ )*-XA_[A/\
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M7BAO$.IH]AX<N/"U@LOB*Q\1W2F+P_?:9;:P2#9 @ _RW/\ @E%_P2>_:/\
M^#BKXS_M+?'O]H?]K_Q-X:@^&UUX/C\??%CQKH6I?&+X@^-/%?CM?$UWH'A/
MPQI.H^+/"FEZ)X;\.:7X<O9;@#5X-+\-6-UX?T+PWX8FLKJ9]%BT'4OVMO\
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MG9Z?"UO:33"]FG)B/^F9_P ''>K_ !4MO^"//[6GA3X+> /B%\1_B'\4M/\
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M7&HZKJ5Q::7IEI=ZC>6MK-^!'_!\I_R-7_!-3_L7_P!K/_TX_LYU_*W\5/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **R=9U_0O#MM%>>(-:TG0K.>ZAL8
M+O6=1L],MIKZYW_9[.*>]F@BDNI_+?R;='::78^Q&VG&M2NFVDU=6NKZJ^UU
MTO9V[V)4HN4HJ47**3E%-.45*_*Y+=*5G:^]G;9A1113*"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^%_C+_R4;Q#_P!PG_TQ:77W17PO\9?^2C>(?^X3_P"F+2Z /=O@!_R)NI_]
MC->?^FK1J]RKPWX ?\B;J?\ V,UY_P"FK1J]RH **** "BBB@ HHHH ****
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MOPAHWB*__M7Q!I'A?0-,US5,D_VEK%AI-I:ZG?Y/)^V7L4]QD\GS,FOY%_\
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M11+/+M;[+I>EVH(GU36=3F"VFEZ59I+>7]W(D,$;,21^"O\ P3N_X*!?'_\
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M?$'QH^*_B/XL_M+_ !/_ &G--_81O]'^*UU\/?\ A&_&?P(TCP=K_P 5]-^
MV@Z!JVEZ9\&[*]N=9\,^"]%U#2QX<_X2SQ#H+66NZK.FBR:S0!_L1T5_*?\
M\&M7_!6[X^_\%#_@=\:O@=^UAJ=[XP^.7[+%_P"#(M/^*VIZ>FG:W\2OAUXN
MAUK3[2U\8+;6T%M?^/\ P!K/AF:P\2:^\5G?:_I7B7PK=:O;7GB*#7]=U?\
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M8&AB\!3HO#4:V(A"/^S_ +B,*LW*BZ;:4I.*_+/_ (( ?\D'^.G_ &5S3?\
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MG^*EQH@^Q-(FA07WB37/%=YX;MK^WNGOKO3(+FT&II/#)=1SVMMI\=M\]_L
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MOA:3Q#I$^@3^,_'>MV4FBV5]H>@W<4-Q#X+\&Z'<7":5>E%M/[0M=!M-*FU
M:;JCVG],-:<&4*D<)F>+]A/"X7,<WQ>-P.&J0]G*GA*G*J4N3["DDHQ2]UQI
MQE#W)1;W\'<%B:65<29K+!5\LRWB'BO-<XR3+J]+V%2AEF(=..'J>PLE2C4C
M%4Z<8^Y*G0A4IN5*<)2****^Q/U\**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OA?XR_\E&\0_\ <)_],6EU]T5\+_&7_DHWB'_N$_\ IBTN@#W;X ?\
MB;J?_8S7G_IJT:O<J\-^ '_(FZG_ -C->?\ IJT:O<J "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\+_&7_DHWB'_ +A/_IBTNONBOA?XR_\ )1O$/_<)_P#3%I=
M'NWP _Y$W4_^QFO/_35HU>Y5X;\ /^1-U/\ [&:\_P#35HU>Y4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!\,?\%*/V(?"/\ P47_ &)?
MCU^R#XOU-?#Z_%7PK"OA/Q8T$ER/!OQ%\+ZK8>+?AWXJEMX'BN+O3]'\8:)I
M$VN:=;36\VK^'VU;1Q/"NH,X_P M7Q7^Q[_P6W_X)E?M9?LD_L[67@WXBZ9\
M8?"_Q9^.NJ_L$1^%W\+?$_X?>)?'?C/0?!_ACXN>./@:^M1:IX<9-6\.Z?\
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M_P#@7?6DL_@K1[+4+&]O$EU?X62V>H^"I[.9+;[/X,A\ F"2_N3JDEO/=_\
M'W=?]?$W_HQJ_H(K^?>[_P"/NZ_Z^)O_ $8U?XM?M@O]V^CY_P!?_%/_ --^
M'9_7/T5?XG'7^#AK_P!*SXKT445_B8?U^%%%% !1110 4444 %%%% !1110
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MO!JZ;91QVUI;>'KG3?%7CO1-*2V@_=?V?8WWA_0H[:)0JQK:6TQ1#%L'U_\
M\&_MY$_P5^/NGJ5\^V^*.@WDBAU+"*^\)PPPDQ@[U5GTZ<*[ *Y5U0DQOCY
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M.GG4KV QF:#3X7LK2>\D3?&;=3:2_P =O[4WPU_:/\/:QX3^+W[3K:NOC_\
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MNE>-?$=K)J%Q=W]Y8:9IVH7'@/09[_4M0FG=_%AU,RW]G8WI_5WQ_P#\$O\
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M "BBB@ HHHH *^%_C+_R4;Q#_P!PG_TQ:77W17PO\9?^2C>(?^X3_P"F+2Z
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M9MBE1R^@J7[RFE5G6E7G&%&GAJ<7>O4J.2E&-._[M3J-JG"<E^O=%>1_L_\
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M'P].G2G7Q.)KN+E[.A0I)SGRQ3E.;Y:<%;GG%R@I?T"T5^6?_!.G_@I9X?\
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M .$[H?\ \@T>QG_=^_\ X']6?E</UPHK\C_^&L?C=_T,>G_^$[H?_P @T?\
M#6/QN_Z&/3__  G=#_\ D&CV,_[OW_\  _JS\KA^N%%?D?\ \-8_&[_H8]/_
M /"=T/\ ^0:/^&L?C=_T,>G_ /A.Z'_\@T>QG_=^_P#X']6?E</UPK^?>[_X
M^[K_ *^)O_1C5],?\-8_&[_H8]/_ /"=T/\ ^0:^9KK_ (^KG_KO-_Z,:O\
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MG#$.C*$\-4C.I1C*ABTH0F_:TN24*<W-TXU*=3^0/X$>"?V@O^"D-_\ LM_
M(>$+O1?V?/V<=)70/$'C'3[2]ATBRT:^U>RO/&VMW_B"\"65]XUURPM++1_#
M?AS3R\EH+>.Y%L+4:[JH_L]1$B1(XT6..-52.-%"(B( J(BJ JJJ@*JJ %
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MONM-CT83A4BI4YQG%[2A)2B^NCBVMFG\PHHHIE!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_,%^T]^UY^TO
M^Q3_ ,%&=>_X6=XV^)7C7]GK6;G4_$&@_#]];D3P[J7PW^(&D:C;*_AS3IA;
M:7<7_P /?$EY?6NG0W9CEEN/"T>E2ZC;65W%?)^<NO\ QUTGXJ?L4_LN_L3?
M#_PKJ_B3XK:5\9_%7BW4KJ.P"[-0\2ZWXLTCPCX1\/RES+J,^OQ>+DU'6)!'
M!9V4FGZ1$)[F9KQ;#^QK]H7]FGX+?M,^#_\ A%?C'\.]&\=V^FK>W7AV:[DN
M]-UK1-2N+8Q&;1/$6DWFFZSI/VEDM_MD-KJ,-G??9[8:A#<);Q!/AS_@F#^P
M=H7[.'PC\,^,/BU\%M \+_M0&^\70Z]XDO\ 5=(\8ZYINDW6LZC:Z+'HNJ:1
MKWB3PYH:W?AAK2WNO^$8GLKFY@FG@U8R3S72-^:8_AC.JV:U<)3Q_/E.80S"
MI*M7A6KU<%0KXC+:F)PD)RC*"J5)4*"P<)55%TJ.)DHPG&3E_-^>^&W&.-XH
MQ.5T,]]MPMGU+/L1+%XVCC,;BLGP6.S#AW$9CE5.M.G.A"OB)X+!PRBE4Q4:
M<L+A,PJ1A1JPJ2G^B7P2\!S?"SX,_"/X8W,T-S<?#GX8^ ? <]Q;O(\%Q-X0
M\*Z3X?EF@>54E>&5].:2-Y$61D92ZJQ('\V?_!P)_P EA_9]_P"R:^)__4HC
MK^IJOF[XX?LA_LX_M):KH>N?&[X7:5X_U7PUI]QI6AWFHZKXDT]]/T^[N1=W
M%M&FAZUI<4BRW($I>>.60$85PORU]5Q#D]7-,DJ95@YTJ4W]5C3E7E-4XPP]
M6G*TG3A4E?DA96B[NUVEJ?J/'_"&*XGX,Q'"^4UL+A:LGEL,/4QLZT</"C@,
M30J<LYT*->KS.E1Y8VI.\K<SBKM>_:+_ ,@;2?\ L&6'_I+%7QI_P4D_Y,5_
M::_[)K??^G'3J^VH8HX(HH(5"10QI%$@)(2.-0B*"220JJ "23QR2:Y/X@>
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M^RV(MOC=\-K/4+JUBM$58XK)-:\:)?V4,2);0-;VCVZI!%&%D_X*C2K\9O\
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M<2_^MEX?G\Z_2;_Y(#+/^RLR_P#]5.>'T91117_0Z?PB%%%% !1110 4444
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MBNBK!9IC:>+-#\^W#E&:V06\C*K(+M"X=/Z(Z*Y9\&\,U+\V545?^2KB:?\
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M8]7]GF>$EVYZ5:'W\OM+?B>75^C;GL;^PXDRFIV]KA<91OOOR?6+=._7MK_
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M6/CY*&E,(&F?"SQCK3[P&))31])OW6+"G$[*(&)4+(2Z!C_6CCFA_&P^)?\
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MC+_9MWK\^GLO[QW0/;,(Y2)HPLJ(Z^B:5_P4@_;HT<6XM/VF_B=-]FD,L?\
M:NIV>NEF+%R+@ZW8:@;N/)($5T9HE7"*@154=4/$S+7;VF78Z/?DG0J=MN:=
M._7MLN^GIT?I(\.RM[?A[.J??V-7 U[;7MSUL/?KVO9;7?+_ 'C45_#[I?\
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M/#OQ4^%?B*V\2>$/$EMYMK=18CO-/O(PHOM%UJQ+-/I6N:5.QMM2TVY E@E
M=#+;RP3RY<,\3X;B##N+4*&848IXC"INS5[>WH<S<I46VDTVYTI-0FVG"<^;
MPV\2\NX]P#A)4L#G^#IJ6898IOEG"ZC]=P+FW.K@YR:4XMRJX2I)4JSE&5"O
M7]3HHHKZD_3@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME1Y2.6<;%!;BO.-0_P""B'[#^F-$MS^T]\))3,'9#I_B:'5U 0J#YK:5'>K
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M"-;8!+?35./>&87Y<95K?]>\'BE?T]K2I;?\-<_1\1XZ>&]&_L\WQ>+M_P!
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M-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P B;J?_ &,UY_Z:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBL75?$GAW0R1K>OZ+HY6W:Z8:KJECIY6U3?ON2+N>'%NOER;I
MC^[7RWRPV-A-J*NVDN[:2^]DRE&"<IRC"*WE)J*7JVTCR']IO_DAOCS_ *]]
M#_\ 4GT6OQWK]-/VG?CK\$8_@SXTTZ3XQ_"M-0O+32)+2Q?XA>$5O+I(/$FC
MR3/;VK:N)YTACCDDE:)&$:([.0JDC\;+K]H'X%VFSS?C!\-G\S=M^S>,] O<
M;=N=_P!COY_+SN&WS-F_YMF[:V"GC\#2@_:8S"4_>?QXBC#I'^::[K[UW/.K
M9UDV'O[?-LLHVW]MC\+3M>R5^>K'=M+YKNCU^BOGBY_:Q_9UM0AE^*OAYPY(
M7[-%JUX1MQG>+/3IS&.1@R!0W(4D@XY:Z_;=_9IM@/+^(%Q>MO*,EKX0\: K
MC/SE[KP_:Q,A(P#'(Y.00-OS5E//\BI_Q,YRJ#[2S#")]-E[:[W6RZGEUN-N
M#:'\;BSAJF_Y9YYEBD]MH_6N9Z-/1/1WV/K"BOBB[_;]_9]M@3#=>,-0Q*8P
M+3PTR%E&[]\/M][9#RCM& Q$WSKF(8?9RU[_ ,%&?@S#O6R\*_$J\=9"H:32
M_#-I;R1C<#+&Y\53S_-A2B26L;%2=^QAM/'/BWAJG?FSK NW\E7VG_IM3O\
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MA7X:V2-'M5I-+\2W=Q&Y!!D20^*H8#C@JDEJZ@CYMX.*XZGB)PO#X<5B:O\
MU[P==7_\&QI_C8\NMX\>'5._)F./Q%O^?.58R-]]O;TZ'XVW7G;]H**_#>\_
M;]_:!N2?(NO!^G9B,8%GX:5PKG=B<?VA>WQ\T;A@,6A^1<PG+[^7N_VW?VEK
MHCR_']O8KL*,EIX1\&8?.?G+W6@74J. < Q21@8! W?-7)/Q-X=A\-'-*G^#
M#8=?^G,73/+J_2'X%IWY,)Q'7[>RP&!C?_P?FE'\5T?6R?[X45_//=?M8_M%
M790R_%7Q FP,!]EATFR!#8SO%EIUN)",#:7W%>=I&3GEKK]H+XZ7GE^;\8/B
M2GE[MOV7QGK]CG?MSYGV*_M_-QM&WS=^S+;-N]]W'/Q3RE?P\MS&?^-X:GV_
MEK5?/[EWT\JM])#AJ/\  R#/:G;VTL!1[?R8G$>??9=WR_T@U6NO^/FX_P"N
M\W_HQJ_F>NOB7\1[X*+WX@>-KP(S,HNO%>NW 5F^\R^=?OAFP-Q&">YKE[S5
M-3U#/V_4;^^S(TQ^V7=Q<YE;=NE/G2/F1MS;G^\=S9/)K^&?IE>":^EBO#FE
M0XF_U%I\"5.+)U:E;)?]8YYE_K-'AN,%3I0S;(XX7ZF\@GS.56O[?ZU&RI>R
M?M/TOPO^G3@?#'^WY4?#3%9_+.HY8H1J\5T<HC0_L]X]OFE'A[-74]K]>LK0
MCR>RN^;GM#^FF\\1^'M/W?;]>T6QV2F!_MFJ6-MLF4L&A;SITVR@HX,9PX*L
M"/E..8O/BS\*].WG4/B7\/[ 1.(Y#>>,O#EKY<A. C^?J2;')X"MAB>U?S7T
M5_'&#_9HY!#E^O\ BUF^)VYOJ?"6"P-UI?E]MGN8<MU>S?-:Z=G9I_>XS]IY
MQ!._]G^$.3X7?E^N<7XW'6T=K^PR#+N:SM>W+=)K2]U_11>_M%_ BP\WS_BW
MX#D\HJ&^Q>(]/U+)?:!Y?]G377G ;AN,/F!,,7*A&QS-[^US^SG8>;Y_Q0TF
M3R@I;[%IGB/4LA]I'E_V=HUUYQ&X;A#YA3#!PI1L?S^T5]3@_P!FYX5PY?[0
MXZ\0,3:W-]3GPY@;_#S<OMLCS#EO:=K\UN:-^;D?/\IC?VF'BO4YO[.X"\/,
M+>_+]=AQ)C[?%;F]AGF6\UKPO;EORRM;G7)^[5Y^W!^SC:[_ "/&.I:CL3<I
ML_"?BA/,;_GFG]H:58$..A,@CCSTD(YKF+S]O_X#6V_R8O'.H;8C(OV/P[:)
MYC ,1"GV_6;'$K$  R;(<LN90 Q7\7+/2-5U (;#3-0OA)*(4-G97-R'F)4"
M)/)B?=*2R@1C+$LH Y&>GM/AG\2+\ V/P^\;WH,@A!M/"FO7(,IVXB!AL'S(
M=ZX3[QW+@<C/K?\ $A?T;<FTS7B3B^;AI+^U^+\@P;;5D^?ZMD676;:=[<NK
M=DM$O(?T_P#Z3.=:Y3PSP=#GUC_8W!O$&-6MVN3ZUGV97T:M=RNDF[N[?ZJW
M?_!1?X3(?]!\&?$2Y'EDYN[7PU9'S?FPF(?$=^/+("YDSN&6'E':"W,77_!2
M'PRA7[%\+==N!M)8W7B33[0A_P"%5$6F7H92.K$J1V1NM?GQ:_L_?'*\#&+X
M1?$9 K!3]J\(:Y8G)Y!47ME;EE]74%%Z%@:Z>V_91_:'NPYB^%NOILVAOM,^
MD61.[.-@O-2@,F-IW&/<%XW8W+D_XEC^A%D__(USOAV?+N\W\6W@V]E[WU;/
MLN2UG#9+5P_FLS_B:/Z<^=?\BG(N(X\VL?['\(%C=%=^[]9X?S&ZM">]]%-W
M]V\?KBZ_X*37S[/L?P?M(,;O,^U>.9KO?G;LV>5X3LO+V_-NW>9NRN-FT[N8
MN?\ @HW\07V_8_A]X-@P6W_:;O6[O<#C:%\JZLMA'.XG>&R,!<'/B]K^Q+^T
ME<%_-\!VMD%"E3=>+O!K"3.<A!9Z]=L"N 6\P1CD;2QR!TUK^P/\?;C/G0>#
M['Y W^E>)-^6.,QC[#87GSKGDG$?!VNW&3_B'_[/3)?^8_PIK<O?Q+S+/WU?
M7BO,7+^)MKM;_ETE _XB'^T8SRW_  G^+5'F_P"K899P\MTM_P#5++5#^&M;
MJZ;>U5N>W=_\%#/C=<#$&A?#>Q <L&@T/Q!+(R'(6.1KOQ5<1G ():.*)BPS
MPI*US%Y^W=^T)<[O)UCPWI^93(/L?AC3WVH=V(!]O^W?NAN&"VZ;Y%S,<OO[
M2S_X)V?&*4@WOBOX;VB-$'Q#J7B6[F24[3Y4B'PM;0C:"X>2.XE4.H"!U;>O
M36?_  3@\9/L^W_$OPS; IF3['HVJWVR3'W$\Z?3_,3.1YC&)L<^7DX#_P!8
M/V>F2?\ +CPHK<FO_)-9CQ!>UW_T*LR]IZ>]?2-GH@_U>_:,9YI]8\6J'/9?
M\E/EG#MKV6_]K99R=+M\MM9.WO,^?;S]LW]I*]WJWQ'DMXWDWB.S\,>#;7R^
M20B3Q>'A=>6,XVO<.6&-Y8C-;VG_ +?7[96D:+'X=T;]HGXD:'HT,DLL%CH>
MJP:+';O/<O>3?9Y-+M;2>W6:YDDEE2&5$D,CJRE&93]&6?\ P384>4^H?&%B
M-K>=!9^!0N&P0HBNY_%S94':S%[,%AE0%)#C]!/@7_P0Y^$WQ(\ >'?&GB3X
MX?$2&74YM82]T_0] \-6,>W3]7U#3H?LMQ?C5VA9DM8I)3+%<AG,@14#+Y?[
MK]'OC7Z./&_&N8<-_1YP?">#XOPW#6.S/,JW#' >*X(KRX<P^9Y/@\="KF^(
MX>R)8N@\QQ>3SJ8..)K/$3C1Q*I5?JSJ4OB^.O!SZ:>'R>AF'B/FG'%3*:V8
M4</0AGWBQA,]I+'5</B:M%QP6'XLS25&2PT,6E-T8.E%5:3Y'4C"I^(NK_MF
M?M=Z[]I75?VHOV@[J&[\O[19_P#"X?B!!IT@B\LQC^S;;Q!#IZ!6BCDQ';*#
M,OG,#*6<^<ZM\;/C+KQG.N?%OXG:R;I%BNCJWCWQ5J)N8T552.<WFJS&9%55
M54DW*JJH   K^I+2?^""/[)%IY$FK?$C]H/5IHI2\L<7B7X>Z;87,>[*PO!'
M\,[B^C&W D>'4XW8_,ABZ5Z-I7_!$/\ 8:T_ROM>E_%+7?+N%F<ZK\0IX3/&
MK(3:2_V)I6C@6[A65FA$-V%D?9<JPC:/^R?]2.+*_P#&Q%+7?VV859[[WY8U
M.[OOL_*_Y-_Q!7Q5QO\ O>885<V_US/\56WWO[.GB+_%*^_VM[Z_QRW^HZAJ
MD_VK4[^\U&YV+']IO[J>[G\M,[$\ZX>238N3M7=M7)P!DU3K^VW2_P#@CY_P
M3WTY1YWP-O-7E6<3I-JGQ1^+99 H3; 8+#QQ86<L 9"Y2XMIF<R.DCO%MC7T
M;3O^"9/[!VEJZVW[-/@24.ZR'^T9_$FL,&48 1M7UV^:-#_%$A6-SRZ,>:N/
MAMG<G>IC,LC?>U7%3E\[X2*O_P!O?,UI_1SXSJ/FQ&;\-TV]7RXK-*T_G?*J
M:;])O3KT/X3**_OZT[]AS]C32_.^S?LK?L^R^?Y>_P#M'X2>!]7V^5OV^3_:
MVBWOV?/F-YGV?RO.PGF[_*CV>D:=^SY\!-(,C:3\$/A#I;2JJ2MIWPU\&61D
M1"2B2&VT6(NJ$DJK9"DG &375#PRQK_B9IA8]^2A5J?^E3IW_ ].C]&S.)6]
MOQ/EE/O[' XJOWVYZN'OT[;OLK_YWOUJ>XMKFT=8[JWFMG>&&=$GBDA9X+B-
M98)T6159HIXG66*0#9)&RNA*D&O]('3/#OA_1&W:-H6CZ0QA6W+:9IEE8-]G
M4J5@S:P1'R5*(5B^X"BD*-HQ\,_M\?L#_#_]MCX?^1/]B\+?&+PM97)^'7Q%
M%L2T#$O<'PMXI%NC7.I>$-2N69I(U6:\T&\F?6-(1W?4M-U<Q?AIBJ.%JU<+
MF4,7B81YH8:6$^KJK;XH1K/%55&;5^12IJ,I)1E*"?-$S7Z.&9X3+,5BLLXC
MHYKF-&FZE#+997]1ABN76=*&,EF6(4*TH7]BJE&-.=3EA4J4HR=2'\+M;'A_
MP_KOBO7-)\,^&-'U+Q!XBU_4+32-$T/1K*XU'5=6U._F2WLM/T^PM8Y;F[N[
MJ>1(H((8WDDD9552:]'\<? 3XO?#OXO7GP(\4>!-?MOBM;:_:^&[?PA:6,VH
MZEK.I:C-'%I!\/I9+,-<L]<$T$^BWVFFXMM3MKB&>UD>-P:_K*_X)G_\$S]"
M_9.T*S^*OQ5L].\0?M%>(-.(9@8+_2_A3I=_!MN/#GARX7S(+KQ)=02-;>)_
M$]LS(R--H.@S?V-_:&H>(_D\AX;QV=XZ6%4)X:CAYVQU>K"2^K)-IT^25G+$
M2:<8479W3E/EA&4E^6<#^'.><9YW5RR%&ME^%R^MR9WCL31G'^SN2;C/#NE-
M0<\?-QG"EA6XR4HRG5=.E"<U^!^@?\$>?^"@6N+#)<?!?3_#L$ZVKQSZ_P#$
MOX9Q-Y=R26DFL],\6:IJ5LUJFU[JWN;*&[3/EQV\LRR1)[%H?_!"G]M/5E#7
M^M? SPP3'(Y37/'/B6X8,DJQK"3X;\!^(4\R9"9XR',0B5EEEBGVPM_8+17Z
MC3\.<@A\=3,:W_7S$4HK_P I8>F_37UN?TSA_H]<!T;>UK\08MI:^WS#"P3>
M^V&R_#M+HE?;=MZG\L.B?\&_GQFG=1XC^/\ \,=*C,L@=M$\.^*O$#K"(0T,
MBI?KX:#2O<9BDB,B+%"!.LTSG[./8=!_X-[M&B\I_$_[4VIWN[[(\UMH/PBM
M=+\K&3?P17VH?$36//WY$=I=OIUMY6PS364WF""+^CVBN^GP+PQ3M?+Y56NM
M3%XQ_>H5X1?SB]_2WNX?P0\-:%G+(:F)DM5+$9KFSZ6UA2QM*G+TE!J[\E;\
M)-#_ ." _P"S/;HO_"2?&#XZ:O($<,VB7?@'P]&TIFW1L([[P3XE=8EM_P!U
M)%YQ>27]^DT*?Z/7LVB?\$1_V%]*96O]%^)OB4+)(Y36_B)>0*ZO$(UB8^'+
M#P^XCA<>?&4=93*2)I)8<0C]=:*[J?"O#M*W+E&"=K6]I3=;;O[9SOYWO?K<
M]S#^%_A]A;>SX3R>7+:WUC#O%[;7^MSK<WGS7OUN?G9H7_!)W_@G[X>\MK7]
MGC2KZ9#;,\VO>-OB9X@\Z6U!VR26VL>,[RQ43,6>YMX+6&TN"0DEN8DCC3V+
M0OV#_P!B_P .JBZ=^RW\"YMB%$?6?AMX8\22@&;S]_G>(M/U68RK)PDY<S1Q
M@0QR+"!&/K&BN^GE&4T?X.5Y=2_Z]X+#0_\ 2:2/<P_"?"N$M]5X:X?PUMG0
MR;+J+^^GAHOS]=3S/1/@M\'/#3*WASX3?#/P^R-(Z-HG@/PMI3*\R".9U-AI
M4!5I8P(Y&&"Z *Q*C%>DQ11011PPQQPPPQI%%%$BQQ111J$CCCC0!$C1 %1%
M 55 50  *?17="G3IKEIPA37:$8Q7W121[5'#T,/'EH4*-"/\M&G"G'[H1BO
MP"BBBK-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_%R+R2Y3^S_$TVD%O,V;O-.E1V1G V#8)S((LOY>SS'W>)/Q+R=?P\#F4O\
M'#"P[?RXFIY_<N[M][6^D?PG'^!DG$57M[:GEM#M_)F.(M]KOLN[Y?[TZ*_S
MY-3_ &N?VK=9"C5OVF_V@M21)'ECCOOC+\1;F**1^&:&&;Q&\4)(^7$2( N%
M "@"O.=4^+'Q3UP$:U\2_'^KAIVNF&J>,O$6H!KI]X:Y(N]2F!G82R;IC^\/
MF/ECO;/)/Q.PJ_AY37E_CQ5.';^6C4\_P[Z>76^DIEL;_5^%,=5[>VS/#T+[
M;\F$Q%NO?9=]/]%2_P!2T[2X!<ZG?V6G6QD6(7%_=06<!E<,5C$MQ)'&9&"L
M53=N(5B 0#CS[5?C;\&=!\\ZY\7/ACHPMI1#<G5?'WA73OL\S,%$4_VS5H?*
ME+$*(Y-K%B !FO\ .RGGFN9IKFYFEN+BXEDGGGGD>6:>:5S)+--+(6>261V9
MY)'9G=V+,22345<L_$^H_P"'DT(_X\?*?X1PE/[K_,\NM]);$._U?@^C3?1U
ML\G6^;4,JH?=?ROU/] O5_VS?V0]"^TC5/VHOV?+::T,:W%F/C#\/[C48VE:
M,(ITVUU^;4&)$J.P2V8I"3.^V%6=?.-6_P""D7["^BFX%Y^TU\,YC;*CR?V3
MJ-]KP82*C*+<Z%I^HB[8!UWI:F9XV#K(JM'(%_@[HKDGXF9D_P"'EV!A_CGB
M*G_I,Z9Y=;Z2/$4K_5^'LEI=O;5<=7MOOR5L/?IVV?=6_M^U;_@KE_P3WT@S
M1O\ M PW]Q%#YRP:3\./BUJ(G)4E88;RW\"-IGG-C;MEOHEC8@3-&.:\XU7_
M (+7?L(Z>7%IXK^(.NA+=IE;2OAQKL(ED DQ:)_;9T=A<-L4*T@CM,RINN5
ME,?\:%K:75]<16EE;7%Y=3MLAMK6&2XN)GP6VQ0Q*\DC;03M12< G& :[S2?
MA#\6=>\K^P_A?\1-9\^;[-!_9/@KQ+J/G7&5'V>+['IDWF3991Y29DRRC;R*
MYWXB<0UG:CA,O3Z>RPN*G+I_-BIJ^J7P]4<#^D%X@8MN.%RO((N]E]6RW,ZT
M]]$^?-*R;U2T@MUHKG]5NJ?\%Y/V.+%@EEX+_:"UEFA9UDLO!O@2WMUE!8+!
M,VJ?$VPN%)(5FDAM;A%1P07<-&/.-2_X. /@5$4_LCX$_%J^!1S(=2U3P=I1
M208\M4%KJ6LB1&&=[L8F3  CDSD?SOZ7^R#^UCK:J^D?LQ?M!ZC$UP+0W%I\
M&OB)-:1W!$9,4UVOATVUN466*20SRQK%&ZRR,D9W5Z/IO_!.K]N+55+6O[,7
MQ7B"RK"?[2\/G1FWL 00NL3V+-$,C=,H,*'(:0%6 /\ 6[C2M_"P]17V]CE4
MI]OYJ=3^F_*R_P"(K^,F,_W7+ZZOM]4X7J5NST]I0Q%]GWT;\K?LEJ/_  <)
MZ-%Y/]D?LI:G?;O,^T?VC\:+72_*QL\KR?LWPOUCS]^9?,W_ &?RMB;?.\QO
M*\WU'_@X*^(LJQ_V3^S9X*L6#,93J/C_ %W5%="!L6-;;P]HYB93DL[-*'!
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MVH/VEM?\_P#MW]H?XYZU]IC6&Y_M?XM>/M2^T1( $BG^V>()O-C4 !4DW*H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX7^,
MO_)1O$/_ '"?_3%I=?=%?"_QE_Y*-XA_[A/_ *8M+H ]V^ '_(FZG_V,UY_Z
M:M&KW*O#?@!_R)NI_P#8S7G_ *:M&KW*@ HHHH **** "BBB@ HHHH ****
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MQ%(MP^C?$'X@+%9:'X4L8)(Q!/I_@=O&$MW;RO<6?BG1M42TN=/_ %C^._\
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ME9)=DEHD%%%% PHHHH **** "BBB@ HHHH **** /!_VF_\ DAOCS_KWT/\
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M .I/HM?CO7[$?M-_\D-\>?\ 7OH?_J3Z+7X[UU4/@?\ B?Y( HHHK8 HHHH
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MUY_Z:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK&2235H]^O >+O%.45?JF?Y;1QTJ=E5C7HU,JS%=/?Y*?L$]-G@HMN]Y=O\
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M5:Z_X^;C_KO-_P"C&K_%+]L3_NWT>O\ K_XJ_P#IOPZ/ZY^BK_$XZ_P<-?\
MI6?$%%%%?XB']?A1110 4444 %%%% !1110 4444 %?L)^R?_P D)\'_ /7Q
MXF_]2C6*_'NOV$_9/_Y(3X/_ .OCQ-_ZE&L5_IW^R=_Y2/XL_P"S-<2_^MEX
M?G\Z_2;_ .2 RS_LK,O_ /53GA]&4445_P!#I_"(4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_CCHMUX2UN.&/++:P^/?!MKKVC:S?SI\D)O/!GA*Q$X43W<$+M-#^!/[1_\
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MMB?]V^CU_P!?_%7_ --^'1_7/T5?XG'7^#AK_P!*SX@HHHK_ !$/Z_"BBB@
MHHHH **** "BBB@ HHHH *_83]D__DA/@_\ Z^/$W_J4:Q7X]U^PG[)__)"?
M!_\ U\>)O_4HUBO]._V3O_*1_%G_ &9KB7_ULO#\_G7Z3?\ R0&6?]E9E_\
MZJ<\/HRBBBO^AT_A$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0GP?_P!?'B;_ -2C6*_T[_9._P#*1_%G_9FN)?\ ULO#\_G7Z3?_ "0&6?\
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M[VPT_4O$MWI]G^RE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?"_QE_Y
M*-XA_P"X3_Z8M+K[HKX7^,O_ "4;Q#_W"?\ TQ:70![M\ /^1-U/_L9KS_TU
M:-7N5>&_ #_D3=3_ .QFO/\ TU:-7N5 !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '@_[3?\ R0WQY_U[Z'_ZD^BU^.]?L1^TW_R0
MWQY_U[Z'_P"I/HM?CO750^!_XG^2 ****V *P?$OA7POXTTBY\/^,?#>@^+-
M!O !>:)XET?3]=TBZ #*!<Z;JEO=64X"NZ@2PO@,PZ,<[U%5&4H2C.$I0G%J
M491;C*,EJG&2:::>J:=T3*,9QE"<8SA).,H22E&46K.,HM---:----;GYA_&
M+_@D;^QU\4_M=[H7A36?A!K]R7E&H_#35FL=+,YW&,2>$]:AUGPW!9AB!):Z
M)I^B.Z#;'<PMAQ^5/QB_X(?_ !Y\*_:]0^#?CWP=\6--C+O;Z-K"R?#_ ,7R
M*VYH[>&+4+G5/"ETT0 BDN[KQ1HRS/MF2SA1WB@_J2HK[#*^/N*<JY8T\SJ8
MNC&W[C,5]<@TK6C[2H_K,(I*RC2Q%-);+16^(S?PXX0SCFE5RJG@J\K_ .T9
M8_J,TWO)TJ2^J3DWJY5<-4;>M]7?^!_XK_LZ?'7X&W3VOQ:^%/C;P,B3"W34
M]9T.['A^[F+%0FG>)K5;GP]JF6! ;3M4NE)Z,<BO(;*]O=-N[>_TZ[NK"^M)
M4N+2]LKB6UN[6>,[HYK>Y@>.:"6-@&22)U=2,JP-?Z&MY9VFH6MQ8W]K;7UE
M=Q/;W5G>017-K<P2J5DAN+>97BFBD4E7CD1D=20RD'%?"'QB_P""9?[&OQF^
MUW>I?">P\"Z]=M)(WB3X63_\(-?)+-O,T[:1I\,OA"\N9I6\^6YU/PS?3O,N
M]I#YDPE_1<L\7\+44:><Y54HM^[*O@)QKTG?1N6&KNG.$%K=*O6DUHHM[_E^
M;>">+I.57(LXI5TGS0P^8TY8>K&SNE'%8=5:<Y]F\/0BGO)+5?S6_![_ (*<
M_ME_!O[+:V/Q6O/'VA6HC4>'?BM;GQQ:21P[1%#_ &U>SV_C*UMXXU,*6^G^
M)[*%8C@1AHX6C_5?X/?\%TO VI?9M/\ CK\']>\+7!\N*7Q)\.-1MO$^DO(V
M ]Q<>'==DT75-+M(SDLEKK'B2Z*?<BD;Y3Y'\8O^"%GC'3_M>H_ CXQ:+XEM
MPTDEOX8^)>G3^'=42!=[+;Q>*/#\.K:9J=ZZA$1KGP_X=M&D+&2:!.1^5/QB
M_8K_ &H_@/\ :Y_B5\&/&.F:-9M)YOBG2+%/%7A%8DWLD\OB;PQ+JVCV2S1(
MTT4.I7=E=B-7\VVBDBECC]OZIX;<7_P7ET<75V]A)Y5CW-VN_8-4'B)+9RE1
MKP[-Z,\'Z[XI\$Z5UF<\%2W^LQCG&7*G'9+$1>(6&@UJHPKX>:5TTGS(_L)^
M#W[9G[+_ ,>/LT'PR^-'@S6=7NO+6'PQJ5^_ACQ=)))@&.'PKXHBT?7KSRY"
M(9)K&PNK42M&%G<2PM)].5_G;U]=?![]N_\ :S^!GV:W\"?&KQ:VBVWEHGA?
MQ7<Q>-O#*6\> ;2TTCQ7%JT.DP2*-KMH;:9< ?-'.CX8?-YIX/R7-/)LV4OY
M</F5.S^>+PT6FWK9?5(K:\NJ^IRCQNB^6GGN3..REB<KJ\R[7^IXJ2:2W;6-
MD^BCIK_<=5:Z_P"/FX_Z[S?^C&K^=+X/?\%U]5@^S6'Q[^"UIJ$8"+<^*/A1
MJ;V%TH3Y68>#?%=U<VUU-,I#NZ>--,A2166.U$<JBW_4[X3?\%&?V/?C;-'#
MX<^,.A>&];O)"R^&OB,'\!ZNDTS,T=G#/K_V;0M5NV!P(=!UK5LM\H8MQ7^'
M'[7WP0\6\UR3P8SG(/#SBSB?)N%JWB//B/-N%\DS#B+ 9%1S*GP.\!B<XK91
M0Q?]EX7%O+\;&CB,PCAJ,IX><'-3Y8R_O;Z)GBIX>U\9Q7@ZO%F39;C\SCD$
M<OP&<XVCE&,QM2A+./;4<'2S">'6,JTO;T7.GA)5Y)5$U=)M?;%%1Q2Q3Q1S
MP21S0S1I+#-$ZR12Q2*'CDCD0E)(Y$(9'4E64AE)!!J2O^?%IQ;C)-23::::
M::=FFGJFGHT]4S_0!--)IIIJZ:U33V:?5,****0!1110 4444 %%%% !1110
M 5^PG[)__)"?!_\ U\>)O_4HUBOQ[K]A/V3_ /DA/@__ *^/$W_J4:Q7^G?[
M)W_E(_BS_LS7$O\ ZV7A^?SK])O_ )(#+/\ LK,O_P#53GA]&5_*W_P60_X*
M_P#[1WP]_:+7_@GO^P9X;CU3XNR:/I]K\3/%T'A*V\=>)TUGQ?X9D\06_@7P
M3X:UBQU#PY##I7@C4+#Q7XL\6ZMI^KVUC#>/;;-#A\.:U?7?]4E?P+?MY?$_
MQ#_P3@_X+S_$O]HSQ_X"U'QCX-\;Z;J?BG08EDM8=2UOX?\ Q@^"5[\*M5UW
MPA?WR&VBU/P9XAE\1Z5#9S26::@/#-YX>GU#3K'5O[4B_P"EOP[RW"9CG&.>
M(P=',L1@LGQF.R[+L1**H8S'TIT8T*=53:A4BE4FW"7NWM.7NP9_F=XDYGC,
MMR; +#8ROEN'Q^<X+ 9GF6&C)U\%E]:-:5>K2E!.=.3=.*]I#WK7IQ]ZHD\'
M_@DW_P %@/VB_P!A9_V9O@'\?-"M]0_8=^(\VO+\/M5U'PI8Z+K?@WP_XI^+
M7C#2?$_Q"\(>+M+M+6Y\8^'O#_Q97QL?%ND^(_[>U&*&VU73M#O-+6QTBR;^
MTW]OCX]ZS^R_^QA^TK\>_#,ME#XL^&OPE\5:SX,GU*VCO=.A\;7-G_8_@N:_
ML9GCBOK.+Q3J6D27-B[JM["KVN1YM?B%_P $/_#W_!/7]JK]@G]E3X0_%SP]
M^SC\<?VB?V?;'X]12_##XG:+X3\7>-O!>D^.OCWX]\:O>V?@KQ=:W)U31]2T
M2Z\+:M)K-AINJZ=ILD\,#WMC?O=VY^D_^#C_ .(J^ O^"7/C_P -Q2_97^+7
MQ/\ A#\-;<1,(2RV7B8?$Z>VCVLAV26/PUN8Y8HP0]L9HW4PF05[/$5/+LYX
M]R_+Z632R_%2SZK@\WO!0P^94/[5:I8^%%I.4\3@U4K8FLTEB)34HN23J3\7
MANIF>2>'^8YC5SJ&982/#]+&9/:;GB<LK_V2G5R^I5NXJ&&QKIT,-14G+#PI
MN,E%M4X?S9Z7_P '$7_!6K6[7[;HS?#W5[+S'A^UZ7\!XK^U\V/:9(OM%I-+
M%YB!EWIOW+N7<!D5_4'_ ,$//VU/VG/VW_V?OBU\0/VI(-+M_%_A+XQR>#O#
MR:5X);P-"?#:^"?"NMJTFGMS=R_VIJNH#[;T*!8/^65?SF?\$V?^"^GPU_X)
M_?LN?";]FA_V7?%?Q%;2-:\>>)/B9\0K+XFZ-X7F?5_%?C;6M4L#X7\(S>#=
M<378[#PD_AW3IYM7\5>&9)-1LKN..(6BP7,O]J7[*'[5?P;_ &T?@?X3_: ^
M!>NW.M>!O%8O+5K?5+/^S/$7AK7]*G-KK?A7Q3I'G7']EZ_H]T EQ#'<75C>
M6LUGJ^CW^I:)J6FZE=]?B#AX9=A,3AH<"X/*,+4QSHX'/\/5PTI5H4*LG%RI
M8>BY89XNE3E*%*O5A-PYI*,K21Q^'6(GF.,PV*J<?8W.<7#+U7QW#V)I8F$:
M-2O1@I\M;$5U'%+!U:D83JT*,X*I9.4.979^UW^TYX"_8Z_9R^*G[1GQ&F7_
M (1_X;^&KC4K72EN(K:]\4^);MX].\*>$-+>4X.I>)_$-WIVCVS[72U%U)?7
M 6TM;B1/YYO^"!G_  4U_;-_;N_:0_:(\,_M)_%2R\9>#/#7PPB\:>#_  CI
MWP_^&_A/3_"NJ:AX\TW3UAL-4\*^$M'\3ZE96.E7LFF6L?B37=;E>!4N+R:Z
MU ->-XQ_P5X^*'C/_@J#_P %$_@=_P $G/@)K=PGP^^&OB]=;^/7B?3&>YTN
MT\:6NF37OC+5=1\L36,]O\%_ ,FHZ7IT=Q);B[^(_BC6_"=V@U&UTQC\_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC%\;U\&>!?AKX'\5^-/A=+XP\'ZGX$^(/A#XFCXHZ;IWQ2MM3\">%])NH/\
MA"GO]7\3Z1/K5I;KH-E*X!_(I_P<T?\ !6[X"?\ !5#]H#X!C]EM/%.M?!+]
MG7P!XIT>W^(/BGPWJ7A&;Q=X\^*&JZ-JWB:/2O#^L0PZS9:%HVD>#?"]C9W.
MMV^F:CJ.K+XA,.E)I=II^I:I_I4_\$O]1O\ 5_\ @FC_ ,$[]6U5)H]4U/\
M88_9)U'4H[@RFX2_O?@%\/[F\2<S@3&9;B602F4"7>&\P!\U_GF?\',O@_\
M8?\  GQB_8E_X)M?\$S/AW\,M+_X5?+\1?$/C[PE\%+U/%D^L?&;]H;6?A=X
M+\%^%?%WBN75-?U[Q+\2K;1_AC8B2U\0Z]J6M:?I7BGP_;3M#'<6\,?]>?\
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M&)PM:GB,/6IRVJ4JU*4Z=2#Z2A*47T84445Q&X4444 %?L)^R?\ \D)\'_\
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M&M*L9;]+BXL]>TCQAH'@34=9BES9>8B:]X<U71[G3HH[[5/] _XR_ ?]E_\
MX*2?L=_ K6_VO=!A_P"$(\4>#_AQ\==*">/O$WPVM/"?B_Q7\.AJ']HP7FG^
M(=)M[B2PT;Q-KNGP6?B==8M;:SNKN9K47<8NH_X=?V6/AK^W9_P5%^&'[)G[
M O@/P5=Z1^RO^SMXH\::OJGQ0M_"^J6?@[0[KQS\0?%/C+QAXU\<>-M0:72-
M9\7:%IOCK5= \$>!]#FM+Z]MMP32II;G6=:MOZR/^"UO_!-;Q%^U=^PAX!\
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MT-G;I%J,-O;W-U+=S9/_  <9?\$Y_C-^T7I'PF_:Z_9P\.Z]XT^(GP-T6_\
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M[Q5;1P:AI&A_&+QC<6_B:TDM1%!G5= \$:[IWAO1!=)MO-;TSP\]]:RV$]]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP])2E)4Z&'IQI4::E.4IR4*<(QYIRE)VO*3;;91116!T!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9O3]KEF8X/'P23D\+B*=64+]*D(2<Z4M=8U(QDNJ-RBBO$OCO^TE\!/V8?"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY17\V5]\>_VZ/#O_  ;-_$7]H']H;Q+\9_A?^W5H/[)_QC\4^+/%7B_PQ?\
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MX ?\B;J?_8S7G_IJT:O<J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M87U%_BQX_P# WPKUB*U4NC/M\/>)-;U":'))L;.Z+)(J,C 'Z%_\/"?V!?\
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M;CR/_HH:JA_UZSZ-E_X<4XV^27H?T"?#3_@Z?_8L\0BVM_B?\$_VA?AM>SB
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MO]M:669(_P"U-$GNH=7TT3$P&^LK<7"20F1&_P B#]H?]G7_ (*2_P#!#/\
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MGQ_XJ\5WGP/T*^TCP[HMINU[7_&?CSPU?WS>.Q:7^LOXL\*FXAU*QM_[./\
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M?@;Q1\-1JMAH>L_$;X1PZCJWC71)/ FIW[V=O+X[\"^+-1UZYTSPW=:C9_\
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M;8W'[>G@#]A=/V4_V^?V>OB?\&O%O[,6JV/A3X,^*OB#800Q>/O@CKD=]?\
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M>(PZ7SJTX(^IPF;Y5F%OJ&9Y?C>;;ZIC,/B+^BHU)OU70]0HHHK@/0"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **CFFBM
MXI9YY8X(((WFFFF=8XH8HU+R2RR.52..-%+N[L%1068@ FOC;]F[]O7]G/\
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MQ!\//BCX7\42Z3KO@_4=.<7=G8>+=*U&ZU#0-?M],TW_ $K_ ((?$+0?C_\
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MKPWX ?\ (FZG_P!C->?^FK1J]RH **** "BBB@ HHHH **** "BBB@ HHHH
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M_@W[_P""J/PY^T3P?L\V/Q$TNVW;M4^&WQ+^'.O^;MC\P?9]!U#Q+HGC"XW
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M^*56=3*H8N2IX&IB*<I)SA0K4:=2%W*C4P\:-7WJ<T^"^$)_:)_X( ?\%/\
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M** "BBB@ HHHH *^,OVCO^1PT?\ [%JW_P#3IJM?9M?&7[1W_(X:/_V+5O\
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MOV*#7O$>G>!-+U?6/'%]:W#-#JVK6%_?6T0\2Z>S?(G_  4,^)/Q1_X)8_\
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M#-<QRGV^-QM9057$5OK6(ASS5.$()\D(Q]V$59;7"BBBOSD_30HHHH ****
M"BBB@ HHHH **** "BBB@ KX7^,O_)1O$/\ W"?_ $Q:77W17PO\9?\ DHWB
M'_N$_P#IBTN@#W;X ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O
M<J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /!_VF
M_P#DAOCS_KWT/_U)]%K\=Z_8C]IO_DAOCS_KWT/_ -2?1:_'>NJA\#_Q/\D
M4445L 4444 %%%% !1110 4444 %%%% !5:Z_P"/FX_Z[S?^C&JS5:Z_X^;C
M_KO-_P"C&K_%+]L3_NWT>O\ K_XJ_P#IOPZ/ZY^BK_$XZ_P<-?\ I6?$%%%%
M?XB']?A1110 4444 %%%% !1110 4444 %?S:_\ !1/_ ).P\?\ _8+\$?\
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M3?&^G32K:P3V]ZVFW@A\16,MO!::@;G]X?\ @IO^Q+^RW_P63^'O@K4/V?\
M]J+X$W7Q^^%R:Q%\.?%OA3X@^#_'WA?Q)H6NR6$^K^"_&P\$:CK>NII0O+*V
MU'1-8TV'4;CPS?SZFT>BZC%K=["?YI/V'_\ @B3^TA^U?\9/V@/@'XR^./A;
MX??#+]EKXXV'@7X[1:1K?BKQ-)K?C#35U;2AJ?PU\,7&CZ=X>U:]_L'3=6T[
M3?%/BN;0[K2;2\MX_P"R+Z"2[TU?TSA"/#F RG^THYCB.'\TP$,$^(:56&+E
M5JT\/F^$KPG2@W?V>/I4W@I4J4)P;Q3A4I-4VJOY=QE+B3,,X662RW#<1Y5F
M%3'?ZN5:,\'&E2J8K)L70G3K3BK>TR^I56.A6K5(S4<*JE.JO:*5']]O^"4?
M[7.E?L8?\$(_ W[2OQK\-_$3QC\.OAIXP\?V%EIOP]L-(USQ6/"WB3X]ZAX0
MTVYM+3Q3XC\*Z4NE:?XU\07UO=N=:B2RTZ-I;:&>2/[+7Z]?L.?MR_!C_@H/
M^S?+\?? 5A<^'_"C:YXQ\'^,O!_CFZ\/SZOX4N/#TTBW-GXQATZ_U'1[2'5_
M"]UI7B989KJ6W&B:W;&>1U\QCZ0O[(/P%'[*$?[%<G@V&?X 1_"J+X/GPO-(
MK7<GAB+2UT]=2?4UA27_ (2S[6@\1_\ "3)&FI+XK'_"1(ZZB!*/X^_B#_P;
M:?\ !0SX8>+?&G@K]F#]H[P-K/P,^(L_]E:I<ZG\1_'OPIU+5_#'E73V]C\7
M/!.@:!K.B:_!IXGGT[&DWOBF+4/M!OTT728KRZT^R^6H4^%.**^?5\;F*X>S
M3$YW7S'!8K%*<\+/+*]24Y89TXSA26+A*4JDI.<93DZ<:7-%5;?65ZG%O"E#
MA_#X'+'Q'E6%R+#Y9C<)A'"GBJ>:8>G"$,4JDX3JRPDXQ5*,5"4815255J3I
M)\U_P;\WEI'_ ,%AOVA;'X(7.WX)7?@?]HBXM;33YIET>?X6V?Q3\,I\.KA+
M="8)1:W-WX5CTV690\%M>7*0NOGR)(S]B:*T_9Q_X.6/B1X,\8W$>AVOBGX_
M_M3^'=$N=4D6%7B^*>B^.O&?PSA:61UW7?B>#4_#&F:=M#M>ZAK5G#'&/M(9
M/Z1/^"1G_!)[PE_P3.^&WB:;6/$UA\2/C_\ %.'1_P#A97CG3K![3P_I&G:0
M)Y[#P+X"%_!%K'_"-6=_=W-YJ.KZDEC?^*]0CL=0OM(TF'3M+TK3_CG_ (+'
M_P#!$'Q7^VM\3-&_:I_96\7^&? ?[0MEI^BZ7XWT+Q3?ZGX=T;Q\OA:.*+PG
MXNT?Q9HEAJ5[X>\?^'["UL]#1[RR.F:OI6G:"1JOAVZT%Y=;^EJ<69%F/$^?
MX2IC)8?)\XX>7#]/-ZE.33Q-&G*-+'5XM1G[.4JM:"G-1ORTI3]G3E)P^7AP
M?G^6\+</XRG@HXG.<EXD?$53)Z52*Y<-7J1E5P%"2<X>TBJ-&<H0<E'FK1I^
MTG&*J?DY_P '.6K+\5_V^OV:/@9X*GBUSQGI_P 'O#6@RZ3:3QSO9^*_BE\2
M_$%OH&AW446Z2UU2\LK;1-2-O-B1]-UC2+I(_*N8WD_M6\1?$'X2_ 7PGX6M
MOB5\3? /PVT&"TL/"^AZK\0_&'AKP39:I<:3IL<:6=E=>(-1TRTN;T6=J;F2
MTM'>1(D>01B)"1_,E_P3!_X((_''X6_M.Z+^V)^WW\0_#OCOQMX'U=/%O@CP
M3IWBK6_B1KFL_$.UB6'1/'/Q)\;Z_9VR32>$)(H=5\.:7I=SKES=ZY:Z-J5]
MK6G6VB/HVL?HU_P6R_X)Q_&__@I'\&?@[\._@=XI^%7A76_A[\3K_P ::U=?
M%?7/%VAZ7=:7=>%=2T..WTN?PAX&\=7<VH+=WD4CQ7=C96PMED=;II0L+>'G
MM;(,;6X2X4IYU3EE>2X;%4\?GE.FWA_K.,:K572C)VG"$Z$%&49RC^_Y5.4H
M2/>R&AQ#@:/&'%U3(ZD<VSO$X2IE^15:J^L?5<$G1IJK.*3A.<*\Y.,H1G_L
M_-R1C.-_LG]LO]J7]BCX1_LS2^//VL/%?A;7?V:/C#Y'@""Z@\*>(/B[X/\
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MF_\ DAOCS_KWT/\ ]2?1:_'>OV(_:;_Y(;X\_P"O?0__ %)]%K\=ZZJ'P/\
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M_$G[-_QHMK+2!&=2UG3_ (>^)=?\.68FDEBB,WB?P_I^J>'@)7AD$174V\P
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M^CP?\IK^)7_:,'&W_KT_!<_R\_:U?\HW<'_]GIX:_P#6)\1#XAHHHK_LS/\
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MLM#\ ?"R+7U\2ZM)9V-I9ZGX@GT#PI%/9W_BB*^ME_8-_;/\*_L<_P#!O?\
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MM-/TW3[6WM+6"-<)%$H)+9)_SR/^#C__ (*E_&?_ (*)?M=:%_P1A_8+:_\
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M3:986_E_:+[4-!U6RLX/-E2"+SKFYM(H8O-FECACWNN^61(UR[J#_L&Z%_R
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MTD7R[W3XKJSFPK@/Y,[^7('BDVRQNB\M>?L+_MJV-S+:3_LC_M+/+"5#O9_
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M^2D_#W_L>/"?_I^T^N'KN/AC_P E)^'O_8\>$_\ T_:?2EL_1_D!^Y%%%%<
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MJQHHHK_*P_UX"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ#X??"_XF7-[I7A\:M=7+Z7JB:5I]H^C^'[J$ZA=VD#6'\DO_$%3_P %3?\
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MXR_:._Y'#1_^Q:M__3IJM?9M?&7[1W_(X:/_ -BU;_\ ITU6OL^ O^2BH?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MYC?\%D_^4:W[3G_8*^''_JY?AU7Z<U^8W_!9/_E&M^TY_P!@KX<?^KE^'5?:
M^&O_ "<7@'_LM>%?_5[@#X7Q1_Y-GXB?]D+Q=_ZS^8'\ %%%%?[%G^)(4444
M %%%% !1110 4444 %%%% !1110!_J1Z%_R ]&_[!6G?^DD-:M96A?\ (#T;
M_L%:=_Z20UJU_B%4_B5/\<O_ $IG^]E'^%2_Z]P_])04445!H%%%% !1110
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MJQ$;S>&])L+-+KQ5XHLHI RRZEI\%WIFF:660I9ZAK=MJ;B3[ MM<?A1>?\
M!/?]JV#]GVP_;9_X3*YO_%=_;:%\1;/0+#5/%FH?%^70=:N;)=)\70ZY;Q2W
M$FO&UO++Q!]BBOWO[?0F-RU\FJ0/I*^;D7!]+,\!1S',LYPV2X?'8MX#*U6H
M2Q$\=BHOEDDE6HQHT54O2=64I)3C-2C!*#GZ?$7'%7*<RKY7E>18K/L3E^"6
M8YNZ&(CAJ>7X1I3BVY4*[K5Y4FJJHQ4&X2@X.;<U3_L&HKXK_P""?WQ6^*OQ
M=_9E\':Y\:_#OB;0?B1H-WJ'@_7[CQ5X?U;PYJ7BB/1%M7TGQ9]CU>TLYKHZ
MQH][8C4=2M4>QO==MM7> PD26EM]D:A?V>E6%]JFH3I:V&FV=S?WUS*<1V]G
M9PO<7,\A[)##&\CGLJDU\GCL%5P&-Q. JN%2MA<14P\I49>TIU)4YN"E2DE[
M\)V4H.R;BU=)Z'V>7X^CF.7X3,:*J4Z.+PU+$QC7C[.K2C5@IN%:+^"I3NXU
M%=I2B[-JS<UQ<6]I#+<W4\-M;PH9)KBXE2&&)%ZO++(RQQH.[.P [FIJ_D1\
M/>$?VD/^"NO[0'Q$U5/&<'AOP7X1\S6;&S\37^K77A+X>>'M5OKNR\)^&M#T
M/3HI8KGQ!J5K:7+WU^L%@=4;3=7U*]O4=;2QE]=_8S\??'3]A#]N;3?V0_B1
MXF_MKP3XM\4:-X)U?0;;4[S4?"O]J>,],L)_ /C;P<=1@@FTRYN9[_1+'4(8
M[:S^UV%S>:9JEK)J&FZ=/I_WN)\/'0PV+I0SS"5L_P !EW]IXS(XT)*=+#J$
M*DXQQ?MG&=6,)QLO8Q4I3IJ\(3A4E^<X7Q,6(Q6#K3X?QM#AS,<S_LG \03Q
M$'"KB93G3A*>#]C&5.C.<)7E[>3A&G4=IU*<Z4/ZD:AAN;:Y,PM[B"<V\[VU
MP(98Y3!<QA6DMYMC-Y4Z*Z,\3[9%#J64!AG\#O\ @LC^T-\5-/\ %_PJ_92^
M%^L:EH(^(VA67B/Q2=%U"73-2\5CQ+XFU'P?X5\+3:A%);O;Z+)?Z+JTVIVO
MV@6^J/<64=\!:V;1W'P/\?OV-_VB_P#@F?:?#'X]^%?C%83WFI^(K;PY>ZEX
M*75M(_L3Q7)I6HZS;Z%>VNH,T'BSPUJNFZ5KD;R7]I;0W<5I<6VH:)#'=1[\
M,IX%IYA@<MK8K/,+EV/SN.(EDV7U,-5K/%1P]TY5L1"I&.'4VKP3IU&XRCR\
M]1NDNG.O$*IEF89IA\'P]B\TR[(98:.>9G2Q5*@L'+$J+4:&&G2G+%.FI6G^
M\I)2C/FY*259_P!=]=Q\,?\ DI/P]_['CPG_ .G[3Z^;_@1\2U^,OP6^%7Q6
M%K#82_$'P#X6\5WFGV[O)!INI:SH]I=ZIIL,DG[R6+3M2DNK*.5_FD2 .>6K
MZ0^&/_)2?A[_ -CQX3_]/VGU\%B*-3#U:]"K'DJT*E2C5C=/EJ4I2A.-UH[2
MBU=::'Z+0K4\30HXBC+GHXBE3K4I6:YJ=6"J0E9ZJ\9)V>NI^Y%%%%>6:A11
M10 4444 %%%% !1110 4444 %%%% '^<'_P4 _Y/F_:__P"SDOC-_P"I_KU?
M(=?7G_!0#_D^;]K_ /[.2^,W_J?Z]7R'7^T'"7_)*\,_]D_DW_JNPQ_ACQ?_
M ,E;Q1_V46=_^K/%!1117T!\Z%%%% !1110 4444 %%%% !1110!_9=_P;E?
M\F@?&+_LY+7O_58?"VOZ"J_GU_X-RO\ DT#XQ?\ 9R6O?^JP^%M?T%5_DOXY
M_P#)V^.?^QPO_4/"G^Q_@!_R9O@#_L2?^[F+"BBBOR<_80HHHH **** "BBB
M@ HHHH **** "BBB@ KX7^,O_)1O$/\ W"?_ $Q:77W17PO\9?\ DHWB'_N$
M_P#IBTN@#W;X ?\ (FZG_P!C->?^FK1J]RKPWX ?\B;J?_8S7G_IJT:O<J "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /!_VF_P#D
MAOCS_KWT/_U)]%K\=Z_8C]IO_DAOCS_KWT/_ -2?1:_'>NJA\#_Q/\D 4445
ML 4444 %%%% !1110 4444 %%%% !5:Z_P"/FX_Z[S?^C&JS5:Z_X^;C_KO-
M_P"C&K_%+]L3_NWT>O\ K_XJ_P#IOPZ/ZY^BK_$XZ_P<-?\ I6?$%%%%?XB'
M]?A1110 4444 %%%% !1110 4444 %?S:_\ !1/_ ).P\?\ _8+\$?\ J&:'
M7])5?S:_\%$_^3L/'_\ V"_!'_J&:'7^\O\ H\'_ "FOXE?]HP<;?^O3\%S_
M "\_:U?\HW<'_P#9Z>&O_6)\1#XAHHHK_LS/^=H**** "BBB@ HHHH ****
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M45#_ +!L5_Z;/BO$#_DFZ_\ V$X3_P!.H^?****_=3\$"BBB@ HHHH ****
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MVEKI6IG4+0+:Z@^HV<<5])?6RK!>27#7$*B.50/>/AC_ ,E)^'O_ &/'A/\
M]/VGU^8G_!+35=;UC]A#X"W.O2W$]S;V'C72K*>Y;,KZ)HOQ(\8:1H40!P4M
M[+2K*TT^S4@9LK2W==R.KM^G?PQ_Y*3\/?\ L>/"?_I^T^OQC.,-/!YIFF#J
MUGB*F%Q^-P]3$/>O.CB*M.=9J[LZDHN;3;:;:;9^ZY+BJ>.R?*<;1H+#4L7E
MN!Q-/#+;#TZ^%I584$[*ZI1DJ::2344TK'[D4445\^>F%%%% !1110 4444
M%%%% !1110 4444 ?YP?_!0#_D^;]K__ +.2^,W_ *G^O5\AU]>?\% /^3YO
MVO\ _LY+XS?^I_KU?(=?[0<)?\DKPS_V3^3?^J[#'^&/%_\ R5O%'_919W_Z
ML\4%%%%?0'SH4444 %%%% !1110 4444 %%%% ']EW_!N5_R:!\8O^SDM>_]
M5A\+:_H*K^?7_@W*_P"30/C%_P!G):]_ZK#X6U_057^2_CG_ ,G;XY_['"_]
M0\*?['^ '_)F^ /^Q)_[N8L****_)S]A"BBB@ HHHH **** "BBB@ HHHH *
M*** "OA?XR_\E&\0_P#<)_\ 3%I=?=%?"_QE_P"2C>(?^X3_ .F+2Z /=O@!
M_P B;J?_ &,UY_Z:M&KW*O#?@!_R)NI_]C->?^FK1J]RH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH \'_:;_ .2&^//^O?0__4GT
M6OQWK]B/VF_^2&^//^O?0_\ U)]%K\=ZZJ'P/_$_R0!1116P!1110 4444 %
M%%% !1110 4444 %5KK_ (^;C_KO-_Z,:K-5KK_CYN/^N\W_ *,:O\4OVQ/^
M[?1Z_P"O_BK_ .F_#H_KGZ*O\3CK_!PU_P"E9\04445_B(?U^%%%% !1110
M4444 %%%% !1110 5_-K_P %$_\ D[#Q_P#]@OP1_P"H9H=?TE5_-K_P43_Y
M.P\?_P#8+\$?^H9H=?[R_P"CP?\ *:_B5_VC!QM_Z]/P7/\ +S]K5_RC=P?_
M -GIX:_]8GQ$/B&BBBO^S,_YV@HHHH **** "BBB@ HHHH **** "OZA_P#@
MVG_Y#G[8G_8*^!7_ *5_%NOY>*_J'_X-I_\ D.?MB?\ 8*^!7_I7\6Z_$OI&
M?\F9XS_P9#_ZT^2G[Q]&7_D^/ W_ %\X@_\ 65ST_JQHHHK_ "L/]> HHHH
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MXY?^E,_WLH_PJ7_7N'_I*"BBBH- HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OC+]H[_D<-'_[%JW_ /3IJM?9M?&7[1W_ ".&C_\ 8M6__ITU
M6OL^ O\ DHJ'_8-BO_39\5X@?\DW7_["<)_Z=1\^4445^ZGX(%%%% !1110
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M\2?#=C\&+?7HM48#XF^);[X?M-)=N+G7M,^'B6D<LFO16X:[5;W1-*:>>6.
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M/$4_:5*U?#8F.+@^92BHQG5C^\BHVE!N*Y5:W;5X6RFIB\GQD(5L-4R+!XK
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M% !1110 4444 %%%% !1110!X/\ M-_\D-\>?]>^A_\ J3Z+7X[U^Q'[3?\
MR0WQY_U[Z'_ZD^BU^.]=5#X'_B?Y( HHHK8 HHHH **** "BBB@ HHHH ***
M* "JUU_Q\W'_ %WF_P#1C59JM=?\?-Q_UWF_]&-7^*7[8G_=OH]?]?\ Q5_]
M-^'1_7/T5?XG'7^#AK_TK/B"BBBO\1#^OPHHHH **** "BBB@ HHHH ****
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M ^%\4?\ DV?B)_V0O%W_ *S^8'\ %%%%?[%G^)(4444 %%%% !1110 4444
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MKS_TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?E_\
MMK?\E4T#_LG^E?\ J1^*Z_4"OR__ &UO^2J:!_V3_2O_ %(_%= ''^ ?VH?'
M_P .O">D^#=$TCP?=:9H_P!O^S3ZKI^M3W\G]H:E>:K-Y\MIX@L;=MMQ?2I%
MY=K%MA6-7WN&D?L/^&UOBI_T /A__P""KQ'_ /-77L'P$^ GPF\:_";PIXF\
M3>%/[3UO4O[=^VWO]N^);/S_ +'XEUG3[;_1M/UFTM(_+M+2WA_<V\>_R_,D
MWRN[M[!_PRW\"?\ H1?_ "Y_&/\ \T- 'Q__ ,-K?%3_ * 'P_\ _!5XC_\
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M1?\ RY_&/_S0T ?'_P#PVM\5/^@!\/\ _P %7B/_ .:NC_AM;XJ?] #X?_\
M@J\1_P#S5U]@?\,M_ G_ *$7_P N?QC_ /-#1_PRW\"?^A%_\N?QC_\ -#0!
M\?\ _#:WQ4_Z 'P__P#!5XC_ /FKH_X;6^*G_0 ^'_\ X*O$?_S5U]@?\,M_
M G_H1?\ RY_&/_S0T?\ #+?P)_Z$7_RY_&/_ ,T- 'Q__P -K?%3_H ?#_\
M\%7B/_YJZ/\ AM;XJ?\ 0 ^'_P#X*O$?_P U=?8'_#+?P)_Z$7_RY_&/_P T
M-'_#+?P)_P"A%_\ +G\8_P#S0T ?'_\ PVM\5/\ H ?#_P#\%7B/_P":NC_A
MM;XJ?] #X?\ _@J\1_\ S5U]@?\ #+?P)_Z$7_RY_&/_ ,T-'_#+?P)_Z$7_
M ,N?QC_\T- 'Q_\ \-K?%3_H ?#_ /\ !5XC_P#FKH_X;6^*G_0 ^'__ (*O
M$?\ \U=?8'_#+?P)_P"A%_\ +G\8_P#S0T?\,M_ G_H1?_+G\8__ #0T ?'_
M /PVM\5/^@!\/_\ P5>(_P#YJZ/^&UOBI_T /A__ ."KQ'_\U=?8'_#+?P)_
MZ$7_ ,N?QC_\T-'_  RW\"?^A%_\N?QC_P#-#0!\)>.OVI/B!\0?"FK>#]9T
M?P=;:9K*6J74^F:?K<-]&+._M=0B-O+=^(;VW4M-:1K)YEK*#$SJH5RKK\V5
M^P'_  RW\"?^A%_\N?QC_P#-#1_PRW\"?^A%_P#+G\8__-#5*<HJR;2W _'^
MBOV _P"&6_@3_P!"+_Y<_C'_ .:&C_AEOX$_]"+_ .7/XQ_^:&G[2?\ ,P/Q
M_HK]@/\ AEOX$_\ 0B_^7/XQ_P#FAH_X9;^!/_0B_P#ES^,?_FAH]I/^9@?C
M_17[ ?\ #+?P)_Z$7_RY_&/_ ,T-'_#+?P)_Z$7_ ,N?QC_\T-'M)_S,#\?Z
M*_8#_AEOX$_]"+_Y<_C'_P":&C_AEOX$_P#0B_\ ES^,?_FAH]I/^9@?C_17
M[ ?\,M_ G_H1?_+G\8__ #0T?\,M_ G_ *$7_P N?QC_ /-#1[2?\S _'^BO
MV _X9;^!/_0B_P#ES^,?_FAH_P"&6_@3_P!"+_Y<_C'_ .:&CVD_YF!^/],D
MC621Y&)#2.SD#& 6)8XR"<9/&23CN:_8/_AEOX$_]"+_ .7/XQ_^:&C_ (9;
M^!/_ $(O_ES^,?\ YH:_+_$KP9\+O&&.31\3N"<EXSCP\\PEDJSFE6JK+GFJ
MP2S%X?V5:CR_6UEV!5;FYK_5J=K6=_H^'^+N)>%7BWP[G&,REXY4%BWA)0C]
M86&=9T/:<\)W]E[>MRVM_$E>]S\>?(3U;\Q_A1Y">K?F/\*_8;_AEOX$_P#0
MB_\ ES^,?_FAH_X9;^!/_0B_^7/XQ_\ FAK\K_XDL^BM_P!&0X)_\)<9_P#-
MOE^?=GTG_$7?$K_HL<X_\&4O_E/E^?=GX\^0GJWYC_"CR$]6_,?X5^PW_#+?
MP)_Z$7_RY_&/_P T-'_#+?P)_P"A%_\ +G\8_P#S0T?\26?16_Z,AP3_ .$N
M,_\ FWR_/NP_XB[XE?\ 18YQ_P"#*7_RGR_/NS\>?(3U;\Q_A1Y">K?F/\*_
M8;_AEOX$_P#0B_\ ES^,?_FAH_X9;^!/_0B_^7/XQ_\ FAH_XDL^BM_T9#@G
M_P )<9_\V^7Y]V'_ !%WQ*_Z+'./_!E+_P"4^7Y]V?CSY">K?F/\*/(3U;\Q
M_A7[#?\ #+?P)_Z$7_RY_&/_ ,T-'_#+?P)_Z$7_ ,N?QC_\T-'_ !)9]%;_
M *,AP3_X2XS_ .;?+\^[#_B+OB5_T6.<?^#*7_RGR_/NS\>?(3U;\Q_A1Y">
MK?F/\*_8;_AEOX$_]"+_ .7/XQ_^:&C_ (9;^!/_ $(O_ES^,?\ YH:/^)+/
MHK?]&0X)_P#"7&?_ #;Y?GW8?\1=\2O^BQSC_P &4O\ Y3Y?GW9^//D)ZM^8
M_P */(3U;\Q_A7[#?\,M_ G_ *$7_P N?QC_ /-#1_PRW\"?^A%_\N?QC_\
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M1O\ %C_HNL\_\&T?_E ?\0$\'?\ HW^0?^":_P#\O/Y2O^'4W[/'_0Y?&?\
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M (9;^!/_ $(O_ES^,?\ YH:/^&6_@3_T(O\ Y<_C'_YH: /C_P#X;6^*G_0
M^'__ (*O$?\ \U='_#:WQ4_Z 'P__P#!5XC_ /FKK[ _X9;^!/\ T(O_ )<_
MC'_YH:/^&6_@3_T(O_ES^,?_ )H: /C_ /X;6^*G_0 ^'_\ X*O$?_S5T?\
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M9;^!/_0B_P#ES^,?_FAH ^/_ /AM;XJ?] #X?_\ @J\1_P#S5T?\-K?%3_H
M?#__ ,%7B/\ ^:NOL#_AEOX$_P#0B_\ ES^,?_FAH_X9;^!/_0B_^7/XQ_\
MFAH ^/\ _AM;XJ?] #X?_P#@J\1__-71_P -K?%3_H ?#_\ \%7B/_YJZ^P/
M^&6_@3_T(O\ Y<_C'_YH:/\ AEOX$_\ 0B_^7/XQ_P#FAH ^/_\ AM;XJ?\
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M  VM\5/^@!\/_P#P5>(__FKH_P"&UOBI_P! #X?_ /@J\1__ #5U]@?\,M_
MG_H1?_+G\8__ #0T?\,M_ G_ *$7_P N?QC_ /-#0!\?_P##:WQ4_P"@!\/_
M /P5>(__ )JZ/^&UOBI_T /A_P#^"KQ'_P#-77V!_P ,M_ G_H1?_+G\8_\
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MZ$7_ ,N?QC_\T-?I7_$;_%C_ *+K//\ P;1_^4'Y;_Q 3P=_Z-_D'_@FO_\
M+S^4K_AU-^SQ_P!#E\9__"B\#_\ SNJ/^'4W[/'_ $.7QG_\*+P/_P#.ZK^K
M7_AEOX$_]"+_ .7/XQ_^:&C_ (9;^!/_ $(O_ES^,?\ YH:/^(W^+'_1=9Y_
MX-H__* _X@)X._\ 1O\ (/\ P37_ /EY_*5_PZF_9X_Z'+XS_P#A1>!__G=4
M?\.IOV>/^AR^,_\ X47@?_YW5?U:_P##+?P)_P"A%_\ +G\8_P#S0T?\,M_
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M (=3?L\?]#E\9_\ PHO _P#\[JC_ (=3?L\?]#E\9_\ PHO _P#\[JOZM?\
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MOBI_T /A_P#^"KQ'_P#-77V!_P ,M_ G_H1?_+G\8_\ S0T?\,M_ G_H1?\
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M"KQ'_P#-71_PVM\5/^@!\/\ _P %7B/_ .:NOL#_ (9;^!/_ $(O_ES^,?\
MYH:/^&6_@3_T(O\ Y<_C'_YH: /C_P#X;6^*G_0 ^'__ (*O$?\ \U='_#:W
MQ4_Z 'P__P#!5XC_ /FKK[ _X9;^!/\ T(O_ )<_C'_YH:/^&6_@3_T(O_ES
M^,?_ )H: /C_ /X;6^*G_0 ^'_\ X*O$?_S5T?\ #:WQ4_Z 'P__ /!5XC_^
M:NOL#_AEOX$_]"+_ .7/XQ_^:&C_ (9;^!/_ $(O_ES^,?\ YH: /C__ (;6
M^*G_ $ /A_\ ^"KQ'_\ -71_PVM\5/\ H ?#_P#\%7B/_P":NOL#_AEOX$_]
M"+_Y<_C'_P":&C_AEOX$_P#0B_\ ES^,?_FAH ^/_P#AM;XJ?] #X?\ _@J\
M1_\ S5UYEXU_:!\9>/-2MM4U?3/#-M<6MBFGQIIMEJL,+0I<7%P&=;K6KQS*
M7N7!99%38$ 0$%F_0W_AEOX$_P#0B_\ ES^,?_FAH_X9;^!/_0B_^7/XQ_\
MFAKJP>-Q6 K+$8.O/#UXQE%5*;2DHR5I+5-6:T>FQRXS!83,*#PV-H0Q%"4H
MR=*HFXN4'>+:33NGJM3\P?\ A96N_P#/II/_ 'XO/_D^C_A96N_\^FD_]^+S
M_P"3Z_3[_AEOX$_]"+_Y<_C'_P":&C_AEOX$_P#0B_\ ES^,?_FAKUO]:N(?
M^AMB_P#P*/\ \AY?GW9Y'^J?#G_0HPG_ (#/_P"3/S!_X65KO_/II/\ WXO/
M_D^C_A96N_\ /II/_?B\_P#D^OT^_P"&6_@3_P!"+_Y<_C'_ .:&C_AEOX$_
M]"+_ .7/XQ_^:&C_ %JXA_Z&V+_\"C_\AY?GW8?ZI\.?]"C"?^ S_P#DS\P?
M^%E:[_SZ:3_WXO/_ )/H_P"%E:[_ ,^FD_\ ?B\_^3Z_3[_AEOX$_P#0B_\
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M0T?\,M_ G_H1?_+G\8__ #0T>TG_ #,#\?Z*_8#_ (9;^!/_ $(O_ES^,?\
MYH:/^&6_@3_T(O\ Y<_C'_YH:/:3_F8'X_T5^P'_  RW\"?^A%_\N?QC_P#-
M#1_PRW\"?^A%_P#+G\8__-#1[2?\S _'^BOV _X9;^!/_0B_^7/XQ_\ FAH_
MX9;^!/\ T(O_ )<_C'_YH:/:3_F8'X_T5^P'_#+?P)_Z$7_RY_&/_P T-'_#
M+?P)_P"A%_\ +G\8_P#S0T>TG_,P/Q_K5T+6+GP]KFC:_9)!+>:'JNG:Q:17
M2R/;27.FW<-[ EPD4L$KP/+ BS+%-#(T98)+&Q#C]:_^&6_@3_T(O_ES^,?_
M )H:/^&6_@3_ -"+_P"7/XQ_^:&CVD_YF!\?_P##:WQ4_P"@!\/_ /P5>(__
M )JZ/^&UOBI_T /A_P#^"KQ'_P#-77V!_P ,M_ G_H1?_+G\8_\ S0T?\,M_
M G_H1?\ RY_&/_S0U 'Q_P#\-K?%3_H ?#__ ,%7B/\ ^:NC_AM;XJ?] #X?
M_P#@J\1__-77V!_PRW\"?^A%_P#+G\8__-#1_P ,M_ G_H1?_+G\8_\ S0T
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M^A%_\N?QC_\ -#0!\?\ _#:WQ4_Z 'P__P#!5XC_ /FKH_X;6^*G_0 ^'_\
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M7_RY_&/_ ,T-'_#+?P)_Z$7_ ,N?QC_\T-'_ !&_Q8_Z+K//_!M'_P"4!_Q
M3P=_Z-_D'_@FO_\ +S^4K_AU-^SQ_P!#E\9__"B\#_\ SNJ/^'4W[/'_ $.7
MQG_\*+P/_P#.ZK^K7_AEOX$_]"+_ .7/XQ_^:&C_ (9;^!/_ $(O_ES^,?\
MYH:/^(W^+'_1=9Y_X-H__* _X@)X._\ 1O\ (/\ P37_ /EY_*5_PZF_9X_Z
M'+XS_P#A1>!__G=4?\.IOV>/^AR^,_\ X47@?_YW5?U:_P##+?P)_P"A%_\
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MA_\ ^"KQ'_\ -77V!_PRW\"?^A%_\N?QC_\ -#1_PRW\"?\ H1?_ "Y_&/\
M\T-><>D?'_\ PVM\5/\ H ?#_P#\%7B/_P":NC_AM;XJ?] #X?\ _@J\1_\
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M_1M0UF[M)/,M+JXA_?6\FSS/,CV2HCKX_P#L4_\ )5-?_P"R?ZK_ .I'X4H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?%GQ@_9;U_XE?$#6O&5CXIT?3+;5(M+CCLKNSO9IXCI^DV6
MG.7DA(C82/:M(NWHK@'D&OJOP1H$WA3P;X6\,W%Q%=S^'_#^DZ/-=0JR0W$N
MG6,-H\T2/\ZQR-$757^8*0#S7444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***_&3]M_P#X+5? /]D3QOJ_PE\+>$=9^.WQ7\-7
MD5GXMT71->L_"?@[PK=F!)Y](U;QO-I?B22;Q':":".\TC1O#6JQ:=<?:[#6
M-1TS5;*;3J /V;HK^7CP%_P<EZ5<:W:VOQ._96OM*\.SW4*WFM>!OBC!KNL:
M=9M)&L\D'AO7O!N@6>KW$<1EFC1_%.C)(\:0%D$IGB_HE^ WQ[^%?[2_PP\/
M?%_X-^*(/%?@CQ&MPEK>I;W-C?6&HV,IM]3T76M+O8H;[2M8TRY4PW=E=0J2
MIAO+5[G3[JSO+@ ]BHK\XOV^/^"F?P/_ &"=.T;3/%EAJWQ ^*OBK3Y-5\,?
M"_PS=6EC>-I$<\MJ-?\ %.N7BW%OX8\/SW=O<V-E=BPU?4]2O;>X33M&N[:Q
MU.ZL/R$\(?\ !R9YOB*UC\>_LI?8O"<TNR^O/"'Q4_M3Q%I\+2H?M-KIVL^"
M]'TW6)8H!(OV*;5=#6XE9'^WVR(T<@!_4Q17CWP&^//PO_:5^%OACXP_"#Q)
M!XF\%>*;9I+6X"&WU'2]0MV\K4M U[3G8SZ3KVCW6ZUU'3Y\E'"7%M+<V-Q:
M7=QYI^UW^V7\$/V*/AQ!\1OC3K-_##JU_+I'A/PGX=M(-4\8^,M8AM7O)['0
M-*GN[&W,-G;JDFI:OJ5]IVBZ9]HLH;[4(;K4=.M[L ^K**_E?U7_ (.4KI=:
MSHG[(-O+X=BD9=NJ_&V2#6KZ(22;)O,M/A=<6.ER21&+=;>7K"PR+)B[G5U\
MO]:/V$/^"J7[/_[=-U<^#= L]9^&GQBT[3KO5[OX9>*YK>]?5-(LI(UN]4\'
M^)[**#3_ !';64=Q;O?V<]KHVO6H-S<C1)M*M)=3(!^G%%>(?M#_ +1/PF_9
M:^%FN_&'XS>)HO#7@[0VAM4*1&\UC7M:O1*=,\-^&M*C9;C6->U,P3&ULH2J
M16UO>:E?SV6DZ?J%_:_SM>*?^#DV*'Q-.G@K]E"34O!L,T:VT_BGXL+HGB;4
M;=9"999[32? _B#2M%FEB*I';QWNOQV\BF5KFY5Q"@!_4I17YB_L&?\ !5'X
M"?MUS7?A#1;+5/AC\9--LKS5;OX7^*+R#47U31K.5!/J_A#Q/:6UE8^)+:TB
MF@?4K*6RTC7+$FXF.D3:5;'59/TZH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHKY[_:;_:A^#O[(OPMU#XN_&OQ#+HGAFUO;72-
M-LM.M#J?B+Q-K]\LTECX?\-:0DD+:CJMS#;75TPDGMK*RL;2\U'4KVRT^TN;
MJ( ^A**_EJ\3_P#!R>D>O21^#/V27N_#$%XXBN_$_P 81IVO:K8!XRDDFG:5
M\/-4T_0+QXQ*CPKJGB2&-VCD$\JHT<GZ4_L)_P#!8'X ?MK>);7X83Z%K/P;
M^-%_#?7.C>!/$>HP>(-&\56^G6DM_?)X1\9V5AI4&HZC8V-O<7MWI&KZ+X?U
M&2U@FN-+@U2"UOI+0 _6RBN4\<^.?"/PS\'>)?B!X]\0:=X5\&>#]&OM?\2^
M(=6F,-AI.DZ="T]U=3LJO+(51=D%M;QS7=W</%:VD$]U-%"_\VWQ9_X./_"^
ME>++W3/@M^S?J/C#PA937$%OXJ\>^.E\(:EK8C=8X[NT\+Z1X;\1_P!EV4FR
M2:W-_KDU_<030&ZT_2KB*:V(!_3I17Y$?L!_\%@/@K^VYXF3X6:GX7U#X-?&
MF>QNK_1_!^L:W:^(M \9V^G6C7FJ)X/\41V.BS7FKZ?:07>I7>@:CHFGWJZ3
M;S7VGSZM#9:H]A^NDDB1(\LKI'%&C2222,$2-$!9W=V(545069F("@$D@"@!
M]%?SV?M,_P#!P=\#_A9XNU3P7\!_A=JOQ\?1;N^TS4O&]WXLB\ ^!WO[.6>V
M:7PQ,OAWQ5J_BW34GB %^UEX=T^_A87.DZA?6;P7<W!?!/\ X.-?ACXE\3:9
MH?QW^ >N_"_0;V;[/=^._!OC(_$2STMI92(KO4O"<OA/PUK*:9;1E3?3:/?^
M(-4*H\MEHUT[I:@ _I0HKG_"?BKPYXZ\,>'O&G@_6;#Q%X4\5Z-IOB'PYKVE
MSK<Z=K&B:Q:17^FZE93K@26]Y:3Q3Q,0K;7 =58,HZ"@ HK^?;_@H!_P6_@_
M99^/&H_ WX,?#OPI\6+WP3:"S^)7B'7=>U.QT[2?&<KB67PCI T>.1;NZ\/V
M?E1^(KF6=A:ZU<SZ&8;>]T74 _[0?LX?%*_^-_[/_P %/C)JNE6>AZG\4_A;
MX&\?ZAHVGS37-CI5YXL\.:=K=QI]G<7(%Q-;6DMZ\$,LP$KQHK2?,30![311
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17X/\
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M]#-]H&A_#^+QM9?#KPY/8),9+>)+#PQ;0:O/'#&+:;4)+V[,;R74K2?T5?\
M!3__ ()L_LJ>'/V$?B-XF^#_ ,$_ WPX\<_ [P]IOB[PWXJ\*Z)#IWB#5-*T
M75K%?%%AXPU>U,>I>,%OO#5SJ\JWGB6YU.[M-1@L;N&=([8PO_-%^P8]P_\
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MZ.C!D=& 965E)#*P(*L"0000<&@!U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5_.]_P68_85_;1_;-^*'PQO?@CX7T+Q+\+OAQX%N;
M6WTR_P#'WA_PYJ$WCGQ'K.H7/B748M,U^]TVR^SC1=*\(:=#=278N'GCN%5!
M;!Y%_HAHH _);]BG_@E=^S3\*/V8OA_X3^.'[./PL\:_&/7_  G9:K\7-7^(
M/AGPG\0?$.F^+]<MI+O5O#NC>)9H]9M=&M?"GVW_ (1VRN/ ^HVUC<-I4>L0
M:AJ%[,=6N/Y(_P!HSPSHW[+7_!0OQ_X>^ 4U\NF_!W]H.TF^'5M9ZC=W%_IE
M[HNOZ=JEIX8@U(/)J,\FA:L9?#*S3RW&H2K8XO)KJZ::27^JG_@J;_P56\*_
ML:^'M1^$GPHN]-\4_M-^(=*4V]H1%?Z-\)=,U.W+6WBCQ;%EH;CQ%/;2)>>%
MO",V6G5[;7M>BCT-]/L_$7X<_P#!'/\ 87\;_M6?M$6/[4'Q5LM2O?@_\+_&
M<GC74?$/B%9[F3XJ?%RVOAK>FZ/;W%X2=8@TS7)8?%/C;4)/M=O(8+70;M))
MM?EFL@#]3?\ @XD^-.J^#/V;_A+\&=(OI+$?&CX@ZGJOB%89WCDU+PM\,+#3
MKZ;29XU8"6RE\3^*?"FJ2[PP%QH]H!PS ^._\$-?V$/V>_B=^S9XT^./QN^$
MW@CXJZ_XU\>Z_P"#O#4/CWP_8^)],\/^$/#6F:9:W$^CZ=JR75A8ZUJ>OZAK
M(GUJWM8]5M(=-TX6%];,)2_G/_!R@]P?&'[),;;_ +*OAKXQ/#D'9]H?5/AT
MMSM.T OY<=IO 8D#R\JH(+_J#_P0O2!/^"<WPM:+9YDOC#XKO=;6W,9Q\0-<
MC7S!D['^S1VX"X7*;'Q\VY@#^6S]N'X=C]@G_@HMXWL/@LT_AW3_ (8>/_!'
MQ1^%B1W%VRZ/9ZOI/A[Q_INBQSS3R7ESIFBW^H7?AHBYN)I+W3K!H[N2;SI=
M_P#95^UIIOQ6_:6_84\::5^S7%8?\)U\>?AEX53PO)J?B&+0K&U\*_$ Z%>>
M)GFULI@-)X%U#6;*W,,:FYN;F$ )&SE?Y/\ _@NW_P I$?'W_8@?"S_U$K2O
M[!?V(6G?]B[]D-[G>;E_V7_@"UP905D,[?"CPF9?,4@%7\PMO! (;((!H _!
M?_@E_P#\$9?%?@#XL>/?&W[=7P4\)ZUHOAS0-!M_A;X9UOQ!X+^(/@WQ#X@U
M>^U&3Q!J^K^'M'U75X;U_#&GZ7I]I!8>+;"/1[P^*'N+:RU.ZTXS:5Y;_P %
M]/V3?V;?@?H/P)^)/P=^'G@SX3>+?&'B/Q1X6UWPUX!T;3O"GASQ%H>D:/IV
MH1:ROA71X+31+&^T&\F@L[B_TJQLI+]?$$8U4WDL-C)!_3-^T9^T=\)OV5OA
M5K_QA^,OB2+P_P"%-#58+>")4N=<\2ZY<)*VF^&/"VE&6*76/$&JM#*+6TC>
M.&WMX;O4]3NK#1]/U#4+3^'?]H'XX?M'?\%=_P!KGPYI/A/PI/+=ZE/-X4^$
M?PUL)Y9M%^'_ (,^UF\U#6O$>JB+R4E$(&M^//%]Q;PQ,EK#;VUO#IVG:-I<
M !_25_P0&\5^(_$G[!":=KSWDECX*^,_Q!\*>%'NYIYE/AQ].\)^*BEGYV1%
M9P>(?%&OVZ0P$P1RQ3;=KF15]S_X*I_MYV'[$?[/]U+X9O[23XZ_%&+4O#7P
MFTMO)GETB1+=$USXAWUI,LD;Z;X.@N[9[.*XBFAU'Q)>Z)836\U@^IR6WN'P
M>\ ?"'_@G#^QGH_AW7?$%KIO@#X&>!;W7_'OC*:W%O-XA\03R2ZMXIUR*S\Q
M[BXU+Q/XEOIK7PYH:SW=ZQN]%\-6,ES)':*W\JWPO\*?%+_@MI_P4*UCQGXV
M35=$^#/AJ6RU+Q/;PW4K0?#KX*:1J5POACX=:+?*#;1^+?&<[7D<EW"(S/K6
MH>+O&,%B]GI4VGH ?D%XY\)>/-!'A3Q3X\L=6@G^+7ANX^)OA[5-;FDFU'Q3
MH%_XN\5>%YO$\TEQ(]Y*-3\3>$_$:I=7N)M16W&IQM-:7MM<S_Z'7[ '_)C?
M[(/_ &;=\&O_ % -"K^63_@X+\/Z)X2_:Z^"?A;PSI5CH?ASPU^R%\-] T#1
M=,MTM=.TC1=(^)WQIT_2],L+:(".WL["RMX+6V@0!(H8D10 HK^IO]@#_DQO
M]D'_ +-N^#7_ *@&A4 ?7=%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5X5^T[H?Q/\ %'[/'QG\+?!9;;_A:OBKX<^*?"W@6>[U9="A
MT_7O$FESZ);:P-7?(L)]$2_DU>UFP3]JLH452S 'W6B@#^4#_@G1_P $4/B;
MX1_:(O?$_P"V]\(O#.K?"WPGX3OK_P )Z0WB_P )^+?#'BWQ[+J]A9:;;Z]H
M>D:Q<ZE>:/INC?VOJ[:?K6E0:3?WC:5%??:$BO-,D[K_ (+Q_L=?LO\ PD_9
M_P#AO\9/A3\+? /PA\>GXLZ1X DLOASX=TCP7HGBGPYK7A3QAK=['?\ A?P[
M9V&CS:GI-YX<L+FUUQ+*&YBMI[VQO)[G[98);_T;_&/XR?#?X _#CQ/\6/BU
MXIT_PAX%\(V+7VKZO?LQ9F8B.TT[3;.(/=ZKK.J731V.DZ180SW^HWTT-K:P
M22N!7\.'[;7[87QL_P""JG[2/@_P7\-_!NN/X4L]9N_"WP'^$FG!+G6)WUB>
M%;_Q9XLFBF;3U\1:Q;6-O>:W>/<IX>\':#8"U%^UI8:OX@U4 _;#_@WI^(>J
MV?[)7[0%EXFN;P^"?AO\4KSQ%I=Y<S33P:=:ZEX'TS5/%&FZ>LS>3;6MFVCP
MZU):6[QQ?;M<N[R2-)KV6:;\"_V;_#UW_P %#?\ @I#X,MOBM)=7L/QX^,OB
M'QSX\LDN[IWD\+:3::Y\0=<\*6-Y"T-U9:?'X5\/3^%=+FM3;G2-,2U-FD"6
M<2)_7#\&?V2;']BC_@FI\3/@UILEAJWC4?!/XP>,/B'K=LK+9>(OB9X@^'^J
M-JLT3N+>272]+@LM*\*Z1<2I:W%QH6@Z=<74<-W+/C^6G_@B4D#_ /!2O]GU
MIMGF16/Q@>UW-M;SS\$_B)&WEC(WO]FDN,KAL)O?'R;E /V*_P""UG_!/[]G
M/P#^R)!\;?@E\(? WPI\3?"3Q7X.L=:N/ F@6GARW\0^"/%%^G@^2SUVTTJ*
MWMM6U6#Q'JWAF^M_$&J)<:L(XM0MI;R;^T&Q/_P;E_&K5?$?PA^/'P'U>]DN
M+3X8>+?#/CCPC%<SR2O:Z3\2+76K37M+L(V)2WTVPUSP@FKM#'M4ZEXJOKC:
MTES(U??/_!:K_E&9^TM_W1O_ -7_ /"JOQ9_X-OGN1\=OVC8U13:-\)?#CSR
M$_.MRGC&);5%7>,J\4EXS'RWP8T&^/=MD .Q_P""DO\ P3!_;X_:M_;&^('Q
MB\,^"_#VN_#G6;[POX7\%,/B1X1M;WP_X&\.Z9I&B_:7TCQ%K&CO;+=7QUSQ
M=<:9:332FYU'4%1/MD\4$O[9'_@EE^P3:_!5O@_=?L\_#5=+M_"[:-<_$>;P
M[HT/Q96>.R,<_BN3XHO:?\)5#K:W ;56E.J#28I@;;^SAI"C3Q^A]?S'_P#!
M83_@K;I6CZ5XT_9#_9EUN'5/$.J6^I>$_C5\4M,G$MAX=T^XC>RUOX>^"[R!
MS'>^(KV)[C2_%FOQ,]IX>MFNM$TQI_$,]Y=^&0#\;?\ @DMXFUWP5_P4=_9X
M7PC>W5[!K'C'Q!X.U,63W,%OK?A37/#/B#3]2EO;9,&XL;6U$?B-+:[C:*WO
M-*LKUA'/9Q31?T ?\'$GQ('AW]DWX8?#>WN!%??$KXS65_<P[P#=>'? GAK6
M[[4$V9#,L>OZUX4F+X*H8U!&Z1"/G3_@@Q_P3_\ $>@ZHW[;7Q9T&?1X[G0]
M1T3X!:+JMNT&HW5KKUO)I_B/XG-;2JEQ96-YHTEYX9\)O* =8TS5_$&K+;_V
M=)H.H7_T%_P6M_8=_:Y_;(\5?!2Z^ G@G2/&GA'X8^%O%8NK"X\;^%?"^JOX
MH\9:KIQU$6MMXLU?1-/E@BTKPKH(^U/?PDRW)B4.(I3$ ?GO_P $TOV;?^"7
MNO\ [+47Q%_;LUSX4VOQ%\7_ !,\7Q^#K;QC\>/%7PYUN+P%HECH6CVD<7A7
MPM\0_"[W-F/$UAXIG.MW>DS-(UU#9M?&.*TA7]O?@3_P31_X)976J>!?CI^S
M[\-?"/BBX\&>+=!\8>"?'?@GX]?%CQSHFG^+?".J6'B#1KM'C^*NN>'K^YTK
M4[6QNY]*U2WO+9RJV^I6,T$LD#_CM\*O^#<GXF>)/AM!KWQ9_: T3X9_$O4M
M-%W#X!T7P.OCS2O#MZQ:6'3/$/BZV\::+;WUT8O+MM1;P]I]]IVG7332Z?J?
MB*V@B-W^;'[.?QQ^-O\ P2I_;4U?0/$L^H1V/@CQP_@7XZ> M+U"YD\.^//"
M,,[P2:K86\ZVT5[<Q:5?)XO^'NLW-K:W<;S6(G6'3]2U6PN #_0&HJ.*6*>*
M*>&1)89HTEBEC8,DD4BAXY$89#(Z,&5@2""".#4E !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7PO\9?^2C>(?\ N$_^F+2Z^Z*^%_C+_P E&\0_]PG_
M -,6ET >[? #_D3=3_[&:\_]-6C5[E7AOP _Y$W4_P#L9KS_ --6C5[E0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 -=TC1I)&5$16=W=@J(B@LS,S$!54 EF)  !).!7\,W_!6O_@I
M;XA_:_\ B5JOPF^&FMW5A^S/\/-<GL]&MK&=X8OBKXBTFXFMY/B!K>P(]SHW
MFJX\$Z1<[HK33A'KMU!%J^I/;:;_ &5?M,> ?'?Q5_9^^,7PQ^&6OZ5X5\<_
M$/X?>)/!6@>)-:GU*UT[0YO$^G3:+>:G+<Z1:WNIV\]IIU[>364]E;27$5\M
MLZ&+:94_E<_XAQ_VHO\ HN7P#_[^_$/_ .8N@#ZA_P""5W@+_@G'^Q]X8TCX
MP?%K]J;]G/Q-^TWXDTA)II;CXB^%;[3/@]I^J6RM/X5\+M]MEMY/%!@D:R\5
M^+;=G>0M=:#X?G30VO[WQ%_0#\(_VF?V?/CW>ZSIWP6^,OP[^*-_X=M;2]UV
MT\$>*-,\07&DVE]++!9W-_%83S-;0W,T$T4+R!5D>)U4DJ:_E=_XAQ_VHO\
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M_!WA#PQXU\*VEK"K-;Z5H>@:#H^GSQ6\$89K:PT[3[.!(US%!#&!M6OYP/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS7VID31?EU_Q#C_M1?\ 1<O@'_W]^(?_ ,Q='_$./^U%_P!%R^ ?_?WXA_\
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M%]C;Q&2Y2X^T6MUO@6+R9)/U]_9H^%^K_!+]G?X'_!W7]0TW5M<^%WPI\!^
M=7U31S='2M0U+PIX:T[1+R]TTWL%K>&QN;BRDEMC=6UO/Y+IYL,;[E ![?11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M^%_C+_R4;Q#_ -PG_P!,6EU]T5\+_&7_ )*-XA_[A/\ Z8M+H ]V^ '_ ")N
MI_\ 8S7G_IJT:O<J\-^ '_(FZG_V,UY_Z:M&KW*@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KX7^,O_ "4;Q#_W"?\ TQ:77W17PO\ &7_DHWB'_N$_^F+2Z /=
MO@!_R)NI_P#8S7G_ *:M&KW*O#?@!_R)NI_]C->?^FK1J]RH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^%_C+_ ,E&\0_]PG_TQ:77W17PO\9?^2C>(?\ N$_^
MF+2Z /=O@!_R)NI_]C->?^FK1J]RKPWX ?\ (FZG_P!C->?^FK1J]RH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BO*_\
MA=GPQ_Z&;_RC>(/_ )54?\+L^&/_ $,W_E&\0?\ RJKU?["SO_H39K_X;L7_
M /*3R?[?R+_H=93_ .''!_\ RX]4HKRO_A=GPQ_Z&;_RC>(/_E51_P +L^&/
M_0S?^4;Q!_\ *JC^PL[_ .A-FO\ X;L7_P#*0_M_(O\ H=93_P"''!__ "X]
M4HKRO_A=GPQ_Z&;_ ,HWB#_Y54?\+L^&/_0S?^4;Q!_\JJ/["SO_ *$V:_\
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M%QI5A=0+IE_'9<AUG]U%%?Q<?L:_MD_M9_\ !-W]K;2OV6_VIM7\3W/PQO\
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M-40AIID=@#^F6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4%N-$:].F""&ZCCN8HA:^7'/&DR*)%5@ ?UH45_)?_P4/^(?C_1O^"T_[/\
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MGOQ5K,4EUX:NO@;H5A)IVX[))/#OQ1\<ZEK\2. 1YES8:_ID#LJDXCB."-H
M!XE<?\$FO^"A]O\ !'_AM!_B!GXA0>%I/B=+X2'Q \;_ /"_(/#(B?Q')J"Z
MU]C\AO%HM&D\1R>&$\4?VP0S6R22>+F/AX_N5_P19_;X\6?M=_![Q7\._C!K
M1U[XS_!6XTJ*[\27$:QZAXW\ ZY'/'X?U_570)#>>(M*U&PU'1->O(HHFNK<
M>']2O3<:IJ=_<R_L%/XV\'VW@>;XC3^(-)3P!;^%)/&TWBK[3&VA)X/BTAM=
MD\0?;$W1-I*Z*IU+[2NZ,V8\U<KBOY,O^#=/3]2O?VG/VC?$>DVMS:^#;3X/
MPZ?=0;3+;VFI:[\0=%OO"UK<7(&!<II6A^)4MU)!GCBNY "(C@ ^3?@UX]_;
M3^)?[</Q_P#V>/V=_BOXGT?Q-\;?&GQ<^&][XDUSQ/XCN+3X=> +'XBS>)_$
MWB+1;G[7=MX7N++2/#/]F)JFD6;:S'I][<Z3X?:TU74;*YAYOXM^'_VJ_P#@
MC9^U_H(T+XL6_BG7]1\.:1\1DU&VF\0-X-^)WA;6]2UG0]1T7Q]X;O;Z.6]=
M]3\/:O9W<,M_/J%D8M-U[2-5L=1-C<VOV%_P2,LX[G_@KY^T#,^-VGVO[2UY
M#\JM^\?XF:78'!(RA\F^E^9<,1E"=KL"G_!P780ZK^W%^S[I=SG[/J7P*\&6
M$^,Y\F\^+WQ*MY<8(.=DC8P0?<=: /"_VT/V)_VYOA'\)_!__!0CXV?'N[\1
M_$;Q/K_AF^UVUTK7O%-EXZ^%<_C6VDU/PV-/UF$6.G:7!I=T+?0[S1/"XTS3
M?#5]/86&B#4-.C>XMOW?^'G[3'Q _:-_X(J_$[XX>+M2GMOB</V:_P!H'1]=
M\1Z06TBYO/$/@+3?&GARU\4VDEA)$UCJ>J6FD:?K-[)8BSBM]:N+W^S[>UM4
MMXUU_P#@NW_RCN\??]C_ /"S_P!2VTKY9_8S_P"5?_XQ?]D8_:^_]*OB#0!^
M2_["W@W]NO\ ;]^'/C7]E7X<?&*^\(_"7PUXMD^*GQ9^(?BSQ-XMN[S4KWQ/
MHND>%_"?@.]O+6ZOM8U;2]OA+6]<TOPK;&PT.>\;6-6\0W4MS8>'8H_7/V3O
MB[^TU_P2D_;S\._LJ?&_Q;=:M\)/%OB/PIX5\3:+%JNI:[X'F\.^-'.F^#?B
MC\/O[3ACNM#CTG4K^&;6X;#3[.YO;+3=;\.ZKI\VI6&GS:?]G?\ !MMXCT!_
M!/[4OA%9[:/Q1;^*?AOXCFMFD"W=UH%YI/B;3+:>&%@#-;6&HV-W'<R1&06T
MNI6JW B^U6WG?+G_  76N8/%/_!1[X ^&?"M["?%5C\*/A'X=NI[5A+<:7X@
MU?XN?$'4=$L[F)?F6[@L]8TO5HXSDO;:I:L.'  !_8E1110 5_'/^WG=2?MZ
M?\%E_A[^SII\C:GX)\!>*/!'P:U".W:1X1HGAB6Y\?\ QNOA!'@)J&F+<^+M
M&N'9E,P\,622SQ0QH8OZS/C1\3]$^"GPC^)GQ>\1E?[$^&G@7Q1XVU")I5A:
M\B\.:/=ZHFG0.W!N]3FMH]/LHP"\UW<PPQJTCJI_S^_V;?%?[=DWQE\7?M.?
MLL^"/BOXT^*S:SXFNO%7CWX??!.?XQQZ1K'Q'DO[_7OMUO>^"_'&BZ5J.O)<
M:B8IKJUBU)[26\2UG$,MSO /T5_:G8_\$[?^"U&B_%ZQB_L3X?>+/'/AOXNS
MK;QK:V\OP^^+R7WA?XNB."-5M62VUB7XB/8P;?*CEM+"4^3+&KQ_UP?'7XQ>
M&_@)\%OB7\;?$ZRW?AWX;^"M:\875K9L#<:M_9MC)/8:38RA9(UNM;OC::99
MS2#[/'/>12SND"NZ_P %_P"V=KG_  4;^,MOX?\ B?\ MJ_#7XV6^G>"+5_#
M&B^./'?[.7_"HM&TRWUV^6ZCT:ZUO1_AOX(TN]>\OXVDTZVU:>[GCGDNETX1
M&ZNEE_H$\6?&_5_VGO\ @@!XO\566H27?C7PK\,?"WP^\>2$FYO3?_"7XC^"
MM/\ $%UJ!C)/VKQ'X%TJV\374APL<6OB:1$5710#\N?@K^S_ /MU_P#!9_Q;
M\3OC+XH^-5MX7\&^&->M-+AF\0W_ (EA\$:3KHB36=*\%_#WP7H*RV%K%X:T
M^XT^^U'4)G@OXCJ.GZIJ%[K.MZG<W4GZ!_\ !(KQQ^W'\"_VGOB!^QO\>?#G
MQ8\>?"+1)O%/ART\<7>D^,O%W@+X:>,_""7&H:?=:%\0KW3Y-/T[P)XYTR"Z
MMK+2KZYLHGU>^\.36MEI-_/K%I>^\_\ !NYKVBWO[&7Q'\/V<ULNMZ%^T-XH
MO-:LDDS=BVUOP'\.?[(U.>(LQ2"]73;[3[:0!$E?1KI0I>)W;],](_;R_93U
MO]H75_V5;'XJVI^/&CZ[-X;F\"R^&_%\;7FKVNC#7;VTTSQ#_8#>%KZ2PL%N
M3?Q1:WY]G-8WL=Q%'Y&Y@#^([XU?LF?M">!?V\-"_9>\5_$CP[J_QW\4^.?A
MKHF@_$&T\8>-]0T'3M4^(C:-/X,N[CQ7J7ANS\8VD6AQ:OIR7L]EX?N+C3#:
MR+I45\L,!E_8[_@H_P##[X^?L@_\$H?V4/A3XZ^*=YJ'Q;\+?M$:[9>+?&_@
M'QOXSNX-;L_$B_'SQCI-HGB76++PSXFU*VM-&U71+2X@U/3K>*WO=.^SVR3V
MMG:74GD'[9A _P"#@#X.DD ?\+H_9!')QR;;X? #ZDD #N2 .:^_O^#C""5O
MV._A%<A<PQ?M+>'()'W+\LMQ\+OBS)"NTG>=Z6TYW*I5=F&*ED# 'Z,_\$S-
M6U37/V"OV7=7UO4M0UC5;_X8V,]]J>J7EQJ&H7LYU+4E,UW>W<DUS<RD*H,D
MTKN0 "V *_!G_@@-\0O'WB_]K+]H+3_%GCCQAXHL+/X/:I<V=CXB\3:UK5G:
MW"_$KPG L]M;:E>W,,$PADDA$L2*XB=XPVQF!_<#_@EIK>G#_@G-^S#K%S=V
MMEINF?#"[6_O;FYBBM+.'0=?\0V>HW-U<R%(;>&V-A/)<O*RI;*D@E<"-FK\
M!_\ @W:N4O/VL_V@;R(.L5U\$+^YC60 2*D_Q*\'2H'"LRAPK ,%9@&R Q')
M /J;_@HM\%/^"DW[:G[9%E\"/!6D^.OA1^RM9"&P\,^,I=1U"R^%>JRZ1H']
MO:]X]\?W7@VZU2>\U2]UH76@>"M(UR&.:&.'28[.PTJ]U+7KU_RY^,/PK_:B
M_P""*W[17PCU/P]\:%\1Z3XCMU\810>$[K7=*\+^,]"T;7?[.\3>#?&W@W4Y
MGL+D7=E+%^\9[\6O]J6^H:3J%EK&GQW-K^C/[3O[<'[;G[8/[=?B?]A+]BKQ
MQ:_!CP_X0\0^+O ^L^+;6[CTO5-4U'X??;D\=>+M>\;V>D:MXD\,:'I6H:?=
MZ/H>F^#(X=0O9TMGN[B_N=4M[73/RC_X*@_L9>.?V0?&GPHB^*G[06M_M"?$
MSXH^%==\1^)_$&NQZS)<Z/'I&K6NG6%A!JOB/Q'XAU[7+6XEN-1E34M0.EB2
M2*6.+38F29W /WS_ .#B6>*Y_8?^%%S V^&X_:A\"SPOM9=\4OPB^-LD;;7"
MNNY&!VLJL,X8 Y%>._$K_E6\T[_L0/A/_P"M6>#:]2_X.#_^3"_@K_V<C\./
M_5-?&FO+?B5_RK>:=_V('PG_ /6K/!M 'S9\ _AOXM\??\$%_BCK/@+7/$.@
M>,?A'\:/&OQ@TJ\\-:QJ6B7LNF>#X]!3QI;W%YI=S;7+V47@/4_$^I-:LTD$
MU[IUBTD8:*.:']._^"#W[0.K_&7]CC4?!WBS7]1\0>+_ (+_ !'\0^&KB]UK
M4;G5M9NO"_BKR_&OAV_OK^]DFO)T.HZOXGT6S%S-,\-KH,<$3K;Q0PQ8W_!"
M30M*\4_\$YM4\,Z]9Q:CH?B+XH?%G0M9T^;/DWVE:OI>@Z?J-G+M(;RKJSN)
MH)-I!VN<$'FOP^_92^.FL?\ !-7XK?\ !1_X'>(-3FL-0C^$WQ.\&>#+QYOL
MTFH?%CP'KMUH7PGUJ%5D4?9]0TCQ?K6O0F ?:98'M4B\E9))80#ZY_8?\<_$
M']M3_@LE\4?B7%XY\977P=^'?B;XE_$:ST*#Q+KD7A:\\+>%I$^&OPHM'TJ&
M^&DK+/+>^&/$<EF('CO'TG4G*S()Y:_K2K^=G_@W8^!O_"*_L_\ Q;^/>I67
ME:E\6_'EKX2T"XFCR\G@_P"&MI,LEW9RG/EV^H^+/$FOV%Y''M\Z?PS;M-O\
MBW\O^B:@#^6?_@Y:_P";+/\ NXW_ -X/7U-\"?\ @M/^P=\)OV8O@GX-USQO
MXWU;QK\.O@=\,?">N>%M"^&_BF6\G\2^%? NAZ+JNE:=JFJ6FE>')BFI6-Q!
M#>SZS;:=,JB9+LQ,K'Y9_P"#EK_FRS_NXW_W@]?0'[-7_!#G]B'XA? GX(_%
M#Q</B_JFO_$7X-_#;QKKMDOC^TL-'AUWQ=X.T'Q#JDNFV^G>&K2^M[>.]O;F
M*SMKC4;M(K639*9YD2=0#\I?^">5[XE_;+_X+!P?'W2/#$N@Z$_Q&^)GQZ\2
MV5LS3P^$?#4ECKD7A[3]0U"SMK6"\O;C6-8\-:#=WC0VBZQ?7=Y?/ %DFA'Z
M(_\ !1;X*?\ !2;]M3]LBR^!'@K2?'7PH_96LA#8>&?&4NHZA9?"O59=(T#^
MWM>\>^/[KP;=:I/>:I>ZT+K0/!6D:Y#'-#'#I,=G8:5>ZEKUZ_[G_LV?LB?L
M\?LC>&M1\+? 'X;:7X&L];GM[KQ#J8N]4UWQ+XCNK6-TMI-<\3^(+[5-<OH+
M4RW,EAIC7R:1I<EY>G2M/LEN[A9/P#_:=_;@_;<_;!_;K\3_ +"7[%7CBU^#
M'A_PAXA\7>!]9\6VMW'I>J:IJ/P^^W)XZ\7:]XWL](U;Q)X8T/2M0T^[T?0]
M-\&1PZA>SI;/=W%_<ZI;VNF 'YS?&'X5_M1?\$5OVBOA'J?A[XT+XCTGQ';K
MXPB@\)W6NZ5X7\9Z%HVN_P!G>)O!OC;P;J<SV%R+NREB_>,]^+7^U+?4-)U"
MRUC3X[FU_<__ (. O&7B3PQ^Q;\+=<\%^)]?\,W=_P#M+>"+<ZGX<U?4]!OK
MG3;KX4?&:\-K+<Z?/9W36LTMO:W#VLK>69K>"1X_,A0K_/;_ ,%0?V,O'/[(
M/C3X41?%3]H+6_VA/B9\4?"NN^(_$_B#78]9DN='CTC5K73K"P@U7Q'XC\0Z
M]KEK<2W&HRIJ6H'2Q))%+'%IL3),[_O'_P '!_\ R87\%?\ LY'X<?\ JFOC
M30!U?@K]K[7_ -EK_@B9\+OCV]]>>(OB7=?#T>%_!%]KTLVN377C_P 5^,/$
M6E:+JVLS:C).VH6OAZW2Z\0W5O>RLFH6^B_V7N!NHP/Q]_8__8/_ &]_VZ_#
MWB3]L_2?VE-7\#^+6\0:Y%X \6^*_%7C6/Q/XW\0Z5>BYU<Z;JFA/M\*>$;;
M7$_LBWFM(KJQCU'3[S3[;P_#8Z8K'Z'_ &K=,U&__P"" '[']U8NZ6VB^/\
MP5J>L*JY$FG2W'QBT>))#D;4&K:MI<@;GYXT7'S9'['_ /!%_6=#U;_@F[^S
MO#HDEKNT6/XDZ-K-I;3)+)8:Y%\6/'%]>QWJ*=UO=7\=_;ZV(9 KFUU6UG4-
M#/$[@'\XW_!-GQ/\3O&'_!:+X>>(/C3"EO\ %RZ\:_M 6OQ*A6SM=/*>-M(^
M!?Q8T?Q&);*Q)L+:Y.J6%RUW%IZQV"W1F^PPP6GDPQ_W U_'!^R_KFB>(_\
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M1F=V+$D_"G_!RU_S99_W<;_[P>ON7_@HW_RA&US_ +(Q^R5_ZL?X'4 >&?\
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MT"[\ 1>-?B+H<FG^)[.VT>^U*^N=/\,:'?:8LNJ6.I:5=K*+AIY8'A,JKM4
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M:7?Z+K.F7:>9:ZCI6J6DMCJ-C<ID;[>[M)YK>9,C='(PR,YKR+X._LX?L_\
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M[XT_;Z_;J\)#]@'X=_';4/"7PRT&#5_B/XO\=Z]J>ORZ]HG@.W;2-#C\"?\
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M^,[F".WN?CKX46VGOIELX5D\;?!W1X/!<8E9MI=;G7M"MK1"P^TSK##@-+M
M!Y-^V=^Q)^VK_P $^OV6]4\/Z_\ &S2_BK^SM\9K[PEX2^(GA729_$5UI'@+
MQEH>O6/CSPK?:3IGB+']G17VH>'+O3%\3Z/%I\>H1/+I6OZ3#<7GA^5/W+_X
M(*?\H^?#O_94_B;_ .G.RK?_ ."Z>MZ)I7_!.CXFV&JW5O;W_B7QI\*M$\,P
MS2B.2^UN#QWI'B.XM;1"RF>X3PWX?\07S1*'(M;.YGVA86=<#_@@I_RCY\._
M]E3^)O\ Z<[*@#]GZ_DW_P""-M\?C[_P4_\ VO/VBM6!O=^A?%3Q+H[W6XS:
M;>?$;XJZ-'HRVXE8RPQ:?X1M=8T2"#;B"SECM\HJ*C?UASI+)!-'!-]GF>*1
M(;CRUE\B5D98YO*<A)?*<A_+8A7V[6.":_DI_P"#<%UL_C+^U#I5R!'?_P#"
MO/!;^5NC8JNG>*M5MKP!E=MP2:\MU+1[XSD$N/DW 'TM_P '(?\ R1+]FW_L
MJ?BS_P!1**OU@_X)G_\ )@G[)O\ V1CPI_Z3R5^7O_!QUH5S<_LU_ 7Q,B.;
M31_CA<Z'.X(\M)_$7@/Q)?6RN-I;<Z>&+K8P8* KA@Q9-OZ*?\$GO&N@^./^
M"?'[,]WH.HVE]_PC_@8^"M9AMYHY)]+U[PCJVHZ)J.G:A KM+9W?^BPWT<-P
ML<D^GWUCJ$*-9WMK+( ?ST_\%X?^4C?P:_[(Q\(O_5J_$JON+_@XI\;>,_!G
M@S]EB7P?XN\3^%);_P 3_%:.^D\-:_JNA27L=OI7@5H$NWTN[M6N4@:65H5F
M+K&TDA0*7;/PC_P67UC1?B=_P50^%/@SPQ?6NLZEH7A[X%_#37+>PN5N'LO%
M&I_$'7]<_L>X: 2&"_CT[QAH[S6X$DT#7**ZB7=$OV/_ ,')W_(D?LF_]C5\
M7/\ TT> : /FO]D[]C#]OW]LGXG_ +,?[;OQ%\<O9_"A?'7@J2QMA\1_$&B^
M-M&^$GP[U*TTR8^%M$B5$TS1M>M?"C:4+FWUN+Q!K]W?OXMO;"_349-5N?.?
MBIXI^*G_  5+_P""A?Q>^ ?C?]J+3?V?/A7X+\1?$?PY\.= \37^H0>%IM*\
M%>)[;P3;Z+H?@TZYX;T_Q+\2/&5KYGB368=8UBUO)[:WUNTL[G^SM*T[1X_Z
MG_V%])BT/]BO]DG3(@@$'[-OP3DE,:JJ/=7GPX\.7M[(H6./(EN[B>0,R>8V
M_=*SREW;\$/VXO\ @DA\/_VI/CU\1_B-^Q9^T5\#=2^)OBF:^^(?Q+^ >J>.
M]*O+ZRU35;Y?[>\8Z+?>&+GQ)JVE6?B;7[S[3=:=XDT"RT>VU_4;DVWB6VM+
MRTTFP *O[,_[$'_!3C]@7]LGP9H/PGO=;^-W[.<]WX9G^(>H6GBG3?#/PVUW
MX?ZE>-I&O17?A#QKXMMX-)^(GA&QMKC4-!BT235-1MFCTI(+Z[T35M3TV;])
M/^"QO[=WB;]C+X":#HOPNOHM-^,_QKU+5_#_ (1UQX[:YD\'>&]!MK*;QAXN
MM+2Y$L<VL6O]KZ+H^A?:+:2UM[W6'U9S(^D)9W?\[?@/]HC_ (*(?\$DOC5X
M.\!_&*Y\;0> UEL[_4/A#XL\46_C;X>^+O )U%;/5+OX?:C!JNM:3X?U P6\
MO]G:GX<N["[TS4X[6W\1Z9<6PO=&N/M7_@Y&TV\;QU^R=XG69Y=$UCP3\3]-
MTY<,(A>:5K'@S4+Z9=V,/<6GB#20P*JVV%,],  ^5?!__!*#_@H?\;O@Q9?M
ME?\ "PUO_'GB#0_^%D>#_#?B7X@>-;CXW^)]$NK8:KIVL6.N2V=U9V&N^(K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME^?=GSW^J?#G_0HPG_@,_P#Y,\!_X9R\$?\ 05\5?^!VD?\ RCH_X9R\$?\
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M=7MJ1;Z5)XM.GZA?_P#">^']8GTZ&PB^T:-X2M?&;64:6]J+BVL)VM_[(:*
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M]X"UR[_X2>QN;>]T'5M53.FZ_JWB+2U@N7B:'3+?2?)!B<1P@'PA_P $@/\
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MJ4[.BP)(9$B(E55=)/!_^&*?A7_T'_B!_P"#7PY_\RE?8%%4IRBK*32 ^/\
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M?RF?\$YM&E_9?_X+5_M0_ /4U&F6'CC3_C#I7A'39#L%WIEUK^@?&GP'<1*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OA?XR_P#)1O$/_<)_],6EU]T5\+_&7_DHWB'_ +A/_IBTN@#W;X ?\B;J
M?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-2M=&\/>&M(U+7]>UB^D$-CI6BZ/93ZCJFI7DQ!$5K8V-M/=7$A!"0Q.Q'%
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M3_O;W0/ACING^38W*@D"RF\1>,=%U-0RAI+S0[<Q/M@G4_KU^SUX7TW]F/\
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MZ*_1O^)-/^KC_P#FG_\ XT'YE_Q/#_U;#_S=?_Q2/]3BBO\ +'HH_P")-/\
MJX__ )I__P"- ?\ $\/_ %;#_P W7_\ %(_U.**_RQZ*/^)-/^KC_P#FG_\
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MV=SX@O[D64&HZ?!;:A?V?X4'_@KC_P %9_A38>%_CI\7/A!;2_ [Q?J&FMI
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M#6#]H6SN#]H&G_98O+Q//$7C#?TE_P##ZK_@F9_T<K_YAOX__P#SJJ /4_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *^%_C+_R4;Q#_P!PG_TQ:77W17PO\9?^2C>(?^X3_P"F
M+2Z /=O@!_R)NI_]C->?^FK1J]RKPWX ?\B;J?\ V,UY_P"FK1J]RH ****
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MX/\ ^;?/\^S#_B+OAK_T6.3_ /@RK_\ *?/\^S/CFBOL;_AB+XK?]#!\/?\
MP;>)/_F3H_X8B^*W_0P?#W_P;>)/_F3H_P")+/I4_P#1D.-O_"7!_P#S;Y_G
MV8?\1=\-?^BQR?\ \&5?_E/G^?9GQS17V-_PQ%\5O^A@^'O_ (-O$G_S)T?\
M,1?%;_H8/A[_ .#;Q)_\R='_ !)9]*G_ *,AQM_X2X/_ .;?/\^S#_B+OAK_
M -%CD_\ X,J__*?/\^S/CFBOL;_AB+XK?]#!\/?_  ;>)/\ YDZ/^&(OBM_T
M,'P]_P#!MXD_^9.C_B2SZ5/_ $9#C;_PEP?_ ,V^?Y]F'_$7?#7_ *+')_\
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MJ<OA9=-U/6-7T2RM]6\1:=;7MEX>O)[G0]0F5M?&F:<+1(ICJ :>*-OYQ_\
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M$/*\*JNF'4H)?LYOO%MAXM:\>VVQW$=K8*Y9[?Y0#\1O^"D'[<OA#]N7XP>
M_C/X/^%FM?"'Q1X8\&P>$-;DN?%MIXA?6ET?7;_7/#6JVUQ8:'H+V6H:8^L:
MG:RSR+<32V\>F)'-&EDB#^ES]JC]I*[^.G_!$7QI\?M%9KO6?B%\$?!&E^*4
ML"D0MO$6I^/O"OPY^*=N@1D5;/3=7;Q3%(F%,FGV[#R?G\HW?^"B?_!-/]F.
M_P#V,_COJ?P4_9[^&'@+XG>#/!\WQ!\,Z_X)\&Z5I&O,O@6YM_$^O:/;S:=;
M1W-R->\,Z;K.D)9*6\ZZO+9E1Y8HU/Y[?\$8-6T;]JG]BS]KW]@'QEJGV1IM
M/U'7O!]Y)N>?2](^(^FMITE_8P1L/.M_!'Q \/Z3XGEAE4+/>>)XX)#<02O#
M" ?7O_!NWH&AV7[&?Q'\165O;G7M=_:%\3V.N7ZPJMXUKH7@3X=G1M*FGQNE
MM;!=5O\ 4+6,DK#-K=ZRX,SY_6#PQ^R'^S%X2^+^O?'WP[\&/ MK\:/$&N:M
MX@U7XD3:>^J^*8M=URSGL=:O],O]4N+X^'KK4["]N[6_&A)IBW-M?7D4J-'>
M7 E_CX_9>_;:_:?_ ."/OC#XN_ 'XA_!>#6[75M>35K_ ,$^+]0U7PRMAXGL
M(%TB/QIX.\16=CJ-EK7AWQ-H]K8(][;6-[8:[9:=HEYINIVB03"[^TO^"2_P
MY_:9_:T_;D\9_M^_$R#Q%X/^&L^J^*/%=])9-XB\.^#?B'XMUO2-0\)^&O!_
MA>TFN"GB;PQ\/]/=9KB[N+W5$TZ7P[H6FZG<WM]?3D '#_MF?\K 'P=_[+/^
MR#_Z2_#ZOOC_ (.,O^30?@]_V<CH7_JL/BE7YP_\%AQX^_9E_P""H_PV_:H3
MPU_:FB23?!GXH>"7O&>'1/$>I?"*?1+'7?"ES?P)-):7'G^'K1=15(S>6FG:
M]87T"'SH&K[=_;%\1?%#_@J+_P $@O"WQV\+_#P:=XX\(_%_4OB?J?PY\)27
MVOW,WAWP%JGQ,^'%Y%I!N+6/4-5NK/PGXEM/%6H1PP12W9TS4'L+8!K;3R ?
MJ7_P2SECF_X)[_LJ/$X=1\,+6(E>@D@UC5X)D^L<L;HW^TIK^?O_ (-XG23]
MKO\ :(DC971_@MJCHZ,&1T;XF^$&5E920RL""K D$$$'!KSK]BW_ (*H?M3:
M%^SKH/[!?P,^ Q^(OQAGM?$7@OX3_$/3M;O$U7P=IWB?5;^[:^U?P:/#MQ87
MLO@V76KZ>S\2ZKXHT'P_H5G:Z?=^);2\L-,O3>^H_P#!OEX=O?"'[97[2WA/
M4Y+:74O"_P (==\.ZA+9O)):2WNB?%3PGIMW):R2Q0RR6SSVTC0/)#%(T15G
MBC8E  ?>W[;O_!3KX+? #]I[_A6G[/'[*'A/]HK]KW16ET"Z\>67A?3QKGAC
MQ-KNGO#<^#]$U/P]X7U?XA^--?DTR5+3Q)HVA:EHEK!%=MI$VK7>H6NJZ78_
M@O\ \%0OB'^W-\4_&/PH\:_ML?"_0_A'>ZEX9\0Q_"WPAHVE6.C-;^'8=3L)
M-:EOM.F\1^)_%MK,VH3V:"+Q=?P709)7L;&WA>9I??OBYXR^)O\ P3&_X*X_
M$+]H'XA_#?4O&WASQ+\2_BYXY\,R7[G3X?&OP^^+IUV5+SPAXKN],OK.+7?"
M<'B6#3-32TM\07VE7_ANZ^PZ?J1G'BG_  4X_:(^/?[:-Y\,/VI/&7P4U7X0
M?L_WT.N_#?X&IJ-Z=2?7WTJ2WUSQ/KL^HSVNE3ZG/J\M]:K%J-AHMIX<6'2F
MT/2[[6=1T#7-1F /W._X.$"3^P9\%B223^TE\.223DDGX-?&DDDGDDGJ:\L^
M)7_*MYIW_8@?"?\ ]:L\&UTG_!=#QEI/Q$_X)H?LP_$#09DN-$\<?&;X+^+M
M(GC;<DNF>(_@'\7M8L75NX:VO(SSR#D$ @BN;^)7_*MYIW_8@?"?_P!:L\&T
M >L_\$;?AAHOQK_X)3_$;X1>(E3^Q?B7XM^.'@F_E>-93:1^(_#^C:6FH0JP
M.VZTV:YBU"SE4>9!=VT,T962-6'YX_\ !'7]I6\_9$M_^"@WPJ^(ACTW5?AA
M\,?%?Q?M-$OGV"+QS\%)M5\(>*?#UM'+Y)N-3UW4=9\,V"VK*LKC12VV...X
M9/U;_P"" G_)@D'_ &6?XC_^D_AJOP*_X+3_  AU7]G_ /;O^)^L^&I;S1/#
M'[1'A33?B.HT^22V@U >))?[-\?:5>2P%%N?[1\<^%]2\0:A:/R8]7L3<)(D
MJ22@'Z1_\&ZGP?O]5NOVD_VJ/$BRWNIZUJ.G_";0M9N5)N+N[N)K;X@?$F66
M9@!(]W=W'P_F9H_^6L=P).=H']0M?GY_P2V^!O\ PS_^PI\ /!]W9?8O$7B'
MPFGQ,\6K)'Y5V=?^),TGBXVVH)QMO=$T?4M(\-R+@%$T6)&+.K.WZ!T ?RS_
M /!RU_S99_W<;_[P>ODGX6?\$!?VD/BM\,_AS\4=(^,WP1TW1_B3X%\(>/M+
MT_4G\>?VG8:9XQ\/Z?XBLK._6U\(SVOVZUM=1B@NA;W,UO\ :(Y!#/)'MD/U
MM_P<M?\ -EG_ '<;_P"\'K^@?]C;_DT']E3_ +-N^!O_ *K#PO0!\*?\$W/^
M"2_@;]A'5M:^)GB3QH/BQ\:==TF7P_;>((M#_L'PUX*\/7<D$^I:=X8TVXO=
M3OKK5-6FMXDU3Q+?7-M-+IT46EZ?I6E02ZO)K'SY^V[_ ,%.O@M\ /VGO^%:
M?L\?LH>$_P!HK]KW16ET"Z\>67A?3QKGACQ-KNGO#<^#]$U/P]X7U?XA^--?
MDTR5+3Q)HVA:EHEK!%=MI$VK7>H6NJZ78_O_ %_$M\7/&7Q-_P""8W_!7'XA
M?M _$/X;ZEXV\.>)?B7\7/'/AF2_<Z?#XU^'WQ=.NRI>>$/%=WIE]9Q:[X3@
M\2P:9J:6EOB"^TJ_\-W7V'3]2,X / ?^"H7Q#_;F^*?C'X4>-?VV/A?H?PCO
M=2\,^(8_A;X0T;2K'1FM_#L.IV$FM2WVG3>(_$_BVUF;4)[-!%XNOX+H,DKV
M-C;PO,TO[P_\'"!)_8,^"Q)))_:2^')))R23\&OC2223R23U-?AC_P %./VB
M/CW^VC>?##]J3QE\%-5^$'[/]]#KOPW^!J:C>G4GU]]*DM]<\3Z[/J,]KI4^
MISZO+?6JQ:C8:+:>'%ATIM#TN^UG4= US49OV?\ ^"Z'C+2?B)_P30_9A^(&
M@S)<:)XX^,WP7\7:1/&VY)=,\1_ /XO:Q8NK=PUM>1GGD'((!!% 'R[^U;J.
MI6/_  0 _8^MK&*22UUCQ_X*T[671MJPZ;%/\8]7BEF'\<9U?2M*A"]II8G_
M (*_8?\ X(L^&-"\.?\ !.'X!7.BP6Z7'BF3XC>)_$-Y#&8Y-3UVX^)WB_2I
M)[O)_>7%AI>D:7H*R *&M='MA@D%F^6? '[,%_\ M=?\$,?A7\(_#R+)XY7X
M:_\ "9?#J-[F*TBNO&W@_P :^(]5TK2);BY*VL*>([9+_P ,FXNY(K:S.LB]
MFFA6V,J?C]^QC_P53_::_86^'_B#]D*?X#O\0?$NC^)M>L/AWX6\5#Q)X>\8
M?#OQAXAOOM-_X8OO"-AHMSJWB?3I?$EQ?:S'X91M!UR35=9U!8M<^S3VMM;
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M%1_98_\ "V^+7_SD*/\ B-_A/_T761_^#:W_ ,H#_B GC%_T;_/_ /P30_\
MEY^!5%?OK_Q#H?MM?]%1_98_\+;XM?\ SD*/^(=#]MK_ **C^RQ_X6WQ:_\
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M)]*N]/O;<VVK:=8.D5K=PK<QHVGW"3V5U<6LW\Y'_!:?]G;Q)^TA\._V=_\
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M LM \87"7-L3HNG:I>_:ICJ$1@_T7RL(_F2)\N?]"ROXU?\ @CQ_REH^+?\
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M-(B,R1*[?*AD8! S?*I;)X%?R5_\&X16]^,W[4>J7+!]0D^'W@LF3Y59EO\
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MP^+.C?LFGX=Z;J=A\?OCKX/TO6M<UF\U+3-=\$WLL3>%=5MTT1+3_2[LO%8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7PO\ &7_DHWB'_N$_
M^F+2Z^Z*^%_C+_R4;Q#_ -PG_P!,6ET >[? #_D3=3_[&:\_]-6C5[E7AOP
M_P"1-U/_ +&:\_\ 35HU>Y4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ:PW,%[#;:K86NH6\5Y;,6MKN.&[BFC2YMV):"=5$L3$F-U)S6E110 4444
M?,O[8_[0MY^RE^S9\3OV@K'P2GQ%G^&]GX=U%_!S^(F\*+K%GJWC#P]X<U$C
MQ NA^)3I[Z;I^LW6K1L=$OEN)+%;1U@2X:YA_D*N?%_QE_X+9?M_?#FZNOA[
M/X9^'.A#POH_B#1-%O+S7M%^%_P8T;7+G7/%-_K_ (KDT[1[6\\0^('O-9M=
M/OY].T5M;UF[T30K*SCBM(!'_<'J&GV&K65SINJ6-GJ6G7L307EAJ%M#>65W
M _#PW-K<I)!/$X^]'+&Z-W4U0T#PSX;\*6 TOPMX?T3PUIBR/,-.T#2K#1[
M2RL6DE%GIUO;6XDD8EG<1[G8DL2230!K0PPVT,5O;PQ6]O;Q1PP00QI%###$
M@CBABBC"I'%&BJD<:*J(BA5   J6BB@ HHHH *S=5T71]=MX[36])TW6+6&Y
M@O8;;5;"UU"WBO+9BUM=QPW<4T:7-NQ+03JHEB8DQNI.:TJ* "BBB@ K-ET7
M1YM5MM<FTG39=;LK:6RL]8EL+635;2SG):>TMM0>(W<%M,Q+2P13)%(22Z$D
MUI44 %%%% 'P%_P4Y_9EO?VKOV,_BQ\-?#]@FH>/-(L[/XA_#>#89+B?QEX)
ME?4X=+L5Q@:AXHT-M=\'VCL4CCE\0AY72-78>+_\$5?CK!\:?V"_AKI%U>&Y
M\4?!.]U;X-^(HI& EAMO#DL>H^"RD+ 2+:)X#UCPWIT4IW1RW>F7\<;[H)8H
MOUEKG?#_ (0\)^$UOE\*^%_#OAE=3N!=ZDOA_1--T9=0N@& N;X:=;6PN[@!
MW FG$D@#L WS'(!T5<]%X1\)P:M+K\'ACP]#KL[*\^M1:+IL>K3.LEU,KRZB
MELMY(RS7M[*K/,2)+NZ<'=<2E^AHH **** ,C3/#V@:+->W&CZ'H^DW&I2^?
MJ,^F:996$U_/S^^O9;6")[J7D_O)VD?D_-S6O110 5FZKHNCZ[;QVFMZ3INL
M6L-S!>PVVJV%KJ%O%>6S%K:[CANXIHTN;=B6@G51+$Q)C=2<UI44 %?BA_P7
M:^,%SX1_9"TKX'>&TN;_ ,>_M-_$7POX"T+1-/!?5=0T3P[J^F>*M<:QB0B6
M<W&LVGA#PU-!$&:X'BA+=@8Y7!_:^N>UCPCX4\0WVCZIK_ACP]KFI^'KG[9H
M&HZQHNFZG?:'=^=;W'VK1[N]MI[C3+G[19VD_GV4D$OG6MO+NWP1,H!\]_L4
M?L]Q?LL_LL_!?X&%;0ZOX+\(6Q\6W%B0]M>^.=>N+CQ'XUNH)_OW5J_B?5M4
MCL)Y#O;3HK1 L<<:1)]2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &'I?ACPUH=S
M>WNB^'M#T>\U%E?4+O2])L-/N;]U2*-6O9[2WAENF6."&-6G>0A(8E!VQH!N
M444 13P074$UK=0Q7-M<Q207%O/&DT$\$R-'+#-%(K1RQ2QLR21NK(Z,RLI4
MD52TG1M'T&RCTW0M)TW1=.BQY5AI-C:Z=9181(QY=K9Q0P)B...,;8QA(T0?
M*J@:5% !1110 4444 ?R ?\ !Q[_ ,G#_L^_]D8U3_U.-7K^NJYT+1+W4K#6
M;S1M*N]8TM)8],U6YT^TGU+3DN,"=+"^EA>ZLTF 'FK;RQB3 WAJU:* "BBB
M@ HHHH **** "L33O#7AS2+V^U+2?#^B:7J.IMOU*_T[2K"RO=0?$8W7UU;0
M13W;8BB&ZXDD.(X^?D7&W10 5B6_AGPW::O=>(+3P_HEKKU\BQWNMV^DV$.K
MWB(9"J76I1VZWEPBF:8JLLSA3+)@#>V=NB@#-U;1M'U^RDTW7=)TW6M.E(:6
MPU:QM=1LI&7(5I+6\BF@<J&."T9(R<=35V"""U@AM;6&*VMK:*."WMX(TA@@
M@A01Q0PQ1JL<444:JD<:*J(BA54* *EHH *S;71M'LKZ^U2RTG3;34M3\O\
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M-#;SQI<QZ/XTUN^L!ICSK']OL_"EMJ]K')IFHZ?>7?\ 13110 4444 %%%%
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M'UOP[X?\2VAL/$>AZ/K]@2Q-EK>F66JVA+*58FVOH)X264E6.SE20<CBM<
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MC;^0!#Y!N?*\H"/;L&*Z&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJMB,IAC\-?M*_P#!>C]EGX'>.M?^'?@/PGXU^.NM^%[Z^TK6M?\ "]WHN@>
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M]7\=^+;_ %'3+?5VTK0='-]9V4LVG6-PDVJZEJ.J:;H&F[K>*\U>&XO]-AO
M#Z^HK^<G3O\ @X^^ $VMM;ZK^SS\7[#P]NC$>K6.M^#-3U<JTLZRM+H,U[I=
MI&(X5MI%$?B&<R22SQ'8MO'+=?N3^SY^T1\(OVH_AEI'Q<^"GBN'Q9X,U::X
ML'N/LMUIVI:/K5DD#ZGX>U[2;^*"]TK6M-^TP&YM9XS'-!/:ZA83WFF7MC?7
M(![;17XU?M6_\%JO@+^R3\??'O[/GC3X5?%WQ+XF^'__  BW]I:UX7C\&MH5
M[_PE?@OP[XVL_L)U;Q/IVH'[-I_B2UM+G[19P_Z9!<>5YD/EROX-I_\ P<:?
MLER7&W5?@Q^T596NQCYVGZ5\--3N/,&-B?9KGXCZ3'L;YMTGVO<F!B)\G: ?
MT'45\F?LE_ML_L^_MJ^$=6\5_ SQ3=:C+X;N;6S\6>$_$&G-H?C'PI/?K.^F
MG6='::YB-GJ<=K<MI^JZ7>ZEI%W):WEK#?M>6-[;V_UG0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=TV\UG7O$&N7]MI>CZ-I.GP/<WVI:GJ-Y)#:V5E:6\<DUQ<W$L<44:,SL *
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MMM<= \@@:3P\;Y;")I(Q$TJKXGE$+O(B/.L2R3 ']&]%?.G[,/[57P4_:_\
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M/!RZ':IX7\+:SXKO%NSI/B;4K_=<6>BSVUMY-G*/M,L/FF.+?(O[&4 %%%%
M!117.^+_ !):^#O"?BCQ=?07%U9>%?#NM^)+RVM/+^U7%KH>FW.IW$%MYSQ0
M_:)H;5XX?-DCC\QEWNBY8 '145^=/[!O_!27X5_M_P!W\3[/X;>!/B!X,?X6
M6WA"YUAO'"^'%344\92^)8K%=-_L'6]8):U/AB[-W]J%N,7%OY)E/FB/]%J
M"BOSY^)G[?WAOX/_ +;_ ,+/V-_B#\/M0T*T^,WAW3]5\ _&%_$EK)X>U'6M
M6EUO3-,\+W>@G2([BTU&_P#$VAR>&[=DUBYD^W:KH$\UK%:ZJLD/Z#4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?"_QE_Y*-XA
M_P"X3_Z8M+K[HKX7^,O_ "4;Q#_W"?\ TQ:70![M\ /^1-U/_L9KS_TU:-7N
M5>&_ #_D3=3_ .QFO/\ TU:-7N5 !1110 4444 %%%% !1110 4444 %%%%
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MXXIC#X>U#6=)T?PW=W5O#=3V.@Z5=7EK#<R30+N=QR7[2/\ P7<_9/\ @/\
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M$?@+Q3XD:VA6VM?^$GU/PYI\OB46MNI*PVJZ]_:"VT8X2 1K@8P/Y;?VDO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIW[-'_!<K]BWX2?LX?L__"GQ5I?QMD\3_#+X)?"GX?>(Y-)\#:!=Z6^O>#/
MF@^'-8?3;N;QM:376GMJ&FW#6=Q+:VTD]N8Y'MX68QK^RG[2O[&/[-7[7\'@
MZV_:*^&__"PX? ,NNS^$D_X3#Q]X2_LF7Q*FD1ZVV[P-XI\,O?\ VU-"TH;=
M3:\6V^RYM! 9[DS?*G_#E7_@F9_T;5_YF3X__P#SU:\H]8ZC]D;_ (*G_LR_
MMJ?$[4OA+\'K#XH6WBG2_!NJ^.;F3QEX5TC1-*.BZ/JN@Z-=K%=V/B?69GOC
M=^(M/,,!M%C>$7#M.C1JDG\_7_!/[_E.U\3_ /LL_P"V5_Z.^)=?TJ?L\?\
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M3H]1T_2-"U:^M8H[:/6[;7M6G@DGNH]7:#^L?X<_#SP?\)? ?A'X9?#[2/\
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M,\-0WDVJP+J%[%#HT=GJ-W)<S:A;7+W=T9ON^@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#XH^+_ /P3I_8N^._C._\ B'\3_@7HFM>,M6PVKZYI'B3QUX*GUBX& ;[6
M+?P-XI\-V.JZI( JS:KJ%K<ZE.B(DUTZH@7R[_AT)_P3M_Z-Z_\ ,L_''_YY
ME?I117F5,ER:M4G5JY3EE6K4DY3J5,!A9U)R;NY3G*DY2DWJVVVWNSYO$<&\
M(8NO5Q.*X4X;Q.)KSE5KXC$9%E=:O6J3=Y5*M6IA95*DY/64YR<F]6VS\U_^
M'0G_  3M_P"C>O\ S+/QQ_\ GF4?\.A/^"=O_1O7_F6?CC_\\ROTHHJ/[ R+
M_H2Y3_X;L'_\I,?]1>"/^B.X5_\ $>RC_P"8S\-_VO\ _@C1^SYK'P/\2W7[
M*GPWD\#_ !E\/;/$/A^V/CGQWX@M/&\&GPS_ &[P3<1^.O%^N:7IMQJ]O*TN
MCZG$EBT>MVFG6M]?6^DW5_(G\HOBCPMXD\%>(-6\)^,- UCPOXGT&\ET_6O#
MWB#3KO2=9TJ^AP9+74-.OHH+JUF4,K!)HD9D9)%!1U)_T@J\,^+/[,G[/?QU
MEM[KXO?!OX>^/]1LTCAM-:\0>&M.N/$%M;QDLMG;^(8H8=;AL2QW/8QZ@MG*
MP5I('**1\KQ#P'A,RE"OE;PV65XQ4)T84(T\)62;:GR4%'V557:E.,)JHE%2
MBFN9_E_'W@;E7$=2CCN&7E_#>-ITHT:V#HX*%#*<7",I.-5TL%"#PN)BI.,Z
MM.C5C6A&"G3C.+JR_P ^K0/#^N^*]:TOPWX8T;5?$7B'6[V#3M&T+0["ZU76
M-5U"Y?R[>RT[3K&*>[O+J>0A(H+>&25R?E1J_JN_8O\ ^"-?P)T[X'Z%JG[6
M_P -9O&/QA\432:_J>E'QQXX\/6_@+3+J*)-,\(B/P+XLT*QU#4[:"/[=KEY
M<_;6AU2]GTRSN'L]/BN+G]7_ (3_ ++?[.GP,O)M3^$?P6^'?@/6)TEAEU[0
M_#6GQ^(GMYP%FL_^$AN(I];6QD &ZQ6_%F3D^1EF)][I</<!X7+9SQ&:O#9G
M6E!PIT)4%4PE).S<W&O%^UJZ<L92A&,$Y-1<FI1C@'P,RSARM6Q_$\\NXCQ<
MZ4J-# U,%#$93AHS<7*LZ>-A)XK$M1Y:<ZE&E"A&4^6$ZDHU*?YK_P##H3_@
MG;_T;U_YEGXX_P#SS*/^'0G_  3M_P"C>O\ S+/QQ_\ GF5^E%%?5_V!D7_0
MERG_ ,-V#_\ E)^I_P"HO!'_ $1W"O\ XCV4?_,9^:__  Z$_P""=O\ T;U_
MYEGXX_\ SS*NZ=_P22_X)Z:7?6FHVW[.UE+<64\=Q#'J/Q(^,.L6+R1MN5;O
M2]6^(5[IE_ 2/WEK?6EQ;2KE98G4D5^C=%"R'(TTUDV4IIW3678---;-/V.C
M0UP-P3%J4>#^%E)---</Y2FFG=--82Z:>J:U3*6FZ;IVBZ=I^CZ/I]EI.D:3
M96NFZ7I>FVL%AIVFZ=8P1VMCI^GV-K'%;6=E9VT45O:VMM%'!;P1QPPQI&BJ
M/XXO^"/'_*6CXM_]@O\ :)_]36QK^RJOC7X._P#!/O\ 9$^ 7Q:U?XY_"7X2
M?\(G\4]=B\10ZKXI_P"$]^)VN_:HO%EZFH^(%_L3Q-XTUGP[!]OO(TFW6VD0
MM:[?+LC;1$H?52222222LDM$DMDET2/J$E%*,4HQBDHQ22225DDEHDEHDM$C
M[*KY:_;<^#VM?'W]DG]H+X0>&;:"]\4>-OAGXAL?"UE<S);P7OBFQ@76/#=G
M)<R_NK87>N:=86ZW,I$5NTBS2,J(S#ZEHIC/XMO^"2GQS_8 ^&GAGXN?"']N
MSX5_!F'Q18^+I_%WA'QY\8?@GH?Q U 0+I-AH/B7X>7&H7W@[Q%K^ASZ'>Z!
M%J^DZ-.J65W>ZQX@BMTM]5 @U/\ 13]@G]K;]F3]I3]M76?AI\!_^"<_[/7A
MGPGX+N_%?BSPE^T=X6^'_@;P7XM\)^$?#B/I^A>*;[1+7X8C4-/U?Q9J]UIN
MGZ;;V7BK0M0TZ+60+BWE>ROT7]%?VA/^"3O[#_[2OC;4/B1X\^%=QHWCK6I1
M<>(?$?@#Q)K'@V3Q%<_,7OM:TG3KAO#MYJL[LTE[K7]CQZUJ,A#ZCJ%V4CV?
M2'[-7[)/[/W[(WA.]\'? 3X>Z=X+L-7N(+SQ!J9N;[6/$OB6[M1,MK/X@\2:
MQ<WNKZDED+FY&G64ETNG:8MU=+IMG:+<SB0 _D0^&UA\%OV%O^"J/Q>\#_MJ
M_"KP3XL^#.NZUX^T2&7QYX T?XE>&_#GASQWKUCXU^&GQ.TW0-7T36EN$33K
M33M'U.\T:RDU?1K#6?$EDB3W%C?:9<?<_P 7/VY?^">=M^TC\._@C^RC_P $
M[?V4/VI]*\82Z)X<N=;T[X/> _ ,EUX[\2ZU_9NGZ+X8N=2^$.L_VC8Z;;/:
MW6JZG-HR:?+)=/%:ZBD-C=7(_>#]J']A?]F#]L6TTE/CQ\,[+Q)K.@12V^@>
M+]*U'5/#'C'2+:5G=[&'Q#H-W8WE_I0DEEG31=9.IZ+%=RR7L6GI>-YX\_\
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MK,.B>'=&\"_%KP@M^YCAB\12QPZAJ2,=T%E:>,/#]S<1W"M-$_U;_P %(O\
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MY_M3PAK>@:RGV:21V\E-16WFW8GBE4 "7X$? #X2?LS_  [T_P"%'P1\)?\
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MYE4VAU;0M*L/$$5NH^6#5XGF"73W$2=__P &\NE66N_L5_'71-2B\_3M8_:
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M)"R1L5$D,R1SPO'-%'(H!_/9I7_!=']GW1/V%-/&CZ]K]C^UMH_P@L_ ^E>
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ME':ZU;Q7NG>'1HZ7)U6&;Q'K>I07EUJUP+?5;\W\$,<UK8&U^N:** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OA?XR_P#)1O$/
M_<)_],6EU]T5\+_&7_DHWB'_ +A/_IBTN@#W;X ?\B;J?_8S7G_IJT:O<J\-
M^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OA?XR_
M\E&\0_\ <)_],6EU]T5\+_&7_DHWB'_N$_\ IBTN@#L/AG\3="\"Z'?Z+K5C
MK,E[)K5U>$6=M9LD2-:6%H8I1=W]G*DZ2V<OF1^40H*_.6+*OHO_  T#X,_Z
M!WB7_P  ]*_^75%% !_PT#X,_P"@=XE_\ ]*_P#EU1_PT#X,_P"@=XE_\ ]*
M_P#EU110 ?\ #0/@S_H'>)?_  #TK_Y=4?\ #0/@S_H'>)?_  #TK_Y=444
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M_P - ^#/^@=XE_\  /2O_EU1_P - ^#/^@=XE_\  /2O_EU110 ?\- ^#/\
MH'>)?_ /2O\ Y=4?\- ^#/\ H'>)?_ /2O\ Y=444 '_  T#X,_Z!WB7_P
M]*_^75'_  T#X,_Z!WB7_P  ]*_^75%% !_PT#X,_P"@=XE_\ ]*_P#EU1_P
MT#X,_P"@=XE_\ ]*_P#EU110 ?\ #0/@S_H'>)?_  #TK_Y=4?\ #0/@S_H'
M>)?_  #TK_Y=444 '_#0/@S_ *!WB7_P#TK_ .75'_#0/@S_ *!WB7_P#TK_
M .75%% !_P - ^#/^@=XE_\  /2O_EU1_P - ^#/^@=XE_\  /2O_EU110 ?
M\- ^#/\ H'>)?_ /2O\ Y=4?\- ^#/\ H'>)?_ /2O\ Y=444 '_  T#X,_Z
M!WB7_P  ]*_^75'_  T#X,_Z!WB7_P  ]*_^75%% !_PT#X,_P"@=XE_\ ]*
M_P#EU1_PT#X,_P"@=XE_\ ]*_P#EU110 ?\ #0/@S_H'>)?_  #TK_Y=4?\
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ME_\  /2O_EU110 ?\- ^#/\ H'>)?_ /2O\ Y=4?\- ^#/\ H'>)?_ /2O\
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M75%% !_PT#X,_P"@=XE_\ ]*_P#EU1_PT#X,_P"@=XE_\ ]*_P#EU110 ?\
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ME_\  /2O_EU1_P - ^#/^@=XE_\  /2O_EU110 ?\- ^#/\ H'>)?_ /2O\
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M *!WB7_P#TK_ .75%% !_P - ^#/^@=XE_\  /2O_EU1_P - ^#/^@=XE_\
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M_P - ^#/^@=XE_\  /2O_EU110 ?\- ^#/\ H'>)?_ /2O\ Y=4?\- ^#/\
MH'>)?_ /2O\ Y=444 '_  T#X,_Z!WB7_P  ]*_^75'_  T#X,_Z!WB7_P
M]*_^75%% !_PT#X,_P"@=XE_\ ]*_P#EU1_PT#X,_P"@=XE_\ ]*_P#EU110
M ?\ #0/@S_H'>)?_  #TK_Y=4?\ #0/@S_H'>)?_  #TK_Y=444 '_#0/@S_
M *!WB7_P#TK_ .75'_#0/@S_ *!WB7_P#TK_ .75%% !_P - ^#/^@=XE_\
M /2O_EU1_P - ^#/^@=XE_\  /2O_EU110 ?\- ^#/\ H'>)?_ /2O\ Y=4?
M\- ^#/\ H'>)?_ /2O\ Y=444 '_  T#X,_Z!WB7_P  ]*_^75'_  T#X,_Z
M!WB7_P  ]*_^75%% !_PT#X,_P"@=XE_\ ]*_P#EU1_PT#X,_P"@=XE_\ ]*
M_P#EU110 ?\ #0/@S_H'>)?_  #TK_Y=4?\ #0/@S_H'>)?_  #TK_Y=444
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M_P - ^#/^@=XE_\  /2O_EU1_P - ^#/^@=XE_\  /2O_EU110 ?\- ^#/\
MH'>)?_ /2O\ Y=4?\- ^#/\ H'>)?_ /2O\ Y=444 '_  T#X,_Z!WB7_P
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M_P#EU1_PT#X,_P"@=XE_\ ]*_P#EU110 ?\ #0/@S_H'>)?_  #TK_Y=4?\
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ME_\  /2O_EU110 ?\- ^#/\ H'>)?_ /2O\ Y=4?\- ^#/\ H'>)?_ /2O\
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M75%% !_PT#X,_P"@=XE_\ ]*_P#EU1_PT#X,_P"@=XE_\ ]*_P#EU110 ?\
M#0/@S_H'>)?_  #TK_Y=4?\ #0/@S_H'>)?_  #TK_Y=444 '_#0/@S_ *!W
MB7_P#TK_ .75'_#0/@S_ *!WB7_P#TK_ .75%% !_P - ^#/^@=XE_\  /2O
M_EU7SMXXU5?&GBS5]=T2QU*2SNOL&V.2V#7,/D:;:69\]+22ZBC\R6UE:+$S
+;HP"<,&52B@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img155424085_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_12.jpg
M_]C_X  02D9)1@ ! @$!2@%*  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /8!R,# 2(  A$! Q$!_\0
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\*
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M\ /^1-U/_L9KS_TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT%S]HG2"9HHV6)RH!W%%?+/_  W-^Q-_T>'^RS_XD%\)?_FNKT?XO?'WX.?
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MVZMXEMM4UFV1+C5$_P"$G\,>,-5:SUL+>/)<6.LS66I:A;M=74,%Y8B:X/\
M3I_P1@_;P\<_MD?!7QMX7^,&IQ:Y\7?@CJV@:=JWB=;2WL;CQ?X-\5VFI2>%
M-;U6&TCM[.7Q#;7GA_Q#I&LW%C:P17%O9Z/J%XC:EJ=U/. ?LU17\G/_  6#
M_P""IWQYT'X[^*OV4OV;O&&M?#/P_P" X]-T'Q[XP\(2):>.?&'C#5].L=6N
M=*T#Q':JVM^%]+T"/4++2-WAV?2M>O=>@U=9K^33/LEN_P _'_@EI_P6.N]
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MM/%OC31+K7-/2>0PVT/A2QO;")8)H+.-8K&9(/3/V6_^"L7[9_[%GQ-'P_\
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MHJK^.?\ P1$_:;_:2^+'[;D/A/XI_M!_'#XE^%C\)?'VI'PUX_\ BQX\\9:
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MAM6N],\.V6M>*]!L'^RPSVT4MMX5TEM-T["VLWV5T$0 /[T**_S_ &7]HO\
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MCS\6_BW\3]4^+_C2Z'@:+XG_ !#\8^.8M%\">!FN_#\5[HD'BS6-3&C7&O\
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M&/A5=+D^+?CB<>,_$>E^&O FG:/HVK>,M4/BF36#KGCCQMK-V)+;4-<35[.
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M]0T_2+5-0CA:SU+6[@VFF6B7\4)M[R\B6ZCCV2*H![%17\*>E_M _P#!3?\
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MTC6-*U"WCN[#4]+U*VEL]0T^^M9E>&YL[VTFFMKFWE1HYH9'C=65B#_G[_\
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M#)K"2_!_PO97;*#<6>FRI\0M6U2VA?8&2'4;J'2);A1(PE?2[4E$,09_0_\
M@Y&L;:3X1?LR:DT:F[M/B1XYL8)2L99+;4?#&E7%U&'*&55DETRS9E218W,2
MF1'9(FCP?^#;'_D2/VLO^QJ^$?\ Z:/'U=3_ ,'(?_)$OV;?^RI^+/\ U$HJ
M -?_ (-PY9#^SI^T!"78Q1_&K3Y4C).U9)? NAK*ZCH&=88E8]2(T!Z"OY]O
M^"I'_*0;]JS_ +*G?_\ ILTNOZ!O^#<+_DWC]H+_ ++/I?\ Z@^D5_/S_P %
M2/\ E(-^U9_V5.__ /39I= ']X/[+W@SP[\//V;_ ($>"O"=K:VGA_P]\)/
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ML3)_:K_P3_\ V-+_ .&G_!-73OV<_B+:W'ASQ5\9_A_\1KOXE6LUL'O=!O\
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M\<J&;,DEY?SR2R9!FE=Y2JERH_T2:_SR/^"I'_*0;]JS_LJ=_P#^FS2Z /\
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M%_CY_P"'"\.?_,%7Y?\ _!5O_@D7\(?V1?V?]"^.7[/MY\1-2LM$\;:?X?\
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M>%/!/A^=XK*PB?PYXCT_7/#EGI/AOPU8_P!M^,+VVTJSTC?::YXCNX8!+<S
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MZ5XECCN)9I_[+L-=\&V:22O<0HTP:.X^S?V;/^"I_P"PE^UE\#/#N@?M[?\
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M1_M[^Q?^%,7'V?[1]G_M#^R_[6G\K?\ 9/[1DV_:6 /Z.J*** /R>_X+=?\
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M&T_.W]C+_@M9^V5^TQ^T5X)^"%M\"?A!XIM/''BLQRWNAP>-]"U/P3X(%_\
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M?#WQ8^FW$'B:2W ,TMCX4U_3%CU VH=K2P\37>K7B+INEWEW:?G)_P $BO\
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M:#K;7R6::[HZW*:=?YT^[LIW>&*\NX'A>9K:YMKJXMKJ&:":2-CX4_ +X'_
MJRO-/^#/PB^''PMM]22W353X$\&Z!X9N=9^R;Q:OK=]I5C;7VM2VXD<0SZI<
M7<T8=@K@$BOYM/\ @IE_P6O\"_$'X6Z#\,_V(_'OQ)TCQ3JGB72M?\6?%?2+
M?Q'\-KK0M$T&:2[M_"^AS3OI7B*[O==U-+.37'-M#HQT*UFTF9M676KN#3_M
M?_@B!\3OVROCG\+OB-\6/VD_B?XN\;?#BYU33?"_P=MO%>B>'H;C5+O2WOY/
M''BBW\1PZ#9>)=;TVVNFTKPY8RSZO>Z0-2M/$EJ(_M^G/]G /Y1-:>[^/O[:
ME\GCR[N3<?%_]IIK'Q3<WMS)'/;Q>-OB>+'4D>Y7:ULEC;ZC)!%Y0C2SA@CC
MMTBCAC1?]'G1M'TKP[H^E>']"T^UTG1-"TVQT?1]*L84M['3-*TRUBLM/T^S
MMXP(X+6SM((;:WA0!(H8T10%4"OX#/\ @IQ^S=XV_8^_;9\?W5G9W^D>%_&O
MC;4?C+\&O%$2*UG/IFMZZWB(V>GW.QXAJ'@;Q%<3Z#=V5R/ML4=CINI7$+V6
MKZ?=7G]"WP!_X+]?LH>(_A7H=[\?6\8_#KXLZ;I=M9^*]$TGP?JGBC0O$&LV
MEK$EUK/A/4M$BFBM=/UF</=0Z7KJZ5/I$TDFG-<:A;6T.K7H!^>/_!QK\//"
MV@_'?X"_$;2;&QL_$WQ#^'?B72?%DUJOE76JCP)K&D0Z#J6I(N(YKE;#Q'+I
M,-ZRFYDL=)M;*21K?3[..+]3?^"!'BW6O$O[ EMI.K32S6G@/XR?$7PEX>$H
M;$.BW%OX:\:/#$S$[XEUOQAK3*5PJ,[1 #RZ_FB_X**_MH:__P %$_VEM'U_
MP9X0US3O"6CV6G_#;X.>!FA34O%FIQW^K2RG4-0M-+%RLWBGQAK5_$%TC39;
MV&QM8=(T:WN=2N;2?4K_ /LA_P"";?[+NH?LA_L@_"_X2>(XX(_'DMO?^-?B
M.MO)#-'!XV\87/\ :>H:2+BV>6VNCX9L#I?A0WMO--;WW]A?;;>1H;B/ !_"
MK\'O#FG^,?VR?A;X1U>V@O=*\4_M->"/#FIV=T@DMKO3]<^*>F:9>VURA5P\
M$]M=2Q3(4<-&[ JP.#_H]^(K>";PYKMK+#%);2Z)J=O);NBM#)!)8SQO"T9&
MPQ-&2C(1M*DJ1CBO\Z7]G#_D_3X#?]G=_"[_ -7+H5?Z,&N_\@/6?^P5J/\
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MU)I$\Q8[+Q9)XOT*XFV]2T,=\TR%2'5T5D*N%(_8W_@NW_RCN\??]C_\+/\
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MA#1_#TI4)\H4OIS%0OR@8V\8H ]7HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\SZ*** /K[X
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M&G>'QX(\1Z9H43V_B2XTJYU$ZBFH>'M;-S(LFCVGV9HGMQ$IF#K(74I]Y44
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M_'&@QZ0OB+4_$<WBBY2"S?P5)-'IPU*=UBMFNY)5MML37+.#*?V(HH ****
M/!OVF/V=/A_^U=\&O%/P+^*$WB&W\%>+Y_#]QJTOA;4;;2=<63PUXBTKQ/IW
MV2_O-/U2WA5M2T>T6Y#V,QEMC-$AC=UE3YW_ &./^";/[/'[#?B7QEXK^"U[
M\1KK5/'.A6'A[6E\;>)=+UVU6PT[4#J5NUC%8>'-$>"X-PQ$DDDLZM'\HC4_
M-7Z T4 %?E;^TE_P1V_8Z_:A^+GB+XU>.K3XB^'O&7BV/3SXD3P#XHTG0-%U
M?4=/M([$:Y<Z;>^&=9*ZQ>VD%M'J5S;W$,5]+;+>36YOI[RZN?U2HH ^?_V8
MOV;/AW^R5\'= ^!_PLF\1W'@SPW?:]J.G2^*]3M=7UMKCQ'K-YKNH"YOK/3M
M*MY8UO;Z86ZI91F. )&S2,I=N2_:J_8I_9V_;,\+V/AKXZ>"$UNYT0SMX7\7
MZ/=R:)XV\*/=2027@T/Q!;*\B6E[]GB%[I.HP:CHUVT<4]QITEU;VT\/U;10
M!_.]_P 0XW[,?]L^?_PO;X[_ /"/?] O'P^_MG_7[O\ D/?\(C]A_P"/;]U_
MR+G^O_TC_5_Z-7ZR?LF_L+_LW?L6>'[[2/@=X*?3]8URVM+;Q3X[\17\FO\
MCOQ6EDS/ FK:W-'!!:V:RMY_]C>']/T30!<@72:2ESF4_7M% &#XJ\+^'_''
MACQ'X+\6Z3::]X5\7:%J_ACQ+H=^C26.LZ!KUA<:7K&EWB*R,]KJ&GW5Q:SJ
MKHQBE8*RM@C\%/%O_!NK^RAJ_B*34_"OQ9^.'@_0+FZN[F?PRU[X.\0I9QSN
M[V]AHFKW_AB#4+6QL@RPQ'6SXCU":&,?:=1EG9K@_P!!-% '@W[,O[._@7]E
M'X)>"?@)\-;SQ)J'@SP)'K:Z3>>+M1M-5U^XE\0^(M6\5:M/?WFGZ;I%@SW&
MM:WJ-PD5EIEE;0)*L44"JN3[S110!\2?\%%?V<6_:H_8[^-'PGT^U-UXLE\.
M-XN^'Z1J&G?QWX*D7Q'X=L("<B,^()[&7PO<2E6,5EKETZJ6"X_GG_X-T/C-
M_P (W\</CE\!-4NUMH/B-X%TOQSH5K=L8V;Q+\-]5ET[4-/LHF8$7U_H'C"\
MU"[C$99[3PN79D%J%?\ KSK^;WXR?\$M?VCOA5_P48\.?MB?L8:5X)F\$MXQ
MT[XE:]X1U7Q3:>$IM-UG6IK[3?BMX.TVUEA\I_#_ (TT:\U:XMI+>:WAT\^*
M;[2(;>VM-+M))@#]T/VDOV?/ ?[5'P6\9_ ;XFS:_!X(\=_\([_;<OA?4+;2
MM=3_ (1CQ9H7C+3?L-_=V&J6\&[5_#U@MSYEC/YMFUQ"GE/(LT?Y4_\ $/I^
MP?\ ]!?X^?\ APO#G_S!5^XX.0"002 <'&1['!(R.AP2/0D4M 'X;_\ $/I^
MP?\ ]!?X^?\ APO#G_S!5V7PZ_X(6_L5?##X@^!/B7X;U3XWOXB^'GC+PQXY
MT!-3\=:!=::^M>$M;L=?TI=0MHO!%M+<6+7VGP"[@CN;>2: R1I/$S"1?V6H
MH AN+>WN[>>TNX(;JUNH9;>YMKB))K>XMYD:.:">&16CEAFC9HY8I%9)$9D=
M2I(/XS_'[_@A1^Q)\:-?O_%?A:S\;? G7-4N[J_U"S^%NK:8G@Z[O;R1Y9IE
M\'^)M(UVPT6!9&_T?3/"5QX:TBV3,<.GHI&W]GJ* /PJ^#?_  ;^?L:_#S7+
M'Q!\0O$'Q/\ C7)82I.GAWQ+J^F>&O!MU+%)))&VH:9X3T[3]>O(T/V<M:2>
M*?L%R89([VTNK2XDM1^WGA[P[H'A'0M(\+^%M%TKPYX;\/Z=::1H6@:'86NE
MZ/H^E6$*6]EIVF:=910VEE96D$:0V]M;Q1Q11JJ(@ Q6S10!X)^T/^S#\"_V
MJ_!*^ /CQ\/M)\=Z!;W$M]I,ET]YI^M^'=3E@:V;5/#GB#2KBRUG1;TQ,$F:
MQO8H;V-$@U""[M@8#^,_B'_@W-_95O=26Y\-?&?X]:!IKW7G7&F:C=> O$#I
M;,\C26>GWR>#=&EM@@:..VGOHM5ECCC/VDWDKF4?T)T4 ?E?^RM_P1V_8T_9
M3\4V/Q T70?%/Q5^(6D7=EJ7A[Q7\7]4TCQ WA+4[(1R)?\ A;0-#T#PUX;L
M;R.]C2_T_5-3TK6=?TBYCB?3-:MF5F?]4*** /R)_:0_X(G?L2_M$>)M0\;P
M:)XP^"_B[5[J\U'6KWX/ZQI.CZ)KVJ7LDDTU]JGA/Q%H/B;0+622>5YY_P#A
M&+3PT]W.S37<LTKR._S3X5_X-T?V4--U!;OQ;\8/CQXILX;S[1%I=A?^!?#5
MM<6R7$,D5CJ=PO@[6+Z>*2!)K:\FTVYT>YE$RRV<VGR1#?\ T&44 >1?!+X#
M?"#]G'P)9?#3X)> M#^'O@RQGDO!I6C13/+?ZE-#!;W&KZUJE]-=ZOKVLW,%
MK:P7.KZU?W^I306MM!)<M#;P1Q_EQ_P7@^-\?PM_89U?P)9WD</B'X\>-/#?
M@"U@1P+U?#FDW0\;>*[^%"0&M/(\.Z=X=OWVN53Q1"BJK2K-%^TE?SX?\%.?
M^">O[77[>O[5'PO_ +,/A+PS^S/\/K#1/#=OK]WXJM7\06D/B;4;#4_BAXSL
M_"A226XU9;:&PT;3-.DEM5U'_A%=.>66WANWN% ,K_@WD_9O;P5\"?B-^TEK
MNGM#K7QF\1KX3\'3W$)#K\/_  !/<07U]92LJD0:_P"-;K5[*]C&])#X-TZ5
M7ZJ/Z)*X_P"'W@+PI\+? OA#X;^!M)@T+P=X%\.:/X4\,Z1;EFCL-%T.QAT^
MP@:60M-<SB"!&N;NX>2YO+EI;JYEEN)I)&["@ K\Q?VJ/^"2_P"RU^V#\6KS
MXS_%G4/BK;^+[[0]$\/31>$?%NCZ/HPL-!@D@L2EE>^%=7G6X*2L9Y#>,LC8
M*QQ@8K].J* /!O@Y^SI\/_@;\ =!_9O\%S>(9?A[X=\-Z_X6T^;6]1MK[Q$V
MF>)+W6+_ %!KC4K?3[*UDNEGUN\%M*NG1I%&(%>*0HS/\"_ _P#X(K?L>?L_
M?%KP)\9_ FI_&67Q?\.]=B\0Z!'K_C70M0T=[^&&>!%U"RMO!MA/<VY2XDW1
MQ7ENQ;:1(,8/ZYT4 %?C]I?_  1%_8UTCXNZ=\:K74_C2?&.F?$>T^*5M%-X
MWT%]&/B6R\31^+(4ELE\%I.VF'5(E5[5;Q)6M<PBZ5SYH_8&B@!" 000""""
M",@@\$$'@@CJ*_&O]HS_ ((:_L7_ !Z\5ZMXZT*'QM\#_$^N7-QJ&K0?"_4=
M&A\':CJEW++-<ZC)X/\ $&BZS9Z7)-+(K/9^%KOPYIF4+K8K/---)^RM% 'X
M3?"/_@WV_8T\!:[IGB#Q]XF^+/QDDTV7SG\,^(M:T3PUX)U)U*M$=1TWPIH>
MG^)YTAD4/]GC\8Q65PNZ&^M;NW=HC^WGA?POX<\$^'=$\(^#]"TGPQX6\-Z9
M9Z-X?\/:%86VF:/HVDV$*6]EI^FZ?:1Q6UI:6T*)'###&B(HX&<D[M% 'BOQ
MY_9V^"W[3?@6Z^&_QR^'^B?$#PG<3+=06NIK<VNHZ/J$>!'JGAW7],N+'7?#
MNJ*FZ%M0T34;&ZFM))[&XDELKFYMY?Q;\5_\&Z7[*NJZVU_X4^+_ ,</">CS
MWGGS:#<7/@SQ&EM:LVY['2M2N?#-A>VZ(,I;3ZH=:N(U"FX>[<,[?T'44 ?G
M+^R+_P $L?V1_P!C;5;?Q?\ #_PGJOC#XFVT,D-M\3OB7J-MXC\3Z6MQ;FVN
ME\.6EGI^D^&O#+3Q2W,+WVC:%;:W+974^GW>KW5FYB/Z-444 ?COX._X(??L
M8^!_BIX5^,&BZI\:W\6>#_B!H?Q*TF.]\<:#/I#>(O#_ (CM?%%@EW9Q^"H)
MIM..I6D2W%LEW#+);%XEN8W(E'[ W5O'>6MS:2[A%=036\I0@.(YXVB?:2"
MVUCM)! ."0>E3T4 ?C]\'_\ @B-^QK\$?BEX ^+W@S4_C3+XK^&_BO1O&/AZ
M/6O&^@WVDOJVA7D=]9+J-G!X+LIKFS,T2B>&*[MGD3*K,A.X?K)XH\/6'B[P
MUXB\*:JUPNE^)]"U?P]J36DBPW2V&M:?<:;>-;2O',D5P+>YD,,CQ2JD@5FC
M< J=VB@#\D_@-_P1>_9 _9U^+W@;XU^ -2^,<WC'X>ZM)K.@Q>(?&FAZCHKW
M<MA>::PU"QMO!VGSW$/V>^F(2.]MV$@1MY"E6_4WQ3X5\->./#>N>#_&.A:5
MXG\*^)=,N]&\0>'M<L;?4](UC2K^%H+S3]1L+N.6WNK6XA=DDBE1E(.1A@"-
M^B@#\%_BQ_P;W?L?^-]=O]=^'OC/XL?""._GEG_X1G2=3T7Q7X4T\RW+3F/2
M[;Q+I4WB2W@2*1[>*&Z\4WR1HEN8POE2K<>Q_LV?\$0_V+OV>O%FF^/=1LO&
MGQL\6Z+>6FI:%)\5M3TB\\,Z%JEC<?:+34K#PEX=T30-,O[F)UC=5\5-XEM8
M9XH[JTM[6X2.1/V%HH **** "OXF?^"['[/FH_ S]L^P^-WAF.YT[P]\>](L
M?'.G:C:@PIIOQ*\&'3]%\76UI(H)6Y*Q>%_%TDS/O>_\2W0152 5_;-7P=_P
M4:_8UTO]MO\ 9G\4_#&%-.M/B-H;CQC\(O$%^%BCTKQSI4$RV^G7=ZJ/+;:)
MXJL9;KPYK3!9HK:*_M]9-I<WFCV*J ?1/[.7Q:L?CS\!/@[\9=/DMGB^)7PY
M\)>+;J.T(,-CJ^K:-:3Z[I) 9PDVC:V=0TFZBWOY-S931%F*;CYE^U=^Q!^S
ME^V?X;L=!^.7@=-5U'15D7PSXWT.Y_L+QYX66=Q)<0Z-XB@BED;3[EQONM$U
M6WU/0KF<1W<VF/>06UQ#\Q_\$EO@!^U'^RS\ -=^!/[2&F>&X-.\+>+KK6OA
M7?\ AWQ3:^)$30/%;7&I^(_#UPENL1L8],\3K>ZY;,T0%U)XIO55S]DVK^J-
M '\5WA__ ()6_"B;_@JIKO[%VI:W\8+KX%Z+X<C\36WC%9-"M/%E\S_##1?'
M4>D7?B-?"+^&&4:MJ<NE7,]GH%K<2V<!2!;.]/VB/^KW]F;]D7]G[]D+PA=>
M#/@-X L?"-EJEPEYX@UB:XN]9\5>)KR)66&?Q!XEU6:ZU6_CM@\OV#3_ +1%
MI.EB>X&F:?9K<3B3Z4HH ^=_VH_V8_AQ^UW\(=5^"GQ6G\2V_@[6-6T/6;N7
MPGJEKH^M"[\/7\>I6 AOKW3=6@2$W$:BX1K)VDCRJO&3N'AO[&W_  3A_9\_
M89USQQX@^"UY\1+J_P#B!I.D:-KH\;^)-,UVW2TT2\N[VS-A'8>'=$:WF,U[
M,)GDDN%= BJB%2S??5% 'YS_ +7_ /P2\_9D_;:^(6@_$[XPO\0['Q7X?\(6
MO@BVN/ _B72]!MKS0['5]8UNS748+[PYK37-U;7NNZD(KA)8<6\J0LC")"/=
MOV2/V0_A%^Q7\,;_ .$_P93Q&?#>J>+M4\;:E=^+-4M-8UR^U[5M.T?2;B:X
MOK/3-)@:"+3M!TRTMH5LU\J.W^9W9V8_45% 'Y&?'#_@BM^QY^T#\6O'?QG\
M=ZG\98O%_P 1-=E\0Z_'H'C70M/T=+^:&"!UT^RN?!M_/;6X2WCVQRWEPP;<
M3(<X'ZIRW&B>!_"LEUJ-]'IOAOP?X>>XOM3U"4"*PT3P_IIDNKZ^F"*HCM;"
MT>XN90B@+&[A .*Z"OA__@HG\//V@?C!^RC\1/A!^S;8:+<^._BC':>"M7O=
M=\00>'+32? 6J-*_C.:.\GW"XN-8TJV;PL;-8Y"UIX@N[@@"V+  _DI_8H\#
MZC_P4._X*GCQYXCTV6[\*:E\5_%W[1OCVTGB,UMI_@[P_P"(F\0:!X;O4&]&
MTV]UFY\(>!7B>;=_9]^Y$TKQEG_NVK\H/^"3'_!/R^_8:^"_B&3XBPZ-<_';
MXH:W]O\ '=[H]V-4L-$\.Z#-=V?@_P (:7J@6..[MX(9[[Q'J=U!;VQN-5U^
M33YC>6^AZ;<U^K] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'YGT444 ?7WP _Y$W4_^QFO/
M_35HU>Y5X;\ /^1-U/\ [&:\_P#35HU>Y4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!^9]%%% 'U]\ /^1-U/_L9K
MS_TU:-7N5>&_ #_D3=3_ .QFO/\ TU:-7N5 !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!117EOQ<^-WPA^ WA6X\:?&7XE^ _AAX:A2Y\G5O'OBW0/"-GJ%U;0-/_9NF
M7&OW]A%J&ISJ%2VTZS::\N)9(HH8'DD16 /4J*_-[]A'_@J1^S#^WOX<DO?
M/B.Q\ >/1XBU;0[7X+_$3Q9X'LOBSJ5GI6G6>I-XETOPAI/B/4[_ %+P_<PS
MW21WMDDXB?2[\W2P)&C/^D- !117AGP\_:?_ &:?B[XKU#P)\)_VA_@9\3_'
M&D65_J>J^#?AY\6O /C7Q7IFFZ7>VNFZGJ&H>'?#?B#4]7LK+3M1OK&PO[NY
MLXH+2]O+6UN)(Y[B&-P#W.BBB@ HK \3^*_"_@G0M0\4>,_$F@>$?#6DQ"?5
M?$7B?6-.T#0M,@9UC6;4-7U6YM-/LHC(Z1B2YN(T+NJ@[F /C_@G]K']ECXE
M^(%\)_#C]I;]G_X@>*6NVT]?#7@GXR?#KQ7X@:_0N'LET;0O$=_J)NT,<@:V
M%L9E,;@H-K8 /?Z**XCQ5\3?AMX%NK:Q\;?$'P/X.O;VW-U9V?BKQ9H/AZZN
M[59&A:YMK?5K^TEGMUE5HC-$CQB160MN!  .WHKQ_P#X:%^ 7_1<?@__ .'+
M\%__ "[KMK+QUX(U+PS/XUT[QCX5O_!MM#>7%SXMLO$.D77AFWM]/>2._GGU
MZ"\DTJ*&QDBE2\EDNU2V>.19F1D8  ZJBO'_ /AH7X!?]%Q^#_\ X<OP7_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _,^BBB@#Z^^ '_(
MFZG_ -C->?\ IJT:O<J\-^ '_(FZG_V,UY_Z:M&KW*@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /S/HHHH ^OO@!_R)NI_]C->?^FK1J]RKPWX
M ?\ (FZG_P!C->?^FK1J]RH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M= 6@TZPA;Q6GVK5M8O6M=(T:Q5A)?ZK?6=G%F2= ?Z :_E]_X.<OVEKWP?\
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MD^,?_!Y??_':/^*N/A/_ -&K\0__  LX;_\ G@'_ !*[Q/\ ]%+D/_@K,/\
MY1Z_T]/V]HKY1_9#\6>)?%_P_P#$.H>*-=U/7[ZW\8W5G!=ZK=RWD\5HFB:'
M.MO'),S,L2S3S2! =H>5VQEC7U=7^D?A'XD9=XO^&W"/B5E&7XW*LMXORO\
MM3"9=F,J$\=A*7UFOAO98F>&G4H2J<V'E*]*<H\LEK>Z/Y_XIX?Q'"O$&:</
M8JO1Q.(RK$?5JM?#J:HU9>SIU.:FJD8S4;5$O>BG=/0****_1CP HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7EG::C:76
MGW]M;WMC?6T]G>V=W#'<6MW:7,307-M<V\JO%/;SPN\4T,BM'+&[(ZLK$&S7
MA_[2TOQ6MO@#\7;[X':C+I?Q<TSP)KVK_#^YM]+TC6[F7Q'I%F^IV>G6NE:]
M8ZGH][=:N+1])M8=0L;B#[1>QN55E5USK5%2HU:KA.HJ5.I4=.FE*I44(N3A
M",G&,IRMRQ4I13DTFTM3FQE=87"8K$RHUL3'#X:O7EA\/"-2O75&E*HZ-"G.
M4(3K55'DIPG.$93E&,I13;7\J?\ P4&_X)H>,/V.O%/A_P"*OPA\4'7/AQXW
M^*^C^$_AKI5C<:C;?$[PAXXUJ#5_$7AK08?LMNL6JQ6S:!>1:#XBTZ_AU1KF
MVLXKS3;>[:*]N_T,_P""5G_!1WXS_$OXLW/[)_[3US=ZSXTDT[7F\#>*=<TA
M=#\;1:YX.LY;[7O OC*QALK 7EW!H6FZQJT&K:A9V^NV]UHVH6>MSZK/?VLN
MG_FQ??\ !1?Q7\=/@_\ "OX??M(>+=0U_P"(G@']MSX3_&6/QK=:#I6F:</A
M;IF@>*M,\1V%U:>%]-TZTM;KPMK5_#>6]M;Z2LMYI^MM!:J_]DM&?K#]F/Q'
MHW[8/_!9[7OVA/@[I%_;_"SPC;ZUXIU/6I[:?2I;_3M+^$P^$VGZY-:SQQ26
M<_C+Q3>V>HV^DW45MJ<VBR7LVH6D=[;:HL7XWEV)P='.\'BN',36P]#'YCEU
M"MD\I-\V'Q*KO&SJ4E.:C'!\GNM\\::JQG3J**2E_(7#V991@^-<IS7P]S'%
MX# Y[Q#P_@<5PE4FYNK@,QCC7G5:OA85ZT*4,H=%.FY.O3PRQ=.KAZ\:4%&?
M]+]KX)\'67BS5/'EIX7T"W\;:WIMAHVK>+H]*LE\2:AH^EF1M.TBZUKR?[1D
MTNRDFFFMM.-Q]CBGFFG2$32R.W\O7_!*S_E*=^T#_P!@S]H/_P!6EH-?U6U_
M*E_P2L_Y2G?M _\ 8,_:#_\ 5I:#7VG$L8QSCA)1BHIYM6D^5)7E)47*3MNY
M-MMO5O5ZG[%XB4Z=/B[PH5.$*:EQ5C:DE",8J52I#"3J3DHI7G.3<IR=Y2DV
MY-MW/VD_X*=_'7X:? S]DSQK-\2_ ^D?$^U^(T]M\._#WP\UR>XMM*\0:_JD
M-UJL%WJ=SI]S:ZQ8:?X;M]&N/$!U+1;BTU:VU*PTN'3-2TG4KNRU*U_E\\.?
M\$[/VO/%7[*>J_M(:%I^FP_"22QOOB!#\/!XHU:'Q5K?AO2([C[3XWTOP>UG
M/I-W9V6F6MU=6+:CK47B;4=(@6YTG3]1ANK)KO\ <G_@O%\//$/B?]E_P#XW
MT6RO+[3?AM\4[2Z\5"V4O%I>B>*-$U+0[?6[T#A;:#Q =$T82\E+C7H%QL>1
MTX'X1_\ !4W]E[PQ_P $[M#\(ZQXDGMOB_X$^!%M\'H/A8^BZM)JGB'Q)H/@
MU/!FB7UGJ,6F2Z#_ ,(]K*06FKW^IW%\#IMJ]];7%O<:E#!9WWB<0T<OS'B+
M&8;.L4L#A\%DRJ9?-2I4)5YU&Y5)>UG%RK\D^>,,,I-2<)<D;^UYOB_$#"9%
MQ!X@9QEW&69QR3+\FX.6(R&LJN&P-3&UL0W4Q%1XFK3=3'*E6]M3I9=&<HU)
M4JGL::F\3[7ZD_X)!?M'?#_XV?LS0>!O"7@'0/AEX@^!\VE^&/%OA;PP+C^Q
M-0&MV]W>Z1XWM'O[F^U9I_%LVGZT^K-K-_J.I2:[IFJ3RZA=0S6[C]7:_G1_
MX-^?A[X@T_PO^T;\4+VVN+?PWXFU?X?^#- G=)$@U+4O"=MXIU;Q$\9=5CF7
M3XO%.A0)+$9 );F\A8H\3*?Z+J^MX3Q.(Q7#V65L3%1JNC.FN6$::=*C6J4:
M$E"*C&*E1ITW[J2=^9)*2/U?PKS#'9IP!PUC,QIPIXF6#JT$H484(3PV#Q>(
MP>#JQHTXPIP57"4*$_<C&$^;VD$HS211117T1^@A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YGT4
M44 ?7WP _P"1-U/_ +&:\_\ 35HU>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0U6TGU#
M2]2L+74+G2;F^L+RTM]5LEA>\TR>YMY(8=0M%N8YK=KFSD=;F!9XI86EC02Q
MNA93_GC_ !)_X*+?M<>#/ O_  4#_8>_;B\9_$7XI>+/'>G:/\/=&NO$.H6]
MY;_#?XD?"OXEZ=JMU/I=B8=.M8?!WCG0;2^,E_HL#+?3VGA'4[>UGL+JZO8?
M]$>OQI_X*[_\$S/AS^V-\"OB3X^^'GP'T7QG^V;IGAWP_I_PK\5:9XBL_ FO
MZLUIXFT2*[TSQ#JNI^)/"_@WQ!:6?A5];2P/CJ:[_LZ*-+?1KBUG^S0N ?SA
M:C\3]!_X*>_\%(O^":W@+]GOPKJUUI'[/GPT_9T\%_$#QQJ&FSZ5<ZGH_P &
M]4@^(/Q/\0$-']JT[PSX:MCJ6@^%7UA+*?5?$UPT<"Q#Q!I:2?WIU\*?L%?L
M.? S]C#X.>$M*^''P=\/_#CXD^(_ G@H?&+6HKR7Q)XKUWQE;:)9S^(;35?%
M][JFNW%YIUGXCFU22STO2-5/A:TD=Y-%M([9HV/W70!_$7\5?^5H'2_^R\?!
MO_UG?P-7]=W[6/[0%G^RO^SE\7?VAM0\,7/C.S^$_A*X\57'A:SU2+1;K6X[
M>ZM+4V4.JS66I16+L;H.)WL;E0$*^6=V1Y1JO_!.3]C/6_VH(OVS=4^#?VK]
MI2'7M&\3Q?$C_A87Q5AVZYX?\.V/A/2+[_A#[?QQ%X";[)H&FV5A]F;PL;.X
M\G[5=6\U[)+<R=]^VE=_ >P_94^.E_\ M/:%K/B?X V/@'4[WXI^'_#\?BF3
M6=6\+6LEO/<6=@?!=_I/B."66XCMMUY8ZMI4%A$)+W4]4T[2;>^O8 #P;_@F
MA_P4)T;_ (*/_!GQI\8=$^%^I_"BV\&_$[4/AK+H6J>*;7Q;/?SV'A7PGXH.
MKQW]IH>@QV\4L?BJ.S%FUK*ZO9/,;AEG6./^=7_@II+=?M%?\' O[+7P2U-X
MKGP[\/?$/[,/A&YTY@'@;1)O$*?&?Q:LL3$QF\U'2/$MS:-*RMOMX-/219(X
M$0_LY_P0@^ VN_!/]BWQ%KFM?#_4OA79?'WX^?$;XZ^!OAUKDE_/KG@SX7^(
MM-\)^%_A]H>I7&KRSZU<XT'P=%JEA=:Q-)J=]INJ6FH7;M->,Q^TM3_X)W_L
M>:S^U+%^VIJ?PA:[_:9AU72-;B^)<GQ!^*:E-3T'PC9>!-(N!X.C\;IX!*V7
MA33K+28[<^%3;,MNMY+#)J!>[8 ^U*_A>_X.._VY/$'Q5_:+M_V.?"6K2VWP
MM^ *Z3JGC>ULKF3[-XN^+WB#1;?5FEU'RR(;FT\">'-7L]%TVV96:Q\0:AXM
M-PTD@M$L_P"Z&OR]^*'_  1B_P"":_QH^(OC7XL_$S]G&7Q1\0?B)XDU7Q;X
MP\0R_&;]H#37U?7]:NI+S4;T:;HOQ5TW1].BEGD;R=/TK3['3;*$1VMC9VUM
M%%"@!^ W[!O_  6V_P"">O[!O[/7A3X)?#O]G']H:ZU2*"WUGXE>.#8_"^+5
MOB)\0;JT@37/$NHR_P#"="9+)98QI_AO2G=TT/P]:Z?IPDGN([J]N_UP_P""
MC_\ P5"A^%?_  2]\'_M-?!V+5O"?CW]K3PYX7T'X*V^M/9IXE\%_P#"P?#E
MYX@U?Q5=1Z9<WMH-6\'>%+34&L;FUN[BQM/%MYX=>62YMV,%QZ;_ ,.%?^"3
MW_1J?_F<_P!I+_Y\-?1_Q:_X)F_L2?'/X5?!?X)?%+X+R^)_A?\ L]:/-H/P
M@\*CXF_&#0X?">ESZ=I.DO!)J?ASQ_H^M^(Y1I^B:;;17GBO4M<O;=8IF@N8
MY+V^>Y /X9?^"4_[9/[(?[%'Q7\3?M _M'?"GXK_ !E^,%K_ *+\*+GPU!X/
MOM"\$MJ45S_PD_C"ZD\5>)=+OKWQSJ8G_LO3;]8&CT;3)=7G2>YO]8232_[/
M_P#@G7_P5;^#G_!2+6OBIHGPL^'/Q,\"W'PGTOPIJNLR_$!/"R0ZE#XMN]=M
M+*/3/^$=\0:VYEMGT&Y:Z^U);KMF@\II#Y@3B_\ APK_ ,$GO^C4_P#S.?[2
M7_SX:^L_V5?^"??[(?[$NH>,]4_9B^$G_"L[_P"(5GHEAXOG_P"$]^)WC/\
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M 3[<**** "BBB@ HHHH _4+]B#_DF?B?_L>KS_U'_#U?9U?&/[$'_),_$_\
MV/5Y_P"H_P"'J^SJ_P"K'Z$G_**?@E_V2"_]6N9'^:/C#_R<SC#_ +&B_P#4
M7#A1117]3GYJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!^$?\ P49_X)@?#?QWJOP_^)OP)^$6O)X]\<_'KP9I?QDL
M_ -ZMIHH^&^LV/B&7QKXW;P]<^9I6C:K;7UGHC7&IZ/#;03W=_=7M_IFH7][
M/=U^K_[//[,/P1_99\(7'@OX)>";3PGI>HW::AK=\]U?:OK_ (AU&.+R8[S7
M->U:XN]3OC"AD%G9FXCTS31-<)IEC91W$R/[[17D87),MP>/Q68T,+0IXC$J
M";C1I1]DTI*HZ+C!2@\0Y<U=I_O)).5]3Y3+."^'LHSS,N(,#EN#H9AF2HJ4
MZ>$PM/ZK*$:L<1/"2ITHU*,L?*ISXUJ?[^<(N=];E?%/P5_8"_9X^ 7QH\4?
M'OX>:;XKMOB%XPA\4P:U<ZKXHNM4TJ2/QAK-MKVM"WTR6!(K<OJ%I"UN5<_9
MX@T2Y#$U]K45WUL)AL14H5:]"E5J86;J8>=2$92HU'9.=-M-PD[+56>B/<Q>
M5Y;CZ^!Q6-P6&Q6(RVL\1E]>O2A4JX.O)14JN'G)-TJC4(IR@TVHI/8Q/$GA
MOP]XQT'5_"WBS1-*\2>&M?L+C2];T'7+"VU/2-6TZ[C,5S9:AI]Y'-:W=M-&
M2LD,T;HW!QD C\I]9_X(E?L-ZMXJ/B.#1_B7H>G-=2W,O@K1O'LB>%91+=I<
MFV#ZCI6I>*;>U1%>SBCL_$]LT=I,X5Q<)!<0_KG16&-RO+LQ=-X[!8;%NE_#
ME7I0G*";3:C)KF46TG*-^65O>3.+..&>'N('0>=Y-EV:2PS?U>>-PM*O4I*3
M4I0A4E%S5.;2<Z?-[.;2YXLXOX=_#KP/\)?!>@?#OX;^&=+\'^"_"]DNGZ'X
M?T>$PV=E;[WFE=FD>6YN[R[N99KS4-1O9[G4-2OI[B_U"ZN;RXFGD[2BBNV$
M(4XQA",80A&,(0A%1C"$4E&,8I)1C%)*,4DDDDE8]BE2I4*5.A0ITZ-&C3A2
MHT:4(TZ5*E3BH4Z=.G!*$*<(I1A"*48Q244DD@HHHJC0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_,^BBB@#Z^^ '_(FZG_V,UY_Z:M&KW*O#?@!_P B;J?_ &,UY_Z:M&KW*@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBOR5N/VKOC9'<3QKXCT\*DTJ*/^$=T,X5790,FQR< #D\U<(2G>UM+7OY
M@?K54-Q;V]W!-:W<$-U:W$3PW%M<1)-!/#(I22*:&16CEBD0E7C=65E)5@02
M*_)7_AK'XW?]#'I__A.Z'_\ (-'_  UC\;O^ACT__P )W0__ )!J_8S_ +OW
M_P# _JS\KA^N%%?D?_PUC\;O^ACT_P#\)W0__D&C_AK'XW?]#'I__A.Z'_\
M(-'L9_W?O_X']6?E</UPHK\C_P#AK'XW?]#'I_\ X3NA_P#R#1_PUC\;O^AC
MT_\ \)W0_P#Y!H]C/^[]_P#P/ZL_*X?KA17Y'_\ #6/QN_Z&/3__  G=#_\
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M8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH _,^BBB@#Z^^ '_(FZG_V,UY_Z:M&KW*O
M#?@!_P B;J?_ &,UY_Z:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "OP'N_^/NZ_Z^)O_1C5^_%?@/=_\?=U
M_P!?$W_HQJZ*'V_^W?\ VX"O11170 4444 %%%% !1110 4444 /3_EI_P!<
M+G_TGEK,K33_ ):?]<+G_P!)Y:S*_P">7]K?_P I"\"?]F9R3_UM^/S^Z/HP
M_P#)"YS_ -E9C/\ U3Y(%%%%?Y8G](!1110 4444 %%%% !1110!^H7[$'_)
M,_$__8]7G_J/^'J^SJ^,?V(/^29^)_\ L>KS_P!1_P /5]G5_P!6/T)/^44_
M!+_LD%_ZM<R/\T?&'_DYG&'_ &-%_P"HN'"BBBOZG/S4**** "BBB@ HHHH
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M>V\:#X6>/[ORXO\ A!?BC)9^';BZNWVH(- \2-<R>%M?,\Q:.QL[?58->NE
MDDT*V+A!^S\#<1X>MET,MS#'4HXRA6E2PL<1-PG5PKC3E2C&I4M"I.$Y5*<8
M*;J*G""4>5)O^Q/!'Q$R_%</TN'<_P [PU+.,#BZF&RRGCZSI5<5EDJ=">%I
MPQ-?EHUZU*M/$8>E0C6EB(T*5&*I\D8M_H_1117Z.?T0%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDS\3_P#8]7G_ *C_ (>K[.K_ *L?H2?\HI^"7_9(+_U:YD?YH^,/_)S.,/\
ML:+_ -1<.%%%%?U.?FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<#\3?BG\._@SX.U7X@?%/QAH?@;P=HJ!K_7=>O%M;82
M,KM#96D2B2[U/5+ORW2PTG3+>[U/4)AY%C:7$Q6,_GI^V[_P52^"/[)B:IX*
M\-26OQ:^.$"R6W_"#Z'J"+HGA&\*D)-\0/$-NL\6F2P']XWAG3UNO$<^(HKR
M#1+2\AU9/Y,?VCOVJOCC^U9XQ?QC\9?&=YKLD,DW]A>&K,R:=X,\)6LS<V7A
MCPW',]GIZ>6(X9[^8W>M:FL,,FL:IJ-P@FKXGB'C7+\GY\-A>7'YA&\72A+_
M &?#RV_VBK%ZRB]Z%.\[IQJ2HMIO\9X_\9LAX1]MEV6>SSS/X<T)8:C5_P!A
MP%177_"AB:;=ZD)?%@L.W7O&4*]3"-QF_P!4OVX?^"T/C_XK_P!K_#?]EW^V
M/A=\.IA-8:C\1)S]B^)?BRWRR2'1GMY'_P"$"T>X',;V4\OBJYB6&5]3T,37
MFCG\,8(=1UC48;>VBO=5U;5;V."""&.>^U'4M1OIQ'%#%$@EN;R]O+F542-%
MDGN)Y JAY' /T[^RW^QE\>OVO/%']@_"/PG)/HMC=0V_B;Q_KAFTSP+X324!
M\ZOK?D3&XOC$1+!H>CV^IZ]<QGSX=-:UCGN(?ZV/V*O^"9OP(_8]M+'Q'':1
M_$KXSFV4:A\4/$NGP"32II(C'<VW@/0W>[MO"-BRO+$]Y'/>^([R&:>"]UN2
MQDCT^W_/\)E7$7&N*6-QM6=/!J32Q5:+CAZ4+VE3P.'3BJC5K-PM%RC^_K>T
MUE^!Y3PMX@>,N:1SG.,75P^4J<HK,\73E3P&'H\WOX;),OBX1KN/+RR=)QI.
M<&\9C/;OW_Y:/%G_  33_;<\'> /#OQ&U/X >-;_ $?Q!9S7SZ/X=M%\2>,_
M#ENAWPMXJ\%Z*U[XDT1KFV/VSRY].9["(/#K TR]1[0>?_#S]AW]KKXG^(+;
MPYX5_9V^+/VRXFMXI;_Q#X+USPCX?TX7,OE1S:KXC\4V>D:)IT/$DF;J_C=X
MX9WBCE\IP/[]:*^MEX:98ZD'',,=&DE%3@XT)3DTDI.-3DBH*3NTG3GRWM=J
MQ^KU/HW\-2Q%*=+/LZIX:,::KT)0P52M5E&*525/$>QA"BJLES*,L/6]FVTG
M)62_B\^./_!&W]LGX.>'+7Q1HV@^'_C-IZ:?%=:[8_"F]U'5_$FA7/E;KJW7
MPSJVEZ/K7B"&*7$4$WABTUBZG7,\VGV<08C\K=0T^_TF^N],U2QO--U*PN);
M2^T_4+::SOK*[@<QSVUW:7*1SVUQ#(K1RPS1I)&ZE756!%?Z2M?+7[0_[%_[
M-G[4EA-#\8/ACHFLZXUL+:S\<:5'_8'CW3%C0);?9?%>EBWU.X@M-JM!I>JR
M:EHI*A9],GC+(W/FOAMAYIU,GQ<J$TO]VQC=2E)I?9KPC[2G?>TJ=9-O>$=#
M@XH^CK@:T)8CA'-*F"K*/_(NS:4L1A:LDK?N\=2A]8P][7:JT,6I3;M.E"R7
M\?'[-'_!2;]J_P#9=-AI?A'X@3^+_ 5EY48^&WQ'^U>*O"L-I'A5M=%DFNX-
M>\+0HI=HK?PSK.E6#3/YUW8WF-A_H3_9G_X+7?LT_%\Z?X?^,-O>_L_^-+@1
M0-<Z_<G6_AO?79 4FV\9VEI;RZ&DA62=_P#A*](TC3+*,I;G7KV8AI/SM_:7
M_P""$WQ5\'"_\1?LS>,[3XK:%'YL\?@7QA+I_ACX@6T0R4MM/UHFU\'^)I51
M2TLUT_@V4DK#:Z?=R')_#[Q]\./'_P *_$EYX/\ B5X,\3>!/%%@3]JT+Q7H
MM_H>I)'O=$N8[?4(('N+*<HS6M];>;9W<6)K6>:%E<_-4\SXNX0G&ABH5I82
M+484L6GB<'.*^SA\3"3]GIJJ=*M'E;3G2OH?G&'XD\6/":M2P>9TL7/*X25.
MEA<UC+,LGJP6T,#F%*I)X?W;RC0PV+I<CDI5\,W>)_HL:+K>B^)-*L-=\.ZO
MI>OZ'JENEWIFLZ+?VFJ:5J-K)GR[FPU&QEGL[RW?!V36\TD;8.&.#6I7^?7\
M OVM/VAOV8M5_M+X+_$_Q%X3M9;A;G4?#)G35O!FLR?*KMJ_A'5DO- N[AXE
M\A=1^PQZK;1.XLK^U<[Q^_\ ^S1_P7A\#^(#8>'/VI? 4W@+4G\J"3XC?#N#
M4->\(22' >ZUCP?/)>>*M#@0 LSZ+>>,99I' 6PM(E)'W>4<?Y1C^6EC>;+,
M0[+]\^?"R;_EQ,4N1;M^WA2A%67M),_<.%/'CA///9X;.54X:Q\K1OBY^WRR
MI-Z>YF$(0]BGJV\;1PU."M%5ZC/Z%:*\\^&7Q;^&/QF\-6_C#X4^//"WQ \-
MW 0#5?"VL6>JPVTSIO\ L>HQ6\K7.EZC&,BXTW4H;2_MG5H[BVBD5E'H=?<0
MJ0JPC4ISA4IS2E"<)*<)1>THRBW&2?1IM,_;*%>CB:5/$8:M2Q%"K%3I5J%2
M%6E5A+6,Z=2FY0G%K:49-/HPHHHJS4**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** /S/HHHH ^OO@!_P B;J?_ &,U
MY_Z:M&KW*O#?@!_R)NI_]C->?^FK1J]RH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\![O\ X^[K_KXF_P#1C5^_
M%?@/=_\ 'W=?]?$W_HQJZ*'V_P#MW_VX"O11170 4444 %%%% !1110 4444
M /3_ ):?]<+G_P!)Y:S*TT_Y:?\ 7"Y_])Y:S*_YY?VM_P#RD+P)_P!F9R3_
M -;?C\_NCZ,/_)"YS_V5F,_]4^2!1117^6)_2 4444 %%%% !1110 4444 ?
MJ%^Q!_R3/Q/_ -CU>?\ J/\ AZOLZOC']B#_ ))GXG_['J\_]1_P]7V=7_5C
M]"3_ )13\$O^R07_ *M<R/\ -'QA_P"3F<8?]C1?^HN'"BBBOZG/S4**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\JOVWO\ @JU\%/V4
MDU7P/X.>R^+OQPMUEMF\(:/J"_\ "->#KW!02>/O$-KYJ6MS;.&D?PKI1N/$
M$K1K;ZB?#T%W;ZG7%C\PP668>>*QV(IX>C#[4W[TY=(4X*\ZDWTA",I-7=K)
MM>/GG$&3\-8"IF>=X^AE^#IW7M*TGSU9V;5'#T8*5;$5Y)/EHT83J-)OEY4V
MOT,^+'Q@^&?P,\%:G\0_BSXST3P-X0TE?])U;6KGR_/N&1WAT[2[*%9M0UG5
M[L1N++1])M;W4[UU9+6TE8$#^73]MW_@L]\1_C$FK?#G]FB/6?A)\-YQ<V&I
M>.)94M?B=XNM&+1-]@N;.61/ 6E7"$GR]*NKCQ+.@B>36],BFN](;\L_VB?V
MH/C7^U/XUD\<?&;QE>^(KR)KA-#T.#=8>$_"=C<.K'3/"_AZ%VLM+MML<,<]
MR1/JNIF"&XUC4=1O%-RW;?LI_L3_ !Z_;"\3G1OA5X9:+PW8744'BCXC>(!<
M:=X&\+H^QW2]U58)GU'53%(DD'A_18-0UF='6X:TAL%GO8/R+.>,LTSZM_9N
M14<10H5FZ<523>.Q2>_-*#:P].U^:-.6D.9U:S@W!?R9Q=XP<3\<8S_5S@G"
M8_ X+%S="$<)&4\[S.+TE[2I0<E@,.XW=2GAZEXTE.6)Q;HRG3C\K6MKJ.LZ
MC;V5E;7NK:MJEY%;6MI:PSWVHZCJ%[,(X8+>"%9;F\O+NXD5(HHTDGGFD"HK
MNP!_H _8>_X(H>)O&1TCXE?M>#4?!GA5S#?:=\&M/N6L_&NNPD+-%_PFVJ6[
M%_!VG3*46?0[!V\621O/!>7/A2]MU$W["_L9?\$U_@%^QW9V>NZ7IX^(?Q@-
MH8M2^*OBFR@-_:R31[+JW\%Z*9+JR\&Z?(K21%[.6[U^ZMII;74M?OK5DMXO
MT.KW.'O#^E0Y,7GG)B*VDH8"#YL/3>Z^LS7\>:TO3C^Y334I5XO3[;@#P%PN
M!='->-G3Q^,7+5I9'2G[3 T):27]H5H_[]5B[*6'I-8--252>,ISM'D_ W@/
MP7\,_"NC^!_A]X7T3P=X1T"U6ST?P]X>T^WTW3+*%>6,=O;HBO<3R%I[R[F,
MEW>W4DMW>3SW,TLK]9117Z9&,81C"$8PA%*,8Q2C&,4K*,8I))):)))):(_I
M*E2IT:=.C1IPI4J4(TZ5*E"-.G3IP2C"%.$4HPA&*48QBE&*2222"BBBJ+"B
MBB@ KRWXM?!+X2?';PU)X0^,'P]\+_$'P^WF-!9^(],ANY].FE4(]YHNIJ(M
M5T'4"BA!J6BWMA?JF46Y520?4J*BI3IUH2I5:<*M.:<9TZD8SA.+WC*$DXR3
MZIIHQQ&'P^+HU,-BJ%'$X>M%PK8?$4H5J-6#WA4I5(RA4B^L91:?5'\Y_P"T
MO_P0:T#41J/B3]E;XA2>'KP^;<Q?#/XFW%QJ.AN0"_V/0?'%E;3ZSIR!%\JS
MM?$6F:^T]Q(#>^(K*W!D3\"?CG^S!\>_V;-:&B?&KX8>)O \DT\EOI^KWEHM
M[X7UJ2,,S#0O%FER7OAS6&6-?-DAL-3GN;>-E-U# S;:_P!":L/Q)X9\-^,=
M$U#PUXN\/Z)XI\.:M ;;5= \1:58ZWHNI6Q(8P7^EZE!<V5W"656\NX@D3<H
M;&0"/A<V\/\ *<=SU<!*668AW?+37M<))^="4DZ=]$O8U(0@KOV4GH?B'%?@
M)PKG7M<3D<ZG#>/E>7)AXO$974F]?>P-2<98=/2*^IUZ-&FKR6&F]'_G>?#3
MXK_$OX-^)K7QE\*_'7B?P!XGM,+'J_A?5[S2KF:'=N:SOEMI%@U+3YN5N=.U
M"*ZL+J,M'<6TL;,I_<_]FC_@O!X]\.?8/#O[4?@2#X@:4GE02?$/X>V]AH'C
M.*,;0]SJWA2>6S\*:_.Q+$G2;KP:D: #[-=2Y9OMS]I?_@B#^SS\41J/B'X%
MZMJ'P'\7SF6X31H$G\3?#6^N7W2&-]"O;I=9\.B>7"++H.L_V3IL+-]F\,SA
M8X1_/?\ M*?\$\?VJOV6GO[_ .(7PYO-9\$V1=O^%E> S/XK\#&V3/\ I>H7
M]K:PZGX9A8@JJ^+M)T"61A^YCE1D=_AIX#B_@^<JN'G6>$3<IU,,WBL!-=95
MJ$XOV3:5G4JT:4E=JG4OJ?B5;(O%GPDK5,5@*F+EE4)N=7$9;*69Y'5BK<U3
M&8*K3;PK<;0=?$X7#5(MN-#$7M(_LT^ /[7/[.O[3NF"_P#@Q\4?#OBJ^CMU
MN=0\+23OH_C71TP!(VJ^$-72RUZWMXI-\ U)+*;2;F2.0V.H742B0_2%?YN.
MC:UK'AW5+'7/#^K:GH6M:7<)=Z9K&C7]UIFJ:==QY\NYL=0LI8+NTN(\G9-;
MS1R)D[6%?L%^S1_P6L_:9^#QT[0/B]%9_M >";816[R^([G^QOB/96J@(&M/
M&]I:W*ZS)'EIYCXMTG6]1OW58/[;L4/FI]1E'B/A:W)2SC#O"S=D\5AE*KAV
M]+RG1;E7I+?X'B/1+;].X4^D1EF*]EA>+LOEEE=\L99GEL:F)P$GI>=;!MSQ
MN&COI1ECVWTBMO[#**^!?V9_^"E?[)_[4'V#2?"GCZ/P9X]O/+C'PX^)(MO"
MWB::Z?:HM]%N9;NX\/>)Y))"_DVWA[6M1U+R8S-=Z=9A@M??5?HN$QN$QU)5
M\'B:.)HO_EY1J1J13M?EERMN,EUA)*2V:3/Z"RK.,JSS"0QV49AA,RPD]%7P
M=>G7@I6NX5.23=*K&_OTJBA4@])QBTT%%%%=)Z04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'YGT444 ?7WP _Y$W4_^QFO/_35
MHU>Y5X;\ /\ D3=3_P"QFO/_ $U:-7N5 !1110 4444 %%%% !1110 4444
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MV2BI5<+S.CCJ"TO[?!5E#$TXI^ZJCINE-I^SJ36IV5%%%>H?3A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'YGT444 ?7WP _Y$W4_^QFO/_35
MHU>Y5X;\ /\ D3=3_P"QFO/_ $U:-7N5 !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y
MGT444 ?7WP _Y$W4_P#L9KS_ --6C5[E7AOP _Y$W4_^QFO/_35HU>Y4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'YGT444 ?7WP _Y$W4_P#L9KS_ --6
MC5[E7AOP _Y$W4_^QFO/_35HU>Y4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5^ ]W_Q]W7_7Q-_Z,:OWXK\![O\
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#/[)X8UVYO74D76NZ<EK/X<\3222",75SK6CW.KR01^1;:M99$B_SV_M+_\
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M<<-S:W$3 K)#/%'(C AE!XK[9_9J_P""C7[5W[+C6.G>!_B'<^)? ]FT:_\
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M%01V\_Q!\"P:?X;\=P1@ />:EX:9K/P?XCG)&/*TU_!*HK&1GN9%\N3^@/\
M9\_;%_9Q_:@TY+KX-_%#0/$6JK;_ &B^\'WDK:'XYTI50-,;_P ):L+36?LT
M#;HWU2SMKS1IG1_LFHW"#>?TG*>)LFSE1CA,7&-=K7"8BU'$I]HTY.U6W5T9
M58KJT]#^C>%O$CA#B^,(95FM.&.FE?*\?RX/,8RM=QA0J2<,3RIKFG@JN)IQ
MO9S3T/IJBBBO?/NC\S/^"B__  4^^!'[ /P[\02ZQXG\(^*OV@#HVEZQ\/\
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M[;B2UN()I.RJ.***"*.""..&&&-(H88D6.***-0D<<<: )''&@"HB@*J@*H
M %24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?F?1110!]?? #_D3=3_ .QFO/\ TU:-7N5>&_ #_D3=3_[&
M:\_]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7X#W?_'W=?]?$W_HQJ_?BOP'N_P#C[NO^OB;_ -&-710^
MW_V[_P"W 5Z***Z "BBB@ HHHH **** "BBB@!Z?\M/^N%S_ .D\M9E::?\
M+3_KA<_^D\M9E?\ /+^UO_Y2%X$_[,SDG_K;\?G]T?1A_P"2%SG_ +*S&?\
MJGR0****_P L3^D HHHH **** "BBB@ HHHH _4+]B#_ ))GXG_['J\_]1_P
M]7V=7QC^Q!_R3/Q/_P!CU>?^H_X>K[.K_JQ^A)_RBGX)?]D@O_5KF1_FCXP_
M\G,XP_[&B_\ 47#A1117]3GYJ%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%,DDCAC>65TBBB1I)))&5(XXT4L[N[$*B(H+,S$*J@DD
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M^S+A893%=6?@S22]K=>,M5B998W6RGM=$LIX9+?5M=TZY,%O/_7!^RG^Q/\
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MEI!:ZQ=>)-%EO-/UO2=.L/$%OJ_\^_[2?AW_ (*&^'O"_P"S)K7_  4N\/\
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MV\\3I+#-$[1RQLKHS*P)GH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH _,^BBB@#Z^^ '_(FZG_V,UY_Z:M&K
MW*O#?@!_R)NI_P#8S7G_ *:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6Y?FV%J8+,\%A<PP=5?O,-C*%+$496V;IU8RBI1O>,TE*#UBTTF?PZ?\%/\
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M!=7\7>+]86"W;6/$6J"VMH9KGR+>TLM/L].T71[+3=#TO3--L_SY_P""C/\
MP16_9W_X*">*;?XK2^)M>^"GQR6PL-'U7XA^%]*L_$6E>+]'TN!K;3(?&?@V
M^OM(AU74])MO*LM-U[3=;T351ID$&EZG/JMA8:/!I?Z*_ C]J7X ?M+:-_;/
MP5^)_AKQH88%N-1T.WNFT_Q9HJ-L7=K?A'58[+Q'I<7FOY,=W=Z;'8W4BN+.
MZN47?7O]??4:U'$4XUL/5IUZ4U>%6C.-2G-=XS@W&2]&S]VP>-P>88>GB\!B
ML/C<+6CS4<3A*U/$4*L>].K2E.G-><9,_!S_ ()__P#! _\ 9Y_8I^)NE?&S
MQCX_UO\ :(^*OA5XKKP'J.N^%K/P3X-\%ZRJ2H_B;3?!UMKOBF>_\20))C1[
M[6?$6H6NAR_\3#3]/36H;#5+'[3_ ."CW_!/#P9_P4=^%O@;X7>-?B)XG^&]
MAX&\?IX^M-5\+:5I6K7E]>)X=UOPZ-/N(=69(8[8PZW+<^;&3+YL$:8V,U?H
MA16ITG@/[+7P"TC]EK]GOX4?L^:!X@U+Q5HWPI\*V_A;3_$.L6MK9:GJUO!=
M75T+N\M;(FU@F9KIE*0$H @(Y)K\]?\ @HW_ ,$:O@A_P45^(O@?XK>)_'_B
MSX4>./"GA2Y\&:OJW@_1]#U0>,-"BU%M4\/1ZQ#JOEB.[\.W%]KD5K>Q.\UU
M9ZJEG<'R-,L53]B** /!/V7_ (*:E^SE\!?AG\#-1^(VN_%9/A=X<M_!^C>-
MO$^G66F^(+_PSI+R0>&M.U.'3I9;2:3P]H8L?#]K=ILEN=/TRTENQ)>&XN)_
M>Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /S/HHHH ^OO@!_R)NI_]C->?^FK1J]RKPWX ?\ (FZG_P!C
M->?^FK1J]RH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2+[R9&P;JQM9U5FMPR?TOU_(Q_P= P7J^)/V,;F1B=-ET3X\06BX.%O;>_\
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M&C6LLR7$MMI/CF_\!^)].@DN(T2.>2&SU2&-YHT1)64NB*K   _7NBOYGO\
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M5Z;O33:7ZRI86RA+M8PK;/,?^C;X5?!3Q?\ \$H_^"4/Q<\(Z7XXL?B1XV^
M/PE_:)^)WASQ=8^&'T;3[GQ%=6_B_P <^'&F\/ZAJ.N 6FD:G=62:CY]W<Q7
M%M:W$S0"-O(H ^P/C#^WA^QI\ /%J> OC+^TQ\'?A[XWWV"7'A+7_&NDQ>(=
M,74X_.L)]<TBWGN+[0+.Z@*W$=]K<.GV?V:2*Y:<02QR-]#^!O'O@?XG>%='
M\=?#?QCX7\?>"O$-NUWH/BWP;KVE^)O#>LVR2R6\DVF:WHUU>:=>QQ7$,UO*
MUO<R>5<0RP2;98W1?X5/^"2?_!)'P/\ \%/?A]\>_C_\?OC3\3M(U*P^(FH>
M#M'E\(WV@7GB/5O'MYH6F>,==\:^/-1\7:1XDN=;TZXE\4:<!I]I_8^HZQ>+
MJ\LGB.U>)0?K;_@W8\8?$?X+?MO?MA_L-ZAXDE\2?#_PKH7Q$UZZCM=TVBP?
M$'X-_%;PO\+IO%.CQ/-,NE6GBG2?$=S%J;VTCC4FT_PQ'=-.=/M9(P#^G?QC
M^W!^R9\/OC9I/[.'C3X[>!_#OQRU[6_"'AS1_AIJ%U>IXDU#7/'TFFQ>#=,@
MACL9+<W/B&35],33U:Y57-Y#YC1Y./JJOX=/^"@W_*R#\"/^SC_V _\ TZ?"
M&OTL_P""_?\ P5(;]G[P+>?L:_ KQ(UM\;?B=H(;XK>)M&NRE_\ "WX::S 0
MNAVUU;N'T_QM\0K%WCC*NM_H/@V6?54CM;SQ#X:U2  _770O^"FG[!7BGX@Z
M=\*O"_[4/PS\3?$/6/%,?@K1_"?AR]U/7=4UCQ3-J7]D0:1I*Z5IEW!J<\^H
M?N+>6QFGM9QB:*=[<B4_=5?S1_\ !!/_ ()2C]GCP=IO[8WQ^\-F'X[?$+0V
M;X5^$]9M"M[\(_A[K=IM?6;RUN%#Z?X_\=:=.5NHWC6_\,^$IUT622UU#7_$
MVF6W]+E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!'QP_P"2
MEZ__ -<M'_\ 3+I]>35ZS\</^2EZ_P#]<M'_ /3+I]>35_260_\ (CR;_L5X
M#_U%I'\S\0_\C[.?^QIC_P#U)JA1117K'CA1110 4444 %%%% !112$@ DD
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ME:YHGA35_$4?CWQ;JCVNH0QWD6G^)_%5UI.G:3!(L'DV/@A)EB:VOK4Q_P!
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M/VO[<%M#ISS*V"BQ%)[2S&U5?3;>RF3>DJR/\V?\&^O_  3&^#O[4.B_$_\
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M O\ ;M\ ?M*_L=_M7^'_ /@HS\$].O4\+7^MV.GIXUCT==9\.>&/'%IX$LO
M_B;P1XSM4#?9-(\>>#+PB"ZO9;!M977/$%CHM_;:GHXG@_0'_@A7_P %<_V;
M_A!\(?A;^PO\9K37_ASXD_X3'Q5!X2^*M_-87OPVUO4O'GBW4M>TS2/$5RCV
MVJ>"[N2^U>+1+.^NK+5?#TLJI>ZMK>A02E(ONO\ 9)_X*8_LX>(?C9XZ_P""
M=_B'P;XZA^(/BG6/B?IDFK>,M$\'I\,-<N=!\!)?/X?B>7Q1J.JZE_PDFFZ'
MJ[:9%J7ANRM[\_8+-4FN-3CA3^6SXP?LG?"+PU_P2A_9&_;)T&:?1_C'X_\
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MVP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW- K>')A.DD,4L;@'YK_ +/'C7]M;PC\1/VG]-_X(^W'[5VI_L^7.I/+J/\
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M?\E+U_\ ZY:/_P"F73Z\FK^DLA_Y$>3?]BO ?^HM(_F?B'_D?9S_ -C3'_\
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MO/\ TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK#5\%BL3@\53=+$X2O6PV(I.49.G7H5)4JM-RA*4).%2$H\T)2B[7C)IIO\
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MF/VG/^"0OP3_ &I/VP?A[^V7XO\ B9\4_#WCKX=77PPNM+\+>&W\)#PE?/\
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M[NO^OB;_ -&-7[\5^ ]W_P ?=U_U\3?^C&KHH?;_ .W?_;@*]%%%= !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUK_Y:T?\-M^/_P#H4_!__?.M?_+6OB^BCV4/Y5][_P _+\^[ ^T/^&V_'_\
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M !$=_M1_]$-^ 7_?KXB?_-K7\\%%?WQ_Q CPC_Z(?*O_  ;C_P#YL/\ .O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^ ]W_ ,?=U_U\3?\ HQJ_?BOP'N_^/NZ_Z^)O
M_1C5T4/M_P#;O_MP%>BBBN@ HHHH **** "BORS_ &S?CY\1[W]H'X%?LK?!
M'Q9JOA+Q+XHU_2-5^(/B+0C"-0T_1=6GDM[?3UDE@G,<6G:!!K?BK5HA&3)
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MVRBBBOMCA"BBB@ HHHH _P!'S_@G_P#\F,_L@?\ 9MOP9_\ 4 T&OKROD/\
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M /S/HHHH ^OO@!_R)NI_]C->?^FK1J]RKPWX ?\ (FZG_P!C->?^FK1J]RH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K\![O_C[NO^OB;_T8U?OQ7X#W?_'W=?\ 7Q-_Z,:NBA]O_MW_ -N KT44
M5T %%%% !113)"ZH[1H)) C%$+; [@$JA?#; S8!;:VT'.#C%']=_P AI7:2
MM=M)7:2UTU;:27=MI+=M(_"/]CZ__P"%X_\ !2CXW?%?4'-Y;>%;7XAZCX;N
MF 81V=OJNE?#/PM%G+!6'@N[N4W(<%H7V\-4G_!5K2_$G@;XX_L__'FTTY-2
MT71K#2]+MDNP9]*_X23P1XOO?&4&G:C"5:.--8M-6 4.I-];:=?(%9;)P,+_
M ((ZDS_$KXYW=TY^WOX3\.EU<A'8W&OW\EV[1$!\K-'"&(P(RX5AEEQ^P'Q9
MU_\ 9S\6NOP-^,'B7X::IJ'C&YTK3X/AOXC\1Z1%XBU&^U.91H3V.C+?PZ_9
MWUS=;/[&U*S2UN?M1C^P72SLF?YDX4R*'&/@[C/;9IA\HS3B+BC,\^H9AC*D
M84?[=AG#>'C7<WS3]NL'&@^55*L8R52%*JZ:IS_VS\=O%/%?1T_:*</K+^",
MXX_X'\'_  .X*\*<RX0X>PE?$YA_Q"[$^'-.&;U<KAAX*GA5E<^(JN9P=:>%
MP-6K2EA,3C<!3Q<L70_+[]B'XK_L[_&?Q5^T3HWQ7M_ RW7Q?^.2_$WP=\.?
MB9!I6I07LVI'4GM+>Q.LVIT+6-9L;C4);"*SMV;4+I9'>/3Q!<%:_6[Q?\'?
MAIXY^'-Y\(_$/A'36^&]];65G-X1T5[SPMI26NG:A;ZK96]HOA>YT>>P@M]1
MM+>[2*QFMXS+$-ZLI96_F6^)G[)_V33OVK/B'X U,67AG]G?XVZEX)/A2\%U
M=:A)X5F\1'2-+U*QUEYY)9[O1Y);47T-Y%ON+$37XOEN+4V]W^\7[$GQDN/&
M_P"R3\,_'?Q(\16EMJ&G6>J^%];\2>(-0BL8;P^&-?U'P_I=]?ZIJ5PB7%]>
M:59Z:VH7L\YEO=4-W,[&5V%>AX2\05\1+&\%\6Y%EL,4LGS;,*>;^SP]3#9[
MDSS[&X+-*.-A5@XNA',:^*IQHS4*%2A"JJF$HJ,95OD_I^^$N6Y/0X:^DGX
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MBFE3<5Q5GE"$\4\;[*\\NX'X>@\36HXB<>9>UPRQF;RI2K5,3C\/E[J4:/\
MD/QYXX^/_P!,GB:7A_X?Y)C\LX4K5%)\)Y%B)PPGU'VMH9EQWQ'-8:A6PT)<
MLO98EX+)XUHT*>&P&)S&-*M6^%+_ %"STV!KF]G2"(<#=R\C=DBC&7D<]=J
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MI'B'1[M=UKJNAZE9ZMIMRN =UO?6$UQ:S+@@YCE88(/<5_ '\*O@_P#M'?\
M!P-^VS\9?%/B3XMR_#GX>^"[2^\1V5_K]CJ?C/1?A/X#UC7O[)\!_#OP+X&A
MUS0[.;6-3L[.6_U65=6\.V>K7.A^(?$.K:C+K%S:VE_Z?^QO<_'_ /X(\_\
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M****_G _I\**** "BBB@ HHHH **** "BBB@ HHHH **** /@CXX?\E+U_\
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MM/\ DS>9?]CO(?\ U,/Y]:***_TW/\I@HHHH **** "BBB@ HHHH *_T9_\
M@G-_R8=^R-_V0+X;?^HW95_G,5_HS_\ !.;_ ),._9&_[(%\-O\ U&[*OY"^
MF#_R2/"?_91U_P#U68@_M'Z%/_)9\8?]DQ0_]6N%/M&BBBO\_#_1\**** "B
MBB@ HHHH **** "BBB@ HHHH _,^BBB@#Z^^ '_(FZG_ -C->?\ IJT:O<J\
M-^ '_(FZG_V,UY_Z:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS#&8FK_)-\=M5^,7Q6^/7C/XLWG@+QGJ7VSQC->^';34?!NN:EIMMX<T:_\
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MJ4$%Y EW;V6LZ3?VT\0EMKJ)9DN;.Z@FAD$D$Z"2.2*0/&Q1P3_G.?&?X*?
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M!\&="U:XB<V9\5>,_%FD:)J&J6*WUPRRW?B^\TK[;I>@%$3_ (*_?MT^._\
M@HQ^UOX>_8._9Y\3:/I_P1\'_$B#P8-8U'Q#;Z!X2^(GQ/L)I;#Q%X^\7Z_/
M(MC!\._AXR:O!H4H-Y:2V6G:OXQ@&I2ZIH=GIG]-O_!/#X$?L=?L)?!'PU\"
M_A3\8?A-XI\::_=Z?>_$'QM%XW\&'Q1\5/B'?+'9BY6RM=:N;J+3K>:8:/X,
M\+6TET-*TTQ0>9J&M7VK:KJ8!U?[7W_!-/\ 9\_;C^+WP.^)G[08\1>)-!^!
MFF>*[72OAG87RZ1X9\7WOBG4?#M^TOC*_M%&N7>DV'_"/1*NBZ3?:.+^2<C4
M;ZXL5FTZZ_F&ET?2?#W_  <UZ+H.@:7IVAZ%HGQH\):3HVBZ/8VVF:3I.EZ?
M^S?I%II^FZ9IUE%!9V&GV-K#%;6=G:PQ6UM;Q1PPQI&BJ/[A:_B+US_E:!@_
M[+QX>_\ 6=],H _IM_X*O?\ *-[]LW_LA'C+_P!)HZ_ST_AE^U;\8?"?[+OQ
M%_8P^%5IJ4&G?M"?%#P]XC\>W7AY;V\\4^,M,T72K;2M ^&NE6%A"]U_9NK:
MTQU'78+3S[W7S:Z3HJK'ICZQ9ZO_ *%G_!5[_E&]^V;_ -D(\9?^DT=?SL_\
M&QG[+'PI\:ZY\:/VJ?%ND_V_\1_A/KVB^ OAJE^D4NE>$CXET"]O_$/BFRMV
M5C)XEN[%X]#L;YRHTK3)M56W5Y]3\ZU -[_@UQ^(GP,M=5_:,^%]YX=TG3/V
MC]4@T;Q;HOC&ZE:35O%GPAL1::?JWA#1UG=HM/C\(^*WLM?UBWT\03^(HO$V
MEW-[%=Q>#X9K'^P^O\^[]N[X>^/?^"/7_!6+2OC=\']/.F^!=7\7?\+U^%5A
M:I]BT+5? ?B^^OK'XF_""8QQRP6FG64MWXH\$"TC,M]I_A/4?#.M(;:\N[*6
M/^\;X-?%OP1\>OA1\/?C/\-]4&L>!?B9X3T;QCX:OF58[@Z;K5G'=)::A;J\
MGV+5M-E>73M8TZ1S-IVJ6EY87&V>WD4 'I=%%% !1110 4444 %%%% !1110
M!\V_ME_\F@?M6?\ 9MOQS_\ 58>**_S6:_TIOVR_^30/VK/^S;?CG_ZK#Q17
M^:S7]\_0[_Y)[C3_ +'.6_\ J#6/\[/IL_\ )1\"_P#8DS7_ -3Z 4445_8Y
M_$04444 %%%% !1110 4444 ?O!_P;P?\GS>-/\ LVWQY_ZG_P **_M8K^*?
M_@W@_P"3YO&G_9MOCS_U/_A17]K%?YG?2H_Y.OB/^Q!DW_I.(/\ 5'Z(G_)G
MZ'_91YY_Z5A0HHHK^<#^GPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M"/CA_P E+U__ *Y:/_Z9=/KR:O6?CA_R4O7_ /KEH_\ Z9=/KR:OZ2R'_D1Y
M-_V*\!_ZBTC^9^(?^1]G/_8TQ_\ ZDU0HHHKUCQPHHHH **** "BBB@ HHHH
M ^5[O_C[NO\ KXF_]&-5>K%W_P ?=U_U\3?^C&JO7\SG]8!1110 4444 %%%
M% !1110 5]<?L7_\E8U3_L1]7_\ 3QX>KY'KZX_8O_Y*QJG_ &(^K_\ IX\/
M5%3X)>@'ZD4445Q %%%% !1110 4444 %%%% !7\:/\ P<:_\G?_  =_[-MT
M'_U9_P 4J_LNK^-'_@XU_P"3O_@[_P!FVZ#_ .K/^*5?T3]%S_D[67_]B;._
M_45'\T?2T_Y,WF7_ &.\A_\ 4P_GUHHHK_3<_P I@HHHH **** "BBB@ HHH
MH *_T9_^"<W_ "8=^R-_V0+X;?\ J-V5?YS%?Z,__!.;_DP[]D;_ +(%\-O_
M %&[*OY"^F#_ ,DCPG_V4=?_ -5F(/[1^A3_ ,EGQA_V3%#_ -6N%/M&BBBO
M\_#_ $?"BBB@ HHHH **** "BBB@ HHHH **** /S/HHHH ^OO@!_P B;J?_
M &,UY_Z:M&KW*O#?@!_R)NI_]C->?^FK1J]RH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\![O\ X^[K_KXF_P#1
MC5^_%?@/=_\ 'W=?]?$W_HQJZ*'V_P#MW_VX"O11170 4444 %%%% !1110
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M.?#[P;X4\">'A=W6H#0?!OA[2/#&C"_OG$E[>C2]$L[&Q%W>2 275R(/.N'
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M?HB?\F?H?]E'GG_I6%"BBBOYP/Z?"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#X(^.'_ "4O7_\ KEH__IET^O)J]9^.'_)2]?\ ^N6C_P#IET^O)J_I
M+(?^1'DW_8KP'_J+2/YGXA_Y'V<_]C3'_P#J35"BBBO6/'"BBB@ HHHH ***
M* "BBB@#Y7N_^/NZ_P"OB;_T8U5ZL7?_ !]W7_7Q-_Z,:J]?S.?U@%%%% !1
M110 4444 %%%% !7UQ^Q?_R5C5/^Q'U?_P!/'AZOD>OKC]B__DK&J?\ 8CZO
M_P"GCP]45/@EZ ?J11117$ 4444 %%%% !1110 4444 %?QH_P#!QK_R=_\
M!W_LVW0?_5G_ !2K^RZOXT?^#C7_ )._^#O_ &;;H/\ ZL_XI5_1/T7/^3M9
M?_V)L[_]14?S1]+3_DS>9?\ 8[R'_P!3#^?6BBBO]-S_ "F"BBB@ HHHH **
M** "BBB@ K_1G_X)S?\ )AW[(W_9 OAM_P"HW95_G,5_HS_\$YO^3#OV1O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOI@_\DCPG_V4=?\ ]5F(/[1^A3_R6?&'_9,4/_5KA3[1HHHK_/P_T?"BBB@
MHHHH **** "BBB@ HHHH **** /S/HHHH ^OO@!_R)NI_P#8S7G_ *:M&KW*
MO#?@!_R)NI_]C->?^FK1J]RH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K\![O_C[NO\ KXF_]&-7[\5^ ]W_ ,?=
MU_U\3?\ HQJZ*'V_^W?_ &X"O11170 4444 %%%% !1110 5^!'[8GPQU7X=
M_&SQ5?W%NPT+Q[J6H>,O#]^H)AN3JMR;K6K/<%"1W6FZO<W$<ML"SI:3:?<O
MA+R//[[UY[\2OA9X'^+?AV3PSXZT2'5K'<\ME< FWU/2+QDV+?:3J$8$]E=*
M,!MA:"Y0>1>07-LSPO\ +<6\._ZQY8L-2J1I8O#U57PE2I?V;GRN$Z55Q4I*
M%2$G[T8MQG&$K.*E&7YQXG\"/CSAY8##UZ>&S/ XA8W+:U9R6'E54)4JN'Q#
MA&<XT<12FUSPA*5.M"C4Y90C.$OYH:GMK:XO+FWL[2":ZN[N:*VM;:WB>:>Y
MN)Y%B@@@AC#22S2RLL<4<:L\DC*BJ20*_4K6/^":ADOYW\/_ !8\G3-DLEO!
MK/A7[3?P+&LCB&6[LM:M;>Z.U5S.EE9@LQ_T=0H+?0WP2_8Y^''P@OX/$=[/
M/XZ\86LB2V&M:S9PVMCI$L8!6XT?1$FO(K:]$@\Q+Z[N]0N[9EC-C-:,)&E_
MSL^D9](7@WZ-L_[$XNIXW&<<X_(XY[D'">7X>K5EF."Q&+Q^6X/&XG.(PEE.
M P$LPRW&4J_M,54S*%+#U*E'+<0W2A4_*_"?Z&7C%XGYK23R[ <.\*X?,E@L
MXXHQ^:Y7B:6%5.%#$8BG@<LP.,Q&98_&/"UZ<\-3>&H8.56I3IXK'81.<X>H
M_L]?#R\^%OP=\$^#-35%UBPT^>]UI$=9!%JVM7]UK%[:^:G[N7[!+?'3Q+&3
M'(MJK(SJ0[>T445_SW<2\09CQ9Q'GW%&;SA4S7B/.<SSW,ITXN%*6.S;&UL?
MBW2@Y2=.E[>O-4J?-+DI\L$VD?[[\,</9;PCPWP_PKD\)T\IX:R7*\ARR%62
MG5C@,HP5# 815:BC%5*OL,/3]K4Y8^TJ<TVDY6"BBBO$/<"BBB@ HHHH ***
M* /P:_X*L?\ ):OA]_V2ZV_]2SQ17Y>5^H?_  58_P"2U?#[_LEUM_ZEGBBO
MR\K_ -!_]EQ_RK[^BO\ ]FRPW_JXS<_Y/_IN_P#*5WCA_P!EE4_]5N7A1117
M]\G\KA1110 4444 %%%% !1110!_H^?\$_\ _DQG]D#_ +-M^#/_ *@&@U]>
M5\A_\$__ /DQG]D#_LVWX,_^H!H-?7E?XO<5_P#)4\2_]C_./_5CB3_<W@[_
M ))'A;_LG,C_ /59A0HHHKP#Z,**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *^3?VI?BMXU^&%OX)D\':C;Z>VM3>(
M$U SZ=8W_FKIZ:,UJ%%[!,(MAO+C)CVE]PWYVKCZRKX'_;F_X]/AI_U\>+?_
M $7X<JZ:3G%-76NC]&P/!_\ AK'XW?\ 0QZ?_P"$[H?_ ,@T?\-8_&[_ *&/
M3_\ PG=#_P#D&OF^BNODA_+'[OZ[?GW8'TA_PUC\;O\ H8]/_P#"=T/_ .0:
M/^&L?C=_T,>G_P#A.Z'_ /(-?-]%')#^6/W?UV_/NP/I#_AK'XW?]#'I_P#X
M3NA__(-'_#6/QN_Z&/3_ /PG=#_^0:^;Z*.2'\L?N_KM^?=@?2'_  UC\;O^
MACT__P )W0__ )!H_P"&L?C=_P!#'I__ (3NA_\ R#7S?11R0_EC]W]=OS[L
M#Z0_X:Q^-W_0QZ?_ .$[H?\ \@T?\-8_&[_H8]/_ /"=T/\ ^0:^;Z*.2'\L
M?N_KM^?=@?2'_#6/QN_Z&/3_ /PG=#_^0:_3SX<:S?\ B+P!X*U[595GU/6?
M"^AZGJ$R11P)+>7VG6]Q<2+#$J11*\LC,(XU5$!VJH  K\,Z_;CX._\ ))_A
MM_V(_AC_ -,]I6-:,8J-DEKT7D!Z11117. 4444 %%%% !1110 4444 ?-O[
M9?\ R:!^U9_V;;\<_P#U6'BBO\UFO]*;]LO_ )- _:L_[-M^.?\ ZK#Q17^:
MS7]\_0[_ .2>XT_['.6_^H-8_P [/IL_\E'P+_V),U_]3Z 4445_8Y_$0444
M4 %%%% !1110 4444 ?O!_P;P?\ )\WC3_LVWQY_ZG_PHK^UBOXI_P#@W@_Y
M/F\:?]FV^//_ %/_ (45_:Q7^9WTJ/\ DZ^(_P"Q!DW_ *3B#_5'Z(G_ "9^
MA_V4>>?^E84****_G _I\**** "BBB@ HHHH **** "BBB@ HHHH **** /@
MCXX?\E+U_P#ZY:/_ .F73Z\FKUGXX?\ )2]?_P"N6C_^F73Z\FK^DLA_Y$>3
M?]BO ?\ J+2/YGXA_P"1]G/_ &-,?_ZDU0HHHKUCQPHHHH **** "BBB@ HH
MHH ^5[O_ (^[K_KXF_\ 1C57JQ=_\?=U_P!?$W_HQJKU_,Y_6 4444 %%%%
M!1110 4444 %?7'[%_\ R5C5/^Q'U?\ ]/'AZOD>OKC]B_\ Y*QJG_8CZO\
M^GCP]45/@EZ ?J11117$ 4444 %%%% !1110 4444 %?QH_\'&O_ "=_\'?^
MS;=!_P#5G_%*O[+J_C1_X.-?^3O_ (._]FVZ#_ZL_P"*5?T3]%S_ ).UE_\
MV)L[_P#45'\T?2T_Y,WF7_8[R'_U,/Y]:***_P!-S_*8**** "BBB@ HHHH
M**** "O]&?\ X)S?\F'?LC?]D"^&W_J-V5?YS%?Z,_\ P3F_Y,._9&_[(%\-
MO_4;LJ_D+Z8/_)(\)_\ 91U__59B#^T?H4_\EGQA_P!DQ0_]6N%/M&BBBO\
M/P_T?"BBB@ HHHH **** "BBB@ HHHH **** /S/HHHH ^OO@!_R)NI_]C->
M?^FK1J]RKPWX ?\ (FZG_P!C->?^FK1J]RH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\![O_C[NO^OB;_T8U?OQ
M7X#W?_'W=?\ 7Q-_Z,:NBA]O_MW_ -N KT445T %%%% !1110 4444 %%%%
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M 4444 %%%% !1110 4444 %%%% !7P/^W-_QZ?#3_KX\6_\ HOPY7WQ7P/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^4KO'#_LLJG_ *K<O"BBBO[Y/Y7"BBB@ HHHH **** "BBB@#_1\_P""?_\
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M_D+Z8/\ R2/"?_91U_\ U68@_M'Z%/\ R6?&'_9,4/\ U:X4^T:***_S\/\
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M6K*TO(/.MI(;B'SK>:2/S8)8IH]V^*1'"L/U0_X9;^!/_0B_^7/XQ_\ FAH
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M]"+_ .7/XQ_^:&C_ (9;^!/_ $(O_ES^,?\ YH: /C__ (;6^*G_ $ /A_\
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M_P N?QC_ /-#1_PRW\"?^A%_\N?QC_\ -#3]I/\ F8'X_P!%?L!_PRW\"?\
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M_P ,M_ G_H1?_+G\8_\ S0T?\1O\6/\ HNL\_P#!M'_Y0'_$!/!W_HW^0?\
M@FO_ /+S^4K_ (=3?L\?]#E\9_\ PHO _P#\[JC_ (=3?L\?]#E\9_\ PHO
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M_ES^,?\ YH:/^&6_@3_T(O\ Y<_C'_YH: /C_P#X;6^*G_0 ^'__ (*O$?\
M\U='_#:WQ4_Z 'P__P#!5XC_ /FKK[ _X9;^!/\ T(O_ )<_C'_YH:/^&6_@
M3_T(O_ES^,?_ )H: /C_ /X;6^*G_0 ^'_\ X*O$?_S5T?\ #:WQ4_Z 'P__
M /!5XC_^:NOL#_AEOX$_]"+_ .7/XQ_^:&C_ (9;^!/_ $(O_ES^,?\ YH:
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M_P U=?8'_#+?P)_Z$7_RY_&/_P T-'_#+?P)_P"A%_\ +G\8_P#S0T ?'_\
MPVM\5/\ H ?#_P#\%7B/_P":NC_AM;XJ?] #X?\ _@J\1_\ S5U]@?\ #+?P
M)_Z$7_RY_&/_ ,T-'_#+?P)_Z$7_ ,N?QC_\T- 'Q_\ \-K?%3_H ?#_ /\
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MO^&6_@3_ -"+_P"7/XQ_^:&C_AEOX$_]"+_Y<_C'_P":&C_6KB'_ *&V+_\
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MA%_\N?QC_P#-#4@?'_\ PVM\5/\ H ?#_P#\%7B/_P":NC_AM;XJ?] #X?\
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M_#J;]GC_ *'+XS_^%%X'_P#G=5_5K_PRW\"?^A%_\N?QC_\ -#1_PRW\"?\
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MW&KW6F:SI&GW&H2PPJUS+9:786SREFBM85(0?H=_PRW\"?\ H1?_ "Y_&/\
M\T-'_#+?P)_Z$7_RY_&/_P T-?.<2>('&?&&&P^$XFXBS#.<-A*[Q.&HXR=.
M4*->5.5)U8*%.#4G3E*%VWHWH?3\+^'' W!6*Q.-X5X:RW(\5C*"PN*KX*%2
M$ZV'C4C55*;G4FG%5(1FK).Z6I\?_P##:WQ4_P"@!\/_ /P5>(__ )JZ/^&U
MOBI_T /A_P#^"KQ'_P#-77V!_P ,M_ G_H1?_+G\8_\ S0T?\,M_ G_H1?\
MRY_&/_S0U\<?;'Q__P -K?%3_H ?#_\ \%7B/_YJZ/\ AM;XJ?\ 0 ^'_P#X
M*O$?_P U=?8'_#+?P)_Z$7_RY_&/_P T-'_#+?P)_P"A%_\ +G\8_P#S0T ?
M'_\ PVM\5/\ H ?#_P#\%7B/_P":NC_AM;XJ?] #X?\ _@J\1_\ S5U]@?\
M#+?P)_Z$7_RY_&/_ ,T-'_#+?P)_Z$7_ ,N?QC_\T- 'Q_\ \-K?%3_H ?#_
M /\ !5XC_P#FKJ]I?[:/Q(N-2TZ#4-&\ VUA/?6D-]<)IGB%7@LY+B-+F96;
MQ1(JM%"SNK-'(H*@E' *GZR_X9;^!/\ T(O_ )<_C'_YH:^/_P!J[X6^!/AK
M_P (%_PA.A?V+_;7_"4_VG_Q,]9U'[3_ &;_ ,(Y]B_Y"VH7_D^3]ON_^/?R
MO,\W][YGEQ[ #]'/"_B_PSXUT^;5?"NLV>N:=;WDFGS7=DSO%'>Q06]S);L7
M1#YB07=O*1@C;,G.20.DKX__ &*?^25Z_P#]E U7_P!1SPI7V!0 4444 %%%
M% 'YGT444 ?7WP _Y$W4_P#L9KS_ --6C5[E7AOP _Y$W4_^QFO/_35HU>Y4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'P'X-_8\\2^&/%_A7Q)/XQT.Z@\/>)-#UR:VAL+]);B+2=4M;^
M2")W;8DDR6YC1G^568%N :^_*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#YT_:!^">J?&2'PK%IFMZ?HQ\/2ZS),;ZWN+@7 U1=+6,1?
M9R-AB^P.7W_>\Q=O0UM_ 7X4:A\(?"VJ^']2U:RUB;4/$$^L)<6,$\$4<4NG
M:;9"%EG)<R![%W+#Y=LBCJ#7N%% !1110 4444 %%%% !1110 4444 %%%%
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M-<V[B2WN$FT_5M,N[[1M4B$PLKZ2XM+^VM/J>@ HHHH **** "BBB@ HHHH
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MP((<G]Y]G/B;5_M.P9Y3S!:>8<<-Y8R,\_3'_!R&!_PI/]FPX&1\4O%@!QR
M?"41(!ZX) R.^!Z"@#[C_P""+?QFUGXP?\$^_AJ-6NAJOB#X5:GXH^$,MQ=7
MDQ:>U\)SV^H>$K2[G,=U+:K8>#M>\-:2I6*X*6MG%/'"0ZP#\BOAM_P0]_:E
M\1_M?>'_ (D_M32?"OQE\+/$7Q2U[XA_%ZZ\'>.]7OI=?6YU#5O$T^E+8ZUX
M;T#7+C3O%6NFTTR]$4=O>Q:+J5T[7%A=1[X?M_\ X-T3<?\ #%_Q6#!/LO\
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M* "BBB@ HHHH **** "OS/\ ^"JW[+OQ]_;!_9LL/@M\!M5\"Z5<W_Q!\/\
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MUHM_^$E_:]+;/M0T/X)B')_>?9S?_%'[3L&<E/,%IYAQPWE D9&0#Q;_ (.
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M<Q^%? %O>0%HKO\ X1N#4=3O-6NH7D@F\0ZUJT%K<7FFV>G7+_E7_P %"_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'5-5OY(-/TZ'5M-M_$%C9W%Y<P)/K,NE:9$7N=0A0_1W_!PK^TO\-/B;XI^
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MCZAK^J?9HYK"&-OL6C:5J.HS;I5Q;VDK#<P"G^?C_B&Q\;_]'9>%?_#1ZO\
M_-[7UC^P[_P1$\4_LA?M1_"_]HC4OVAO#_CFR^'O_":^=X6L?AUJ.A76J?\
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M/_$-CXW_ .CLO"O_ (:/5_\ YO:/^(;'QO\ ]'9>%?\ PT>K_P#S>T ?1?\
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M.>'(;@JYMX)I8I]2UF\CBN)M.\/:9K&IPVMY+9K:S?5-?EI_P4Y_X)[>-/\
M@H'H?PC\+Z#\9-,^%?A_X<ZMXLU[5[#4?"=_XI3Q+K&MV>B:?HEV$M?$&AQV
M3>'[*TUZ&-I%NWG'B"8(;=87%P ?QNS^.O$W[=O[5%MXK_:;^.>@^ (_'>L&
M3Q=\3/%[3)X8^'W@[3EGN8]%\+:! [,+73K3=I?A3PS8M&EWJ=U'<:M?P_:=
M9UU?Z^/V:_VLO^"3O[)WPJT/X0?!K]HKX4Z%X:TD&ZO[ZXU&_NO$'BK7IXHH
M]1\4>*M571H9-6UW4C#'YTYCAM;.UBM=+TFST_2+&PT^V_++_B&Q\;_]'9>%
M?_#1ZO\ _-[1_P 0V/C?_H[+PK_X:/5__F]H _8#_@H/I_A3]L[_ ()F_''6
M?@IK>F_$/1-4\&'XB>!]>T$7%W;ZS+\(_&=KXCUN'1D,,=Q<WUQ#X.\1>'8(
M! 9)[R9[>)&=XVK^>[_@@=^TG\./@?\ M'?$GP/\3O%>A^"-(^,G@+3['P_X
MB\3:I9Z+H3>,?!^L/?Z7H5YJNHRV^GV$^LZ3K&OC3);RY@2[U.SM-'MO.U'5
M+&WE_JM_8K_9TO/V3OV8?A;^SWJ7BFT\;W?P[L_$UK/XGL])ET2UU;_A(/&O
MB3Q8K1Z5/?:G+:BVBU]+%U>]G\U[9IP4641)^*W[7O\ P;[>'_B1X_UOXA_L
MN?$GP_\ "RT\3:A+J>I_"SQGH^HS^#]&U"\F:;4)O!^OZ"+S4=&T:5V::U\+
MW6@:C;Z?,\L&G:M9:2++2[  ^//^#@[]I/X;_%OXI_ KX3_#CQ?X=\:#X1:!
MXZUGQAJ?A;5K'7-,L/$7CV^\,VEOX<N=0TZ6XM!J^CZ=X*6]O[.*X>2T77+>
M&[6.Y5HH_P!SO^"-_P &]5^#'_!/_P"#5EK]D^GZ_P#$/^W_ (LZC:21O%)'
M:>.=3DN_"LDJR)')YMSX(M?#%U*LB!HI)V@!=(E=OS0_9:_X-Y+7PC\0-'\8
M_M2?%3PSX_\ #'A[48-0B^&/P^TW6XM*\626S+-;VWBGQ1KB:3?V^BF= NI:
M+I6B?:-4M2T UW3T:19/Z*OBIX+UCQC\(OB)\._!6MVW@?7/%7P[\5^"_"WB
M..Q>>U\(:CKGAR^T/2-;@TVRN+!YH_#\]U!?6]C;75EYGV1+>.XMP1(@!_&-
M_P %?O\ @I1XB_:J^)^O? WX8Z[<6/[-WPU\03Z9&FG7.R+XL^+-"NGM[KQE
MJ\D!Q>>&K'4(IH_!&EM)+9R6T,7BJZC_ +3O[.VT7[6_X)1V7_!-3]DCPQHO
MQL^,?[2_PAUW]IOQ)I N$@N[Z\O-.^#.EZM:@3>&=!V:=-;7'C&:UE>U\5^*
M87?R1+<^'/#TJ:2-3U+Q+D_\0V/C?_H[+PK_ .&CU?\ ^;VC_B&Q\;_]'9>%
M?_#1ZO\ _-[0!_15\%OVR/V7_P!HOQ)J7A#X(?&GP9\2?$NCZ)-XDU/1O#ES
M=SWEEH4%_8:9-J<RW%G;H+:/4-4T^U9@Y;S;N(!2"2/Q"_:$_P""Y_Q:_9]_
M:M\6? 3Q?^S_ ."-'\*_#CXLVWA7Q?XBDU_Q+KGB'4_AVFMPSR>+/#^G0P:%
M:VFIZ]X%O+'Q#H=E=C4[>UN;J**X.HPR +]3_P#!-3_@DOXB_8%^,OC3XJ:O
M\;=%^)=OXK^&6H?#^/1M-\#WWAB:RFO?%7A3Q&-3>]NO$NM)/%&GAM[0VJVT
M3L]VDHG A,<GL/\ P4(_X)4_!S]O"2Q\:S:]J'PL^->AZ,=$TSX@:-IMKJVF
MZ]ID$CSZ?I7CKPY++8R:W;:;)+<II>HZ?J^D:O817<D,USJ5A;VFFP@'U%X]
M_;9_9A\ _ [5?V@KKXR_#[6OA[:>'+G7]'N]"\6:)?WOBN>.S-S8^'/#MA'>
M&\OO$NIW#0Z;!HHMUO[6^F\K4(+3R+DP_P 7O_!)#X7^)_C?_P %$/@SJFFZ
M?)+8^!/$^I?&?QI?6H:"ST32/"ZS:A;SS&+F.WO_ !7>^'] MH "LLVK012
M6_G.GWK;?\&X'Q]?7H+>\_:(^#\'AAKF-+G5[;0O&EUKT5F4!EG@\.2V5GI]
MQ<H^Y8[23Q3;12( [7L1)C7^@G]A/_@GU\&/V#/ NHZ!X >]\5^.O%0LY/'W
MQ1\0VUK!K_B62R5C:Z;865J9(/#OA:PGEN)].T"VN;R599VGU75-8O4CNU /
MN^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#\SZ*** /K[X ?\B;J?_8S7G_IJT:O<J\-
M^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH _,^BBB@#Z^^ '_(FZG_V,UY_Z:M&KW*O
M#?@!_P B;J?_ &,UY_Z:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /S/HHHH ^OO@!_R)NI_]C->?^FK1J]R
MKPWX ?\ (FZG_P!C->?^FK1J]RH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5F9@H)IEI>6E_;17EA=6U[:3KO@NK2>*YMID!*EHIX6>*10RE=R,PR",Y!H
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M /S/HHHH ^OO@!_R)NI_]C->?^FK1J]RKPWX ?\ (FZG_P!C->?^FK1J]RH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^5_VF/^9)_[F3_W U]45\K_ +3'_,D_]S)_[@:^
MJX)_Y*?+/^YW_P!5^+/D^.?^26S3_N2_]6.$/E>BBBOWX_GL**** "BBB@ H
MHHH **** /JC]F?_ )G;_N6__<]3?VY_%.I>"OV,OVJ/%&C2FWU;2?@#\59=
M,N5 +VE_/X,U>TM+Q 2 9+.>X2YCW97?$NY'7*,[]F?_ )G;_N6__<]7<?M-
M?#.Z^,W[.GQV^$M@%.I_$?X1?$/P9I!=HD6/6O$/A35=,T:8O.\<*^1JEQ:3
M;II(XEV9=T4%A^ \;?\ )3YG_P!R7_JOPA_0G W_ "2V5_\ <[_ZL<6?SK_\
M&V7@_1G_ .&K_'TUM%+XAMO^%3^#]/O'B7S[#1KW_A.-:U>V@GSO$6KWUAHD
MMW%@*7T2R?+$?+_3?XW\#^$/B3X4USP+X^\.:3XN\'>)K)M.\0>&]=M(K_2-
M7L&DCE:TO[.8&*> RQ1R%'!&]%;J!7\FO_!O/\=?#GPT^-/QT_9Y\=:G!X:U
M[XL:=X3U+P98ZZZZ;)=^,?AO=^*++6_"=LESY3GQ#J&E^)WOH]-E7SY8O"U[
M'"JW$9AG_H,_X*)?M>6'[%W[,/C7XK6FH>'E^(MTMKX<^$WA[7UENH?$OC;4
M[F&..(Z9;75E=W^GZ'I?V_Q#K BN[1%T_39(3=PW-U:)+\J?6'O.O2?"']E/
MX+>._&&A^"_"GP\^&_PN\%^)/'&JZ!X$\-Z)X6TU-,\*Z)=:K<PV&DZ+9V%@
M;V>VL3:64:PAIKAX85R645_'-\*_@Y^UY_P7!^._Q,\?^*_B1:^$/ W@FXM[
MB6ZUQM5U3P5\.;3Q%/>CPSX"^'GA"TGM([Z_73M-N9=1O3-I\]W%8MJ_B;5Y
MM6U6R74/V?T3]K'XF_\ !1'_ ()*_MB?$3Q-\+]-^'&LZ'\/_B5X=@F\-ZSJ
M&J:3XXE\#^#M/\:>(M2T+2-1LAJFBV+Q2/H<.GS:OXC:>\CO(4U226&6%/)/
M^#<'Q=X9G^"'[0O@.*\LE\8Z5\5='\77]AOVZC)X9U_PCINC:1>"-L>=90ZI
MX:UN%GAW_9IYU6Y\K[7:>< ?G?\ !KQO^T9_P17_ &W?#OP7^+7C&36/@-XT
MO-$O/%MII=SJ5[X#\3?#[Q3?SZ/%\3_#6D:BD<FB>*_"5_:7,NK16L$.H3RZ
M%J/AVXO-2TB\LK^?[0_X.5/^0'^QY_V%?CK_ .DGPDKP+_@XA\0Z-XO_ &G?
M@#\-_#!CUGQQH'PTN(M8TS35-UJ$5SXV\5M_PBNBS)$&(U&Z2PFO;:P)^T_9
MM6LKDQB&_MGE]>_X.*;'4-+^'?[#&F:M<-=ZKIUK\7+'4[MW\Q[G4+30_@Y;
MWMPT@)#M-<QRR,X)W%BV>: /DCXV_P#!/#]J+XW_ +&-Q_P4;^-7QTM]7\2_
M\*]T3QYX?^#5_H=]-:Z+\$F%DGAM= \2IXADTWP\H\*3VGB;3/"5EX7EMYK"
MX275=?'B.\U!17_8S^"7[8'_  5J^&4/P1\9?M(:CX*_9^_9=TNPL+"[UC2-
M6\97?B+Q/XHO-;U#PQIVJ:8/$7A\^+)_#.E:?<Z78:IK.O%? OAL:-IVAZ5.
MVJ7;2?OW\?H8K?\ X(N:W;PH(X8/V%_ L,2 DA(HOAEX82- 6)8A44 $DDXY
M)/-?'O\ P;B64,?[-GQ[U%1_I%U\<+:RE.%YAL/ 7AN> 9QN.'U*Y."2HSE0
M"6+ 'Q=_P10^)7Q9_9Z_;N^*7[$'B7Q"VH^$+B^^+'AK7O#B7$EWH>F_%#X/
M7U_;W/B;PX9@6L/[0LM US3=0^S"WCUJU?2I]12>?1]--OY=_P %8_''Q!^&
MW_!72V\:_":WBNOB=H>E?!I_ $$ME'J(?Q=>^%K73- ,5A,Z6]Y=)J5[;R6=
MM=%[.:[2%+R&>V:6"3TO]C/_ )6 /C%_V6?]K[_TE^(-<E_P4T\6:!X#_P""
MUWPP\<>*YK>W\+^#?''[)_BOQ)<7?%K;Z#X>U/PIJ^KW%QV\B#3[.XEER"NQ
M&W*RY! .._;&_P""4/[5_P"R9\,O^&T]2^/X^(GQ"T+6]"\3_%/5/#4OBK2_
M''@GQ#K^IVUBGBG1/&T^I3:EXJM]-U^^L;.^UL6_AG4;2.ZCU"/3CIUO=S6O
M](G_  2N_:SU[]L7]D#PA\1O&MPE[\2/">MZS\,/B3J,5M!:0ZOXJ\+V^F:A
M;ZXMO;1P6L5QKOA77O#6LZG%:V]O9PZO?:A#9V\-I'#&LO\ P5B\3>'_  U_
MP3Q_:<O->NK:*VU?P+:^'-+660_Z9KOB3Q#HNE:%!:K&P>>?^T+J"Z58]RI#
M;RW$P^S0S,/@W_@W6TF^T[]C_P"+NOWUP\.E:M^T'KJ6,,[+';1KH_P[^'BZ
MAJ<;,J@)</=):32-(4!THC:FQF< _H&HK)TS7M#UHS#1M9TG5C;",W TS4;.
M_, EWB(S"UFE,0D,<GEE]N_8^W.UL:U 'XZ?\%ROCS_PIW]A7Q5X4TZ]^R^)
M?COXDT3X5Z<L,H6[30)6E\2^-;H1[E+V%QX>T&?PS?OAU0^*+9"H:9&7\7_^
M&&A_PXK_ .%Q?V*?^%B?\+7_ .&EO,\EO[5_X0#[;_PJ7^S=^=G]C_\ "(?\
M7(Q_SP_?;O-_<U?_ ."^7Q7UWXU?MC?"O]F/P)::AXFOOA=X:TC2+7PQHMO-
M?ZKJ?Q7^,UWI6HKHMAI]HDD]_?WOAN'X=P:;;HLEP]YJ-Q;PQ*TI\WQGS_\
M@N+_ ,*G_P"%&?\ "N_VD_\ A4O_  K_ /X59_P@W_"C="_L?_A7_P#PC_\
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M$'X^_P#JZ_ %'PV_Y6+=1_[+1\5O_5$^,:/^"*__ "E1_:5_[$'X^_\ JZ_
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M5O\ +\Z7;O;]E?V??VO/^&WOV$/BA\=_^%>_\*Q_M#PK\:/#/_"*_P#"6?\
M":>3_P (YX;U&V^V_P!N?\(UX3\S[9YV_P"S?V.GV?;M^T3YW#T7X9?L2?L8
M7_PW^'U]??LB_LPWM[>^"/"EW>7EW\ _A3<W5W=7.@V$UQ<W-Q-X3>:>XGF=
MY9II7>261V=V9F)/JWC;X;_#OX5?LY?%WPE\+_ 7@OX;^%(?AM\2[Z'PQX"\
M+:'X/\/17U[X4U5[V\CT7P]8Z=IJ75VZJ]U<+;":X95:5W(! !_.S_P;5_\
M(<_;#_[!7P*_]*_BW7EGPV_Y6+=1_P"RT?%;_P!43XQKU/\ X-J_^0Y^V'_V
M"O@5_P"E?Q;KRSX;?\K%NH_]EH^*W_JB?&- 'H7_  5-^-WQM_;4_;H\*?\
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MK7[5H>I?!^;1EL6,CV=Q>^$_'VKZMKEJDK)$)//L_%FE0S$*DGE&%G2,.@H
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M_P")/!7@/0?#FIQZ9J>H^.;!7TZ74]-G-K?74%L[VA2=K59#]GKSW_@Y4_Y
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MMX0!%#%X6\-:9H:1Q[2PVH+$ $,V>I9B<G^7/_@X]@EM/C%^RQJ]Q$;G3I/
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M_1-_P;WZ-<6G[$OQSUN9'2+6?CKXNMK7>,++#I'PM^'@>>(%1N0W%_-;EP[
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MJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH **** "BBB@ HHHH
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MJ_\  [2/_E'7OU%'^M7$/_0VQ?\ X%'_ .0\OS[L/]4^'/\ H483_P !G_\
M)G@/_#.7@C_H*^*O_ [2/_E'1_PSEX(_Z"OBK_P.TC_Y1U[]11_K5Q#_ -#;
M%_\ @4?_ )#R_/NP_P!4^'/^A1A/_ 9__)G >!OASHGP_P#[4_L:ZU6Y_M;[
M%]I_M.>TFV?8/M?D^1]EL;+;N^VR^;YGF[ML>W9AM_?T45X^*Q6(QM>IBL76
MG7Q%7D]I5FTYSY(1IPNTDO=A",5ILD>SA,)AL#AZ>%PE&%##TN?V=*FFH0YY
MRJ3LFV_>G.4GKO)G\V__  4=_P"")/B?XO\ Q3UW]HG]D/7/#?AWQ?XIU)_$
MOC;X8Z]?S^&;2\\7M*+F[\6> ?$MI;7%KINK:Y?A=3U31]:_LRR367O]9L_$
M-O\ ;(])@^$_!_\ P1"_X*(?'+QGH*?M(^/M.\)>&-,5;&X\6>-?B9-\7_$6
MDZ)&L6;7PKH.FZSJB7$CE4C@T^\\0^'+!1 SRW48C@CG_LTHKG.@\7^!7P"^
M&O[/'P8\'_ CX=Z'#:^ _"&A-HJ6E]'!=SZ[)>F:?7M8\0,8E@U'5/$NHW5]
MJ6M2-"MO/<WL\<5O#:"&VC_FP^.__!%7]K3X%?&W6/BU_P $[OB9-I'A_5Y]
M1GT?1=.^(E]\,OB+X(LM7O/M5[X,AUXSV.E>*/!T CMX[.74=<M;ZZLX+>QU
MK2]1N+(ZOJ/]6]% '\UG[ 7_  1K^,.@?'K3?VJOVZO%UEXO\:Z!KD7C'0?!
M4WBF\^(OB#7/'=JQ;3?%GQ,\8WXN;:]D\/W<5KJ^D:?I>JZY)?ZI:Z=<ZGJE
MM::?-I&I_5O_  6'_8"^.G[=>F_L_P!I\$[OP':R_#*^^)MQXC/CCQ!J.A(\
M?BZ#P'%I7]FG3]!UPW3*WAO4/M8E%L(0UN4,OFL(_P!IJ* /A?XK_LZ?$#QI
M_P $\-5_9<T>;P\OQ+O?V:O#?PFAGO-1N8/# \4Z3X.T;0KJ1]433YKM=*-[
M83F*[&F&9X#'(UHC,8U\%_X)%?L5?&']A_X*?$OX?_&:Y\&76N^+?BD_C'2G
M\%:W?:Y8+I+>$_#NBA;NXO\ 1M%DAO/MFE71\E()4\DQ/YVYRB_K%10!^ _[
M//\ P31_:*^%_P#P50^(/[97B6]^&[_"/Q/\1/C[XITVVTSQ-JEUXP73/B7#
MXJC\.K<Z-+X<MK&*Z1M9L_[2B36)$M@)C%+<[%#_ )9?\%5OAQI_QC_X+'>#
M/A%J^H7FDZ5\5/$/[,/PXU/5=/2&2_TS3_'$_AKPQ>ZA8QW :WDO+*VU26YM
MDG5H6FC1904+"O[1:_GP_:H_X)R?M+_%O_@JC\(_VM?!^E^#YO@]X.^(_P"S
M;XFUJ]O_ !9:6.OII?PPU_PQJ/BI[?0W@>>XFAMM*NS90K*&O'5$0J7! !\"
M^.O^"0/_  55^(VH^&_@-XV^,]CXW^ ?@#4HH/ _B3Q;\8-9U'P+H^C6L8T_
M3M0L/ %R^H^*+/4],T.:6PTW2WT2:#1K?[3H>DZS'I,BW$_]*/PD_95\/?L_
M_L?1?LM_#2>.\32_AAXL\*PZ[J<,6G2>)/%_BK3-6?6/$VL"T2X-K_;'B+5K
MF]>(&^?3-/>WT^*:ZBL8F;ZXHH _#W_@CQ_P3Q^/G["FI?M 7?QLO/A_=1?$
MVQ^&5OX<'@?Q%J6NNDGA&?QY+JO]I#4/#^ABU5E\2:?]D,1N3,5N XB\I3)^
MX5%% '\Y_P  O^"6/[3C?\%*;O\ ;3_:.OOAA<^$6^)'C_XI66B>&_%>K^(-
M8@U>_@U:W^'&CK;7_AG3(8K'P=]LT::WN!?R20CPY90*)A(TB_T8444 ?SB?
MM9_\$J?VG]>_X*%VW[9?[+VH?"VPTQ/%_P ./BD^E>+/%FL>&[X>.?"HTN+Q
M)9-:Z=X4UB&72O$[:&E_J,SW4AO)M?U:&>#RCL;W?_@K+_P2M\0_MI7_ (6^
M-GP0UG0/#_QQ\(Z"GAG5]$\17,NE:/X]\.6-W<ZGHRPZ]9VMR=)\6:#=WNH6
M]A=ZA ^GZK97EK97NI:/%I%I/)^XE% '\@&@?\$?/^"FG[3GC+P3IO[8WQ@U
M/3OAUX1Q;#6?''Q?N/B_XATC1&>U_M"U\$:#:ZMKUB-<U2*..%[W5]2TF%DL
MXY]1NKT65C877]!7[6?[%.B_&;]A'Q-^QU\*WTWP7::9X(\%:!\+'U:6\FTS
M2;OX9ZIH&K^%[/6+Z.*\U!K;4U\/1Z/K.KFWO[]8M3O-4:WOKM3%+]ZT4 ?S
M4_\ !*?]@G_@HG^RQ\?]!N/C!J<WAO\ 9RT72O'4^H^!+;XQP^(/"VH^)/$6
MC&PT_5])\!:#JNHZ2VL_VA;V$\^J:G8:;-!8+<M'<M=.;6;R+]JO_@C]^V1X
M!_:Y\0_M#?L'Z_#;Z;XN\4:]X\T:\TWQ_IWP^\:_#/Q!XMEOI?%GA])]1N-*
MM-2\*W<FJZE;Z3]@NKJ2;P[?R^'-=TV9+1K_ %G^K.B@#^1[XY?\$-?VW/BO
MIO@OXC>)OC/X.^*W[0?BVZ\4:C\:-9\>>.?$2Z5HUFL/AFW^'_AGPOJ4OA?4
M;O6#I=M#XE.L7"VNBZ/8^?I>BZ#IKZ=IBZC?_LM_P4C_ & -7_;8_9@\&?#S
MPWKND>'_ (M?"B?3/$'@F]UB6Y7PWJU]#H T/7_#.JWEM:7-W8V.M0"*>SU2
M&QG>UU+3=.-Q +*6[*?J710!_*=\(O\ @EO_ ,%1OB?\/M&_9?\ VC/CTOPM
M_90\)+<B#PEI?BS0O&&HZS%8SG4=#T33X/#UJUW?>'DUA;:XL[3QKX@;3?#$
M5NE[I7AJXNK.RL&_0/\ X(^?L)_M)?L+V_QS\/?&R7X;WOAWXBS>!M9\-W'@
MCQ/JFMWMGK7AQ/$ECJT.H6^H>'=%C2UO['5M->WFBED>.73Y4>,K.K1_M=10
M!^ __!.C_@FC^T7^RQ^V[\8OVA?B;>_#>?P%X[\+?%+1]$A\+^)M4U7Q EWX
MQ^(_A;Q5I!OM.N_#FEVT$*Z9HUVMX\>H3M#=&&)$F1VE0\'_ /!-']HO0O\
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MU\.?_,I7V!15^TG_ #,#X_\ ^&*?A7_T'_B!_P"#7PY_\RE'_#%/PK_Z#_Q
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445^>_[=_\
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M0:-_*N6UOXD%_#][<6<N#Y5YH_A:7Q'XAMY%PZR:./+9)=C#^1?_ (8ANO\
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M^$[/PG!<1O?ZI;:-K'A74O&NH>%K)+-Y&\47?]IFRTQ+Z]37HK(W=U7[[_\
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M36KQ87'VNX6@#R"\_P""J/\ P5S_ &J_$.MZK^SAX>\7Z;X9TF5I)_"WP"^
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M%)\3=-C\3AV*JFHVT)E+0Q.& /ZL**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HK_+'HK^X/^)-/^KC_P#FG_\ XT'\#_\ $\/_ %;#_P W7_\
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MV]]J5]JFD:1;W6FIJ,NKZ< ?HG17\6;?\%%/^"UTO@N3]J:-/%T?P'%RU_\
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M%.@0'Q+!I2:\SVNM:'IUQ).U^9KJ.%[>X>2&65&_HGK^)/\ X)Z?&%OV@/\
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M]_\ !MXD_P#F3H_X8B^*W_0P?#W_ ,&WB3_YDZ/^)+/I4_\ 1D.-O_"7!_\
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M^ 7Q5@TJTB&9;W48?!FL75E8Q#!'FWUS!':1YP-\RY*CD/\ V:?@AXK^#?\
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MXKT?4;BUFUZRTW5+J/4AX?TFU?6+74+(2ZAI8FO&N+;3H##=PF6Y^-/'=_\
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M]XCLM'LXIKC5)/#5U86;W<=M%)<6>CZEJNH[?LEI>,OY=?"/]O']M?\ :?\
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MQ)H6J:'/=P1^%9(WFMHM4M;62>))/D>2)717^4L&XKYL_; TH?M"_P#!?7X
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MZ-_G_P#X)H?_ "\_ JBOWU_XAT/VVO\ HJ/[+'_A;?%K_P"<A1_Q#H?MM?\
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MB3)*_K'_  4!_P""=/[.7C3]CSX[6'P9_9K^"?@;XIZ+X+NO&?@C7?AO\(O
MOA7Q=)JW@BXM_%<F@:9J?AO0-.U&1_%>FZ3?^&&LO/,%U_:ZAXS(D3Q_F_\
M\$9?#/B/XP?LK_M<_L(?&WPGXX\)^'/%&EWOB#PAJ/B+PUK6D_9+/Q]H[>&?
M$<NBRZM9V<!N?"7B/1_"OBFPL@\L4NI:O=3RP^6;@3 'TI_P;K:7HT'[&GQ0
MUFTMK?\ MO4OVC_%%AK-\(8UO);;2?AQ\+IM)T^6X$:2R6=B-5OKRSA=Y8X+
MC5M1>(HUQ*@_7_PY\!_V;-+^*_BOXJ>&OA;\)5^-=QJGV[Q9X]L_#?AJ]^(]
MEJFJ:1%"S7FOM;W'B#0Y-4T6:(RV\-S8QZC97 FDBG2X,C_QP?!+]I3]M?\
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MWFGGGF^%'BR.*&&*-6DEEED94CC16=W8*JEB!7U#10!_-S_P;DZ+K.B_"_\
M:=CUC2=3TF2?Q[\/G@34["ZL'F1/#VOJ[Q+=11-(JL0&9 0I(!()%?TC444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!^9]%%% 'U]\ /^1-U/\ [&:\_P#35HU>Y5X;
M\ /^1-U/_L9KS_TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!^9]%%% 'U]\ /^1-U/_L9KS_TU:-7N5>&_ #_D3=3_ .QF
MO/\ TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !17 _%;Q#X@\(_"[XD^*_">E_P!N
M>*O#'@'QCXA\-:+Y,EQ_:_B#1?#NHZEHVE_9X7CFG_M#4;:VM/)BD227S=B.
MK,"/\]SXE?%3XC?&'Q3J7C7XG^,_$/C?Q-JMW<7EUJGB'4[K4)(WN65G@L89
MI&M]-L8ECB@M=.T^*VL;.U@M[6UMX;>"&-/D^)N*J?#GU6#P4\95Q2JRC%5E
MAZ<(4G!2;J.E6;DW-6C&&B3<I1O&_P"5^)/BAA_#QY92ED];-\5F<<15A!8M
M8##TJ.&E2A.4L0\-BY3JRE6CRTH4&E%.52<+P4_]&&BO\U^BOD_^(H?]2/\
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M/AGQ'=>*?B/+%XFN=>T&PT^WTK5[CQ%%(\>NS:A:7$FKQNZ:@UPK$$ _J/\
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M6R\2^%OA!XTN?#FH0-(D^F:_>Z3/I6C:K"\1619=+U*_MM0C967#VP)=%!8
M'YM_M>?\%V_V?OV<OB!KOPM^&_@'7?V@/%OA+4+S1_%FHZ7XFL/!7@/2]:L9
M'M[S1+'Q3-H_BF_US4=-O(I;359+#PV='MID,5IJ^H7$=S!;>P_L'?\ !7_X
M$?MM^*Q\+9?#>L_!OXQ7%C=:CHO@SQ'J]AK^C^+K>PMI;W5+?P?XKM+326U/
M5M*L;>XU&]TC4=!T6^DTR&XU#38]0M['5&T_\L/^" /[(7P=^*GA[XR?M$_%
M?P1X<^(^M:!XSL/ASX(T_P 9Z-I_B/1O#T\&AV7B;Q+KT.EZM'>6%SKNHKKV
MAVEIJ5S9&ZTFWL[P6%P'U6[V>!?\%@O@]X8_81_;:^!OQW_9IT?3/AG+XCTZ
MP^)MGX;\.6D6F>'-)^(/@/Q5Y>IW&E:/9M%8Z;H'B'3I]#BU+P[9V=OI4LAU
MK$3V^JS6L !_17^WI_P4E^"/[ ^C^'X/'%CK?CCXD>,[2[U#PC\-?"TME;ZA
M<Z78W"6MQK_B+5KYS;>&O#QNC)96=Z]KJ-_JE_;W<&E:5?1Z;J]QIOYF_"[_
M (../@YXD\86.B_%7]GKQE\,O"E]J1LCXRT'QSI_Q%;2K66:&*UU76?#Q\)^
M#;R.SC5Y;C5HM'N]<O[."'_B76FM3R+ /CO_ (+A:%\0_!7[6_[.W[9-AX6M
M_&'PMU?P'\,+WPH_BS1QKW@=/$W@?Q'JOB^;X>>+M-4QQ_V7KECJECJ\FFWM
MQ;'Q!:ZKXC@TR=VTK46LM^\_X*5?\$YOV[I/A]X5_;S_ &8]7^%^I>%=5LWT
MSXA?#K6KS4O#OD-9R:==:7XDU'PM:^%OB-H_@V=7MIQHFEVWBIK.XLK2>/4+
M58)990#^I3QY\:/AC\-?A'KGQV\7>+]*L/A5H'A)/&]WXP@F&H:;=>'+FU@N
M],O-(:R\]]8EUQ;JR@T"TTY;FYUJ\O["STV*XN;RWCD_GQ\4_P#!R1\-['Q+
M<67@W]EOQGXC\(QWEY%!X@\0?$W1O">NW%E$ +&[_P"$7L?!WBVSAENWW>?:
M/XI/V.+8ZW%U(S0Q_=/_  41^ EM\2?^"6'B/X9?LEVI\1>#/#O@SX9>*OAM
MX=\(:U>^+K;Q9\+_  5K.@>([;3/#FJWM_K.I>);6#PK:+KGARWAU"_O=6DT
M?3-.TLW,T]K;2?SW_L0?\%5/AY^SM\"C^RM\>?V4_"'Q7^$UW?>((]>UW0QI
M6E^--2LO$6HWUYJ'_"5:)K>F7&F>--7TY=1N=-T:_?7?"=[IVE6NF6"WF^Q2
M[(!_6)^Q=^VW\&_VYOAE=_$7X32:OIMSH&IQZ%XU\$^)XK*V\4^$=9EMQ=6T
M=]#87E]9W>DZK;B6XT/6K*YDM-2BM[N!UM-3T_5--L?PD_;>U:7]C3_@MO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!^9]%%% 'U]\ /^1-U/_L9
MKS_TU:-7N5>&_ #_ )$W4_\ L9KS_P!-6C5[E0 4444 %%%% !1110 4444
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M"?\ !.W_ *-Z_P#,L_''_P">97Z4457]@9%_T)<I_P##=@__ )2:?ZB\$?\
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M=V-_$JW5K;R[K:[@<F,*6*%E(!_.9_P1<_Y1=_MM_P#8U?&[_P!9Y\%5RO\
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M5%2[5'(Q*CIE: /S?_X(:?\ *./X2?\ 8U?%C_U9'B.OQV_X-Y?^3OOVB_\
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MW[ T.DPR%YO!7QF^(WAN[0E,Q37D'ASQA&%"G=L>V\4PN"X!+F0#Y5%?C/\
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MNO$_Q"U?P_/J]W:2VTUUJ$?@SP1HGA\:IKNJ7B:="=NK7;6KV6FVFH7'Z_\
M_!QO86^E_!S]D_3+7>+73O&?CFPMA*YDD^SV?A;PW;P^9(>7?RXUWN>6;+'D
MU^H__!-[]ASP'^R3\"_A_-JGPC\)>#_VBM2\()8?%WQ;:7,'B7Q%J&JRZA+<
MWEA%XJ:^U9(='E\G3YGTKP_=VNA--;02"S\Z!67Z;_: _95_9^_:FTWPYI'Q
M]^&VF?$?3?"-]?ZEX<M=3U/Q#IJ:7>ZG!!:W]Q$WA_6-(DE:X@MH(V6Y>9%$
M8,:HQ8D _FC_ ."JGPQ_MC_@EA_P2]^+T%L9)_ 7PH^#7@:\FBCRT6F_$CX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF\-!->\-V]^F@ZQ<1Z,]K:175[82SQ_V5HTJN)M+M'C^G*** "BBB@ HHHH
MSM8TR#6M)U31KJ6\@MM6TZ]TRXGT^[GT^_A@O[:6UFEL;^U>.YLKR..5GMKN
MWD2>VF"30NLB*P\%_9F_92^!W[(7@74OAU\!_"4GA/PSK'B.[\5ZM'=ZQJ_B
M#4=1UR\L=/TV2ZN]6UR\OM0DCBL-+LK:UM/M M;5(G:"%)+BX>7Z+HH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\
MSZ*** /K[X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_,^BBB@#WCX9_$W0O NAW^BZU8ZS)>R:U=7A%G;6;)$C6EA:&*47=_9RI.DM
MG+YD?E$*"OSEBRKZ+_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK
M_P"75'_#0/@S_H'>)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#
M/^@=XE_\ ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]
M*_\ EU110 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\-
M^#/^@=XE_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?
M_ /2O_EU1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#
M0/@S_H'>)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\
M ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU11
M0 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE
M_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU
M1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>
M)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%
M% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#
M/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_
M )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU1_PT#X,_
MZ!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\ P#TK
M_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_PT#X
M,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=XE_\
M ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_ )=4?\-
M^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU1_PT#X,_Z!WB7_P#
MTK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\ P#TK_P"75%%
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MZ!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\
MEU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H
M'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_
M )=444 '_#0/@S_H'>)?_ /2O_EU1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S
M_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#
MTK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X
M,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2
MO_EU110 ?\- ^#/^@=XE_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '
M_#0/@S_H'>)?_ /2O_EU1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\
MP#TK_P"75'_#0/@S_H'>)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\
M- ^#/^@=XE_\ ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_
M , ]*_\ EU110 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110
M?\- ^#/^@=XE_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H
M'>)?_ /2O_EU1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"7
M5'_#0/@S_H'>)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=
MXE_\ ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\
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M- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P#
M/2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU1_PT
M#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\
MP#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_
MPT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=
MXE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_ )=4
M?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU1_PT#X,_Z!WB
M7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\ P#TK_P"7
M5%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_PT#X,_Z!
MWB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=XE_\ ]*_
M^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_ )=4?\- ^#/^
M@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU1_PT#X,_Z!WB7_P#TK_Y
M=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\ P#TK_P"75%% !_PT
M#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_PT#X,_Z!WB7_ , ]
M*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=XE_\ ]*_^75'_#0/
M@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_ )=4?\- ^#/^@=XE_P#
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M*_\ EU110 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\-
M^#/^@=XE_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?
M_ /2O_EU1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#
M0/@S_H'>)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\
M ]*_^75%% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU11
M0 ?\- ^#/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE
M_P# /2O_ )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU
M1_PT#X,_Z!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>
M)?\ P#TK_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%
M% !_PT#X,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#
M/^@=XE_\ ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_
M )=4?\- ^#/^@=XE_P# /2O_ )=444 '_#0/@S_H'>)?_ /2O_EU1_PT#X,_
MZ!WB7_P#TK_Y=444 '_#0/@S_H'>)?\ P#TK_P"75'_#0/@S_H'>)?\ P#TK
M_P"75%% !_PT#X,_Z!WB7_P#TK_Y=4?\- ^#/^@=XE_\ ]*_^75%% !_PT#X
M,_Z!WB7_ , ]*_\ EU1_PT#X,_Z!WB7_ , ]*_\ EU110 ?\- ^#/^@=XE_\
M ]*_^75'_#0/@S_H'>)?_ /2O_EU110 ?\- ^#/^@=XE_P# /2O_ )=4?\-
M^#/^@=XE_P# /2O_ )=444 ?)T6GW]Q&LT%C>31/G9+%;321MM8JVUT1E;:R
-E3@G# @\@BBBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img155424085_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155424085_13.jpg
M_]C_X  02D9)1@ ! @$!2@%*  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /9!PT# 2(  A$! Q$!_\0
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
M>#?^@GXF_P# S2O_ )34?\* \&_]!/Q-_P"!FE?_ "FKW*B@#PW_ (4!X-_Z
M"?B;_P #-*_^4U'_  H#P;_T$_$W_@9I7_RFKW*B@#PW_A0'@W_H)^)O_ S2
MO_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH \-_X4!X-_P"@GXF_\#-*_P#E-1_P
MH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\* \&_]
M!/Q-_P"!FE?_ "FKW*B@#PW_ (4!X-_Z"?B;_P #-*_^4U'_  H#P;_T$_$W
M_@9I7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]
MRHH \-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#
M?^% >#?^@GXF_P# S2O_ )34?\* \&_]!/Q-_P"!FE?_ "FKW*B@#PW_ (4!
MX-_Z"?B;_P #-*_^4U'_  H#P;_T$_$W_@9I7_RFKW*B@#PW_A0'@W_H)^)O
M_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH \-_X4!X-_P"@GXF_\#-*_P#E
M-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P# S2O_ )34?\*
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MGXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^% >#?^@GXF_P#
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M7_RFKW*B@#PW_A0'@W_H)^)O_ S2O_E-1_PH#P;_ -!/Q-_X&:5_\IJ]RHH
M\-_X4!X-_P"@GXF_\#-*_P#E-1_PH#P;_P!!/Q-_X&:5_P#*:O<J* /#?^%
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M,UY_Z:M&KW*O#?@!_P B;J?_ &,UY_Z:M&KW*@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KX;^,7_)1O$7_ '"/_3%IE?<E?#?Q
MB_Y*-XB_[A'_ *8M,H ]R^ '_(FZG_V,UY_Z:M&KW*O#?@!_R)NI_P#8S7G_
M *:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN)
M\9_$OX<_#FW@N_B%X_\ !/@2UN21;7/C/Q5H7A>WN"'6,B";6[^QCE(D=$/E
MLV'=5/S, <[P9\8_A%\1[JXL?AY\5/AQX\O;2/SKJS\&>./#'BBZMHO^>MQ;
MZ'JE]-#'_MR(J^] 'H]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8%]XL\+:9=2V6I>)?#^
MGWL&SSK2^UG3K2ZA\R-)H_-MY[F.6/S(I(Y4WH-\;HZY5E) -^BHH9H;F&*X
MMYHKBWN(HYH)X9$EAFAE021312QEDDBD1E>.1&9'1@RD@@U+0 4444 %%%%
M!1110 4444 %%%,EECACDFFD2*&)'EEEE=8XXHXU+/)([$*B(H+.[$*J@DD
M$T /HKFH?&G@ZYFBM[?Q9X:N+BXECA@@AUW2Y9III7$<4,44=TSR2R.RI'&B
ML[NP5020*Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ*>>"U@FNKJ:*
MVMK:*2>XN)Y$A@@@A1I)9II9&6.***-6>21V5$169F"@F@"6BL"Q\5^%]3N8
M[+3?$F@:A>2AS%:6.L:==W,HC1I)#'!;W,DKB.-'D<JAVHK.V%4D7]2U;2M'
M@2ZU?4]/TJVDE6!+C4KRVL8'G9))%A26ZDBC:5HXI76,,7*1R,%*HQ !H45E
MZ9KFB:T)CHVL:7JPMC&+@Z9J%I?B R[S$)C:S2B(R".3RP^W?L?;G:V-2@ H
MHHH **** "BHIIH;:&:XN)HK>WMXI)IYYI$BAAAB0R2S32R%4CBC16>21V5$
M12S$ $US7_"=>"/^AQ\*_P#A0Z1_\F4 =517*_\ "=>"/^AQ\*_^%#I'_P F
M5U(((!!!! ((.00>001P01T- "T444 %%%% !165J>NZ)HOD?VSK.E:3]I\W
M[-_:>HVEA]H\GR_.\C[5-%YOE>;%YOE[O+\V/=C>N9M.U72]8@:ZTG4K#5+9
M96A:YTZ\M[V!9D5'>%IK:26,2JDD;-&6#JKHQ #*2 7Z*** "BL34?$OAS1Y
MUM=6\0:)I=RT2S+;:CJMA93M"[.B3+#<SQ2&)GCD59 I1F1U!)5@-*SO;/4+
M:*]T^[MKZSG!:"[LYXKFVF569&:*>%WBD"NK(2CD!E93R"  6:*** "BBB@
MHHHH **** "BBB@ HHHH **YVZ\7^$K&XFL[[Q1X=L[NW<QSVMUK>F6]Q"X
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MS-XU\&V\LL$_BWPS!/!(\,T,VO:5'+#+&Q22*6-[M7CDC=2CHZAD8%6 ((H
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ME&\1?]PC_P!,6F4 >Y? #_D3=3_[&:\_]-6C5[E7AOP _P"1-U/_ +&:\_\
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M222:_D[_ ."G_P#P3 _;F_:(_;F^.'QB^#OP/_X3#X<>,/\ A6G_  CGB/\
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M%\2M9:7#<+K6HZ%X9UJUL]3_ +#CTXR6UQ=03+8&VG,0CD61@#_0KHK\6?\
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MRUC71].N=-GN=6 .?_X+A_L5?M,_M@_\,P_\,Z?#3_A8G_"N_P#A=7_"8_\
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MO%ME\=O&/ANUU[Q%-!-?0:%8>#/AS?V>F(]O!;H+:WO-5U&XC4H6$EW,2Q!
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M_P#8S7G_ *:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGK#Q&9M.GOO#J2Q*VJ031>B_\'(?_);?V;?^R6>+/_4MBH _2C_@@!X"\/\
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MUCP?;Z[J>J)<R:MXIO;M_$\EKJFK7\;:EI<=AIL;3-$EA!*TA?\ <S_@B/\
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MGC8#:\<BNA96#$ _T%_ O_(D>#?^Q5\/?^FBSK^$7_@M5_RDS_:6_P"Z-_\
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M=?!KPT-&T]@1;+JGB[5]=UG7M7A!R6GU"WAT+3;B12$*:#;1A \4CO\ O?\
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MJMO#W_!/KQ#I$\ICE\=_%3X9>%;) 0/.N;/4K[QN\1!() L_!MW-@!CF('&
M6 !^;'_!MEK,\'CW]J[P\JRFVU3PA\*=9E<;_(6?0M9\;V-NLF!Y?FO'XCNC
M#N8/L2?8&7S"O]8]?R[?\&V?@6]BTS]JOXF7$0&GW]_\+O NDS;3F2]TFW\8
MZ_X@B+E0H$,&M>&7"HS$^<3(J!8B_P#430 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?#?QB_Y*-XB_P"X1_Z8M,K[DKX;^,7_ "4;Q%_W"/\
MTQ:90![E\ /^1-U/_L9KS_TU:-7N5>&_ #_D3=3_ .QFO/\ TU:-7N5 !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX_U>QA>3>;2/Q1I_CKP'#/%$A:*WDN/#LDZH(VN);J19))?Z7Z* /Q8\%?\
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M3\7= _X-L?!5MXHM[OQ1^UGXHUGP8EY))=>']!^$.E>&_$T^GEV,-K#XNO\
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M7O-93Q'XOU779#>ZEXD%SJ5_#+J,DC;M/>PTJUBL])T?2["U_3G]DS]GJ/\
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M1RF6)5&UW 5_EK]F** "BBB@#\B/^"V?[.5S\?/V'O%^O:';/<>+?@+JMO\
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MY_9U_9YL+B-Y[:/Q'\8_%%MNW20K<E_!G@=PJG">8(?'WFB0;BHMF3:I;?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7PW\8O^2C>(O^X1_P"F+3*^Y*^&_C%_
MR4;Q%_W"/_3%IE 'N7P _P"1-U/_ +&:\_\ 35HU>Y5X;\ /^1-U/_L9KS_T
MU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7PW\8O\ DHWB+_N$?^F+3*^Y*^&_C%_R4;Q%_P!PC_TQ:90![E\ /^1-U/\
M[&:\_P#35HU>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110 4444 %%%% !1110
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M6;1? 6K:U9VDR@'Z-_LZ_P#!?[P;^TS^W3X:_9$^'G[.]Q+X&\9_$#QEX/\
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M6VV3 OYJE_N$5^0__$4U\ _^C5_B_P#^%GX,_P#C-?OO^RY^RY^RM^SE\/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?#?QB_Y*-XB_P"X1_Z8M,K[DKX;^,7_ "4;Q%_W"/\ TQ:90![E\ /^
M1-U/_L9KS_TU:-7N5>&_ #_D3=3_ .QFO/\ TU:-7N5 !1110 4444 %%%%
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M !7@\2:CXONUOYYKOQ+H6C?$*V&@Z1IFEW^EZAK5L\VH:E:6%JL5^ ?T_?\
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MN-#TCXD?#'PQX9\/:AX/U2ZC\M(-65O!5CXKM+.::%]0TC59?[/DF.E:G]B
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M\(-;66JWMUJ=Q:ZHK-8R?.7_  4<_P""!'[)GP=_8S^*7QB_9SF^(GAOXE?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY_&^F^(O"M]9:YIFN^&HM+DUF+4M!O[.Y>PU2WO;"/SK&>"[-O<AXRLP1MX
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M:\_]-6C5[E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT_QS_@BG_P %@OV@/C'\=E_8A_;*N+GQ)X^U.P\41_#CX@:UH4/AGQY;>)O
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MU/?]EUKQ?807-M)#HOABWU36_P"AK]D']CRP_89_X)R/\!MUG=^,++X5>/\
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M3FA__(-?YR<0_M0?H[\,\09YPWF&0>*U3'\/YQF>28ZIA>&^&JF%GC,JQM;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9O+.&YO_  ^/$/BR.SUM](GE5VT^?4[*TBL;NYMO+N9+$SV1E%K=W4,WN_\
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M_7T?Y8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1116AT!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&QN$KQYJ.)PE:GB*%6/>%6E*<))/1VD[.Z=F@HHHK4Z@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KX;^,7_)1O$7_<(_],6F5]R5\-_&+_DHWB+_ +A'_IBTR@#W+X ?
M\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.3_-7]MW_DKW[-?_ &'I?_4G\)U^E5?-7QN_9X_X7)XO^&OBO_A+_P#A'/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY.SXH?\ 9Q.-O_6ES,_U:X5_Y)CAS_L0Y/\ ^J_#A1117YV>\%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7PW\8O^2C>(O^X1_P"F+3*^Y*^&_C%_R4;Q
M%_W"/_3%IE 'N7P _P"1-U/_ +&:\_\ 35HU>Y5X;\ /^1-U/_L9KS_TU:-7
MN5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 ?)_P"V5_R2.V_['#1O_2'6*_*^OU0_;*_Y)';?]CAHW_I#K%?E?750
M^!_XG^2 ****V **** "BBB@ HHHH **** $U+_CZ'_7IIW_ *;[6J%7]2_X
M^A_UZ:=_Z;[6J%?\;?B]_P G9\4/^SB<;?\ K2YF?ZM<*_\ ),<.?]B')_\
MU7X<****_.SW@HHHH **** "BBB@ KW/]FK_ )+C\/\ _L(ZA_Z8]4KPRO<_
MV:O^2X_#_P#[".H?^F/5*_7OH^?\G[\$/^SO>&O_ *V>2GRW'/\ R1/&'_9+
M<0?^JG%G[.T445_U]'^6 4444 %%%% !1110 4444 ?G-^U+_P $N?V5OVH!
MJ>NWWA0?#'XE7QEG_P"%B_#>&TT:^O;Y\M]H\3^'O*/ASQ0)YMC7UW>6-OXA
MN(D,-MXALMQ<?S<_M2_\$EOVJ/V;EU'Q#I&B)\:_AM9F:;_A,/AQ97MWJ^G6
M$>2+CQ1X%87&OZ.5B62XO+G2F\2:#I]NGF7FOQ$[1_:_17RF<\'9-G'-4E1^
MIXN5W]:PBC3<I=ZU*WLJUW\4G&-5K158GY=Q?X0\'\6^UQ$\'_9&:U.:7]IY
M5&G0G4J/7FQF%Y?JV+YI:U*DH0Q4E[JQ,-S_ #98)[FRN8;JUFGM+NTGCGM[
MB"22"YMKF"02130RQLDL,\,J*\<B,LD<BAE8, 1^N7[+7_!9/]IKX$#3?#7Q
M*G3X_?#VU,,!M/&>H3V_C_3+) $*:/X_6.[O+THOS^5XNL?$C,J):VMWIL/S
MI_1-^U+_ ,$T/V6?VJOM^M>)?!Y\"?$:\$LO_"R_ATMGH'B"[O'#,)O$EC]E
MGT+Q8))?+%S<:UILVM-;1_9K'6M.#>8O\W?[4O\ P2"_:D_9Z;4O$'@_2O\
MA?'PWLQ-<#Q'\/\ 3[AO%.FV,9)\WQ%\/C+>:W;,D2R3W-QX=F\4:59VT;7%
M]J5F,QI^;XGAWBCA:M+%Y;6K5Z$=7B,!S2O".J^MX*2FW%:RDI0KT8)7E41_
M.N9>'OB9X88NIFW#F+Q6,P5-\T\?DGM)\U&'O)9ID\U5<J<5S3FITL=@Z27-
M.NG:W]+_ .S!_P %%?V7/VK8[#3/ OCJ+PYX_NXU\SX8>//L_ASQE]HV@R0:
M1%+<S:3XJV_,X/A?5-6FC@7S;VWLFW1)]SU_FRJUQ:7 93-:W5K,&5E+PW%O
M<0OD$$;9(IH9%R"-KQNN1AAQ^K?[+'_!8+]J']GQM.\/>-]2/Q[^'%L8H6T'
MQ]J5S_PE^F6:;5*>'OB%Y5[K$3+&D<4-MXEM_%.FVUO'Y%A96&XS+]!DWB/3
MGRT,[P_LI:1^N86,I4^UZV';E4AWE*BZEV_=HP1]YPA](?#U?98/C/ ?59Z0
M><973G4P[Z<^+R]N=>E9+FJ5,'/$<TG:GA*45I_9_17P%^RW_P %*OV6OVJH
M[#2?#'C./P/\1;L11/\ #+XB26?A_P 23WDFU/(\.7CW,FA^+A)+YGV:'0=1
MNM7-L@N+_1]-W>4OW[7Z5A,9A,?1CB,'B*.)HRVJ49QFD[7Y96=X37VH2491
M>DDGH?T;E6<95GF$AC\GS#"9C@ZGPU\)6A6@I6NX5%%\U*K&]ITJL858/2<(
MM-!11172>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?#?QB_P"2C>(O^X1_Z8M,K[DKX;^,7_)1O$7_ '"/_3%IE 'N7P _Y$W4
M_P#L9KS_ --6C5[E7AOP _Y$W4_^QFO/_35HU>Y4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\G_ME?\ )([;_L<-
M&_\ 2'6*_*^OU0_;*_Y)';?]CAHW_I#K%?E?750^!_XG^2 ****V **** "B
MBB@ HHHH **** $U+_CZ'_7IIW_IOM:H5?U+_CZ'_7IIW_IOM:H5_P ;?B]_
MR=GQ0_[.)QM_ZTN9G^K7"O\ R3'#G_8AR?\ ]5^'"BBBOSL]X**** "BBB@
MHHHH *]S_9J_Y+C\/_\ L(ZA_P"F/5*\,KW/]FK_ )+C\/\ _L(ZA_Z8]4K]
M>^CY_P G[\$/^SO>&O\ ZV>2GRW'/_)$\8?]DMQ!_P"JG%G[.T445_U]'^6
M4444 %%%% !1110 4444 %%%% !1110!\(_M1?\ !.3]EO\ :MCU#5/&G@>+
MPK\0KQ7=/BAX 6U\.^+Y+LJ=MQKICM9M(\6@L(TD/B;3-2O5MD\BQO[ E94_
MF^_:F_X(Y?M-_ -=1\2?#RV7X_?#RT$L[:EX)TVX@\<Z7:1[FWZU\/S-?:C<
M!$&6G\*WOB6-(T>XO$T^,;1_9?17S&<\(Y-G//4JT/JN+E=_6\+RTZDI=ZT+
M.E7N[<SG#VC6D:D-U^:<7^%'"'&"JU\3@EEN:3N_[5RM0P^(G4>O-BZ7*\-C
M>9VYYUZ3Q#@N6GB*6Z_S9IX;FQN9K>XAGL[RSGDAG@GCDM[FUN;>0QRPS12!
M)8)X)49)(W59(Y%*L%92!^H?[+7_  5P_:F_9R&F>'M?UI?C?\-K(Q0?\(G\
M1+Z[N-=T^QC"K]G\->/0MUKVF>7$D<%I;:PGB31+&W3RK/18-V]?Z?OVGO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC.TU6+P]X?GNIP\]\O@O6/#&M:=9W$]S(]IX?U/P[HL44-II5MO_ #B\6?\
M!.W]L+_@JM_P4Y^.VL?M4Z+\9?V=?@OH$?BN[^'_ (I\4?#W5AII^&/ASQ#'
MX;^&G@7X;W6I):^#;O6=0L;ZU\4^*I[+4+D_:G\0ZO>63ZAJD- ']C/PT^+G
MPJ^-'AW_ (2_X/\ Q+\ _%3PK]J:Q;Q)\.O%_A_QIH<=]'##<26$NJ>'-0U&
MRAOHH+FWEFLI9DN88YXFEB02+GC?C7^TY^SU^S?%X<G^/GQF^'7P@A\7R:K%
MX7D^('BC2_#*:_)H:Z>^L)I3:E/ +QM,75M,:]$.XP"_M3)CSDS_ !=_L5Z;
M\2/^"5O_  6XM_V/O#WC_4O&?P^\9>//"OPD\7P-$]C8>,_"OQ0\(Z1XM^'>
MOZOX>M=3NK"R\5>#[CQ1H=T=2#27%G'%XBM;00Z5KMY:S?:G_!U=_P @#]A_
M_L,?M#?^D7P6H _K&\+>*/#GCCPQX<\:^#]:TWQ+X2\7Z#H_BCPMXCT:[BO]
M(U_PYX@T^WU;1-:TJ^@9X+S3=5TR[M;ZQNX7:*XM9XIHV9'!/SM\5OVX?V/?
M@9XQNOA[\8OVE_@O\-?'-C9V&H7WA+QAX_\ #^B:_96>J0"ZTZXO-+O+V.ZM
M4OK5DNK7SXXVFM98;B-6AFB=_P X/$'[?/@7_@GO_P $>/V.OBKKGV#6_B-X
MA_9 _9T\,?!?P!<3E9O&/CJ7X&^#)(I[R&&2.[3PEX7CDCUKQ=J$3P"*Q6VT
MBWNHM:UW1HKC\%O^"0/_  3W\>?\%*?VB_%O[<7[7IU'QC\(M&\>WGB769O$
MT18?'KXM"YBU$>'%M6C2U?X=>$F:TD\3VUO&FBS0PZ3\/M,LY=.;7H]! /[D
M_#/B70?&7AW0_%OA;5;37/#7B;2;#7?#^MZ?)YVGZQHVJVT=[IFJ6$^ MQ8Z
MA9S0W=G<IF*YMI8IXF>*1&.Y3(XXX8XXHHTBBB18XHHU5(XXT4*D<:* J(B@
M*JJ JJ    !3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^&_C%_R4;Q%_W"/_3%IE?<E?#?QB_Y*-XB_P"X1_Z8
MM,H ]R^ '_(FZG_V,UY_Z:M&KW*O#?@!_P B;J?_ &,UY_Z:M&KW*@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?E)-;\7^*M0M[>TCU'Q!K=Q&CW,T5M;6=I:PV>DZ59V&CZ=I]A:_BC_P4?\
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M9Y*?+<<_\D3QA_V2W$'_ *J<6?L[1117_7T?Y8!1110 4444 %%%% !1110
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M7PW\8O\ DHWB+_N$?^F+3*^Y*^&_C%_R4;Q%_P!PC_TQ:90![E\ /^1-U/\
M[&:\_P#35HU>Y5X;\ /^1-U/_L9KS_TU:-7N5 !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y/_;*_P"21VW_ &.&
MC?\ I#K%?E?7ZH?ME?\ )([;_L<-&_\ 2'6*_*^NJA\#_P 3_) %%%%; %%%
M% !1110 4444 %%%% ":E_Q]#_KTT[_TWVM4*OZE_P ?0_Z]-._]-]K5"O\
MC;\7O^3L^*'_ &<3C;_UI<S/]6N%?^28X<_[$.3_ /JOPX4445^=GO!1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV@6[UGQ!JECHVE6K74\=K;+<ZCJ,]M9P-<7,T-M )9E,L\L<,>Z1U4_QM?\
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M'H7B.7X@#7-.T3QEHMGK^C1:HNG>#+VQ6[?3+^UFD6UN[B%?- 65L9K^O/\
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MOC3PWXTTZ!;L2M:-->^&]2U*VB6Z6"8VY>51,(93&6$;X_BU_P""A%A\8/\
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MO8=$T*^N$LTT?^QVABL/J_\ X)X^,/'/QU_X-\OVZ_AGK,]_K8^"^F_'30O
MQG$TS0>#]'^'OA;XR)X?M)5#7%W-IVN:AXGEM+4M(8;34-+TR%$M([>%?YU/
MZ1/S'_X)6_\ !4KX:?\ !,WX2?'2_7X1:G\8OC7\8_&'A*ST[2DUZ'P7X?T#
MP3X%T35Y+2_UOQ5+H?B.[E>_U_QAJ/V+P_HVCW#WB:3>2ZMJ6B :-)?_ --/
M_!+C]N?]A'_@H'\1?'/C_P '_LR?#CX(?MF:1'<^-O&3:CX4\&>(_B'KFB7<
M%GX8OO&7AKXSV?A+0O$/B'3[==6MO#>MP7EOH6I6":I%"^F3:9J?VF7\N_\
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MD?!;X7_L]> /&/A33?&WB3QAX[\8>+-3\7O?:WKGBRYLHK6&SGT-M.TKPO\
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M:_M+2>=(VU+2QI^KPJUIJ-M(X!]14444 %%%% !1110 4444 %%%% 'X8_\
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M;7P]96<?A72/MM^-/U;6-0O-6MK2RTNXM9]5O+#]??\ @W+\9?$7X@?LW_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5L$TR]O+N8Q'7O#/A&RMXXGU.[E?^M*B@ HHHH **** "BBB@ HHHH ****
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MKJ\-HNGW.@:9JDU]I5[X@CG73E\%^*]4U^07*Z;9*O\ :=110 4444 %%%%
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M@SXJ_P#1!\1_^$$_\S_'#_B.7A#_ -'"X8_\.$/\O/\ /LS\//B7_P $M?\
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M)L8KT.I;Z]_XB#OV#O\ H$?'W_PWOAO_ .;ZC_B(._8._P"@1\??_#>^&_\
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MU*_9A_:4^'?[6WP=\/\ QQ^%D'B.W\%^)+_7].TZ+Q7IEKI&MK<>'-9O-"U
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M^'6HV?ALW7V73_B#X?+>(?A_JK._EVX@\2647E:;<WC9-KI/B*#1-<E16?\
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M;PWXRFB;4[V_B1MS:9XGN-5TZ^CB^R0RZ+//_:</]?/@#QYX4^*'@GPM\1/
MVL6VO>$?&>B:?XA\/ZO:D^5>:;J4"3P,R-B2WN8MQ@O+.=8[FRO(I[.ZBBN(
M)8U_SCJ_6/\ 8L_X*R_$[]CWX86_P?7X;^&OB;X*L/$6LZ]I7]J:_J_A[7=)
MBUP03WFC6.H6]OJ^G1Z8-5CNM7B6319)UN]3U$/,Z2P"W^GX2XSJ8"I/"9UB
MZU7 RA>A7J*IB*N'JQ:]R\5.M*C.+?NOG]G*$5!1C*1^E^%7C%7R*O6RKC'-
M,9BLDG1Y\'C<1'$9ABLOQ,)Q2H\T(UL55P=:G*5X/VOU>=*G[&,(5*B?]GM%
M?@+X)_X+_P#P0U$P+\1/@1\4?"32;%F?PCK?A;QY! S)\[;]6F^'T\L,<N%+
M);"5H0TJP&4"V;Z]\$?\%A_V"/&1@BNOBQJO@>^N/*$=CXW\">,+ *TB;G6?
M5=&TG7?#UMY!^262YUB*$N<PR3)EQ^F8?BCA[%6]EF^"3>RKU/JK=]E;$JB[
MOHK7OI:Y_2. \3N ,RY?JW%F3Q<K*,<;B'ELFWLN3,HX27,]E&UV]$KZ'Z>T
M5\_>"/VL/V8?B1Y"^!OV@O@YXENKCR1'IFG?$7PJVM!KC=Y$<VAS:I%K%M+,
M4<1Q7%C%([)(JH61P/?HI8IXHYH9(YH9HTEBEB=9(I8I%#QR1R(2CQNA#(ZD
MJRD,I((->U2KT:\>>A6I5H_S4JD*D?\ P*#:_$^QPN-P>.I^UP6+PN,I?\_,
M+B*6(IZ[>_2G..OJ/HHHK4Z@HHHH *_C]_X+4_\ !%#PYH]K\>OV^/@9X[TS
MPII5O:ZI\4/BY\(O$6G71M+SQ#J.K1/XCU[X>ZWI4,HL7UZ[U!]5N_#.M:>U
MJFL2:A=6GB&TL+VVTK3?[ JS=8T;1_$.F7NBZ_I6FZYHVHPFWU#2=8L;74],
MO[=B&,%[87L4]K=0EE5C%/%(A*@E<@4 ?S/?\$;?^"+/@_X0M\&?VZOC3\0(
M?BI\0?$WPZ\&_$KX0^"]/TN\L_#'PX_X3OP;::EI^MZ[J.I7DMWXO\6Z5H.M
MPZ?I4']FZ5HGA;4(9]1L_P"W-0BT/4M$_5/_ (*6?\$VOA=_P4?^$6E>"_%>
ML7'@3XC^!+W4=9^%?Q0T[3+?5KKPW?ZG:);:KHFM:9-+:R:UX.\0FVTV;6M)
MMM1TN]^VZ/I&H66HP264EO=_HM86%CI=C9Z9IEG::=ING6EO8:?I]A;PV=C8
M6-G"EO:6=G:6Z1P6MI:P1QP6]O!&D,$*)%$BHJJ+5 '\7/@K_@V._:>UCQ=H
M'AWXR_M5?#6+X)>'KT/:#P5-\0?$WBZ'3)YVN-5M- \(>*O#V@^$O"][J141
MB^C\0ZQ;V\\[7]SINI?9A97?]:O@O]G'X-^!?V?-'_9;T?P9I]S\$-(^'+_"
ML^"]7+ZE::OX-NM*FTC5;+7)YB)]3NM=M[J]GUN_E=;K4+^^N[Z21;B8N/<:
M* /XW?C)_P &ROQST'Q]XBN_V2?VF_!NF?#/Q++)9_V-\5-1\<^%?%^E^%[Z
M17O/#VJ:OX \->)-+\<06VT>4]WI_AF#4T6%+RTMY8VNI?VV_P""57_!*;P+
M_P $VO!?BJ]N/%8^)OQQ^)<.FVWCSQ[%ITND:)IVB:5)+=:=X-\&Z3<7-W<V
MVC6]]<37NIZM>S+J/B6^CL[J[M-.M=/TW2['];** /Y^?^"I?_!#/P_^W'\2
MH_VA_@G\1-,^#?QTO;/2]/\ &L.OZ9>7?@;QZ=#M?L>B>(KFYT.,Z]X;\86-
ME#8:5=:M;6VM66J:7IFEJ=*L=1L[G4=1^1_V,?\ @W'\7>$OCAX<^-?[<7QI
M\'_%F'PCK5CXFM_AWX$N/%WB>R\:Z]H]U#<Z(WCKQMX\T?PUJ=UX=LY+2VDU
M'PW;^&[@Z\@73;K6+73(KFVU/^KZB@#\K_\ @K9_P3[\8_\ !1KX"> /A!X*
M^(7AGX<:EX.^+VF?$FYUCQ3IFJ:K8WEC8>#/&OAA]-@@TEEGCNY)_%-O=++(
M?)$-K,A&]TKZ4_8+_9MUO]D+]D?X+_LX>)/$NE>,-;^%VB:WI5_XDT2TN['2
MM4DU7Q?XB\21RV=I?DW<*10:U%;.LQ+-+!(Z_(RU]>44 ?@/_P %9_\ @BK+
M_P %"OBIX!^-7PP^(WA/X3>/M*\*7'@SXB3^)-"U35++QGI6FW:7?@S4(QHL
MD4D.M:*E[KFEWUW>)</J&D/H-FDL$6AQ1R_JQ^QG\*_C%\#?V:_A9\'?CIX]
M\/?$_P >?#/P]#X,_P"$\\.6FJV,'B'PSH+&Q\(2ZE;ZR9+YM=T_P[%I^D:M
M>R33G5KK3VU>607-_/%']044 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!\'?'3_DI&K_]>FD_^FVVKR"O7_CI_P E(U?_ *]-)_\ 3;;5Y!7]
M(</?\B+)_P#L6X/_ -1Z9_-'$7_(^SG_ +&>-_\ 4BH%%%%>P>,%%%% !111
M0 4444 %>D_"#_DI'A;_ *^[K_TVWM>;5Z3\(/\ DI'A;_K[NO\ TVWM>;G/
M_(GS7_L6X[_U%JGJ9'_R.LG_ .QIE_\ ZET3]!Z***_FD_IP**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX;^,7_)1
MO$7_ '"/_3%IE?<E?#?QB_Y*-XB_[A'_ *8M,H ]R^ '_(FZG_V,UY_Z:M&K
MW*O#?@!_R)NI_P#8S7G_ *:M&KW*@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /D_]LK_DD=M_V.&C?^D.L5^5]?JA
M^V5_R2.V_P"QPT;_ -(=8K\KZZJ'P/\ Q/\ ) %%%%; %%%% !1110 4444
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M_P HX?A'_P!C5\6?_5D^)*_E[Z6W_)LLM_[+'*__ %59Z?UE]#;_ ).KF?\
MV1.;?^K?A\_7BBBBO\X#_3X**** "BBB@ HHHH **** "BBB@ HHHH ****
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M\;CQ%9QVZ)]RV6 6Z.!(D:R ./KSP3_P6^_;A\+&!?$%_P#"[XDHFP3-XN\
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M>*]"\2P&$L5$PET6_O8S$6!42!MA8$9R"*]S#X_ XNWU7&X3$WV]AB*-:_\
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M#_PI+;_Y3T?\-R:5_P!$ZU#_ ,*2V_\ E/7YWT4>QAV?WO\ K_AWY6#]$/\
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M;_["'B+_ -/E]656G&,4TM;I;M]'_D!](4445@ 4444 %%%% !1110 4444
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M .8&C_B)2\$?]&E^*O\ P[ND?_,#7\G-%'_$M7@W_P!$M7_\2#B+_P">@?\
M$TOC?_T5N'_\1SAG_P"=']7?E;^L;_B)2\$?]&E^*O\ P[ND?_,#1_Q$I>"/
M^C2_%7_AW=(_^8&OY.:*/^):O!O_ *):O_XD'$7_ ,] _P")I?&__HK</_XC
MG#/_ ,Z/ZN_*W]8W_$2EX(_Z-+\5?^'=TC_Y@:/^(E+P1_T:7XJ_\.[I'_S
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M7](</?\ (BR?_L6X/_U'IG\T<1?\C[.?^QGC?_4BH%%%%>P>,%%%% !1110
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M_P!BS;_^GS2:^I*^6_VUO^36?C-_V+-O_P"GS2:_IGZ%?_*9'T2_^TF? ?\
M]>GPJ?C?TB_^4?/';_LS?B?_ .L3GA_+W1117_H_G_'V%%%% !1110 4444
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MKCX=VFG^+=4L;>YL+BTU?4?#=I%J=@-.N+U(OY=OA%_P2S_X*-_MJ_ +6/\
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MB;Z2NP_M;Z0'#?\ %I\3UJ=/XY5\MH9_2Y5;X\3]6S!QB]G-5XMWTG=G[_\
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M2VJ4*D*M-^DZ<I1?R94*D*D5.G.%2+VE"2G%^DHMK\0HHHK8L**** "BBB@
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M% !1110 4444 %?#?QB_Y*-XB_[A'_IBTRON2OAOXQ?\E&\1?]PC_P!,6F4
M>Y? #_D3=3_[&:\_]-6C5[E7AOP _P"1-U/_ +&:\_\ 35HU>Y4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\G_ME
M?\DCMO\ L<-&_P#2'6*_*^OU0_;*_P"21VW_ &.&C?\ I#K%?E?750^!_P")
M_D@"BBBM@"BBB@ HHHH **** "BBB@!-2_X^A_UZ:=_Z;[6J%7]2_P"/H?\
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MV%Q'^G\L44\4D,T<<T,T;Q2Q2HLD4L4BE)(Y(W!1XW0E71@59258$$BOQO\
M''_!'SPSIGQ#U;XD?LG?M%_%/]D;5-=V2:EH_@=M5UCP^DQNS=7,&GQV/C'P
M;K4&B7.Z0CP]?:YJ>DVDTC)906^EK%I4>&883'X?.*&=X#"PQ_\ PGSRS%8-
MUZ>'K*E]86)I5\-4K-47)3YHU85)TU*/+9MZPX,_RG/<#Q?@>,\BRVEGO_"!
M6X;S+*'C</E^+CAGCUF6'QN7XC&.&$E4C7YZ6(HUJU!3I^S<93E[U'C/^"\/
MBSP+:_LQ^ O VJ3V5S\0O$7Q8T;6O!FDJ8Y-8@TW0]$\0VOB/7(X@CSIIL::
MM8Z-,5:/[1?:M9*@F^SRB+]4?V7O#_B#PG^S3^SWX7\6+<IXG\.?!+X6:'X@
MAO(G@O+?6-*\#Z'8ZC:W<<I,HNK2Z@EMK@S8E>:)WE59&91\%_ C_@DM\.O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^3_VRO^21VW_8X:-_
MZ0ZQ7Y7U^J'[97_)([;_ +'#1O\ TAUBOROKJH? _P#$_P D 4445L 4444
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M-O\ DZN9_P#9$YM_ZM^'S]>****_S@/]/@HHHH **** "BBB@ HHHH ****
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M?\E(U?\ Z]-)_P#3;;5Y!7K_ ,=/^2D:O_UZ:3_Z;;:O(*_I#A[_ )$63_\
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MP<<1YVQ%.E"NK];5%=Z]#S:^2Y1B;^WRW U&]YO#4E4^52,5-?*2/QM\3?\
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M?"^M6UJVX$@QW<ED+:53M8;HY77*NN=R, O]:N/<LTQM'$RC'_H/RKDC9?\
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M]I/_ +(%\8O_ %7?B.O\T2O[U^AU_P B/C?_ +&N4?\ J)BS_/#Z;?\ R/N
MO^Q1G7_J;@@HHHK^RS^'@HHHH **** "BBB@ HHHH _L9_X-Q/\ DUSXY?\
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M4 %%%% 'OO[*/_)T?[-G_9??@[_ZL3PY7^EW7^:)^RC_ ,G1_LV?]E]^#O\
MZL3PY7^EW7\%?3%_Y'G!'_8JS?\ ]2\(?Z'_ $)/^1#Q[_V-\E_]0L:%%%%?
MQH?W"%%%% !1110 4444 %%%% !1110 4444 %%%% 'P=\=/^2D:O_UZ:3_Z
M;;:O(*]?^.G_ "4C5_\ KTTG_P!-MM7D%?TAP]_R(LG_ .Q;@_\ U'IG\T<1
M?\C[.?\ L9XW_P!2*@4445[!XP4444 %%%% !1110 5@^*/^1>UC_KQF_P#0
M:WJP?%'_ "+VL?\ 7C-_Z#7FYS_R)\U_[%N._P#46J>KD7_(\R;_ +&N7?\
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MH^>.W_9F_$__ -8G/#^7NBBBO_1_/^/L**** "BBB@ HHHH **** "O[P/\
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M&C_AK'XW?]#'I_\ X3NA_P#R#7S?11R0_EC]W]=OS[L#Z0_X:Q^-W_0QZ?\
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M7_Z]-)_]-MM7D%>O_'3_ )*1J_\ UZ:3_P"FVVKR"OZ0X>_Y$63_ /8MP?\
MZCTS^:.(O^1]G/\ V,\;_P"I%0****]@\8**** "BBB@ HHHH *P?%'_ "+V
ML?\ 7C-_Z#6]6#XH_P"1>UC_ *\9O_0:\W.?^1/FO_8MQW_J+5/5R+_D>9-_
MV-<N_P#4NB?-M%%%?SR?TV%%%% !1110 4444 %%%% !7ZX?LG?\D1\-_P#8
M0\1?^GR^K\CZ_7#]D[_DB/AO_L(>(O\ T^7U8U_@7^)?DP/I"BBBN4 HHHH
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?)_[97_)([;_ +'#1O\
MTAUBOROK]4/VRO\ DD=M_P!CAHW_ *0ZQ7Y7UU4/@?\ B?Y( HHHK8 HHHH
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M?&__ &-<H_\ 43%G^>'TV_\ D?<!?]BC.O\ U-P04445_99_#P4444 %%%%
M!1110 4444 ?V,_\&XG_ ":Y\<O^R^R_^J[\%5_0_7\\'_!N)_R:Y\<O^R^R
M_P#JN_!5?T/U_DUX[_\ )W../^QK2_\ 5?@S_8OZ/?\ R9G@'_L45?\ U98X
M****_)#]E"BBB@ HHHH **** "BBB@ HHHH *^&_C%_R4;Q%_P!PC_TQ:97W
M)7PW\8O^2C>(O^X1_P"F+3* /<O@!_R)NI_]C->?^FK1J]RKPWX ?\B;J?\
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M#7/_ $NEKR^NZ'P1_P ,?R0!1115 %%%% !1110 4444 %>X?LW?\EN\ _\
M80U#_P!,>J5X?7N'[-W_ "6[P#_V$-0_],>J5,_@E_AE^3 _9"BBBN$ HHHH
M **** "BBB@ HHHH *_@_P#^"YO_ "D>^+G_ &*OPF_]5MX;K^\"OX/_ /@N
M;_RD>^+G_8J_";_U6WANOZA^B3_R<W,O^R.S3_U:Y$?R;],G_DU66?\ 9;93
M_P"JCB _(>BBBO\ 1\_S!"BBB@ HHHH **** "BBB@#WW]E'_DZ/]FS_ ++[
M\'?_ %8GARO]+NO\T3]E'_DZ/]FS_LOOP=_]6)X<K_2[K^"OIB_\CS@C_L59
MO_ZEX0_T/^A)_P B'CW_ +&^2_\ J%C0HHHK^-#^X0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ^#OCI_P E(U?_ *]-)_\ 3;;5Y!7K_P =/^2D:O\
M]>FD_P#IMMJ\@K^D.'O^1%D__8MP?_J/3/YHXB_Y'V<_]C/&_P#J14"BBBO8
M/&"BBB@ HHHH **** "L'Q1_R+VL?]>,W_H-;U8/BC_D7M8_Z\9O_0:\W.?^
M1/FO_8MQW_J+5/5R+_D>9-_V-<N_]2Z)\VT445_/)_384444 %%%% !1110
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MO/\ TU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#@C7H'_#%/PK_Z#_Q _P#!KX<_^92C_ABGX5_]!_X@?^#7PY_\RE 'S/\
M&7]IC_A;?A&+PK_PA/\ PC_EZQ9:M]O_ .$D_M;/V."\A^S_ &7^P=-QYGVO
M=YOV@[/+V^6V_*_*]?J!_P ,4_"O_H/_ ! _\&OAS_YE*/\ ABGX5_\ 0?\
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M_94>1_M_^.__ &5?J1_PQ3\*_P#H/_$#_P &OAS_ .92C_ABGX5_]!_X@?\
M@U\.?_,I1_Q3M^AS_P!&?_\ .@>*7_T;A_Q'GQ7_ .BJ_P#,'PW_ /.<_+?R
M/]O_ ,=_^RH\C_;_ /'?_LJ_4C_ABGX5_P#0?^('_@U\.?\ S*4?\,4_"O\
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M#7PY_P#,I1_Q,AXT?]%E_P":[PI_\X@_XE@\#/\ HA__ #9>,/\ Z(#^2/\
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M\&OAS_YE*/\ ABGX5_\ 0?\ B!_X-?#G_P RE?FY^H'G_P#PW1_U2[_R]_\
M\$:/^&Z/^J7?^7O_ /@C7H'_  Q3\*_^@_\ $#_P:^'/_F4H_P"&*?A7_P!!
M_P"('_@U\.?_ #*4 >?_ /#='_5+O_+W_P#P1H_X;H_ZI=_Y>_\ ^"->@?\
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M_E[_ /X(UZ!_PQ3\*_\ H/\ Q _\&OAS_P"92C_ABGX5_P#0?^('_@U\.?\
MS*4 >?\ _#='_5+O_+W_ /P1H_X;H_ZI=_Y>_P#^"->@?\,4_"O_ *#_ ,0/
M_!KX<_\ F4H_X8I^%?\ T'_B!_X-?#G_ ,RE 'G_ /PW1_U2[_R]_P#\$:/^
M&Z/^J7?^7O\ _@C7H'_#%/PK_P"@_P#$#_P:^'/_ )E*/^&*?A7_ -!_X@?^
M#7PY_P#,I0!Y_P#\-T?]4N_\O?\ _!&C_ANC_JEW_E[_ /X(UZ!_PQ3\*_\
MH/\ Q _\&OAS_P"92C_ABGX5_P#0?^('_@U\.?\ S*4 >?\ _#='_5+O_+W_
M /P1H_X;H_ZI=_Y>_P#^"->@?\,4_"O_ *#_ ,0/_!KX<_\ F4H_X8I^%?\
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MW%Q/_9WVS^S_ +5Y]C=66S[9]EO?(V?:?-W?99MVS9M7=O7]"/\ ABGX5_\
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M<3Q=F_\ :U;+:5:A@I_4,LP'L:5><*E6/+EF"P4*G/.G!\U6-24;6BXIM/\
M1."/#?@OPYP^/PO!F3?V-0S2M1KXZ']HYMF'MZN'A.G1GS9KCL=.ER0J37+1
ME3C*]YQDTFO/_P#ANC_JEW_E[_\ X(T?\-T?]4N_\O?_ /!&O0/^&*?A7_T'
M_B!_X-?#G_S*4?\ #%/PK_Z#_P 0/_!KX<_^92OC#[@\_P#^&Z/^J7?^7O\
M_@C1_P -T?\ 5+O_ "]__P $:] _X8I^%?\ T'_B!_X-?#G_ ,RE'_#%/PK_
M .@_\0/_  :^'/\ YE* //\ _ANC_JEW_E[_ /X(T?\ #='_ %2[_P O?_\
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M]!_X@?\ @U\.?_,I0!Y__P -T?\ 5+O_ "]__P $:/\ ANC_ *I=_P"7O_\
M@C7H'_#%/PK_ .@_\0/_  :^'/\ YE*/^&*?A7_T'_B!_P"#7PY_\RE 'G__
M  W1_P!4N_\ +W__  1H_P"&Z/\ JEW_ )>__P""->@?\,4_"O\ Z#_Q _\
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M_$#_ ,&OAS_YE*/:U/YOPC_D!^7]%?J!_P ,4_"O_H/_ ! _\&OAS_YE*/\
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M?#G_ ,RE'_#%/PK_ .@_\0/_  :^'/\ YE* //\ _ANC_JEW_E[_ /X(T?\
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M!_;-?*Z->A@9_P!J9UE_L*6(G"I6ARY5F.!A5YYTX/FK1J2C:T)13:?\D?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KX,\>_LA^(_%_C3Q1XHMO&&B6=OK^MZAJL-K/8
MW\DUO'>7#S+%*\;;&= VUF7Y21D<5]YT4 5K* VMG:6S,':WMH(&8 @,88DC
M+ 'D E<@'G!JS110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XG\
M>?A7J'Q=\(:;X;TW5;/1Y['Q)9ZX]S>PSSQ216VEZQ8- J0$.)&?4XY Q^4+
M$X/)%<W^SY\#]5^#7_"7?VGKFGZU_P ))_8'D?8+>YM_LW]C_P!M>;YOV@G?
MYW]J1[-GW?*?=]Y:^D** "BBB@ HHHH *^&_C%_R4;Q%_P!PC_TQ:97W)7PW
M\8O^2C>(O^X1_P"F+3* /<O@!_R)NI_]C->?^FK1J]RKPWX ?\B;J?\ V,UY
M_P"FK1J]RH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HK\_?VW_\ @I)^SQ^PG8:;9?$B[UGQ
M1\2/$>ES:MX6^%_@ZVANO$.H:='<-9)K&L7UY+;:1X9T&2]22VBO]3NC>W[6
MNH?V'I6L2:;?Q6_Y$Z=_P<H^%9=8:#5OV1?$%EH (VZGIWQHT[5-8(W1 EM#
MN?AGI%DI"&9@!XA;+1Q)D"9W@ /Z>**^4?V2/VT/@/\ MK> KGQW\$O$=S>M
MHTME9^,?!^NV1TGQCX(U/4(9I[.Q\0Z7YMS;&.]CMKEM.U?2+[5="U(VMY#8
MZG/=6&H6]KL_M5?M9_!C]CCX777Q6^-.NW&G:0;Q-)T#0M'MH]1\5>,-?FAE
MN(="\,Z3)<6D=W>M;P37-Q<7=W8Z7IUI%)=:EJ%I"%=@#Z5HK^82?_@Y2\,K
MX@>VM?V0]=F\*B^$<>LS_&O3[;Q VFY&Z[?PS'\,+K3H[X+N(T]?%LD!("G4
MU!++^Y'['W[:/P1_;;^&TGQ$^#FKWGFZ5<P:;XR\%>((K:P\9>"-7N(FFM[/
M7M-MKJ]MVM=0BCFFT?6M.N[W2-6C@NX[6\-]I^IV5B ?6=%>=_%CXK_#WX'?
M#SQ3\5OBIXGL?!_@+P9IKZKXAU_4%N)8[6W$D<$$-O:6<-S?ZCJ-_=S06.F:
M5IUK=:CJ>H7-M8V%K<74\43_ ,]WQ(_X.0OA?HGB&_L/A7^S-XO^('AVUNG@
MM/$/BWXCZ;\-[C4H8]RM>PZ'8^"_B#+;P3.H:UCO+Z"Z>W=9+JWLK@/:* ?T
MJT5^.'[&O_!:O]FC]J[QMI?PLUW1?$/P.^)?B.^@TWP?H_B^]L];\,^,-3NV
M$=IHFC>+M,M[2*VU^ZEW16>FZ]I6BQ:E.]M8Z3?:CJMW#IY_73Q)XD\/^#O#
M^M^+/%>M:9X<\,^&]+OM;U_7]:O8-.TG1M(TRWDN]0U+4KZZ>.WM+.SMHI)[
MB>:1(XXT9F8 4 ;=%?SC?&?_ (.,O@OX0\67FA_!7X"^+/C)X>L+BXM7\9>(
MO&T'PHL-5,#[([[P_I$G@SQUK5SI=T 9()=>M/#6I!-OGZ3"Q*CZF_8O_P""
MU?[-_P"UEXVT[X6>(M!UOX%?$SQ#=6MAX0TCQ9JMEKOACQCJMVXB@T'0_%]C
M9Z:D/B">8B*QTW7-'T9=6FDM[/2+J_U2XCT\@'[)T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'\-ZI!I=PLVFZMJ%AJUM=:?" ?L_17\\/[/W_!P[\#?B1XUTSPG\;/@YX@^
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M&_\ AEXFN?"NH^(]&\1>&[+3=0U.PAM_[26UMKQ&N8A8WTEQIT@F;<TUI(X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /X\?VGO^"6W[?W[37[='BWXF^/\ X87D/PD^*'QQL;&;
MQO8?$CX::Q=^!_@S+XKA\/:/='06\73:^)O"WP[M;2_EL[+0+J 7$918GN)9
MK=?V:_:7_P""6/[!MG^RK\4]*T3X&^"_A_>^!?A7XN\0^'?B1I O+;QEH6J^
M$O#&IZOI^N:UXKN+R75O$=O%<68EUJU\1W>HVNI6AG2=4D6WGMOUS) !)(
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MQKN&#Y$/@OPQ#:\;4X%LD(4X.5P=SYWL ?TQ?"G_ ((Y?LGZQ^P_X5\ :_\
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MG6=II]A;06=C86T%G96=M$D-M:6EK$D%M;6\,86.*""&-(HHD4)'&BJH  %
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M_;OC:]N;E9M/LKIT2>3PWX5MPN@^'(V6!);>WN=:DL[74M<U,2=I_P &V_\
MR2W]J+_L?_AY_P"H[X@H _I9HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB:1H^MZE=&YU&X\!Z]H^DZU#!I%_=7$]Y'X7U33]/M-!(EM])U9]-DL-'TP
MC_X.._C%X7?PA^S]\!K'5[*]\6GQ;KWQ0\0Z/:W<$MYH&D:=H3>&_#L^K6B.
M9[3_ (2";Q%K;:2947SXM%U!P-@C9_J__@W^^%&I^ _V(]3\<:Q:/;2_&3XM
M>*O%NALY*M/X3\/Z?HG@73Y6A8!HR_B#PYXJFB<\7%I-:SQYB>-W_,/X ?\
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M37EY>WMW.S3WVJ:MJ5U>:KJVH3LT]_J=[=W<Q\R9J /3**** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1_P5<^"G[4_QX_9W\&>$/V1-5U_2/B3IWQH\.^)-;N?#OQ&7X8WK^![/P/\
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MG3XB:Y^Q5_P62^.?[+&MZMJ$_P '/VI=1'BSP);:GJ%S/I_ASQ)X@TN_\?\
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MQX9U&]T>Z^%GQDOI+"74]!OK*YN--N+FRL;Q[5IWM9I[2TN&C:2WA=/YW?\
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MBB@ HHHH *^P/V*?^2J:_P#]D_U7_P!2/PI7Q_7V!^Q3_P E4U__ +)_JO\
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M?^"4-M#:_P#!)[X,I @19/ _QPN9.I+S77Q3^*<\SL3R2TDC8R<*H5%PJJ
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MX5D\1ZA9Z1I!\50WUFNA^+%BUC6+70_$&FV.I^)+.&742#'JNC-J-Y;>M_\
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M:,"1<_G?_P &X$\;? #]H>V!/G0_&'1)W7!P([CP581Q$-C!+-:S @'*[02
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M5_KMQ/\ ]#/_ ,LLO_\ F0^3_P!1^%O^A7_Y>YC_ /-9\K_\,S_]3M_Y;?\
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M"6]2^T[Q]X_\1:1?:MHSG3+QI-=TO3K37-6U6^\0BSU'79M.&FRZ;JOZB?\
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M]9_V;XP\8^']7N_(TC5M/N_M%CI]S:R_:/L\,\EU%/!%_1_10!^:_P#P5D^
M'Q;_ &F/V,_%_P */@CX2_X3;Q_JGB_P#JECH']O>&?#?GV&B^(K>^U.?^U?
M%VLZ#HL7V:U1I?*FU&.:;&RWCED(0_*GPF^ _P 5OV;/^"(WQY^$GQJ\*_\
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MY\)6S6TL?_"-1S6$EY9"+3Y[%_W,HH _CR_9N_8W_P""SMSX,O?V++N_\1?
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M>F3WS*/,^QVNJ^!S9V\CYB@O-<$0*R7RA_W9_9L^(<'Q:_9Z^!WQ.@O$OO\
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MX9>*OM?B*Y\=^ M9@T_[#X)\:>)-2@WZ;HNIW/VNYLX;%?LWDO<K<36\4O\
M2_110!^!O_!</]BK]IG]L'_AF'_AG3X:?\+$_P"%=_\ "ZO^$Q_XK+X?^$O[
M'_X2W_A4O_"/?\CUXJ\,_P!H?VA_PC.N?\@O[=]D^P_Z=]F^TV?VCZL_;4_9
MT^,OQ;_X)::K^SE\/O!W_"0?&:Y^&7[._AZ#P;_PD/A72M^L>!?&WPJU?Q59
M_P#"0ZWKFF^%5_LO3O#>M7'VA]<6UOOL7E:=/>3W-I%/^HU% 'XZ_P#!-_\
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M9])\.:-IFA:7!G/DZ=I%E!I]E#GOY=M;Q)GOMS6S110 4444 %%%% !1110
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M^)K.[F\4_$'1]9\+K%X:T'QQKFNV)N]&MKF>)KO1+5;!$-M>-:3ND#?T444
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M3[V.VA:)-5UKP]HVKZ9&MJ_G6R-9R/\ V\JP9589 8!@&5E;!&1N5@&4^JL
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M@U1(/^$;?2O[6U.U@L=)N+JRT_5M&@UJ?^K"B@#^3#0O^">W_!2/_@HQ\?O
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M;Z8(;MG5 6']4\,,5M#%;V\:0P011PPPQ*$CBBB4)''&B@*B(BJJ*H 50
M*_"3]F/]E;XR_%3_ (*H?M%_MN_M ?#CQ#X&\(^!+B\\+?L[V7B>.UMY/$$
MTV?X=:'XIL+&*:Y:.RL_ .DZEJUY!=) \7B#QQ97=M-/<Z?<LG[OT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?#?QB_P"2C>(O
M^X1_Z8M,K[DKX;^,7_)1O$7_ '"/_3%IE 'N7P _Y$W4_P#L9KS_ --6C5[E
M7AOP _Y$W4_^QFO/_35HU>Y4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %?#?QB_Y*-XB_[A'_IBTRON2OAOXQ?\E&\1?]PC_P!,
M6F4 >Y? #_D3=3_[&:\_]-6C5[E7AOP _P"1-U/_ +&:\_\ 35HU>Y4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?#?QB_Y*-XB
M_P"X1_Z8M,K[DKX;^,7_ "4;Q%_W"/\ TQ:90![E\ /^1-U/_L9KS_TU:-7N
M5>&_ #_D3=3_ .QFO/\ TU:-7N5 !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17\]]%?XI_\
M5A/^L=__ #K?_P"3(_KS_B57_JO/_-7_ /QB/Z$**_GOHH_XK"?]8[_^=;__
M "9!_P 2J_\ 5>?^:O\ _C$?T(45_/?11_Q6$_ZQW_\ .M__ ),@_P")5?\
MJO/_ #5__P 8C^A"BOY[Z*/^*PG_ %CO_P"=;_\ R9!_Q*K_ -5Y_P":O_\
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MH\\?BWXM>)+,%O+OM0@>W\'^"YSC"@Z;!+XZ0@[R_P#::$"/RLR_N1_P3_\
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M*TG2[G1K>^GN[/D/AE_P7#_:[^"G[02>!_V\/A)9^'/!EY/ /%'ANR^&VO>
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MUJV\&^!/!GAF\M;C6-5T_2+O3[G5-1N'U)(KV>\T9-#6?3+B\8 _H1K\N/\
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M_P":?_\ C0'_ !/#_P!6P_\ -U__ !2/]3BBO\L>BC_B33_JX_\ YI__ .-
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MQHGQ&.G>&_AKK_C*QF;5Y?B!-X9-[+J>EV\%W(/"(@DL'FBAMH+ADNH_H_\
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M>+_"QC\(:3>:-I']F:'%H[V3"SO=4U>?[43?3^?+]LV2 )MB3:=W\\'[5/\
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M6I_X*)_&KQ-X[\<?LL_LVZ=??!/X<SW.H:A;P?"GQU\3;O2_#D<3207'Q/\
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MZ/!G_P T5'_#*WQZ_P"A$_\ +H\&?_-%1_Q+7](S_HP/C7_XJOCK_P"<(?\
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MUV36=6TN\GU&]\.Z]J.L^&==L+C1PC0:A91ZK<64TTW[SR;#2EB;%OQ_2_\
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M/PW9!P0+C3_ 'A33[A;V'DJT+ZEXUU2RW!0?/T^=6)"+C^B*@ HHHH ****
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M[R^629-2CCLHX=S?,L'*K2HU%5I1Q6#P=:@ZE-M*I!3<H-I22;/RQHK]3O\
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M^> ?\0I\4?\ HVW'W_B'<1?_ #N/RQHK]3O^'*?_  4U_P"C:?\ S,G[/_\
M\]6C_ARG_P %-?\ HVG_ ,S)^S__ //5H_XB=X;?]'"X'_\ $LR'_P"> ?\
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M7_!R'_R6W]FW_LEGBS_U+8JXGXD_\%B?VE_A/^S'XB_8A^)GP(;PA\>_#O@
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MT^2VVR6MMXF\9:O:ZWX[U_D/L;1?^$AMM)UAY%$4">#)',16.268 Q?V$O\
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M6UVNZ-_RL6S?]EIUW_U16HT '_!4_P#Y3._LZ?\ 85_96_\ 5EM7TM_P<:?
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M%/ .N:S\0M+TNWMS^[BTG5/BUXGLVN[=RMN]YXJU">197N#!-_?=0 5_GO\
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MXM0U'5?"VLPZ!:^++SP3X5TJ*31;4W6K7FC7=_J4=MIUS/=:#K,: 'Y0>%_
MVC?$3_@X%U+PUK^G6^K:7'^T_P"/O%$EA=PBXMI;KP%X5\1>.],>:!DD26.V
MU/PW9W3)(C0L(<38BWD?V@"- [R!$$CA%>0* [K'NV*[ ;F";WV DA=S8QN.
M?Y _@-_RL7:[_P!EG_:/_P#5#_%&OZ_Z . ^+'_)+?B5_P!B!XR_]1W4J_D4
M_P""'/P-\&_M*>"OV^?@=X]MUF\-_$/X8_"_19KD1+-<:-J8UCQU>:!XDT]&
M9%.J>&=>M=-U[3=[")KW3H$G5X&DC;^NOXL?\DM^)7_8@>,O_4=U*OY?/^#;
M'_D=_P!K+_L5?A'_ .G?Q]0!^5'AKXM>/OV0_ ?[>7["'Q5M[JUM_']A;^'&
MT]!/-9:+\6?AMX\\/W]EKM@60?\ $C\9>$M/U.V_M&"$+JR+X+O6E%A;>8/Z
M4?\ @WT_Y,/U?_LOGQ"_]1SP%7PA_P '"W[(7]FZYX(_;+\':7BT\0_V?\,_
MC%]EAXCUNQM9/^%?^+;S8'<_VCI%K<^#]1O9C%;6[:)X1LDW7.H_-]W_ /!O
MI_R8?J__ &7SXA?^HYX"H _GT_9K_9.\&?MI?\%(OC+\#_'GB3Q/X5\/W_C;
MX_\ B.35_"+:4NL)=>'O%NJW%M AUG3M4LOL\[3,L^ZU,FT#RY$.2?VW_P"(
M<?\ 9=_Z+E\?/^_OP\_^8NOY^_ W[6/C/]BW]O'XU_'#P'X;\,>*O$%A\1?C
MAX;CTGQ<-5;1WM?$/C#5[>YG<:-J&F7OVB!85:#;="/<3YB., ?H9_Q$<?M1
M?]$-^ ?_ 'Z^(?\ \VE 'ZG_ /!1_P#9IL/@7_P1R\9_ OP!J&N^)]#^#=C\
M.;BTU'7%L9-=U#1;'XP:!J>J7E^=-MM/L0UA;ZM=WL[VUI&BV5BQ,1;<]<'_
M ,&Z_C?2-8_9&^*?@..]M6\0^"OCOJVKZAID;J;NWT#QEX+\'?V!J5U$ &2+
M4=4\.>*[.UD;(D.C7"J?W15?JW]@S]HC4_\ @J'^QE\6+_X[^"O"F@:=XM\5
M?$+X'ZWH7@D:K'83^%[CP/X5FEU"&77[_6[JWUQ6\77K6MY'+Y=G/9V%U;PI
M<0M(_P#,G.O[:/\ P10_:>\07.BV#3>&=7N;K1;#5]?T34;WX1_'7P3;SSW6
MBS3RV-W:?9]=TZ&9+^6PT_6[/Q+X1U62ZLYI9])O+E-7 /[@_BIXTTGX<?#'
MXA_$#7KZSTW1?!/@CQ3XKU2_U Q_8K2QT#1+[5+B:Y$H*/$D=JVZ)E;S?]4$
M<N%/\DW_  ;D>&=0N_VI?CAXRBA=M*T'X 7'AF]N Q$<6H>+?B+X'U73(73:
M0SSVW@K5WC8NI5;:4!7#DI\^_M0?\%:?VP/V^_"]C^SCX1^'VE>%-&\;WUG9
M:MX+^$&E>*?$GC;XD3H\4UOX=N)Y[G4K^;1&O88[UM&T/2[2XNVB2'5+[4+!
M)+=_Z0_^"1_["VJ_L3_LZW4/Q @MX?C3\7M3L?%_Q'M+>6WND\,6MA:2VGA/
MP(+^U>2WU"7P[9W>HW^J7,$DMLOB'7]:L[&YOM.M+*^N #\"_P!L']G3]NG_
M ()S_MC?%O\ :B_9UM/&L7@+QUXH\;>*]%^*?@OPW;^,M#T[POX^UX^+-;\"
M?$G1KNP\0V>G6^C:H8++[1XJT^/3-9.DZ7K^DWD>I(8-,]__ &3?^"X'@KQM
M\6/!H_;7^ 'PCD\47(TGP=IW[3?@_P )Z7!XD\)Z;_:,LFF+XHL-?CU;4H?#
M-GJNJZCJ^J7WA;Q+IEKH@NK^^T_P=>37%QE_CS_@H'^WQ_P3I_;;\7Z=^US>
M>-?CS\%=33Q-H_@RUN+3PYX,T'Q-X-OM7MM3\*^/O ][X8\*Z3X5/C#1[*VM
MM.\1:/+9NMH;[7=!NVL9CINJVWP_^T-XON/^"O\ ^UU\/M-_9:_9F7X87L^E
M6.B>./$5M9V-S/=0W>KF?4OB5\5=4\-Z/9:7INF>&[*8V%G>7\VHZMJ,-M#I
M\%]>7MYH^@V@!_3E_P %C;:WO?\ @FS^TVD[PK&FC_#V[C>55=#/9_%[X?7E
MJ$R0!++/#%' X.5E=& 8C:?&/^""U[<W7_!/CPS!.A6+3OBA\3K*R8L&$EM)
MJUKJ#NH'* 7E_=Q[3@EHV?HP)T/^"X7BBR\!?\$V_'OA1))?^*W\4_"3X>Z9
M)/,SW+MI?B_2?&[;YLHTTTNF> [Q;AB#YJ/,63#$CT[_ ((W_#V?X>?\$[/V
M?K>]CDBU#Q=8^*_B%=K("H:#QCXSU[5-"DC4EL1R^&&T.0$$"1F:4!1)M !^
MGU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5\-_&+_DHWB+_N$?^F+3*^Y*^&_C%_R4;Q%_W"/_ $Q:
M90![E\ /^1-U/_L9KS_TU:-7N5>&_ #_ )$W4_\ L9KS_P!-6C5[E0 4444
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MK!9W.K+IMDNI%Y(FMY&-\(1=%G@9H7;S<M$S1L2A*UKT44 ?GG_P5+_9GO\
M]JG]BSXJ^ ?#NG?VIX]\-067Q-^'-HB&2XNO%G@AIKV32[&,*3)J7B3PQ<>)
M/"NG*6C3[;KL!EE2(2$^;_\ !&3XZQ?&[]@?X46]Q>&Y\1_!U]1^"OB-'D+O
M O@S[/-X110Y,GD#X?:KX2C5B/+\^&YAB.V#:OZJ5QO@[X=?#[X>0ZE;^ /
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MT\-^';"]?4;'0=%LM0D,IDO[32[&VO7,Y+3E[J&!)V,S$F4M(?,))?)K:HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&YU/5]9UB^M=,TK2M-LH7N+S4-2U&]E@L[&QM+>.2>YN[J:*""%'EED1%9@
M:-%<#\+_ (H> _C/X&T3XE?#+Q%:^+? WB0ZI_8'B.PBNX;'5HM'UG4- O;F
MR%[;VL\UG_:>EWL5K=B$6][!''>6<D]G/!/)WU !117YO_M8?\%0?@%^QW\<
M/ OP"^)OA#XP:[XQ^(/ACPQXKT;4O F@>"]3\-6VG>*_%_B/P7IT.IWGB#X@
M>&-4AO8=4\,7]Q>QVFC7L$>GS6<L%S<W$DUK;@'Z04444 %%?E)^UK_P6,_9
M#_9,\8:A\-M4OO%?Q7^)&BW!L_$?A?X6V&E:E;>$[U& FT_Q+XDUO6-$T.UU
M2 "2.ZT?2KG6=6TZZ06NKV.FNVY>8_9?_P""VG['7[2?C#1?AU>R^,O@KXXU
M][>RT:W^*5IH-GX4US7+J9(+70M&\8:+KVJV:ZA>22+%8+XDLO#*:C=%-/L3
M<:A/:6MP ?L%1110 4444 %%%? W[<7_  46^"7[ ?\ PK#_ (7%X7^*?B7_
M (6Q_P )K_PCG_"M-$\):S]B_P"$$_X1+^U_[:_X2GQOX-^S?:?^$RTO^S?L
M/]I>=Y%_]J^Q^5;_ &H ^^:*YCP3XKT[QYX-\)>.-(AO;;2?&?AC0?%>EV^I
M1P0ZC!IWB+2K35[*&_AM;F\MHKV*VO(DNH[>[NH$G618;F>,+*W3T %%%?*_
M[9/[6GP__8K^!NM_&_XA6E]K-G8ZKHOAW0/"VDW%K;:UXM\1ZY=&.VT?29;Y
MEM4FM]-M]5UZ]DF;;#I&C:C,B2S1QPR@'U117B?PV^-FC^,/@!X3_:$\9Z<?
MA-X8\0_#:R^*FL6?C+5+&,^#/"E]HH\2+=^)-37R+&T^QZ \6HZF7\M=/W2P
M3XD@DK\(?BA_P<&?"?2/VD/AUIWPUT+Q9XF_9GTE/%5E\8=<F\#V-OXW\2W[
MZ=J$'@_5?A9#JOC?1_(T.UU<Z7>ZRGB_3M%U6\TU;ZWMM.@N! TH!_2517BO
MP0_:$^%'[1?PET?XU_"'Q-%XL\"ZS9W<\=S##):ZGIU]IJG^U=!UK2[OR;G2
MM>TN93!>:?=A.6ANK>6XT^ZM+R?\DO#/_!PA^Q5XG\2>'_#<7P^_:4TF7Q#K
M>DZ''JNL^#OA;!H^F2:M?V]@FH:K/9_&6^NX=-LFN!<WTMK97EQ':QRO!:W$
MJK"X!^Z]%9'B#7--\,:#K?B769Q:Z1X>TC4M<U6Y(R+?3=)LYK^^G(R,B&UM
MY9,9&=N,CK7XI_#[_@OQ^QU\2/'O@CX=Z'\-OVE[36_'OB_PUX+T>ZU;P=\+
M8-+MM4\4ZS9:'I]QJ4]G\9+Z[AT^&[OH9+R6UL;RXCMUD>"UN)0L+@'[AT5\
M&?ML?MY^#_V&[WX*W?Q(\!^)]<\"?%OQ?=^$=4\>:#>6":?\/;BSET:62\UW
M3KI!=ZA'-I&H:IK%G;Z;(UQ<6_AO5H=J2_9_-^[;:YMKVVM[RSN(+NTNX(KF
MUNK:6.>VN;:>-98+BWGB9XIH)HG62*6-FCDC971BI!(!-1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%\*- _X*B?\ !2+XP_%#]H*.\\5>";&+Q9\8]4\,W5_>):ZO;KXIT;PY\._
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M:-X@AU6&WN[O7_#'A#Q[J-@-/DU*:Z\.:=IL\^[RW_@Y:_YLL_[N-_\ >#T
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M  ,1_:3_ ,$D_P#@HQXT_;:^%'Q4\$?&9=+F^,GPBTBQN[WQ-I5C;Z1;^/\
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MH7B_X4^)8+7C;#<^*]&\;Z7=SCC.;F+P991MDD8M5P <Y /Z::*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KX;^,7_)1O$7_<(_],6F5]R5\-_&+_DHWB+_
M +A'_IBTR@#W+X ?\B;J?_8S7G_IJT:O<J\-^ '_ ")NI_\ 8S7G_IJT:O<J
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-?\ @H%^SC=_M7?LA_&CX*Z.D+>+-=\.PZUX$,\D-NA\<>#]2LO%7ABR:\N
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M?&UTUJV-HMM*TN[EOF5%EEMM.C23/DQA?VE_X*O #_@LC^RL   !^RV  ,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %?#?QB_Y*-XB_P"X1_Z8M,K[DKX;^,7_
M "4;Q%_W"/\ TQ:90![E\ /^1-U/_L9KS_TU:-7N5>&_ #_D3=3_ .QFO/\
MTU:-7N5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7PW\8O^2C
M>(O^X1_Z8M,K[DKX;^,7_)1O$7_<(_\ 3%IE 'N7P _Y$W4_^QFO/_35HU>Y
M5X;\ /\ D3=3_P"QFO/_ $U:-7N5 !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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*_P"W#_V\H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img160360374_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img160360374_0.jpg
M_]C_X  02D9)1@ ! @$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #' ,<# 2(  A$! Q$!_\0
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MBO/K44T]+^OEW[/L_DS>$VGY_GMOK_P_KOMQR=.?H?7V/^>?KUNQR?E^H/\
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MTLUQ/H^GS3S2N=SR2RR6[222,Q)9W8LQ.22:C_X0_P )#IX6\.#_ +@FF?\
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M=>AA[1LGKS5XR=VE:+UO:_Q9')TY_P ^H]O\GL:OQR=_QQ_4?Y^O8US\4N,
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M1^,5U+$"0CSVGBF]BMY"N<%HDO;E4)!(69P"-QSI[#+\DQ_&N,PF6X:6"Q?
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M8VD5W'JMX9X+JRD%W9W;75YI^I217>EVL=M%>='\&=?_ &4_VSO$TGP2U?\
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M4)Z+,_K7RI^SE)GX^?!4?]54\!#W&?$^F<?0]O\ ..[/,_IY5Q1POEV5</\
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M'BZ-J^A-KEY-JM]8ZS9BQOWC;3[BYFA#2O%?&*,?;;"SN \5?EC%+V)P1_\
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ML'\7:^C)LE&J>)F74%@N%/(GT_3&T[2I 0"#88(!S17TT         !@ #@
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MIG@CZ=!C]/Z_G6A')TYQC]/8^W^?IY56DU^C_3S7XK\^N,KI:ZK^KHW8Y/\
M$_XCG_/Y5_2!_P $^OV?I/@]\(H_%?B&R^S^.OB<EEKNHQSQ[+K2/#BQ%_#F
MBR*ZB2&=H)Y=7U"(A'2YU!+2X3S-/3'Y=_\ !/O]EZ;XV_$!/'OBS3R_PQ^'
MNH6]S=I<QG[-XI\3Q!;K3O#\08;+BRM#Y.HZ\OSI]E-II\JXU3?'_1V
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H8:A2H4]^2C3C3BWW:BE=]V[M]6+1117H&X4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>22
<FILENAME>lits-20250630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-09-26T15:24:38.5797+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://litestrategy.com/20250630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:lits="http://litestrategy.com/20250630" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" namespace="http://xbrl.sec.gov/ecd/2025"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2024-01-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd" namespace="http://xbrl.sec.gov/cyd/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/CoverPage" id="CoverPage">
        <link:definition>75000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1" id="StatementConsolidatedBalanceSheets1">
        <link:definition>75010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>75020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="StatementConsolidatedStatementsOfOperations">
        <link:definition>75030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>75040 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>75050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>75060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>75070 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation" id="DisclosureDescriptionOfBusinessAndBasisOfPresentation">
        <link:definition>995457 - Disclosure - Description of Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>995467 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails" id="DisclosureBalanceSheetDetails">
        <link:definition>995477 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>995487 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits" id="DisclosureOnetimeEmployeeTerminationBenefits">
        <link:definition>995497 - Disclosure - One-Time Employee Termination Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>995507 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreements1" id="DisclosureLicenseAgreements1">
        <link:definition>995517 - Disclosure - License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/OtherLicenseAgreements" id="OtherLicenseAgreements">
        <link:definition>995527 - Disclosure - Other License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/Leases" id="Leases">
        <link:definition>995537 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity" id="StockholdersEquity">
        <link:definition>995547 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1" id="DisclosureSharebasedCompensation1">
        <link:definition>995557 - Disclosure - Share-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation" id="DisclosureSegmentInformation">
        <link:definition>995567 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAsset" id="DisclosureDispositionOfANonfinancialAsset">
        <link:definition>995577 - Disclosure - Disposition of a Non-Financial Asset</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>995587 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>995597 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" id="DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies">
        <link:definition>995607 - Disclosure - Description of Business and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995617 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995627 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables" id="DisclosureBalanceSheetDetailsTables">
        <link:definition>995637 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsTables" id="DisclosureOnetimeEmployeeTerminationBenefitsTables">
        <link:definition>995647 - Disclosure - One-Time Employee Termination Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>995657 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityTables" id="DisclosureStockholdersEquityTables">
        <link:definition>995667 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables" id="DisclosureSharebasedCompensationTables">
        <link:definition>995677 - Disclosure - Share-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationTables" id="DisclosureSegmentInformationTables">
        <link:definition>995687 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>995697 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" id="DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail">
        <link:definition>995707 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail" id="DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail">
        <link:definition>995717 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Associated with License Agreement (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail" id="DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail">
        <link:definition>995727 - Disclosure - Summary of Significant Accounting Policies - Schedule of Changes in Unbilled Receivables and Contract Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail" id="DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail">
        <link:definition>995737 - Disclosure - Summary of Significant Accounting Policies - Antidilutive Securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>995747 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail" id="DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail">
        <link:definition>995757 - Disclosure - Balance Sheet Details - Schedule of Prepaid and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail" id="DisclosureBalanceSheetDetailsAdditionalInformationDetail">
        <link:definition>995767 - Disclosure - Balance Sheet Details - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail" id="DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail">
        <link:definition>995777 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail" id="DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail">
        <link:definition>995787 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail" id="DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail">
        <link:definition>995797 - Disclosure - Balance Sheet Details - Accrued Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail" id="DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail">
        <link:definition>995807 - Disclosure - Balance Sheet Details - Accrued Liabilities (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" id="DisclosureFairValueMeasurementsAdditionalInformationDetail">
        <link:definition>995817 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail" id="DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail">
        <link:definition>995827 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used to Calculate Fair Value of Warrant Liability (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail" id="DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail">
        <link:definition>995837 - Disclosure - Fair Value Measurements - Schedule of Changes in Estimated Fair Value of Warrant Liability (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail" id="DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail">
        <link:definition>995847 - Disclosure - One-Time Employee Termination Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail" id="DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail">
        <link:definition>995857 - Disclosure - One-Time Employee Termination Benefits - Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" id="CommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>995867 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail" id="DisclosureLicenseAgreementsAdditionalInformationDetail">
        <link:definition>995877 - Disclosure - License Agreements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails" id="DisclosureOtherLicenseAgreementsAdditionalInformationDetails">
        <link:definition>995887 - Disclosure - Other License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
        <link:definition>995897 - Disclosure - Leases - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail" id="DisclosureLeasesScheduleOfTotalOperatingCostsDetail">
        <link:definition>995907 - Disclosure - Leases - Schedule of Total Operating Costs (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail" id="DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail">
        <link:definition>995917 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail" id="StockholdersEquityAdditionalInformationDetail">
        <link:definition>995927 - Disclosure - Stockholders' Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails" id="DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails">
        <link:definition>995937 - Disclosure - Stockholders' Equity - Schedule of Warrants Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail" id="DisclosureSharebasedCompensationAdditionalInformationDetail">
        <link:definition>995947 - Disclosure - Share-based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail" id="DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail">
        <link:definition>995957 - Disclosure - Share-based Compensation - Share-based Compensation Expense for Stock Awards (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail" id="DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail">
        <link:definition>995967 - Disclosure - Share-based Compensation - Summary of Stock Option Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail" id="DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail">
        <link:definition>995977 - Disclosure - Share-based Compensation - Fair Value of Stock Options Weighted-Average Assumptions Used (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails" id="DisclosureSegmentInformationAdditionalInformationDetails">
        <link:definition>995987 - Disclosure - Segment Information - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails" id="DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails">
        <link:definition>995997 - Disclosure - Segment Information - Summary of Financial Data for Development of Pharmaceutical Products Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail" id="DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail">
        <link:definition>996007 - Disclosure - Disposition of a Non-financial Asset - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail" id="DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail">
        <link:definition>996017 - Disclosure - Income Taxes - Pre- Tax loss Jurisdictions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail" id="DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail">
        <link:definition>996027 - Disclosure - Income Taxes - Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax rates to Income Tax Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail" id="DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail">
        <link:definition>996037 - Disclosure - Income Taxes - Deferred Tax Liabilities and Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail" id="IncomeTaxesAdditionalInformationDetail">
        <link:definition>996047 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" id="DisclosureSubsequentEventsAdditionalInformationDetail">
        <link:definition>996057 - Disclosure - Subsequent Events - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1" xlink:href="lits-20250630.xsd#StatementConsolidatedBalanceSheets1" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="lits-20250630.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="lits-20250630.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="lits-20250630.xsd#StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="lits-20250630.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies" xlink:href="lits-20250630.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes" xlink:href="lits-20250630.xsd#IncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="lits-20250630.xsd#DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables" xlink:href="lits-20250630.xsd#DisclosureSharebasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables" xlink:href="lits-20250630.xsd#IncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail" xlink:href="lits-20250630.xsd#DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail" xlink:href="lits-20250630.xsd#DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail" xlink:href="lits-20250630.xsd#DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="lits-20250630.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureLicenseAgreementsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails" xlink:href="lits-20250630.xsd#DisclosureOtherLicenseAgreementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail" xlink:href="lits-20250630.xsd#LeasesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail" xlink:href="lits-20250630.xsd#DisclosureLeasesScheduleOfTotalOperatingCostsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail" xlink:href="lits-20250630.xsd#StockholdersEquityAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails" xlink:href="lits-20250630.xsd#DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureSharebasedCompensationAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail" xlink:href="lits-20250630.xsd#DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail" xlink:href="lits-20250630.xsd#DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail" xlink:href="lits-20250630.xsd#DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails" xlink:href="lits-20250630.xsd#DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail" xlink:href="lits-20250630.xsd#DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail" xlink:href="lits-20250630.xsd#DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail" xlink:href="lits-20250630.xsd#IncomeTaxesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:href="lits-20250630.xsd#DisclosureSubsequentEventsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/CoverPage" xlink:href="lits-20250630.xsd#CoverPage" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="lits-20250630.xsd#StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="lits-20250630.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation" xlink:href="lits-20250630.xsd#DisclosureDescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="lits-20250630.xsd#DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits" xlink:href="lits-20250630.xsd#DisclosureOnetimeEmployeeTerminationBenefits" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreements1" xlink:href="lits-20250630.xsd#DisclosureLicenseAgreements1" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/OtherLicenseAgreements" xlink:href="lits-20250630.xsd#OtherLicenseAgreements" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/Leases" xlink:href="lits-20250630.xsd#Leases" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity" xlink:href="lits-20250630.xsd#StockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1" xlink:href="lits-20250630.xsd#DisclosureSharebasedCompensation1" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation" xlink:href="lits-20250630.xsd#DisclosureSegmentInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAsset" xlink:href="lits-20250630.xsd#DisclosureDispositionOfANonfinancialAsset" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEvents" xlink:href="lits-20250630.xsd#DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="lits-20250630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsTables" xlink:href="lits-20250630.xsd#DisclosureOnetimeEmployeeTerminationBenefitsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables" xlink:href="lits-20250630.xsd#DisclosureLeasesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityTables" xlink:href="lits-20250630.xsd#DisclosureStockholdersEquityTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationTables" xlink:href="lits-20250630.xsd#DisclosureSegmentInformationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail" xlink:href="lits-20250630.xsd#DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail" xlink:href="lits-20250630.xsd#DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails" xlink:href="lits-20250630.xsd#DisclosureSegmentInformationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail" xlink:href="lits-20250630.xsd#DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheOneMember" xlink:label="lits_GSRWarrantsTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsRightOfUseAssets" xlink:label="lits_DeferredTaxAssetsRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReductionLimitOfAdditionalPaidInCapital" xlink:label="lits_ReductionLimitOfAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncrementalPaymentMember" xlink:label="lits_IncrementalPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DavidMUrsoMember" xlink:label="lits_DavidMUrsoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ClosingAgreement" xlink:label="lits_ClosingAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AgentCommissionRate" xlink:label="lits_AgentCommissionRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LiquidityPolicyTextBlock" xlink:label="lits_LiquidityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_METhreeFourFourMember" xlink:label="lits_METhreeFourFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TargetedOrTrackingStockStockLineItems" xlink:label="us-gaap_TargetedOrTrackingStockStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" xlink:label="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformDomain" xlink:label="lits_TaxReformDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MinimumBidPricePerShare" xlink:label="lits_MinimumBidPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedMilestonePayments" xlink:label="lits_AccruedMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalHomeLoanBanksAbstract" xlink:label="us-gaap_FederalHomeLoanBanksAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseTerminationDate" xlink:label="lits_LeaseTerminationDate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedLiabilitiesLineItems" xlink:label="lits_AccruedLiabilitiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TargetedOrTrackingStockStockTable" xlink:label="us-gaap_TargetedOrTrackingStockStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract" xlink:label="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrepaidClinicalCosts" xlink:label="lits_PrepaidClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PaymentForLicenseAgreement" xlink:label="lits_PaymentForLicenseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventDomain" xlink:label="lits_EventDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseTerminationFee" xlink:label="lits_LeaseTerminationFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" xlink:label="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DispositionOfNon-FinancialAssetsPolicyTextBlock" xlink:label="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RevenueFromCollaborationAgreementsMember" xlink:label="lits_RevenueFromCollaborationAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UsLicenseMember" xlink:label="lits_UsLicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfPurchasesFromMajorSuppliers" xlink:label="lits_PercentageOfPurchasesFromMajorSuppliers"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TerminationAgreement" xlink:label="lits_TerminationAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OtherLicensingArrangementsTextBlock" xlink:label="lits_OtherLicensingArrangementsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:label="us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DevelopmentServicesMember" xlink:label="lits_DevelopmentServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventAxis" xlink:label="lits_EventAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:label="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ConsultingFee" xlink:label="lits_ConsultingFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxesLineItemsLineItems" xlink:label="lits_IncomeTaxesLineItemsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NonRule10B51ArrModifiedFlag" xlink:label="lits_NonRule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" xlink:label="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_O2024Q2DividendsMember" xlink:label="lits_O2024Q2DividendsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseExpirationAmendedDate" xlink:label="lits_LeaseExpirationAmendedDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="us-gaap_OtherCommitmentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialSecondReturnOfCapital" xlink:label="lits_PotentialSecondReturnOfCapital"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ExUsLicenseMember" xlink:label="lits_ExUsLicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheTwoMember" xlink:label="lits_GSRWarrantsTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CurrentEventsAndReductionInForcePolicyTextBlock" xlink:label="lits_CurrentEventsAndReductionInForcePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:label="lits_ReconciliationOfStatutoryFederalTaxRateLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PhaseThreeClinicalTrialMember" xlink:label="lits_PhaseThreeClinicalTrialMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AfterTaxReformMember" xlink:label="lits_AfterTaxReformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OtherWarrantsMember" xlink:label="lits_OtherWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SbioPurchaseAgreementMember" xlink:label="lits_SbioPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" xlink:label="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" xlink:label="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:label="lits_ContractWithCustomerAssetAndLiabilityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LegalFeesMember" xlink:label="lits_LegalFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="us-gaap_OtherCommitmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MaximumAmountOfCommonStockOfferingPrice" xlink:label="lits_MaximumAmountOfCommonStockOfferingPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" xlink:label="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedReimbursementToRelatedParty" xlink:label="lits_AccruedReimbursementToRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NumberOfSquareFeetUnderLease" xlink:label="lits_NumberOfSquareFeetUnderLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SoftwareLicenses" xlink:label="lits_SoftwareLicenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdvisoryAgreementMember" xlink:label="lits_AdvisoryAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetManagementAgreementMember" xlink:label="lits_AssetManagementAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_KyowaKirinCoMember" xlink:label="lits_KyowaKirinCoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalUnitsAuthorized" xlink:label="us-gaap_CapitalUnitsAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" xlink:label="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PlacementAgentWarrantsMember" xlink:label="lits_PlacementAgentWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetManagerOwnershipThresholdRate" xlink:label="lits_AssetManagerOwnershipThresholdRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SanDiegoCaliforniaMember" xlink:label="lits_SanDiegoCaliforniaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NumberOfWarrantsExercised" xlink:label="lits_NumberOfWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_KkcAgreementsMember" xlink:label="lits_KkcAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReimbursementAmount" xlink:label="lits_ReimbursementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="us-gaap_LossContingencyPendingClaimsNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TotalUpfrontPaymentReceivableForGrantOfRights" xlink:label="lits_TotalUpfrontPaymentReceivableForGrantOfRights"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Rule10B51ArrModifiedFlag" xlink:label="lits_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PassThroughServicesMember" xlink:label="lits_PassThroughServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_InterestIncomePolicyTextBlock" xlink:label="lits_InterestIncomePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TwoThousandAndEightOmnibusPlanMember" xlink:label="lits_TwoThousandAndEightOmnibusPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MeasurementInputWeightedAverageGrantDateFairValueMember" xlink:label="lits_MeasurementInputWeightedAverageGrantDateFairValueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CaresActMember" xlink:label="lits_CaresActMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageLicenseAgreementMember" xlink:label="lits_PresageLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" xlink:label="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UpfrontAndMilestonePayments" xlink:label="lits_UpfrontAndMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_BeforeTaxReformMember" xlink:label="lits_BeforeTaxReformMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PlacementAgencyAgreementMember" xlink:label="lits_PlacementAgencyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SaleOfSharesAndWarrantsUnderAgreement" xlink:label="lits_SaleOfSharesAndWarrantsUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerAssetAndLiabilityTable" xlink:label="lits_ContractWithCustomerAssetAndLiabilityTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OperatingLeasesFutureMinimumRentalPayments" xlink:label="lits_OperatingLeasesFutureMinimumRentalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LicensingArrangementsAbstract" xlink:label="lits_LicensingArrangementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncreaseDecreaseInUnbilledReceivable" xlink:label="lits_IncreaseDecreaseInUnbilledReceivable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheThreeMember" xlink:label="lits_GSRWarrantsTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdvisoryFeeRate" xlink:label="lits_AdvisoryFeeRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TotalTransactionPriceInRespectOfColloborationRevenue" xlink:label="lits_TotalTransactionPriceInRespectOfColloborationRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdoptedAgreement" xlink:label="lits_AdoptedAgreement"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" xlink:label="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MilestonePayment" xlink:label="lits_MilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DanielPGoldMember" xlink:label="lits_DanielPGoldMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PreTaxIncomeLossLineItems" xlink:label="lits_PreTaxIncomeLossLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FinancingCostsIncludedInAccountsPayable" xlink:label="lits_FinancingCostsIncludedInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DirectCosts" xlink:label="lits_DirectCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncreaseInRightOfUseAssetBalance" xlink:label="lits_IncreaseInRightOfUseAssetBalance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_InducementPlanMember" xlink:label="lits_InducementPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_BeigeneLtdMember" xlink:label="lits_BeigeneLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="us-gaap_OneTimeTerminationBenefitsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TorreyaPartnersLlcMember" xlink:label="lits_TorreyaPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageBiosciencesIncMember" xlink:label="lits_PresageBiosciencesIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrepaymentOfRemainingRent" xlink:label="lits_PrepaymentOfRemainingRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" xlink:label="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfDeferredOfferingCosts" xlink:label="lits_PercentageOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedPreclinicalAndClinicalCosts" xlink:label="lits_AccruedPreclinicalAndClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TheSalesAgreementMember" xlink:label="lits_TheSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialMilestonePaymentsReceivable" xlink:label="lits_PotentialMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts" xlink:label="us-gaap_RecoveryOfDirectCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForCommissions" xlink:label="us-gaap_PaymentsForCommissions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformAxis" xlink:label="lits_TaxReformAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ExpectedMilestonePaymentReceivable" xlink:label="lits_ExpectedMilestonePaymentReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredRevenueMember" xlink:label="lits_DeferredRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" xlink:label="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorWarrantsMember" xlink:label="lits_StrategicAdvisorWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeaseOptionToExtend" xlink:label="us-gaap_LessorOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxableIncomePercentage" xlink:label="lits_TaxableIncomePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetPurchaseAgreementMember" xlink:label="lits_AssetPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheFourMember" xlink:label="lits_GSRWarrantsTrancheFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="us-gaap_TransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CydexLicenseAgreementMember" xlink:label="lits_CydexLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NonCashLeaseExpense" xlink:label="lits_NonCashLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EmployeesMember" xlink:label="lits_EmployeesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketOfferingAgreementDescription" xlink:label="lits_AtTheMarketOfferingAgreementDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UpFrontPayment" xlink:label="lits_UpFrontPayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RightsAndTheRightsAgreementExpirationDescription" xlink:label="lits_RightsAndTheRightsAgreementExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_JustinJFileMember" xlink:label="lits_JustinJFileMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="us-gaap_DilutiveSecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MilestonePaymentsMaximumAmount" xlink:label="lits_MilestonePaymentsMaximumAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementAndServiceFeesRate" xlink:label="us-gaap_ManagementAndServiceFeesRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_VoruciclibMember" xlink:label="lits_VoruciclibMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfSecuritiesSoldAtOffering" xlink:label="lits_PercentageOfSecuritiesSoldAtOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FeesPaidOnBehalfOfRelatedParty" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorAgreementMember" xlink:label="lits_StrategicAdvisorAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketSaleAgreementMember" xlink:label="lits_AtTheMarketSaleAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">GSR Warrants Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">GSR Warrants Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GSR Warrants Tranche One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Supplemental Cash Flow Information Related to Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale of Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReserve_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Restructuring Reserve, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReserve_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Reserve</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReserve_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restructuring Reserve, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReserve_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Restructuring Reserve, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Right-of-use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Right-of-use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReductionLimitOfAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reduction limit of additional paid in capital.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReductionLimitOfAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reduction Limit of Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReductionLimitOfAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction limit of additional paid in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Short-term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncrementalPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incremental Payment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncrementalPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Payment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncrementalPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue from customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer Benchmark [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DavidMUrsoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">David M Urso [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DavidMUrsoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">David M Urso.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Right-of-use assets obtained in exchange for operating lease obligations:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease right-of-use assets obtained in exchange for operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ClosingAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing agreement date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ClosingAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Closing agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ClosingAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Closing Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturity of short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of supplemental cash flow information related to operating leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Supplemental Cash Flow Information Related To Operating Leases [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Severance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AgentCommissionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agent Commission Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AgentCommissionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agent commission rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AgentCommissionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agent commission rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring and Related Costs [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance for deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax benefit at U.S. statutory rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tax (benefit) expense at U.S. statutory rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LiquidityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The Disclosure In Its Entirety Pertaining to the Accounting Policy In Respect Of Liquid Resources Held By The Entity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LiquidityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liquidity [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LiquidityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate, Continuing Operations, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_METhreeFourFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ME Three Four Four [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_METhreeFourFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ME Three Four Four.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_METhreeFourFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ME-344</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TargetedOrTrackingStockStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Targeted or Tracking Stock, Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Other Assets, Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the disposition of a non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchaser initial payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Risk Free Interest Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential payments on achievement of development regulatory and commercial milestones.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential Payments on Achievement of Development Regulatory and Commercial Milestones [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential Payments on Achievement of Development Regulatory and Commercial Milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized for performance obligations that will no longer commence</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Other Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in unrecognized tax position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares option grants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TaxReformDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Reform [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MinimumBidPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum Bid Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MinimumBidPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Bid Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MinimumBidPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum bid price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic income (loss) per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Revenue Associated with License Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Adjustments to reconcile net (loss) income to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Commitment, Excluding Long-Term Commitment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Commitment, Excluding Long-term Commitment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments for New Accounting Pronouncements [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued milestone payments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Milestone Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued payment for potential future payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FederalHomeLoanBanksAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal Home Loan Banks [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accumulated losses since inception</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated losses since inception</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Surrendered warrants to acheive common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Surrendered warrants to acheive common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-02 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2016-02 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease termination date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Termination Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease termination date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedLiabilitiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Liabilities [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedLiabilitiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Measurement Input</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TargetedOrTrackingStockStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Targeted or Tracking Stock, Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TargetedOrTrackingStockStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Targeted or Tracking Stock, Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments of Dividends, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividends_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of cash dividend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contract with Customer, Liability, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Contract liabilities, end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Contract liabilities, beginning of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract liabilities included in deferred revenue and deferred revenue, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets and Liabilities Eliminated upon Consolidation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets and Liabilities Eliminated upon Consolidation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnusualRiskOrUncertaintyNatureDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unusual Risk or Uncertainty, Nature [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax (benefit) expense at U.S. statutory rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax (benefit) expense at U.S. statutory rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercisable date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrepaidClinicalCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrepaidClinicalCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrepaidClinicalCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PaymentForLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment for license agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PaymentForLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment For License Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PaymentForLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment for license</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued to purchase common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Event [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net (Loss) Income Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net cash provided by (used in) operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease termination fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Termination Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Termination fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Option grants, Exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: accumulated depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Operating Income (Expense), Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating and other (income) expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total operating and other (income) expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Closing price of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsClosingStockPrice</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Closing price of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disposition of Non-Financial Assets Policy Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposition of non-financial assets policy text block.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposition of Non-Financial Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RevenueFromCollaborationAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue from collaboration agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RevenueFromCollaborationAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue from collaboration agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RevenueFromCollaborationAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Collaboration Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Stock Options Weighted-Average Assumptions Used</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net (loss) income per share - basic and diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UsLicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Us License [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UsLicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Us License Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UsLicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US License [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfPurchasesFromMajorSuppliers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of purchases from major suppliers.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfPurchasesFromMajorSuppliers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Purchases from Major Suppliers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfPurchasesFromMajorSuppliers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of Purchase Requirement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TerminationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Termination agreement date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TerminationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Termination Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TerminationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Termination agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TerminationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Termination Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Right-of-use asset balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OtherLicensingArrangementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other licensing agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OtherLicensingArrangementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Licensing Arrangements [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OtherLicensingArrangementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other License Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Arrangements and Non-arrangement Transactions [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total anti-dilutive shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReservePeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restructuring Reserve, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReservePeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Reserve, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReservePeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in accrued restructuring</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DevelopmentServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Development Services [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DevelopmentServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long-lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Long-Lived Assets to be Disposed of</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Event [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Type of Adoption [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potentially Dilutive Securities Outstanding [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potentially Dilutive Securities Outstanding [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potentially Dilutive Securities Outstanding [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Decrease in ROU asset balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Stock and Warrants for Services or Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ConsultingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consulting fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ConsultingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consulting fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ConsultingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consulting Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncomeTaxesLineItemsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Line Items [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Rule 10b51 Arr Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non rule 10b51 arrangement modified.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Rule 10b51 Arr Modified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringReserveAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Reserve [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Timing of Transfer of Good or Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Obligation Account Transaction Price Allocated Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License obligation account transaction price allocated deferred revenue.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction price of deferred revenue remaining performance obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposition of a Non-financial Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Performance obligation revenue recognised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_O2024Q2DividendsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">O 2024 Q2 Dividends [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_O2024Q2DividendsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">O 2024 Q2 Dividends.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_O2024Q2DividendsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">O 2024 Q2 Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseExpirationAmendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration amended date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseExpirationAmendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Amended Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LeaseExpirationAmendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration amended date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax (benefit) expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State tax (benefit) expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-Based Compensation Expense for Stock Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Tax Liabilities and Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Term [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected life years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock option vested percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.01 par value; 100 shares authorized; none outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialSecondReturnOfCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential second return of capital.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialSecondReturnOfCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential Second Return Of Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialSecondReturnOfCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential second return of capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ExUsLicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ex US License [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ExUsLicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ex US License</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain (Loss) on Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gains and losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring and Related Activities Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One-time Employee Termination Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Nondeductible Expense Section 162(m) Limitation Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Section 162(m) limitation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Section 162(m) limitation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Commitments and contingencies (Note 6)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forecast</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">GSR Warrants Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">GSR warrants tranche two.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GSR Warrants Tranche Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Category of Item Purchased [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability revenue recognized upon satisfaction of performance obligations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Revenue Recognized Upon Satisfaction of Performance Obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized upon satisfaction of performance obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest and Dividend Income, Operating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest and Dividend Income, Operating, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndDividendIncomeOperating_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest and dividend income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CurrentEventsAndReductionInForcePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Events and Reduction in Force [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CurrentEventsAndReductionInForcePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Current events and reduction in force.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CurrentEventsAndReductionInForcePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReconciliationOfStatutoryFederalTaxRateLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation Of Statutory Federal Tax Rate [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares used in calculating basic net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PhaseThreeClinicalTrialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Phase Three Clinical Trial [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PhaseThreeClinicalTrialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Phase Three Clinical Trial</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AfterTaxReformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">After Tax Reform [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AfterTaxReformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">After tax reform member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax Rates to Income Tax Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from private investment in private equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalization of R&amp;D costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Asset, In-Process Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OtherWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OtherWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OtherWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SbioPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">S Bio Purchase Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SbioPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SBio Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SbioPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">S*Bio Purchase Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type of Restructuring [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Nondeductible Expense Section 162 (m)Limitation Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Section 162(m) limitation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity and Related Data</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recognized Revenue Associated with The Following License Agreements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recognized Revenue Associated With The Following License Agreements Abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets, operating loss carryforwards, expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carry forwards Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration year of operating loss carry forwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long-lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Impairment charge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Warrants Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of warrants outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated development cost sharing reoverable through earnings.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Development Cost Sharing Recoverable Through Earnings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated development cost sharing recovered through earnings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerAssetAndLiabilityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer asset and liability Line items.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerAssetAndLiabilityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer Asset and Liability [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerAssetAndLiabilityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer Asset and Liability [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LegalFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Fees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LegalFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Legal fees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LegalFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock subject to repurchase or forfeiture</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnusualRiskOrUncertaintyByNatureAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unusual Risk or Uncertainty, Nature [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value Measurements, Significant Unobservable Inputs [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements, Significant Unobservable Inputs [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value measurements Significant unobservable inputs [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MaximumAmountOfCommonStockOfferingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum amount of common stock offering price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MaximumAmountOfCommonStockOfferingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Amount Of Common Stock Offering Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MaximumAmountOfCommonStockOfferingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate offering price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reasonable accountable expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of fair value measurements significant unobservable inputs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements, Significant Unobservable Inputs [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value measurements Significant unobservable inputs [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Pre-tax income (loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on disposition of a non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on disposition of a non-financial asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gain of disposition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets fixed and intangible assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Property Plant And Equipment And Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed and intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recognized Revenue Associated with The Following License Agreements [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recognized Revenue Associated With The Following License Agreements Table</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedReimbursementToRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued reimbursement to related party.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedReimbursementToRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Reimbursement to Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedReimbursementToRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued reimbursement to KKC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Disposition of Property Plant Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NumberOfSquareFeetUnderLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of square feet under lease.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NumberOfSquareFeetUnderLease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Square Feet Under Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NumberOfSquareFeetUnderLease_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of square feet under lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SoftwareLicenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software Licenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SoftwareLicenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Software licenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SoftwareLicenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software license</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Purchase of Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock to purchase asset, shares | shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Not Settleable in Cash, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdvisoryAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advisory Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdvisoryAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Advisory agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdvisoryAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advisory Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetManagementAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Management Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetManagementAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset Management Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetManagementAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Management Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash dividends declared</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_KyowaKirinCoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Kyowa Kirin Co [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_KyowaKirinCoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Kyowa Kirin Co. Ltd</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalUnitsAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Units, Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalUnitsAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total authorized share capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Groups, Including Discontinued Operations [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Shares used in calculating diluted net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average shares used in calculating diluted loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other segment expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Details</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Investment in Private Equity and Related Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Private investment in private equity and related agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private investment in private equity and related agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Timing of Transfer of Good or Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PlacementAgentWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Placement Agent Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PlacementAgentWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Placement agent warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PlacementAgentWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Placement Agent Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetManagerOwnershipThresholdRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Manager Ownership Threshold Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetManagerOwnershipThresholdRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset manager ownership threshold rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetManagerOwnershipThresholdRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset manager ownership threshold rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SanDiegoCaliforniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">San Diego California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SanDiegoCaliforniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">San Diego California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NumberOfWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Warrants Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NumberOfWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Warrants Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NumberOfWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Rental Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_KkcAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Kkc Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_KkcAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Kkc Agreements [Member].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_KkcAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Kkc Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_KkcAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">KKC Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation arrangement by share-based payment award, award vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business and Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue related to non-refundable payments for performance obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets and liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReimbursementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reimbursement Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReimbursementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reimbursement amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ReimbursementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reimbursement amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyPendingClaimsNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Pending Claims, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyPendingClaimsNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of pending claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Asset Impairment Charges, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Impairment Charges</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charges</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carry forwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Discontinued Operations and Disposal Groups [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Dividend Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend Yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income (loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TotalUpfrontPaymentReceivableForGrantOfRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total upfront payment receivable for grant of rights.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TotalUpfrontPaymentReceivableForGrantOfRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Upfront Payment Receivable For Grant Of Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TotalUpfrontPaymentReceivableForGrantOfRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total upfront payment receivable for grant of rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rule 10b51 Arr Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rule 10b51 Arr Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rule 10b51 Arr Modified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized for performance obligations that will no longer commence</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Revenue Recognized Performance Obligations No Longer Commence</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability revenue recognized performance obligations no longer commence.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PassThroughServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pass through services member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PassThroughServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pass Through Services [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_InterestIncomePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for interest income.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_InterestIncomePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_InterestIncomePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and Dividend Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TwoThousandAndEightOmnibusPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and eight omnibus plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TwoThousandAndEightOmnibusPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Eight Omnibus Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TwoThousandAndEightOmnibusPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2008 Omnibus Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows from operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Supplemental cash flow</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MeasurementInputWeightedAverageGrantDateFairValueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MeasurementInputWeightedAverageGrantDateFairValueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Weighted-Average Grant Date Fair Value [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MeasurementInputWeightedAverageGrantDateFairValueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Measurement input weighted-average grant date fair value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research And Development Arrangement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CaresActMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CARES Act [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CaresActMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CARES Act [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CaresActMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CARES Act [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PresageLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Presage License Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PresageLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Presage License Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PresageLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Presage License Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Pre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-Funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Pre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-funded warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_Pre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Tax loss Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Changes in Unbilled Receivables and Contract Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remeasurement of right of use asset for direct costs associated with lease modification.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remeasurement of Right of Use Asset for Direct Costs Associated with Lease Modification</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Re-measurement of right-of-use asset for direct costs associated with lease modification</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UpfrontAndMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront and milestone payments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UpfrontAndMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront And Milestone Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UpfrontAndMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First milestone payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransactionTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Cost and Reserve [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred tax assets (liabilities):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_BeforeTaxReformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Before Tax Reform [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_BeforeTaxReformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Before Tax Reform [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_BeforeTaxReformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Before tax reform member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PlacementAgencyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Placement Agency Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PlacementAgencyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Placement agency agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PlacementAgencyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Placement Agency Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SaleOfSharesAndWarrantsUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale of shares and warrants under agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SaleOfSharesAndWarrantsUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Shares And Warrants Under Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_SaleOfSharesAndWarrantsUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of shares and warrants under agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Consideration Received on Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate principal amount authorized for sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss&#8212;basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerAssetAndLiabilityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer Asset and Liability [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerAssetAndLiabilityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer Asset and Liability [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ContractWithCustomerAssetAndLiabilityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer asset and liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OperatingLeasesFutureMinimumRentalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating leases future minimum rental payments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OperatingLeasesFutureMinimumRentalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Rental Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_OperatingLeasesFutureMinimumRentalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining future minimum rental payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LicensingArrangementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Licensing arrangements [Abstract].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_LicensingArrangementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Licensing Arrangements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncreaseDecreaseInUnbilledReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase Decrease In Unbilled Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncreaseDecreaseInUnbilledReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Unbilled Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncreaseDecreaseInUnbilledReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Unbilled receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">GSR Warrants Tranche Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">GSR warrants tranche three.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GSR Warrants Tranche Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenues, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Equity compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdvisoryFeeRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advisory Fee Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdvisoryFeeRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Advisory fee rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdvisoryFeeRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advisory fee rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TotalTransactionPriceInRespectOfColloborationRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total transaction price in respect of colloboration revenue.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TotalTransactionPriceInRespectOfColloborationRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Transaction Price In Respect Of Colloboration Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TotalTransactionPriceInRespectOfColloborationRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Transaction price relating to the performance obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdoptedAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adopted agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdoptedAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adopted Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AdoptedAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adopted agreement date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage Of Reimbursement Of Pass Through Costs As Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Reimbursement Of Pass Through Costs As Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of reimbursement of pass through costs as revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Directors</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected life (years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurements, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DanielPGoldMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Daniel P Gold [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DanielPGoldMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Daniel P Gold.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue, long-term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PreTaxIncomeLossLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre tax Income Loss [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FinancingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing costs included in accounts payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FinancingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Costs Included in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FinancingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing costs included in accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DirectCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Direct costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DirectCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Direct costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DirectCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Direct Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation arrangement by share-based payment award, expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investment Income, Interest and Dividend, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest and Dividend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and dividend income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncreaseInRightOfUseAssetBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in right of use asset balance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncreaseInRightOfUseAssetBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase in Right of Use Asset Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_IncreaseInRightOfUseAssetBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in right of use asset balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Voting Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock voting rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_InducementPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inducement Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_InducementPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Inducement Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carry forwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_BeigeneLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">BeiGene, Ltd</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_BeigeneLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">BeiGene, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_BeigeneLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">BeiGene, Ltd</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with customer liability non current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OneTimeTerminationBenefitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One-time Termination Benefits [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OneTimeTerminationBenefitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One -Time Termination Benefits [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OneTimeTerminationBenefitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Termination Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, $0.00000002 par value; 226,000 shares authorized; 6,663 shares issued and outstanding at June 30, 2025 and June 30, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss&#8212;diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TorreyaPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Torreya Partners LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TorreyaPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Torreya partners llc member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TorreyaPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Torreya Partners LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Furniture and Fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of furniture and fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax losses carried forward</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PresageBiosciencesIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Presage Biosciences Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PresageBiosciencesIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Presage Biosciences Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PresageBiosciencesIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Presage Biosciences, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax (benefit) expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrepaymentOfRemainingRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment of remaining rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrepaymentOfRemainingRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment of Remaining Rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PrepaymentOfRemainingRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment of remaining rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount on reduction in remaining right of use asset and lease liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount on Reduction in Remaining Right of Use Asset and Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount on reduction in remaining right of use asset and lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Deferred Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of deferred offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of aggregate gross cash proceeds received in the offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedPreclinicalAndClinicalCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued pre-clinical and clinical trial expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedPreclinicalAndClinicalCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Preclinical And Clinical Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AccruedPreclinicalAndClinicalCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued pre-clinical and clinical trial expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TheSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">The Sales Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TheSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The sales agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TheSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The Sales Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized from change in estimate for performance obligations that are being closed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other (expense) income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential milestone payments receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential Milestone Payments Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PotentialMilestonePaymentsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone payment receivable amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net cash proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RecoveryOfDirectCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recovery of Direct Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RecoveryOfDirectCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reimbursements costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Restructuring</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Commissions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriters commission and expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TaxReformAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Reform [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Cost [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ExpectedMilestonePaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expected milestone payment receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ExpectedMilestonePaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expected Milestone Payment Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_ExpectedMilestonePaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected milestone payment receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued and sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of securities authorized for sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued in the offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares issued &amp; sold in the offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Diluted loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Data for Development of Pharmaceutical Products Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable, Trade</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred revenue.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DeferredRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remeasurement of right of use asset and related lease liability upon lease modification.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remeasurement of Right of Use Asset and Related Lease Liability Upon Lease Modification</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Re-measurement of right-of-use asset and related lease liability upon lease modification</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_StrategicAdvisorWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Strategic Advisor Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_StrategicAdvisorWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Strategic advisor warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_StrategicAdvisorWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strategic Advisor Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Change in estimated fair value of liability classified warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in fair value of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LessorOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessor, Operating Lease, Option to Extend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LessorOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Extended date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TaxableIncomePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Taxable income percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TaxableIncomePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Taxable Income Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_TaxableIncomePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Taxable income percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expire date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs included in general and administrative expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Purchase Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer, Asset and Liability [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock for vested restricted stock units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">GSR Warrants Tranche Four [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">GSR warrants tranche four.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_GSRWarrantsTrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GSR Warrants Tranche Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">(Loss) income from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Supplemental Cash Flow Information Related to Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Supplemental Cash Flow Information Related To Operating Leases [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of supplemental cash flow information related to operating leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recognized Revenue Associated with The Following License Agreements [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recognized Revenue Associated With The Following License Agreements Line Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Price Volatility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CydexLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CyDex License Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CydexLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CyDex License Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_CydexLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CyDex License Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of workforce reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NonCashLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Lease Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NonCashLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash lease expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_NonCashLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncash lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, long-term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Text Block [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Total Operating Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EmployeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EmployeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_EmployeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AtTheMarketOfferingAgreementDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At-the-market offering agreement description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AtTheMarketOfferingAgreementDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At-the-Market Offering Agreement Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AtTheMarketOfferingAgreementDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At-the-market offering agreement, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Commitment, Excluding Long-Term Purchase Commitment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Commitment, Excluding Long-term Commitment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Other Current Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Prepaid and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Warrants Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense) [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UpFrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Up Front Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UpFrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Up Front Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_UpFrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RightsAndTheRightsAgreementExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rights and the rights agreement expiration description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RightsAndTheRightsAgreementExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rights and the Rights Agreement Expiration Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_RightsAndTheRightsAgreementExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rights and the rights agreement expiration description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Contract with Customer, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net change</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses, Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses related to an agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transferred over Time [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Services Performed Over Time</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_JustinJFileMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Justin J. File [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_JustinJFileMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Justin J. File.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Dividends, Per Share, Declared</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash dividends declared, per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unpaid common stock dividend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Issued for Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued upon cashless exercises</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DilutiveSecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MilestonePaymentsMaximumAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payments, maximum amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MilestonePaymentsMaximumAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payments, Maximum Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_MilestonePaymentsMaximumAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future aggregate milestone payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManagementAndServiceFeesRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Management and Service Fees, Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManagementAndServiceFeesRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset management fee rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance or Sale of Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance or Sale of Equity, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross cash proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_VoruciclibMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Voruciclib [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_VoruciclibMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">voruciclib</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_VoruciclibMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Voruciclib.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation expense related to unvested stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares used in computing net (loss) income per share - basic and diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments of Financing Costs, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Financing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfSecuritiesSoldAtOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Securities Sold at Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfSecuritiesSoldAtOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of securities sold at offering.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_PercentageOfSecuritiesSoldAtOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of securities sold in the offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fees Paids On Behalf Of Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fees paids on behalf of related party.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fees paid on behalf of a related party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining future minimum rental payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Labor and Related Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares available for future grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected weighted average period for recognition of compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued legal and professional services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents and short term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_StrategicAdvisorAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strategic Advisor Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_StrategicAdvisorAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Strategic Advisor Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_StrategicAdvisorAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Strategic advisor agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AtTheMarketSaleAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At-the-market equity offering sales agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AtTheMarketSaleAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At The Market Sale Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="lits_AtTheMarketSaleAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ATM Sales Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock, Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock by Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pass through services at a point in time [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transferred at Point in Time [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Pass through Services at a Point in Time</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfLand_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area of Land</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfLand_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of square feet under lease</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_GSRWarrantsTrancheOneMember" xlink:to="lits_GSRWarrantsTrancheOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DeferredTaxAssetsRightOfUseAssets" xlink:to="lits_DeferredTaxAssetsRightOfUseAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ReductionLimitOfAdditionalPaidInCapital" xlink:to="lits_ReductionLimitOfAdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_IncrementalPaymentMember" xlink:to="lits_IncrementalPaymentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DavidMUrsoMember" xlink:to="lits_DavidMUrsoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ClosingAgreement" xlink:to="lits_ClosingAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract" xlink:to="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AgentCommissionRate" xlink:to="lits_AgentCommissionRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LiquidityPolicyTextBlock" xlink:to="lits_LiquidityPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_METhreeFourFourMember" xlink:to="lits_METhreeFourFourMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_TargetedOrTrackingStockStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" xlink:to="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TaxReformDomain" xlink:to="lits_TaxReformDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_MinimumBidPricePerShare" xlink:to="lits_MinimumBidPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AccruedMilestonePayments" xlink:to="lits_AccruedMilestonePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalHomeLoanBanksAbstract" xlink:to="us-gaap_FederalHomeLoanBanksAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LeaseTerminationDate" xlink:to="lits_LeaseTerminationDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="lits_AccruedLiabilitiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_TargetedOrTrackingStockStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract" xlink:to="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:to="us-gaap_UnusualRiskOrUncertaintyNatureDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PrepaidClinicalCosts" xlink:to="lits_PrepaidClinicalCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PaymentForLicenseAgreement" xlink:to="lits_PaymentForLicenseAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_EventDomain" xlink:to="lits_EventDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LeaseTerminationFee" xlink:to="lits_LeaseTerminationFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" xlink:to="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock" xlink:to="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RevenueFromCollaborationAgreementsMember" xlink:to="lits_RevenueFromCollaborationAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_UsLicenseMember" xlink:to="lits_UsLicenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PercentageOfPurchasesFromMajorSuppliers" xlink:to="lits_PercentageOfPurchasesFromMajorSuppliers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TerminationAgreement" xlink:to="lits_TerminationAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_OtherLicensingArrangementsTextBlock" xlink:to="lits_OtherLicensingArrangementsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:to="us-gaap_RestructuringReservePeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DevelopmentServicesMember" xlink:to="lits_DevelopmentServicesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_EventAxis" xlink:to="lits_EventAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:to="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ConsultingFee" xlink:to="lits_ConsultingFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="lits_IncomeTaxesLineItemsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_NonRule10B51ArrModifiedFlag" xlink:to="lits_NonRule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_RestructuringReserveAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" xlink:to="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_O2024Q2DividendsMember" xlink:to="lits_O2024Q2DividendsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LeaseExpirationAmendedDate" xlink:to="lits_LeaseExpirationAmendedDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="us-gaap_OtherCommitmentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PotentialSecondReturnOfCapital" xlink:to="lits_PotentialSecondReturnOfCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ExUsLicenseMember" xlink:to="lits_ExUsLicenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" xlink:to="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_GSRWarrantsTrancheTwoMember" xlink:to="lits_GSRWarrantsTrancheTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" xlink:to="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDividendIncomeOperating" xlink:to="us-gaap_InterestAndDividendIncomeOperating_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_CurrentEventsAndReductionInForcePolicyTextBlock" xlink:to="lits_CurrentEventsAndReductionInForcePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="lits_ReconciliationOfStatutoryFederalTaxRateLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PhaseThreeClinicalTrialMember" xlink:to="lits_PhaseThreeClinicalTrialMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AfterTaxReformMember" xlink:to="lits_AfterTaxReformMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_OtherWarrantsMember" xlink:to="lits_OtherWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_SbioPurchaseAgreementMember" xlink:to="lits_SbioPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" xlink:to="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract" xlink:to="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" xlink:to="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" xlink:to="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lits_ContractWithCustomerAssetAndLiabilityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LegalFeesMember" xlink:to="lits_LegalFeesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="us-gaap_UnusualRiskOrUncertaintyByNatureAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_MaximumAmountOfCommonStockOfferingPrice" xlink:to="lits_MaximumAmountOfCommonStockOfferingPrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:to="lits_FairValueMeasurementsSignificantUnobservableInputsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" xlink:to="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:to="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AccruedReimbursementToRelatedParty" xlink:to="lits_AccruedReimbursementToRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_NumberOfSquareFeetUnderLease" xlink:to="lits_NumberOfSquareFeetUnderLease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_SoftwareLicenses" xlink:to="lits_SoftwareLicenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AdvisoryAgreementMember" xlink:to="lits_AdvisoryAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AssetManagementAgreementMember" xlink:to="lits_AssetManagementAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_KyowaKirinCoMember" xlink:to="lits_KyowaKirinCoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitsAuthorized" xlink:to="us-gaap_CapitalUnitsAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" xlink:to="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PlacementAgentWarrantsMember" xlink:to="lits_PlacementAgentWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AssetManagerOwnershipThresholdRate" xlink:to="lits_AssetManagerOwnershipThresholdRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_SanDiegoCaliforniaMember" xlink:to="lits_SanDiegoCaliforniaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_NumberOfWarrantsExercised" xlink:to="lits_NumberOfWarrantsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_KkcAgreementsMember" xlink:to="lits_KkcAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsDomain" xlink:to="us-gaap_DividendsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ReimbursementAmount" xlink:to="lits_ReimbursementAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyPendingClaimsNumber" xlink:to="us-gaap_LossContingencyPendingClaimsNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TotalUpfrontPaymentReceivableForGrantOfRights" xlink:to="lits_TotalUpfrontPaymentReceivableForGrantOfRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_Rule10B51ArrModifiedFlag" xlink:to="lits_Rule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" xlink:to="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PassThroughServicesMember" xlink:to="lits_PassThroughServicesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_InterestIncomePolicyTextBlock" xlink:to="lits_InterestIncomePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TwoThousandAndEightOmnibusPlanMember" xlink:to="lits_TwoThousandAndEightOmnibusPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_MeasurementInputWeightedAverageGrantDateFairValueMember" xlink:to="lits_MeasurementInputWeightedAverageGrantDateFairValueMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementMember" xlink:to="us-gaap_ResearchAndDevelopmentArrangementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_CaresActMember" xlink:to="lits_CaresActMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PresageLicenseAgreementMember" xlink:to="lits_PresageLicenseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_Pre-FundedWarrantsMember" xlink:to="lits_Pre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" xlink:to="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_UpfrontAndMilestonePayments" xlink:to="lits_UpfrontAndMilestonePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_BeforeTaxReformMember" xlink:to="lits_BeforeTaxReformMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PlacementAgencyAgreementMember" xlink:to="lits_PlacementAgencyAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_SaleOfSharesAndWarrantsUnderAgreement" xlink:to="lits_SaleOfSharesAndWarrantsUnderAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ContractWithCustomerAssetAndLiabilityTable" xlink:to="lits_ContractWithCustomerAssetAndLiabilityTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_OperatingLeasesFutureMinimumRentalPayments" xlink:to="lits_OperatingLeasesFutureMinimumRentalPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_LicensingArrangementsAbstract" xlink:to="lits_LicensingArrangementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_IncreaseDecreaseInUnbilledReceivable" xlink:to="lits_IncreaseDecreaseInUnbilledReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_GSRWarrantsTrancheThreeMember" xlink:to="lits_GSRWarrantsTrancheThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AdvisoryFeeRate" xlink:to="lits_AdvisoryFeeRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TotalTransactionPriceInRespectOfColloborationRevenue" xlink:to="lits_TotalTransactionPriceInRespectOfColloborationRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AdoptedAgreement" xlink:to="lits_AdoptedAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" xlink:to="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_MilestonePayment" xlink:to="lits_MilestonePayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DanielPGoldMember" xlink:to="lits_DanielPGoldMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="lits_PreTaxIncomeLossLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_FinancingCostsIncludedInAccountsPayable" xlink:to="lits_FinancingCostsIncludedInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DirectCosts" xlink:to="lits_DirectCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_IncreaseInRightOfUseAssetBalance" xlink:to="lits_IncreaseInRightOfUseAssetBalance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_InducementPlanMember" xlink:to="lits_InducementPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_BeigeneLtdMember" xlink:to="lits_BeigeneLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OneTimeTerminationBenefitsMember" xlink:to="us-gaap_OneTimeTerminationBenefitsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TorreyaPartnersLlcMember" xlink:to="lits_TorreyaPartnersLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" xlink:to="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PresageBiosciencesIncMember" xlink:to="lits_PresageBiosciencesIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PrepaymentOfRemainingRent" xlink:to="lits_PrepaymentOfRemainingRent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" xlink:to="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PercentageOfDeferredOfferingCosts" xlink:to="lits_PercentageOfDeferredOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AccruedPreclinicalAndClinicalCosts" xlink:to="lits_AccruedPreclinicalAndClinicalCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TheSalesAgreementMember" xlink:to="lits_TheSalesAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PotentialMilestonePaymentsReceivable" xlink:to="lits_PotentialMilestonePaymentsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecoveryOfDirectCosts" xlink:to="us-gaap_RecoveryOfDirectCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForCommissions" xlink:to="us-gaap_PaymentsForCommissions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TaxReformAxis" xlink:to="lits_TaxReformAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_ExpectedMilestonePaymentReceivable" xlink:to="lits_ExpectedMilestonePaymentReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DeferredRevenueMember" xlink:to="lits_DeferredRevenueMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" xlink:to="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_StrategicAdvisorWarrantsMember" xlink:to="lits_StrategicAdvisorWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorOperatingLeaseOptionToExtend" xlink:to="us-gaap_LessorOperatingLeaseOptionToExtend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_TaxableIncomePercentage" xlink:to="lits_TaxableIncomePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AssetPurchaseAgreementMember" xlink:to="lits_AssetPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_GSRWarrantsTrancheFourMember" xlink:to="lits_GSRWarrantsTrancheFourMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" xlink:to="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionDomain" xlink:to="us-gaap_TransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:to="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_CydexLicenseAgreementMember" xlink:to="lits_CydexLicenseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_NonCashLeaseExpense" xlink:to="lits_NonCashLeaseExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_EmployeesMember" xlink:to="lits_EmployeesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AtTheMarketOfferingAgreementDescription" xlink:to="lits_AtTheMarketOfferingAgreementDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_UpFrontPayment" xlink:to="lits_UpFrontPayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_RightsAndTheRightsAgreementExpirationDescription" xlink:to="lits_RightsAndTheRightsAgreementExpirationDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_JustinJFileMember" xlink:to="lits_JustinJFileMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_DilutiveSecuritiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_MilestonePaymentsMaximumAmount" xlink:to="lits_MilestonePaymentsMaximumAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementAndServiceFeesRate" xlink:to="us-gaap_ManagementAndServiceFeesRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_VoruciclibMember" xlink:to="lits_VoruciclibMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_PercentageOfSecuritiesSoldAtOffering" xlink:to="lits_PercentageOfSecuritiesSoldAtOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_FeesPaidOnBehalfOfRelatedParty" xlink:to="lits_FeesPaidOnBehalfOfRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_StrategicAdvisorAgreementMember" xlink:to="lits_StrategicAdvisorAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lits_AtTheMarketSaleAgreementMember" xlink:to="lits_AtTheMarketSaleAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredAtPointInTimeMember" xlink:to="us-gaap_TransferredAtPointInTimeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/CoverPage" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RevenueFromCollaborationAgreementsMember" xlink:label="lits_RevenueFromCollaborationAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_RevenueFromContractWithCustomerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lits_RevenueFromCollaborationAgreementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NetIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_6"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncreaseDecreaseInUnbilledReceivable" xlink:label="lits_IncreaseDecreaseInUnbilledReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" xlink:label="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" xlink:label="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FinancingCostsIncludedInAccountsPayable" xlink:label="lits_FinancingCostsIncludedInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NonCashLeaseExpense" xlink:label="lits_NonCashLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lits_IncreaseDecreaseInUnbilledReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividends" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lits_FinancingCostsIncludedInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lits_NonCashLeaseExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Rule10B51ArrModifiedFlag" xlink:label="lits_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NonRule10B51ArrModifiedFlag" xlink:label="lits_NonRule10B51ArrModifiedFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="lits_Rule10B51ArrModifiedFlag" order="14.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="lits_NonRule10B51ArrModifiedFlag" order="15.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_JustinJFileMember" xlink:label="lits_JustinJFileMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DavidMUrsoMember" xlink:label="lits_DavidMUrsoMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DanielPGoldMember" xlink:label="lits_DanielPGoldMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="lits_JustinJFileMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="lits_DavidMUrsoMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="lits_DanielPGoldMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreements1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/OtherLicenseAgreements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LicensingArrangementsAbstract" xlink:label="lits_LicensingArrangementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OtherLicensingArrangementsTextBlock" xlink:label="lits_OtherLicensingArrangementsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_LicensingArrangementsAbstract" xlink:to="lits_OtherLicensingArrangementsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/Leases" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalHomeLoanBanksAbstract" xlink:label="us-gaap_FederalHomeLoanBanksAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalHomeLoanBanksAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAsset" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CurrentEventsAndReductionInForcePolicyTextBlock" xlink:label="lits_CurrentEventsAndReductionInForcePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LiquidityPolicyTextBlock" xlink:label="lits_LiquidityPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_CurrentEventsAndReductionInForcePolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LiquidityPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_InterestIncomePolicyTextBlock" xlink:label="lits_InterestIncomePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DispositionOfNon-FinancialAssetsPolicyTextBlock" xlink:label="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="lits_InterestIncomePolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TargetedOrTrackingStockStockLineItems" xlink:label="us-gaap_TargetedOrTrackingStockStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TargetedOrTrackingStockStockTable" xlink:label="us-gaap_TargetedOrTrackingStockStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract" xlink:label="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" xlink:label="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_O2024Q2DividendsMember" xlink:label="lits_O2024Q2DividendsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialSecondReturnOfCapital" xlink:label="lits_PotentialSecondReturnOfCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ClosingAgreement" xlink:label="lits_ClosingAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract" xlink:to="us-gaap_TargetedOrTrackingStockStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsDomain" xlink:to="lits_O2024Q2DividendsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_Pre-FundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="srt_StatementScenarioAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_DividendsAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_TargetedOrTrackingStockStockLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="lits_PotentialSecondReturnOfCapital" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="lits_ClosingAgreement" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_PaymentsOfDividends" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract" xlink:to="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_RevenueFromContractWithCustomerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:to="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredRevenueMember" xlink:label="lits_DeferredRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:label="lits_ContractWithCustomerAssetAndLiabilityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerAssetAndLiabilityTable" xlink:label="lits_ContractWithCustomerAssetAndLiabilityTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="lits_DeferredRevenueMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="lits_ContractWithCustomerAssetAndLiabilityTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityTable" xlink:to="lits_ContractWithCustomerAssetAndLiabilityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiability_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:label="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="us-gaap_DilutiveSecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PassThroughServicesMember" xlink:label="lits_PassThroughServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReductionLimitOfAdditionalPaidInCapital" xlink:label="lits_ReductionLimitOfAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" xlink:label="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lits_PassThroughServicesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ShortTermInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lits_ReductionLimitOfAdditionalPaidInCapital" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SoftwareLicenses" xlink:label="lits_SoftwareLicenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrepaidClinicalCosts" xlink:label="lits_PrepaidClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PrepaidInsurance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_SoftwareLicenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SecurityDeposit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_PrepaidClinicalCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedLiabilitiesLineItems" xlink:label="lits_AccruedLiabilitiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedPreclinicalAndClinicalCosts" xlink:label="lits_AccruedPreclinicalAndClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedReimbursementToRelatedParty" xlink:label="lits_AccruedReimbursementToRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="lits_AccruedLiabilitiesLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="lits_AccruedPreclinicalAndClinicalCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="lits_AccruedReimbursementToRelatedParty" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="us-gaap_OneTimeTerminationBenefitsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_OneTimeTerminationBenefitsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MeasurementInputWeightedAverageGrantDateFairValueMember" xlink:label="lits_MeasurementInputWeightedAverageGrantDateFairValueMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="lits_MeasurementInputWeightedAverageGrantDateFairValueMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_2"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="lits_FairValueMeasurementsSignificantUnobservableInputsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_2" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:to="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SeveranceCosts1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="us-gaap_OneTimeTerminationBenefitsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:label="us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_OneTimeTerminationBenefitsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserve" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReservePeriodIncreaseDecrease" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_PaymentsForRestructuring" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserve_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="us-gaap_LossContingencyPendingClaimsNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SbioPurchaseAgreementMember" xlink:label="lits_SbioPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="us-gaap_OtherCommitmentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PhaseThreeClinicalTrialMember" xlink:label="lits_PhaseThreeClinicalTrialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="us-gaap_OtherCommitmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedMilestonePayments" xlink:label="lits_AccruedMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CydexLicenseAgreementMember" xlink:label="lits_CydexLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MinimumBidPricePerShare" xlink:label="lits_MinimumBidPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageLicenseAgreementMember" xlink:label="lits_PresageLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MilestonePaymentsMaximumAmount" xlink:label="lits_MilestonePaymentsMaximumAmount"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfPurchasesFromMajorSuppliers" xlink:label="lits_PercentageOfPurchasesFromMajorSuppliers"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UpfrontAndMilestonePayments" xlink:label="lits_UpfrontAndMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_LossContingencyPendingClaimsNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_SbioPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="lits_PhaseThreeClinicalTrialMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_AccruedMilestonePayments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_CydexLicenseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_MinimumBidPricePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_PresageLicenseAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_MilestonePaymentsMaximumAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_PercentageOfPurchasesFromMajorSuppliers" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_UpfrontAndMilestonePayments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ExUsLicenseMember" xlink:label="lits_ExUsLicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_KkcAgreementsMember" xlink:label="lits_KkcAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventAxis" xlink:label="lits_EventAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventDomain" xlink:label="lits_EventDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_KyowaKirinCoMember" xlink:label="lits_KyowaKirinCoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UpFrontPayment" xlink:label="lits_UpFrontPayment"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncrementalPaymentMember" xlink:label="lits_IncrementalPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UsLicenseMember" xlink:label="lits_UsLicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TotalUpfrontPaymentReceivableForGrantOfRights" xlink:label="lits_TotalUpfrontPaymentReceivableForGrantOfRights"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DevelopmentServicesMember" xlink:label="lits_DevelopmentServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TotalTransactionPriceInRespectOfColloborationRevenue" xlink:label="lits_TotalTransactionPriceInRespectOfColloborationRevenue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ExpectedMilestonePaymentReceivable" xlink:label="lits_ExpectedMilestonePaymentReceivable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" xlink:label="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" xlink:label="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TerminationAgreement" xlink:label="lits_TerminationAgreement"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_ExUsLicenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_KkcAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_EventAxis" xlink:to="lits_EventDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="lits_KyowaKirinCoMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_UpFrontPayment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lits_IncrementalPaymentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_UsLicenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_TotalUpfrontPaymentReceivableForGrantOfRights" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_DevelopmentServicesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_TotalTransactionPriceInRespectOfColloborationRevenue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_ExpectedMilestonePaymentReceivable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ProductOrServiceAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DeferredRevenue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lits_EventAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_TerminationAgreement" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageLicenseAgreementMember" xlink:label="lits_PresageLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_BeigeneLtdMember" xlink:label="lits_BeigeneLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PaymentForLicenseAgreement" xlink:label="lits_PaymentForLicenseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncrementalPaymentMember" xlink:label="lits_IncrementalPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageBiosciencesIncMember" xlink:label="lits_PresageBiosciencesIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" xlink:label="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialMilestonePaymentsReceivable" xlink:label="lits_PotentialMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts" xlink:label="us-gaap_RecoveryOfDirectCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_PresageLicenseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="lits_BeigeneLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_PaymentForLicenseAgreement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lits_IncrementalPaymentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="lits_PresageBiosciencesIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_PotentialMilestonePaymentsReceivable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RecoveryOfDirectCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NumberOfSquareFeetUnderLease" xlink:label="lits_NumberOfSquareFeetUnderLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SanDiegoCaliforniaMember" xlink:label="lits_SanDiegoCaliforniaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseTerminationDate" xlink:label="lits_LeaseTerminationDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeaseOptionToExtend" xlink:label="us-gaap_LessorOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseExpirationAmendedDate" xlink:label="lits_LeaseExpirationAmendedDate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseTerminationFee" xlink:label="lits_LeaseTerminationFee"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrepaymentOfRemainingRent" xlink:label="lits_PrepaymentOfRemainingRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" xlink:label="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ConsultingFee" xlink:label="lits_ConsultingFee"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DirectCosts" xlink:label="lits_DirectCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OperatingLeasesFutureMinimumRentalPayments" xlink:label="lits_OperatingLeasesFutureMinimumRentalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncreaseInRightOfUseAssetBalance" xlink:label="lits_IncreaseInRightOfUseAssetBalance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_NumberOfSquareFeetUnderLease" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="lits_SanDiegoCaliforniaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementGeographicalAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfLand" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LeaseTerminationDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LessorOperatingLeaseOptionToExtend" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LeaseExpirationAmendedDate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LeaseTerminationFee" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_PrepaymentOfRemainingRent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_ConsultingFee" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_DirectCosts" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_OperatingLeasesFutureMinimumRentalPayments" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_IncreaseInRightOfUseAssetBalance" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_VariableLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract" xlink:label="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TorreyaPartnersLlcMember" xlink:label="lits_TorreyaPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketSaleAgreementMember" xlink:label="lits_AtTheMarketSaleAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_O2024Q2DividendsMember" xlink:label="lits_O2024Q2DividendsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OtherWarrantsMember" xlink:label="lits_OtherWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalUnitsAuthorized" xlink:label="us-gaap_CapitalUnitsAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RightsAndTheRightsAgreementExpirationDescription" xlink:label="lits_RightsAndTheRightsAgreementExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NumberOfWarrantsExercised" xlink:label="lits_NumberOfWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SaleOfSharesAndWarrantsUnderAgreement" xlink:label="lits_SaleOfSharesAndWarrantsUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketOfferingAgreementDescription" xlink:label="lits_AtTheMarketOfferingAgreementDescription"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MaximumAmountOfCommonStockOfferingPrice" xlink:label="lits_MaximumAmountOfCommonStockOfferingPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ClosingAgreement" xlink:label="lits_ClosingAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdoptedAgreement" xlink:label="lits_AdoptedAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lits_TorreyaPartnersLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lits_AtTheMarketSaleAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsDomain" xlink:to="lits_O2024Q2DividendsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_OtherWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CapitalUnitsAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_StatementScenarioAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_Pre-FundedWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_DividendsAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_RightsAndTheRightsAgreementExpirationDescription" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_NumberOfWarrantsExercised" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_SaleOfSharesAndWarrantsUnderAgreement" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_AtTheMarketOfferingAgreementDescription" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_MaximumAmountOfCommonStockOfferingPrice" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dei_EntityPublicFloat" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_ClosingAgreement" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfDividends" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_AdoptedAgreement" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheOneMember" xlink:label="lits_GSRWarrantsTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheTwoMember" xlink:label="lits_GSRWarrantsTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheThreeMember" xlink:label="lits_GSRWarrantsTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheFourMember" xlink:label="lits_GSRWarrantsTrancheFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorWarrantsMember" xlink:label="lits_StrategicAdvisorWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PlacementAgentWarrantsMember" xlink:label="lits_PlacementAgentWarrantsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheFourMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_StrategicAdvisorWarrantsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_PlacementAgentWarrantsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TwoThousandAndEightOmnibusPlanMember" xlink:label="lits_TwoThousandAndEightOmnibusPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_InducementPlanMember" xlink:label="lits_InducementPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EmployeesMember" xlink:label="lits_EmployeesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" xlink:label="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="lits_TwoThousandAndEightOmnibusPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="lits_InducementPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lits_EmployeesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_VoruciclibMember" xlink:label="lits_VoruciclibMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_METhreeFourFourMember" xlink:label="lits_METhreeFourFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FeesPaidOnBehalfOfRelatedParty" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_VoruciclibMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_METhreeFourFourMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_LaborAndRelatedExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ProfessionalFees" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_LegalFees" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="lits_FeesPaidOnBehalfOfRelatedParty" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_InterestAndDividendIncomeOperating" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="us-gaap_TransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetPurchaseAgreementMember" xlink:label="lits_AssetPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdoptedAgreement" xlink:label="lits_AdoptedAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MilestonePayment" xlink:label="lits_MilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReimbursementAmount" xlink:label="lits_ReimbursementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_TransactionTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransactionDomain" xlink:to="lits_AssetPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lits_AdoptedAgreement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lits_MilestonePayment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lits_ReimbursementAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PreTaxIncomeLossLineItems" xlink:label="lits_PreTaxIncomeLossLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="lits_PreTaxIncomeLossLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:label="lits_ReconciliationOfStatutoryFederalTaxRateLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" xlink:label="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsRightOfUseAssets" xlink:label="lits_DeferredTaxAssetsRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lits_DeferredTaxAssetsRightOfUseAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformDomain" xlink:label="lits_TaxReformDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_BeforeTaxReformMember" xlink:label="lits_BeforeTaxReformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CaresActMember" xlink:label="lits_CaresActMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxesLineItemsLineItems" xlink:label="lits_IncomeTaxesLineItemsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformAxis" xlink:label="lits_TaxReformAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AfterTaxReformMember" xlink:label="lits_AfterTaxReformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" xlink:label="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxableIncomePercentage" xlink:label="lits_TaxableIncomePercentage"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_TaxReformDomain" xlink:to="lits_BeforeTaxReformMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:to="lits_CaresActMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="us-gaap_UnusualRiskOrUncertaintyNatureDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_TaxReformAxis" xlink:to="lits_TaxReformDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="lits_TaxReformAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_TaxReformDomain" xlink:to="lits_AfterTaxReformMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="lits_IncomeTaxesLineItemsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="lits_TaxableIncomePercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LegalFeesMember" xlink:label="lits_LegalFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TheSalesAgreementMember" xlink:label="lits_TheSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdvisoryAgreementMember" xlink:label="lits_AdvisoryAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketSaleAgreementMember" xlink:label="lits_AtTheMarketSaleAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetManagementAgreementMember" xlink:label="lits_AssetManagementAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PlacementAgencyAgreementMember" xlink:label="lits_PlacementAgencyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorAgreementMember" xlink:label="lits_StrategicAdvisorAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorWarrantsMember" xlink:label="lits_StrategicAdvisorWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheOneMember" xlink:label="lits_GSRWarrantsTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfDeferredOfferingCosts" xlink:label="lits_PercentageOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheTwoMember" xlink:label="lits_GSRWarrantsTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementAndServiceFeesRate" xlink:label="us-gaap_ManagementAndServiceFeesRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheThreeMember" xlink:label="lits_GSRWarrantsTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetManagerOwnershipThresholdRate" xlink:label="lits_AssetManagerOwnershipThresholdRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheFourMember" xlink:label="lits_GSRWarrantsTrancheFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfSecuritiesSoldAtOffering" xlink:label="lits_PercentageOfSecuritiesSoldAtOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdvisoryFeeRate" xlink:label="lits_AdvisoryFeeRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AgentCommissionRate" xlink:label="lits_AgentCommissionRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForCommissions" xlink:label="us-gaap_PaymentsForCommissions"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_LegalFeesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_Pre-FundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lits_TheSalesAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_AdvisoryAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lits_AtTheMarketSaleAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_AssetManagementAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_PlacementAgencyAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_StrategicAdvisorAgreementMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AwardTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_StrategicAdvisorWarrantsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_ProductOrServiceAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheOneMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_PercentageOfDeferredOfferingCosts" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheTwoMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ManagementAndServiceFeesRate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheThreeMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_AssetManagerOwnershipThresholdRate" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheFourMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_PercentageOfSecuritiesSoldAtOffering" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_AdvisoryFeeRate" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_AgentCommissionRate" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsForCommissions" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RevenueFromCollaborationAgreementsMember" xlink:label="lits_RevenueFromCollaborationAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_RevenueFromContractWithCustomerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lits_RevenueFromCollaborationAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_JustinJFileMember" xlink:label="lits_JustinJFileMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DavidMUrsoMember" xlink:label="lits_DavidMUrsoMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DanielPGoldMember" xlink:label="lits_DanielPGoldMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="lits_JustinJFileMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="lits_DavidMUrsoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="lits_DanielPGoldMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CurrentEventsAndReductionInForcePolicyTextBlock" xlink:label="lits_CurrentEventsAndReductionInForcePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LiquidityPolicyTextBlock" xlink:label="lits_LiquidityPolicyTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_CurrentEventsAndReductionInForcePolicyTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LiquidityPolicyTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TargetedOrTrackingStockStockLineItems" xlink:label="us-gaap_TargetedOrTrackingStockStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TargetedOrTrackingStockStockTable" xlink:label="us-gaap_TargetedOrTrackingStockStockTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" xlink:label="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_O2024Q2DividendsMember" xlink:label="lits_O2024Q2DividendsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialSecondReturnOfCapital" xlink:label="lits_PotentialSecondReturnOfCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ClosingAgreement" xlink:label="lits_ClosingAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_TargetedOrTrackingStockStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DividendsDomain" xlink:to="lits_O2024Q2DividendsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_Pre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TargetedOrTrackingStockStockTable" xlink:to="us-gaap_DividendsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="lits_PotentialSecondReturnOfCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="lits_ClosingAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_PaymentsOfDividends" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TargetedOrTrackingStockStockLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:label="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:to="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_RevenueFromContractWithCustomerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" xlink:to="us-gaap_Revenues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:label="lits_ContractWithCustomerAssetAndLiabilityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerAssetAndLiabilityTable" xlink:label="lits_ContractWithCustomerAssetAndLiabilityTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredRevenueMember" xlink:label="lits_DeferredRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" xlink:label="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lits_ContractWithCustomerAssetAndLiabilityTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="lits_DeferredRevenueMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lits_ContractWithCustomerAssetAndLiabilityTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lits_ContractWithCustomerAssetAndLiabilityTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:label="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PassThroughServicesMember" xlink:label="lits_PassThroughServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReductionLimitOfAdditionalPaidInCapital" xlink:label="lits_ReductionLimitOfAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" xlink:label="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lits_PassThroughServicesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lits_ReductionLimitOfAdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetImpairmentCharges" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AssetImpairmentCharges" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedLiabilitiesLineItems" xlink:label="lits_AccruedLiabilitiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedPreclinicalAndClinicalCosts" xlink:label="lits_AccruedPreclinicalAndClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedReimbursementToRelatedParty" xlink:label="lits_AccruedReimbursementToRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="lits_AccruedPreclinicalAndClinicalCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="lits_AccruedReimbursementToRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_AccruedLiabilitiesLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="us-gaap_OneTimeTerminationBenefitsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_OneTimeTerminationBenefitsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MeasurementInputWeightedAverageGrantDateFairValueMember" xlink:label="lits_MeasurementInputWeightedAverageGrantDateFairValueMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="lits_MeasurementInputWeightedAverageGrantDateFairValueMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:label="lits_FairValueMeasurementsSignificantUnobservableInputsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="lits_FairValueMeasurementsSignificantUnobservableInputsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lits_FairValueMeasurementsSignificantUnobservableInputsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SeveranceCosts1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="us-gaap_OneTimeTerminationBenefitsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:label="us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_OneTimeTerminationBenefitsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserve" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReservePeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_PaymentsForRestructuring" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="us-gaap_LossContingencyPendingClaimsNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SbioPurchaseAgreementMember" xlink:label="lits_SbioPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="us-gaap_OtherCommitmentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PhaseThreeClinicalTrialMember" xlink:label="lits_PhaseThreeClinicalTrialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="us-gaap_OtherCommitmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="us-gaap_OtherCommitmentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedMilestonePayments" xlink:label="lits_AccruedMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CydexLicenseAgreementMember" xlink:label="lits_CydexLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MinimumBidPricePerShare" xlink:label="lits_MinimumBidPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageLicenseAgreementMember" xlink:label="lits_PresageLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MilestonePaymentsMaximumAmount" xlink:label="lits_MilestonePaymentsMaximumAmount"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfPurchasesFromMajorSuppliers" xlink:label="lits_PercentageOfPurchasesFromMajorSuppliers"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UpfrontAndMilestonePayments" xlink:label="lits_UpfrontAndMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_LossContingencyPendingClaimsNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_SbioPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="lits_PhaseThreeClinicalTrialMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_AccruedMilestonePayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_CydexLicenseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_OtherCommitmentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_MinimumBidPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_PresageLicenseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_MilestonePaymentsMaximumAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_PercentageOfPurchasesFromMajorSuppliers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lits_UpfrontAndMilestonePayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ExUsLicenseMember" xlink:label="lits_ExUsLicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_KkcAgreementsMember" xlink:label="lits_KkcAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventAxis" xlink:label="lits_EventAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventDomain" xlink:label="lits_EventDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EventDomain" xlink:label="lits_EventDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_KyowaKirinCoMember" xlink:label="lits_KyowaKirinCoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UpFrontPayment" xlink:label="lits_UpFrontPayment"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncrementalPaymentMember" xlink:label="lits_IncrementalPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_UsLicenseMember" xlink:label="lits_UsLicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TotalUpfrontPaymentReceivableForGrantOfRights" xlink:label="lits_TotalUpfrontPaymentReceivableForGrantOfRights"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DevelopmentServicesMember" xlink:label="lits_DevelopmentServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TotalTransactionPriceInRespectOfColloborationRevenue" xlink:label="lits_TotalTransactionPriceInRespectOfColloborationRevenue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ExpectedMilestonePaymentReceivable" xlink:label="lits_ExpectedMilestonePaymentReceivable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" xlink:label="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" xlink:label="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TerminationAgreement" xlink:label="lits_TerminationAgreement"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_ExUsLicenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_KkcAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lits_EventAxis" xlink:to="lits_EventDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lits_EventAxis" xlink:to="lits_EventDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="lits_KyowaKirinCoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_UpFrontPayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lits_IncrementalPaymentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_UsLicenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_TotalUpfrontPaymentReceivableForGrantOfRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_DevelopmentServicesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_TotalTransactionPriceInRespectOfColloborationRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_ExpectedMilestonePaymentReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DeferredRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lits_EventAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_TerminationAgreement" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageLicenseAgreementMember" xlink:label="lits_PresageLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_BeigeneLtdMember" xlink:label="lits_BeigeneLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PaymentForLicenseAgreement" xlink:label="lits_PaymentForLicenseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncrementalPaymentMember" xlink:label="lits_IncrementalPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PresageBiosciencesIncMember" xlink:label="lits_PresageBiosciencesIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" xlink:label="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PotentialMilestonePaymentsReceivable" xlink:label="lits_PotentialMilestonePaymentsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts" xlink:label="us-gaap_RecoveryOfDirectCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lits_PresageLicenseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="lits_BeigeneLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_PaymentForLicenseAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lits_IncrementalPaymentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="lits_PresageBiosciencesIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="lits_PotentialMilestonePaymentsReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RecoveryOfDirectCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NumberOfSquareFeetUnderLease" xlink:label="lits_NumberOfSquareFeetUnderLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SanDiegoCaliforniaMember" xlink:label="lits_SanDiegoCaliforniaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseTerminationDate" xlink:label="lits_LeaseTerminationDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LessorOperatingLeaseOptionToExtend" xlink:label="us-gaap_LessorOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseExpirationAmendedDate" xlink:label="lits_LeaseExpirationAmendedDate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LeaseTerminationFee" xlink:label="lits_LeaseTerminationFee"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrepaymentOfRemainingRent" xlink:label="lits_PrepaymentOfRemainingRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" xlink:label="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" xlink:label="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ConsultingFee" xlink:label="lits_ConsultingFee"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DirectCosts" xlink:label="lits_DirectCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OperatingLeasesFutureMinimumRentalPayments" xlink:label="lits_OperatingLeasesFutureMinimumRentalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncreaseInRightOfUseAssetBalance" xlink:label="lits_IncreaseInRightOfUseAssetBalance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_NumberOfSquareFeetUnderLease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="lits_SanDiegoCaliforniaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfLand" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LeaseTerminationDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LessorOperatingLeaseOptionToExtend" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LeaseExpirationAmendedDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_LeaseTerminationFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_PrepaymentOfRemainingRent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfFurnitureAndFixtures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_ConsultingFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_DirectCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasePayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_OperatingLeasesFutureMinimumRentalPayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lits_IncreaseInRightOfUseAssetBalance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_VariableLeaseCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LeaseCost" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TorreyaPartnersLlcMember" xlink:label="lits_TorreyaPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketSaleAgreementMember" xlink:label="lits_AtTheMarketSaleAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_O2024Q2DividendsMember" xlink:label="lits_O2024Q2DividendsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_OtherWarrantsMember" xlink:label="lits_OtherWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalUnitsAuthorized" xlink:label="us-gaap_CapitalUnitsAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_RightsAndTheRightsAgreementExpirationDescription" xlink:label="lits_RightsAndTheRightsAgreementExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NumberOfWarrantsExercised" xlink:label="lits_NumberOfWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SaleOfSharesAndWarrantsUnderAgreement" xlink:label="lits_SaleOfSharesAndWarrantsUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketOfferingAgreementDescription" xlink:label="lits_AtTheMarketOfferingAgreementDescription"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MaximumAmountOfCommonStockOfferingPrice" xlink:label="lits_MaximumAmountOfCommonStockOfferingPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ClosingAgreement" xlink:label="lits_ClosingAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdoptedAgreement" xlink:label="lits_AdoptedAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lits_TorreyaPartnersLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lits_AtTheMarketSaleAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DividendsDomain" xlink:to="lits_O2024Q2DividendsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_OtherWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CapitalUnitsAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_Pre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_DividendsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_RightsAndTheRightsAgreementExpirationDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_NumberOfWarrantsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_SaleOfSharesAndWarrantsUnderAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_AtTheMarketOfferingAgreementDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_MaximumAmountOfCommonStockOfferingPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_ClosingAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfDividends" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="lits_AdoptedAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheOneMember" xlink:label="lits_GSRWarrantsTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheTwoMember" xlink:label="lits_GSRWarrantsTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheThreeMember" xlink:label="lits_GSRWarrantsTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheFourMember" xlink:label="lits_GSRWarrantsTrancheFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorWarrantsMember" xlink:label="lits_StrategicAdvisorWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PlacementAgentWarrantsMember" xlink:label="lits_PlacementAgentWarrantsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheFourMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_StrategicAdvisorWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_PlacementAgentWarrantsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TwoThousandAndEightOmnibusPlanMember" xlink:label="lits_TwoThousandAndEightOmnibusPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_InducementPlanMember" xlink:label="lits_InducementPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EmployeesMember" xlink:label="lits_EmployeesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" xlink:label="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="lits_TwoThousandAndEightOmnibusPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="lits_InducementPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lits_EmployeesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_VoruciclibMember" xlink:label="lits_VoruciclibMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_METhreeFourFourMember" xlink:label="lits_METhreeFourFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FeesPaidOnBehalfOfRelatedParty" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_VoruciclibMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_Revenues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_METhreeFourFourMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_LaborAndRelatedExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ProfessionalFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_LegalFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="lits_FeesPaidOnBehalfOfRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_InterestAndDividendIncomeOperating" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="us-gaap_TransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="us-gaap_TransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetPurchaseAgreementMember" xlink:label="lits_AssetPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdoptedAgreement" xlink:label="lits_AdoptedAgreement"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_MilestonePayment" xlink:label="lits_MilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReimbursementAmount" xlink:label="lits_ReimbursementAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_TransactionTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransactionDomain" xlink:to="lits_AssetPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lits_AdoptedAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lits_MilestonePayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lits_ReimbursementAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PreTaxIncomeLossLineItems" xlink:label="lits_PreTaxIncomeLossLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_PreTaxIncomeLossLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:label="lits_ReconciliationOfStatutoryFederalTaxRateLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxesLineItemsLineItems" xlink:label="lits_IncomeTaxesLineItemsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformDomain" xlink:label="lits_TaxReformDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_BeforeTaxReformMember" xlink:label="lits_BeforeTaxReformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_CaresActMember" xlink:label="lits_CaresActMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="us-gaap_UnusualRiskOrUncertaintyNatureDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformAxis" xlink:label="lits_TaxReformAxis"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxReformDomain" xlink:label="lits_TaxReformDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AfterTaxReformMember" xlink:label="lits_AfterTaxReformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" xlink:label="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TaxableIncomePercentage" xlink:label="lits_TaxableIncomePercentage"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_TaxReformDomain" xlink:to="lits_BeforeTaxReformMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:to="lits_CaresActMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="us-gaap_UnusualRiskOrUncertaintyNatureDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="us-gaap_UnusualRiskOrUncertaintyNatureDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lits_TaxReformAxis" xlink:to="lits_TaxReformDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lits_TaxReformAxis" xlink:to="lits_TaxReformDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="lits_TaxReformAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_TaxReformDomain" xlink:to="lits_AfterTaxReformMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_UnusualRiskOrUncertaintyByNatureAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lits_IncomeTaxesLineItemsLineItems" xlink:to="lits_TaxableIncomePercentage" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SurrenderedWarrantsToAcheiveCommonStock" xlink:label="lits_SurrenderedWarrantsToAcheiveCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_LegalFeesMember" xlink:label="lits_LegalFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_Pre-FundedWarrantsMember" xlink:label="lits_Pre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_TheSalesAgreementMember" xlink:label="lits_TheSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdvisoryAgreementMember" xlink:label="lits_AdvisoryAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AtTheMarketSaleAgreementMember" xlink:label="lits_AtTheMarketSaleAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetManagementAgreementMember" xlink:label="lits_AssetManagementAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PlacementAgencyAgreementMember" xlink:label="lits_PlacementAgencyAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorAgreementMember" xlink:label="lits_StrategicAdvisorAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_StrategicAdvisorWarrantsMember" xlink:label="lits_StrategicAdvisorWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheOneMember" xlink:label="lits_GSRWarrantsTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfDeferredOfferingCosts" xlink:label="lits_PercentageOfDeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheTwoMember" xlink:label="lits_GSRWarrantsTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManagementAndServiceFeesRate" xlink:label="us-gaap_ManagementAndServiceFeesRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheThreeMember" xlink:label="lits_GSRWarrantsTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AssetManagerOwnershipThresholdRate" xlink:label="lits_AssetManagerOwnershipThresholdRate"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_GSRWarrantsTrancheFourMember" xlink:label="lits_GSRWarrantsTrancheFourMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PercentageOfSecuritiesSoldAtOffering" xlink:label="lits_PercentageOfSecuritiesSoldAtOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AdvisoryFeeRate" xlink:label="lits_AdvisoryFeeRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AgentCommissionRate" xlink:label="lits_AgentCommissionRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForCommissions" xlink:label="us-gaap_PaymentsForCommissions"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_SurrenderedWarrantsToAcheiveCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="lits_LegalFeesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_Pre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lits_TheSalesAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_AdvisoryAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lits_AtTheMarketSaleAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_AssetManagementAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_PlacementAgencyAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_StrategicAdvisorAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_StrategicAdvisorWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_PercentageOfDeferredOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ManagementAndServiceFeesRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_AssetManagerOwnershipThresholdRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lits_GSRWarrantsTrancheFourMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_PercentageOfSecuritiesSoldAtOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_AdvisoryFeeRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="lits_AgentCommissionRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsForCommissions" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDividends" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lits_NonCashLeaseExpense" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="7" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lits_IncreaseDecreaseInUnbilledReceivable" order="10" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="15" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="16" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="17" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="18" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_NonCashLeaseExpense" xlink:label="lits_NonCashLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncreaseDecreaseInUnbilledReceivable" xlink:label="lits_IncreaseDecreaseInUnbilledReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lits_SoftwareLicenses" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_SecurityDeposit" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lits_PrepaidClinicalCosts" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_SoftwareLicenses" xlink:label="lits_SoftwareLicenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_PrepaidClinicalCosts" xlink:label="lits_PrepaidClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="lits_AccruedPreclinicalAndClinicalCosts" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="lits_AccruedReimbursementToRelatedParty" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedPreclinicalAndClinicalCosts" xlink:label="lits_AccruedPreclinicalAndClinicalCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_AccruedReimbursementToRelatedParty" xlink:label="lits_AccruedReimbursementToRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_LaborAndRelatedExpense" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_Revenues" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherExpenses" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_ProfessionalFees" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_LegalFees" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lits_FeesPaidOnBehalfOfRelatedParty" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_InterestAndDividendIncomeOperating" order="8" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_FeesPaidOnBehalfOfRelatedParty" xlink:label="lits_FeesPaidOnBehalfOfRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestAndDividendIncomeOperating" xlink:label="us-gaap_InterestAndDividendIncomeOperating"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" xlink:label="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" xlink:label="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="lits_DeferredTaxAssetsRightOfUseAssets" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="11" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" xlink:label="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="lits-20250630.xsd#lits_DeferredTaxAssetsRightOfUseAssets" xlink:label="lits_DeferredTaxAssetsRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" name="RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_NumberOfWarrantsExercised" name="NumberOfWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_CydexLicenseAgreementMember" name="CydexLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_FeesPaidOnBehalfOfRelatedParty" name="FeesPaidOnBehalfOfRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_DavidMUrsoMember" name="DavidMUrsoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_TaxableIncomePercentage" name="TaxableIncomePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_BeigeneLtdMember" name="BeigeneLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_IncreaseDecreaseInUnbilledReceivable" name="IncreaseDecreaseInUnbilledReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_NonCashLeaseExpense" name="NonCashLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_AdoptedAgreement" name="AdoptedAgreement" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_AfterTaxReformMember" name="AfterTaxReformMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_MaximumAmountOfCommonStockOfferingPrice" name="MaximumAmountOfCommonStockOfferingPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_OperatingLeasesFutureMinimumRentalPayments" name="OperatingLeasesFutureMinimumRentalPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_DirectCosts" name="DirectCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_RevenueFromCollaborationAgreementsMember" name="RevenueFromCollaborationAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_EmployeesMember" name="EmployeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_Rule10B51ArrModifiedFlag" name="Rule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" name="DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_DeferredTaxAssetsRightOfUseAssets" name="DeferredTaxAssetsRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_PotentialSecondReturnOfCapital" name="PotentialSecondReturnOfCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_JustinJFileMember" name="JustinJFileMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_ClosingAgreement" name="ClosingAgreement" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_PresageBiosciencesIncMember" name="PresageBiosciencesIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_IncomeTaxesLineItemsLineItems" name="IncomeTaxesLineItemsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_ConsultingFee" name="ConsultingFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue" name="PercentageOfReimbursementOfPassThroughCostsAsRevenue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" name="ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_PrepaidClinicalCosts" name="PrepaidClinicalCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_ReconciliationOfStatutoryFederalTaxRateLineItems" name="ReconciliationOfStatutoryFederalTaxRateLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AgentCommissionRate" name="AgentCommissionRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_LeaseExpirationAmendedDate" name="LeaseExpirationAmendedDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" name="RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_SbioPurchaseAgreementMember" name="SbioPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_DispositionOfNon-FinancialAssetsPolicyTextBlock" name="DispositionOfNon-FinancialAssetsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_PercentageOfPurchasesFromMajorSuppliers" name="PercentageOfPurchasesFromMajorSuppliers" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_GSRWarrantsTrancheOneMember" name="GSRWarrantsTrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_METhreeFourFourMember" name="METhreeFourFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PercentageOfSecuritiesSoldAtOffering" name="PercentageOfSecuritiesSoldAtOffering" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="lits_UsLicenseMember" name="UsLicenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_DanielPGoldMember" name="DanielPGoldMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_DevelopmentServicesMember" name="DevelopmentServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_LicensingArrangementsAbstract" name="LicensingArrangementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PlacementAgencyAgreementMember" name="PlacementAgencyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_EventAxis" name="EventAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" name="RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" name="ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_GSRWarrantsTrancheThreeMember" name="GSRWarrantsTrancheThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" name="RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_ReimbursementAmount" name="ReimbursementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_PotentiallyDilutiveSecuritiesOutstandingLineItems" name="PotentiallyDilutiveSecuritiesOutstandingLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_TaxReformDomain" name="TaxReformDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_ExUsLicenseMember" name="ExUsLicenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" name="Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="lits_TheSalesAgreementMember" name="TheSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_GSRWarrantsTrancheFourMember" name="GSRWarrantsTrancheFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_RightsAndTheRightsAgreementExpirationDescription" name="RightsAndTheRightsAgreementExpirationDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_AccruedLiabilitiesLineItems" name="AccruedLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_MeasurementInputWeightedAverageGrantDateFairValueMember" name="MeasurementInputWeightedAverageGrantDateFairValueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" name="DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_TotalTransactionPriceInRespectOfColloborationRevenue" name="TotalTransactionPriceInRespectOfColloborationRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract" name="DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" name="IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_PhaseThreeClinicalTrialMember" name="PhaseThreeClinicalTrialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" name="DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" name="PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_TorreyaPartnersLlcMember" name="TorreyaPartnersLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_TwoThousandAndEightOmnibusPlanMember" name="TwoThousandAndEightOmnibusPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_OtherLicensingArrangementsTextBlock" name="OtherLicensingArrangementsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_FairValueMeasurementsSignificantUnobservableInputsTable" name="FairValueMeasurementsSignificantUnobservableInputsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_FairValueMeasurementsSignificantUnobservableInputsLineItems" name="FairValueMeasurementsSignificantUnobservableInputsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_DeferredRevenueMember" name="DeferredRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_NumberOfSquareFeetUnderLease" name="NumberOfSquareFeetUnderLease" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="lits_TaxReformAxis" name="TaxReformAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_IncrementalPaymentMember" name="IncrementalPaymentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" name="AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_ContractWithCustomerAssetAndLiabilityLineItems" name="ContractWithCustomerAssetAndLiabilityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_SurrenderedWarrantsToAcheiveCommonStock" name="SurrenderedWarrantsToAcheiveCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_AdvisoryAgreementMember" name="AdvisoryAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_Pre-FundedWarrantsMember" name="Pre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AtTheMarketSaleAgreementMember" name="AtTheMarketSaleAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AtTheMarketOfferingAgreementDescription" name="AtTheMarketOfferingAgreementDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_PotentialMilestonePaymentsReceivable" name="PotentialMilestonePaymentsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_OtherWarrantsMember" name="OtherWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_StrategicAdvisorWarrantsMember" name="StrategicAdvisorWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PaymentForLicenseAgreement" name="PaymentForLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract" name="RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PresageLicenseAgreementMember" name="PresageLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_StrategicAdvisorAgreementMember" name="StrategicAdvisorAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_KyowaKirinCoMember" name="KyowaKirinCoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PercentageOfDeferredOfferingCosts" name="PercentageOfDeferredOfferingCosts" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_CaresActMember" name="CaresActMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_LegalFeesMember" name="LegalFeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AdvisoryFeeRate" name="AdvisoryFeeRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_NonRule10B51ArrModifiedFlag" name="NonRule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_IncreaseInRightOfUseAssetBalance" name="IncreaseInRightOfUseAssetBalance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_LeaseTerminationDate" name="LeaseTerminationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_SaleOfSharesAndWarrantsUnderAgreement" name="SaleOfSharesAndWarrantsUnderAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_O2024Q2DividendsMember" name="O2024Q2DividendsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AccruedPreclinicalAndClinicalCosts" name="AccruedPreclinicalAndClinicalCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_LiquidityPolicyTextBlock" name="LiquidityPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_MinimumBidPricePerShare" name="MinimumBidPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_SoftwareLicenses" name="SoftwareLicenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_KkcAgreementsMember" name="KkcAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_AssetManagementAgreementMember" name="AssetManagementAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_SanDiegoCaliforniaMember" name="SanDiegoCaliforniaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" name="PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_LeaseTerminationFee" name="LeaseTerminationFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_FinancingCostsIncludedInAccountsPayable" name="FinancingCostsIncludedInAccountsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_AccruedMilestonePayments" name="AccruedMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_AssetManagerOwnershipThresholdRate" name="AssetManagerOwnershipThresholdRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_ExpectedMilestonePaymentReceivable" name="ExpectedMilestonePaymentReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_UpFrontPayment" name="UpFrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_EventDomain" name="EventDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PassThroughServicesMember" name="PassThroughServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_ReductionLimitOfAdditionalPaidInCapital" name="ReductionLimitOfAdditionalPaidInCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract" name="AssetsAndLiabilitiesEliminatedUponConsolidationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings" name="EstimatedDevelopmentCostSharingRecoverableThroughEarnings" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_AccruedReimbursementToRelatedParty" name="AccruedReimbursementToRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_TotalUpfrontPaymentReceivableForGrantOfRights" name="TotalUpfrontPaymentReceivableForGrantOfRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" name="LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_InducementPlanMember" name="InducementPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_VoruciclibMember" name="VoruciclibMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_CurrentEventsAndReductionInForcePolicyTextBlock" name="CurrentEventsAndReductionInForcePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_PrepaymentOfRemainingRent" name="PrepaymentOfRemainingRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_TerminationAgreement" name="TerminationAgreement" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_ContractWithCustomerAssetAndLiabilityTable" name="ContractWithCustomerAssetAndLiabilityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_PreTaxIncomeLossLineItems" name="PreTaxIncomeLossLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_UpfrontAndMilestonePayments" name="UpfrontAndMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_InterestIncomePolicyTextBlock" name="InterestIncomePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_BeforeTaxReformMember" name="BeforeTaxReformMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_MilestonePayment" name="MilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="lits_PlacementAgentWarrantsMember" name="PlacementAgentWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_GSRWarrantsTrancheTwoMember" name="GSRWarrantsTrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="lits_MilestonePaymentsMaximumAmount" name="MilestonePaymentsMaximumAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Sep. 23, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">000-50484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0407811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9920 Pacific Heights Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">369-7100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LITS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lite Strategy, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001262104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.00000002 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,655,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte and Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Lite Strategy, Inc. and subsidiary (the "Company") as of June 30, 2025 and 2024, the related consolidated statements of operations, stockholders' equity, and cash flows, for each of the two years in the period ended June 30, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2025, in conformity with accounting principles generally accepted in the United States of America.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 18,011<span></span>
</td>
<td class="nump">$ 3,705<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">2,424<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">18,285<span></span>
</td>
<td class="nump">40,769<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">18,285<span></span>
</td>
<td class="nump">41,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">3,168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">1,178<span></span>
</td>
<td class="nump">5,187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">8,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">8,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value; 100 shares authorized; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00000002 par value; 226,000 shares authorized; 6,663 shares issued and outstanding at June 30, 2025 and June 30, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">421,095<span></span>
</td>
<td class="nump">421,239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(404,164)<span></span>
</td>
<td class="num">(388,219)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">16,931<span></span>
</td>
<td class="nump">33,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 18,285<span></span>
</td>
<td class="nump">$ 41,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00000002<span></span>
</td>
<td class="nump">$ 0.00000002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">226,000,000<span></span>
</td>
<td class="nump">226,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">6,663,000<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,663,000<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 65,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,923<span></span>
</td>
<td class="nump">16,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">13,532<span></span>
</td>
<td class="nump">23,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,899<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">17,455<span></span>
</td>
<td class="nump">50,755<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="num">(17,455)<span></span>
</td>
<td class="nump">14,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividend income</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">3,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain on disposition of a non-financial asset</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">3,236<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (15,945)<span></span>
</td>
<td class="nump">$ 17,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net (loss) income per share - basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="num">$ (2.39)<span></span>
</td>
<td class="nump">$ 2.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="num">$ (2.39)<span></span>
</td>
<td class="nump">$ 2.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares used in computing net (loss) income per share - basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=lits_RevenueFromCollaborationAgreementsMember', window );">Revenue from collaboration agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 64,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=lits_RevenueFromCollaborationAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=lits_RevenueFromCollaborationAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 24,624<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 430,621<span></span>
</td>
<td class="num">$ (405,997)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">17,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Cash dividends declared</a></td>
<td class="num">(11,660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">2,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Jun. 30, 2024</a></td>
<td class="nump">33,020<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">421,239<span></span>
</td>
<td class="num">(388,219)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(15,945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,945)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="num">(144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Jun. 30, 2025</a></td>
<td class="nump">$ 16,931<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 421,095<span></span>
</td>
<td class="num">$ (404,164)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared, per share</a></td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (15,945)<span></span>
</td>
<td class="nump">$ 17,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(144)<span></span>
</td>
<td class="nump">2,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_NonCashLeaseExpense', window );">Noncash lease expense</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain on disposition of a non-financial asset</a></td>
<td class="num">(500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_IncreaseDecreaseInUnbilledReceivable', window );">Unbilled receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">4,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="num">(2,992)<span></span>
</td>
<td class="num">(3,147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(4,009)<span></span>
</td>
<td class="num">(7,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(64,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,612)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(20,844)<span></span>
</td>
<td class="num">(50,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(58,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">34,640<span></span>
</td>
<td class="nump">107,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Proceeds from the disposition of a non-financial asset</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">35,150<span></span>
</td>
<td class="nump">49,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payment of cash dividend</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,660)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,868)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">14,306<span></span>
</td>
<td class="num">(13,201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of the year</a></td>
<td class="nump">3,705<span></span>
</td>
<td class="nump">16,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of the year</a></td>
<td class="nump">18,011<span></span>
</td>
<td class="nump">3,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification', window );">Re-measurement of right-of-use asset and related lease liability upon lease modification</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification', window );">Re-measurement of right-of-use asset for direct costs associated with lease modification</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_IncreaseDecreaseInUnbilledReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Unbilled Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_IncreaseDecreaseInUnbilledReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_NonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_NonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement of right of use asset and related lease liability upon lease modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement of right of use asset for direct costs associated with lease modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the importance cybersecurity has to the success of our business, as well as recognize the need to continually assess cybersecurity risks and evolve our responses in the face of a rapidly and ever-changing environment. Accordingly, we aim to protect our business operations, records and information against known and evolving cybersecurity threats.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Risk Management and Strategy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established policies and processes for assessing, identifying and managing material risk from cybersecurity threats and have </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing within these systems.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks and the sufficiency of existing policies, procedures, systems and safeguards in place to manage such risks.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Following these risk assessments, we re-design, implement and maintain reasonable safeguards to minimize identified risks, reasonably address any identified gaps in existing safeguards and regularly monitor the effectiveness of our safeguards. Primary responsibility for assessing, monitoring and managing our cybersecurity risks rests with the Senior Director, Information Security and Infrastructure who reports to our Acting Chief Executive Officer and Chief Financial Officer to manage the risk assessment and mitigation process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with our Information Technology department. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings and internal communications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If required, we </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">engage</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consultants, or other third parties in connection with our risk assessment processes. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These service providers, where appropriate, assist us in the assessment, testing or other aspects of our security controls to help identify material cybersecurity risks to our critical systems, information, products, services and our broader enterprise IT environment, as well as assist us in designing and implementing our cybersecurity policies and procedures. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing. For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#8220;Risk Factors,&#8221; in this annual report on Form 10-K.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Governance </span></span><span style=""></span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board considers cybersecurity risk as part of its risk oversight function and has delegated oversight of cybersecurity and other information technology risks to the Audit Committee. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee oversees management&#8217;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.</span></span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee receives annual reports from management on our cybersecurity risks. In addition, management updates the Audit Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential.</span></span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established policies and processes for assessing, identifying and managing material risk from cybersecurity threats and have </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing within these systems.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Governance </span><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board considers cybersecurity risk as part of its risk oversight function and has delegated oversight of cybersecurity and other information technology risks to the Audit Committee. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee oversees management&#8217;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee receives annual reports from management on our cybersecurity risks. In addition, management updates the Audit Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential.</span></span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee oversees management&#8217;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee oversees management&#8217;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. </span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">11 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pay Versus Performance</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provided below is our pay versus performance disclosure as required pursuant to Item 402(v) of Regulation S-K promulgated under the Exchange Act. As required by Item 402(v), we have included:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of our most important measures that our Compensation Committee used in fiscal year 2025 to link a measure of pay calculated in accordance with Item 402(v) (referred to as compensation actually paid, or CAP) to our performance; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A table that compares the total compensation of our named executive officers&#8217; (also known as NEOs) as presented in the Summary Compensation Table (SCT) to CAP and that compares CAP to specified performance measures; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Graphs that describe:</span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the relationships between CAP and our cumulative total shareholder return (TSR), GAAP Net Income and our selected measure, Total Cash (defined as all cash and cash equivalents); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the relationship between our TSR and the TSR of the Nasdaq Biotechnology Index (Peer Group TSR).</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note: pursuant to Item 402(v)(8), Lite Strategy, as a smaller reporting company (SRC), has provided the information required by 402(v) for three years, instead of five years and is not required to provide the disclosure required by 402(v)(2)(iv) or 402(v)(5) with respect to the total shareholder return of any peer group, or our-Selected Measure disclosure required by 402 (v)(2)(vi), or the Tabular List provided pursuant to 402(v)(6).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given our current pay program, the only difference between the SCT and CAP amounts for our NEOs is the value of equity awards, which for purposes of the SCT is based on the grant date fair value of equity awards granted during the year and for purposes of CAP is based on the year over year change in the fair value of equity awards that are unvested as of the end of the year, or that vested, or were forfeited during the year.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Most Important Metrics Used for Linking Pay and Performance. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required by Item 402(v), below are the most important metrics linking CAP to performance for fiscal year 2025. Besides stock price, the only financial performance measure the Committee used to link executive compensation to performance in 2025 was Total Cash which is defined as total cash and cash equivalents on the consolidated balance sheets as of June 30, 2025.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation decisions are made each year taking into account a number of other factors. Target pay levels are primarily set based on clinical milestones, individual performance, scope of responsibility, and an annual assessment of pay competitiveness within the market, but aside from Total Cash and stock price, no additional financial performance measures were used by the Company to link compensation actually paid to our NEOs in fiscal year 2025 to our performance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pay Versus Performance Table</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In accordance with Item 402(v) and under rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the tabular disclosure for our Chief Executive Officer (our Principal Executive Officer or PEO) and the average of our NEOs other than the PEO for fiscal years 2023, 2024 and 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
     <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:96.0%;border-collapse:separate;margin-right:auto;">
      <tr style="visibility:collapse;">
       <td style="width:2.28%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.26%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.18%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.18%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:4.44%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.18%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.18%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.26%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.18%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.92%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:4.68%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:4.58%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
       <td style="width:5.68%;box-sizing:content-box;"></td>
       <td style="width:1%;box-sizing:content-box;"></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="5" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Value of Initial Fixed $100 Investment Based on Total Shareholder Return</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table for Total Current PEO<br/>(File)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Actually Paid to Current PEO<br/>(File)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table for Total Former PEO<br/>(Urso)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Actually Paid to Former PEO<br/>(Urso)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table for Total Former PEO<br/>(Gold)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Compensation Actually Paid to Former PEO<br/>(Gold)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Summary Compensation Table Total for Non-PEO<br/>NEOs</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Compensation Actually Paid to Non-PEO<br/>NEOs</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(2,3)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lite Strategy Total Shareholder Return</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Peer Total Shareholder<br/>Return</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(4)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lite Strategy Net (Loss) Income<br/>($ Millions)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Company Selected Measure: Total Cash ($Millions)</span><span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;">(5)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(c)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(d)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(e)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(f)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(h)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(i)</span></p></td>
       <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;">
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">912,667</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">893,199</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866,258</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">615,372</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">677,662</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">614,958</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">113</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#cff0fc;word-break:break-word;">
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,905</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,789</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">730,912</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">558,052</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
      <tr style="height:5pt;background-color:#ffffff;word-break:break-word;">
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,101,058</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,721,979</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,446,640</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,857,113</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772,486</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">642,744</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">109</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
       <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
       <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
      </tr>
     </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PVP table reflects required disclosures for fiscal years 2023, 2024 and 2025. The following table reflects our Principal Executive Officer (PEO) and non-PEO NEOs in each of the fiscal years presented:.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:8pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:12.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:26.6%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:59.18%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PEO</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-PEO NEOs</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current) <br/></span><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Former)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File and Richard G. Ghalie</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current)<br/></span><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Daniel P. Gold</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Former)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Brian G. Drazba and Richard G. Ghalie</span></p></td>
        </tr>
       </table></div><div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.</span></div></div></div><div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div></div><div style="font-size:9pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.306%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.479%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.479%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.738%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current PEO (File)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">912,667</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,787</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,681</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">893,199</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Urso)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,101,058</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,905</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866,258</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,352,600</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,097,045</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,864</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">511,128</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,660</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,988</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,757</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,643</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,721,979</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,789</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">615,372</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,446,640</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">584,700</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">193,830</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,139</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,518</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,857,113</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Non-PEO(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772,486</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">730,912</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">677,662</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">177,850</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,900</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104,625</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,797</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,041</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93,289</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,476</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,468</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,858</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">642,744</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">558,052</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">614,958</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilized in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the fiscal year ended June 30, 2019. As a SRC, we do not have to provide and have not provided, this stock performance graph in subsequent annual reports. The comparison assumes $100 was invested for the period starting June 30, 2022, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. </span></div></div></div><div style="font-size:9pt;font-family:Times New Roman;"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We determined </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total Cash</span></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Total Cash is defined as total cash and cash equivalents. </span></div></div></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Total Cash<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:12.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:26.6%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:59.18%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PEO</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-PEO NEOs</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current) <br/></span><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Former)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Richard G. Ghalie</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Justin J. File and Richard G. Ghalie</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David M. Urso</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Current)<br/></span><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Daniel P. Gold</span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;(Former)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Brian G. Drazba and Richard G. Ghalie</span></p></td>
        </tr>
       </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilized in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the fiscal year ended June 30, 2019. As a SRC, we do not have to provide and have not provided, this stock performance graph in subsequent annual reports. The comparison assumes $100 was invested for the period starting June 30, 2022, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. </span></div></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.306%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.479%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.479%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.738%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current PEO (File)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">912,667</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,787</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,681</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">893,199</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Urso)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,101,058</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,905</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866,258</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,352,600</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,097,045</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,864</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">511,128</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,660</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,988</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,757</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,643</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,721,979</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,789</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">615,372</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,446,640</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">584,700</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">193,830</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,139</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,518</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,857,113</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Non-PEO(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772,486</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">730,912</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">677,662</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">177,850</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,900</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104,625</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,797</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,041</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93,289</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,476</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,468</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,858</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">642,744</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">558,052</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">614,958</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 677,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 730,912<span></span>
</td>
<td class="nump">$ 772,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">614,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558,052<span></span>
</td>
<td class="nump">642,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: </span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.306%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.479%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.479%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:7.738%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current PEO (File)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">912,667</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,787</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,681</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">893,199</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Urso)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,101,058</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,905</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866,258</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,352,600</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,097,045</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,864</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">511,128</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,660</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,988</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,757</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,643</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,721,979</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">220,789</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">615,372</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Former PEO (Gold)(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,446,640</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">584,700</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">193,830</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,139</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,518</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,857,113</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Non-PEO(i)</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SCT Total</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772,486</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">730,912</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">677,662</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Stock and Option Award Values Reported in SCT for the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">177,850</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,900</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104,625</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,797</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,041</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93,289</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,476</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,468</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,858</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Actually Paid</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">642,744</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">558,052</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">614,958</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718</span></p></td>
          <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and TSR</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><img alt="img155424085_11.jpg" src="img155424085_11.jpg" style="width:609px;height:286px;"/></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and GAAP Net Income (Loss)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP and our GAAP Net Income (Loss).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img alt="img155424085_12.jpg" src="img155424085_12.jpg" style="width:531px;height:286px;"/></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and Total Cash (our Selected Measure).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The chart below reflects the relationship between the PEO CAP and average non-PEO NEO CAP and our Total Cash.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img alt="img155424085_13.jpg" src="img155424085_13.jpg" style="width:525px;height:287px;"/></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Relationship between CAP and TSR</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><img alt="img155424085_11.jpg" src="img155424085_11.jpg" style="width:609px;height:286px;"/></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15,945,000)<span></span>
</td>
<td class="nump">$ 17,778,000<span></span>
</td>
<td class="num">$ (32,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="nump">101,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.</span></div></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonGaapMeasureDescriptionTextBlock', window );">Non-GAAP Measure Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We determined </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total Cash</span></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Total Cash is defined as total cash and cash equivalents. </span></div></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=lits_JustinJFileMember', window );">Justin J. File [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 912,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 893,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Justin J. File<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=lits_DavidMUrsoMember', window );">David M Urso [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">866,258<span></span>
</td>
<td class="nump">$ 2,101,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 894,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 615,372<span></span>
</td>
<td class="nump">$ 1,721,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">David M. Urso<span></span>
</td>
<td class="text">David M. Urso<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">David M. Urso<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=lits_DanielPGoldMember', window );">Daniel P Gold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,446,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,857,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Daniel P. Gold<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Justin J. File [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Justin J. File [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,681)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | David M Urso [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,352,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | David M Urso [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,097,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | David M Urso [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (511,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | David M Urso [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 1,757<span></span>
</td>
<td class="num">$ (52,660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | David M Urso [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(252,643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Daniel P Gold [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (584,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Daniel P Gold [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Daniel P Gold [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Daniel P Gold [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (68,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79,900)<span></span>
</td>
<td class="num">$ (177,850)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,797<span></span>
</td>
<td class="nump">104,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,289)<span></span>
</td>
<td class="num">(32,041)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,468)<span></span>
</td>
<td class="num">$ (24,476)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (62,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonGaapMeasureDescriptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonGaapMeasureDescriptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=lits_JustinJFileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=lits_JustinJFileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=lits_DavidMUrsoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=lits_DavidMUrsoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=lits_DanielPGoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=lits_DanielPGoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Award Grant Practices</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have had no program, plan or practice pertaining to the timing of stock option grants to named executive officers coinciding with the release of material non-public information, or MNPI.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee has historically approved grants of options </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">annually each year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as part of our annual compensation cycle. The timing of any equity grants to newly-hired employees, or in connection with promotions or other non-routine grants, is generally tied to the event giving rise to the award (such as an executive officer&#8217;s commencement of employment or promotion effective date). Any grants to executive officers are approved at meetings of the Compensation Committee or our board of directors. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all stock option awards, the exercise price is no less than the closing price of our common stock on the date of the grant. The following table sets forth information for certain stock options granted to our named executive officers through fiscal year 2025, which there were no grants made to our named executive officers or any employees during the fiscal year ended June 30, 2025. In the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">event </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an issuer grants stock options or option-like instruments within the period commencing four business days prior to and ending one business day following the filing by the Company of a Form 10-K, Form 10-Q or Form 8-K containing material non-public information as required under Item 402(x) of Regulation S-K, Item 402(x) of Regulation S-K requires tabular disclosure of certain information related to such awards.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compensation Committee has historically approved grants of options </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">annually each year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as part of our annual compensation cycle. The timing of any equity grants to newly-hired employees, or in connection with promotions or other non-routine grants, is generally tied to the event giving rise to the award (such as an executive officer&#8217;s commencement of employment or promotion effective date). Any grants to executive officers are approved at meetings of the Compensation Committee or our board of directors. </span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_Rule10B51ArrModifiedFlag', window );">Rule 10b51 Arr Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_NonRule10B51ArrModifiedFlag', window );">Non Rule 10b51 Arr Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_NonRule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non rule 10b51 arrangement modified.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_NonRule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_Rule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rule 10b51 Arr Modified [Flag]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_Rule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Description of Business and Basis of Presentation</a></td>
<td class="text"><p id="fn1_title" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. Description of Business and</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Basis of Presentation</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Business</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pharmaceutical company that has been developing novel and differentiated cancer therapies. In August 2025, we implemented a Litecoin Treasury Strategy (as described below) with the net proceeds from the PIPE (as defined below). We built our pipeline by acquiring promising cancer agents and creating value in programs through development, strategic partnerships and out-licensing or commercialization, as appropriate. Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit. Our pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, zandelisib, </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an oral, once-daily, selective PI3K&#948; inhibitor </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and prior to its sale, ME-344 as more fully discussed in </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) related to annual reports on Form 10&#8209;K. The accompanying consolidated financial statements include the accounts of Lite Strategy, Inc. and our wholly owned subsidiary, Meadow Merger Sub, Inc. We have eliminated all intercompany accounts and transactions in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated subsequent events through the date the consolidated financial statements were issued.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Events</span></p><p id="fn1_stratalt" style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2024, we announced that our Board of Directors (Board) had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force (the Strategic Alternatives RIF) beginning August 1, 2024, which continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets will continue to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consistent with our intention to preserve cash, David M. Urso, our former President and Chief Executive Officer and Richard Ghalie, M.D., our former Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the former Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as our Chairperson of the Board.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy (as described below) and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Investment in Private Equity (PIPE) and Related Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in July 2025, we closed on a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million PIPE and issued an aggregate of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,216,898</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the Shares) of our Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the Common Stock, the Securities)), to purchase up to an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">6,022,869</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the Pre-Funded Warrant Shares) at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4199</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant. On July 24, 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,084,509</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">2,807,967</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock upon </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,808,070</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, in July 2025 and as more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Treasury Strategy (as described below), including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the-market sales agreement. As partial consideration for services provided associated with the PIPE, we issued warrants for the purchase of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,070,177</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock with a weighted-average exercise price of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">546,348</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litecoin Treasury Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), a related party, which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Common Stock that was declared on November 6, 2023 to stockholders of record at the close of business on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 17, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Cooperation Agreement). The total dividend of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements. We have accumulated losses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million since inception and expect to incur operating losses and generate negative cash flows from operations for the foreseeable future. As of June 30, 2025, we had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash and cash equivalents. In connection with our July 2024 announcement regarding the evaluation of our strategic alternatives, we discontinued the clinical development of voruciclib, while certain nonclinical research and development (R&amp;D) activities continue. As a result, we will continue to incur R&amp;D expenses in connection with our nonclinical projects. We believe that our cash balance will be sufficient to meet our obligations and fund operations for at least the next 12 months from the issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements and to continue the development of our drug candidates, we would require one or more capital transactions, whether through the sale of equity securities, debt financing, license agreements or entry into strategic partnerships at some point in the future. There can be no assurance that we will be able to continue to raise additional capital in the future.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="fn2_sumsigpolicies" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosures made in the accompanying notes to the consolidated financial statements. We use estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents consist of cash and highly liquid investments with original maturities of three months or less when purchased. Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We attempt to minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. Our investment portfolio is maintained in accordance with our investment policy, which is designed to preserve capital, safeguard funds and limit exposure to risk. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short-term investments are marketable securities with maturities greater than three months but less than one year from date of purchase. As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t hold any short-term investments. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024, we held short-term investments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in United States government securities. Our short-term investments were considered to be held to maturity and were carried at amortized cost. For the fiscal year ended June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gross unrealized gains and losses. For the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the gross unrealized gains and losses were immaterial.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value is as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1 &#8212; Observable inputs such as quoted prices in active markets for identical assets or liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2 &#8212; Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> property and equipment. Property and equipment were previously stated at cost and depreciated over the estimated useful lives of the assets (generally </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_75abda38-a80b-45e0-b57c-64913feff94d;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) using the straight-line method and leasehold improvements were stated at cost and were amortized over the shorter of the estimated useful lives of the assets or the lease term.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for our leases under ASC Topic 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Topic 842). Leases which are identified within the scope of Topic 842 and which have a term greater than one year are recognized on our consolidated balance sheets as right-of-use (ROU) assets and lease liabilities. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected remaining lease term. The lease term includes any renewal options and termination options that we are reasonably certain to exercise. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, we use our incremental borrowing rate. The incremental borrowing rate is determined based on the rate of interest that we would pay to borrow on a collateralized basis an amount equal to the lease payments for a similar term and in a similar economic environment. The interest rate implicit in lease contracts to calculate the present value is typically not readily determinable. As such, significant management judgment is required to estimate the incremental borrowing rate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease expense for operating leases is recognized on a straight-line basis over the lease term based on the total lease payments. We have elected the practical expedient to not separate lease and non-lease components for our real estate leases. Our non-lease components are primarily related to property maintenance, which varies based on future outcomes and thus is recognized in operating lease expense when incurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 18, 2024, we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of September 30, 2024, the lease for our existing office space. See </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the impact of the Agreement on our consolidated financial statements.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Customers</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606), we recognized revenue when control of the promised goods or services was transferred to our customers, in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. For enforceable contracts with our customers, we first identified the distinct performance obligations &#8211; or accounting units &#8211; within the contract. Performance obligations are commitments in a contract to transfer a distinct good or service to the customer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments received under commercial arrangements, such as licensing technology rights, may include non-refundable fees at the inception of the arrangements, milestone payments for specific achievements designated in the agreements and royalties on the sale of products. At the inception of arrangements that include milestone payments, we used judgment to evaluate whether the milestones were probable of being achieved and we estimated the amount, if any, to include in the transaction price using the most likely method. If it were probable that a significant revenue reversal would not occur, the estimated amount was included in the transaction price. Milestone payments that were not within our or the licensee&#8217;s control, such as regulatory approvals, were not included in the transaction price until those approvals were received. At the end of each reporting period, we re-evaluated the probability of achievement of development milestones and any related constraint and, as necessary, we adjusted our estimate of the overall transaction price.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent a contract included multiple promised deliverables, we applied judgment to determine whether promised deliverables were capable of being distinct and were distinct within the context of the contract. If these criteria were not met, the promised deliverables were accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, we allocated variable consideration related to our 50-50 cost share for development services directly to the associated performance obligation and then allocated the remaining consideration among the performance obligations based on their relative stand-alone selling price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When not directly observable, we typically estimated the stand-alone selling price for each distinct performance obligation. Variable consideration that related specifically to our efforts to satisfy specific performance obligations was allocated entirely to those performance obligations. Other components of the transaction price were allocated based on the relative stand-alone selling price, over which management has applied significant judgment. We developed assumptions that required judgment to determine the stand-alone selling price for license-related performance obligations, which may have included forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical, regulatory and commercial success. We estimated stand-alone selling price for R&amp;D performance obligations by forecasting the expected costs of satisfying a performance obligation plus an appropriate margin.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the case of a license that is a distinct performance obligation, we recognized revenue allocated to the license from non-refundable, up-front fees at the point in time when the license was transferred to the licensee and the licensee can use and benefit from the license. For licenses that are bundled with other distinct or combined obligations, we used judgment to assess the nature of the performance obligation to determine whether the performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. If the performance obligation is satisfied over time, we evaluated the measure of progress in each reporting period and, if necessary, adjusted the measure of performance and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. Revenue is recorded proportionally as costs are incurred. We generally used the cost-to-cost measure of progress because it best depicted the transfer of control to the customer which occurred as we incurred costs. Under the cost-to-cost measure of progress, the extent of progress towards completion was measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation (an input method under Topic 606). We used judgment to estimate the total cost expected to complete the R&amp;D performance obligations, which included subcontractors&#8217; costs, labor, materials, other direct costs and an allocation of indirect costs. We evaluated these cost estimates and the progress during each reporting period and, as necessary, we adjusted the measure of progress and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In connection with our now terminated April 2020 License, Development and Commercialization Agreement with Kyowa Kirin Co., Ltd. (KKC) (the KKC Commercialization Agreement) described in Note 7. License Agreements, we performed development services related to our 50-50 cost sharing arrangement for which revenue was recognized over time. Additionally, we performed services for KKC at their request, the costs of which were fully reimbursed to us. We recorded the reimbursement for such pass through services as revenue at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of reimbursed costs, as control of the additional services for KKC was transferred at the time we</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incurred </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such costs. The costs of these services were recognized in the consolidated statements of operations as research and development expense. The costs of these services were recognized in the consolidated statements of operations as research and development expense.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended June 30, 2025, we did not recognize any revenue associated with the KKC Commercialization Agreement. During the year ended June 30, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:77.16%;box-sizing:content-box;"></td>
           <td style="width:1.56%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:19.279999999999998%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Timing of Revenue Recognition:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Services performed over time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">743</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pass through services at a point in time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contract Balances</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contract liabilities were included in deferred revenue and deferred revenue, long-term in our consolidated balance sheets. Our contract liabilities accounted for under Topic 606 related to the amount of initial upfront consideration allocated to the development services performance obligations.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:75.52%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:20.619999999999997%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beginning balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Recognized as revenue:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized upon satisfaction of performance obligations</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized from change in estimate for performance<br/>&#160;&#160;&#160;&#160;obligations that are being closed</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized for performance obligations that will no longer <br/>&#160;&#160;&#160;&#160;commence</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ending balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The timing of revenue recognition, invoicing and cash collections results in billed accounts receivable and unbilled receivables (contract assets) and deferred revenue (contract liabilities). We invoiced our customers in accordance with agreed-upon contractual terms, typically at periodic intervals or upon achievement of contractual milestones. Invoicing may have occurred subsequent to revenue recognition, resulting in unbilled receivables. Advanced payments from our customers before revenue was recognized resulted in contract liabilities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Collaborators</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At contract inception, we assessed whether the collaboration arrangements were within the scope of ASC Topic 808 Collaborative Agreements (Topic 808), to determine whether such arrangements involved joint operating activities performed by parties that were both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment was performed based on the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of Topic 808 that contain multiple units of account, we first determined which units of account within the arrangement were within the scope of Topic 808 and which elements were within the scope of Topic 606. For units of account within collaboration arrangements that were accounted for pursuant to Topic 808, an appropriate recognition method was determined and applied consistently, by analogy to authoritative accounting literature. For elements of collaboration arrangements that were accounted for pursuant to Topic 606, we recognized revenue as discussed above. Consideration received that did not meet the requirements to satisfy Topic 606 revenue recognition criteria was recorded as deferred revenue and classified as either current or long-term deferred revenue based on our best estimate of when such amounts would be recognized.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and development costs are expensed as incurred and include costs paid to third-party contractors to perform research, conduct clinical trials and develop and manufacture drug materials, as well as personnel, related benefits (including share-based compensation) and other expenses attributable to our R&amp;D activities. Clinical trial costs, including costs associated with third-party contractors, are a significant component of R&amp;D expenses. We expense R&amp;D costs based on work performed. In determining the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to expense, management relies on estimates of total costs based on contract components completed, the enrollment of subjects, the completion of trials and other events. Costs incurred related to the purchase or licensing of in-process R&amp;D for early-stage products or products that are not commercially viable and ready for use, or have no alternative future use, are charged to expense in the period incurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Share-based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Share-based compensation expense for stock options and restricted stock units (RSUs) granted to employees and directors is recognized in the consolidated statements of operations based on estimated amounts. The cost of stock options is measured at the grant date, based on the estimated fair value of the stock option using the Black-Scholes valuation model, which incorporates various assumptions including expected volatility, risk-free interest rate, the expected term of the award and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our stock over the expected option life and other appropriate factors. We use the simplified method to calculate the expected term of share options and similar instruments as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as we do not intend to do so in the foreseeable future. For RSUs, we estimate the grant date fair value using our closing stock price on the date of grant. The estimated fair value of stock options and RSUs is amortized over the requisite service period, adjusted for actual forfeitures at the time they occur. The requisite service period is generally the time over which our share-based awards vest.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest and Dividend Income</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest on cash and investment balances is recognized when earned. Dividend income is recognized when the right to receive the payment is established.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our income tax expense consists of current and deferred income tax expense or benefit. Current income tax expense or benefit is the amount of income taxes expected to be payable or refundable for the current year. A deferred income tax asset or liability is recognized for the future tax consequences attributable to tax credits and loss carryforwards and to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2025 and 2024, we have established a valuation allowance to fully reserve our net deferred tax assets. Tax rate changes are reflected in income during the period such changes are enacted. Changes in our ownership may limit the amount of net operating loss carryforwards that can be utilized in the future to offset taxable income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Financial Accounting Standards Board (FASB) Topic ASC 740 - </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prescribes a recogn</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ition threshold and measurement attribute criteria for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unrecognized tax benefits as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disposition of Non-Financial Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for infrequent dispositions of assets in its product pipeline in accordance with ASC 610-20, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets, which requires dispositions of long-lived assets that are not a discontinued operation be accounted for on a net basis and included in income from continuing operations before income taxes in accordance with ASC 350, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets - Goodwill and Other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Proceeds from sales designated as dispositions of non-financial assets are classified as cash flows from investing activities in the consolidated statements of cash flows.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Income Per Share</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net (loss) income per share is computed using the weighted-average number of shares of Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) outstanding during the period, less any shares subject to repurchase or forfeiture. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) subject to repurchase or forfeiture for the fiscal years ended June 30, 2025 and 2024. Diluted net (loss) income per share is computed based on the sum of the weighted-average number of common shares (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) and potentially dilutive common shares outstanding during the period determined using the treasury-stock and if-converted methods.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the diluted net loss per share calculation for the fiscal year ended June 30, 2025, potentially dilutive securities are excluded from the calculation of diluted net loss per share because their effect was anti-dilutive due to our net loss. For purposes of the diluted net income per share calculation for the fiscal year ended June 30, 2024, potentially dilutive securities are excluded from the calculation of diluted net income per share because their weighted-average exercise prices were above our weighted-average share price. Therefore, basic and diluted net (loss) income per share were the same for the fiscal years ended June 30, 2025 and 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:65.5%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.8%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.7%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,357</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total anti-dilutive shares</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,460</span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncement</span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures, which modifies the disclosure and presentation requirements of reportable segments (ASU 2023-07). The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (the CODM) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Lastly, the amendment requires that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The adoption of ASU 2023-07 resulted in enhanced disclosures as included in </span><a href="#fn_segments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 12 Segment Information</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, but did not impact to our results of operations, cash flows and financial condition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that are adopted as of the specified effective date. We believe the impact of recently issued standards, other than those noted below and any issued but not yet effective standards will not have a material impact on our consolidated financial statements upon adoption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (PBE) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local,and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all periods presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows and financial condition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2025, the FASB issued ASU No. 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment in this update clarifies the effective date of ASU 2024-03, which is that public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026 and in interim periods within annual reporting periods beginning after December 15, 2027. The impact of adoption of this ASU on our disclosures is currently being evaluated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act of 2017, including 100% bonus depreciation, domestic research cost expensing and the business interest expense limitation, among other tax changes. Many of the tax provisions of the OBBBA are designed to accelerate tax deductions, which could lead to lower cash tax payments. The new legislation has multiple effective dates, with certain provisions effective in 2025 and others in the future. While we continue to assess the impact of the tax provisions of the OBBBA on our consolidated financial statements, we currently believe that the tax provisions of the legislation are not expected to have a material impact on our statement of operations.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text"><p id="fn3_bs_details" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prepaid and Other Current Assets</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid and other current assets consisted of the following in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.863000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.083%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insurance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">176</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">460</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software license</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">442</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Security deposit</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">263</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical costs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,050</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid and other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,424</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p id="fn3_prop_equip" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30. 2025, we had no property and equipment, net. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consisted of the following as of June 30, 2024, in thousands:</span></span></p><div style="font-size:11pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.68%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.68%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="border-top:0.5pt solid #ffffff;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equipment</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">969</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,156</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,764</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">392</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">_____</span></p><p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes impairment charge of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></p><p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation expense of property and equipment for the fiscal years ended June 30, 2025 and 2024 are presented in the consolidated statements of cash flows.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impact of the Agreement (as discussed in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As noted in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we agreed to sell our furniture and fixtures to the landlord for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on our lease termination date of September 30, 2024. We completed an evaluation of the impact of the Agreement, as defined in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, on the carrying value of our property and equipment (Other Long-Lived Assets). This process included evaluating the remaining estimated useful lives, significant changes in the use and potential impairment charges related to the Other Long-Lived Assets. Based upon our evaluation, we recorded an impairment charge of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the furniture and fixtures to be sold to the landlord, which is included in the impairment of long-lived assets in the consolidated statements of operations. We also changed our estimate of the remaining useful lives of our leasehold improvements resulting in an acceleration of depreciation of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during our fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued liabilities consisted of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.863000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.083%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued pre-clinical and clinical trial expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,407</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and benefits</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">873</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,821</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued legal and professional services</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued reimbursement to KKC</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">892</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,178</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,187</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Includes one-time employee benefits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">21,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="fn4_fvm" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts of financial instruments such as cash equivalents, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. We invest our excess cash in financial instruments which are readily convertible into cash, such as money market funds and U.S. government securities. Cash equivalents are classified as Level 1 as defined by the fair value hierarchy. As of June 30, 2025 and June 30, 2024, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> assets or liabilities measured on a recurring or non-recurring basis.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>One-Time Employee Termination Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAbstract', window );"><strong>Restructuring Reserve [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">One-time Employee Termination Benefits</a></td>
<td class="text"><p id="fn5_onetimetermbene" style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. One-time Employee Termination Benefits</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with our joint decision to discontinue development of zandelisib outside of Japan, in December 2022, we announced a realignment of our clinical development efforts that streamlined our organization towards the continued clinical development of our two earlier clinical-stage assets, voruciclib and ME-344 (prior to its sale in October 2024).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, we commenced the </span><a href="#fn1_stratalt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> RIF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as discussed in our strategic alternatives announcement described in </span><a href="#fn1_title"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 1. Description of Business and Basis of Presentation</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Including contractual pro-rata bonuses, we expect to incur charges not to exceed a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in retentions, severance and COBRA costs related to the termination of our employees due to our related wind down activities. The charges that we expect to incur in connection with the </span><a href="#fn1_stratalt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> RIF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> are subject to a number of assumptions and actual results may differ materially. We may also incur additional costs not currently contemplated due to events that may occur as a result of, or that are associated with, the </span><a href="#fn1_stratalt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> RIF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For each of the periods presented, one-time termination benefits primarily represent severance related costs and payments. During the fiscal years ended June 30, 2025 and 2024, we recorded employee termination benefits of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within research and development expense, respectively. During the fiscal years ended June 30, 2025 and 2024, we recorded employee termination benefits of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within general and administrative expense, respectively.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our activity related to one-time employee termination benefits, included in accrued liabilities, in thousands:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:69.96%;box-sizing:content-box;"></td>
         <td style="width:2.06%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:25.98%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">One-time Employee Termination Benefits</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">993</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in accrued restructuring</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,528</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in accrued restructuring</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,734</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,027</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/420/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="fn6_commitcon" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have contracted with various consultants and third parties to assist us in pre-clinical R&amp;D and clinical trials work for our leading drug compounds and general and administrative activities. The contracts are terminable at any time but obligate us to reimburse the providers for any time or costs incurred through the date of termination. See the discussion of the sale of ME-344 within </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for additional information regarding contracts associated with ME-344 assumed by the Purchaser (as defined in </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ). We also have an employment agreement with our Acting Chief Executive Officer and Chief Financial Officer that provides for severance payments and accelerated vesting for share-based awards if their employment is terminated under specified circumstances.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litigation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may be involved in various lawsuits, legal proceedings, or claims that arise in the ordinary course of business. Management believes there are no claims or actions pending against us as of June 30, 2025, which will have, individually or in the aggregate, a material adverse effect on its business, liquidity, financial position, or results of operations. Litigation, however, is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnification</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with our amended and restated certificate of incorporation and sixth amended and restated bylaws, we have indemnification obligations to our officers and directors for certain events or occurrences, subject to certain limits, while they are</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">serving in such capacity. There have been no claims to date and we have a directors and officers liability insurance policy that may enable it to recover a portion of any amounts paid for future claims.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Presage License Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in</span><a href="#fn8_othlicagree"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Other License Agreements</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we are party to a license agreement with Presage under which we may be required to make future payments upon the achievement of certain development, regulatory and commercial milestones, as well as potential future royalties based upon net sales. As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accruals for potential future payments as achievement of the milestones had not been met.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">License Agreements</a></td>
<td class="text"><p id="fn7_licagree" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">KKC License, Development and Commercialization Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2020, we entered into the KKC Commercialization Agreement under which we granted to KKC a co-exclusive, sublicensable, payment-bearing license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in the U.S. (the U.S. License) and an exclusive (subject to certain retained rights to perform obligations under the KKC Commercialization Agreement), sublicensable, payment-bearing, license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in countries outside of the U.S. KKC granted to us a co-exclusive, sublicensable, license under certain patents and know-how controlled by KKC to develop and commercialize zandelisib for all human indications in the U.S. and a co-exclusive, sublicensable, royalty-free, fully paid license under certain patents and know-how controlled by KKC to perform our obligations in the Ex-U.S. under the KKC Commercialization Agreement. KKC paid us an initial nonrefundable payment </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2023, we entered into a termination agreement with KKC to mutually terminate the KKC Commercialization Agreement and all other related agreements between the parties (Termination Agreement) and jointly decided to discontinue zandelisib development in the U.S. Prior to the execution of the Termination Agreement, KKC was responsible for the development and commercialization of zandelisib in Ex-U.S. and, subject to certain exceptions, was solely responsible for all costs related thereto. We also provided to KKC certain drug supplies necessary for the development and commercialization of zandelisib in the Ex-U.S., with the understanding that KKC would have assumed responsibility for manufacturing for the Ex-U.S. as soon as practicable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2023, we updated our assessment of the total transaction price from the KKC Commercialization Agreement to reflect the upfront payment, milestone payments, estimated development cost-sharing and deferred revenue. After announcing our plan to discontinue the global development of zandelisib outside of Japan, in December 2022, we decreased our estimate for variable consideration related to development cost sharing.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With the execution of the Termination Agreement, we regained full, global rights (subject to KKC's limited rights for compassionate use) and KKC has no further rights to develop, use or commercialize zandelisib in the U.S., nor do we have any remaining performance obligations with all consideration received from KKC being nonrefundable. Therefore, the remaining long-term deferred revenue as of June 30, 2023, of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that was allocated to the U.S. License obligation accounted for under Topic 808 at inception of the KKC Commercialization Agreement was recognized as revenue from collaboration agreements in the three months ended September 30, 2023, utilizing contract termination analogous to guidance provided in Topic 606.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million transaction price allocated to the U.S. License obligation accounted for under Topic 808 was included as noncurrent deferred revenue as of June 30, 2023. As of June 30, 2023, we also had deferred revenue of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the transaction price allocated to the Development Services performance obligations and recognized the remaining revenue based on the proportional performance of these development activities. The KKC Agreement was terminated on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 14, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and all remaining amounts of deferred revenue were recognized during the fiscal year ended June 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_LicensingArrangementsAbstract', window );"><strong>Licensing Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_OtherLicensingArrangementsTextBlock', window );">Other License Agreements</a></td>
<td class="text"><p id="fn8_othlicagree" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. Other License Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Presage License Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2017, we, as licensee, entered into a license agreement with Presage Biosciences, Inc. (Presage). Under the terms of the license agreement, Presage granted to us exclusive worldwide rights to develop, manufacture and commercialize voruciclib, a clinical-stage, oral and selective CDK inhibitor and related compounds. In exchange, we paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to Presage. With respect to the first indication, an incremental $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million payment, due upon dosing of the first subject in the first registration trial, will be owed to Presage, for total payments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million prior to receipt of marketing approval of the first indication in the U.S., EU or Japan. Additional potential payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will be due upon the achievement of certain development, regulatory and commercial milestones. We will also pay mid-single digit tiered royalties on the net sales of any product successfully developed. As an alternative to milestone and royalty payments related to countries in which we sublicense product rights, we will pay to Presage a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tiered </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">percentage (which decreases as product development progresses) of amounts received from such sublicensees. During the fiscal years ended June 30, 2025 and 2024, we made no payments under the Presage license agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BeiGene Collaboration</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2018, we entered into a clinical collaboration with BeiGene, Ltd. (BeiGene) to evaluate the safety and efficacy of zandelisib in combination with BeiGene&#8217;s zanubrutinib (marketed as Brukinsa&#174;), an inhibitor of Bruton&#8217;s tyrosine kinase, for the treatment of patients with B-cell malignancies. Under the terms of the clinical collaboration agreement, we amended our Phase 1b trial to include evaluation of zandelisib in combination with zanubrutinib in patients with B-cell malignancies. Study costs are being shared equally by the parties and we agreed to supply zandelisib and BeiGene agreed to supply zanubrutinib. We record the costs reimbursed by BeiGene as a reduction of our research and development expenses. We retained full commercial rights for zandelisib and BeiGene retained full commercial rights for zanubrutinib. With the discontinuation of the zandelisib program outside of Japan, this clinical collaboration was terminated on September 28, 2023. During the fiscal year ended June 30, 2025, we did not recognize cost reimbursements as a reduction of research and development expenses. Cost reimbursements recorded as a reduction of research and development expenses, in the consolidated statements of operations, during the fiscal year ended June 30, 2024, was approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_LicensingArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements [Abstract].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_LicensingArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_OtherLicensingArrangementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_OtherLicensingArrangementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p id="fn9_leases" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2020, we entered into a lease agreement for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,800</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in San Diego, California. The lease agreement contained rent escalations over the lease term and was originally scheduled to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_10d9387d-fef2-414e-8898-e24c8f8f9759;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2028</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We accounted for the lease agreement as an operating lease. The lease agreement contained an option to renew and extend the lease term, which was not included in the determination of the ROU asset and operating lease liability, as it was not reasonably certain to be exercised. In July 2022, we amended the lease to extend the lease termination date from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bee66b44-7fcb-482f-938b-2dcb4681b6b7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2028</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 30, 2029</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and to add an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,300</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space adjacent to our current office in San Diego (the Amended Lease). Upon commencement of the Amended Lease, we recognized an additional ROU asset and a corresponding operating lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Amended Lease includes variable non-lease components (e.g., common area maintenance, maintenance, etc.) that are not included in the ROU asset and operating lease liability and are reflected as an expense in the period incurred as a component of the lease cost.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lease Termination</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 18, 2024 (the Agreement Date), we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 30, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the lease for our existing office space. The original (as amended) scheduled expiration date was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 30, 2029</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As consideration for the Agreement, we agreed to pay the landlord a termination fee of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the Termination Fee) and to prepay the remaining rent due under the Agreement in the amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the Remaining Rent) and sell all the furniture and fixtures to the landlord for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (see </span><a href="#fn3_prop_equip"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">within </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for further discussion on the impact of the Agreement on our property and equipment). During fiscal year 2025, we received our security deposit from the landlord, which was previously classified as a component of prepaid and other current assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreement was accounted for as a lease modification of the original contract. As a result of the Agreement, we reduced both the remaining ROU asset and lease liability by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, resulting in no impact to our consolidated statements of operations. We reassessed the lease classification, as of the Agreement Date, noting the current classification as an operating lease remained appropriate. Both the Termination Fee and the Remaining Rent were paid prior to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subsequent to the payment of both the Termination Fee and the Remaining Rent, our lease liability was relieved and the balance was reduced to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We incurred direct costs of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in connection with the Agreement which accordingly was recorded to the ROU assets as a direct cost of modifying the Agreement. As of the Agreement Date, we determined a triggering event, in accordance with ASC 360, had occurred and therefore completed an impairment analysis on its ROU asset resulting in an impairment charge of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million being recorded in our consolidated statements of operations for the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease costs for the Amended Lease were as follows for the periods presented, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.643%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.303%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">214</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,434</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">123</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs included in operating expenses</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">214</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,557</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended June 30, 2025, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> supplemental cash flow activity. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplemental cash flow information related to our operating leases for the year ended June 30, 2024 was as follows, in thousands:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:76.155%;box-sizing:content-box;"></td>
         <td style="width:1.98%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.863999999999997%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amount included in the measurement <br/>&#160;&#160;&#160;&#160;of lease liabilities:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,612</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> remaining future minimum rental payments for our operating leases and the remaining ROU asset balance was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. During fiscal year 2024, the ROU asset balance was increased by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to direct costs associated with the Agreement. Additionally, the ROU asset balance was decreased by: (1) approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> associated with our reassessment of the lease liability as of the Agreement date and (2) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million associated with the impairment of the ROU asset, as discussed above. As of September 30, 2024, we had vacated the facility and the leased property reverted to the landlord. In addition, the ROU asset has been fully amortized.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalHomeLoanBanksAbstract', window );"><strong>Federal Home Loan Banks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p id="fn10_stockequity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. Stockholders&#8217; Equity</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Shelf Registration Statement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a shelf registration statement (February 2024 Shelf Registration Statement) that permits us to sell, from time to time, up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of common stock, preferred stock, warrants rights and units. The February 2024 Shelf Registration Statement was filed February 20, 2024 and declared effective February 28, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">At-The-Market Equity Offering</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 20, 2024, we entered into a capital on demand sales agreement (the On Demand Sales Agreement) with JonesTrading Institution Services LLC, pursuant to which we can offer and sell shares having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the ATM Program). </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of January 2, 2024, the date used under applicable rules of the SEC to determine our public float at the commencement of the offering, one-third of our public float was equal to approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> did not offer or sell any shares of our Common Stock (as defined below) under the On Demand Sales Agreement. Effective July 21, 2025, we terminated the On Demand Sales Agreement. On July 22, 2025, we entered a new Sales Agreement (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), see </span><a href="#fn_new_sales_agree"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Entry into a New Sales Agreement</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> discussion within </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for details related to the Sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> between the SPA Closing date (as defined in  </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) and September 19, 2025, we issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">882,924</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock (as defined below) for aggregate proceeds, net of the underwriter's commission of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">4.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, through our ATM Program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cooperation Agreement, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Common Stock (as defined below) that was declared on November 6, 2023 to stockholders of record at the close of business on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 17, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The total dividend of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid on December 6, 2023 and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rights Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 1, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, our Board approved and adopted a rights agreement (Rights Agreement) by and between us and Computershare, Inc., as Rights Agent (as defined in the Rights Agreement). Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a Right) for each outstanding share of our Common Stock (as defined below), par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00000002</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (each a Common Share and collectively, the Common Shares). The Rights were distributable to stockholders of record as of the close of business on October 12, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Rights and the Rights Agreement expired at the close of business on September 30, 2024. No rights were redeemed or exchanged under the Rights Agreement.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrants</span></p><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we have outstanding warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102,513</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock (as defined below) issued to Torreya Partners LLC. The warrants are fully vested, exercisable at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expire in October 2027. During the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants were exercised.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), we issued the following warrants:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.025%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.484%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.502%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.103%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:23.885%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Warrants Outstanding</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial Exercise Date</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Asset Manager Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 1</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">584,795</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.42</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 2</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.93</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 3</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.62</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 4</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.13</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Strategic Advisor Warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">438,597</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Placement Agent Warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,169,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,070,177</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,022,869</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to an investor that participated in the Offering. The Pre-Funded Warrants are immediately exercisable and have an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In July 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">2,084,509</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined below) were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,807,967</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined below) upon cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,808,070</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">546,348</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Description of Capital Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our total authorized share capital is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226,100,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares consisting of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00000002</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share (Common Stock) and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The holders of Common Stock are entitled to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one vote per share</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In the event of a liquidation, dissolution or winding up of our affairs, holders of the Common Stock will be entitled to share ratably in all our assets that are remaining after payment of our liabilities and the liquidation preference of any outstanding shares of preferred stock. All outstanding shares of Common Stock are fully paid and non-assessable. The rights, preferences and privileges of holders of Common Stock are subject to any series of preferred stock that we have issued or that we may issue in the future. The holders of Common Stock have no preemptive rights and are not subject to future calls or assessments by us.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), we issued </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">23,216,898</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">3.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, for net cash proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board has the authority to issue up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock with a par value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share in one or more series and to fix the rights, preferences, privileges and restrictions in respect of that preferred stock, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption (including sinking fund provisions), redemption prices and liquidation preferences and the number of shares constituting such series and the designation of any such series, without future vote or action by the stockholders. Therefore, the Board, without the approval of the stockholders, could authorize the issue of preferred stock with voting, conversion and other rights that could affect the voting power, dividend and other rights of the holders of shares or that could have the effect of delaying, deferring or preventing a change of control. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock outstanding as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalHomeLoanBanksAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalHomeLoanBanksAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Compensation</a></td>
<td class="text"><p id="fn11_sbc" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. Share-based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use equity-based compensation programs to provide long-term performance incentives for our employees. These incentives consist primarily of stock options and RSUs. In December 2008, we adopted the MEI Pharma, Inc. 2008 Stock Omnibus Equity Compensation Plan (the Omnibus Plan), as amended and restated from time to time, under which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,850,739</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock are authorized for issuance. The Omnibus Plan provides for the grant of options and/or other stock-based or stock-denominated awards to our non-employee directors, officers, employees and advisors. As of June 30, 2025, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">920,737</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares available for future grant under the Omnibus Plan.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2021, we adopted the 2021 Inducement Plan (Inducement Plan, together with the Omnibus Plan, the Equity Plans), under which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were authorized for issuance. On June 9, 2023 our Board approved an amendment and restatement of the Inducement Plan to increase the aggregate number of shares of Common Stock authorized for issuance by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares. The Inducement Plan is intended to assist us in attracting and retaining selected individuals to serve as employees who are expected to contribute to our success, by providing an inducement for such individuals to enter into employment with us and to achieve long-term objectives that will benefit our stockholders. As of June 30, 2025, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163,698</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares available for future grant under the Inducement Plan.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total share-based compensation expense for all stock awards consists of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.86%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.940000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.700000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">128</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,929</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total share-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,278</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock options granted to employees vest </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% one year from the date of grant and ratably each month thereafter for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months and expire ten years from the date of grant. Stock options granted to directors vest ratably each month for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months from the date of grant and expire </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of grant. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025, there were a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869,148</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options outstanding of which </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">815,846</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> were granted under the Omnibus Plan and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,302</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> were granted under the Inducement Plan.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> A summary of our stock option activity and related data follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.689%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.902%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.202%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.523%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:6.2010000000000005%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Options</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Remaining Contractual<br/>Term (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,357,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">488,065</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.64</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869,148</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869,148</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025, the aggregate intrinsic value of outstanding options is calculated as the difference between the exercise price of the underlying options and the closing price of our Common Stock of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">2.47</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on that date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unrecognized compensation expense related to non-vested stock options totaled </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025. Such compensation expense is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.17</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025, we expect all outstanding options to vest.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use a Black-Scholes valuation model to estimate the grant date fair value of stock options. During the year ended June 30, 2025, we did not grant any stock options. During the fiscal year ended June 30, 2024,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">following weighted-average assumptions were used to calculate these fair values:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:79.52%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.86%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life (years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.7</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.8</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend yield</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average grant date fair value</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.20</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><p id="fn_segments" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 12. Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the CODM, which is our Acting </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2254fbc2-926d-4ef0-b4be-2c017a79ef44;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Chief Financial Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in deciding how to allocate resources and assess performance. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our CODM evaluates our financial information including year over year profit and loss comparisons and cash projections on an aggregate basis when assessing performance for allocating financial and personnel resources.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are not organized by market and are managed and operated as one business.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We identify our operating segments based on our business activities. We operate within a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b5129ee1-cc18-4e29-a225-35da57c0a01a;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment, the development of pharmaceutical products. During fiscal 2025, we did not generate any revenue. During fiscal 2024, all revenues were generated in the United States. Our administrative functions including finance, business development and information systems, support the development of pharmaceutical products segment. We operate in one geographic area, the United States. The CODM allocates resources (inclusive of both capital and personnel) based upon our net loss, which is utilized to monitor year over year variances on a quarterly basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the development of pharmaceutical products segment are the same as those described in </span><a href="#fn2_sumsigpolicies"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Significant Accounting Policies</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All our assets are in the United States. The measure of segment assets is reported on the balance sheets as total assets. We do not have intra-entity sales or transfers.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended, June 30, 2025 and 2024, we had no transactions denominated in foreign currencies nor any intangible property for which we recognized amortization expense. During the years ended June 30, 2025 and 2024, we did recognize depreciation expense which we have included in "other expenses" within the table below. Depreciation expense is reported in our statements of cash flows and is expected to be zero during fiscal 2026. Non-cash expenses such as depreciating assets and share-based compensation are not part of the CODM's evaluation or decision-making process.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our financial data for the development of pharmaceutical products segment:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenues</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,297</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating and other (income) expense</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employee expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,293</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,207</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment expenses</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,647</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,946</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,754</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,092</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal fees</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,723</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,397</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,899</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fees paid on behalf of a related party</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,118</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">voruciclib</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">801</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,413</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ME-344</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">253</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,724</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on disposition of a non-financial asset</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,026</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating and other (income) expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,519</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total segment costs (loss) income and net (loss) income</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,778</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________</span></p><p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of a Non-Financial Asset<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Disposition of a Non-financial Asset</a></td>
<td class="text"><p id="fn_dis_nonfin_asset" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 22, 2024 </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Closing Date), we and Aardvark Therapeutics, Inc. (the Purchaser), entered into an Asset Purchase Agreement (the Asset Purchase Agreement), whereby we sold to the Purchaser our rights, title and interest in and to certain assets related to ME-344, including relevant intellectual property rights, technology and contracts (the ME-344 Sale). Pursuant to the Asset</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchase </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreement, the Purchaser paid us an initial payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash plus a reimbursement amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> at the closing of the transaction. The Purchaser may also make future milestone payments up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after the Closing Date, payable upon the achievement of certain regulatory and revenue milestones. The Purchaser also assumed certain of our liabilities after the Closing Date, including liabilities arising under the contracts transferred under the Asset Purchase Agreement. During the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025, no milestone were met.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ME-344 Sale did not trigger a discontinued operation as the intellectual property sold did not represent a component of our business. Additionally, we concluded the ME-344 Sale met all the criteria to be derecognized on the Closing Date. Variable consideration, such as future potential regulatory and revenue milestones have been fully constrained. As such, as of the Closing Date and December 31, 2024, we determined the transaction price to be the initial payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Accordingly, we recognized a gain, upon satisfaction of our obligations under the Asset Purchase Agreement, of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a separate component of other income (expense), net in the consolidated statements of operations. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reimbursement by the Purchaser represented work performed at the Purchaser's request prior to the Closing Date, which they agreed to reimburse. The reimbursement did not represent a liability assumed or relieved by the Purchaser and was, therefore, not included in the calculation of the gain on the disposition of the ME-344 asset. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reimbursement was recognized as contra research and development expense in accordance with our reimbursement policy for pass through services.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 14. Income Taxes</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-tax loss consists of the following jurisdictions, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:67.313%;box-sizing:content-box;"></td>
         <td style="width:1.5%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.843%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.5%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.843%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Domestic</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,778</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-tax (loss) income</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,778</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The reconciliation of income tax computed at the U.S. federal statutory tax rates to income tax expense is as follows, in thousands:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:39.1%;box-sizing:content-box;"></td>
         <td style="width:1.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.84%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.98%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax (benefit) expense at U.S. statutory rates</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,349</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,733</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax (benefit) expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,733</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">796</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,671</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">901</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,782</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,281</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 162(m) limitation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">507</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">483</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">122</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">368</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax liabilities and assets are comprised of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:67.606%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.817%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.817%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets (liabilities):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax losses carried forward</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,346</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,721</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalization of R&amp;D costs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,456</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed and intangible assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,881</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,058</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,375</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,081</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">700</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">647</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,700</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,918</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance for deferred tax assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,700</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,918</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets and liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We evaluate the recoverability of the deferred tax assets and the amount of the required valuation allowance. Due to the uncertainty surrounding the realization of the tax deductions in future tax returns, we have recorded a valuation allowance against our net deferred tax assets as of June 30, 2025 and 2024. At such time as it is determined that it is more likely than not that the deferred tax assets will be realized, the valuation allowance would be reduced.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We had federal and state net operating loss carryforwards of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">246.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The federal net operating loss will carry forward indefinitely subject to an </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% taxable income limitation. The state net operating loss carryforwards will begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2031</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unless previously utilized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards may be substantially limited due to ownership changes that have occurred or that could occur in the future under Section 382 of the Internal Revenue Code (Section 382) and similar state laws. A Section 382 study was completed through December 31, 2021, to analyze whether one or more ownership changes had occurred and determined that two such ownership changes did occur. We have not completed a Section 382 study through June 30, 2025. If an ownership change occurred our ability to utilize our net operating loss carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None of our prior income tax returns have been selected for examination by a major taxing jurisdiction; however, the statutes of limitations for various filings remain open. The oldest filings subject to potential examination for federal and state purposes are 2021 and 2020, respectively. If we utilize a net operating loss related to a closed tax year, the tax year in which the loss was incurred is subject to adjustment up to the amount of the net operating loss.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not reduced any tax benefit on our consolidated financial statements due to uncertain tax positions as of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and we are not aware of any circumstance that would significantly change this result through the end of fiscal year 2026. To the extent we incur income-tax related penalties or interest, we will recognize them as additional income tax expense.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="fn_subevent" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. Subsequent Events</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Securities Purchase Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 17, 2025, we entered into securities purchase agreements (the Securities Purchase Agreements) with certain investors (the Purchasers) pursuant to which we agreed to sell and issue to the Purchasers in a private placement offering (the Offering or the PIPE) an aggregate of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,216,898</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock, at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and (ii) Pre-Funded Warrants, to purchase up to an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">6,022,869</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4199</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant in exchange for net proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at the exercise price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant Share and may be exercised at any time until all the Pre-Funded Warrants issued in the Offering are exercised in full. Each Purchaser&#8217;s ability to exercise its Pre-Funded Warrants in exchange for shares of Common Stock is subject to certain beneficial ownership limitations set forth therein. The Offering closed on July 22, 2025 (the SPA Closing Date). On July 24, 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,084,509</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were exercised, respectively, for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,807,967</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock upon</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,808,070</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Placement Agency Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 17, 2025, we also entered into a Placement Agency Agreement (the Placement Agency Agreement) with Titan Partners Group LLC, a division of American Capital Partners, LLC (Titan), pursuant to which Titan agreed to serve as the exclusive placement agent for us in connection with the Offering. We agreed to pay Titan a cash fee equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate gross cash proceeds received in the Offering (or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million). We also agreed to issue Titan warrants (the Placement Agent Warrants) to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,169,591</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Securities sold in the Offering) (the Placement Agent Warrant Shares), at an exercise price per share equal to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, exercisable, in whole or in part, at any time and from time to time, for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_471041f0-6337-4d57-89cb-a763e2396550;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance. In addition, we agreed to reimburse Titan for reasonable accountable expenses in an amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including legal fees in connection with the Offering.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Asset Management Agreement (the Asset Management Agreement)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, we and GSR Strategies LLC (GSR or the Asset Manager) entered into the Asset Management Agreement. The Asset Manager shall provide discretionary investment management services with respect to, among other assets, our proceeds from the Offering (the Account Assets) in accordance with the terms of the Asset Management Agreement. The Asset Manager will pursue a long-only investment strategy investing primarily in LTC. The custodians under the Asset Management Agreement will consist of Coinbase and other cryptocurrency wallet providers agreed to by us and the Asset Manager.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We shall pay the Asset Manager an asset-based fee (the Asset-based Fee) equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum of the Account Assets under management. The Asset-based Fee shall be paid in shares of Common Stock until the Asset Manager owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our issued</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">outstanding Common Stock and thereafter, the Asset-based Fee shall be paid in Pre-Funded Warrants (the GSR Pre-Funded Warrants) to purchase shares of Common Stock (the GSR Pre-Funded Warrant Shares). The number of shares of Common Stock or GSR Pre-Funded Warrants will be issued to be equal to the dollar amount of the Asset-based Fee being paid, divided by the average volume-weighted average price (VWAP) of the Common Stock for the 30 trading days ending with the trading day prior to the date that is the applicable 12-month anniversary of the SPA Closing Date (the Fee Reference Date).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As compensation for services rendered by the Asset Manager under the Asset Management Agreement, we issued warrants (the GSR Warrants) to the Asset Manager on the SPA Closing Date to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,461,989</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the GSR Warrant Shares) at various exercise prices per share of Common Stock as follows: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">584,795</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.93</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; (iii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.62</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; and (iv) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The GSR Warrants are exercisable, in whole or in part, at any time for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_da2a1c44-7a41-4557-8068-3921e2100485;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Asset Management Agreement will, unless terminated earlier in accordance with its terms, remain in effect until the tenth anniversary of the date of the Asset Management Agreement. Beginning on the first anniversary of the AMA Effective Date (as defined below), the Asset Management Agreement may be terminated upon at least 90 days prior written notice to the other party (i) by us upon a determination of the Board to end the Lite Treasury Strategy, or (ii) by the Asset Manager for any reason. Additionally, the Asset Management Agreement may be terminated for cause (i) by us upon at least 30 days prior written notice to the Asset Manager or (ii) by the Asset Manager upon at least 60 days prior written notice to us.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">546,348</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advisory Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025 (the AMA Effective Date), we also entered into an Advisory Agreement (the Advisory Agreement) with Green Dragon Investments LLC (Green Dragon). Pursuant to the Advisory Agreement, Green Dragon will provide us with asset management services with respect to the Account Assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We shall pay Green Dragon an asset-based fee (the Annual Advisory Fee) in warrants (the Advisory Warrants) to purchase a number of shares of the Common Stock (Advisory Warrant Shares) equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum of the Account Assets for such year, as calculated in accordance with the Asset Management Agreement. The number of Advisory Warrants to be issued for any given year shall be equal to the dollar amount of the Annual Advisory Fee for such year, divided by the average VWAP of the Common Stock for the 30 trading days ending with the trading day prior to the associated Fee Reference Date. The exercise price per share of the Advisory Warrants shall be set at a price equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Advisory Warrants shall be exercisable, in whole or in part, at any time for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e6417c3a-45fe-44f8-aa59-aea60d182067;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance. The Advisory Warrants issued each year shall vest in four equal installments on the Fee Reference Date on which they are issued and then the succeeding three month anniversaries thereof.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Advisory Agreement will, unless terminated earlier in accordance with its terms, remain in effect until the tenth anniversary of the Advisory Agreement. Either party may terminate the Advisory Agreement, with or without reason, by written notice to the other.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Advisor Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, we also entered into a Strategic Advisor Agreement (the Strategic Advisor Agreement) with Green Grass Ventures (GGV). Pursuant to the Strategic Advisor Agreement, GGV provides us with strategic advice and guidance relating to the private placement of equity and equity-linked securities in connection with a proposed cryptocurrency asset management strategy, as well as with the Offering. As compensation for services rendered by GGV under the Strategic Advisor Agreement, upon the closing of the Offering, we issued warrants (the Strategic Advisor Warrants) to GGV to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">438,597</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the Strategic Advisor Warrant Shares). The exercise price per share of the Strategic Advisor Warrants is equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Warrants shall be exercisable, in whole or in part, at any time for a period of five years from the date of issuance. The Strategic Advisor Agreement terminated in accordance with its terms on the SPA Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Termination of the Cooperation Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective July 22, 2025, upon closing of the Offering, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Board of Directors Composition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, in accordance with the certain Cooperation Agreement, Taheer Datoo and James Flynn tendered their resignations from the Board upon the Investors (as defined in the Cooperation Agreement) ceasing to own the Minimum Ownership Amount (as defined in the Cooperation Agreement). The Board accepted the resignation of Taheer Datoo and rejected the resignation of James Flynn. Upon closing of the Offering, the Board elected Charlie Lee to the Board. Mr. Lee is the creator of LTC and Director of the Litecoin Foundation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, Steven D. Wood informed the Board of his decision to resign from the Board, effective immediately. On August 5, 2025, the Board elected Joshua Riezman to the Board. Mr. Riezman is Managing Director and Head of U.S. Legal and Compliance for GSR.</span></p><p id="fn_new_sales_agree" style="margin-left:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Entry into a New Sales Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We entered into a Sales Agreement (the Sales Agreement) with Titan (in such capacity, the Agent), pursuant to which we may sell, from time to time, at its option, up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in aggregate principal amount of an indeterminate amount of shares (the ATM Shares) of Common Stock, through the Agent, as our sales agent. We will pay the Agent a commission of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the gross sales price of the ATM Shares sold pursuant to the Sales Agreement, if any.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any ATM Shares to be offered and sold under the Sales Agreement will be issued and sold (i) by methods deemed to be an at-the-market offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or in negotiated transactions, if authorized by us and (ii) pursuant to the Registration Statement on Form S-3 filed by us with the SEC on February 20, 2024 for an offering of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of various securities, including shares of our Common Stock, preferred stock, warrants, rights and/or units for sale to the public in one or more public offerings, which became effective on February 28, 2024 (the Registration Statement).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The offering of the ATM Shares will terminate upon the earliest of (a) the issuance and sale of all of the ATM Shares by the Agent on the terms and subject to the conditions set forth in the Sales Agreement and (b) the termination of the Sales Agreement by either of the parties thereto.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Option Grants</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 15, 2025, our Board approved option grants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">124,250</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options to members of our Board and employees, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.07</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On August 8, 2025, commensurate with Mr. Riezman's appointment to our Board, our Board approved an initial option grant for Mr. Riezman for the purchase of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.19</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sales under our ATM Program</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Between the SPA Closing Date and September 23, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">882,924</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock at an average selling price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4484</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for gross proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, less underwriter's commission and expenses of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, for net proceeds of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, through our ATM Program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Master Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 3, 2025, we entered into a master loan agreement (the Loan Agreement) with BitGo Prime, LLC (Lender). The Loan Agreement creates a framework under which we may borrow any digital assets or cash from Lender from time to time. Each loan is documented in a separate loan request agreed to by the parties setting for the specific terms, including principal amount, fees, collateral requirements and the date on which the loan is to commence and mature.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The loan fee, effectively the interest rate on the borrowed amounts, is to be determined for each loan and is calculated on a daily basis at the annualized rate specified in each confirmation.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each loan may have a fixed term, or may include a call option or prepayment option, as specified in each loan request. In general, either party can terminate a loan by providing notice within the time frame set forth in the Loan Agreement. Upon termination, the borrowed digital assets or cash must be returned and the related collateral released.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Borrowings under the Loan Agreement are secured by collateral in favor of the Lender. Collateral may include cash or other forms agreed upon by the Parties. The collateral&#8217;s required value is typically higher than the borrowed amount, subject to margin calls as set forth in the Loan Agreement. If the value of posted collateral falls below the margin call threshold, the Company must promptly</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">post additional collateral. Failure to maintain sufficient collateral can result in an event of default and remedies available to the Lender, including the right to liquidate pledged collateral.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Loan Agreement contains representations and warranties and affirmative and negative covenants customary for financings of this type, as well as customary events of default.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Business</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pharmaceutical company that has been developing novel and differentiated cancer therapies. In August 2025, we implemented a Litecoin Treasury Strategy (as described below) with the net proceeds from the PIPE (as defined below). We built our pipeline by acquiring promising cancer agents and creating value in programs through development, strategic partnerships and out-licensing or commercialization, as appropriate. Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit. Our pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, zandelisib, </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an oral, once-daily, selective PI3K&#948; inhibitor </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and prior to its sale, ME-344 as more fully discussed in </span><a href="#fn_dis_nonfin_asset"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 13. Disposition of a Non-Financial Asset</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) related to annual reports on Form 10&#8209;K. The accompanying consolidated financial statements include the accounts of Lite Strategy, Inc. and our wholly owned subsidiary, Meadow Merger Sub, Inc. We have eliminated all intercompany accounts and transactions in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated subsequent events through the date the consolidated financial statements were issued.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_CurrentEventsAndReductionInForcePolicyTextBlock', window );">Current Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Events</span></p><p id="fn1_stratalt" style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Alternatives</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2024, we announced that our Board of Directors (Board) had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force (the Strategic Alternatives RIF) beginning August 1, 2024, which continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets will continue to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consistent with our intention to preserve cash, David M. Urso, our former President and Chief Executive Officer and Richard Ghalie, M.D., our former Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the former Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as our Chairperson of the Board.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy (as described below) and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Investment in Private Equity (PIPE) and Related Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in July 2025, we closed on a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million PIPE and issued an aggregate of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,216,898</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the Shares) of our Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the Common Stock, the Securities)), to purchase up to an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">6,022,869</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (the Pre-Funded Warrant Shares) at an offering price of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4199</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant. On July 24, 2025, Pre-Funded Warrants for the purchase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,084,509</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were exercised for a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amount of cash proceeds. As of September 23, 2025, we </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">issued </span><span style="font-size:10pt;font-family:'times new roman',serif;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">2,807,967</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> shares of Common Stock upon </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;">cashless exercises of </span><span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,808,070</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, in July 2025 and as more fully discussed in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Treasury Strategy (as described below), including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the-market sales agreement. As partial consideration for services provided associated with the PIPE, we issued warrants for the purchase of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,070,177</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of our Common Stock with a weighted-average exercise price of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">546,348</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litecoin Treasury Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cooperation Agreement and Cash Dividend</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), a related party, which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Common Stock that was declared on November 6, 2023 to stockholders of record at the close of business on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 17, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Cooperation Agreement). The total dividend of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_LiquidityPolicyTextBlock', window );">Liquidity</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements. We have accumulated losses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million since inception and expect to incur operating losses and generate negative cash flows from operations for the foreseeable future. As of June 30, 2025, we had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash and cash equivalents. In connection with our July 2024 announcement regarding the evaluation of our strategic alternatives, we discontinued the clinical development of voruciclib, while certain nonclinical research and development (R&amp;D) activities continue. As a result, we will continue to incur R&amp;D expenses in connection with our nonclinical projects. We believe that our cash balance will be sufficient to meet our obligations and fund operations for at least the next 12 months from the issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have obtained cash and funded our operations primarily through equity financings and license agreements and to continue the development of our drug candidates, we would require one or more capital transactions, whether through the sale of equity securities, debt financing, license agreements or entry into strategic partnerships at some point in the future. There can be no assurance that we will be able to continue to raise additional capital in the future.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_CurrentEventsAndReductionInForcePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current events and reduction in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_CurrentEventsAndReductionInForcePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_LiquidityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Disclosure In Its Entirety Pertaining to the Accounting Policy In Respect Of Liquid Resources Held By The Entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_LiquidityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosures made in the accompanying notes to the consolidated financial statements. We use estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents consist of cash and highly liquid investments with original maturities of three months or less when purchased. Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We attempt to minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. Our investment portfolio is maintained in accordance with our investment policy, which is designed to preserve capital, safeguard funds and limit exposure to risk. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short-term investments are marketable securities with maturities greater than three months but less than one year from date of purchase. As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t hold any short-term investments. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024, we held short-term investments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in United States government securities. Our short-term investments were considered to be held to maturity and were carried at amortized cost. For the fiscal year ended June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gross unrealized gains and losses. For the fiscal year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the gross unrealized gains and losses were immaterial.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value is as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1 &#8212; Observable inputs such as quoted prices in active markets for identical assets or liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2 &#8212; Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> property and equipment. Property and equipment were previously stated at cost and depreciated over the estimated useful lives of the assets (generally </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_75abda38-a80b-45e0-b57c-64913feff94d;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) using the straight-line method and leasehold improvements were stated at cost and were amortized over the shorter of the estimated useful lives of the assets or the lease term.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for our leases under ASC Topic 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Topic 842). Leases which are identified within the scope of Topic 842 and which have a term greater than one year are recognized on our consolidated balance sheets as right-of-use (ROU) assets and lease liabilities. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected remaining lease term. The lease term includes any renewal options and termination options that we are reasonably certain to exercise. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, we use our incremental borrowing rate. The incremental borrowing rate is determined based on the rate of interest that we would pay to borrow on a collateralized basis an amount equal to the lease payments for a similar term and in a similar economic environment. The interest rate implicit in lease contracts to calculate the present value is typically not readily determinable. As such, significant management judgment is required to estimate the incremental borrowing rate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease expense for operating leases is recognized on a straight-line basis over the lease term based on the total lease payments. We have elected the practical expedient to not separate lease and non-lease components for our real estate leases. Our non-lease components are primarily related to property maintenance, which varies based on future outcomes and thus is recognized in operating lease expense when incurred.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 18, 2024, we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of September 30, 2024, the lease for our existing office space. See </span><a href="#fn3_bs_details"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 3. Balance Sheet Details</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the impact of the Agreement on our consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Customers</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606), we recognized revenue when control of the promised goods or services was transferred to our customers, in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. For enforceable contracts with our customers, we first identified the distinct performance obligations &#8211; or accounting units &#8211; within the contract. Performance obligations are commitments in a contract to transfer a distinct good or service to the customer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments received under commercial arrangements, such as licensing technology rights, may include non-refundable fees at the inception of the arrangements, milestone payments for specific achievements designated in the agreements and royalties on the sale of products. At the inception of arrangements that include milestone payments, we used judgment to evaluate whether the milestones were probable of being achieved and we estimated the amount, if any, to include in the transaction price using the most likely method. If it were probable that a significant revenue reversal would not occur, the estimated amount was included in the transaction price. Milestone payments that were not within our or the licensee&#8217;s control, such as regulatory approvals, were not included in the transaction price until those approvals were received. At the end of each reporting period, we re-evaluated the probability of achievement of development milestones and any related constraint and, as necessary, we adjusted our estimate of the overall transaction price.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent a contract included multiple promised deliverables, we applied judgment to determine whether promised deliverables were capable of being distinct and were distinct within the context of the contract. If these criteria were not met, the promised deliverables were accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, we allocated variable consideration related to our 50-50 cost share for development services directly to the associated performance obligation and then allocated the remaining consideration among the performance obligations based on their relative stand-alone selling price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When not directly observable, we typically estimated the stand-alone selling price for each distinct performance obligation. Variable consideration that related specifically to our efforts to satisfy specific performance obligations was allocated entirely to those performance obligations. Other components of the transaction price were allocated based on the relative stand-alone selling price, over which management has applied significant judgment. We developed assumptions that required judgment to determine the stand-alone selling price for license-related performance obligations, which may have included forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical, regulatory and commercial success. We estimated stand-alone selling price for R&amp;D performance obligations by forecasting the expected costs of satisfying a performance obligation plus an appropriate margin.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the case of a license that is a distinct performance obligation, we recognized revenue allocated to the license from non-refundable, up-front fees at the point in time when the license was transferred to the licensee and the licensee can use and benefit from the license. For licenses that are bundled with other distinct or combined obligations, we used judgment to assess the nature of the performance obligation to determine whether the performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. If the performance obligation is satisfied over time, we evaluated the measure of progress in each reporting period and, if necessary, adjusted the measure of performance and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. Revenue is recorded proportionally as costs are incurred. We generally used the cost-to-cost measure of progress because it best depicted the transfer of control to the customer which occurred as we incurred costs. Under the cost-to-cost measure of progress, the extent of progress towards completion was measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation (an input method under Topic 606). We used judgment to estimate the total cost expected to complete the R&amp;D performance obligations, which included subcontractors&#8217; costs, labor, materials, other direct costs and an allocation of indirect costs. We evaluated these cost estimates and the progress during each reporting period and, as necessary, we adjusted the measure of progress and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In connection with our now terminated April 2020 License, Development and Commercialization Agreement with Kyowa Kirin Co., Ltd. (KKC) (the KKC Commercialization Agreement) described in Note 7. License Agreements, we performed development services related to our 50-50 cost sharing arrangement for which revenue was recognized over time. Additionally, we performed services for KKC at their request, the costs of which were fully reimbursed to us. We recorded the reimbursement for such pass through services as revenue at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of reimbursed costs, as control of the additional services for KKC was transferred at the time we</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incurred </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such costs. The costs of these services were recognized in the consolidated statements of operations as research and development expense. The costs of these services were recognized in the consolidated statements of operations as research and development expense.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended June 30, 2025, we did not recognize any revenue associated with the KKC Commercialization Agreement. During the year ended June 30, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:77.16%;box-sizing:content-box;"></td>
           <td style="width:1.56%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:19.279999999999998%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Timing of Revenue Recognition:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Services performed over time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">743</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pass through services at a point in time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contract Balances</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contract liabilities were included in deferred revenue and deferred revenue, long-term in our consolidated balance sheets. Our contract liabilities accounted for under Topic 606 related to the amount of initial upfront consideration allocated to the development services performance obligations.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:75.52%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:20.619999999999997%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beginning balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Recognized as revenue:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized upon satisfaction of performance obligations</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized from change in estimate for performance<br/>&#160;&#160;&#160;&#160;obligations that are being closed</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized for performance obligations that will no longer <br/>&#160;&#160;&#160;&#160;commence</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ending balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The timing of revenue recognition, invoicing and cash collections results in billed accounts receivable and unbilled receivables (contract assets) and deferred revenue (contract liabilities). We invoiced our customers in accordance with agreed-upon contractual terms, typically at periodic intervals or upon achievement of contractual milestones. Invoicing may have occurred subsequent to revenue recognition, resulting in unbilled receivables. Advanced payments from our customers before revenue was recognized resulted in contract liabilities.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Collaborators</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At contract inception, we assessed whether the collaboration arrangements were within the scope of ASC Topic 808 Collaborative Agreements (Topic 808), to determine whether such arrangements involved joint operating activities performed by parties that were both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment was performed based on the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of Topic 808 that contain multiple units of account, we first determined which units of account within the arrangement were within the scope of Topic 808 and which elements were within the scope of Topic 606. For units of account within collaboration arrangements that were accounted for pursuant to Topic 808, an appropriate recognition method was determined and applied consistently, by analogy to authoritative accounting literature. For elements of collaboration arrangements that were accounted for pursuant to Topic 606, we recognized revenue as discussed above. Consideration received that did not meet the requirements to satisfy Topic 606 revenue recognition criteria was recorded as deferred revenue and classified as either current or long-term deferred revenue based on our best estimate of when such amounts would be recognized.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and development costs are expensed as incurred and include costs paid to third-party contractors to perform research, conduct clinical trials and develop and manufacture drug materials, as well as personnel, related benefits (including share-based compensation) and other expenses attributable to our R&amp;D activities. Clinical trial costs, including costs associated with third-party contractors, are a significant component of R&amp;D expenses. We expense R&amp;D costs based on work performed. In determining the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to expense, management relies on estimates of total costs based on contract components completed, the enrollment of subjects, the completion of trials and other events. Costs incurred related to the purchase or licensing of in-process R&amp;D for early-stage products or products that are not commercially viable and ready for use, or have no alternative future use, are charged to expense in the period incurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Share-based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Share-based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Share-based compensation expense for stock options and restricted stock units (RSUs) granted to employees and directors is recognized in the consolidated statements of operations based on estimated amounts. The cost of stock options is measured at the grant date, based on the estimated fair value of the stock option using the Black-Scholes valuation model, which incorporates various assumptions including expected volatility, risk-free interest rate, the expected term of the award and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our stock over the expected option life and other appropriate factors. We use the simplified method to calculate the expected term of share options and similar instruments as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as we do not intend to do so in the foreseeable future. For RSUs, we estimate the grant date fair value using our closing stock price on the date of grant. The estimated fair value of stock options and RSUs is amortized over the requisite service period, adjusted for actual forfeitures at the time they occur. The requisite service period is generally the time over which our share-based awards vest.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_InterestIncomePolicyTextBlock', window );">Interest and Dividend Income</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest and Dividend Income</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest on cash and investment balances is recognized when earned. Dividend income is recognized when the right to receive the payment is established.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our income tax expense consists of current and deferred income tax expense or benefit. Current income tax expense or benefit is the amount of income taxes expected to be payable or refundable for the current year. A deferred income tax asset or liability is recognized for the future tax consequences attributable to tax credits and loss carryforwards and to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2025 and 2024, we have established a valuation allowance to fully reserve our net deferred tax assets. Tax rate changes are reflected in income during the period such changes are enacted. Changes in our ownership may limit the amount of net operating loss carryforwards that can be utilized in the future to offset taxable income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Financial Accounting Standards Board (FASB) Topic ASC 740 - </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prescribes a recogn</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ition threshold and measurement attribute criteria for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unrecognized tax benefits as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_DispositionOfNon-FinancialAssetsPolicyTextBlock', window );">Disposition of Non-Financial Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disposition of Non-Financial Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for infrequent dispositions of assets in its product pipeline in accordance with ASC 610-20, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets, which requires dispositions of long-lived assets that are not a discontinued operation be accounted for on a net basis and included in income from continuing operations before income taxes in accordance with ASC 350, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets - Goodwill and Other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Proceeds from sales designated as dispositions of non-financial assets are classified as cash flows from investing activities in the consolidated statements of cash flows.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Income Per Share</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net (loss) income per share is computed using the weighted-average number of shares of Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) outstanding during the period, less any shares subject to repurchase or forfeiture. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) subject to repurchase or forfeiture for the fiscal years ended June 30, 2025 and 2024. Diluted net (loss) income per share is computed based on the sum of the weighted-average number of common shares (as defined in </span><a href="#fn10_stockequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) and potentially dilutive common shares outstanding during the period determined using the treasury-stock and if-converted methods.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the diluted net loss per share calculation for the fiscal year ended June 30, 2025, potentially dilutive securities are excluded from the calculation of diluted net loss per share because their effect was anti-dilutive due to our net loss. For purposes of the diluted net income per share calculation for the fiscal year ended June 30, 2024, potentially dilutive securities are excluded from the calculation of diluted net income per share because their weighted-average exercise prices were above our weighted-average share price. Therefore, basic and diluted net (loss) income per share were the same for the fiscal years ended June 30, 2025 and 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:65.5%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.8%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.7%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,357</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total anti-dilutive shares</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,460</span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncement</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncement</span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures, which modifies the disclosure and presentation requirements of reportable segments (ASU 2023-07). The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (the CODM) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Lastly, the amendment requires that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The adoption of ASU 2023-07 resulted in enhanced disclosures as included in </span><a href="#fn_segments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 12 Segment Information</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, but did not impact to our results of operations, cash flows and financial condition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that are adopted as of the specified effective date. We believe the impact of recently issued standards, other than those noted below and any issued but not yet effective standards will not have a material impact on our consolidated financial statements upon adoption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (PBE) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local,and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all periods presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows and financial condition.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2025, the FASB issued ASU No. 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment in this update clarifies the effective date of ASU 2024-03, which is that public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026 and in interim periods within annual reporting periods beginning after December 15, 2027. The impact of adoption of this ASU on our disclosures is currently being evaluated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act of 2017, including 100% bonus depreciation, domestic research cost expensing and the business interest expense limitation, among other tax changes. Many of the tax provisions of the OBBBA are designed to accelerate tax deductions, which could lead to lower cash tax payments. The new legislation has multiple effective dates, with certain provisions effective in 2025 and others in the future. While we continue to assess the impact of the tax provisions of the OBBBA on our consolidated financial statements, we currently believe that the tax provisions of the legislation are not expected to have a material impact on our statement of operations.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_DispositionOfNon-FinancialAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposition of non-financial assets policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_DispositionOfNon-FinancialAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_InterestIncomePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for interest income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_InterestIncomePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue Associated with License Agreement</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):</span>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:77.16%;box-sizing:content-box;"></td>
           <td style="width:1.56%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:19.279999999999998%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Timing of Revenue Recognition:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Services performed over time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">743</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pass through services at a point in time</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Unbilled Receivables and Contract Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:75.52%;box-sizing:content-box;"></td>
           <td style="width:1.86%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:20.619999999999997%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beginning balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Recognized as revenue:</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized upon satisfaction of performance obligations</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized from change in estimate for performance<br/>&#160;&#160;&#160;&#160;obligations that are being closed</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue recognized for performance obligations that will no longer <br/>&#160;&#160;&#160;&#160;commence</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ending balance</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
           <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Antidilutive Securities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:65.5%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.8%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.7%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,357</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
           <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total anti-dilutive shares</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,460</span></p></td>
           <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid and other current assets consisted of the following in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.863000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.083%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insurance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">176</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">460</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software license</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">442</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Security deposit</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">263</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical costs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,050</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid and other current assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,424</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consisted of the following as of June 30, 2024, in thousands:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.68%;box-sizing:content-box;"></td>
         <td style="width:1.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.68%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="border-top:0.5pt solid #ffffff;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equipment</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">969</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,156</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,764</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">392</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">_____</span></p><p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes impairment charge of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></p><p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued liabilities consisted of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.863000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.083%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued pre-clinical and clinical trial expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,407</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and benefits</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">873</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,821</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued legal and professional services</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued reimbursement to KKC</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">892</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,178</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,187</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Includes one-time employee benefits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">21,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>One-Time Employee Termination Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAbstract', window );"><strong>Restructuring Reserve [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our activity related to one-time employee termination benefits, included in accrued liabilities, in thousands:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:69.96%;box-sizing:content-box;"></td>
         <td style="width:2.06%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:25.98%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">One-time Employee Termination Benefits</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">993</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in accrued restructuring</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,528</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in accrued restructuring</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,734</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,027</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Total Operating Costs</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease costs for the Amended Lease were as follows for the periods presented, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.453%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.643%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.303%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">214</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,434</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">123</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs included in operating expenses</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">214</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,557</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Operating Leases</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplemental cash flow information related to our operating leases for the year ended June 30, 2024 was as follows, in thousands:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:76.155%;box-sizing:content-box;"></td>
         <td style="width:1.98%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.863999999999997%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amount included in the measurement <br/>&#160;&#160;&#160;&#160;of lease liabilities:</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,612</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants Issued</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 22, 2025, i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n conjunction with the closing of the Offering (as defined in </span><a href="#fn_subevent"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span></a><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), we issued the following warrants:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:27.025%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.484%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.502%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.103%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:23.885%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Warrants Outstanding</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial Exercise Date</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Asset Manager Warrants</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 1</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">584,795</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.42</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 2</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.93</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 3</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.62</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tranche 4</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">292,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.13</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Strategic Advisor Warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">438,597</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Placement Agent Warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,169,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2025</span></span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 22, 2030</span></span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,070,177</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-Based Compensation Expense for Stock Awards</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total share-based compensation expense for all stock awards consists of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.86%;box-sizing:content-box;"></td>
         <td style="width:1.3%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.940000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.700000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">128</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,929</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total share-based compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,278</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of Stock Option Activity and Related Data</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> A summary of our stock option activity and related data follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.689%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.902%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:11.202%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.523%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:6.2010000000000005%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Options</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Exercise Price</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Remaining Contractual<br/>Term (in years)</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic Value</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,357,213</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">488,065</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.64</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869,148</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.90</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at June 30, 2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">869,148</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Stock Options Weighted-Average Assumptions Used</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">following weighted-average assumptions were used to calculate these fair values:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:79.52%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.86%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life (years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.7</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.8</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend yield</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average grant date fair value</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.20</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Financial Data for Development of Pharmaceutical Products Segments</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our financial data for the development of pharmaceutical products segment:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenues</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,297</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating and other (income) expense</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employee expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,293</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,207</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment expenses</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,647</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,946</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,754</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,092</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal fees</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,723</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,397</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,899</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fees paid on behalf of a related party</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,118</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">voruciclib</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">801</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,413</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ME-344</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">253</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,724</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on disposition of a non-financial asset</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and dividend income</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,026</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,277</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating and other (income) expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,519</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0ff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total segment costs (loss) income and net (loss) income</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,778</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________</span></p><p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Pre-Tax loss Information</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-tax loss consists of the following jurisdictions, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:67.313%;box-sizing:content-box;"></td>
         <td style="width:1.5%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.843%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.5%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.843%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Domestic</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,778</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-tax (loss) income</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,945</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,778</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax Rates to Income Tax Expense</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The reconciliation of income tax computed at the U.S. federal statutory tax rates to income tax expense is as follows, in thousands:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:39.1%;box-sizing:content-box;"></td>
         <td style="width:1.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.84%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.98%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Fiscal Year Ended June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax (benefit) expense at U.S. statutory rates</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,349</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,733</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax (benefit) expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,733</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">796</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,671</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">901</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,782</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,281</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 162(m) limitation</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">507</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">483</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">122</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">368</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred Tax Liabilities and Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax liabilities and assets are comprised of the following, in thousands:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:67.606%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.817%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.38%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.817%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30,</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets (liabilities):</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax losses carried forward</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,346</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,721</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalization of R&amp;D costs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,398</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,456</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed and intangible assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,881</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,058</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based payments</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,375</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,081</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">700</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">647</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,700</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,918</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance for deferred tax assets</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,700</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,918</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets and liabilities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 23, 2025</div></th>
<th class="th"><div>Jul. 17, 2025</div></th>
<th class="th"><div>Dec. 06, 2023</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 24, 2025</div></th>
<th class="th"><div>Jul. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockStockLineItems', window );"><strong>Targeted or Tracking Stock, Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Unpaid common stock dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ClosingAgreement', window );">Closing agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividend paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses since inception</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,164<span></span>
</td>
<td class="nump">$ 388,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and short term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=lits_O2024Q2DividendsMember', window );">O 2024 Q2 Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockStockLineItems', window );"><strong>Targeted or Tracking Stock, Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Unpaid common stock dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockStockLineItems', window );"><strong>Targeted or Tracking Stock, Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_SurrenderedWarrantsToAcheiveCommonStock', window );">Surrendered warrants to acheive common stock</a></td>
<td class="nump">2,808,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,022,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">2,807,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Private Placement Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockStockLineItems', window );"><strong>Targeted or Tracking Stock, Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from private investment in private equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued in the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,216,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Subsequent Event | Private Placement Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TargetedOrTrackingStockStockLineItems', window );"><strong>Targeted or Tracking Stock, Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ClosingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ClosingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_SurrenderedWarrantsToAcheiveCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Surrendered warrants to acheive common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_SurrenderedWarrantsToAcheiveCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TargetedOrTrackingStockStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TargetedOrTrackingStockStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=lits_O2024Q2DividendsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=lits_O2024Q2DividendsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_Pre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_Pre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Revenue Associated with License Agreement (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems', window );"><strong>Recognized Revenue Associated with The Following License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 65,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems', window );"><strong>Recognized Revenue Associated with The Following License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Services Performed Over Time | Revenue from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems', window );"><strong>Recognized Revenue Associated with The Following License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Pass through Services at a Point in Time | Revenue from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems', window );"><strong>Recognized Revenue Associated with The Following License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognized Revenue Associated With The Following License Agreements Line Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Changes in Unbilled Receivables and Contract Liabilities (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ContractWithCustomerAssetAndLiabilityLineItems', window );"><strong>Contract with Customer Asset and Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities, beginning of year</a></td>
<td class="nump">$ 317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations', window );">Revenue recognized upon satisfaction of performance obligations</a></td>
<td class="num">(317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized', window );">Revenue recognized from change in estimate for performance obligations that are being closed</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract', window );">Revenue recognized for performance obligations that will no longer commence</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities, end of year</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ContractWithCustomerAssetAndLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer asset and liability Line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ContractWithCustomerAssetAndLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability revenue recognized upon satisfaction of performance obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Antidilutive Securities (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PotentiallyDilutiveSecuritiesOutstandingLineItems', window );"><strong>Potentially Dilutive Securities Outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive shares</a></td>
<td class="nump">972<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PotentiallyDilutiveSecuritiesOutstandingLineItems', window );"><strong>Potentially Dilutive Securities Outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive shares</a></td>
<td class="nump">869<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PotentiallyDilutiveSecuritiesOutstandingLineItems', window );"><strong>Potentially Dilutive Securities Outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive shares</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PotentiallyDilutiveSecuritiesOutstandingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potentially Dilutive Securities Outstanding [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PotentiallyDilutiveSecuritiesOutstandingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gains and losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation', window );">Changes in unrecognized tax position</a></td>
<td class="text">An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Common stock subject to repurchase or forfeiture | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=lits_PassThroughServicesMember', window );">Pass Through Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue', window );">Percentage of reimbursement of pass through costs as revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Reimbursement Of Pass Through Costs As Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-6<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 93: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 94: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 95: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 96: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 97: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-3<br><br>Reference 98: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 99: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 100: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 101: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 102: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 103: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 104: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 105: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 106: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other information relative to a tax position which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=lits_PassThroughServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=lits_PassThroughServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Prepaid and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Insurance</a></td>
<td class="nump">$ 176<span></span>
</td>
<td class="nump">$ 460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_SoftwareLicenses', window );">Software license</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PrepaidClinicalCosts', window );">Prepaid clinical costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">$ 2,424<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PrepaidClinicalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PrepaidClinicalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_SoftwareLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Software licenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_SoftwareLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 18, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfFurnitureAndFixtures', window );">Proceeds from sale of furniture and fixtures</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480095/942-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480035/942-10-S99-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfFurnitureAndFixtures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfFurnitureAndFixtures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Property and Equipment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,764)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 969<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes impairment charge of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in </span><a href="#fn9_leases"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</span></a><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Schedule of Property and Equipment (Parenthetical) (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480095/942-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480035/942-10-S99-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AccruedLiabilitiesLineItems', window );"><strong>Accrued Liabilities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AccruedPreclinicalAndClinicalCosts', window );">Accrued pre-clinical and clinical trial expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 1,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">873<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued legal and professional services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AccruedReimbursementToRelatedParty', window );">Accrued reimbursement to KKC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,178<span></span>
</td>
<td class="nump">$ 5,187<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Includes one-time employee benefits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">21,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AccruedLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AccruedLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AccruedPreclinicalAndClinicalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued pre-clinical and clinical trial expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AccruedPreclinicalAndClinicalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AccruedReimbursementToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued reimbursement to related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AccruedReimbursementToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Liabilities (Parenthetical) (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 873,000<span></span>
</td>
<td class="nump">$ 2,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember', window );">Termination Benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Includes one-time employee benefits of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">21,000</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the fiscal years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>One-Time Employee Termination Benefits - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>One-Time Employee Termination Benefits - Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities (Detail) - One -Time Termination Benefits [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Beginning Balance</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Increase in accrued restructuring</a></td>
<td class="nump">5,734<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(5,027)<span></span>
</td>
<td class="num">(1,528)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, Ending Balance</a></td>
<td class="nump">$ 728<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReservePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the accrual for restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReservePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember', window );">Presage License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems', window );"><strong>Purchase Commitment, Excluding Long-term Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AccruedMilestonePayments', window );">Accrued payment for potential future payments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AccruedMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AccruedMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License Agreements - Additional Information (Detail) - Kyowa Kirin Co. Ltd - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_TotalUpfrontPaymentReceivableForGrantOfRights', window );">Total upfront payment receivable for grant of rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_TerminationAgreement', window );">Termination Agreement</a></td>
<td class="text">Jul. 14,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=lits_KkcAgreementsMember', window );">Kkc Agreements [Member] | US License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=lits_KkcAgreementsMember', window );">Kkc Agreements [Member] | Development Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue', window );">Transaction price of deferred revenue remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License obligation account transaction price allocated deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_TerminationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_TerminationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_TotalUpfrontPaymentReceivableForGrantOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total upfront payment receivable for grant of rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_TotalUpfrontPaymentReceivableForGrantOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lits_KyowaKirinCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lits_KyowaKirinCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=lits_KkcAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=lits_KkcAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lits_UsLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lits_UsLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lits_DevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lits_DevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other License Agreements - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lits_BeigeneLtdMember', window );">BeiGene, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecoveryOfDirectCosts', window );">Reimbursements costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember', window );">Presage License Agreement | Presage Biosciences, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PaymentForLicenseAgreement', window );">Payment for license</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember', window );">Presage License Agreement | Presage Biosciences, Inc. | Incremental Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember', window );">Presage License Agreement | Presage Biosciences, Inc. | Potential Payments on Achievement of Development Regulatory and Commercial Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PotentialMilestonePaymentsReceivable', window );">Milestone payment receivable amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PaymentForLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment for license agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PaymentForLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PotentialMilestonePaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential milestone payments receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PotentialMilestonePaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecoveryOfDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecoveryOfDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lits_BeigeneLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lits_BeigeneLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=lits_PresageLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lits_PresageBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lits_PresageBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=lits_IncrementalPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=lits_IncrementalPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 18, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Number of square feet under lease | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expire date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2028<span></span>
</td>
<td class="text">Mar. 31,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_LeaseTerminationDate', window );">Lease termination date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2029<span></span>
</td>
<td class="text">Nov. 30,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_LeaseExpirationAmendedDate', window );">Lease expiration amended date</a></td>
<td class="text">Sep. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_LeaseTerminationFee', window );">Termination fee</a></td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PrepaymentOfRemainingRent', window );">Prepayment of remaining rent</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfFurnitureAndFixtures', window );">Proceeds from sale of furniture and fixtures</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability', window );">Amount on reduction in remaining right of use asset and lease liability</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_DirectCosts', window );">Direct costs</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment charge</a></td>
<td class="nump">$ 10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">10,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Supplemental cash flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,612,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Remaining future minimum rental payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Decrease in ROU asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lits_SanDiegoCaliforniaMember', window );">San Diego California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Number of square feet under lease | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount on reduction in remaining right of use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_DirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Direct costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_DirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_LeaseExpirationAmendedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease expiration amended date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_LeaseExpirationAmendedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_LeaseTerminationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease termination date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_LeaseTerminationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_LeaseTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease termination fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_LeaseTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PrepaymentOfRemainingRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment of remaining rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PrepaymentOfRemainingRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfFurnitureAndFixtures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfFurnitureAndFixtures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lits_SanDiegoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lits_SanDiegoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Total Operating Costs (Detail) - General and administrative - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 2,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs included in general and administrative expenses</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 2,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract', window );"><strong>Disclosure Of Supplemental Cash Flow Information Related To Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of supplemental cash flow information related to operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 23, 2025</div></th>
<th class="th"><div>Jul. 17, 2025</div></th>
<th class="th"><div>Oct. 22, 2024</div></th>
<th class="th"><div>Feb. 20, 2024</div></th>
<th class="th"><div>Dec. 06, 2023</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 01, 2023</div></th>
<th class="th"><div>Sep. 23, 2025</div></th>
<th class="th"><div>Sep. 19, 2025</div></th>
<th class="th"><div>Sep. 19, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 24, 2025</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th"><div>Jul. 24, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalUnitsAuthorized', window );">Total authorized share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,000,000<span></span>
</td>
<td class="nump">226,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00000002<span></span>
</td>
<td class="nump">$ 0.00000002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00000002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_RightsAndTheRightsAgreementExpirationDescription', window );">Rights and the rights agreement expiration description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Rights and the Rights Agreement expired at the close of business on September 30, 2024. No rights were redeemed or exchanged under the Rights Agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one vote per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_NumberOfWarrantsExercised', window );">Number of warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ClosingAgreement', window );">Closing agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 17,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividend paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AdoptedAgreement', window );">Adopted agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 22,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants | Torreya Partners LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsAxis=lits_O2024Q2DividendsMember', window );">O 2024 Q2 Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lits_AtTheMarketSaleAgreementMember', window );">ATM Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AtTheMarketOfferingAgreementDescription', window );">At-the-market offering agreement, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As of January 2, 2024, the date used under applicable rules of the SEC to determine our public float at the commencement of the offering, one-third of our public float was equal to approximately $9.9 million.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_MaximumAmountOfCommonStockOfferingPrice', window );">Aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_SaleOfSharesAndWarrantsUnderAgreement', window );">Sale of shares and warrants under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_SurrenderedWarrantsToAcheiveCommonStock', window );">Surrendered warrants to acheive common stock</a></td>
<td class="nump">2,808,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">2,807,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,022,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | ATM Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.4484<span></span>
</td>
<td class="nump">$ 5.4484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Private Placement Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued in the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,216,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Maximum | Private Placement Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AdoptedAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adopted agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AdoptedAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AtTheMarketOfferingAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>At-the-market offering agreement description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AtTheMarketOfferingAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ClosingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ClosingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_MaximumAmountOfCommonStockOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of common stock offering price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_MaximumAmountOfCommonStockOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_NumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_NumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_RightsAndTheRightsAgreementExpirationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rights and the rights agreement expiration description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_RightsAndTheRightsAgreementExpirationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_SaleOfSharesAndWarrantsUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of shares and warrants under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_SaleOfSharesAndWarrantsUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_SurrenderedWarrantsToAcheiveCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Surrendered warrants to acheive common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_SurrenderedWarrantsToAcheiveCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalUnitsAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalUnitsAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lits_TorreyaPartnersLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lits_TorreyaPartnersLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=lits_O2024Q2DividendsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=lits_O2024Q2DividendsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lits_AtTheMarketSaleAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lits_AtTheMarketSaleAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_Pre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_Pre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Warrants Issued (Details) - Subsequent Event<br></strong></div></th>
<th class="th">
<div>Jul. 22, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">3,070,177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheOneMember', window );">GSR Warrants Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">584,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 3.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">Jul. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 22,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheTwoMember', window );">GSR Warrants Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">292,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 3.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">Jul. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 22,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheThreeMember', window );">GSR Warrants Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">292,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 4.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">Jul. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 22,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheFourMember', window );">GSR Warrants Tranche Four</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">292,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 5.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">Jul. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 22,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorWarrantsMember', window );">Strategic Advisor Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">438,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">Jul. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 22,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=lits_PlacementAgentWarrantsMember', window );">Placement Agent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants Outstanding</a></td>
<td class="nump">1,169,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price | $ / shares</a></td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">Jul. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 22,  2030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 09, 2023</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">869,148<span></span>
</td>
<td class="nump">1,357,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to unvested stock options</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted average period for recognition of compensation expense</a></td>
<td class="text">1 year 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">869,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice', window );">Closing price of common stock</a></td>
<td class="nump">$ 2.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based compensation arrangement by share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Stock option vested percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lits_TwoThousandAndEightOmnibusPlanMember', window );">2008 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock authorized</a></td>
<td class="nump">1,850,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant</a></td>
<td class="nump">920,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lits_TwoThousandAndEightOmnibusPlanMember', window );">2008 Omnibus Plan | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">815,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lits_InducementPlanMember', window );">Inducement Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant</a></td>
<td class="nump">163,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lits_InducementPlanMember', window );">Inducement Plan [Member] | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">53,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing price of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=lits_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=lits_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lits_TwoThousandAndEightOmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lits_TwoThousandAndEightOmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lits_InducementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lits_InducementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Share-based Compensation Expense for Stock Awards (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">$ (144)<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(128)<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="nump">$ 1,929<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Stock Option Activity (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance</a></td>
<td class="nump">1,357,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(488,065)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance</a></td>
<td class="nump">869,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at end of period</a></td>
<td class="nump">869,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance | $ / shares</a></td>
<td class="nump">$ 31.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="nump">25.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance | $ / shares</a></td>
<td class="nump">$ 32.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at end of period</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at end of period</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at end of period | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at end of period | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Fair Value of Stock Options Weighted-Average Assumptions Used (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">89.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember, srt:ChiefFinancialOfficerMember<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">Our CODM evaluates our financial information including year over year profit and loss comparisons and cash projections on an aggregate basis when assessing performance for allocating financial and personnel resources.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summary of Financial Data for Development of Pharmaceutical Products Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 18, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 65,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,400<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain on disposition of a non-financial asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,945)<span></span>
</td>
<td class="nump">17,778<span></span>
</td>
<td class="num">$ (32,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">65,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,293<span></span>
</td>
<td class="nump">13,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other segment expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,647<span></span>
</td>
<td class="nump">9,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,754<span></span>
</td>
<td class="nump">4,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
<td class="nump">3,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_FeesPaidOnBehalfOfRelatedParty', window );">Fees paid on behalf of a related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain on disposition of a non-financial asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest and dividend income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,026)<span></span>
</td>
<td class="num">(3,277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Total operating and other (income) expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,945<span></span>
</td>
<td class="nump">47,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,945)<span></span>
</td>
<td class="nump">17,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | voruciclib</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other segment expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">801<span></span>
</td>
<td class="nump">3,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | ME-344</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other segment expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 4,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_FeesPaidOnBehalfOfRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paids on behalf of related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_FeesPaidOnBehalfOfRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lits_VoruciclibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lits_VoruciclibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lits_METhreeFourFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lits_METhreeFourFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of a Non-financial Asset - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 22, 2024</div></th>
<th class="th"><div>Oct. 01, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AdoptedAgreement', window );">Adopted agreement date</a></td>
<td class="text">Oct. 22,  2024<span></span>
</td>
<td class="text">Oct.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ReimbursementAmount', window );">Reimbursement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Purchaser initial payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain of disposition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember', window );">Research And Development Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ReimbursementAmount', window );">Reimbursement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=lits_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ReimbursementAmount', window );">Reimbursement amount</a></td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Purchaser initial payment</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=lits_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_MilestonePayment', window );">Milestone payment</a></td>
<td class="nump">$ 62,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AdoptedAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adopted agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AdoptedAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_MilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_MilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ReimbursementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reimbursement amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ReimbursementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=lits_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=lits_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Pre- Tax loss Jurisdictions (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PreTaxIncomeLossLineItems', window );"><strong>Pre tax Income Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (15,945)<span></span>
</td>
<td class="nump">$ 17,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax income (loss)</a></td>
<td class="num">$ (15,945)<span></span>
</td>
<td class="nump">$ 17,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PreTaxIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PreTaxIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax rates to Income Tax Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_ReconciliationOfStatutoryFederalTaxRateLineItems', window );"><strong>Reconciliation Of Statutory Federal Tax Rate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax (benefit) expense at U.S. statutory rates</a></td>
<td class="num">$ (3,349)<span></span>
</td>
<td class="nump">$ 3,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax (benefit) expense</a></td>
<td class="num">(2,733)<span></span>
</td>
<td class="nump">796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Equity compensation</a></td>
<td class="nump">1,671<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">3,782<span></span>
</td>
<td class="num">(6,281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount', window );">Section 162(m) limitation</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax (benefit) expense at U.S. statutory rates</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax (benefit) expense</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Equity compensation</a></td>
<td class="num">(10.00%)<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(24.00%)<span></span>
</td>
<td class="num">(35.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent', window );">Section 162(m) limitation</a></td>
<td class="num">(3.00%)<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Other</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate, Continuing Operations, Total</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_ReconciliationOfStatutoryFederalTaxRateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_ReconciliationOfStatutoryFederalTaxRateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Liabilities and Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Components of Deferred Tax Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Tax losses carried forward</a></td>
<td class="nump">$ 53,346<span></span>
</td>
<td class="nump">$ 45,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalization of R&amp;D costs</a></td>
<td class="nump">9,398<span></span>
</td>
<td class="nump">11,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets', window );">Fixed and intangible assets</a></td>
<td class="nump">7,881<span></span>
</td>
<td class="nump">8,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based payments</a></td>
<td class="nump">2,375<span></span>
</td>
<td class="nump">4,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_DeferredTaxAssetsRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">73,700<span></span>
</td>
<td class="nump">69,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(73,700)<span></span>
</td>
<td class="num">(69,918)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets and liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets fixed and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_DeferredTaxAssetsRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_DeferredTaxAssetsRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_IncomeTaxesLineItemsLineItems', window );"><strong>Income Taxes Line Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carry forwards</a></td>
<td class="nump">$ 246.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carry forwards</a></td>
<td class="nump">$ 23.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_TaxableIncomePercentage', window );">Taxable income percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_IncomeTaxesLineItemsLineItems', window );"><strong>Income Taxes Line Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear', window );">Expiration year of operating loss carry forwards</a></td>
<td class="text">2031<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, operating loss carryforwards, expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_IncomeTaxesLineItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_IncomeTaxesLineItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_TaxableIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Taxable income percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_TaxableIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">2 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 23, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 08, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 22, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 17, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 15, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 20, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 23, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 19, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 19, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 24, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 24, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
<td class="nump">6,663,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lits_TheSalesAgreementMember', window );">The Sales Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of securities authorized for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lits_AtTheMarketSaleAgreementMember', window );">ATM Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net cash proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of securities authorized for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net cash proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Option grants, Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate principal amount authorized for sale | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Private Placement Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued in the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,216,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Private Placement Offering | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | The Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AgentCommissionRate', window );">Agent commission rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | ATM Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.4484<span></span>
</td>
<td class="nump">$ 5.4484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net cash proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of securities authorized for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross cash proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Underwriters commission and expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_SurrenderedWarrantsToAcheiveCommonStock', window );">Surrendered warrants to acheive common stock</a></td>
<td class="nump">2,808,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">2,807,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,022,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Advisory Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AdvisoryFeeRate', window );">Advisory fee rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Asset Management Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementAndServiceFeesRate', window );">Asset management fee rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_AssetManagerOwnershipThresholdRate', window );">Asset manager ownership threshold rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,461,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Placement Agency Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PercentageOfDeferredOfferingCosts', window );">Percentage of aggregate gross cash proceeds received in the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,169,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Reasonable accountable expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lits_PercentageOfSecuritiesSoldAtOffering', window );">Percentage of securities sold in the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Placement Agency Agreement | Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Reasonable accountable expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Strategic Advisor Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Strategic Advisor Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | GSR Warrants Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">584,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | GSR Warrants Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | GSR Warrants Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | GSR Warrants Tranche Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrant exercisable date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AdvisoryFeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advisory fee rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AdvisoryFeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AgentCommissionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agent commission rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AgentCommissionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_AssetManagerOwnershipThresholdRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset manager ownership threshold rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_AssetManagerOwnershipThresholdRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PercentageOfDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PercentageOfDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_PercentageOfSecuritiesSoldAtOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of securities sold at offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_PercentageOfSecuritiesSoldAtOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lits_SurrenderedWarrantsToAcheiveCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Surrendered warrants to acheive common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lits_SurrenderedWarrantsToAcheiveCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lits_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementAndServiceFeesRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate for management and service fees under arrangement to manage operations, including, but not limited to, investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementAndServiceFeesRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lits_TheSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lits_TheSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lits_AtTheMarketSaleAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lits_AtTheMarketSaleAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_Pre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_Pre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_AdvisoryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_AdvisoryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_AssetManagementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_AssetManagementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_PlacementAgencyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_PlacementAgencyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lits_LegalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lits_LegalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_StrategicAdvisorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=lits_GSRWarrantsTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>172</ContextCount>
  <ElementCount>360</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>72</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>75000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>75010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>75020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>75030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>75040 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>75050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>75060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>75070 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Description of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Description of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995477 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995487 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995497 - Disclosure - One-Time Employee Termination Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits</Role>
      <ShortName>One-Time Employee Termination Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995507 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995517 - Disclosure - License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreements1</Role>
      <ShortName>License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995527 - Disclosure - Other License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/OtherLicenseAgreements</Role>
      <ShortName>Other License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995537 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995547 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995557 - Disclosure - Share-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1</Role>
      <ShortName>Share-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995567 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995577 - Disclosure - Disposition of a Non-Financial Asset</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAsset</Role>
      <ShortName>Disposition of a Non-Financial Asset</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995587 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995597 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995607 - Disclosure - Description of Business and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies</Role>
      <ShortName>Description of Business and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995617 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995627 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995637 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995647 - Disclosure - One-Time Employee Termination Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsTables</Role>
      <ShortName>One-Time Employee Termination Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995657 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/Leases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995667 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995677 - Disclosure - Share-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables</Role>
      <ShortName>Share-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995687 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995697 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995707 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail</Role>
      <ShortName>Description of Business and Basis of Presentation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995717 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Associated with License Agreement (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Revenue Associated with License Agreement (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995727 - Disclosure - Summary of Significant Accounting Policies - Schedule of Changes in Unbilled Receivables and Contract Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Changes in Unbilled Receivables and Contract Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995737 - Disclosure - Summary of Significant Accounting Policies - Antidilutive Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Antidilutive Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995747 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995757 - Disclosure - Balance Sheet Details - Schedule of Prepaid and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail</Role>
      <ShortName>Balance Sheet Details - Schedule of Prepaid and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995767 - Disclosure - Balance Sheet Details - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail</Role>
      <ShortName>Balance Sheet Details - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995777 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail</Role>
      <ShortName>Balance Sheet Details - Schedule of Property and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995787 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail</Role>
      <ShortName>Balance Sheet Details - Schedule of Property and Equipment (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995797 - Disclosure - Balance Sheet Details - Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail</Role>
      <ShortName>Balance Sheet Details - Accrued Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995807 - Disclosure - Balance Sheet Details - Accrued Liabilities (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail</Role>
      <ShortName>Balance Sheet Details - Accrued Liabilities (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995817 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995847 - Disclosure - One-Time Employee Termination Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail</Role>
      <ShortName>One-Time Employee Termination Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995857 - Disclosure - One-Time Employee Termination Benefits - Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail</Role>
      <ShortName>One-Time Employee Termination Benefits - Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995867 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995877 - Disclosure - License Agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail</Role>
      <ShortName>License Agreements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995887 - Disclosure - Other License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Other License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995897 - Disclosure - Leases - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail</Role>
      <ShortName>Leases - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995907 - Disclosure - Leases - Schedule of Total Operating Costs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail</Role>
      <ShortName>Leases - Schedule of Total Operating Costs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995917 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail</Role>
      <ShortName>Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995927 - Disclosure - Stockholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995937 - Disclosure - Stockholders' Equity - Schedule of Warrants Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Warrants Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995947 - Disclosure - Share-based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Share-based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995957 - Disclosure - Share-based Compensation - Share-based Compensation Expense for Stock Awards (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail</Role>
      <ShortName>Share-based Compensation - Share-based Compensation Expense for Stock Awards (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995967 - Disclosure - Share-based Compensation - Summary of Stock Option Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail</Role>
      <ShortName>Share-based Compensation - Summary of Stock Option Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995977 - Disclosure - Share-based Compensation - Fair Value of Stock Options Weighted-Average Assumptions Used (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail</Role>
      <ShortName>Share-based Compensation - Fair Value of Stock Options Weighted-Average Assumptions Used (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995987 - Disclosure - Segment Information - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails</Role>
      <ShortName>Segment Information - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995997 - Disclosure - Segment Information - Summary of Financial Data for Development of Pharmaceutical Products Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails</Role>
      <ShortName>Segment Information - Summary of Financial Data for Development of Pharmaceutical Products Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Disposition of a Non-financial Asset - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail</Role>
      <ShortName>Disposition of a Non-financial Asset - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Income Taxes - Pre- Tax loss Jurisdictions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail</Role>
      <ShortName>Income Taxes - Pre- Tax loss Jurisdictions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Income Taxes - Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax rates to Income Tax Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax rates to Income Tax Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Income Taxes - Deferred Tax Liabilities and Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail</Role>
      <ShortName>Income Taxes - Deferred Tax Liabilities and Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="lits-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Subsequent Events - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail</Role>
      <ShortName>Subsequent Events - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="lits-20250630.htm">lits-20250630.htm</File>
    <File>lits-20250630.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img155424085_0.jpg</File>
    <File>img155424085_1.jpg</File>
    <File>img155424085_10.jpg</File>
    <File>img155424085_11.jpg</File>
    <File>img155424085_12.jpg</File>
    <File>img155424085_13.jpg</File>
    <File>img155424085_2.jpg</File>
    <File>img155424085_3.jpg</File>
    <File>img155424085_4.jpg</File>
    <File>img155424085_5.jpg</File>
    <File>img155424085_6.jpg</File>
    <File>img155424085_7.jpg</File>
    <File>img155424085_8.jpg</File>
    <File>img155424085_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="517">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="14">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="91">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lits-20250630.htm": {
   "nsprefix": "lits",
   "nsuri": "http://litestrategy.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "lits-20250630.htm"
     ]
    },
    "schema": {
     "local": [
      "lits-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 308,
   "keyCustom": 52,
   "axisStandard": 31,
   "axisCustom": 0,
   "memberStandard": 33,
   "memberCustom": 37,
   "hidden": {
    "total": 13,
    "http://xbrl.sec.gov/dei/2025": 3,
    "http://fasb.org/us-gaap/2025": 10
   },
   "contextCount": 172,
   "entityCount": 1,
   "segmentCount": 72,
   "elementCount": 727,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 517,
    "http://xbrl.sec.gov/ecd/2025": 91,
    "http://xbrl.sec.gov/dei/2025": 40,
    "http://xbrl.sec.gov/cyd/2025": 14
   },
   "report": {
    "R1": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/CoverPage",
     "longName": "75000 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1",
     "longName": "75010 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "75020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "us-gaap:CommonStockSharesOutstanding",
       "us-gaap:CommonStockSharesIssued",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "longName": "75030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "longName": "75040 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_57a12f24-8485-49fc-8a47-a37e1dd17d35",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_57a12f24-8485-49fc-8a47-a37e1dd17d35",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical",
     "longName": "75050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_8dd1452a-e99e-4349-bd47-9b1ed7689611",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R7": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "75060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "75070 - Disclosure - Cybersecurity Risk Management, Strategy and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_9fad389a-e538-433a-b7d3-4a232940c916",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9fad389a-e538-433a-b7d3-4a232940c916",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation",
     "longName": "995457 - Disclosure - Description of Business and Basis of Presentation",
     "shortName": "Description of Business and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "995467 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails",
     "longName": "995477 - Disclosure - Balance Sheet Details",
     "shortName": "Balance Sheet Details",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurements",
     "longName": "995487 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits",
     "longName": "995497 - Disclosure - One-Time Employee Termination Benefits",
     "shortName": "One-Time Employee Termination Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies",
     "longName": "995507 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreements1",
     "longName": "995517 - Disclosure - License Agreements",
     "shortName": "License Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/OtherLicenseAgreements",
     "longName": "995527 - Disclosure - Other License Agreements",
     "shortName": "Other License Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "lits:OtherLicensingArrangementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "lits:OtherLicensingArrangementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/Leases",
     "longName": "995537 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity",
     "longName": "995547 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1",
     "longName": "995557 - Disclosure - Share-based Compensation",
     "shortName": "Share-based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation",
     "longName": "995567 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAsset",
     "longName": "995577 - Disclosure - Disposition of a Non-Financial Asset",
     "shortName": "Disposition of a Non-Financial Asset",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes",
     "longName": "995587 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEvents",
     "longName": "995597 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies",
     "longName": "995607 - Disclosure - Description of Business and Basis of Presentation (Policies)",
     "shortName": "Description of Business and Basis of Presentation (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995617 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995627 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables",
     "longName": "995637 - Disclosure - Balance Sheet Details (Tables)",
     "shortName": "Balance Sheet Details (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsTables",
     "longName": "995647 - Disclosure - One-Time Employee Termination Benefits (Tables)",
     "shortName": "One-Time Employee Termination Benefits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables",
     "longName": "995657 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityTables",
     "longName": "995667 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables",
     "longName": "995677 - Disclosure - Share-based Compensation (Tables)",
     "shortName": "Share-based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationTables",
     "longName": "995687 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables",
     "longName": "995697 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
     "longName": "995707 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)",
     "shortName": "Description of Business and Basis of Presentation - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "us-gaap:CommonStockSharesIssued",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "lits:LiquidityPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail",
     "longName": "995717 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Associated with License Agreement (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Revenue Associated with License Agreement (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_71ae9d25-7183-44c7-86d1-e4821a8dc42d",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail",
     "longName": "995727 - Disclosure - Summary of Significant Accounting Policies - Schedule of Changes in Unbilled Receivables and Contract Liabilities (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Changes in Unbilled Receivables and Contract Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_57a12f24-8485-49fc-8a47-a37e1dd17d35",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_57a12f24-8485-49fc-8a47-a37e1dd17d35",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail",
     "longName": "995737 - Disclosure - Summary of Significant Accounting Policies - Antidilutive Securities (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Antidilutive Securities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "995747 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail",
     "longName": "995757 - Disclosure - Balance Sheet Details - Schedule of Prepaid and Other Current Assets (Detail)",
     "shortName": "Balance Sheet Details - Schedule of Prepaid and Other Current Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:PrepaidInsurance",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:PrepaidInsurance",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
     "longName": "995767 - Disclosure - Balance Sheet Details - Additional Information (Detail)",
     "shortName": "Balance Sheet Details - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a",
      "name": "us-gaap:ProceedsFromSaleOfFurnitureAndFixtures",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8dd1452a-e99e-4349-bd47-9b1ed7689611",
      "name": "us-gaap:Depreciation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
     "longName": "995777 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Detail)",
     "shortName": "Balance Sheet Details - Schedule of Property and Equipment (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail",
     "longName": "995787 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Parenthetical) (Detail)",
     "shortName": "Balance Sheet Details - Schedule of Property and Equipment (Parenthetical) (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_498df639-b914-4e6f-a5bd-5f79abcd206f",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "link:footnote",
       "p",
       "ix:continuation",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R47": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail",
     "longName": "995797 - Disclosure - Balance Sheet Details - Accrued Liabilities (Detail)",
     "shortName": "Balance Sheet Details - Accrued Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "lits:AccruedPreclinicalAndClinicalCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "lits:AccruedPreclinicalAndClinicalCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail",
     "longName": "995807 - Disclosure - Balance Sheet Details - Accrued Liabilities (Parenthetical) (Detail)",
     "shortName": "Balance Sheet Details - Accrued Liabilities (Parenthetical) (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7c38ad79-231e-469a-9a63-b80988a7ff5e",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "link:footnote",
       "p",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
     "longName": "995817 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_aa875931-fb24-4796-91f3-c3924bcf1ebb",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_aa875931-fb24-4796-91f3-c3924bcf1ebb",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
     "longName": "995847 - Disclosure - One-Time Employee Termination Benefits - Additional Information (Detail)",
     "shortName": "One-Time Employee Termination Benefits - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_eb55a398-d9e2-4bc4-b646-4c8ff5f95e44",
      "name": "us-gaap:SeveranceCosts1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_eb55a398-d9e2-4bc4-b646-4c8ff5f95e44",
      "name": "us-gaap:SeveranceCosts1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail",
     "longName": "995857 - Disclosure - One-Time Employee Termination Benefits - Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities (Detail)",
     "shortName": "One-Time Employee Termination Benefits - Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_aa5f4327-ba0e-4b78-9b28-61fb4396f64d",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
     "longName": "995867 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_5c746096-0191-4a12-b56d-6cedc776485d",
      "name": "lits:AccruedMilestonePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c746096-0191-4a12-b56d-6cedc776485d",
      "name": "lits:AccruedMilestonePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
     "longName": "995877 - Disclosure - License Agreements - Additional Information (Detail)",
     "shortName": "License Agreements - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_4038fe7e-0797-4545-9817-044b66f01547",
      "name": "lits:TotalUpfrontPaymentReceivableForGrantOfRights",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4038fe7e-0797-4545-9817-044b66f01547",
      "name": "lits:TotalUpfrontPaymentReceivableForGrantOfRights",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails",
     "longName": "995887 - Disclosure - Other License Agreements - Additional Information (Details)",
     "shortName": "Other License Agreements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_e7db8cf6-cb55-4ae2-94f9-5eb5ba8827f8",
      "name": "us-gaap:RecoveryOfDirectCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e7db8cf6-cb55-4ae2-94f9-5eb5ba8827f8",
      "name": "us-gaap:RecoveryOfDirectCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail",
     "longName": "995897 - Disclosure - Leases - Additional Information (Detail)",
     "shortName": "Leases - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_1d242087-6da3-4ba4-9ecd-f789815f32a7",
      "name": "us-gaap:AreaOfLand",
      "unitRef": "U_sqft",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1d242087-6da3-4ba4-9ecd-f789815f32a7",
      "name": "us-gaap:AreaOfLand",
      "unitRef": "U_sqft",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail",
     "longName": "995907 - Disclosure - Leases - Schedule of Total Operating Costs (Detail)",
     "shortName": "Leases - Schedule of Total Operating Costs (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_55a276dd-3278-431b-bb6a-72afcf0a97f5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_55a276dd-3278-431b-bb6a-72afcf0a97f5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail",
     "longName": "995917 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Detail)",
     "shortName": "Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail",
     "longName": "995927 - Disclosure - Stockholders' Equity - Additional Information (Detail)",
     "shortName": "Stockholders' Equity - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CapitalUnitsAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CapitalUnitsAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
     "longName": "995937 - Disclosure - Stockholders' Equity - Schedule of Warrants Issued (Details)",
     "shortName": "Stockholders' Equity - Schedule of Warrants Issued (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_fa1c20a4-edb7-43ee-b979-1cf83c11f686",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_76333d67-a7a6-4b6b-b653-9ff65dcb2312",
      "name": "us-gaap:WarrantsAndRightsOutstandingMaturityDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
     "longName": "995947 - Disclosure - Share-based Compensation - Additional Information (Detail)",
     "shortName": "Share-based Compensation - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail",
     "longName": "995957 - Disclosure - Share-based Compensation - Share-based Compensation Expense for Stock Awards (Detail)",
     "shortName": "Share-based Compensation - Share-based Compensation Expense for Stock Awards (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_65ce1f21-fab6-461d-b692-0bcf9b01d489",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail",
     "longName": "995967 - Disclosure - Share-based Compensation - Summary of Stock Option Activity (Detail)",
     "shortName": "Share-based Compensation - Summary of Stock Option Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
     "longName": "995977 - Disclosure - Share-based Compensation - Fair Value of Stock Options Weighted-Average Assumptions Used (Detail)",
     "shortName": "Share-based Compensation - Fair Value of Stock Options Weighted-Average Assumptions Used (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_8dd1452a-e99e-4349-bd47-9b1ed7689611",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8dd1452a-e99e-4349-bd47-9b1ed7689611",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails",
     "longName": "995987 - Disclosure - Segment Information - Additional Information (Details)",
     "shortName": "Segment Information - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
     "longName": "995997 - Disclosure - Segment Information - Summary of Financial Data for Development of Pharmaceutical Products Segments (Details)",
     "shortName": "Segment Information - Summary of Financial Data for Development of Pharmaceutical Products Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
     "longName": "996007 - Disclosure - Disposition of a Non-financial Asset - Additional Information (Detail)",
     "shortName": "Disposition of a Non-financial Asset - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_e968e6a1-e1dc-4b6b-b7eb-2349e035aa81",
      "name": "lits:AdoptedAgreement",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "lits:ReimbursementAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail",
     "longName": "996017 - Disclosure - Income Taxes - Pre- Tax loss Jurisdictions (Detail)",
     "shortName": "Income Taxes - Pre- Tax loss Jurisdictions (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail",
     "longName": "996027 - Disclosure - Income Taxes - Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax rates to Income Tax Expense (Detail)",
     "shortName": "Income Taxes - Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax rates to Income Tax Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_496692d5-8b11-4647-b7db-ff47b1d1be07",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail",
     "longName": "996037 - Disclosure - Income Taxes - Deferred Tax Liabilities and Assets (Detail)",
     "shortName": "Income Taxes - Deferred Tax Liabilities and Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail",
     "longName": "996047 - Disclosure - Income Taxes - Additional Information (Detail)",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
     "longName": "996057 - Disclosure - Subsequent Events - Additional Information (Detail)",
     "shortName": "Subsequent Events - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "us-gaap:CommonStockSharesIssued",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_42469529-12e3-4edc-a0e6-3a47d45ab69f",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lits-20250630.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingStandardsUpdate201602Member",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]",
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842)."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Payable, Current, Total",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r929"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1169"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "lits_AccruedLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AccruedLiabilitiesLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Liabilities [Line Items]",
        "label": "Accrued Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AccruedMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AccruedMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued milestone payments.",
        "label": "Accrued Milestone Payments",
        "terseLabel": "Accrued payment for potential future payments"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AccruedPreclinicalAndClinicalCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AccruedPreclinicalAndClinicalCosts",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued pre-clinical and clinical trial expenses.",
        "label": "Accrued Preclinical And Clinical Costs",
        "terseLabel": "Accrued pre-clinical and clinical trial expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued legal and professional services",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "lits_AccruedReimbursementToRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AccruedReimbursementToRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued reimbursement to related party.",
        "label": "Accrued Reimbursement to Related Party",
        "terseLabel": "Accrued reimbursement to KKC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r142",
      "r689"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1232",
      "r1294"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r162",
      "r163",
      "r164",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r199",
      "r255",
      "r256",
      "r259",
      "r260",
      "r261",
      "r262",
      "r269",
      "r270",
      "r275",
      "r305",
      "r306",
      "r307",
      "r308",
      "r402",
      "r403",
      "r404",
      "r405",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r489",
      "r490",
      "r491",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r585",
      "r600",
      "r601",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
        "negatedLabel": "Cash dividends declared",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r89"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r25",
      "r89"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]",
        "verboseLabel": "Adjustments to reconcile net (loss) income to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AdoptedAgreement": {
     "xbrltype": "dateItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AdoptedAgreement",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adopted agreement",
        "label": "Adopted Agreement",
        "terseLabel": "Adopted agreement date"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AdvisoryAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AdvisoryAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisory Agreement [Member]",
        "documentation": "Advisory agreement.",
        "terseLabel": "Advisory Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AdvisoryFeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AdvisoryFeeRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisory Fee Rate",
        "documentation": "Advisory fee rate.",
        "terseLabel": "Advisory fee rate"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AfterTaxReformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AfterTaxReformMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "After Tax Reform [Member]",
        "documentation": "After tax reform member."
       }
      }
     },
     "auth_ref": []
    },
    "lits_AgentCommissionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AgentCommissionRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agent Commission Rate",
        "documentation": "Agent commission rate.",
        "terseLabel": "Agent commission rate"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r980",
      "r991",
      "r1001",
      "r1034"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r983",
      "r994",
      "r1004",
      "r1037"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1029",
      "r1038",
      "r1042",
      "r1050"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "lits_AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount on reduction in remaining right of use asset and lease liability.",
        "label": "Amount on Reduction in Remaining Right of Use Asset and Lease Liability",
        "terseLabel": "Amount on reduction in remaining right of use asset and lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Total anti-dilutive shares",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AreaOfLand",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of Land",
        "terseLabel": "Number of square feet under lease",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Asset Impairment Charges, Total",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r21",
      "r938",
      "r939"
     ]
    },
    "lits_AssetManagementAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AssetManagementAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Management Agreement [Member]",
        "documentation": "Asset Management Agreement [Member]",
        "terseLabel": "Asset Management Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AssetManagerOwnershipThresholdRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AssetManagerOwnershipThresholdRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Manager Ownership Threshold Rate",
        "documentation": "Asset manager ownership threshold rate.",
        "terseLabel": "Asset manager ownership threshold rate"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement [Member]",
        "terseLabel": "Asset Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r111",
      "r143",
      "r171",
      "r173",
      "r174",
      "r217",
      "r232",
      "r243",
      "r247",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r516",
      "r520",
      "r588",
      "r672",
      "r673",
      "r679",
      "r777",
      "r872",
      "r873",
      "r887",
      "r929",
      "r945",
      "r946",
      "r958",
      "r1180",
      "r1181",
      "r1248"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AssetsAndLiabilitiesEliminatedUponConsolidationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AssetsAndLiabilitiesEliminatedUponConsolidationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities Eliminated upon Consolidation [Abstract]",
        "label": "Assets and Liabilities Eliminated upon Consolidation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r147",
      "r171",
      "r173",
      "r174",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r516",
      "r520",
      "r588",
      "r929",
      "r1180",
      "r1181",
      "r1248"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, Fair Value Disclosure, Total",
        "terseLabel": "Assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r567",
      "r919"
     ]
    },
    "lits_AtTheMarketOfferingAgreementDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AtTheMarketOfferingAgreementDescription",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-the-market offering agreement description.",
        "label": "At-the-Market Offering Agreement Description",
        "terseLabel": "At-the-market offering agreement, description"
       }
      }
     },
     "auth_ref": []
    },
    "lits_AtTheMarketSaleAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "AtTheMarketSaleAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-the-market equity offering sales agreement.",
        "label": "At The Market Sale Agreement [Member]",
        "terseLabel": "ATM Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964",
      "r987"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964",
      "r987"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964",
      "r987"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]",
        "terseLabel": "Auditor Opinion"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r522",
      "r524",
      "r525",
      "r526",
      "r527",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r587",
      "r916",
      "r917",
      "r1078",
      "r1259"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r522",
      "r524",
      "r525",
      "r526",
      "r527",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r587",
      "r916",
      "r917",
      "r1078",
      "r1259"
     ]
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Consolidation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1145"
     ]
    },
    "lits_BeforeTaxReformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "BeforeTaxReformMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Before Tax Reform [Member]",
        "label": "Before Tax Reform [Member]",
        "documentation": "Before tax reform member."
       }
      }
     },
     "auth_ref": []
    },
    "lits_BeigeneLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "BeigeneLtdMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BeiGene, Ltd",
        "label": "BeiGene, Ltd [Member]",
        "terseLabel": "BeiGene, Ltd"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r723",
      "r901",
      "r902",
      "r1223",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r723",
      "r901",
      "r902",
      "r1223",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Description of Business",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "us-gaap_CapitalUnitsAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalUnitsAuthorized",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Units, Authorized",
        "terseLabel": "Total authorized share capital",
        "documentation": "Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies."
       }
      }
     },
     "auth_ref": []
    },
    "lits_CaresActMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "CaresActMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CARES Act [Member]",
        "documentation": "CARES Act [Member]",
        "terseLabel": "CARES Act [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash and cash equivalents at end of the year",
        "periodStartLabel": "Cash and cash equivalents at beginning of the year",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "label": "Cash and Cash Equivalent",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r140",
      "r851"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "terseLabel": "Cash and cash equivalents and short term investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation",
        "periodStartLabel": "Cash and cash equivalents at beginning of the year",
        "periodEndLabel": "Cash and cash equivalents at end of the year",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r73",
      "r168"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "documentation": "Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r73"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1017"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r144",
      "r145",
      "r146",
      "r171",
      "r174",
      "r203",
      "r204",
      "r211",
      "r213",
      "r219",
      "r220",
      "r258",
      "r293",
      "r296",
      "r297",
      "r298",
      "r302",
      "r303",
      "r309",
      "r310",
      "r312",
      "r313",
      "r315",
      "r318",
      "r321",
      "r322",
      "r325",
      "r328",
      "r335",
      "r588",
      "r732",
      "r733",
      "r734",
      "r735",
      "r739",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r765",
      "r785",
      "r806",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r1073",
      "r1147",
      "r1148",
      "r1156"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r219",
      "r312",
      "r321",
      "r322",
      "r323",
      "r325",
      "r328",
      "r333",
      "r335",
      "r538",
      "r732",
      "r733",
      "r734",
      "r735",
      "r888",
      "r1073",
      "r1146",
      "r1147"
     ]
    },
    "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Date from which Warrants or Rights Exercisable",
        "terseLabel": "Warrant exercisable date",
        "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Exercise price",
        "terseLabel": "Exercise Price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r177",
      "r336"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Warrants outstanding",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Warrants issued to purchase common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Number of Warrants Outstanding",
        "verboseLabel": "Number of warrants outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "lits_ClosingAgreement": {
     "xbrltype": "dateItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ClosingAgreement",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing agreement date",
        "documentation": "Closing agreement.",
        "label": "Closing Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies (Note 6)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r97",
      "r682",
      "r764"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r287",
      "r288",
      "r835",
      "r1173",
      "r1175"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared, per share",
        "verboseLabel": "Unpaid common stock dividend",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r955",
      "r1152",
      "r1153",
      "r1155",
      "r1232",
      "r1289",
      "r1294"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r765"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Common Stock, Shares, Issued, Total",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r53",
      "r765",
      "r783",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "totalLabel": "Common Stock, Value, Issued, Total",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock value",
        "verboseLabel": "Common stock, $0.00000002 par value; 226,000 shares authorized; 6,663 shares issued and outstanding at June 30, 2025 and June 30, 2024",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r310",
      "r317",
      "r684",
      "r929"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Voting Rights",
        "terseLabel": "Common stock voting rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r1026"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Share-based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax assets (liabilities):",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r254",
      "r724",
      "r725",
      "r834",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r254",
      "r724",
      "r725",
      "r834",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r109",
      "r171",
      "r172",
      "r179",
      "r180",
      "r217",
      "r234",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r249",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r676",
      "r872",
      "r873",
      "r1180",
      "r1181"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r109",
      "r171",
      "r172",
      "r179",
      "r180",
      "r217",
      "r234",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r249",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r676",
      "r872",
      "r873",
      "r1180",
      "r1181"
     ]
    },
    "lits_ConsultingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ConsultingFee",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting fee",
        "documentation": "Consulting fee.",
        "label": "Consulting Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetAndLiabilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]",
        "terseLabel": "Contract with Customer, Asset and Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_ContractWithCustomerAssetAndLiabilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ContractWithCustomerAssetAndLiabilityLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer asset and liability Line items.",
        "label": "Contract with Customer Asset and Liability [Line Items]",
        "terseLabel": "Contract with Customer Asset and Liability [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_ContractWithCustomerAssetAndLiabilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ContractWithCustomerAssetAndLiabilityTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer Asset and Liability [Table]",
        "terseLabel": "Contract with Customer Asset and Liability [Table]",
        "documentation": "Contract with customer asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Changes in Unbilled Receivables and Contract Liabilities",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1186"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Contract with Customer, Liability, Total",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liabilities, end of year",
        "periodStartLabel": "Contract liabilities, beginning of year",
        "terseLabel": "Contract liabilities included in deferred revenue and deferred revenue, net of current portion",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r341",
      "r350"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized from change in estimate for performance obligations that are being closed",
        "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized",
        "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract",
        "terseLabel": "Revenue recognized for performance obligations that will no longer commence",
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Contract with customer liability non current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r341",
      "r350"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "verboseLabel": "Performance obligation revenue recognised",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "lits_ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedPerformanceObligationsNoLongerCommence",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized for performance obligations that will no longer commence",
        "label": "Contract With Customer Liability Revenue Recognized Performance Obligations No Longer Commence",
        "documentation": "Contract with customer liability revenue recognized performance obligations no longer commence."
       }
      }
     },
     "auth_ref": []
    },
    "lits_ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability revenue recognized upon satisfaction of performance obligations.",
        "label": "Contract With Customer Liability Revenue Recognized Upon Satisfaction of Performance Obligations",
        "terseLabel": "Revenue recognized upon satisfaction of performance obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpensesRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpensesRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses, Related Party",
        "terseLabel": "Expenses related to an agreement",
        "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "lits_CurrentEventsAndReductionInForcePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "CurrentEventsAndReductionInForcePolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Events and Reduction in Force [Policy Text Block]",
        "documentation": "Current events and reduction in force.",
        "terseLabel": "Current Events"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1061"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1061"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r974",
      "r1063"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r974",
      "r1063"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r976",
      "r1065"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r974",
      "r1063"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r967",
      "r1056"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r968",
      "r1057"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r968",
      "r1057"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r966",
      "r1055"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r966",
      "r1055"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r966",
      "r1055"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r969",
      "r1058"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r971",
      "r1060"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r971",
      "r1060"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1061"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r975",
      "r1064"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r1062"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r970",
      "r1059"
     ]
    },
    "lits_CydexLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "CydexLicenseAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CyDex License Agreement.",
        "label": "CyDex License Agreement [Member]",
        "terseLabel": "CyDex License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_DanielPGoldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DanielPGoldMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Daniel P Gold [Member]",
        "documentation": "Daniel P Gold."
       }
      }
     },
     "auth_ref": []
    },
    "lits_DavidMUrsoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DavidMUrsoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "David M Urso [Member]",
        "documentation": "David M Urso."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Offering Costs",
        "terseLabel": "Reasonable accountable expenses",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Total",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Current, Total",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "lits_DeferredRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DeferredRevenueMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue.",
        "label": "Deferred Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Noncurrent, Total",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Deferred revenue, long-term",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization of R&amp;D costs",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets and liabilities",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "lits_DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, operating loss carryforwards, expiration year.",
        "label": "Deferred Tax Assets Operating Loss Carry forwards Expiration Year",
        "terseLabel": "Expiration year of operating loss carry forwards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Tax losses carried forward",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carry forwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carry forwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "lits_DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets fixed and intangible assets.",
        "label": "Deferred Tax Assets Property Plant And Equipment And Intangible Assets",
        "terseLabel": "Fixed and intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "lits_DeferredTaxAssetsRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DeferredTaxAssetsRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Deferred Tax Assets Right-of-use Assets",
        "documentation": "Deferred Tax Assets Right-of-use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Share-based payments",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesDeferredTaxLiabilitiesAndAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance for deferred tax assets",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Total",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r22",
      "r160",
      "r854",
      "r856",
      "r858",
      "r860"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Depletion and Amortization, Total",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation expense",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r161",
      "r217",
      "r235",
      "r247",
      "r854",
      "r872",
      "r873"
     ]
    },
    "lits_DevelopmentServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DevelopmentServicesMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Development Services [Member]",
        "terseLabel": "Development Services"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DilutiveSecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_DirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DirectCosts",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct costs",
        "documentation": "Direct costs.",
        "label": "Direct Costs"
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "DirectorMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Directors"
       }
      }
     },
     "auth_ref": [
      "r1168",
      "r1290"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table Text Block]",
        "verboseLabel": "Schedule of Revenue Associated with License Agreement",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1187"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensation1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r370",
      "r398",
      "r399",
      "r401",
      "r904"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity and Related Data",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1188"
     ]
    },
    "lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of supplemental cash flow information related to operating leases.",
        "label": "Disclosure Of Supplemental Cash Flow Information Related To Operating Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DisclosureOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Operating Leases",
        "label": "Disclosure Of Supplemental Cash Flow Information Related To Operating Leases [Table Text Block]",
        "documentation": "Disclosure of supplemental cash flow information related to operating leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureTextBlockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAsset"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Disposition of a Non-financial Asset",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r77"
     ]
    },
    "lits_DispositionOfNon-FinancialAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "DispositionOfNon-FinancialAssetsPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposition of Non-Financial Assets Policy Text Block",
        "documentation": "Disposition of non-financial assets policy text block.",
        "terseLabel": "Disposition of Non-Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends [Axis]",
        "documentation": "Information by event wherein earnings are distributed to shareholder."
       }
      }
     },
     "auth_ref": [
      "r1183",
      "r1185"
     ]
    },
    "us-gaap_DividendsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends [Domain]",
        "documentation": "Event wherein earnings are distributed to shareholder."
       }
      }
     },
     "auth_ref": [
      "r1183",
      "r1185"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964",
      "r987"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964",
      "r987",
      "r1030"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1019"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net (loss) income per share - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic",
        "verboseLabel": "Basic income (loss) per share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r155",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r200",
      "r203",
      "r211",
      "r212",
      "r213",
      "r216",
      "r308",
      "r404",
      "r451",
      "r513",
      "r563",
      "r564",
      "r671",
      "r695",
      "r862"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted",
        "verboseLabel": "Diluted loss per share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r155",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r203",
      "r211",
      "r212",
      "r213",
      "r216",
      "r308",
      "r404",
      "r451",
      "r513",
      "r563",
      "r564",
      "r671",
      "r695",
      "r862"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net (Loss) Income Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r215"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective Income Tax Rate, Continuing Operations, Total",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r908"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Corporate tax rate",
        "negatedLabel": "Tax benefit at U.S. statutory rates",
        "verboseLabel": "Tax (benefit) expense at U.S. statutory rates",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r176",
      "r415",
      "r438",
      "r908"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r908",
      "r1146",
      "r1151",
      "r1217"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r908",
      "r1146",
      "r1151",
      "r1217",
      "r1218"
     ]
    },
    "lits_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Section 162 (m)Limitation Percent",
        "terseLabel": "Section 162(m) limitation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Equity compensation",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r908",
      "r1146",
      "r1151",
      "r1217",
      "r1218"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State tax (benefit) expense",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r908",
      "r1146",
      "r1151",
      "r1217"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Employee-related Liabilities, Current, Total",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted average period for recognition of compensation expense",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense related to unvested stock options",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1216"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock options",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214"
     ]
    },
    "lits_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "EmployeesMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees.",
        "label": "Employees [Member]",
        "terseLabel": "Employees"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquipmentMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment [Member]",
        "terseLabel": "Equipment",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r126",
      "r133",
      "r134",
      "r151",
      "r152",
      "r153",
      "r181",
      "r182",
      "r183",
      "r186",
      "r194",
      "r196",
      "r198",
      "r218",
      "r259",
      "r262",
      "r270",
      "r307",
      "r337",
      "r404",
      "r433",
      "r434",
      "r447",
      "r448",
      "r449",
      "r452",
      "r512",
      "r513",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r562",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r603",
      "r620",
      "r694",
      "r711",
      "r712",
      "r713",
      "r739",
      "r806"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r980",
      "r991",
      "r1001",
      "r1034"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r977",
      "r988",
      "r998",
      "r1031"
     ]
    },
    "lits_EstimatedDevelopmentCostSharingRecoverableThroughEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "EstimatedDevelopmentCostSharingRecoverableThroughEarnings",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated development cost sharing reoverable through earnings.",
        "label": "Estimated Development Cost Sharing Recoverable Through Earnings",
        "terseLabel": "Estimated development cost sharing recovered through earnings"
       }
      }
     },
     "auth_ref": []
    },
    "lits_EventAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "EventAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event [Axis]",
        "documentation": "Event"
       }
      }
     },
     "auth_ref": []
    },
    "lits_EventDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "EventDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event [Domain]",
        "documentation": "Event"
       }
      }
     },
     "auth_ref": []
    },
    "lits_ExUsLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ExUsLicenseMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ex US License [Member]",
        "terseLabel": "Ex US License"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "lits_ExpectedMilestonePaymentReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ExpectedMilestonePaymentReceivable",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected milestone payment receivable.",
        "label": "Expected Milestone Payment Receivable",
        "terseLabel": "Expected milestone payment receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r567",
      "r577",
      "r919"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r567",
      "r577",
      "r919"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r569",
      "r570",
      "r909",
      "r911",
      "r923"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r569",
      "r570",
      "r909",
      "r911",
      "r923"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r576",
      "r577",
      "r579",
      "r586",
      "r627",
      "r628",
      "r629",
      "r848",
      "r885",
      "r886",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r919",
      "r923",
      "r927"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r567",
      "r568",
      "r570",
      "r919",
      "r1236",
      "r1241"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r572",
      "r574",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r669",
      "r919",
      "r924"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r567",
      "r568",
      "r569",
      "r570",
      "r577",
      "r586",
      "r629",
      "r848",
      "r885",
      "r886",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r919",
      "r923",
      "r927"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 0.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in estimated fair value of liability classified warrants",
        "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "verboseLabel": "Change in fair value of warrant liability",
        "negatedLabel": "Change in fair value of warrant liability",
        "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held."
       }
      }
     },
     "auth_ref": [
      "r573",
      "r578"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r567",
      "r568",
      "r570",
      "r919",
      "r1236",
      "r1241"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net",
        "totalLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net, Total",
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r1238",
      "r1240"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r576",
      "r577",
      "r579",
      "r586",
      "r627",
      "r628",
      "r629",
      "r848",
      "r885",
      "r886",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r919",
      "r923",
      "r927"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r919",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1241"
     ]
    },
    "lits_FairValueMeasurementsSignificantUnobservableInputsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "FairValueMeasurementsSignificantUnobservableInputsLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurements, Significant Unobservable Inputs [Line Items]",
        "label": "Fair Value Measurements, Significant Unobservable Inputs [Line Items]",
        "terseLabel": "Fair value measurements Significant unobservable inputs [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_FairValueMeasurementsSignificantUnobservableInputsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "FairValueMeasurementsSignificantUnobservableInputsTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of fair value measurements significant unobservable inputs.",
        "label": "Fair Value Measurements, Significant Unobservable Inputs [Table]",
        "terseLabel": "Fair value measurements Significant unobservable inputs [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_FederalHomeLoanBanksAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalHomeLoanBanksAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal Home Loan Banks [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_FeesPaidOnBehalfOfRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "FeesPaidOnBehalfOfRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Paids On Behalf Of Related Party",
        "documentation": "Fees paids on behalf of related party.",
        "terseLabel": "Fees paid on behalf of a related party"
       }
      }
     },
     "auth_ref": []
    },
    "lits_FinancingCostsIncludedInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "FinancingCostsIncludedInAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing costs included in accounts payable.",
        "label": "Financing Costs Included in Accounts Payable",
        "terseLabel": "Financing costs included in accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1038"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1038"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1038"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1038"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1038"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "lits_GSRWarrantsTrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "GSRWarrantsTrancheFourMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GSR Warrants Tranche Four [Member]",
        "documentation": "GSR warrants tranche four.",
        "terseLabel": "GSR Warrants Tranche Four"
       }
      }
     },
     "auth_ref": []
    },
    "lits_GSRWarrantsTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "GSRWarrantsTrancheOneMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GSR Warrants Tranche One [Member]",
        "documentation": "GSR Warrants Tranche One [Member]",
        "terseLabel": "GSR Warrants Tranche One"
       }
      }
     },
     "auth_ref": []
    },
    "lits_GSRWarrantsTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "GSRWarrantsTrancheThreeMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GSR Warrants Tranche Three [Member]",
        "documentation": "GSR warrants tranche three.",
        "terseLabel": "GSR Warrants Tranche Three"
       }
      }
     },
     "auth_ref": []
    },
    "lits_GSRWarrantsTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "GSRWarrantsTrancheTwoMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GSR Warrants Tranche Two [Member]",
        "documentation": "GSR warrants tranche two.",
        "terseLabel": "GSR Warrants Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": 1.0,
       "order": 7.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "Gain on disposition of a non-financial asset",
        "terseLabel": "Gain on disposition of a non-financial asset",
        "verboseLabel": "Gain of disposition",
        "documentation": "Amount of gain (loss) on sale or disposal of other assets."
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "totalLabel": "Gain (Loss) on Disposition of Property Plant Equipment, Total",
        "negatedLabel": "Loss on disposal of property and equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "General and Administrative Expense, Total",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r787"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative",
        "verboseLabel": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964",
      "r987"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of long-lived assets",
        "verboseLabel": "Impairment charge",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r21",
      "r80",
      "r157",
      "r856",
      "r920"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r78",
      "r921"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r175",
      "r414"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Pre-tax income (loss)",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r102",
      "r110",
      "r672",
      "r674",
      "r691",
      "r857",
      "r859",
      "r861",
      "r866",
      "r872",
      "r1157",
      "r1164",
      "r1165",
      "r1166",
      "r1167"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r175",
      "r414"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8",
      "r10",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r81",
      "r272",
      "r273"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r274",
      "r280",
      "r523",
      "r528",
      "r529",
      "r537",
      "r571",
      "r573",
      "r578",
      "r589",
      "r590",
      "r591",
      "r706",
      "r708",
      "r791",
      "r847",
      "r848",
      "r909",
      "r910",
      "r917",
      "r918",
      "r922",
      "r927",
      "r1222",
      "r1224",
      "r1260"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r280",
      "r523",
      "r528",
      "r529",
      "r537",
      "r571",
      "r573",
      "r578",
      "r589",
      "r590",
      "r591",
      "r706",
      "r708",
      "r791",
      "r847",
      "r848",
      "r909",
      "r910",
      "r917",
      "r918",
      "r922",
      "r927",
      "r1222",
      "r1224",
      "r1260"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r415",
      "r416",
      "r423",
      "r431",
      "r908",
      "r1220"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r415",
      "r416",
      "r423",
      "r431",
      "r908",
      "r1220"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r176",
      "r409",
      "r415",
      "r420",
      "r421",
      "r422",
      "r425",
      "r430",
      "r439",
      "r441",
      "r442",
      "r443",
      "r678",
      "r722",
      "r737",
      "r908"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Tax Expense (Benefit), Total",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "negatedTotalLabel": "Income tax expense",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r121",
      "r171",
      "r197",
      "r198",
      "r217",
      "r236",
      "r247",
      "r413",
      "r415",
      "r440",
      "r697",
      "r857",
      "r859",
      "r861",
      "r908"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r411",
      "r412",
      "r425",
      "r426",
      "r429",
      "r432",
      "r731"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "negatedLabel": "Change in valuation allowance",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r908",
      "r1217"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax (benefit) expense at U.S. statutory rates",
        "negatedLabel": "Tax (benefit) expense at U.S. statutory rates",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r908"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "negatedLabel": "Other",
        "terseLabel": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r908",
      "r1217",
      "r1218"
     ]
    },
    "lits_IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Income Tax Reconciliation Nondeductible Expense Section 162(m) Limitation Amount",
        "negatedLabel": "Section 162(m) limitation",
        "terseLabel": "Section 162(m) limitation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "negatedLabel": "Equity compensation",
        "terseLabel": "Equity compensation",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r908",
      "r1217",
      "r1218"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State tax (benefit) expense",
        "negatedLabel": "State tax (benefit) expense",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r908",
      "r1217"
     ]
    },
    "lits_IncomeTaxesLineItemsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "IncomeTaxesLineItemsLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Line Items [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue",
        "verboseLabel": "Net change",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r633",
      "r1142"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1142"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "lits_IncreaseDecreaseInUnbilledReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "IncreaseDecreaseInUnbilledReceivable",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Unbilled Receivable",
        "label": "Increase Decrease In Unbilled Receivable",
        "negatedTerseLabel": "Unbilled receivables"
       }
      }
     },
     "auth_ref": []
    },
    "lits_IncreaseInRightOfUseAssetBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "IncreaseInRightOfUseAssetBalance",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in right of use asset balance.",
        "label": "Increase in Right of Use Asset Balance",
        "terseLabel": "Increase in right of use asset balance"
       }
      }
     },
     "auth_ref": []
    },
    "lits_IncrementalPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "IncrementalPaymentMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Payment.",
        "label": "Incremental Payment [Member]",
        "terseLabel": "Incremental Payment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1029",
      "r1038",
      "r1042",
      "r1050"
     ]
    },
    "lits_InducementPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "InducementPlanMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inducement Plan [Member]",
        "documentation": "Inducement Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r965",
      "r1054"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r965",
      "r1054"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r965",
      "r1054"
     ]
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestAndDividendIncomeOperating",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest and Dividend Income, Operating",
        "totalLabel": "Interest and Dividend Income, Operating, Total",
        "negatedLabel": "Interest and dividend income",
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r103",
      "r105",
      "r106",
      "r107",
      "r859",
      "r1296"
     ]
    },
    "lits_InterestIncomePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "InterestIncomePolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for interest income.",
        "label": "Interest Income [Policy Text Block]",
        "terseLabel": "Interest and Dividend Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterestAndDividend",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Investment Income, Interest and Dividend, Total",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Interest and dividend income",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Short-Term Investments",
        "verboseLabel": "Short-term Investments",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r727",
      "r728",
      "r729",
      "r730",
      "r814",
      "r815"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "lits_JustinJFileMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "JustinJFileMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Justin J. File [Member]",
        "documentation": "Justin J. File."
       }
      }
     },
     "auth_ref": []
    },
    "lits_KkcAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "KkcAgreementsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Kkc Agreements [Member]",
        "documentation": "Kkc Agreements [Member].",
        "label": "Kkc Agreements [Member]",
        "terseLabel": "KKC Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_KyowaKirinCoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "KyowaKirinCoMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kyowa Kirin Co [Member]",
        "terseLabel": "Kyowa Kirin Co. Ltd"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labor and Related Expense",
        "terseLabel": "Employee expenses",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r670",
      "r859",
      "r1099"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs included in general and administrative expenses",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r928"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Total Operating Costs",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1244"
     ]
    },
    "lits_LeaseExpirationAmendedDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LeaseExpirationAmendedDate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration amended date.",
        "label": "Lease Expiration Amended Date",
        "terseLabel": "Lease expiration amended date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expire date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "lits_LeaseTerminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LeaseTerminationDate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease termination date.",
        "label": "Lease Termination Date",
        "terseLabel": "Lease termination date"
       }
      }
     },
     "auth_ref": []
    },
    "lits_LeaseTerminationFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LeaseTerminationFee",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease termination fee.",
        "label": "Lease Termination Fee",
        "terseLabel": "Termination fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r613"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfChangesInUnbilledReceivablesAndContractLiabilitiesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LegalFees",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Fees",
        "terseLabel": "Legal fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r1080",
      "r1292",
      "r1293"
     ]
    },
    "lits_LegalFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LegalFeesMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Fees [Member]",
        "documentation": "Legal fees.",
        "terseLabel": "Legal Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1245"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "Leases",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_LessorOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LessorOperatingLeaseOptionToExtend",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessor, Operating Lease, Option to Extend",
        "terseLabel": "Extended date",
        "documentation": "Description of terms and conditions of option to extend lessor's operating lease."
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities",
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r171",
      "r173",
      "r174",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r517",
      "r520",
      "r521",
      "r588",
      "r763",
      "r865",
      "r887",
      "r958",
      "r1180",
      "r1248",
      "r1249"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities and stockholders' equity",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r98",
      "r686",
      "r929",
      "r945",
      "r946",
      "r1146",
      "r1149",
      "r1170",
      "r1243"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r139",
      "r171",
      "r173",
      "r174",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r517",
      "r520",
      "r521",
      "r588",
      "r929",
      "r1180",
      "r1248",
      "r1249"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total",
        "terseLabel": "Liabilities",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r1233"
     ]
    },
    "lits_LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License Obligation Account Transaction Price Allocated Deferred Revenue",
        "documentation": "License obligation account transaction price allocated deferred revenue.",
        "terseLabel": "Transaction price of deferred revenue remaining performance obligations"
       }
      }
     },
     "auth_ref": []
    },
    "lits_LicensingArrangementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LicensingArrangementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements [Abstract].",
        "label": "Licensing Arrangements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_LiquidityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "LiquidityPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Disclosure In Its Entirety Pertaining to the Accounting Policy In Respect Of Liquid Resources Held By The Entity.",
        "label": "Liquidity [Policy Text Block]",
        "terseLabel": "Liquidity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Category of Item Purchased [Axis]",
        "documentation": "Information by category of items purchased under a long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]",
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyPendingClaimsNumber",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of pending claims",
        "documentation": "Number of pending claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177"
     ]
    },
    "lits_METhreeFourFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "METhreeFourFourMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ME Three Four Four [Member]",
        "documentation": "ME Three Four Four.",
        "terseLabel": "ME-344"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementAndServiceFeesRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ManagementAndServiceFeesRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and Service Fees, Rate",
        "terseLabel": "Asset management fee rate",
        "documentation": "Rate for management and service fees under arrangement to manage operations, including, but not limited to, investment."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "lits_MaximumAmountOfCommonStockOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "MaximumAmountOfCommonStockOfferingPrice",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of common stock offering price",
        "label": "Maximum Amount Of Common Stock Offering Price",
        "terseLabel": "Aggregate offering price"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r289",
      "r290",
      "r291",
      "r292",
      "r364",
      "r394",
      "r395",
      "r396",
      "r406",
      "r570",
      "r632",
      "r705",
      "r707",
      "r721",
      "r755",
      "r756",
      "r812",
      "r816",
      "r818",
      "r819",
      "r821",
      "r829",
      "r830",
      "r832",
      "r833",
      "r845",
      "r846",
      "r879",
      "r888",
      "r903",
      "r909",
      "r911",
      "r912",
      "r923",
      "r924",
      "r925",
      "r926",
      "r941",
      "r1182",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Dividend Yield",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Expected life years",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected volatility",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r923",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk Free Interest Rate",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r568",
      "r569",
      "r570",
      "r909",
      "r911",
      "r912",
      "r923"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r569",
      "r570",
      "r909",
      "r911",
      "r912",
      "r923"
     ]
    },
    "lits_MeasurementInputWeightedAverageGrantDateFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "MeasurementInputWeightedAverageGrantDateFairValueMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value",
        "label": "Measurement Input Weighted-Average Grant Date Fair Value [Member]",
        "documentation": "Measurement input weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "lits_MilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "MilestonePayment",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Milestone Payment",
        "documentation": "Milestone Payment",
        "terseLabel": "Milestone payment"
       }
      }
     },
     "auth_ref": []
    },
    "lits_MilestonePaymentsMaximumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "MilestonePaymentsMaximumAmount",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payments, maximum amount.",
        "label": "Milestone Payments, Maximum Amount",
        "terseLabel": "Future aggregate milestone payments"
       }
      }
     },
     "auth_ref": []
    },
    "lits_MinimumBidPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "MinimumBidPricePerShare",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Bid Price Per Share",
        "label": "Minimum Bid Price Per Share",
        "terseLabel": "Minimum bid price per share"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r289",
      "r290",
      "r291",
      "r292",
      "r364",
      "r394",
      "r395",
      "r396",
      "r406",
      "r570",
      "r632",
      "r705",
      "r707",
      "r721",
      "r755",
      "r756",
      "r812",
      "r816",
      "r818",
      "r819",
      "r821",
      "r829",
      "r830",
      "r832",
      "r833",
      "r845",
      "r846",
      "r879",
      "r888",
      "r903",
      "r909",
      "r911",
      "r912",
      "r923",
      "r924",
      "r925",
      "r941",
      "r1182",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "totalLabel": "Net cash used in financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "terseLabel": "Net cash provided by (used in) operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "verboseLabel": "Net income (loss)",
        "totalLabel": "Net (loss) income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r75",
      "r104",
      "r134",
      "r137",
      "r148",
      "r149",
      "r153",
      "r171",
      "r173",
      "r174",
      "r179",
      "r185",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r197",
      "r198",
      "r209",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r308",
      "r311",
      "r314",
      "r319",
      "r404",
      "r451",
      "r513",
      "r564",
      "r588",
      "r693",
      "r784",
      "r804",
      "r805",
      "r857",
      "r859",
      "r861",
      "r956",
      "r1180"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "verboseLabel": "Net loss:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic, Total",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Basic",
        "verboseLabel": "Net loss\u2014basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r156",
      "r190",
      "r191",
      "r192",
      "r193",
      "r200",
      "r201",
      "r210",
      "r213",
      "r311",
      "r314",
      "r319",
      "r513"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Diluted",
        "totalLabel": "Net loss\u2014diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r202",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r213"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r162",
      "r163",
      "r164",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r192",
      "r199",
      "r216",
      "r255",
      "r256",
      "r259",
      "r260",
      "r261",
      "r262",
      "r269",
      "r270",
      "r275",
      "r305",
      "r306",
      "r307",
      "r308",
      "r402",
      "r403",
      "r404",
      "r405",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r489",
      "r490",
      "r491",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r585",
      "r600",
      "r601",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r726"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "documentation": "Disclosure of information about change in accounting principle or amendment to accounting standards or both. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards and other change in accounting principle."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r162",
      "r163",
      "r164",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r192",
      "r199",
      "r216",
      "r255",
      "r256",
      "r259",
      "r260",
      "r261",
      "r262",
      "r269",
      "r270",
      "r275",
      "r305",
      "r306",
      "r307",
      "r308",
      "r402",
      "r403",
      "r404",
      "r405",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r489",
      "r490",
      "r491",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r585",
      "r600",
      "r601",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r726"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncement",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "lits_NonCashLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "NonCashLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Lease Expense",
        "documentation": "Non cash lease expense.",
        "terseLabel": "Noncash lease expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r995",
      "r1005",
      "r1029",
      "r1038"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "lits_NonRule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "NonRule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b51 Arr Modified [Flag]",
        "documentation": "Non rule 10b51 arrangement modified.",
        "terseLabel": "Non Rule 10b51 Arr Modified"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r873",
      "r1163"
     ]
    },
    "lits_NumberOfSquareFeetUnderLease": {
     "xbrltype": "integerItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "NumberOfSquareFeetUnderLease",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of square feet under lease.",
        "label": "Number of Square Feet Under Lease",
        "verboseLabel": "Number of square feet under lease"
       }
      }
     },
     "auth_ref": []
    },
    "lits_NumberOfWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "NumberOfWarrantsExercised",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Warrants Exercised",
        "documentation": "Number Of Warrants Exercised",
        "terseLabel": "Number of warrants exercised"
       }
      }
     },
     "auth_ref": []
    },
    "lits_O2024Q2DividendsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "O2024Q2DividendsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "O 2024 Q2 Dividends [Member]",
        "documentation": "O 2024 Q2 Dividends.",
        "terseLabel": "O 2024 Q2 Dividends"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OneTimeTerminationBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OneTimeTerminationBenefitsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One-time Termination Benefits [Member]",
        "terseLabel": "One -Time Termination Benefits [Member]",
        "verboseLabel": "Termination Benefits",
        "documentation": "A lump sum payment to an involuntarily terminated employee in conjunction with exit or disposal activities."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r855",
      "r858",
      "r881",
      "r882",
      "r883",
      "r884"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "totalLabel": "(Loss) income from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r857",
      "r861",
      "r866",
      "r1157",
      "r1164",
      "r1165",
      "r1166",
      "r1167"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r928"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total operating lease liability",
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "totalLabel": "Total operating lease liability",
        "terseLabel": "Operating lease liability, long-term",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "verboseLabel": "Supplemental cash flow",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r611"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use asset balance",
        "terseLabel": "Operating lease right-of-use asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in ROU asset balance",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due",
        "terseLabel": "Remaining future minimum rental payments",
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114"
     ]
    },
    "lits_OperatingLeasesFutureMinimumRentalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "OperatingLeasesFutureMinimumRentalPayments",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating leases future minimum rental payments.",
        "label": "Operating Leases Future Minimum Rental Payments",
        "terseLabel": "Remaining future minimum rental payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r248",
      "r872",
      "r873"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Description of Business and Basis of Presentation",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r1081",
      "r1144"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses",
        "terseLabel": "Other segment expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r945",
      "r946"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities",
        "totalLabel": "Other Liabilities, Total",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r680",
      "r759",
      "r760",
      "r887",
      "r945",
      "r946",
      "r958",
      "r1257",
      "r1290"
     ]
    },
    "lits_OtherLicensingArrangementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "OtherLicensingArrangementsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/OtherLicenseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other licensing agreements.",
        "label": "Other Licensing Arrangements [Text Block]",
        "terseLabel": "Other License Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (expense) income, net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r915"
     ]
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherOperatingIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Income (Expense), Net",
        "totalLabel": "Total operating and other (income) expense",
        "negatedTotalLabel": "Total operating and other (income) expense",
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1086",
      "r1171"
     ]
    },
    "lits_OtherWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "OtherWarrantsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Warrants [Member]",
        "documentation": "Other warrants.",
        "terseLabel": "Other Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r982",
      "r993",
      "r1003",
      "r1036"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r985",
      "r996",
      "r1006",
      "r1039"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r985",
      "r996",
      "r1006",
      "r1039"
     ]
    },
    "lits_PassThroughServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PassThroughServicesMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pass through services member.",
        "label": "Pass Through Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "lits_PaymentForLicenseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PaymentForLicenseAgreement",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment for license agreement.",
        "label": "Payment For License Agreement",
        "terseLabel": "Payment for license"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForCommissions",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Commissions",
        "terseLabel": "Underwriters commission and expenses",
        "documentation": "The amount of cash paid for commissions during the current period."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash payments",
        "label": "Payments for Restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r1141"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments of Dividends, Total",
        "label": "Payments of Dividends",
        "negatedLabel": "Payment of cash dividend",
        "terseLabel": "Dividend paid",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments of Financing Costs, Total",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Payment of financing costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of short-term investments",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchases of short-term investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "lits_PercentageOfDeferredOfferingCosts": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PercentageOfDeferredOfferingCosts",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Deferred Offering Costs",
        "documentation": "Percentage of deferred offering costs.",
        "terseLabel": "Percentage of aggregate gross cash proceeds received in the offering"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PercentageOfPurchasesFromMajorSuppliers": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PercentageOfPurchasesFromMajorSuppliers",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of purchases from major suppliers.",
        "label": "Percentage of Purchases from Major Suppliers",
        "terseLabel": "Percentage of Purchase Requirement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PercentageOfReimbursementOfPassThroughCostsAsRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PercentageOfReimbursementOfPassThroughCostsAsRevenue",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Reimbursement Of Pass Through Costs As Revenue",
        "label": "Percentage Of Reimbursement Of Pass Through Costs As Revenue",
        "terseLabel": "Percentage of reimbursement of pass through costs as revenue"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PercentageOfSecuritiesSoldAtOffering": {
     "xbrltype": "pureItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PercentageOfSecuritiesSoldAtOffering",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Securities Sold at Offering",
        "documentation": "Percentage of securities sold at offering.",
        "terseLabel": "Percentage of securities sold in the offering"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PhaseThreeClinicalTrialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PhaseThreeClinicalTrialMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phase Three Clinical Trial [Member]",
        "terseLabel": "Phase Three Clinical Trial"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PlacementAgencyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PlacementAgencyAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Placement Agency Agreement [Member]",
        "documentation": "Placement agency agreement.",
        "terseLabel": "Placement Agency Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PlacementAgentWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PlacementAgentWarrantsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Placement Agent Warrants [Member]",
        "documentation": "Placement agent warrants.",
        "terseLabel": "Placement Agent Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "lits_PotentialMilestonePaymentsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PotentialMilestonePaymentsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential milestone payments receivable.",
        "label": "Potential Milestone Payments Receivable",
        "terseLabel": "Milestone payment receivable amount"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential payments on achievement of development regulatory and commercial milestones.",
        "label": "Potential Payments on Achievement of Development Regulatory and Commercial Milestones [Member]",
        "terseLabel": "Potential Payments on Achievement of Development Regulatory and Commercial Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PotentialSecondReturnOfCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PotentialSecondReturnOfCapital",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential second return of capital.",
        "label": "Potential Second Return Of Capital",
        "terseLabel": "Potential second return of capital"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PotentiallyDilutiveSecuritiesOutstandingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PotentiallyDilutiveSecuritiesOutstandingLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potentially Dilutive Securities Outstanding [Line Items]",
        "label": "Potentially Dilutive Securities Outstanding [Line Items]",
        "terseLabel": "Potentially Dilutive Securities Outstanding [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_Pre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "Pre-FundedWarrantsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Funded Warrants [Member]",
        "documentation": "Pre-funded warrants.",
        "terseLabel": "Pre-Funded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PreTaxIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PreTaxIncomeLossLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre tax Income Loss [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r321"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r765"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r321"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r765",
      "r783",
      "r1294",
      "r1295"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "totalLabel": "Preferred Stock, Value, Issued, Total",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value; 100 shares authorized; none outstanding",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r310",
      "r316",
      "r683",
      "r929"
     ]
    },
    "lits_PrepaidClinicalCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PrepaidClinicalCosts",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid clinical costs",
        "label": "Prepaid Clinical Costs",
        "terseLabel": "Prepaid clinical costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Insurance",
        "terseLabel": "Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r852",
      "r880",
      "r1171"
     ]
    },
    "lits_PrepaymentOfRemainingRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PrepaymentOfRemainingRent",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment of remaining rent.",
        "label": "Prepayment of Remaining Rent",
        "terseLabel": "Prepayment of remaining rent"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PresageBiosciencesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PresageBiosciencesIncMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Presage Biosciences Inc.",
        "label": "Presage Biosciences Inc [Member]",
        "terseLabel": "Presage Biosciences, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "lits_PresageLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PresageLicenseAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Presage License Agreement.",
        "label": "Presage License Agreement [Member]",
        "terseLabel": "Presage License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "PrivateInvestmentInPrivateEquityAndRelatedAgreementsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Investment in Private Equity and Related Agreements [Member]",
        "documentation": "Private investment in private equity and related agreements.",
        "terseLabel": "Private investment in private equity and related agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement Offering",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net cash proceeds",
        "verboseLabel": "Net proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from private investment in private equity",
        "verboseLabel": "Gross proceeds",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance or Sale of Equity",
        "totalLabel": "Proceeds from Issuance or Sale of Equity, Total",
        "terseLabel": "Gross cash proceeds",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r732"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments",
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r70"
     ]
    },
    "us-gaap_ProceedsFromSaleOfFurnitureAndFixtures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfFurnitureAndFixtures",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Furniture and Fixtures",
        "terseLabel": "Proceeds from sale of furniture and fixtures",
        "documentation": "The cash inflow from sale of furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Other Assets, Investing Activities",
        "terseLabel": "Proceeds from the disposition of a non-financial asset",
        "verboseLabel": "Purchaser initial payment",
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities."
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "totalLabel": "Proceeds from Sale of Property, Plant, and Equipment, Total",
        "terseLabel": "Proceeds from sale of property and equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r250",
      "r634",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r849",
      "r856",
      "r859",
      "r861",
      "r891",
      "r893",
      "r940",
      "r941",
      "r942",
      "r944",
      "r947",
      "r1077",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1178",
      "r1179",
      "r1258",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r250",
      "r634",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r849",
      "r856",
      "r859",
      "r861",
      "r891",
      "r893",
      "r940",
      "r941",
      "r942",
      "r944",
      "r947",
      "r1077",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1178",
      "r1179",
      "r1258",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Fees",
        "terseLabel": "Professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r859",
      "r872",
      "r956",
      "r1292",
      "r1293"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r137",
      "r148",
      "r149",
      "r165",
      "r171",
      "r173",
      "r174",
      "r179",
      "r185",
      "r194",
      "r197",
      "r198",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r308",
      "r404",
      "r451",
      "r513",
      "r515",
      "r518",
      "r519",
      "r564",
      "r588",
      "r672",
      "r674",
      "r692",
      "r738",
      "r784",
      "r804",
      "r805",
      "r913",
      "r914",
      "r957",
      "r1098",
      "r1180"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r613"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r141",
      "r690"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "verboseLabel": "Property and equipment",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r613",
      "r677",
      "r690",
      "r929"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r118",
      "r120",
      "r688"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r613"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Commitment, Excluding Long-Term Commitment [Line Items]",
        "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Commitment, Excluding Long-Term Purchase Commitment [Table]",
        "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Table]",
        "documentation": "Disclosure of information about purchase arrangement. Includes, but is not limited to, term of arrangement with supplier, minimum quantity required, milestone, period covered by arrangement, and committed amount. Excludes long-term purchase arrangement and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r97"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r289",
      "r290",
      "r291",
      "r292",
      "r353",
      "r364",
      "r394",
      "r395",
      "r396",
      "r401",
      "r406",
      "r570",
      "r630",
      "r631",
      "r632",
      "r705",
      "r707",
      "r721",
      "r755",
      "r756",
      "r812",
      "r816",
      "r818",
      "r819",
      "r821",
      "r829",
      "r830",
      "r832",
      "r833",
      "r845",
      "r846",
      "r879",
      "r888",
      "r903",
      "r909",
      "r911",
      "r912",
      "r923",
      "r924",
      "r925",
      "r926",
      "r941",
      "r950",
      "r1174",
      "r1182",
      "r1236",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r289",
      "r290",
      "r291",
      "r292",
      "r353",
      "r364",
      "r394",
      "r395",
      "r396",
      "r401",
      "r406",
      "r570",
      "r630",
      "r631",
      "r632",
      "r705",
      "r707",
      "r721",
      "r755",
      "r756",
      "r812",
      "r816",
      "r818",
      "r819",
      "r821",
      "r829",
      "r830",
      "r832",
      "r833",
      "r845",
      "r846",
      "r879",
      "r888",
      "r903",
      "r909",
      "r911",
      "r912",
      "r923",
      "r924",
      "r925",
      "r926",
      "r941",
      "r950",
      "r1174",
      "r1182",
      "r1236",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255"
     ]
    },
    "lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized Revenue Associated with The Following License Agreements [Abstract]",
        "documentation": "Recognized Revenue Associated With The Following License Agreements Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized Revenue Associated with The Following License Agreements [Line Items]",
        "documentation": "Recognized Revenue Associated With The Following License Agreements Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "lits_RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RecognizedRevenueAssociatedWithTheFollowingLicenseAgreementsTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized Revenue Associated with The Following License Agreements [Table]",
        "documentation": "Recognized Revenue Associated With The Following License Agreements Table"
       }
      }
     },
     "auth_ref": []
    },
    "lits_ReconciliationOfStatutoryFederalTaxRateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ReconciliationOfStatutoryFederalTaxRateLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation Of Statutory Federal Tax Rate [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RecoveryOfDirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RecoveryOfDirectCosts",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Direct Costs",
        "terseLabel": "Reimbursements costs",
        "documentation": "Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r977",
      "r988",
      "r998",
      "r1031"
     ]
    },
    "lits_ReductionLimitOfAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ReductionLimitOfAdditionalPaidInCapital",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction limit of additional paid in capital.",
        "label": "Reduction Limit of Additional Paid in Capital",
        "terseLabel": "Reduction limit of additional paid in capital"
       }
      }
     },
     "auth_ref": []
    },
    "lits_ReimbursementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ReimbursementAmount",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reimbursement Amount",
        "documentation": "Reimbursement amount",
        "terseLabel": "Reimbursement amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "terseLabel": "Related Party [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r257",
      "r360",
      "r363",
      "r621",
      "r622",
      "r681",
      "r687",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r782",
      "r811",
      "r1291"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r621",
      "r622",
      "r1247"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r1247"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r257",
      "r621",
      "r622",
      "r623",
      "r788",
      "r789",
      "r791"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r257",
      "r360",
      "r363",
      "r621",
      "r622",
      "r681",
      "r687",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r782",
      "r811",
      "r1247",
      "r1291"
     ]
    },
    "lits_RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remeasurement of right of use asset and related lease liability upon lease modification.",
        "label": "Remeasurement of Right of Use Asset and Related Lease Liability Upon Lease Modification",
        "terseLabel": "Re-measurement of right-of-use asset and related lease liability upon lease modification"
       }
      }
     },
     "auth_ref": []
    },
    "lits_RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remeasurement of right of use asset for direct costs associated with lease modification.",
        "label": "Remeasurement of Right of Use Asset for Direct Costs Associated with Lease Modification",
        "terseLabel": "Re-measurement of right-of-use asset for direct costs associated with lease modification"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentArrangementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Arrangement [Member]",
        "terseLabel": "Research And Development Arrangement",
        "documentation": "Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Research and Development Expense, Total",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r847",
      "r857",
      "r858",
      "r872",
      "r1256"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r978",
      "r989",
      "r999",
      "r1032"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r979",
      "r990",
      "r1000",
      "r1033"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r986",
      "r997",
      "r1007",
      "r1040"
     ]
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "One-time Employee Termination Benefits",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r279",
      "r282",
      "r286"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Number of workforce reduction",
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r278",
      "r279",
      "r283",
      "r284",
      "r858"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285"
     ]
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Restructuring Reserve, Ending Balance",
        "label": "Restructuring Reserve",
        "totalLabel": "Restructuring Reserve, Total",
        "periodStartLabel": "Restructuring Reserve, Beginning Balance",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r284"
     ]
    },
    "us-gaap_RestructuringReserveAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringReserveAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Reserve [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReservePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringReservePeriodIncreaseDecrease",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Restructuring Reserve, Period Increase (Decrease), Total",
        "label": "Restructuring Reserve, Period Increase (Decrease)",
        "terseLabel": "Increase in accrued restructuring",
        "documentation": "Amount of increase (decrease) in the accrual for restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated losses since inception",
        "negatedLabel": "Accumulated losses since inception",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r89",
      "r685",
      "r715",
      "r720",
      "r736",
      "r766",
      "r929"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r133",
      "r134",
      "r181",
      "r182",
      "r183",
      "r186",
      "r194",
      "r196",
      "r198",
      "r259",
      "r262",
      "r270",
      "r307",
      "r404",
      "r433",
      "r434",
      "r447",
      "r448",
      "r449",
      "r452",
      "r512",
      "r513",
      "r541",
      "r544",
      "r545",
      "r548",
      "r562",
      "r600",
      "r603",
      "r711",
      "r713",
      "r739",
      "r1294"
     ]
    },
    "lits_RevenueFromCollaborationAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RevenueFromCollaborationAgreementsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from collaboration agreements",
        "documentation": "Revenue from collaboration agreements.",
        "label": "Revenue From Collaboration Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from customers",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r1159",
      "r1160"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreements1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "License Agreements",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue related to non-refundable payments for performance obligations",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues",
        "totalLabel": "Revenues, Total",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r154",
      "r171",
      "r173",
      "r174",
      "r217",
      "r233",
      "r234",
      "r241",
      "r247",
      "r250",
      "r252",
      "r254",
      "r258",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r588",
      "r672",
      "r674",
      "r872",
      "r915",
      "r945",
      "r946",
      "r1180"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Right-of-use assets obtained in exchange for operating lease obligations:",
        "terseLabel": "Operating Lease right-of-use assets obtained in exchange for operating lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r928"
     ]
    },
    "lits_RightsAndTheRightsAgreementExpirationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "RightsAndTheRightsAgreementExpirationDescription",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights and the rights agreement expiration description.",
        "label": "Rights and the Rights Agreement Expiration Description",
        "terseLabel": "Rights and the rights agreement expiration description"
       }
      }
     },
     "auth_ref": []
    },
    "lits_Rule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "Rule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b51 Arr Modified [Flag]",
        "documentation": "Rule 10b51 Arr Modified [Flag]",
        "terseLabel": "Rule 10b51 Arr Modified"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "lits_SaleOfSharesAndWarrantsUnderAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "SaleOfSharesAndWarrantsUnderAgreement",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of shares and warrants under agreement.",
        "label": "Sale Of Shares And Warrants Under Agreement",
        "terseLabel": "Sale of shares and warrants under agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Aggregate principal amount authorized for sale",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued and sold",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "verboseLabel": "Number of securities authorized for sale",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "lits_SanDiegoCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "SanDiegoCaliforniaMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "San Diego California [Member]",
        "terseLabel": "San Diego California [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_SbioPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "SbioPurchaseAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "S Bio Purchase Agreement.",
        "label": "SBio Purchase Agreement [Member]",
        "terseLabel": "S*Bio Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r199",
      "r365",
      "r1074"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Liabilities",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Antidilutive Securities",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Operating Leases",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred Tax Liabilities and Assets",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about diluted earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r211",
      "r213"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Income Taxes Computed at U.S Federal Statutory Tax Rates to Income Tax Expense",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r908",
      "r1217"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share-Based Compensation Expense for Stock Awards",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Pre-Tax loss Information",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1146",
      "r1150"
     ]
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r621",
      "r622",
      "r623",
      "r788",
      "r789",
      "r791"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Activity Related to One-Time Employee Termination Benefits Included in Accrued Liabilities",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r82",
      "r83"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Financial Data for Development of Pharmaceutical Products Segments",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r401"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair Value of Stock Options Weighted-Average Assumptions Used",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r87",
      "r88",
      "r89",
      "r144",
      "r145",
      "r146",
      "r219",
      "r321",
      "r322",
      "r323",
      "r325",
      "r328",
      "r333",
      "r335",
      "r538",
      "r732",
      "r733",
      "r734",
      "r735",
      "r888",
      "r1073",
      "r1146",
      "r1147"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Warrants Issued",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r1184"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security deposit",
        "label": "Security Deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r223",
      "r252",
      "r253",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r672",
      "r673",
      "r674",
      "r675",
      "r752",
      "r753",
      "r754",
      "r813",
      "r817",
      "r820",
      "r822",
      "r829",
      "r831",
      "r832",
      "r833",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r850",
      "r863",
      "r891",
      "r894",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r943",
      "r950",
      "r1258",
      "r1261",
      "r1262",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r871",
      "r878"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r868",
      "r875"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r217",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r237",
      "r238",
      "r239",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r254",
      "r867",
      "r869",
      "r870",
      "r872",
      "r874",
      "r876",
      "r877"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance Costs",
        "terseLabel": "Severance costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSharebasedCompensationExpenseForStockAwardsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, award vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Number of shares option grants",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value",
        "verboseLabel": "Granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding at end of period",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning Balance",
        "verboseLabel": "Options outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning Balance",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest at end of period",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest at end of period",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at end of period",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "lits_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (in years)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted",
        "verboseLabel": "Option grants, Exercise price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Stock option vested percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1189"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, expiration period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationFairValueOfStockOptionsWeightedaverageAssumptionsUsedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding at end of period",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest at end of period",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "lits_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing price of common stock.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsClosingStockPrice",
        "verboseLabel": "Closing price of common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Offering price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Short-term Investments, Total",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments",
        "verboseLabel": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r1087"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Other Information",
        "terseLabel": "Changes in unrecognized tax position",
        "documentation": "Other information relative to a tax position which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "lits_SoftwareLicenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "SoftwareLicenses",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Licenses",
        "documentation": "Software licenses.",
        "terseLabel": "Software license"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r144",
      "r145",
      "r146",
      "r171",
      "r174",
      "r203",
      "r204",
      "r211",
      "r213",
      "r219",
      "r220",
      "r258",
      "r293",
      "r296",
      "r297",
      "r298",
      "r302",
      "r303",
      "r309",
      "r310",
      "r312",
      "r313",
      "r315",
      "r318",
      "r321",
      "r322",
      "r325",
      "r328",
      "r335",
      "r588",
      "r732",
      "r733",
      "r734",
      "r735",
      "r739",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r765",
      "r785",
      "r806",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r1073",
      "r1147",
      "r1148",
      "r1156"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r53",
      "r56",
      "r57",
      "r126",
      "r133",
      "r134",
      "r151",
      "r152",
      "r153",
      "r181",
      "r182",
      "r183",
      "r186",
      "r194",
      "r196",
      "r198",
      "r218",
      "r259",
      "r262",
      "r270",
      "r307",
      "r337",
      "r404",
      "r433",
      "r434",
      "r447",
      "r448",
      "r449",
      "r452",
      "r512",
      "r513",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r562",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r603",
      "r620",
      "r694",
      "r711",
      "r712",
      "r713",
      "r739",
      "r806"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r223",
      "r252",
      "r253",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r672",
      "r673",
      "r674",
      "r675",
      "r752",
      "r753",
      "r754",
      "r813",
      "r817",
      "r820",
      "r822",
      "r829",
      "r831",
      "r832",
      "r833",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r850",
      "r863",
      "r891",
      "r894",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r943",
      "r950",
      "r1258",
      "r1261",
      "r1262",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPrepaidAndOtherCurrentAssetsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables",
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r218",
      "r309",
      "r310",
      "r312",
      "r315",
      "r603",
      "r634",
      "r727",
      "r740",
      "r751",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r765",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r786",
      "r787",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r806",
      "r859",
      "r861",
      "r951",
      "r1291"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r199",
      "r365",
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingencies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfPropertyAndEquipmentParentheticalDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesPreTaxLossJurisdictionsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesComputedAtUsFederalStatutoryTaxRatesToIncomeTaxExpenseDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationTables",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxes",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesTables",
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r218",
      "r257",
      "r309",
      "r310",
      "r312",
      "r315",
      "r603",
      "r634",
      "r727",
      "r740",
      "r751",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r765",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r786",
      "r787",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r806",
      "r859",
      "r861",
      "r951",
      "r1291"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r981",
      "r992",
      "r1002",
      "r1035"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Number of shares issued upon cashless exercises",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Number of shares issued in the offering",
        "verboseLabel": "Number of shares issued &amp; sold in the offering",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r52",
      "r53",
      "r89",
      "r732",
      "r806",
      "r824"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "terseLabel": "Issuance of common stock to purchase asset, shares | shares",
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r52",
      "r53",
      "r89",
      "r379"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "verboseLabel": "Issuance of common stock for vested restricted stock units",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r89"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stockholders' equity",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r56",
      "r57",
      "r76",
      "r767",
      "r783",
      "r807",
      "r808",
      "r929",
      "r958",
      "r1146",
      "r1148",
      "r1149",
      "r1170",
      "r1243",
      "r1294"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Stockholders' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r320",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r337",
      "r538",
      "r553",
      "r809",
      "r810",
      "r828"
     ]
    },
    "lits_StrategicAdvisorAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "StrategicAdvisorAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Strategic Advisor Agreement",
        "label": "Strategic Advisor Agreement [Member]",
        "documentation": "Strategic advisor agreement."
       }
      }
     },
     "auth_ref": []
    },
    "lits_StrategicAdvisorWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "StrategicAdvisorWarrantsMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strategic Advisor Warrants [Member]",
        "documentation": "Strategic advisor warrants.",
        "terseLabel": "Strategic Advisor Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r625"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r625"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r625"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r625"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r625"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r626"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Details",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "lits_SurrenderedWarrantsToAcheiveCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "SurrenderedWarrantsToAcheiveCommonStock",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Surrendered warrants to acheive common stock",
        "documentation": "Surrendered warrants to acheive common stock."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_TargetedOrTrackingStockStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TargetedOrTrackingStockStockLineItems",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Targeted or Tracking Stock, Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TargetedOrTrackingStockStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TargetedOrTrackingStockStockTable",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Targeted or Tracking Stock, Stock [Table]",
        "terseLabel": "Targeted or Tracking Stock, Stock [Table]",
        "documentation": "Disclosure of information about quantitative and qualitative information related to target or tracking stock issued, including, but not limited to, pricing of transactions and cost allocation method used."
       }
      }
     },
     "auth_ref": []
    },
    "lits_TaxReformAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TaxReformAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Reform [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_TaxReformDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TaxReformDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Reform [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_TaxableIncomePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TaxableIncomePercentage",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxable income percentage",
        "label": "Taxable Income Percentage",
        "documentation": "Taxable income percentage."
       }
      }
     },
     "auth_ref": []
    },
    "lits_TerminationAgreement": {
     "xbrltype": "dateItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TerminationAgreement",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination agreement date",
        "label": "Termination Agreement",
        "documentation": "Termination agreement.",
        "verboseLabel": "Termination Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lits_TheSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TheSalesAgreementMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Sales Agreement [Member]",
        "documentation": "The sales agreement.",
        "terseLabel": "The Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of Transfer of Good or Service [Axis]",
        "documentation": "Information by timing of transfer of good or service to customer."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r891",
      "r895"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of Transfer of Good or Service [Domain]",
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r891",
      "r895"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1168",
      "r1246"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "lits_TorreyaPartnersLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TorreyaPartnersLlcMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Torreya Partners LLC",
        "documentation": "Torreya partners llc member",
        "label": "Torreya Partners LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "lits_TotalTransactionPriceInRespectOfColloborationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TotalTransactionPriceInRespectOfColloborationRevenue",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total transaction price in respect of colloboration revenue.",
        "label": "Total Transaction Price In Respect Of Colloboration Revenue",
        "verboseLabel": "Transaction price relating to the performance obligation"
       }
      }
     },
     "auth_ref": []
    },
    "lits_TotalUpfrontPaymentReceivableForGrantOfRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TotalUpfrontPaymentReceivableForGrantOfRights",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total upfront payment receivable for grant of rights.",
        "label": "Total Upfront Payment Receivable For Grant Of Rights",
        "verboseLabel": "Total upfront payment receivable for grant of rights"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransactionDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction [Domain]",
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r853",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1227",
      "r1229",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDispositionOfANonfinancialAssetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r853",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1228",
      "r1229",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferredAtPointInTimeMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pass through services at a point in time [Member]",
        "label": "Transferred at Point in Time [Member]",
        "verboseLabel": "Pass through Services at a Point in Time",
        "documentation": "Contract with customer in which good or service is transferred at point in time."
       }
      }
     },
     "auth_ref": [
      "r891",
      "r892",
      "r895"
     ]
    },
    "us-gaap_TransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferredOverTimeMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAssociatedWithLicenseAgreementDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred over Time [Member]",
        "terseLabel": "Services Performed Over Time",
        "documentation": "Contract with customer in which good or service is transferred over time."
       }
      }
     },
     "auth_ref": [
      "r891",
      "r892",
      "r895"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "lits_TwoThousandAndEightOmnibusPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "TwoThousandAndEightOmnibusPlanMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and eight omnibus plan.",
        "label": "Two Thousand And Eight Omnibus Plan [Member]",
        "terseLabel": "2008 Omnibus Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/LeasesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r162",
      "r163",
      "r164",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r199",
      "r255",
      "r256",
      "r259",
      "r260",
      "r261",
      "r262",
      "r269",
      "r270",
      "r275",
      "r305",
      "r306",
      "r307",
      "r308",
      "r402",
      "r403",
      "r404",
      "r405",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r489",
      "r490",
      "r491",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r584",
      "r585",
      "r600",
      "r601",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOtherLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureBalanceSheetDetailsAccruedLiabilitiesParentheticalDetail",
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureOnetimeEmployeeTerminationBenefitsSummaryOfActivityRelatedToOnetimeEmployeeTerminationBenefitsIncludedInAccruedLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r278",
      "r279",
      "r283",
      "r284",
      "r858"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized gains and losses",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r424",
      "r907"
     ]
    },
    "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnusualRiskOrUncertaintyByNatureAxis",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unusual Risk or Uncertainty, Nature [Axis]",
        "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost."
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "us-gaap_UnusualRiskOrUncertaintyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnusualRiskOrUncertaintyNatureDomain",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unusual Risk or Uncertainty, Nature [Domain]",
        "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost."
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "lits_UpFrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "UpFrontPayment",
     "crdr": "debit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up Front Payment",
        "label": "Up Front Payment",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "auth_ref": []
    },
    "lits_UpfrontAndMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "UpfrontAndMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront and milestone payments.",
        "label": "Upfront And Milestone Payments",
        "terseLabel": "First milestone payment"
       }
      }
     },
     "auth_ref": []
    },
    "lits_UsLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "UsLicenseMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Us License [Member]",
        "documentation": "Us License Member",
        "terseLabel": "US License [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r221",
      "r224",
      "r225",
      "r226",
      "r672",
      "r674",
      "r864"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureLeasesScheduleOfTotalOperatingCostsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r928"
     ]
    },
    "lits_VoruciclibMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://litestrategy.com/20250630",
     "localname": "VoruciclibMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSegmentInformationSummaryOfFinancialDataForDevelopmentOfPharmaceuticalProductsSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voruciclib [Member]",
        "terseLabel": "voruciclib",
        "documentation": "Voruciclib."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAntidilutiveSecuritiesDetail",
      "http://litestrategy.com/20250630/taxonomy/role/StockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "terseLabel": "Warrants",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r949",
      "r952",
      "r953",
      "r954",
      "r955"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureStockholdersEquityScheduleOfWarrantsIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangesInEstimatedFairValueOfWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Not Settleable in Cash, Fair Value Disclosure",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of warrants",
        "verboseLabel": "Warrant liability",
        "negatedLabel": "Warrant liability",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r1233",
      "r1234",
      "r1239"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Shares used in calculating diluted net loss per share",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted",
        "verboseLabel": "Weighted average shares used in calculating diluted loss per share",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r213"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation",
        "terseLabel": "Common stock subject to repurchase or forfeiture",
        "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall)."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares used in computing net (loss) income per share - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://litestrategy.com/20250630/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares used in calculating basic net loss per share",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r213"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-13"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-15"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Subparagraph": "(Note 3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481418/840-10-55-40"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 1.B.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/420/tableOfContent"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "942",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480095/942-10-S50-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "942",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480035/942-10-S99-6"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "SubTopic": "310",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-15"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477346/946-830-45-39"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0001193125-25-220421-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-220421-xbrl.zip
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M[BPC=&-H:PIDQ,;0R\I*1F^]PV570LPA9VMM+YM3:=2K<XMC1KOH[V27KDL
M&0,)\"""*"OND  I"!.-#\]ZD:W!IK78KSH34A( *3>7(BZJ#A=H(*J;MSPW
MAQBB5.]=HJS&G9["M;SJNZ35O.B61DU*^\3J(9("-4A+MPY\1=R?4!/.(7[O
M+TIQJN+YW0]\28S2WC<VVW%RX,I5UN7L^T<I78I"983@#_*6SX@JZ@VA#GX<
M/#XI 9(Q<G!;0=#$JKY@830WS<&K C$6Z5\W$KPW#LRJBR,])I;=&OK\H"N!
MBIW7T<GLW5M_ZF5O5)PEIWRI!R=!19(%A+XKUB<RH, )=4@CGH[4$T[_S9
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M*9 7&WM=."^@KF[;F Q[;]_"6\G670ZDNET]\2DR./#L>P-9LPH1#5G7>/>
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MI+>F1BV+U1EU=[+=$;X]3L>B@Z-"0*=*S"0Z.OC:LI]&TRI*H2: U@N)R6<
MMHI.-1I ]F,Z1OY#W"FX::/IT-#DHE_K=&9FW7&C1MLJ9N\5<?63 M]!#&80
M642D0SVQL1O*"%_+JWM%6_,0$X4],P.* >YBV[=1R0?)J$F]8X=;?BVCGE&;
M'E136_TV(6^C:#RAQSLH9?1@0&1$D.=*)>QOHHCQ7/&O@Y?(:BS=1&+3QR
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MVU?\ZH=4"F?55T67@T59@.HSQHI:47#<0!;Z1OCSD!A4DI,&_B7;Q,HZ_:N
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M<E(/BXC%4WI^T(>)*FG"<JODJD&;>K')P>I^ZX(=NX &U&J*-GDOI,DWU1$
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M-" U\)$$!]UX0=X.6?%'4$U(C>Z\V+_FI/:U]<R^2*N*1*DOQS;N*+[L/&:
M>/^&]<>"ER.?/_]:A_%I[O8>XF*.B+M$(TK8RG\@=VD<*4TPFZPPAZ1"R_BP
M1M.0NM&4@B9^$M@SS,-,U0QX+>CREGS!EYD8<K4\?;/4L3G'="&_N@=U4C4X
M6:R V2&,*D24%S5IF?"][I"=A5A]*/;X -.Y;'A2L<L!@S_WF40]]^A\76I
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M-7?(KF+=*>F^'Q](L[N8Z-(A[T$<<H?XUH-M=6I9[F)ZVBX&31_WVCCH;?7
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MW2<N6ES1]>:9^+G!OA<_?VL$E8%U]B%?H$=\_8@@5U<Q->EB=]_CP$#"<8/
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MS I(EC+)&$40!"1_9"$" @(R"U$0$2)$1"1*2!R8P[ $@24(6<@\1F:9$H$
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M6-AM"GSDJJ?"Y#T+Q>.[^2TJ !74(J7@E?C2@H=F&.#[KZJ7&3T,B5B*+,X
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M[A1N8PN&9C8$KJ"VU/EW@>:50N%Z#QOG"V&R(N[4HW9/@&D-AE58STA(XLX
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M:Y6Q$]JW8PN[#>N\0+U%2#!Q3\)++<[U;,,.0OOP'Z$#)"\CBDH+4-H5C7
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M.7VW-11KTVO2Z*QQ]?UCK=H&@_P^Y%4TWR_7;^&K)L52W3&! H4? \V@S:^
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M[)QR%1:W9W1K3O8EQ55!U<LN$$F!V<R^[HO_1#5/^-0!YH<R+S+^(WT.Q?D
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M>^BWU0-5@88R-PZ#6P]V3+G8=#BLV$K:2MDTMP]T[:.] ZQ_=JFG]7J>5#
M[T7-__#(%'K."%@$-F@._#8"\V^FRG9AC\-FZ_=J[F:=JXCG9^6[4F7SCW1B
MEN:Y-%;IYW6O_S+7?VC>!,*S/-&7)($&RRY18@@G/%S<%.V1QS%;GA<___#K
MZTRPF_V6<\T3XW)(+;;\\J(J34LE))P#KGIZ[7DL-(@5'ZK3IR'FK6\BT'_.
MPLG&KMXD O]M)B3_FNQN<<=N\>?C!L)II\L?U&^U9FP-=>HICMWQMZ[/08B\
M+9%QUY>S&54O0@I_O/9VR-;&>CJW%98A^9_6;!_]3*$)VI&;%O9I?CCLDMQ0
M45YGG B17EA)V< _;R\SP[J1)!JD^XCPY(Z_;Q0?[K&;"I3)!?IS=/[J2>ZM
M6M$W#RMW'8>5P^/!;1N#4TMC:%=X IT-(H%^YRFZ$/FAS[)VRS66W ;C7^TV
M2(8C/M;H]ZPB:K]697LAOK@)X4O_87_0<(E'(XL.).G1F="@2D)]2)_Z26KX
MJ$$#WI&!:R3]@JL[ Q<'%OO\0B)K#(L12_<[SYII[/.X+-WL[/$L]?;A<<,,
MI7.V>_L'3<8Y\3_W;<.YJQHEC7@IW/46B0B+1.B.9Q!)^>9S20JC";6/<R(J
M911#;9%[%^7\7>C>KT+E^.R):.6U!\U7QXG=2;H1EU\UJ2(>W+O<\>9"V:6.
M )V O#?AP]J>]>@;%:4B-F62.WSK7_TF@!O+Y(M, E5&G\2VI Q.< $@,#*4
M1&\C6'GO'G<-8R5DNW'I,5."E!>VM],EB[(-NE+:A7[(S/9I(PJ=]QJM1FC3
MXFX.\TW!J"@@KH=F -Q5 NZ->1&IKL5HTF;7XTE/0-_";I#F*YY9O#**2SK>
M*D!4:4>^M*D\UES\0;7$=6?AFXD]&PP N@%X1^U8BP'@8 !PYJ33#$#1]K&6
MVE+EV@/)T]F[RX+HO6N&YSI*,-%$P%SD+%)4+_L"*FT]@?KO-M(=0[_XXN@2
M%E,\W/A=B?W.1?Y<'RBH$+?CI41H[4I!%CJ4%]JA;<+(0A-&VT=UW5[_;%BK
M82SJ"SORS2?*;A?_#^K>*J[I/_[CG3^#% 2D2^D4:05D*@("(B(-P@0D!E("
M,B2F=*,@(#F1SDE.J0$CE)26(;$A#;*!C,'JS/^Y//]S+L[CW)R+76U[[)/O
M]_/UW3N>3T43/?IJH\\D#^'GEUD[+HC&XR$B(L79*XOJ;\9$&T_C5#DWWD\$
M5UIX=3ZPJ,1SR\]4;EN6V;_(U$$01"CPH.4%!\R%.KR?"4[]&$7R41IL&W^3
M?P\Y]Q3/>FA2LMDE..M@SCM[ZI0I8*A%3%2<_;F@:C!;=S4WIEB<?)NX.TGV
MHN_!7K@6+JY8; D,8NMPQGV:,TXR*U)K)$:L")JEY,S6I@BSNO9E>CL]<WNI
M>[QT@:!.N4SF(;+C,@DAN,*Y-Y&LD&N#W5U<G7-*.B;!);9.V\<XTWK0_!8Z
M8NFC^VR+\,.]9T7C1E,KGI.8IU:MUO>SE@PBM<TH[Y >IDJK,;#FU'B4\+7E
MU2!$6U&)=/I '=9(G:=S5@<8@G$TAGXVJ3/Z=#800]JIN_YQZISY'5G(XYL9
M-VUJ1-^[AV:#,C -M@7J#PRXE+M75;62\R[CU7!COK4R Y?%>66_&CQ*J9J,
M5[/Z969R"Z,K@55(CC[8'5<>]EX]J+_Z/3!2HD_)VY#]@_/!B0TD[X:6I;\E
M=L-J)J9JJL:0Q20O;_V]IFX:?$"4>*TBU4]'DR3@V2706#"@>Y7LAGOYIKJ7
M210\$13!V^^D['];_$5_/3$0=? T2O.\+W,5?'X;+YHFVA3?8X8V-)@(!^(1
MW2]%="<ZM*N&:S=G!>)*ZL%XV^U =.=[1 ):I*IL6"'56^+M&^VAA/I^#KM$
MW?+@:/@'-]M=-H&@K=G^1UF,#VO>@_LMO537_5/6/,QRP;PO=W?SO;=O#,H,
M>I"5"G]_]?'B"W?W>%,55>; I?6YF'$N(-;/6TZMQLH\B\&:)U7V\*9,\Z<%
MIXLTP+D)W#.1\Y18H'NG&.,,L+E+5&_U9J[EA6RHZ'8;+$W$B _@V( ]GVK7
M:'UC-84SX0NIB"ZBF2 V*.IY'#PNG -S2T-1L'>)#4=-Q8 N>N), M2T;.+)
MMRH<P (:^:QS@4\<3;C3"CU\O(40FER_[K]CR ,_4]C[86/-P'ZDP\/.](?N
MO3#^1.A+,OSG9*SVP):VKN.US-;MC;*,M1W9[XT%52_4L]<^")W?6GY',6,Q
M88<$RGSO)VGW#RG[V#47_C#7YYY^Y?S_KT[19\C-="ZS.XK&T0V\!9U@O/%S
M\? .4]R.W@]=3DBAPCF.[VPUY>% 8F:]EY,LCI#M\:6UZ>OTWKT&+Z!+9Y&V
MA2ZB(O6V($NCQ#&2*+W10P/,>Q PQ!"2D>?RY>9.S4%[?TIKEVRX.PX:[]#7
MAHC5<>"-UW' T/D.O=76.5,1WY(JVO\R[T*3G]KLL;+:9]M?7GGV!G_FVNXF
M )V 7OOS>BLY>R$KVDKQRWR[;D:*\(HV'"A)S7OAEM* +M^L1VO_KR4!9'MK
M9YQ59W.K>?7F<;966DZ5'M@O(.3IL8!/[ P,#Z^ECHORZS)N03F@GONQ1=(=
M+3ADMQ+:NQ]TUBQ%S?&Q#^_ DBB>/;;^.>@V_E9_W9>T&W\[0]59PC@)O(A(
M@U*)1F2SB78[V!<H,[;IHB+TIU6WGCG.[_WJ-K8AV'_2/,O6*58&.V,[5K J
M%V2C:.]EGJ5K65!F5/6-:K_Z@,VY1PB</!X0JL&>1+30Z5NW:Y57+ "/<^E'
MF%PT4SV=D9OVOEO&*F2I;.FJ%2P3=D-_#.)>;0IUI@&:.Y&ID8R1@R+:$S2
M^T5QFRFR\XI2?)MTK.XESTCAR3\='K5;O;.'^KC9Y K//*<JMLZ06D?PJ67<
M15WM;\&R7-^2C'A 4L@,)?0&09VXAA/$P%_K:E$G=<4ZVH@M^.6!+JD("Y1
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MK?.IP>,1+RUT3$D((W7Y8/?O:4:7&%QW(L6P70,^@C3 -+>""/VW*BXK$AU
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M+%X #TPPW1;0UF/U+7LW\V[1(3N2WW6&4N01D^/[RJKX^(!D$BF=8[.Y4#1
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MC_8:]ROHZRB.:OR7.+D-@[K:G'5:</IU]/EX!TUP<#R@ 2#3-CC2O^0FAW_
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M%-R R_]+J/M;@UF.L'JEACY9:-W8D^0^N5,![:&+[J?#R]I[NC?P ^_60L.
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MEY)TIFZ%R+HYA(?:,9052#[^O-MJ0[\81V':X(?,*E;%JW-GJF5>3B->QKM
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MXR; 5\-$F\+N*P]UK\GV7I/MY-6]8G:S]XJ9WF?!=ZHC9^^/ BQU3UG=M@(
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MR0OH(08/!^2_7I$8$F8("DS<2=>6CQ30EQ\4%1^6FIW+?>$[]VL@+2<4S:(
MO5JQ1:1*_WE8\G7#LLA"?F#MW#$ ).'\QS))6+C,KX*A+4D158:=#2<YG4 U
M('U";VP<Q[*5O(3B(L.M'8+J"2SOH$*A,CATU]6_@8T^1BSGR*DX\.L&V@F<
M3[OQ'6%0/[5'>AZW6244[9H%&Y]7H5\LIYR?J<NN.D?>MF6*C\^"=R'8[]74
MYF0^7.?P>N!X)/LA3U9[V3NL:I>W:N2$XM(9X">TNA\T2X)= 'DA8ANUKXY;
MJ_JVG%MBU@'&'@-8\'7&GS>?M@"79C3O%GB^'^*]F >[C/E]0"SFG2,MN!E8
MP.6/5 DT;>],]A]:OY[-MEWFU-PD/G<&W<MCF7)LJ[J)-P$4])FJ$]8$PP.?
M5%^UMTVVV=?LGOB+@3F^L!=7%Z0Q*J+(0@@J!];@,0&*M@XQSSC+(E)*Y,!/
ME=4"'M878QX25[IS+)ION*<OS'$]1%\+OQF<>*1\@MK.+M.BZUW8ZF@9=*ZA
MY1]2J10;?833>5G6\Q]]X"]BLR)N#$UT&.4;I<I)KZ RP+.=],LUQ+Q<$C.0
M5$O+JC?E<*A*XUQ[UW;6)X2?;]+\%B%)@ZI![%ZM*=I 3E_*= ^'Q/)?K;6;
MC.*2[93O]:5L451A[4]!B]FP>O2,I*8"19<<B$/';[<4\C.05_@B1*<*OB-.
M,UY4@K'W<;]JJ- )T;94AO(2H4C-.M\XSL(4)1BZ3H8Q\%I"EA79E''3N6KJ
MV54F$>D8<4I 'E?.FJ&*P_1;,:=I^W)ZWX<G5.'![X+I*[]$HZHDA*.[7+_[
M.<:M^6K?UVOC^D_LO6=44]O7+AZ[B!BE2\M12J1;0)"2'$5 0$"0WJ(BTH2(
M@ 0)B84F+0H""D*4WB,EH(!$".4H(M(%A) @TF5'(&P@Y<;?I_N^YXP[QKWC
M_=W[_X_Q?I@C?-I[K\F:SWR>N>9:ZZF_%0O_)MMN-$#GQO"(B^EB\):"C]+N
M/N0-Z CKHS]F]%CE%*@/;)#: O?>VHQJAJ5LVDZFW4FGCV1,7[/;YD'(QQX&
MD?25P!!8-%*HUNB&HGCL!4 S>K7?#RXL$$WYNOH&>_]XYE7-M/I/PG_!],<0
M][W#?8M=7%%?W5U13A,M8H/92R^8;J/N8U8):A+BPP=KJ 8B)ET*E\\OR\1]
MG&V_H-2-73R.<4%16^ESM=SV?;=J'+A.95I]J]6+N%A3E8^O61ALO6:>OVZ#
MKH&VOKJ4;W\1;#K!83%S1.QF^<V0L9#:_O*EF^J>&A\"O-!"%0VGJL*4]PO(
M^+E_\#YR]H9BLIE2A8UQB$)*M8/%^?0/=_3[S!12S%05TE+<4UP41&V,=_Q3
MDC: _</MYY1KR'_8*U(:RP?Y-AY$89NQJ,/[?[RZW&6!BPA$+C31-D^4=CLT
M\""$+,+FL@XWT8\'$:7<M-ZJ[UW@4L R/GU@ZR$K<?&4MBD2<&N8FT8\:&,L
MQCT*&Z;_XWKNWWDN\R?E*O(Z#[)Q!,'_0A)!!#]O4^ZX&;8%QT_+@S7<3\/"
M?*;L1=]@+ZS^'N$.-1ZDND:3!QFTPD0>-A9UY!P@MA[Y=R]$_[?]/UJ8_X\'
MY0'PI2-\;'S+N<^#^"TO2?<D4FITJ$FF;:,Y,PW,Y:C:$80L^VSFS/0)]PE,
MS_M@,,)]2+'^ND.\T-UE^RHOVGY6JFN7UDG<#NZ_TNY],G))R)-ER<E?H^W[
M5N5[LTF0.6Q<ST0D_[JP[;@I4[#%(?-T1?[(627Z]G&,2+M$Q8ZC;AY=6M9!
M09SP7I3E4R9!^'M3U?L;8+%-= K5,;/]JIWC2-)^\S*K3%_G!G/ANCY+)6PS
MN@6KF1-L<?P#D%JA7Q__:D]4^QG# C43L;X2FZ)2>R];0T:_+P_RC+0$XP_N
M=VDRA?N)-BK!5>!D-YUEPEOO[)_ABJ#N!\/;D^0B,&\S-RU%J$\HA-I(A!CB
M^G". A#X:*?-GK1OIJ+EQ#3'.L?,@.DA8O&HVU?4UV^6OA&>$3OKZM/#''YI
M.8H/._3G![M^.ZNB%6RDHO#D0GERZ?O[W,ZU7\M+>[9$N!_P9/<70Y1:^.(&
M0&%$?WI=T8")]0"Z7\AI5]^7=TI75^UL^+,?&Y#W\I$\(3"--++]25O1T6.M
MW(PT3$]<K+K!LG*!BY[RM=NCR4GGTRHG) ZI/"Z!-TZW]2:QXJVMNU;P.U_W
M_RAY,B/F8^$H<]K+TJ%P;+;*"=-?8J7JU1U#4D4K#=(V\-P>?-WZ4M"6\C@U
M:,N0^X4BBI!T,3[EAHS50@F/NX-'?]VY_2/@,IU+YI1,)EUS7UPDE8(XYM,/
M&GT&(SJX=>YG&!#2N82<)"QRY%G/P!/ PE0A85^^#N(8X-7=TXJ"?91^I$G*
MJZ]C:MX/-<NC3[WN-U"F2]Z M T_SA QW33;,N7SU@ID]7 ROE8;/U(T!6O#
MW]O\]&G%%>/=_L65[09&'J!EJDH?"@^E4^1\JRP^W?:3(B9B'=4@Y1\\SR2]
MS )@K,<\R,,(Y&0^/PYJ0Y%0MA8?F7WP D[+::'+]Z4 IGCE4*?Z=@IU_&X_
M%7^PDKQ#<BS8E[XL!,:,"M[K-2YV/W_U3=8"L@Y[:DHS3%JF6;*A ;FT#S7R
M;.&=J(.><'ZI^?*%RQUVC5L:\SS('[^L13'**U>\GO4(6-ASLEVW+D,&PE+?
M6VF[Z^:3L]W$5$V7%+(IY:3?7($/M0]N8OE^[@^E/=KL65QC= T:!^R8ZGB
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M)OBI&2NI\>@7=[.?QCNX1G#._"RO?(GYJ5ZI^.#"=_3:<J5C1\Y.P+2- /4
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M ?FP[@>E>>[&^-/2AQ9+SR"_OV1"NQ?0?=4$<=#ZY'2,2IT\G*2JX18JH7+
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M\6F@B38^'E4'YXS-KO$@*+8]7U[C9&'#2&,4(V@8U/7G0<Q[XOC,B <Y!%T
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MWO'-#1/FGFH\J-5XX;.%8F45PR*7>%M9>AIA^KL:XCPEBURZ2WA/2'31?!1
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MM#3#@$':/>TR2R/[7J+%6W(JU2&S/D9;M62,FIE='Z^)QI-O5B!Z@HLC#?D
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MJ.]F>@DW#0E8<$QX$$=^,/OP!Z*_%F"O1+ ;X,M+P@C<9B#OS<FL*,H[<!?
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M&.PL!QL7PS1V;E^WZN4C4%4Q]::+0ZQMO\>*7Z?7FQU@'["^%,JL82$X!?@
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M1XN>JO7*7F5_YN=?/.N3IPQJ]CFRDKV0QFIA,7;@%O5%3\)M#T1)>PCS>9'
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M+2>7$2#-0%C2M0-3%_;CX#02@>\W/.''0TB0/2-:A)VA:_33GK7<85;<_55
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ML/X!>_I-O:_>-SRI@'?$_<EWJ<IP!$BB!G+%H-DVLG3(]YY:0^LB)'T]Z8;
M3*+LG\,_ZU#"5_?M3[7,)DKY7C\OJ.[256U\"\![TJQI$]FK[6_IMU%RR^YR
M[X*S5O-B<Q^PAJ) 687SVSX,E!\C=>#JG2OL'PTDORAFT/9]E6U\XOGQ^Y46
MOQ >(KL*8QY8$!<EF_@F#L%<N=J]S?IFN057R7L\V>R8A4N;QRE7Z5?8C^T!
M.#L']#.;9&:@+^KV[4T270"6'F-'L@(GRO!:D'87L'MMOW%=MEW5699 NTV(
MLV?&@GGM*Y8=1F=%8HK6;A@[3BE^<U=\!ZV('RE:3>!]T(0WFQ:#W(>39'8Z
M940DH<061@U<.I/_VF9;XF-U+'SJ2<=>7(LENBYMAT0=;(JSX^1P3^'$&_TQ
M24@A.&#:9E;VX+!^K]"RYA[VY5N.5JQ].OU_ST<;WQP*U<A_O_W.A<JCK\BM
M@TN:=8JZ["7KX6.%EDE&F\+/RI8TM92-\G*H\U^8.8)YQOE5AH8Y]O<K$UEB
M;#V.5+/K!Z(41ZG9JN^UI-BS\Z&W&R>L@^ZS/"B- ]5/I/<XE77E1%[1#<RP
M'Y-G7MMMH1LK9ZU0=^;G_HU0;&>;4V<:-KO=:<^AX@=!L5JRG_<H1Y]Z*>:U
M4.+D_&W 5Z,D,.Z[Q14KBQ)K/NHX1]6 NB$4GSD:<:KQ8I$9HV.,]/X.3:%Q
M/KS:QV<._AC(ZN_T0]1B\;$*4CVKH%E8[FF&L/8^E[=%MY6G'E7CB_]C=^$;
M5L!N\R21U4-'QANKA'2=*F A*;WG)CL-3Q@%B(4&_[V@_7)^PZWL1I5/V1I2
MXDL XN6%CS; 1Z0L^8; T':*=KG':\PA^I+LLIS"FG(RWY)//0A^?2T/;$8+
ML11TKX[6:Z'-H]^A1G=5//?K53O%0[B"J*&PMCV:[%,XFLY'2%ZGN$? -.&6
M[EU<2<O(,:9&!DI 2*, U[.I8V34KO6>N_)/PIO<NZUBW'&@1KN;4&,*4IBJ
MT?I?7!;^C*,8-$9C@SO[?FR[06C/44FZR-KY+N6I^6%V5F1GP]-S93\5A0%3
MU+]FMHQPGEV5Z3+>N4IBFB@Q<_8QK$7[7TV)!FF/ZEJKOULQ0?86::_UWU,.
M?W,G(*;].EUZR.+*RS3?B9KO)@^=V>8=^/V>^XEBWJ<=(C)&&!_)$Q[+.(K@
ML^D2H-WZSJ*(M5"=G^X=W]I":FO1AFZUL6E^!?EO_RS)OM'WY3X;.8_'-&33
MR\>N5.?TDIR2#CQZ*;E_A^>GTVX%3Q12PC4XD%5GL:JW=%9D5AC:S> G(*F7
M_]RET;>PJ;!L[#,N;E, _SXK[(?^YE%8G9-16RGO#IN]@OA 6+!_ O8L\KF%
MO;GBQ$,\F&28)YL<LISUJ:?F5(EFLG%36FD6!*^\('9\V97%YLP7?R<M?#A:
M7N64!7VV5MZ?4#3/" I=N!XD==5#YDI+^.-2A[QD95FSOOQO6D[G=1QKKS^^
M0!&.R8UJI[]R<O'+D!>,RXNA#%YYDFXH&QY4<#[KR3>U]^>>*ROY?KARISE_
M,N")C=F?(?_5!S3_?W/]:['#UN__*C3V2: )]^]ZIMC ?U$]_7]&V"2:^^^B
M6C_,_Z&X0>AE" D1OVZ5,!C_QW,?_PG8.9>,85@K03R$VPP/,9""860N)O 0
M=S;. &,\A!2P2HLS7^L?<(2>AW+W\$GB8 V##Q7)':8;\/\H?%8>X>E=['+5
MR>]D1@/;(,A8YHYC/<O-Q>WL@<G#!M)#^0][)8L/,A_MEU70?801@/_\[QFQ
M/(0L=R04 $MZWKHLCB[CS,"2::S23[7#[Q\#/UQEO<& D8^$S0DM?:2(>]_R
MSSL/GZFLF/QZ23X+KG02)6&57J >/LX22,8*Z-U^4,* +.-K+J4Z%8C%9ACF
M8!)SS8]3ZK#]HBFD>,I(]*UBBULWM6>PV=&GS%.. Y<94_O?06F"/4?;4T,S
M_ES9:9Y]ESZ;4'"E4*XDO*M"*:2D_:+%B>3'WBN^K&CN;E]F@,&B"Y]6)VT@
M$Q9C?QT QSHB#9F4\.KS;S0"Q1+TCJY%:MLV/OQ3^8M/JV+=5-#AJLI^3#I-
M%N6!H@+3YE02E GZ=[F<)WBW%++./[N><Q1,_..-AMZ4&MC1V!KGI9)\MUB4
MLU;^Z?=V5^S75#OTS]M\-(UN5N+4$BW<?]NH$.A()D<W^[XO6CY7]]>L=MSN
MH+^^#]5Z6,?MO=4B=/I<6E10<<+'U^B3G?99*2[I))3//']B!'5_,FC?H\P>
M3Y7JF'V^,_7%9[7I(-V^9?O3?K.VFKWS=MWZO66^UX++%&6/,(7\C$N0LZF"
M._9>./!5O&U'R 'V(?(?9*] 2'U]D8?85#$ES6%V WR")P^T(TGO+J'$C.]J
M5G80?S/_:WD_J6IH54S^;+EJG&:%EW?6'?#YQLY)J\,UY8-6>A5\OA#7A1QW
M9%^&OMZ\B;L+>K0#DV&N4^A]6!<J9B?T[*?"2:V*-8*P90&ZU&K_]7=9X\.+
M[Q$7=\3_-O9QZ@"?4EXKXZK!)X9,E/&]R-HT*,QUY/#HB/%V5@UEL>A[@$I&
M9='X9'SK0>C(E*;MI7J[VA@16_@,:R=%4,FA67MW*I/S9.,8?A! <#.?C2I'
MJX..$B!&P?/JZ62&@I=KYVF\/1'<^##GM?^\6ZJSN<2W$?7K&OK)'ZM'KIR"
MDPZGF\F.)'L5&:"AK?6%EV&)7!$Z/>?;7:X;\0:4W)ZZ*U;[4/?UY>2)L1 =
MIT3M_>F,EO2CE9YQ':?*3GH^=?FYI^].ILU62;S1\#KRN!Z!.L;VK!WV4'+!
M0"ML8$RI?='F>/("V-^]ON[0$"91X?78B:LZ=_E8XGO1Q*V<6QHP0>$*J_U'
M'3]29TKF?1["%R4 F7:&=1V-NX\_WDP4A*T;:D2Z"R<:DF-?T&GBM%==X\W*
M#+&]>3HZ985F(1BZ,)NPM5#,Y^7F/(27=@,&HK #68ZI.+4;0SHL<EL 41IG
MS'X8J#OOZ("7D,DY!G*?)\::-[(PL7H[4W7+#_SNOSP_0V7T,1A]RU/^KDW.
M!?6-=6\2+VAI5O#C;\X40]!>)=;'TR'5*=_^\6FI1\/'#P !#./3T_B#!<<<
MS).<O#4C"QV32<GMQ99<_+7Y#PVJG'"2K9A7N:<7H?O5E J+)CJ2*F/2UGPE
M-:?G9)M=V_7/RH'TZ[[GHHL'-EUJJXP_.#8UN_ 0'M^]$AE'25%.LU'801^O
MF-$+A8EF8@I5%V(>7_AZ?D]JLOUP[)6SN_(KEX,Y+\B!Q$EM-CIC'-]/JPW<
M8J/A]F4]AEB+,4S:57!'C8:TQ!?8B/5'..U^X(V>4[IN4+@W=5EKL>(M]Q>^
M#P6&"BP*T[5??><A:GF(MP0$[MH@TV>:V$D679.GQ;3J.0'?ZMBY!>[F#++
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MH<>Z>M!B[S4:N_<]=GL/;BXZW*F^T&:UR$DI*&C<];HYBSKB$K11 Q*9VNU
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M!9?B!UMU#=M>-PZO?I'L$(U0I12OG<S:[' _%;O$D*P]B4>"K;D,]*K>_[S
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M*YD[!$RGT&IG8<D>=B<G\Q#$]S,[.) *V,3&#]RL,^)S'3?(9CHP1FD[9,]
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M%4:QC99^7UA?RSK_@H5YI"/9':BYU"O!2:](IRW&TQ)0H)] MZ+!HBB?@C1
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MNK2Z""%N?6+IAO_8TO!8[VFEJ#@,+QD0FD@QL8<RN=UQY#^,"==<SYKEA'H
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MZTQ9Z_]DKNZ7[37O#WI!VGNOII7\">Y__]9BG-$^WAP/!0H]R .,]>*/#"3
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M!'.KLKWCR?72.?KCLX<%7?NE9.Z?6$&M(5E#:\ )KM".IMPL!5^$+@*'GLV
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M;(+,VK(L:7ST1JC*:J#1B(^7GQWL&?=WFXK].2J=C''M^6EV),HZO&CV9OA
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M@[B**3D2!D3&I<S$V0<>]O,K=50^R_;&7KW[E"+$!0"IZ$/$6T0ND6+H0\N
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M[-01?K%)7"]54(W.[D2"_*T8&VXXAQC..36\U<I/'T%**".$J+) 6,%ZB7<
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MP2IEDW_]N)#:4E];JCM%"8D[L#2F-2$?<84(J_JKS<J1[TV4XS._987)D:,
MH^).OED!B*SQ4RKTDI%JK]'.=,2&RU.GEU<+TRF6B!\A2TWSJZ@:M[;$1R-7
MLF9,LY4(?SHW#19T7]U>@DEX0DX/B/RH'.!+/',AP-CY^2<'XY4<%G&.75SE
MLVKC77SIK8&-;%QMV*D85R&VV33QB.SQ25G9A(JF4K-YB6W#X(5T$A)_N>GI
M9)9<-W=T2'?NG8GM@ +8;*==9-5@3!)1@YSU85CY6VK/IO##M50I_B-C.4.F
M$QJ)WE,+JXV%V:73L8XL0058>P^!CL?L0VPY([:YO+F-ZCW0D.B[USC5AQ3O
MGT.$^$76P'^^>4K1S??O*-=!';]MOK:>ZIL^&28Z^F,X-TZ1X[^J0/Q+Z=[W
M_W8-CE,[D"]&3EU68H#,4/P$5FI:  .T(<<DD446NTM\%M!&5/B_RB\\P_"
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M*_3\I+T'>[A'%03W#\TP6;#\/'.^Y!"8)P-D@^+ACOF/S'NU.CWP7\O4_IO
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MG*,LB0G'J%IJ$:WB,-X_[2AVJBB^6%\2K@:\\PLM@,$])JW5"M9B"]S)R7D
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MD>COE$MWF&Q67@TN0*^L8L&D"!0S9A*;$##=2;W&@BD@G<P821YL+%C?))G
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M!!1^;S<G!76A=>V$NAW( 4VB!3:2.3H!&91$PQ/B]+<]P+1, KX[!"*J8S?
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MC#,&;,#$\%<X_0CQ^U?52 +=764&RML:,?4 0[("PB@M4V&;W"-FH?Z,VX>
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M")/9KGMZVY!]_>-QF<27!\0N#-UZH, S.[$@ X\4I"$?#T/.0PVJ6X\)4%*
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M6"O#K/]RK0N&/=I>>S;^8''J8&\;^N4=<VN?E(M%T_?;42-*[R83X+6.8C5
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M:PWA$L]%$#,OG&/L$!TMW%%7ZI,O@X6\[S(KE)(C@AC1%=OPCWKW8L^>6N8
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MF)P5^_4<OHOM8RY;C=@VUHR11F$!L7#Z;]J53@7/\P%OL$NL4<I+K>8TXMQ
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M<*;B$/]RMQ"UY ,8P!'',>$;%/$7TM0%=L9MMV:$*L^!''9] 1[3$:V=5JZ
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MO%#@>6;U<@HJ4,76:FVR8+3;L#6*^/L P6-MAEDJ-:(KY+@OO#D7 4S&H-:
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ML9_Q9?M\@C@6='%!L4O4JV"VMJC],C9LK^;MO'6!L\\1<=P:XF.)%Y%# O[
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MS_@H8)I2S_05M 9VI3Q^]^RM%:\[WJOK8TWG!\O/K,WTC+]N6E']:+.:;Q4
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MWA5?&AV)Q$(^9^HFUK+?2BH=@1@@I*INJTWHI<<WPS)<Q:]EE$4S2$)'@E4
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M101X1P&[AUE/^K$7<\G];-&>TKWF<: ")M]2Q,?(E.7;2;PA%D7Z'J*D=1X
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M6TM.886Y G:1U&*"XN5PZ>A9&PE&ZCTH#>''&I\!M00X97Q/LS>"'&+KR[^
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MB^'4D0N]M,MUKVISS@T8V[KSQ[J)@9Z1;Y?BM+VXR?4_8FJ/KEI1<00,L&B
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M6?'[YX>I\/ 7WI Y!FV6O..>).MX_0#?<CMBT!MFW?+O?F[W\J1X(PM1;)K
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MP_S'-6[>HH1L"77GW?9-*83U\E,)&O Z, M1]!$=%\NT[9T28J'P)'PS !Q
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M!J_YX8XHA,@X(;914B?VO@D>F A*(%GP>NY!P3FYRW>7*/(T"37!_K?I%=O
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MCJ WS:F_1RD=RWSWG>V)W<7D,9#=,$9K+MPL@>0/\-,H]W+(EN##R5:)P>2
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MCKSUM<2O$_O U8(%](P,V;T)_(SU1 9!A6C6$?-WKFI6*1!$'#@$6::MUXR
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M^*^-+C  S=*^Y3FY8KR;DAWMN$*MY,!^0OWF;YPOD6]JEKIM@O\*V^B,:07
M81FERE@;/$I91?1_3=;/ZFI0$%#2,'6XSO% @N*L_<Z\=NSZQ1[E'H&*X9G8
M<9VO1@0EUA-B;$>,?GQ(==@9B[N:UN$5/<HU'-(33"]N3DL4/86E9S^&*%V^
M*F!@(1^S6FP')P3QJ HN5!\'LQ1;%[^=MT,JNP4J5]MZN_V>=E^WX#X,+_3B
MS)0,<PPR)\X5A+"5\!\7Y&0<Z(0-B2,@BE+439$V=Z8 3;BS5WP<XB:>[<(J
M>#D)]A43 7YT<K-GZ58(]=)*+G)H<<P]FV 8^5S^]BWWG4Q3F69(H=3CYFU
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ME(3](<(Y6PKEG17 >P: KMC1^S+P.@ OE(LW20H0;:*2(#K>%F/5@5&>113
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M+X%OG<<+PO4Y"3*@;!(@8KU?SE":FU,T=>ZH2*-1L9_0<8E'/Q<?B45EC62
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MZ8LYAHNAV?'ELO@X"P6_MRW*)^?ADK/]WX@=WPP,&B>TABUL3?'A(47VUPU
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M?<')\Y7538,0N>21$=>OMJ?H-_1BYQ.TCS^SQ-IVCBN"7 ]08C%FB-)Q=-0
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MXC/R9 _,[5#_E^K:>IF1>N^"&\==:;9R0&R(=FJOW"B)TQW&2^-98OL@$I1
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M]]U 5HI7TA>]2]C;-LQ.I'1B26S[0*[BWL^*1X#"V<&9F9_)YXJ)<W ;0I9
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MU\_6#WWZ+VS,=*PQX,0!_]R74BU:.21N)E\!)I1JX1T&_;@HP7.R.8H@'2I
M3V6OQ8JW[RLT;FVT+AY.VJ@0NV<$'M=D\=[#KL0Z3^=5[FPX.=LWL)#@GVWF
ME;@74\_\,)3*?07!T]TV&(FD@K#?DQ'+-^:D<2]QA@H,DHFI!N7X0WSG*'F
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MDW6; >-T8GR.\<']SWXSSO7S]32R[#4/EE_?])?'RW*X$WD'OGVCPLMH-9=
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M2:3Q2[_[G;[]@BWFI_SN.?<P*&O9X[L[X_N<:\/-7#\"/!O_"<GQ[!F)X):
M\07\ TV]37X<%$LR'NV"X/@7I3BG/F!6* >Y/#0P,C"EC5HNE@2PS#L\M*KZ
M,66FYTD#128-^/3B>=5F-CF+$4OAV"V-++<2ZRK8$0!ERHU]O&@,YUS+R7Y.
MV8VID &C_2F]30A @@6+0V<Z?Z 'AX0<4$UYG.<YO- W-FOJ:)G47_Y4\5.$
MM')5(Q<.&A(7 SFI7%0C".79"'NL=O?A=WMC$]L:4J/Y3F_ '9T6ILPQ@D*@
MDNN$-@<=WW0R;\XQN!#K=SG*TM0S 3!"1>BCBDC],-_:&*[TPJN/LK,E4YF+
M<KS]^+X<HT26;H=L5 ,TE1^P*]Z/^8DT+I9J>.+?63HO[T1B_*X9K,#D N_;
MFD<DVW)M_AE3&?[::N]]9;,(HD-0I]Q$/\(KB7=A<)98K?.(L^;<C]_JC?,5
MY%B<A%.'21KA3F9."NUP&:'*@H_V>[/D]A*3)JU!C-.]*XU9-H-G <NI@IKW
M9Y_:0;ER/%W^Y0'\"?P7L94:+@1+;#34$\J!TFU6!U"W7$?I0OE(!#4+1]96
MJIUWH 8UK'&CQFQ/G-N">I0D^[..^TP$28]K,A?+V66NBP@R:,>Y_Q">]Y^#
M-(XS9;AQ4IFFH<PJ:I5]9"89A2,PATGNH4AY]P6A,;G^?:)7'SK4\J)6[9"%
MT]NYW]+-^A>;J^]9_EL@?Q^;=$_O'-F-AQ8+,1?"S:7A@$O]31I3%UF(..@>
MDM>!@3<@9G)[S:MLL?0PE,OIN *D%)7,AX<0F6,:9[4,B9LU7+P;71-^&<C5
M= 2?ACN@0#L0#LQP;P(=_#W]+!&$+<.['V1'(^R< I"T"CDLX?P _U Q=N$L
M?;4;[EW#Z:'"=RY8J??5C)]G8-%4O.RVZ?8AX<A*L5KKJ%-& ?=M0(37>]FY
MQ_^_GD!:XV%\7Q#%46;.Q GU^%>!D,Q)XF:LZS?O!=5?)5J++EJE)AE*)O\<
MH(^65Q1[6[AZNJ86CGD'>68O?AMU'^VQB%<1ZE(F<PDU\,4',/8ACBE7'%>B
M'MC[,^'R6,];QB*(:B 9"A)*^28<=E%2DTK%7'C%$]*LD729KG7_#R)-*0T9
M*-1*M7MD@-EN%/=C<)]I5O)@MP@R6\=7]P!RUBYQ,A=S.5VG!F<0.\!VJ KN
M*CVT)K@R"!WHSTR&?C2E;WK@ZX\J![\=\,_2>;9XSNU+E"X$>@K.5_?G&1!:
M732)RBWHE&2F4OTY?\"H4AP^/4^<+]!D6QS)T<\Y])<[<*P=9ZW157BY]1DD
M=G5(!)F"4HFIXK!CERPT%&L2@XI$BZU3\,?$W:LR"AZDE(C[OLHQF"[S,;4%
M_;?,IGZ,MZ%P8L9YT*AK^*_&]Y3:G%%L^I0Q@(ZA3*8AJV+C*-<U)"?M0;])
M)]F.B7W@Q;PFA@:TQ?-F!:#O!.:^!?'2?RSNK_/3AK$9ZZ,]-/JQ"4+KOAR=
M_IK 4$NATJ/2T,Y-B=6"?T407QYT^#C77/ :OV<.JB@.5]9.@&2,U7ZP>YI>
M$VQZNJIW]14EMCK0[,6WT#']; ?6UZY+L?;]13E#2ZX#2N:OPG*4[ U#LJ[)
MSH1MM-T+Y"L(XG!_\7SX-F!;\;RL826*8^? 04;QS=%;19!$/KITK!NX'O'*
M4O[S]/37/C5+,ZG]'X8P9<[<#H<^9M:02CGRXD!H&?R"X+L@20SO-=#J3#$*
M.G1,?N14)%O)B]4T33\4IRR9.-U+@LF"M=.?>RL">F^O=N^?;8Z-NT&*^CW]
MF7JIOVR1M)TM0\HI,2F[$UC0L_&-?HN,X 59K,=!!I#:+H(H-<DQ&7%9 :VP
MK6 @SIQ)5)[EAHL@,=<!>(IQI+,Y8;?/K=$D4]6;N83\N1REP>"5MR3]B!)4
MX*J]\3F#]J*B0'JM_7^.%WPG"2.-0FDYCA[RB8]2+TXB+XAL+,@BZ]@PEZ2&
M1V>S-&+JX32U8%.7M/-]AZ_%.O>Q!GY9G$"'++(-GGWU*NFJ'U4?=W@BL9(H
MW*4!HD(96\D0X3>AQG(ISHV3R.H"@S'-ELGDO,*Y'.,^AN?[ 7R_)KT]C94J
M<:NKJ/YFA'FWC[U!5&3ASU0V8K$1R) =5>9B0!A0OI<5A18+IZ:C+.]+?9OB
M#EN<QA190^-#/STXF7@>V&F60U0+F''TO[US<J/IQM:J;V4D(JC3T[$0?VVY
MO,DR@D/T[D^9I7^J1R1I;NG[5?0E^_[L>OG;5Q<S;)=-REFXNAG"I-A6&NF$
MR6RX]&)(088O$[D7=Y'#SGW^Z]"MB9.#3=;JYV@91\^N\XOW^O%J-A_8?*+W
ME.3"^/]&RM'_7;*'/%L1+3PF@G3: K*"5L)*FYA(-N+^9[E4+/K_*JKZOW,I
M$GD2WP^M,EUD\/RP^\>8#+8!)Y-*4&S2]\5A+'5DO%>]81[?C)7/IJ 8,M@*
MJF=*(JM'YNIX:WQPI,FCLKD>0M";H96>$(MWZR8)0]'AH.< L#=H\._5.7OG
M]'!%75O2H;("YX*3MG\_FSO8:?R]G:P9HY=\WDHO6MU9L_2!WK<*9\6W@X\'
MVPOTGC[75<O_XZ]4,\P/%D'B"/#)I\250.2?'$)@A1"W0J#!B9QS/>M&%?P>
M> U=!+$*%SQ[TTQ<+8D7 VA>#X4#O" LGQ8'GW<X?1'D;(^LF#Z],A1!IOV
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M+]"5FW4_.T!I^C>[E)T;?>S^Z\ZR43!'"Y"%?P5$$/>6J3LCAO+_6J;OU)2
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MNZQFP?+O^KRZ:"@4#1KDU<_K #QV^BJ]KYN79*&"8PT[5;[G[VQ@+O+BQV6
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M/*Z *XAM^;:)CR*?C8QC45STO:7[%/*FHJ*ZHK*9*)+'_46'<M+L^1#]']+
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MAO[S%8@<_O.KO\!^@?T"^P7V"^P7V"^P7V"_P'Z!_0+[!?8+[!?8+[!?8+_
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M*BXF4(%H/[Z(D<.I*Y1VH< UD].\<3<HA5=!BD<"*?Y0CD]\AZE)/ ^T]]/
MJ/"V46\-A6])_K5IT.TKL[?'C&4J&9'!E-80[D S0$@GO%:?TB:#9<"U'37]
ML5)=J,"Q&0>,\!#I]LKKJ8[D5WACNXW44!JB$G-C]OQH5TQ4]LT@,];U'!ME
MY=T].W]5'9!;""/X? OH+SPA^;T(<@8?#YQX SXFN(!9*>D&\.%+(U$RV'Q+
MF/EVLP!TVPZ/O_\:]OS[]?R$@>;CF$T24\I[!+3;A$E/EL&TD9</$WQ!=YY2
M1JL15"SV X6Y!!1?!M.::STX\NEYB%)2S_-[PP1G4GF8\<?>G@/U5!O'$^M]
MSW@4//KYPT6LQ9)N6N3)8&.+G3HR6"U\GD$J\R&<'J@3'6DU%GOD]G?[Y+P;
MT2U6FQR#7-J;(HIPT<7=O-N6C544:E7(N7IZ?9\Y50^KXC@B(@1,?/L5WE>B
M)=Z,AT]YB[4JA!1@HJN3LJE#=$;L DP76^"J"/Y5A(OTON#A%Z+376;Y&G5R
M"V^)JHIT=_WRR[@3%Z4WOB%[XXO:C,LUSW8NL<9P4OG%(=(.LH:+W%=EV98Q
M55.DZWJC?^^ED0 *7^M3122HW/YH_/#];_A@IN->=3R9L=KZ5-F4'6I+[6$E
M+E3Q_0W+1I\)J/Y;51<B4GE$7?$)(*F#E215@<A3^D'F,6U$!V#Z"8^B$O:Z
MPD788N);F_ICL&?MO6NUM!2C'XA*B_-VS<JCU6;5O-3IC<%HK@E:SLV[TD'.
M)N1U 8YYITN@(G+&5W 7&3AV[/GA9?>$'P2Y<NDDTERG6$J$B[E2T3OWX@GL
MRIT=?@8U!=_[H=MUH@R+N=,HY2?A5@^&[U6-*HKF"^GIB.2@C?*IY>1H.TZP
MY]1=S$X#%5TA_U>5JXL,3E*K)I12)#;M0W+A/_[*CFE5!QSD#C]*/Y)9\^&2
MJ6LI5!24=FY(C%I;'64G.<Z>'AX45X@T2&UG2)BL,3T^,K&2%@GJ\912I5O+
M4JN6D*F<S8X[9YMFDOG]2[[48R'RRJGH/C+3.$@PY4F4HH=+-.]X?N]Y&7;+
MM'1N>"6[UGT=C$18\MR=?:0H,_2*ZZ6GZCXE*<.GOF8Z;WY\<O9TD^W#][.G
MWSP\MC/>_<6:5IR$0D1BR&]6YH? -'YIL; 3IP#9G&L&EDL&%+94\!U.R972
MY.1#^!\=KR"*1]]\Q":S#*VZ =;7)F9[ZT/*UQGI%G-)L;2G5*PG^3U*[X?Q
M8$D.'\'TV?E[N;^>RZ"]%;!RYNV/'WM2%U:DZH*@A8^WG#1ST4F+#\[N:7@*
M0V9G^)\?HDI0%\$M-=$QY;-W6LNBR[&ZU''[%9VF^@J'CN6AH:^,D+B)Y;:F
MQD=_+CYCLCX-&XH"Y1N@0I0+)]!(NG*D50V;PYOI1-<F-MF;O/$]D>,-WR(^
M,]+$N4NY^F'=^4X?&HIKZI/]R\/OD]H#W:Y[:ATYW931).G&?N)!4IL)*0R>
M'*,+9[<:$_P'X1WD]<782U;?7TO(QH.E U5+MZ(0*B.9]BXF3-7U@?L5=@S+
MLW#@V9;!7\27Y/(>(BE5FO\NBL!OZ?(=5,FY1[1A$E6@VI[?C9ZW+*90S*\"
MUE7[WSO3<,%\;*!V>_CQ:\F85>.:ZM/7?*[D'SF*;#F]ES)M*-TDDCN*FU 6
MT,"S:) 7VNX[,IAXMRXGP;"^ :*"?NVFJ)9;'-_!Z[MICDK A9%S$W[?54M\
M)L=MDFFN:ZP;<%6GV(Y/K%-N%,[JV"8K+2TZDY2DBI*'I"F*#*9'TX +%+AY
M.#8\L)]:$2IV+\8G,9$[BGO%6%[>Q6/VNM,IA7@*;_TSOL/9(U7!B3]=6G7E
M "+8#I6M>D\NJK^K6E(2:^1)-PE T91W)UR%H"9Y91_"PQD0X$-B)]5[T6F+
M*1J?@_ _IX0--\H[BHUK(WD.5_68.;GKX^^HE*6(K7AZS9W]EF]#WO8.=\Z<
M?7)F\!VRC#Z^(LP D?,YHMWBRY(7A.T%W_)W@^YWY\6&!DDE^/1)&>Q2-TFN
M>LD&&H!9S)W?[T0)<QJL5WW 0V&E'R=_]"SF?[C>\[7PTX@:<0NI38L>YIX%
MIX8(^&!.%UJ?N!M+M!GR%-X ]_9;SCWS8C$<=6K?0D5 59X;4)9HYJ6B<_2-
MZ0[4+Z]K,Z<E/%35^>G5OTN:'C>(=?@,)'6B*RM"[,[%DM--17 ?@AZ$PX#&
MXZ?!B$8L$.&NB^Q ;NVX+#4&TFT';;6+JC*"5MZ=G!0N.C>]S03MD0<_42Y=
M%\K-*?H-*9&$I6M"BT$UD@P+XB]L\8GX=F\;HB'I_J3YB+T^[R3@-V=K9H,I
M#[/=4ELP$1":%)!W_. 8*M*\F9.VD;W^\88OZ8H2PY>4+D'(!4E!ZS92FZZ]
M9R7!#;216Z?-Q#ZBIB2?%AA+@2H"P%LTXK[O!GOC?8:NU@Y:$'YMJI3N=+NF
MK%0K<GR16QOHC/M2'/FJ\)7TB%R]U) 8.AO%ZQ(TJCZ0[I/VDG8X&D$^8B-0
M6$RPDI>F- /[__A9]XC8T6SQ4P;/G'1^($/P(O=2>%0X#5K[)KGXF.$719%*
M(<U=F#-$=5,2WI"\L.I1/3]H&8X["1F!WEY]RQG&/_AGARRK/,\"QBVWRV;]
M(@I"]MC<LDW(^/S+A.^D7X]61Q73@[4V9;^I*K]+NO&8R(<XR%&C3[U U]+C
M'7<1^SEP<<R4!'<>7+K#2K"_"C[A(>1\JB@AMV<9A%ECRK_Y<9(7ZYJ7J(-F
M H0@>V'88YV@BCIXS.3^/DU%T9U"NC%]JDH&:Y VBE3$&H 8J7)YH!0: F,\
MANH0:X-F?W,B!4]-F+B\2<2IX7GA%M/*:>9^HC,Y'OV6$B77(4/=J\,E+Y\?
M7]4_RW!N[5M6G?;D*K7+>S1Y@FJNY_A!15,X;?%UZ!YW:9AB5BV^)/<776U$
M+>EX0^)0]1)KRQ@VR+3W.GS^-2M<LWY2J]_?;>!U?6W<T]X3,&3+)E.Q#'95
M4BB#3163@+.X=,$425N,@LJF%K4AS'PT=C$IR!Z,[F*BD_(-^Q;9OI>:W/;_
M]!FAF5:&LO^ZO, 113)RSH59_ZSZ<NM.?5[EZ/MA\N>8^0_@&X8P4T)NW2J^
M.3"__@F<R5KSC6A,ZV-2;$/9/3VODYBZEC8']^!BUC^J;GOY?7@E0]/M]KJZ
M&..]-([Y421+Q*.(R67,+)$=?1MI]NL@5E0BE]QTTH<DZ0A<>%2ZAS1[)!;=
M/M*!_AOIG@(7QA!_D<&&NE^.K*#D0K9-!GNB*JE&SM\3GY+!!F\*[R(?4Z!=
M)N)BEW=(X4Z"I_S+TPOT)C^I-GWJ ?G'(SA,!AN]![K+8!ZF3:OC4N58/IP]
M+@R5E"]1- DVDA)2*&6=>"\TQM5SWXJ/9$QJ00/@(<:DCKS?2J7MTR<G$3 O
MON4ZYO#\ ZW;5>A %KXPU(R;NJX1#&@_7'11^2A\)$[K[V:Y8/\I*8Y&L&.$
MNR!?WJ+&7,.D(71OBB) ))#4K.+\I''>/H/V+E.-N[+<AZ*KSB_X4JCF(4%
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M=OU7K]>#T<F6DGW+*LA35+?CA_U8YX<75$J?A>: Q\,7$;O]7_+'=K]4JO%
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M$S.BL.Z0$T'G0+I&BP7:'V0_YAYW>'Q]TI?6A 3"5SK#A<@ZW/Q*W"V%AB:
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MBM*<H@B+T=HPW)ZI_9;YW3<VM5JE]HT4VXFWS,<)JL ^?BH#LA"7D>7?B,S
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M5QU<N-!+#$BB&M4+5)^53]+B,>M@WO2:6A,U4^#M"<#NA%$1V2 CR5H%.4W
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M@-ZXI>;#'U'("NT@GOGN$)TEQEG2^:%K<C.P_QQ\J14_DTK/8-?_=(,7&5:
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M,H0+X37O!DF2W8; #\$CL%UX3'01/"^T& MLA)\%"[5+'].B)R,Z]^)_&W0
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M67*]%%<37+V&%3H$-'K<*C"]F'[@F8="R Z(TE0R7VJ4 M$/T:M>1&4I+_0
MZ$V(R4)#'7_TL3EL3]^T]]DNN!H="*9:9FG C>OX2L_"N3G1,3;_I$DBUV9A
M^@,%\5V7BQT_W&VYV8#_Q^/EP0,0I8K__J_.;D+BX\"=FQ"[;BD@2@[1I3]^
M7WYH\SCYGZSNJ1TD.33!#JT).K1!,=FNM37S/E9HE=F9=A8QB?NU-8;DT<;_
MN=7J:,F+5R6Y9?#:,B^T/:;$.'7:IQ?2\&=IM@@F+J?[(U(WQ#-Q< 5B/WD[
M'(8O1?8O6]N2N)2X38A&&Q2_"4'7?C:&A8DM%KQ:^UN/\[11UQOZEVC:J"NO
MWPQ]:W \A@NW@8\XC$1/!/X#68\Z1LE80T\,"@Y^ICDY7AS9A-S;A(PC[$?"
MHH6]1FX#YFB6$5>67('QS".''BV6Y)2[>X-=6BU:0JTW?K36^N9DHQ1L8E%\
MX,!%/PC4_?I-LVJWJZ-AO9:H?G,C1=]+(R=/KGGKN0U0C-<436\-FBO@EQ?-
MC2TD P[5L"I8M4'R_*?O(Q[!R\%?TP+OXB?=V?G;DX_]_^/_YE#^>T.JVN%M
MX+9-B&Z(-/5]S6<DV=2@]1, ^R'TN\$\26#J0YJKO$3Y[7_OW.A]:"&49RA2
M+Y7L+ISNDR<X@Z\J0$2[9LPFA(E:448=$4;CM;AR'?_"-"X#N$?6-I53K+$)
M[,:J:W. 8'+1]6_G^G+LE,40-=CNWG+8..)S 3V.!!ZW%^V;$;P7IY""Z >(
MH_3:M"R^!AK$\)35\5D\GU@>*7:N(FC*!CQ#XD4:MO CXJU=\N?4O\__ '_N
MJ<(^>!#UUX.HT01<J_+);+=4@U3F:@0'JB#IW80 CE!6@"!#"E-0XC"Z[FA;
MRS0NR94.)7@ H]Z ZPN>\AX\U 5X0E3[;'V61U$0.7PF8'@P5=!U@*E+IY.O
M#.E&SU*H2X["?9L0YR;\LLGS;N&Z./4?<8&65&2?E5OR+4+-TJGP'.[%?N*Q
M\]C*6<W%J'A: 7IJSB)/-^,F\/:K(-9F)=D,96/:&?57U#W>U*C+,,QXWX$=
M.C=(*F3@"@DTSET7J4Z_,P94I0)WY[TV79'.L.3P/-&BC6\8;[Z0JLRS3ZAI
MM0MX-=?<*1!8%;!!+/-!0T.S8E7S@^3O>+A_GN.C4)[!I:0[DB6X+"$$Q KM
M14<!1-?*$QW=="9"J>W([+0',%67N:[^VX?]$6Z:,>+4M=0OH=YS&S7/*L;1
M&,TV\GU-I&_YV"3KO<)%!XC$F\XIHP/H7@TTL)Y,\L>-:4GVQ:"8Q*,QMNU3
M,'"195):V%/L>65=TY^2+]('Q.(BN'X+WZ!0N" S[62+'-B$O.;\* 6*,PLK
MO.>F]#ZW*6Y"8N_2OQZ66&]"ZMW!E*VJ89ROI"M;#9 X+]!U<HLN0+K@(9@
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MP;Y [LH[.-2*4*? <]2&GS;R,2M$DZ+ZM._#R^IZ^[Y<=+?:A)B2@)!-R+M
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MLX>ER-]OA9&W28L4*5J\/Q8026L@#YB/* :&BF(ZY2"(+>^89(\]D@?SK3-
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MS<+@[0WD^(D/O$'H[PW)/:X9UZ+49OI$OGZMDAX;O'SK153J#)\3W,KJ0(\
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M.A[W%\&5),U%'?P%4O6#;7KZL2+[BV?EDTV?I8MX;P:VRW6?O:;3+739A2^
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M%D4%K^'Z"7O%1]E]1<3ZYG>W<U%K)GE6B_9,;L/D<Z[P&(>;)$HIP9MC_45
MD'+I'[3J.1E>@]HD6)413ZYW/1$_J9H_[>]V/"NA9<) V>0=!(397Z>A?9X=
MW'DF^0)+O5WQEFF$<P,$]98VLN/( "7QJC) U35,F\N01Z$V#) ,;/6?0N!W
MV2B7F9]U(:(.A3#070AI-R0+?I'>#?EU_^BHA]/$"CV?+H2I*:=7A(;G_(H)
M945-7\;N>KR'+"?&07_YWNRB]S*9H,DS@@Z7U:[J?HF)#A?HWUH<KI"+*2D
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M!?=!D+C3>?+0GB,0W'M:^O!]S>&L8*%;O#?3Q6\$T+?^"J^D_C@ N0,^U"K
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MS%C)&)F9)TRK"IK'C1OJ_!$KC1X>+?H75>W^3XS_1=J%2H/^YN3>ZD,>GCL
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M/1/:U_WH9;SXNPD4?!O[WRN"1DGZ[R!+[.K =^;LTN6+F?04M@.0]9MDA@?
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MD#)/FJS6KM/&2=1M?O'J2;S0KZEQN]<<;;5R4F)!%NR6!"A)A>\6O(;[42L
ME!)S38.AD!@P^ZO.*6V5C6=EWQS()A/3S M"5$\_J%:5_7J?^1>(;(F 1)KT
M3?HGP(&21(#V+[#W$;?""TYKRU%8<.-!,,E"0H+3M/D^]WBA?^,D6A35XC'S
MS,I%,J?:P0[:UQ3>_.[J84 !V-V718Z"&R\W^*,2P"<1!HL[&4_"3*>_MIA
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M#UN2FSL#G5U\7GEDO+!?XW,2'W/MP.]V2IF^IASMJJ/M,\:1PDP-CP2">PY
MC9)-S'=?D:D8&Q T<C!#8#["D^ HU]LEU83?51LKQ<OG'X#T\+OL]K.]O@"4
MJ/,M#+/VO$2/(J5_3C)E?L *<D$LS"Y[8:> P392N\(XS)RY OGN '2NP^(L
M);.[D+RV"(Y?K_5?BK,>4ULX";"0P'%-*'X@4+\M\0F^R5/R-;Q)IJBE]73'
M.1G\8*MQ23+6$+S8B6V&K)<SF<CQ]P<@UJ1G#"7:):"06!<_?Q& U=!4\!W"
M1*8LVCJ;LUZM33$DICJ@ON4KTWX+WR_SMJE%'( B'VZJ.01K%$ZJC149GW!J
MFKCX]'A9JHGJ)-Z^+'](MS)_S\O02,%(Q;#?L"S;:Z4,XXFVL%<-.;[OCSA/
M!F^0F I_OZF!'H<)G] 6+$%H  $4J45PF/<#I4PS398>WLBIGX2EC%QVQBN$
M2QG@<HNB%"Z_4R]9Z!M"G)7>"0O2:%??!3:8L_SV[ZTBQ.B)V+MV8'>?Z*[#
ME&$T)7.1 D3YD)'3-\<WE+252!# N.-Z'3!RHY'RL-JWQO,G0U!3) YA4+'2
M1APHGWM-GFP*G[G9.7ER#P$N+2#?JDO8*UC78DZO0"[8$"1A#\'K!@24PFH[
M@DEQT&-PI+?N +25[!/;I;X ($?,,2'6MAMW\6*9%JV4@(_X,V+PD$TU-EM%
M8X<!7^-%O@U?YDP^]%== @")<8*'N5.;]2&R'TD)M\ -+[!A\C4:DR6<V#<'
M&E%$]-GI7ETABFGJ*R;;]]@B*0G IYZT=#!/4+3J%OOJTXE\*>-9VX#J!&.C
MCM:8>)KE 2C,I\"AGBF'M+7FP.;I)S_':<> >A>BM-+YUI8.3 H')UR N"RW
M%OCC?DMKG VF.1+^L.BC1:K@C=1PCP-0T\+,,B0A9E\%X0?YW/:!RF0ZD],X
M%.?* >CX!7PM1D[N.R*@\E-7P:M5WDRD=&L3>:-CSVIIW"MY$/W%H*RR\0!D
M/'?JJ\^2"(/]%>!#A,:(-$$V;/9MUY[Z.BI!R";?PO1H+VXJ2%&P?5O"GET:
M$Z3Q3:,2\R\K I#0;TEFB=KO83"BR94/R:4TILCU=7E0W7Y*!C1N&!&R[KEO
M!A<A%*P?@,A;/4YR0#)Y^AJ07 %/LK-Y0QF(0%P7;@EK4N*$[>UDVT3Y@X_#
MUW!4^XCY/#_='$[%XAJXZZE:^>5LN[?@$P>@^QO7?E*U?Y?^!J!]*+(MQV&$
M=2OP&>UU3ICY"9#GX;C^IWQQ&.A).+97;T>$%6%.N;%W:UX4CP@BZ!Q'BXWM
M*$!Z\B\RW@.^P86F@T5>-LBS+:]'P?=1B]\7?JE"/F\SAG5%Z-:Z.G6#!R#@
M2AAII,=GIH!:2\_7/8L<1IXG_^P'<P/JW8&ZG).[=9%[$9EQ\FHH/MIUBG<6
M>0!'5[(;J_51I?O8XA,P?N]A9<9^/'D_8S--,A97DU=YK<'%4/+C_K@@ O:3
M,15"WBQ$S.07OD)XDN?C0BIUU5?YLFVZ%\[:?EG0Y3FV]N95T"QKF(J0;"*(
MY4<RT<2&FD.O8/#;KXU[=(E2?+H/0)^J"7SAB OBV0IIU021"%W621KD6()S
MT-.Z2V)K\Y<H3^H5"ZOG+KR9W&55J'UXRYK!38XMBZ(S&5KW(2R,XQAC%/6Z
M/%R7?V4O,*I#C:G1GY.]D7S (,Z>!YV?(\Q(DKWCI<L.A/O/WOA3@E):0(U_
MRBA57$MP&1 0B6MR"!7XQ;:+(M],^IRY&%] -E**R&=)??OT5C;'AA1YH%>S
MI;\W^61FEPZ6,CI)TT'?\?HY;/_D(H#4<A2\>3/[RDZ<H)S9_>3A!HC2C\_[
M<@AC2A3MC#OC1"<1%8D]W22(!:QYD<H%BS_[C-?>N84N. '*Q'VZE@T9TJ?:
M:%(O,9]4?@<.'5B<O>ZG:2L5K:WN\6NBEO\9JM"1YRAZ$KV+;MI-&.I<2E_J
M4+<.S&@T\(4%P'P%AGS\O'W9M"UF1[A*7@]Q81[W?_C^L>9X_C_9 /YG#_"E
M[TQ$OK?_M[#E:ASRGV*;_[5KH;$PP4-2>]T>D,/4534D[3_:2HJB9@] +2CJ
MHMR8'L_HWUVUA_]][++)OX]JQG[+I+8<@#Y<(TO1LW)3#T .2#"X33<>_./:
M-S#5V@6\"TDYRFT&78JAG_^GXF:%R'^V@)!$/H4Q# MB#D#K3SL.0!,HW"0U
M #69-)K*,(-T*^V+\S'0?F*T,4H4P]2='_5I#+6J*,1D/8QRL-K_HQ!D-<IB
MYV7<\VT70UGG/<NRIJX4QJHIB3>\6S*_0M)3W%SGX>:]!Y+$GD#]U0[IF2[7
M_]4.J9XA@] +'_I'.Z060GEX[<6Q=S.79C\4D//7>+])JC?D*YUP,!K]N)??
MYMPQ-I"3M?P+"8F"YR)%59VKRCEBFSR5ZO53?E896P4KVDJ6:NBKI_R:ER#6
MQ(6_YOSH]R5$7D(DZ'8I[9:U2HD5/9&+761^NK)J><DH3WQBS;+<1*-N8FO&
M@%H+".Y+ ]H CJ0>O^&O]L8P\CDAA\<1TN\D_^89^U2^ /FK2ND<Q09>]&;"
M':;#=<N3$ *UQ!/27<'OZS:8)^"H.3"W;Z=;N5C';AA 3EU$;$A@:1<$)%]M
MH(&VH3OK.0.,"RVGC2OUKM!)<'>( _34U9?%'6$.[8U15J@12 R6FR%*<Z-D
M5%-8B 7Q:B-"P(#]H^F]S4[XM(VDA+N'? W!3+@LJ_1SS#DM=K%;+8WC.]]O
MAO:/SQ^U'9B%UJ-H7%JD;QMA <Y$.0<^P(?\X$O$A*X,O*C?1\PL5/U^:]3;
M&2Y#SR 2VZ1_"N^;T&"E4S,CW*-06///Y-*T ]"+Y5RS/(KIA:4L_7--0FH.
M?<[?8=%UIBL:Q+6R8M/$+AIWX379.TWN5A)BOY1B:+=(8*[ZK4@ <CB^>ZDU
M4]I Z6TS!9A1-TN_,WV610".D,@.J.@OE1>^,C3  ^7B$8@C_"ZPWU_ A;#Z
M1X']7>Q9>#NT[=\*[&^JZ9A2W08U$N<_"Z?,SU_<GG?\Z()I:$IT:'^_V!QI
M9['G^CMO+J:+CQSJ"3[#/#P+K^$C?>>OAI0C!/%*[ -AJF?3,^ H@MKD^E<(
M<.N_L??>04U]W]]OK(@(D=Z$*$5 2D2J$LA7_0 " @H"4B,B-11I$B0DBM(%
ME*JTB)2 5.EB($(H(@)*E2"!)(+2)*%Y)"'<^/G-_>/WS[WSW)GGN<\?STS.
M)#.9.;/W/GNO]7[ML]=:.A(WY8:+%D?PCXO#"BG;/WJ:]4Y>WNEDJ7)Z(?NX
MC@_,]7ZWT*<9;1KOL,ACLLI ;,T?J;14@K."L4N!@^/Q2\UM=U_\T[PCD':X
MH,CIXS$F5X[XI].6L)65R_I1#^I:P=[)@[N%>F+5RM3JP<=%ZI/GTA&.Y6UO
M2XT-2JT"3(IV\/&<0YZ1D+I!_=JOWN<;(_UL!T:V7U@=OJ^S>DJ_=E6*L7SF
M2ZJ84(!)K(.$@XHO.;"@>'';R>J9NV?IXOV ZO;4@K+%B;J;BSO1*546AZH+
ML@H:@YV=R-.7$OG;"8)]__?^RJJ(PT_?_SI;XJ20W:^1"/FLHEPJ4?KWW$E)
MNIGJWP,IC68^3Z\;B_3^_YEO473=>E6:Q<_YA&LRK!ID>E,+LT)I]O$?FX"'
MU/<P'?JR4+E\+)$J/VISOLDG($-NUI)YX@(E35@S&"]. E>75VE*^!MI9);?
M+K?IOH[K,6_2'WNT,9_KMUSLA'_MF^\8YYRS\-7IN=KPH=A/9\,=ULY^_2CR
M1L0S( ]O?RXI,P@UJ*AL>'O4#$?"LT7V0)PC6C3PU/![R'&B;U ,!RYKQ!"/
MS; >8U^D6MI>14)DITTKD6V!\2<8T[YU@R6H[']:Q^9P-F/:])<N^E UC.33
MTL%IC@U@NXU]!\ CO/62"88T5^G>"/+IO(KJVN2PJ':!]3[K"?_T);X4@ZL=
MS2T% >%\D:&'2WK#"4WG&U\$+&1:</*;OD,D.D!LB=V7:!A:_6\VL5C,*9^E
M^NJ7DV'S =9FON\=\9]UENV;)PD&D7(/TJ**_.Y'4Z_B<8U/,:$7J"OV>JJ1
M@<XO[#MM+&O=[3XVG6F,=)>@*KJM"5N#!>Q'%JJJE2P[1ZX]@1O0-4"?&FHD
MT8:D?-,G_8POH6EC;T(KD[MH9P.SSH2MOZ5+9WM<WF<Y&O)8YNKMZQ4P@U*U
M<\7F.7_&4&L6.33(HRH8/TW&V0%'VE'<W:ZE#AS !JOCXG6BK92+QIKX93]&
MI(_TNMJIKXK?=$;==K7SK[)<RU-,R<S>Q7,%JPJFNRVM)UJ'NX36DG!BVMCX
MNWYBMA=+ $B76+')N#VO7#82+HTB6DV$6TOX7M#9J"2[]LVM';2NW$TUDYKL
MEE(?SHGFV8QD67"5UN$ 3W&*_&Z6D9Q.U8OL.;0V4'IWU%G/T6B0N@>269SP
MHAUO75>K@ID6S[R0'*\E7!>J_# ; Y>&>T-3X0UE1"[=S?;BX@J5&*+L]'[1
ME(E*SX6?%X:S/J6CL-T3X CJ#$;D1+]&6@6EQ%1%)64\$^/SYH1'YT?MLM?1
M)EH$NRNFDCD?=Y1[ZZU0X7JO2Z6>1[9$ZKLV[X'RB].845VBQW1\:/ WRA,$
M>;<G6OXQM5IFMOCDI.VO1\8QZZ31;L^M4B65"RY#EGN@>QS>4:(W] EQGSP0
MR5AAGV=R7?/OU\!Q]MDT$D:H?50G[5#:@8)]:!B%/RI:-]*F2]J2-^-JAL7S
MZ=G%GY4B;Z:_F:[O@2X8G>$"CR-&P \A&!B.X\6,4^ ,8M=RBI5%.?M0.5OK
M"\R2-BVC:S^[F^7-E.8(RXA;G][OI.K,V@/%3XZJMR8&TMM;'0.]V0Z '1-'
M([Y?$^KY6_\4<1QFRV!U*]\6FD4A[5KK+ #W>ZB5K611K]&F=H,H+:.\*B?$
MS2N.A 'O_MH9XM^C,/VT:.5%BO3N:R,(B98GNEY=!F0Q)OBX>'^%<(HP"1..
M,.QX^/KCKU[G"C:\'/ R0!U/MCRZ?EL^J/XC^O* )KJQX8S-0*4!U"^O^G$&
M^5=P4J7)FK.5T&.''F<+7"T#/W(@;@/A'4N#&5K)]EIDPQVM4)]>E\QDS=R\
M>/MN_LAD=I-4IJ^IT_-W2O*_*[=M=S,[^#B]\,-H.$-KSB%>^B(#DZ@^5!P=
M%7T! 63T="B.B1T:9[O2=MUOM01X=#O]/=F'Q,E11@:L&T8;764'+#]OMFM9
M-K#_ONQ\PIU]HD1O+*"LE!3 4;6@!43-X?L4Z^J^;"$2,.(C56SC4A31=&0.
M&7 .(@GH[K"NQ-N-;>8%G1FPG&R<"?IGW.3%02DWO%&ENWMQ9RDGB7UDMP(#
MPHR0];:'.Q&)'"EF4=RAUK$P@ZBR4;;CJV)_5_+LX_";*P33TIX%8H;,#"5/
M)F4LB3:T-"\>';4;O24U%BQ"=P;;%]RW=8AUTDHQ#W6EZ^M)0DV&9^I0WV3=
MX_')[V_7 =_4?3:N=U-5;;NO5<IN+HUD+@Y&]EYEG^#V"<OMTP$N5N.^XFF!
M6<R&7B/XQ![()RVI0Q150^ I7^X0:V!8/T*+5[TV3Z,%Z'5.D->2O(E,!=[3
MVE&KWMU.L37Q4/95[5U#G7)_'0M(XQYHKGB680T^C.TTQ8@!TM2(%(P<"D=M
MCW](P!0:-8ZCU4M]G9KFMVBH"&?&S]%?I\9?G$K]2JH>"%WHO=KA+UBFJ^7P
M,U:T8@0%7FEB\%W9S29Z$V,A#0L/:?P6/4YZ7;BCTX"S-5/@#1+I6;$TP7!U
M=>5[-^ L%W#K1>YB9LG!ET>.?,]E;_T-0N!V3JKC"+;3&",'0&@MB6PL;3A6
M5I^!C]5 2U8N4<!?-@VOH4B7DJ\'V)*^+!]?ZKB9ND9J$2=_MV]Y8S 8[OVZ
MM*!S77M U/IKDO*!3K@G]Z:Y.2OS#'$J[OV@*4WW'=/12!P5,MNYHY="L,8[
M^G:<)#*&TM<O4JL-;..MLIW-2AC;<6IH./)>GN+;T<T!L\#NG#@:#1OUO^!M
MQ?\I8?Z_4PGSEVUMS6^:6]O;6V-&AD9X:VI^_2I+I9 GR!3=[*CDQ/D[24=.
M)LHZEF5-Z-/M(SSM%*0#3X]8-J>;K[8+6=R;_2=Q>0%']MYN!219BB@8T$(7
M3WXYJO0NCDHX/[>K9ER!FNX5UZ7S(ZG#X$1J+FK")%6ZP&G'F9_',MW'I.+U
M%.\KZ!];5B"VTX_ QY@)Q\7#ZU\MXH30D<+6^%GV-4+:*E8 IG-A0>4.8\S\
M)P4VMOK5;#NJVP<F+_**\DN5*$Q^L0+>X&/*TX*ZP4]DSXX3L$QX#_E'"MNC
MQG)AR6F;&*4X_SV)3R(@8&RUI6ZT6O3)!4P6GH3DREBJNK^Z^NH7.<0P*C[M
M;"2VL6O>;5@FQ>%))2*/)SX'>+4'(I\FIN=G:7/.5/>,8A\&[X%2(ZW^4^F9
M#UW1(M!@8TL>Y_/7\P].I&ZI],.B47N@X2H8/?X);DU3X&X!S^^UU6HN@9D"
M:RSGX=<H"XNWK8 MP_Q>-@4:CY$9\]2C*-3/K%LP#W2?+6WJ2Y#RYY6^W)(Z
M0+*?NY16-DMQ2K''#N- ;"-F7P]4S%?V$!!*=0WM+81.UAQJSN+*"K#OQM*%
ME&EZ6'KD6=4CZ@'%_(:K6Z3+GAY^Z3-N+A<#1-)K9R%O3-G"XO3:56RH.RVQ
MNA1P9]SX)+5&0R1L+N9:WCLRO_ZCF2'P2)[\#?7J1TB_L%\<$LI/-A/M#O5;
M1TRGG,,N.VR[[Z9V'/A[(LE(!H!3C_@W&4S[W&(JI88_$L/3:\4(Q@C,VUKM
MXZV-&YG6 LFEG64_Q4+%LH<M8GP5TZW3!O21,!KATJ<&%V._FTXI>HDUQ"BG
M@K7^F")/"9OF9S@U99-?UU),\JW[]8-(A;I,:]G6M"3-KX33C@E^UN?ZC E6
M9V*_99W [1]3&2$Y-EG5*I[@-_*^<+S;7*MD#Z1,=%\#Y'"/V0?#TA+A376C
ML$BZQ!,]<E"7-.\$ZSU&]OFA;"AP-8C>!4S;MF3X#98X93$>VQAKZYU#U0^A
MOL?_)@\-C5HU-HUNLIR1TGS2/FHK5?YS21/<U3"A&$.>F" ?NA*P6DW])^[(
MJ7^2E)]YI-B)[/-*VL6>Z5]GYPG4 <=@OL;39#O,UOUU"WJU78UO.SGU:2P9
M?\3T\LYHG+[IR3GV_H%UM6-G/_M!!1,+7GL$-\E5KP:CLC.7/JZV=H9\*1U4
M_EQJ#L[D+LC-X=+_V1M4_T/7#YCCW!HOZO=_QF"J]+1C*&ROD<3XJ[-^&%FF
M21I^F:Q1Q'LP,B+7JR(HW/-NL4)M'E\ _!SU@<Z7+^;7G[RB*U>8F'$_^OV&
M4KXSVA,IAI+"^*-U!1?J8LW#Y:@70I/RE7A/ETKVFO5>3P_0;QRU+*O"2&-&
M(8S+V(<00<XL#3KUNUM\#W2 ;:OW0I\Q_F,:9L>8V)G[A=4PL'B7S83&\7=_
MBAC&+[759'D>N5(%TY0Z>9D-8$;@=?!54Y;J0&@X\S*UB4T1C+,] 1<DR'HR
MK1\$BM_[4()SJ6\Q"Q-KO=4U,=QC?^%P\5U!BNII8S5X>U*2C_O;.&14PNW6
MEM:D*]XQ/B,WO>)N: X<^W)%4B'I'R\S^? [8;>KCB@X]'BQ>=,78.-G/T=Z
MG79  S?Q\9DX1ZKSM98LWFL!2]-3'+T>#,_=B.,L%Q-7<Q>]YT/K=O7D8!3O
MX%9UUL=K+U^]N_4C)H UDMF,76!1UP2!^"ZG(1P-?A39-AR'OEPRI-%8'44B
MEVXG5RWFF!^M'L*]]FV81C@.O?[T"NE+?WKXI"YO[93U7X4;SC)FJ_XM):RW
MV(;MJ^7I<G_89+%XBO&C.X_/KCN*RI1)J5R\_R?NW$@;*MD$9S>F^(\9VLQ/
M<KZ6C"![<'CY6*<YG^%DJ1]QF[Q&AU&<%8NS3"62A86%-=C-S2R] 4D$?U]'
MGX^$Y(Y8A^R V7([3>QU[9S<;OQ^8N$L&<'A560Y<8;A01.;N&-*O400.3(#
M+(J&-K>/AUNH:G^C!!+G[B4 >98^5-/"=?K5ELE-"XD;[;VMA(<,G7HC-:IY
M???<&?N*>.M<NSH-N_)^C=;\$S1*,BU<>2@_?/[U:B@CW_L@4$D-E*MQ?W9;
M$_7DH.?J&8]SYZW%'U<>654;4*[@-?\2^_8'@M<9;.%VU:)%<]>(,XAE7$=,
M66R7B$D%/>B0(_^4U>^X.8;6 1ZHLU7HMF%SD#>+S2UZMHNR2JW7+,X!%C<G
M[YE4;1R)J4.T+K._?LBFV!Q)YYU[&G/$IS3N9M[!X_<((2;+'ZC/XF^K;K;\
MFV&D#C,QVX#?QB0'TZC_IEG4)U+Y@6*=A99@7Z\'I^(O,A^\0-N62!39)?5.
M1.W:7GISI,/M\?);Z=F/Z"N/YHL+W%T42]R@A_/B _U:?<V&="DVI>=GV-HV
MGUD=(CO&-KB&+F;<S9\#5V"3*D_P%J]^=,^/>RUUJIZ_41%;Z]B\:LTKD@YO
MWE%=3_NW.21,_QY(-A57!!!OXN:@:1J?KA7PT71FZ@'[7[\N[4LS!A+W._\\
MUU6S*!) XSK1Z' MD:;1LJ,NG$IGEVF*\S3%\=OE<-_P8PZZ+?8C?8;M@X2?
M]9W!0;"K3,MC7\[UB[QI,)4[UZ9IP[LK?^#%+:T+;K/[DHJ3\*4S*GAEO?H*
M2W*I"O9>B0=4?D=)@::6EL"HE'RV\!PV#/8<5-.Q.Y/IDC6F*:(XD$"Z@41X
M)I2:ES8%-YSFJI3&[4O_O?KK/'3ZT79Z_>ZS/9"G=0H<\DMHB&[#@#[V-A(>
MK<4%-%?3J^\O3),Z>$>]C8W\)UIDE<;#>L<\6OC/^0;/6NF60.5"Z&]:_5L.
M/?D4G"5ZXO0!/H1DTNNM&PS S[;:*2#PCV^7U8 #4MT:&XOR/D]W4Z(."5 _
M*30(G*01?JM0/Z4=.%RLYA7TMR;LVWN29HN0@.3N+V4_H/>.6MG47]UI)A!I
M^%Y<+/9@V!J?WZP8+.@5(&[%;$G9M([CB+R;5,Q5;AH^ :3SF_RXQ!A,C)$<
M6'+*E[(J5J_7OS+EOS C]W3?WY=H,9K&56@![G<D.V*WE:/CQY%C>KUEFEX#
M*IFSW1?B*LK[PRO]C$  '(]ZHA:\V^QP):@)(;A(% Q'W9'CBWK>]([79M\1
M,SSG+D8/;;+[E@LZ+[>WB8W#W6"('X)1W;1&KGV/;?A-0APSH\TXF#/$'W+4
M4/2+DVQC:C6\LU"X3MC)]RYPF70AO)4)3N%/8"KV3VI7)M8TO9N>,5Z%RPVS
MG0KM2)&'/>.I;$O_C<2SHEHN M:KKO=15^N%'Q>G]-%.'16Z5AU7>2EL<12/
M1=K?^/;--W1L#_0/06&W,%-_#]2+$]>'ZC&C% <(Z@SKY+,N!WJ,Y&%'/P;G
M7^[3)QC)Q09*4&%YHHF#OF/=GF\G>+2Z:,R;!)?,.GVIFQ^H[K:R# "Z:?.*
MF(L%Y'A6L2R'I5DQC ZF&][TF*++3*UFI,]VIU!G95 ?D7N@X\L8<2;\(=HV
MB(J50FM.HH-/$F65DQRA>3<9U93BRAF7FU,_I08+LK:+BF=\)L@.*]ZKM:PP
M]+'=."/1)>)Q(U54:A="R!KOUD):B]UV2FD#1KE =<)&O;"@>/&]BZN3#XUA
M+/:6]JY2]PL!'KC@7'&:D-UGU<%"IZ6L^]/C(*+V^>OH0X<2XCRLM9N.OKTG
MSW-]I/MS[4B(K<54E,%0?865)EYJ),R#_9:6\P7;C1. A:8]>.$%X:?!1;WJ
M^X-/R"3/F=KJOF>F7N]&F:-6<G0'A)(J+L6ZZ)C!HGK6W=<7J<%9?K>7YL?<
MG]NSSB5Q#(ES\? F;-\LUY ?O<C$=V/%C)0 >K=34'+',;0=\RM#9RV98!PU
M!Q7PRXWO7HNS(3NC/+HBR%F]*<6./O9.64//7BF6EH3<7/2?>--?[T@87C38
M7MRM0ANR1#"?L()<\N8/M4YS(3)F"LIRYH:/F1DX0Y/0$33IS%&8YJM!V*W^
MP[CM*:O2&I=+4K1)TDY@93CRQ.^SI(,$@F;?6X0@HT,OV=.\S#'KEM^">2/3
M]LF/$[JNLI&T.Q5]5O?==HI%SU=$)0Y9(F:8PS^S^CKX@&42W+3MYC?(B>#?
M(O-L<=@[\#/W)?>[6Z%#6N6,5I?TE*L!@4[)?"EN767>]C?]U181HC82?IHX
MZ&28 R.X= G.<").@ZDYW=;3#5VS$ACMKVQ=AADS\&T@3)*)M0-<2YKSJ'?:
M",PP.!]'"HAP&5'?LH22[*^[+$YN]+BK4UK#IJN%5SD*DVI! <([$MP%>A%#
MEOK-%G'8O@*DS&'30B[7HDT9!US8ZL"+*K)B81XTE2!.;S]P/>T_3)WY[((@
M)+(4*96-$T\(D[GJZ-3G&Q[ULJ,AL*ZC2#T+E]S%.7.K-4^W.',/=.O'>1V7
MT0,)GU 1@GDV*<>,(F-)*N8A1?IG4O/"Z&?Z.V^K7#B;OUNKUQ"+&$6'[1P,
MAL? ]KT 8@@.C,GN)^#]3!/K3LJY>2.(Q[+7B^'8%[_";;*.Z1P;YDM"Z:0\
M#LZJF&\ZE5!HG9KJB>"/1XE:++<^ :]&B[*'L9W\'#W4&A7>!R&W<'BKF8_<
MB),ZQ,>RYYBXI X9O[;!S4D]K<M4G+ S .^[;Y?9DF&MD!M8^P/EW<N!O&G.
M+ EV _ V1Q=#UDUWSTY.,G*$KM$(&>"\$=+P(7N[8/VK]Q#VKRJ=H7USE</@
MI"Z[\B)+R]$* 1]+V_C&T@NAWQ_EG.&$[EP$5%X !VB8 .HO@_.D8".$-;1?
M/SX6>'?@<2$/E/9+B.9?R9]_!W8QIG.L^_:/6'QR%RTZ59Y/S5YIJ75%%WKL
MC2C=V/X%E])'<(G_8Q'I_R=YP/]NR0-$G=;7N336-J;#5_F7QGS7H$&U2O]%
M8Z<+%Y:6%N[]2V.FN9$+85P:*WF6)?(,$/XWFQ02IC0G7\G6W4VW>D$?ENCV
M>C/6 46\;Z$<8&R^U[;9 W7)N)\6[R47$/)R9=Q^0A_+I2M[-:?U9(?VGS#R
M0N9[_M&5H6ENT<TUE@IT?!UJ%8-"4A3^E&TYW+\D;E5"E;'.I6$T/NC#0<P_
MORX42@G9W$1K!]A*/ZD0C;#@C4W>SO*,$%5A-?J&FM@MC3Q:@-_$^JZ1N?[8
M826-"@',C<ZBZE6EES]X8?E12E>.+[GI,\.8@8=E>"X*OU_UK]\G.M1088G_
M*29$")Y=RAX9/!C"'=S99B);9/E??,=248&>_^*[_2@5'Z\C^2^^;YQ\R]QN
MEW+Z%]_[SBS>EOX7WPE/%X40TP56V!C,2?0_S-D>A)A?QP7@&6TFJI<"G5@0
M]L.<9,H6!U<LZ1F8?+TE[&*0'*5ZDWDH);:>Y.'N]XP\Y=P9(!(,_0E>X<[#
M@^W #Y;K,![5<CT&&XL[6'@GG4Y32@A;=-KHOE?^-1<<3SY8'0!/* DYIN12
MZ P]1F[[MJ\",3O5\4SO^WF<T(]\AT3.X,=R^^+8BK"Z1L@:\M)V:*\#P>.H
M$^OS0NR1F3/IY6-WL(I,:,(W)*WP%A :R]#_NP$0R*?^OI]@KY$RYNI//Y&O
M,M*U5&#NLGE7>RP3.2RHW%7!@)*P<8CCW+$EF3%X2. CRX5ZS-2W>EEE/R\<
MRLS)25<^<[JMU;V90K)JM!?VDZHITJG)PSO'MQ'?M;289F'Q\*]8SI'JN>%X
MI2M !NLFUA-MS.PVH>R!+ $[SY/M0!2UHO?T$]3K[Z_39/R>&O7D6?)!'I]Z
MIA&PD-QC/W(Q0GQI;660)<\^MIM.D(4I,B*ZSOIFS) ".^29<>6WQP@!=+Z\
MX*PV)B3AV/%!&%+>3*<YPT,T[E%9OW:?Q4C5XY'X':<.8GPKF">'!;-'KC"_
M]OB:Q+ZM0T7Z3+Y3*)0K09#+L[0Y4I:EUSDM[V4/S9_GJ1O4+_[J'4F(]+/M
M#-F8EY"LU&&U/;,^6\NS!X)J'D^556<]]]:_]"YF8H+<2Z9\_$CALS"X<JJI
ML;$ISB *Z8Q$32BKK\XEVBB?C%'X-XR(GF(G:'=CGZ&(PT]G?\S.OVD#'!5?
MF?FG__S[AO;8_^H#[?]/%W"9[CGS#2$4_CUI@:8MZ"MQ9>&9B+=)G=+1*E"_
M0KZ V6"D]?0:\<?VVAYHO]<>B+8\VJ&/[;>8W ,M9Z?M@<I<C0BYQ.)UJ;N1
MLE;?3DY_9/"WB-[C5%HX%+%'NT5/-WR;5QE4S/6HRLRUV"VKM<CFS$;O@> M
M6$!8;P\D;OK?[KU4*KH<=0&[\0L"',-^6#<LM?[S!\X^BEAP9D7_9O_=/YZ[
M.LMVA01U[(%PTT0V;]X>*/EUYO45KJ$>;L7.:>Z!3FYGP7]\WP,Q5+ O@E9_
MSV[\S2_X4 O+#(ON8'&P@=Q_3@=Q-%Y?-VW [X&,J'N@!WWL1^0;W!MF[('>
MEW*\!R'2V#O8AUC(H?$?*813_+5)&@<$Z5A^[?M*R0=+SB76K%'C+*)]7MX6
M@AYW7/K<E]\GI6\/>8J5QL[ES(JCP=N#'E2K4E^F XD9]-SWHOMG-A().O1Q
M#^3U[9MN3G6D2B:XS$]S23R59VI3QUL0_-,JB;V1Q#XS-P2U.T.O_S#7(,EM
MV=&W#J?YI+YS9CPE+/B3HY347(]N7'>IR]=#G,]E]%[/>WNCVWTW^[1#D&B<
M7U:$TL3]"^%Y2TNC^=6O?#B:.NU\SHR)BL@B(,UT7)L?:9U)PI8@G:(I.153
M5T&G52NEO[YL:\DX*)/>G1(C</9B;22@SG)D1P$\:H)H0R:G.NBE,?0%]%%X
MXL($[%2(9++Y(Y.VG,#\T>9CD_<5R/9%IT%Z#T/ FS-,T[FT+ER*U,T1S&F4
M_#_,J]>[OSA29J:;.EK*5+.56*IN;Z("O*\.O(FP4/WID46<5'ATDG,5'< 5
M@->7[&/6G  ^^J%QN4/SB(, [69 .(C0DE$"E$T<J=+(?R,X/8T4D[IM*I3=
M.E&6L88][]W!&SS)0RL,Z/P3ZT\N./S#JL;1)A(3;L);H3]PY/6TL,PKZN-:
MM_"5;W5/D^?A\-Z[F*@,.]2G/&';XT41DE1O-5U=P1F\U3FW+_[YOC?R<$YF
M/ICGG$]$ALMLC)NAJQX)T6@=!^4<0V5UZP[25D^X ;74]I5I.Q@KJR7.6A2%
M&,[*DF_!63/%< $24<E[($'G7@&X/T&&CCW,_H>QFY8,.T C"@"C)*G<H%'V
M96J M_5D([)GG\41'9ESM(41T[201 ]'](?G*\_LZE79OXW4T0) .T.^VY**
M> (18-LQ6,Y&[LV/NIU<)B;NEVB*@B.*EIB)8=&83L<8K(]/SDYL(OIEJT;5
MJ[7.6C(?W6'E-TV0EO8((H2^SM@#V7G'KHG_0X1/76B;?N-S:Y(-1[4X\20$
MR-]V]-]J/\<9=UX0/ Q*BQM 7_K$T)$5AW59"*_,#]B4W*IK7;)T6BI5,1%Y
M;:;^BAZ?-1U2/CRF']1'D>M756M(.??62[-(T;Q93L3>N<#]FPUQXNQH+$Q#
M+CBEVNH&PTXZT$YUL&$77%Z[T+#MRWVZ&Q_P5HS953O&]PN<);)U(I'/G4PO
ML8BH1?'9O"/_T6\="R*<K^YKY(4WH,_\&&BNI0S'[($:X9U0,N0_>Z#'?_,#
MU_*AN'XC13[J:QB2T3:4Z@7J$R!2I\>;F(<?WIV+R=X9>N&A52&0\.%CWV95
M94+(DP75)?V/H97( 7[;WS>?3[E2GJRJE&\50'VM=D(;=@SB]%FQ^AV"G)[!
M<KN>D UKC6YL_<*-JEI5JFK(4)5[8Z7[S'W>GZ\;IKA:<#NM_E^YQO&!SRT@
MDD)_0AJ&5Y@,#'D!&<I4I1$3"+[H9UJO*(NXHVPM@?SM"$63?O6X"J;6E8[U
M._[2E=*.XX[5)*5-(N)#'UOFP*$E(&-;\^VSQ%'/+T:PBSZM^L[34=QNIOL=
M$WC_UD<C[/U_GB5\U9/;7ZTT3]&^[4>%:=/\,IUM*BR@)'.+4C6W@ <D!^N/
M87Y#N-V.=O"O/=!4WK/Y/UP)'?5^Y;2GQ(VB1WW,N$B3S-7(A1-PZF\Q;T>7
MHK!)(^ES[ZG!R1;EU!(:7=4,L\V^L)OW<A(^]\)(;#=K<Z'Q,YX9L>+NRRBH
M#;R=5>T/,Z-;/X9\;4M]%RERT/P[*L.A;:)6[(3!IY$_M\3V$V.KY>G>O8@I
MI^FKNVD8;=2Y/= EQEHG5T%;4_&K6C0<'V7*#)P2!I5B&WP)A_(N9TO)NR"<
M?<7)B"=HE0K?EN:<<V)OQJ1-/X<;JMJ[0FU:"W_L\L)<F<74EO>(J3$VDLDI
MC2YF:S+T'L#T:I$7"G'%2QT*[?6??S2.^*\J<9%R^WYJ\7W1VH"#ZT[D?E'"
M8>?IG+B/O+_D."CB'!XG2KP# 92#5J98&FQ_P+1D"CGPFJMD+QF)8 8QJLSQ
MM<=%#'QW*TRK&H#V2=4FL$_N5 ^VL!5T=\2* R*H@_>Z*)&#>+)[ R%UPJ#2
M5Q0#[<'(OI\8J+__QRHZ=D _.7Y=\9B1G<IH9H-+4OC95M^+U#]95ZX7N^5F
MJIZQ+5FU%TK*/V63MCF[PF;&)X50M)C2RO0UWHU?>HR@GEE1BJH>G:P/<[UP
M8A^M5YJ_X(>^_U6MQ&LHJ3_9'MFT>0O1[+$^]^#/'0<$32J+$GK<M2 SQ"GP
M]H_=/&(@F&<6U3 GGC+T)K1(^B;;=:[Z?J_E@3[,L=8.DZ@K[(M45GRFM'/1
MB0K?ZI\MN7WQ4'S,KY$!Q[?OZMMC9N=PY!S.$2:U=EIK>[5IMQ2C"Y 5 6@1
M2OX]12:-ZA!_FYC<W7%A#*UUNB$\*H@&%0IJ2";)2F0'7)J0S/A'*OMM);EZ
ME:!'D<Q9(3_B&&"Z]D \0<1;:P#TQFS],&E6>(FCR#!<>$$/XO43;UG_VE_I
MYP9BBK^/ ^9?.@)95=75_JGXETBIB%C.;&B0=UGUZD1Z8("Z^LLQ^4;LRGK'
MNSA56R8T'DG5GU8F64!(Z.M) UI7127''*/1TPI/U.TNZ7BOWMWNA2+CLYPR
MSXP_SLRLV[B!VR"F1MZ#_KQ(UW#&[4K +@\K,W IF(-WT 'O\ZV?4QDV-#:>
MRTK"RPX_WEL(VAZ(W\D.Q),RLGGTBA]T>K4>$SCSJ-0F->@2:IY]!]LIL!FM
M2B(R',!D'&E'-+8FZY6/&VCW56,TQ.)-XJWZT;!J+3J1]$[=J&OHX+Y330V-
M,=)1J*>'4I6_B(!>=<SN@1[EPAPB/5@ZF&'9HTFWL]T4@)D*('5=\5Q%(>((
M2OKFZ.J!@-U18PC[M-8[A9(W.?WI.D;.]6Q/+A%P]4=F-V82MZV"&87L?#8"
MU?X]8[%@S3.[!&]06MD#T?-04LZ0H^B@#L9VD4+PAX5)CC#TP+)#=H;Y!_/+
M_J.HB]5D1UO?MX4CHL\47@@%#9S[,.:V/SC_[L>A\\V!;V]5%5\ZW\$S79*=
MI"KPVE5=Q/8G-C*XW5\&0?ZRZ56;/V[G[DQ:$UA8HGD/GWE;&@1&%<UG%)BG
MVA3<?T&H2Q7*",V*-,8/C<(-C0YB.Y'L:)8VYQ/DL)$ FV\WRY\0S7@T-_D@
M#"Z =F7^2#W%U+[OA:=C18>C:@&B97,K8T48B"))14\FZ+"6U767NT.1XIA3
MLIX;BV+)J.S$71BVTPB.!#\D-NNML$K8=H B-47OO:#SK%X<.Y)!&>F[4D=@
M**5HLRR<\V:DJ&%12 /+RY;9Y.W9:XSM%M'2UWYMQM^$!KS+EC27+MC%]\,9
MYMA];/E)[!Q7H0J@M72SJ-/#/*@-:E^O*( 7>>8X&%2YU(9/A"%+4%T(P;<;
M!R>;)^R?^9:NF14.7QT-&[AS?'J*W >9A[.E>2J6*^EP,LLTX2I',H<$X=DR
MH-T)/=3\+N@UP)DTYP-K5DVV14_4NUULFE&3MZ>\J1E^-<<>2&S%GF=,[WOQ
MXT;H)WQ*:V!57:OR/."O1?V=,R_A$BB5?;1=9-F>U =6,Q(KJ30[0VAZ(YP&
M\Y!G$DN\#Z%D:'N@.*PE1F,N[5@#G(]P:><L,/Z@M)"I$WAVJ*&4QM;OZU9;
MC@O-QXIXOLBDYGB^';RZ$!>$HZIX;BJJ[:_.\=0W'^!S:CH')<?;P!MXV"=L
M&4%].SX9YJ.8<\"CN??C0E\/-K^M UJH)(9XM[B#H-B48F-N0<%"PWU'"S[
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M_^WE=Q!X[5<26V6W#HUDF;/EN6-W?,E-DQF1PE%!&^V6PS096G-'F+B4D\S
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M:P\$F&)$V:>:F(H3N.#J*2!D!!X_B94(']@>E7M7%_4UK!SM6/GMFY,S9?I
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M2:"#&6ND/= 3W8G0I8V?A<<^PRRH!@; 9<L3Y'S<P0Z%GYRC[1TC_H5G@WX
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MH$4+.%3SG/PK7A#QWKE-#UZ .8#:XF[+]G K^280J8?$_A764#%8_:C-4/M
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MXA3L<NRSG5=3T0]E(VH]+!W>70ZS/KH%^OO@)4S^H*D@313%4)D*]\([+G.
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MK+.<_<U )2V@%$MLEZ?X#EC-PMQ)L9/DA/0)?;_86J(E&FJ7*IX41;<A-4
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MY7U<@V!)@&,F:+3[]]@'O'O'&!3,XI.W@]K+]T#/@)(0V=Y^NK'Q-Z*&B/V
MAFF8W2,BQ2\V7UQQ'ZR-*)H^&/P*+')J&C3S"H.;N:BL=KL%157-=AG^2O5?
M?6A=3BTHE6R4EAG;8.0Y\H[\/W!'99UY]>EFZ>O'F:U5NT AWS7?).6#%>C<
M E,XO.1<E7)[.34L>KE9'Z2PQTR Y>*2+_B4.,0\;'$-HL JQ83<=DR<HX[,
M9*8B@9.\3%(-:BX3T!3*S8P]UTAN&5-X!TRFF:7R4F$JB\86;G(&;.I"X,[<
M5N&A@\U72^KYF;M UUOWW:KU=)A)Z&Z!KOF\8'KH7'6_)C TKEL_YR3,! \P
MVU'Q<F8=F'J=H"EB";O;<.EK$*5](D&(YVU7"A^[;4;/9)".$BZHV@G"$-;Y
M&-8C+WPH"UW\F5+UX\U7_#W>6:L\?!RI;O[P?E1O*#,%5K\@V5&TS 9]BP@$
M<$( SX2MDQVP"ZX$JUST3$2D=+J10&XA9RJ[!!2LL%:1&92$!19,G;!'/_DU
M=_2+4Y"9(=F!-K#D:W>: Y_]9_WJ;V/FDUKL;7[/.^:#VL42YT$;A0J)O0B7
M09OIWBBQ N:R!TN>%<+4'%^.A6Z)%>I>#I:-4/"W^[A=WYX$K=XJ+^.AOGVQ
M5W\<K3*=@WV?48V4LRQNX#(/=!="N=8N@S;& AR7(EAHY:ETF5$2LUK?P#9(
M'$7S9/ZHH2=P,3EZV\,1_$U=JX,O 6K[UVB66TUU_<!\E5D"/=>-L08YPTQC
MUJ!F5\3N]D"G&S@(_&0Q-2*QB;?7(!)#V?H^NFNN569\+F; --E4'(=U!V;^
MRD,FO] *^/9RQ$6DFT-Y5?ZY/HQ"^ZK1?U*2(*<O?OR$$9EBN?@P9J1=30,(
M(5=_.G)R6ZC:$99FN\.9ERGZ6Q^V:QUZ%?[R]<L[KR&0"Y]WY(4_O_"XZ(!U
M58U9L-'\XYR,KET>16?IAJY4RX&TJ8'B_?O+*1=MLG>3VQX+7U4,#KVT9?Z/
MB=J_&X8H=!0)8 ]4AXD]B*UU*E^-F8EAS&JBOC>ZTBN5O&%TU(=-;=QT9B]V
M2ZC66%G<W@_(9?4T[-XUB E#';A&4I-<$BJFYI]?++_2.&"6V(2)>K=Q@>:T
M[?RQ#Z:*6CO'/+=A]WW<JKDA>PUR82$5 %N%?'B[-BDQ!\OU0Y+Y0^F%@'G^
M<J>MM=BN0P4,=4=M&R8%A5AHY,4E<FDE;^_/Y0[=JKO%""1'A&_;_!\<*!=;
MDEH:L/6![1318]*N *!JMH7R8UM.HP_19-"4G*0I.\K1&!-XN>8& +PVJ\_9
M&O<#]V2,K6 9G+[3H3U<DVQJ4I4]LY./]U3*)@6A]K<-=LX(RWHI6[/2CMYH
MC;6JC(@,'JPMH6@(.]&O^H(1H4'$P!R\;^X-]K*4N.U3N/=V:VL6_\AB*(>"
M,B]Z7($XR"D_K+L-DW[V8_,)*V*W9A+U@V5'R"V?Q(_DZH(F(?9+JG A_G>Y
M;X+6?'8%GL+2L/J>TXA,L;%=IBIZR)&JI*LXY);%5' YFL?6J>L_ZK0H[C3Z
MM_A"4.4YG.<4,U3NK-]YRZ_DV_5$ I6^H*/XG; $T3"8NASQ5N22-P-__6-9
M<7Q!?8KZ.O0&MCO WT;K2EW*4 ?W^ZZK;T[N;QH=2XH?&$,!]<LWI"\DBN+
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MH>.89NAX?8LSZ3[CT."YUC$SD45JA22N-"@GHT)W$06EQ$>&[37VR=(^2:I
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M = N"Y2&WNM89H%,%BMZAZ'[GFQTJ(S:S77XC-E?9%2R0-LO6H^Q0/?=S[)
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M8CX<=.:(E8;[S5O#2AE*'%Y"6CX^BU58IDQ[F#C=I(=<)RF;!Y6R]K=7)TJ
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MCR60^R-,R@CY3O3"R;ZS+R^ ]C69!:&E7QZHN(<L+,BY/D\P^?*QP.FL]ZK
M\5Q'11-(*0#;A5&L>M87X1'$L8#LA0DA3VUX65/N@T6KV,;PXXR#P&V?(^<D
M^\[WG9']]+R+6&+9?C-/6ZUW^_,#X>NHF/NM5JD/&>#U]?P$[M$569&A@K?\
M?$I9E9;*>V5S]AVG QZ969<?VQKQQJJUC&A-V?E5UURVG">N!NF>V2R,OIE8
MU=WY\L6V=GU[EX4AJI3.01@X KB]M"3,<G\D9UR$G; GREQ7?JNEVFFDBQ'-
M=%UMNEL%-"E@O*-+(6X\%GEB=G"K(K[>@.-]XIEW)67/N 2MZI2\W>#V9UZ_
M-9IGSE-KV?*C</'<%)NMTUR?_[<]I?\'\W;)8S3KM8/Q"(C;UJ1QEZ38J$HM
MY!3<;UZV^PSJ][':OA@E326PPR!3$AYG,51GIK\I9._K5TM;\U#>4)9R2Q:/
M=GTIHA8.^X"FZ[I3V;2QH F@L4!1LIUH>A9L%K.1S@*=>TJS04W4TP-8H-$[
MQ%@62#.3N70@<R]#V?L%)>+&L%SOCOQ@__9WRUS(H>?=YJ]DPLOEC;*K!,HN
M&9F=(PFE>&TX,0\=W'.?6()VZ@I"Y;\$.+W+\<E2S_%PFTA4Y^2N2=1^%K]J
MS.OPRNNZPK5>D]I:,^D-,  ?V&!#?^, R@\6Z 0T!K)_,>E?W,,JY^,J6:"1
MS5-L=N 8!2'WI*%VY.GNS&9*.D.P%<I^EW4V3<ZDIT^'%;! ?**,5M3W3:0^
M"T3X1&&+_-S@O[HYWC5BP2Q^F,0X/7V9S:=U:UB@# -&$$GE0 '.U@:^"0Q[
M%/95&FG&3$EU&IQ-8*;I82P0/H4(99H5_(M[F+B2 H8Y 7P@T\@>QN,A;/U2
MBSI8ZX;MVE @3' -C.F]#?.G)OT+*1C_*\D(6Q@?Y'1 =DT?+C-%M@>8;GQ[
MX_&X[Y5$%!UR'T<?7\"2_I\,8=*>SG/4]S3" %UU$4WO!:]A1%&#CITL$(#L
M1^UC/H7U[/:S0+]H,BHAGIA$6+UPG"Z8$D=JZ.*+00K5 L=(>LAQ/%.=@L1@
M/"]XV[AH KYNGF6&;F'^BO)A?IZE7D)?ISE/G]5*/UJH6,&W5P3K@M#%VUD@
MV7X2E'9Q3A*UBB+GX^K8NG49FP(_?L21&(%0=G[6<?M"GU3ON?> HJ:$$N?E
MGE,#FM>?RP];IJ9K-/DI*#2X,K0.Y)<N1WH2]([;N"=UW[]4W"G:KQ730RPG
MKC4_3!-//E$O%73^T=6M--WIJI9J6VZY?%SNP,J%OV1]_^/%,9^4"-ZVW&.!
M#A;9"K.2#L6<P]@#!+;/4H&Q0.\<(,R,P(-M+V;R1]2"<0KJ&^80"U12F[2$
M9&.DEU2V=%UOH)B%H^RFVEQ[_IH(KF_[3X>FVI8+_W.8Z@O*[F^S/,R?)LP"
M?;(;A:P;C[) NQ3"ZKXDMI$1QP(M5'BAJ=*K[+["R7N&T&<N?R)_9GEU_O6X
MU4.P[B2ZA#=[P%'D8&9_PQ7V5$93KN.J5YD:J'D2;%^'!0K'47V;^9@5+%"L
M-8-_UXD%2JECS_YO6>S_C=Q":80I01;ZEV!4G8^HO0O,,(]\MK3,!K9?_^T\
MM'])G?<_VQ[\K-!]&;> Q]WSH_T*X\7MB5=C%E3>\M&3==F3SNT,BF%SEV\#
MG >EIR'NL$#WNO@8#@1H[7^T!.';1?R[D@#T@9]R6]OZR[H(AO?OBR?_2TZ
M^^]O_D_LET:!_?F/0<AWL6 _)ILO3_V)8>.R_RI>J[/*)1MBQ\X>[3I9_V'S
MT/D(\A3'Q4.^E;42\R0!E#,+]%O1X^2Z*1/GPKIAFTF38-_"!E]I<A)5'\<"
M1?RLDBH'S%!@-P-"? F.L.@G29&;KX^<FIA:;;;%0W@,L]_;2/*T-)E]?.@@
M/(6_A29;5ZITYAX!2#0(/:1V.,5R,-";5\6TWO2]^Q".<)9L'+>%<#N24])A
M79"@&6=FQWFB<,[1<_RC8-JG#QTLT#/M%$@G)C$XV!PYR^0GKP0].O5MVOO'
MMG/+'[\C*@8[1.*/]D7<27-"?D#8C__< B#43.<%VHFPR,RW>23Q' 5H. $7
M33<N-"0J&=&L,HR>4[75YO"8B3FG&1]F]TC%T-CRAA'DO;/B>@;S'N%&K(3K
M_*;ZU/W7B (-HK+<YYU5T4BUPCO&M,>B>#A\/  Q3%WC$N-+O54N\HF-4=]E
M%D.H SU^ A28,712'K^F,A]/2@+ ;#O#T:C0D=WW_%+H,1C_:U2G<B<08"[:
MYO1.!'X>;ITZ$%VV]#"H..+#:/EUNQOF6H>@PHK.?'U;WZ*(N/4M"KH+5FN>
M0'&9^] 71$&1DNEFY& \.N:%I\,KX1HO8\M0TU#^BLD<'KLQGP>:QWRD:AKN
MCRBG&<-W*9SM#HP'%%3[7&3N92 @A)S4J7]JV)'0ME>7FCU[:M!EIV/2TF%E
M,@);[N;G@15N&EQ^_VS.HK:AY5K%_8;XOI.S%46IN R_&'0U:D)C:[*&"/Y3
M4]6-@)Z8(STHFD\AF+8'!968$.Q;_PA,4+&L&G,)D<G=,DYVM CC77#<5/QC
MG+C_0,FL;6Y+>-V$DDSJ9H&JH7C(&?HUBF!1?5ZQ_2I6>(QN0N2]JB#BQQ>I
MR3#&'SCO,4M+G:2<8"Z>-D^\O81KOKBUC?).?^FVO>,2];SU"NR4HA\GY8%A
M&EZ@&C%UH3B+IJMWXV)HBBY-_%F_'.F.S0GEYP%B0)E_@2:WH-S5LM+G^06B
M-ON0XJWG30^@!I'89"0(7M#].CN)*04&/4Q4P?^([W\8,AZ1*S5,+H\$DIY2
MZ)=AG-$1=O>#&HV5/ZD&50'V=P,DE-UC/@SPY"[Q5]KD.B_B))"R=/;D?H9"
M\*'"L9+DI0;=62WR<N=],BPR?Z;<.+1D[5"EGS+"[-UJ\.%KM7VA.8_'^-3<
M1E3N#?GP5IQT-GU0QE1B>[0T0/YGH0*X0@].D YU#2[TG..WQ=L@3[QOL?==
M'@E4XJ&YK,).:]:0M)'%^A@!;9G.6(R_GWM(",B;9\HT+JD9>1[Y!5*3ON'_
MU@XH[KHXAM2^IL$;^CLY/4%7EF1FMJ'Q9WKZR[GI[T-PE+V^^(@F+\2I.ED\
M;<2G[H_$+?.4&ZT1>8FK;!"B")E/1Y]L=9V?2\3Q0]S%&0^V',AN.5&Q6[LT
M3TGCFB&Z"0%\RFY%2RPMG:=VK7AR+<U6V(AYU,VNN"G<_.7G%",7Z Z&&GM'
MU2[:/_+*B[YS[7V'",51$]/D1B<]OW*BKF8?4!PGFT:X8)UG*:)[T?,Y\;A0
M<$+E^OL]N;%/J_,/1];,:Q?W4!/(N(QZC@1DI(L> 0@^TVW=>I<%<I;S#QZR
M5:5(J7<2 ?0%_+*@*IVN$,\<[+S[?E2-KB^NDA:DR )Q&6AVWP^LB576[SL5
MG@,>XHN"5&EUH",A9_:V)OD-QQ"^9<!P9P"\^8 YW)F9&%/RG3K9$+]EN%19
MYNGM3=C0L:IM]M.RJ+?0+X*CW4;>_<9=)@QYA2-;Z5F9 "TT&\0EX,Z\0)(=
M)2VEP,.%<W1Y./7^*WA*9ZYT8_-PX)$TJ1LI*R>];CH[*6^D67G53'T<G+[R
M^"4R@3F+JY=I6)^8+VE5)8C'A2;%ZVN];V13_R="IYQDG^_>'7*8AO=8U#_\
MOGUV1:DXRF?S9CNJ%._O?]YI8D6KOH;>Q-:5&<:+(/\21^8H6"2_K8ERI-9/
M$QJE[5)_'VWQ:HU'VIEN-):[DDGTGG%0R'I*( 2EAX9FT*\2C9L'-]G>#-*J
M]CG@BV"O/^2:WVGU;!<I^/%PP0Y]<;?7$\6)1-U[);8=!()YYDW4MPS4Q7/*
MYFJ/ZA6$/Z>=CO='?YWE6VHU;@\YI[(")<Z==/6WZKOD*OIA]K2;Z',2HZ +
MOG^'8J>KI!WXRK,./P'35Y;8/!U0KR6Q*#(O9P"F_MC8F"_1=:5)(UR&%XQS
M2?A9R3I*6 +^Z5GRP#S#J,^QJ7%:@'?',^U)1!T^ MS4G)W0]$M(%/WT5L\.
M,$RU&PKT[DMK:@4"B+A3<!6U*L]Q\W/#G9.656?3GLV.=QI :WTXK_EP-L<[
M9AZT4%_:P:C! #6=\P]>,HR8_,6Y7BZBE>]=#,^E\Q:/A?J..!?(2HMB^@<
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M6RD^;<*'$.=O',[6(-0)-(4G?8/M 8RY:)=0<ULQ.'J[[=H6_?0R\Y@JC3T
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M2]?2U9MVWC87#VPPQ].>A'TN=B)WQ_T2R2._=<Z*>4R&)H(<AKWW:P<+(CB
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MO1(#\N1IH7Q==I-+G\D2RTQ!V>J[NU@W6* #%MIA&L5PIT635 2I\+KQ4OF
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MF(?:.92^=8<()-!^ 9C+WZK%'/EX'MC)T7W!N3EL*0<"U"]5M+XPM]<C> V
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M<>N6=&-TZ-.7)4?RIP0V90I):;.@20@]<S:*9X /X/[3>G;#6(1.E#A%[Y=
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M@&742R54+FGNR:Q<JRU#F$5CDI:H=+:R8T<37)YC0<1I(AG=;P4W70N*\)?
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M^R2Z5(Z_'2QFIB88K<K9WXQR&N$<86QTW/0?5#'[AW!IL&&2C3%CE]?'1/W
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M4K"R]K?6]QO6WFM].2-$9X ]'I4!F1(\#_I%O/(CV@#S\2;24T;"B]'/ZYN
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M$U!2"GYKP9W+<>L/M*CCG,=:<]7S*MWMQ#$_>?_UW9QEO-@5_I:CI+=4568
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M7.;CFV7/EZO]0KQS/N" ,$IZDVEH.33DMS;_^_N1#JTA*I#<'N.;7J^5]$K
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M&2F%A4H++1G]ZZ]":%N) "=3@':2^1P65?K>8UC]DL1)CC!= R<Y>(6:2%Y
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M[HOM@XN<Q1)[!,D.[J,=^BJ:JRAFR))(FZ1;@,]4Y*SM80*NC;R)>&&\I8)
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M"[Q1&F+%9.&V3O^!N0$[UK9IZWTV=@**FGW@YN7X2>\%[_"\PXS^9[ERA-/
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M"2LCT>'^;HD#,.H*TN$G%[C)E'-#WF)7).S$4G0$ROO#2L@D\>UA*W1 Q6A
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M?/>*, G8_0C3#VFNOAS85%T9<7$P]\R 7LS![V.U 8\)QKH%:G^R'DT@?70
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MJ-'4D"DR:&5N>Y[O8WMRL)(1<O^8@0?KSN,7^:>O1KE%;2Y)-C^'GLE/AO_
M33V9!"]B>>EG9>73LF3<;SU:2JS$)DL/ E-/M#^/[X/ILC8:E@9$%6*30J2F
M_&.&[6;+C/CK=>E*,RJ5$WN'Z_-VBLD16TP]?)U4NMD_W"WH7=%(7$8(E&*<
M1(T2!F+B<2%C2N.D5MV=N<ZLD9:CT^BU%,M!TZ-6VC'EW0$5$*W5]Q!$*)H5
M<Y<;[GUU//J,Q>(:[[QUVB0W5\=T?T'^=C2O#S(R$#J*<L5VLBRIJ0@W%9!X
MW<IT6L=QVC[>2CNR+,@:,T!Q6).SKH*/Q01Q&RJN5(_B/;N,LILV/MHYKF<8
MJM4F*DK9-E@1958L"8#[S29!.TB.NI[8<JD$V]4)9CVHP*AAE*"HNLF&<0JE
M%M0;!-H.A'_CRZKXY46UB#H/6/ \W7))\_B9(PAY//+[R6RQ)GBRQL)!C5X7
M>?MJVNGW%J?35TK=5.PJ+-_WYIVMX=X==]:H*)/-_M_YE&?2I2H8<1[4(?&"
MWT73.G!I6K+T)*L DBB@ U9+.<>IT]%F9\T_(6B9WUTT"DZC%WB^'S7)N!S4
M6,U=IVH5:^>IDV6BM)R!?YN]X">RG_[Q&NG2SO0.]#U6;79B%<5RFI3 JLMO
M%.@0ODB/%I#SCSFV:FH!MTW0FWE*Z$T>DZ-M1KB&RA8'TW\/=D0J5\>%;KOQ
ML"1_*^L:;BH35__Y'G"=/FK-Z6*I1G@K^PGH=ULB!9._0//GGG'"A1J&\RF$
M*HH]?_[?@;KF6X[:6]+C*?:%A+&JX$'MBJK]7V\XL2\_15%S!O"]I#8&M,=%
MZ"FQ02*N5XN3Q(1R1,3,N"(Q)V,%YJG73<</8== SO \O&GQ;O3997SB)UV#
M%X,A];7!TUCMV5]Z^\XE2QV#,4E":JMIY4'OG[B!!RCJ%N2?$7'!BSQ#\<%!
M9&(L&:,(R<_!QY= -$!T :UN5LIWV4A^C+?CWP)H@X%MZJ)U>65*NT)X<,E5
ML]A=H9^W__TBP9B>)J:#%_&0T="R<NF]WP:LB+<07]S/;7>;V.DR2G+)9+OS
MUO;41<<W,#0:@Z?LGN>>:GEVW_)%A"5Q(-CT[_*PM7U9;XUC$"VAL ]X@Q9;
MR5'/&%UXF1[D@*_!U;"Z7&)]-61)+/\= M(]G!+%BH=>: 9WZH2:,C"0JV.F
M?:X+Y,KW(/&'IE\-%]S:6ODI^71(P4N/HEB/B;V7?,[<1O=A5NY8::SNH-=G
MMQ]E!=!YF--@9ZX(=WYPR8G$Y]YK,0Q:WO]H6F^@ZHNI$XEMP8P_)OQP,W_G
MLP'^R^'OW3T[!KLN#(;W.!LV*VF/_?JE/GUF)XO&&G5T!;,[<)#Q1)* <=OL
MO!TX[R8KM-Y+9K$/$<P.>1+ND_4YIT59Y4^)9C?1A$#>J91JP@ >3Q"KCHZ:
MQE>7$TIR;T4-;,</X:$]C5)U)7$A!Q=$1E9X^OO#IV(7!?O31K1(25:.I61W
M>U%?BBFP=2*P6^#-4B:[G!$I,ROXWL:[VI;75)@G1P0'G'Z5KW-*V4TS\^1S
M4#;<6[)*AN%^,I>JITQ/"K4E1^$>:QW1Y,+KQD61RH^577RKPU23Q35>T#(
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MID(0K&7I$&**V\ L^CK^@1QPF;.DC'/C4.93N#7FD19&O+3BT.*^F#]63;-
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M;N]F;W_NS<SK"D/#7[9ZJ&P]O3W69@LR8S;X$QL5!8R-<,K$%C!2^RIY0EM
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M*]6.X8]9DN[@ZP)25";&(Y0#!'TT*\O0FS5ES5E];%\T[4)M8Y9/,V]B M#
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MY/,J*^]6!5&+64@(6YL:?Y?N7SM43Z@;1V303].5?$\?J!_P]=6O0!823;I
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MBYV'#+QD=-9U8#1;W ,ZU7I/S W,F)N;;R:=I@LPKR=5"-$CV6$QH=HA24N
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M)W*)Q;=!;8_3/4[8!7ZJLU?=:K<_;0;!B$DZ>^6?M[-MSQ[N?;2-/?:"V(D
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M&](+[Z3M'S+X18^SW %V91>\-4H0*W&:9*.%:Y\7?BD$@L?*1*47[*@I\&R
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M$E!1(.Z!B[OH=A;^?9XTCZ==!TM #_+QE:V*$M"9F)T2$/OX _P7C6]?66!
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M^>PI4X_A__5X$?IWVQ6<R\Z=PKET@TT3H2DX ;:@PT8(MPY1OT7;JH#PM!/
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M[K[CFKT"9,G(]^T86!4TMU8I+K%0:'1\NY "W]3&57'HO\*I3;8X3(1%$PZ
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M8Q,L#AF;?X2A.+!$?4@%=/\I I &ZBO),;>693V:S4Q*TQT_#*VJVD2_^KG
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M7UH98$1ECD_3,XM?KN/_ME(\+YDFGAAI+.RP6*).M>8FPHTR.CE,&E9J%CI
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MV@K"3L#Z; 3;A6/B*YFY50_O^6BRSI$?5"GOT:0+SL>^2#TW8'71:KKTY0L
M(+$5>,9@\ N\A_ 5]:;8_TVZM1&K+4U&X"!GZA07GANX)U[=B5;K=;"?6&N4
MGN*VT^-2W]#<N<<%TA8CA?+?/T4*Q<JBV8#X7958E2Q,;0P1 8X&BG0.BE/.
MWE_'B6$3:;GB?N 1PH71$.HX9,>:8DA\GYM#.8CP>LW=E+UQWN]BI\_QH5Q%
MESO?I/W'7;NW^&X0FE^)D''=4UT=K8/!^!9$C(]+]>W8':$HW[;EL'7YK@M6
MJB]M5 _E[XVZM!D@_?HF#@5)8,"ABX?X P8+>R;$XF.&5^\24\(UC:%<]RYV
MVY@TU#XE3G_!87''88P/_Y7N_+$23'8R23^L>X^7'BWE?RU^<$\B\56WN&9\
M$%<02GCM6O!Y!?Y:#0=>IO'$()@:K;&[S[BN:0_:_6V'0=:+X1EWKZQ0+/M@
M#N[LO?OI,<$A10Z*O*IQ3W2[77XM=(SJVQU'T/WC&W_8+G"QF:!,S6A%:<#W
MH=VU'UCL4Y6N1LUSMZ9-Y*Z;"6'ZI/Z +1P5((I\RRN0$LG7E=CCHZ<_WHR_
MN&'MZ'\<0U_E>HEY0N*"\)^5X<7*7">0Q>H>]CG#;1S9Z8P1 ;6"8S#Y%9=T
MZR>VO5ZXY&;>W2-U3RZW3AR]\?=KP9]_]J"A44A2&-&D!?+9V#B"[)C E4YQ
M8,D@I<#;[,[6= VU.DYU87V^G[O@]>CXM.J<[=K[MWW^?X_(V-CZ[T^R2=>)
M/BFT(S9;BX ;ZJBV7(Y]'20A@#_&J#+G5\15R\IYPPK3BG8KH>L2I$!"M]V@
MO^ZVJLLU):$3(_X!RPW!=C\-5M;Y%[\,S<BY1>RB"L22AU<,2O./"H*X7G%\
MNVDOU7K0F^M#6_.*M?!@8[<,XW)H[Z%#/=4[?P;IG5EC3-H/_*PP<K!F7APD
MCSE#G_[2+<YPH% M2T8NC[H#X>;\ &*S'UP5&B96H9*@]>/09[/N&&/8=GN6
M$$F#ZP_ ]Z+-)C@9L?CC)/1:==,;S'58Y"UM=,GKVH&@8UW5*Z_>HNO;A%6V
M/9<=%./$>GH&-^78A_ 3JP/J_\;:F\9#U<=_X].J0F,)14R+I1):+%>%J11)
MFDK9)J:2&-.8"ID8,V5?0G)EKK@RR9YERF"R3I;A4LE.1LRB9!O.B.ED%O?I
M=[_^3_[W_>S_?S //'#.=_E\WLOGNQQXQO<^.Q']?=UHV-RG<U,:;0V\5&WP
MO*X:_^7779EH+S-VXYX4JSV]S=2@![??=OQ%Z&.-1,DWV4G6D[L0RI6=3CQX
M+,6WBX,0E+-*)D539 W@<P(?KDH,=0)^GF&&B>F",D*S^%)3;I=>=MSYON :
M@I:[?)A5G1FQ#Z>H[.P#D;E!G/#Y*S*GAW1:Y)HD08!F/ -F2]%BV?IY@4+,
MDHGZ!8;(LJH\MH':$N;) 16::Y.+*]XPDBX-EHVX#.QBI/PXB1W.NLQ<@"%5
M63Q!UV\;6@Q7C+/=N (;J!(ULH(@]L]>WU._&PJR2="N#+M,T@QCMA)42"@1
M-6'.)T4CZU*_4+Z;F-54BQ_XU.-;<!-@15<J^DL'S90N[#_F<OTBZ/N_]S;-
M2O_L;?( 4/(R>O*2#(+4)AW6=QT$PPB*/^CYT]_ A..(1 A&[YG%+4HP22R&
M6>*-:J:SBR<8,EZV:5FXZTK-NPJ FV >+CRZ[3O,/ WM+$AV+.M)4+7H;+I@
MW4+KH8,[-U,5XBF\%U8<96FZ+,X5S!=A[-\=^-#3J9&=7SCI.K2:<R)][:/
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M94W$#P] PFY4$5D)U_$I"'F/5NT$D]>)$[R@)LL/?IVZ?S! OD-D^.R!X(0
ML6V$,_S5&PN@BL G-DNT+(NO%T^8OARZ]"!)%5*\!73PKUQQNK;60[*:_ -'
M\Z7+)='@2ZY&/06O].@F9B/QGF#& ?"*Z;WY.R/L1Z)]U>M5E5OGK=4#)/$W
M"GEPT*!0JN;4!'D11#-!C^0-,L8)"%"KA4-(W@GX/=H->$ZJ?"SKRL?>G=;;
MWT_@MFJ;EC.^-%G27V$Y-S., TO"L>4M=W[67RQ[IS"%$D+^8-TK*(.)\F[:
M*OD^J?)0)2'E#1:I9JU83KQD3 7O\JM3[?O+2_\%PZ]&:HB&,<B6S&]';S%O
MUNEJ_C@?=; V,EGZ2=Z.J-3,E9B0^S *Y*/N52V>Q-UL\24P\W,_,^LUT<C-
M,1BI@[WXZD4%*H*/=[H2^_&3Q^Y8*>?J[\#N'?2IG_*=[3(J9;*&1%J!L5AP
MY.\D>C,+W.<F55]H$:\#W_)0FT$D1N20U*A-L@=NUG+C2$Z"_Q8'!I!\_>ZE
M(^8K,$V0C#5/4K9L]LD?&04)EY,%5<EL9KR)@!K>VON7@MA%<I=D3VUAO6$*
MC42(IJ-Y+O4LQJ_D)83B3"VI;GQ!ZL!WRG(VOMI7:'^A;4_(F9!CV_Y^MO])
M1]70-\(X)%X[@)\M7%4*[Q5BC0G)&8>C%!)1<G4$8L3=2WCPZ\R8"D!F%!-O
M$7MJGHX[B%1ZI2=6TQW-G]W_Y#]-(5-XSQ$J ED=DI=!45F!W8J@N*?*U6EK
M0'@;A5&V-/"MO,_37_M'S'P?'Y%@X"X=0BL;GZME=IO<*^WKXN$F_+=MW8C\
MIVOXV#@B@7*--6+W'@*@(+YSP-!E\-AX1&@+0DVJ95)_9P; :J?02D!$N^=5
M36H09\2VIG JK#P_*.]T4 C!UY+N=ZUWE'V[C7\<V0-GVV[KEF+Y-%4BLI5#
MTF;&6;OE3(_I#"W6Y</QQ?ZUWV/:GK]V/U\X;Q?J&V*MMGEJ)SV^\8_+.,"Z
M@1BN:UU62&G4E&YAO!'-Q_IES#N(JNL$-&UB(891GST8OBU0>+Y!H",T;?:K
MJ,D>B,TJ\#AYX^DY]H3C;E84Z?(?4B0W-ZJ#A^FD$P"<_1$5KV=!@'L[\[IB
M,VQU1;ZI"2&H+1]OEN5/>7[3+HCS(? E&\P*HR1^E_M-?:H3/RM.](Y<J4]4
M/$;K0/Q)B2T.?]#/B3R @-LJ@5&""%:J7*<D@&P 4B/HTK^ 8*JM'F :A[.1
M+28+S)0GPS3+\"%ET\F%1#>'Q@%"B 9SP&)FW4)>I$;* ?@K).];ZF\#5L6\
M+!627RNP)5U %LH" I'2S/EV,XG94\A>U0->=VG /8MGGV@*T)QZG=X5Y(<3
M&;6)73YK)#H$4?@1EN%GGK_GT,T]\3.O,I2:-VZ*W?"=? _JN@%Y#%G!G2T#
M=,;CHFUMI>>KP(C24=+9:E%;,B[D)5CB2</TS$F-<B>?%J3!8Q=-KI<3RLPJ
M[1U+*Y@&9B83[O4Q&9=A$K?_73@[\:=PYK<[AS+]!LSW/@AYZB\KL/_2)!Z4
M+P, U'YG/5MZ'H7'-U/$@.GB[0 E?K'(>ZZO"8.HAPN4O2?6>Y@(*TTP37\.
M_ICHSE1\,[\WT[@#D.5=,M8P(>8JUQ^20SC:M)&%QSR"'"<BR?:(U!J<&E=$
MQG%0['#,*ISM%E%*[4\V'^=%:+H'OFJ_T+T4_BXWV\9PW*-"Y%4FC"T.JZZ]
MY/"2B^9RV7=MGV]YCZA" %[#JDA>MMXQMV!7JD"K^8O ]5J!@]X^YM]YUYYX
MM=[MV'FE8Z-.HV6)ZF\[J$]CE Z\+(\UFT%$K< N#>.Z(6_$I  7*<._QJV:
M:'!Y)V45"5] <NE?0FC[-UJ*NI*LC?6I8RK=E9C-PP$F!9,9G"_)^ZO*?*[T
M+QD?&T8[9(H_.E;VEIM4;10TUB6.F5G_[^6U:GDO1NQD;;0"*[Y=N4IR&@+(
M32!D<=9^ 76P^ >2&R0K\+I(O=UV[UNM9:/H='YH#"E41$#WS0[,[AS8/S=?
M)C1=U+5Q?IQY):6FC$AMX42T<*YB[WM&E^&""%K?0Q-9//Y(N).)U7L, SZ;
MO">VK;GK.'"#V,56\JED])5I?G3L%9*W@^KV&8XF0I-KD7MNEUKCM:@$&#-I
MD^;E_]D%R(",S@"+E\.J'"<.XIZ;0:)$AS-UU-REKO)^(_P-,)&D%76],OF9
MFB*69!D\TOSDI:-I8+FI5T&V /M=7HJ\Q>)$R3?Z26SDGQJ51:P6LP0$Y%?-
M-MOQ(G0DN/-O^JTM$&W'1CV5#WUV=CDK\HN=A;RH>CUJ_#HQOVI#X*+PK%PT
M8";\5.OB^?4)7$ 0/Q2UI]H:D/!@CDA=$!I[#?!K1>F ?6B1W^/ZP]B<@,:M
M40XBS8;[R]FY:X]J,H-"2[&)0UHF=W;T!\X1-O[]T7RA/M9^!7:B:^3BG+XL
MAH)S-&U)JD'>[$J%!^L_/B7@-\*)Q85PE<NJ[_ZNGFS>8_\AYNHU"@Q1Y<:6
M(%*YE=1V>++VE9C/SW.E9\'G J[&9%C$9#)!:&[BY/HN8K/RB>M/W=TN.AO<
M;GOYYJ/^KI]=JF=$,3ZR%1B9$Q;36";9*!\,*\M5J.I?@=UDI2S',$H47)D-
MX#%!R3\>7F17Y>V)=INW;D]1AE&VT_Y/I?.G AR5A/S6T:A%&>XC0K%SQ:QM
M60JIHDCH]\%1#N'F%V/!+WDQ2\]M;EZZW6,%9N@,U,D_9S4AEXO)5MT*G5P
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MV"B3N5>U^%;5Z4QR5M'I4-_ 5=(%2M,#6VUB.']>*'H]W8AXR^A;@?$#2":
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MW6/M95#A;)B$#3%,UZQZ-3TTA<^[.A) &[9DWO.><KM#7^J3V$AU@!78[!*
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M\S(WUD)V8Z;5X?@0W1R-=YUW&%I,]G,=C"G/*7(?GM0ZJB#&YP:H!&3X6NR
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M;+_<&Z[80' $4N,J96K.84XZ>8ESG[F>_<(J90?GZH9(CEQWGZ#-YN3@X.]
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M?/-I7W#T5T4<UP16E9:UU"7?\$QP1027JE-XOF__<0[BXU$":FSY9YZG99R
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M:D\@$>Z*L]!J@V\CGLZT,KZT?%=O'./L1?Q*60)HPH^0NHP"[TKND;!58(^
M]5C/"C MQO%>*#89OP+#3W:'Z"A4==.7ZD!Z<EO>S!U3HXA ]V^/X2:N&SXL
M=&+HE1<4/M-@C>NP2(;5[# /HGMMS88BD.8(XGE"M-W;H2H<#F?C<"D1E^QV
M^?#HB$<Z7BG)0-*JJ78Y+X!+S)1O9/&R;;=W6V,D@>1/8QHBUZ1\,+7%=A=8
M_'*R5OZH[,M(0)@M(R_ -J),GE4\-936B0OW>8#?_^3JR-73^BZG9E/R'37D
MB9P7]=3,P!RL9H_)0/)H_>F.#?K9&W<YMZX^.7?]W<,SVW;H/9.^D+?]V0 \
M/Z+#0PJ= .-Q1/(2,DH-=.)WM3K#V;8[4NU$U7644MOGA6?G[]2&O&B/VG^M
MIG9G''4+,V.RO;3D.,*9A/NS(<-6&>QJ"XN+M]TD?2 R:J(H3;NI>]'6S)#7
MI KR8]/TV>X>(,4CJ]U[TR!^L>C\"FP7%TUKM9HN55WR6*TDZY1LA)#' .G'
M^A+G@53!6RBC!=PV3 7*!RO28@]J>H:P8O$$$WEG43LO5='CXP,<?ZKJ+Z6,
M7YEE$_GE..Z-[!_.50-EP2/"D[T_E\XFPHR!(3$DM2+A\DY,)3S)(C4>J4AR
M*R=_;CP@TEA<SFCP>>EOZ6T&WHTH&OUJTRDNQ/'"7Z!:J&$&W[]5U&2,G!"=
M?_[2_GY#=0QA[XL?L@\0"F2BXB 6ZFKQVHUYVP"^D%P@MK3;ZC%K/>C!9AM(
MAWL;=3$!FI-Y28?+ \CF8+S))8^320DYO?7BZD-V@6*FLNXW3+=#$R&2I<3R
MH\?*=4 GB/LR*5'UBGRT"Z$ :[G+43\3B_[4,&"!EL1E2-P&JXY%_@HKH!=U
MW8V(N"?<__,@1ZM_\B6\ S72)=]H#,R+%T 6ORM);@(RQU&K KRW@_A<J564
M S"1D#/M:F5Y%)D@O2X@+NWUZQ_U<RHN%,5TEC1'=;C?YH4<^_:T<5SV-](O
M0D=\049KU)5WC>F)- L%G0C^:#4+[RO0O378^_%2OQM&=*M!T)$Y/=A:56H_
M-NZ=V7M0=6<.,WGDQRV-Q=-;5OU^!AFYU=!0^X):\DUK2DD'!ZVOBXZQ:?!\
MT*< S'5^$]?B:9]:7%"4O:>VQ[3<H Y_\5E.N&O/KC.GCFPV>L+:5P6!_UOX
M;!2?]26)ETA2 YB/+5C;L8Z"40H[]ZIH77+LBR*=Y CSQ<SND:E/@V/.[_JZ
MV8:DMI\Z=WAN0_T7%+ZAA.E0UMZ242DX@@8.J7Y[CF0'8 3M\49:M2NPQ'IE
MW>2)1X*(4R]3O%Q:QS;U/]L?&.+T4-.IT^%$O[55>/'H?./ G(5.1T$FJ@N/
ME"N7 HMAN9VOY5^T.^<2?>]EDFF ;?NY <TU1P_9+[.[V%Z>/=_1%X#Z%KMD
MO?M.::OM8P=14_)$&!@D_K.H'4[^3'LSF% T(MW=O63BU):]ZTU5GQ0CLF+_
M*GX-MK>Z5O<IYO?U\"*[SG8'GR!J?O-?7I]5V!1DT/"84Y]9)HRIF@Y3$.(E
M"*FFK+)Q*[)Y_O&RS1+[&22YQ$,Q4N>7H^T%1$93+5B5W1E"@4]?&AD=B7W*
M$;B;!7>>_WBQIVI//9V)_=F)\[5@]@=?4/BIBI#J>/%/"#:4^\K*ZT_*-=$/
M^R9[I%O[;HC69M2=\;\A,B8Y99V/Y35NO<J*_I%\6</R\9F0Y1\"-ZF*G]A.
MY-<,>6QE:W@QD<ZO+N$E^WD.AE 2GMCE$[/::2KZ0[?-9XY])&AR,2V^MP;O
M5V MM8Y:OLCWF.+8)^SL1SOWF?P8K,(E=8U,[UDC2/V"$A_JHUQ/C:X=:IJ'
M2\^)K%I3E0/T#O=;^^5_%"0?/M=77H^\6X*MO1*;7^"N;#%FV1?HU^O3WWI>
MZP.KCO7\7N"_0_^MP)ATJ2J#CQ R1*:$9$V$6KT#$"H@%^=.U2(3JG00<'=B
M5XNM@;RE(M6Y)P2] H-?G<[6Z=\YB#?_S\0\*RD+J78"^Z!@BA-\JUGGG5]#
MK2P5RG$M"H^& 1R\%,0:("M<] J3ROG%-E-SYGOAFC4SO9@/S5=@L,F-^3,,
M+%4+7XSN$-"W!QR-^71XZOY/SX;JPOS6E"T?E?@'AEE50U)5*WZH,$1B1SHA
MRZEW$-6UCZD,DG>LP)J-Q%V;)[/U *'X>2&EV8A'42;NXLX.N7UF7I*5#[5<
MP#A//*H03+CW_?)_)L&>AMU!;)2N\@-H?+\6R.V1<X)*W$D6((7'A;E/,]^>
M7C=1Z,?C;IYJU*WN-^4__.=Z34.<L]-S0?0_N1D.9SZ_-Q:P1NSD&Z,D9O*1
M]'8!*OZH80F/FR >3/ CB%SXLYS[:8*L$1QQ=V1;._O V!0G)5TP:OOA+SR_
M2C[T-L*S^0/BC?_R9RI>/Y[["@JG!>C5G 9UB<<MS C\BK;*NP2:,W)UV>;2
MP9=F+S;-V DXP_FMT4<2OTW"M^_\VR;O^T;*,.(+2[[QH\22W)(9,LO=M*AK
MYR62,V]5ZT&T-HY+\D*WU3Z+3_.+,$)E#'YN<0+&HG_M>_JQP%\[)*%?2=.L
M?!1GI1WQ[!/BP<7C>G@1E=^0VH:*1FB050+"G@TF0\(4Q(_38I=CW_HH66EQ
MG%-32 =?$V_,7V)$\N(-:]]&77XZ/;;MOUC'5Z>>1-^B=W"_2.0;R@"6V%;V
MDJ0A.0X2QC&I))]2HND(VW*P46_(&LF?4;9<(KGP;7#-H<IW0ZY-3!_&$<J<
M0C<\5OEY0AOYWR><N#P1UCE8V3\8'(%VR'"+-4$[L_IN9A[8QG>:\<![7W;]
M[3'NX504J B#:X#7)3:4I@VV:O(NC$[C5BF^I]%:>EJTN01H9]?Z)=TVMT&U
MD+6K^I:<D@\.]_;."0;M@I0.9;1T;#AD=AU3;_X_WVA7$!0*PR&@@R)4F"SZ
MP:;I2D,E)TFG>T)0JB.3F8$T?H-1"UFGID=J\<I?V[F ZI,W=6_L;*#G>J)I
MR#$J5=FVL!CS58@Y%B!_)O](83"C5F"^B(=0;C2N)FI/S%_L)BD4>D.Y<GOZ
MP,B)XAE.>=EK+BYSC%G4[E^R:33 LSH_].[WG2'5CUY6)G.,B9T1J_Z8HB[A
M#XF"]*BL0:Y#1+_7.R+:S.#5S:\GUEB[\>>UP/L?48T#LU*AZ:^S Y6N49<0
M?NE.@]=K&._JCU_"5/LO7^TP_*)WA#P!I=^^%=@U"FC BF5=0^E!@L)6 1P=
M3]7!9ML I7HZ(JUHDL/+R?O:5]AM+U[;%?N'+89JWVSFASAOM2SS"=CN&#CH
M*2Y(161V.VV.$[*@@<J492'Q93?!7V@\@1_*'L<3L"$BK?<]4[/RW4Q&W.S@
M0>)0"R=:N1!,F,6WWO&<OM"5AYO!$?RNFU:99OGA?1'3!EM629O\:0">$&>R
MM([:2JL2,U]/G7@4;J+.2TZ-6UJ/.>BTKG]>OA?,''9OW;9&=^?[)Z7Y'I=;
MN>^X%6:S#A*DO'5,J=]Z)V#7XI9!]=[QM&V\S?:P2/-E"%V;^/FG<Z+_;<,A
M"Y3A8*\.3O]=K>51RX1"K+;&WY"M<>7<= O]-:2%1/<<1YB1OR J,"UF(TZ\
MZA+ 39 ^HZGMU59<"*8>%VG%%59'>0/TQ,KX.7Y?2*<Y%^W]Y?/I,GE.08"F
M6T8%.SQOVDW<TY#?G_%+S(H64P!\:$PZ)G$"(I2ZH3G2?E.[KEP/J69?:<CO
M_6)>DU;"+3"K"-O]E?H[9@0\3XR4%G2D=F'Z.B%'9KL//,%#(:0&+-!(I.B0
MVJX'&ZS?B>>Q5+"9/]4-:_+1P^CAA+FY_>O^SN!D2_Q#-ECH'O@RBEW^]P)W
MJL+CZ\A(A];/T?$NT'*</U@B2/KX/W>:5"&2K#7XV^8\<01E8@G__O-QF7>;
M5OJ#RE2V-B6E7D%)="KF%?/I>$O%^:+=N(3 / ]]ZC(&"AE-:PUHHO^244D;
M)4CI)= N'XQBU\:E-IKZU^I%"9 I1[]7IQ41<^U[@PE:1$*;&E9/$5AH(>00
M@QS[Y^LM<,K+$Q+/^D2_E!685T,UDU')%,._*,HW!O',OL#;$"K6&#X\$5**
MCX)$:UK"_&+G]TL=<_TY-[5)VK>*.'FAEKW8P%ZG_14'$WHOOC'ZQ+(@YT*S
M]0^-296J,7A&PN&(0F(7IK^*%4O1JGQA.72J&DSE.X4[K<"$$6J]#_*K>NN]
M^'4_(KLPB:U>7LJ6\K%?9P:%=BUXPY*@?$Y3 ?V'0PL2M)3P V,$X7@G 4MH
M#%FT^$:MZNQMW!8]=3"H4&I>U^C^XH703&KW8!P3KR9+^?;@+DKVHF"*^<KL
MV.S0X$_'+8,KL-YG6U:!#J)Y^08MR4&2EP@041[57Q>@'F6J@806/432>[)"
MMSE:MGZO]>$\]&1"25*RMU^_X8 %[M@QQZ6ZCS7EA!"\!\&BS'YNWJ6?'N@K
M.Y\E#DN]*$NW0 R[>8L^UY0-3[-@2Y2'5*[*7.EM:BO5\WPQ[Q@+!E?[ZF%<
M]7CYVU%\L[=SPR<KILB<H6)(BM ]#2/O([=S@=.$&$@$_A*NX=$Y"BT4;6GX
MN*Y/T_VQO=55@+B&#T&4.Y99(J!MG/%6?X=+*E&PNIB%C@A OSMU+2YS0X_<
MW@?C+Q^CO+6*81',HO6V@R<$7)T9^>H^TA&1D0.8MOXMOQ-YOI]>3JBD*!%;
M6E2G*IJ**]YG,$Z,*V85/H?_R_!XGVCI:!!1!;4HB-)DR^+]*U>$M%S$L/0*
M PAMI6PAG<0D,FV5:OH1K;6NZ?G53\>4DMBJ:)-_>H>C!8O$5T%':.L/X^#4
M%_.IW9*9&5W3MI\N_?^+O?<,:VKKVD:CB*B(D2X@1 5$I<1"V5*2K6Q 1(P5
MA C9B HA(AL1B1"2;8%0!!05%(0(B("42 E=(GTK(IT(""'!0@NLI1"6I)W%
M\YWSYWG?Z_PZY_N^]YSWNC)SP8^L-<L8][CO-<>:8][TNL#J.*NZH=]"<28F
MT.3*E<#M$?%U'1UU]$1%//Z<?G)$?.R7(SY1>LZZ)SVB7DEANQC/(0"N2&A7
M4!MZN&["+TZZCHS'@_2WW)BQ'=V+Q3O?80Y QLUINU(F&L<T<)O?Y4/VK7H'
MN]-V/0=M/3]L4'6I3OMJ(N5LQ6T5=NU5X%4)3A= 2+Z[P ]L/@LIYXYVC1.V
M4OS T/;F4>NA-;T!I:2QG34B@S2+%\I9\3B.A?%3,[%=;M$%DNE^$:[OF7GW
M/NRDLFB;>&VIY(D,<3GH#DKNRL2MJQ3Y\02SCI8#(^K^:/&E_%@+ML[T VO)
M9"A68SJ\<U;+;W>0[<F;B9OWB5<."""N/&"FA )W^%U1;'_4\/OYIHY\LMP)
M>@L**86-^ Q.N8**?OVH(8F/TR'=$,[DK!/;7'] \M1+X(D$9[P"@*G4X90"
MTEI&2/8TH>_2OQ[(_872L%WE!_KR_%K846G162$O/E&.0K0)-((04'G2P>[;
M4[\)]*9I;]V:?M/MSV(NUY313T4\V?$DYD6*N?.F)A(X(?2$^Z8KWB-)D6(H
M!Z%?SRG7H#O\# +O8VY!@)LG;#;<31Y3M0^GO5$#8@SH=7[HR-7L(UD#7ZKM
MUQET;-C]2ZMP2?M_'&%7&.E[J6#(FUC[.*,D*R] HTK#2J@Y"'H-$3R\6@ O
MCS'/C\F'0D@A:Y+M@X/,@]1Z;-IW[#^P6TK&'(3GI@XE)PZ;4,*U,.2IEN3T
M\>CX5Y]9$V3C,\!YE)JYJ9Z'MU,FIYD3 K4WIHUFIOYT$N)=\:<X5TV/OL]>
M/J*WSI26G;9+#N@3AL$#4J2^9Z^[SE!^!]J<YS3801TM>FJ@0E0QBZE,M,1L
M!:JBDF(J\)T:WULP6X"SQ7/E7\G)[XVG2JY'XKQ!9,RFV$C=S-R<5I_"(?RT
M,TND3VO4@.$518D _-J9<M)N@G+H&WP3L7AHE!QV%OA.-ZU(4B;J;>M!+[C:
M'^W_4IXJ6*V4^HYV%8SVM]#1T<D]!9A2/\&HF,Y>*4V]<^DV;?PY%\B7(7C[
MH(=\)IW]K[\QTH\RQ%T_YUX+G( &X=@\19'?"(VE14F:E2&@PP)JYQ>_3E%@
M>WJ2F?4B"I81:*!]=C<0Y Y9\;#:,V,V?1:T&&U.TI=!BD/>U'+@@E7:8"PO
M0\7+SG1AD'2C\C9Z8Z/MM=*?GBX%9Z/[CXH<8<'6(?PHN=L@)_W<H% &Y+6.
M[EGN\ )^CIXG&_&-HKY4E(*,NU=+NDT_6,+1.+6R-CJ6VO-VF$E?="%E6"\^
MO_W-L+Q?<"54!]<Z*B=5*@7.5L69SHE/BCR@' _@@K>S(8>^@+IK[1XM=L5D
M>MVS? W!>I2/C+M>1ZIP+33]">WYIG7N0.[=5;>-%K@P\AC\ZRVQ+=1.E&9%
M5Q1&%\#&U;L"N";N!HIA)"_=5+]I^?C#DL]0FNCTP+=!"ZP&.<^38V"=6,AW
M=;QYRKANZ,M?IL7%)L6G.,?+RLHJ)5:2E ;$I Q1QGV+I6,1"\C- =Y[>C%;
MIVI3TB\QIX65E9XIN7JY?"5""])T@/6 ="YS-^NF:?_AHQ5_Y3">/G%G]_SK
M$;/>=M$1\5J +C@(6/%Q;Y.VU@/D$+X5/;?G6W_@CML1 M535355 ^;(S9\<
MKA4'&:Z4_YQ1LO(LC_/YZA+LN_74 YU29@=A""M=%P&X"#TA<#PI:3/%;243
MT9TGKLW,>DX.:0E'T1<DNJ%UHSN7G,L&S2Z^WG_>!7,/_;7??+*M->E,]/O9
MAL"S*.&W.(0Q'SEB+%T/BGZC?@['/%5H0R&GW3!F@"!C("F*:DBV7-;5;!M6
MS^U[RCUNY:Z1%OVT>)(;L'/:3K]%V[N 2 PV_;S\9]\<LV1NIX@:AY#^:8&"
M+,N;>Z>)9@]$?Y(LK?<^.):BG?16I.M^VC^JY=X_::RJ5B^] 0/+E[O<W'HN
MGJUV-CN&VQI/U)Q$S_K!!.2BY GM8I+&%%9UGDFQ!_/X;/K<!!OHBK,EJ;_,
M> ZYG(C3WQJ>%RW6RJU(.3D-VKRS*\EC3NOMJ.W]CB<5:U5TS/B090CFF1,*
MZ91+4) O^)"GT$JXJYV9&YI#9*M3=<C?>0U91>>:E5J%#WTG&!L#,K?4]1>-
M5^]87U+TYX!!;57TM>W)_@\,MFL5_@@38F S,J:@)4DPULI3NS$Z$&>"NV5&
M3[$2=&4QZ:PN)!3>[/J&H ;A/(&,YO->YP[6WAL>F3DUVJ2_QK;;,>G' 6U)
MX?]Y$J88YHFW;\,@=5"\4MAB33ETUF\"%2/=!86S-Y10_$+RV-$5Q49G CWJ
M_32C^#7XQE?[8^3O _5KY=8>BYX..J"CBLTQ/Z'02'AM-*O.0WW2?)MY$#"Z
M:QO)QZ*&R=];*\=,Z]C@SO27Q%0-*XUANY+$RA20>*_'6=$AH%S+ //G@_>W
M*C:(!N-VR3T"NVY1=, #39Y+?TNW0;Y_@(P[MK@+RT$QM@?X=M8C9WM8)*/K
MCU9>?M[ZX& T.:N6]61/%_&F_)NO1?='#VTL@.3 5*E2#Z3 %US]Z0:9@E7M
M- 63H,O)-,BQWI[7@8H;WOGD8L9YS\ER5R9DU++OD\-:Z$*2)X<U ^J;]$Z?
MWK.%L+P;9IZ9N%LHX.K\K&0<K3Q,DB&V8M!D]@0K,^-ZJIM4I<_6"MG$4)P^
MO'_#,!1S#F*TZ1FR608:Y 6:*CGTBXV;LS?*4HOV'(TDA_T.)$:](!.:ALT>
M\[J4(-KQBEYS4SG[UZS>A4C4T==1IK,5@@/'R^)T7(R-C^@?"104\Q-WY9S]
MX_>UQI=A#',1_I#\356C<C$(@!N%V4;2AF'4UFG<Z_2) ;'B!$/)\'&G--ZR
M-"B05#Q5M>R=HS,<L*Q1JIN882%([LSSCN\T=JUF#9@F&S]!8_=@-M$:ZV$"
MY0<2&@G*+,9P<XNW?I\8R1]5;-.^2L^B;.^C&+[JI/'>!'1Y]F:GM[C+$)O%
M/@&EZXNR$P4Y0/?-6WYWAY_MDC[8]1QYEWT5"QE5O66/M#>E.::"^^WPS9D6
MP"//VV0=OGN4]QA:F1P9JK^F*AP>U.?31.EV0##:65R_9(W)T>Y0+.J='$Y,
M" L+#45_48AFCX^@Y3S)*3IL3>F@WAY._;:'*8Q#P'R3JU%3PXXT;J?CN=.M
MGDE)]80\>Z-'>E;/H,,G/G;L:=YBKRI#N#XZH<!K;\="VZIF&>!A)%V#@+1@
MJE"098#"W9= +A_RQ?51#M$FZ)'>/SUPRA#[+.>B56UJK/S'7-K&VGO)E@*[
M6?/"<T4+&2B7URS)0<E#K!\<M2X1_LY4@!2)$QDA?+V'XVL&31:PRN3$MO?-
M[MJ.><73VJ.5CVUO;!+.K[V__&A0.^*VMIVUCHM7EFEO0^+*UA)& ?8KN09E
MRF;H'5 ^L?,Q*.)C:@K$)M M'A8UM6R9Q6-LQ'^:KLI4'9QEU45B?O"'[8.5
M6)\K7=;T-FTLT"G?9B)/_=4#"_%X/A8VGC;MM>4\@OIDFGLL[!&FEC\=.?78
MDG/X@#1,^8OIS78LX?^U:7 I+,C@_F?\>0>#4VVS)2^TA^'^,(*2L$"0U>P(
MJ.C=3SD$ZTQ: E4NXSAOCM#T<TJ#K5JO_M+F6;VG>G1N$>37JG'CX\@+D9T,
M<2_4GW=YW[ B_FS<,'8W@!7K! (CQ_N+_: $T2FHKW7X3!C1<) Q#HN]</3?
M5^>N#+I<CCC3SZ)IBO]('/;0=ZGN[.[[NL'OUN!G'3\\<PH&90 WQ!%>@%"B
MW>3UF*V4]<#.C''&)KOWT]I%]SO#\F>H^@/B& $<[)V9 2&CT[4?<PQ.[M$?
M];)X\VC5E84.DLXZ'BO);X+[EA#%K6AOZE(1;X6:>?^(7<>3U!R"A'4G;2L]
MHQDT7VNOJ?#!V((1]=I>5H;9CUUS)O.F(QO75*8&>Q&7W%/"]%H=$+1]TFTR
MQ)TKMEHA_/57*<8B3W*Z U#HK;6C)Q1V-FU";"@TJ]08'" U[)-N)Y_&I<QZ
MJM\1-#<]:+FZJE:$N">Y'TD,@>.$MN1^ZK@\IU&@?Q(,9"0LHE163C9/:H\\
M:F?D 8IP6<T%>$OZ2X\W;U)BL\ENRR/N;)<,3=?*6*:1UWZ1QYO!H HO,_Z(
M\$<<0@Q/YFT:K=&:@H4O+$,D\2_1[TC1Y':^QAW05&QU,R(;EKT]"S.!*'=@
M>+J[]=54,C'Y@,ER5&;18%J<M: ZL?VXR5#%H;/L0!ID2)]])[H:8-3F?:",
M8RL/7K:S5-J/CAU;75U1,6!AC#<<RL.3RQW[38/,":J-OGJF6;698UV$Q,9M
M?<6+,Q$Z>#R9=A3V^*\P5VMDA1L)&6G8*W8G_(=0DPKC9[/ZP2_R^B*\5.,3
MZUW-A[<RQ(7@M:8Q^Y$LU$#2IX?2]5XB<VJ+=9)X9^;F2@YF&^5\<MN2*RU.
M[V#F6*"+2]^BNC+A'!EGWY=5V6-K)3_Z6F31.?L7@7R;/TSJT&)Q^M [7V-S
M81?OY+(XLZ/95 ZAO*L%-?2]A6HX0-F>0SD$KQ).D+FCQ]04S;*SD2ICMY))
M;4)8SK :C$GHX;EZ"_E[8T0=T[E+#[#D6((FM1$+.,_3V:_=6['JXM- 4BM#
M"UJ6(5H)R'G*JN!<<M(?/>8C-BXV7&5R4(MKOKWE$\&!SR_&=&X/70C^NJ7D
MTK6P;/<9=;557QAZ#2I$KEZ#(N4$A"Z<7JI=FPK:-V*V :Y2ULM&^4YI*HFO
MN+YH9T-Y5>V.,5+\]2?OU$*4=?:N@I@?T)_8TG4]0)=P+S2?30D#VMMHNN0^
MMQYSK(I_L+^U\!9/@CV>B58A7IL*Z3+\F"FX5H9WVIUB>)+U69Z6PKZ\Z_GJ
ME82V?Y(@4\;LUQ#PIU /I+[)&K%KCZ>NGJZ4(;2NY_-BZCF9J.Y9"R6K]LJ-
MTUH3E7>:M%_F\OW..!+G;??YK-^74Q\/T,4Z46 "6BPGLA>O;F@X&<QCJD$A
M_"JZR>4GYGV?R.7',.K@Z:&6#UZFYG7<#9#'W-G#3:G>VQ(=] (_?.#V?EU\
MG)EWZ>;+:<L4SC(UBQ1\*=+WYL8PR]24L&!;3;=4MY_&K7:L%A7; \U[S*^U
MS"86%1V27FQ8M<(ZL"3VIQ#IA@L,5>DJ,3JU#>:SU%(^K)21 =:=[!8D7?OL
M*+T)&7-A.!+GV'\=I0IQG,'+63>!<G=K:J[<\%3J:7*J=/.,8KR][?*SRGU_
MTXZP-S?H0?I\]NUZ)V"&[Q1MGJ1%1K4.7TG#Q=1;E'@6CZ6_.O?/U)X7I<E,
M-2%GWZ&;OA&!!E:UH9(W)5D^P8$1@4&VM'\88O73TO6J $UH!SG11(?%*(@^
ML2_KO/A0#\62O='6W<^GQ/[E(7Z2P"7&_0AX[\!4;=JGR:;V66'E\L?TD@#W
M&YVHD=""JSDITQ,BO2+<9K)?,]6D#QX>Y31/HMI2Z\[0[1(&Q9@7*OGA1,>V
MW[5"^?8'S@760W>J$PGH#_=LY'VJO\@!BM+UOV (<).DFC-7BY4D.=3=TQA#
MJ(=/TZ1@ <T6$5:>G,)U[J-N(5I)38&/J?P($CQ[&_'XL0"]7=8&PW&'M@PN
M3IG;'1NY64NGZQVD=J 6=JN=Q+>J;7;8NM=>VV'COAWM:B<=L_3C=G7O<=KJ
MGZ6\6?[LJC,(1'Y14='"B(VKS?&*RM=]LZ;/RTI+RVX;XVV,;<XE*Y)<7/Q5
M?C,5%(\G;+^][N2.:(,C$PX."(_GR,9Y%+RRZS JD$AX!V0*Y&^"W_EFC"*8
MIAK%8O9[D<-'FJG:J<?*^L5.$R2N#BX'/^JRK3:Y;7@:++I0?5^17N7PH/V)
M*Y4E[2,@Q =$)\0*T$- M4V3D^9]"T3]03]:,U !F<X%5<37*9W&<<PCO3^.
MS>H02ZZ_\3O:M[C.-WW=#_RKE/-S>@)8=Z&H[[F />,.K6RIO8O.UBNBP@[7
MGI;:G"YP/]-;?X YJ:?[NO?JHHU [FR/"=.LQ$2K9&#AYJ+%H,E=?$C^N>%?
M=UL,'$410J&$3MDM"A>; 'E-79ID6&"O>@TP6Q31J)'IAJU]%:-'?\S]Z&AN
M, "FIW[:%Y0UI70A8XUJB"=^9>/][RLE+B[IJJT"D+/RHE5D>Z$<0&]!KB/;
M\Q5B,=OPE-_!G4_Y+AU=*L0T[Z<8!N9I;F5*RF#/U)6>#K72JK1Y,]WS@2A3
MJAD\L^TRA/:VY._"4$GF%3/]FX(<$-6&5<-?'34POD9HS%3XZ]5?F7_2V\?\
M[U_=8_K4LB!0AAB0I^WER!" Z_QPNY -QY9G 3)$A:;@$O"$K"G\JQ0DD;2]
M4G(GN-&9NR)#WK*1#@T9P'<>T%VO,X':/'W#J36[M\,-I U?"32'!'/B<]@*
MU;/UKUU>(_L9D('?+"Q#RVFS!P"&8_]L6D>K#*'Z9_J$4\*%!QM/MQ>2I7VX
MZAZ3N>T^W_"C4YBUI4!*$BUP-U<CUR>BYL)E_X<+36DQ#[+;M5_MV).]8]>9
M/TZHGSW[^X97B W/$0C$Q@VA_[](]/KO]C^W_7L)BH8OS&CI/MH[1U!3TH1=
M:'UY0J&&@I A'EB=EB%*TW[",L/3(N(Q.>@M\I=J*%:DQ<0N#.2XU_QK]^Z_
MVW_11E 27Y ADA/X:-%=VE3\,6;-OU<K>;1JCO ?7-];Y]_PX0QBY77H_XEM
MU2\=&4)^%PSE392U\'=(5S9D?!:8*P;I$_28BOSZ0WEB8^ ;,XCWR9RVZ;S+
MS<!+3')?ZU+XU?) WHCKJ;FVZ9&CI64]+,&UV4.&7])<*Y]T$W#B)>I[&G"-
MT,JELU4Q>P((%=Q;8B<PB<=L2=+3C6@<]K[##]I(U.YZ2UCO^FK&W95'4!Q"
MKIDZ0?FCJJ(/)M^X:)P*2;KU38VTB97I>E2SKO;T3YR@AH^5(\M)%;LF"!K2
M3YX*8@/V.G/"L YOL'3"U?A<+].BV&R"]QO O,OFJ=;7=WN.G$QMR=S:(S:_
M;F=_%I 4/U[ ;"OM"U72T%%,JM2QE*SD)(5)V]CE[F*U1!ID['Z+<@JHNL5B
MC!@[@5U-A%B8/Q;;8C5CQ.AL+_(27UB>-XU%LEP)#@,F%:-&K9GJRD3-%.Y0
MKX?79!B84J&ID:(R@J"Y8U=1K<7[)+E29<AH@M;(53G$9](SL;WN;MVL(P^>
M5\<F$P,M=(W<2N__6KY<DS5]8RG<L2KW\RH,HV!HU//=PRV7%]Z0/'O$!W.F
M&[:#FPKS_#TW1>5YSVB/515YCQ!KCS]X,579ZQU@G9F7/^:LE!O-\"5NY+BG
MIIYV" H,4GOHNL/Q7O,7YJ<(X7;(7;2:LHT-&0(A+5P5L<OXC RQ)<#;:K\8
MQUG ;@X0IGTL?>F_[)VCQ\#<XM'6?_(@5NV;O)$:Z+,V[75)EL4B/S#Y1R#W
M0Y)@:B()VH,5J_4)&R&N2$&,[&6:!PVQ>7FM7KBWWMOZZVU>3$LW0;Z6&<\_
MC^#T6& 7_Z+@U;NB3E*5Z#A*GABV6O<4B>1105@5,#R0\>+]JF4KT4JY,5J]
MCNB8=!2C+7F T:-^7%*!=-IHFVTOP=IU@_A&#51%'S3'*?IG&@P647Q0S;Y
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MSV^SM1$IDATY$U9M&3:.H)7 =T)I5WSZW1\6K@?&2VX5C,A7 ^Y1Z+/?*NI
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M'/'VDNE:-<VP9;M,!I%O@U/UZ-J9NK;P9<!P9OE/;GL7=-!^'-V"'$*VC6D
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M!#HUIWDDMA]Y'6>SQ"FY>C?EI'_8N-X#6".PJ7W>^T'L72F&^GYLUZ#A .4
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M)5[UG*BGWUL2ZH59.MJ?5SI@:JI?6Y4B<NUGSE[U/JC62;H9K)B<_!KKT>.
MH-2 )*&!Y'Z#+;D6AQ)?EJ1CE"BN8,5P:,I#;)S8;]Q4[CPGK^]ZSXXI89AV
MQM=GJ:>;+R;7NW68)_K0K^SZXV1;_"Q6L4%5; $9CG=:\3A-6#DHB-?U]\)-
MYIPYK$&=CE7UU&-?NK[R[BH(P/GD#IO<J&1<[;]Z-:@D9=V$!]/LJIG7L;ZC
M@LDS_^MS"OXKM/^M\QY6C=-8?G'UN''"4)@P&63?OE1-;Z-N@A1 >JNW<MJ
MN"Z_'L>;IV?N&%A8'_BB<2A8K]#/'VC8-+2Z\C?FSV)('D@?M[I'\V5O$;N
M%JU),6Q_95&@]",;:=C#LO.\W%_!O:-GVEN/HY5,5RY[3J\W7- S!VU5B.&#
MY7:/^LY9T:^8FH8JGB[R;@V3/@F/9OB^^N0]%9Z;49+S,L MU9J:D\<]I#[P
M>#'A"SHHS.]FH'6]E665VP]G^195_5;SX^ _1?<.21&T\4(4X(2.P;[&QJ9.
MM#<25#VAU'&%>,RNR3$4=//EH8APACI%CC^_^8VPG,=>_WEJQE\?5,\M'GP8
M3.*QE:<TRP/"L+XL5]^C90W[O+A_TQRQKXW$RLD_A1LDKZ5&U&XI EK6X1G%
MS]:'\%P5QH]1D0-H,Q\ ';-8YQ76-'RU;D+BU':PMK]>.31W:C>1(E7O+UG\
M;4>=,TO1 VWVLAI@0*8TL5J2\"GD"EHUK1SW-J3Z-KQ.3(#F@27[02S/EQS@
M4NS;?L<%A.$/N8'6M!T8::YT6U41I/(Q4Z.NNA;LKXUJ_4C/\W8)SO&87,Y]
MIF?8)PZ1KLN#P]-MR7/,/O$-PB>Z\'UU#6B4Q+)!JCD!$_RUK"Q['D,/3TY_
MF^8U5LJD'(3HN1Y3:5[%7]^3PQPXBXJF5.G[YA:WY9>QP2]FNIC>,VY5UGX+
MWQ@;I#I.X(Z9B<T .BJ=7\R-6H#E=P>HXJ71%K3%Z*YYW>CIDV5 9PG;')T_
MY!\\K?TQ+\(L_9+=F^*!@3Y<F-H/)T7'5>+]M,8&[\T@LID+[6''U<OQ1ZY7
M@(1;4BU*"$"/+=:ONRVU(6R&2"W::^.+\>V1)(-!3L&FW$LAVJ,CG2::&[+]
M+Y)'S\D0$19BV%\:4>RO-C064A*-O8*6>$X11G(1E':1-_4=0Y$62+L=WO46
M>\]=SY@%6-8401'GWZ0VIK$R8TOBN4H!)Z=K_[IS@MW+2B>/DYX\.M\VN*FW
M]9'3O8SF7S\DI7 \BF$#+K1/7&$@E">RAR;.2[*-2@%-NE]U]X(6QIA\_.-$
MJW1__[H^,8JGN%Z'U_R/F>TAYF</CR[;S9\QZ7DZD@O^VGW':RY)7_WKY.P[
M"1@S<NH$H9TYA)2NYP!S7[_TBT_R<4KD[RV6,08IPS_;9 B5^D,A )MW-J/)
M@?ZSPN4@A9 _>EANO@(\SMC[J>?V[^:T\>&@3\?G'7O$9T44,B^HZ!MX-B^F
M09VBUA-B^B:7$RU8M#$ OR?..>U<-BX..P*K,IMFL"+;AFB.4_\\BO]LUY84
M&AB-'7\@0U2P!7385@*@*O".<!YRY1>BAGP]P; 6M"HYXF0%]'!<5&WK,8[=
M2*B*EBI2[*PRY<'*7#Y[W1"7?%573X9PKZJL[&;E%RT(CLNGV_<OG@M=1WN5
M!,?R#;;&@!$/U8R[HZ=0J9&I N'':1LAU=_O91OT$:7:O8'7\YE!&_P^]H>J
M7AF.SKL^^],[0-/*ZO0[DY_.^M<8<,>V X5"%\AT(B@)I17ZM;M>=3SCM\_O
M']R\-J.W;6!N/=T!8$87&:2H%D!)+58"#4;NT/H=,<[Z8X3/'L245,[@6U2S
M#"'6( @]5NK>KNF6L&A^C"W2]LT!#*4Q&:*9BH+JLB%'4QH!U"=CVZD;P,[.
M-XF%V0&9!OV+C,V6CYF=+X?>FR<X2J6[T+,L_V(#+[,Y[M$^&>(&;!IL5#E:
MT"CR$IM#<@!7>!YR+X*6WH9C:OA=NA2?ONOS.F3%YEYFS/-R8.X!\.UCH%&+
MU!20R! Q:S,V%4ZDQSH^]GLU/-QAROK\;?1YG*?82Y)LJPXF215A.2Q_*%WX
M"&KFU01B5E/V#%*P?)0&\6T7-MK6=!R]WGMT&KN1*D],NW-HPW0M(VXQV((3
M.X1IMEN,XB913FL3?W;ZY+V3<+L5?OB*KM$:5=B^24/MTO5A$\A8:RNZQ:B.
M\#YD \PW8= <J0F7W-&JV0NQ6WNGJ:A2T(^^2%CWF50.:7?9#QKUSYLSD2/^
MGH:)63FX30F_#;"<HRN&98@WM$:YAFUD=AL-< Y*6%:(+9E'5S"CI#80.!XD
MYWQ=U-O1Q*$IB@TGABK23W'K+869N\"JF#F.84Z2Z _\X<; #R=7CE"5;U[)
M-R!Q64LMG6CI^F;1]A$N)&HNA;6J8W?#]@",BGW!9XHW5)PWW=.:3;$!7E>9
MI#:H V$QOM$SI_J7)*F>8.1=3<M>^VSH O?,H R1Q1Q2$-J^ED33QI\E 3JA
M&=Q[)@WJ\/5:&>H6\5K:)"\_/BVN'AT9R7]:?%7K@L@M/:<,MA#[VKUXY]#G
MY(BCU=6W;0J,_E'X>5*&6-L#_6R4(10;#*C#!&5XQ'>. WFW;94!N4,@-J[>
MJ?"8Z8) Q[Y'?#HD(I_P^5WTM=<C35^WQQI45S_*?5-QJLLDF-V%W;(B[FB-
MU)4=F6&G6PTZS040:9P3E<M^#9SQ?*;2E4-!06B__&&C6*H15/EQ?6\O00MJ
M^*.TIN9UXM3._M#T)$5(@W,ZN=FY<D!?' OI7@([^&:E5K-#@)VM?=$TN\*Q
M:B7S:QJS%@#/?0%;VZ(*.XK($<<'C7ZM]M>VS.<"R=.N$2%!69]H%P_QE7SX
M],-Q<WW"5.GZW2"[C0NX$*#=80FT2[AA97,98I,_2J7>V0_0YT=UG*\2FB5,
M&.M,E<#2YH^^4)N."(74IMK<L<I*X7*&.#PPAWR@O9-/@K9'6J[S14A':)>Y
M0QQ>V&PN0'C+78W9-.F<1=9_6WOJW/"\,J:@>/JT*J:<3U/V;E73/P5JQK T
M&:<'YN^=?)%Z^DEQ5F59]. @,H3Y 1F'JN"TPHJ*X@#FT2LBP]N4T(Z@7D$>
M$7CW?/)GO5M*U2F'#>9]'O5E9=E_>SOZ72UR_E:-A4BT1.S"?B(7.NY/$]\A
M?#?:+.U'Y; W@FMO-M^,/L1G':,AOVME.B<61/$:M NB,@_L:1M\>\$ONN#T
MO<G^@L-G\X^?\3N5L/L]PR3WN JE<.F#0D]'TH&MFQ3W9B7PGG2W^^R%WN\K
M?')9.;_@0G[3&XM3^][[;>D\3'1UO';4_>@I3S:GUOB'JE2;.Y$DV9@6)E5-
M0\D0VWID"*4@L%T:[6HC0ZSOA"W_/@G&^KB22!WL9"88(4,H)\(">9*[7/Z#
M31"[6,5@%U!-7"CX _O71^J;'L)]!@ ;]U;:Y,4^-O"L6X;XM3;IWP;K)#X;
M,CDD0_RQ%,^%[OT%2U1'&6* \;@+2@G:3)M<.3]TXBGMYS-)1#9[.Y97+/U-
MANA^ET?C'<R2(7XHH?Z3&[SZWE,NC9W79(-;>#1I@@Q1B#5F@"9CV^!?TA1I
MO/;],L3W@\M+#M3#M&:\.!AVOX?'98BF$'L9XHOV?W(/\&Q7CI]$=0Q-X^^#
M];)$1X9PH[IC^1[UAV2(YU(-&)83+\D0'T,6Y^+$=V6(Z"IH0H:PWYD!![%O
M<*3ZQV*:)H_UER'B]<RA'!YJ(_G.^;+:GD52QS]!Q?R5%!V#1%TSZ=3JS_AA
M)_.+KFNN'+OZXN\SSU20/7_1!9;+F&"FQE_LM5^UD''7R[U-^28/HZ^]KY[3
MY=7^MN=F=.13GVM%ZL<N!=A>BBEV4=QXW.Q9J?INGYG^J"T?STP.)-\S;$R3
MZ$(SNSH.;!U13^ 5^)35KSVPK\4Q$;LW@WBBT6?Z LGQD=^COKNO:J^_*&@[
MNUW+-7=WJY7A,DRLW9<-J)O^5Z> _%=J_YNGJ^@A12==P3B., 0:H8GLQN)1
MB=KNS3A-$F'#IRGMRV^$7)W)6KN/Q<_]<XX,!I8L= R"\HO/PE4,O]8_:!N.
M>2)/[N% [F"86+V.CQ2<%AD-4]0D)?6A87Q:@IZ&I *S@>(-M-_["@1%4TQS
MW@%,ASZ6':I53Z^>!6#HS_UK0[_?6?35*U?\/-DS%E"9N9W]$UV2U]MR5GI7
M70P[?Z,/'&X2: IB$BE+'"EYBEE/^?WA!#:):DU&.4.Y/-Q=9><P'DPVUD+W
M P03C!A-S ;ZD?X+W:%XYRL+HO11/_N'SKT&;'9M/ZL8?;(_='W),SD^<ZBC
M=4SS7Z5J^86,857A];Z2D@8D>0]_OEW[^[WB69;2]E "$E(<SV4V=4''@DQ"
MUQ67%(V#58ESYJX[FSZ2;'1F.O7/5#7T%UUH"/2@"PL).Z3_H%ZWS_:(-I*-
M3@*X6<'XNOI]J!BS0&:]%S_#33K?HF<)/EY\A%-Z)-T![LS^X>4:Z+OU88:-
M0U_?<4"8:CHJ:7OZPO/\M.==#L'KA (((^D:.-@^$DC[L<(MDM?L15(N[1RV
M,D_P &@7JD"Z-%#$_Q8UT:5,ML&!1O1ZM&4Z,'$,D#+YE_MM78(M6/=Z/*#T
M5KW-O<,?C6YU?DXJ>@%FG5:J__)8SPY 2=<'BW9)/V(KF/=D"!(R.MPIT92*
M)O^8:*_";*L?M/6[6>B_WP74Q^MM _>QNK]6)BI>2CVYJJCI/?<B?<FY.N1\
ME5AC+6HH'/<)SX]L%Y!"2O*:$_9'*.&;T]RC@Q:5;+Q ;*NI==^96BB"%XF9
M.%Y9'?K08_ $_@/G,N?8[7Y<6 '!8PC?:8V(=!%MHPX0D+1 PM!*YD=%6%.G
M3ENXPBUQ: @_W4O_*'0KSS_</4[P DB-6V0J3+OF?X+"6KSW]&YW7K3;,!>A
M&ECB;9ZR'^]B/7+>MO*U#+&'N\F5*["3(10LH3PWSEW-6JO&KI@&:V5/\W3>
MZPI( <A>:O36MO2'1FRI=GW7$ZY^,U>XM+#TDWDP6+*.UJC;H$AN'T>*5<.$
M%Z!04,&Q#I A[O4U>^\!4VJRI_>Z^A40_?BX%JRF^'"ON>14&^_>,+7 AS>O
M2M3P?'SWW1IAZN#2YE%\X_7REC?NC5W03MQL%7! F _=$ETD:QX#R\2!T--7
M8L=!RND"$F9OS8"Y5I!T]\P\'Z?A[/O\39';X'K+7/WX=<_O&T851J9LOL#_
M&WMH1OP+.U[#J'J\) @279@FK%F85_.>0I4S9K_R9]CTY6M$'Q;>CM0V'/H3
M#BXJ5*//_L"8I^=,E5#SSBF <Y<O[3Z';Z[=6]-7LC!4[UZLA>V^RE:R8$)6
M\=+U[7Q=/S?.8J3"A/JWXI* L.6V E@A:%C\ON29F!=J*A T1_4U16=^NWGI
M3P2B].WJOS%[),FP [%D", 9]:E]/.B.5(ZB _@)=//(I&9+*;6@<)2R#X@G
M2<W!LU].*$6T9>ZIC^?OB*PC<*YN<WKZ-]X+TZ:CI'KT=I=C[\*,3M K^&HK
MY?9.F)*$9R0IMEB@@W>\/#2;0I#D^PY4V!WP[IL;[L #N&;=_;U-A*WD)%S:
ML'U(WDQM]: Y<]UDJK]/\J =GC!H7C=I$80<KN; .N4:>SR-L&!"^1,.RJ7P
M'7XT-+ EL(6,/V:7T01=_"YY<L?$MPQ0[M0 9=7X%P ;G05T):)M#^9Y3A86
M> >4V0[>&'QHVI85'$)VXX.?S>_C/1U*_SCX)_*+NW0=3[124M@:ZZ, (ML8
MPPI_0.P)U##>C7&BFV(4QF,B_+6_1TFUR#O\58:GZFTB"J NYTR"!E05^<%S
MCB5AJ*5H(^XT+Y^_WYA/3EBDS?2-HP4< ">$2<7C!CNQ&Z1.FHC';20?;^8;
M-8^>PNI-6M/HBVZ<HH:M0^1DOXJ*/E9GN%;%SSPH]?B9ZHC\%Z3'-3$CKUJ2
MG<$JL?UC&$%Z83;C.Z$@U4UPER$>+R[KB/90&U'EW%D2$-;.E<.LGQK;4PH@
M6S(BSH.H6('8@1_!V!R0/$W= 30\&)<X%RWN'H]V.8)WZ#%1V7)RB\-?99]7
M>QY&*/PHA#&W%G)O#F<*#HKLH;S3W0N=]BW>JI!5C@,OX?*/CSKI,@0R:3-4
M9F,7N!#[U3T0$WG\?:^Q3EUZD-DW%U6[!X\\1T?MK>K@">RDE5(>>(DM)+6V
MZGG*:C,OQ7I0;^4#A&\-79!*VRCV"_F:,.M'%^$:/5GBV0+-(5M%GW7H@TPN
M;>7@T#LB8VHCQ@ADQK/].HW:AF^43P@4<  WAM#JO;\>M*M/NYR>;YD7D'+_
M_,COE>6*+PV_G6KM^[)M$VD&F420P^A(>]D*XIO  ?ZW&(H]\)-O&3=L%%/Q
M:4[OH^"436&@T_'^BI%/MY*;W7M"2<9*ODX-#I?+^V=-S0X?V;'K+:J#-HL4
MN7M+![ARL[;V?(%'*#9>;V/*2!--=6>:UW)T<?[P\(Y)Z;YZ=U_C=WS)_E61
MD6&5OQF!NE4Q/JP_HOMAA_"6&P_Z9#QN-!L$/N2'4%22VH8#W[0.YO",ZY0B
M6JL\%Z.^I?X?Y+UG5)/MNBX:/T5$!)3>H]([2"^23U 0$) :.@H"!J2W("4J
MO4N7+B)-"*%WB1#*!XA(ETZ"@#1)$$* E!WG.?N,N>9:/\Z/O=9<<^T?]Q@9
M(^]XWKQYGMS7==TM%>[5_A6C_AZ^WMQZE=^ZI%M:5VN^HD)@EXO%#UR\(Q G
MUT^-#5YN0\\PY0*HN0WD]H9$4F.7\71CDI"&L(S,%_>UG>Z;GTR3)2VEV1JV
MN;8_@QH\.M*J-!J@]V<J+F.K8$=,*,1>= ^OXA6\BC=B<M@G@%3.7/-A A&5
M?$F2)D35[#W: 2KS^*C2KVWPZH<VO9X^T7<)1,ZSAW^?8T?XD_*0W]N(( J@
M+H7*ELMOFW;=^CB&=Z< TM>H/I3<JQ9+?G.D3PK]<4(!B.SW,)VI+W-3 #MN
MZ<52@Z"#N[A84OHBE49_*+ ^4Z?R35(X</W%?W%GW+^T_4/!A<1/?8+W&@<Q
MT_L:;%&  GA@XP((S?F'#E1P#/'?]ZG^Y]+B2(S,98)S/UX64B2)W8C$)"O-
MFDT<==J#^FPTB^'?%CS4^ [5BA*K>R!5MHL]C!6EVY8SIS$Y,%Z/X(J5.PQ+
M[^O&F.]W@\[N$X[[5A@C^'LP3)<=M)T_@.(.EU3+\[[,'#' 1VM+):N^+_5+
MWLG=P]SH];9__\=Y7B)5K3$XXSK),;>IAY1NZ6\J]OYDYO0T/-2=I$'EA+3?
M:7>BV4Z __XZ*JK&U!.6J%J.OYBJY7[^3<LY#,"6SJB  J-J0*;9RQ('(#+W
MX%HPZ<IS&)FEXW_KYG]<"2]/WE^A ,Y3I7);1)N)8QH5^&9 /,@?SI/45X7_
M6QL#DU<.Y;8H (+1C]_BN+[XF$H)"4"J($8=]2804_^##Z0 0UD1O:AN/]68
M*F*#_R9B;U,Y7N<Q!?")7$.L!=:R@M>4DY%>,@E IBZQ6L)8W[+,9$V3,=,W
M UBH#%&@@R[;\,U]*2F3FJ^&H>%^V#FKA1@&WV -V2J:'L2F&_YW[5QTQ"2R
MF?W=.'0$(]Q8 A5?VC24^<1_K<.;@1 N5?:XP3!(BNT93S]W6K)9X,]6?.6J
MO\K$7L!(R/=6[VR,D5 /=E%,ITLHOA]S<U.73E__5@!FRMYFFCN]S#@/E[A>
M4*$RI,6@Y1>[0;X.S<WPH>'5D MPWU M5V*NBAJ1G;ZA;Y0D6"*I(]XU-</#
MN#YZV1]OX6Y9Q350**93")DDO^A6@0T](F10 ,XI[11 V<1L-OB7&#J5DX#H
M>1ZEAH@BZM80@A_&F&=Y!21K;?S5KE7##$6G.75$)T1GTV?FT95^]NL7?%)%
M*B:E(R&YW4J0Y[$QQ$<S["M7PVY?";ZE^-[#@S9>P<GYQ3;61H)S]6-S^Y-$
MR]:6:_/5=O-V\_>NR ]Y0B@ %9!^ZCME+BR_0&*8[8A\F B[SP"D+Z0EM' <
MM2KA,H=@0(%&=YRJ]%N8K0H")2/L8^!),<S=SMHL^C5"0W'PG*\H?;@^<!ZD
M@RRON$"HSWU"YG7-O2C_2J7B3#.&22!%1*&TP$7U\&"1V<+G4)YSM:&C[<$P
MG%<#QRIKE41?YB!7R*TRWU;LHM,ZEVER#W8!N(3^^QR>P^:9(FS(EP"C ![S
M40_*@^=E4)?0XMUIJCP=1%-)2%0@$TEN.^OT>/P7V7CE%1 ?W*5( <R,"6G:
MIL"^QZ\QG0FU15( %BJ-^* $4<3I*6CD/ZETZW^F_</  /!BUC^&"P#',B^
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M_DX$+4XZ!W-;(^I7W@#LL%KD-;N5HI2F2P(5V]K$Z>E#SSQ"$H@]EU\;3U$
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M4F\A(GLM^SM"<AB5C<\S>8K[F?6Y, _7,U>;S/:-L<\VYARXK<* T!5T<7P
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M^[G/Y;C'=6FC/>])!>[QGD3ULQYG7YM;5I/_9K>DW6)Y_($"4)&A(Z#ZB_[
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M;MZL"-ZRU:$HN+1NLANAW4^F]XEE#;4S8H\]1>:-Y3G:C8AIJ;@W\W=]Z^K
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MY+6GB+0O4!GAT?;M@9PI.;_.TP%FN20WD9D6H+Z%UU%FZ>[VT$?WX@P<++(
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M<3.<-XU!6;S:U$$:=";+##4W=TP?[83;!#8!R*<[&TNA^"%2&E%FC=#-!LW
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MQ:0;&BTI]M>+6E[25AR$NFH[V+DH"RSSSD-U7-K(46;Z= S#)\.1+^L)]%P
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M$[VU.Q(3U\:>G0J%QWOU_BG$'GY,1Y$.)]OUT:4XTP,KL<DA1982+KX"C<%
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M2Y^J&E+":6PK8[];<0\TBS$YUL,>42G5@YK17]%?\>WC0G#8(3 FN..W\V]
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ME'Y5D.G5=NZ1Z>.7B_<0#$'JU8&OI]7NQF(HD4P%R\@WNFW-"MT_^,B@A*Z
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M0.I'^?M#F2C 1GN$%X*U3+,>0B+YEK'7@-46;1&W ]/G!SAUIH,(,FVDXHM
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M9W!HRX9( :U['%*%+U84"L88%3VAS;I0T8<.)A<9789%BR&/F^2^K6TP[4E
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MKSI\B,8FH'&ER#M.2QTD2,!<%9;ODK1Z$8"74OVJ]\]G(6_U68L0"S_KWO\
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M48P"T9(X*(, /K0M^&A5:ZZY]!\Y1R%N$F/ 2\6@&=L9X-S]_&*$N(7%8QJ
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MN1'I?<HA#J'&#$&!.RCM.)A=\7\TF*("\1W?E:M<[Q&.KJZMLOR/SJ:2S+K
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MSZ;\JAQMVHD-]P1> .QTFL6-D@<W"%=XWS?[)+5<PV$#+=<FT<0]!2H9SG*
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ME+:ME0CAR3HLS\K-X^\*"KRS9PRVR@\).K7IA85^//?LSV=_'#L[^-<9-'_
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M4$RR.7PTZF=9J<S,,%P=0^T=B>U^IT.952<J*'-YJFXU"Y<XOR1=_IKOD/E
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MY#2UR31X^U<3IZ4K"+K( F$_^\9>?8(,=C%]W_<_;@^U>I*RUP]0"N?)3K/
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MW-6^KMS6>')6^*SL:$R$1%#EM2J$FI)4*/IX9[K IRSU/=9L_.E2$BMV94Z
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M8+2.)<JBA2X"\O]+CWSX/6S!\ ^8L<3OQ6@VL%+0'WR]HDU97^7L+0-UW)\
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M''F-HF2I'<<HTB-9,';BQB.09P+'.#26.(NB&Q%[$_L@QPI$!U_MAK0V"U8
MD)$=R'SH S(?K*,-YUHR7WU; NL>_5B3V]PN\8>YI^5?F0+!/QN#[T,3<3,C
M+@@+2#4Z&#78&;U[EMAQLI$M+]7R0881HN0>^X[=<4OI;$U&BF)"9K+'"Z A
M-H+CH,N1XM20[!5OE&B*>]H*!>F3@.UXKW]QIO_SJ=;$TPYAM5>C125U'[9&
M*M>OQMUM<_A/8X?4&.>G?Q0F/_FG%H1%,RY2YJ*?E[N--N^Q^SBH=_OM3%]4
MM(WB4K78]RB:N]P>O4>B^\PO+)U\?U+!B/+N?F2H)O<6B"K\J_3#T6J#CR%;
M\C&_Y)4EE>(5;.XQ()Y!;GGZPU?TUKMRZ:ICTA>>-9ZKT4)TXO\T+,X) S^]
M].9.L$D6[(,%"Q9-9,&>*4[^6J3^?[(DN A]9FR8(4X0+:-R,HXF]B;:^[7)
M?02<F/D-&S(%CS<(K4R<75GCXNK85XN2_JB:L<W\)RTLV'LX>(,%VQA&N?[J
ME(PX//B3_ZX+84*<K[U4^#VO)6O ;WQI#H]7?E^):"=I/RS0-XY(E2ASG,9\
MD_"A/^(+R ZJLAYJ(QS-FC%*[*)2)C+TKSZ*EI:__MPCI;_ BC\[7.<B&:";
MP5>@%M8GLF!>D 5\W[%@UY ,2#.O$@B3OTQL^IF/1X%U 1;L1Q0*>ED_Y#22
M'6C!0]9]! <=U/C^6##N]Y7.S/_2+-\?*W@*)E.*-U>/%U?EH9[)_T>U ]GM
M!.'RNT30% I+C*_P?VHSIOTRJ.P;.E?+<\&OB]CN;:1Q%LS6(\&2&CJ$ZDD>
MQLTOW%P/VAC^%7!3&;A=A0Y2?+"2+^QI.'4CV0@:.K4Q\2:?KB):*VNNCX?$
ME-]-P;NVYRN^JRA7\L-K'K@H\SW;/_/J9P'F([BL=D':!X-H::K^\Q(;[C5K
M ?6^-EV+7^7RQM\VS!*;Z)H,7/I_9/;\W[%\X/4_Z_F_)DT(G^AZ&P:0/^,I
M&K$CP_3SR&)D_KRBP+\$4PFP<8DP[*TZWYP'_8;J>P^L<?P/IPV#M5CW.=U^
MMM9? QAM@XC(E'F\=WCW]R=+$)7[W;2(YN\!&__K(NF?&YW^NQ3$-DJ<@UR4
M'4EVKL+[$2E/(#$(]2.)PA:"X6 60JI!CY9(TV2($0YUN'+.Z<TNT#456+ Y
MSMG-OPJ9P7,TE,,B!E?8[Y'P$%! _G[J.G-]X)=[:V-H+Q49AM[J=Y:C\LP$
M3?=@?;8@O0>X]YW.@CD:/9>X&E&2CR *J6!>9"@V:-\8DQK2UA4GGAT#=BMO
MJ[JOL8VGQH.-UH3)"?7DA\:EO8TID)L:$"=IY"]K^'KDMG&"Z\A:ID9*LL.%
MZ[KIC)<0S?N];D@&#T'&,F9CP5Y#@%1C")@G_M*H1=G\:9;=_Y](AO\!"P?7
M?VZ0#RCF\Z5Y_0AD*NLQ3C" \SON)V/!_Z-=CAR]BX (25(#"Z8XQ,V"3>P#
MJG+14.]=0H+WRZ%1V+KE']93FHPK_J'P95-@O*PRD3'*^?-2B#1R),X(25EH
M]B6<H3M  :BRGP5[WEZ[,)8XEYU(>0K<FZ?,![X%H'!IXTQ-[)=GXFC$(B:A
M&VF[J/85D:B":ODC:OT[)JE/>R>,E^O&CN7/+O"L#'2?_) YYF))XO"C=5I=
MY8[X[,<5!N>XVC%5B2AXWQX677S*$:PE#2 C'N3H1%-H%Y^O^^E%MKJ>4$9F
MW<FSK(SX<#7?OTN^,(__0W&&_L/Q;,N4SS/''Z9$_Z>7U8U?>$G\O[&\_W,1
M&\$DPM%VC%9:'ZK'HN?;4D_/D(59[[#YL*K/L'E@U!#YW>',XUPUV:+7WNS1
MWQ=D& F< 6R=>R<J@%T8OE0ZCA23'B3GC,=<MT[2X2WV2AGHRT[]]BI[N/QE
MJE]@6J/L]K[[N\/:R^\H1?"_>2.L-D:#"%),*@OV4!.<Z]BR_K_W_'(P[K!@
MX:&C<AO/@:G@*_B2GW=81FR91_UI,X^ET$\[?F[\:Z= _ZUG"P7N U@U<]&M
MJD$>JB@HWS+_EK(:J*#ZT,'VOER;>4!!O'X7>/FHNV.@:)V3E080:?K4:0N>
M^%^X<_/_^*R-T9[093Y@K/(IU45OLDULF]X.3+]J[.Y:Y=LZ8K_?I":8O_AP
M1DB?_)V!?3-A?@3_I"<(J1&)2EU-,IN_8OP!_<[9PD WU?O3><U6VRF:W/<J
MO[77N\5%V0S>;R[!6F2Q77,8M/TGMH]^JI;X$1[ 0(WI<:.3^FL$Q>()Q.QI
MP:S3^3W#=8KE[M&<)ZNE:OH%6DYW6:]I"1PT'G*]ML/A&$=V?&K^B<?%1<]^
MN[5SS^U $>DMW[<:'Q9^8-_TTS;S_XL/6R##@V[\'F-!\8LE?U8RS&^=R*.*
M)7Q:5<IM1NBK.Z;.\')L3=FN_#+1(.Q<[0_V SYU/$U@<^*V%90/BA(-V,W$
M8#?YA 2-[26-W2L6R >LH-CN07#NVS4\ =AKYML,+B:Z#YFM7_COMD7Y#X_4
MTBH-@J5GX=AF>&Z\7ZPU]>B"*56S"K=_ZI']$"\=-3)CZU1^\;U=ZX!BN(-@
M]<KWHCY-/U<!.7T=6_S*V60O;%>I/TTX,DLK;;C:>>U .E!1K\83;6*KZ-S+
M5\5K!A-Q2D_'V+87ZMX*;=UJ?K&$;I-B>GSGO5ML >8R![5>B+L_V;:.3B)<
M9X8C'3DA/E=4_"0'XT[1J7)7RD[6L;89@[/-%&EJ47'/%%4O"*3GYU'W1H\/
M]/,O6!65.)XU;I,KM&#7/UW\HF?ZT:")/2^M#%EH/&=#L:(ITRW<J.9C5\M<
MTNU^HRK$;[O0.I?<@3$<X\#:6G_ROT#Y]DJL.L7=/=MY>[<2'Y_[8Q7+>#ON
M:+.H=W8[C6]QIMKBQ[D ^AD=DM0H6U$A\\5*;[FDW'.7F5,,A_:Y\G-]3AHS
MQ91&8(]LP>3"LWD1/11OW9;#QSLZN!HV7F[ L7W([8 CT:\-<XE^)G/(H]2P
M4= YI)QG=&=V%L)Z)-1R5#QFJ-FRW3$'[]C7?2WH3%KK2K;*_.KESN1G\V?-
M2=[ITX^-#L--6RW=J5:C1-+PTV%.A '5?#0]<!8#'Y'[S0[_@>Z/ZN =-9ES
MK'I9L?TT+>K!P/"T2BASH,5D*L8HWL'M_;2G;U-AJ&]V=0?U$@O6[%Z%HY]A
M)V,#1X4V.'V!?*5@\##Z<=?42 &5,Q@K,D7DF%<\9C60[;77WVJ$&'"RO^+4
M>P>3!;FWI5[NIK+9LSG;^HZQ+6>J8Y6Q-42*&;$WF99#+8JFY%NT8BY2SHZB
M A;>MF/@R70"K=F<TARB>+9H?Y]MC%)P08/7Y>S"C0QW=9NTF3ZC8-[4L_TF
M4TI]89GN>Q, "X36J!XG_2QI?3@889QMEW"0TNRW7#;GC.I>R>Q1F)/0:%-H
M\)!=X=#1)Y2BY^:D9^>2PKT"QU^*A"G<NP>[]ML@#V,, Y%;GQ "._UB=70,
MO +UA"!-KR//L <'&U.C \H=V2J#.6Y\V1 A4,"7$CX(M^R;4^[G! Y'6Q90
MNE(..">F5%:]7X^ER4&NT+EY2W9A=&C!@F_"T18WXE/4 <1%-X?;9 Z1ZICL
MJ#(RCG^ZV.FHS_D6!LK*)BU%[7#"G:-Y[6Y-< T+,SN9V>7@3*;^J"KB";:N
M]=\?&?\#CW%966%N80F!4%+\\>/'XICYQ<5YV[EL1QG'9+L<62<G\;M^[.@C
MFE%VJ:YAQUKC>PVU8+S'\!/--,C=?'PAC@CX@<<Z$*<H!F3W(():1:J66&%M
M<&+5 XP"!?O.G;OFS&]/W0%R,_?,>GR09)Z%]@3)T_IS@Z_#?G<;4?><A5Z(
M2^_E8<831.F95RBU-8E^PL?I.W[+&NV3@[A'I29;%8[-KOBC#O?C&;S%%'B(
M\NUSNHGN9]+T"_1#L*^I4Y3(6Z0Q2NO9MKX[*;-WR,R>-ZJ8QF?4W<77U6)I
M:MG;S-.4^B.U44>QL#.[49HR8'[SPI3T@:H%[CR5.J&3)R2HR;1!J-^Z,5N9
M+QF//C#$*(G/%0$<DKM<\<%]!BK55NUH'B7=IUPB0\-X3N4W_-B9 B*7KE+@
M_>(='0K9<))GBJ!%95/:=)^O7[:C6WKEE@VD.H! YJ\R#IZE*(UJAKHV[V+<
MIY\9Y7S2=Z\0^"W>9LP+)=3'T*841<O470I:J XA[*=HX).FGMU;G""V+W_V
M/*M^W U=1'-XY.+(9#?]=S=)=&LUS]KGC8= Q36B#:K'4@>U!]VZ0CS$,.UT
M?>^6+44&?*R*52)4##N6S/NFAR2ZY89D1$@JCAU1W4=[K;WFG.;N+,TNGXT]
MV:VU9IH,0;+POD036\3Y#5'TJRLMVU/$TY,Q5NV*@[??#5SXVG=H@92XMU<Z
M]43-D5&^:U7OWSP9.H=,UY8:7^AUI^71139N,Y1PH^Y?%KC5RI)('LQ7>#O!
MR+@8O2"$6$YV@=)#VP2QUC0[X6_46PEGCI06)&QH=MP95'N5,<T[V<Z98@M+
M(JI"=#DID7*-<P?V"W'7,IYW6E"U.$Q-A-YL8@$G+Y >987RZCX\>UQF@BK[
M.<-^ETW&3;LA.&4^$:'CXK$WWD.LIC##UE._ELO^P+"I"YQR!4<_9IG/@NW8
M3DFL=N::@;,7-/O)48:K+(5:1@K:$89NH\\[7UFVNPFMED0Y9'->.AUZ__XE
M'4'-!V)<O+*^%W+9IIC_U1E>_N4QKH<7-L\E4T1H$A2.:)R:DL,JS>=F>6D[
MX@@9N7>*!>M7.T&-RK!VH#64J;)?.=5G5LL1]YLXL4LQ_J)6B^N:;)8,WNVR
MG*+,Z:'9;=/K4FO^$ _WB<!(QK3XZ#%?8LZ[D8?E*SJ=U13LN@1;GFN="*QY
MRD92U:CZ2I4I*T=1PG>$:=T+O!=Y2RL':0'<@=./R\U2-]QZ['E1>^44<>P8
M+0H8Y^9\ "--#2T_/23:OEQ8ZE>]\EF25F.>#:_RY.R7=9SK6]4MVW!\-=";
M4YAJ=]*RMU:9;?(0SP\63(!PDJ'$3"0(HO&C"]5XKCZTWA<L1RY?7Q?>]6/C
M6@PZ6UJ!J5;?*U;6L>)M!([V7VTK:#AVKXQ(+'G6M[/W.S_H@8!PFTT<+:1'
M59R+?H*TAA^@XRM/?+/*H[(%$62F$MBZG6^;INBI.;-/)7*6N]O8$'C";$<A
MM9OV(_BL^I%@F]<C\'8+GK6)#7:@0AN[!3ND\AAO-2(W!_R&T:%4AW@F!H)\
MZ,]9?B7.J5HJ9BR8,QT+UMA)E^N1)W-^//LVO=[IZ%S0D!FKO!(OH6NAJ>.U
M0'#[['"9,A2:B0ZN$HP/"WX[J>)(R\]V$$SM.&WF%)DR%=4V-*T2]<[C ;7"
MSMK:;D^WDO$I%?4]^Q'A)Y/"80J3^ F',6?&00,*9P56Y'.KVBX&/S6Z9E"V
M.@1)B9I1$_,G:_A^N))_]$V!COD".YI8%3XUOG4^6K#+Y^U0P>01%?O*T=G'
MP_E0$=LV3C,LJ4[1(\TA:ENH$K,K[MEUSG;I].3KW7,(]Y%C;E*!(GY2JLZ6
MN:V8LYF3+YH5/KR8[K84\!;>SG73@:]/M>">/8RYD!03%GZT3D@J^4.IRHF[
MKK<$3$VU]F3ME/SRXOSV@X*,8\QDXDA9XF^;D2 ,=4!MIR7C /WIF! +YF<I
M7D+)21Y5%8(\ZV.[&\?52B%@3JRPJ%RC),!D6,LE_;*X8Y-B2AC," ;#SK:B
MFKH9E_PI.F!H\6@BR)/ Q8*-&6[ -[BQ781#S$+";R:8AQ3B<S?\]BEC4)3*
MY]=^H7LARXWCPAG&61>.\FZ91^F2_?PY9K=:#PNU'.>L>\N9_?[?.#S_?WK^
M^_%Q) [>YP7N<MP L.VH8LU@K#B=!2/[?D?N4CN&<<G+BZVAP;G4!!WXL&ST
M4W)!9 H-Y^K*2W7MH\=6#N^=<Y3[D?^Q1?8MW_X(DX11T^QNF@,M&@J-)F!%
M$? 17ZTJ=8DN-$+T7R7LH!N/+NRCNX]JO)"3*;=^9T_@HM2D9TZMCQ>.E@77
MN3GO[Z]VN2?6E8W1='_?-VWDYQJOKUZ<T+_2^&*+Z!.8:/@#V,%PK1&82@RH
M!XQ\A%.,5.&U9C9!P%UX;[IY82?C^./:R_16JK'V)_-@^+[L\BFQ;M+P=LLO
M-5+Q[,V^MZG. 2/N/N:[9)^F(F*D[(W-/K'5P"GG\4+H:-+FMFK?<OF4FR@.
M]E$XB04+*.4+EGZ7X)8;U:!.&1P.7L[LG[GKLKVM=\9L1V1AW)*(:DE'>ACO
M>;=CV$R0G4HE&=-]-^SE*J\#9RC%7U!;Z0[J!6U1HYIY*![TC'8N=2*@L/!)
M7M#9C4$1$TI"Z./)MZ\Q9VUQ_IH\ZW8LV/;#S"<,=8H_J90XYT9UT"AM1=RF
MGB(!E#",!.5;NI/CPC+@K^+;Y)?QGEY[O3!QM2L:5"C);4]JN1TNY)#IO,=4
M%R",ME>[U#IO7ORWXUZX!P!%OT*IFW>_(MQ2:\K\.%]R/F/(<^"%#)[>?^&K
M?.;FH>;XV2U,><QQJ*_.8.O6:V>19-3F5J<]KF= 13J1S!N;8P_PRXIW1%>O
MHZJ1^]%W[?/L3ZO$N9_K1P.D/MH[GDB\OU6QH"H-EWZNM"C1VUNQLV/X*8H"
M\?Y0P84*5/_2%Y#]TZ>2 @H+5J.CMQ\C0?6+:'^YS1YYJ[P+(_-(K(@%RV]X
M;X(NNY3;_O;3F9BA!N/.I&+OXE?JR%7.$=0:%T)H\\BB/W&YU08U\6-#Y"F$
MW#ODZ1S"\9%!<OT'*KI:UNXV[GB%,2PJ=MM;<V'R?F]GBG13[ANE[\XP>'LB
M@S>?=HN)9\$<]'8PA.CN&Z?1!]&UE6K"71@=",\#'LN,$7?0+TV;4?PUVQ \
MSCSXX')-\HP7.<74@EX*>HB]KH#WRS#\E&SSD*J;F:TA4ZECA.D>&VIF#LC"
MYB^<[/3,L>$0Q<3]3:.Z?*-<=I;RQ10UWW0'XQBDOX(J+SO'14-*@2Z0-M5*
M3QHS;;<<,_CDO$\F9/UE46Y1?B'S!_Y;,_V8,X-;APS,'J(,+KCQY5*=:W#<
M)GHLV.YF\EWW6-E"@<"808S!:&+^I](VQ/XTBTNCTTNKQIZ# YQ)D^ES2$="
MVQ?D"SVZI,V71'_DQ\2YZK$%?Q9LF^ ,R9*W70:Q?TSU@$9^)SY'EL&>Y;#.
MFYC3E&K7E[)Z<CHW-74F+3]98'YH22^O0_I6&+EK2"!V_3/S/98=VP(O!A@'
M$LG^3[!"].;*H6W4YNKFK1A>:G25.?&0A0/-#)N9VD#F0%:7UOJEE5- 7,[T
MXU?3PO(JW,7Y\6JCI]MGW=A-1S[Q:?"!$ M@P7K]QR08/$C:EVZ$&_7DA&%'
M.?S1: =U=8Z3RG^NZ_&#J6XEN*U/A>>>]U9%^5T(]1U96"%*S:L[C8@S;\^?
MSN2)BW'V;RH@#D5&QJ?%V]BE]YB?M[&Z[;@C/C*^0(NC,#4U2VM'86&YO&_8
ML<-^"D''7E[0%)1\#]MR#OX,2;DJMYE]_0F!C>Y0VU<\]Y(R1K:I@0>N%P=:
MMV%DMB]JC1%AMD-;BML42NYT*#3)H5J77QM7Q=24N66I>WM]L&T&TDVF!*^U
MB>7RQ;Q" 2HL&,4 YY>XB[ -.SC,PSBPH:P=(^%;?NH#W>!:^S)QSW0TGSQ:
MI&;5;"\NTV%]K\_[BD>*@W&E\$#Q-^_R@F;FA ]V"%KL/6+?IV]>P;P/5!B#
MW-@>E)#:;V@^\L*LBU)@P0+/($.OL OAGH6V&KV72"&,RFV?2N"B&A;3-%(_
M#*)?D8H]TR(ST3X&K>/16GDJS^H\4GL&+<TU=^3&(R-03^U2@0H5X'[\,1#2
M*?GBG\=TG2O=2S5*'))1]*BZ;E(T7\S3A/;1A$ ;IYAB7S7I6.31<<>];< ^
M<UOGK+Z;B)@(P?$87#H,0 ^S.Y5?]Z(TD#LG0D?"NVNBL=LIH=W!<ZG&6HZ,
MZRYDIIH%=A?7I<"NRX7&9:&=HZ&=$7Z7#K^?G\'1O<<6=F$,*$K/":)H3M,B
M*J</XG^P]^9!365]NVAL153$,"@1$*(BHLW4*D/+D*@(B$A'4!F%:",R1$@K
M($%"HBBS$)466FB(R"R$B!"0,3*WTHH0"!*&#"C(O+=*V)*!NWWOO>?6][[G
MU#UUOWK/K5/U_;&JH&IG9Z^U?L_O>9ZU5]8O7"@S[-35Y#(L*ZP2TBJ&.V,"
M#J><2X\)EI:=,ZFH?)+PN6MZ;W53G%*I?K+UIO_/-/P_3=<"(K0_JYW(4YPP
MG8L%T4+TW/"3-(((V1&3MK;=.X[:YO($<IEO4N,56I6DQLUDBXN*WC?=X.84
MHS>->^8\6,ZF)IE,!,G?&F2:M@0]1DXJRC?BX501U@#4-H+67=0Z]LM0S)1[
MO\^1/LIVDG:GUG(\^:+0::*YMKD9-$TA7@ "DR-E2)\7\;]D%$[79E=\YGE:
MSW!L[_)N5K_@4& 9$;<H_PLVAG-]$[2;XR:0IM 6+>1(/?KE.T=(=2_'=0[Z
MD"B&M+4N@JHB$NUDWZGG(Y_2GMJ)<AC6IVN?.1L?G'39S5O@_L5_57'^C<Q+
MSF'7?-_M.*PM=&"!,1,&22C'=V838EN]DS6JHQ"M2W=7WOY+G"93H:]Q4?*2
M;>#ISY=^*SYQI69V7Q@KU.\+KM^(2&3 R1.90E7%!J,A(^1\3N'()UT=11]0
ME=9.40#B_^2\$5+OP$Q2TSB\L&"N$^4>=$_)UIA8R6)KD!Z(-@1R(U.K HH\
MNX9TT<#7G>@^CSD%B3-4(NR5JOXZ->'>;/ZVB"%5 12[<@^U#F5W]HQ10^B;
M"..[6%!D25-&\J;@[(#YR33!K/5O3)W:1P5'B6I;T_S1O8M2-7_Q%8 ]7R )
M=2PD$^H:P.X[4JP0IR7UAVZ7S&2G0?2NJ.LKF1D%(_:,D-_.VY>.&B^F2@.*
M0GA5*"=,D0YKL.GS'PLEO5_O2Z+A!UB<>P//92A4!!QZN2\L I< ]TFZ1OBA
M*=N<E>/5F",JN6UJXR,BO-"XG*ZTBE"964FH%SF/D(I(F9+3V=NW30QK2DFP
M>;KVZTWY(%7[\@4,!SWW+7JK8_3FG3DB[$T_P89EA0N7XD;"'^IO..?NJK<>
M,0Y/^+R\C;\.&YAF*6!WT6_IKNUKT0K.,QXRYR?*?P9Z$_*S.3#X:ZRNW( U
M"RL7Z_S%K\>I*4;;5'4XI.I]MP+K\]&BM[7@:&NT+7^V5ZHR-5%;!9:(U0 N
M360]S=()%V3=)1\%8IDFD\%,DR9LX7!0RUX@^??&0TJQINTM/SX'FI/7>,RU
MZ!RW+DQW)-*Q@@G3;V;HVWSQ-2N4O!R9<@[61ZUU_:<H"O*^O@/$ZI).NK*3
MBN'GY"+@AM%''TTC-^W?>E[,K]FP]JK1&A"=SA9DK"+J N?5)1$A:%B?!R'C
MZU:H;;A4K$[Q$#E\0ME0A&_WO?ZE';^9:3Z]<+'/:*ZBZ6*TR!H_AU/P\H+P
M#IG&&@LCSJK!]TM?J!J9KH"2"&KK@57$Q3$#\4%(6$YR%&3=@CU7JM"Q#:<)
M+;>V_ S\C;(B)H5&LG\@^9\>BNBQ)7H_6(#5S=;AV>?!/4]"?B.E^%X6S4>B
M&EGHD?N>XW82K%&53Z?1EYX=/]EI]YCU-W1O=74H^I#IM>.IXXZ@HK'1^',*
M?]S<R/R@)%="PC+DU_Z6P]X$]O.L.7ZY8RR0K>RP';.??.KY]9^DC@-FOL>L
M2\FF0LW?;\H5.$O.UC'-=OA3,.[P,<%$W=]GA4%:BYT(7?AYUG^%)CH:T//T
M">2Z]^?QL!#8(=T*VHSO[I^HOV\V,&!CS(3\3W^O3V+"6/.YI)E#&2H/RE1O
M6*R[W:D5Y_#R_ EMB3J4!:);V1O(:V!5DPS'X5(C?@O)\&7#EGP15HU@F994
M\77,2B/[Z%;_Y2R/.A.]:DZ-)/+!HNN B?$5H_SLA<GM=%!/OB%8L@ZBB<,A
M@LB49R#B)F/B0>>)RVDEP7DH8+(H+'2)IDC>[R3@/M&J,'(GZ."[O0N]_:JI
M!6,.)A'-ED<!T9B2[R\39SGSF,UP% _(>7(]64&+Z2?L,],Y8&A\;[^9J5:P
MMP$M5/KS9+1<CWPIRS41UV>S)DCODC/#LM7JSYYM7]W>B'WH6G^M(H)34$#:
MPP^/T1GH6NJ\.D@0?X9:01_Q@X$:7S_31,HF>>>[&F/S,;P3%""PQ7G7<VR4
MA"./I)P0'CQ8IH4#YK$NQKI>2[Z7<:HS[K\5TXH;WE,@:BLL.C\[4T-,)6BY
M+G7&6K0)'K-0YOOJ=OJS9:EJ<XO62R-S=%+#*J(3%Y]G"#6+&H\KRQHG"",Y
M#W-PSQLBG#X _/C0MD^8'6F9ZS+'QZ>\'[P=<ALR/V#PO4+PR"KBE;&LE#U'
MA6 C5[J8M&_MBM<_'\KQ[VC,CSCYIEG)6AB91Z@AJPA>B0]$ _C"'>.6D)T0
MOQ$*;\,B%=@=M(25V 'OT/2,]4R1\Q+0G63C7QBBL6R5E;KD>WVK#^'PDK;$
M%HN+GCCK?")CI0*VAR9R3?BFNV"T]6XF;P(6V^@HJ0(0E1KY1:BM8]V%55G:
MMS#2O5*78F(V$CFT)$&B6F^8YZYWBG2]&EGL%13%S;Z<H9K.[1H.O5W(?D6=
MLX\IDWZ/#SI9 P[K=AG\L&>K^[$AAK@[SD]YN#VF(N2ZV9:?<X1OJZ))QIEC
M!M7-P*#L;4GDVK;:OU5.7#RJ=4<>CQ4PV(![KI)@2[*(/EPN)@WMXF)L"1J6
M5N@T<G#1^6Z+'""D:V6_\9*2->&O/<0:LLN#,9ZA\\\G\(HU[6X#EUU^Y0V=
M(L9A!;=7$<_P2=) \&"WN ]**SP?S$=2=%^5>TEWUPU<>& )=J<OA(9]A:&J
M/MS]$SH(6(R;KV3FWS[]_F(32*Z=+1FUD6L._IJT=@#.D[WI6@TS?)BL)TKP
M3L0GN7I>4(^H<</D;PU%\V]D4[=M5(T[G%GDYOUF_!U_U'U+-6K(!*J:GU3+
ME&&>@5DU[E?*ZSR,+)&L#2(G:/",24^ 0]W:1-597@*+B2F1%0B9RLI4USZ;
M0T6D7SZ_E7-QR-=FS;N5KX?BG7R,?R7(+L_TBU9$;?VOM[,/L 7"P!?$D8*V
M5*MU*=CAH9?[+[?>U@SM36LQ./'VY:$KNQ><2VOOW:D(D9RXL"@[#,_R(;T3
MJX@+V.'#_L?3<*U,I;_.;=UG:A3N;'CO\0^?3RSN21L<>_0^\]<3BF )0//F
ML@7T[TK8%^O2STIM+99JRPK-\0DWQC[4&5X9UX/\L:D+-CH,BZ*//X[\Q"6C
M2+P'A>_,-&ZD>OMM4(OYN8D]2Y-OZ@2HX@?0*D*B/_-].>@R?@M-E43ODO\$
M?,68L8@:I)A680LZJ"_$>R'_<C8MB16JRYWT]>CPCDHPF^)TONZ,]+?]/-[@
ME>R.G^B5;Z+<]X'[<10;PG^>>Y/L,S@Y^N#0MA>9W+;H]X=_?0VGE6C/TIT.
MP_8;MNY;1=@Y.^8Y^P2;%*B,OB(JC1XK,=PZKU735S8ZO'%7@&+X)633C7O(
MR6[YQG/P]) X4LT2L@M8,L\'E!P&FB(:9/0$"AK2Z\IF)I )0@:V_=XG\4H"
M4U0Z3S84Z5#;>,WCU=2G]H6\GK)749ATLFT$5Y77$V/#_ ;+"H4>689<@?(W
M=8=<PT^Z&1C/%5@C4S"*W$BZ&H2T?R",,#8]]\[\18TD-LJ14Q+MW\>(G"6T
MAZSXT?=XGX^RVKIL4>O^?.P\K.:XCO-1D@O2';+4EJU\LBM47_'[EU-B#!((
M>Z1?DV<,+B?I)5]R46^_0>[OV*.Z<5>6^V"8ENTAN^K[82RE.P=Y[>%2W/AY
M2C\5\*2.A!WVK_9<6D5LQX5>3@[+\O!3AO2!Q..-UW0GA7=.-5@FABXNF)1D
MXYZ/DZH[&RK*"0BNC9U"/D+>Q!;\+K<=:H*1LFY&EFWC,T'H*1FX(E45*6^:
M.CT8%I!]_9UT[015 [*T:ZIOJ(]Z*,)H 9./#CKKW3,6JUQ?@^]FS_4)B6OD
M/#S@&I S8?Q! Z\D_U'J!C6"/B*_HG+"HI!@B%7*(6J2CS?+^T TKV:J;U=C
M?4KO21\^R]O, _7N^//C;Q]30^'$;5@F-96ED,])L)1>K2/-0])#$ELH54AM
M*]=^XXCK'__2@1/D\+=\\BXN?QJBYA,,^H[.HC8R9E%9!]MUW@QD7:LN>/."
MN@>[CBVXPZ]#=^!UQR!_$2VA!G<S;UO_O/W;_ FF*G2[;=RBMC'X9&H,4CE8
M=RUHP32I*SW)G/K;A/DUU.KUAN+T+VZW3ZL$+R/0M9@?O@.<VJHA_W'V(!0E
MI+ %Z&3=G;=TG;Z:KJ$,>B?>-?_#S?S^A^B(7B3YR #1_[CGY<# FPJ>A9=W
M.G10:N1OV=6);<1A'R&#V8:/XVU;3"0C \MG>'-:8?F5(?)=+WR=?3(/LS33
M"QACX_R#SGM.N&O\V:FR/>VLFB%4+F-C!5G\[53!GP4OJ5N_4E-4I<< DW*1
M=:R!(W1?F(L^"U%%5$7H,U>;$7BREMV?/V0N[M_35,,)8S;95@;[[6MXN%#3
M?$P[*>+5XV>QCBMA<'>P<IZNGJR*&O"Q'DH.M\@'\<(M=:CVQ1V$Z@UW\DQN
M2ZR4'=MU?WIT<5-9:4C#^0>>!/O[+MRZ@AFK[(JK(:IV*HHS8_^9MQW_O+;:
M\H&9(#] ?>4 HF1MV*^=Q:<5Z\G_>N(EB?A/YV+^K]HD,F2B>C>D0NCYI'&K
M UGGZ=NR7?8&:_YP^'ATCYYJS4VJ*9Q.?>C0_I9&82[NO"P5\P.!,XUJQZ7S
M)Z;2(Q[][0$>K?"R#T>US?\@1ZEY:W[M*:TDA\>&M$7%B?EM5:-V=1W<:^08
M&(&9LLQ5Q*]U62=E1=0K1)ZAF,"9XK#V&T $ -6-UJ1L#XXZMGBJ_L$VD-J)
M5"90].+ B^F?U4T3;73*O.UU1'8:K,JCX27G/=^?O^YG \_T6LHX7[6).(%,
MTC6 ZB6F,[IZ8'>*^:+&[%"=KC74:#/DS4YB.3/PKGE.A=!N/X<'"PONHZ/W
M'-<^_K"*$.E@1P+E*;2Y:MBSU'4RY=>VKI']2D*+2V59<GTH P?@81..%1AT
M(%$SR==7/.Y(D2!5N)@B=2KM+O'"E?)KZ8\_87:S!TWZNW^I:6AI)!"\-+BO
M>3%E*4<WI[.[ J4H:V%" :PHY)N0H%)'.*_)RK&3OY&,A1+S3ZZM.=BIF&#4
MI%BA<#^+F&=C)V"X3P;9-1[/^NWPQJWO2F6P-H^+A(D#ECJPC!O6%M=#P> 7
MD6.Z_(=9"A((S4J?9[E8MNKN@^++2)E1(/8FV47HL_9B()-L G"S?K0K)5A4
M^VFG71[H#M#IN,?HF-9I8C^E ZY(R*"DG3^R**S,R"=H-4)ZHJA;EP:(+5K2
MXW55OO81]9$GYH?.?=?W$;U6PTMXI=DT?W_]@=.^/B%: 4L/\XI*WO;HR'.>
MWKR.5\02Z/%6M+E#@EY>EBMX.1Y]^RLNCN>11/:RGN&JZASJU-4%FC:*T.O?
MC@>=D#HCD^9-R-C0(@5)P&2A^)W7R-]#[CT&X# <'6E0.(,,"Z^X5*EZL^3
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MI#H'CER1; OY3NPJ=+&I=?0!J'?,7+9)[82VSJ<Y<XN,L)KF<"=?0MM*QTI
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M/V?S_=W'BGS$3P?<-OE00$1)=4!VO&FE2X7N+KP&(4_]19:S<VEQ74Y'B\Y
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M"[;0S&ZPNG*CKW1QC+5P^^H(] /G]RF*7]E3?\0#CJ;0ONYYY%6)PQN)%F7
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M746$+JK+V^C/,NL+R<;50%:2S3E!&J&KNOB/[+?,IR1ETXSNEMU<LD]T$92
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M@_:A$G//BL0W[MZ,Y9U.8/&= NTB=^%Y>V>16C[_K=Z-7%Q $)S*T2;K#0J
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MOS9P!LSZKE!TP+J]??3#-\M^8L(B7?%-'F,6KZKC R[UUSL$6LQ1RC&,BP
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MY+[+2WFV.$9\[74QCPXZX_1^Y&Q'JN@FM4/?;EN>YJP4'<N4;RP]]""!?FQ
MOD/H2G3F]DZO-_M0\UBSWF/[P:UY&?C:RKH[#HR.^DH4@,6!?NB_AWF-3)DI
M6HT[$R0_PNRB0?^X""-:Z/& )N[R>VX"6KL^%(0G3TLZ:<$S+O1%Y"H_L+"M
MD!2<&W#"NQ&PB7UVQOGFLI7.&_YMO=JS 6]:N[5J!^[)_'G:V=ZN$KI\E4A
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M;^N>6K;X^'84\K-:)9K0D2#7LYW?#.5,[>*R;)OQ-&YE<;-(I!D$+/;^X>=
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MKLCY]I7S#7G((]1V'HL@CN"C;P]CIB3@-*RG5\SGZD/_&WMO&M54]L4+QG)
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M[<*753S!E[G<*YZ(F$TT:*[OY=OUEY=3 @,?SEVN9B5:R 9/8_ FT#U%\G;
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M?G=D^4I<&7ZN1V@EYL*\<[T8$(@_@+,=CMU(N0G\</H0_11@E/XUEQ967)3
M0*Z?8!L #&J"9;O7E(E@PU3@RXFE6Q$5' L,/RO)KEW,R+L9#Y0V8@"OGSUM
MU)IQVD2FR+V1,!#.55I!.T>/?F.!N%CY7J!#Y)@LEEL);[ZSNHW<1'+JLMSB
M0DTRG3\]_M?"@\+ I3UQ@^=YXX!G=YE9'A,ARQ?&RS?529- .%/6N2H2%O#F
M<=- 4(_(N%FB[A 6*,RYB-(S./1>A5AGBQ<IM&E7*!O;?PNAN0&*AR,?+<ZG
M\?43_)+4GMRD+HHX29C/QF/K$V7'*0VW209@%3?K9M&+"9H6BP .-B^1GY0I
M_IS*NNY%GU& :/_7]9%'BQ@9>$_6/V<[S_CE7+AYF4K)X/"_(H@T,0ILY:*J
M<.\Y22@#V]_69>ER"6MQ^([K3U<7]EN>Z/(@AG/[N].O)\TUY>ZH[Z[6/WK=
M\*R[UZ.#9]V,[J(VP<!M-_HHN1M7W3'3\XH4KL@GV1=.+:*/0M$B9TJ<5 \3
M9X'5F%PB/)!;@ %I[9N[R\HKS'._-=<H=_4TU3Y;[#$J3 Z8_J/[RA4=*%2Y
M?A_TX9Z0," 9Y36X'(8&,<V<!*^BQ+")':%L&9>RSF)ZBT[CY/'W5=E-(Z:
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M#CMI5I;J<5#9S)N# _FJH0UH'7+O]<<(<)';Z'0$@5P/Q3QU&D589\UQ4@6
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M_EU2(>+"7!R;IE%-YIMK8NF*Y$LUX&Y:X'*CA$^YUWMVZ\PIOQ__G6-$EO-
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MZAR%BI'86NDFCL;/Y)(_6+X+OIG4:/"K35Q6U+73\Y\]OSU9CHC,T98_#>(
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MI.@CSOC^7!*559YS_''NKYYN$K4$5B?3E3SYR!WT85U?Q!TD7@6J-L.D6U1
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M\10"60P^N@;.L>Q=?+=1<;(5A*8+)A)8[T_)-P@OREZ@"+5&".#*VT*;28V
MVOQR@TT?>">4+1%J 585[!6+#9=7Z[$TRH'-'*RFHQ.GM<%8SR=WX,Z8@AY8
M+:5S16Y1?XNI_&]]UO/;R#;M"H-:Q/@]I+01OA^'?K6/_0K7UK&J_XYU(_QS
MEN)DX1,?MOK.C:NJ[2MUUT>)H8HYK#X%NKYIPS##.4CM5P(O5FL(5X).Y$@3
MF5QY%S\M,*R<:G6UBR*(Q=%0)K*0-?<U.)"++R2;'5(U>ST\U5T=<>F'V5&'
MM6=<&U;&&C<=YO3!998[R]'( *8@[5?YWV6?-7__=NAH40-:D[P@%35%F7%Y
MR#,>FUZ89YV%.,L\8:('BBE*&W^*Q7G7+H>?!QRBB!Z(V2,]FV@)W\?R(TI.
MO9]#'$H__)S]^^&3;WRK05R.\1,<_FO0!,;Y!A?54Y@,5?3LA@H%"OO<&/[]
M_7(PSN 9V\I8/KVN[(9D[R,$BO[^4^Z@*-FD7[AKX)5'[4<,[BJ,6H&KYF-\
M8MUBWP<#Z"L3,9VD[[GBP"ZD0Q*8>W&4J^-*<51MHT[/+O=C(U\H$V-IUS/S
MF!JD:NOZCYJK?^0ZCXI^209/XI8]6-?VSI?C_":3)VTW[U2/TT%$":;V-I.3
M0H<)(FJ6&$!VI^%/@]N8GO9I@Z&NHB]G0 FGU%V(4\Q?Q!%47D<M&&JG)#GR
MVYYS*/OV #.9?>0"RP63V6J@) >,=Z"?*QUD=A<@-N7"C_G6FRB/_AK^F>ZF
MQ)UGKC13I+ILP3[K]0EEOZ!>HI6'A$;+_9R'7O'+5*[L!\R2Q=C>0SCJ>WNX
M $>%?86900JB,K1G?*+8I@6+X7KCQ*OYBJ'M6?;E1>ZZ.A1X/R)8L:7 \YRS
M6PBDILQ*J;U#T;H5)= W$\SFZFKZ8; 4=;"R11;\PYRS'0KLOZOP8@5.Y:33
M<PQH&?_^-',Z&.-)JQ)>RCC<\KT@WO39PU[9Q!T8=TTL.<Z(#)302:KGLB9A
M)'>371NUDV:3G9@[S6-OZ)38EI-,MLSA:3_R]?@02<."A7LNDWAW5B<YL?E]
M3DF_BOZVNE^RZGHC&K97[!J48JYMRNY\JH!1\Z'[UEU8*P>6IH\-&R-+,"_(
M5F7S2I)@9*G3 (TDAS'H'B,'=;44(&APJ&.O\OMWC_1S4.%8AU(,SGJ$L:&N
M?KL56KGW> 8. 6V[*,#-E7@3Y?$*C??C)G)+)&&B$[7Y-DW2%6$X5L!4:)\6
M'#'IT^>)9-EVY)X:"^S5[ BQM7B$UG@QY+)739N+?@#3O8H. X\Y,-!%B^B_
M-UL.@D$L+XSME7-]&F6ZL9S#[IBNU._F7XXW6'EV-=8<RI\\_.I&6W!3VI]!
MENL>I)-\X>"I74@T5HRECE4#]VE'\<4:FQ;XR>]=4Z9;6=/Y7G".(ALM_8?P
M76U<6XVJ(%Z@3AG=>HULC*HL0)6J%DWG%2T&<U0)-4.5P@,K8RDL[>3ONQ#.
MH0UF'S5Q>2PX]_00SBN/#(,S-XON79V$8^:Z8$)L!!ZYQ$/5)B^OAVB]!7Z]
MP=PV:!P*=.'_F:CR^-:^/]PY\2#'@J BX:TXP+;J\/R2^N*V:,> V)*A\R7S
MG#I%;2JITW))ZGFID"KR]7&QEY>GKQ_2FR<!J,SGN@9P<E//$'FRG^YB#]K2
M! 7'$Q3P1E=;E S&ZI".)Q;KM_LY.?G]P;*R(;KJ)V!_VP^P%89I;NH]\-H5
MQAMJ8I!WF$2W(27:6+U"0RC6".%^#+".(R1>]@A1SM!]17;_2]DG[IK#48+_
MVU+V3U""N393M==<\@/8!\QUXT2*F -1V$N:ZV[HRRW-V>WZ+2; KZAROW-8
M$["(2A)35'=-M",PS)Q6C^IGCGDA#5NBRGM\\ LM]S/V+9.  .WG1%@^9QPG
M1+0J(CN3D2:ZH%RA*YB#_U9(3O\5Q8U6TKYD_W+LXZB,60+F 2$P.^"13S[Y
MTN=2'N]=2*5VDO0'.%8:)'D'#JKBY]I7H.0?A$4EWHB9]B<$6]U_.]6O*3\^
M>^KHV?W\D/&][M2\8B"%.;F)!Q.I*^0"^ES'1+@<!D;/C-'6A3YKD4Y=7=Q6
MQ\6X\Y N:XXF,C;>9P=53+B#D9V-.</@*X2S6\:G<JNR^C<>2 \$SZF=KG!R
MBUXD;7PYBF4%?GTL0(:V5L6=<]K?Q=-8-QY9AQ26_O'1VTO&N7DJ_5.0T7#_
MCV>O>8]"(W$ RILQDL7'B"PV%/-!5F"%FR.L6LNGX!-8APC&_K!9G:[W$^=T
M:,_+9%[Y<=ZJ_YGBZH]')E!77U(MND<TUD&L]S!SKEL0)CS!QR.8"&M5DAS^
M+;VI=(.@78H9OU/S0Q(*L\YQ?!F?/!_W5&"O"M/_Y@W;3Z)RM_C/6?A>*1/.
M_U'*A!3_F0/ J(2\FJT>:_+ I@L@TY$WL5=C%L@#^TQ!%@VMX/?$@*TR+0I4
M31!UBK%&8.D[]T4<64F?R1>]7DK,<>C,TJSZCE\I&E%AH?.D"C/&MAY=9G/9
M=,>KO20*TCH*]N<-S(?K.4_J.#%A"A_'(Q]J"WWX*+02C_%4ZS&[T+_8QYLU
M-V$/CT\\75?:&*0:W46?'[NSJ/+C!*U/-SO^,:P?7L2W/Z#G, 8?_^6ADC"=
MN**=89%V.\GH).T'Y6S;9_QI/2EGFZZ[0%")X:O)&X62/]Z2;UO4KG;'[7#%
M5,RIO<+NN'DR;NUL.)?OLS=\_[N+R*TJ,'9: 3?83L6Q+<]".1CHUUT(4P!K
MLPLI0/50P)@ +G8;)??)JV\8<8X4<PU,C_L-8A?RI9?%Q=.UT8+_S=7CP=&4
M];\_0G<AXE]B=B&Y^W8AAXN[H-OZ/\)V(2^"Q7!K']G5^21;$NTS%Q/@V_IY
M["]YM7OM?RXZP_Z[:W0U#%=!F ER:0)3XU_<'RKT_[-I_K?IGQG_W2QW]LZ-
M:.':C'<A#Z 3YS8+F2N=:#(?391]5$EXK&4?IKC-\#[WMUQ+;-^%2(45=VXG
M=UI'93$RWNSD4?/DP32[F*]#1 .\6U@]O5O3!%8=(C[5\R@ P55GV9B.'C;?
M&]"[&R/4D/C1[$S/O1H_PH>/&J+B7M^)[B?*\:9E@6>^8U$W1LMTLV\5\UL4
M3A%\%DT$,(_HTG;TA@._+A3O#\APR:2=:[0+P"SC!.<PQDK2J05.AA\3[)4/
MW(R21Q#^6;RI8U442L!9R6R24-7$&LIL6.40??S+)*F/=4U;>B<[+;R?5;_B
M]KU[]JL9LXA+I3CPY/WATU )-A\=L]<U\'(95H2Y%>51FS,CH1V+U6$>:)7/
M+2ID&!,_+&QK?0I0RYCS'79]/<6?JKT\34J&@:=6EC.96YMR.Y6_=II)]^-1
M[J+[P<AN [C83R8L9KVZS!1HH(LT^CMT/X$E$'[69PW!>,"AF5LCLX06TC-=
MHS[T83^EPR-"Y[KN;O?\>8JK4-O8*E\D/XXL7,SZ714L%9V6OS#>6%\:9H2*
MZ+LYC"\B-C>]^30IU4PXVZ_L^?Q*J$,OA9>K?D4G9C;S ;X$K#7K/-;R&SN4
M+BH(VMJ.^[,5-!P:U1((\2\T*N7_12J)CVL^T/OXX/U(05);D..#W[K([&BQ
MB46#8S,^G-LD7QBH26)XLVS9*J2=/()US#0_H$?IS+:AP:07\X0?L)U*P:JN
MQL?X^J]K[2WR'T;TW.RMCH]W5O>=>%-*;LWZ6E[B^*.WV!GNW!/PMQ;L$8P:
MA_N0%T_RJHHP46=N=34KKD/C<8K^ND:L78B G_1[1<]6#C_P\\EKX->SBL*B
MW &W4:V@1$N7\<!1Q]RO%PAN!K:)05:GZ0IW13^O@ 8Q[<[0)!@BF7R 3HJ_
M)C^7Q%8'.-U6HC:CHN0ZV2#1%R:J32:GF5*U-RHD;',550,G<RR<M#*&W4B$
MZV?\'/PH-KBV'LX^H) DB/-!QQUL_ZRM,,&]\W! ?C$EOZ>$@G&Q!V;'7ZA6
M?PKL<'=:R*J/Y=FTA+W6_5.'G$'.XA!3?RBYTYH?=M[AJ%R7J]^*PP;3M ^X
M@GE4ZR2MNBF9=DU\?Y#H<Q-5[-E1-'YC25O(DG[Q@M;P53"*^@;%0%EU325O
MIM=-9P>4O8\*HUEA34OO80-VWL(0 Z#F+J2'$@47#%=DGX+O \^UI;KIRNOG
ME"V:J'_;.P5V:GT>:\N$TJT3O(;8%SP>*:9G9*/1!9.5B85?[%0&==7#KCJ/
M_91Y"WW,H;2HC[*YD,.COI.,-:VZV$FNZUII533\O?C;R:>)A#K0ZJX/L)W3
M1SN_K+FZ+OZ-"/"3D1%OLC >UU:O/9>*NTRBIDR+?"/ 0569IU[UPQKBN",8
MW$S5"ZRMRN-J[<VIG9XD8AAMOGBDY1+Z1'*'\XG8_-H?<ORUPRA&1XC8]7@J
M!7!)C@F'[E76Y^D$;8"J]A1==WDP@*E&[8G0U4NQN1^FW<[A868D^N@-9$BY
M_Z8KZ'ULRE1XWYCA]$]MD\YV,H>?BY GWX'JNY![?-W).TXDR9,'F$B.< ^0
MFU?"&<0I8;T?>0MM<63 B\6^C4$_GNIFP(!TL.-F+C!9BE7)/ -Z>X2,G4CQ
M6+OKE)_TRW$./BDR+0@#STO0C.M35 D-% 6<EV5\[U$;B1\#)]X OSY;W/=J
M2_E)B%! R-6XRX[I?TYP<..BQ.0NI/?V3@EI^1(8L@LIE7FAGKE3"YN]*QI)
MVGM^[@7=407#+LGG 0^A[ S*1 .GUR<>MJ$91RJ$B[./@H&4ZNA:P"(0?X9]
M-F8SD CHU3U[JOG<79$ 8K?#TH<.=1!M7;J$#!,,4J2;HC=U6^)L'\=KX@S@
M_W6\CWFQ,, QCPRGP99[Z-K?8^@^K=% 3 ])!(2P)4<YIQ<Y:BWUQ$@N/'\O
MI]4QQ<$+ZZ>$=R%Q>M!#-3D&71E*YS*OC&P(EA@CBEVL?%3DO=XJD;CKFT#*
M/W<WV"E?Y['(OM'"O56)]W[=VH7, XOR]E4SH>HJOGVXRL;Z,?2$F\-O9\,F
MT9?0)0'2(1PU$EZCEF "P>YC]G2+QLJ?**)5R7"^/:F*\5]'B_IMKB!*%BC"
M;$5D6;*0GT/&N8K@)T%SL1O:XDO;+^L^)2JYB8B*4%#[E_R8>8!U%7ARCJ'#
MNLX-\Y?"=3A?2>(;UGQ36#W +KG;)5%DW Q(?Y]6WJ,6@0TKQ 1?,3 D.(A;
M_JT\C%9S>3F83/AB;]]VZ^2!;;&J-A)X'CK3R]4?RB"2.OTF]"<R#TH,\?$.
M\T]]/9O9FB<J/]#E?C1% #MK'?L34'U5G9K2CP@-5J@],5^X\[-J1H$C,$Q'
MN6SV<>-A >; IB>0^#,-P1$9X3KFP>&?]9.J^(98HG<Y>2G<:/R/:#772\Q1
MA!R/GS:2_-3>(YWV%U1?'Y#9%/_/&8H!:(W/<EI%>'^X-L@[0U%RPZQQY7$!
MT\AQ*&A%&$&&OXA)K!COT$2@>9<?NFN<P:A9#P:^L>J]-WYKRE*\XNSQ\0M<
M#SH&[J"![,T?,.%*]/T&((;!2T-YMNFH+IB/8NUH*["NW(/-Q-77/9L+'A_&
ML7H/8EO4FIF73"%2*;#B%S!J!ARPCL<<>QK^F2+D?;CKR!4GAIY%\<OK<1$6
M12C;P)J6J2%SRKE/]XW3X%\H;*F\S;!!+A7,XP+<0)MU JR6$E5AS$OM=[$&
M8CI)!Q#RMW]<S4? Q,(EP>BOVH<7'@=8Z*Z&I3KBV=!*OY/W/2[VQ*)M\AV_
MASQ5VLL:;/ E[J4LG=_)P>ZCAP8KB2L= $_1^N)#8P()+</&=DQTMV85Y5B2
MXT_3CPW-AFZ=L2JB7$[SKN[EVW1265X"?!]' HL%7<K8TB">.LF-UCICF5>2
MN#2D>LK/6;@AG89WL1HC.%:@L1="N7'SAA,<H>_N-(2N@"]7-V?L0FJL=+79
M<WO=U#@\2Q2":(?U1!]'0!40O3D>M'.ZAY87,Q"OI7NHN'&4> '8LJ,PE6F[
MD,0L(QD#_8Q<N1&B*5T!+0[OD&A).U'PWFVJ&9\>-=M%ZLHC&+"ELV?&&0$L
M@^_A?8W6;1]UM5^TG$]K?Z*6@ VCX@XO;G^MG2E=S[&U'AFW!M!/'V#UT#A:
MSM7.K+'L8H42%-:2;J%2CYS2ZIX^N9*.;X45K) GJ7GM51.LO:YC]E@#4(^:
M"&U5XJ\&%9DW.91+@Z:]]2PNO8OQ=][<#EGQUUKQ7]%*L,F.+V]Z,Y?99[6J
M6 #-A0+^,NSL'@;OWG][EKN0$:AY54G+/L[G/"B6RR)YTL "P)+N7T4GR6'#
MP%H /G.BS!@V(RK&Q8\1HE$52&D+'G,_!#Y"!U5.35D4F63[(-ZZ^!FZ%9B]
M7S#1:!EWG_#G3UU= 9HXAX99&#]8+;2S3W3BX18MIZ42YDM)VCN#8!!$GS+K
M-'BBNO4,C5Z!T80:"=D=?%>:4'Z_?RUN=QL%9CI\F[1LC*.Z72V)356_*WH7
M1.WEG2["-IU-U'&+L<S$L)Y="-^1L\D3..J]#(7D'L+=3PIQ51T4N>B[AB^+
M7ND<@-1$COBL(3D"QTE2L+O6H+HJB8%$TGC&L#ITM P"+F5\0&]I)\V4F9NC
M]IPP(,B^ :0M9@#NE2EX%^N02D3-C<UQ!S*JOO0=)H7 >HW&O\OKPU&+X/5;
MW6CPI';[R@&L:SVH4X)5W7G3(@NNCK<^-C!,^F!\;5H#[)V!BV#B7=^\91[P
ME>>167B+<6G+W%QYC]!?K8S9*9":;GBXADDVKZN&<%YR[P-)GFN]7#?@R02/
MS223Y46%W=B*P/@RBW;1NCO#1',PD&OROHWIA(>M6?=?82^63DZ1D4]R2RLM
MWB.V15Z-#5OA*G\LC-67^!<]3_XBNA_79MMBPK[R8:1EKTP:-T92<[+0,5C^
M8J1\V:0?GA92R38J\)-G3%(&2A>?B#X;;X<*LP^4NX65:DL/.#$K&XK-3L6?
M6&U7;4 CP 8@C0[MAH-'?=K1(EC=X8V+C^#?.!)L56;S7#0!4_1IA&A&6^%'
MZF_G-GDBO'D>6I4,%$^H@W&:)KS([$^!YVFU2:'=$=/H >V]AE-LJ7*WO8[A
MD[ ) UK/,@./-0<W NA5DLY8->(WE:CUJ6 G9C]C=">Q)RY079V?:(I?<A:I
M#<SXME!_C%2_KF"DJ&\%OVQU\?Y=D4F.,-WP%;QN@"&#*NW.:.B@?LT/,E+'
MJ6K>&WD+OJ&9SR6=QSOA][M8J7ZY%<+[+LG ^QGQ_6R6 ;O"Q6 G(R=X%W+'
MON .B1I1ZT<1P:&KDO,$.:J7M:*8TNBH<!CP%5_D9^O2O!Y^'H!W#APBQ>E>
M4!JSP%?J"<)KD)FV%RN&)@E/['Y\Z%-Q<:N<IZQ6/Z!L.@=1=FR<$R%0X Y7
MH/^ULKRP"_& 3[CL0NQ='(8H0$!QZX066Q40W$P?9+S1-M:N]"/Q&SN$^><M
M'+ >I^5UM1S*M2C8[Z@9F&-KQ@P45-=)< ?CR+HZEJ=C6[@2+X(K]S[[X'RL
M60*<SY3M&C*I0!0\B6LM8)F%=\.@'&GR1!@)W@QP"6,L5G'_=7>ZM1PH;X[U
MI,6[V)N&W,N\,QIH&29O%FM95UGTB-\AR>$ZA/.0:R*5\+K1<88J:T]+&Q%E
M:*S,,6-39FB[/5R.C2YTS".X6LR$P?Z*IX7G^.R_PD?VPLE/L>V&4O2Y4=EW
M^%:(I?)9TQWS\"]P/HU=B ]E8HXZT(;4?0Z-WH6($'5H^.O(L/?JC/#AOYZQ
MK<HBGMUJJ::?"K*RM[>S0Z 57T$N5=$5./R7@0;7G4*<?]Y$0SOGZ,?F,384
MN 3'7@EUJ4_]/=#1(@F(?*I@7QE:;PI]Q/I(R+&EC\<NDW]/?9YLGHNKX__I
MY$YM,]B:NL2+R]V%/"/=A\61ZGH8,\PJZDH;21+T;./H-X/QS YXI#/S<0,=
M)CJ_4.SK?F9T;D238@-4/J.[.?EK*:=+'TJSQ*C>O;9VY:T$Y[D4VX^[)R=W
M(;,Z>5*[D.53+&O<HF7)+3X'&@PT\-DL9LK$:?J ;:Q+6-EA79F,T2!-9#O7
MML3"CV'>X953['WQ7 >6Q!BT/K8^[7)0&F]"/.ZD'Y-P7027OU050ZHA+9NR
M9%TQT!YY^Z=YM3YME(,'Z"[61Q8,?>*H3.-4OVJ*=3#>=VOS-H*CPO1)-$;B
M%+O>YTA%<%5J7!#22/'XYU&K1 +,=WQVA2VM35/KA"60/L"Z\OY/=]T0/829
M7NMP-K[]8]%=&=AZ3KR,*%VJU\^X9:9"3M@.2R6]R!^FVG]JRKQJ_F FE_FV
MX?6!U9[6/.#.2C+I<(6>=A0,N+$+ =7N9],H^Q'D[K)Z<CG&'4D2F2='-SW>
M6EM\DAM)#0)B.G"0Q7&XGV57[1@6B5\8_'ROE_@A%C79B:-.*Y>:LEPY@X_)
M_R"06!.A137;FH;5VV.:-T1C<R63,#-QHUG?5 E#KEU\+YUE9QX[*GSVQ^3]
MOPL9_MF<0^KZ>&!N<QO\ Y#H=\3GX6+W08>978C0(MF^2*^)8C:3S,O^"X@'
M"ZZF,+RRR#.WZE@G/@6=(_=K-ID5N?4)U9C6?=__^[^601B#=>%/#].+V4=.
M>;P#R?U:Z^7625 AZ8OG;B7T(S2KGII(@"Y.WXXA[Y\PJ!W16E=0GS@:=,8U
M>\*9?DH\)&53%_W'L1[-TC1<X93@KS=RI3:T=1<2#Z_59F12M<&3#NU(RX7
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MQ1I;T^"B%'"2RUU>_!QE'R??7N(/HJU(+S9(?SLV%LBXW;>\1OA2^[ON+.I
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M[]6(,C-K4\@]"HCN:"QID,^-S%^\,J1]XAM\X;%!Q!CT58@^G<[/H^/AL!7
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MQ I2+T@:FB<)-!J>.?WOYQLU'XX].QHA;!('H:Y#HW!"QNIEUI48.*WG*=L
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MQDJN5TOFS:40O#4DTB%,I@CJQ8](UYBK"5K@R6#9-$-2I]MR Z,Y2C2J%H8
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M7<J<4WLZ@B\51((SW,2/CEWD.,D&PNF>@+GV]]VX,KRA1_^7Z+ [1=X)W)[
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M8]:_3MC:?Q5X1[9R>!/P^=.#,L)R@VHC\KNZ%%*G+*8_598._S=02P,$%
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ME\Y'[[N4IY>KTN_;X5J?GZ\Z];#V$G,A&Z-5#/7_;P( 4$L#!!0    ( !B
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M[]OA6I^?KSKUL/82<R$;HU4,]?]O @!02P,$%     @ &( Z6Y7M34#W @
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M<_>$/[MV.^**4N/6V>8[&/[?! !02P,$%     @ &( Z6_P '3J; @  D0,
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M];#V$G,A&Z-5#/7_;P( 4$L#!!0    ( !B .EN5[4U ]P(  .D#   2
M:6UG,34U-#(T,#@U7S<N:G!G^W_C_P,& 2\W3S<&1B9&A@0@9/A_F\&9@9%"
M #*$4C,8_Q]@$.1@$&#@96948F 29&069/Q_A$&>@8&1%:*  0H8F9A96-G8
M.3BYN($*M@HP,#$R,S.Q,+.RLK  96N!\@PL@JQ"BH:.;,*!B>Q*A2)&C1,7
M<B@[;3PH&G3Q@XIQ4E$3)Y>8N(2DE*J:NH:FEHFIF;F%I96SBZN;NX>G5W!(
M:%AX1&14<DIJ6GI&9E9Q26E9>45E57-+:UM[1V?7I,E3IDZ;/F/FK$6+ERQ=
MMGS%RE6;-F_9NFW[CIV[#AT^<O38\1,G3UVZ?.7JM>LW;MYZ^.CQDZ?/GK]X
M^>KCI\]?OG[[_N/G+Y"_&!F8X5['ZB]!H+^86%B86=A!_F)D*@<I$&1A531D
M$W(,9$\L%%8R:N00<9JX<.-!3F7CH ^B2447N<143!ZJ?@1Y#>PSXCS61);/
MX!Y#^.L6 P\S(S#RF 49[!D^K?]A/?_A^;?:'ZN_'?KAMY_?/M._Y9[F#]N'
M\]NBQ";ROWFR?RO[(?GV?88_O#^:FO9F!U[[D_AH?\L_@Q^M#V.#BA_SJOUG
M./Q=*KS_/\/F]U'7#GOGJGW*53OMOW%VT+\U^Q\T;+LOOJ7_A^KU-Y\?SN^7
MW^+>4)]IWR4GN?VCV?PU/]8?D!>OT?UX[OHA*=/C'?E?]=G_&%[_IU[A'O-1
M;O(C?Z$?TH>^[XJ;O&)+U;E%NZ)T][5FU]8G+HV*CZD7F"?XX?[;]@^;'X:_
MG?[@Y]:W^?\X+_YG8#7]L1I(,NSX<?NQ?D_\EFU3@6[=U7],_F9YU(=_^UY_
M^/UP^5O5\@?W!3/\<Q^N[[9JV6?XT;RMI%[DQLT_7A=+9;5RM;X?#<Q(=UT?
M_K?!1AYH5O^/P(^'OSW]T?_;M$;]Q_'?WA7AC]V/^+?_:MO[V^&/SH_0\M\F
M-0H_MC_*YXFHN/!JGMZ/X@?W)3/EV7+TMZSN?B]T+^I.UC[9#W/WA#^[=COB
MBE+CUMGF.QC^WP0 4$L#!!0    ( !B .EO\ !TZFP(  )$#   2    :6UG
M,34U-#(T,#@U7S@N:G!G^W_C_P,& 2\W3S<&1B9&A@0@9/A_F\&9@9%" #*$
M4C,8_Q]@$.1@$&#@86948F 29&069/Q_A$&>@8&1%:*  0H8F9A96-G8.3BY
MN($*M@HP,#$R,S.Q,+.RLK  96N!\@PL@JQ"BH:.;,*!B>Q*A2)&C1,7<B@[
M;3PH&G3Q@XIQ4E$3)Y>8N(2DE*J:NH:FEHFIF;F%I96SBZN;NX>G5W!(:%AX
M1&14<DIJ6GI&9E9Q26E9>45E57-+:UM[1V?7I,E3IDZ;/F/FK$6+ERQ=MGS%
MRE6;-F_9NFW[CIV[#AT^<O38\1,G3UVZ?.7JM>LW;MYZ^.CQDZ?/GK]X^>KC
MI\]?OG[[_N/G+Y"_&!F8X5['ZB]!H+^86%B86=A!_F)D*@<I$&1A531D$W(,
M9$\L%%8R:N00<9JX<.-!3F7CH ^B2447N<143!ZJ?@1Y#>PSXCS61);/X!Y#
M^.L6*/: D<<LR&#/\+?U/T/3H8KT1_.[_S-DO.<Y_W!]5QSWE3^Z2RO*7;=>
MLA&KT_^A?-AJ_>'[PLXZE[+$H\ZWF;X7?G'=*O7<ND^W7P54S'W[9V?.G]G6
MJT]7?+D=DG_O_$W+/<[_&7@>?ZCB%Z_X[/QCYJ/9^JR99G$*'Y>WU[BF/WJK
M'W;E;;*AU\0?LXX]>G4[=L?EQ8*9TW=MNN-SJ_?IG.^3O)7/G;M_M/QX?UN]
MK,GZKGWFNW],__#X$7_[']]'\F*O;^V]$J=PH;3B^=Y=5TN]9]],W[IG&EMS
M:%ME>GK?OV./WEU[;9<C+JS,;K]D_L;^]OUY_QG:[W/DE;QOG\_Z3V=[6VF]
M>-:LOULNN9JW/=HY[;GGA1RY1Y?.1^^[E*>7J]+OV^%:GY^O.O6P]A)S(1NC
M50SU_V\" %!+ P04    "  8@#I;E>U-0/<"  #I P  $@   &EM9S$U-30R
M-# X-5\Y+FIP9_M_X_\#!@$O-T\W!D8F1H8$(&3X?YO!F8&10@ RA%(S&/\?
M8!#D8!!@X&5F5&)@$F1D%F3\?X1!GH&!D16B@ $*&)F865C9V#DXN;B!"K8*
M,# Q,C,SL3"SLK*P &5K@?(,+(*L0HJ&CFS"@8GL2H4B1HT3%W(H.VT\*!IT
M\8.*<5)1$R>7F+B$I)2JFKJ&II:)J9FYA:65LXNKF[N'IU=P2&A8>$1D5')*
M:EIZ1F96<4EI67E%955S2VM;>T=GUZ3)4Z9.FSYCYJQ%BY<L7;9\Q<I5FS9O
MV;IM^XZ=NPX=/G+TV/$3)T]=NGSEZK7K-V[>>OCH\9.GSYZ_>/GJXZ?/7[Y^
M^_[CYR^0OQ@9F.%>Q^HO0:"_F%A8F%G80?YB9"H'*1!D854T9!-R#&1/+!16
M,FKD$'&:N'#C04YEXZ /HDE%%[G$5$P>JGX$>0WL,^(\UD26S^ >0_CK%@,/
M,R,P\I@%&>P9/JW_83W_X?FWVA^KOQWZX;>?WS[3O^6>Y@_;A_/;HL0F\K]Y
MLG\K^R'Y]GV&/[P_FIKV9@=>^Y/X:'_+/X,?K0]C@XH?\ZK]9SC\72J\_S_#
MYO=1UPY[YZI]RE4[[;]Q=M"_-?L?-&R[+[ZE_X?J]3>?'\[OE]_BWE"?:=\E
M)[G]H]G\-3_6'Y 7K]']>.[Z(2G3XQWY7_79_QA>_Z=>X1[S46[R(W^A']*'
MON^*F[QB2]6Y1;NB=/>U9M?6)RZ-BH^I%Y@G^.'^V_8/FQ^&OYW^X.?6M_G_
M."_^9V U_;$:2#+L^''[L7Y/_)9M4X%NW=5_3/YF>=2'?_M>?_C]</E;U?('
M]P4S_',?KN^V:MEG^-&\K:1>Y,;-/UX72V6U<K6^'PW,2'=='_ZWP48>:%;_
MC\"/A[\]_='_V[1&_<?QW]X5X8_=C_BW_VK;^]OAC\Z/T/+?)C4*/[8_RN>)
MJ+CP:I[>C^(']R4SY=ER]+>L[GXO="_J3M8^V0]S]X0_NW8[XHI2X];9YCL8
M_M\$ %!+ P04    "  8@#I;07MY2JV; P  52X $0   &QI=',M,C R-3 V
M,S N:'1M[+U[<]PXDB_Z_WX*'L_.CCNN((,@2()R=Y]0R]:LIFW+QU+O[-X;
M-QQX2AQ7D34D2X_Y]"<3K"J57I8L5:E8$GMGNU5\@$ B'[],)!(__^^SX2 X
ML56=E\4O?PDWZ5\"6^C2Y,71+W_9/MC9V_O+__[UWW[^7X0$[W;W/@6?[&FP
MK9O\Q+[+:STHZW%E@]<''W\*]HI!7MC@OW_[\B%X5^KQT!9-0(+CIAEMO7ES
M>GJZ:5Q>U.5@W,"WZDU=#M\$A$P:WZFLQ.O!.]G88(M1%A.:$98<AO$6XUN1
MV RS5/P_E&Y1.O=:.3JO\J/C)GBM?PKP+?AV4=C!P)X'NWDA"YW+07 P_>H&
M=%-O!MN#0? %7ZN#+[:VU8DUFVVCQPW0 VA2U+^\FNOZ:;195D=OPBS+WISA
M,Z_:A[;.5#4P^>Q9_.F?9)0F;]J;EQYM;GPT;A]MYA_-+W5@_NGH#="Q@:'9
MZ?- ^6_?>1QO*UG/'C^[]ORE\>'=Z:/YV6WMAM@-G'*<\>GC15E\@IFO<GWS
M:Z:IWC3G(_L&'B1%^^2L5W5^4Y]@!.&;__[XX4 ?VZ$D5X<^KLF1E*/9FT[6
MRK\WN?$&F6+Z,'R>X.?K.WH'[W!"0Q*%%Q1N+EZ"'[9N*N#4HW//Q_@-FD1T
M^K0^-Y?GN;9Z\Z@\>0,W+G4H/VL(W+O4G>FS%]1] ]\J:E=60R\C2'R0#C'7
M/:L-J<?JYH].;E[Z<%TUUTD&%R\]-&ZJ6[DJ>P-W9W2U^<V?AAN7QUN7G(7I
M]UB[?6(V,& 2=I/,,/K&GC6VJ',UL,1Z7O+4J0G;I'-TN94F5R?BYDY];Q88
M(Y21,'GUZ[\%/Q];:>"_P<]-W@SLKR$EO__\IOT;KPYM([TR)/:?X_SDEU<[
M90'=;\@A,-RK0+>_?GG5P*C>> WS!EM],VGV9U6:\Z!NS@?VEU<C:5!!;XG1
MV=NAK([R8DN.F_)_Y<-168%T-&__!7)B[-D6?4M.K?J6-P3;)77^+TND^<>X
M;K9"2O_\=E36.0YFJ[(#B5K][2O?6Y.?3#]F\GHTD.<HVGCWY_QL"_MDJ_;/
MW!A;^#\O9#_(@>J[7X6B.HIL2+23E'!G#1$B3(!SC<V,B)-(1*^"0@[Q*S;?
MFEJ-7; L<O 96BK-+ERK)^0Y:[Y8!X3[RK,DR9B)B5!A2'C"4Z)2HXAS/%6A
M"96EZ:M?=__GYS>7NG5S+UV<N"B&J8P$EX0KDP*%!#8K$LTC'2G#YWOYOH!)
M/=^!?E9RL(=4_MV>/ZR'%%0;2UA(^;UZRC--+8N GJG*"#>*DHRSE!AHGE(M
MHX1G\SW=!F(:3]"!/'I8#YT<U/:6SNU64GN3/>F=5(Y%(@:M!"3DCD/OA(._
MA(U%8BGEH9[V;J*;MW;*X3!OL(OU=F%0(H"M 7_D]MJ<*Q>J*)6"4.5@\,I9
M(J)8$J-M&B8NBQ()S8^+O'WACZ]_'+P#X:[SK2(?@%A58PO,^^9RUV\92A:G
ML>2 0&*>,,*ML 1()8C,J$T2D6;"RD<,)3$Q-5DD2:)#2[@6E*@,1@9LF B5
M1EJKAP_E,LO .)21$71=4$5X;.%3<:H)<$H8.>M<QLW5D7RNRI&MFO// ] D
M,);WH*]&.+ _:NO&@P^YLU='))126G)!8%A ,!TZ NT#1U&JC-8<M*UZ]>OG
MZ'X2&2)U1&H(=!!:"SE,M<@$L0QHY83+TCB[VND/%O#-^[-1WAH!1)'APU@>
MU#HP601L?*_.*@LLH3@GJ=- 8<%@Z)%0A!FM0(6$*E'I0SH;)<8DSFKB&+ Z
MB#DH;J1)'/*0Z<AE5F<_W%G&8NZ49L#.B0'&=L .7%G"- U3F6;6<7ZULP?V
M""?_BT7; CR]4YHAJ+W\)#=C.3A$ P=,\GEB2/:KOU;E>+1?M?+06/L)6GL_
ML]3O+PSUPZ;G-LSRIYWCW+KW9U:/T8[M.Y=K6WVT0V6KX/LOS?R$2R_=3^NI
M.&2911NG0P$491F10&42Q4:"H%%)PVNJ EJ$]O?=_LA3HCB:D/AA=FY>44P:
M>A48J_,AZ.Y?7NU]VGT5M*#EEU<3N+D%DW!:5J:VQ:M?]PM[/UW"4S!4(;!,
M$H%H<Q.G1&3 \S)-(C!+61+'])I6',BZWG=_EQ5@IV:_0J>K;I#A=ZMR^/?C
M7!]/[M7MS::&*:QT7DM@EFOT",'PV4B3+$/VU0@H4@Y0.$IM*L$$Q F]--@M
M U\B0VCDF!AY3LZMK,#LI@3,/:,1O9?0&,EDJ%'")8=9B''<- 'TG;'0@O&F
M7,3+';=10L81HZ!>0Z \!<,OJ) D!NW-7!)Q&D6+'[=-@-X:S!2/40-Q!U9$
MQL#?5B;4A(+1Y)IF6^RX 7I9T%8)4:%S "FH(5G*&5%6NYAI!F//'C?N-Y<A
M;&6=K<!HV_K7G]$+WJJ]TPG=";Q7O(7>X2^O:@#:V-OVVG&%O44'D4S]P,VS
MV@!^]\W/M^E_UN6X\K^\E[\U&;(G.EA2&BH%< Z\BB0!<Y(HDB5  <?C5%F5
M  *DKZ:O6@]%I[]R@[]=#OK.=]O>Z%7N[/U^&7A>?7G:7-WJDO:G@8^=C0:Y
MSIN)2C7Y$%5Z6<P!!P ,J.VWS_+ZU:](D"TP%&-ML1V\.56L-[;XZ[0KLP^_
MN6F4(^\6S,;LHP'-KVV\*"$XQ9?O3']/WWMSB>JW3$+$ +*@8K$(M,%/(2H!
MEUN%%K LIPAGNSH)!PV( +Z#L W\E!)\PL*CTHM9^>O!EZD4'L*_H9^[P)-W
MS,[]>S!6-?BXV(43^!?ZM^VW;WE@V5R!TK\8KA ,N((A+ 5]&*6<B%!: 'Y2
MR BU$R"]->:*@S:BE>MM<Y+7935ED9XO[N +'L69 <,LX@BL5&(YN'. D+3A
MDF?@0DJ[KGPQ[]R6Q4%3ZF]+G16^0!T>.QHK!OY3G($.URGH< W^4YJ%-(G#
M%/QYUK59 3=Y:^;![* PEM5Y.Q-XZU-9?+;E)UL^5B*QL6WSC\,2Y_NB_??_
M;,ZW3\$MV"L.QL-AY=FA;HI#-=@MJ^W10 W^YRXK\8#YASFN/$3\M8VHIH2&
MLW9F]V8S9::/1I>997KG0<R2TE0XL/6,)0"P,721,6Y(Y+@5+*4RM:YKS#*5
MS;U"ET-[*,^VQ\UQ64'7KFA5%''PT#^46@[^-J[RVN3>RUOR3/+[SV2\T)FT
M(8\PI)'%X#(XP,\PE<2 QYPYDQDIPJ[.Y((-Y ]]-S>YK,X/Y,#N.Z_G+W_Y
M<Y6?P)0 B&_1_))YQUOG,+TG[\P_^BC>R6C$$R6(<&C(:1P1P6,+*"^.9>QB
MF]#.F8S'P?Y#\%WM\\%WUWGH N'=R4,7CSZ.AV2D;&Q(;#'@KL&<9-P8DLE,
M.LJ=B$76-1Y"VW\1T9UCF'<2+GW\HZJ7A3AVCHNCO6*W^B^,O>Z/F]H41V"J
M_BA.ZL;,X,A?JZ(Q>\7GJOJ?ZM'>R!T8Z_.=Z.JQ?.EA"[T77RX2X=QKA:9;
M?%E7S=8761Q-U C^_)@7^7 \7)M DC$ACYDD-LLP9, SH@")D$R%UJ2)R))P
MZ6CD ?QY7]S&%\B?-N8"%^"-0 2><48$E9I$L75AY#)&TZB+_+E38DI;;OR*
MUAZ8X"N>\[4UGL?J+_SHYZHT8]WL5P>V.LGU?,#UXWMOTS&>=X^8W@)TV2IX
MQ?$T=520),PD >O*B7)90D*NN(M!S]&LD[SBUTKWW8VF]OUP-"C/K5U8M&W[
M5%;F.@:;?L=C_/W1\_4#G>*93 P)(X/I(IH2$2<<_B5M:I,TM-1TD4=>MCY9
M#:]D--3:. :\POP"+V"CA .O)&BQ3<PC)KK&*U-^V)4YHN>Q_>W\HY68C>T3
MOBKO9^DKH:#9PW./UE\ "U<5<-2Z1'8SJN*8:4%L$G-0_U2"AYXPXB2ETFHJ
M72P[ *KF!A^1D,ZQ]:,&'ZG,9E:0D*44$"6T+9VB)(TE@*0TB<.DNTN3M\>9
MO*[9;@Z/[4=9?;,-/K!]!(KGJ8)-]PX49"3,%J)T./@ ,2!<H5)PR*1E),MD
M1!S7*DPEBX5;.A<_="*WH063#[P+?8#J(V]R6[\_TX.QL08S/=#-'S?>B.V[
M][(J0+_4GVUU<"PK4%4W-W!964U"5<\2P69)DF0I [&U-B+<2@%2K"VQG+$L
M2UT69;:KD[^R*/7#(IRGRX[GK";.F"6ILS;,B# 1Q:SU$#"+L$3',-\I2T)P
M@[K&02M>WO1AQNUZW_E XOO"@&:Z,<2X.S#_53>8Z5J8^ET%?YQ49NDKGS^
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M2:V2B0#,F$GC@"M KXHL28F+0\NT=9E).QO9?9*]!I,)[<[:SP(S+ZGCH6:
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M#SS#18-',-#\YKE',9 *G6-<$L%YAE&)C$CE8A([SA+%0QMWK[ =5C#^7)4
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MBQ."U^_/I&[\;&,*9#6;Y4#603VRVLMMD!=!WM2!/I85C.:GM=5*ZZEY^E2
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MIV./(7L,V:=:/E<KNUSHR'KDN/+XP MF[CLCE?$J8>3GJAPAZ6T?FNQ#D^M
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M<+P9R)OA)%-D4&(<'M@"&*(H3]KVT94#)PW "?87\Y8J>R5G +Y\7'B7$7D
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MAXQ2B;$])WN>CHW?SQU(2WA 0M;H0*Z8HLA,Q=<Y<1@GG3).G++7A[?B&$J
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M').G]-QH&$T9O#?U0C]!KN*NUDV*$$9WJ%P-.SS1JG4%,,Y8GI 7U9T4@JG
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M&:][<G/L0 ZR<K/]K.WK3U[' HVT=L' >V+J-.7VOE$AF[RIJUHVYNZ>3/$
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M$)E*+,XJJPJ6WUD+F'_$^PT:-PQ-*F%S*5PHJ\IUSG3DQ% @^$J:[,0>%^^
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MFL(MY&HK=F8-*HUM@BE@&H<91^56GE^655XIZEPII#7TOX?)Q-K,0]=*Y+F
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M:5\+NR6\:VAQ6!%X)UU8_,IC(83;AG0IEPTC,P=S9FH>7I>:PQWI=0D_DJ;
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MO*LRN1:T#-8UV% :8]$U/$=>0MW8GE ;^-;LQ-IZX5IZSY59VDS@Y*2_10]
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M/<(ENOA4BPDT'EK7Z+=.#S.?-_SZ<C#J%8%RH6_!%Y%2D=E?/4M++.OE:/-
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M8?(&I&-KRRA*:I$KC"U>2 >:L2UW<C6%L'])1\ L&"P>7+OELO"-\8R*1-T
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M95P*2GWS-HY@=(CDD:NBR1.=\,-$HOC7-3;BE9)LZG%+_RZ(X8MB79B[Y(Z
M79]*#BIYK!R/=!XBK:-;!68.,S>D:Z:^HJ9@?5+3.EQ+95Z:>ASSD1:OI=,O
MU7M59[RL:54UT@L]JJ04S 0!"$%^KDH'_.O0 1?Z+,5#$HV#AMS=FGI[GX+X
MG*52P2-:S;G=9<CN"Q(.K; ND-F2>ZJ55<WFRR<EV==S/D81'WFN'.)-W12I
M;ZKL2VN)+V%Y2JE>IUYG3(QIAD*-RS?'07&TOB>8WE=V@+!P!L:!72KQ1HC)
M2VKJT*N+]C$FQTO6/E=H?[8/']>,(3$5&T=O CNY0H:*&[]5$H>MF>DU0XT
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MBC8FFI6#W6F1A(Z[GA?A)_0'J'JE9Q\'JXIJ)=$HP]T@W3P,?8"SEE;#"!O
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MW!2O_Q\^ZU\;47V++!\.5N,XCG& ^J-CCE:-CX[VQ9Y"G4N85=Z#1"_60:B
MZ--.)+8)LBC$)-.'65.U<":N!<)1/WL^25CM98.V&4SE[[F8'A0M8ZRF''X(
M@ZHW9A#'VMJVK#-0N<+0.>X$<P=3\2OLVLE>B*P$AWR<Z/*2%WC/M_:>[TQT
M*GCR]Q=OWSVEU2;<(U8X@UK3@&$I:Z#<$#ZX\QX,R";M;GD]&"6YL.9*I9F>
MN^]&\3*>81R&$[!E\PJ#;%7JK*X5'U=M26R?I\8L"CU,5R3K8U@.9\(@N4HX
MU;U'W=C?4N$9F%;+#31^K4?,FX^55M_<;+[L2P=!9&$(:W,""2M*!UM@V(3I
MJ<[.$+L1%$:IX<V79@)#;>.:!I-<'D KS-?W@&>]]G7J3@R?&JE-(@MD4!QS
MDHC*8S1<F7)2,^9[(UU.7B'<U54?6F_ >HCI+?O%2-1+G?$\AOT1/'GY\O@I
M2"=QD%3<191+VH/?A_\<:M2Y3B7ST?H'R$^%->W<OY1'QSCM1($X)K8Z7?(K
MYNG8P1+>BK3A,1@DIZ8=A5JQRRJ,2[R%-%XFA^G595 &A(I^*I@(#1NJ1"E0
M8!.^7 4S5%V3\:6/?XUI#[2*G>1P<%9<:-/XLL=IV)@9J$TET0I@[*.L-1$P
M?<0L4OJCBS,EU/JZG!YYZY><2R 4'\VC8S+![<UKH,>/D/I?T'U\+PXE*%M*
M=%1=\U^>2.V53TME2@E:J$?2<%JBC+;:."TNFQ63,B^IH"9W#J] I-Z(XPK4
M!OU]01:".Q0<;(MG"JE3D7DML?.+A(06+_+R]Y:<(G4%SEA59(UIL8MF#F9E
M_E3F-:O-G6-O^?+89'(M\PI52-#"H(&KEX;L<?AQZ':A)@='U_YQW81#*;F1
M%>HJ:3??:!3TO"EA3]O:"&$? ]L)]!R^#Z'9VK;1HG#@N]:&>$E-"O461TCL
MVG91="H.95ZWZQIWQG[>4!G"QD)A^I"="RZ&B1+8:G& F(V%PWAB'$ L@LJ[
M)D-H0CA&"*KVDCGO9,: Y7V<3EQO^$NF:!,5C"DAR]4IF&VNV=+N@,$:+TVD
M:@I%5;><,'E%!5*ST)+A+CULCB:N=5BE5(NF@KF$W:TQ-(PM-A :N^G;8;$J
MU1V?J5D'):25CM;9'N>R)0EMDM;.QB)9KE(3(*)LJ\8=L\-N0%S.2_8=-N[,
MTV=@POV!-H _Z_59WZ:?.<$D=0&7160MHZ@Z'YT@CA7V,R@R]H:H>.WDY"U6
MKTEE&09ZB!7(:%CM.@F]T8)K(NE&5? D$JD%USU!EX$(49@:2;,4D=D173QE
MZQA# )6CAES/S#@YKGD/@H\JAS8(2$]"Y8<;HF*'!.,[ S-3G159(H8[OB))
M:Z>>P.)G;); 5F4ZD:D.)Z!1G().X-[S'8OV*ZU9L&)4GO Q*UI'7B-/(L<L
M<-97+^L[7BE>W;?OP ZC,YI])_>(,$O;*OVV-9]H]41Y@[MZ3(;/U(F,=_H%
ML]>JE\'<FMQ8C(V+-<8L8+HET_^FN,G2* Q^KZ.S$"64FA3'C>Y+CCV(DT*,
M#&8OHPA>JS"51\:8&;'HN"B8AF!T/YL0"TI<$(ZD)A[-!9;;@).K*QZ=H9H@
MABYW5CE*#(4/VZ_OOF\G%45;BIY16FY ._5;HB(MJ72!EZWH&,=!L'I5/U]'
M770U(7ATJ()1^DQE#;^^+M>D +D,61 DMLQ&W]?=D<YHO!XV$2\DIR)V=:DX
M<^M]#/^I0-M;=3TVFF2JB3CO8#(ID2:CD@K^8DM&*J3^+J=L6G"/'D-QZ>Y'
M4E@4GS&9#C=\5B)3'BTQ:/4L"3>*N-B)U+RL98O0%6]H Q\$LW >JFE9N3Q=
M1,LY^5L3(TFAOJR75&!Q"$;G=-OET9>&&#S@Z>$#GO8\X,D#GCS@R0.>=A/P
MQ.U$L&"\&YE7^7E:%D)_$NK,##E W,PGZT&A._6_8@*+,RPU'QQ?78&!FI'W
M8F#5CH^B.2HZ;3R\%==A;')F-D=O!K,6-UPTMSP3O2_.IG%:3,IRUFP_)>1C
MZ!2+]G1#C+Z$E.>/L"LCL14;[ 4J\:+B-EIGT9]1F>!0-7> !&J0[P"K^BF>
M!5-#[B3^+^-4I"X<79RP:VJQ.\!I5_R9)!7MH\A[S:+EDG2\>7 K17JFEAA>
M$KA22MB-F$K#W&$:>FI=PF\?0F\P#%[:TB034>L)HBTDS>#.#4?>>^;%):G5
M) :P3146*N0Z9Z(9NT@ATN="&Y#F?S2EKN9P*PW=AY''UJ(-N?Y]>,++UKO@
M$O6L=4L_@'AF;(9K/J/<O3U;S[8EE;77=8\BHBB7!"=C.6R\TR4A<!$A_0'G
M.#U/B=<@+FE.=>Z5@D%&6^$8'2XG5UM:!J?+BA:^=[5E\&&(H>'&U=B3@DO0
M\TK0A :2X*)B%H4^)#06+:=4E%M/(E@^$M34QF]M*?4VV>W52R$</;4&.W8!
M/88'3J?Z3*70!@VU$5PBJ_^?XD(1GY?MXF5FQ3Z&VJ>YNMR1?BJ@_)S&\-_2
MH(3<!FU,!-4BE/)2Z,"';6"J)3V;'54PS(96>7>S.[D*Z2!PHW-W&)Q<?J/>
MJPR!05IJW:>B,CYK,T04)A&"6TIB:IVPW!959NNP>A_=WX*&U&78MNP\M]<7
MJ$:Q!]I60K/"YJ^Z()Q(1,PF[P2..-:^02!ETJ0F2BN@"PT$TK_4#$5K3'XX
MG4"T@LM,JW/#CQAIWAAS$Z]F](J^9$1ST=2(1-$6D8!U6^2WO2LF);RB1Q18
M]]*H5H<YJ>!?9>O+PH]?QHA[108(551? @AY#3=>@I+=_>^PAIL2<R),C136
MLIX0PY/0WRK1@5CZ5"5&Y@3EKN/0'2(O=V)A-Y %:7ZJ*Q3:]0(VS>,&JQ=1
M+">V[>5@&\O+G*ND.^-@[H,*)K(TV:9NM3,A)'0.GX@C0TYW64;/9K//I-FX
MS/CI*EW,JA<)N0X@J$(+L;&?6_47SN[G?:X!]IC,)^ SL9D@_1HR@VGKILLI
MN+GUW5)G^IG)_F^>KL9Z@UF/]($BT!@JOH:9S75'%\XW?-E;?0TS],WV@3_;
MMI(5X(+:+#FCLV@/6^ZJ7-7.K LO[S42)!YE>0W+0L0?JT@PC+-ENLDV?*%B
MTX_M(+397(<)EW++ LRRB>4Z^MQ*ZB*E0)%GZW9W(\9Z?(#?GC3BR/VCF L&
M0'\%?SQE529_:3X&1W(8+M4K-?"<P]%/+BO/&LQC'* 4VV%44BB\-B5S\Y;V
MD;:8KVBAA% WPDB9/(*9,W1H3H@:+)8!AR'WZLBUX>WM(];],CE_7&KG9IV'
MI9 7C>A?A44+Y_ UL7@;# 7,]WODAOL.IO'FG@G&FF4O(;#5[ [B&[4FB)#*
M&=(RA[N4(C8:>.U ]7=634^FX\7DODN12--V9W&7FG:U!<& .@FT\[E&9);+
MO2C.I9:!18'MY32B74C9P >@5#;E7=_\[^L7@_%12*0Z:*4[ *&ZS4XO!2V*
MD44(C;71-B-H27&1@PV9Z_I"*GXU72'$HBWAT"+-/(_R3U+"5*.I3L"2B-BT
M?_]48H:1/VM6<(#@#VFY5KK2@)[L5C;Q&:')Y\Z9!/Z%+2#6 ^@NN'R\ G.7
M3VX^$!BDF&99^N\F3:1:!WT5@RGOW CY\Z4>&O]V:Y=Q?#]C0-^YVX6.R>.R
MQJ)$V7+(KS28>TZF\)*#C'@[";X\#'[/%]%YP3#</C8ZBN7W#JX% -.4=!2W
M"_ED9\JQ6!<-]TUV43KAK C;&:34*&".$+6<RN<Q!D)U8C4&7V+L9E@+QYVT
M""3G4+*=!EYMG3D<FBD9MC.AD8!2^DQ3K7T?KIKF*EM;(6-?2K]&:D\SW:]!
M9_2<&2 S^Q(]<N_*;FVFQ0"NM1OOA# WWV'=KB_#+[ $)(:9#3Z4A)]<VWJ0
MO@B((3YLMSO8</B^![OJU@$#=8O9.).Z2EM,(7J*&>:"$Y%AMLY<ODGJY:RW
M@4#P8B>$AIX%4_J&&ZR"LMM[MKJ.@_8UM# )22T?!G:]C4G\>[11WG1FG^@1
MC#D@:P9?R@(SJ)(0S.LE2&CPR^L/[XGIWN2[.-[#<M*SO-HIVRXQ4:?X=*G@
MI-,1-GWG-F[<! A#K,#6%7A$_<JC8F8$F(1TV2P#!,=2-#%-K!S^.!Z.1FCZ
MPA$ 0Z @Z TWA9;QWG>4K5 )88OQ:#AY64::A16]8_69_='0K8VB:<02 ]M1
MBXJDW(1X[E#H5LQ'PJ4//$W/F!U1&V[68F X! USZP9]WKXX;RBX0-!B/+F*
MDFL)A4P4!TJ<"-P#OF>[NU&]C;W:509,>XV+7Z_UML]/G^,IKT'$+FTAQA,N
M--H@RM;(P&#8'Q=PF#\7U# 2CN2GNW2@^FZZ#Q\GO.]QPAXG[''"#PHG_$@,
MNZZ'55$'01NT=BP/S-8RQ;'SO3E;VSC-#MJ$;1F#O1*#AV &O2>YPX(8Y4EH
MS9-:\]U=C@SVWIK$%;6A:*PTLLG1<*UZK6Z'KRC1_0=,$ )1F_ 6L%02ZE-.
MM$+:0:(8()M'BW=[&Q*3L_JX8:4-5)"ENLWFSOI>WX2J:F,=-U;. FL[2T3,
M/CID6L#B<.Y^H?OQ+J6U%MO7S"FX+C3!P@9HA9&1&!G3$2L,P=+.UU'>9^[2
M.3H9?KT<H"(8* [CT*2M'+7LGCBPO)/#G]KF:6=Q>\U0,H^>TS(.\(G5LWE4
M*93-C06W,XZR=/#3[DC ;'BP-QD?'.[/CB;3@]G!9.^GYUC SE;=LT]*K6"<
M6=?VH4FZ9%;P]#R<3/;-\>G8*>U;[8KP.SA%RV5(U?O,/-G3$,[:!F3H\G^]
M&'HQ_ HQK'MT<.CD>EJ<0T6I(_MNNQ2\!9^,H&QU[/IYX(75"^LM"RMS[=HL
M',4935L.?+;)N50U'.I>97HIO /$0)X7B/=8&O(SPXO,2-R\.)?$\'R-^5*A
M%-$M*<$X]6+IQ?*VQ1+9=PQ-6(K>#?=_HA)$EMC$"Z07R'L32 =*:O/3NL\6
MZ48G!B?9*2^(7A!O_\!F2E-2A+;1,L:++*O6!EK&"Z(7Q-L61/5YE9:&>@#;
MS!HF@H5NIUN%IOC5<"TXA:>VJ2SE$)#[E^Q0+ZY>7&_] '?Z)Y=(?Y(G+L18
MDR>"S[W4),_XU3PM;#.C,%@AZ0T,MN%"1?S5J2)(+'&=-MC8P#OJ7GYO7WZ1
M)L)I \&\HYA2$H17IU!SDP A*99HK\8LM"[JW8NK%]<[])=05$5(N8.$YA*U
M?9>E#;871"^(=Y$3LI!8+(S/UUH<-3^R==T)0>JET$OAK4LAL7?G$L)D'][B
MK?J@(D+@PCX5)8'P4PTB'_8)Z7<-P'G),'*G2N]46H)I6][9]2VS7E#C"["H
MXI3!]>9(TD5\R! 2E2'7*]EN&>UN8)QSQKN=(VI;!0MLI:%//*I"H^N+!8R9
M$5Q-KEMJ"3U?66 ;'ESRVC3"L?$<^ <16TN33#M,3'OK-@E%I6R-80OAYYS*
M?:5\#B%[Z/0EPJ&QP8BX/CL;F;%$:14^MPS/EH6I.7$$/$BD21U,XVE94,@?
M%C6:9^MA<*Q+&LU 9? 1%1X(:X]%/QDPG*T7W. 3D58WW?I(G4/H+8C498#4
MD<)8V]R:%?V]M09IT</U(RT;AB-Y!A>V'=N' 9/3J$PR59GONYU2>\7!T$-B
M76KH%/-R_3?=S*G];=ME9F"1B-1:>/\JYVP,W1 WG86##3P@01,=\4:O):T;
ME^I.&&3I*</@/;$RFNM#).;LN:@Q(L0=N;EP<QLK'!<VPY(CR4\>G=(I;=XH
MJJD063<V,,24'J.Z3;5*G7(59=N$MM7)TJT_HZYGM-_59U7&J>X#7E.!%5YP
M$95E)("<8B7%L;B5$H6UVU6OG&Z<EERUW%2J75$E/6>EM5&2<L,MCUIU4:M7
MSFT;.MP)-!BA<+>AT]1WXVZZ?)ZYQY92*F@%Z-K"(A6(MF*>3'L<!H/0W:%A
MFV32N7"NT$?4A6\ZHFXT>R%S;"7]CY*QZ#Y4*] 69UC5/AY-PKWQU%'F;8E$
M96U?Q)8F[@\/G=)$73)'X73" >]2W=H;.-F8;6AR@,K:S"U,Q.84RG:_<N::
M%?XY#4<'HW!\<+!M!G6_<U)X*AE$4NO7,Z>SX7B$DKE+9!S4IT?C8*NX3.=L
MH.DQFKJK1?X1I)8LI>UJ8;'H'_I5=5=W\FJ_@?4<C/>&5\WW?0WZAN>:(\_,
M!NE6BNW"]KMR@N^=U1[)/MB'<52EUL'N'C_</PK'L\,M>]M0#U9*?6IUFY3R
M:G"8B^;T#)O]HJZGO>3\3&J&J>UC%+>\%TU!;TDCJ66PH65/W".BJ\;8B? ;
M]Y%MW'O?*L^Q42^SB),<M@15-^=UVD.(#>;2ZICN]'&4$_,%TO-I]G&V=+;=
MV(BZYCVHD!-/=F)GFQCZ#NKG)@WGY KFF9;\D5Q.SSB/2M/%NU(N^D080IPJ
MLB$3N&F+G*YW;'*WWDS;Y]*=8>L8HEH/N=V(<:XR;H^L(S'ZA6BJD*J6BJI:
M'@+S'&QC$?'N'QJ!T@D:>:8J1R7R=%/?"93<7+BUQ&RKF.8'6?"MC#J<^FE.
M?$UX9D1K78=(1PNQ]T=IPGWPB(N*NHA2REY"-]N.E3==3@V2-[PC,G*+(5JJ
M6*7$.U0JY!\3&I/4W+;),^UYFF*039=S!2M#+2K,;ET;F37WVEE?<YQ,)I/#
M^_0EK!AQPU$^Z=\IIH"[V"531TLBJG"216Y''&=1J9)+Q'(C)H%>D1%TD#8J
MS(;+=3.!B 932?,E[JG1[HZNNVG 'A)P5:NR&@TIV5$6$(A;BEARM@UTE^;:
M<Z,\?&Z4 \^-XKE1/#>*YT;Y%L#.S>#RHD#8L>*V94)U\@&=*?PBW"1>^S(C
MT2'UO'-#T3L@''BB%2*;C/.PV!4;UH4LHG-A,91&89HE7KI)ZU8X^?KJK )G
M5WU7N"^8?2+:59N3S@2\E,SYTJF7[+KF'Q0:>)T3X! '=M81;D5\]!]-<LJ4
ML[S__E9$92*( )T ELRZ815<K4 *3<4"QQGT\(?!<5:?403R0I,:ZU?M='AA
MM,;U!4]HJS??&G$I&K("IL(*K07,D\&_*M$<<.=3S(DZCD"[OP[_(EI68<N;
MCC(P*9AXGUZS/4K,I<$+8AS%/,YKHZL(]\%./2M*HBPWE%SS+,H_8:=2D-25
M::S10XVYT3.%>K7*:=1SAGAMY'+<1DND_DXT?J,FR49260H%UHKY2_4>(J0'
MHF$J#1NY:JTXA$5V8F5YZS,\M/.4FCL*RJKOM,=K0<.)E\_LV><8=F?@GY"7
M7[7>U/X$!ZJA7I%0<#$W1&NT)C_/;.MMRE038: $>541T_)YE&:FIRLH<] =
M\T:K\RN&1CU8MPNQS!II*^PBUNKX!?- 58GTF]"DYN5I!&$RW;?2,FZ6J&9C
M@A[A[\Q\.%VCJ.F5L-XONLRQ?= &'3DLX=M/3"7,R#()8Q*63#/V,TR),T*F
M49C7C5MWYS'LE$$=?5)DE%$+UHH.-^W )/HXO\$>QEZ=Z6<,+O==.U]C0TS;
M @C^UWD^W.T%N$<7J+GA?UQ 8HI-V\R8$1VV7&U98Z]P;W6QM%2X"V7:Y**-
M"8*"@(\FQSA)S#QVCG!1+VNYI.7/"2<B]5L03L14>V]S& /%9'$PTHZZE,RV
MDY&+MDDRLZ:WA<D]VA/X9LW=7;D9G]$OTK(;] N2K)\J/!I":WCJ!S",])/J
M:!VI5%P6Y]R_VS%L-?+5F;)67K#3'%$WWN9^[*MHK2WG",>\3)ME("^M\*!
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MNKAQS&1+Z-7$9!C<J"J-:2;#C4;/L&?M_B/96\J48&CA7ZA2\AY"I[=]]C;
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M\I<K#N#[BC+.)D<JBA;S0;RW.,!*M/'@<!%'@\.#>30]/-A7AW>@^Z\_#0_
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M?*U9_1^F%O=2IKOQT"Y\KU8UI::"R30,)J/)7LB-BY@L?;H7[N_MA>.]/8?
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MD-";Q#([+U(L*LD3;Q0;URL/?BO.V2#>)WMX&K:ZU7)K58,\"(Y/2Z6$"\-
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MO28H2US>(V$_@M,Q&HT=J0I @?X!>T8K&U("@G1V*1ML#9<$:&1[N#MZFY^
M]6ASU[XE\WS-E3E@K:497KJF0@3[(ZHWS#(O]P\D!+4]L/H]3-IUE84$J/<<
MY\/-OF^&>*DVI(1# 294Y\[XS*5X03O&;>+'4E>"H88D/:5(-5^4YHLR:@>M
M;8A;![6=4/>3Z)*(^5-3:$+9=3>1ZL2FG_SRX01^67Q2F+ '>YE<;# \J.ZT
M,4:+JRUS&*KVW?1G>$ /[6U3!@BL%+PV/#Y687":%7,8OM:\<).+HOPDU;65
M-N0):E-B08L<_UAXBOI(/M?,,)39!84,S\8BP[CBUHJJTB.DFU/YX')57"@J
M26T1MN#*EP5IM[0,*-]%"0*\KWF/A8IJNNL"U@7/ HN&P!LL4EWBR!ZEK#K7
M@X"%P;8$YJ!2,M'@95E!9RHB\PZN/I,#AY-?\9HREW.5I>"P,+3 " X9D1&2
M"F#N$=X!7@C>+%T8Z4-RJ_R,JEFTO#B/)\<)-QZ?0@H3[90'V,R,;$V<>Y 3
MI])-9M>: IP3Q\C&"Q0TE2=>N5KE^B:N"[3#IIS,GW;4*\%!8$>N;3[<3G$G
M(7Z<8X(6+9G*M<E^>2LK@&GZDPAKV7D+_/++2?"D=\F>2DX]Q-@4YNLI8HH,
M<G9/:, -\:*%NNY+!P+U-BL5* I"4;C():>"?TE>1)"(:.AO;$SLQ_'P8,^)
M^W9C2:0I,?</2C*+2HY6_P:JALS;?9[5C0$09T1<:'B$1+KQ8XW6;=UF?"#W
MV3)?3&I58T,0^RHT>!B]"9E?D(F=X@AWUD+T=3$/LBYFXNMB?%V,KXO9P;J8
M1V_$O #GI'76HK5Q0;PD>, 2>L<%)].!+X@_\GS29."@D\0 B%W2*X=PA:!5
M]B#_2Z (*"+8H> L0E\33*,X;I8-6RB)0E._!C\N(CN&W WFK81O543O".[-
M2X.O=(%Z>V$O 9FV&0C.N&CE73FJA!ABJ:TGA&&O:;QLD 4IDR SA<H,A)$1
MQ+W7/;8 T[>JJ[][C^A7!FU_D$7U=1U."K/&5,I*D3>Q5*J6K=0M<PC.5)98
M^.Q4^TFMWYP7M259:F=C5AGA*C1^_HDLB37>VZFN#FX8'D1U 4A-LT 8Y%HX
M;3352R6D-4_T]XQ6^U5%27$1R,/>-W/^&2-Z+V#8R+QT@0JH:N95FJ3XO"?V
MY^!2P 21"NC,$:N7[EN VY%02JR84T:.XSW,E[?F-,TYW(/ RQLS# ,.466"
MNH8'((YD<[HO,* .SS'3$.'C,$BO-9:.CW6'=L=E=+@='@S/!H;H$+5Z#).-
M:028LI?@"&'^[!;@C-^D5^:=S5%DYV@%ID!,/(+$6X.N^K*H:HPJ%F4=Y287
MA'^6T1JK75B3V(!%W**1+2V-K*U&D&^(3LW)#QNZ6J1J2F.X+L1=^P=;"Z%P
M#JW @PW^:))3SBP5X#;E72)"WI5\T"^1G4WIQ<>*TX9#$5SGP;R%=8W[DV(<
M^.II?D944; S#;\B%P=%:Z'7HN(+BS#0Q)?!B?ZUG57GX:48+/!R$1:O55BO
M1+;07,51PZ$1C@E7(#!4RHCA5'@/.\-5F_FP?276)53I/,U0=P@K)X%/X,=L
M>(GZT*-R.2'M,VM-"]FS/+I00B]"U0D:N]RS\652IFDM\1*2,^?Y[JS!2YIG
MP1EAJ2EAA\!TMD#\+8.V;\X>FU'W2,R4EX9GT80XB;Z6CN%2/ YBY<H+PUTJ
M>[&RQ4)]\F8EB8K'0, ,-VZNZST=P>N3U%:.NP?B-?E8-4NXB;[@VR.];EX_
MK8()YOZ7E%=$8*0S-\YY^E9>]1Y153=\I^\"SGA3AHCE*DI+4S2$^=Y?4LP?
M'G,I[Y.W)9[;-:?OL%ID92S^USF8!*<I1MKXUT^_AXF^WK3F8N?3Z6TK%25]
MS(3:ITW*WU.3$6<A2H24PCG.YA4EX3-:%*FO=G;A>V$;K(*3(K',!T^.WY\\
M#3X4JS0.IOLCQ*/S,H;4M*3NK";^''_WE--B5 7F5#3;L9DV1QN#:M7OFX>I
MEL!01!)Y$=%<T9==G*E<=#P5LJ..1HL';3$Q7-#P$T6/,:*TC$'9$FMBI0G*
MY0(Z J*R7%OR2S1OT&$CFOL8^1<Q-DPF"_X-NNU/"F4Y"Y"!"67&A3@LK-%L
M<J8-K<Z"!1P=B*=><2\6+G _53G:MUS@;M"/3V#LIV71K"@<Q[N$S$""9)N,
M/'UC#:S6&X"'FJ\M^_#&.#6)_Y(@&!P'=')[,!HNQ+OJ.41UC* *Y(1=P#/D
M8XHSVDX!_<%&'4YLW]'4]G.$T()3L#K[E*>NUT- 4+YA,6<@A3G$M0&H"T$Q
MG-$GD=KZI:%HGP.CS7@%W&319$%&U:*1(1;ZS%2GY%-8UX/2CFNL=,0I8#-:
MUID@I*JF@U*8S]V= -H)BU(SPXJNZ0I ;)L*\\WT;J XBB5LU1KLZD2 '/F6
M*YV=X+(>&9Q&Z%Q:P')%E2:%U:6<=9E:2O@A$JO#."-\?2+-0%#R9_1G:!]&
M\.!*8KB8^F421GJTP&TEHBPDL"XI"&^,=@N!CM X<J99&7#TJS*M%"DC00@:
M\2>)H8RR+*^S'UBJ+(L'D^7B1:;D%B=''UJ&K0*T,P5;%,O#=V$O?*EUH.>6
M*X^=Y@$@% C^8H9<69.<X&3$<VN# +C<&8*A1 _(OBQ$CJ.,SL+J3*EZ&/P3
M09^."I!29^XEH!M5N/T$Y,E6/X=:G1#0":<;/C*PI,]($9H2NBK4D;4,-?4%
M"$-IW$ZM^?DCYL1&I@)-1'+)/B %J1E.2!JE[<,P>-&4!N0&#X 'KY'DEULH
M_J.!'38=.1P\1N=V55R?[!,:8C0\TFB(+W@:8PZ1V =<K KF-HM*N2]K"2>=
ME&!>)\/DTVE$T4S-Y]'97+S\ F%QS BD:.OQHZ8?Y]5'N??#]J&F=,I.GO]-
MY/H]RG7P@E]MURI1:)EZEN/H8X9;^X$OQ9$LQ2_T+KLV]Z$VJ:^,7+4V$^@_
MY?3%4%FE+MB([FVP<26:\A$<:3>4D7?H933*'_HR'WC&K5;(XT8GQCGBF-0*
M";IPFK331&?<LDA41@:4V/]P6J[(DD.'DMW/_=%^&,@<<YP.,3G8V%),KQ.L
M55MB_)W<4/C]TV'PNQ2_I!4_!(\FKCV3&-Y:PQ?H5E)TUOH.3G]J H/:U[9F
MJ1SD@[T4KC5V*[>&<:#65".CJ]*RK!!WL^=')CURO4>;*C;KB.I91N^3,AX1
M\K68/A?8,KE:4(9FRT/ <]KR#<'BI6T$J8G(#@3'C2^#20!$B2([$GQ\6A3<
MI10[L<1*> C$*T[)LG&BI7!+64 <A+ZW\38W9PL')/.9" 1687<&\_PM+V):
M_6@D4,!-%\ ^PNPIV#VFLI]5ILQNPFU\>F:8?&,0>G!4T'C9/H%Z 9(AOM=H
MUM_\\WM4&X3,A1UD2AVIQNNTW< I:%:@ B0<Q'1]H!04&N'O_A-<T.<OM*S!
M)S @\/IQ3<DI)U 1<Q6=4LJ-:SEL%2:(#F:@=# 3\4CHA1;:C1<W6!)T+KM1
M&-A_@46+@*9"?',J)I4B"0Y'M?B3RF*-'&?LQW#AJ2"G=6L4[,U1%NCR8E1C
M2V&OGA;S3NCVZ@PIO(@J2PX&]FEA JRW&O!)Z=R%D62:'U<3F>+"RL%QL(.#
MP3F3D<O23UAQ*K&DI:K/"O+!3?80XQ^T9[1+Q%L%UX2F2Z;.K&5U^6(.@[_#
M2K&:/$M/01<H'!T5UII.=U@/"./AJBAJ05A2K )!:Q@ET>O$_*-?/@@GV<2%
M0?ANH+Z$Z12G%I5Q:T";9<-87:EOF*+>J83$LW48NO+5&1_+UKIS%ZO+.-R)
MYB U!*2 )>DSPW1928/&HK3A3&U ;M%QIOF-T71X-26MR=VW"I!I42W))^PG
MTRVG_W3$H!WJ]Y)L4E+2+*Y199?!X _TA+EKM2T*3*_9IY(]SOY!XNRG'F?O
M<?8>9[^#./OOT;1]UV-TH2]@^1%<4R!IC!^XQ3BRN2PWK8$IO"CA9%/E0M9<
MFL\,^3!QPS'=;^L&?#0SP\NFK8>?=FWLEHVN'\RV'I_!>A#&VH"QJ)5MJJ%Z
M;\6EOG2$&Y. [M![^L-S"W(CE^!_54QH+G%O!._F?1 TFZ!"@QTF)2):2\E[
M)5$=R6-TT,S:] +1Y=>UL?4M2T7=F]$^:('U9'GM[*3YJB&K/:$NC0[GC0M7
M _\"@7_LII]86Z8-$!2/6FH\8;0(3&;B.>]T=@/7KZF'XJI /U)6Q9+?1^(4
MV$9O+3Y9,M3_^<\3V+'7S) P/IL[^TK1L!&!N*AJ*>V7%C4D[1J5V1\1TJ3:
MG"%C28G(\5$ET](33*"X((B'W+D5 B&3'F_&?F?%OC9Z1*03B)A7)H;K9KLC
MUM3&)<\CY7),3D\RO>R!JD2[G^#(FE00PM@OE.N86!_5] K FF8P?$ 3<7S%
M==VW!<NDI^LYY_J<!@R(1T N@IPYF&&FYH8Z&?T227BY2\FYM#27?)6>$5S\
MDVX;4Y==9Y?Z_D5$A]%>",K6D;OFS/\N 5R9]"&C+AT#XG5WB:25T]'I^Z Y
MOW&.PN'$=IN'GN >_AXF[LNGR57UHNI*AK;D%8>"C:)DP U;6?Q3X@\@+9&6
MR0##'VL3T18"/AU:TWSEH28W[R!M*G<T4D60-PCKP8 =<:AK. 76#[11.C0:
M%U$D;[(1;NH=9B@=O%UX,^XWF$..D6J#4&:%AWIA9LE\ST\UAP[1V\C[H\8]
M:9\[CN)OL^.5@=.B90$7#(C)!XXX_2"*&V)IQ("ZY)C0:<"F$/_;U&F8@X'T
M-YAHYVS#L<T7)6NZ7U-Q\8B<)6ZG !TVI9\0#,P"T_0<Z%H##E7IE_1E!#NI
M 3I=A;1X<3<#^$;;>5<FVQD)6[:19R;J;?8+&VYD;E#)WX;;I7>C!/SAU$YH
M8QH=8=H=%.5IE(L-4@5/3MZ]J9Z&NC%+I//_<E=]=86H-8>^DGUV?,G"[;70
MT4CL^[C$2Y*WX;"U'?-Y)&D0SD=H&)>FT6(@++>]*6@WPNP(U%0JHJCCN5BY
M1LTY.44IBM(U'_QZ%,4WH_!;;2>WVAL*,TANC=+"A:9PT_E4W7RMBSTUVT?\
MBZNA+_.UN.J\@;$RT;U)2T&+M+4%3!]6#+B57DG&($@DGR&^MTXIND\Q=;OF
M6-/NF>B:SCLB1[1&9,\QB0,F;UZ;JW2!)#EFZ5).1$-(2SZ_N37=<>BR31FT
M @VL;!S'KC+4>W8F"4-A(8W<.%73@;;RWA42Y7(GNJ*I,1)BLO^R2<M*^KMT
M)Z&K9/RVW<5M*]YQU%DN/N\2S&.UI5F;0:W@)^(^D%+#H/>E@-34O1MAI&W5
MJ<%EV$B)I+5V>]''%#)I08$Y@M$*=RSH:*)<?BL)^"DG_U+ZL"$G(C?_ZFY,
MWB].-:[@F$D/8,@.:?.1V01!OTZX$G8Q'LI./M(UN^5DYT?2,4:@%(>X!-59
MPY?;'6^TE-50!M4B>TRF^KJ7XU&]Y=SNU [81?);=1>W*C>FV K1COCD[8BW
M;F9Y_UV5=Y0,XITM,'IC"HR^<'*^D4!]S=S<F%MTB6Z2]"!\Q3'4_P,>2A6\
MW*P8(!V#P=7[WK,DK3NZ;3^T&!!JLJPJJJ>&!U4&\V4",08QUT^6\83L6[ *
M8:ZKI\^<F?Y_@R#XJ]Q_$]%-P =)D.-KX[A!,O'G@RQ:@W7'/^%7.!H/1S_I
MGV.SHVA5J6<5\RNH=JZ;+ON!'@_/-Z",\U033SS3-]"_@I\E)C%.SYM-A^/#
MHY_<9+Y.3E,V_^=M%X[OZQJ8D,EDEP=XLY>:SA[=2XV&^Z-']U+CX>$=K=1?
M?Z[+C<TKH!M2@_,H_G1*",N!Z- %_=_S"U /#*-ZQF J_*!?L_9L_!;N!Y$]
M\C?#:>"#<U42>8?H=%;U&P@\YTJ!WL G/4?!7:*!!$MW;<C/37$\=7*_TW@?
M(*K[G3008/SJOW[8_^'V)]# SS0V=%4S!"_05L>.2NJ-#=!KK<DK >0[UF/'
M>+Q'(;]DC5BKC::[NDI>GWQG^L3+H9_&FTRCM^@>W))Y#?S5&GCB+;K[LN@P
MUN=M-J\QO,;P&N/:&F/F-8;7&%YC>(UQO37Y44JBO-;P6L-K#:\UKK<F/WFM
ML1-:X[9#4->(-O6^S%7+"A?OK'JZ[D[YDJ+UZHLWQHVF]?M6_->8R;QX#//8
MEM OL.UV3PI[=>5=SB<]^DZWO/"<>CG]X5ZWME>27DEZ)?E0E.3^7C@Y.O!B
MZG6DUY%>1WH=V3?+3[R2_$HY?;I[<NJUY8.=QX=_5#]&)3D>C88C+YTWUY$_
MW58D.5XL1HO81Y+O*I+<SZJU>UK&'W$/=A[]$;>#1]PT/)I,O7 ^ N'TFO'!
MSN/#%[Y'J!G'^^'>_MA+YR.03J\:'^P\/GSA>X2J\<EX$NY/#[UX^N"Q5Y([
M,(]>2>ZBDCS8'WK/>A=BQQZ%?)=R_G>5*VQ=2GU $OA5BHTTD;=R]]2,/^,>
M[#SZ,VX'S[CQ--R;3KQT/@+I]*KQP<[CPQ>^1Z@:)]-P<O3EC"I>.G=/.KUJ
M?+#S^/"%[Q&JQB='X<&^#XWXZ+'7D;LPCUY'[J*.G(V'1UXX=R!Z[)''=RGG
MKY>K*"VIX5VQH&;?@RP]I^:]E:H]M84_Z/Q!]Z@/.L]H\7C$T^O&!SN/#U_X
M'J%N'(_"PR/O!3P&Z?2J\<'.X\,7OD>H&I]XW>B#R%Y)[LP\>B6YFTK2\U?L
M1A398Y#O4M#?U&>J#-(\+I8J#'+EB2O\V>;/MD=]MHW#O;$_VAZ#<'K-^&#G
M\>$+WR/4C--P,MWWPOD(A--KQ@<[CP]?^!ZA9GPR#@\F7C7ZF+'7D;LPCUY'
M[J*.W)MZVHH[#!G#/Z)YIIP7DH'1/,V&>]/I3\^WO^,^_/D-HK ;G1OMX"X;
M#?\4'_4LK6$4\1=Q$E-WNV=Z.F\R["\8Y;7&%+QH2OA14)^I8)%6(,S!6D5E
MH/)$)<$_FEP%TU$83$:3O3"X4$&IXN(TAT$D05[ 7_1&00+_ORZ"*,N"1"U4
M6<+7^KNHJHHXC6KXZ"*MS^A)__SG27!2+)>JA&^R],^H3HL\.#XME2+@]%ET
MCH.:*Y6[3TSSUABQ77<8-"NX%"XJU_ ]# +O_T&5\,*=NPZO_ZZS[KOJERD6
MP8_[>\-I -.>X=T79;$,+EG0R72\F-SG@EYC>H>M_9RDY[B-_PK_J\?^YR"%
M*?G\;/)\D:G/@R2%F<!;/(.7:I;Y\R2M5EFT?H;?;JB[X1ZH-QR=I(]&PPE^
M\D=3U>EBK4=*UPY@YI^OBBJEFY<J(Y*5Y_/B,TX+OJII6_KYFAIS/+FY.I$#
MS]5>(_V7:.Z;:IO;7N7IK'<-S\J."D[S+,UA2'54UL^BIBZ>M[^ !>"/5]&I
MXC3>(%K +#R+LHMH73W_X6<M'/=S8$7!6:D6__7#?]1%_!$'=6U+U57H=.,$
MMF])HO^L 7$N\86YYZT18)F%>5;$G^YFH3[@T8AJXX0_LO4?T?;]U[)%:#_9
M';FYLVYW WW="G[)WKF_W=)C;+NS'F=P1N&6@<OE(OI?^%N5/W25XE[/A/_@
MC9\O:LCP8K,APWV_QK4&O5NFV@>T6XHL*R[(BB'- F9(0^QD<%,\^N-B"?80
M*AI4.D53@NG2WPDC4)]7*J_@ND51TK5H#%7!"B_(T5Q[ O96?58T%5Q9/7WF
M[I^[/PJ"-(&[I]7')D\3&$^Z2%7RD5[ZX]%7G<)760A?L"+.E) GQ&O2HPCH
MC!5=C"/#6\-+X\\'<! 5C?R$GW(T&HY^TC^'E\NB5:6>56H5X4*WU2I=]L,&
M=N<\K=)YFJ7U^IF^01\HAY^W/QT>'/[D'AM:#=*Y\?.VZ\;#Z4VNNLDU>\.#
MR7T]Z_[>:CH\NI-'W3:<JW=+787Q&H[&3NCCJX,F?+N> _ N=9&-@7WC<.F=
M3.;CBS2#,.-7__7#_@]W,HW&G-:^[JIFER+0I\_N2NV-K:IKK<PK,2)><6#E
M_V!@Y64KL'*_ G_)2K&J&TUW>*WN;IL\WJ/A\6DS/W5??Q!,_$%POP<!I@J\
MJM\%5>]UB-<A#U:'S+P.V04=<M^%83RI=U@;]LV4U:UB6OZ,P+7*,,9WDVUR
MMRBBQWH<7&\^;QLKM"/R>OUI_'%7)?(Q0MO&7]BRSLOKUR* O0;U&M1KT$>C
M06?3&P4K'J6\?BN'X:OXB+W#<*T5.R_*)D[CS#L,_KC;9?6Q X+X"$^YP]'8
MB^DC$U.O+Q_X;#X607R$^G(:SL9?6#+H!=4G$AZ@7_#KR\%T=J-<FS_C_!GG
MS[B'>\9-]OP)]]C$U.O+!SZ;CT40'Z&^G(4'-P,E>4'UN8('Y1,0]_2N:A9_
MQ-TOVO2AZI;[%=6OA_(^EF-R$AX>'NRRL%\.Y_7B[C7S#@FKU\Q>,]^69CX(
MCPZ_L+V8U\P/-?%!;X:$1;D\Y5Z]'I?Z9#P\W)O^U!K0Z!)&I-UUBSX4=91=
M3:>S SIO5_;/8SR>)\,)JJRD:)#J9]<.Z(<,.;[Q/#_"LWH:'DV^?7KFTA5Y
MG*>U5]1>47M%[17U===CO!_N[7][<.UWJ*D?./_\;;.#OMOFE\1%55?P20PN
M9*628+X.?AQ/AON&PKPN@A^GPR-+:2Y,7E?2P2/7:(14[WB'\;YSR^O=8C8,
M/IRE=FS!150%^/_0R6JR6C.81GD.WG',U/!I#O?(UG0]/AC<+IAP)-U$;LS3
M- ZB##1+3L2\51A$=0"+ /-2P]020WV<I3EN*KBD25*8[@L%U\<\.SA[%PJ>
MDM;,60_OUQ#Y>86/QN& %_X)7C!6</.LR$\MK3V#Z8+W$>RZ)Q&^V"+-F;=>
MB[#AMU[D'Y.T^@AK"K_Y&%65JK=+$@8#^B3I*I[K.Y&TWXI:!>/I\#+:^_L<
M-#WYRPF)7Z25)G)&08N"WXI\\"K-HQQ)\X-C7!&7K'L7-OG3X15S?K^$Q+V,
MP ]!^7X#_NN_JUR5(%>H8(X3^%5*&@N4E&? OK; N9,8M2;1LEG;D^['H^%A
MZY0#I;7WE<?<9.HV_[CY,;<J4Y!MF([6:4>'#5R>J5-YRU59+%15P=/@@X52
M1.L-Q_6!&83T7CF'NQ5-!4M4Q)_.0!X44G]G=(;!^BPK;E6"PX5GP\#=0=,)
MEA=!W)0E'K(K!3_!LX\_B-409#8A70DGZ!KGI%RA_E9! 3;JF8J2,%!+.(G7
M2IG'RI+0>\"ZQE%U%E1G,)6#.:T/3BS\@+N3M V4Z7"F7S ,?IS9O^AF/XZM
MN1+B]*VP/PF8/# R.[$R,?C&M=,/1HR*C)8"[W8')D9'-JMF!;-5!Q&.$F81
M5E'/$=S^,GL$10<,.S,[\B7((Y@GL!+P-@LXIW#.TES_!&G;G1>>PZ:!?:0E
MQUAI0Z^^KZ]Z7H,.2$L2#YC&7PKTTF!I$[83JMW6X5=9:O>JQ*4)TV8CIW;'
MI=1.>%94E2B^\:BK"D96I8=!P19Z9I>'#.O6=J.>"#CC@V(Q:&!O/7GWYO>G
M_,/@"6]DT-9+W/&+!O=8HJJX3.=;#?FCCZ1,JF]OO]]0N,FB/QH&O]!K[)S1
M>T_2>\/)VZG-I<^S10,_KIN23[A%^AG_C8='$&$7,-H(E8*32C9$!C^#$2<W
MVP#3C_/J8Z+J*,T>^":8!H/@;Q',1JR"]V<*-,(+?JU=VQ0AZ<HRX36)8OPW
MC9I,N6/XN\EKU+/O:UC:J$RJX*1(T@48&F043/='\*J[O;/>E@48HC48=6]A
M16H2Y9?_;M*O[AMTZQJJ;81^0:-!<"\0;*W8K ,+O$IA+/!3,!W!,N; DW?Z
M'ZK52$CZX'4.GHX*X9[U;KG3/+Q4AI>K.NS&B1T_DQSHF_C/X.VV7.CI<'(3
M#]HZ012(W1PZNM7B\V4%[*<@ M<T.L6?@YM6DRDY9]U>]7I047 :I:V&H_C:
M\. JXAY^>%)*C)?,Q7X/:KO@?TUSRF\E^=<[.^$:Y\P!Q6W=Z:IWDEPXV*XJ
MC-N>I?=*]5E/XX]U6F?=1I</S'":#(/WS1(6 C=4\!ZFGFP-V'*N7,"PXG3W
M/(Q0QXE.X+3%J2-?T>8"P(:J6991XV1-LL423O8.#V?C9#SZ]/&L7GZLBY@^
M^#B>/MC%?0TO'AP.KS$S:)V];U:KC/Y&07@1U=&N+35*9XW1V.,\;^ %WBF,
MS'E%+M/S2PKV=9+6:UK.DVB% @.35,'1%RNORO4\_4MACW*%CM?_9>_;F]O&
ME7R_"BM[YMY,E>#!BR#@G-TJ3^+9]=Z<.'?LN:?VKQ2>,7=DR2M*3CR?_@(@
M)<N6G3@R)9,2ILZ);3U(HM'=OV[T:W8YJ\^6EHZI**1+1DY5!L<L_',UG9];
MA;-Q/0UZQ[_NS8K@Z<BH))O+A ]]CN$.KUU']G-]DAS/T)TW;YKC_.9K(3J]
M,*7&(479QDF4;A;\_H/L*#[6ZC3W"QD.T_D!7#RK5VOQ'N'V\1?K&>+:VS]>
MQ ^RT_G).%X:DSX_._?6W86<1B/IU['W../5C:V/HOV[,Z\TRLOQK/(7\.M6
M]G-9FU?67W]VYW#^L9/V6OL&*EV-PTX$%;3L*05;\TLXU@A9!/YJ(2G&W^U+
M&7(BQE_JZR](YJ_G,GEUY=W,20CV1QBXE%^]"_:7C4\6'FQA^35'B8'.]3,N
M BV>,B>>;N/1J)Z3?IL14(<.%FM[;%U?XN#62QNI*&]S#KQ8@9AJ$"S1H]GG
M637-4$WZ.L_#F\WC@*VS2'U[&TM8S@#Q-[YM_QF983GF%+7A<OQC$)?W^_^2
MEU=OWCT45ZMNT3W$K^*QTITG"=]?/,G\0K?!CX/,BX\,,8XZW!0O4H4H5^,S
M!PN\IL;\^8,T/[:V<+?IEW%F)K//GF=')J)4?1=EAZ7_=/U$37 KLG7C"(2#
MKFKF7#!+1E$<W2P<H=T5*\_5X81W&A]NY#52AKQT^^5>5 \CQSZJQ)/;J%FM
M7&*&7[24XF&C)W\=^KKR4'(1@V_A*+(V'OQKU4S6.U"?0'Z)ADX,$EX&'1JD
M+?+\1[^*WV;11_RGG'CACU:99^F/)Q^/Z^WZ["_\N=:;TQ!!U=::6C$+?(!N
MPP7R[BFG9^%953V>KU/-E.>E4;_R=/*^Y^F<S53E02B(Y_'U'7^R(R9E5/Z-
M<EXP_VT"F6Q"TC>Q=&@2C(88:@J\7%[.S>6($ T\W&1J5@;E'+C:E)^C#59_
MJ1RYB5=$7IDO#O=CL"N K%=LM;E6>F5^75_QM<S>>SKHL6?I\Z"^9_XYSIK;
M_.SUV60\^WQ1PYOV2'^;#[7XVNOWYV_])\=_VH"87AB& >0:36ULB/G/-7&M
M'N^*7'@M2&92E'-^.4I:)VF=#3SRH%-GR\I.OUA;&_AG'X^RM]ZO"5KC7<#E
M>\FQB>\3W^](-D"WA#">R=FKJ;U4=I(AL>3ZEU4U:_+=HYW-.1X([U;&!+UJ
M[E?=L;[OVM9SD(_1ESG21Z[]X@U]._G?,>QS6<;DQ?I4Y#;W;'#']#@Z_T>(
M&7R>R,L>Q#KWT68Y]^YU/"'YTAQ\C=541O6]."URM4\VOCW,"N[S;3KF?,/#
M@=+T)G/U&?+H<WW4Y:6LSA6]]0G#R]X=#"<5E[:Q-E<<_WM.?WB^+^/9,.2N
M^OM,PL&)__^DMKCF!O+RD9%?TH6-P<3Y RY'_.J'[2Q/_F+*ZU #]7?_<_Y@
M?T7>_'J(WWA+_2LPG@AQI8?^B6>7HS?>X+P:RIO#\.Y**=E!7H[BK9L&%?
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M?9Z[U!LNWC"U=T4E="K;/FF I %Z0^V7F9V5C+GN[ENB92=5^>,S^!9GN/,
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M?-)&XQW7"N]H9$Z#MCN*2J[)PVW)$L$%[9X9LG8;B23E?;+R$B E5DV ]"Q
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ML_OI#^,#'%25&<_4T';.$.ES5\2UZ=P-9M^"3<*M=D*+ G@GV-LD!<- %I
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M& 9<%A*H(G32A=H4MI5^N1MT04F^1I_]Q]ANI65"$NA^N 8[ZZ,FX$G LX/
MXQAB@ED$($74@PB6@ ML00&%YHI;:$DK'N[&@(=[X%FC(5 "GMV*H";?MT7?
M-_F\R>>]I?\>]^]_<>,DM??_MOEBM$/<*@>X$AA0XRT7F3L',&<*:BQ,H7C+
M?O.>.\Q[U_"_ V"7G.J$;)VB?$*VC2,;*;3A.N> >1<<4.=1BAL&@8<[_S_"
MN;2P9<=\SSWRO4.V'6THM\7MN+LIH+(:E%_!16F,'1W^]HE*Y3#A.2#(%*'%
M-@2"NR(6K(6P#J1(W]_9E8N(O,@EQ3G(*?,FKN46"&PXD ):QG@AN)4;U4]O
MQY>7Y33,LJKB*-GPCO^2'6FO,[+7'\93F[&?%QSVX(]4"9\Z-O22LHF:O:3F
M[GE,2<1[SY2[3LW4+:^3,9VSZ5C_>3$>>N>FFG<;MO\S*Z<WJ6E>4MX]IVRB
M9B^IF>RSQ)2=8\I=I^;+5ZBD/@>M6'0?)];9R<0&LGO;;I MFLUL._SN7&&)
M-(!B0@'-'072OP2P<91IKK6VK;1862PXVK(?Y>1T<C:54VO^GQS.[$<[.;N0
M$WLW?N%_#9_WGZI.W=&EG7AN>C<>#N6D:C[=1#?@<G0#?R>X\3 =\AQRF%,*
M<JK\FJ 0@'M> Y)AKJ51Z $ZK).&T!TZ!%%[(,;S2-!G8VQ9:[LK.<FN P7>
M9"\D" 5AO&#0 %1PSP A4,<%DJ#@3$F'N+"2M"\(<?^JH]GT8CSQ&LS<V?@J
MOKEF#.^1*A7E"BXQ!)@9YUE6<R!RJH%@D$I."IC;5MKN;6N5",+.\'"]D$PN
MEOEBO$Q(07,N&5#0>J5N<0&X(A8H2AQVQNLSLM(5HRU>/IU-JZD<!4Q?=YM#
M "UL=3!1*CMZO/>'@%@1 Z#5_HFY\=K:\W$(JU$ML)24K\37V^+E3:PR;'1G
MF'E\N\"NYE3MNK&?ZOC[F^_7#=[<1MDK$@PC1 "FSAL4H0N3<,0;SWE.,&6(
M<2';5\+16%XOV<F57ZT!?]G)./ 0QPB_26TU=ET<=^^P,C%B+QEQ;W!!"%M@
M)!3P/PR@+E= 0(A!3KFVWC8G1;Z""\]W01(N]$@<7[[D-!UFMY9>.AZ]]$DV
M9[DNG%<<*+=>>R!OCDH+"R"-Y%Z<C7)PY6AK'8U3KW;CQ[=\K?,]RXCQ2T<
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M"+)<2^"@@8!2"('$F@/%<D>($-H5[<PI7*BGCUX[G8S>UKIIR6QHJ448Q6@
MQ1I-PI*(]DM$DR_9<VKN"B/N#59PXQS7%((B-PQ0S@G@V!7 <<OR7%!HL6UE
M9.$VL0(3D;"B:RYF2J?KI(NI]>QR-@P)55[*7*G+:=+)N^];[G$KZ\US;^I5
M/=^2UR^4RP5QCHM"<, H]E9-#C$0S!'@"H]"JA#4>\%M>,"_VZDL1]8<R_BH
MU9(V?5<KTZ=;-97?$O_;]\P;2 >(K3$)X@4U2N?:8=_EP*<SV\\=4"Y=H6'"
MP82#"0<[CH.&<2F%Y4 9)KUW+Q%0U$" '>%(8"QP.TF_V\=!POD HPZZ^?N+
M@R\?=DY3'5O1)?54Q^K1/L =@)8. T<RC))AE RC9YDMEBM>,"5!3A &E% '
MA,P+[\US[+UPB)5JI7'<<JOSXZC:VIK6R :"/-3PL+M2W3GCI(=RW172)0A*
MK)H@Z%D0I(V"Q#D$#"0*4)9C[P5[.!$%1EC:0I-BY01Y'<]Y8Q!$R #BA^J\
MNRO5NPE!+Q\J3VYQBV[Q\'8 :BSF36YR<I/GK^ #'-29&<_4T';.2EGWM.]O
M'6#DM>G<#6;?@L&BJ#,8:@B$"#WP#-& &Z6!SG,)G8%:H95$OG5\YJ4!T$<C
MLSD/F@\P[V#&]S<9<3<-F Y 5O*A$SXE?.HU/N4Y%KF5!%AM/3X))H$,(T]R
M)XJ"<9,SV8I#O25\HFA BH1/7<"GA8/M?Y%^G9M=QJV4/@TM;N_^K1L^AQ#;
M7^U3U<4/K#U>^3"4A)3Z!ZAQ9FTFM1Y?^J>[\9_.1N.IO_AT'#1)/%:*F>VN
M',F1+F-4V[]PZ;]<W6V\9<KKP$-_]S_GJ_PK'E=\/<1OW-!^!::<V"CDAW[Y
ML\O1&U-65T-Y<QC>71'%@]Q+5'CJYJ0'>DGTK_SWK)J6[F:^@OA=8$?FS=6X
MBO4QAQ,[E-/RVGI)_AH(&$BP$.JO3Q12A+]#\^]O^?(1#IS_U>B++?##DW:?
MP@?W\&)QS-8\=CD:EB/_2%,YF1[*V73\YNX;?@/JEZ_D9UN?N 'I/!4.Y?"+
MO*G>O/IESAS;T9$RNY@$A/H7#U^?PD,]6=U\J=E-><BK+^P1:SR1D;5FGITG
M8<'U@>N"@1LJJ*''RLULU'G0R]G896_KEZK%OLG'Y>\N5 ;IN97(5<EJ5X">
MMX,_(CLOB1QWJ*Z'LJJ"R/BO-U^*/T-BW^35?:68/T#PK>FF5]&F-#GG%!D$
M__QT,;W\-/T:__Z$()F3.'S*E=6G<N01PGY:Z/Y7S^H9N2QB&]FH]_[.V=G4
M2ZW]?#/(3D;ZH!]XOW'*O#W]<';Z_N3=T?GQN^SLW/_XQ_&'\[/L]+?L]./Q
M[T?G)_X#_:!5VZ1Y?3+*IA?C625'IAID]JNVWO*_LAX+0X?23%Z.9U[Q_MPG
MZGQ/4SR=.MG2LJ.K$#V%A\)5T0YH\"(\6;BT7UCX./!@.9XU'ZGO(KSO]-/\
MXSJTF+^J[&%EKV20WKNJ/W[MU4HH\+JLRNBQWAS.+_!0C*^^'\L/*"(_+6/;
M7%='</OEL2^B@[6^M<YWR(' 6[O9]I9%#R#;S,W:3IQ^4*R>%C;>7*AQ;MH^
MH'/X"[GF_1HWOUG:O< 1N&?E\-:_OF*O-D+%YZ<X?8-G.X*3*Q;7DW;FM_'$
MVPHV^ZT,9Y_9?UDYR8Z]67_;FGR[_+YV3E G]FIS8I* H9_[EH"A'6# "1BV
M"PQA1$52_4F%]#^_(NF0%]0A-.F0+NB0MC//-V@^KIMHWL<\\M_MM1W-;'68
M%'\/%7^'L[AVQ1I)U$PBGD1\IYERUZGY\KUP4G_<-HVUS$W&EYF>5?X)[*3J
M0,;YGNCZ+:5-=X6:?:Z!Z+"BWT8C?2F<X4P#B6$8RH8)X A20!#%!122(;TR
MG%EP8DWN$&".*_\=9X'(L0)$(6DDHX4+?6[NM]JKO<<TC*T?U0D=D,&$"CVG
M9D*%OJ*"M+G*(<X!T1 #F@L%I'$%4(056A7:*%3<1P6<D\)JC4$!0]-6BBR0
M2D' -$<<$X5U@=I%A97JMB+'"19VO"M,<A WX""&!%[5U-MD\O/$UK5F7=7#
MR3+8;OBWK]HJ]:;KDE$A)$2$0 L8T[DW$ H.!,(,D+RPG ?+0IN55B^68\:<
M WE1>*-"%-X0R0L&L():(FY$D<L]=#7WKAM= IT$.HE5$^C\..B8G%DM"@ %
M)X!R+8!01@'N#!/*(F?S%= 17"M+C "Y<090PAV0!&E0(,V(@KEUB&[8DV5T
MD-/.]VG9 ^!YF8CH5OW;/KJO=5/322-T'=##7:%R,AEZJ&22R= EDP%C[XDJ
M@;R?RCW\>_P'4AL-%!<8*R$H=/2^R4 %8P*;''"%$*",%D 5WLQPCA8*&:0L
M+)*?NOOF0@*=!#J)51/H_/CH9U<PI"+>A#ZC$%,@)(% .^B=4$J(UOP^Z'!C
M$,VQ!%8(&^9-":",1QZAD#4%XX*A34=<63[ HDC \^+2_*"?VITZ^X[[IKN2
MG[Y[I$M%$[UGRD3-).))Q'>:*7>=FJDDO9-1@-,K&W+61I\S^_7*CJI4G)XT
M=&]T2M+0_:5F$O'$E)UCREVG9BI.WYG:@\K*B;Z(@VB-O;;#\56H-^A F&)/
MM'TJ?>IZO*S#&GX+T3!JF) %SP'4# +*!0/2$@5@H841 DGF5J;NK9>"46NB
MHY%Y=ZN'CFMGLJV)]@.!2?<B9$DV>T^Z!!*)$?<8)+01SBMV#8C1'B2T0T R
MS0'GQEJH4.&L:B=E8O,@@=@@9RBA1-=R^5/Q>A<=R'^W(SN1P^@_2N,_559A
M[%QY;;NJE)-UT'-J)NN@9]8!UXY!@BQ01'FD=\@K<$R8Q_Q"&LHT-:85%[+1
M1=XX.+JCB5JV#\@@)ZFYS<Z+9\*)GE-S5QAQ;W "(6:1-A08S0R@>2CV5BX'
M"D$N"-:4KU9[K>-%;@<G,!E@T<&Z\9T2SQ2(W!$_\N3R2I:3<)J3C5TV' >Z
M>9'T3F55V=3^;.>,A%3AERK\7J["CPB)("Z ]SZ]&XHY!5(R"%B>0Y<3[@HM
MVW!(;Y7:J7OO5=K[H-&.HD+[#SLTOXTG?ZQK;J2:\R3F72%=0J3$J@F1GH5(
MSDI6%#8TY'0$4,4$D!!9@!WQ;JPBW+_9ANN[041:/2B% RY$0J47%_67#[;B
M%W62R4$!BUUPDNM6:^.54JL.*/BN"$RR17JHH)(MTB5;A$&FD/#6A-.% -1I
M"E1NO57BC-/0D,))U(9W_'9<3:NCD6F.W=OJ@X.* <T[>.Z^=V9' J $0(E5
M$P#]^/$L(B+T]P;:$ \F%C*@*%<@1T@Y2YBPHA5G>$, E,-!D0"H U*=&H9W
MTHM]_7Y<53]GY4B/+YNI5XU+.QXE5S99$KW6.<F2>!E+XO5\-[9LJWBGN$!:
M,: ATX!"B($PV #&,6&*8"+9RGC.=9SE17^EDZ@V@PI]NKE2^3WPOR7'N;-S
M=G_N@#+I"@T3[B7<2[CWO'"RL%8*4@!,.0,>;\*L1JV 1DQ K:1A&+?A03\+
ME;X-1F'J5@>K;/H$1IT,'J=^F^WTVYQ>V,G<AW[=!()_3CTW4T.^GK202PWY
M^DO-).*)*3O'E+M.S53JMBNE;H$Y;36M>VZ6UZ5?BVE,N0[XUGNB\5.U;=</
M>3JLY;=PA$,84=QB#0A2"E!:<" +0_P*"IEC9'E>D%9JU$;77A>%BH#Z#&>N
MG4*+M48WM76D,X"8=>]$)TEH[TF7H"(QXAY#!2T(U"@G(%?8AKXI!G &(; &
MY9(51%BB6RD>VQI4D $N.CC*=*<D].6KPI(_V4X+3EF.,J\,3%E=C:LR*H:Q
MRV3FOP5<.9(C788.G:'*LZNZ.AD-/:=F,AIZ9C00!!%G0@(%(0-4(06X%0H@
MH;0F,-<(LU::<GKM%/("3D=GWA X=3%P65><MY9O#Y.IL.MRF0"BY]3<%4;<
M&X 06 A)<@Y,&.Q <P*!$,)XM5\8ISFCU+E6NG&V#1"]:(VU4V*90I,[XDK6
M665--MD@&R6'<>?L@927GO+2=[@>JS":%8KF !/C+1!($%"Y+H!4"$/K/5Y+
M6IDU$37EA_%H?#<#_H=;B#^Q-*N#<=,^9<*GLJP$?PG^$OSM//QA@KE#.0*"
M"NP=<(]\WNEVP!3*RMP8Z,1*UM!:A5];A3_:P7&,^PM_+Q\X3NU$6U$A33O1
MI4JRY/(GFR?9/,GF:7,TM&94":0 R0L'J*0:2$TED(;+W#*7.P[;<,A;,$:^
MD[V<HP[&F?MDAO10NKM"N@1$B543$#WO9-C[OC97'"@<LJ0ADX CI %WDN6:
MYU2Z5KJ*;AJ(R "3=!S\\M*=NHMVTJG]8*?9Z^%2A]$.J.:N$'H7K0A\@(.J
M,>.9&MK.V1'KGKS]K0-<NS:==]"D>*GS?.28_\\Q(!DT@'+F@)(D'.\3@H@A
MSJXV<EO+>[;3#386S0>"=KZQZ#T&[YS1DF+8"0 3 "8 [))/;:4KJ( **(9R
M0*EVWJ<V$@2@*7*MJ1"M5!ZO"4_?:W==%#RA4E==Z1]TG_>WK^BN-'#;/=*E
MKH*]9\I$S23B2<1WFBEWG9HODZ^7 A4_&JC(KJS?G@LYL1G(E*Q*W70('<ZF
MUG3 '^[*-NS&*4Y7J-GG$YH.Z_.="#\4))=400MD+A&@1LM02,> =;+0UG&)
M"]E&^.%8QD>L/MK)65" OP;M=_><Q_]JS=E43FUUZHXN[<0SR+OQ<"@G5?S*
MXA0(+I\"X:?&*!YIDE,HHRAT0"O-_/H9 A+[?W#!&7(YD5*I3:S_7:WSMTH!
M?$#$ Z=A73L>Z[O:3.&8!.3=XL@$Y"\=1J'(*4>$!HXR#&@A'>"Z8$!0@TF!
ML<CM"LRL$T;9),RN@:Y""HHP$@#G-/?+)A8(S3A0@E._?.^$HE8R,C>+KM\!
M5?90']L$JBF:U-$MV)53O=TC73IJ[CU3)FHF$4\BOM-,N>O43&4OG8PF_3/N
M@#5 >B+(S[8.)%79K+)AMIS7+)=7LU"2%CH\W"N049-?FAU?_3?%I#H!#,D/
M['KY;8?!8!MU*CE&FBH)-.((4(%AJ*LM .2(<PDYQ@JU$2B9J[FC6LM]F%TJ
M.SEU\82F.IU-JZE73WX-JR=;M3Y<,U?XX44K(X7U"P;820-H6"]G3@/HN"+*
M%5SF*QVR6UQT<XRULO;VELT&C)%T?+5W:BOA9\^IN2N,N#?X62!GF;466)&S
MT"5) N6@ ;C(G4(06D57$BW6"85T"C\E<EAH@0 IM/(+8!0H9A@0J'!%@8K"
MM%,]E/!SG]36XH#"_R+5T&YV&;=JZ6EH5M\=^[M_ZX;/(<3V5_M4_7C[+-]=
M>[SR83GUM]4_0(TS:S.IPUF''-W$PX[QU%]\.@Y:)':CD5[BL]NAB%4(^(:)
MIM7!'68RY77@H;_[G_-5_A6;?7X]Q&_<T'X%IIS8*+Z'?OFSR]&;,'YQ*&\.
MP[LK0G:0>XD*3]V<E,$#'%[Y[UDU+=W-? 7QN\".S)OY(,?#B1W*:7EMWZCQ
MUT# 0()%A>#7)PKI=_GM^UN^W  5SO]J],46^.%)NQ_:!#^PAQ>+8\KFL<O1
ML!SY1YK*R?10SJ;C-W??\!M0OWSET:(^L032>2H<RN$7>5.]>?7+G#FVHR-E
M=C$)</0OT['^%![JR>KF2\UN:CPT]84]-HU#;RK/6C//SI.PX+I/TX*!&RJH
MX5C_N9F-.@]Z.<PH?5N_5"WV33XN?W=!,$C/K42N2E:[ O2\'?P1V=F>M#P
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M+Q@UZ<M>$W-7V'!/SYH,88H7&H&"60IH;B505D*@F),6\MS1U2Z(DA$BG&;
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M<CE:;.NMA:.\H$!#[ET.037@BE%@N$8TEQ1C9[85IDHN1X*V-&6J]U.F: =
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M"]LC1$TGL0E:$[3V&UJ3R[/#"KJ'[-X1RB6]G!@UN3S]=7D*9*U@UGLN.=*
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MG^-/-]I.2;_@=8'5#;IL=)O2V9Y.X?*B:/"\$ES;EI>9V0XN\&Y #+6M#P.
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M5[B2\--53WF-47-1%[D)?E+R1C)O!]1?9["*%0PE]T=.K@ZY$!3OHSX$#8Q
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M'$@M*;Q##>_H/+!DE/#3/F_-2P?+F30S9W6Y1,DJ+[%$[1*8!)P8 <^!KR]
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M7W<IHVM#N\,T&W>S!)@[%K48IALKWJ[A6;>Y9X==+$#28$@K$!I3P&SS"U@
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M2PW]6 +0D3-RT-6BKLJR#:<WZ_P?@ 2:61O8PDO;>J@]&+6@\ (?B &!9C4
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M)Y G?7+:YQ5P&A'ZQPI=_E?O3S[_^-JF=V%^:!*Z#GNHN/H1S-^HM@#@Z8T
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M3$4!"+:?!HR[W&=Y&B@%7\ TCM)6]%ZG]N0ZBJX'U#"^0FLT^-2E^,8C?/#
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M-%6KR\/$PMJS^XCUK6,*]T+,7ZJ5<CQW?ZSI$09]VQQ*)#S&%57=_*?S$ZW
M\&S%&/CVM5.M5PW&P)$+=W8Z9B8RA$#-LJ!-L#:[],/4Z#ZU9_ZT@B]!P ,A
M/,Z$JV(6AEG 4B$S!OR5XA&&/(QVBH7?QG;]W8KWB9'N7TBX/VK2HXT1:^*8
MSX;"6 VSI>_'^BV"M;(T4<=A3,,LRS$C-L*/?%=HE\E,PMSR/&+<<S53KI=Q
M%7I!%NS8\MN4"1T?/9Y<F&<R"Y-9N">S< T]/]@+0VFC_(S&491.NS^HAYE@
M-T-'&_G2S;K+S[X"*PDC"E8V)EF89.&NLH#LNZSP5W-,BR ^9N%LLMJ52&I8
M4:>'_*N:MHCQN!@J;@KP:'PW%FKL<O6OXYI/A^>?U>'Y;#H\/QV>GP[//Y_#
M\_=P"O[FX<R7&)E[;TK&86W$IDM-':!02KGLP6=[9@S)O ??[H.WL_W@ +S+
M=6U3>*GNDMVXZ?::AJ^"@5TQJ%P);D_R%3 $K1&98VDY#F]EW1OENBMIU#[$
M)(Y=-?\=^'US"H3W0(&=86W28 ?_=\<+Z=2;+;A(!?^('CO7FX?2Q39>A3ME
M=)[U!H%<>@NY)OS\-O[0J*()0P5ZU'P&7P<ZS'C O%#&+,QB4%2)#ZK2S4(O
M<*5(O> HR7WB3,EUJ3[J$^#%E@T_=USXDV7 ]\!_;\G#M"UFMK>5KI'U\'(+
M?NL*$^[)@R'P@SF^M)NX7P<8WX@VP"F-/\?S$=]4!5<)7:L)C#(#9;"I!:UZ
M?$5[G]6Z 6%K7K\9JZ0-2LT;<FX"?$):A. MTL/QX0O WN+E#& N^)WF$O.N
MS)V[W[>74WW59:/>-&K)\;3#)FBCV[X[T'WGHK %?"_?M(\YW%;'O#N.YM'W
M0WS:XBT"J'^Y^F;O,>X,YNG3&O#M[PSGR;V_]GX:8.X5S>MU>!IT!;IS/Z'-
M-BNM7KY/IZMOY7(]S^J>VPL=F9C/M3,3L#1>\'^_B[\[/AEOW.5P+%Q[OQW)
MWEOL_=Y@[_\//96?-J#W@S/\+?KYC66M[EM,)C/Q#!9Q,A-',A/^9"8>RDQ@
M^&4R!),.F73(I$/NH$/"28>,1X<\9@/I^^T>/88NNG=<O<_#8H*WE)K[[1+]
MC*W#->AYYTZQHZ#F(Q#N7ACQQ71QSB(>A3R-F!M+K'@@0L93&3/7XWFJ\B0+
M\IVD>R7<(! Z9K%4>"S:2UGFPHUA*L-0AJZ7I3M)YG?<"#RA.DVW33#'Y'(F
M*TI5PBN^^W]IG!VEX_,DQ",6XLF:/'%J/A=&?#'6Q$\#+_)<C\5)H, >Q!I+
M9PB69JD429:Y6>!O6Y,@#X/0UYIY0>2Q,."<Y1I^TBK,HD0($?@[169&9DV\
M61 EDSUY #&^G_V*R<4\BD[X.[4-7DW>Y80'1J]()CSP('@@X2GG@<O2V 7O
M,DP]EOM:,#\*DTQD$9;7VL8#KLIYG.8NR[C4+.0B!?@0)PPP@?*%TIE,]-CQ
M@!M,:."Y"_%D39XX-9\+([X8:X+E2*4K?2:C) !/,0X8CZ.$R5QJ$2LE4I=O
M6Y,LS#T5<7!!\\0':Z)\EN$)"!V*W$NX'Z6:3]9D$N*[^);'V;X<'F2A%SV<
MLSD\X^#-TRCX?F,T[A4G:L;KC?Y&?6PWCZ08.1RK(G_FB,)F3MC#U@=36.Y%
M5VUF;?AS']\OJS4>]#F<0_.T]=F1:'\$5K\=]5\,KA'@[X::2Z9=%SQ>#^!)
MYH4>"Z(XSUWN!EZ>'>-8YLAP39;XM\4UA]AY)P/KX97)%4E@ST>=3*9Q-.IY
M,HV3:7R^IC'.W#2)HAA\?-]E8>Y+EDGALER%(HQ"/\UVNY;<I@;FR$RC-PMC
M=S*.3T>A;,4.X%<L"G#3&G%'+?8A0#Q<)0(6^!XV_-&<Y3E(4A"&&0#*-)!Z
M1W1N@RIA('T;OT]UM:BP!Q;5M3=5X:<.NC>IQ/BK0HT^[(RX0=-O%WI_VJ6D
M[D2U\M(YD=5RI>14#[]KU>'\4ETHJLGJNWXP,X>S3S[_Z!1-@VU/]O;@_'V)
M/2J<5R>??W\-#YC3O<Q-9LYG=4I]%']5U&T6[GIE>G3ZJ?O:^7"^K/%U5(=F
M5=FKJ)Y*>^.[HA%EA?T8NP8NYY7$=AJ-K8G5?F_J?9JJ-J8@C>WTTC7-J/O'
M-^;Q#8VY'>YK*BGE@+Y:2/.M;<2Q-O.SS]M^+Q;Z[_L3MH]NNRL/NLC4ZG1=
M\AKX#J==2-,\DLKHG!5*#QK*HFEOJ!<DAW5S7N$U;S^^^]OKS68RV 6FP'[M
MU-8&)Z>Z]I4T+#L4>!TV=VX;(N],$V!&U<UN<V;4&9C:\+0/ UX\;[#-Y"XY
MZ0T<&Z6(NEBV18&P\P]6!K;U^>8@=9)^PI)#,]M8MQO+_F%0U=5B5=I5'O1L
M:DECWHTUBI8E7W05B<ZJ+_TEZ\9RS3:Q7C6O]] +^U)C13=LO8/]AJC^:W>-
MJ@F483<>TX=;% A2S!LKZF\L#-<TU;H6V(3S9]ZL=J;<-R0RC.(L ?V A&!1
MIM5E6X().['B^TNUC^Z6GVBU-KFS(RAUE!XPNZ$77-\ULFX?-KP9IM[)JV4;
M674K.WP<7+TN;0=FM3A#NLB-1_%FHPO2GI+.?[12^?C5G&]I6$Q]9[_37H.F
MHV.KCSQS\C6NM:3F5L4YO'+5EB$T:TDZL^]*-1OV+D+FZ;L=P5.-1.]O77T/
M -W6+1Z+W70FH'4UT/I Z&'"66W9&ZJ?5YQ3X4_\=^8LX#&\!U?+#=?(,07V
M"8%A@^<6E&&S.6.<.RS6J!4]( >4- 0?W$!=VTF4BE\NP6117S)3>X]JD8+%
MFCM_QVI]9:$N#-:QRH$0E%U/.Y;NM3,[#FI&;!I>@UK!T2K0%]8V=[>AYD&M
M<ZE6@W?W<^@:'U/I00XHB+IXE]U(%J2F-OJC[>GLW9CNV*W%&F_9SA<M"^!S
MO .VNLKG )C1>Q79K.UG]ALU1K0.11*ZK]_L>!3]E?L\"5T)@H2V445MX!H,
M311EP;N&\!M]&)>\D//M(?48KH-O.;8+P"Y,%L>]^O3C3Z]Q2!83@<C3X^&_
MQ1JXEGI%FE[P.7H)>T=C6A# BIXA_D19Y*?*6&.QKFNU$)< +*DS)]CWNJ)>
M]6LLRPLO[N4=<>EI5:-^H$:2;1/R[FWP$@/S];HFN1X\"_0/P.O6X?K'NBX:
M69@HK/5F@,\0_!@U8)ZCOF([1<2PW2!6@/L:;"(QAU5RN/4)9@:3(LW: L0=
M@!T0;W=-9E1\E'24!O37D*ZB9IYP#S\]!>>+] 0,7RL A[R<&4WQ%\3IY8P0
M354K$ ^:&%RW,;="6]B.U,5F)Z!72_ >5D[T/6E42B 9MG'GE\2&!P=FBCP#
M6S2&Y=$"M#H07]!K1JQ0;-G$M*7 %J$@VRA<#C4&Z$7(B]KBSK2TBOS-#K0O
ML9G%:H4O/UFTK'G.X8KELKS<]L7(_861(+>#7.':X7C@PKSU80O;$J-6%T6S
MA?C;PLJVE88R/3:ZD0;>H*[RH!$J+'/KS]#=H'UP 'N?# ^N6YK,T!P>G$NM
M5K>; ?)C2W4;7D#R_5V1AX^@N241HN<%&D=KI<!$#1]&Z[&H[-?-/8'M%VI"
M_H>#>-27MK+[%18D8J[769#/+53XCW]+?<__H0]3X09.K<[4HD$!-)?;BWXR
M@1TT**U>0=$:V!?GU>=UOC)^,VY$H65Z"SH=/):6VW[JA/L=0:Z-B$PG>#;P
M).C>-N2UB=8&?GC(W* U;86%?GNMT3[-2BJ"GG^Z+DR3X:(S3G5'E^OJG]A:
M3C0]<,MY=Z.-6=WZP8FA58])AP&)3A0M0MP(93361B)^S16^05WP<HU681*E
MH2BMRZ$<?5PHY\?BU/E1\37XW.L2?@.5>(+%NE$B?/>'CS_^^.,)_>S]\)HZ
M'*@%K ZJ25PK^II"F=0= 0:$//ZGNG14V4=G\5V(T]ZN5T;E_4^5-_0:^-)W
MO61FXT>X<I[K?@\X:+'&-F% $6$ TLR1(*?-"C@>-36O01)$U;3!6.*JA:17
M=1)!#*JZ:Y13%F B[>/ W&-K;N/;P. $^#>G&,K[&[HS;6 2K3W:DJ9M!KWJ
M9HUB9AI'6S$3 B9-V YODPH;HAN-;P07/,!2(K*@RT'_PYO)%@PQA:$K H82
MQ*6Q!=@Q2G@.MJ18EMM:HIEM(KW!</L+X?/.'M.4NP"X7IL.H7\_*TILG]"U
M:*8I46QTRU/\%EVNZ\+-Z&T#N6W=4KZZXAU#JK3]VXVU-JMPM5_9O7W3)D_M
MO%Y8.Z_(G=IY3>V\IG9>XVOGM9.^HOPTR((@8W@>F&'*"DNE'[! NAG/=.[R
M:*>4R*UZU:S!MR3;P,L?>8DP^?.94JL!^'_DU!4BB%X$?^3-'U(!><LKMM/N
M+9WE^KMEP=RQA'2(D@#X:= WW$EZK)R?^]]#^00^$B\DH;*/!$3?&CCDG #P
MVJR?<=24,.6*-$B3A&59&K%0ARE+O=1E'O=<[JM$"7V4#NM]_R>:GIV=F1QI
M]JFOTS58P_@H%BD3)J>T"W!Z&@2]%ACW7:"&?9;>#'CH_W0IHH_?U^@&78UV
M>QJ%\Q"/)EZG_\UNWYSYK>^\[7WA/(T#M_]SZP<]I2F[Z?V^=#/1]A[;5>PJ
MB+UCW\2<KG?,<NGF<<^Q5/1$P",0\%LEY^]*S!M7G7]$<M]OH?F-IJ$/S]6W
M*#G_O#E_4AV3ZGB"JN.*9A63ZKA_SK\E=+QV=9>KU_ >J[D\R(K=>[V6#XMF
M76/4Z+92<K^'T!^-R(]J3^^S8-1(V/;ZI/SW,7/FBSD2'@I/1$(E+-)9Q,)4
MN"S50K,@2%//]P7W KT=Q(QEY,HLX"P6GF*A2%V69SQE.HCB-$\"(?*=&N,V
M%->II8W3W;]_?G?;H]U)?(.#W2]0.A]#M4WF8C(7D[EXEN8B$Z$6'FC]+,M2
M%B9YS+*<*Q:';AJ[6<*C6&Z;"RPT&B1@']Q<9RS,M6)I$'$FP>QXL<Z"F#^4
MN;A9'9 7*)V/[1Y>N['$Y![>K7]AI5=?,/.O+ 0F=8Y9N4YF_QE0]#GAT!=C
M[8,XU0&/0!7' BRW'T2,9SI@G.LDEWD2>^%.*<V;.(=EL6K>M*KH9Z.)FB.9
M^N F+0DG@7S2 CE9B&= T>?$D"_&0H1^J&/E!BR/0A^TO4A9YJ<>D]P/W#R7
M//9V<B!OX@_>IX4(PYM43)XD<MHK',_2'-<9-"5:+_&H()XJ&+-FG4S],Z#H
M9.J?H*E/I71CB>Y<%',6QI%F>9!G+-'25V&0^XG>Z3YXFYW"5AN],\KH=L9>
M%U^59/]2=84\1&4))EO_4D1RLA'/@*+/B2%?C(W0D<IUY((OE^8Y"Z64+(UR
M,!1NDO$H]422'V5[\"@V8L<A]..;M :<9'+:'1S/TAQ5N-MSDZ(L%D@"JA%S
M1:._Q]>PD\E_!A2=3/X3-/F)[Z=@I058^S" O^"G+)4QB[AVA9O'?I;=*8&4
M(L!6(;VU^N@MJJ/),9R$<OSDFZS$Q)"3E?@C2GR1)%*S) Q2%KK@WW'.$Y8I
MG0=@([Q,W7V?\'A68D\+.3>:4D='[1Q.NX4/XQQ2$:(Q*]7)RC^[L^;/" ?<
MDL O!BEPD4L5)P'SW,QG(<\REF8\9UZBA)M$/%)B!RG<9IN1U)A%#+9BN:VL
M=B3($(TT 76L10R>D8R/A7R369I8=C)+QPES!MR-).?,4S&8)>F!D^'KG.7@
MH(9YDJ2I%QQC9_/>S9+O3G9I/$+^N!NAPZJP/K[I09W?8<W48)ZXR?<; W*O
MJ% [7N_X-VISM?Q&X=F1*/VQB--SQ2G^W$<M)JLUE@H>&U)YZI48;DWK%P-:
MM.=ZD8X]\*"UQ\(@B%B6R(CYH4K"@(M4RJ.D[&[BE9.%)!1C*I0?&;TDX5-
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MM+F-Y$H4_7Y_!:)G?*<5@81SJZQ,M=]$J*76W)[KMA2M]CCNIXY<2=@@0*,
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M?76M]&"W?2,/V*OJ2BNUU@NVVUANRQ%S*CEB<LM*=WNG@L9_E%U?I#%)%JS
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M$'8$HUA2*0K/)::I@I"4+&CB%/R(BFEC@G#:A_O'P"O##Y_9Y*/K9L+*\>Y
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M9%JMZC1G0+%FBN4PGWD[G_G47H .-:HRN)9=<&V&?HZ^?QO=<FV7EW5"V.=
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MS$K,FR:7:I=;PZ\QY(2LZEUZE>-S]@TV2EM6^:X-+Z==7LZ_E.XV*8M^\W)
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MNN9)GZ-?[-R>@#5V*-ELD-5'9@5\B2-MN<5# C>__8E(@0&B [D/Y/Z\D7.
MZ$#NO0+?@) #0O8*?,\!(1\B<'YSP[6;B5? BP[N]:&LVYU2N(GANXF!]#,Y
M@?VU?K$]MS^-(W9;$KK5"0QLZ<8PG2^>"$2_!? >"B'[P>@?8Z1P*A/UR1$7
M\_Q.)8CSR9!2L\)PX[S<S],OE1 BJ)+8TBHBG8*[52&(24D5P3LNV%X'RH-%
M0YU,B#N6LA5:CDMS?7_=@4"?&($.$N,)0'27O]T<E/_>9\Q\-J*#&>I%@9.B
MA2N)3(4B)GI&HHTR*$.="WME:_<F.OI0;RHF\OJF6 .!#Q+GR4B<I\DKKZEL
M-+R,P3!2\  :<2HM<3:4)*0@F9(%4\KN]60W3GE@?L2R$BL;A2<:GD*P?CY*
M)@MI;\36JA4F&N!0H;^=3C?='C9<[:=M>X('[OMYP^KO3O'@3;J9]0S[!HI^
M'A0=8@@FA *,VL"P 6<@KO"16.=Y:;DHN=YKVGD;1:4EUU?S4--KQ[[]Q:ZP
MG<LETG?/:%?0KZ7=ATAX&ES$W]Q%S/O,6)XSLQ[L@1XBY/.Q\TLN#2L*(GD)
M"K$M$M$B:L*U24I&4P0<.'1%?&H>I*:2>.6P/0AG1--4D.2+0D<N&=?[@]H>
MUD7,#1\+HP>#_;D0Z" QG@!$!Q?Q,8L.L),LI8(3&W%< DY;U!9D01+!>:8"
MMWJO)>&]B8Y^N(C-]?TU!P(?),Z3D3A/DU<>=BBQE")3R9)@)"4R&4JL4B51
M0GHCRH)%*?>FP"BE3,DI*2...XY6$YM\)%%R;DR9C#!Q<!'W#?L&BGX>%%U(
MJ:V*Z-\-.%176>(2FKR>*R[!S$U^+^AS&T5E<!$/6<3'["(6?68LSYE9#_9
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MFU^O - ^U[10$F'M2\2T=TA2KI UKLB%+ZE09OCU(?F(\F)$<CK,YKPDX@=
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MQ$6.S=QQ%D?\[32^;UQ@@+56S2A0*OW\,:.:XW#0/UL/KPG#E^#=+P:D:=6
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M@_]NQS:<U/ 0]>PR3IT!* 6JM0"4_6NA9O,P+[/%GS0%<)@*/7"0,J9>3*-
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ME)<"8*(H0VD(E<AA(9Q4\)/X!\S7W=]GN19,BE(D-'DN,IM Y  H>D@,^6Q
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M\#?N#5UWKM3=AF,?W2PL^NZ]X 1H*5F9H&T/*9J@;=#0=H7/Q+'+?2$1YPJ
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MN%DS82/"AX[I[=L'/7H2!\0LX;OCQ5!'?'(ZJ<]=P/J]GL=!:,D46 9(44?
M&>842</#CMY&P?\Y+O3&+A,/PHK-=_'B/[K=98[:WLFU^L;'&9",!UZ<>S'#
M(R',!54N\BBRQY@0\@)^7(3BRU:65U(E_]4$Y*FK:;M!<\AI]FI@*SK%$!X8
M76JR!E01IU8S,-MPJ_4XAZ\R<F]*$R<Q@AY S+BP+2HV*%<%T\03IME&D;WB
MWL<B9L*I0"QTUDM74N2QT5IS8YU7>X!>>^"07NUO[C=0T9P74DN!E&-A")0#
MH')*(*%%X4KF-,DW!D<]"-?M%U#Q<3[PC96>&U#=M>LQNN!MS#5(=H@*?)S5
M "\G]Z?;O2M'A\!)/[GY5^>NV/LMV.PK Q]IB_Y#$H35-KUE"'\/]+*0VC)1
M(D>*L!D3.!"JD!)AK7$N& 9[8'-2CK(E+RQ'A DP(Q3H\E([CJS01:%+Y76^
M,=#O4<//4I)12=BP%><U2-\.D^\'RX2*AKAM9P_W0WJ-?3 ]A&:F+ ER6 *[
M:@+>,B<Z!&YR,$3 9][<'T%+)YBR$I5"4,086"K*6XN<YMH4DI3@)6\U/3I^
MC@8"F! =]#_\)!@^9DP.G.,OVD.#_]2FI,'Q"G,VFL37W]^2BG-#"@[<7#C@
M:Y&72%GK$#9>,)E35Y*-XHF[J.Z/W1*]F]4G[[MDQX=9J]!_COWXMZL&0OS&
M%M.!C_/M2H%&69QC$HVY, 7$S?ZK62V]B0'&;\'Y:/5[#"]\@W<,Q:")R[]S
MXG#A7 %F"&AB1<.,+X.D#VSKR[SPF%C[_[/WIMUM&UG"\/?Y%3B>9-IZ#LEP
M$R79W<\YLBP[2L?+:SF=GO=+3A$HDHA!@,$BF?WKG[M4%0HD2"V69%"J/C.Q
M2 *UW+IU]T6L"2@!T/3QT>"@/1*C?GLH?7C[0 J@WJ-#;.>V?^2O8SFK@MF;
M)"UCA;([PNQNI^&=CPQF(V6.9>[H\C?T8PJZ([_;.V@?]H?[6$ARTA9"CMN#
MP02EC5YW/%R3-VZ%L75T><*"),F1=T:61SN"O#IZ<D7!?FS)&,WOX7!+(\D[
MD0$S]7Y-Q)VFRC<?7C?O>3&PZD*MA-K/&8H10E%4 ^ZKD%7Q]J_"_&T"=X6B
MY*EZ]*^4:Z:RMJKO<#X41B)[$[A:\C))ORBS5B4,?YRD:7))=36"<(J8P%67
M,H^:K&0S#M'GF=;#]3O>*1;\HSU@YDWB%SB[JI\!*O%"D,.''DCE7P4&Y909
M_BK01H>UP+Q49$J[;;!.=3@)?5U@K@SW6HWK;F$1Y@R]3!%6KTWA!YPM3-F6
MK&L&JI(@5F5!LW18#;NH5(00T-DBW86*'D_QBGW6!P>G;B5S18Q.(=TS0+14
MG39^R8B.1C]"&,0F'0.L<P%446)I,!KQ(*P41>9.20)6[XU%!K^)W&I?0T&U
M-*G"7+X'-" L?A(B][:S#I_\09;4 XG13%Q@_?-)^!7) YP)Q3/C+WSS\4>?
M0O;8Z0L_PO),)R&5,22R&O#;!*CCG<7>5,9()EHZPHZK3?J8T%<FAO!KXZ4J
MEX>41Y611(JL@ORX'A$2V?4 P"I15NFO5N1?JXJ;&TCP'#WI8TRL!9H4ER50
MN2P?ULVSR1YVJ9*!PS'CL"#H8HRN%4N_PBW1V$6!Q1S-;L$3:]>*"RN)F#AA
MQSLI'[$1E,X+GR:D0GD]T_R.HE,5Q_O('(\Y=SG;__SW8;]W\#+3S"OP+D14
M<([S<A'Z5"!G%DYGM M12]E:=H J'Q%=FHPNQE4(>L:[Y&EARXLD6T&P"8U%
M7>OH46L**L&;S9(H:.GRZ@N4+ A_,:=AD4?+QG)45SWH454/ZKOJ0:YZD*L>
MU*CJ0;>K_/\-%8<&USO21R+I(+/VA&FN:G'MCO<&E!80;U@H".GH0%"8@'8=
MDKF@9/ ^2<I9$5'A?@QDNY"<'HV!7/@U5WS!NAEH8+B D>D.JX08EI!L;9U$
M541Q?"0*_\*JTE0\6@;3BG#AA%9;PUVUZ/"%0^$0YL[@*U56"(]#I;31@<!'
M,5'*Y@5;,V),A\</?@*'23D=/H@;L*AT24KO!!22V"<AF01=ECAEI=!V^09A
M1&:A1'/M)$ZJ>U12W<!)=4ZJ<U)=<Z2Z>Z9-5@VJ8/_P<-@+>MTO?\SR^1]P
M4>B+/WI##6"J5!5F?PAN<P?P^<.G.HG9LV_RA-I7[%X.ZBR7<^^HXW%5QXSE
M+BQ@EQG'D*JOH#KX"=4[Z=CLE%YXPUP<A#AX%:OL@<3G1"H%Y/?P8[V N05U
M#^\7=?=O"9L'PLCC9LIUC808,KHTB5C^IIB/ #OT[.SU^Q: W;9T'YJ=346$
MDH1YCPVV=XU[%JA\&U0+ RKR<%1^8P^%]01&0%+;)&JR,1/L%0FH@":[ZRE_
M4_)O7'Z3#\MX*Y0_E5=3ME[5@RJ? ^BO28J]-&B<G(H(D;,K*\9SK,!2NFE.
MOS(#IX)'(:J^6*T7"QW1PK,,_\R*.9P3.5_9,H'#8Q>F%1\==PM9\0ZJ@D6E
MYZ6(E Y-SIN.=PW8*N=/R[2?BT+8AW+P;7KI6P$K[A"L(# 5<^7BQF5B)$01
MASY7D$KL0S2 *MMRV:8>G*<,SI!?I5\8(T3Y_<3(*0E:H-!:A+Y<F69HSX!_
M$014U@< B<U_)T6L2UB)C -U833J")A@$1?T1<$11TM3_!5Q92I26I0!8V#.
MDGJ$*9>>C -38(4;RJ"5)-7X"_!1W88_$81IK;\4,78*MBMHV  QM; HM 4W
MK:D:/ED'( 6(JP$U P!()I2J^*V)?X@QW%G-$5R#)*R5(,N\WD"T>_O/Y1X]
MW,,N2/1I ^X(FJ\"C(Y'*9LHG5)=4&F(>NM;-\\! K =NFX!87I+K8'F0K-B
MZ[K;OX0C+F'73$EGYSC;=Y :WIE[9VA3Y;XB)IZAA0M-XDJ2\#[ !;?4)7X2
MIMI9P-]Y%&.%HC'OS198<!8-.Q0GE>5B'(793&N?VJ] GP/L&I>K8"QV1C#D
MD;1:5SO5D%^M4E^A1Y,*/9KL:7IM$Z.]3GG,5TZ&3$_+$"4K+JE<5BRP7Z3)
M$]E.T.MYX3>3>NP*R7TZ54-;,JJ)#*MH<%=.S>%4,% HQF&$/3BI(]KZKG7<
M$$5-I68+ "VR#Q)'*=_+=$DZ+@ %>,K 710IMNO,ZMHGE*87O34\115LA=V=
M=%<!);1PFAU7OR,ZKC+M.EYYK:G$6N&S<$*Q45FF>XYNY'_7Q[NQ9E?<1@#S
MA$)A1<HH(9:R3?)<DE7S'&]"0E7I/J13$8?_4;X8M:3/<%[!I5AZ98X*[GB5
M#!'!ZK_$KZ<I0?^-"=9]WN_V!GL6-R5)I-S]JM"Q@2_6""K7!\TERAJFDJ$%
M*#A^ RKGM"N==GA"S'L8B%Z0P%AQDI<1C%@1-D?:J21\9E&,M"E5A"314]67
MM.X3>O2L*W_M4[2ODA5@1O/B >/JK) Q>W6 ^M=;UFKI6-:B=%G#LFXM$B!#
MLZV[03K+ N,B<RPE:Q&^)(Z6%I:O;B#4]\*&^NYBY'<0GRR;\YJ4E#@IZ4HW
M/2@1I$G$B:><#;I^U3V)/O6JV![?H<2G[MF@ZA:I%@Q $$LQTX1*1*\R!'J+
M]"K,>P5R3ER::+ZJ)XU6("-^++TH_$*!]LGZ"S=D+T[EVE6:<18CW@.Y_]48
MNHC:KQ(09Z$M2^)M51/@ N.?)[-03N!::TWA@Z4I\&\E,?Z@M00C8F N._)P
MH@/7LX$D:>V5S;:(A-3/(E4Q82DESZ A"+Z5::H:'.&G22J*H.,=&S*0+4&&
MF+>04,Y1R$B]67+)P45& 2/#-#4F0^*#D6@5.:#4@EJT8S$&O:7(*4Q)*T6T
M?21["8DT $8CB%170H1M+O..][HPP6NAQNS(PFS4<Z)HY?6,=B(K+@L#/GOE
M>I&K:[2'I()$?#IAC.WM?5XU 5$W<VC9%FUM_"72/<:"3'P2,J"D@FSC5E@,
M9841[HFJ)PWK^;,(IJSMA;$QH[;GX@L>.VYH#'H_!GLME1X)[U#D3)!<QKQE
MXCY4 KW@8HL"+;B@ BK<P&P>D"3%%[2_FCC%:-FJ0@XF\L/4+^87G$LXUGE=
M00@013E/^!Q^EB5LU\_(-*PR-PK=6"6_3,IZ[3)9(-K Y[$M4!*FIX1A%211
MN1F,F=PV9JD1QSYI$64)6A-8.5*]RE539-5&$,]]KHK=BC'Z!RCQ$/EH.$M4
M__("TPUU8)W2T_'B,C@ TU:Q!S,V>7%T);/"QRQSULF!5%QH:SQI\8$W36"E
M2G9 S%LD2)GP;JNIRSKF';:.<3LFLU'*%I4^ AS(@C;O6&?MEX)D.18!G#(O
M)48R,.A,F[/2JI)$&(B:<4J7(4\X)V7GA1C1!$CSJIQNZVV%2;*\7:JNJS0(
M]8[2NA'P_3<X2K>.)F>$I@C*)->Y@G3);AI(<#<Q,!C=0HZ[/RPWD1W^LC'2
M8+03(3"O /?(+WE6;N^&D+[3(GO?,U;K2<M+;]8;PZ&@HDRC:XU2J7].;P0*
MTR;C,%WBP+3(Q<M-8:^<C<_O=\?[[1X2 %A:V_XJ3P6):L*J3TI+H-Q2<CUA
M4B>EP)>+(I0>=@]Q/9_D%/VKU.FC_<\]E#F,?H99<R")P-YG69V2UJC"+C$U
M09E43P/E0 /:;ZS\8LJUO"_(%*S2/8[ZDYX0HV[[2!Z.VL/#4:\MC@Y&[=[1
M_O[!9"3V1_MKU5J.)B(8'!Z)MMP?'+:' U"HQP?!H#T4_4'_:-CUCWJF@KKT
M@Q=XY'CBO>,T/0X2M%._B<2T6G>%LI-A\5$F-RP5!I@,^_VC]FC4';>'4NQC
ML7? H_WA:'+4#>#'M;X#-UWJ^R2^Q6J;@$""EVHH706"-9^;@_JM>T+M?E>,
MCXX.97M\B.4.9?^P/09T;LON<-(=!^)0=K\)7ZB['F/+*\*6=TE \2^W06Y_
M,CF4_@A[$0P"F/CHH#T>[0/A/3@8!(='_FA?KI4EO_%B#7;?;+U-0)*Y6NL.
MXC>2\?O!<#GJ#H?!@6P?!?Y!&\C?L#V6^T%;BB,@W ='P:$_O$OB_3F=Q_FM
MT%L>'':'O9YHCPX$H/?19-(^%+U1>]S='_K] U\,1FME[+Z1=E]OL4U $%,9
M8R>Q&S7F)BV(=%+ADRTPR]/"US5-L%8E/.,MHK*%19,67LVO<WETNYA'-W1Y
M="Z/SN71[50>W2,Q[9AF3$WB:;KGJ[)LE$UFV=J.<3+H)"/C3)YXV*XFF[!;
MPLZU#^0$RTG;34'1^%.:DI[[>^13!UGD&D:F[V1E!J#/_SCRFYV;=H*I&8TV
M:1OOZR<3M/4F226Z;'X![,J"T%<=$!'%/BJ?ZEF,^2GT@[,&F]3-'),^HM!'
M=MAQ\N?.RY_[3OYT\J>3/W=*_NS?K.];'6VZ(AW^H*DBQ\?C3Y^]L[.SBKRA
M'?+&]?6'B(,_M%.L]+<_K/"V$;B'304NR7.]+LIS"I"M]1@X#HHY2=(%A8)X
M;S%N!\/3Z@M<W">8&PI& [U&"\4/'F=+Y]U0N?:\3#*B>KHBY<@\]!5@JO-4
MQ03J2+)QB(TR%C.L!%Q)%!<FQI$KW&/Z%S6CT\7<UC(B01/!2]?^I_>\\MN>
ME6+"0:0*JQH;K0ULT/M[3G)*57@D+D[2H9(B<&4X--QI?+P-(E12J$=XEJ-A
MI_NC?ISJ$BXR^4*W,:@*!/3:,YH>YC>2*R8-<A;>"SV ?@H>"XST0//U1YWA
MP?Z/ML2C.3B)/#]M>K'7&=WF+9#&>H</-EV_VSD\NM4Z;S7=X* SZ VN?/'O
M/^7IVJDID13+_8R%_V6:)B!SMQ5Z3^A_+R\!+5C'>,&:!GY1C_0U!UX1BE'L
M59]9UH0O@)_E>+$5G6+RM::>PH-&)M8*ZR)GO<#3%U&_I"37,-X@X1W>8^C<
MK3G.]2P"0"$K G$>?">0,W)T!XT ^C<VRJI1-+X;7#>B<@T([A'*6G%Y2.0^
MGCK<=KC].''[HS(^9-[/,@J:<1P.S1V:WS&:GWY=A&6!C<\RG=<>R<UE41\0
M=>(W1A9MPHVYTUZAGV>PA,P[Z8 ^O(SAT$$/?]=YW6EY'V?PSP->K*W7IL3I
M>P0VS;SK]&FWJ<_UO&FCIL#3H>63)9S:_.Q0T:'B=T;%-R$VT,;<N9$V?+^3
M,E?V<.JYC4WJ9)K=D5#6, /AHSO07Y)L5@CO4RC_ TMY8E=C]\G)HQ.XAGV'
M@SN&@SM. 1LA73F\VP68[;8HY>Q;]RQ*86B)]R9:QM]7CG*:FA.M:D6K_:;
MTZ'EDR62C9"V'"HZ5+0%L -GRWH,!WHR$RF6=W[5\7Z5#QGGTP1([CXY>7P"
MUZ'#P1W#P1VG@(V0KAS>[0+,=EN4<K:L^SW0]Z$/!R8R[U/'>QMA0J"+TGHT
MQ.;1"5K[+DKK$:#ECI/,1LA>#A4=*MKBV*&S;#V* TUE@&5?OWB_=[S7*1QO
M$D5/[(;L/E5Y='+7P=#AX([AX(X3PD8(60[O=@%FC92HX ^LC_)$VRT]T%[5
MR?<'O4F_8>T]K\B!I,)$WFC4\NH(W9,N5/HZ+6'FS0"&U)E1F"I*> ]_A<7
M9<2"0M.EEX78".^-'*>%2)<>-GWO>#]+;"7U,959&$AN=/_Y,O$^ L%"U_%)
M$F=%1/?ZUU]/U!"OI2_G8YG2$"W5?1(?\<NG,YE>A#YW*!Z'22[]&2PUF7)'
MQ\5,I'. 44'D4W68#&6&PKRU+1P$6W5B:2KLR2@7D@ZYLLG/:1A%83'')HH
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M0IE1&%=*!?,F%5W.FXLE:&I>EI"65XP1!?1YFW68P6(QIVSLK)@SX1V'R13
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M06^!<:Y5 Y]N;KEJB',26R,IU0>*+C:$2-T_OJ-D(46-5C7EP(X',1*0O.Z
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MPF,;1)8K8E="T&!TX[W-0G I^^J0GE(DP!4)= M$47*9O7 R\#9L_H[4 .B
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MM_EU[4VS&9>1QP1?*+PY<(AU%PA%K-61O&*A[ P5:P9\F(=Y+N7?0 &32#R
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M\PDQ1%0W91COO<1[>:=AOPZG'4YC&,V*I",P#L5@'ZE<2N2A8D%;*C.L5&+
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M+H/1/I*SICQ>_0(&H/UX*D]T.P,8W#.0PI$<G<N+^OC@^P4XGB:Q*,EI99S
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MV*'!<(*+>TTE3D@8N0.1N5LCQZ(!"[$2W#.<]LX@8278>3^WUP)WPAM "?=
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M?\F%EG QM&L=U\!;-+L"SXW]:]U:P!* &@;^!H)=(& !@"MP;O14'8M'M\<
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M1R8R?+E]HD4%0 584H!+_!O0 J3G'H&VO\]KJN]DG<G_D!^+LM'J= (]/[D
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M+3*M"F4N&)>9'@W,0G*I%(RMG"A-SHOFE+Q]]>E'$OL"5?=1$\SOJIGPEX3
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M\[09_PFQM?W@3^8YZYU!1$-\!@88;')E:/'].41C]6DQM='T7+]_!&Z&P2S
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MF=G\YFHSD_WZ'=:L6)G,P%34ER^\).6;I'5EJEJ1M2[4\M7Y9L7)=*VJ(EV
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M3SVV(;DQ+OM2&>*'7V* 8F6(TS %P^NT[$ZW-1@,[A $&FHPRD&F1@'N)R%
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M_+:>R3RP[?CN(OI@.ZU*^$%]K?S([>B#G/LLBJ?%H7_+%ZL&(LH2_QM83Y:
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M&\Q>7Z0F+I[(3<$-U7L6 #>8W'YH+FEDV8>3N6=;5%L&F"&YG:0\+I*B+]^
M#L@O(T!R][?-QR"%/>Y?\5F2)P?_>7<4>K.__]?/NP P_^__'U!+ P04
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MZX_'2E5@"#Y0SBA7#73T3E)K)NSV6>A156_?"WGLVOM:4]34XA^53JSO^I]
MW!3_[0D&^C+:AXJQU=:O\XT59KCR6G4!&A9CC_:,K4^=:-V]E[?^3LQU/,<C
M3NL:W*D]FM=(M\,DJQW#/FW-;'14''S*FC(U-D-12_L.Q#BZ%KGNA]8Y@?TA
M#<QV'&JAYK0-2DMK-O='([S'E,W10716_*I>!8-:,#42P['U^H[ 6,I6.5>$
M*#=IC)3V82:C.0H43=$H3FC;U.A-!/CJ.U!*FIG/F.C&L5(WK&9Z:DUS.F%Q
M3J-J:BT.PQ/JNV[&4#6V^T9 Z?3>+Z-IZ^6^!WQ,.XN]"1A;M_U15'HOVJ$D
M=1L8!P$\=)D61Q SIM\9CFS06Y\SEK1=FXH:7=98TG9Y'Q'!/FU$1C=H>9QZ
MQ&9/')C>+=@=B4EAR-.&2$'3QL9.;UQE[W$TT0UC=MD)D8&];;&3VS U&OU#
MX/KR/I2B!4ZUA7^-&"/-?3'FE3%AWPRC8LZ".2!@H[^M<C#1<?RNG.21.@,G
M<<HX(Q^.,?8V;\^_I.""_1C@\W"WX1Z85SYY*K4XSQ7H,>^Y($TH4:">Y(YT
MT(8A?]Q3\"R\(9=UMUZG5'!V?J;3'8='T+<\"@+L<KHC<8626@_3!%S][V/'
M\\/U AZ@S,>U;;]T.9MVD53)P,WS-C^!1O>YELH,G>FT>,S-TWU&M8_,# S?
MDVS:LS S3K04SL^PI=+T9-U4TAELU*>NWM[7&R2Z^MU>RX2IHI\]PI8B?KBV
M?1Z*L@$+MH. /:75%$W3S-1#RG1 MI^SX]^L\Y2%=,E$U@)W>O5N<"#/"*H6
MI<&A['62F(]4-92UH13-&O6'<E-7RY[I>O NZJ!@[Z8=S$D'A9DXQ>.MXWOD
M94Z%W--=#+JL(@:6(G_XO@W9<IF9F(AFK%N-DF;M[0HUCF+CZ%HP;_6$C1MA
MK!I$>1SG93"9GQBC(5[#$KMR'G$/&"7 <)&K 1+-3\?O/QR__Y$R5T=-1W>I
M.YK:/E=):NDXX#HH[GB%9'O' RAZ13[QTM!$8^^_9SV @AEU/X4*&9EBJQB,
M8![V)'2OK.'(+10E?SMI%'=M&/CF[Q_O;H6+VCWY/SE B=SVJ0#51#O$"+06
M?SNR9_5FNUURO':<K62ZX]_D"G[^Q=^E6 5^U,O'?WXN,/'MGHSD">G(YQ)_
M4ZE98_\FCER,O>0BCC9WCAPF=Q/ :TF*E6M@>0@%:VRR4QU\,Z";S-5]1V[N
M')/G!),[33[]+\B?Y-G8P/4$@M8&X18NV9V;[F+24?('CI]Q WNU195T7)C=
M/.RS/I,/>5?)'W\_)V.9[F'@XFW$!I-:/T_AW1[O3R.OW.N^M2SN,BY*T+<4
MU5QRI][&3=58P1H3\F/B"EH \:^ (EABHJ7"6"8:+B))4F.RV2UX-RY7#PEF
M?]==1]V5[*T7,G#7S@8OOOCEKM<643R<MQA<%ZF?S,8G(Y)+_C?DP7@9GCI;
M/\T=*^1![5O5VM#RV(+'A.)J- QNJ9#1@X^_PV\Q.<;@<4F=X,JKH+.X/7D*
MSJJ3BD]_[O1QLL^+W#A[^(JZKG/'Y.4N35(G!$\1X:/,TQ:=?\&QZR?X)O9=
M?!L% ;E?H6*3*&:^(]8&O262+Y<YNV37@42L,@N7>W8Q+G;I4Q3[_VJ\3=MJ
M6!1)GXF014$HP!"Q[YJ>YO)J6:BZ/&9=)W_\G?NU+^,[(A.2]5]S1346,W2.
MGD7N#L;I@JQ:<N_@V(^\"_)=W2':7-;HH4]DI"" <\H)]XU'?:&0M75+E<75
M<&A^#S4LWHY*BN47\@J(^9.;'^S-2HG&LO;.-R=Y@@.8_ -RR#-Y4\.1G)XZ
M<;PG1S)UHFHZZ7K55;JTW3WWGR0?<F;('W\?"IC:()1-(C6?6ZKUO==4VOY,
MW7"OCF09,P$AQ1#&D6PCYE7/!,_[Z"0B$M!%X*R'S=YP\K:&A/9@N3KS8^P2
MXLF2K+4$Y,*FBWLL%8OZ(0KT*!1:L'\ ZO%TEZ31!L>U9^BPNJJ?_<ZS[WUZ
MB).H^7ROE+'W,A(N_%3WV_1J*1:RMQ:*NI#E8^KX(0"AG']Q*:;/1107[9\9
MC$_3"IE 4?&Z.25O&8A$$(ZC=>NF4L;:5%Q%X1H<8&YV,1FH!.?OM%.X^")P
M<+HDBT;\[K4JY<92.UB%PD<&H1 RV;[TE*<_GLF@7IJT"4-[8?^4NB*[$Q9"
MDP*RIJ ]U;0(9W&)T,L$"OJ1[-UV#75GO?DN^Z1CQ9U_V?K<%-6P[ IZK+'K
M7G4WK TX-TVW2CG%,D8U!!=^@&-Q1#>J"(JE9F%5_N2D')N9.ISM,P6C$P00
MO/E$Y/N47$BY?JO1Y#&1JKT;O. ]U!Q[4;ZJNZJI%J=S]]NQ/G -3WCEY.=A
M0P?$+3(SW#[>8JSKJF5SH]:[:ISL[TFS;?;''C7M79X8KI;0Q103[7W3W58J
MI7@[+=8TAIN(UPFD@ , B[IM45?,EH[C_LF/R25.IC732Y"IO?1(#VGX!.Q-
M>@J3%US25]DSG.@,G,$*.Y;N5GHBT972WPFL'Q5K[%8\(.#MP02\@!S(<A*K
M$HM]:MHS\:]6&$# <N<KV%1%Z)E%6L:8*11N\@M00-GNBX(KEJFL3:1Q^EV;
MZ%];WAX+Q>"\SB=J4W'%)_V53RX_#W!'6BVY[67MJ_KS@_H\7)/O1JCSZTD8
MMOLFN1<@]D[VMW!687(B-<W+L+HS.];J7$\'G5ZU!.PQR2/^)*S"UA=Y<WG+
MOL9P,S(ODW3?(D8W%%9\0'TZOR>_XXMH%\-_S=:2^H)&'4QXX-%''*UC9_M$
MTW/4Z?#:RUJ;_7LG7F-R=BP![\C]3#WRP*H+_^NZK_K5M<9:@R^G9+MNX*M'
MQ5FHJECX O-5H5(MTQZ![,Y 9:7(^,XHB XR]F2HUECXKJ=-O\KSTV=T;;T>
M%:TQ)0$F78;;70HBUP4YI2_#E @G20JW>.LE.8" XHOG)DKAF9_Y5B7+<.$^
M^?@9,\Q<"4#W%J\AO0YY+U'OT\T&K ).\,D/2 ^C$"?-MY:&5BSZ#56])S)#
M^.EN0[/</^-3)W6?'K8+[Q\[IMZ^C[@+QJ?(R]0JRY4@U^AWI*>U.9QN+/<0
M9-:,R0.=?/TOJJ_(<KLDMV1;D$OI,2!OL81Z&]$SNP:.I_D45-'(?&V,@XS:
M'V/"H!'S.6M)\5$%SR$(V=O42INU1>P_V6N='^O\B\;34?T4\4-_L]N<^*TZ
MJ-:B]AZG3AP2>2<1/0'H3+?I85I;UIZJUT^<]3J&X'1Z4O/CNU=0<[^Z!WN*
M28$^U[L6*4I].W,P2+?[[2OTU5?P_!321P+B!].YXVN<YK'8D*4Q>2*R_+/O
M@?H.<EE<AID1.7]^=<3_:6G*WJ.HXNIW_@7RVH%9/0K7X":1_]3Y4!I'; ZK
MYB**K_&+]&Z-HY!\='D.M&8EW3 :JLW(+&HF>Z&(-TZM+;FIK%$-7HY;3HX]
M.OV-"KS&HA;]'RMYR-K/BI8*9D/(-DX0"(?&YABR0BEKH\Q-I+_0P]0)3YSP
M<]>9W%K%IK(_!M>D,\S^K<L4VJSZ[ZYJT=&)^><+.9;TC:D#(#L4>?OZ3?/4
MH^)\'![(!_$=3RA3D.U"+\LB6RO\@2-'7P\)%4TIOEKNJ$A'MA7V,F"F:.$^
M85#Y-&KU!U6U=^]G5_0="-V0&^]A"ZDT/KQ[_^.[#ZWZTGYUC9[NO^$@^$L8
MO81W5)]$9$WPRR@ST%W^8%]I1/!:83\%["RA!M+T3JMK2;7#")SW$JCM68-O
M8&TY/?*E=.DT/0$ZB]OVW0<W:1IF)K^UR\:/=M?^?B1F:5UN"ROLKF=3,Y6Y
MA<L;5O:5K.S73D/E5*KV'NNB*Q&/1**A#/?] B1ZU;6''!&OG=#_%Q=GI(<?
MV7-R^B$ISV:>]JKC=:"&MO59A\AP4"B%7M<<RR7MZ1';@CX:"LW3LCK&/JK\
M)J;O!+)@I<OU//#IY8^]AVUY9;?$VHPE96UR'L)=LG,"L$HMXX?0Q3&\(M/]
M-<1YM0=Q]JIJ2%A?D+WI43RAJNML]7<;P$TTE(QA,C6KY9K+VO>J+'K;E_/!
M\D?T./=^M6W8.^@")R'W Y=HES'(LPF++X^CS6]/OOLDI%WV8YKP&-P6"7(B
M4=5^12QWP2DI"4Z?5)RK]0RJ*Z>Z+^Q&)L_&<D*RVAXUEY[5@DF9C7*YNF,.
M V !=(( 3%WE>1ZP8H9053Q-- 2DV;=#_GDV#@;]D &[:LW!S%P;P-PE./:M
M;E03M_ \\IY(;LA1X@3_R]^VXE'7%K8V']<X[6FT;IB1 01F9)$9AE/4O[[%
M\.8U\V7EF+]D56W(G!"9!#P3N+;JE^@%9D=*^]ND+QU);0[0>JUJ_&HYS6K<
M"]Q+BPO%+)X!C=X+RUAXL\HE?"((;X-:IT(U-&UY4=Y&$*8AQ2X.P?%KKCQ?
M"TL75$\K1I41L* !/;!I6,SMV=L8NSY/A$46-%<X+C9PDOY+(!L,2J>BC+Q=
M@.#LSF1O8OYROL:M ,'-E50;OK/<P:ZT4)U\H3[NDZP(1Q=R8)U&;)VZ#!PP
M@:ME6[,A-#6B'N\GS]E['87'%X6<O4F/:/:A)*PCQ$D"#.RDP0%PP^DHS\TA
M :T&I'<\V4V>!;TY3JIW71L/*O[/%1G>,F!/>]D9H,747VI23+J$CY(DNPW[
M;F!&,26-V//X$]"6)_OLXR\^.>]C]VE_!0%Z+0ZX/2O/1F_3E5ZFJ;A][7K?
M7!0-Q14?=@\)5Y(VGVGE(O9BLE(BM#I!L%]0F WPM<AC_Z[\SSC8WT?E4K=X
M[</<UQJ,]+5C$<"G%?>OR]6Z9VW5"G[R[H VUY#;D(<_<!#*?T0Q[10YB^KM
M#SVKJHYES)4-K<:(VG+V9+2:?'$MET)C<7LOGX*BL 1XWO3P::TS'T_IMNC>
MAL)6,S5DV2269)L]NN(O*;4$X,V/S^$PEK[BG4[?S>P&!/V[I&II?;?UJ688
MM0M00VOD_L+/]OPN">WE2AJGEG.IOJP]?94TN>2I>EU004 >YL2A"1OKWXUC
MJ1A]09YB\-(*+D,/?_D+;D;'+I>S=4!QM%-R0##IA6Q!W6>6ZB:M9L<JI;>B
M**L^B,(\_57Q"ZDDTRN7+7Q9 *O(1 +N.PPLK\FR9+83<\';A).MU16ON;R]
MXX_L?,\/=@!CDSN=L-'&'E.%;;8[X1U<>9IO0+'7="@JH3T/+',.1UZ_.!OX
M'T!@%H\*[OR?QP9TN2[WK*Q:+Y_#50GORY;\5HV%[2F3-EO'CQGT%F "7)'M
MX?$@R.@$,YL!]I:K)NU2[_IS<$&X<6)R=T(L@4?UDAVHRGUJZO!\JQ%82S_:
M%JZYW:M5#*TMJ@NS+MB?50YW*2KLJBU,;C@1B]Y$3$P\P]24U^@E5"PU3R6+
M;!KGYN,Q>I<Z,G;].AZ[XUD?!R<RO\4@FU&7+Q;FLG,"4 E^://O,-P3>[=8
MDNS@\E^NZ&%-)'KAH4Q>1.*J7<:G@>,W@N4,HV%8X7+ADVMHDY['<12?1C$D
M) 7GM/K E1Z5[$*VL#P%9U0493(HRU\@VT>%!U%CY/AP0G:];'AX@\"3Z$[!
M75]!\04*H66[ ,[6!H?(8@&;GER#DIB;S%_.S*M2<'VKM-%>P3Z8/SOI&MP#
M@R 2^+&W&88JVWDT7J>)<UVM&#J&^=JY(.]))_@K=N+ST*O!@6@MJGC=74?A
M[2[ []^=_/">W.H,V[<V#4AG\5DI-3I>^:U5[+V*(%IWO5Q1Y?H*8J8^1I&W
M%&)#FP&B1TT;'E[TJ;N,:?1(-;549W'E27NHV\CR,? 9L"EWXI.,&=33F)\<
M%+V*6CFY%UVMI_]4FA:!\WE/&"X(E7@D<;UAI775LGD*8' .(Q*WI"#C8@]S
M6FH^##IKVL1*(:]O)_@81[LMI"IB)@/02;(L/MC+D_CDFLH>8"G3R)I-$"-P
M.^2T+S7'87O9><)0\',@EU :M8B#B*AV.B!?_>&_/F0 ),W:Z8:2.N*P\D33
M%&0!UPE37:7M^U\6D0?H\@44#])H( GY76Z9/:G,P'-:C?#>WXE:=7MS6S%$
M)B>+F0BS8+KGMQ9]^0];,LUD;*;V66&:(M<)+G!;(J9BL1DL\HI_7!&89V <
MP#!J<_$=:#7KU)>U[OS(+])VK5!#8?N!%G6+@T=S>\OP%NPY/"TQV>VQ^!/R
M5.2!)/?8?0I],C-)6_ROUB9GDW8+CD%PYP&[Q*!T6S45#]4=YF1?3Z -/%]C
MB_.-M>X(=,[%3]UHMG4M'9XID_[O5Y9$D<$#Y9$5JHV5K6T=[(H#AK '$>+B
M-(K@*TE;L^ Y?B M(#F6$]^E9[JF=3F^/W9-;GERDWKXO(["%HVDTB/PS^00
M33S?[?2WZ:IE4<%'O?%HJG%)N]IR#[75F(G:M6V_U974Y?AT!V]!(M"FNQB2
M.K)LO:U>3O4U5/NQ?>D1#UHM9%0YR7/6U?:O^KL],9 *ZORMTI4,J[;LH8 5
MGCL9,"4OVZ12G4S7_I.//C<2&A#_?>NYWE9C-K!F7=' 3<4M@AC'V E 5_B1
MW/6 GK8,NU';NVK- ;ZQWTG14F$>_@ T+(>* 3E287\SV2A2<Y.0ND(>.JO9
MSNB3W&(7^\^@&P(XRBZ/K>8JNIRVNC7I=\QK\OV/'SY=^>2!P.U0-9%&*BE;
M#9;@KR":=)T")>'0;<89;:MA,=D!$80PRV;0#R:EK88U-C[B$$#+ ;7*VQ!I
M%+8UJ-;X"FH5&_K5G4EH0!?0JU98UQZI G:>3VA<^/'FLJS\J_YNUL."/)^<
MV(\NHAB[3E)ONVDIJ/AD_7AWF^68(_]WG_#]2]3\ FPK;M/KPZ71YS0)$8!(
M[$_(@?:T<>+/+4J+SFKV3L,H7(-!HYH/^&1_"KGDHWB_7(%'K2CAM? YEIIZ
MS_4!;C601N6.S$RR8C+2<G6#8XI&!"$?F0]@K<>VII8LNB.D.";R,;C-<6<?
M)K9DIVRC T)G17O^ZS3\GMQOA<0>12E,P!M7K/(Y&%\01"].U>%55RNJ]P03
MEZEAGF;'8S(GI$4AQ[[;D:-@% GED)GR4$(L%L_7PO.W\!&_:HNP&$S#JI\,
M@VYO\9#A!>R!Y0G<[!N.'@M1< )\))'01P:!G(PA:VV>2A&0F::Q[$0-WA%N
MPU0.HV''2U?(B%T>NH5RAD,A)1#!IE.@L[AJ8PP(.?>D"!;)B^X!T+%9[&VO
MH+AWBQ6YM:E& D:BN5.UY6;@D=?GSAWHEC>"Y P&8CQD?YM#F#KZ-J_1>F#]
M3A"D/C5GA#R67YHJKN!I#=B<;1=CCT*SYD'[-['_3/8PF4BW#D)U8.6Y>.)V
M>\LWEK>G^_?^L>/VL/MHX7E4N'."&\<GKT7N;E#O\'5+./&),"@\_ID+'']:
M0X$VIPOMS5IW<<X>DI<AW[KU 7 =SL^]R<PM7F+Z\UT!8;O(&86<>HU^8)6"
M,_&9&@B_U;.R1;BZQ$^6JU)"D7T_>U//RCH@B(7&O244L*:876](AC W."UE
MO[JJ,Q8]^I%0?6=0[<V#W5;<,LY;P8NB59!N+F_/PR>!EUZ2^N3UWVB]+A6R
M:+ FLP^K\W*SC:/GENQ ?6I8S@E4QB1K+VO?%4_"">TZMMOKJ':B[:&FZ.U9
MP@,C:OUP=;1C$WB!S\PDE48W#H/25C3849@]DALHB4 ;07Y"[($9\_X)7T0@
MTU)8RV)N\R:O,W5T#S8P1U+3WQ(V+Z(8?M04==/0V P4D55PM8'ZUTX"L_%K
MA@3+EV0.GGT/8"[]-( 0&V&R6L84AD72E5T[D LSQ4Q;=A[N-AR+I:=CM+KV
ME -=E][&N4M6E"2GY*VPYRM4"F,$_+.Z4V0\,7LOV< )8;#;U<G%0O8EFPE!
MWE<=4'YJVS JL=;.8>5G>P;W:5GC!IKA534V1PC[7W#@D8/DH1%9NE]=^ZX7
M('"3^R$IY#&?[GK1G^R\0LBZT>XZJZE^JG$5@JQ !_@AD/ H4J4;@=\'C.D3
MN<+73P([H?8]-IJ8 1]+!KJ>G_;[IHMB#(791>"<[.5?AH<LUQ%0CJBV9O!)
MS2K&<I'Y6>K[*<U[5Y^GIYB43^1N]_@/<I'>1T3RY[I?(M6#A2D(VMX+ZNC;
MT!&>DH_+^#YZ:1:^JB5G@R'1LOMKBUJ,;=TEY/4(=_TR?B!S'J=$H$WW)_MK
M)R5B>0LCO:HJ/L"REX0$QI3<^>O07_DNV>@/8?0(0,]PX?$8Z+8K9PHY0YM"
M)&@1^>/@S5BS(VJ+*1[\3\X7 #E@<8?+E72$+(FH3Q,K  IRW4#WK3J_VZ8M
M06Y')>M>(&)L*;AEAZM'L:SU;5OGACB)E&4/%5!6,5 TBKP,0.X9]/()>-%B
M"<'U_ L1A*.8/#Z<>$]/F^LH!,SF. I(U]8BN*;5=45/BP>KC^\&IF("DB8-
M?>_F[0409R@5=PXHWJF<PO0;#6/25F,V\(Z=?KTM%68&Y]BI4^ZLIEO1WW@A
M+B#\CRST-:B*:A>5 H(SLHLV7E_3B<[ J*<(;;M7I('*MHQ&2MW"S= 88B__
M:M_V(YV!L JK,E31P>.V9)GANCF1F":YQDVBB<X65<=",</S+?8WC[LXH5T%
M'4FNH:N-C.JN-2_]N,AY1]]?V8\)_S5Y/T1IWDEK'L!X3;=GH8SA4$5V5C7G
M"JLO9_1 HQX&RU7N<M 0^EE?;E:'7))]^8M/WD2Q^U1OZ!U'P]#2N717,4>3
M6:0I>4PX+8D^6PK/YL51$/8R2:_GXZ.ALN)+(5.B_W-'Y) +C-.'T,,Q=;"M
MNPY:R\_!3?Z"O/C)->L$PF^HOY=\<U753O+1*B5/:<P%XMJ70Z6,W>";IFRS
MPGE_N6I]60^C8=$2*@/:4(_>7K:Y[GKVMP87<%B"YV8C2'-Y>W9%+G9=1^D=
M3LE=S(3J4R=YJG%);S(>#B.B6O;VGOTDBO<]0F*:BMIWQ+D#?"^\WB]"[R,X
M8<!IV8A&,XV6];4&Z#]4QI<4FI_ "@@^<E6)=G#U.8#E-@772"54;P,XW_-%
MT&<WM->8=:!WEDWP,CS_ K'&H,L!DS+V&CR@5%-7/'U_V4<OSE]\<G^?MN :
MUI2RIR%@8_5 +N5DL4N?HK@M665]8<N&MNQ"/G$"."3OGC#U(,N7A12.=;(?
ME".U36-IJO6YN2N=@;T!>WU3"P^E8M3UZ,(/<*T5L+;(K$Q<+2)J8W&[WE(\
M,+#532HK8Q.58$NN$=X1LI,E(V>[.K%/38O8,=MM0)>$$\A'U8#PUD$D5*.H
M,1">/)T"X)/0KWBX?H[BGUG/6B#6QE.S@M_\$"9;[/HK'WNU6LOVLH?GP5'T
M7.V42]2W8VW(1(^RF#<> ]AT:#:7MS?K5#M+U2+@B+!<21[OK3KW'A7M05[X
M@(#&N[2"$?\81=XRYD;J=OB+7G5G$]7:/X]*GYIS38_09&3HJ*7Z6A.@<HLU
MV,4[L7=:R\\%EZ[5S:.NJ#XE2KQ\(?.9//E; %1- !'EMJJ<ZEM+M97#"<]\
MO(Y.G<!?17'H.RTX0$UEK;L<YV':+=GI&PK/P;.IE*:8OTM/]LQCG2KY>_HM
M]:8T:Z4</U28+6J"^JU(1Y-55IR P@^EW.&.PH<G&?=V+BZI70J..M8\GEL[
M-;](D(<$KW;!E;]J!B'LKFGO*8%?) #!. K)1R8\)$.P" >3L9S7JR$;E# N
M]0*C&4-)M2GAL]M'DU%7;-9I5NJ@PMHDAVDT#^^ EY/6,Q^0)H=,I4T<4K 4
M>3!#YYMR:4RA:%&:WL;8]=NBNPM%[&GRX[43^O]BT,AD+,GA[[&%%WHWY+$$
MVF'FEI]YBV4F,BFO*BDMA?"5@&[];EVT\6[8L]!*<?L]36ZM5>RMG/KKM-VF
MTE%I%ON5? XP7WN+#:C"_M5W'S=6M>_A!TI)=D%4\]-U>?FUUK6(_<D=0EJU
MM>52]MW*.! _3B F=PUN85Z-S_=((H:C'J@.W&<!/J U;@E\J!2=CZI+\@!K
MCGSJJJ4\>%$*0&K.05U7S**43.85TH7FEMA&M]NZHA9/R;JD&.VFA?8Z]E[-
M *J9)>;>WV J)IP&CK])6@/D>U2T&_V5X_>=$BEHW>AXTE!X5GJ,3H&XH])\
MSLXJFNN*H[E2 1V@WTA'@MZ&A)[D[,<7+%?4ESZ(7II M'M5.3CM3KV> H*T
M%:M\6AJ:46*>ZRC% TSLO>M;A=2O^J[2--"RKVO'FA]*93:^F,+8(=X-L%9;
M<W,,(##+M\?83+YME"P:2=)<7]AH 9'+')Y*N9HR@$Q![)/'E=N6,T]?>XI?
M/O<1!"5L5S$Y/W@_R&6!?8HM<1'%'RE@P8K%&]6]B8814/UNVP7X_;N3']Z3
MD?T4>=1QL^9YWU[6 +1OIGLKQG(RU)6JFB>YC@ SFP%?XFK6/7WMS$3!V2+@
MU!0\O%,E=_O@/G.2&WB7?*NU3=4N>N"VPY"TN<-FFW]>8V'%O1+P?.QB:K?D
M]ZAP>,M/SC"QV[ ;ITZ24KT$>[>K^I)[B>Z?HEU"+E1P-*&(]9O0?]PEX'S2
MO")[U9O)D<G'N3% J+ZP:LS;DGA>\EFBL@!$*$L(,4UC/Y:49="DCM.[5&AF
M.EAI"[>^POK6_CI.1GB*7<08BUO U,E8VZY-7Y,8CHXSS/Z%J"\:LB>TBK6A
M>\UN)F.(J9;4:>"2VP(04"IAV-YW000T)X#L7!?DF_)8MI6TZ' 10HY*IH&"
M!7Q"GA5/&R?^W&HW[JRF/"(2)^02*6.&M@4]ME50W[OCBQWH:'L$M325M:D5
M L7[31R!0.>=[!_(67<9,M,CI"L#]30UY';<E2,(V;O\F?=30LYTT'MT0"?6
M%YY!0 =[X)1<_(2#'SF,+\CW_CH<F)1R'-69R4;\1AHA%Q5KVCR:NQ-&]9K9
M,924.VQL\O<!URXN5^2 H/T@"^K,C\FSDJ(9%S&CZ?N'Z?_<.G\LY>2M6X^Y
M+K##*"Q**9XHKADF*^.3'Y -'X5-+]7.XO;BE_-0Z@[PD+J2-L^Q--ZYZ4XD
M*J'(#( ;W8BK-JBJ3:_>+5D8@)6\JO@T= @5_>HJW@3LZ@-;/'S8-$MS]05U
MQDV[?5 #.VK81<;IQIRK%%,>BQS@# <CS 1QBEV;C57=N/:K:!\+NK]UHK6*
MU3  D3\N]'*_.[(6I'"&SH-C (TY (A : =Y.,4B)0"&%+S+4+JCFB3W033F
MX7ZP>';\@(J<D13!P9U_( U"4\334"H&K,7ULG1?&W!#;:LN3FQWT$QVF5:4
M@T11&9H>@8^24K2/Q],$HHHGL>0Y>K&#A(Z?_!"2^-U2R*\VF7= ;<O&C?Z
MR,WEK0*M^)[OQ'OI?&O#JFXLKWCU,*4B*+1R.T'3^N]10;FQO*RJ?PC)N1+
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M1'^$=/(7CA]/T8"I]/QB/893C/6YQOV+%D'0<00]9XK$W_E,U/I].7S UG3
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M=\(4J;\&WN@(94V@K U#CK@:N V&,7I('/[$. SQ&M8TG]&<)T<0I)X7GAB
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M$=!%&5E#GN=74;@&R\\-*?-$KJ3\K7BR/W52O([B_7(%^;A$"6\*PYPBJ/6
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M[JD$Q6'!;K&_>=R1_0F\@(MU'H0S4402N&.QW )SK68A.5MH1.]S2CV30BO
MF;LM,V<DF$H3;W6H<979^\M?3JT$?I]_P;'K)Y@Z?64_)OS7Y+WZ('[1(O-U
M*T3!BT+:+QHC0U'4KV9L&W&%,\)@$;9,GE7M>CNJ*C@EY_YXL.\%A]_C5&;=
MY6KZ0I<1TJPT 5_F,W[_W A_R#-R$H[5B7%:XJ5T'E*T9JV^V$KZ+R]UTTS
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M2=Z'%6:%<D>#?%7$91O;JQ0X8-QL'BR6-1PBY(9?W(*0Z7$-[^SJO!GI!B7
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M3YQW*<[R37!4,U[R2?79I.;="]S.XJZ0\N=1C(9A*I5@!]XL*#R@9PGQ2(7
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MA)ZWRPQ?HXQ92"V-7B&:8YYFGP$#8;&DY4<'>MTHM/Z.=E8F3&1E=R1F9$6
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ME56;% M)() #>Y^EX*$++_?/^(5YFU#0F2A9S2"MDD!P#;2?D4Q;W@V\SG^
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M#Y/V.&T+>W5\WE1%$/K.H^F;0E,5Z6X@GF)+W:<[>[C38S,G98@YPB&!W83
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M'*J4%?W;+HD,9T%_?GS@WE-(=0G6:([;#GKQ8I*5 YT1]8"JG9?AF!S5GKS
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M6TT>1_6(5K#%/Z-TE?G;-=9^XZ9]M;6A$XOHR<]6")].B^P)O_5_(S&K$#X
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MNK)"KP]=7"?<YP9O"7Q7P>.^^N7 N*#>-)V8>V7F: >*:=<WT]_7W%(C>D\
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MH)>-T;9_996!CO"&QM!U[:T.>A:&6-G(V7_@IOZH';"J[<2#_73 8#]-,EB
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M'$6Q-Q1LTVUW>.L@HF-?<!W!_F=Q:MAZU/7+/3!2V=,UD;M\4/_]9S.3H >
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MNEHJY3EF@>U7 -$[.+?[0_^D&?0W47"'_@[WD:)M9-A;S9?8<[MM:4/SW^V
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M!"GP?]K'GW\. "R@CWXX QW]\ML#V'OA+>*CV8F"Z+015N%&#WB"SKAJ[Y@
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MW_&EA<GF/OK(2:^E./+1!LFI/W<V4FS]5/7L3MEYP6-^T3P8Y>5^[A3S&[D
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MD;XSBJNM$%!O(RM:NNK"W<N/:R$I,-L(9/ (JE)JE/)-LRG14^WQ!1TYQ 7
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ML0)P%N>QEZZ0N[@G3U'O.?;H!>2WE[?\%8Q3'P*D :;HRT*A@#K<;(>KR@0
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M^FF[ZY(N\9GU$')(S(C"5RR+!U,*ZK(A*4W/><@EJ.G\EA;0I<#_:1]__CD
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M!=NO1?AHA,/=@8]^?(WQGQIL:[/?)TBOR, DU_GP]3A[68FW+'ES<&OGV;'
M&=/)J+J6].?M!;#HDJKN(:,WI=HBS $;V]COTS0'P4V>U)EB1;V 9@I&M5ZF
M[43]16[$23F"]'=QL@,PPZJ_2;1778:] %??Z$@<F_8E>\$FYHM5,J1A]JRV
M#'L!KK[1D?"4]B5GP>:$O^BWO\X"P-/Z%EP&FK+^- 6R7K@H.V*GZ$$::[5(
M QFR%X=)C%0N@$]:8YSI1Z%"95Z2676R8U2;66YJP;@A#M/4SE@$VD\1&C#2
M<74M[K,F+)-.=BT%@R[Q/<_Z9/6[ET>BMQ8C7H_$'G%/IXM]84DE&H4]G72\
MC%-P1D:D1D^L9V2C?'A!Q,:L#W0N\J/.<)!9'[C=8J5\P,AZ2.X(FHI!*K/.
MD#4@Y0P(>]%Z!/\HCB BMVM@PR%8G:;L(E).96N0YF(K#W'G>E .YUH+NUNE
M!E/#P[2>D7TWR#@<TXPVMI*3.[Q2.:1P;;]@%:^DABAJ/:.E\,J)3)$K_=C#
M'+5%DH[2!J4(Y;B-YD%SY@-NUG-RC@(OC=F=KO.-A;7@[CR8$)=3JQI<+<Y[
M!<0V:9H?BR=OZ 5KD;B1%[NP(G&S*JBU]EFPK<^"/A5@2;526&NO;XS&I? ,
MT]_O$H"C& "Z!K)GA &Z82;]7?>J2]"V5@LS8U2+$']P31T?B50J,/\:A^@U
M2(P[344LC"_/"ZPWN"\[DC2G!FKKN^Z!5"8XESR\0?NKX3!2OJ/J*NQ0IM<$
M1^WFB34-;H+6#Q;U= DM@I9E?@-YJ7L1N#QJTL3D76(6@O<CJ4;+",IU)$MH
MGK%O:^BFLY<D2]^>-;XZ>#YMQ7V-#C,6^*QL Y@N6,6L_Q3L,:CNHUV<' N8
MUK$\C3\6OM'SR3CA'"WW]@P^XB3#:8F"?AJLX<8,7T7PQG:W_0 XT"W:ETMD
M>6[8X\W9[CI O8Z#XWT48+:(@V<Q'FVBX"E."<YMDR])G']L$T3D1YAE #QZ
M1W"+$2F%2,R[C?(C*&+^) ]1W_>L N%3$N\@TN'2]"OP,!W_,_Y>Q#"D?@(_
M% $D\S9++A<!23>O# [U+,.:H "K$<ET]J:%"\$L1<ICR/4](%HFB-0-/>]@
MY$4^]$(DHGEW<=+H*[W=/2&I[^CY(,^@[X4(F$'N9VE%ZO;(+6F2-9@]^NW,
MZ-$OOY4+WR9E<UQ*8 USF-Z;26ZA*6('Y1I2JJ.;/W;2)5\C^3\.84#.FV@8
MS!4SAQJ[_7NW5]6;FGJ[LT9K;D7V:YSD/O1#^$Y=#7V,-0*4<WI PTS:65N#
M72(%N'@H&2(I_2;#M,K@A(R!UB!9 YX]PX8 X:A3C6WL&=VV40Y8BZ\?:V8Q
M7V]?T7-P%^<)_H_-9^@#C8$+B5YQ@BZ\9Q#BI#%L"(Q2%CDR!IN[;+(#2,I5
ML Z\/<;84K'8#-*42+YW@+G:WC!SB($]+9R5GI^;BXX^?G@P*>3JASC:/\!/
M$&S2%&3I/T$8(-'[C8G*<G,U,PD,KB</!MOH"AR\<+?=E93TY"79B<8M!#.,
M@?X+$C*Q#KB-7CQ\/1,J*\#' #AOAL'X^B)H _&TRO51Q!W4@BDSR%XXT2Q7
MK-=1+*MD@(^ )44*)IFS*8.L6,P#NT%E>XQ9,XM(.<;F%8%>.M>@+AG=MFE]
M8JJ2<P:0T%Y1%POI*[6KF;AKOQRBB,X5NS1HYQ7S8FF]<P6=6--G0V;N7'V(
M0:%)HV=]?0P(?8+D/;:#@:EQ=X8]86EAED,Y%%T$6YIO3Y8&64:@%=O$V*8&
M^TD<HPYB8,>2MXRXT(&PZIL2EQ&H.92YG0V9RZCH-1!.DM;4,>HR.0]#*>ON
M="6.'(*<E$&YA-S?YUXE<2CE2EBQ2Q#^UPI"MOS!L9F7X/O'".![C3,OG ,,
M.Z;Z2GG0:XZD LMH)"#ZZ:,*--UM'N-H5\7_$?;%R4^P(,Q/Q2&,9 *<[/F4
M)_[!2T$13(LQY1I#*\:ACQ@WJN<!MTK5T+<9C"M) :*A V:RYX#.1D8/-]!-
M=K8Y=S_S/*Y.C!/A%%,;^C9;"JU=>2$B8?!R  #?JF<:;A0*OCH5E.^%)+H\
M1:\(<USH$H^)(\0Y<Q"45TH<I;PPMZF^;@R\KPC/4\_'2WE%G^%@#FVDL673
M84G$K";L!0&:JF^QX92XO+L_3G.<#+DX*\ZPV2> S6#%XV?,4WKBV.1\Y>'B
M@$\6"@1(1$2W0G68U&/OCIDT]/<97]V,:-_S,]UAIC!$XFD<@3)GF!IAVATS
M/5BHI-I]JADTSP >W_,D):BP.<8Y'3JT82:C0GT @O0.*6 ]N\=]](G.$8<X
M(%;[B4B5%S6J]IHU;E =L;]Z/^ Q/S)1N_W<#E7^0IVM[:>7U'\6$85TH;K4
M\D\,/:.Y1Y1,K),USX2JK\P=W@.U'4[1MO&.;.YGP5&8&7BZ%*[ 5%)K/QQ?
M>US$]61 ]3R#OZ>YK2 ?Y[;J:*%SCVXSB=1]O7L1L7$&1;#!$O9<0^RH-J<6
M&^A<<9KK7MH  QM8 =7.M(B 18/<8-(#'R.<<J6>X=;*40[$HLP02\Y%)@1/
M:^BL14? \%Q4UVO']EM%<DY16-IH;%.!D:_>#Y ^)?A?C!__+T]@&D"B@J<N
M1C+5%,8M/=0>I-E954#S'"[7(\RFRXH]V+!O&ZWJC"N"* C>#,/;P##%E]%U
MP3 1]SQSS"NPBUMT<(-^0!>4S]WFL#>Z!(8[]"O<\WM0#GJA2T"X_8'P%UT&
M,/*2$Z'(QSC"URYBHR&)G"T"L_5!2?J+=D@T=$Y;JU(<+CAW,[8$ VUE%W8
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M#=+ D1#YHW=$/[XB)I!ZQ'3 1W/Q1&.;>DK@)Y(%GD+/)\(B%^$9@VTA5FX
M'6VH-0M'G^)$;[!&&UT^#*"7G!JH+=@ ?;S9< F,PSC?)3N=XW%YV^#.,5<$
MM[T:+BNBC]7?A_-/=SD6[2M!B2V[,,?:0INB$@3,X<8VT!!&25I1>I^F.0@8
MZV>-UAV6<0"8]M/-/@'LBX8[=%HII:+U2@IA*(KT<;K#IH)/F,;)20)XK*$&
M&2W"K *G;O($1OLG@* 4-'$-"7B5VLKDO$HO,;;9#38W"F[S]AASYT+-.-Q@
M'KPGB)->G<YCGKP3R0G%:S]O( IPUBB6:?GR[QB?TDUB&6([7[WD=Y!AYB-#
M:?P9NM>'3=Q?O<@K(":S/OZ,2;DIZ0+/X*#G9],OB:E[-I_:R3H?P7?R:!#+
M/$\V)[4>/\+X! !9Y_9#&*G,'J];>JVTV\T>1+[,G2N889;%E]<C4MU][+P@
M?^/Q:>IXW5;8PO\ _5):D8"Q:(I! TKL Q"0CK08=#B-=;MCVY+EYXT,=+%N
M)IAA3L$)O33=[LKE;!.2]'_[ R0^3 %!W/IA6CY-?V:I/X/>->E-]=7[ 8\Y
M/5NB_UPSUGQY>:Z]'>C__@%L(_JU*1RNFT_7GMAS"O5VA_Y%=QTNG$%-UA%/
M&AU^K]]C%?B=AQNCMX8063L8L;N)T]F/.V5\$*/Q2DC:G#">X)YLOT<@20_P
M W\O/<1A0 &A[*S1H7@7YXD*$!OC[;H:'G.\J.WN!?A($L:5$JZ], 3!U:G+
MV54N"86WV@6.;9ZEF1<%B.6I[+<YS7@J'H_1\\>.> N=,>$%$>DFJSXLNHB8
M\ZS"FS2[06P'BZO?#M _=)&\E)DX+K@+7SJ2317=2DPFW!EB@^?Y.HY2&)0U
ML)^!CZ-/@FW4\"B+G= 2[[!AJS6#;:BE]VH[%;]"-U;M$5%C)0ZF*08N"[,H
MP^RU!+.LLX45)OU"2/8^*@Q,O(*L8WS)7K QK=K4W7P#F..!8/.)"',/6BJH
M=KNZ^@KLLJ\D!8T7WFP5 TM[HKE-%6>1WL7)F0NPJ(8QV&P<M2B6%D=/"\)8
MYYZ3)@J!K0/,I8-2YPHQJ7CG&ER]B-AEY.N)8FM;*8[T*-99 THJ'+9B2ZP@
MU%E#2#V0M8E3K$C198",$VG*(;QS*,A<6;=T2&@+2A((N 2 <4* !4BU&"C)
MA.FV^H?1@V'G#B=N#' M.;$#<Y?(Q+EUEND,?^YH)*.R",.,EY'0KR1#\4.@
MEP$P@03%";J>:Z4-->;-# )?(OIP.9-JR/DBRD%00]-;4!LE(+R"[4^SNS.%
M62)=6P/%*#%?Z%QP3XI"\1=!KM(&![Z"--=Z08I7IR!Y8M881<V_J'A3*PMB
M =Q(EQ31R+Y81'NV,;/%6N8;=E9(!6>]V&D?I!4LS0R#ZUQK=RD:NP1Y/,N@
M6Q6&QTX76D0311D+1>,B'0,F[E&9,)5KB:C#)3.)A+%%=-^4O>@ZAHLQ8.,^
MV3'\.8O"(+ZW8EC.X!@=73]!\A[; 4E&(GQUVW4R#RM@+%P"9X<^CH$M[O$F
M;LKH*"V2+<<@*F.2S6'5VA#9$8#)AE<]].I5:P73'$BOD6V\1$SBR@3\O.91
M&FG;!J[!:-7,L%X$I*1YNDS"=PFQ?\P:8D-QJYEWO@A 7:S'J"2X5]$BBY+A
MU4':2I*O8*8UQ,8B-7 (U/CBZL_S]*5>)."SRP-40%M]$;H*$%007<W.]&('
M%7Q6 ^' &@L5 %=#QK#*#17\M&JCCEZI[,H1%916U6K48A45F+6J&8XBHY'R
M%E7DF5:EQ/$#D"E\4<%MC?T75=:H(#6!7B+9K"\ .QC!ZFD+CG5GO/*O+4C*
M-O"K(X.Q.!.',$"_!E=>B/'HY0  ]F\:[[[2.\MNB9O^0/,M8[A]AMJ#M"PV
M!?Y/^_CSSP& Q3K1#^?EH5^*DABW48:PFE)EG3;"7(L$TJM5T%2E,\AL!79L
MMD6$7O!<43<8]@2#%91*GD86]ZL7YBSDI8TTMNP'Z+W#D-A+L'M&]22DI]NP
MP6M2 2B3WU)W@F%REEL_?:RY(I=>>D"H@?_!*/&))"N<-Y.1UM$PVO,H16ZN
MN5/Q_3A'"T+2$+Z&2I"SCH4^>**KJ[B3J/UC>H_M6])O2(KS\M".;E]<A.T.
M,U["]QD@83X'CW'D<]&3/=Y@Z<<XR5Y!<KR//I$L3A0.ED! &VJ2+R0Y4FYZ
M%PF;-3#&&]O"]H,89J/] _!24/CJ=F\I()<+8QO\.>9.HVZD_N3!X#ZZ]CY@
MYH7BWB$2$RTYGPIS3D(R%\\S*4!_(#C?_L!F,)S'MLT.(&E),VR!6CC3%D;,
MWPECL,FRL AALA-.*<3A6U@*^\#<]9')!;A3C&WD&61(C@#!K9=$"/M3Q'+S
M8QYB8PV".?0A:SL2$VU0;<2ZC"7*BXS28AU;Y:]=,,DPW+D M\GF(VWK,:L%
MP$*ZQ&II'.%3!Y'/)D#>#!OX!A^S;9)(19:F@08JVH;./@.JZ^5<"0IO)LC^
M/S^,4Q#\W_^3)40Q+/^(SAK\R&Y#8J?^O_\G!?MC ])=STWM]X!1]N< 'FO'
MC1>&#'\-T[I/K5Q2FM,Y;IG!D/B/'B1V7I@"Y:T>T)L3/W\'?T)_1:(</#>?
M8&R]E\) -=/;O.> &#C^=&QEA@TYZ*[%W_E-BRS1;2\NQ?CN. 14+?-->/",
MWHZ#A6L*;P4WRAF>'0>'V+W18A(,B[7C0*![._O<T2U:J.[ /P4M&WFQ=8X_
MNKH'VP9V1[9:&OHOV6OM+1AESWVQS_#%+W]/. \.E2NP[[%Q?/N7R ,<;Y#C
M4)$6!^C>),=WKWS[L_Q2CL-!+  ('%IC[/\76UFCC$?,<8!<PBPE?&N.0T>:
M:4KYY!P'AAH/9;GS' >"F('R78%C;/\_;>6?,LY$QP&BR?CD/!RD.>4$/-',
M\4OL7>0U=1P8LM:E<3;Z%UNY(,T%YS@ +N%Z7-_P?. BP0ZFTB__Z@9B3&V1
M^YL;8!'[\^6 4^8!MO/\[,L"?"+YEP>001^MWWAR7<^BO&8$SCPCL.TB1^BX
M30C, F(=/Q>AIT)7<K)]F2.VP+NHT;')LP-B:?\^<QLNG'N3K-I,JW:7]&Z:
MLVS(YE$D!)F9-FQ+$M]X,^S91M7R5&X+Y6A[EB\F%.Z4-4#1FCB%-4#Q@H.6
M%4"L!H;],3G6Q:>(!"''/2?#@="Z%QRWD<I!04KN<MQ6I@R):2AB0F/90 A4
M4I[C-K&!NQ_ #.RU?-5_3+>[TCF$RX,9-R"M5J_1=)X(%V N:[G"]/>KTQ6(
M_,/12WZG&,:DIQG,%R;A':R%UX^-+;"*/:CN34%1(.9P:S9PY:70EUQ],=8B
M;*^0EFJ3E)XVMPV9+]M3TBDN[HD]LACCO\'L<)VG67P$=?\+'HT+YAH\LY1X
MFLO8/%&M/^9P@V>3 B17X1RM&P3J,";19.7ZF&?"FV-L*X]((*IB8.XC)"V!
M*F*2?RCB><:V=.?!A"AF#3_M5^"E.6Y&@<NUYPGNJH Y<7I]P-6*[Z.W* %>
MB'68+XCZ'TC19^J^-;W<&' Z99;;A=@;DKS@^)5?8_V&>9>XVCO,T3+("E+$
M*":B7^I82Y;^Z<$0:P6O<4/9+$,L>.>D^A9K),@;&.89TT_$&CUT^;B=P)\J
MI9BLBS08:$D-(5I#7(A'=<?NE"ITJ,TU!O(O($+$&Z+K=Q,<802)A0!^ OZM
M+9IE;#OG5+ "X^^C#"!FA,/;;^ G#$#$PB:9F;9QZQ+C99V2JF]Q@.WQ.83Z
M>\S7J3HOF+$IVDAS]';\0)(?IIKM[B&.]@^XY4\1//U/$ 9W<?+&9")R<\UQ
MQE(HW49%[XA&HA2+*W)F6*-52FJ3!BD!0XVI1[&(@C_)/CU257^TA!G+,-HU
MOL6>\ 8-\2WR'@&; :'-SW?V(SB^79&_H;EIAFG?:@AP WM4W5Q\0NC:UAV!
M"ZTRSYB &;>,SX2D(^M=H? -D>/"><CP?1AMB'#=!8Y#0MJ#T 2)+AN]X[ ;
M:HUO@E+1P.TXQ+@V[B98E"W*BXAH9;,MQ[=_B9!7V]8<AX'*;:UH\7<>,O*W
MM=!1X#@L!MW74NX&QP$SXF7,]E\X#K,1KN-1N;%UV154=XCC.U?AMI)^%<<A
M,HCG<OTRBTBZD0";XW!0(96^@\OQS0^B"I'7;!$Y6(QKU_&]#\*'B5'!NF0T
MMN+K^/:'84/;A[N(A#QUO65.27J4\EO&\]YZQ[4FZVE>;''22'G\B"-2MY"=
MJ<>?LW815(I;;H.0FV)%'^ONTLVGA#5L)=STK_XXMV.JC#;;YD*:/\<L;RF*
M$MSDV(^*A$,8%]4JGO&U"_VLK.>Q^>XE 3J![>XN3G8 9GG"#)V\^+4&$_;:
M9<\%V9/4P081\U]YV?7E-69@W#<O2;PHXY8;4W^/U5NN_ [I?73[PP<ID@6[
M)W<!(&3>;C5XB/C_[B$%!=]C2&\JO(( 76TIDKU?0/()?5!0\#/PXWTAQ9<-
MIP;#[:+/KO&TUH1B:(RG%0CM-D-!FXX^5<7Y:8-*I=2QEK&*+H0[ @E>&*D>
M4,PF<)2K;3&J2<TDUF2 !=_Y/4L?MT#)<MS-JW 77*2=.0XF:6QAJ6V.^SWE
MT&2 VN>X_T\?7*1T0\?]8_J@=9FJZ) SZ0:F^%@0$[T^(;BF.,T K1R'RG[U
M(F]/P/E2OF@3!5_B3Y!$N!.*%I]2U1["/P6%EH]^."OWZ)??5)?%*/)RT:NT
M=L+0MU6:>VKX>TQM\BI&%SJ.!TV CUZ>;M&R4NR^?44(?A62_K7B+4J\Q>@&
MBX9B&0#;Y"5_]ZO?D'"#;OP4H@- XLP%6Q_Z?DM1N\? +T#O![T>Y8LV^Y3$
M^.X%*3H-'+>8ICB4 ]W+&=R=<$!"%)#!Z,=7]&T/75$JJ*#G0Q:!"0?5[_&9
M!G>AUZUM,_ EIK97K@<=R'VTBY,C3D ;F37H_J25F'$IA=#>9&JCSS$.:SXO
M4FEO[,GFS^WU )/@R4NRTVVT1W\;0,_T5YC?VE.<$@$]W28U7:5-4E+G7#)O
M-+7Q\S'4# )=)N75 GVB*)UO'\F]J[_4_G,?RI>D7VL.!!E2?+TP/&UV.X M
M<]OD&7@I4G#?P],#_!V$I]>X.^H9[$GB8)3)$X2&[YC'$QRCFV0P;?'FR_%$
M_K6NXHDB8'1]S"+Y\'RP.GC,91\P3T@BSO@,/N(D>XV)B*O_UNV_WKG@#!T&
M-6Q*O<!:Y:@7]T+3%1-HEVF <P*FJD5( @\OLK;,$[8:#% J@._:;QQUZIOD
MFPW$GQ/T-/!.[0:U.<%7&SN5.:AY LX8KQP9LA/$M8Q%\AS[Z)P@-34.,JRS
MC@85C85\JB;?.8%O&HP<8%MV-,#+/(Z.S#I-P7 JUJG#!.YHN-WXN*M@,I\3
M#-W W9&!/T$QD0D54A4+_AC0_+N[T+S(\&]!"&[+X0'\H BXO8\"'(F=HU/8
M1J&>RBS-CQ2YLG[#JX)^^6T3AHT/4W.]F<,T]]3[?WF:P>C_W<$0L)OG]0=I
M7L6-AS;Y]2U)8_8B>F.TKR&"('SZ$H<!;Q'=039;GT6X5M=9IF"!HT8DZ2WW
M4<Y1DX7"CGL(;@%?EDV-**X:DB>"Q"W<N /=YR#R(4C7>EI.U-.J[L4 P&*=
MZ(?S\M OOSV O1?>HI/-3I1Z6;011DL=,=#QG,3#B@<9^)*)3J$ +[7^5.^Q
M<S$7:T$,3D$,*@W:O&>-;4?4R-EJH'!+8W#X;(4";0;@D(Q0%"QX]7ZL,H$C
M,L%%B[T.O;0JL"I37[,WWF!S]!)1Y64%[A1S8E #I-R*E92!+BZ:5V-S%7R<
M%7PD6(O-$- F!O'YDM4@4*L'QKHZ6C(AA4TX @*I0F##8*!: <P*P?",SC<@
M]1-(UKG=7>4IHH84B_RDD>=V]Y2 %(&F"&V(0[B:EYP1)6=E7JHPLX&NN-^?
M[\<Y44TKW!1)C>KO<</(--$I%$RA ZY3\7\AZ.4F:_9B7>=)@D,V/DM3QC,(
M<A\?^WUT%R<^X*]]T"LT[^ !_I'# )V^Q%*98U?QW!JQ9+5+7G#0 ^X!J^%B
MPC1IG8]:$04D+R%'W==RP!AVMSD:\JT $O9EZ:1V1B_T2.Z#50U;U;#IH>@?
M$(_!24ZWQX\P/H&JUBA!U*LNHFY"L@QB6RCKD/X;!$5=4M(<5:0SC/>]5:T[
MG^J9WY1-"/N Q56+BVC7].IT'O/DG?#?2-5KT5GJ_HH%1$!?(C$.;LGEDN*2
MN\7>TC0_%G\CS$4>\[5\9-7_K)'Y5_WODH,>[P*R&GZKGJB,*MIOM5DKE&-=
M;@ZI78UHJ57#<DC#6FC,U)E2"\2] KLX >>(!?1/FD%_$P5WZ.]P'RG*G</>
MZF(0DPUG>$O26.'G&=3/"..PS!+Y,(1GNX^"RJS^2@L <0-V($E @):+4XN)
M8?,!>N]HQ1D$JLJ3VMM6+<D:B7<-8AM!I!MX45@-)7?CW*S3F"Z[C1:F'BG>
M4P[I08." \^=RHKB$N2/-[B%6VA,C7KUDCT@!41>$\__'49[0M/D?R+-2FZN
M,7F)MSR>_B6>ISEZZ87XJ!$Q@Z#L?8C;VB$J0LRET4J6%LPD.U7O(:1)UC@
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MS"M?_@7.AE0J!8\T0X0D0C.L#J@3ATHI@T8M$L1FZ$B'I4H'Z&#X= )+; :
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M!14_:G08&L5X2^-[I+U1H[O1B6NE57R#[J)(,E]GVET59AM3=:^\$,>FOQP
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M@*2AQ+'XF]Z/&.6,E$5S.")MM#DG"<!EJ$&P^42RT1[4%?))[>%FR?/\_5_
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MMA!FLW5A4O.>2$YM'@E;G+,9G!):M%AXX(&!)T]9#1@I&Y](AA<AR(SL>7I
M,9L8+A.W@IID[+AQ]#*V1).E';=V7@80AASN:'J?7B2A"?".YOJI >8RW6".
M)O"B,6AZ']VF&3SB0/713-\,58V^P',GW+Z#GV6KOOAUFI50]:70C,87O<J\
M5?WJ5/_X3X@(+/$/IP?P"4*YF$7>9/.;:YY&?Z7* 7'L=RQGJ_;88Q_C[ 5D
M60@*HKKVTH-\-)WB2\R?[TP#BTL6CWG&?\H%WE)FF-_&&A_M5GPT7S<FRG#5
MDATWI/="W([^"SJ4!W8W(4TO=\XNK4M*K!6 P7*9U28<U1@^";%,&.7(%@0<
M 95D0-^8L'+>0JB3/H?*8#:#3NCAT:$LKK':$GH)%4@T"7&&P%D#V9T-9)^J
MKJ!F'JY+&+89I"9Y.U<H<=)6O8U AL!854ZAE("PL6!"M=P7=((0UYGS<,TY
MA%37\?$#X019XR8D'T<_X4(8?HS.'B'Y$T#'%)"2I"RC]EA?,5<HKO8]Z-D2
MM][<*-\R!SJ 7521#\AB?F9MNC/*V'+O(T3UX%PMJ80MQZ;(FV';-KCF-_Z<
M^6S%O+4>%U?"E]\F"F[P]1>3!A;8TQVE_.A4F9EV5*@D-:1(%3%,TH\Y7MIV
M]Q2GY"Y,;T-([LGS/<PK7"G_,F.;_X)N^X14[=X$:#&02!'P$\B<JMQ<YXR@
M(PL;K:J%XUS05NN-8IUZ"L!WKW>;029?+W),>:\)/JZX83,HY:P6$M*4!#1F
M9)_7"1#GC?!*$EZG6*M8?K+9!&,'[QXJKSD.665TDQ3M9FJ^>LF/1R\Y;7<;
M'VT:[:]$D]=8/!>!.LS18N\CW;WIQBRG+S)K24VUP%;%H6])"Y3X#78HF^ZW
M0YA![X )"^X;0+$22V3PJAIJU<(+H0 QY 0@*>(&%/\J;(?Q G/=S;U3X4"/
MD]9R&5MB#G?6K*)R@]%M)1(7A-6JQ5KNWXFJ]M9"8R@%T2\&FX$QP/(E+3T:
M;Z,RH>ZH$V-8-[+C*;!#0<2^SQU2K*_CXQ%F19^,"-%*E*$=@,A'^JZ-82!/
M>>(?$-*=EWW[ VOL:-$/<;3/$.<_/Q*IQ0-?9DZ 5%DO3U\>\")SY>+C-#VC
MY>D)D,($UZ$'CVEA]&-L4F*B8>5Y@\.O]T3:YE@ Z&/-5;P_+R0MRD]XY[^0
M@M^>3PRP7!U:]2V:DX9?WF%<$<%FGP#R679U*MYPLTWG&^R;:WUA#-8,UB<,
MH%<T!%2-P%\3Z(5LP/(G6 -:#G52AUJS\ $X<7&P$0,W2GOZ5Q@BN22.0"4]
MT="".5;SFJY/ ?CQ 'WL%)%@ [SANDOK(6HXYL<K&) 2*TCR)OXTVJI80W73
M=@)2;P_DH<6?H!U>'53YZOW 4-D<X[S7F5=FAF[H(646?03!8[NK;I+T#JDA
M7[U_Q<E+_O$10I!0B4%VJN85OWT@+2G"NI 4R?*&&VR7'?N_WZ<IXB4W1#4K
M-%A"'VD%2U*A'/1V->P=SMIF+U.L6FKQ "W%9DN4A 5!'_!DM!VK@25EX>:J
M/ZU6":K*AM6P$2/20.6J3KKGZC6.PX8OV]8@$.@@5@-!BGAXRDG+&<* ER,0
MX 4E7@8"-\(0I1T@PZV"?0]BCR4[[OVX_&(6Z*Z.P^?2^X:K0-L,FXFIB\ZP
M'/>;:2(NIJG#<?!<2EL"@XOC-7:U(0_?[N-XP5U-4)*V/HT!KK\Z!RZNZ6L,
M$/W-)1 --*XY%!-Q3C;H,E\K8R+*.*<G+RD[+A?W2N_P>B&S@FE6) 10UYA>
MG5I/)%,#Y-^E=^MIDC6VC7X[;QG]@B[Z.,C];)N4F5,4;R-SF(F%8FFF7 /=
MP<@?Z]Z2QW*)WOYX2TL.PW:C]0>M42L+C5KY[]_]\TW$QAC:,-V8^TD__<[#
M,;Y*)=_>8V-?MJ%6"_6>X^:8L6?8M@UN1 M_SGRVHA?)4N#_M(\__QP 6.P&
M_7#>!/KEM]LHPXU):.OM/=;-\T[Q=^^_(=(OKF,.R^N/LNVT.W*F.CG27F#%
M)J7QV"8Z5%ST2&Q=(+T^8]F"BO7=IY,NJ[2Q,1?6?CX1CWH >R\L.!&%MF@C
MIC]*AF9W?J8]ANL.&[)*XQ4];*LU0O/W2:H0?K$7EE]@LW#F6-TP$:M<NA0N
MQ@I>8[3'TL98;O49^ "2RK1W<4)ZHVUW13-&VOK47J!Y]8WZ-966S(8D>_ 8
M,&U<EL25=!\]@Q0WX]ONKN,PC-_CA-CKGM&JHIP:3#OH/=K- D4#P:[Q^7S&
M=#N!<);N=5;-[!JGC-/GL 68) WZ,2ZUAK[\>DCB?'^X]9((/: KC8-?9DR<
MN $[D"0@H*,3:Y2QY>*PP@1A]3>8':YSA")'D-1-!\O5G4LR,7:C^!([-_L8
M1[@L>O]*5)UM4)(M(8UET\+U0KP1D0^V[R'<$_;$%&YEYFKF%>6%>O[ QO>Q
MA[;+:LOZ8)@-\(A+SSMUWT'GL@.U_8UZQ]#&.1LX+NM]8A7T4'#PV!RNQX_=
M%+EY,' $[@I'-D\+V[QX]VY$;'*\[U*NJ#K^@.(7LGK?:\R_R3@QJE?(:IAP
M\87N7SK31M,3X\@N:3Q1?IN.,#_)TE9"WU2[" W7<>((/'B9##H!X@BBL#DB
MR]5T9G449Y#5>[V$*#@.(Q9*S)\P!@/%>>)@^(,JV;GCD[%ZDURJX/AR\%[[
M/,+FK0ZJ8J<<\F@HCVLZU;GG/*NPOD405N]1I@R=O"&%ZMV;Y_X9H@#;M6AS
MVIDV$\$D!H+)D^VT<4$5Z<%FR(W!-A3=SXYFX:F1$\>I;?/^IR,LJE1F,VA&
MHQSE( .;$S6MX<SC(=2$.:W*""43Z6%S!NMTZ-/1 FP&RBB(,CS4QN:4WFGQ
MA^Z"M!D^FE&)&;AD<T[S=#C2=<G8#)61,$,U1FP,$/W=81 U(\O&@,U_V0T;
MR;"T,2#S#SLAHRGX;10;A7G;'D?5HL;2.5E#@M1^4BDDD:Z5)-9*$FNRON/)
M^I;42U_3R9>23KXF&(^4@GX%X!Y$X"$+V,3;&Z.;FQ2&P;NX)TE060E[] (R
M/$M&>@7CU(< Z1ZXJ[>0[U*'FVWDTN@]SD#^WC#=H(R1*)S!^L#2+=)=#A"I
M)?BW[:YACGP&^SS$+SZ1/G)'I!;[N.YV9=KF9(F.\)6QX- K",A/RI2:9Y#'
M$K/Q"4$8)L G%F7VG4$;NV8MS3EK:4W=F%^)7RM"F^<=[[^&>@\S##)B<_KB
MM\U[7B-^#5F,>1K2/&&QE,A8!5[!5?ULWKXU@5A+#Y%E*^#S! *+D$90_&T.
M%[6&_I8962MG7UE0>*C 1..0(_P!X&8C-O9->,G0XJEM+GHM8'L##;:T+=?"
M=56W!YESY ;_RM.BXQ62RQ_!]S+P!8<&)0A'<B2A%<83MK-*[1V:[;Y%R]7M
M[N6/W$O '0#9&R*(A. TS=[+'3]IO=&7PF+Z!<3[Q/LXX#Z8S,8'[+&:P?GB
M13<0[.-K+X2("T308SL%F&--1U0$!:OEQAY0A[JZ</,E[<\DCSA;%'A)D+Y]
M!(C'_?(?/__M/W[AAX%(S9V6-BOVW*0X1FU@]ECWV(D%B)0 ;[M[0'C #!JJ
M!QA;)+DM;G]\P"*1[ 8AP,^,Y5*'ZB[=B+_1B,?$'Z$Q;.HX@T!,TSC9(JW.
MP[1/%K<E3.TUOB5R+1.DPHGFH@):JZJCSEG! 8S18^#'&0<W1Z(S<+&$/GID
MO$72F S:XF'Z U(^"G466PW*V/AG5NP.<[ QM$-RM@] 0#I&OGC8]G&7(X$L
MRQ.PB8([^ /_Q)+?)2=K!GG1_W,;/0.<\H6.%:?I5L#$F>W;W5L*2&]"M HN
M.5W^/LU[NXZC%-VBZ,L,E&X/T%W_G1DJTGML#&'OCQ\>3 H:PETM'^ G"(I&
ME/\$88#TR+>>_J8VUY(KX-R65.(&J =;LOCT+L>T7_9_KE9WPZRD+CM;,\+S
M/OO<=+-1Z4%AMB7'TF%G4H?1G3-&E"GZ#&*Z[0]=>2%.+J,!7CC'3G"CBR;)
MX+^)*(++ T1,1J7\&F>#]=B&VG8_XK9EU&:GO[R[B6KN;<7<J=E8;8:*A ^%
MCPH2-EM']R]E@ZE!P+:S6KU]J1"Z03X%2KQ4QQKJ"&!X)5-'@8SS=5-EC. M
M?BIG:[8:&L*"FD(+=%4SA<-S'($ JR'%Y2 8ES2FCRQCBAH"<-F\^XM%"IKG
MP/'H'+D-T[T0CH?@2(B/='>'XP7'9(]<[#-QO%R6'""8?A;'2T+)HC_#F^-X
MM:<!Q$\,[(X7<I+8-L=!Y7BM)CEZEW5PN5Z&20(5+G.<C0(@:V1!FO=ME!U;
M(PSV/7ZC[-<:"5#1@3@*,*P3"UDNQU%V;[DLR/%9C@(.NX1#%5?H*."P1EJ4
M=)V. @2[9$>Q;W84(%@G0ZI[=1U*XCE7LRPH_YP%1WHBU'LG0L*:UC/SM!Y$
M\O$1G,&'/U*G+E)7SIMA21P&1EVI2 LRT#;8<TOD\><8V\H7$"&XADB-W 1'
MQ+X((T*"=LD@N5D=<G.-;>U7+X&81D68U1]G-NN LU3N$M<X(N?CB+A,W688
MC"3!%:1@]<:EXF4D+FL)-'#"Z2]&!*G;LPD.R3MJ$2YPRJ6V'$^XRGZM4-E>
MLMC__1"'"*;I[1\Y;MIG80V&Z]!+T^V.+%:DK]''6M!;@*SHZD36)]=!H#_#
MV#:N\A3!,DTW/D*2M*!._&," %>I$,_3G 3P&B<).'FX? KBR>E#R*GIS!QK
M#EOR]Q3\D2->0SI,X6A$+GC9XVW9 E<_HX\UDV7_XH,(75VQ*,.^-6[:I99?
M?HMP)U&X@R!@9]<SQTZZY%;G]=XBFT\G7=97[P=V1C 7UGYNY)#OX@3X7DJG
M'\Y <W3OU5?6HW?$-E_)_AD2$W6G_6:O!_#52WX'&?ZX1-<5P0QC0+^!GS!
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MPL=KX6-*J8<O+\]U7#3Z/^(=VXC>A4 XW*X:">(:8\)IHX/Z]7NL NKS<+M
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M!)2%N*X]%;TC%_D[;*=(5J'.K72<(2U&*%_GRL#A_+?QWO/T6R@4T*]-I 9
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MPD4.+EUDQ3\0\?2_I75QM]-YUR^T%:1Q;$!RLG)_S:N3BG'=6%U5KY\+%8V
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MB]_AKG#5"@Q.J+&68R :I_BPVJ@W52:$O)!Z"OAT,M(A_?$KJ$64?1V:NY3
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MPN7^M<.P=?-IP"_T-_O_:K)QQY'T=\F/KS"0MM#,G^-Z_,=C&H)R-:>"6TU
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M@*<.3,3EE,^M[_Q&';KS?_EHU/'_+? ?4$L#!!0    ( !B .ENX#8M:MA\
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MH&%"(*Y1HN$=L^XJ *K .8%1W#E+\##]H1XZA'WY1+,8"X.%B'Z>P"!@JC%
MS'&,0)^M<YC%:---Q  D)GO4IB?UT/T&Q@MJ5IC3'7C D88]P&_Z5W0))V3
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M,34U-#(T,#@U7S N:G!G4$L! A0#%     @ &( Z6[E/R.M$ P  , 0  !(
M             ( !)P,  &EM9S$U-30R-# X-5\Q+FIP9U!+ 0(4 Q0    (
M !B .ENY3\CK1 ,  # $   3              "  9L&  !I;6<Q-34T,C0P
M.#5?,3 N:G!G4$L! A0#%     @ &( Z6YHF9YE!@P0 TE$% !,
M     ( !$ H  &EM9S$U-30R-# X-5\Q,2YJ<&=02P$"% ,4    "  8@#I;
M*A,D:E]R P#"* 0 $P              @ &"C00 :6UG,34U-#(T,#@U7S$R
M+FIP9U!+ 0(4 Q0    ( !B .ENX(F'+$$ # %?Z P 3              "
M 1( " !I;6<Q-34T,C0P.#5?,3,N:G!G4$L! A0#%     @ &( Z6_P '3J;
M @  D0,  !(              ( !4T + &EM9S$U-30R-# X-5\R+FIP9U!+
M 0(4 Q0    ( !B .EO\ !TZFP(  )$#   2              "  1Y#"P!I
M;6<Q-34T,C0P.#5?,RYJ<&=02P$"% ,4    "  8@#I;_  =.IL"  "1 P
M$@              @ 'I10L :6UG,34U-#(T,#@U7S0N:G!G4$L! A0#%
M  @ &( Z6Y7M34#W @  Z0,  !(              ( !M$@+ &EM9S$U-30R
M-# X-5\U+FIP9U!+ 0(4 Q0    ( !B .EO\ !TZFP(  )$#   2
M      "  =M+"P!I;6<Q-34T,C0P.#5?-BYJ<&=02P$"% ,4    "  8@#I;
ME>U-0/<"  #I P  $@              @ &F3@L :6UG,34U-#(T,#@U7S<N
M:G!G4$L! A0#%     @ &( Z6_P '3J; @  D0,  !(              ( !
MS5$+ &EM9S$U-30R-# X-5\X+FIP9U!+ 0(4 Q0    ( !B .EN5[4U ]P(
M .D#   2              "  9A4"P!I;6<Q-34T,C0P.#5?.2YJ<&=02P$"
M% ,4    "  8@#I;07MY2JV; P  52X $0              @ &_5PL ;&ET
M<RTR,#(U,#8S,"YH=&U02P$"% ,4    "  8@#I;*(9=,("4 0#XOA< $0
M            @ &;\PX ;&ET<RTR,#(U,#8S,"YX<V102P$"% ,4    "  8
M@#I;4"(+4!\K  "X7P$ %0              @ %*B!  ;&ET<RUE>#$Y7VEN
M<VED97(N:'1M4$L! A0#%     @ &( Z6S(7J(O6 P  XPT   \
M     ( !G+,0 &QI=',M97@R,U\Q+FAT;5!+ 0(4 Q0    ( !B .EO3=S"A
M9@D  .A'   /              "  9^W$ !L:71S+65X,S%?,2YH=&U02P$"
M% ,4    "  8@#I;:\;+3DH&   0(0  #P              @ $RP1  ;&ET
M<RUE>#,R7S$N:'1M4$L! A0#%     @ &( Z6[@-BUJV'P  <@,!  X
M         ( !J<<0 &QI=',M97@S7S$N:'1M4$L%!@     5 !4 . 4  (OG
$$     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>lits-20250630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:lits="http://litestrategy.com/20250630"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lits-20250630.xsd" xlink:type="simple"/>
    <context id="C_801bb470-1666-486b-9626-f457beb6c0e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_8324ec45-0eb9-4638-b615-b1ee584086e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:StrategicAdvisorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_84359d17-853f-46e4-b937-cd4a49546ae7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_85f05b2c-f599-4c78-bc7d-791065172d82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_87078fb9-2267-4137-924d-3f4e8270a7ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_870e143e-2c95-4ffb-9924-d47b9fd9da81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-17</startDate>
            <endDate>2025-07-17</endDate>
        </period>
    </context>
    <context id="C_890346b8-8f3f-4053-845e-8155a5f5e602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_89a3be5d-5e0b-4c67-94dd-9a9af04f8589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_8bbbca48-d932-4c1f-9137-b00bdcc4ecdb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_8dd1452a-e99e-4349-bd47-9b1ed7689611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_8e54884a-d867-4942-80ac-35ef13f92073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:METhreeFourFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_8f477f08-619a-4dd4-bf96-14b4f5bbc093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">lits:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_8fb49a6d-13d9-4bc0-8564-85ae7e671e0d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:METhreeFourFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_901ccdf2-1321-455f-9644-864349d54328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_90b552c8-e654-4d0a-8162-fa00aec0af5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2023-10-01</instant>
        </period>
    </context>
    <context id="C_93b9e9e8-1270-4323-afb0-75af92765160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-09-19</endDate>
        </period>
    </context>
    <context id="C_94b1e5ac-8b72-4ae2-99a3-f4cb17a258fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_96669720-7ee3-4ea8-afce-e422997f939e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_967fee19-8d30-4bd1-968e-c52107261bbc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_983ed5f1-6f8b-49fe-952b-3b1ada647fbb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_98cbe3d9-5dfd-438f-a31c-71c63b05ef14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">lits:RevenueFromCollaborationAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_9d600850-46b8-413c-9e85-0dc26debca2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_9de02997-3191-4520-97dc-7a314cccb702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="C_9e2c011a-0538-44df-bed0-dea64b704da8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="C_9f90a9a5-a66d-4313-8307-9321f5ab31b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_9fad389a-e538-433a-b7d3-4a232940c916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_a06c0f95-2711-45fa-8758-3af29c6ca47e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-17</startDate>
            <endDate>2025-07-17</endDate>
        </period>
    </context>
    <context id="C_a389e895-814a-41cb-8aac-4d799cc61fe6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_a5fffeed-2536-49c6-8e93-f0cbbb5cdefa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-08</startDate>
            <endDate>2025-08-08</endDate>
        </period>
    </context>
    <context id="C_a6339fc6-e7e2-479d-814d-64200ed7d803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_aa5f4327-ba0e-4b78-9b28-61fb4396f64d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_aa875931-fb24-4796-91f3-c3924bcf1ebb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_b2d601f8-e5d6-44a2-a04a-f2df09be09f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_b7080d02-4c79-40ef-9fa1-ea37d0856660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_b8e64ad8-9663-44a6-afdd-eb5bc7829282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-19</instant>
        </period>
    </context>
    <context id="C_b9008131-b16c-4d88-88b8-b98335565844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="C_bbdcc299-39eb-4e27-b604-ab146bacfa01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:TwoThousandAndEightOmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_bf2d5251-793c-4326-8260-9fc5c59df6da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-23</instant>
        </period>
    </context>
    <context id="C_c80491ff-d878-4596-938d-77d3e4dc6ba0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_cb253871-f434-42be-badc-455136d75117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_cf8f1efe-c282-41f0-90aa-477e9df58d2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="C_cfc6a080-d7ad-48cf-9593-13de2e93cbdd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_d153b937-6a62-4ec2-97ea-eb68558e59ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-18</startDate>
            <endDate>2025-09-19</endDate>
        </period>
    </context>
    <context id="C_d190719d-ba9d-4549-9346-f6c2c6a02045">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-23</startDate>
            <endDate>2025-09-23</endDate>
        </period>
    </context>
    <context id="C_d2e5d3c1-839a-4550-89aa-0ed3da951bff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_d31b2e6f-0ff1-46fd-864d-d501e482dc79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_d3e5d951-4348-4f5f-b2be-82d3b6a4f3ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lits:SanDiegoCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="C_d5b61db4-8dab-4058-ac3f-a2da29438702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_db6f4ce3-b159-4f84-a6ec-7529098c2c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_db8a5320-d917-40b0-808a-594d2f634033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AssetManagementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_dcba7e4a-11d0-4a3e-b398-fd6721e793ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_dd4f6857-b631-463e-8ad2-bfe9435bf776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:JustinJFileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_dfabb534-74be-4288-92af-5556895040ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_e1e0a909-dd46-42bb-8478-62d44158460b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_e3b3e1bb-0d52-409c-8d44-386e016474a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_e7db8cf6-cb55-4ae2-94f9-5eb5ba8827f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:BeigeneLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_e8ae3059-8bf8-46fc-9780-e37bde448693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_e968e6a1-e1dc-4b6b-b7eb-2349e035aa81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2024-10-22</startDate>
            <endDate>2024-10-22</endDate>
        </period>
    </context>
    <context id="C_e9c5cddf-20f7-4aeb-a9be-fe852d96546b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_eb4c8b50-1cde-40b3-95ce-38094a76fdac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_eb55a398-d9e2-4bc4-b646-4c8ff5f95e44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="C_eb963958-2863-459f-bc33-6b787def5d3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_ebb8eacd-9a9f-4b19-8cc4-c8435984244b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">lits:PotentialPaymentsOnAchievementOfDevelopmentRegulatoryAndCommercialMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_ec033cf6-6de4-4e18-90c4-48d44d401981">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_eebe7de3-feed-4cd9-8e5d-19e4577417b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:StrategicAdvisorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_efee07f7-2a59-42fe-b86a-e2563b5f1277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">lits:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-22</instant>
        </period>
    </context>
    <context id="C_f0b7c1b2-6b39-4391-a802-da6e61227686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2023-10-31</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="C_f12fbef6-72e6-4260-86e6-fc02f15df7a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">lits:O2024Q2DividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_f3472b73-4e34-47a0-be62-77eed918f8bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2024-06-18</startDate>
            <endDate>2024-06-18</endDate>
        </period>
    </context>
    <context id="C_f738a573-a0f1-4605-bcb6-b67c8411a1fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-17</instant>
        </period>
    </context>
    <context id="C_fa1c20a4-edb7-43ee-b979-1cf83c11f686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_fbc3fa56-1138-411a-86db-d0f5176a096d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="C_fcab84f5-286d-44a9-a098-875d5677014f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_03a52d86-9327-469f-9cca-e384b91706f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_046dad52-7060-4b22-a684-7b4095cf956f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">lits:IncrementalPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lits:PresageBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_07682bb1-2b3e-4319-8e57-ef12c2e28266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-15</startDate>
            <endDate>2025-07-15</endDate>
        </period>
    </context>
    <context id="C_07f286c0-e5a6-4c38-9799-941180c82a4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-24</instant>
        </period>
    </context>
    <context id="C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_08b96565-9169-4635-945d-9321b9c399be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-24</instant>
        </period>
    </context>
    <context id="C_08fe00f6-b289-43d7-b3de-b6f4be2b0660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2025-09-23</instant>
        </period>
    </context>
    <context id="C_09f1e527-d411-49b0-8987-c4eeed8a7d14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_0a639547-5eb3-4035-a49b-df9413032521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="C_0b16e06a-f891-41fa-a61d-1dcab0a16b52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_0b90534f-7f35-47c8-a101-7fbee1ae76c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0c124857-32c7-4d51-83ca-319184ab60ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-17</startDate>
            <endDate>2025-07-17</endDate>
        </period>
    </context>
    <context id="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_0eba68b0-9adf-4ac8-8967-f51e2cef9d7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_0f41c2fa-b332-4ddf-b708-46d3bd043fa7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_17b85b55-1836-4eb6-8ee3-7afafbc45023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:StrategicAdvisorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_1d242087-6da3-4ba4-9ecd-f789815f32a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="C_1d85b2ba-2068-4a8d-b780-07d1f807c029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_21e223f0-5d79-475c-a98b-446086b5ce4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_23b7781d-5a70-4950-ab3d-ed36fea479a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="C_2537ecc2-706a-441e-abb0-6c81823b2c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_2847194b-f51e-4d7d-8f4b-3169aeb8ad38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_28d2a101-457d-43c9-9dbe-68711aac1f9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_2c0b1dcd-adce-47b9-ae07-a9ae57be522c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AssetManagementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_2d40854b-8b85-47ad-ae8c-ed3f241c7c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_2f5d0c47-45b0-40b0-8304-92a36ee32203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-17</instant>
        </period>
    </context>
    <context id="C_303a0d36-3cb7-4d85-bdff-8bcece057b3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_31fc6baf-8276-4e06-a067-f35d671133c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_32364034-e8a2-411c-b37e-a487f90ff512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_32d99983-1b3d-4c08-8e53-fb1cf89c3852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2023-12-06</startDate>
            <endDate>2023-12-06</endDate>
        </period>
    </context>
    <context id="C_32df5392-7969-40b6-9827-2e4cab47aa33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_365bd362-44cf-4f5e-882d-def50fff7f57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2024-06-18</instant>
        </period>
    </context>
    <context id="C_36dd6fec-f2fe-427e-a87d-51412c3f9ec9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_37467610-00f1-43d7-b2ec-970dbeaab385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:JustinJFileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_39b6c9ec-a171-463c-827e-3d4ee41454a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_3ad957d5-2461-4ae3-9be5-d6b77b9afb1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-09-23</endDate>
        </period>
    </context>
    <context id="C_3b1ff24a-8449-4e09-abf5-5f426b41e513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:KkcAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_3b4342ff-1351-43aa-bf51-fe4957ccc32c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_3bdebc26-b1ff-4f0d-9742-becf52c22f69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:AdvisoryAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_3d482d2c-7007-47bd-bd9f-a3222d384265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_3e7dfd70-bc4a-4b0f-89af-eaa0c4be659f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_3e8cceec-9f3f-4c61-8560-6f8645289b52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:TwoThousandAndEightOmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_3f481bc3-5122-47d6-b340-52e2c78f1b31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_3fc533f8-752c-4ec5-904f-8e635dc124f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_4022bccc-441f-4478-9790-7dc6fba82efc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lits:InducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_4038fe7e-0797-4545-9817-044b66f01547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_417b9e3c-996d-4ced-8745-037e7a936560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_42469529-12e3-4edc-a0e6-3a47d45ab69f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:TheSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="C_4477116c-5b49-4100-b4a7-28181e73d4e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lits:TorreyaPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_44c9191d-9975-403e-a883-48ca3b8d97f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_4599d307-ed5c-4842-ac28-146c1c1c5cbd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">lits:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-22</startDate>
            <endDate>2024-10-22</endDate>
        </period>
    </context>
    <context id="C_45f6bbd9-6d25-4221-88e3-beeb4bcc1f68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_47d0895f-dcab-4868-bb7e-4888006739cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_496692d5-8b11-4647-b7db-ff47b1d1be07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_498df639-b914-4e6f-a5bd-5f79abcd206f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_4a72990a-99c7-448b-bc43-8b9348a0a984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_4aadd502-4418-4743-994c-0a56dc532d10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:Pre-FundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="C_4dfa8660-229c-4efc-b1ce-209781894ed6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:UsLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:KkcAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lits:KyowaKirinCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_4f503b69-15af-4b8f-a96a-caa0ddcce497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_55a276dd-3278-431b-bb6a-72afcf0a97f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_57a12f24-8485-49fc-8a47-a37e1dd17d35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_588ef89b-8dde-48fe-9eb4-42e303780ef8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-17</instant>
        </period>
    </context>
    <context id="C_5c746096-0191-4a12-b56d-6cedc776485d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">lits:PresageLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_5da12cd1-97de-4b4d-b577-ec7e3184e27c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-02</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_5de81fb4-2434-47f3-8fae-5c41690c6230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:VoruciclibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_5eb52ed6-f76b-48ea-a2e5-62167666a0fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="C_5fb23a8d-14cb-4175-877b-89e01b2aff80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="C_60c2b2ea-9737-4be7-9d43-b2cdb939b23d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DanielPGoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_65ce1f21-fab6-461d-b692-0bcf9b01d489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_68bebf1e-062c-4c48-8787-5346a1c6828d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_6b9d4b1e-ad8f-4235-877b-c5777163e5ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_6d37e90f-283f-41b0-b124-b327504c907e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:TheSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_6e8266ff-577a-497b-a576-2b0ca18d975a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">lits:RevenueFromCollaborationAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_6f868094-4e34-494e-b2e9-24e875f17c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:DavidMUrsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_6fd2496a-603e-4079-bd68-56583b109120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_71ae9d25-7183-44c7-86d1-e4821a8dc42d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_782d4804-c6b3-4521-80f5-fc558e241284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_78b08baa-a398-4c87-8856-dccadb025d83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-02</instant>
        </period>
    </context>
    <context id="C_7bc39535-b788-4030-8e06-f7b6e0eac901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_7c38ad79-231e-469a-9a63-b80988a7ff5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_7c7a543b-cf8d-4e11-8cd1-eb898eaf4c1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:LegalFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:PlacementAgencyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-17</instant>
        </period>
    </context>
    <context id="C_7d0e8349-e426-46da-ab51-1707c24a1af7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lits:JustinJFileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_7d14d4db-d882-45a5-8109-0ae6bd9376fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lits:VoruciclibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_7d1dd293-c91b-41db-ae9c-cff76e94081f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">lits:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-22</instant>
        </period>
    </context>
    <context id="C_7e65b259-8510-471f-b0d9-635c29c62a42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lits:GSRWarrantsTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-22</instant>
        </period>
    </context>
    <context id="C_7ee6ad01-be31-465e-9644-4d6400b09ee1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">lits:PassThroughServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_7fd455f4-c990-45c2-b727-b3da37aaffb0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_7fda2453-8aa5-405b-b3ee-795a3fca2cda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lits:AtTheMarketSaleAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Segment">
        <measure>lits:Segment</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_8b0c33e1-cfa0-4fed-8816-08de9d856383">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f56f3522-384a-4bd7-ad81-4686c43c3bd4">0001262104</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_49c0e231-c7b9-4db0-9427-d64700ca3649">false</dei:AmendmentFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      id="F_4abf2385-31d7-4f40-98f7-48e586e0041c"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      id="F_9575a425-5462-4e8e-92d8-a90e668798ea"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_8bbbca48-d932-4c1f-9137-b00bdcc4ecdb"
      id="F_75abda38-a80b-45e0-b57c-64913feff94d">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_10d9387d-fef2-414e-8898-e24c8f8f9759">2028-03-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_36dd6fec-f2fe-427e-a87d-51412c3f9ec9"
      id="F_bee66b44-7fcb-482f-938b-2dcb4681b6b7">2028-03-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2254fbc2-926d-4ef0-b4be-2c017a79ef44">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember http://fasb.org/srt/2025#ChiefFinancialOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="INF"
      id="F_b5129ee1-cc18-4e29-a225-35da57c0a01a"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_417b9e3c-996d-4ced-8745-037e7a936560"
      id="F_471041f0-6337-4d57-89cb-a763e2396550">2030-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_db8a5320-d917-40b0-808a-594d2f634033"
      id="F_da2a1c44-7a41-4557-8068-3921e2100485">2030-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_3bdebc26-b1ff-4f0d-9742-becf52c22f69"
      id="F_e6417c3a-45fe-44f8-aa59-aea60d182067">2030-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <dei:DocumentType
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_1936cd8c-aabf-4ce4-a7e2-9ff740c0b05e">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_053e6e05-7746-413e-8ab0-8667de659cc7">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f454bd0c-f0cf-4a79-a753-8acfeb501d12">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_72397549-909b-4c70-b91f-852333ab4191">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2490b6b1-712e-4686-bb1a-eabfb1834acf">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_d7b5e082-df92-4049-ad32-621aa3f8b0d2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_071511cf-7d0e-4a60-8dfb-d3f028b8c6ca">000-50484</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_4ebad043-ab0e-46bd-be03-36c551385f48">Lite Strategy, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_a89ab4b9-d655-4573-add5-61de488234f8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f277a69b-5bde-4d7e-af9d-e1102f2debad">51-0407811</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_aece8f20-10c4-418c-a5ea-e041ec6b832e">9920 Pacific Heights Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_d22c4eb3-c075-4ccf-95ac-f8ad0f047e6f">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_39bf79fb-a086-466f-94d1-49fec7b958a2">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_41585427-3077-4eb3-8611-c8d3a2711140">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_ac2e2445-2a30-4c7a-88f5-d0fdc388b0a5">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_6330ed5f-e60c-422d-95d1-8a7c58a863c5">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_5111de49-a856-4bb8-a3d2-33016086052b">369-7100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_7cd43ff9-a177-4b9a-9726-0d34a4c13143">Common Stock, $0.00000002 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_a51c57a8-743f-46a2-bb23-d58ae041404b">LITS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_53fed102-8085-47b7-8bb7-cf2f5ad1e42a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_00fb045b-91c9-4845-b349-5cd05f2a2d2a">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_77d1be78-4b0b-4f06-844e-a103b4e48081">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2bc7c17a-6cb2-4dae-9372-08cf2d377d68">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f3800a66-f73a-4045-aad8-0f44591984b5">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_34b92d3e-071a-4bec-baca-244076b974e3">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f6d125e7-533b-4953-ac49-7a45b01a067f">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e591a1f4-3a0c-4972-9d2a-30c7de52c2cc">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_9e99911b-1c57-4fea-b594-6f0e27df38f7">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_999367fd-6b44-4ebd-a305-8f857725a7da">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_a94c5ee5-f320-4e48-82fa-0e6fb6ec5fba">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0b90534f-7f35-47c8-a101-7fbee1ae76c8"
      decimals="-5"
      id="F_159b5798-1aad-47e3-9b48-3e3cf97fceed"
      unitRef="U_USD">12000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_08fe00f6-b289-43d7-b3de-b6f4be2b0660"
      decimals="INF"
      id="F_cf27d54c-16a4-4d72-af28-5ef38684b2bf"
      unitRef="U_shares">35655155</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_851bdded-de42-4a3e-ae5e-445113cf5da2">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cybersecurity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognize the importance cybersecurity has to the success of our business, as well as recognize the need to continually assess cybersecurity risks and evolve our responses in the face of a rapidly and ever-changing environment. Accordingly, we aim to protect our business operations, records and information against known and evolving cybersecurity threats.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  Risk Management and Strategy&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have established policies and processes for assessing, identifying and managing material risk from cybersecurity threats and have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing within these systems.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks and the sufficiency of existing policies, procedures, systems and safeguards in place to manage such risks.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Following these risk assessments, we re-design, implement and maintain reasonable safeguards to minimize identified risks, reasonably address any identified gaps in existing safeguards and regularly monitor the effectiveness of our safeguards. Primary responsibility for assessing, monitoring and managing our cybersecurity risks rests with the Senior Director, Information Security and Infrastructure who reports to our Acting Chief Executive Officer and Chief Financial Officer to manage the risk assessment and mitigation process.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with our Information Technology department. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings and internal communications.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; If required, we &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;engage&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; consultants, or other third parties in connection with our risk assessment processes. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These service providers, where appropriate, assist us in the assessment, testing or other aspects of our security controls to help identify material cybersecurity risks to our critical systems, information, products, services and our broader enterprise IT environment, as well as assist us in designing and implementing our cybersecurity policies and procedures. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing. For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#x201c;Risk Factors,&#x201d; in this annual report on Form 10-K.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Governance &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board considers cybersecurity risk as part of its risk oversight function and has delegated oversight of cybersecurity and other information technology risks to the Audit Committee. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee oversees management&#x2019;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee receives annual reports from management on our cybersecurity risks. In addition, management updates the Audit Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e89b2f3e-b3a3-4349-9eac-0c4f9b0a154a">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have established policies and processes for assessing, identifying and managing material risk from cybersecurity threats and have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing within these systems.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_91d48d31-a236-4a58-a031-c44f3ca6632b">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_8058ccb8-6686-4a39-8f9e-c69ea6ded67b">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_0939c083-93a6-406a-aa19-66c6c8acf782">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_941b5fce-7f0d-4ddb-837b-b01becff5879">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2d3a1bbb-5d39-44b5-8aa9-8df0c593dfa4">&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Governance &lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board considers cybersecurity risk as part of its risk oversight function and has delegated oversight of cybersecurity and other information technology risks to the Audit Committee. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee oversees management&#x2019;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee receives annual reports from management on our cybersecurity risks. In addition, management updates the Audit Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_ab63ce1e-c060-41e0-b36f-b1cc94c0a840">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee oversees management&#x2019;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Our management team, including our Acting Chief Executive Officer and Chief Financial Officer and Senior Director, Information Security and Infrastructure, provide periodic briefings to the Audit Committee regarding our cybersecurity risks and activities, including any recent cybersecurity incidents and related responses, if applicable.&lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_af7bdff5-7fbe-424f-bd15-a1bbb215a882">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee oversees management&#x2019;s implementation of our cybersecurity risk management program and is responsible for monitoring and assessing strategic risk exposure, while our management team is responsible for the day-to-day operations over the material risks we face&lt;/span&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_fae7a987-c780-431c-b8c1-1c65a2f65482">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_eed4e0a5-efbd-4dae-b89f-c999b792fab2">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program, in the discretion of the Board and management. Board members may receive presentations on cybersecurity topics from external experts as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_5b50b3fc-36c5-4848-9563-6498b19e8aeb">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Acting Chief Executive Officer, CFO and Senior Director, Information Security and Infrastructure, are responsible for assessing and managing our material risks from cybersecurity threats and have decades of experience in overseeing operations, including information technology functions, in the public company environment.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The team has primary responsibility for our overall cybersecurity risk management program and supervises our retained external cybersecurity consultants as needed.&lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_429eaafb-c5f7-4341-8fca-87ba3876e8b2">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_67b1ef74-92fc-4704-a867-4325737df9fd">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team supervises cybersecurity risk management efforts to prevent, detect, mitigate,and remediate cybersecurity risks and incidents through various means, which may include briefings from external consultants engaged by us; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in the IT environment. The cybersecurity risk management program also includes tools and activities to prevent, detect and analyze current and emerging cybersecurity threats and plans and strategies to address threats and incidents. &lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <dei:AuditorName
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f6905033-b1a3-4b50-b5f1-14d662f77a00">Deloitte and Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_53b4b5b5-1395-4c24-8cf2-f1feb8a85abb">San Diego, California</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_7ce17d27-2106-46dd-b00e-49c7c6e24e88">34</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2b03a700-6f52-4744-9230-bbde9225dfff">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheets of Lite Strategy, Inc. and subsidiary (the "Company") as of June 30, 2025 and 2024, the related consolidated statements of operations, stockholders' equity, and cash flows, for each of the two years in the period ended June 30, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2025, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_fac06d6e-340b-4163-a306-3cabf757985c"
      unitRef="U_USD">18011000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_698bb029-76e5-4060-a3e1-026f3ac3e3b7"
      unitRef="U_USD">3705000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_6ed7e186-7e81-41be-8337-b7a916ea3afe"
      unitRef="U_USD">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_086d0008-7300-450c-a30f-59dedd709fd5"
      unitRef="U_USD">34640000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_5945d1a1-d17b-44f3-9ec5-7bc1c10aa123"
      unitRef="U_USD">274000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_77bdd6c9-1b35-4e5d-853a-0d0645b94a81"
      unitRef="U_USD">2424000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_42b1bc86-9557-487d-a091-b1cc2436b646"
      unitRef="U_USD">18285000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_0912ad40-098b-463b-af66-29373e101151"
      unitRef="U_USD">40769000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_51725ae3-1188-4e7f-835c-f4c09abd8bb4"
      unitRef="U_USD">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_904318c4-734c-44a2-a82e-e2ccc5632b9c"
      unitRef="U_USD">214000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_786e8873-6c37-4009-afa4-4fda5afbef72"
      unitRef="U_USD">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_1dc0bccb-ec80-4427-a97f-1393638c20f7"
      unitRef="U_USD">392000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_8ecf9c97-f720-4762-a703-03fd76ecb675"
      unitRef="U_USD">18285000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_26a966a6-5b30-4f4d-823f-56aec429cf6d"
      unitRef="U_USD">41375000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_af06ac71-f3a8-48e5-aa8b-8ba351b85f2b"
      unitRef="U_USD">176000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_f48c87b3-a3a0-478a-b1ab-b19ad6cfe445"
      unitRef="U_USD">3168000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_716136b5-7631-4669-8431-e25910e870f6"
      unitRef="U_USD">1178000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_2aefd396-dc3c-49be-9aa0-5c110ec3b9c4"
      unitRef="U_USD">5187000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_aa2d36a0-3149-4b62-8a7a-b7786e0cd7e2"
      unitRef="U_USD">1354000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_f61696e1-0414-4c2a-892e-709c8b8e0e34"
      unitRef="U_USD">8355000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_dcf18ebf-8b92-4d2e-a5ff-286b0c29d7b8"
      unitRef="U_USD">1354000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_37cd8c58-60e3-4f80-8d60-18e18e388ae0"
      unitRef="U_USD">8355000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="2"
      id="F_dff7e3ad-4234-45f4-aff7-2df46c8ccce5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="2"
      id="F_55080544-54b9-4099-8853-a628cadb1ce5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_7368760d-1789-4d60-891a-786baf189ea3"
      unitRef="U_shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_abf78a20-26df-4cc8-954c-9604a83705eb"
      unitRef="U_shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_337458a6-b0e4-4e27-8b3e-b43f2fdcad36"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_71902b3d-0ec9-48d3-a960-a904c92aa480"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_a1962113-24ff-4631-9f39-85532461689a"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_99e7219b-e72d-4f5b-9002-548ce2aa375a"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="8"
      id="F_865c7ff9-15e9-41ff-ae07-ada8821dbf0b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00000002</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="8"
      id="F_e63d41f1-1c71-4bab-a591-45c9cc385afa"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00000002</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_fb0cc765-826e-46e9-b701-30596e416f75"
      unitRef="U_shares">226000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_30fc679d-b032-4419-affc-a9e403710367"
      unitRef="U_shares">226000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_8beda4ec-5c20-4fa6-9c26-88963f559977"
      unitRef="U_shares">6663000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_1b391154-1871-4d5d-88d2-6168b13c0c3c"
      unitRef="U_shares">6663000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_ae1c7aa9-35eb-4110-acec-72db64005c45"
      unitRef="U_shares">6663000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_916dccf4-f540-4676-b813-1fb6e57a33ff"
      unitRef="U_shares">6663000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_f0cfb2e1-3b91-435c-9210-5a156dae9e22"
      unitRef="U_USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_fe8bfc48-13b1-4946-843d-92c38c837822"
      unitRef="U_USD">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_5731e8ca-f0d0-4400-a2c8-b65f3399cf76"
      unitRef="U_USD">421095000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_8dff8c40-75d6-4883-82f7-f8e655940e2e"
      unitRef="U_USD">421239000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_02527798-6426-4502-96f3-f7cffb794399"
      unitRef="U_USD">-404164000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_d68aa9e8-bd6a-48a1-b4d0-2f381922923c"
      unitRef="U_USD">-388219000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_e8b876ba-5312-434f-9a57-6482cbc02bbb"
      unitRef="U_USD">16931000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_cdb03ff1-d03b-4652-83a8-97212ae7c379"
      unitRef="U_USD">33020000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_b4fd20c0-992d-4d3c-8dbc-c55a0fd0cb1e"
      unitRef="U_USD">18285000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_55295ea3-eced-496a-a91a-5f97768d56a9"
      unitRef="U_USD">41375000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_983ed5f1-6f8b-49fe-952b-3b1ada647fbb"
      decimals="-3"
      id="F_8a9fd86c-a201-4923-8104-3142709a61cf"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_2537ecc2-706a-441e-abb0-6c81823b2c71"
      decimals="-3"
      id="F_ae5b5025-3c02-459b-adf7-b367cb7cdb17"
      unitRef="U_USD">752000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_6e8266ff-577a-497b-a576-2b0ca18d975a"
      decimals="-3"
      id="F_9a01330e-66c5-4478-9126-357e88367ccd"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_98cbe3d9-5dfd-438f-a31c-71c63b05ef14"
      decimals="-3"
      id="F_9d56ec97-0983-48c9-9bdb-8fd69be1fe5d"
      unitRef="U_USD">64545000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_227ccb91-668d-4438-acdc-b8922b9940f4"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_0f761b8d-44ed-4024-9a30-cf0dfd433cc8"
      unitRef="U_USD">65297000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_4d69a785-0c60-4896-ae3b-07c9d991a6f9"
      unitRef="U_USD">3923000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_cd9fb1dc-3dc0-4cf1-a6c8-88dee0b17feb"
      unitRef="U_USD">16561000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_8cf6031e-b3be-4f1d-b236-437ad46c4dd9"
      unitRef="U_USD">13532000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_116e1cd4-dc6d-458f-abf5-b108932c48f4"
      unitRef="U_USD">23295000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_039a1027-d466-4284-aa60-6550f538f7ca"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_fea677ee-66f3-4b69-a01e-2f3ed7b3877e"
      unitRef="U_USD">10899000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:CostsAndExpenses
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_606b1949-fc79-4fc4-b5e3-4fdfc0d37fa1"
      unitRef="U_USD">17455000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_01391c63-cd31-4e06-b48b-511bfe369e9e"
      unitRef="U_USD">50755000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_4fd71cb6-c06c-4002-9d2d-68236b323a67"
      unitRef="U_USD">-17455000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_f9eea937-2486-496b-a5cb-c1690cbad622"
      unitRef="U_USD">14542000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_363b8e2c-31bb-4478-a7d3-fa7a521e8573"
      unitRef="U_USD">1026000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_4730c153-5b2e-458d-8600-ed15a6739e3c"
      unitRef="U_USD">3277000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_3101869a-b006-4b1b-8e9b-19bcc305c126"
      unitRef="U_USD">500000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_9299a358-d1dc-4530-999d-467dfc8644ff"
      unitRef="U_USD">0</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_7dc67b45-23de-4031-b5c7-ab120e186e39"
      unitRef="U_USD">-16000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_2328f151-9492-43c7-896f-d7bea5dd0f93"
      unitRef="U_USD">-41000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_cc64b91b-357f-4a4c-ac4a-ad8a5e6f5f80"
      unitRef="U_USD">1510000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_70f9e5b8-b22e-406a-811c-8fa65c854afe"
      unitRef="U_USD">3236000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_1f6666f6-a60d-486f-ba31-943313d3fe22"
      unitRef="U_USD">-15945000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_eaf7490b-b615-44cf-81da-47b175cc499c"
      unitRef="U_USD">17778000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_735a4b0e-a5a1-4dca-ab16-efa7cef8a27a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_37bdb40f-cbc6-4d61-a261-27861f53aabb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_41fbf39c-f462-47af-8c76-94d2372295eb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_9a941219-2545-473e-9c68-b984c76cff1e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_1521c4ba-c181-4920-8fa7-08188a0822b1"
      unitRef="U_shares">6663000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_bda9ec18-2fad-4fa7-86fc-0f8b3bf78a5f"
      unitRef="U_shares">6663000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_71fe6eee-e956-4a4a-bf0d-275fb100eb4a"
      unitRef="U_shares">6663000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_a1f29c91-37cb-4364-b6d6-917f77177d9c"
      unitRef="U_shares">6663000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_68bebf1e-062c-4c48-8787-5346a1c6828d"
      decimals="-3"
      id="F_a7badc35-b039-42b9-9a5d-66154c519e85"
      unitRef="U_USD">6663000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6fd2496a-603e-4079-bd68-56583b109120"
      decimals="-3"
      id="F_30a5c8f9-5b32-4be6-ba86-8acc4864facb"
      unitRef="U_USD">430621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bf2d5251-793c-4326-8260-9fc5c59df6da"
      decimals="-3"
      id="F_fb68594a-592e-4dbd-b36c-2cc236b0d5e2"
      unitRef="U_USD">-405997000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_57a12f24-8485-49fc-8a47-a37e1dd17d35"
      decimals="-3"
      id="F_6caec5f2-ba1b-41d0-badd-0a1359fb913e"
      unitRef="U_USD">24624000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_a6339fc6-e7e2-479d-814d-64200ed7d803"
      decimals="-3"
      id="F_d36b87c1-76e4-45ea-bea0-b6fae085f49c"
      unitRef="U_USD">17778000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_5b2007eb-787a-4391-a8c8-fc9c875b7d17"
      unitRef="U_USD">17778000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_98625982-bb86-4864-b357-8c4026a31aee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.75</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="C_d5b61db4-8dab-4058-ac3f-a2da29438702"
      decimals="-3"
      id="F_cd9c6fb0-3e5d-450e-afc1-a270ed53c3de"
      unitRef="U_USD">11660000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_e0d42c1a-635d-4c6e-927f-dcd3bf96e92b"
      unitRef="U_USD">11660000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_d5b61db4-8dab-4058-ac3f-a2da29438702"
      decimals="-3"
      id="F_c198e6a8-0848-47fd-ad4a-def9f29a7f45"
      unitRef="U_USD">2278000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_3c9f4874-c088-494c-8b64-d8c145a422fd"
      unitRef="U_USD">2278000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="C_84359d17-853f-46e4-b937-cd4a49546ae7"
      decimals="-3"
      id="F_be31c8ff-5f0b-4fc9-aeb1-235ec334bb23"
      unitRef="U_USD">6663000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b7080d02-4c79-40ef-9fa1-ea37d0856660"
      decimals="-3"
      id="F_2ce4fcf8-b120-493e-8b73-a83ae0aa6649"
      unitRef="U_USD">421239000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_44c9191d-9975-403e-a883-48ca3b8d97f4"
      decimals="-3"
      id="F_4a8e8bcb-36f3-4cc6-bebb-15cfe7ad1376"
      unitRef="U_USD">-388219000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_27534d2b-cfde-4812-9835-427247a0cde5"
      unitRef="U_USD">33020000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_1d85b2ba-2068-4a8d-b780-07d1f807c029"
      decimals="-3"
      id="F_41628754-6862-4729-9fa3-9be9ea0bab15"
      unitRef="U_USD">-15945000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_ab15aaca-c297-4a72-b2d3-eb3520462c62"
      unitRef="U_USD">-15945000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0f41c2fa-b332-4ddf-b708-46d3bd043fa7"
      decimals="-3"
      id="F_3b342206-2c4d-4afb-a45c-c7a372e4745a"
      unitRef="U_USD">-144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_71ee96e2-451c-406d-8dd2-2c8afffce2c5"
      unitRef="U_USD">-144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="C_c80491ff-d878-4596-938d-77d3e4dc6ba0"
      decimals="-3"
      id="F_c266c816-25ec-4a8e-95ec-e3a6fea849e9"
      unitRef="U_USD">6663000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b2d601f8-e5d6-44a2-a04a-f2df09be09f8"
      decimals="-3"
      id="F_ab3d1f21-3381-403b-b1e8-be84013e834e"
      unitRef="U_USD">421095000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_31fc6baf-8276-4e06-a067-f35d671133c1"
      decimals="-3"
      id="F_08aff056-a299-4781-bdbe-d17b8f91d686"
      unitRef="U_USD">-404164000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_7ea92a46-d56d-4b1b-bb6f-141955208291"
      unitRef="U_USD">16931000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_04d4ce33-4017-4696-a24f-dc65596e0875"
      unitRef="U_USD">-15945000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_85c66db6-47a5-4b00-af81-7e5ea266e5a8"
      unitRef="U_USD">17778000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_ebe12d41-bf58-408f-9558-24b5994836ca"
      unitRef="U_USD">-144000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_b4f7bb11-d0fc-411f-b220-f4c57850865a"
      unitRef="U_USD">2278000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_0a9c9ce4-f3f4-4f54-86e4-0b91f337ae71"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_498d5d8f-e870-4d36-846b-392bea4a2570"
      unitRef="U_USD">10899000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <lits:NonCashLeaseExpense
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_401a1082-5e1b-4537-a1f1-3d8058605093"
      unitRef="U_USD">214000</lits:NonCashLeaseExpense>
    <lits:NonCashLeaseExpense
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_33f445ed-2bd4-4f8a-8797-7b6613f9d038"
      unitRef="U_USD">2433000</lits:NonCashLeaseExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_cd557f82-c7e4-47b1-9068-470d4db78d22"
      unitRef="U_USD">368000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_44cf1278-e3d3-457f-be55-274326507631"
      unitRef="U_USD">383000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_5ffb7db6-dd13-4414-a5f1-ed06447852bd"
      unitRef="U_USD">-14000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_36cf641f-ae00-44be-a23a-7b09aeee2a5d"
      unitRef="U_USD">-32000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_3db07e74-b57e-4df0-b328-5b53713605fc"
      unitRef="U_USD">500000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_494898b8-58c1-4ae2-b019-05cbbf072435"
      unitRef="U_USD">-0</us-gaap:GainLossOnSaleOfOtherAssets>
    <lits:IncreaseDecreaseInUnbilledReceivable
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_191daafd-4946-4ae8-83a9-d333e2ddee29"
      unitRef="U_USD">-0</lits:IncreaseDecreaseInUnbilledReceivable>
    <lits:IncreaseDecreaseInUnbilledReceivable
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_5d2d6371-b23b-45e7-82b9-ff5f28b1858d"
      unitRef="U_USD">-85000</lits:IncreaseDecreaseInUnbilledReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_b8ee87c8-7df8-477d-a341-2608d89ef3ab"
      unitRef="U_USD">-2150000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_d22cef4c-5159-453b-8019-782a69d2347d"
      unitRef="U_USD">-4534000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_de1a551e-a5c4-4430-906e-2f368af2d576"
      unitRef="U_USD">-2992000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_14e32910-5393-4651-af71-2f6378e58258"
      unitRef="U_USD">-3147000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_52048378-cab4-44f1-915d-fece5b6c3a3c"
      unitRef="U_USD">-4009000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_927c8e6f-eedc-442e-b45f-c5821d36616f"
      unitRef="U_USD">-7274000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_bc5b203e-7ad3-466e-82c5-3bf675b18b30"
      unitRef="U_USD">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_668c229b-fe9a-4846-9c2a-730150167f74"
      unitRef="U_USD">-64862000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_d2033087-9e0a-4295-a1f8-d61793884a22"
      unitRef="U_USD">0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_eadeb9d2-d1c2-4060-bfc3-8a560fffa0d8"
      unitRef="U_USD">-13612000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_d32af503-73c8-4df3-b2f9-222e49fc201e"
      unitRef="U_USD">-20844000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_977e4d1c-5132-4318-830a-0e2462fd288f"
      unitRef="U_USD">-50473000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_b3db5f6b-80fa-4f4c-adb4-b05bfa3475c9"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_ec828633-9e49-42ce-91fa-d96d094018fb"
      unitRef="U_USD">58232000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_a456a9d8-9ebc-4782-a2c4-e903e6165212"
      unitRef="U_USD">34640000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_4381b002-96a1-4683-9be0-cc2e663d36c1"
      unitRef="U_USD">107379000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_fa81bb8d-69af-424d-9b58-a49113f57ea4"
      unitRef="U_USD">10000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_ae67cf3b-777b-43c7-b3d9-1da8ac05f9db"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_c7da8de1-c666-4826-bbee-8292efc72ad5"
      unitRef="U_USD">500000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_7976c063-5e57-436a-8048-fdec29976030"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_2fc4150d-57db-49c7-9de7-83cbfa2724f7"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_22e139e7-e98b-40fc-a35f-648f09095f3d"
      unitRef="U_USD">7000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_d8d6748b-16f5-4052-a57d-c07a50e5110b"
      unitRef="U_USD">35150000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_e167d15e-73ba-4c5a-94bf-c9b83ce0e370"
      unitRef="U_USD">49140000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_0c262af4-04af-476b-bcb5-68e489761132"
      unitRef="U_USD">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_8ded16b0-53e5-45fd-a273-ce85d5bc21f7"
      unitRef="U_USD">11660000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_7d337e0b-0ed0-4b6a-830c-1ebafe4f8a4a"
      unitRef="U_USD">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_243ca418-6afa-4dc4-b92f-1679e9093775"
      unitRef="U_USD">208000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_1cdbc6a7-ffc2-4af4-b64e-459f88d8b620"
      unitRef="U_USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_b000f44f-1769-4145-8744-e9ad8e7422f9"
      unitRef="U_USD">-11868000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_c0c304cc-07c6-4c00-beb9-a84a70cdc0ca"
      unitRef="U_USD">14306000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_21e61e3f-4526-4f40-8e6f-9dd48f2a4bc8"
      unitRef="U_USD">-13201000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_6eb23285-3760-492b-b8ec-3ca7a8f57194"
      unitRef="U_USD">3705000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_57a12f24-8485-49fc-8a47-a37e1dd17d35"
      decimals="-3"
      id="F_cd6aef9f-eea4-4da5-8f16-ba97d96da642"
      unitRef="U_USD">16906000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_511a451f-faa0-4ae9-9b4c-32054f8fed77"
      unitRef="U_USD">18011000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_23d5031c-dfac-4886-b5d2-562670ed48b7"
      unitRef="U_USD">3705000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <lits:RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_585d8e40-d3d3-45f0-8d6f-8d5996348948"
      unitRef="U_USD">0</lits:RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification>
    <lits:RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_2d71c8de-5856-4fac-8887-36dd0a3aa18d"
      unitRef="U_USD">-22000</lits:RemeasurementOfRightOfUseAssetAndRelatedLeaseLiabilityUponLeaseModification>
    <lits:RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_539bac13-e1e9-4ac9-a32c-02f65062faa2"
      unitRef="U_USD">0</lits:RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification>
    <lits:RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_c4cc32a4-13e7-4e06-80fa-84ddc3b31cdc"
      unitRef="U_USD">181000</lits:RemeasurementOfRightOfUseAssetForDirectCostsAssociatedWithLeaseModification>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_24c95209-e342-4fc3-8eba-4532437cd1b0">&lt;p id="fn1_title" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 1. Description of Business and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;pharmaceutical company that has been developing novel and differentiated cancer therapies. In August 2025, we implemented a Litecoin Treasury Strategy (as described below) with the net proceeds from the PIPE (as defined below). We built our pipeline by acquiring promising cancer agents and creating value in programs through development, strategic partnerships and out-licensing or commercialization, as appropriate. Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit. Our pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, zandelisib, &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;an oral, once-daily, selective PI3K&#x3b4; inhibitor &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and prior to its sale, ME-344 as more fully discussed in &lt;/span&gt;&lt;a href="#fn_dis_nonfin_asset"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 13. Disposition of a Non-Financial Asset&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) related to annual reports on Form 10&#x2011;K. The accompanying consolidated financial statements include the accounts of Lite Strategy, Inc. and our wholly owned subsidiary, Meadow Merger Sub, Inc. We have eliminated all intercompany accounts and transactions in consolidation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has evaluated subsequent events through the date the consolidated financial statements were issued.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Current Events&lt;/span&gt;&lt;/p&gt;&lt;p id="fn1_stratalt" style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Alternatives&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2024, we announced that our Board of Directors (Board) had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force (the Strategic Alternatives RIF) beginning August 1, 2024, which continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets will continue to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Consistent with our intention to preserve cash, David M. Urso, our former President and Chief Executive Officer and Richard Ghalie, M.D., our former Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the former Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as our Chairperson of the Board.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy (as described below) and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Private Investment in Private Equity (PIPE) and Related Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As more fully discussed in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in July 2025, we closed on a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million PIPE and issued an aggregate of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,216,898&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares (the Shares) of our Common Stock (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), at an offering price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the Common Stock, the Securities)), to purchase up to an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;6,022,869&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (the Pre-Funded Warrant Shares) at an offering price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4199&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Pre-Funded Warrant. On July 24, 2025, Pre-Funded Warrants for the purchase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,084,509&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock were exercised for a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;de minimis&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amount of cash proceeds. As of September 23, 2025, we &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt;issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;2,807,967&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock upon &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt;cashless exercises of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,808,070&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Also, in July 2025 and as more fully discussed in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Treasury Strategy (as described below), including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the-market sales agreement. As partial consideration for services provided associated with the PIPE, we issued warrants for the purchase of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,070,177&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock with a weighted-average exercise price of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;546,348&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Litecoin Treasury Strategy&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cooperation Agreement and Cash Dividend&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), a related party, which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share of Common Stock that was declared on November 6, 2023 to stockholders of record at the close of business on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 17, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (Cooperation Agreement). The total dividend of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, we have obtained cash and funded our operations primarily through equity financings and license agreements. We have accumulated losses of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million since inception and expect to incur operating losses and generate negative cash flows from operations for the foreseeable future. As of June 30, 2025, we had &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash and cash equivalents. In connection with our July 2024 announcement regarding the evaluation of our strategic alternatives, we discontinued the clinical development of voruciclib, while certain nonclinical research and development (R&amp;amp;D) activities continue. As a result, we will continue to incur R&amp;amp;D expenses in connection with our nonclinical projects. We believe that our cash balance will be sufficient to meet our obligations and fund operations for at least the next 12 months from the issuance of these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, we have obtained cash and funded our operations primarily through equity financings and license agreements and to continue the development of our drug candidates, we would require one or more capital transactions, whether through the sale of equity securities, debt financing, license agreements or entry into strategic partnerships at some point in the future. There can be no assurance that we will be able to continue to raise additional capital in the future.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_c437a560-b26b-48b2-aba6-7681a3d15518">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 10, 2025, MEI Pharma, Inc. changed its name to Lite Strategy, Inc. and its ticker symbol to LITS. We are a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;pharmaceutical company that has been developing novel and differentiated cancer therapies. In August 2025, we implemented a Litecoin Treasury Strategy (as described below) with the net proceeds from the PIPE (as defined below). We built our pipeline by acquiring promising cancer agents and creating value in programs through development, strategic partnerships and out-licensing or commercialization, as appropriate. Our approach to oncology drug development has been to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit. Our pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, zandelisib, &lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;an oral, once-daily, selective PI3K&#x3b4; inhibitor &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and prior to its sale, ME-344 as more fully discussed in &lt;/span&gt;&lt;a href="#fn_dis_nonfin_asset"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 13. Disposition of a Non-Financial Asset&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_cd01128f-0ddd-4d39-bcdf-604a2c4f81cc">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We prepared the consolidated financial statements in accordance with accounting principles generally accepted in the United States (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) related to annual reports on Form 10&#x2011;K. The accompanying consolidated financial statements include the accounts of Lite Strategy, Inc. and our wholly owned subsidiary, Meadow Merger Sub, Inc. We have eliminated all intercompany accounts and transactions in consolidation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has evaluated subsequent events through the date the consolidated financial statements were issued.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <lits:CurrentEventsAndReductionInForcePolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_13b31399-25c1-41f1-9b6f-c042e21f8ae6">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Current Events&lt;/span&gt;&lt;/p&gt;&lt;p id="fn1_stratalt" style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Alternatives&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2024, we announced that our Board of Directors (Board) had determined unanimously to begin the evaluation of our strategic alternatives, including potential transactions as well as an orderly wind down of operations, if appropriate, to maximize the value of our assets for our stockholders. We commenced a reduction-in-force (the Strategic Alternatives RIF) beginning August 1, 2024, which continued in stages as our operational and strategic direction evolved. In connection with this evaluation, we discontinued the clinical development of voruciclib, while certain nonclinical activities related to our drug candidate assets will continue to be conducted by us. As part of the review of strategic alternatives, we considered options such as out-licensing or the sale of our existing programs and merger and acquisition opportunities, as well as other potential opportunities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Consistent with our intention to preserve cash, David M. Urso, our former President and Chief Executive Officer and Richard Ghalie, M.D., our former Chief Medical Officer, stepped down effective August 1, 2024. Mr. Urso also left the Board at that date. We entered into a consulting agreement with Dr. Ghalie under which he remains available to assist us in strategic efforts or ongoing operations. In addition, we entered into a consulting agreement with Mr. Urso, which was terminated in February 2025. Charles V. Baltic III, the former Chairperson of the Board, also stepped down from the Board contemporaneously with the announcement on July 22, 2024. Our Board appointed Justin J. File, our Chief Financial Officer, to assume the position of Acting Chief Executive Officer and appointed Frederick W. Driscoll as our Chairperson of the Board.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The evaluation of strategic alternatives concluded with the August 2025 implementation of our Litecoin Treasury Strategy (as described below) and a commitment to long-term innovation in capital structure and financial technology, along with the initiation of an expanding strategy that could include the commencement of Litecoin mining activities, as well as our continued assessment of pre-clinical activities with our drug candidate pipeline, as to which we anticipate conducting further investigational research and development in the next several months.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Private Investment in Private Equity (PIPE) and Related Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As more fully discussed in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in July 2025, we closed on a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million PIPE and issued an aggregate of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,216,898&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares (the Shares) of our Common Stock (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), at an offering price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and (ii) pre-funded warrants (the Pre-Funded Warrants (together with the Common Stock, the Securities)), to purchase up to an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;6,022,869&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (the Pre-Funded Warrant Shares) at an offering price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4199&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Pre-Funded Warrant. On July 24, 2025, Pre-Funded Warrants for the purchase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,084,509&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock were exercised for a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;de minimis&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amount of cash proceeds. As of September 23, 2025, we &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt;issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;2,807,967&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock upon &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt;cashless exercises of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,808,070&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Also, in July 2025 and as more fully discussed in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we entered into various agreements with certain advisors to the PIPE, asset managers and custodians who will deploy our Litecoin Treasury Strategy (as described below), including but not limited to: (i) a placement agency agreement, (ii) an asset management agreement, (iii) an advisory agreement, (iv) a strategic advisor agreement and (v) a new at-the-market sales agreement. As partial consideration for services provided associated with the PIPE, we issued warrants for the purchase of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,070,177&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock with a weighted-average exercise price of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;546,348&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Litecoin Treasury Strategy&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE. Litecoin is an open source, global payment network that is fully decentralized without any central authorities. Mathematics secures the network and empowers individuals to control their own finances. Litecoin features faster transaction confirmation times and improved storage efficiency than the leading math-based currency. We believe this strategy will allow us to diversify reserves, enhance capital efficiency and align with emerging financial technologies.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cooperation Agreement and Cash Dividend&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 31, 2023, we announced our entry into a cooperation agreement with Anson Funds Management LP and Cable Car Capital LLC (Cooperation Agreement), a related party, which, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share of Common Stock that was declared on November 6, 2023 to stockholders of record at the close of business on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 17, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (Cooperation Agreement). The total dividend of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was paid on December 6, 2023, and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</lits:CurrentEventsAndReductionInForcePolicyTextBlock>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_5eb52ed6-f76b-48ea-a2e5-62167666a0fd"
      decimals="-5"
      id="F_ad2e0020-1242-4b61-b990-66f016f01dd5"
      unitRef="U_USD">100000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_870e143e-2c95-4ffb-9924-d47b9fd9da81"
      decimals="INF"
      id="F_4dfb2c7a-3c10-4301-977c-7f9f5d94b3da"
      unitRef="U_shares">23216898</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c"
      decimals="2"
      id="F_a27031ff-1478-4e9d-9248-2ecf14e828f6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.42</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"
      decimals="INF"
      id="F_8817aca8-e1af-4377-935b-b38d414a922c"
      unitRef="U_shares">6022869</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_4aadd502-4418-4743-994c-0a56dc532d10"
      decimals="4"
      id="F_713d62f0-3c54-4c29-9ce7-2cc90d059129"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.4199</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_07f286c0-e5a6-4c38-9799-941180c82a4c"
      decimals="INF"
      id="F_6e3a8eb5-4936-4e05-bd8d-50475988c17d"
      unitRef="U_shares">2084509</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738"
      decimals="INF"
      id="F_c4f064f2-a8ba-41e4-ae3a-b9ed9b5bbd94"
      unitRef="U_shares">2807967</us-gaap:CommonStockSharesIssued>
    <lits:SurrenderedWarrantsToAcheiveCommonStock
      contextRef="C_d190719d-ba9d-4549-9346-f6c2c6a02045"
      decimals="INF"
      id="F_30beb6cb-315a-4c0b-ae66-81ded3b26626"
      unitRef="U_shares">2808070</lits:SurrenderedWarrantsToAcheiveCommonStock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_9e2c011a-0538-44df-bed0-dea64b704da8"
      decimals="INF"
      id="F_aeaf7b07-4a0a-4aee-9085-3be15b3e06af"
      unitRef="U_shares">3070177</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_b9008131-b16c-4d88-88b8-b98335565844"
      decimals="2"
      id="F_d2c9ee75-47dd-4e72-b86a-b77c9c7fdc06"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_08b96565-9169-4635-945d-9321b9c399be"
      decimals="INF"
      id="F_c738df08-1264-4d42-be1f-926c42841a20"
      unitRef="U_shares">546348</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_08b96565-9169-4635-945d-9321b9c399be"
      decimals="4"
      id="F_2c847937-4ded-49ef-9d8e-f3efe5f49a91"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="C_f12fbef6-72e6-4260-86e6-fc02f15df7a4"
      decimals="2"
      id="F_8b525380-138b-47ca-9f77-5d76ac0c0088"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.75</us-gaap:CommonStockDividendsPerShareDeclared>
    <lits:ClosingAgreement
      contextRef="C_f0b7c1b2-6b39-4391-a802-da6e61227686"
      id="F_a4f2d7db-388f-487f-8560-65bb822d49ee">2023-11-17</lits:ClosingAgreement>
    <us-gaap:PaymentsOfDividends
      contextRef="C_32d99983-1b3d-4c08-8e53-fb1cf89c3852"
      decimals="-5"
      id="F_4dff9fa4-d0d4-41e0-92d4-86770a1d633e"
      unitRef="U_USD">11700000</us-gaap:PaymentsOfDividends>
    <lits:LiquidityPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_4543b1ac-ac12-4501-89d2-546339066878">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, we have obtained cash and funded our operations primarily through equity financings and license agreements. We have accumulated losses of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million since inception and expect to incur operating losses and generate negative cash flows from operations for the foreseeable future. As of June 30, 2025, we had &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash and cash equivalents. In connection with our July 2024 announcement regarding the evaluation of our strategic alternatives, we discontinued the clinical development of voruciclib, while certain nonclinical research and development (R&amp;amp;D) activities continue. As a result, we will continue to incur R&amp;amp;D expenses in connection with our nonclinical projects. We believe that our cash balance will be sufficient to meet our obligations and fund operations for at least the next 12 months from the issuance of these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, we have obtained cash and funded our operations primarily through equity financings and license agreements and to continue the development of our drug candidates, we would require one or more capital transactions, whether through the sale of equity securities, debt financing, license agreements or entry into strategic partnerships at some point in the future. There can be no assurance that we will be able to continue to raise additional capital in the future.&lt;/span&gt;&lt;/p&gt;</lits:LiquidityPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-5"
      id="F_24683460-5aa7-4a57-8f18-18eb6f2d3a62"
      unitRef="U_USD">-404200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-5"
      id="F_d04b2466-9c02-48c2-b80a-b848aa6795f0"
      unitRef="U_USD">18000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_5ef2cfe4-b575-4580-ab15-28dbf24a0ef2">&lt;p id="fn2_sumsigpolicies" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosures made in the accompanying notes to the consolidated financial statements. We use estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents consist of cash and highly liquid investments with original maturities of three months or less when purchased. Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We attempt to minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. Our investment portfolio is maintained in accordance with our investment policy, which is designed to preserve capital, safeguard funds and limit exposure to risk. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Short-term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Short-term investments are marketable securities with maturities greater than three months but less than one year from date of purchase. As of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t hold any short-term investments. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024, we held short-term investments of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in United States government securities. Our short-term investments were considered to be held to maturity and were carried at amortized cost. For the fiscal year ended June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; gross unrealized gains and losses. For the fiscal year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the gross unrealized gains and losses were immaterial.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value is as follows:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1 &#x2014; Observable inputs such as quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2 &#x2014; Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; property and equipment. Property and equipment were previously stated at cost and depreciated over the estimated useful lives of the assets (generally &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_75abda38-a80b-45e0-b57c-64913feff94d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) using the straight-line method and leasehold improvements were stated at cost and were amortized over the shorter of the estimated useful lives of the assets or the lease term.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We account for our leases under ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (Topic 842). Leases which are identified within the scope of Topic 842 and which have a term greater than one year are recognized on our consolidated balance sheets as right-of-use (ROU) assets and lease liabilities. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected remaining lease term. The lease term includes any renewal options and termination options that we are reasonably certain to exercise. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, we use our incremental borrowing rate. The incremental borrowing rate is determined based on the rate of interest that we would pay to borrow on a collateralized basis an amount equal to the lease payments for a similar term and in a similar economic environment. The interest rate implicit in lease contracts to calculate the present value is typically not readily determinable. As such, significant management judgment is required to estimate the incremental borrowing rate.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease expense for operating leases is recognized on a straight-line basis over the lease term based on the total lease payments. We have elected the practical expedient to not separate lease and non-lease components for our real estate leases. Our non-lease components are primarily related to property maintenance, which varies based on future outcomes and thus is recognized in operating lease expense when incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On June 18, 2024, we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of September 30, 2024, the lease for our existing office space. See &lt;/span&gt;&lt;a href="#fn3_bs_details"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 3. Balance Sheet Details&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for the impact of the Agreement on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Customers&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606), we recognized revenue when control of the promised goods or services was transferred to our customers, in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. For enforceable contracts with our customers, we first identified the distinct performance obligations &#x2013; or accounting units &#x2013; within the contract. Performance obligations are commitments in a contract to transfer a distinct good or service to the customer.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Payments received under commercial arrangements, such as licensing technology rights, may include non-refundable fees at the inception of the arrangements, milestone payments for specific achievements designated in the agreements and royalties on the sale of products. At the inception of arrangements that include milestone payments, we used judgment to evaluate whether the milestones were probable of being achieved and we estimated the amount, if any, to include in the transaction price using the most likely method. If it were probable that a significant revenue reversal would not occur, the estimated amount was included in the transaction price. Milestone payments that were not within our or the licensee&#x2019;s control, such as regulatory approvals, were not included in the transaction price until those approvals were received. At the end of each reporting period, we re-evaluated the probability of achievement of development milestones and any related constraint and, as necessary, we adjusted our estimate of the overall transaction price.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To the extent a contract included multiple promised deliverables, we applied judgment to determine whether promised deliverables were capable of being distinct and were distinct within the context of the contract. If these criteria were not met, the promised deliverables were accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, we allocated variable consideration related to our 50-50 cost share for development services directly to the associated performance obligation and then allocated the remaining consideration among the performance obligations based on their relative stand-alone selling price.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When not directly observable, we typically estimated the stand-alone selling price for each distinct performance obligation. Variable consideration that related specifically to our efforts to satisfy specific performance obligations was allocated entirely to those performance obligations. Other components of the transaction price were allocated based on the relative stand-alone selling price, over which management has applied significant judgment. We developed assumptions that required judgment to determine the stand-alone selling price for license-related performance obligations, which may have included forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical, regulatory and commercial success. We estimated stand-alone selling price for R&amp;amp;D performance obligations by forecasting the expected costs of satisfying a performance obligation plus an appropriate margin.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the case of a license that is a distinct performance obligation, we recognized revenue allocated to the license from non-refundable, up-front fees at the point in time when the license was transferred to the licensee and the licensee can use and benefit from the license. For licenses that are bundled with other distinct or combined obligations, we used judgment to assess the nature of the performance obligation to determine whether the performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. If the performance obligation is satisfied over time, we evaluated the measure of progress in each reporting period and, if necessary, adjusted the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. Revenue is recorded proportionally as costs are incurred. We generally used the cost-to-cost measure of progress because it best depicted the transfer of control to the customer which occurred as we incurred costs. Under the cost-to-cost measure of progress, the extent of progress towards completion was measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation (an input method under Topic 606). We used judgment to estimate the total cost expected to complete the R&amp;amp;D performance obligations, which included subcontractors&#x2019; costs, labor, materials, other direct costs and an allocation of indirect costs. We evaluated these cost estimates and the progress during each reporting period and, as necessary, we adjusted the measure of progress and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; In connection with our now terminated April 2020 License, Development and Commercialization Agreement with Kyowa Kirin Co., Ltd. (KKC) (the KKC Commercialization Agreement) described in Note 7. License Agreements, we performed development services related to our 50-50 cost sharing arrangement for which revenue was recognized over time. Additionally, we performed services for KKC at their request, the costs of which were fully reimbursed to us. We recorded the reimbursement for such pass through services as revenue at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of reimbursed costs, as control of the additional services for KKC was transferred at the time we&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;incurred &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;such costs. The costs of these services were recognized in the consolidated statements of operations as research and development expense. The costs of these services were recognized in the consolidated statements of operations as research and development expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended June 30, 2025, we did not recognize any revenue associated with the KKC Commercialization Agreement. During the year ended June 30, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:77.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:19.279999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Timing of Revenue Recognition:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Services performed over time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pass through services at a point in time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Contract Balances&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Contract liabilities were included in deferred revenue and deferred revenue, long-term in our consolidated balance sheets. Our contract liabilities accounted for under Topic 606 related to the amount of initial upfront consideration allocated to the development services performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:75.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:20.619999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Beginning balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Recognized as revenue:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized from change in estimate for performance&lt;br/&gt;&#160;&#160;&#160;&#160;obligations that are being closed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized for performance obligations that will no longer &lt;br/&gt;&#160;&#160;&#160;&#160;commence&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Ending balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The timing of revenue recognition, invoicing and cash collections results in billed accounts receivable and unbilled receivables (contract assets) and deferred revenue (contract liabilities). We invoiced our customers in accordance with agreed-upon contractual terms, typically at periodic intervals or upon achievement of contractual milestones. Invoicing may have occurred subsequent to revenue recognition, resulting in unbilled receivables. Advanced payments from our customers before revenue was recognized resulted in contract liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Collaborators&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At contract inception, we assessed whether the collaboration arrangements were within the scope of ASC Topic 808 Collaborative Agreements (Topic 808), to determine whether such arrangements involved joint operating activities performed by parties that were both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment was performed based on the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of Topic 808 that contain multiple units of account, we first determined which units of account within the arrangement were within the scope of Topic 808 and which elements were within the scope of Topic 606. For units of account within collaboration arrangements that were accounted for pursuant to Topic 808, an appropriate recognition method was determined and applied consistently, by analogy to authoritative accounting literature. For elements of collaboration arrangements that were accounted for pursuant to Topic 606, we recognized revenue as discussed above. Consideration received that did not meet the requirements to satisfy Topic 606 revenue recognition criteria was recorded as deferred revenue and classified as either current or long-term deferred revenue based on our best estimate of when such amounts would be recognized.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and development costs are expensed as incurred and include costs paid to third-party contractors to perform research, conduct clinical trials and develop and manufacture drug materials, as well as personnel, related benefits (including share-based compensation) and other expenses attributable to our R&amp;amp;D activities. Clinical trial costs, including costs associated with third-party contractors, are a significant component of R&amp;amp;D expenses. We expense R&amp;amp;D costs based on work performed. In determining the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amount &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to expense, management relies on estimates of total costs based on contract components completed, the enrollment of subjects, the completion of trials and other events. Costs incurred related to the purchase or licensing of in-process R&amp;amp;D for early-stage products or products that are not commercially viable and ready for use, or have no alternative future use, are charged to expense in the period incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Share-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Share-based compensation expense for stock options and restricted stock units (RSUs) granted to employees and directors is recognized in the consolidated statements of operations based on estimated amounts. The cost of stock options is measured at the grant date, based on the estimated fair value of the stock option using the Black-Scholes valuation model, which incorporates various assumptions including expected volatility, risk-free interest rate, the expected term of the award and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our stock over the expected option life and other appropriate factors. We use the simplified method to calculate the expected term of share options and similar instruments as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as we do not intend to do so in the foreseeable future. For RSUs, we estimate the grant date fair value using our closing stock price on the date of grant. The estimated fair value of stock options and RSUs is amortized over the requisite service period, adjusted for actual forfeitures at the time they occur. The requisite service period is generally the time over which our share-based awards vest.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Interest and Dividend Income&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Interest on cash and investment balances is recognized when earned. Dividend income is recognized when the right to receive the payment is established.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our income tax expense consists of current and deferred income tax expense or benefit. Current income tax expense or benefit is the amount of income taxes expected to be payable or refundable for the current year. A deferred income tax asset or liability is recognized for the future tax consequences attributable to tax credits and loss carryforwards and to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2025 and 2024, we have established a valuation allowance to fully reserve our net deferred tax assets. Tax rate changes are reflected in income during the period such changes are enacted. Changes in our ownership may limit the amount of net operating loss carryforwards that can be utilized in the future to offset taxable income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Financial Accounting Standards Board (FASB) Topic ASC 740 - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;prescribes a recogn&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ition threshold and measurement attribute criteria for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; unrecognized tax benefits as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Disposition of Non-Financial Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for infrequent dispositions of assets in its product pipeline in accordance with ASC 610-20, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets, which requires dispositions of long-lived assets that are not a discontinued operation be accounted for on a net basis and included in income from continuing operations before income taxes in accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Proceeds from sales designated as dispositions of non-financial assets are classified as cash flows from investing activities in the consolidated statements of cash flows.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net (loss) income per share is computed using the weighted-average number of shares of Common Stock (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) outstanding during the period, less any shares subject to repurchase or forfeiture. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) subject to repurchase or forfeiture for the fiscal years ended June 30, 2025 and 2024. Diluted net (loss) income per share is computed based on the sum of the weighted-average number of common shares (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) and potentially dilutive common shares outstanding during the period determined using the treasury-stock and if-converted methods.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For purposes of the diluted net loss per share calculation for the fiscal year ended June 30, 2025, potentially dilutive securities are excluded from the calculation of diluted net loss per share because their effect was anti-dilutive due to our net loss. For purposes of the diluted net income per share calculation for the fiscal year ended June 30, 2024, potentially dilutive securities are excluded from the calculation of diluted net income per share because their weighted-average exercise prices were above our weighted-average share price. Therefore, basic and diluted net (loss) income per share were the same for the fiscal years ended June 30, 2025 and 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:65.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total anti-dilutive shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures, which modifies the disclosure and presentation requirements of reportable segments (ASU 2023-07). The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (the CODM) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Lastly, the amendment requires that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The adoption of ASU 2023-07 resulted in enhanced disclosures as included in &lt;/span&gt;&lt;a href="#fn_segments"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 12 Segment Information&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, but did not impact to our results of operations, cash flows and financial condition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that are adopted as of the specified effective date. We believe the impact of recently issued standards, other than those noted below and any issued but not yet effective standards will not have a material impact on our consolidated financial statements upon adoption.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (PBE) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local,and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all periods presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows and financial condition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In January 2025, the FASB issued ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment in this update clarifies the effective date of ASU 2024-03, which is that public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026 and in interim periods within annual reporting periods beginning after December 15, 2027. The impact of adoption of this ASU on our disclosures is currently being evaluated.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In July 2025, the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;) was enacted. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act of 2017, including 100% bonus depreciation, domestic research cost expensing and the business interest expense limitation, among other tax changes. Many of the tax provisions of the OBBBA are designed to accelerate tax deductions, which could lead to lower cash tax payments. The new legislation has multiple effective dates, with certain provisions effective in 2025 and others in the future. While we continue to assess the impact of the tax provisions of the OBBBA on our consolidated financial statements, we currently believe that the tax provisions of the legislation are not expected to have a material impact on our statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_405f6580-86a2-4bf1-b8a0-8f7c09fcf836">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosures made in the accompanying notes to the consolidated financial statements. We use estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_ddcf8c93-0ac8-4c96-a8fc-8d801bf149aa">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents consist of cash and highly liquid investments with original maturities of three months or less when purchased. Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We attempt to minimize credit risk associated with our cash and cash equivalents by periodically evaluating the credit quality of our primary financial institutions. Our investment portfolio is maintained in accordance with our investment policy, which is designed to preserve capital, safeguard funds and limit exposure to risk. While we maintain cash deposits in FDIC insured financial institutions in excess of federally insured limits, we do not believe we are exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. We have not experienced any losses on such accounts.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_99e56a92-345c-416b-b35c-7581ee58acec">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Short-term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Short-term investments are marketable securities with maturities greater than three months but less than one year from date of purchase. As of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t hold any short-term investments. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024, we held short-term investments of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in United States government securities. Our short-term investments were considered to be held to maturity and were carried at amortized cost. For the fiscal year ended June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; gross unrealized gains and losses. For the fiscal year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the gross unrealized gains and losses were immaterial.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-6"
      id="F_244eedd9-5ee0-45ba-9c97-2d23f376843e"
      unitRef="U_USD">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-5"
      id="F_952e7843-b720-4b21-85d6-e37848f57b22"
      unitRef="U_USD">34600000</us-gaap:ShortTermInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-6"
      id="F_d96f87ad-8113-4605-a63d-eecdf99206dc"
      unitRef="U_USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e4604121-27f5-408c-9a85-647c5699ffda">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value is as follows:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1 &#x2014; Observable inputs such as quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2 &#x2014; Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_d6bb6a9b-9550-48b3-be1f-da5c7e2f7c88">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; property and equipment. Property and equipment were previously stated at cost and depreciated over the estimated useful lives of the assets (generally &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_75abda38-a80b-45e0-b57c-64913feff94d;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) using the straight-line method and leasehold improvements were stated at cost and were amortized over the shorter of the estimated useful lives of the assets or the lease term.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_34e3844b-58a0-4bc6-8d71-ca014dfe8a51"
      unitRef="U_USD">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_3e7dfd70-bc4a-4b0f-89af-eaa0c4be659f"
      id="F_178f31f1-8b9b-4137-a0e5-51e5aa004f7a">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_688d7246-8365-4592-b624-ce53d0c940c9">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We account for our leases under ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (Topic 842). Leases which are identified within the scope of Topic 842 and which have a term greater than one year are recognized on our consolidated balance sheets as right-of-use (ROU) assets and lease liabilities. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected remaining lease term. The lease term includes any renewal options and termination options that we are reasonably certain to exercise. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, we use our incremental borrowing rate. The incremental borrowing rate is determined based on the rate of interest that we would pay to borrow on a collateralized basis an amount equal to the lease payments for a similar term and in a similar economic environment. The interest rate implicit in lease contracts to calculate the present value is typically not readily determinable. As such, significant management judgment is required to estimate the incremental borrowing rate.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease expense for operating leases is recognized on a straight-line basis over the lease term based on the total lease payments. We have elected the practical expedient to not separate lease and non-lease components for our real estate leases. Our non-lease components are primarily related to property maintenance, which varies based on future outcomes and thus is recognized in operating lease expense when incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On June 18, 2024, we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of September 30, 2024, the lease for our existing office space. See &lt;/span&gt;&lt;a href="#fn3_bs_details"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 3. Balance Sheet Details&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for the impact of the Agreement on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_9482d861-b342-4fa1-902d-7e0b38deb47b">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Customers&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In accordance with ASC Topic 606, Revenue from Contracts with Customers (Topic 606), we recognized revenue when control of the promised goods or services was transferred to our customers, in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. For enforceable contracts with our customers, we first identified the distinct performance obligations &#x2013; or accounting units &#x2013; within the contract. Performance obligations are commitments in a contract to transfer a distinct good or service to the customer.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Payments received under commercial arrangements, such as licensing technology rights, may include non-refundable fees at the inception of the arrangements, milestone payments for specific achievements designated in the agreements and royalties on the sale of products. At the inception of arrangements that include milestone payments, we used judgment to evaluate whether the milestones were probable of being achieved and we estimated the amount, if any, to include in the transaction price using the most likely method. If it were probable that a significant revenue reversal would not occur, the estimated amount was included in the transaction price. Milestone payments that were not within our or the licensee&#x2019;s control, such as regulatory approvals, were not included in the transaction price until those approvals were received. At the end of each reporting period, we re-evaluated the probability of achievement of development milestones and any related constraint and, as necessary, we adjusted our estimate of the overall transaction price.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To the extent a contract included multiple promised deliverables, we applied judgment to determine whether promised deliverables were capable of being distinct and were distinct within the context of the contract. If these criteria were not met, the promised deliverables were accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, we allocated variable consideration related to our 50-50 cost share for development services directly to the associated performance obligation and then allocated the remaining consideration among the performance obligations based on their relative stand-alone selling price.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When not directly observable, we typically estimated the stand-alone selling price for each distinct performance obligation. Variable consideration that related specifically to our efforts to satisfy specific performance obligations was allocated entirely to those performance obligations. Other components of the transaction price were allocated based on the relative stand-alone selling price, over which management has applied significant judgment. We developed assumptions that required judgment to determine the stand-alone selling price for license-related performance obligations, which may have included forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical, regulatory and commercial success. We estimated stand-alone selling price for R&amp;amp;D performance obligations by forecasting the expected costs of satisfying a performance obligation plus an appropriate margin.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the case of a license that is a distinct performance obligation, we recognized revenue allocated to the license from non-refundable, up-front fees at the point in time when the license was transferred to the licensee and the licensee can use and benefit from the license. For licenses that are bundled with other distinct or combined obligations, we used judgment to assess the nature of the performance obligation to determine whether the performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. If the performance obligation is satisfied over time, we evaluated the measure of progress in each reporting period and, if necessary, adjusted the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. Revenue is recorded proportionally as costs are incurred. We generally used the cost-to-cost measure of progress because it best depicted the transfer of control to the customer which occurred as we incurred costs. Under the cost-to-cost measure of progress, the extent of progress towards completion was measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation (an input method under Topic 606). We used judgment to estimate the total cost expected to complete the R&amp;amp;D performance obligations, which included subcontractors&#x2019; costs, labor, materials, other direct costs and an allocation of indirect costs. We evaluated these cost estimates and the progress during each reporting period and, as necessary, we adjusted the measure of progress and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; In connection with our now terminated April 2020 License, Development and Commercialization Agreement with Kyowa Kirin Co., Ltd. (KKC) (the KKC Commercialization Agreement) described in Note 7. License Agreements, we performed development services related to our 50-50 cost sharing arrangement for which revenue was recognized over time. Additionally, we performed services for KKC at their request, the costs of which were fully reimbursed to us. We recorded the reimbursement for such pass through services as revenue at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of reimbursed costs, as control of the additional services for KKC was transferred at the time we&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;incurred &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;such costs. The costs of these services were recognized in the consolidated statements of operations as research and development expense. The costs of these services were recognized in the consolidated statements of operations as research and development expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended June 30, 2025, we did not recognize any revenue associated with the KKC Commercialization Agreement. During the year ended June 30, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:77.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:19.279999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Timing of Revenue Recognition:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Services performed over time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pass through services at a point in time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Contract Balances&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Contract liabilities were included in deferred revenue and deferred revenue, long-term in our consolidated balance sheets. Our contract liabilities accounted for under Topic 606 related to the amount of initial upfront consideration allocated to the development services performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:75.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:20.619999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Beginning balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Recognized as revenue:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized from change in estimate for performance&lt;br/&gt;&#160;&#160;&#160;&#160;obligations that are being closed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized for performance obligations that will no longer &lt;br/&gt;&#160;&#160;&#160;&#160;commence&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Ending balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The timing of revenue recognition, invoicing and cash collections results in billed accounts receivable and unbilled receivables (contract assets) and deferred revenue (contract liabilities). We invoiced our customers in accordance with agreed-upon contractual terms, typically at periodic intervals or upon achievement of contractual milestones. Invoicing may have occurred subsequent to revenue recognition, resulting in unbilled receivables. Advanced payments from our customers before revenue was recognized resulted in contract liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Collaborators&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At contract inception, we assessed whether the collaboration arrangements were within the scope of ASC Topic 808 Collaborative Agreements (Topic 808), to determine whether such arrangements involved joint operating activities performed by parties that were both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment was performed based on the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of Topic 808 that contain multiple units of account, we first determined which units of account within the arrangement were within the scope of Topic 808 and which elements were within the scope of Topic 606. For units of account within collaboration arrangements that were accounted for pursuant to Topic 808, an appropriate recognition method was determined and applied consistently, by analogy to authoritative accounting literature. For elements of collaboration arrangements that were accounted for pursuant to Topic 606, we recognized revenue as discussed above. Consideration received that did not meet the requirements to satisfy Topic 606 revenue recognition criteria was recorded as deferred revenue and classified as either current or long-term deferred revenue based on our best estimate of when such amounts would be recognized.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <lits:PercentageOfReimbursementOfPassThroughCostsAsRevenue
      contextRef="C_7ee6ad01-be31-465e-9644-4d6400b09ee1"
      decimals="2"
      id="F_35325e0b-f996-4ee9-b8c3-0dfa504c1ebe"
      unitRef="U_pure">1</lits:PercentageOfReimbursementOfPassThroughCostsAsRevenue>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_4b3c86ec-38d6-4ec4-83c4-aa8b11ea3bf0">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;we recognized revenue associated with the KKC Commercialization Agreement as follows (in thousands):&lt;/span&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:77.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:19.279999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Timing of Revenue Recognition:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Services performed over time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pass through services at a point in time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="C_71ae9d25-7183-44c7-86d1-e4821a8dc42d"
      decimals="-3"
      id="F_4e463592-b60e-4b95-a4cc-01ec1c0334d2"
      unitRef="U_USD">743000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_2847194b-f51e-4d7d-8f4b-3169aeb8ad38"
      decimals="-3"
      id="F_91c39a0a-15ce-47fc-a9e7-970afdcfdd25"
      unitRef="U_USD">9000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_2537ecc2-706a-441e-abb0-6c81823b2c71"
      decimals="-3"
      id="F_51c6f038-d759-4a67-9759-9b7f14256530"
      unitRef="U_USD">752000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_afe2ccca-be14-4f08-9f81-5dde435054e2">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accounts receivable, unbilled receivables or contract liabilities. A reconciliation of the beginning and ending amount of contract liabilities as of June 30, 2024, which primarily related to the combined performance obligations for the transfer of development services under the KKC Commercialization Agreement and was a separate performance obligation in our contract pursuant to research plans under the agreements were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:75.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:20.619999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Beginning balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Recognized as revenue:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized from change in estimate for performance&lt;br/&gt;&#160;&#160;&#160;&#160;obligations that are being closed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue recognized for performance obligations that will no longer &lt;br/&gt;&#160;&#160;&#160;&#160;commence&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Ending balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_6c64a70a-c2b3-4502-94d2-1de6fa7c130e"
      unitRef="U_USD">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_312f9a01-4e60-4048-85e2-6a746a0b3177"
      unitRef="U_USD">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_57a12f24-8485-49fc-8a47-a37e1dd17d35"
      decimals="-3"
      id="F_2b4c0d4d-a95b-482e-bcfc-4f387cb70588"
      unitRef="U_USD">317000</us-gaap:ContractWithCustomerLiability>
    <lits:ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_30a86dcb-f5dc-464c-a6c3-a8bfe0d35eb7"
      unitRef="U_USD">-317000</lits:ContractWithCustomerLiabilityRevenueRecognizedUponSatisfactionOfPerformanceObligations>
    <us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_a8dfcde7-d2c2-4447-a35d-fd36a4384888"
      unitRef="U_USD">0</us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_f1295be2-1594-4b0c-992b-6359d1bbfa65"
      unitRef="U_USD">0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_81592088-8d38-43fb-b695-97fe7197e30d"
      unitRef="U_USD">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_c42d5d09-252a-45fe-a915-f169db9a72d5">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and development costs are expensed as incurred and include costs paid to third-party contractors to perform research, conduct clinical trials and develop and manufacture drug materials, as well as personnel, related benefits (including share-based compensation) and other expenses attributable to our R&amp;amp;D activities. Clinical trial costs, including costs associated with third-party contractors, are a significant component of R&amp;amp;D expenses. We expense R&amp;amp;D costs based on work performed. In determining the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amount &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to expense, management relies on estimates of total costs based on contract components completed, the enrollment of subjects, the completion of trials and other events. Costs incurred related to the purchase or licensing of in-process R&amp;amp;D for early-stage products or products that are not commercially viable and ready for use, or have no alternative future use, are charged to expense in the period incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f3929912-e8ed-4890-b6a9-ece2c7afca27">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Share-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Share-based compensation expense for stock options and restricted stock units (RSUs) granted to employees and directors is recognized in the consolidated statements of operations based on estimated amounts. The cost of stock options is measured at the grant date, based on the estimated fair value of the stock option using the Black-Scholes valuation model, which incorporates various assumptions including expected volatility, risk-free interest rate, the expected term of the award and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our stock over the expected option life and other appropriate factors. We use the simplified method to calculate the expected term of share options and similar instruments as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as we do not intend to do so in the foreseeable future. For RSUs, we estimate the grant date fair value using our closing stock price on the date of grant. The estimated fair value of stock options and RSUs is amortized over the requisite service period, adjusted for actual forfeitures at the time they occur. The requisite service period is generally the time over which our share-based awards vest.&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <lits:InterestIncomePolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_b43288e1-5530-458b-805f-782d712769fc">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Interest and Dividend Income&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Interest on cash and investment balances is recognized when earned. Dividend income is recognized when the right to receive the payment is established.&lt;/span&gt;&lt;/p&gt;</lits:InterestIncomePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_feea44a1-4948-401a-934e-eb2597d70aad">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our income tax expense consists of current and deferred income tax expense or benefit. Current income tax expense or benefit is the amount of income taxes expected to be payable or refundable for the current year. A deferred income tax asset or liability is recognized for the future tax consequences attributable to tax credits and loss carryforwards and to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of June 30, 2025 and 2024, we have established a valuation allowance to fully reserve our net deferred tax assets. Tax rate changes are reflected in income during the period such changes are enacted. Changes in our ownership may limit the amount of net operating loss carryforwards that can be utilized in the future to offset taxable income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Financial Accounting Standards Board (FASB) Topic ASC 740 - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;prescribes a recogn&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ition threshold and measurement attribute criteria for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; unrecognized tax benefits as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_19f2cb3a-d84c-4aac-ac7d-b438632f0feb">An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleOtherInformation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_bfa8c2fa-5b8d-420d-9c97-d8fa22c469bb"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_00d570e0-e53c-4283-a0a2-b83ee70e6d57"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <lits:DispositionOfNon-FinancialAssetsPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_b6d3a4a0-87d4-4eaa-9027-4cd5e4f1c5ac">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Disposition of Non-Financial Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for infrequent dispositions of assets in its product pipeline in accordance with ASC 610-20, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets, which requires dispositions of long-lived assets that are not a discontinued operation be accounted for on a net basis and included in income from continuing operations before income taxes in accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Proceeds from sales designated as dispositions of non-financial assets are classified as cash flows from investing activities in the consolidated statements of cash flows.&lt;/span&gt;&lt;/p&gt;</lits:DispositionOfNon-FinancialAssetsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_89c00c7c-959b-46b2-9098-7ef26e62890c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net (loss) income per share is computed using the weighted-average number of shares of Common Stock (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) outstanding during the period, less any shares subject to repurchase or forfeiture. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) subject to repurchase or forfeiture for the fiscal years ended June 30, 2025 and 2024. Diluted net (loss) income per share is computed based on the sum of the weighted-average number of common shares (as defined in &lt;/span&gt;&lt;a href="#fn10_stockequity"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders' Equity&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) and potentially dilutive common shares outstanding during the period determined using the treasury-stock and if-converted methods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For purposes of the diluted net loss per share calculation for the fiscal year ended June 30, 2025, potentially dilutive securities are excluded from the calculation of diluted net loss per share because their effect was anti-dilutive due to our net loss. For purposes of the diluted net income per share calculation for the fiscal year ended June 30, 2024, potentially dilutive securities are excluded from the calculation of diluted net income per share because their weighted-average exercise prices were above our weighted-average share price. Therefore, basic and diluted net (loss) income per share were the same for the fiscal years ended June 30, 2025 and 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:65.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total anti-dilutive shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_33a3cc1a-c0e6-4493-8cd9-00f84a0eb458"
      unitRef="U_shares">0</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_c2520cf0-d9d1-4bb5-a10f-e019ae41393c"
      unitRef="U_shares">0</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2f3f49a3-14d6-4962-9725-4094130dc813">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents potentially dilutive shares that have been excluded from the calculation of net (loss) income per share because of their anti-dilutive effect (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:65.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total anti-dilutive shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #000000;padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_ec033cf6-6de4-4e18-90c4-48d44d401981"
      decimals="-3"
      id="F_95a54a85-06dd-42c4-a8d6-01ab8eb793b8"
      unitRef="U_shares">869000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_3b4342ff-1351-43aa-bf51-fe4957ccc32c"
      decimals="-3"
      id="F_28315101-673e-486f-87dc-898dc7990932"
      unitRef="U_shares">1357000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0eba68b0-9adf-4ac8-8967-f51e2cef9d7f"
      decimals="-3"
      id="F_27a8aa30-860d-4481-b2fc-25479c95d3a4"
      unitRef="U_shares">103000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_94b1e5ac-8b72-4ae2-99a3-f4cb17a258fa"
      decimals="-3"
      id="F_bf1bd0d2-d573-4363-a657-dbdfc6eec80a"
      unitRef="U_shares">103000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_ca684fad-f00f-41a3-9141-356bb0a031b9"
      unitRef="U_shares">972000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_69087556-db20-4b2d-9dc0-be4c45428957"
      unitRef="U_shares">1460000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_c5420ec3-321c-42fa-bb56-34491b983df7">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures, which modifies the disclosure and presentation requirements of reportable segments (ASU 2023-07). The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (the CODM) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Lastly, the amendment requires that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The adoption of ASU 2023-07 resulted in enhanced disclosures as included in &lt;/span&gt;&lt;a href="#fn_segments"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 12 Segment Information&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, but did not impact to our results of operations, cash flows and financial condition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that are adopted as of the specified effective date. We believe the impact of recently issued standards, other than those noted below and any issued but not yet effective standards will not have a material impact on our consolidated financial statements upon adoption.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity (PBE) to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local,and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. For PBEs, the new standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments in this ASU prospectively by providing the revised disclosures for the period ending December 31, 2025 and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all periods presented. We expect this ASU to only impact our disclosures with no impacts to our results of operations, cash flows and financial condition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In January 2025, the FASB issued ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. The amendment in this update clarifies the effective date of ASU 2024-03, which is that public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026 and in interim periods within annual reporting periods beginning after December 15, 2027. The impact of adoption of this ASU on our disclosures is currently being evaluated.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In July 2025, the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;) was enacted. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act of 2017, including 100% bonus depreciation, domestic research cost expensing and the business interest expense limitation, among other tax changes. Many of the tax provisions of the OBBBA are designed to accelerate tax deductions, which could lead to lower cash tax payments. The new legislation has multiple effective dates, with certain provisions effective in 2025 and others in the future. While we continue to assess the impact of the tax provisions of the OBBBA on our consolidated financial statements, we currently believe that the tax provisions of the legislation are not expected to have a material impact on our statement of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e2839339-0eba-491b-8d23-3d09a9fb0a52">&lt;p id="fn3_bs_details" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 3. Balance Sheet Details&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid and other current assets consisted of the following in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.453%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.863000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.083%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software license&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Security deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p id="fn3_prop_equip" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of June 30. 2025, we had no property and equipment, net. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net consisted of the following as of June 30, 2024, in thousands:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="border-top:0.5pt solid #ffffff;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: accumulated depreciation &lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net &lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;_____&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Includes impairment charge of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;).&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense of property and equipment for the fiscal years ended June 30, 2025 and 2024 are presented in the consolidated statements of cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impact of the Agreement (as discussed in &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As noted in &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;we agreed to sell our furniture and fixtures to the landlord for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; on our lease termination date of September 30, 2024. We completed an evaluation of the impact of the Agreement, as defined in &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, on the carrying value of our property and equipment (Other Long-Lived Assets). This process included evaluating the remaining estimated useful lives, significant changes in the use and potential impairment charges related to the Other Long-Lived Assets. Based upon our evaluation, we recorded an impairment charge of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the furniture and fixtures to be sold to the landlord, which is included in the impairment of long-lived assets in the consolidated statements of operations. We also changed our estimate of the remaining useful lives of our leasehold improvements resulting in an acceleration of depreciation of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during our fiscal year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accrued Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued liabilities consisted of the following, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.453%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.863000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.083%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued pre-clinical and clinical trial expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued legal and professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued reimbursement to KKC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;________&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Includes one-time employee benefits of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;21,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the fiscal years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e0c83877-9985-4f48-8180-1a10a2e7ecf8">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid and other current assets consisted of the following in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.453%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.863000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.083%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software license&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Security deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidInsurance
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_4c1c5ce7-5f95-48c0-8fcf-3388122ca13f"
      unitRef="U_USD">176000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_9c4fc11e-9998-47b6-9bae-64086097a56d"
      unitRef="U_USD">460000</us-gaap:PrepaidInsurance>
    <lits:SoftwareLicenses
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_368f3a5d-b6c9-4235-a9f3-aaf7bdb76149"
      unitRef="U_USD">39000</lits:SoftwareLicenses>
    <lits:SoftwareLicenses
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_424f6e03-b542-4cc8-9281-da230bbda618"
      unitRef="U_USD">442000</lits:SoftwareLicenses>
    <us-gaap:SecurityDeposit
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_8dd06d80-b56a-465f-b3b9-7fd2e43b27f4"
      unitRef="U_USD">0</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_f5ebf50a-d8bb-4ddd-85bf-b079a581c7bd"
      unitRef="U_USD">263000</us-gaap:SecurityDeposit>
    <lits:PrepaidClinicalCosts
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_72286f9c-4d43-4d9c-98d6-5af0c0b6299f"
      unitRef="U_USD">0</lits:PrepaidClinicalCosts>
    <lits:PrepaidClinicalCosts
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_572c77df-7438-405a-aaa7-9efb362919e8"
      unitRef="U_USD">1050000</lits:PrepaidClinicalCosts>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_acbde673-1092-4a99-89ab-17ec075a5ec8"
      unitRef="U_USD">59000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_73a05daa-1e62-4d1d-b2fb-b7a84b778813"
      unitRef="U_USD">209000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_f1015f61-89f1-4335-97d5-24e743ac8dd4"
      unitRef="U_USD">274000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_f10a8d6a-975c-4117-9e91-df9b8bfc9650"
      unitRef="U_USD">2424000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_4ca4e87a-99f7-4769-b611-d758bbd1a7c0">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net consisted of the following as of June 30, 2024, in thousands:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="border-top:0.5pt solid #ffffff;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: accumulated depreciation &lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net &lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;_____&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Includes impairment charge of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in &lt;/span&gt;&lt;a href="#fn9_leases"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;).&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:-2.339%;padding-left:2.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_dcba7e4a-11d0-4a3e-b398-fd6721e793ed"
      decimals="-3"
      id="F_3f303eaf-aca8-4b56-8dcb-b310dd192842"
      unitRef="U_USD">1000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_cb253871-f434-42be-badc-455136d75117"
      decimals="-3"
      id="F_5e930d41-2e04-43b9-9a13-b006397f273a"
      unitRef="U_USD">187000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_47d0895f-dcab-4868-bb7e-4888006739cb"
      decimals="-3"
      id="F_e756e1cb-cd53-46df-b7dd-0e7d0c829c03"
      unitRef="U_USD">969000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_8905090e-119b-4df2-a073-5b9c5be34a14"
      unitRef="U_USD">2156000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_f4e683b4-eea6-4c3b-91ee-2e4e849aa6a2"
      unitRef="U_USD">1764000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_ff070178-64d3-451b-afc0-28aaa364dc42"
      unitRef="U_USD">392000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_498df639-b914-4e6f-a5bd-5f79abcd206f"
      decimals="-5"
      id="F_7f7dbc00-ff0c-494f-b25e-f4f56c828018"
      unitRef="U_USD">500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ProceedsFromSaleOfFurnitureAndFixtures
      contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"
      decimals="2"
      id="F_c5e7191e-0415-4f6e-bb58-09f8a7f0605e"
      unitRef="U_USD">1</us-gaap:ProceedsFromSaleOfFurnitureAndFixtures>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_498df639-b914-4e6f-a5bd-5f79abcd206f"
      decimals="-5"
      id="F_a99d74df-aea7-4614-b50f-d752aeab7fac"
      unitRef="U_USD">500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:Depreciation
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-5"
      id="F_f05bb2c0-0ecc-4727-b7b9-022ddc081d5f"
      unitRef="U_USD">100000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_a6a436f7-ab85-4512-92e3-b95df01144d2">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued liabilities consisted of the following, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.453%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.863000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.083%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued pre-clinical and clinical trial expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued legal and professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued reimbursement to KKC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;________&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Includes one-time employee benefits of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;21,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the fiscal years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <lits:AccruedPreclinicalAndClinicalCosts
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_781afde8-544b-47d2-9efb-9be03043f39f"
      unitRef="U_USD">134000</lits:AccruedPreclinicalAndClinicalCosts>
    <lits:AccruedPreclinicalAndClinicalCosts
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_01ab3448-7e8e-4d7c-a655-fb0be82676cf"
      unitRef="U_USD">1407000</lits:AccruedPreclinicalAndClinicalCosts>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_7a425758-0352-4dbc-bf50-c6ed7dd8ba32"
      unitRef="U_USD">873000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_92c3a739-20a7-4fb8-b471-9586192be188"
      unitRef="U_USD">2821000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_fe610b15-8c91-4a03-a4c4-578e6b90c40b"
      unitRef="U_USD">144000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_7d0f35c3-738b-43bd-a8fe-644433f13656"
      unitRef="U_USD">33000</us-gaap:AccruedProfessionalFeesCurrent>
    <lits:AccruedReimbursementToRelatedParty
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_d2a188fe-a4ef-4f26-b1f1-be100ffed2ab"
      unitRef="U_USD">0</lits:AccruedReimbursementToRelatedParty>
    <lits:AccruedReimbursementToRelatedParty
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_a766fd55-ec97-4958-8971-cfa95b9cfeef"
      unitRef="U_USD">892000</lits:AccruedReimbursementToRelatedParty>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_f2bfaa0f-4044-47fc-956f-266b09a2c5da"
      unitRef="U_USD">27000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_032dd384-7db1-4d20-a081-2cfd3d173489"
      unitRef="U_USD">34000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_bead8922-8db6-4b8a-8f22-0964f3af6a69"
      unitRef="U_USD">1178000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_9fb4f286-a6a5-4aab-8788-63635ac3ec05"
      unitRef="U_USD">5187000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_7c38ad79-231e-469a-9a63-b80988a7ff5e"
      decimals="-5"
      id="F_c31c4a78-4b89-433d-a963-3ef9fdebae77"
      unitRef="U_USD">700000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0"
      decimals="0"
      id="F_58ca6b4f-6338-4cd6-837b-e712c38e41e6"
      unitRef="U_USD">21000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_c5cfe1b9-f14f-49a9-b317-a1b91e3d292a">&lt;p id="fn4_fvm" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 4. Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying amounts of financial instruments such as cash equivalents, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. We invest our excess cash in financial instruments which are readily convertible into cash, such as money market funds and U.S. government securities. Cash equivalents are classified as Level 1 as defined by the fair value hierarchy. As of June 30, 2025 and June 30, 2024, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; assets or liabilities measured on a recurring or non-recurring basis.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_aa875931-fb24-4796-91f3-c3924bcf1ebb"
      decimals="-3"
      id="F_da0b91bf-c1ba-4c5e-b658-59f4d61e1db3"
      unitRef="U_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_901ccdf2-1321-455f-9644-864349d54328"
      decimals="-3"
      id="F_657b5465-d948-476b-a862-486555b8d5ae"
      unitRef="U_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_901ccdf2-1321-455f-9644-864349d54328"
      decimals="-3"
      id="F_09d93d5f-9041-446f-b70c-20d2ca9eeed2"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_aa875931-fb24-4796-91f3-c3924bcf1ebb"
      decimals="-3"
      id="F_3f76173b-b212-4c4b-be17-890adb40b14b"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_f6202e86-9002-4a63-bfb9-faa5697a84da">&lt;p id="fn5_onetimetermbene" style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 5. One-time Employee Termination Benefits&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with our joint decision to discontinue development of zandelisib outside of Japan, in December 2022, we announced a realignment of our clinical development efforts that streamlined our organization towards the continued clinical development of our two earlier clinical-stage assets, voruciclib and ME-344 (prior to its sale in October 2024).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2024, we commenced the &lt;/span&gt;&lt;a href="#fn1_stratalt"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Alternatives&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; RIF&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as discussed in our strategic alternatives announcement described in &lt;/span&gt;&lt;a href="#fn1_title"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 1. Description of Business and Basis of Presentation&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Including contractual pro-rata bonuses, we expect to incur charges not to exceed a total of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in retentions, severance and COBRA costs related to the termination of our employees due to our related wind down activities. The charges that we expect to incur in connection with the &lt;/span&gt;&lt;a href="#fn1_stratalt"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Alternatives&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; RIF&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; are subject to a number of assumptions and actual results may differ materially. We may also incur additional costs not currently contemplated due to events that may occur as a result of, or that are associated with, the &lt;/span&gt;&lt;a href="#fn1_stratalt"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Alternatives&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; RIF&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For each of the periods presented, one-time termination benefits primarily represent severance related costs and payments. During the fiscal years ended June 30, 2025 and 2024, we recorded employee termination benefits of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million within research and development expense, respectively. During the fiscal years ended June 30, 2025 and 2024, we recorded employee termination benefits of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million within general and administrative expense, respectively.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes our activity related to one-time employee termination benefits, included in accrued liabilities, in thousands:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:69.96%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:25.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase in accrued restructuring&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,528&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase in accrued restructuring&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="C_eb55a398-d9e2-4bc4-b646-4c8ff5f95e44"
      decimals="-5"
      id="F_80fdac50-2af0-407c-86de-6d5b1c2ab8ec"
      unitRef="U_USD">6700000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_65ce1f21-fab6-461d-b692-0bcf9b01d489"
      decimals="-5"
      id="F_313e69e5-76d7-480b-b01c-076aa04869d7"
      unitRef="U_USD">1800000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_0b16e06a-f891-41fa-a61d-1dcab0a16b52"
      decimals="-5"
      id="F_5c3296e1-fc23-4a07-afc3-1eac9afa78a8"
      unitRef="U_USD">200000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5"
      decimals="-5"
      id="F_1f6f6f58-5490-4e71-b40d-73f70e606141"
      unitRef="U_USD">3900000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203"
      decimals="-5"
      id="F_266d0de4-be74-4647-bbf9-27380f1292dc"
      unitRef="U_USD">300000</us-gaap:SeveranceCosts1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2ebaeb00-7255-4fd6-b426-25da7139a9af">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes our activity related to one-time employee termination benefits, included in accrued liabilities, in thousands:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:69.96%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:25.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;One-time Employee Termination Benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at June 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase in accrued restructuring&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,528&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase in accrued restructuring&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="C_aa5f4327-ba0e-4b78-9b28-61fb4396f64d"
      decimals="-3"
      id="F_98e48a1d-a01c-4009-bcdf-88ae30b49d6a"
      unitRef="U_USD">993000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="C_f738a573-a0f1-4605-bcb6-b67c8411a1fb"
      decimals="-3"
      id="F_0262c272-6915-41ec-8510-10b26059ad55"
      unitRef="U_USD">556000</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:PaymentsForRestructuring
      contextRef="C_f738a573-a0f1-4605-bcb6-b67c8411a1fb"
      decimals="-3"
      id="F_2a933f41-6f04-4e68-b499-f21fd59e00f4"
      unitRef="U_USD">1528000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="C_08ae31ee-3bc6-4ab8-b28c-00db2cf22bc0"
      decimals="-3"
      id="F_78674ba8-490b-4a38-ae5b-76ae17c4dc2b"
      unitRef="U_USD">21000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="C_2d40854b-8b85-47ad-ae8c-ed3f241c7c66"
      decimals="-3"
      id="F_8642635f-80aa-4169-88b2-13d126648719"
      unitRef="U_USD">5734000</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:PaymentsForRestructuring
      contextRef="C_2d40854b-8b85-47ad-ae8c-ed3f241c7c66"
      decimals="-3"
      id="F_80966d92-dacb-434a-a738-b9fb77cbb51d"
      unitRef="U_USD">5027000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="C_7c38ad79-231e-469a-9a63-b80988a7ff5e"
      decimals="-3"
      id="F_baaff4ab-be9d-4006-929c-3b2dabdf0a20"
      unitRef="U_USD">728000</us-gaap:RestructuringReserve>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_fd5e3390-6270-49ef-aff6-0831eef1d497">&lt;p id="fn6_commitcon" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 6. Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have contracted with various consultants and third parties to assist us in pre-clinical R&amp;amp;D and clinical trials work for our leading drug compounds and general and administrative activities. The contracts are terminable at any time but obligate us to reimburse the providers for any time or costs incurred through the date of termination. See the discussion of the sale of ME-344 within &lt;/span&gt;&lt;a href="#fn_dis_nonfin_asset"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 13. Disposition of a Non-financial Asset&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for additional information regarding contracts associated with ME-344 assumed by the Purchaser (as defined in &lt;/span&gt;&lt;a href="#fn_dis_nonfin_asset"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 13. Disposition of a Non-Financial Asset&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ). We also have an employment agreement with our Acting Chief Executive Officer and Chief Financial Officer that provides for severance payments and accelerated vesting for share-based awards if their employment is terminated under specified circumstances.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Litigation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, we may be involved in various lawsuits, legal proceedings, or claims that arise in the ordinary course of business. Management believes there are no claims or actions pending against us as of June 30, 2025, which will have, individually or in the aggregate, a material adverse effect on its business, liquidity, financial position, or results of operations. Litigation, however, is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Indemnification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In accordance with our amended and restated certificate of incorporation and sixth amended and restated bylaws, we have indemnification obligations to our officers and directors for certain events or occurrences, subject to certain limits, while they are&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;serving in such capacity. There have been no claims to date and we have a directors and officers liability insurance policy that may enable it to recover a portion of any amounts paid for future claims.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Presage License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in&lt;/span&gt;&lt;a href="#fn8_othlicagree"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Other License Agreements&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we are party to a license agreement with Presage under which we may be required to make future payments upon the achievement of certain development, regulatory and commercial milestones, as well as potential future royalties based upon net sales. As of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accruals for potential future payments as achievement of the milestones had not been met.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <lits:AccruedMilestonePayments
      contextRef="C_5c746096-0191-4a12-b56d-6cedc776485d"
      decimals="-3"
      id="F_f68bdd31-d1b6-48b8-83ab-39c668877749"
      unitRef="U_USD">0</lits:AccruedMilestonePayments>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_dc0938df-f9bd-4478-9104-a9e848610bb8">&lt;p id="fn7_licagree" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 7. License Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;KKC License, Development and Commercialization Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In April 2020, we entered into the KKC Commercialization Agreement under which we granted to KKC a co-exclusive, sublicensable, payment-bearing license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in the U.S. (the U.S. License) and an exclusive (subject to certain retained rights to perform obligations under the KKC Commercialization Agreement), sublicensable, payment-bearing, license under certain patents and know-how controlled by us to develop and commercialize zandelisib and any pharmaceutical product containing zandelisib for all human indications in countries outside of the U.S. KKC granted to us a co-exclusive, sublicensable, license under certain patents and know-how controlled by KKC to develop and commercialize zandelisib for all human indications in the U.S. and a co-exclusive, sublicensable, royalty-free, fully paid license under certain patents and know-how controlled by KKC to perform our obligations in the Ex-U.S. under the KKC Commercialization Agreement. KKC paid us an initial nonrefundable payment &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In July 2023, we entered into a termination agreement with KKC to mutually terminate the KKC Commercialization Agreement and all other related agreements between the parties (Termination Agreement) and jointly decided to discontinue zandelisib development in the U.S. Prior to the execution of the Termination Agreement, KKC was responsible for the development and commercialization of zandelisib in Ex-U.S. and, subject to certain exceptions, was solely responsible for all costs related thereto. We also provided to KKC certain drug supplies necessary for the development and commercialization of zandelisib in the Ex-U.S., with the understanding that KKC would have assumed responsibility for manufacturing for the Ex-U.S. as soon as practicable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During fiscal year 2023, we updated our assessment of the total transaction price from the KKC Commercialization Agreement to reflect the upfront payment, milestone payments, estimated development cost-sharing and deferred revenue. After announcing our plan to discontinue the global development of zandelisib outside of Japan, in December 2022, we decreased our estimate for variable consideration related to development cost sharing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;With the execution of the Termination Agreement, we regained full, global rights (subject to KKC's limited rights for compassionate use) and KKC has no further rights to develop, use or commercialize zandelisib in the U.S., nor do we have any remaining performance obligations with all consideration received from KKC being nonrefundable. Therefore, the remaining long-term deferred revenue as of June 30, 2023, of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, that was allocated to the U.S. License obligation accounted for under Topic 808 at inception of the KKC Commercialization Agreement was recognized as revenue from collaboration agreements in the three months ended September 30, 2023, utilizing contract termination analogous to guidance provided in Topic 606.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million transaction price allocated to the U.S. License obligation accounted for under Topic 808 was included as noncurrent deferred revenue as of June 30, 2023. As of June 30, 2023, we also had deferred revenue of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to the transaction price allocated to the Development Services performance obligations and recognized the remaining revenue based on the proportional performance of these development activities. The KKC Agreement was terminated on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;July 14, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and all remaining amounts of deferred revenue were recognized during the fiscal year ended June 30, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <lits:TotalUpfrontPaymentReceivableForGrantOfRights
      contextRef="C_4038fe7e-0797-4545-9817-044b66f01547"
      decimals="-5"
      id="F_f0238754-45f4-400c-998f-38a21aa45be2"
      unitRef="U_USD">100000000</lits:TotalUpfrontPaymentReceivableForGrantOfRights>
    <us-gaap:DeferredRevenue
      contextRef="C_4dfa8660-229c-4efc-b1ce-209781894ed6"
      decimals="-5"
      id="F_618012cb-b18d-4cda-9a44-1c00dcb6a4c6"
      unitRef="U_USD">64500000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="C_4dfa8660-229c-4efc-b1ce-209781894ed6"
      decimals="-5"
      id="F_cc2064cc-bd48-40ff-ae52-b0cfe6d0de8f"
      unitRef="U_USD">64500000</us-gaap:DeferredRevenue>
    <lits:LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue
      contextRef="C_3b1ff24a-8449-4e09-abf5-5f426b41e513"
      decimals="-5"
      id="F_31819369-ab4e-4a6b-b53e-19736630b877"
      unitRef="U_USD">300000</lits:LicenseObligationAccountTransactionPriceAllocatedDeferredRevenue>
    <lits:TerminationAgreement
      contextRef="C_9de02997-3191-4520-97dc-7a314cccb702"
      id="F_2a9d2540-b721-4e10-82fb-9b5fe92406d9">2023-07-14</lits:TerminationAgreement>
    <lits:OtherLicensingArrangementsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_4f1c1e4f-1ed6-4be6-a046-6f8450240e68">&lt;p id="fn8_othlicagree" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 8. Other License Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Presage License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2017, we, as licensee, entered into a license agreement with Presage Biosciences, Inc. (Presage). Under the terms of the license agreement, Presage granted to us exclusive worldwide rights to develop, manufacture and commercialize voruciclib, a clinical-stage, oral and selective CDK inhibitor and related compounds. In exchange, we paid $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to Presage. With respect to the first indication, an incremental $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million payment, due upon dosing of the first subject in the first registration trial, will be owed to Presage, for total payments of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million prior to receipt of marketing approval of the first indication in the U.S., EU or Japan. Additional potential payments of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;will be due upon the achievement of certain development, regulatory and commercial milestones. We will also pay mid-single digit tiered royalties on the net sales of any product successfully developed. As an alternative to milestone and royalty payments related to countries in which we sublicense product rights, we will pay to Presage a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;tiered &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;percentage (which decreases as product development progresses) of amounts received from such sublicensees. During the fiscal years ended June 30, 2025 and 2024, we made no payments under the Presage license agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;BeiGene Collaboration&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In October 2018, we entered into a clinical collaboration with BeiGene, Ltd. (BeiGene) to evaluate the safety and efficacy of zandelisib in combination with BeiGene&#x2019;s zanubrutinib (marketed as Brukinsa&#xae;), an inhibitor of Bruton&#x2019;s tyrosine kinase, for the treatment of patients with B-cell malignancies. Under the terms of the clinical collaboration agreement, we amended our Phase 1b trial to include evaluation of zandelisib in combination with zanubrutinib in patients with B-cell malignancies. Study costs are being shared equally by the parties and we agreed to supply zandelisib and BeiGene agreed to supply zanubrutinib. We record the costs reimbursed by BeiGene as a reduction of our research and development expenses. We retained full commercial rights for zandelisib and BeiGene retained full commercial rights for zanubrutinib. With the discontinuation of the zandelisib program outside of Japan, this clinical collaboration was terminated on September 28, 2023. During the fiscal year ended June 30, 2025, we did not recognize cost reimbursements as a reduction of research and development expenses. Cost reimbursements recorded as a reduction of research and development expenses, in the consolidated statements of operations, during the fiscal year ended June 30, 2024, was approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;</lits:OtherLicensingArrangementsTextBlock>
    <lits:PaymentForLicenseAgreement
      contextRef="C_fbc3fa56-1138-411a-86db-d0f5176a096d"
      decimals="-5"
      id="F_9fe3616a-0ee1-4068-9984-4027ecbf76d9"
      unitRef="U_USD">2900000</lits:PaymentForLicenseAgreement>
    <us-gaap:OtherLiabilities
      contextRef="C_046dad52-7060-4b22-a684-7b4095cf956f"
      decimals="-5"
      id="F_e7b05da7-ad94-4efd-bb05-a865c5d41748"
      unitRef="U_USD">2000000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="C_03a52d86-9327-469f-9cca-e384b91706f2"
      decimals="-5"
      id="F_49eb166c-d2ea-4113-8aac-280f5463fc73"
      unitRef="U_USD">4900000</us-gaap:OtherLiabilities>
    <lits:PotentialMilestonePaymentsReceivable
      contextRef="C_ebb8eacd-9a9f-4b19-8cc4-c8435984244b"
      decimals="-5"
      id="F_bce2ec28-ca02-4460-8d7d-c0e44645a559"
      unitRef="U_USD">179000000</lits:PotentialMilestonePaymentsReceivable>
    <us-gaap:RecoveryOfDirectCosts
      contextRef="C_e7db8cf6-cb55-4ae2-94f9-5eb5ba8827f8"
      decimals="-5"
      id="F_97b154ce-6aba-4e28-b430-3486955374eb"
      unitRef="U_USD">100000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_0751a7bd-12c1-4a5a-accc-c38232af236b">&lt;p id="fn9_leases" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 9. Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In July 2020, we entered into a lease agreement for approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,800&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in San Diego, California. The lease agreement contained rent escalations over the lease term and was originally scheduled to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_10d9387d-fef2-414e-8898-e24c8f8f9759;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 2028&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. We accounted for the lease agreement as an operating lease. The lease agreement contained an option to renew and extend the lease term, which was not included in the determination of the ROU asset and operating lease liability, as it was not reasonably certain to be exercised. In July 2022, we amended the lease to extend the lease termination date from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bee66b44-7fcb-482f-938b-2dcb4681b6b7;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 2028&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 30, 2029&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and to add an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,300&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space adjacent to our current office in San Diego (the Amended Lease). Upon commencement of the Amended Lease, we recognized an additional ROU asset and a corresponding operating lease liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Amended Lease includes variable non-lease components (e.g., common area maintenance, maintenance, etc.) that are not included in the ROU asset and operating lease liability and are reflected as an expense in the period incurred as a component of the lease cost.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Lease Termination&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On June 18, 2024 (the Agreement Date), we entered into a lease termination agreement (Agreement) with our landlord pursuant to which the parties agreed to terminate, as of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 30, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the lease for our existing office space. The original (as amended) scheduled expiration date was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 30, 2029&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As consideration for the Agreement, we agreed to pay the landlord a termination fee of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the Termination Fee) and to prepay the remaining rent due under the Agreement in the amount of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the Remaining Rent) and sell all the furniture and fixtures to the landlord for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (see &lt;/span&gt;&lt;a href="#fn3_prop_equip"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;within &lt;/span&gt;&lt;a href="#fn3_bs_details"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 3. Balance Sheet Details&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for further discussion on the impact of the Agreement on our property and equipment). During fiscal year 2025, we received our security deposit from the landlord, which was previously classified as a component of prepaid and other current assets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Agreement was accounted for as a lease modification of the original contract. As a result of the Agreement, we reduced both the remaining ROU asset and lease liability by approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, resulting in no impact to our consolidated statements of operations. We reassessed the lease classification, as of the Agreement Date, noting the current classification as an operating lease remained appropriate. Both the Termination Fee and the Remaining Rent were paid prior to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Subsequent to the payment of both the Termination Fee and the Remaining Rent, our lease liability was relieved and the balance was reduced to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We incurred direct costs of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in connection with the Agreement which accordingly was recorded to the ROU assets as a direct cost of modifying the Agreement. As of the Agreement Date, we determined a triggering event, in accordance with ASC 360, had occurred and therefore completed an impairment analysis on its ROU asset resulting in an impairment charge of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million being recorded in our consolidated statements of operations for the fiscal year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2024.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total operating lease costs for the Amended Lease were as follows for the periods presented, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.453%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.643%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.303%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs included in operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended June 30, 2025, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; supplemental cash flow activity. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Supplemental cash flow information related to our operating leases for the year ended June 30, 2024 was as follows, in thousands:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:76.155%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.863999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amount included in the measurement &lt;br/&gt;&#160;&#160;&#160;&#160;of lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; remaining future minimum rental payments for our operating leases and the remaining ROU asset balance was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. During fiscal year 2024, the ROU asset balance was increased by approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to direct costs associated with the Agreement. Additionally, the ROU asset balance was decreased by: (1) approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; associated with our reassessment of the lease liability as of the Agreement date and (2) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million associated with the impairment of the ROU asset, as discussed above. As of September 30, 2024, we had vacated the facility and the leased property reverted to the landlord. In addition, the ROU asset has been fully amortized.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfLand
      contextRef="C_1d242087-6da3-4ba4-9ecd-f789815f32a7"
      decimals="INF"
      id="F_c3ab1414-b053-488d-b98b-65bc07889ad4"
      unitRef="U_sqft">32800</us-gaap:AreaOfLand>
    <lits:LeaseTerminationDate
      contextRef="C_36dd6fec-f2fe-427e-a87d-51412c3f9ec9"
      id="F_1cdf4b67-f67d-424f-8fb3-537963ec519e">2029-11-30</lits:LeaseTerminationDate>
    <us-gaap:AreaOfLand
      contextRef="C_5fb23a8d-14cb-4175-877b-89e01b2aff80"
      decimals="INF"
      id="F_4e2843de-56ff-4508-9b24-78fd464f7422"
      unitRef="U_sqft">12300</us-gaap:AreaOfLand>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_d3e5d951-4348-4f5f-b2be-82d3b6a4f3ea"
      decimals="-5"
      id="F_1ad67a0c-8e3f-4d22-98e1-03617356b294"
      unitRef="U_USD">4300000</us-gaap:OperatingLeaseLiability>
    <lits:LeaseExpirationAmendedDate
      contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"
      id="F_156ed20d-4c27-455a-83b0-f6c0826deb1c">2024-09-30</lits:LeaseExpirationAmendedDate>
    <lits:LeaseTerminationDate
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_98c5b395-f9c0-4c08-9807-23d1fbdd53ae">2029-11-30</lits:LeaseTerminationDate>
    <lits:LeaseTerminationFee
      contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57"
      decimals="-5"
      id="F_499f4515-3481-4fda-8c37-1280346ff68c"
      unitRef="U_USD">11100000</lits:LeaseTerminationFee>
    <lits:PrepaymentOfRemainingRent
      contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57"
      decimals="-5"
      id="F_04dc5e3e-8ddf-4521-a7da-3998aede96b4"
      unitRef="U_USD">200000</lits:PrepaymentOfRemainingRent>
    <us-gaap:ProceedsFromSaleOfFurnitureAndFixtures
      contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"
      decimals="2"
      id="F_606de046-ed67-4075-8a12-c65513b128f0"
      unitRef="U_USD">1</us-gaap:ProceedsFromSaleOfFurnitureAndFixtures>
    <lits:AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability
      contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"
      decimals="0"
      id="F_f5efcf5d-107d-440e-9675-aee8371e33f3"
      unitRef="U_USD">22000</lits:AmountOnReductionInRemainingRightOfUseAssetAndLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57"
      decimals="0"
      id="F_76e31c3e-722f-4481-8095-563aace9f36c"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiability>
    <lits:DirectCosts
      contextRef="C_365bd362-44cf-4f5e-882d-def50fff7f57"
      decimals="-5"
      id="F_bab2af89-3446-4e31-8883-d904f8c10a70"
      unitRef="U_USD">200000</lits:DirectCosts>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"
      decimals="-5"
      id="F_a3604da4-421e-4c8c-9925-b4004e9c1590"
      unitRef="U_USD">10400000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e2392920-e68d-4b7d-99fd-b3484f8753fc">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total operating lease costs for the Amended Lease were as follows for the periods presented, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.453%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.643%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.303%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs included in operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5"
      decimals="-3"
      id="F_609cf61b-6e74-4380-8f17-1e5ea1ccdc51"
      unitRef="U_USD">214000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203"
      decimals="-3"
      id="F_f8c828ad-cca0-4542-9d52-c1597432bf7c"
      unitRef="U_USD">2434000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5"
      decimals="-3"
      id="F_0284e5ac-15f0-4cc2-b5c8-c61b87a04642"
      unitRef="U_USD">0</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203"
      decimals="-3"
      id="F_f63d1ee6-6ee7-4336-ba80-01984748e0b2"
      unitRef="U_USD">123000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5"
      decimals="-3"
      id="F_89ad9260-bee5-40ee-9237-8a74b14bcd43"
      unitRef="U_USD">214000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203"
      decimals="-3"
      id="F_1a3bc181-b318-4bd0-ad18-045d64ae86e2"
      unitRef="U_USD">2557000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_81623d9d-1b58-4917-83a8-8d0869c1123a"
      unitRef="U_USD">0</us-gaap:OperatingLeasePayments>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_636fbb51-aec7-489d-8ce4-6cd347e9d5fb">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Supplemental cash flow information related to our operating leases for the year ended June 30, 2024 was as follows, in thousands:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:76.155%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.863999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amount included in the measurement &lt;br/&gt;&#160;&#160;&#160;&#160;of lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_373dadec-fcd3-4fe8-8f21-85c4aff8e52b"
      unitRef="U_USD">13612000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-6"
      id="F_b130a85b-6c6b-4e11-983e-fd45040d3e55"
      unitRef="U_USD">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-5"
      id="F_f735c248-43e8-41d8-b6d8-e61899d3b8cd"
      unitRef="U_USD">200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <lits:DirectCosts
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-5"
      id="F_e4144542-2060-4d09-8dfa-072a437cfffb"
      unitRef="U_USD">200000</lits:DirectCosts>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_0bbc3cd0-70e7-4b7b-b91a-ee098af72db1"
      unitRef="U_USD">22000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_f71f99ef-3d6a-42ba-922c-c98ef5a5602a"
      decimals="-5"
      id="F_dd4ca17b-cf59-4e00-8cf1-28345946b1d9"
      unitRef="U_USD">10400000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_08f658da-4bf4-4a25-ad74-7ec0c6e64162">&lt;p id="fn10_stockequity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Shelf Registration Statement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have a shelf registration statement (February 2024 Shelf Registration Statement) that permits us to sell, from time to time, up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of common stock, preferred stock, warrants rights and units. The February 2024 Shelf Registration Statement was filed February 20, 2024 and declared effective February 28, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;At-The-Market Equity Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 20, 2024, we entered into a capital on demand sales agreement (the On Demand Sales Agreement) with JonesTrading Institution Services LLC, pursuant to which we can offer and sell shares having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the ATM Program). &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of January 2, 2024, the date used under applicable rules of the SEC to determine our public float at the commencement of the offering, one-third of our public float was equal to approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; did not offer or sell any shares of our Common Stock (as defined below) under the On Demand Sales Agreement. Effective July 21, 2025, we terminated the On Demand Sales Agreement. On July 22, 2025, we entered a new Sales Agreement (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), in conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), see &lt;/span&gt;&lt;a href="#fn_new_sales_agree"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Entry into a New Sales Agreement&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; discussion within &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for details related to the Sales.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; between the SPA Closing date (as defined in  &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) and September 19, 2025, we issued and sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;882,924&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock (as defined below) for aggregate proceeds, net of the underwriter's commission of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;4.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, through our ATM Program.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cooperation Agreement and Cash Dividend&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Cooperation Agreement, among other non-financial related items, provided for a capital return to stockholders in the form of a dividend in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share of Common Stock (as defined below) that was declared on November 6, 2023 to stockholders of record at the close of business on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 17, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The total dividend of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was paid on December 6, 2023 and was recorded as a reduction of additional paid-in capital in the consolidated statements of stockholders' equity, as we have an accumulated deficit, rather than retained earnings. Effective July 22, 2025, in conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Rights Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;October 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, our Board approved and adopted a rights agreement (Rights Agreement) by and between us and Computershare, Inc., as Rights Agent (as defined in the Rights Agreement). Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a Right) for each outstanding share of our Common Stock (as defined below), par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00000002&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (each a Common Share and collectively, the Common Shares). The Rights were distributable to stockholders of record as of the close of business on October 12, 2023. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Rights and the Rights Agreement expired at the close of business on September 30, 2024. No rights were redeemed or exchanged under the Rights Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we have outstanding warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;102,513&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock (as defined below) issued to Torreya Partners LLC. The warrants are fully vested, exercisable at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and expire in October 2027. During the fiscal years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants were exercised.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2025, i&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), we issued the following warrants:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:27.025%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.484%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.502%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.103%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:23.885%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Warrants Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Initial Exercise Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Expiration Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Asset Manager Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;584,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Strategic Advisor Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;438,597&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Placement Agent Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,169,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,070,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,022,869&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to an investor that participated in the Offering. The Pre-Funded Warrants are immediately exercisable and have an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. In July 2025, Pre-Funded Warrants for the purchase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;2,084,509&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (as defined below) were exercised for a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;de minimis&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amount of cash proceeds. As of September 23, 2025, we &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt;issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,807,967&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (as defined below) upon cashless exercises of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,808,070&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;546,348&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Description of Capital Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our total authorized share capital is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;226,100,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares consisting of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;226,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00000002&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value per share (Common Stock) and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of preferred stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.01&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Common&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The holders of Common Stock are entitled to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one vote per share&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. In the event of a liquidation, dissolution or winding up of our affairs, holders of the Common Stock will be entitled to share ratably in all our assets that are remaining after payment of our liabilities and the liquidation preference of any outstanding shares of preferred stock. All outstanding shares of Common Stock are fully paid and non-assessable. The rights, preferences and privileges of holders of Common Stock are subject to any series of preferred stock that we have issued or that we may issue in the future. The holders of Common Stock have no preemptive rights and are not subject to future calls or assessments by us.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), we issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;23,216,898&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;3.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, for net cash proceeds of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Preferred&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board has the authority to issue up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of preferred stock with a par value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.01&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share in one or more series and to fix the rights, preferences, privileges and restrictions in respect of that preferred stock, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption (including sinking fund provisions), redemption prices and liquidation preferences and the number of shares constituting such series and the designation of any such series, without future vote or action by the stockholders. Therefore, the Board, without the approval of the stockholders, could authorize the issue of preferred stock with voting, conversion and other rights that could affect the voting power, dividend and other rights of the holders of shares or that could have the effect of delaying, deferring or preventing a change of control. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of preferred stock outstanding as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <lits:SaleOfSharesAndWarrantsUnderAgreement
      contextRef="C_cfc6a080-d7ad-48cf-9593-13de2e93cbdd"
      decimals="-5"
      id="F_59e6718f-61f6-4e1f-92d4-a129618af70d"
      unitRef="U_USD">100000000</lits:SaleOfSharesAndWarrantsUnderAgreement>
    <lits:MaximumAmountOfCommonStockOfferingPrice
      contextRef="C_cf8f1efe-c282-41f0-90aa-477e9df58d2c"
      decimals="-5"
      id="F_a541589c-d9de-455d-8cd9-d22135cb4b51"
      unitRef="U_USD">25000000</lits:MaximumAmountOfCommonStockOfferingPrice>
    <lits:AtTheMarketOfferingAgreementDescription
      contextRef="C_7fda2453-8aa5-405b-b3ee-795a3fca2cda"
      id="F_99873aca-4df4-42f5-a899-d6c9ea1dcbc4">As of January 2, 2024, the date used under applicable rules of the SEC to determine our public float at the commencement of the offering, one-third of our public float was equal to approximately $9.9 million.</lits:AtTheMarketOfferingAgreementDescription>
    <dei:EntityPublicFloat
      contextRef="C_78b08baa-a398-4c87-8856-dccadb025d83"
      decimals="-5"
      id="F_bb4d46a4-ce6a-4003-ac6e-46480b626aae"
      unitRef="U_USD">9900000</dei:EntityPublicFloat>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_93b9e9e8-1270-4323-afb0-75af92765160"
      decimals="INF"
      id="F_5b38838c-f79c-4360-9028-62d39802d078"
      unitRef="U_shares">882924</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_93b9e9e8-1270-4323-afb0-75af92765160"
      decimals="-5"
      id="F_c8fb003e-702b-4086-8164-58f62bef2b96"
      unitRef="U_USD">4600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="C_f12fbef6-72e6-4260-86e6-fc02f15df7a4"
      decimals="2"
      id="F_e98d41df-98e3-45ba-b3a8-6757954bfd50"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.75</us-gaap:CommonStockDividendsPerShareDeclared>
    <lits:ClosingAgreement
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_63288475-3749-4138-abfe-19935b97c7d5">2023-11-17</lits:ClosingAgreement>
    <us-gaap:PaymentsOfDividends
      contextRef="C_32d99983-1b3d-4c08-8e53-fb1cf89c3852"
      decimals="-5"
      id="F_b509ce35-2d84-43b9-ad2c-f60cb82a2fb8"
      unitRef="U_USD">11700000</us-gaap:PaymentsOfDividends>
    <lits:AdoptedAgreement
      contextRef="C_23b7781d-5a70-4950-ab3d-ed36fea479a3"
      id="F_b30b9d0a-e8b9-4adc-a995-9573aa4b33ce">2023-10-01</lits:AdoptedAgreement>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_90b552c8-e654-4d0a-8162-fa00aec0af5a"
      decimals="8"
      id="F_2057ccfc-87fb-4191-a76f-d6178cf2fd98"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00000002</us-gaap:PreferredStockParOrStatedValuePerShare>
    <lits:RightsAndTheRightsAgreementExpirationDescription
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_ecb68564-98f4-43da-976e-2782541caedb">The Rights and the Rights Agreement expired at the close of business on September 30, 2024. No rights were redeemed or exchanged under the Rights Agreement.</lits:RightsAndTheRightsAgreementExpirationDescription>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_4477116c-5b49-4100-b4a7-28181e73d4e7"
      decimals="0"
      id="F_0863fe08-c065-480e-b834-3e0376a14476"
      unitRef="U_shares">102513</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_4477116c-5b49-4100-b4a7-28181e73d4e7"
      decimals="2"
      id="F_de263f14-9a31-4a6d-a50d-d0357f21327b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.8</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lits:NumberOfWarrantsExercised
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="INF"
      id="F_f201b87f-bdaf-44a3-b766-d2f3f35b23c1"
      unitRef="U_shares">0</lits:NumberOfWarrantsExercised>
    <lits:NumberOfWarrantsExercised
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="INF"
      id="F_6e926b47-340a-4812-b2af-84aa6b7dfbf3"
      unitRef="U_shares">0</lits:NumberOfWarrantsExercised>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_b684b22f-bbf3-4544-acdd-9925304f02ee">&lt;p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2025, i&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n conjunction with the closing of the Offering (as defined in &lt;/span&gt;&lt;a href="#fn_subevent"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Events&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), we issued the following warrants:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:27.025%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.484%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.502%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.103%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:23.885%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Warrants Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Initial Exercise Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Expiration Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Asset Manager Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;584,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tranche 4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Strategic Advisor Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;438,597&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Placement Agent Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,169,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 22, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,070,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312"
      decimals="0"
      id="F_af7f0cfb-be98-4c63-bcf9-7815929bc4f3"
      unitRef="U_shares">584795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312"
      decimals="2"
      id="F_190c356a-43b7-4f56-9ec1-eae4d690bbd1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.42</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_39b6c9ec-a171-463c-827e-3d4ee41454a2"
      id="F_b927ed91-52d8-4f7a-bad7-dfd41645166a">2025-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312"
      id="F_dedd9dd5-78d1-4d0d-b5ce-abc27a237288">2030-07-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284"
      decimals="0"
      id="F_17249155-4278-4a5f-83e8-289f64e95d52"
      unitRef="U_shares">292398</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284"
      decimals="2"
      id="F_cb2a0032-aefb-4bfe-8a21-f3dbc16d2a8b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.93</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_96669720-7ee3-4ea8-afce-e422997f939e"
      id="F_1ffe16fa-d940-4f90-a667-634c93751e44">2025-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284"
      id="F_5448a6e3-9fdd-4c6a-bf55-4c2624f64fca">2030-07-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42"
      decimals="0"
      id="F_c632242b-c704-4e13-94fe-6afbc333c441"
      unitRef="U_shares">292398</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42"
      decimals="2"
      id="F_95bc4a61-1a24-464c-8b7c-7c5fd9b13a2a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_890346b8-8f3f-4053-845e-8155a5f5e602"
      id="F_7e0b4874-b47e-4a7e-aca1-ab82e0cfb6b3">2025-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42"
      id="F_ea57b926-bd13-470f-a409-b389212a550e">2030-07-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0"
      decimals="0"
      id="F_18a6df1f-94b9-4ee8-9d76-91669058b80c"
      unitRef="U_shares">292398</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0"
      decimals="2"
      id="F_e54a7d3f-ed92-4a60-b139-6ef67e396ecc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_e3b3e1bb-0d52-409c-8d44-386e016474a0"
      id="F_4d5eb19a-59d7-40e2-ada6-b6ee2875f91c">2025-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0"
      id="F_a4111205-16c6-438c-99e3-1a9c819f2647">2030-07-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7"
      decimals="0"
      id="F_e59c8e57-8b39-48b3-83d1-e9a7adbe38a8"
      unitRef="U_shares">438597</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7"
      decimals="2"
      id="F_28835757-d844-4130-9540-a3bf11acd7c7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_17b85b55-1836-4eb6-8ee3-7afafbc45023"
      id="F_d9fe3d73-ed51-4216-9925-2ddc335465c0">2025-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7"
      id="F_e64d9926-a670-4a43-a1be-21d68e519580">2030-07-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33"
      decimals="0"
      id="F_69a262e8-29e2-43d9-abfd-5bd91e9038fd"
      unitRef="U_shares">1169591</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33"
      decimals="2"
      id="F_035867d9-587d-4a06-b3e3-4660c4168881"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_eb4c8b50-1cde-40b3-95ce-38094a76fdac"
      id="F_aa0e5770-b21d-4551-bc80-2b76aec67b8d">2025-07-22</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_0dcc0a36-3ce3-4a92-a3ab-1de6046bac33"
      id="F_98eeb208-82fd-40ee-9cf8-a49d9d46a4ca">2030-07-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_fa1c20a4-edb7-43ee-b979-1cf83c11f686"
      decimals="0"
      id="F_52878f1e-2727-46be-915b-b86b9e8d7f71"
      unitRef="U_shares">3070177</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"
      decimals="INF"
      id="F_6bb1804b-05bb-4de9-a7ce-33c8b8a6a36b"
      unitRef="U_shares">6022869</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"
      decimals="4"
      id="F_780666a3-abc5-4576-9032-7041da44e8bf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_07f286c0-e5a6-4c38-9799-941180c82a4c"
      decimals="INF"
      id="F_207b9938-39ce-43b9-84e6-cc96a025596e"
      unitRef="U_shares">2084509</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738"
      decimals="INF"
      id="F_3ff5c976-42a1-4948-b391-139b620e08a6"
      unitRef="U_shares">2807967</us-gaap:CommonStockSharesIssued>
    <lits:SurrenderedWarrantsToAcheiveCommonStock
      contextRef="C_d190719d-ba9d-4549-9346-f6c2c6a02045"
      decimals="INF"
      id="F_03899286-2512-446d-a7c6-9c2e1e7bfe2e"
      unitRef="U_shares">2808070</lits:SurrenderedWarrantsToAcheiveCommonStock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_08b96565-9169-4635-945d-9321b9c399be"
      decimals="INF"
      id="F_94da3d06-50b8-4ee3-9848-d4251d19b1f8"
      unitRef="U_shares">546348</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_08b96565-9169-4635-945d-9321b9c399be"
      decimals="4"
      id="F_eec800d7-c1c3-4659-992f-7c2d48d588df"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CapitalUnitsAuthorized
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_3e9fe592-ed80-4fad-98db-a8e402c6cc04"
      unitRef="U_shares">226100000</us-gaap:CapitalUnitsAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_0693a282-2899-4f66-ace3-e1025fec600b"
      unitRef="U_shares">226000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_6c1b7804-b616-4615-994b-27866ddd069d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00000002</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_b928825b-60ab-46cb-a8b4-ec281d9e41d8"
      unitRef="U_shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_18ebcbd5-0e3b-460c-ba69-05a22b7ace1e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_552bbee9-f3ca-4e3e-9aa4-c84632608c65">one vote per share</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_870e143e-2c95-4ffb-9924-d47b9fd9da81"
      decimals="INF"
      id="F_95f9498f-8276-4108-93f7-cffc95fa99ec"
      unitRef="U_shares">23216898</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c"
      decimals="2"
      id="F_784b860f-e35f-4c04-a62b-28e639747215"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.42</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_a06c0f95-2711-45fa-8758-3af29c6ca47e"
      decimals="-5"
      id="F_bb977883-2a69-4814-9763-c60dd1fddb42"
      unitRef="U_USD">92100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="0"
      id="F_d995dc68-9c91-40b3-9755-2a800d6f6104"
      unitRef="U_shares">100000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="2"
      id="F_cf238d7a-9a4f-4ceb-b8d3-76fe921fb5ce"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_ed905e36-6ca7-4ed2-bc15-a96b3138f737"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_469ac399-e625-45e0-b89f-229e61a65daf"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_4e909bb2-60fa-4a8c-8ea4-2358aae161c8">&lt;p id="fn11_sbc" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 11. Share-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use equity-based compensation programs to provide long-term performance incentives for our employees. These incentives consist primarily of stock options and RSUs. In December 2008, we adopted the MEI Pharma, Inc. 2008 Stock Omnibus Equity Compensation Plan (the Omnibus Plan), as amended and restated from time to time, under which &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,850,739&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock are authorized for issuance. The Omnibus Plan provides for the grant of options and/or other stock-based or stock-denominated awards to our non-employee directors, officers, employees and advisors. As of June 30, 2025, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;920,737&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares available for future grant under the Omnibus Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2021, we adopted the 2021 Inducement Plan (Inducement Plan, together with the Omnibus Plan, the Equity Plans), under which &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock were authorized for issuance. On June 9, 2023 our Board approved an amendment and restatement of the Inducement Plan to increase the aggregate number of shares of Common Stock authorized for issuance by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares. The Inducement Plan is intended to assist us in attracting and retaining selected individuals to serve as employees who are expected to contribute to our success, by providing an inducement for such individuals to enter into employment with us and to achieve long-term objectives that will benefit our stockholders. As of June 30, 2025, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;163,698&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares available for future grant under the Inducement Plan.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total share-based compensation expense for all stock awards consists of the following, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.700000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,929&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total share-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock options granted to employees vest &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% one year from the date of grant and ratably each month thereafter for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months and expire ten years from the date of grant. Stock options granted to directors vest ratably each month for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months from the date of grant and expire &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of grant. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025, there were a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869,148&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; options outstanding of which &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;815,846&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; were granted under the Omnibus Plan and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,302&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; were granted under the Inducement Plan.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; A summary of our stock option activity and related data follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:43.689%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.902%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.202%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.523%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.2010000000000005%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Remaining Contractual&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,357,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;488,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest at June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of June 30, 2025, the aggregate intrinsic value of outstanding options is calculated as the difference between the exercise price of the underlying options and the closing price of our Common Stock of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;2.47&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; on that date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unrecognized compensation expense related to non-vested stock options totaled &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025. Such compensation expense is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1.17&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025, we expect all outstanding options to vest.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use a Black-Scholes valuation model to estimate the grant date fair value of stock options. During the year ended June 30, 2025, we did not grant any stock options. During the fiscal year ended June 30, 2024,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;following weighted-average assumptions were used to calculate these fair values:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:79.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_bbdcc299-39eb-4e27-b604-ab146bacfa01"
      decimals="INF"
      id="F_7db99271-f378-405e-96b6-2e5d85b94fef"
      unitRef="U_shares">1850739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_bbdcc299-39eb-4e27-b604-ab146bacfa01"
      decimals="INF"
      id="F_0a9cc37d-01ce-4b9b-9930-ee61100e331b"
      unitRef="U_shares">920737</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_4022bccc-441f-4478-9790-7dc6fba82efc"
      decimals="INF"
      id="F_03f90676-c065-4df0-8e34-7b786ab58ca0"
      unitRef="U_shares">125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0a639547-5eb3-4035-a49b-df9413032521"
      decimals="INF"
      id="F_73d2d0cb-8137-4efe-b7cb-0d8b2e314b1d"
      unitRef="U_shares">92000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_801bb470-1666-486b-9626-f457beb6c0e0"
      decimals="INF"
      id="F_278f595f-6ae2-43b2-88bd-076df48d348a"
      unitRef="U_shares">163698</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_d88534ab-3cd5-458f-b3ab-a7d29270fbc9">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total share-based compensation expense for all stock awards consists of the following, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.700000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,929&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total share-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="C_65ce1f21-fab6-461d-b692-0bcf9b01d489"
      decimals="-3"
      id="F_122305e1-b12a-4855-a4d5-f211110725e9"
      unitRef="U_USD">-128000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0b16e06a-f891-41fa-a61d-1dcab0a16b52"
      decimals="-3"
      id="F_1595c22c-4c46-4343-a3e0-b21c1f0c6ce8"
      unitRef="U_USD">349000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_55a276dd-3278-431b-bb6a-72afcf0a97f5"
      decimals="-3"
      id="F_f27e1f69-fb1c-42bd-9fb9-b677d717854c"
      unitRef="U_USD">-16000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_2f5d0c47-45b0-40b0-8304-92a36ee32203"
      decimals="-3"
      id="F_19acdb29-905d-4b2d-b058-fcb621119caa"
      unitRef="U_USD">1929000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_11ff3fe6-3673-4319-9284-a7c1e46f8f44"
      unitRef="U_USD">-144000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_893671fc-6764-47e8-bf23-2fae0fab14d0"
      unitRef="U_USD">2278000</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_8f477f08-619a-4dd4-bf96-14b4f5bbc093"
      decimals="2"
      id="F_b5e4d31c-2585-4a0a-b4ed-d26d393685b8"
      unitRef="U_pure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_8f477f08-619a-4dd4-bf96-14b4f5bbc093"
      id="F_c0106206-aad7-43f1-b79d-a5a660edf5d6">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_4f503b69-15af-4b8f-a96a-caa0ddcce497"
      id="F_58426dec-0d8f-4c18-b421-99513f925d94">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_4f503b69-15af-4b8f-a96a-caa0ddcce497"
      id="F_56c2981a-0ffe-44cc-b52f-72fe564a2291">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_09f1e527-d411-49b0-8987-c4eeed8a7d14"
      decimals="INF"
      id="F_9531ba9e-ba97-431e-b09c-7814e2405464"
      unitRef="U_shares">869148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_3e8cceec-9f3f-4c61-8560-6f8645289b52"
      decimals="INF"
      id="F_6cdecf96-7bcc-44d0-bee2-7c1fc298813a"
      unitRef="U_shares">815846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_32df5392-7969-40b6-9827-2e4cab47aa33"
      decimals="INF"
      id="F_f11f5b59-3df2-45bf-ab28-5110077f1797"
      unitRef="U_shares">53302</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e7fe1e55-fa7d-41da-87f7-c0630f24af82">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; A summary of our stock option activity and related data follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:43.689%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.902%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.202%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.523%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:6.2010000000000005%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Remaining Contractual&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,357,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;488,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest at June 30, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;869,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="INF"
      id="F_b85b9995-c1c4-45ce-949d-5370e308b7ed"
      unitRef="U_shares">1357213</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="2"
      id="F_31f6b80a-06ee-4dc0-a858-c91b69f353e4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">31.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="INF"
      id="F_4983d688-9a91-4c1b-bf6f-230c07c4ba45"
      unitRef="U_shares">488065</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_cb3031eb-0055-4fee-98dc-0cb54a22b434"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">25.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_8506d544-ed81-492e-8603-5caa2622fc9a"
      unitRef="U_shares">869148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="2"
      id="F_9a6c4762-b2a9-4bad-accf-0fd62a294946"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">32.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_bdb841e4-2b0a-485f-b6cd-05c463159218">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_e767c862-5e6e-4b59-b554-8082f34cda07"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="INF"
      id="F_b5182fe6-568a-4b48-b0da-2edc330404e1"
      unitRef="U_shares">869148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_d3e1fbbd-3e1b-43a3-9063-400fdd3797d3">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_77440a3d-b1e0-4c54-b309-5fc84ff725aa"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <lits:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice
      contextRef="C_09f1e527-d411-49b0-8987-c4eeed8a7d14"
      decimals="2"
      id="F_66c800d0-084a-47be-bc99-6d1016de683e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.47</lits:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsclosingstockprice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-5"
      id="F_60499f59-0e81-4fd6-8a3d-40cc97b810a8"
      unitRef="U_USD">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_2b61a9fd-54e3-4a2a-8eb1-e24d16daf8c7">P1Y2M1D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_218e1b8d-4fcf-425e-8642-332e17cf5def">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;following weighted-average assumptions were used to calculate these fair values:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:79.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="3"
      id="F_1946f39f-118f-4c9b-b8ad-68769ed12dc3"
      unitRef="U_pure">0.045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      id="F_d6a9cab3-c3a7-450b-8c33-fb51fde21840">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="3"
      id="F_6ca6f0c8-96ed-4b80-9363-8b89a21eba95"
      unitRef="U_pure">0.898</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_573877c6-f307-47a2-95d2-3321b697b161"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_328db247-e9c8-4cfb-b786-7886b1285ec1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_d25a2024-7e9c-4cc0-aaf6-d4d188626320">&lt;p id="fn_segments" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 12. Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the CODM, which is our Acting &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_2254fbc2-926d-4ef0-b4be-2c017a79ef44;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Executive Officer and Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in deciding how to allocate resources and assess performance. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our CODM evaluates our financial information including year over year profit and loss comparisons and cash projections on an aggregate basis when assessing performance for allocating financial and personnel resources.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; We are not organized by market and are managed and operated as one business.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We identify our operating segments based on our business activities. We operate within a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b5129ee1-cc18-4e29-a225-35da57c0a01a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment, the development of pharmaceutical products. During fiscal 2025, we did not generate any revenue. During fiscal 2024, all revenues were generated in the United States. Our administrative functions including finance, business development and information systems, support the development of pharmaceutical products segment. We operate in one geographic area, the United States. The CODM allocates resources (inclusive of both capital and personnel) based upon our net loss, which is utilized to monitor year over year variances on a quarterly basis.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accounting policies of the development of pharmaceutical products segment are the same as those described in &lt;/span&gt;&lt;a href="#fn2_sumsigpolicies"&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 2. &lt;/span&gt;&lt;span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. All our assets are in the United States. The measure of segment assets is reported on the balance sheets as total assets. We do not have intra-entity sales or transfers.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended, June 30, 2025 and 2024, we had no transactions denominated in foreign currencies nor any intangible property for which we recognized amortization expense. During the years ended June 30, 2025 and 2024, we did recognize depreciation expense which we have included in "other expenses" within the table below. Depreciation expense is reported in our statements of cash flows and is expected to be zero during fiscal 2026. Non-cash expenses such as depreciating assets and share-based compensation are not part of the CODM's evaluation or decision-making process.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes our financial data for the development of pharmaceutical products segment:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating and other (income) expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Employee expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment expenses&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,754&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,092&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,723&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,899&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fees paid on behalf of a related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;voruciclib&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ME-344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain on disposition of a non-financial asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest and dividend income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating and other (income) expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total segment costs (loss) income and net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;________&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_90745f29-5abc-43e5-b0d5-52837f1944e6">Our CODM evaluates our financial information including year over year profit and loss comparisons and cash projections on an aggregate basis when assessing performance for allocating financial and personnel resources.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_86acc6d8-b55f-4522-a52c-e9cfce1b0ca5">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes our financial data for the development of pharmaceutical products segment:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating and other (income) expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Employee expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment expenses&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,754&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,092&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,723&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,899&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fees paid on behalf of a related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;voruciclib&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ME-344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain on disposition of a non-financial asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest and dividend income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating and other (income) expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0ff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total segment costs (loss) income and net (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;________&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_e385c18a-4334-4ca4-a720-f9b4de0dfc56"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_72bfb449-79dd-4d23-b484-d4271c87fcba"
      unitRef="U_USD">65297000</us-gaap:Revenues>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_15f877ef-8b55-42ee-9852-7c64581f51dc"
      unitRef="U_USD">9293000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_b97ff31f-94b1-41a3-b090-506b5e33d3ad"
      unitRef="U_USD">13207000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:OtherExpenses
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_6672378b-77c3-44f1-871c-5952bed8854f"
      unitRef="U_USD">2647000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_d33196ca-3de0-4094-82d0-c8df56d8e926"
      unitRef="U_USD">9946000</us-gaap:OtherExpenses>
    <us-gaap:ProfessionalFees
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_09ef7c23-e10e-44f9-a1e5-6eef18705ef6"
      unitRef="U_USD">2754000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_b438aea6-7d20-4213-bdae-03069884de77"
      unitRef="U_USD">4092000</us-gaap:ProfessionalFees>
    <us-gaap:LegalFees
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_1b8828b6-8d0a-4e03-bc21-4d7804cb30c2"
      unitRef="U_USD">1723000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_8c3448ed-6227-4b40-bd6a-a27edd602528"
      unitRef="U_USD">3397000</us-gaap:LegalFees>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_dffbd0d0-5695-4a72-8b9e-1c8a931080b1"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_29ae7fac-fb10-42f4-a587-e9d0934bd714"
      unitRef="U_USD">10899000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <lits:FeesPaidOnBehalfOfRelatedParty
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_bb0c9cb1-3d8d-4963-af57-4c93161677a7"
      unitRef="U_USD">0</lits:FeesPaidOnBehalfOfRelatedParty>
    <lits:FeesPaidOnBehalfOfRelatedParty
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_e54b0873-64ec-4dcc-bfc5-0442427e6b68"
      unitRef="U_USD">1118000</lits:FeesPaidOnBehalfOfRelatedParty>
    <us-gaap:OtherExpenses
      contextRef="C_7d14d4db-d882-45a5-8109-0ae6bd9376fc"
      decimals="-3"
      id="F_bc4edfc9-43f2-44b7-aec3-290d1e42de06"
      unitRef="U_USD">801000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_5de81fb4-2434-47f3-8fae-5c41690c6230"
      decimals="-3"
      id="F_47b11a89-62c8-48ec-a3c1-a19cdd866493"
      unitRef="U_USD">3413000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_8fb49a6d-13d9-4bc0-8564-85ae7e671e0d"
      decimals="-3"
      id="F_7d489e53-c0bd-4c39-b4e3-f3f542afaae9"
      unitRef="U_USD">253000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_8e54884a-d867-4942-80ac-35ef13f92073"
      decimals="-3"
      id="F_71a137c3-8fc6-49d8-9cd4-03942dc78560"
      unitRef="U_USD">4724000</us-gaap:OtherExpenses>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_fd0fa07d-961d-4cd0-aa59-55e4fc1ad253"
      unitRef="U_USD">500000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_8d7f4fe6-1767-4cbd-a6f0-3a285589835f"
      unitRef="U_USD">0</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_e5abb520-49d5-489e-80d8-2645b1b23986"
      unitRef="U_USD">1026000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_b33b70e2-64cc-466e-b0c0-0ed351e7eb1b"
      unitRef="U_USD">3277000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_632e5b54-f4b4-46bd-a4e9-47fc0be6bc82"
      unitRef="U_USD">-15945000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_6bed2cd1-a0f6-4b3c-a390-193c56f06be1"
      unitRef="U_USD">-47519000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:NetIncomeLoss
      contextRef="C_b6a20c39-8eb1-4f5c-a7fb-2eb431c0ac09"
      decimals="-3"
      id="F_7b3607a6-15bc-4334-b19a-60cbcae63482"
      unitRef="U_USD">-15945000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_be6c2ea7-f820-4dce-af96-f91a01ecbeb3"
      decimals="-3"
      id="F_43b7cef3-edf2-4205-a080-ed142f77d159"
      unitRef="U_USD">17778000</us-gaap:NetIncomeLoss>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_10b8b78b-6887-489d-b11b-8367e197cd79">&lt;p id="fn_dis_nonfin_asset" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 13. Disposition of a Non-Financial Asset&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;October 22, 2024 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Closing Date), we and Aardvark Therapeutics, Inc. (the Purchaser), entered into an Asset Purchase Agreement (the Asset Purchase Agreement), whereby we sold to the Purchaser our rights, title and interest in and to certain assets related to ME-344, including relevant intellectual property rights, technology and contracts (the ME-344 Sale). Pursuant to the Asset&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Purchase &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Agreement, the Purchaser paid us an initial payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash plus a reimbursement amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; at the closing of the transaction. The Purchaser may also make future milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after the Closing Date, payable upon the achievement of certain regulatory and revenue milestones. The Purchaser also assumed certain of our liabilities after the Closing Date, including liabilities arising under the contracts transferred under the Asset Purchase Agreement. During the fiscal year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2025, no milestone were met.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The ME-344 Sale did not trigger a discontinued operation as the intellectual property sold did not represent a component of our business. Additionally, we concluded the ME-344 Sale met all the criteria to be derecognized on the Closing Date. Variable consideration, such as future potential regulatory and revenue milestones have been fully constrained. As such, as of the Closing Date and December 31, 2024, we determined the transaction price to be the initial payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Accordingly, we recognized a gain, upon satisfaction of our obligations under the Asset Purchase Agreement, of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as a separate component of other income (expense), net in the consolidated statements of operations. The $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reimbursement by the Purchaser represented work performed at the Purchaser's request prior to the Closing Date, which they agreed to reimburse. The reimbursement did not represent a liability assumed or relieved by the Purchaser and was, therefore, not included in the calculation of the gain on the disposition of the ME-344 asset. The $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reimbursement was recognized as contra research and development expense in accordance with our reimbursement policy for pass through services.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <lits:AdoptedAgreement
      contextRef="C_e968e6a1-e1dc-4b6b-b7eb-2349e035aa81"
      id="F_843f9b21-45b1-4419-a088-65ce9489ba0e">2024-10-22</lits:AdoptedAgreement>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_4599d307-ed5c-4842-ac28-146c1c1c5cbd"
      decimals="-5"
      id="F_b9241d46-a8fb-462a-bdf6-be8c3e3e7e63"
      unitRef="U_USD">500000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <lits:ReimbursementAmount
      contextRef="C_7d1dd293-c91b-41db-ae9c-cff76e94081f"
      decimals="0"
      id="F_66d2117e-e0aa-4ca2-a200-bace655a4949"
      unitRef="U_USD">55000</lits:ReimbursementAmount>
    <lits:MilestonePayment
      contextRef="C_efee07f7-2a59-42fe-b86a-e2563b5f1277"
      decimals="-5"
      id="F_05c00e1a-144b-4e68-8ca4-65d9ebf3cba5"
      unitRef="U_USD">62000000</lits:MilestonePayment>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-5"
      id="F_7321abb6-bb95-41fe-8ef7-fdb73f05ac95"
      unitRef="U_USD">500000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-5"
      id="F_3a4aa4c0-672c-443f-bf9d-e300b9e485e3"
      unitRef="U_USD">500000</us-gaap:GainLossOnSaleOfOtherAssets>
    <lits:ReimbursementAmount
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="0"
      id="F_f5fbd8ce-bf44-4a0f-9c27-27f3becdb688"
      unitRef="U_USD">55000</lits:ReimbursementAmount>
    <lits:ReimbursementAmount
      contextRef="C_e9c5cddf-20f7-4aeb-a9be-fe852d96546b"
      decimals="0"
      id="F_48e9bd41-fb30-45ef-8dbe-36fbe41d813f"
      unitRef="U_USD">55000</lits:ReimbursementAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_fe5edc01-2e08-459f-a6e7-dc578dc5e1ac">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 14. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pre-tax loss consists of the following jurisdictions, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Domestic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pre-tax (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The reconciliation of income tax computed at the U.S. federal statutory tax rates to income tax expense is as follows, in thousands:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:39.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax (benefit) expense at U.S. statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State tax (benefit) expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,671&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;368&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities and assets are comprised of the following, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:67.606%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.817%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.817%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax losses carried forward&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalization of R&amp;amp;D costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,456&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed and intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share-based payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,918&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,918&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets and liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We evaluate the recoverability of the deferred tax assets and the amount of the required valuation allowance. Due to the uncertainty surrounding the realization of the tax deductions in future tax returns, we have recorded a valuation allowance against our net deferred tax assets as of June 30, 2025 and 2024. At such time as it is determined that it is more likely than not that the deferred tax assets will be realized, the valuation allowance would be reduced.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We had federal and state net operating loss carryforwards of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;246.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The federal net operating loss will carry forward indefinitely subject to an &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% taxable income limitation. The state net operating loss carryforwards will begin to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2031&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; unless previously utilized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our ability to utilize our net operating loss carryforwards may be substantially limited due to ownership changes that have occurred or that could occur in the future under Section 382 of the Internal Revenue Code (Section 382) and similar state laws. A Section 382 study was completed through December 31, 2021, to analyze whether one or more ownership changes had occurred and determined that two such ownership changes did occur. We have not completed a Section 382 study through June 30, 2025. If an ownership change occurred our ability to utilize our net operating loss carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;None of our prior income tax returns have been selected for examination by a major taxing jurisdiction; however, the statutes of limitations for various filings remain open. The oldest filings subject to potential examination for federal and state purposes are 2021 and 2020, respectively. If we utilize a net operating loss related to a closed tax year, the tax year in which the loss was incurred is subject to adjustment up to the amount of the net operating loss.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have not reduced any tax benefit on our consolidated financial statements due to uncertain tax positions as of June 30, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and we are not aware of any circumstance that would significantly change this result through the end of fiscal year 2026. To the extent we incur income-tax related penalties or interest, we will recognize them as additional income tax expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_b5a5e7b9-ed2e-4ff8-88b8-5d92d0b9d93f">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pre-tax loss consists of the following jurisdictions, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Domestic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pre-tax (loss) income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_2fdd132b-a39c-4284-8e32-b1a71979e79c"
      unitRef="U_USD">-15945000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_1095fce9-5cb3-4a14-8754-1bbfa43b1206"
      unitRef="U_USD">17778000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_ed2a0c8c-2f90-464b-ab68-316e78c83b3b"
      unitRef="U_USD">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_0dc9745f-8062-47e1-b3ed-b4001927f74e"
      unitRef="U_USD">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_bc422db1-b77f-4602-9ab9-a07b551f1b89"
      unitRef="U_USD">-15945000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_972ebdc0-e565-4651-aef6-826ec9dacbdd"
      unitRef="U_USD">17778000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_8a420fa1-1581-4acc-b422-7554c17144d2">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The reconciliation of income tax computed at the U.S. federal statutory tax rates to income tax expense is as follows, in thousands:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:39.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="14" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Fiscal Year Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax (benefit) expense at U.S. statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State tax (benefit) expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,671&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;368&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_628c3006-2c04-4f87-a71b-0650d3ebcf2d"
      unitRef="U_USD">-3349000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_0b4c0b05-8b25-4205-8fe1-e0dcd7d11ff9"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_ab7b4a38-24aa-43ba-b74d-443ff4161005"
      unitRef="U_USD">3733000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_51ceac99-3ffe-45a0-a36a-0eefd5950526"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_0b3ab206-b173-4be1-8d57-7f30b5f56bfe"
      unitRef="U_USD">-2733000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_facb08e8-92ca-4f62-a002-0e577b368c29"
      unitRef="U_pure">0.17</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_035b2003-1961-4795-8f38-e066e8a0662f"
      unitRef="U_USD">796000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_1f0ef29c-7c21-478d-bb09-814a4ae450a7"
      unitRef="U_pure">0.05</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_88c62756-5c53-4ad2-821b-302a6b8d10a7"
      unitRef="U_USD">1671000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_38e9c23f-1ede-431e-8197-47e2fd76c0c1"
      unitRef="U_pure">-0.10</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_b4f5ad32-3081-4f67-9595-4b27f0bced7e"
      unitRef="U_USD">901000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_fa908e19-5b24-4308-83fd-b864222e1174"
      unitRef="U_pure">0.05</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_79e28d15-f5bf-4268-a8f2-906bfbf8db6d"
      unitRef="U_USD">3782000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_634ae3a9-ad47-4b7a-b20a-81265ca7d062"
      unitRef="U_pure">-0.24</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_605338da-bc36-4ae1-9a82-d413a822c3d0"
      unitRef="U_USD">-6281000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_7d21b805-7202-48b7-a768-fbdc5fb77056"
      unitRef="U_pure">-0.35</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <lits:IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_b2a7a05b-6003-4a59-90ec-082afd5e2c7c"
      unitRef="U_USD">507000</lits:IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount>
    <lits:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_98795853-5c55-4294-b81c-dd5d2f5dc0fc"
      unitRef="U_pure">-0.03</lits:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent>
    <lits:IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_b50e1f78-55a5-4ea5-904f-e8e0474513ba"
      unitRef="U_USD">483000</lits:IncomeTaxReconciliationNondeductibleExpenseSection162MLimitationAmount>
    <lits:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_4c85c355-4803-406f-9170-f0d94928a05b"
      unitRef="U_pure">0.03</lits:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162MLimitationPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_8f4ca980-fed5-49c2-9c43-867f804730fd"
      unitRef="U_USD">122000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_2fc4b6ee-5362-49f7-9db0-d8cd59338fa3"
      unitRef="U_pure">-0.01</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_78559cce-d459-441c-85a1-d06ebfe395b7"
      unitRef="U_USD">368000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_3b7cf371-ae7c-41bc-a67c-f02379c3c456"
      unitRef="U_pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-3"
      id="F_b250988d-458e-49fc-9bdc-d50955ceb006"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="2"
      id="F_a6588a34-7b14-4ad0-9093-f046cf498211"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-3"
      id="F_f74ce751-1273-42fa-948f-3396bc4000ca"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="2"
      id="F_b65a3551-7b56-4f65-8b45-2a0f775e9fe7"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_3ff97ca0-73b8-4685-8bd7-b027834bf454">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities and assets are comprised of the following, in thousands:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:67.606%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.817%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.817%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax losses carried forward&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalization of R&amp;amp;D costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,456&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed and intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share-based payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,918&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69,918&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets and liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_291eed64-26e7-4e2a-b132-3fceaae95d66"
      unitRef="U_USD">53346000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_b03b020b-065f-4672-a7c9-9d3319379ee9"
      unitRef="U_USD">45721000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_9f0b9f6c-955e-4732-925a-dd4d0fcb11d7"
      unitRef="U_USD">9398000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_3592660c-5e21-46c5-9e4d-0dde8f40ce56"
      unitRef="U_USD">11456000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <lits:DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_da670191-0e9d-4c00-b3e6-fa8d57be5de9"
      unitRef="U_USD">7881000</lits:DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets>
    <lits:DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_7625e53d-1f57-4216-8e57-e3e976dac037"
      unitRef="U_USD">8058000</lits:DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_a4b615f4-1658-4f76-94cf-dfc8581d2889"
      unitRef="U_USD">2375000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_c32a3772-3774-40c4-b160-1f006cff734d"
      unitRef="U_USD">4081000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <lits:DeferredTaxAssetsRightOfUseAssets
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_29a7c65e-6c93-4d69-95f2-c49d5646a1b8"
      unitRef="U_USD">0</lits:DeferredTaxAssetsRightOfUseAssets>
    <lits:DeferredTaxAssetsRightOfUseAssets
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_a7b08241-bfdf-4ee1-9ce5-2cac310c4adf"
      unitRef="U_USD">-45000</lits:DeferredTaxAssetsRightOfUseAssets>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_93ffb517-1ab4-4e92-abf2-37ae6af566c9"
      unitRef="U_USD">700000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_697e894c-70e9-4901-8bf9-db4e025e0a2d"
      unitRef="U_USD">647000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_a8a79d37-d41a-4c4a-8ca3-66cdcda96b80"
      unitRef="U_USD">73700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_a29eede2-685e-4ea5-b728-10aee770bf73"
      unitRef="U_USD">69918000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_8e16e180-65a7-43d2-a31c-1ba73ab4c04a"
      unitRef="U_USD">73700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_2fa18258-1af6-41dd-ae81-48ec2bb8adb6"
      unitRef="U_USD">69918000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-3"
      id="F_b3ff5daa-26a4-4940-8113-26693a5270fd"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_bf1b37a8-0bf9-4bfe-835a-dce716f936ac"
      decimals="-3"
      id="F_10c728a0-5236-4f4d-a9e1-fee230607a55"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-5"
      id="F_0c82571c-4607-49fd-8f7a-2acc76ac377f"
      unitRef="U_USD">246100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_6d50d93a-6c1e-4c80-b9a8-f3568b73ccbc"
      decimals="-5"
      id="F_57a1749b-92e8-4e00-a973-52dc7595ac69"
      unitRef="U_USD">23800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <lits:TaxableIncomePercentage
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="INF"
      id="F_55ba3ae1-e925-42e5-8fd4-3884dbec59d0"
      unitRef="U_pure">0.80</lits:TaxableIncomePercentage>
    <lits:DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear
      contextRef="C_87078fb9-2267-4137-924d-3f4e8270a7ef"
      id="F_3b168a8d-253d-4a6a-a154-0106f8c69a56">2031</lits:DeferredTaxAssetsOperatingLossCarryForwardsExpirationYear>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_c6598c48-41e0-4082-be09-30da8df10ae9">&lt;p id="fn_subevent" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Securities Purchase Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 17, 2025, we entered into securities purchase agreements (the Securities Purchase Agreements) with certain investors (the Purchasers) pursuant to which we agreed to sell and issue to the Purchasers in a private placement offering (the Offering or the PIPE) an aggregate of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,216,898&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock, at an offering price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and (ii) Pre-Funded Warrants, to purchase up to an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;6,022,869&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock at an offering price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4199&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Pre-Funded Warrant in exchange for net proceeds of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Each Pre-Funded Warrant is immediately exercisable for one share of Common Stock at the exercise price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Pre-Funded Warrant Share and may be exercised at any time until all the Pre-Funded Warrants issued in the Offering are exercised in full. Each Purchaser&#x2019;s ability to exercise its Pre-Funded Warrants in exchange for shares of Common Stock is subject to certain beneficial ownership limitations set forth therein. The Offering closed on July 22, 2025 (the SPA Closing Date). On July 24, 2025, Pre-Funded Warrants for the purchase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,084,509&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock were exercised, respectively, for a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;de minimis &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amount of cash proceeds. As of September 23, 2025, we &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt;issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,807,967&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock upon&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; cashless exercises of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:'times new roman',serif;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,808,070&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'times new roman',serif;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 5, 2025, we announced the commencement of our primary reserve asset and implementation strategy built on a digital asset infrastructure and long-term capital innovation (a Litecoin Treasury Strategy) through our acquisition of Litecoin (LTC) tokens, reflecting the full deployment of the net proceeds of the PIPE.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Placement Agency Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 17, 2025, we also entered into a Placement Agency Agreement (the Placement Agency Agreement) with Titan Partners Group LLC, a division of American Capital Partners, LLC (Titan), pursuant to which Titan agreed to serve as the exclusive placement agent for us in connection with the Offering. We agreed to pay Titan a cash fee equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the aggregate gross cash proceeds received in the Offering (or $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million). We also agreed to issue Titan warrants (the Placement Agent Warrants) to purchase up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,169,591&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the Securities sold in the Offering) (the Placement Agent Warrant Shares), at an exercise price per share equal to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, exercisable, in whole or in part, at any time and from time to time, for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_471041f0-6337-4d57-89cb-a763e2396550;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of issuance. In addition, we agreed to reimburse Titan for reasonable accountable expenses in an amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, including legal fees in connection with the Offering.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Asset Management Agreement (the Asset Management Agreement)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2025, we and GSR Strategies LLC (GSR or the Asset Manager) entered into the Asset Management Agreement. The Asset Manager shall provide discretionary investment management services with respect to, among other assets, our proceeds from the Offering (the Account Assets) in accordance with the terms of the Asset Management Agreement. The Asset Manager will pursue a long-only investment strategy investing primarily in LTC. The custodians under the Asset Management Agreement will consist of Coinbase and other cryptocurrency wallet providers agreed to by us and the Asset Manager.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We shall pay the Asset Manager an asset-based fee (the Asset-based Fee) equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum of the Account Assets under management. The Asset-based Fee shall be paid in shares of Common Stock until the Asset Manager owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of our issued&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;outstanding Common Stock and thereafter, the Asset-based Fee shall be paid in Pre-Funded Warrants (the GSR Pre-Funded Warrants) to purchase shares of Common Stock (the GSR Pre-Funded Warrant Shares). The number of shares of Common Stock or GSR Pre-Funded Warrants will be issued to be equal to the dollar amount of the Asset-based Fee being paid, divided by the average volume-weighted average price (VWAP) of the Common Stock for the 30 trading days ending with the trading day prior to the date that is the applicable 12-month anniversary of the SPA Closing Date (the Fee Reference Date).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As compensation for services rendered by the Asset Manager under the Asset Management Agreement, we issued warrants (the GSR Warrants) to the Asset Manager on the SPA Closing Date to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,461,989&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (the GSR Warrant Shares) at various exercise prices per share of Common Stock as follows: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;584,795&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share; (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.93&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share; (iii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.62&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share; and (iv) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;292,398&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.13&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The GSR Warrants are exercisable, in whole or in part, at any time for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_da2a1c44-7a41-4557-8068-3921e2100485;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of issuance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Asset Management Agreement will, unless terminated earlier in accordance with its terms, remain in effect until the tenth anniversary of the date of the Asset Management Agreement. Beginning on the first anniversary of the AMA Effective Date (as defined below), the Asset Management Agreement may be terminated upon at least 90 days prior written notice to the other party (i) by us upon a determination of the Board to end the Lite Treasury Strategy, or (ii) by the Asset Manager for any reason. Additionally, the Asset Management Agreement may be terminated for cause (i) by us upon at least 30 days prior written notice to the Asset Manager or (ii) by the Asset Manager upon at least 60 days prior written notice to us.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 24, 2025, as payment of the annual Asset-based Fee under the Asset Management Agreement, we issued to GSR, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;546,348&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. Subject to the limitations on exercise set forth in the warrant agreement, the Pre-Funded Warrants may be exercised at any time until they are exercised in full.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Advisory Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2025 (the AMA Effective Date), we also entered into an Advisory Agreement (the Advisory Agreement) with Green Dragon Investments LLC (Green Dragon). Pursuant to the Advisory Agreement, Green Dragon will provide us with asset management services with respect to the Account Assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We shall pay Green Dragon an asset-based fee (the Annual Advisory Fee) in warrants (the Advisory Warrants) to purchase a number of shares of the Common Stock (Advisory Warrant Shares) equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum of the Account Assets for such year, as calculated in accordance with the Asset Management Agreement. The number of Advisory Warrants to be issued for any given year shall be equal to the dollar amount of the Annual Advisory Fee for such year, divided by the average VWAP of the Common Stock for the 30 trading days ending with the trading day prior to the associated Fee Reference Date. The exercise price per share of the Advisory Warrants shall be set at a price equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Advisory Warrants shall be exercisable, in whole or in part, at any time for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_e6417c3a-45fe-44f8-aa59-aea60d182067;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of issuance. The Advisory Warrants issued each year shall vest in four equal installments on the Fee Reference Date on which they are issued and then the succeeding three month anniversaries thereof.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Advisory Agreement will, unless terminated earlier in accordance with its terms, remain in effect until the tenth anniversary of the Advisory Agreement. Either party may terminate the Advisory Agreement, with or without reason, by written notice to the other.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Advisor Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2025, we also entered into a Strategic Advisor Agreement (the Strategic Advisor Agreement) with Green Grass Ventures (GGV). Pursuant to the Strategic Advisor Agreement, GGV provides us with strategic advice and guidance relating to the private placement of equity and equity-linked securities in connection with a proposed cryptocurrency asset management strategy, as well as with the Offering. As compensation for services rendered by GGV under the Strategic Advisor Agreement, upon the closing of the Offering, we issued warrants (the Strategic Advisor Warrants) to GGV to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;438,597&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock (the Strategic Advisor Warrant Shares). The exercise price per share of the Strategic Advisor Warrants is equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Warrants shall be exercisable, in whole or in part, at any time for a period of five years from the date of issuance. The Strategic Advisor Agreement terminated in accordance with its terms on the SPA Closing Date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Termination of the Cooperation Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Effective July 22, 2025, upon closing of the Offering, the parties to the Cooperation Agreement mutually agreed to terminate such Cooperation Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Change in Board of Directors Composition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 22, 2025, in accordance with the certain Cooperation Agreement, Taheer Datoo and James Flynn tendered their resignations from the Board upon the Investors (as defined in the Cooperation Agreement) ceasing to own the Minimum Ownership Amount (as defined in the Cooperation Agreement). The Board accepted the resignation of Taheer Datoo and rejected the resignation of James Flynn. Upon closing of the Offering, the Board elected Charlie Lee to the Board. Mr. Lee is the creator of LTC and Director of the Litecoin Foundation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 5, 2025, Steven D. Wood informed the Board of his decision to resign from the Board, effective immediately. On August 5, 2025, the Board elected Joshua Riezman to the Board. Mr. Riezman is Managing Director and Head of U.S. Legal and Compliance for GSR.&lt;/span&gt;&lt;/p&gt;&lt;p id="fn_new_sales_agree" style="margin-left:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Entry into a New Sales Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We entered into a Sales Agreement (the Sales Agreement) with Titan (in such capacity, the Agent), pursuant to which we may sell, from time to time, at its option, up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in aggregate principal amount of an indeterminate amount of shares (the ATM Shares) of Common Stock, through the Agent, as our sales agent. We will pay the Agent a commission of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the gross sales price of the ATM Shares sold pursuant to the Sales Agreement, if any.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Any ATM Shares to be offered and sold under the Sales Agreement will be issued and sold (i) by methods deemed to be an at-the-market offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or in negotiated transactions, if authorized by us and (ii) pursuant to the Registration Statement on Form S-3 filed by us with the SEC on February 20, 2024 for an offering of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of various securities, including shares of our Common Stock, preferred stock, warrants, rights and/or units for sale to the public in one or more public offerings, which became effective on February 28, 2024 (the Registration Statement).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The offering of the ATM Shares will terminate upon the earliest of (a) the issuance and sale of all of the ATM Shares by the Agent on the terms and subject to the conditions set forth in the Sales Agreement and (b) the termination of the Sales Agreement by either of the parties thereto.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Option Grants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 15, 2025, our Board approved option grants for the purchase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;124,250&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; options to members of our Board and employees, with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.07&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; On August 8, 2025, commensurate with Mr. Riezman's appointment to our Board, our Board approved an initial option grant for Mr. Riezman for the purchase of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.19&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Sales under our ATM Program&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Between the SPA Closing Date and September 23, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, we issued and sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;882,924&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of our Common Stock at an average selling price of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4484&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for gross proceeds of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, less underwriter's commission and expenses of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, for net proceeds of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, through our ATM Program.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Master Loan Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 3, 2025, we entered into a master loan agreement (the Loan Agreement) with BitGo Prime, LLC (Lender). The Loan Agreement creates a framework under which we may borrow any digital assets or cash from Lender from time to time. Each loan is documented in a separate loan request agreed to by the parties setting for the specific terms, including principal amount, fees, collateral requirements and the date on which the loan is to commence and mature.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The loan fee, effectively the interest rate on the borrowed amounts, is to be determined for each loan and is calculated on a daily basis at the annualized rate specified in each confirmation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each loan may have a fixed term, or may include a call option or prepayment option, as specified in each loan request. In general, either party can terminate a loan by providing notice within the time frame set forth in the Loan Agreement. Upon termination, the borrowed digital assets or cash must be returned and the related collateral released.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Borrowings under the Loan Agreement are secured by collateral in favor of the Lender. Collateral may include cash or other forms agreed upon by the Parties. The collateral&#x2019;s required value is typically higher than the borrowed amount, subject to margin calls as set forth in the Loan Agreement. If the value of posted collateral falls below the margin call threshold, the Company must promptly&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;post additional collateral. Failure to maintain sufficient collateral can result in an event of default and remedies available to the Lender, including the right to liquidate pledged collateral.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Loan Agreement contains representations and warranties and affirmative and negative covenants customary for financings of this type, as well as customary events of default.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_870e143e-2c95-4ffb-9924-d47b9fd9da81"
      decimals="INF"
      id="F_63836c53-6a9e-4c8a-b330-a2c6800616d4"
      unitRef="U_shares">23216898</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_f8fe8388-272b-46fb-9ea1-e5324c26c86c"
      decimals="2"
      id="F_40260e3e-986f-4c20-a6b5-0f145f65fdae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.42</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"
      decimals="INF"
      id="F_cc65713e-c597-47fc-b8ed-0404cde2aeb8"
      unitRef="U_shares">6022869</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"
      decimals="4"
      id="F_820ff5c7-68d0-430a-8468-f3043b82a2da"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.4199</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_a06c0f95-2711-45fa-8758-3af29c6ca47e"
      decimals="-5"
      id="F_4997fbc5-b52f-470d-bb45-c599f06960e4"
      unitRef="U_USD">92100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2f8e3b33-57c4-4306-a76e-98b799f23f2e"
      decimals="4"
      id="F_47c15284-5eef-407e-929e-72325c11fbc1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_07f286c0-e5a6-4c38-9799-941180c82a4c"
      decimals="INF"
      id="F_e84da28a-0de2-42a8-afba-0b0ee0421d59"
      unitRef="U_shares">2084509</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_c3b4f0ba-7a4d-47e8-8bb4-f63b248c3738"
      decimals="INF"
      id="F_9858f9de-a20f-472d-854e-02272c4cc9f8"
      unitRef="U_shares">2807967</us-gaap:CommonStockSharesIssued>
    <lits:SurrenderedWarrantsToAcheiveCommonStock
      contextRef="C_d190719d-ba9d-4549-9346-f6c2c6a02045"
      decimals="INF"
      id="F_370cf18e-4626-4f60-94c6-ac14762aa8f3"
      unitRef="U_shares">2808070</lits:SurrenderedWarrantsToAcheiveCommonStock>
    <lits:PercentageOfDeferredOfferingCosts
      contextRef="C_0c124857-32c7-4d51-83ca-319184ab60ce"
      decimals="3"
      id="F_32bebab9-7e92-46d2-b77f-e969431de049"
      unitRef="U_pure">0.07</lits:PercentageOfDeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8"
      decimals="-5"
      id="F_61791c93-a6d5-466b-872b-535d1c2ce3b8"
      unitRef="U_USD">7000000</us-gaap:DeferredOfferingCosts>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8"
      decimals="INF"
      id="F_2a1f3e6c-709f-4c71-9af8-5f56276ade4f"
      unitRef="U_shares">1169591</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lits:PercentageOfSecuritiesSoldAtOffering
      contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8"
      decimals="3"
      id="F_6193d006-de85-427f-afca-78e411f8ed8d"
      unitRef="U_pure">0.04</lits:PercentageOfSecuritiesSoldAtOffering>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_588ef89b-8dde-48fe-9eb4-42e303780ef8"
      decimals="2"
      id="F_30377f66-9f9e-46a6-a59c-96a2cf7b4ea2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_7c7a543b-cf8d-4e11-8cd1-eb898eaf4c1a"
      decimals="0"
      id="F_0087a535-2d45-40f4-919a-1642ab0ccc95"
      unitRef="U_USD">150000</us-gaap:DeferredOfferingCosts>
    <us-gaap:ManagementAndServiceFeesRate
      contextRef="C_db8a5320-d917-40b0-808a-594d2f634033"
      decimals="4"
      id="F_29c14fbf-3ffe-4d89-9295-5e3e69c82249"
      unitRef="U_pure">0.0175</us-gaap:ManagementAndServiceFeesRate>
    <lits:AssetManagerOwnershipThresholdRate
      contextRef="C_db8a5320-d917-40b0-808a-594d2f634033"
      decimals="4"
      id="F_58ac882c-39b3-4552-ae79-0c40182d2bfc"
      unitRef="U_pure">0.0499</lits:AssetManagerOwnershipThresholdRate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_2c0b1dcd-adce-47b9-ae07-a9ae57be522c"
      decimals="INF"
      id="F_5d2b1798-84e9-4382-8656-c937600097f1"
      unitRef="U_shares">1461989</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312"
      decimals="INF"
      id="F_b16c50e6-1eb4-42a4-b845-29afc2ce641f"
      unitRef="U_shares">584795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_76333d67-a7a6-4b6b-b653-9ff65dcb2312"
      decimals="2"
      id="F_c261be23-554f-4512-b404-816b2c687514"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.42</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284"
      decimals="INF"
      id="F_0f83712a-247f-4a9d-9e52-a5796e9fd35c"
      unitRef="U_shares">292398</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_782d4804-c6b3-4521-80f5-fc558e241284"
      decimals="2"
      id="F_0f216bb2-3339-4875-8dbb-1741693eb950"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.93</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42"
      decimals="INF"
      id="F_4bb58ffe-fe23-4daa-bbe7-3cb77334308e"
      unitRef="U_shares">292398</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7e65b259-8510-471f-b0d9-635c29c62a42"
      decimals="2"
      id="F_9ab42383-6edb-493a-aeb2-563ece250a8e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0"
      decimals="INF"
      id="F_77bc0665-9a38-4082-9022-351f3bb81592"
      unitRef="U_shares">292398</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8324ec45-0eb9-4638-b615-b1ee584086e0"
      decimals="2"
      id="F_8823fc2a-c50d-446d-b512-341211c38e3d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_08b96565-9169-4635-945d-9321b9c399be"
      decimals="INF"
      id="F_ed2546a4-f9f5-449c-a3c2-d40225e4f24f"
      unitRef="U_shares">546348</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_08b96565-9169-4635-945d-9321b9c399be"
      decimals="4"
      id="F_5fdb3e1f-4672-4f07-b831-6b2217e119cc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lits:AdvisoryFeeRate
      contextRef="C_3bdebc26-b1ff-4f0d-9742-becf52c22f69"
      decimals="4"
      id="F_8d0ba9c6-582d-4f86-8f6e-d65893176b13"
      unitRef="U_pure">0.0075</lits:AdvisoryFeeRate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_303a0d36-3cb7-4d85-bdff-8bcece057b3b"
      decimals="4"
      id="F_346e663a-f624-4b9a-89c2-6610c8172409"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8382ec42-fefe-4374-81ae-7fa8a34f0db7"
      decimals="INF"
      id="F_0c156edf-a0e3-471c-ae15-ffc5a87b2b37"
      unitRef="U_shares">438597</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_eebe7de3-feed-4cd9-8e5d-19e4577417b5"
      decimals="2"
      id="F_d9625b7a-7b11-4dff-88a6-c12482836e78"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_e1e0a909-dd46-42bb-8478-62d44158460b"
      decimals="INF"
      id="F_fdd49ed7-547f-494d-81c4-6272b417f333"
      unitRef="U_USD">100000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <lits:AgentCommissionRate
      contextRef="C_6d37e90f-283f-41b0-b124-b327504c907e"
      decimals="3"
      id="F_6b664ec9-c0ee-4ffb-9af0-ed24724ce86f"
      unitRef="U_pure">0.035</lits:AgentCommissionRate>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_42469529-12e3-4edc-a0e6-3a47d45ab69f"
      decimals="INF"
      id="F_44159f57-3cdc-4e6a-91ba-e09692ea468b"
      unitRef="U_shares">100000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_07682bb1-2b3e-4319-8e57-ef12c2e28266"
      decimals="0"
      id="F_85b2201f-726c-4d32-b745-9f36890d7f79"
      unitRef="U_shares">124250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_07682bb1-2b3e-4319-8e57-ef12c2e28266"
      decimals="2"
      id="F_2394aeca-a3e2-4153-8c5b-cfcacac107b1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_a5fffeed-2536-49c6-8e93-f0cbbb5cdefa"
      decimals="0"
      id="F_1fc9ca41-4768-4ce0-800c-1a74b2f24b47"
      unitRef="U_shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_a5fffeed-2536-49c6-8e93-f0cbbb5cdefa"
      decimals="2"
      id="F_31578b86-ae49-46e3-8ea6-6b67e94eb21c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_3ad957d5-2461-4ae3-9be5-d6b77b9afb1e"
      decimals="INF"
      id="F_368bd469-e276-4b53-a788-0bb01640f243"
      unitRef="U_shares">882924</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_b8e64ad8-9663-44a6-afdd-eb5bc7829282"
      decimals="4"
      id="F_36b4c992-e081-4b2a-a52b-4d3146e15392"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.4484</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_3ad957d5-2461-4ae3-9be5-d6b77b9afb1e"
      decimals="-5"
      id="F_d01c275a-a7e1-4619-adde-0cf64813e92f"
      unitRef="U_USD">4800000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForCommissions
      contextRef="C_d153b937-6a62-4ec2-97ea-eb68558e59ce"
      decimals="-5"
      id="F_57ee70f2-96a3-4b9c-8fe3-9f917f02dda3"
      unitRef="U_USD">200000</us-gaap:PaymentsForCommissions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_d153b937-6a62-4ec2-97ea-eb68558e59ce"
      decimals="-5"
      id="F_7d06c017-8245-4f0f-aaeb-33f6e1510b42"
      unitRef="U_USD">4600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916"
      id="F_92f1aa60-9e86-4861-a976-19557f6a5652">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916"
      id="F_b51f4229-660b-4ea5-8c55-1546f90df429">false</ecd:NonRule10b51ArrAdoptedFlag>
    <lits:Rule10B51ArrModifiedFlag
      contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916"
      id="F_20ab998e-b82b-4e28-b565-e04f0bda8e09">false</lits:Rule10B51ArrModifiedFlag>
    <lits:NonRule10B51ArrModifiedFlag
      contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916"
      id="F_cff8ec69-8e3d-4397-b65a-1773d89c65e7">false</lits:NonRule10B51ArrModifiedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916"
      id="F_e6044d7e-9dc7-4294-be5d-ea9a5679d8c4">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_9fad389a-e538-433a-b7d3-4a232940c916"
      id="F_e780411a-67ad-49ff-8a16-b054c27ca363">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_8968c567-f37b-48cc-b001-63ec1eaee33f">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_1b470f53-5e95-46a8-9dc8-ab73866e2b9d">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Award Grant Practices&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have had no program, plan or practice pertaining to the timing of stock option grants to named executive officers coinciding with the release of material non-public information, or MNPI.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Compensation Committee has historically approved grants of options &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;annually each year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as part of our annual compensation cycle. The timing of any equity grants to newly-hired employees, or in connection with promotions or other non-routine grants, is generally tied to the event giving rise to the award (such as an executive officer&#x2019;s commencement of employment or promotion effective date). Any grants to executive officers are approved at meetings of the Compensation Committee or our board of directors. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;all stock option awards, the exercise price is no less than the closing price of our common stock on the date of the grant. The following table sets forth information for certain stock options granted to our named executive officers through fiscal year 2025, which there were no grants made to our named executive officers or any employees during the fiscal year ended June 30, 2025. In the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;event &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;an issuer grants stock options or option-like instruments within the period commencing four business days prior to and ending one business day following the filing by the Company of a Form 10-K, Form 10-Q or Form 8-K containing material non-public information as required under Item 402(x) of Regulation S-K, Item 402(x) of Regulation S-K requires tabular disclosure of certain information related to such awards.&lt;/span&gt;&lt;/p&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_ecfa733c-b325-4e69-a959-8e271e460ef6">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_771e4d9a-e7be-4111-b867-737706ba9806">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Compensation Committee has historically approved grants of options &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;annually each year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as part of our annual compensation cycle. The timing of any equity grants to newly-hired employees, or in connection with promotions or other non-routine grants, is generally tied to the event giving rise to the award (such as an executive officer&#x2019;s commencement of employment or promotion effective date). Any grants to executive officers are approved at meetings of the Compensation Committee or our board of directors. &lt;/span&gt;</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgPredtrmndFlag
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_726818f1-f474-46f3-afcf-1e77fd17b87c">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:PvpTableTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_06ec4875-7ba3-46cd-931c-8bb5ea46be56">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pay Versus Performance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Provided below is our pay versus performance disclosure as required pursuant to Item 402(v) of Regulation S-K promulgated under the Exchange Act. As required by Item 402(v), we have included:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A description of our most important measures that our Compensation Committee used in fiscal year 2025 to link a measure of pay calculated in accordance with Item 402(v) (referred to as compensation actually paid, or CAP) to our performance; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A table that compares the total compensation of our named executive officers&#x2019; (also known as NEOs) as presented in the Summary Compensation Table (SCT) to CAP and that compares CAP to specified performance measures; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Graphs that describe:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;o&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the relationships between CAP and our cumulative total shareholder return (TSR), GAAP Net Income and our selected measure, Total Cash (defined as all cash and cash equivalents); and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;o&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the relationship between our TSR and the TSR of the Nasdaq Biotechnology Index (Peer Group TSR).&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note: pursuant to Item 402(v)(8), Lite Strategy, as a smaller reporting company (SRC), has provided the information required by 402(v) for three years, instead of five years and is not required to provide the disclosure required by 402(v)(2)(iv) or 402(v)(5) with respect to the total shareholder return of any peer group, or our-Selected Measure disclosure required by 402 (v)(2)(vi), or the Tabular List provided pursuant to 402(v)(6).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Given our current pay program, the only difference between the SCT and CAP amounts for our NEOs is the value of equity awards, which for purposes of the SCT is based on the grant date fair value of equity awards granted during the year and for purposes of CAP is based on the year over year change in the fair value of equity awards that are unvested as of the end of the year, or that vested, or were forfeited during the year.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Most Important Metrics Used for Linking Pay and Performance. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As required by Item 402(v), below are the most important metrics linking CAP to performance for fiscal year 2025. Besides stock price, the only financial performance measure the Committee used to link executive compensation to performance in 2025 was Total Cash which is defined as total cash and cash equivalents on the consolidated balance sheets as of June 30, 2025.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Compensation decisions are made each year taking into account a number of other factors. Target pay levels are primarily set based on clinical milestones, individual performance, scope of responsibility, and an annual assessment of pay competitiveness within the market, but aside from Total Cash and stock price, no additional financial performance measures were used by the Company to link compensation actually paid to our NEOs in fiscal year 2025 to our performance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pay Versus Performance Table&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. In accordance with Item 402(v) and under rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the tabular disclosure for our Chief Executive Officer (our Principal Executive Officer or PEO) and the average of our NEOs other than the PEO for fiscal years 2023, 2024 and 2025.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
     &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:96.0%;border-collapse:separate;margin-right:auto;"&gt;
      &lt;tr style="visibility:collapse;"&gt;
       &lt;td style="width:2.28%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:4.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:4.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:4.58%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:5.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="5" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Value of Initial Fixed $100 Investment Based on Total Shareholder Return&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Summary Compensation Table for Total Current PEO&lt;br/&gt;(File)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid to Current PEO&lt;br/&gt;(File)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2,3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Summary Compensation Table for Total Former PEO&lt;br/&gt;(Urso)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid to Former PEO&lt;br/&gt;(Urso)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2,3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Summary Compensation Table for Total Former PEO&lt;br/&gt;(Gold)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid to Former PEO&lt;br/&gt;(Gold)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2,3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Average Summary Compensation Table Total for Non-PEO&lt;br/&gt;NEOs&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Average Compensation Actually Paid to Non-PEO&lt;br/&gt;NEOs&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2,3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Lite Strategy Total Shareholder Return&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Peer Total Shareholder&lt;br/&gt;Return&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Lite Strategy Net (Loss) Income&lt;br/&gt;($ Millions)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Company Selected Measure: Total Cash ($Millions)&lt;/span&gt;&lt;span style="color:#000000;top:-2.5795pt;white-space:pre-wrap;font-weight:bold;font-size:3.685pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="height:5pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(c)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(c)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(c)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(d)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(e)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(f)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(h)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="height:5pt;background-color:#ffffff;word-break:break-word;"&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;912,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;893,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;866,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;615,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;677,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;614,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="height:5pt;background-color:#cff0fc;word-break:break-word;"&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;730,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;558,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="height:5pt;background-color:#ffffff;word-break:break-word;"&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,101,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,721,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,446,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,857,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;642,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;109&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:5.5pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:5.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:5.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;/tr&gt;
     &lt;/table&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The PVP table reflects required disclosures for fiscal years 2023, 2024 and 2025. The following table reflects our Principal Executive Officer (PEO) and non-PEO NEOs in each of the fiscal years presented:.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:8pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:26.6%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:59.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;PEO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Non-PEO NEOs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Justin J. File&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Current) &lt;br/&gt;&lt;/span&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;David M. Urso&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Former)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Richard G. Ghalie&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;David M. Urso&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Justin J. File and Richard G. Ghalie&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;David M. Urso&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Current)&lt;br/&gt;&lt;/span&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Daniel P. Gold&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Former)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Brian G. Drazba and Richard G. Ghalie&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(2)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(3)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:9pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:71.306%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.479%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.479%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.738%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current PEO (File)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;912,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;893,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Former PEO (Urso)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,101,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;866,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,352,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,097,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;511,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;162,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,757&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;252,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,721,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;615,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Former PEO (Gold)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,446,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;584,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;193,830&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,857,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Average Non-PEO(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;730,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;677,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;177,850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;104,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;642,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;558,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;614,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(4)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilized in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the fiscal year ended June 30, 2019. As a SRC, we do not have to provide and have not provided, this stock performance graph in subsequent annual reports. The comparison assumes $100 was invested for the period starting June 30, 2022, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:9pt;font-family:Times New Roman;"&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(5)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We determined &lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total Cash&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Total Cash is defined as total cash and cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776"
      decimals="0"
      id="F_8fbb24c6-102d-4a9e-b528-566b203be8d8"
      unitRef="U_USD">912667</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776"
      decimals="0"
      id="F_efa2de60-439b-4500-a3f7-b43426cf6b06"
      unitRef="U_USD">893199</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58"
      decimals="0"
      id="F_13764353-6616-4e20-b300-13d349f6394e"
      unitRef="U_USD">866258</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58"
      decimals="0"
      id="F_2551e09c-7e1b-4d3c-b352-093299b9ca30"
      unitRef="U_USD">615372</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693"
      decimals="0"
      id="F_2ecb21e4-6ac2-422a-9a55-4cdcf4e57e4e"
      unitRef="U_USD">677662</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693"
      decimals="0"
      id="F_52f2ec8a-9fad-4692-a9bc-4d639581d3af"
      unitRef="U_USD">614958</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="0"
      id="F_78fa81dd-4c5c-4620-a95f-2a2249b74fac"
      unitRef="U_USD">26</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="0"
      id="F_845ee64f-5f2b-4fdd-8eee-b63b8bb10f1e"
      unitRef="U_USD">113</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-6"
      id="F_87658232-02b8-41ea-bc96-13b2cc0a5e6b"
      unitRef="U_USD">-16000000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      decimals="-6"
      id="F_36aae0d1-929b-4224-b556-ad9dc7c9ed93"
      unitRef="U_USD">18000000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0"
      decimals="0"
      id="F_fdef6975-eda0-46c8-8505-ee0af5821369"
      unitRef="U_USD">894905</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0"
      decimals="0"
      id="F_658de52b-01c9-4880-ae8c-b6678ce9c2a8"
      unitRef="U_USD">220789</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_309d4f0d-44ca-4aa7-b532-c4aa2672483b"
      unitRef="U_USD">730912</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_84ee108f-76cd-4fec-8939-c6b61796dc08"
      unitRef="U_USD">558052</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_813cdbb3-d3bc-4105-b0b3-3e000d154f8d"
      unitRef="U_USD">31</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_bf93602e-6eb7-4984-b605-282f2990c967"
      unitRef="U_USD">121</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-6"
      id="F_ccbcc27e-659a-45fe-84d4-738c8cd1a3f9"
      unitRef="U_USD">18000000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="-6"
      id="F_ed3c60cd-7fc1-4241-ac2b-e8a0fa844627"
      unitRef="U_USD">38000000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913"
      decimals="0"
      id="F_23906535-b6e6-4e01-8a84-c8fbea7cca6e"
      unitRef="U_USD">2101058</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913"
      decimals="0"
      id="F_72bf4207-c5bf-4e8f-a567-ed15bc3bb318"
      unitRef="U_USD">1721979</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b"
      decimals="0"
      id="F_798af036-556d-4df9-8a5f-111bb4eb220e"
      unitRef="U_USD">2446640</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b"
      decimals="0"
      id="F_504a088d-23a3-4cfa-a92d-fdff6b1ae5da"
      unitRef="U_USD">1857113</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="0"
      id="F_454c4a97-f809-4376-a469-cfd41d4ce89b"
      unitRef="U_USD">772486</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="0"
      id="F_c9dd03e5-b42f-4127-8150-5e3939c659c0"
      unitRef="U_USD">642744</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="0"
      id="F_271234ef-aff4-4503-8b84-e964f5a12c0a"
      unitRef="U_USD">54</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="0"
      id="F_b9a675ff-242e-495c-8bb3-6b18e097da38"
      unitRef="U_USD">109</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="-6"
      id="F_d3f9f477-9299-440e-b338-84956a009d81"
      unitRef="U_USD">-32000000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="-6"
      id="F_293cf8f5-cb83-4e4b-955d-36c55f90de4f"
      unitRef="U_USD">101000000</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_5140fab0-2013-4a96-9e5f-8f0b200a5969">
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:12.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:26.6%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:59.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;PEO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Non-PEO NEOs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Justin J. File&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Current) &lt;br/&gt;&lt;/span&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;David M. Urso&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Former)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Richard G. Ghalie&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;David M. Urso&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Justin J. File and Richard G. Ghalie&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;David M. Urso&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Current)&lt;br/&gt;&lt;/span&gt;&lt;span style="font-size:8pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Daniel P. Gold&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;&#160;(Former)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Brian G. Drazba and Richard G. Ghalie&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName
      contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776"
      id="F_446d7c70-4927-49c7-b355-5f93940b21aa">Justin J. File</ecd:PeoName>
    <ecd:PeoName
      contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58"
      id="F_ba6bbcda-d133-4cca-b11d-4bbfb4068ed6">David M. Urso</ecd:PeoName>
    <ecd:PeoName
      contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0"
      id="F_0717132c-b610-4b62-9746-dcfbb73dadd2">David M. Urso</ecd:PeoName>
    <ecd:PeoName
      contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913"
      id="F_aaad0df8-3246-488e-9ef7-7c5074f98794">David M. Urso</ecd:PeoName>
    <ecd:PeoName
      contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b"
      id="F_3e6f54dc-0754-40d0-8e80-f39d6be7ec73">Daniel P. Gold</ecd:PeoName>
    <ecd:Additional402vDisclosureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_883e1701-9b90-4962-894a-41c759b15c53">&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(2)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The amounts shown for CAP have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation earned, realized, or received by our NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</ecd:Additional402vDisclosureTextBlock>
    <ecd:AdjToPeoCompFnTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_e2216ef8-b3b9-4f11-b501-6db5fa7e0853">&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(3)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:71.306%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.479%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.479%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.738%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current PEO (File)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;912,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;893,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Former PEO (Urso)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,101,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;866,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,352,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,097,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;511,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;162,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,757&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;252,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,721,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;615,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Former PEO (Gold)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,446,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;584,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;193,830&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,857,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Average Non-PEO(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;730,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;677,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;177,850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;104,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;642,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;558,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;614,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_5a3bff3d-41b8-4b5f-8804-0ee20a406652">&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(3)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid (CAP) is calculated by taking Summary Compensation Table total compensation: a) less the stock award and stock option grant values; b) plus the year over year change in the fair value of stock and option awards that are unvested as of the end of the year, or that vested, or were forfeited during the year. No adjustments were made for pension arrangements, which we do not sponsor. Reconciliation of the Summary Compensation Table total compensation and CAP is summarized in the following table: &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:71.306%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.479%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.479%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:7.738%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current PEO (File)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;912,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;893,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Former PEO (Urso)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,101,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;866,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,352,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,097,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;511,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;162,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,757&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;252,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,721,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;220,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;615,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Former PEO (Gold)(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,446,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;584,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;193,830&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,857,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Average Non-PEO(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;SCT Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;730,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;677,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Stock and Option Award Values Reported in SCT for the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;177,850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Outstanding Unvested Stock and Option Awards Granted in the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;104,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Granted in Covered Year that Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Change in Fair Value of Stock and Option Awards from Prior Years that Vested in Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;Fair Value of Stock and Option Awards Forfeited during the Covered Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;642,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;558,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;614,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td colspan="9" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(i) The fair value of options awards used to calculate CAP was determined using the Black-Scholes option pricing model, in accordance with FASB 718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776"
      decimals="0"
      id="F_0b9180a8-cf71-43f2-a125-eeaf5d08701d"
      unitRef="U_USD">912667</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_7d0e8349-e426-46da-ab51-1707c24a1af7"
      decimals="0"
      id="F_1bf054b1-fb72-4007-a8c4-62a2f1ca8109"
      unitRef="U_USD">-15787</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_37467610-00f1-43d7-b2ec-970dbeaab385"
      decimals="0"
      id="F_bb311044-83e8-443c-8015-a7ff3e0d08b5"
      unitRef="U_USD">-3681</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_dd4f6857-b631-463e-8ad2-bfe9435bf776"
      decimals="0"
      id="F_57487e2e-e479-46dc-83b1-fe9556d6fc93"
      unitRef="U_USD">893199</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913"
      decimals="0"
      id="F_3156ec40-2203-4741-8e45-847123b66064"
      unitRef="U_USD">2101058</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0"
      decimals="0"
      id="F_3a6bc536-70bc-4b66-b2fe-956ee7ddfb80"
      unitRef="U_USD">894905</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58"
      decimals="0"
      id="F_5b748c40-503f-4058-b6ac-1db4f247e011"
      unitRef="U_USD">866258</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_45f6bbd9-6d25-4221-88e3-beeb4bcc1f68"
      decimals="0"
      id="F_76668768-4062-4574-b306-6a86d1d723b0"
      unitRef="U_USD">-1352600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_5da12cd1-97de-4b4d-b577-ec7e3184e27c"
      decimals="0"
      id="F_4c4d0691-69cb-41d5-97d4-af88226d19a0"
      unitRef="U_USD">1097045</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_89a3be5d-5e0b-4c67-94dd-9a9af04f8589"
      decimals="0"
      id="F_ba805486-0f52-4834-a8fa-2fc36c809c88"
      unitRef="U_USD">-70864</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_32364034-e8a2-411c-b37e-a487f90ff512"
      decimals="0"
      id="F_4b523756-5aae-4a38-81e2-712d019406d9"
      unitRef="U_USD">-511128</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_a389e895-814a-41cb-8aac-4d799cc61fe6"
      decimals="0"
      id="F_4982a5e8-1ba7-4bec-9208-c9f37f0f7c2f"
      unitRef="U_USD">-52660</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_3f481bc3-5122-47d6-b340-52e2c78f1b31"
      decimals="0"
      id="F_c98318c2-8297-4a15-9fc8-cb615bf6b450"
      unitRef="U_USD">-162988</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_28d2a101-457d-43c9-9dbe-68711aac1f9d"
      decimals="0"
      id="F_92ad1c51-034b-46ef-b406-5fb462e7b228"
      unitRef="U_USD">1757</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_f3472b73-4e34-47a0-be62-77eed918f8bc"
      decimals="0"
      id="F_ae18fdf3-ca4c-426c-ae30-e08972ef42a7"
      unitRef="U_USD">-252643</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_f84e711b-2a3a-4cc8-a088-2e9b427a6913"
      decimals="0"
      id="F_44081d8f-4de1-42e4-8bc0-892f8f2c4d44"
      unitRef="U_USD">1721979</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_3fc533f8-752c-4ec5-904f-8e635dc124f0"
      decimals="0"
      id="F_3388f73d-978d-4eed-95ff-4bb2d83c602d"
      unitRef="U_USD">220789</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_6f868094-4e34-494e-b2e9-24e875f17c58"
      decimals="0"
      id="F_4c39ad00-7876-4cb5-a9c1-ede58eb390b7"
      unitRef="U_USD">615372</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b"
      decimals="0"
      id="F_9d9b111a-46bc-4722-a27c-bf5a6f4cbacc"
      unitRef="U_USD">2446640</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_dfabb534-74be-4288-92af-5556895040ee"
      decimals="0"
      id="F_18d97c99-07e7-42ce-bc1d-971b69576101"
      unitRef="U_USD">-584700</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_d2e5d3c1-839a-4550-89aa-0ed3da951bff"
      decimals="0"
      id="F_2889bd38-612a-4ca0-b3a3-0a550ac1acb2"
      unitRef="U_USD">193830</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_3d482d2c-7007-47bd-bd9f-a3222d384265"
      decimals="0"
      id="F_cdf481db-4538-4b3f-b12d-9d99b9bce529"
      unitRef="U_USD">-130139</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_60c2b2ea-9737-4be7-9d43-b2cdb939b23d"
      decimals="0"
      id="F_21ec85eb-9743-4ac1-af5e-c47bcd250a98"
      unitRef="U_USD">-68518</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="C_21e223f0-5d79-475c-a98b-446086b5ce4b"
      decimals="0"
      id="F_78130aaf-a6e5-4fdb-ab16-9ba15994e4ed"
      unitRef="U_USD">1857113</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="0"
      id="F_b0c6b484-bc76-4af9-81d4-03cd63b6eb28"
      unitRef="U_USD">772486</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_7fde3da9-1602-488d-8ada-700c84fd7404"
      unitRef="U_USD">730912</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693"
      decimals="0"
      id="F_32f42cec-688e-4aa0-85f3-4bc23c6395bb"
      unitRef="U_USD">677662</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_85f05b2c-f599-4c78-bc7d-791065172d82"
      decimals="0"
      id="F_9e3d1c52-9159-49ef-906a-75c8e82fece7"
      unitRef="U_USD">-177850</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_eb963958-2863-459f-bc33-6b787def5d3b"
      decimals="0"
      id="F_a3481d4b-0300-44d1-88b0-954aaecdc5ef"
      unitRef="U_USD">-79900</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_9d600850-46b8-413c-9e85-0dc26debca2e"
      decimals="0"
      id="F_ceaf5d28-eca9-4a98-b17e-0ab72e69c54c"
      unitRef="U_USD">104625</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_9f90a9a5-a66d-4313-8307-9321f5ab31b2"
      decimals="0"
      id="F_49cdaca8-a33e-4861-bddf-a5cd8b87c6e4"
      unitRef="U_USD">28797</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_7bc39535-b788-4030-8e06-f7b6e0eac901"
      decimals="0"
      id="F_08cbcd76-540e-40d6-8896-bfc8954ac03f"
      unitRef="U_USD">-32041</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_d31b2e6f-0ff1-46fd-864d-d501e482dc79"
      decimals="0"
      id="F_1376c0e4-1afc-4d89-a882-767fc6a92064"
      unitRef="U_USD">-93289</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_6b9d4b1e-ad8f-4235-877b-c5777163e5ac"
      decimals="0"
      id="F_37708eb0-00a1-467d-afaa-7c0787ac293e"
      unitRef="U_USD">-24476</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_7fd455f4-c990-45c2-b727-b3da37aaffb0"
      decimals="0"
      id="F_c9e4525e-32bd-4204-8907-30138429f6ca"
      unitRef="U_USD">-28468</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_fcab84f5-286d-44a9-a098-875d5677014f"
      decimals="0"
      id="F_45e5cf73-5c7b-4b46-a0f0-8802236ef6f0"
      unitRef="U_USD">154</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="C_967fee19-8d30-4bd1-968e-c52107261bbc"
      decimals="0"
      id="F_a31ed3c4-e0f5-4e6d-a870-521b6ef16ca6"
      unitRef="U_USD">-62858</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="C_4a72990a-99c7-448b-bc43-8b9348a0a984"
      decimals="0"
      id="F_ad6a9e25-d13b-453e-b960-8f9463adb0af"
      unitRef="U_USD">642744</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="C_8dd1452a-e99e-4349-bd47-9b1ed7689611"
      decimals="0"
      id="F_58c262fb-56e8-43d3-8ef9-b2d2b560b918"
      unitRef="U_USD">558052</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="C_e8ae3059-8bf8-46fc-9780-e37bde448693"
      decimals="0"
      id="F_f0dfeb70-463e-467f-823b-59e6a8dc2d03"
      unitRef="U_USD">614958</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeerGroupIssuersFnTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_282910e8-7e11-4bfa-b030-76a1a0538953">&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(4)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilized in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the fiscal year ended June 30, 2019. As a SRC, we do not have to provide and have not provided, this stock performance graph in subsequent annual reports. The comparison assumes $100 was invested for the period starting June 30, 2022, through the end of the listed year in us and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:NonGaapMeasureDescriptionTextBlock
      contextRef="C_db6f4ce3-b159-4f84-a6ec-7529098c2c22"
      id="F_7f7847e7-2102-473e-a93d-544de41b7de0">&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(5)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We determined &lt;/span&gt;&lt;span style="font-size:9pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total Cash&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to be the most important financial performance measure used to link our performance to CAP to our PEO and Non-PEO NEOs in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Total Cash is defined as total cash and cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</ecd:NonGaapMeasureDescriptionTextBlock>
    <ecd:CoSelectedMeasureName
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_5afde0a5-9e4d-48a3-af28-4bc45e35a1fc">Total Cash</ecd:CoSelectedMeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_15250011-9efa-46ae-8547-058ca986e146">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Relationship between CAP and TSR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;img alt="img155424085_11.jpg" src="img155424085_11.jpg" style="width:609px;height:286px;"/&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_c1db31c4-165e-4229-b891-7c13fbd6b924">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Relationship between CAP and TSR&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP versus our TSR and the Peer Group TSR.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;img alt="img155424085_11.jpg" src="img155424085_11.jpg" style="width:609px;height:286px;"/&gt;&lt;/p&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_10001570-7ac4-40dc-b137-a15d426417da">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Relationship between CAP and GAAP Net Income (Loss)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The chart below reflects the relationship between the PEO and average non-PEO NEO CAP and our GAAP Net Income (Loss).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;img alt="img155424085_12.jpg" src="img155424085_12.jpg" style="width:531px;height:286px;"/&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock
      contextRef="C_496692d5-8b11-4647-b7db-ff47b1d1be07"
      id="F_26b24806-ad4f-4e7c-91a1-07f9e9e7c075">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Relationship between CAP and Total Cash (our Selected Measure).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The chart below reflects the relationship between the PEO CAP and average non-PEO NEO CAP and our Total Cash.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;img alt="img155424085_13.jpg" src="img155424085_13.jpg" style="width:525px;height:287px;"/&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_f4e683b4-eea6-4c3b-91ee-2e4e849aa6a2"
          xlink:label="F_f4e683b4-eea6-4c3b-91ee-2e4e849aa6a2"
          xlink:type="locator"/>
        <link:footnote id="FNT_c0357743-16b9-4466-828d-a177877f67f6" xlink:label="FNT_c0357743-16b9-4466-828d-a177877f67f6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes impairment charge of </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during fiscal year 2024, see below discussion on Impact of the Agreement (as discussed in </xhtml:span><xhtml:a href="#fn9_leases"><xhtml:span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 9. Leases</xhtml:span></xhtml:a><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_f4e683b4-eea6-4c3b-91ee-2e4e849aa6a2"
          xlink:to="FNT_c0357743-16b9-4466-828d-a177877f67f6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_ff070178-64d3-451b-afc0-28aaa364dc42"
          xlink:label="F_ff070178-64d3-451b-afc0-28aaa364dc42"
          xlink:type="locator"/>
        <link:footnote id="FNT_4cf4506a-9cb5-4411-a0e1-ff4c3f4d43e7" xlink:label="FNT_4cf4506a-9cb5-4411-a0e1-ff4c3f4d43e7" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal 2025, upon termination of our lease, we either sold or disposed of all property and equipment.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ff070178-64d3-451b-afc0-28aaa364dc42"
          xlink:to="FNT_4cf4506a-9cb5-4411-a0e1-ff4c3f4d43e7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_7a425758-0352-4dbc-bf50-c6ed7dd8ba32"
          xlink:label="F_7a425758-0352-4dbc-bf50-c6ed7dd8ba32"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_92c3a739-20a7-4fb8-b471-9586192be188"
          xlink:label="F_92c3a739-20a7-4fb8-b471-9586192be188"
          xlink:type="locator"/>
        <link:footnote id="FNT_457d9bd2-0d55-4b6e-a5ce-4e011cdc6cae" xlink:label="FNT_457d9bd2-0d55-4b6e-a5ce-4e011cdc6cae" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Includes one-time employee benefits of approximately </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">21,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the fiscal years ended </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2025 and 2024</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_7a425758-0352-4dbc-bf50-c6ed7dd8ba32"
          xlink:to="FNT_457d9bd2-0d55-4b6e-a5ce-4e011cdc6cae"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_92c3a739-20a7-4fb8-b471-9586192be188"
          xlink:to="FNT_457d9bd2-0d55-4b6e-a5ce-4e011cdc6cae"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_d33196ca-3de0-4094-82d0-c8df56d8e926"
          xlink:label="F_d33196ca-3de0-4094-82d0-c8df56d8e926"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_6672378b-77c3-44f1-871c-5952bed8854f"
          xlink:label="F_6672378b-77c3-44f1-871c-5952bed8854f"
          xlink:type="locator"/>
        <link:footnote id="FNT_8630c987-7a19-4c14-a093-626d0f0d4875" xlink:label="FNT_8630c987-7a19-4c14-a093-626d0f0d4875" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="margin-left:6.667%;text-indent:-2.041%;padding-left:1.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes product development costs associated with zandelisib determined to be immaterial for both periods presented, occupancy costs (including rent and utilities), share-based compensation costs, depreciation expense, administrative costs, travel and business taxes.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_d33196ca-3de0-4094-82d0-c8df56d8e926"
          xlink:to="FNT_8630c987-7a19-4c14-a093-626d0f0d4875"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_6672378b-77c3-44f1-871c-5952bed8854f"
          xlink:to="FNT_8630c987-7a19-4c14-a093-626d0f0d4875"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
